{
    "LIPITOR": {
        "Active Ingredients": {
            "ATORVASTATIN CALCIUM": "CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.[Ca+2]"
        },
        "Drug Information": {
            "Identification": {
                "Summary": "Atorvastatin is an HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke.",
                "Brand Names": "Atorvaliq, Caduet, Lipitor, Lypqozet",
                "Generic Name": "Atorvastatin",
                "DrugBank Accession Number": "DB01076",
                "Background": "Atorvastatin (Lipitor\u00ae), is a lipid-lowering drug included in the statin class of medications. By inhibiting the endogenous production of cholesterol in the liver, statins lower abnormal cholesterol and lipid levels, and ultimately reduce the risk of cardiovascular disease. More specifically, statin medications competitively inhibit the enzyme hydroxymethylglutaryl-coenzyme A (HMG-CoA) Reductase,8 which catalyzes the conversion of HMG-CoA to mevalonic acid. This conversion is a critical metabolic reaction involved in the production of several compounds involved in lipid metabolism and transport, including cholesterol, low-density lipoprotein (LDL) (sometimes referred to as \"bad cholesterol\"), and very-low-density lipoprotein (VLDL). Prescribing statins is considered standard practice for patients following any cardiovascular event, and for people who are at moderate to high risk of developing cardiovascular disease. The evidence supporting statin use, coupled with minimal side effects and long term benefits, has resulted in wide use of this medication in North America.9,10\nAtorvastatin and other statins including lovastatin, pravastatin, rosuvastatin, fluvastatin, and simvastatin are considered first-line treatment options for dyslipidemia.9,10 The increasing use of this class of drugs is largely attributed to the rise in cardiovascular diseases (CVD) (such as heart attack, atherosclerosis, angina, peripheral artery disease, and stroke) in many countries.11 An elevated cholesterol level (elevated low-density lipoprotein (LDL) levels in particular) is a significant risk factor for the development of CVD.9,12 Several landmark studies demonstrate that the use of statins is associated with both a reduction in LDL levels and CVD risk.13,14,15,16,17,18 Statins were shown to reduce the incidences of all-cause mortality, including fatal and non-fatal CVD, as well as the need for surgical revascularization or angioplasty following a heart attack.9,10 Some evidence has shown that even for low-risk individuals (with <10% risk of a major vascular event occurring within five years) statin use leads to a 20%-22% relative reduction in the number of major cardiovascular events (heart attack, stroke, coronary revascularization, and coronary death) for every 1 mmol/L reduction in LDL without any significant side effects or risks.19,20\nAtorvastatin was first synthesized in 1985 by Dr. Bruce Roth and approved by the FDA in 1996.34 It is a pentasubstituted pyrrole 3 formed by two contrasting moieties with an achiral heterocyclic core unit and a 3,5-dihydroxypentanoyl side chain identical to its parent compound.35 Unlike other members of the statin group, atorvastatin is an active compound and therefore does not require activation.4",
                "Type": "Small Molecule",
                "Groups": "Approved",
                "Structure": "3DDownload MOLSDF3D-SDFPDBSMILESInChI\n\n\n Similar StructuresStructure for Atorvastatin (DB01076)\u00d7 Close",
                "Weight": "Average: 558.6398 Monoisotopic: 558.253000445",
                "Chemical Formula": "C33H35FN2O5",
                "Synonyms": "Atorvastatinatorvastatinaatorvastatineatorvastatinum"
            },
            "Pharmacology": {
                "Indication": "Atorvastatin is indicated for the treatment of several types of dyslipidemias, including primary hyperlipidemia and mixed dyslipidemia in adults, hypertriglyceridemia, primary dysbetalipoproteinemia, homozygous familial hypercholesterolemia, and heterozygous familial hypercholesterolemia in adolescent patients with failed dietary modifications.2\nDyslipidemia describes an elevation of plasma cholesterol, triglycerides or both as well as to the presence of low levels of high-density lipoprotein. This condition represents an increased risk for the development of atherosclerosis.36 \nAtorvastatin is indicated, in combination with dietary modifications, to prevent cardiovascular events in patients with cardiac risk factors and/or abnormal lipid profiles.2\nAtorvastatin can be used as a preventive agent for myocardial infarction, stroke, revascularization, and angina, in patients without coronary heart disease but with multiple risk factors and in patients with type 2 diabetes without coronary heart disease but multiple risk factors.2\nAtorvastatin may be used as a preventive agent for non-fatal myocardial infarction, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure and angina in patients with coronary heart disease.2\nPrescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.9,10\nReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See how",
                "Associated Conditions": "Anginal Pain\nCardiovascular Complications\nCardiovascular Disease (CVD)\nCoronary Artery Disease (CAD)\nCoronary artery thrombosis\nDysbetalipoproteinemia\nFredrickson Type III lipidemia\nHeterozygous Familial Hypercholesterolemia (HeFH)\nHigh Cholesterol\nHomozygous Familial Hypercholesterolaemia (HoFH)\nHospitalizations\nHypertension, Essential Hypertension\nHypertriglyceridemias\nMixed Dyslipidemias\nMixed Hyperlipidemia\nMyocardial Infarction\nNon-familial hypercholesterolemia\nNonfatal Myocardial Infarction\nPostoperative Thromboembolism\nPrimary Hypercholesterolemia\nStroke\nThrombosis\nTransient Ischemic Attack\nElevation of serum triglyceride levels\nHeterozygous familial hyperlipidemia\nNon-familial hyperlipidemia\nPrimary Hyperlipidemia\nRevascularization procedures",
                "Contraindications & Blackbox Warnings": "Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events with our Clinical APILearn more",
                "Pharmacodynamics": "Atorvastatin is an oral antilipemic agent that reversibly inhibits HMG-CoA reductase. It lowers total cholesterol, low-density lipoprotein-cholesterol (LDL-C), apolipoprotein B (apo B), non-high density lipoprotein-cholesterol (non-HDL-C), and triglyceride (TG) plasma concentrations while increasing HDL-C concentrations. High LDL-C, low HDL-C and high TG concentrations in the plasma are associated with increased risk of atherosclerosis and cardiovascular disease. The total cholesterol to HDL-C ratio is a strong predictor of coronary artery disease, and high ratios are associated with a higher risk of disease. Increased levels of HDL-C are associated with lower cardiovascular risk. By decreasing LDL-C and TG and increasing HDL-C, atorvastatin reduces the risk of cardiovascular morbidity and mortality.21,9,10,27 \nElevated cholesterol levels (and high low-density lipoprotein (LDL) levels in particular) are an important risk factor for the development of CVD.9 Clinical studies have shown that atorvastatin reduces LDL-C and total cholesterol by 36-53%.3 In patients with dysbetalipoproteinemia, atorvastatin reduced the levels of intermediate-density lipoprotein cholesterol.2 It has also been suggested that atorvastatin can limit the extent of angiogenesis, which can be useful in the treatment of chronic subdural hematoma.1\nMyopathy/Rhabdomyolysis\nAtorvastatin, like other HMG-CoA reductase inhibitors, is associated with a risk of drug-induced myopathy characterized by muscle pain, tenderness, or weakness in conjunction with elevated levels of creatine kinase (CK). Myopathy often manifests as rhabdomyolysis with or without acute renal failure secondary to myoglobinuria. The risk of statin-induced myopathy is dose-related, and the symptoms of myopathy are typically resolved upon drug discontinuation. Results from observational studies suggest that 10-15% of people taking statins may experience muscle aches at some point during treatment.30\nLiver Dysfunction\nStatins, like some other lipid-lowering therapies, have been associated with biochemical abnormalities of liver function. Persistent elevations (> 3 times the upper limit of normal [ULN] occurring on two or more occasions) in serum transaminases occurred in 0.7% of patients who received atorvastatin in clinical trials. This effect appears to be dose-related.41,42\nEndocrine Effects\nStatins are associated with a risk of increased serum HbA1c and glucose levels. An in vitro study demonstrated a dose-dependent cytotoxic effect on human pancreatic islet \u03b2 cells following treatment with atorvastatin. Moreover, insulin secretion rates decreased relative to control.7\nHMG-CoA reductase inhibitors interfere with cholesterol synthesis and may theoretically interfere with the production of adrenal and/or gonadal steroids. Clinical studies with atorvastatin and other HMG-CoA reductase inhibitors have suggested that these agents do not affect plasma cortisol concentrations, basal plasma testosterone concentration, or adrenal reserve. However, the effect of statins on male fertility has not been fully investigated. The effects of statins on the pituitary-gonadal axis in premenopausal women are unknown.42\nCardiovascular\nSignificant decreases in circulating ubiquinone levels in patients treated with atorvastatin and other statins have been observed. The clinical significance of a potential long-term statin-induced deficiency of ubiquinone has not been established. It has been reported that a decrease in myocardial ubiquinone levels could lead to impaired cardiac function in patients with borderline congestive heart failure.42\nLipoprotein A\nIn some patients, the beneficial effect of lowered total cholesterol and LDL-C levels may be partly blunted by the concomitant increase in Lp(a) lipoprotein concentrations. Present knowledge suggests the importance of high Lp(a) levels as an emerging risk factor for coronary heart disease.42 Further studies have demonstrated statins affect Lp(a) levels differently in patients with dyslipidemia depending on their apo(a) phenotype; statins increase Lp(a) levels exclusively in patients with the low molecular weight apo(a) phenotype.28",
                "Mechanism of action": "Atorvastatin is a statin medication and a competitive inhibitor of the enzyme HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase, which catalyzes the conversion of HMG-CoA to mevalonate, an early rate-limiting step in cholesterol biosynthesis.1,8 Atorvastatin acts primarily in the liver, where decreased hepatic cholesterol concentrations stimulate the upregulation of hepatic low-density lipoprotein (LDL) receptors, which increases hepatic uptake of LDL. Atorvastatin also reduces Very-Low-Density Lipoprotein-Cholesterol (VLDL-C), serum triglycerides (TG) and Intermediate Density Lipoproteins (IDL), as well as the number of apolipoprotein B (apo B) containing particles, but increases High-Density Lipoprotein Cholesterol (HDL-C). \nIn vitro and in vivo animal studies also demonstrate that atorvastatin exerts vasculoprotective effects independent of its lipid-lowering properties, also known as the pleiotropic effects of statins.25 These effects include improvement in endothelial function, enhanced stability of atherosclerotic plaques, reduced oxidative stress and inflammation, and inhibition of the thrombogenic response. Statins were also found to bind allosterically to \u03b22 integrin function-associated antigen-1 (LFA-1), which plays an essential role in leukocyte trafficking and T cell activation.29\nTargetActionsOrganismA3-hydroxy-3-methylglutaryl-coenzyme A reductaseinhibitorHumansUDipeptidyl peptidase 4inhibitorHumansUAryl hydrocarbon receptoragonistHumansUHistone deacetylase 2inhibitorHumansUNuclear receptor subfamily 1 group I member 3ligandHumans",
                "Absorption": "Atorvastatin presents a dose-dependent and non-linear pharmacokinetic profile.4 It is very rapidly absorbed after oral administration. After the administration of a dose of 40 mg, its peak plasma concentration of 28 ng/ml is reached 1-2 hours after initial administration with an AUC of about 200 ng\u2219h/ml.6 Atorvastatin undergoes extensive first-pass metabolism in the wall of the gut and the liver, resulting in an absolute oral bioavailability of 14%.2 Plasma atorvastatin concentrations are lower (approximately 30% for Cmax and AUC) following evening drug administration compared with morning. However, LDL-C reduction is the same regardless of the time of day of drug administration.41\nAdministration of atorvastatin with food results in prolonged Tmax and a reduction in Cmax and AUC.3\nBreast Cancer Resistance Protein (BCRP) is a membrane-bound protein that plays an important role in the absorption of atorvastatin.26 Evidence from pharmacogenetic studies of c.421C>A single nucleotide polymorphisms (SNPs) in the gene for BCRP has demonstrated that individuals with the 421AA genotype have reduced functional activity and 1.72-fold higher AUC for atorvastatin compared to study individuals with the control 421CC genotype. This has important implications for the variation in response to the drug in terms of efficacy and toxicity, particularly as the BCRP c.421C>A polymorphism occurs more frequently in Asian populations than in Caucasians.31,32 Other statin drugs impacted by this polymorphism include fluvastatin, simvastatin, and rosuvastatin.31\nGenetic differences in the OATP1B1 (organic-anion-transporting polypeptide 1B1) hepatic transporter encoded by the SCLCO1B1 gene (Solute Carrier Organic Anion Transporter family member 1B1) have been shown to impact atorvastatin pharmacokinetics. Evidence from pharmacogenetic studies of the c.521T>C single nucleotide polymorphism (SNP) in the gene encoding OATP1B1 (SLCO1B1) demonstrated that atorvastatin AUC was increased 2.45-fold for individuals homozygous for 521CC compared to homozygous 521TT individuals.33 Other statin drugs impacted by this polymorphism include simvastatin, pitavastatin, rosuvastatin, and pravastatin.26",
                "Volume of distribution": "The reported volume of distribution of atorvastatin is of 380 L.41,42",
                "Protein binding": "Atorvastatin is highly bound to plasma proteins and over 98% of the administered dose is found in a bound form.41,42",
                "Metabolism": "Atorvastatin is highly metabolized to ortho- and parahydroxylated derivatives and various beta-oxidation products, primarily by Cytochrome P450 3A4 in the intestine and liver.41,42 Atorvastatin's metabolites undergo further lactonization via the formation of acyl glucuronide intermediates by the enzymes UGT1A1 and UGT1A3. These lactones can be hydrolyzed back to their corresponding acid forms and exist in equilibirum.5,26\nIn vitro inhibition of HMG-CoA reductase by ortho- and parahydroxylated metabolites is equivalent to that of atorvastatin. Approximately 70% of circulating inhibitory activity for HMG-CoA reductase is attributed to active metabolites.41,42\nHover over products below to view reaction partnersAtorvastatin\n\n\npara-hydroxyatorvastatin\n\n\npara-hydroxyatorvastatin glucuronide\n\n\npara-hydroxyatorvastatin lactone\n\n\northo-hydroxyatorvastatin\n\n\northo-hydroxyatorvastatin glucuronide\n\n\northo-hydroxyatorvastatin lactone\n\n\nAtorvastatin lactone",
                "Route of elimination": "Atorvastatin and its metabolites are mainly eliminated in the bile without enterohepatic recirculation. The renal elimination of atorvastatin is very minimal and represents less than 1% of the eliminated dose.41,42",
                "Half-life": "The half-life of atorvastatin is 14 hours while the half-life of its metabolites can reach up to 30 hours.41,42",
                "Clearance": "The registered total plasma clearance of atorvastatin is of 625 ml/min.5",
                "Adverse Effects": "Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support & research outcomes with our structured adverse effects data.See a data sample",
                "Toxicity": "The reported LD50 of oral atorvastatin in mice is higher than 5000 mg/kg.MSDS In cases of overdose with atorvastatin, there is reported symptoms of complicated breathing, jaundice, liver damage, dark urine, muscle pain, and seizures.38 In case of overdose, symptomatic treatment is recommended and due to the high plasma protein binding, hemodialysis is not expected to generate significant improvement.Label\nIn carcinogenic studies with high doses of atorvastatin, evidence of rhabdomyosarcoma, fibrosarcoma, liver adenoma, and liver carcinoma were observed.Label\nIn fertility studies with high doses of atorvastatin, there were events of aplasia, aspermia, low testis and epididymal weight, decreased sperm motility, decreased spermatid head concentration and increased abnormal sperm.Label\nAtorvastatin was shown to not be mutagenic in diverse mutagenic assays.Label",
                "Pathways": "Not Available",
                "Pharmacogenomic Effects/ADRs": "Interacting Gene/EnzymeAllele nameGenotype(s)Defining Change(s)Type(s)DescriptionDetailsKinesin-like protein KIF6---(C;C) / (C;T)C AlleleEffect Directly StudiedPatients with this genotype have a greater reduction in risk of a major cardiovascular event with high dose atorvastatin.Details3-hydroxy-3-methylglutaryl-coenzyme A reductase---(A;T)T AlleleEffect Directly StudiedPatients with this genotype have a lesser reduction in LDL cholesterol with atorvastatin.DetailsCytochrome P450 3A4CYP3A4*1B(G;G) / (A;G)A > GEffect Directly StudiedPatients with this genotype have an greater reduction in LDL cholesterol with atorvastatin.Details"
            },
            "Interactions": {
                "Drug Interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. ApprovedVet approvedNutraceuticalIllicitWithdrawnInvestigationalExperimentalAll DrugsDrugInteractionIntegrate drug-drug interactions in your software\n\n\nAbametapirThe serum concentration of Atorvastatin can be increased when it is combined with Abametapir.AbataceptThe metabolism of Atorvastatin can be increased when combined with Abatacept.AbirateroneThe metabolism of Atorvastatin can be decreased when combined with Abiraterone.AcalabrutinibThe metabolism of Atorvastatin can be decreased when combined with Acalabrutinib.AcenocoumarolThe risk or severity of bleeding can be increased when Atorvastatin is combined with Acenocoumarol.AcetaminophenThe metabolism of Atorvastatin can be decreased when combined with Acetaminophen.AcetazolamideThe metabolism of Atorvastatin can be decreased when combined with Acetazolamide.AcetylcysteineThe excretion of Atorvastatin can be decreased when combined with Acetylcysteine.AcipimoxAcipimox may increase the myopathic rhabdomyolysis activities of Atorvastatin.AdagrasibThe serum concentration of Atorvastatin can be increased when it is combined with Adagrasib.Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more",
                "Food Interactions": "Avoid grapefruit products. Grapefruit products may increase the risk for atorvastatin related adverse effects such as myopathy and rhabdomyolysis.\nTake with or without food. Food decreases absorption but not to a clinically significant extent."
            },
            "Products": {
                "": "Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access now  Access drug product information from over 10 global regions.Access now",
                "Product Ingredients": "IngredientUNIICASInChI KeyAtorvastatin calciumC0GEJ5QCSO134523-03-8FQCKMBLVYCEXJB-MNSAWQCASA-LAtorvastatin calcium trihydrate48A5M73Z4Q344423-98-9SHZPNDRIDUBNMH-NIJVSVLQSA-L",
                "Product Images": "PreviousNext",
                "International/Other Brands": "Atogal (Ingers (Czech Republic)) / Cardyl (Pfizer (Spain)) / Faboxim (Fabop (Argentina)) / Hipolixan (Pasteur (Chile)) / Lipotropic (Drugtech (Chile)) / Liprimar (Pfizer (Hungary, Ukraine), Goedecke (Russia)) / Lowden (Saval (Chile)) / Normalip (Quesada (Argentina)) / Sincol (Indeco (Argentina)) / Sortis (Pfizer (Austria, Czech Republic, Germany, Hungary, Poland, Portugal, Switzerland), Godecke (Germany), Parke, Davis (Germany)) / Torvacard (Zentiva (Czech Republic, Hungary, Poland, Russia, Ukraine)) / Torvast (Pfizer (Italy)) / Totalip (Guidotti (Italy)) / Tulip (Lek (Czech Republic, Russia), Wermar (Mexico), Sandoz (Poland, Ukraine), Pharmacia (Spain)) / Vastina (Penn (Argentina)) / Xanator (Sieger (Greece)) / Xarator (Parke, Davis (Italy)) / Zurinel (Prater (Chile))",
                "Brand Name Prescription Products": "NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImageAtorvaliqSuspension20 mg/5mLOralCmp Pharma, Inc.2023-03-01Not applicableUSAtorvastatinTablet10 mgOralActavis Pharma CompanyNot applicableNot applicableCanadaAtorvastatinTablet10 mgOralNora Pharma IncNot applicableNot applicableCanadaAtorvastatinTablet40 mgOralAngita Pharma Inc.2022-02-01Not applicableCanadaAtorvastatinTablet40 mgOralSanis Health Inc2010-05-27Not applicableCanadaAtorvastatinTablet40 mgOralPharmascience Inc2013-03-262021-04-20CanadaAtorvastatinTablet80 mgOralDr Reddy's Laboratories LtdNot applicableNot applicableCanadaAtorvastatinTablet20 mgOralApotex Corporation2013-01-07Not applicableCanadaAtorvastatinTablet40 mgOralSivem Pharmaceuticals Ulc2012-06-262018-05-09CanadaAtorvastatinTablet20 mgOralLaboratoire Riva Inc2018-05-16Not applicableCanada",
                "Generic Prescription Products": "NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImageAch-atorvastatin CalciumTablet10 mgOralAccord Healthcare Inc2019-10-18Not applicableCanadaAch-atorvastatin CalciumTablet20 mgOralAccord Healthcare Inc2019-10-18Not applicableCanadaAch-atorvastatin CalciumTablet40 mgOralAccord Healthcare Inc2019-10-18Not applicableCanadaAch-atorvastatin CalciumTablet80 mgOralAccord Healthcare Inc2019-10-18Not applicableCanadaAg-atorvastatinTablet10 mgOralAngita Pharma Inc.2018-09-27Not applicableCanadaAg-atorvastatinTablet20 mgOralAngita Pharma Inc.2018-09-25Not applicableCanadaAg-atorvastatinTablet40 mgOralAngita Pharma Inc.2018-09-25Not applicableCanadaAg-atorvastatinTablet80 mgOralAngita Pharma Inc.2018-09-25Not applicableCanadaApo-atorvastatinTablet10 mgOralApotex Corporation2010-05-19Not applicableCanadaApo-atorvastatinTablet20 mgOralApotex Corporation2010-05-19Not applicableCanada",
                "Over the Counter Products": "NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImageCoffeerazzi Minerang DutchcoffeeLiquid3 g/100mLOralAML Bio Co., Ltd.2022-08-17Not applicableUSDengue KillLiquid3 g/100mLOralAML Bio Co., Ltd.2022-08-17Not applicableUS",
                "Mixture Products": "NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImageAmlodipine and AtorvastatinAtorvastatin calcium trihydrate (80 mg/1) + Amlodipine besylate (5 mg/1)Tablet, coatedOralPrasco Laboratories2022-03-14Not applicableUSAmlodipine and atorvastatinAtorvastatin calcium trihydrate (10 mg/1) + Amlodipine besylate (5 mg/1)Tablet, film coatedOralZydus Lifesciences Limited2019-05-30Not applicableUSAmlodipine and atorvastatinAtorvastatin calcium trihydrate (10 mg/1) + Amlodipine besylate (5 mg/1)Tablet, film coatedOralMylan Pharmaceuticals Inc.2015-04-02Not applicableUSAmlodipine and AtorvastatinAtorvastatin calcium trihydrate (40 mg/1) + Amlodipine besylate (10 mg/1)Tablet, film coatedOralbryant ranch prepack2020-07-29Not applicableUSAmlodipine and atorvastatinAtorvastatin calcium trihydrate (10 mg/1) + Amlodipine besylate (2.5 mg/1)Tablet, film coatedOralZydus Pharmaceuticals (USA) Inc.2019-05-30Not applicableUSAmlodipine and atorvastatinAtorvastatin calcium trihydrate (20 mg/1) + Amlodipine besylate (10 mg/1)Tablet, film coatedOralZydus Pharmaceuticals (USA) Inc.2019-05-30Not applicableUSAmlodipine and AtorvastatinAtorvastatin calcium trihydrate (40 mg/1) + Amlodipine besylate (10 mg/1)Tablet, film coatedOralApotex Corp.2020-07-29Not applicableUSAmlodipine and AtorvastatinAtorvastatin calcium trihydrate (10 mg/1) + Amlodipine besylate (5 mg/1)Tablet, coatedOralPrasco Laboratories2022-03-14Not applicableUSAmlodipine and atorvastatinAtorvastatin calcium trihydrate (10 mg/1) + Amlodipine besylate (2.5 mg/1)Tablet, film coatedOralZydus Lifesciences Limited2019-05-30Not applicableUSAmlodipine and AtorvastatinAtorvastatin calcium trihydrate (10 mg/1) + Amlodipine besylate (5 mg/1)Tablet, film coatedOralbryant ranch prepack2020-07-29Not applicableUS",
                "Unapproved/Other Products": "NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImageCoffeerazzi Minerang DutchcoffeeAtorvastatin calcium (3 g/100mL)LiquidOralAML Bio Co., Ltd.2022-08-17Not applicableUSDengue KillAtorvastatin calcium (3 g/100mL)LiquidOralAML Bio Co., Ltd.2022-08-17Not applicableUS"
            },
            "Categories": {
                "ATC Codes": "C10BA05 \u2014 Atorvastatin and ezetimibeC10BA \u2014 Combinations of various lipid modifying agentsC10B \u2014 LIPID MODIFYING AGENTS, COMBINATIONSC10 \u2014 LIPID MODIFYING AGENTSC \u2014 CARDIOVASCULAR SYSTEMC10BX11 \u2014 Atorvastatin, amlodipine and perindoprilC10BX \u2014 Lipid modifying agents in combination with other drugsC10B \u2014 LIPID MODIFYING AGENTS, COMBINATIONSC10 \u2014 LIPID MODIFYING AGENTSC \u2014 CARDIOVASCULAR SYSTEMC10BX12 \u2014 Atorvastatin, acetylsalicylic acid and perindoprilC10BX \u2014 Lipid modifying agents in combination with other drugsC10B \u2014 LIPID MODIFYING AGENTS, COMBINATIONSC10 \u2014 LIPID MODIFYING AGENTSC \u2014 CARDIOVASCULAR SYSTEMC10BX19 \u2014 Atorvastatin, amlodipine and candesartanC10BX \u2014 Lipid modifying agents in combination with other drugsC10B \u2014 LIPID MODIFYING AGENTS, COMBINATIONSC10 \u2014 LIPID MODIFYING AGENTSC \u2014 CARDIOVASCULAR SYSTEMC10BX18 \u2014 Atorvastatin, amlodipine and ramiprilC10BX \u2014 Lipid modifying agents in combination with other drugsC10B \u2014 LIPID MODIFYING AGENTS, COMBINATIONSC10 \u2014 LIPID MODIFYING AGENTSC \u2014 CARDIOVASCULAR SYSTEMC10AA05 \u2014 AtorvastatinC10AA \u2014 HMG CoA reductase inhibitorsC10A \u2014 LIPID MODIFYING AGENTS, PLAINC10 \u2014 LIPID MODIFYING AGENTSC \u2014 CARDIOVASCULAR SYSTEMC10BX15 \u2014 Atorvastatin and perindoprilC10BX \u2014 Lipid modifying agents in combination with other drugsC10B \u2014 LIPID MODIFYING AGENTS, COMBINATIONSC10 \u2014 LIPID MODIFYING AGENTSC \u2014 CARDIOVASCULAR SYSTEMC10BX03 \u2014 Atorvastatin and amlodipineC10BX \u2014 Lipid modifying agents in combination with other drugsC10B \u2014 LIPID MODIFYING AGENTS, COMBINATIONSC10 \u2014 LIPID MODIFYING AGENTSC \u2014 CARDIOVASCULAR SYSTEMC10BX08 \u2014 Atorvastatin and acetylsalicylic acidC10BX \u2014 Lipid modifying agents in combination with other drugsC10B \u2014 LIPID MODIFYING AGENTS, COMBINATIONSC10 \u2014 LIPID MODIFYING AGENTSC \u2014 CARDIOVASCULAR SYSTEMC10BX06 \u2014 Atorvastatin, acetylsalicylic acid and ramiprilC10BX \u2014 Lipid modifying agents in combination with other drugsC10B \u2014 LIPID MODIFYING AGENTS, COMBINATIONSC10 \u2014 LIPID MODIFYING AGENTSC \u2014 CARDIOVASCULAR SYSTEM",
                "Drug Categories": "Agents Causing Muscle Toxicity\nAnticholesteremic Agents\nBSEP/ABCB11 Substrates\nCytochrome P-450 CYP2B6 Inducers\nCytochrome P-450 CYP2B6 Inducers (strength unknown)\nCytochrome P-450 CYP2C19 Inhibitors\nCytochrome P-450 CYP2C19 inhibitors (strength unknown)\nCytochrome P-450 CYP2C8 Inhibitors\nCytochrome P-450 CYP2C8 Inhibitors (strength unknown)\nCytochrome P-450 CYP2C8 Substrates\nCytochrome P-450 CYP2C9 Inhibitors\nCytochrome P-450 CYP2C9 Inhibitors (strength unknown)\nCytochrome P-450 CYP2D6 Inhibitors\nCytochrome P-450 CYP2D6 Inhibitors (strength unknown)\nCytochrome P-450 CYP3A Substrates\nCytochrome P-450 CYP3A4 Substrates\nCytochrome P-450 CYP3A5 Substrates\nCytochrome P-450 CYP3A7 Substrates\nCytochrome P-450 Enzyme Inducers\nCytochrome P-450 Enzyme Inhibitors\nCytochrome P-450 Substrates\nEnzyme Inhibitors\nFatty Acids\nHeptanoic Acids\nHydroxymethylglutaryl-CoA Reductase Inhibitors\nHypolipidemic Agents\nHypolipidemic Agents Indicated for Hyperlipidemia\nLipid Modifying Agents\nLipid Modifying Agents, Plain\nLipid Regulating Agents\nLipids\nOATP1B1/SLCO1B1 Inhibitors\nOATP1B1/SLCO1B1 Substrates\nOATP1B3 substrates\nOATP2B1/SLCO2B1 substrates\nP-glycoprotein inhibitors\nP-glycoprotein substrates\nToxic Actions\nUGT1A1 Substrates\nUGT1A3 substrates",
                "Chemical TaxonomyProvided by Classyfire": "DescriptionThis compound belongs to the class of organic compounds known as diphenylpyrroles. These are aromatic heterocyclic compounds with a structure based on a pyrrole ring linked to exactly two phenyl groups.KingdomOrganic compoundsSuper ClassOrganoheterocyclic compoundsClassPyrrolesSub ClassSubstituted pyrrolesDirect ParentDiphenylpyrrolesAlternative ParentsAromatic anilides / Medium-chain hydroxy acids and derivatives / Pyrrole carboxamides / Medium-chain fatty acids / Beta hydroxy acids and derivatives / Fluorobenzenes / Halogenated fatty acids / Hydroxy fatty acids / Heterocyclic fatty acids / Aryl fluorides / Vinylogous amides / Heteroaromatic compounds / Secondary carboxylic acid amides / Secondary alcohols / Azacyclic compounds / Carboxylic acids / Monocarboxylic acids and derivatives / Organonitrogen compounds / Carbonyl compounds / Organofluorides / Organic oxides / Organopnictogen compounds / Hydrocarbon derivatives\n\n\n show 13 moreSubstituents2,3-diphenylpyrrole / Alcohol / Aromatic anilide / Aromatic heteromonocyclic compound / Aryl fluoride / Aryl halide / Azacycle / Benzenoid / Beta-hydroxy acid / Carbonyl group / Carboxamide group / Carboxylic acid / Carboxylic acid derivative / Fatty acid / Fatty acyl / Fluorobenzene / Halobenzene / Halogenated fatty acid / Heteroaromatic compound / Heterocyclic fatty acid / Hydrocarbon derivative / Hydroxy acid / Hydroxy fatty acid / Medium-chain fatty acid / Medium-chain hydroxy acid / Monocarboxylic acid or derivatives / Monocyclic benzene moiety / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organofluoride / Organohalogen compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Pyrrole-3-carboxamide / Pyrrole-3-carboxylic acid or derivatives / Secondary alcohol / Secondary carboxylic acid amide / Vinylogous amide\n\n\n show 30 moreMolecular FrameworkAromatic heteromonocyclic compoundsExternal Descriptorsstatin (synthetic), aromatic amide, pyrroles, dihydroxy monocarboxylic acid, monofluorobenzenes (CHEBI:39548)",
                "Description": "This compound belongs to the class of organic compounds known as diphenylpyrroles. These are aromatic heterocyclic compounds with a structure based on a pyrrole ring linked to exactly two phenyl groups.",
                "Kingdom": "Organic compounds",
                "Super Class": "Organoheterocyclic compounds",
                "Class": "Pyrroles",
                "Sub Class": "Substituted pyrroles",
                "Direct Parent": "Diphenylpyrroles",
                "Alternative Parents": "Aromatic anilides / Medium-chain hydroxy acids and derivatives / Pyrrole carboxamides / Medium-chain fatty acids / Beta hydroxy acids and derivatives / Fluorobenzenes / Halogenated fatty acids / Hydroxy fatty acids / Heterocyclic fatty acids / Aryl fluorides / Vinylogous amides / Heteroaromatic compounds / Secondary carboxylic acid amides / Secondary alcohols / Azacyclic compounds / Carboxylic acids / Monocarboxylic acids and derivatives / Organonitrogen compounds / Carbonyl compounds / Organofluorides / Organic oxides / Organopnictogen compounds / Hydrocarbon derivatives\n\n\n show 13 more",
                "Substituents": "2,3-diphenylpyrrole / Alcohol / Aromatic anilide / Aromatic heteromonocyclic compound / Aryl fluoride / Aryl halide / Azacycle / Benzenoid / Beta-hydroxy acid / Carbonyl group / Carboxamide group / Carboxylic acid / Carboxylic acid derivative / Fatty acid / Fatty acyl / Fluorobenzene / Halobenzene / Halogenated fatty acid / Heteroaromatic compound / Heterocyclic fatty acid / Hydrocarbon derivative / Hydroxy acid / Hydroxy fatty acid / Medium-chain fatty acid / Medium-chain hydroxy acid / Monocarboxylic acid or derivatives / Monocyclic benzene moiety / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organofluoride / Organohalogen compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Pyrrole-3-carboxamide / Pyrrole-3-carboxylic acid or derivatives / Secondary alcohol / Secondary carboxylic acid amide / Vinylogous amide\n\n\n show 30 more",
                "Molecular Framework": "Aromatic heteromonocyclic compounds",
                "External Descriptors": "statin (synthetic), aromatic amide, pyrroles, dihydroxy monocarboxylic acid, monofluorobenzenes (CHEBI:39548)",
                "Affected organisms": "Humans and other mammals"
            },
            "Chemical Identifiers": {
                "UNII": "A0JWA85V8F",
                "CAS number": "134523-00-5",
                "InChI Key": "XUKUURHRXDUEBC-KAYWLYCHSA-N",
                "InChI": "InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1",
                "IUPAC Name": "(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid",
                "SMILES": "CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C1=CC=C(F)C=C1)C1=CC=CC=C1"
            },
            "References": {
                "Synthesis Reference": "US20020183527",
                "General References": "Qiu S, Zhuo W, Sun C, Su Z, Yan A, Shen L: Effects of atorvastatin on chronic subdural hematoma: A systematic review. Medicine (Baltimore). 2017 Jun;96(26):e7290. doi: 10.1097/MD.0000000000007290. [Article] McIver LA, Siddique MS: Atorvastatin . [Article] Ye YC, Zhao XL, Zhang SY: Use of atorvastatin in lipid disorders and cardiovascular disease in Chinese patients. Chin Med J (Engl). 2015 Jan 20;128(2):259-66. doi: 10.4103/0366-6999.149226. [Article] Ray SK, Rege NN: Atorvastatin: in the management of hyperlipidaemia. J Postgrad Med. 2000 Jul-Sep;46(3):242-3. [Article] Lennernas H: Clinical pharmacokinetics of atorvastatin. Clin Pharmacokinet. 2003;42(13):1141-60. [Article] Lins RL, Matthys KE, Verpooten GA, Peeters PC, Dratwa M, Stolear JC, Lameire NH: Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients. Nephrol Dial Transplant. 2003 May;18(5):967-76. [Article] Zhao W, Zhao SP: Different effects of statins on induction of diabetes mellitus: an experimental study. Drug Des Devel Ther. 2015 Nov 24;9:6211-23. doi: 10.2147/DDDT.S87979. eCollection 2015. [Article] Moghadasian MH: Clinical pharmacology of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Life Sci. 1999;65(13):1329-37. doi: 10.1016/s0024-3205(99)00199-x. [Article] Anderson TJ, Gregoire J, Pearson GJ, Barry AR, Couture P, Dawes M, Francis GA, Genest J Jr, Grover S, Gupta M, Hegele RA, Lau DC, Leiter LA, Lonn E, Mancini GB, McPherson R, Ngui D, Poirier P, Sievenpiper JL, Stone JA, Thanassoulis G, Ward R: 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. Can J Cardiol. 2016 Nov;32(11):1263-1282. doi: 10.1016/j.cjca.2016.07.510. Epub 2016 Jul 25. [Article] Grundy SM, Stone NJ: 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol: Primary Prevention. JAMA Cardiol. 2019 Apr 10. pii: 2730287. doi: 10.1001/jamacardio.2019.0777. [Article] Kreatsoulas C, Anand SS: The impact of social determinants on cardiovascular disease. Can J Cardiol. 2010 Aug-Sep;26 Suppl C:8C-13C. doi: 10.1016/s0828-282x(10)71075-8. [Article] Kannel WB, Castelli WP, Gordon T, McNamara PM: Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med. 1971 Jan;74(1):1-12. doi: 10.7326/0003-4819-74-1-1. [Article] Authors unspecified: Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 1998 Nov 5;339(19):1349-57. doi: 10.1056/NEJM199811053391902. [Article] Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM: Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004 Apr 8;350(15):1495-504. doi: 10.1056/NEJMoa040583. Epub 2004 Mar 8. [Article] Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9. [Article] Nicholls SJ, Ballantyne CM, Barter PJ, Chapman MJ, Erbel RM, Libby P, Raichlen JS, Uno K, Borgman M, Wolski K, Nissen SE: Effect of two intensive statin regimens on progression of coronary disease. N Engl J Med. 2011 Dec 1;365(22):2078-87. doi: 10.1056/NEJMoa1110874. Epub 2011 Nov 15. [Article] Authors unspecified: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002 Jul 6;360(9326):7-22. doi: 10.1016/S0140-6736(02)09327-3. [Article] Authors unspecified: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet. 1994 Nov 19;344(8934):1383-9. [Article] Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, Voysey M, Gray A, Collins R, Baigent C: The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012 Aug 11;380(9841):581-90. doi: 10.1016/S0140-6736(12)60367-5. Epub 2012 May 17. [Article] Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, Ward K, Ebrahim S: Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013 Jan 31;(1):CD004816. doi: 10.1002/14651858.CD004816.pub5. [Article] Henwood JM, Heel RC: Lovastatin. A preliminary review of its pharmacodynamic properties and therapeutic use in hyperlipidaemia. Drugs. 1988 Oct;36(4):429-54. doi: 10.2165/00003495-198836040-00003. [Article] Adams SP, Sekhon SS, Wright JM: Lipid-lowering efficacy of rosuvastatin. Cochrane Database Syst Rev. 2014 Nov 21;(11):CD010254. doi: 10.1002/14651858.CD010254.pub2. [Article] Pedersen TR, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Holme I, Larsen ML, Bendiksen FS, Lindahl C, Szarek M, Tsai J: High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA. 2005 Nov 16;294(19):2437-45. doi: 10.1001/jama.294.19.2437. [Article] Jones PH, Davidson MH, Stein EA, Bays HE, McKenney JM, Miller E, Cain VA, Blasetto JW: Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). Am J Cardiol. 2003 Jul 15;92(2):152-60. [Article] Liao JK, Laufs U: Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol. 2005;45:89-118. doi: 10.1146/annurev.pharmtox.45.120403.095748. [Article] Elsby R, Hilgendorf C, Fenner K: Understanding the critical disposition pathways of statins to assess drug-drug interaction risk during drug development: it's not just about OATP1B1. Clin Pharmacol Ther. 2012 Nov;92(5):584-98. doi: 10.1038/clpt.2012.163. Epub 2012 Oct 10. [Article] Bradford RH, Shear CL, Chremos AN, Dujovne CA, Franklin FA, Grillo RB, Higgins J, Langendorfer A, Nash DT, Pool JL, et al.: Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: two-year efficacy and safety follow-up. Am J Cardiol. 1994 Oct 1;74(7):667-73. doi: 10.1016/0002-9149(94)90307-7. [Article] Yahya R, Berk K, Verhoeven A, Bos S, van der Zee L, Touw J, Erhart G, Kronenberg F, Timman R, Sijbrands E, Roeters van Lennep J, Mulder M: Statin treatment increases lipoprotein(a) levels in subjects with low molecular weight apolipoprotein(a) phenotype. Atherosclerosis. 2019 Jul 3. pii: S0021-9150(19)31392-9. doi: 10.1016/j.atherosclerosis.2019.07.001. [Article] Weitz-Schmidt G, Welzenbach K, Brinkmann V, Kamata T, Kallen J, Bruns C, Cottens S, Takada Y, Hommel U: Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med. 2001 Jun;7(6):687-92. doi: 10.1038/89058. [Article] Harper CR, Jacobson TA: The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis. Curr Opin Lipidol. 2007 Aug;18(4):401-8. doi: 10.1097/MOL.0b013e32825a6773. [Article] Keskitalo JE, Zolk O, Fromm MF, Kurkinen KJ, Neuvonen PJ, Niemi M: ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin. Clin Pharmacol Ther. 2009 Aug;86(2):197-203. doi: 10.1038/clpt.2009.79. Epub 2009 May 27. [Article] Lee E, Ryan S, Birmingham B, Zalikowski J, March R, Ambrose H, Moore R, Lee C, Chen Y, Schneck D: Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment. Clin Pharmacol Ther. 2005 Oct;78(4):330-41. doi: 10.1016/j.clpt.2005.06.013. [Article] Pasanen MK, Fredrikson H, Neuvonen PJ, Niemi M: Different effects of SLCO1B1 polymorphism on the pharmacokinetics of atorvastatin and rosuvastatin. Clin Pharmacol Ther. 2007 Dec;82(6):726-33. doi: 10.1038/sj.clpt.6100220. Epub 2007 May 2. [Article] Corey E., Czako B. and Kurti L. (2007). Molecules and medicine. John Wiley & Sons, Inc. [ISBN:978-0-470-26096-8] Kumar R. and Bandichhor R. (2018). Hazardous reagent substitution. A pharmaceutical perspective. The Royal Society of Chemistry. [ISBN:978-1-78262-050-1] Merck Manuals [Link] Chemocare [Link] Laguna Treatment [Link] FDA Approved Drug Products: Lipitor (atorvastatin calcium) oral tablets [Link] INVIMA Product Authorization: Lipomega (atorvastatin calcium/omega-3 ethyl esters) oral capsule [Link] FDA Label - Atorvastatin [File] Health Canada Monograph - Atorvastatin [File]",
                "External Links": "Human Metabolome DatabaseHMDB0005006KEGG DrugD07474KEGG CompoundC06834PubChem Compound60823PubChem Substance46506188ChemSpider54810BindingDB22164RxNav1483793ChEBI39548ChEMBLCHEMBL1487ZINCZINC000003920719Therapeutic Targets DatabaseDAP000553PharmGKBPA448500PDBe Ligand117RxListRxList Drug PageDrugs.comDrugs.com Drug PagePDRhealthPDRhealth Drug PageWikipediaAtorvastatin",
                "Human Metabolome Database": "HMDB0005006",
                "KEGG Drug": "D07474",
                "KEGG Compound": "C06834",
                "PubChem Compound": "60823",
                "PubChem Substance": "46506188",
                "ChemSpider": "54810",
                "BindingDB": "22164",
                "RxNav": "1483793",
                "ChEBI": "39548",
                "ChEMBL": "CHEMBL1487",
                "ZINC": "ZINC000003920719",
                "Therapeutic Targets Database": "DAP000553",
                "PharmGKB": "PA448500",
                "PDBe Ligand": "117",
                "RxList": "RxList Drug Page",
                "Drugs.com": "Drugs.com Drug Page",
                "PDRhealth": "PDRhealth Drug Page",
                "Wikipedia": "Atorvastatin",
                "PDB Entries": "1hwk",
                "FDA label": "Download (387 KB)",
                "MSDS": "Download (56.5 KB)"
            },
            "Clinical Trials": {
                "Clinical Trials": "PhaseStatusPurposeConditionsCount4Active Not RecruitingPreventionAging / Cognitive Deficits / Dementia of the Alzheimer's Type / Dementia, Mixed / Neurodegenerative Disorders / Vascular Dementia (VaD) / White Matter Hyperintensity14Active Not RecruitingPreventionDisability Free Survival / Elderly / Healthy Subjects (HS) / Independent Living14Active Not RecruitingPreventionMitochondrial Disorders14CompletedNot AvailableCardiovascular Disease (CVD) / Cholesterol, LDL / Cognitive Functioning / Type 2 Diabetes Mellitus14CompletedNot AvailableChronic Stable Angina Pectoris / Coronary Heart Disease (CHD)14CompletedNot AvailableCoronary Heart Disease (CHD)14CompletedNot AvailableHealthy Subjects (HS)34CompletedNot AvailableHigh Cholesterol14CompletedBasic ScienceAtherosclerosis / Coronary Artery Disease (CAD) / Endothelial Dysfunction / HMG-CoA Reductase Inhibitor Toxicity / Stress Oxidative14CompletedBasic ScienceDrug intolerance1"
            },
            "Pharmacoeconomics": {
                "Manufacturers": "Not Available",
                "Packagers": "Advanced Pharmaceutical Services Inc.\nApotheca Inc.\nA-S Medication Solutions LLC\nAtlantic Biologicals Corporation\nBryant Ranch Prepack\nCardinal Health\nDirect Pharmaceuticals Inc.\nDispensing Solutions\nDiversified Healthcare Services Inc.\nGoedecke GmbH\nHealthcare Pharmacy\nHeartland Repack Services LLC\nKaiser Foundation Hospital\nLake Erie Medical and Surgical Supply\nMurfreesboro Pharmaceutical Nursing Supply\nNucare Pharmaceuticals Inc.\nOrifice Medical AB\nPCA LLC\nPD-Rx Pharmaceuticals Inc.\nPfizer Inc.\nPharmaceutical Utilization Management Program VA Inc.\nPhysicians Total Care Inc.\nPrepackage Specialists\nPrepak Systems Inc.\nResource Optimization and Innovation LLC\nSandhills Packaging Inc.\nSouthwood Pharmaceuticals\nTya Pharmaceuticals\nUS Pharmaceutical Group\nVangard Labs Inc.\nVitrum Ab\nWarner Lambert Company LLC",
                "Dosage Forms": "FormRouteStrengthTabletOral80 mgTablet, coatedOralCapsuleTablet, film coatedOral30 MGTablet, film coatedOral60 MGTablet, coatedOral21.65 mgTablet, film coatedOral10.825 mgSuspensionOral20 mg/5mLPowderNot applicable1 kg/1kgTabletOral10 mg/1TabletOral20 mg/1TabletOral40 mg/1TabletOral80 mg/1Tablet, coatedOral10 mg/1Tablet, coatedOral20 mg/1Tablet, coatedOral40 mg/1Tablet, coatedOral80 mg/1Tablet, film coatedOral10 mg/301Tablet, film coatedOral10.36 MGTablet, film coatedOral80 mg/301PowderNot applicable20 kg/20kgTablet, film coatedOral21.7 MGTablet, film coatedOral43.38 MGTabletOral10 mgTablet, coatedOral10 mgTabletOral20 mgTablet, coatedOral20 mgTablet, coatedOral20.7 mgTablet, film coatedOral20 mgTabletOral40 mgTablet, film coatedOral10 mgTablet, film coatedOral80 mgCapsule, liquid filledOral10 mgCapsule, liquid filledOral80 mgCapsule, liquid filledOral43.376 mgCapsule, liquid filledOral20 mgTabletOral10.000 mgTablet, film coatedOral40.00 mgTabletOral40.000 mgTablet, film coatedOralTablet, film coatedOral10 MGLiquidOral3 g/100mLTabletOral20.0 mgTabletOral21.640 mgTabletOral10.000 mgTablet, film coatedOral40 mgCapsuleOralTabletOralTablet, film coatedOralTabletOral10.00 mgTabletOral20.000 mgTablet, film coatedOral10.85 MgTablet, film coatedOral21.69 MgTabletOralTabletOral80.000 mgTablet, film coatedOral10 mg/1Tablet, film coatedOral20 mg/1Tablet, film coatedOral40 mg/1Tablet, film coatedOral80 mg/1Capsule, liquid filledOralTablet, coatedOral40 mgTablet, coatedOral80 mgTabletOral21.649 mgTabletOral10.825 mgTablet, chewableOralTabletOral21.648 mgTablet, chewableOral10 MGTablet, chewableOral20 MGTablet, chewableOral40 MGTablet, chewableOral5 MGTablet, film coatedOral10.000 mgTablet, film coatedOral20.000 mgTablet, film coatedOral40.000 mgTablet, film coatedOral80.000 mg",
                "Prices": "Unit descriptionCostUnitLipitor 20 mg tablet5.0USD tabletLipitor 40 mg tablet5.0USD tabletLipitor 80 mg tablet5.0USD tabletLipitor 10 mg tablet3.5USD tabletLipitor 40 mg Tablet2.52USD tabletLipitor 80 mg Tablet2.52USD tabletLipitor 20 mg Tablet2.34USD tabletLipitor 10 mg Tablet1.87USD tablet  DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.",
                "Patents": "Patent NumberPediatric ExtensionApprovedExpires (estimated)RegionUS4681893No1987-07-212009-09-24USCA2521776No2006-04-252022-05-21CanadaCA2220018No2001-04-172016-07-08CanadaUS5969156Yes1999-10-192017-01-08USUSRE42461Yes2011-06-142017-04-25USUS6455574No2002-09-242018-08-11USUS11369567No2017-06-072037-06-07USUS11654106No2017-06-072037-06-07US"
            },
            "Properties": {
                "State": "Solid",
                "Experimental Properties": "PropertyValueSourcemelting point (\u00b0C)176 \u00b0C'MSDS'boiling point (\u00b0C)722 \u00baC at 760 mmHg'MSDS'water solubilityPractically insoluble'MSDS'logP6.36'MSDS'pKa4.46'MSDS'",
                "Predicted Properties": "PropertyValueSourceWater Solubility0.00063 mg/mLALOGPSlogP4.24ALOGPSlogP5.39ChemaxonlogS-6ALOGPSpKa (Strongest Acidic)4.31ChemaxonpKa (Strongest Basic)-2.7ChemaxonPhysiological Charge-1ChemaxonHydrogen Acceptor Count5ChemaxonHydrogen Donor Count4ChemaxonPolar Surface Area111.79 \u00c52ChemaxonRotatable Bond Count12ChemaxonRefractivity158.2 m3\u00b7mol-1ChemaxonPolarizability59.45 \u00c53ChemaxonNumber of Rings4ChemaxonBioavailability0ChemaxonRule of FiveNoChemaxonGhose FilterNoChemaxonVeber's RuleNoChemaxonMDDR-like RuleYesChemaxon",
                "Predicted ADMET Features": "PropertyValueProbabilityHuman Intestinal Absorption+0.8947Blood Brain Barrier-0.7825Caco-2 permeable-0.8956P-glycoprotein substrateSubstrate0.5246P-glycoprotein inhibitor IInhibitor0.7164P-glycoprotein inhibitor IIInhibitor0.8724Renal organic cation transporterNon-inhibitor0.8131CYP450 2C9 substrateNon-substrate0.7887CYP450 2D6 substrateNon-substrate0.9116CYP450 3A4 substrateSubstrate0.6841CYP450 1A2 substrateNon-inhibitor0.8551CYP450 2C9 inhibitorNon-inhibitor0.719CYP450 2D6 inhibitorNon-inhibitor0.9042CYP450 2C19 inhibitorNon-inhibitor0.6191CYP450 3A4 inhibitorNon-inhibitor0.6675CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.6894Ames testNon AMES toxic0.9133CarcinogenicityNon-carcinogens0.7777BiodegradationNot ready biodegradable0.9974Rat acute toxicity2.5686 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9904hERG inhibition (predictor II)Non-inhibitor0.5101  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)"
            },
            "Spectra": {
                "Mass Spec (NIST)": "Not Available",
                "Spectra": "SpectrumSpectrum TypeSplash KeyPredicted GC-MS Spectrum - GC-MSPredicted GC-MSNot AvailablePredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableLC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-0a4i-0000090000-ae5c999b091a2bc93933LC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-0a4i-0000190000-dd563e18b1f0f74aadd5LC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-0zfs-0007960000-cb66a18d2f0a687261baLC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-002b-0059000000-0942bc1e35434cd7d0d3LC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-004i-0093000000-f42ba46820a3cf3295c5LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-0udj-0005910000-b09ba5f3b86948c7f3cbLC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-0a4i-0000090000-6f297ca79ae1761aac33LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-0002-1009300000-9479520f395dcdd585e7LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-004i-0092000000-9b561b8d35c3bdc5e46aLC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-004i-0090000000-3aad87273e7f9942a50fLC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-01t9-1090000000-3f0efff41ebdb5320ce4LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-03di-2090000000-0227638704b90c4249d0LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-0a4i-0000090000-65c729c6734f6533c431LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-0002-1009300000-9122e4479d8c0c32bb0dLC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-004i-0092000000-22d639a8882509e1bcdbLC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-004i-0090000000-30a0198165bae85fa258LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-01t9-1090000000-cb3feea45f5280f05c37LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-03di-2090000000-8db2f70b373277f143c0LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-0udj-0005910000-a63c845ca248d958068dLC-MS/MS Spectrum - LC-ESI-QFT , negativeLC-MS/MSsplash10-0a6s-1085190000-9e43612012842effca5aLC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0006-0031900000-4081fba1ae61b0d871cfLC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-052f-0000980000-6751fefdee0a257e52f8LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0006-0000900000-4009a70e947dcceb6e0fLC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0006-0085900000-e1a4447e4c9a4bda83b2LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0udi-0092100000-4a5517154ad5f7375ea2LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0a4i-0000090000-e741fcb91eb29d1032cbLC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-00kf-0000900000-fdd41dae94afd3f4d3c5LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0a4i-0000490000-25199beeece682c7de9eLC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0006-0020900000-71cacdfc979c4386762bLC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0udi-0092000000-38374b1412250df34777LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0udi-0090000000-87710909ebad67c88f3bLC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0udj-0190000000-60e7ef3dc3f76db11c5fLC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0f72-0290000000-e8c2cda8588874b2aaa5LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0a4i-0000490000-a5ee6b466e73e9e72383LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0006-0011900000-b8fc562d4be5ffb07f59LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0udi-0092000000-df78998b01951a3dd03aLC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0udi-0090000000-19c391db652668c97d59LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0udj-0190000000-931a1911dcd7ec9dbbc8LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0f72-0290000000-6157ef91cb98aeef5cf7LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-00kf-0000900000-cd6fb2c00146543cbb47LC-MS/MS Spectrum - LC-ESI-QFT , positiveLC-MS/MSsplash10-0f6x-0092420000-fb2c084ecdd5af8f6f7b"
            },
            "Interested in using DrugBank in a commercial product or application?": {},
            "Stay up-to-date with the latest from DrugBank!": {},
            "Thank you for subscribing!": {}
        },
        "Additional Information": {
            "targets": [
                {
                    "Label": "3-hydroxy-3-methylglutaryl-coenzyme A reductase",
                    "Detailed Info": {
                        "Name": "3-hydroxy-3-methylglutaryl-coenzyme A reductase",
                        "Synonyms": "1.1.1.34\nHMG-CoA reductase",
                        "Gene Name": "HMGCR",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0001146|3-hydroxy-3-methylglutaryl-coenzyme A reductase\nMLSRLFRMHGLFVASHPWEVIVGTVTLTICMMSMNMFTGNNKICGWNYECPKFEEDVLSS\nDIIILTITRCIAILYIYFQFQNLRQLGSKYILGIAGLFTIFSSFVFSTVVIHFLDKELTG\nLNEALPFFLLLIDLSRASTLAKFALSSNSQDEVRENIARGMAILGPTFTLDALVECLVIG\nVGTMSGVRQLEIMCCFGCMSVLANYFVFMTFFPACVSLVLELSRESREGRPIWQLSHFAR\nVLEEEENKPNPVTQRVKMIMSLGLVLVHAHSRWIADPSPQNSTADTSKVSLGLDENVSKR\nIEPSVSLWQFYLSKMISMDIEQVITLSLALLLAVKYIFFEQTETESTLSLKNPITSPVVT\nQKKVPDNCCRREPMLVRNNQKCDSVEEETGINRERKVEVIKPLVAETDTPNRATFVVGNS\nSLLDTSSVLVTQEPEIELPREPRPNEECLQILGNAEKGAKFLSDAEIIQLVNAKHIPAYK\nLETLMETHERGVSIRRQLLSKKLSEPSSLQYLPYRDYNYSLVMGACCENVIGYMPIPVGV\nAGPLCLDEKEFQVPMATTEGCLVASTNRGCRAIGLGGGASSRVLADGMTRGPVVRLPRAC\nDSAEVKAWLETSEGFAVIKEAFDSTSRFARLQKLHTSIAGRNLYIRFQSRSGDAMGMNMI\nSKGTEKALSKLHEYFPEMQILAVSGNYCTDKKPAAINWIEGRGKSVVCEAVIPAKVVREV\nLKTTTEAMIEVNINKNLVGSAMAGSIGGYNAHAANIVTAIYIACGQDAAQNVGSSNCITL\nMEASGPTNEDLYISCTMPSIEIGTVGGGTNLLPQQACLQMLGVQGACKDNPGENARQLAR\nIVCGTVMAGELSLMAALAAGHLVKSHMIHNRSKINLQDLQGACTKKTA",
                        "Number of residues": "888",
                        "Molecular Weight": "97475.155",
                        "Theoretical pI": "6.72",
                        "GO Classification": "Functionscoenzyme binding / hydroxymethylglutaryl-CoA reductase (NADPH) activity / hydroxymethylglutaryl-CoA reductase activity / NADPH bindingProcessesaging / cellular lipid metabolic process / cholesterol biosynthetic process / coenzyme A metabolic process / isoprenoid biosynthetic process / myoblast differentiation / negative regulation of insulin secretion involved in cellular response to glucose stimulus / negative regulation of MAP kinase activity / negative regulation of striated muscle cell apoptotic process / negative regulation of vasodilation / negative regulation of wound healing / positive regulation of cardiac muscle cell apoptotic process / positive regulation of ERK1 and ERK2 cascade / positive regulation of skeletal muscle tissue development / positive regulation of smooth muscle cell proliferation / positive regulation of stress-activated MAPK cascade / protein tetramerization / response to ethanol / response to nutrient / small molecule metabolic process / sterol biosynthetic process / ubiquinone metabolic process / visual learningComponentsendoplasmic reticulum / endoplasmic reticulum membrane / integral component of membrane / peroxisomal membrane",
                        "General Function": "Nadph binding",
                        "Specific Function": "Transmembrane glycoprotein that is the rate-limiting enzyme in cholesterol biosynthesis as well as in the biosynthesis of nonsterol isoprenoids that are essential for normal cell function including ubiquinone and geranylgeranyl proteins.",
                        "Pfam Domain Function": "HMG-CoA_red (PF00368)\nSterol-sensing (PF12349)",
                        "Transmembrane Regions": "10-39\n57-78\n90-114\n124-149\n160-187\n192-220\n315-339",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0010398|3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR)\nATGTTGTCAAGACTTTTTCGAATGCATGGCCTCTTTGTGGCCTCCCATCCCTGGGAAGTC\nATAGTGGGGACAGTGACACTGACCATCTGCATGATGTCCATGAACATGTTTACTGGTAAC\nAATAAGATCTGTGGTTGGAATTATGAATGTCCAAAGTTTGAAGAGGATGTTTTGAGCAGT\nGACATTATAATTCTGACAATAACACGATGCATAGCCATCCTGTATATTTACTTCCAGTTC\nCAGAATTTACGTCAACTTGGATCAAAATATATTTTGGGTATTGCTGGCCTTTTCACAATT\nTTCTCAAGTTTTGTATTCAGTACAGTTGTCATTCACTTCTTAGACAAAGAATTGACAGGC\nTTGAATGAAGCTTTGCCCTTTTTCCTACTTTTGATTGACCTTTCCAGAGCAAGCACATTA\nGCAAAGTTTGCCCTCAGTTCCAACTCACAGGATGAAGTAAGGGAAAATATTGCTCGTGGA\nATGGCAATTTTAGGTCCTACGTTTACCCTCGATGCTCTTGTTGAATGTCTTGTGATTGGA\nGTTGGTACCATGTCAGGGGTACGTCAGCTTGAAATTATGTGCTGCTTTGGCTGCATGTCA\nGTTCTTGCCAACTACTTCGTGTTCATGACTTTCTTCCCAGCTTGTGTGTCCTTGGTATTA\nGAGCTTTCTCGGGAAAGCCGCGAGGGTCGTCCAATTTGGCAGCTCAGCCATTTTGCCCGA\nGTTTTAGAAGAAGAAGAAAATAAGCCGAATCCTGTAACTCAGAGGGTCAAGATGATTATG\nTCTCTAGGCTTGGTTCTTGTTCATGCTCACAGTCGCTGGATAGCTGATCCTTCTCCTCAA\nAACAGTACAGCAGATACTTCTAAGGTTTCATTAGGACTGGATGAAAATGTGTCCAAGAGA\nATTGAACCAAGTGTTTCCCTCTGGCAGTTTTATCTCTCTAAAATGATCAGCATGGATATT\nGAACAAGTTATTACCCTAAGTTTAGCTCTCCTTCTGGCTGTCAAGTACATCTTCTTTGAA\nCAAACAGAGACAGAATCTACACTCTCATTAAAAAACCCTATCACATCTCCTGTAGTGACA\nCAAAAGAAAGTCCCAGACAATTGTTGTAGACGTGAACCTATGCTGGTCAGAAATAACCAG\nAAATGTGATTCAGTAGAGGAAGAGACAGGGATAAACCGAGAAAGAAAAGTTGAGGTTATA\nAAACCCTTAGTGGCTGAAACAGATACCCCAAACAGAGCTACATTTGTGGTTGGTAACTCC\nTCCTTACTCGATACTTCATCAGTACTGGTGACACAGGAACCTGAAATTGAACTTCCCAGG\nGAACCTCGGCCTAATGAAGAATGTCTACAGATACTTGGGAATGCAGAGAAAGGTGCAAAA\nTTCCTTAGTGATGCTGAGATCATCCAGTTAGTCAATGCTAAGCATATCCCAGCCTACAAG\nTTGGAAACTCTGATGGAAACTCATGAGCGTGGTGTATCTATTCGCCGACAGTTACTTTCC\nAAGAAGCTTTCAGAACCTTCTTCTCTCCAGTACCTACCTTACAGGGATTATAATTACTCC\nTTGGTGATGGGAGCTTGTTGTGAGAATGTTATTGGATATATGCCCATCCCTGTTGGAGTG\nGCAGGACCCCTTTGCTTAGATGAAAAAGAATTTCAGGTTCCAATGGCAACAACAGAAGGT\nTGTCTTGTGGCCAGCACCAATAGAGGCTGCAGAGCAATAGGTCTTGGTGGAGGTGCCAGC\nAGCCGAGTCCTTGCAGATGGGATGACTCGTGGCCCAGTTGTGCGTCTTCCACGTGCTTGT\nGACTCTGCAGAAGTGAAAGCCTGGCTCGAAACATCTGAAGGGTTCGCAGTGATAAAGGAG\nGCATTTGACAGCACTAGCAGATTTGCACGTCTACAGAAACTTCATACAAGTATAGCTGGA\nCGCAACCTTTATATCCGTTTCCAGTCCAGGTCAGGGGATGCCATGGGGATGAACATGATT\nTCAAAGGGTACAGAGAAAGCACTTTCAAAACTTCACGAGTATTTCCCTGAAATGCAGATT\nCTAGCCGTTAGTGGTAACTATTGTACTGACAAGAAACCTGCTGCTATAAATTGGATAGAG\nGGAAGAGGAAAATCTGTTGTTTGTGAAGCTGTCATTCCAGCCAAGGTTGTCAGAGAAGTA\nTTAAAGACTACCACAGAGGCTATGATTGAGGTCAACATTAACAAGAATTTAGTGGGCTCT\nGCCATGGCTGGGAGCATAGGAGGCTACAACGCCCATGCAGCAAACATTGTCACCGCCATC\nTACATTGCCTGTGGACAGGATGCAGCACAGAATGTTGGTAGTTCAAACTGTATTACTTTA\nATGGAAGCAAGTGGTCCCACAAATGAAGATTTATATATCAGCTGCACCATGCCATCTATA\nGAGATAGGAACGGTGGGTGGTGGGACCAACCTACTACCTCAGCAAGCCTGTTTGCAGATG\nCTAGGTGTTCAAGGAGCATGCAAAGATAATCCTGGGGAAAATGCCCGGCAGCTTGCCCGA\nATTGTGTGTGGGACCGTAATGGCTGGGGAATTGTCACTTATGGCAGCATTGGCAGCAGGA\nCATCTTGTCAAAAGTCACATGATTCACAACAGGTCGAAGATCAATTTACAAGACCTCCAA\nGGAGCTTGCACCAAGAAGACAGCCTGA",
                        "Chromosome Location": "5",
                        "Locus": "5q13.3-q14",
                        "External Identifiers": "ResourceLinkUniProtKB IDP04035UniProtKB Entry NameHMDH_HUMANGenBank Protein ID306865GenBank Gene IDM11058GenAtlas IDHMGCRHGNC IDHGNC:5006",
                        "General References": "Luskey KL, Stevens B: Human 3-hydroxy-3-methylglutaryl coenzyme A reductase. Conserved domains responsible for catalytic activity and sterol-regulated degradation. J Biol Chem. 1985 Aug 25;260(18):10271-7. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Schmutz J, Martin J, Terry A, Couronne O, Grimwood J, Lowry S, Gordon LA, Scott D, Xie G, Huang W, Hellsten U, Tran-Gyamfi M, She X, Prabhakar S, Aerts A, Altherr M, Bajorek E, Black S, Branscomb E, Caoile C, Challacombe JF, Chan YM, Denys M, Detter JC, Escobar J, Flowers D, Fotopulos D, Glavina T, Gomez M, Gonzales E, Goodstein D, Grigoriev I, Groza M, Hammon N, Hawkins T, Haydu L, Israni S, Jett J, Kadner K, Kimball H, Kobayashi A, Lopez F, Lou Y, Martinez D, Medina C, Morgan J, Nandkeshwar R, Noonan JP, Pitluck S, Pollard M, Predki P, Priest J, Ramirez L, Retterer J, Rodriguez A, Rogers S, Salamov A, Salazar A, Thayer N, Tice H, Tsai M, Ustaszewska A, Vo N, Wheeler J, Wu K, Yang J, Dickson M, Cheng JF, Eichler EE, Olsen A, Pennacchio LA, Rokhsar DS, Richardson P, Lucas SM, Myers RM, Rubin EM: The DNA sequence and comparative analysis of human chromosome 5. Nature. 2004 Sep 16;431(7006):268-74. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Brown MS, Goldstein JL: Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J Lipid Res. 1980 Jul;21(5):505-17. [Article] Sever N, Yang T, Brown MS, Goldstein JL, DeBose-Boyd RA: Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain. Mol Cell. 2003 Jan;11(1):25-33. [Article] Leichner GS, Avner R, Harats D, Roitelman J: Dislocation of HMG-CoA reductase and Insig-1, two polytopic endoplasmic reticulum proteins, en route to proteasomal degradation. Mol Biol Cell. 2009 Jul;20(14):3330-41. doi: 10.1091/mbc.E08-09-0953. Epub 2009 May 20. [Article] Leichner GS, Avner R, Harats D, Roitelman J: Metabolically regulated endoplasmic reticulum-associated degradation of 3-hydroxy-3-methylglutaryl-CoA reductase: evidence for requirement of a geranylgeranylated protein. J Biol Chem. 2011 Sep 16;286(37):32150-61. doi: 10.1074/jbc.M111.278036. Epub 2011 Jul 21. [Article] Stormo C, Kringen MK, Grimholt RM, Berg JP, Piehler AP: A novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) splice variant with an alternative exon 1 potentially encoding an extended N-terminus. BMC Mol Biol. 2012 Sep 18;13:29. doi: 10.1186/1471-2199-13-29. [Article] Nickerson ML, Bosley AD, Weiss JS, Kostiha BN, Hirota Y, Brandt W, Esposito D, Kinoshita S, Wessjohann L, Morham SG, Andresson T, Kruth HS, Okano T, Dean M: The UBIAD1 prenyltransferase links menaquinone-4 [corrected] synthesis to cholesterol metabolic enzymes. Hum Mutat. 2013 Feb;34(2):317-29. doi: 10.1002/humu.22230. Epub 2012 Nov 27. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Istvan ES, Palnitkar M, Buchanan SK, Deisenhofer J: Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis. EMBO J. 2000 Mar 1;19(5):819-30. [Article] Istvan ES, Deisenhofer J: Structural mechanism for statin inhibition of HMG-CoA reductase. Science. 2001 May 11;292(5519):1160-4. [Article] Sarver RW, Bills E, Bolton G, Bratton LD, Caspers NL, Dunbar JB, Harris MS, Hutchings RH, Kennedy RM, Larsen SD, Pavlovsky A, Pfefferkorn JA, Bainbridge G: Thermodynamic and structure guided design of statin based inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Med Chem. 2008 Jul 10;51(13):3804-13. doi: 10.1021/jm7015057. Epub 2008 Jun 10. [Article] Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington J, Lipshutz R, Daley GQ, Lander ES: Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet. 1999 Jul;22(3):231-8. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00227Lovastatinapproved, investigationalyesinhibitorDetailsDB00439Cerivastatinapproved, withdrawnyesinhibitorDetailsDB00641SimvastatinapprovedyesinhibitorDetailsDB01076AtorvastatinapprovedyesinhibitorDetailsDB01098RosuvastatinapprovedyesinhibitorDetailsDB00157NADHapproved, nutraceuticalunknownDetailsDB01992Coenzyme Ainvestigational, nutraceuticalunknownDetailsDB03169(S)-Hmg-CoaexperimentalunknownDetailsDB03461Nicotinamide adenine dinucleotide phosphateexperimentalunknownDetailsDB04377MeglutolexperimentalunknownDetailsDB044471,4-DithiothreitolexperimentalunknownDetailsDB01095FluvastatinapprovedyesinhibitorDetailsDB00175PravastatinapprovedyesinhibitorDetailsDB05317TAK-475investigationalunknownDetailsDB06693MevastatinexperimentalyesinhibitorDetailsDB08860PitavastatinapprovedyesinhibitorDetailsDB09270Ubidecarenoneapproved, investigational, nutraceuticalnosubstrateDetailsDB09061Cannabidiolapproved, investigationalunknownstimulatorDetailsDB14011NabiximolsinvestigationalunknownstimulatorDetailsDB14009Medical Cannabisexperimental, investigationalunknowninducerDetails"
                    }
                },
                {
                    "Label": "Dipeptidyl peptidase 4",
                    "Detailed Info": {
                        "Name": "Dipeptidyl peptidase 4",
                        "Synonyms": "3.4.14.5\nADABP\nADCP-2\nADCP2\nAdenosine deaminase complexing protein 2\nCD26\nDipeptidyl peptidase IV\nDPP IV\nT-cell activation antigen CD26\nTP103",
                        "Gene Name": "DPP4",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0010603|Dipeptidyl peptidase 4\nMKTPWKVLLGLLGAAALVTIITVPVVLLNKGTDDATADSRKTYTLTDYLKNTYRLKLYSL\nRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNY\nVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNL\nPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSF\nYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYL\nCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPS\nEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISN\nEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLY\nTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKY\nPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGT\nFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWE\nYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQIS\nKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP",
                        "Number of residues": "766",
                        "Molecular Weight": "88277.935",
                        "Theoretical pI": "5.92",
                        "GO Classification": "Functionsdipeptidyl-peptidase activity / identical protein binding / protease binding / protein homodimerization activity / receptor binding / serine-type endopeptidase activity / serine-type peptidase activity / virus receptor activityProcessesbehavioral fear response / endothelial cell migration / locomotory exploration behavior / negative regulation of extracellular matrix disassembly / positive regulation of cell proliferation / psychomotor behavior / regulation of cell-cell adhesion mediated by integrin / response to hypoxia / T cell activation / T cell costimulation / viral entry into host cellComponentsapical plasma membrane / cell surface / endocytic vesicle / extracellular exosome / focal adhesion / integral component of membrane / intercellular canaliculus / invadopodium membrane / lamellipodium / lamellipodium membrane / lysosomal membrane / membrane / membrane raft / plasma membrane",
                        "General Function": "Virus receptor activity",
                        "Specific Function": "Cell surface glycoprotein receptor involved in the costimulatory signal essential for T-cell receptor (TCR)-mediated T-cell activation. Acts as a positive regulator of T-cell coactivation, by binding at least ADA, CAV1, IGF2R, and PTPRC. Its binding to CAV1 and CARD11 induces T-cell proliferation and NF-kappa-B activation in a T-cell receptor/CD3-dependent manner. Its interaction with ADA also regulates lymphocyte-epithelial cell adhesion. In association with FAP is involved in the pericellular proteolysis of the extracellular matrix (ECM), the migration and invasion of endothelial cells into the ECM. May be involved in the promotion of lymphatic endothelial cells adhesion, migration and tube formation. When overexpressed, enhanced cell proliferation, a process inhibited by GPC3. Acts also as a serine exopeptidase with a dipeptidyl peptidase activity that regulates various physiological processes by cleaving peptides in the circulation, including many chemokines, mitogenic growth factors, neuropeptides and peptide hormones. Removes N-terminal dipeptides sequentially from polypeptides having unsubstituted N-termini provided that the penultimate residue is proline.",
                        "Pfam Domain Function": "DPPIV_N (PF00930)\nPeptidase_S9 (PF00326)",
                        "Transmembrane Regions": "7-28",
                        "Cellular Location": "Secreted",
                        "Gene sequence": ">lcl|BSEQ0010604|Dipeptidyl peptidase 4 (DPP4)\nATGAAGACACCGTGGAAGGTTCTTCTGGGACTGCTGGGTGCTGCTGCGCTTGTCACCATC\nATCACCGTGCCCGTGGTTCTGCTGAACAAAGGCACAGATGATGCTACAGCTGACAGTCGC\nAAAACTTACACTCTAACTGATTACTTAAAAAATACTTATAGACTGAAGTTATACTCCTTA\nAGATGGATTTCAGATCATGAATATCTCTACAAACAAGAAAATAATATCTTGGTATTCAAT\nGCTGAATATGGAAACAGCTCAGTTTTCTTGGAGAACAGTACATTTGATGAGTTTGGACAT\nTCTATCAATGATTATTCAATATCTCCTGATGGGCAGTTTATTCTCTTAGAATACAACTAC\nGTGAAGCAATGGAGGCATTCCTACACAGCTTCATATGACATTTATGATTTAAATAAAAGG\nCAGCTGATTACAGAAGAGAGGATTCCAAACAACACACAGTGGGTCACATGGTCACCAGTG\nGGTCATAAATTGGCATATGTTTGGAACAATGACATTTATGTTAAAATTGAACCAAATTTA\nCCAAGTTACAGAATCACATGGACGGGGAAAGAAGATATAATATATAATGGAATAACTGAC\nTGGGTTTATGAAGAGGAAGTCTTCAGTGCCTACTCTGCTCTGTGGTGGTCTCCAAACGGC\nACTTTTTTAGCATATGCCCAATTTAACGACACAGAAGTCCCACTTATTGAATACTCCTTC\nTACTCTGATGAGTCACTGCAGTACCCAAAGACTGTACGGGTTCCATATCCAAAGGCAGGA\nGCTGTGAATCCAACTGTAAAGTTCTTTGTTGTAAATACAGACTCTCTCAGCTCAGTCACC\nAATGCAACTTCCATACAAATCACTGCTCCTGCTTCTATGTTGATAGGGGATCACTACTTG\nTGTGATGTGACATGGGCAACACAAGAAAGAATTTCTTTGCAGTGGCTCAGGAGGATTCAG\nAACTATTCGGTCATGGATATTTGTGACTATGATGAATCCAGTGGAAGATGGAACTGCTTA\nGTGGCACGGCAACACATTGAAATGAGTACTACTGGCTGGGTTGGAAGATTTAGGCCTTCA\nGAACCTCATTTTACCCTTGATGGTAATAGCTTCTACAAGATCATCAGCAATGAAGAAGGT\nTACAGACACATTTGCTATTTCCAAATAGATAAAAAAGACTGCACATTTATTACAAAAGGC\nACCTGGGAAGTCATCGGGATAGAAGCTCTAACCAGTGATTATCTATACTACATTAGTAAT\nGAATATAAAGGAATGCCAGGAGGAAGGAATCTTTATAAAATCCAACTTAGTGACTATACA\nAAAGTGACATGCCTCAGTTGTGAGCTGAATCCGGAAAGGTGTCAGTACTATTCTGTGTCA\nTTCAGTAAAGAGGCGAAGTATTATCAGCTGAGATGTTCCGGTCCTGGTCTGCCCCTCTAT\nACTCTACACAGCAGCGTGAATGATAAAGGGCTGAGAGTCCTGGAAGACAATTCAGCTTTG\nGATAAAATGCTGCAGAATGTCCAGATGCCCTCCAAAAAACTGGACTTCATTATTTTGAAT\nGAAACAAAATTTTGGTATCAGATGATCTTGCCTCCTCATTTTGATAAATCCAAGAAATAT\nCCTCTACTATTAGATGTGTATGCAGGCCCATGTAGTCAAAAAGCAGACACTGTCTTCAGA\nCTGAACTGGGCCACTTACCTTGCAAGCACAGAAAACATTATAGTAGCTAGCTTTGATGGC\nAGAGGAAGTGGTTACCAAGGAGATAAGATCATGCATGCAATCAACAGAAGACTGGGAACA\nTTTGAAGTTGAAGATCAAATTGAAGCAGCCAGACAATTTTCAAAAATGGGATTTGTGGAC\nAACAAACGAATTGCAATTTGGGGCTGGTCATATGGAGGGTACGTAACCTCAATGGTCCTG\nGGATCGGGAAGTGGCGTGTTCAAGTGTGGAATAGCCGTGGCGCCTGTATCCCGGTGGGAG\nTACTATGACTCAGTGTACACAGAACGTTACATGGGTCTCCCAACTCCAGAAGACAACCTT\nGACCATTACAGAAATTCAACAGTCATGAGCAGAGCTGAAAATTTTAAACAAGTTGAGTAC\nCTCCTTATTCATGGAACAGCAGATGATAACGTTCACTTTCAGCAGTCAGCTCAGATCTCC\nAAAGCCCTGGTCGATGTTGGAGTGGATTTCCAGGCAATGTGGTATACTGATGAAGACCAT\nGGAATAGCTAGCAGCACAGCACACCAACATATATATACCCACATGAGCCACTTCATAAAA\nCAATGTTTCTCTTTACCTTAG",
                        "Chromosome Location": "2",
                        "Locus": "2q24.3",
                        "External Identifiers": "ResourceLinkUniProtKB IDP27487UniProtKB Entry NameDPP4_HUMANGenBank Protein ID535388GenBank Gene IDU13735GenAtlas IDDPP4HGNC IDHGNC:3009",
                        "General References": "Misumi Y, Hayashi Y, Arakawa F, Ikehara Y: Molecular cloning and sequence analysis of human dipeptidyl peptidase IV, a serine proteinase on the cell surface. Biochim Biophys Acta. 1992 Jul 15;1131(3):333-6. [Article] Darmoul D, Lacasa M, Baricault L, Marguet D, Sapin C, Trotot P, Barbat A, Trugnan G: Dipeptidyl peptidase IV (CD 26) gene expression in enterocyte-like colon cancer cell lines HT-29 and Caco-2. Cloning of the complete human coding sequence and changes of dipeptidyl peptidase IV mRNA levels during cell differentiation. J Biol Chem. 1992 Mar 5;267(7):4824-33. [Article] Tanaka T, Camerini D, Seed B, Torimoto Y, Dang NH, Kameoka J, Dahlberg HN, Schlossman SF, Morimoto C: Cloning and functional expression of the T cell activation antigen CD26. J Immunol. 1992 Jul 15;149(2):481-6. [Article] Tanaka T: Cloning and functional expression of the T cell activation antigen CD26. J Immunol. 1993 Mar 1;150(5):2090. [Article] Abbott CA, Baker E, Sutherland GR, McCaughan GW: Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene. Immunogenetics. 1994;40(5):331-8. [Article] Goshima N, Kawamura Y, Fukumoto A, Miura A, Honma R, Satoh R, Wakamatsu A, Yamamoto J, Kimura K, Nishikawa T, Andoh T, Iida Y, Ishikawa K, Ito E, Kagawa N, Kaminaga C, Kanehori K, Kawakami B, Kenmochi K, Kimura R, Kobayashi M, Kuroita T, Kuwayama H, Maruyama Y, Matsuo K, Minami K, Mitsubori M, Mori M, Morishita R, Murase A, Nishikawa A, Nishikawa S, Okamoto T, Sakagami N, Sakamoto Y, Sasaki Y, Seki T, Sono S, Sugiyama A, Sumiya T, Takayama T, Takayama Y, Takeda H, Togashi T, Yahata K, Yamada H, Yanagisawa Y, Endo Y, Imamoto F, Kisu Y, Tanaka S, Isogai T, Imai J, Watanabe S, Nomura N: Human protein factory for converting the transcriptome into an in vitro-expressed proteome,. Nat Methods. 2008 Dec;5(12):1011-7. [Article] Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Darmoul D, Lacasa M, Chantret I, Swallow DM, Trugnan G: Isolation of a cDNA probe for the human intestinal dipeptidylpeptidase IV and assignment of the gene locus DPP4 to chromosome 2. Ann Hum Genet. 1990 Jul;54(Pt 3):191-7. [Article] Bohm SK, Gum JR Jr, Erickson RH, Hicks JW, Kim YS: Human dipeptidyl peptidase IV gene promoter: tissue-specific regulation from a TATA-less GC-rich sequence characteristic of a housekeeping gene promoter. Biochem J. 1995 Nov 1;311 ( Pt 3):835-43. [Article] Gorvel JP, Ferrero A, Chambraud L, Rigal A, Bonicel J, Maroux S: Expression of sucrase-isomaltase and dipeptidylpeptidase IV in human small intestine and colon. Gastroenterology. 1991 Sep;101(3):618-25. [Article] Durinx C, Lambeir AM, Bosmans E, Falmagne JB, Berghmans R, Haemers A, Scharpe S, De Meester I: Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides. Eur J Biochem. 2000 Sep;267(17):5608-13. [Article] Davoodi J, Kelly J, Gendron NH, MacKenzie AE: The Simpson-Golabi-Behmel syndrome causative glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26. Proteomics. 2007 Jun;7(13):2300-10. [Article] Morrison ME, Vijayasaradhi S, Engelstein D, Albino AP, Houghton AN: A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase. J Exp Med. 1993 Apr 1;177(4):1135-43. [Article] Kameoka J, Tanaka T, Nojima Y, Schlossman SF, Morimoto C: Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science. 1993 Jul 23;261(5120):466-9. [Article] De Meester I, Vanham G, Kestens L, Vanhoof G, Bosmans E, Gigase P, Scharpe S: Binding of adenosine deaminase to the lymphocyte surface via CD26. Eur J Immunol. 1994 Mar;24(3):566-70. [Article] Loster K, Zeilinger K, Schuppan D, Reutter W: The cysteine-rich region of dipeptidyl peptidase IV (CD 26) is the collagen-binding site. Biochem Biophys Res Commun. 1995 Dec 5;217(1):341-8. [Article] Cordero OJ, Salgado FJ, Vinuela JE, Nogueira M: Interleukin-12 enhances CD26 expression and dipeptidyl peptidase IV function on human activated lymphocytes. Immunobiology. 1997 Nov;197(5):522-33. [Article] Abbott CA, McCaughan GW, Gorrell MD: Two highly conserved glutamic acid residues in the predicted beta propeller domain of dipeptidyl peptidase IV are required for its enzyme activity. FEBS Lett. 1999 Sep 24;458(3):278-84. [Article] Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ, Rettig WJ: Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem. 1999 Dec 17;274(51):36505-12. [Article] Cordero OJ, Ayude D, Nogueira M, Rodriguez-Berrocal FJ, de la Cadena MP: Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer. Br J Cancer. 2000 Nov;83(9):1139-46. [Article] Salgado FJ, Vela E, Martin M, Franco R, Nogueira M, Cordero OJ: Mechanisms of CD26/dipeptidyl peptidase IV cytokine-dependent regulation on human activated lymphocytes. Cytokine. 2000 Jul;12(7):1136-41. [Article] Ikushima H, Munakata Y, Ishii T, Iwata S, Terashima M, Tanaka H, Schlossman SF, Morimoto C: Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation. Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8439-44. [Article] Gines S, Marino M, Mallol J, Canela EI, Morimoto C, Callebaut C, Hovanessian A, Casado V, Lluis C, Franco R: Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase-CD26 interaction. Biochem J. 2002 Jan 15;361(Pt 2):203-9. [Article] Alfalah M, Jacob R, Naim HY: Intestinal dipeptidyl peptidase IV is efficiently sorted to the apical membrane through the concerted action of N- and O-glycans as well as association with lipid microdomains. J Biol Chem. 2002 Mar 22;277(12):10683-90. Epub 2001 Dec 28. [Article] Salgado FJ, Lojo J, Alonso-Lebrero JL, Lluis C, Franco R, Cordero OJ, Nogueira M: A role for interleukin-12 in the regulation of T cell plasma membrane compartmentation. J Biol Chem. 2003 Jul 4;278(27):24849-57. Epub 2003 Apr 3. [Article] Chien CH, Huang LH, Chou CY, Chen YS, Han YS, Chang GG, Liang PH, Chen X: One site mutation disrupts dimer formation in human DPP-IV proteins. J Biol Chem. 2004 Dec 10;279(50):52338-45. Epub 2004 Sep 24. [Article] Aertgeerts K, Ye S, Shi L, Prasad SG, Witmer D, Chi E, Sang BC, Wijnands RA, Webb DR, Swanson RV: N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding. Protein Sci. 2004 Jan;13(1):145-54. [Article] Liu T, Qian WJ, Gritsenko MA, Camp DG 2nd, Monroe ME, Moore RJ, Smith RD: Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J Proteome Res. 2005 Nov-Dec;4(6):2070-80. [Article] Ghersi G, Zhao Q, Salamone M, Yeh Y, Zucker S, Chen WT: The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices. Cancer Res. 2006 May 1;66(9):4652-61. [Article] Ohnuma K, Uchiyama M, Yamochi T, Nishibashi K, Hosono O, Takahashi N, Kina S, Tanaka H, Lin X, Dang NH, Morimoto C: Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1. J Biol Chem. 2007 Mar 30;282(13):10117-31. Epub 2007 Feb 6. [Article] Shin JW, Jurisic G, Detmar M: Lymphatic-specific expression of dipeptidyl peptidase IV and its dual role in lymphatic endothelial function. Exp Cell Res. 2008 Oct 1;314(16):3048-56. doi: 10.1016/j.yexcr.2008.07.024. Epub 2008 Aug 3. [Article] Cordero OJ, Salgado FJ, Nogueira M: On the origin of serum CD26 and its altered concentration in cancer patients. Cancer Immunol Immunother. 2009 Nov;58(11):1723-47. doi: 10.1007/s00262-009-0728-1. Epub 2009 Jun 26. [Article] Chen R, Jiang X, Sun D, Han G, Wang F, Ye M, Wang L, Zou H: Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009 Feb;8(2):651-61. doi: 10.1021/pr8008012. [Article] Burkard TR, Planyavsky M, Kaupe I, Breitwieser FP, Burckstummer T, Bennett KL, Superti-Furga G, Colinge J: Initial characterization of the human central proteome. BMC Syst Biol. 2011 Jan 26;5:17. doi: 10.1186/1752-0509-5-17. [Article] Raj VS, Mou H, Smits SL, Dekkers DH, Muller MA, Dijkman R, Muth D, Demmers JA, Zaki A, Fouchier RA, Thiel V, Drosten C, Rottier PJ, Osterhaus AD, Bosch BJ, Haagmans BL: Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013 Mar 14;495(7440):251-4. doi: 10.1038/nature12005. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Oefner C, D'Arcy A, Mac Sweeney A, Pierau S, Gardiner R, Dale GE: High-resolution structure of human apo dipeptidyl peptidase IV/CD26 and its complex with 1-[([2-[(5-iodopyridin-2-yl)amino]-ethyl]amino)-acetyl]-2-cyano-(S)-pyrrolidine. Acta Crystallogr D Biol Crystallogr. 2003 Jul;59(Pt 7):1206-12. Epub 2003 Jun 27. [Article] Hiramatsu H, Kyono K, Higashiyama Y, Fukushima C, Shima H, Sugiyama S, Inaka K, Yamamoto A, Shimizu R: The structure and function of human dipeptidyl peptidase IV, possessing a unique eight-bladed beta-propeller fold. Biochem Biophys Res Commun. 2003 Mar 21;302(4):849-54. [Article] Rasmussen HB, Branner S, Wiberg FC, Wagtmann N: Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog. Nat Struct Biol. 2003 Jan;10(1):19-25. [Article] Thoma R, Loffler B, Stihle M, Huber W, Ruf A, Hennig M: Structural basis of proline-specific exopeptidase activity as observed in human dipeptidyl peptidase-IV. Structure. 2003 Aug;11(8):947-59. [Article] Meng W, Brigance RP, Chao HJ, Fura A, Harrity T, Marcinkeviciene J, O'Connor SP, Tamura JK, Xie D, Zhang Y, Klei HE, Kish K, Weigelt CA, Turdi H, Wang A, Zahler R, Kirby MS, Hamann LG: Discovery of 6-(aminomethyl)-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-a]pyrimidine-2-carboxa mides as potent, selective dipeptidyl peptidase-4 (DPP4) inhibitors. J Med Chem. 2010 Aug 12;53(15):5620-8. doi: 10.1021/jm100634a. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB01261Sitagliptinapproved, investigationalyesinhibitorDetailsDB018842-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-OneexperimentalunknownDetailsDB020045-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-AmineexperimentalunknownDetailsDB04491Diisopropylphosphono GroupexperimentalunknownDetailsDB03253(2s)-Pyrrolidin-2-YlmethylamineexperimentalunknownDetailsDB04876Vildagliptinapproved, investigationalyesinhibitorDetailsDB05001PSN9301investigationalunknownDetailsDB11723DutogliptininvestigationalunknownDetailsDB06127BisegliptininvestigationalunknownDetailsDB06011AMG-222investigationalunknownDetailsDB06203AlogliptinapprovedyesinhibitorDetailsDB06335SaxagliptinapprovedyesinhibitorDetailsDB01076AtorvastatinapprovedunknowninhibitorDetailsDB045771-(1-phenylcyclopentyl)methylamineexperimentalunknownDetailsDB04578(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamideexperimentalunknownDetailsDB06880(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-PROP-1-YN-1-YLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINEexperimentalunknownDetailsDB06939N-(TRANS-4-{(1S,2S)-2-AMINO-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-1-METHYL-3-OXOPROPYL}CYCLOHEXYL)-N-METHYLACETAMIDEexperimentalunknownDetailsDB06993(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amineexperimentalunknownDetailsDB06994(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amineexperimentalunknownDetailsDB07015(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amineexperimentalunknownDetailsDB07021(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amineexperimentalunknownDetailsDB07067(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINEexperimentalunknownDetailsDB07072(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINEexperimentalunknownDetailsDB07081(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINEexperimentalunknownDetailsDB07092(2S,3S)-3-AMINO-4-(3,3-DIFLUOROPYRROLIDIN-1-YL)-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YLCYCLOHEXYL)BUTANAMIDEexperimentalunknownDetailsDB07135(2S,3S)-3-AMINO-4-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-5-YLCYCLOHEXYL)BUTANAMIDEexperimentalunknownDetailsDB07154(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONEexperimentalunknownDetailsDB071814'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamideexperimentalunknownDetailsDB07193(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amineexperimentalunknownDetailsDB072397-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrileexperimentalunknownDetailsDB072714-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-oneexperimentalunknownDetailsDB07328METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATEexperimentalunknownDetailsDB07356(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINEexperimentalunknownDetailsDB074121-biphenyl-2-ylmethanamineexperimentalunknownDetailsDB07465(1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrileexperimentalunknownDetailsDB07482(2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDEexperimentalunknownDetailsDB07666(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINEexperimentalunknownDetailsDB07779N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDEexperimentalunknownDetailsDB07830(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONEexperimentalunknownDetailsDB07851(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINEexperimentalunknownDetailsDB080241-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILEexperimentalunknownDetailsDB08044ABT-341experimentalunknownDetailsDB08051(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINEexperimentalunknownDetailsDB08164(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINEexperimentalunknownDetailsDB08382GosogliptininvestigationalyesDetailsDB036604-Iodo-L-phenylalanineexperimentalunknownDetailsDB08429N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamideexperimentalunknownDetailsDB08445(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINEexperimentalunknownDetailsDB085046-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUMexperimentalunknownDetailsDB085307-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONEexperimentalunknownDetailsDB085882-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILEexperimentalunknownDetailsDB086724-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDEexperimentalunknownDetailsDB087432-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILEexperimentalunknownDetailsDB08882LinagliptinapprovedyesinhibitorDetailsDB06655LiraglutideapprovedunknownsubstrateDetailsDB13928Semaglutideapproved, investigationalnosubstrateDetailsDB01276Exenatideapproved, investigationalunknownsubstrateDetails"
                    }
                },
                {
                    "Label": "Aryl hydrocarbon receptor",
                    "Detailed Info": {
                        "Name": "Aryl hydrocarbon receptor",
                        "Synonyms": "Ah receptor\nBHLHE76\nClass E basic helix-loop-helix protein 76",
                        "Gene Name": "AHR",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0017202|Aryl hydrocarbon receptor\nMNSSSANITYASRKRRKPVQKTVKPIPAEGIKSNPSKRHRDRLNTELDRLASLLPFPQDV\nINKLDKLSVLRLSVSYLRAKSFFDVALKSSPTERNGGQDNCRAANFREGLNLQEGEFLLQ\nALNGFVLVVTTDALVFYASSTIQDYLGFQQSDVIHQSVYELIHTEDRAEFQRQLHWALNP\nSQCTESGQGIEEATGLPQTVVCYNPDQIPPENSPLMERCFICRLRCLLDNSSGFLAMNFQ\nGKLKYLHGQKKKGKDGSILPPQLALFAIATPLQPPSILEIRTKNFIFRTKHKLDFTPIGC\nDAKGRIVLGYTEAELCTRGSGYQFIHAADMLYCAESHIRMIKTGESGMIVFRLLTKNNRW\nTWVQSNARLLYKNGRPDYIIVTQRPLTDEEGTEHLRKRNTKLPFMFTTGEAVLYEATNPF\nPAIMDPLPLRTKNGTSGKDSATTSTLSKDSLNPSSLLAAMMQQDESIYLYPASSTSSTAP\nFENNFFNESMNECRNWQDNTAPMGNDTILKHEQIDQPQDVNSFAGGHPGLFQDSKNSDLY\nSIMKNLGIDFEDIRHMQNEKFFRNDFSGEVDFRDIDLTDEILTYVQDSLSKSPFIPSDYQ\nQQQSLALNSSCMVQEHLHLEQQQQHHQKQVVVEPQQQLCQKMKHMQVNGMFENWNSNQFV\nPFNCPQQDPQQYNVFTDLHGISQEFPYKSEMDSMPYTQNFISCNQPVLPQHSKCTELDYP\nMGSFEPSPYPTTSSLEDFVTCLQLPENQKHGLNPQSAIITPQTCYAGAVSMYQCQPEPQH\nTHVGQMQYNPVLPGQQAFLNKFQNGVLNETYPAELNNINNTQTTTHLQPLHHPSEARPFP\nDLTSSGFL",
                        "Number of residues": "848",
                        "Molecular Weight": "96146.705",
                        "Theoretical pI": "6.34",
                        "GO Classification": "FunctionsDNA binding / E-box binding / enhancer binding / Hsp90 protein binding / protein dimerization activity / protein heterodimerization activity / RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding / sequence-specific DNA binding / transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding / transcription factor activity, sequence-specific DNA binding / transcription factor binding / transcription regulatory region DNA bindingProcessesapoptotic process / blood vessel development / cell cycle / circadian regulation of gene expression / intracellular receptor signaling pathway / negative regulation of transcription from RNA polymerase II promoter / negative regulation of transcription, DNA-templated / positive regulation of RNA polymerase II transcriptional preinitiation complex assembly / positive regulation of transcription from RNA polymerase II promoter / positive regulation of transcription, DNA-templated / prostate gland development / regulation of B cell proliferation / regulation of gene expression / regulation of transcription from RNA polymerase II promoter / regulation of transcription, DNA-templated / response to toxic substance / response to xenobiotic stimulus / transcription from RNA polymerase II promoter / xenobiotic metabolic processComponentscytoplasm / cytosolic aryl hydrocarbon receptor complex / nuclear aryl hydrocarbon receptor complex / nucleoplasm / nucleus / transcription factor complex",
                        "General Function": "Transcription regulatory region dna binding",
                        "Specific Function": "Ligand-activated transcriptional activator. Binds to the XRE promoter region of genes it activates. Activates the expression of multiple phase I and II xenobiotic chemical metabolizing enzyme genes (such as the CYP1A1 gene). Mediates biochemical and toxic effects of halogenated aromatic hydrocarbons. Involved in cell-cycle regulation. Likely to play an important role in the development and maturation of many tissues. Regulates the circadian clock by inhibiting the basal and circadian expression of the core circadian component PER1. Inhibits PER1 by repressing the CLOCK-ARNTL/BMAL1 heterodimer mediated transcriptional activation of PER1.",
                        "Pfam Domain Function": "PAS (PF00989)\nHLH (PF00010)\nPAS_3 (PF08447)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Cytoplasm",
                        "Gene sequence": ">lcl|BSEQ0017203|Aryl hydrocarbon receptor (AHR)\nATGAACAGCAGCAGCGCCAACATCACCTACGCCAGTCGCAAGCGGCGGAAGCCGGTGCAG\nAAAACAGTAAAGCCAATCCCAGCTGAAGGAATCAAGTCAAATCCTTCCAAGCGGCATAGA\nGACCGACTTAATACAGAGTTGGACCGTTTGGCTAGCCTGCTGCCTTTCCCACAAGATGTT\nATTAATAAGTTGGACAAACTTTCAGTTCTTAGGCTCAGCGTCAGTTACCTGAGAGCCAAG\nAGCTTCTTTGATGTTGCATTAAAATCCTCCCCTACTGAAAGAAACGGAGGCCAGGATAAC\nTGTAGAGCAGCAAATTTCAGAGAAGGCCTGAACTTACAAGAAGGAGAATTCTTATTACAG\nGCTCTGAATGGCTTTGTATTAGTTGTCACTACAGATGCTTTGGTCTTTTATGCTTCTTCT\nACTATACAAGATTATCTAGGGTTTCAGCAGTCTGATGTCATACATCAGAGTGTATATGAA\nCTTATCCATACCGAAGACCGAGCTGAATTTCAGCGTCAGCTACACTGGGCATTAAATCCT\nTCTCAGTGTACAGAGTCTGGACAAGGAATTGAAGAAGCCACTGGTCTCCCCCAGACAGTA\nGTCTGTTATAACCCAGACCAGATTCCTCCAGAAAACTCTCCTTTAATGGAGAGGTGCTTC\nATATGTCGTCTAAGGTGTCTGCTGGATAATTCATCTGGTTTTCTGGCAATGAATTTCCAA\nGGGAAGTTAAAGTATCTTCATGGACAGAAAAAGAAAGGGAAAGATGGATCAATACTTCCA\nCCTCAGTTGGCTTTGTTTGCGATAGCTACTCCACTTCAGCCACCATCCATACTTGAAATC\nCGGACCAAAAATTTTATCTTTAGAACCAAACACAAACTAGACTTCACACCTATTGGTTGT\nGATGCCAAAGGAAGAATTGTTTTAGGATATACTGAAGCAGAGCTGTGCACGAGAGGCTCA\nGGTTATCAGTTTATTCATGCAGCTGATATGCTTTATTGTGCCGAGTCCCATATCCGAATG\nATTAAGACTGGAGAAAGTGGCATGATAGTTTTCCGGCTTCTTACAAAAAACAACCGATGG\nACTTGGGTCCAGTCTAATGCACGCCTGCTTTATAAAAATGGAAGACCAGATTATATCATT\nGTAACTCAGAGACCACTAACAGATGAGGAAGGAACAGAGCATTTACGAAAACGAAATACG\nAAGTTGCCTTTTATGTTTACCACTGGAGAAGCTGTGTTGTATGAGGCAACCAACCCTTTT\nCCTGCCATAATGGATCCCTTACCACTAAGGACTAAAAATGGCACTAGTGGAAAAGACTCT\nGCTACCACATCCACTCTAAGCAAGGACTCTCTCAATCCTAGTTCCCTCCTGGCTGCCATG\nATGCAACAAGATGAGTCTATTTATCTCTATCCTGCTTCAAGTACTTCAAGTACTGCACCT\nTTTGAAAACAACTTTTTCAACGAATCTATGAATGAATGCAGAAATTGGCAAGATAATACT\nGCACCGATGGGAAATGATACTATCCTGAAACATGAGCAAATTGACCAGCCTCAGGATGTG\nAACTCATTTGCTGGAGGTCACCCAGGGCTCTTTCAAGATAGTAAAAACAGTGACTTGTAC\nAGCATAATGAAAAACCTAGGCATTGATTTTGAAGACATCAGACACATGCAGAATGAAAAA\nTTTTTCAGAAATGATTTTTCTGGTGAGGTTGACTTCAGAGACATTGACTTAACGGATGAA\nATCCTGACGTATGTCCAAGATTCTTTAAGTAAGTCTCCCTTCATACCTTCAGATTATCAA\nCAGCAACAGTCCTTGGCTCTGAACTCAAGCTGTATGGTACAGGAACACCTACATCTAGAA\nCAGCAACAGCAACATCACCAAAAGCAAGTAGTAGTGGAGCCACAGCAACAGCTGTGTCAG\nAAGATGAAGCACATGCAAGTTAATGGCATGTTTGAAAATTGGAACTCTAACCAATTCGTG\nCCTTTCAATTGTCCACAGCAAGACCCACAACAATATAATGTCTTTACAGACTTACATGGG\nATCAGTCAAGAGTTCCCCTACAAATCTGAAATGGATTCTATGCCTTATACACAGAACTTT\nATTTCCTGTAATCAGCCTGTATTACCACAACATTCCAAATGTACAGAGCTGGACTACCCT\nATGGGGAGTTTTGAACCATCCCCATACCCCACTACTTCTAGTTTAGAAGATTTTGTCACT\nTGTTTACAACTTCCTGAAAACCAAAAGCATGGATTAAATCCACAGTCAGCCATAATAACT\nCCTCAGACATGTTATGCTGGGGCCGTGTCGATGTATCAGTGCCAGCCAGAACCTCAGCAC\nACCCACGTGGGTCAGATGCAGTACAATCCAGTACTGCCAGGCCAACAGGCATTTTTAAAC\nAAGTTTCAGAATGGAGTTTTAAATGAAACATATCCAGCTGAATTAAATAACATAAATAAC\nACTCAGACTACCACACATCTTCAGCCACTTCATCATCCGTCAGAAGCCAGACCTTTTCCT\nGATTTGACATCCAGTGGATTCCTGTAA",
                        "Chromosome Location": "7",
                        "Locus": "7p15",
                        "External Identifiers": "ResourceLinkUniProtKB IDP35869UniProtKB Entry NameAHR_HUMANGenBank Protein ID533324GenBank Gene IDD16354HGNC IDHGNC:348",
                        "General References": "Itoh S, Kamataki T: Human Ah receptor cDNA: analysis for highly conserved sequences. Nucleic Acids Res. 1993 Jul 25;21(15):3578. [Article] Dolwick KM, Schmidt JV, Carver LA, Swanson HI, Bradfield CA: Cloning and expression of a human Ah receptor cDNA. Mol Pharmacol. 1993 Nov;44(5):911-7. [Article] Ema M, Matsushita N, Sogawa K, Ariyama T, Inazawa J, Nemoto T, Ota M, Oshimura M, Fujii-Kuriyama Y: Human arylhydrocarbon receptor: functional expression and chromosomal assignment to 7p21. J Biochem. 1994 Oct;116(4):845-51. [Article] Scherer SW, Cheung J, MacDonald JR, Osborne LR, Nakabayashi K, Herbrick JA, Carson AR, Parker-Katiraee L, Skaug J, Khaja R, Zhang J, Hudek AK, Li M, Haddad M, Duggan GE, Fernandez BA, Kanematsu E, Gentles S, Christopoulos CC, Choufani S, Kwasnicka D, Zheng XH, Lai Z, Nusskern D, Zhang Q, Gu Z, Lu F, Zeesman S, Nowaczyk MJ, Teshima I, Chitayat D, Shuman C, Weksberg R, Zackai EH, Grebe TA, Cox SR, Kirkpatrick SJ, Rahman N, Friedman JM, Heng HH, Pelicci PG, Lo-Coco F, Belloni E, Shaffer LG, Pober B, Morton CC, Gusella JF, Bruns GA, Korf BR, Quade BJ, Ligon AH, Ferguson H, Higgins AW, Leach NT, Herrick SR, Lemyre E, Farra CG, Kim HG, Summers AM, Gripp KW, Roberts W, Szatmari P, Winsor EJ, Grzeschik KH, Teebi A, Minassian BA, Kere J, Armengol L, Pujana MA, Estivill X, Wilson MD, Koop BF, Tosi S, Moore GE, Boright AP, Zlotorynski E, Kerem B, Kroisel PM, Petek E, Oscier DG, Mould SJ, Dohner H, Dohner K, Rommens JM, Vincent JB, Venter JC, Li PW, Mural RJ, Adams MD, Tsui LC: Human chromosome 7: DNA sequence and biology. Science. 2003 May 2;300(5620):767-72. Epub 2003 Apr 10. [Article] Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, Wagner-McPherson C, Layman D, Maas J, Jaeger S, Walker R, Wylie K, Sekhon M, Becker MC, O'Laughlin MD, Schaller ME, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Cordes M, Du H, Sun H, Edwards J, Bradshaw-Cordum H, Ali J, Andrews S, Isak A, Vanbrunt A, Nguyen C, Du F, Lamar B, Courtney L, Kalicki J, Ozersky P, Bielicki L, Scott K, Holmes A, Harkins R, Harris A, Strong CM, Hou S, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Leonard S, Rohlfing T, Rock SM, Tin-Wollam AM, Abbott A, Minx P, Maupin R, Strowmatt C, Latreille P, Miller N, Johnson D, Murray J, Woessner JP, Wendl MC, Yang SP, Schultz BR, Wallis JW, Spieth J, Bieri TA, Nelson JO, Berkowicz N, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Bedell JA, Mardis ER, Clifton SW, Chissoe SL, Marra MA, Raymond C, Haugen E, Gillett W, Zhou Y, James R, Phelps K, Iadanoto S, Bubb K, Simms E, Levy R, Clendenning J, Kaul R, Kent WJ, Furey TS, Baertsch RA, Brent MR, Keibler E, Flicek P, Bork P, Suyama M, Bailey JA, Portnoy ME, Torrents D, Chinwalla AT, Gish WR, Eddy SR, McPherson JD, Olson MV, Eichler EE, Green ED, Waterston RH, Wilson RK: The DNA sequence of human chromosome 7. Nature. 2003 Jul 10;424(6945):157-64. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Bennett P, Ramsden DB, Williams AC: Complete structural characterisation of the human aryl hydrocarbon receptor gene. Clin Mol Pathol. 1996 Feb;49(1):M12-6. [Article] Hayashi S, Watanabe J, Nakachi K, Eguchi H, Gotoh O, Kawajiri K: Interindividual difference in expression of human Ah receptor and related P450 genes. Carcinogenesis. 1994 May;15(5):801-6. [Article] Ema M, Ohe N, Suzuki M, Mimura J, Sogawa K, Ikawa S, Fujii-Kuriyama Y: Dioxin binding activities of polymorphic forms of mouse and human arylhydrocarbon receptors. J Biol Chem. 1994 Nov 4;269(44):27337-43. [Article] Nguyen TA, Hoivik D, Lee JE, Safe S: Interactions of nuclear receptor coactivator/corepressor proteins with the aryl hydrocarbon receptor complex. Arch Biochem Biophys. 1999 Jul 15;367(2):250-7. [Article] Wolff S, Harper PA, Wong JM, Mostert V, Wang Y, Abel J: Cell-specific regulation of human aryl hydrocarbon receptor expression by transforming growth factor-beta(1). Mol Pharmacol. 2001 Apr;59(4):716-24. [Article] Puga A, Xia Y, Elferink C: Role of the aryl hydrocarbon receptor in cell cycle regulation. Chem Biol Interact. 2002 Sep 20;141(1-2):117-30. [Article] Antenos M, Casper RF, Brown TJ: Interaction with Nedd8, a ubiquitin-like protein, enhances the transcriptional activity of the aryl hydrocarbon receptor. J Biol Chem. 2002 Nov 15;277(46):44028-34. Epub 2002 Sep 4. [Article] Dunham EE, Stevens EA, Glover E, Bradfield CA: The aryl hydrocarbon receptor signaling pathway is modified through interactions with a Kelch protein. Mol Pharmacol. 2006 Jul;70(1):8-15. Epub 2006 Mar 31. [Article] Harper PA, Wong Jm, Lam MS, Okey AB: Polymorphisms in the human AH receptor. Chem Biol Interact. 2002 Sep 20;141(1-2):161-87. [Article] Van Damme P, Lasa M, Polevoda B, Gazquez C, Elosegui-Artola A, Kim DS, De Juan-Pardo E, Demeyer K, Hole K, Larrea E, Timmerman E, Prieto J, Arnesen T, Sherman F, Gevaert K, Aldabe R: N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12449-54. doi: 10.1073/pnas.1210303109. Epub 2012 Jul 18. [Article] Kawajiri K, Watanabe J, Eguchi H, Nakachi K, Kiyohara C, Hayashi S: Polymorphisms of human Ah receptor gene are not involved in lung cancer. Pharmacogenetics. 1995 Jun;5(3):151-8. [Article] Smart J, Daly AK: Variation in induced CYP1A1 levels: relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms. Pharmacogenetics. 2000 Feb;10(1):11-24. [Article] Cauchi S, Stucker I, Solas C, Laurent-Puig P, Cenee S, Hemon D, Jacquet M, Kremers P, Beaune P, Massaad-Massade L: Polymorphisms of human aryl hydrocarbon receptor (AhR) gene in a French population: relationship with CYP1A1 inducibility and lung cancer. Carcinogenesis. 2001 Nov;22(11):1819-24. [Article] Wong JM, Okey AB, Harper PA: Human aryl hydrocarbon receptor polymorphisms that result in loss of CYP1A1 induction. Biochem Biophys Res Commun. 2001 Nov 9;288(4):990-6. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB01404Ginsenginvestigational, nutraceuticalunknownagonistDetailsDB01097Leflunomideapproved, investigationalunknownagonistDetailsDB00499Flutamideapproved, investigationalunknownagonistDetailsDB00393Nimodipineapproved, investigationalunknownagonistDetailsDB00379Mexiletineapproved, investigationalunknownagonistDetailsDB01076AtorvastatinapprovedunknownagonistDetailsDB06732beta-NaphthoflavoneexperimentalunknownagonistDetailsDB12116Epigallocatechin gallateinvestigationalunknownDetailsDB12328Cantharidinapproved, investigationalunknownagonistDetailsDB08995Diosminapproved, investigationalunknownagonistDetailsDB07715EmodininvestigationalunknownagonistDetailsDB02052Indirubin-3'-monoximeexperimentalunknownagonistDetailsDB12379IndirubininvestigationalunknownagonistDetailsDB02709ResveratrolinvestigationalunknownDetailsDB086241-[(4S)-4-amino-5-(1,3-benzothiazol-2-yl)-5-oxopentyl]guanidineexperimentalunknownDetailsDB04216Quercetinexperimental, investigationalunknownDetailsDB11937Kynurenic AcidinvestigationalunknownDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknownagonistDetailsDB13009CarbendaziminvestigationalyesagonistDetailsDB06083Tapinarofapproved, investigationalyesagonistDetailsDB16862Indigoexperimental, investigationalunknownbinderDetails"
                    }
                },
                {
                    "Label": "Histone deacetylase 2",
                    "Detailed Info": {
                        "Name": "Histone deacetylase 2",
                        "Synonyms": "3.5.1.98\nHD2",
                        "Gene Name": "HDAC2",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0004647|Histone deacetylase 2\nMAYSQGGGKKKVCYYYDGDIGNYYYGQGHPMKPHRIRMTHNLLLNYGLYRKMEIYRPHKA\nTAEEMTKYHSDEYIKFLRSIRPDNMSEYSKQMQRFNVGEDCPVFDGLFEFCQLSTGGSVA\nGAVKLNRQQTDMAVNWAGGLHHAKKSEASGFCYVNDIVLAILELLKYHQRVLYIDIDIHH\nGDGVEEAFYTTDRVMTVSFHKYGEYFPGTGDLRDIGAGKGKYYAVNFPMRDGIDDESYGQ\nIFKPIISKVMEMYQPSAVVLQCGADSLSGDRLGCFNLTVKGHAKCVEVVKTFNLPLLMLG\nGGGYTIRNVARCWTYETAVALDCEIPNELPYNDYFEYFGPDFKLHISPSNMTNQNTPEYM\nEKIKQRLFENLRMLPHAPGVQMQAIPEDAVHEDSGDEDGEDPDKRISIRASDKRIACDEE\nFSDSEDEGEGGRRNVADHKKGAKKARIEEDKKETEDKKTDVKEEDKSKDNSGEKTDTKGT\nKSEQLSNP",
                        "Number of residues": "488",
                        "Molecular Weight": "55363.855",
                        "Theoretical pI": "5.75",
                        "GO Classification": "Functionschromatin binding / core promoter binding / deacetylase activity / enzyme binding / histone deacetylase activity / NAD-dependent histone deacetylase activity (H3-K14 specific) / NF-kappaB binding / poly(A) RNA binding / protein deacetylase activity / RNA polymerase II repressing transcription factor binding / sequence-specific DNA binding / transcription factor bindingProcessesATP-dependent chromatin remodeling / behavioral response to ethanol / blood coagulation / cardiac muscle hypertrophy / cellular response to dopamine / cellular response to heat / cellular response to hydrogen peroxide / cellular response to retinoic acid / cellular response to transforming growth factor beta stimulus / chromatin organization / chromatin remodeling / circadian regulation of gene expression / dendrite development / embryonic digit morphogenesis / epidermal cell differentiation / eyelid development in camera-type eye / fungiform papilla formation / gene expression / hair follicle placode formation / histone deacetylation / histone H3 deacetylation / histone H4 deacetylation / maintenance of chromatin silencing / negative regulation of apoptotic process / negative regulation of cell cycle / negative regulation of dendritic spine development / negative regulation of DNA binding / negative regulation of gene expression, epigenetic / negative regulation of MHC class II biosynthetic process / negative regulation of neuron projection development / negative regulation of peptidyl-lysine acetylation / negative regulation of sequence-specific DNA binding transcription factor activity / negative regulation of transcription from RNA polymerase II promoter / negative regulation of transcription, DNA-templated / neurotrophin TRK receptor signaling pathway / odontogenesis of dentin-containing tooth / positive regulation of cell proliferation / positive regulation of collagen biosynthetic process / positive regulation of epithelial to mesenchymal transition / positive regulation of interleukin-1 production / positive regulation of oligodendrocyte differentiation / positive regulation of proteolysis / positive regulation of receptor biosynthetic process / positive regulation of transcription from RNA polymerase II promoter / positive regulation of transcription, DNA-templated / positive regulation of tumor necrosis factor production / positive regulation of tyrosine phosphorylation of Stat3 protein / regulation of gene expression, epigenetic / response to amphetamine / response to caffeine / response to cocaine / response to drug / response to hyperoxia / response to lipopolysaccharide / response to nicotine / transcription, DNA-templatedComponentscytoplasm / ESC/E(Z) complex / nuclear chromatin / nucleoplasm / nucleus / NuRD complex / protein complex / Sin3 complex",
                        "General Function": "Transcription factor binding",
                        "Specific Function": "Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Forms transcriptional repressor complexes by associating with MAD, SIN3, YY1 and N-COR. Interacts in the late S-phase of DNA-replication with DNMT1 in the other transcriptional repressor complex composed of DNMT1, DMAP1, PCNA, CAF1. Deacetylates TSHZ3 and regulates its transcriptional repressor activity. Component of a RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development. May be involved in the transcriptional repression of circadian target genes, such as PER1, mediated by CRY1 through histone deacetylation. Involved in MTA1-mediated transcriptional corepression of TFF1 and CDKN1A.",
                        "Pfam Domain Function": "Hist_deacetyl (PF00850)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Nucleus",
                        "Gene sequence": ">lcl|BSEQ0016767|Histone deacetylase 2 (HDAC2)\nATGGCGTACAGTCAAGGAGGCGGCAAAAAAAAAGTCTGCTACTACTACGACGGTGATATT\nGGAAATTATTATTATGGACAGGGTCATCCCATGAAGCCTCATAGAATCCGCATGACCCAT\nAACTTGCTGTTAAATTATGGCTTATACAGAAAAATGGAAATATATAGGCCCCATAAAGCC\nACTGCCGAAGAAATGACAAAATATCACAGTGATGAGTATATCAAATTTCTACGGTCAATA\nAGACCAGATAACATGTCTGAGTATAGTAAGCAGATGCAGAGATTTAATGTTGGAGAAGAT\nTGTCCAGTGTTTGATGGACTCTTTGAGTTTTGTCAGCTCTCAACTGGCGGTTCAGTTGCT\nGGAGCTGTGAAGTTAAACCGACAACAGACTGATATGGCTGTTAATTGGGCTGGAGGATTA\nCATCATGCTAAGAAATCAGAAGCATCAGGATTCTGTTACGTTAATGATATTGTGCTTGCC\nATCCTTGAATTACTAAAGTATCATCAGAGAGTCTTATATATTGATATAGATATTCATCAT\nGGTGATGGTGTTGAAGAAGCTTTTTATACAACAGATCGTGTAATGACGGTATCATTCCAT\nAAATATGGGGAATACTTTCCTGGCACAGGAGACTTGAGGGATATTGGTGCTGGAAAAGGC\nAAATACTATGCTGTCAATTTTCCAATGAGAGATGGTATAGATGATGAGTCATATGGGCAG\nATATTTAAGCCTATTATCTCAAAGGTGATGGAGATGTATCAACCTAGTGCTGTGGTATTA\nCAGTGTGGTGCAGACTCATTATCTGGTGATAGACTGGGTTGTTTCAATCTAACAGTCAAA\nGGTCATGCTAAATGTGTAGAAGTTGTAAAAACTTTTAACTTACCATTACTGATGCTTGGA\nGGAGGTGGCTACACAATCCGTAATGTTGCTCGATGTTGGACATATGAGACTGCAGTTGCC\nCTTGATTGTGAGATTCCCAATGAGTTGCCATATAATGATTACTTTGAGTATTTTGGACCA\nGACTTCAAACTGCATATTAGTCCTTCAAACATGACAAACCAGAACACTCCAGAATATATG\nGAAAAGATAAAACAGCGTTTGTTTGAAAATTTGCGCATGTTACCTCATGCACCTGGTGTC\nCAGATGCAAGCTATTCCAGAAGATGCTGTTCATGAAGACAGTGGAGATGAAGATGGAGAA\nGATCCAGACAAGAGAATTTCTATTCGAGCATCAGACAAGCGGATAGCTTGTGATGAAGAA\nTTCTCAGATTCTGAGGATGAAGGAGAAGGAGGTCGAAGAAATGTGGCTGATCATAAGAAA\nGGAGCAAAGAAAGCTAGAATTGAAGAAGATAAGAAAGAAACAGAGGACAAAAAAACAGAC\nGTTAAGGAAGAAGATAAATCCAAGGACAACAGTGGTGAAAAAACAGATACCAAAGGAACC\nAAATCAGAACAGCTCAGCAACCCCTGA",
                        "Chromosome Location": "6",
                        "Locus": "6q21",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ92769UniProtKB Entry NameHDAC2_HUMANGenBank Protein ID1667394GenBank Gene IDU31814GenAtlas IDHDAC2HGNC IDHGNC:4853",
                        "General References": "Yang WM, Inouye C, Zeng Y, Bearss D, Seto E: Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):12845-50. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Mungall AJ, Palmer SA, Sims SK, Edwards CA, Ashurst JL, Wilming L, Jones MC, Horton R, Hunt SE, Scott CE, Gilbert JG, Clamp ME, Bethel G, Milne S, Ainscough R, Almeida JP, Ambrose KD, Andrews TD, Ashwell RI, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Barker DJ, Barlow KF, Bates K, Beare DM, Beasley H, Beasley O, Bird CP, Blakey S, Bray-Allen S, Brook J, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Carder C, Carter NP, Chapman JC, Clark SY, Clark G, Clee CM, Clegg S, Cobley V, Collier RE, Collins JE, Colman LK, Corby NR, Coville GJ, Culley KM, Dhami P, Davies J, Dunn M, Earthrowl ME, Ellington AE, Evans KA, Faulkner L, Francis MD, Frankish A, Frankland J, French L, Garner P, Garnett J, Ghori MJ, Gilby LM, Gillson CJ, Glithero RJ, Grafham DV, Grant M, Gribble S, Griffiths C, Griffiths M, Hall R, Halls KS, Hammond S, Harley JL, Hart EA, Heath PD, Heathcott R, Holmes SJ, Howden PJ, Howe KL, Howell GR, Huckle E, Humphray SJ, Humphries MD, Hunt AR, Johnson CM, Joy AA, Kay M, Keenan SJ, Kimberley AM, King A, Laird GK, Langford C, Lawlor S, Leongamornlert DA, Leversha M, Lloyd CR, Lloyd DM, Loveland JE, Lovell J, Martin S, Mashreghi-Mohammadi M, Maslen GL, Matthews L, McCann OT, McLaren SJ, McLay K, McMurray A, Moore MJ, Mullikin JC, Niblett D, Nickerson T, Novik KL, Oliver K, Overton-Larty EK, Parker A, Patel R, Pearce AV, Peck AI, Phillimore B, Phillips S, Plumb RW, Porter KM, Ramsey Y, Ranby SA, Rice CM, Ross MT, Searle SM, Sehra HK, Sheridan E, Skuce CD, Smith S, Smith M, Spraggon L, Squares SL, Steward CA, Sycamore N, Tamlyn-Hall G, Tester J, Theaker AJ, Thomas DW, Thorpe A, Tracey A, Tromans A, Tubby B, Wall M, Wallis JM, West AP, White SS, Whitehead SL, Whittaker H, Wild A, Willey DJ, Wilmer TE, Wood JM, Wray PW, Wyatt JC, Young L, Younger RM, Bentley DR, Coulson A, Durbin R, Hubbard T, Sulston JE, Dunham I, Rogers J, Beck S: The DNA sequence and analysis of human chromosome 6. Nature. 2003 Oct 23;425(6960):805-11. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Schmidt DR, Schreiber SL: Molecular association between ATR and two components of the nucleosome remodeling and deacetylating complex, HDAC2 and CHD4. Biochemistry. 1999 Nov 2;38(44):14711-7. [Article] Zhou S, Fujimuro M, Hsieh JJ, Chen L, Hayward SD: A role for SKIP in EBNA2 activation of CBF1-repressed promoters. J Virol. 2000 Feb;74(4):1939-47. [Article] Rountree MR, Bachman KE, Baylin SB: DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat Genet. 2000 Jul;25(3):269-77. [Article] Ahringer J: NuRD and SIN3 histone deacetylase complexes in development. Trends Genet. 2000 Aug;16(8):351-6. [Article] Shi Y, Downes M, Xie W, Kao HY, Ordentlich P, Tsai CC, Hon M, Evans RM: Sharp, an inducible cofactor that integrates nuclear receptor repression and activation. Genes Dev. 2001 May 1;15(9):1140-51. [Article] Amann JM, Nip J, Strom DK, Lutterbach B, Harada H, Lenny N, Downing JR, Meyers S, Hiebert SW: ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol Cell Biol. 2001 Oct;21(19):6470-83. [Article] Fischer DD, Cai R, Bhatia U, Asselbergs FA, Song C, Terry R, Trogani N, Widmer R, Atadja P, Cohen D: Isolation and characterization of a novel class II histone deacetylase, HDAC10. J Biol Chem. 2002 Feb 22;277(8):6656-66. Epub 2001 Dec 5. [Article] Sun JM, Chen HY, Moniwa M, Litchfield DW, Seto E, Davie JR: The transcriptional repressor Sp3 is associated with CK2-phosphorylated histone deacetylase 2. J Biol Chem. 2002 Sep 27;277(39):35783-6. Epub 2002 Aug 9. [Article] Hollenbach AD, McPherson CJ, Mientjes EJ, Iyengar R, Grosveld G: Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek. J Cell Sci. 2002 Aug 15;115(Pt 16):3319-30. [Article] Bereshchenko OR, Gu W, Dalla-Favera R: Acetylation inactivates the transcriptional repressor BCL6. Nat Genet. 2002 Dec;32(4):606-13. Epub 2002 Oct 28. [Article] Bhakat KK, Izumi T, Yang SH, Hazra TK, Mitra S: Role of acetylated human AP-endonuclease (APE1/Ref-1) in regulation of the parathyroid hormone gene. EMBO J. 2003 Dec 1;22(23):6299-309. [Article] Wysocka J, Myers MP, Laherty CD, Eisenman RN, Herr W: Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor HCF-1. Genes Dev. 2003 Apr 1;17(7):896-911. [Article] Hakimi MA, Dong Y, Lane WS, Speicher DW, Shiekhattar R: A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes. J Biol Chem. 2003 Feb 28;278(9):7234-9. Epub 2002 Dec 18. [Article] Fleischer TC, Yun UJ, Ayer DE: Identification and characterization of three new components of the mSin3A corepressor complex. Mol Cell Biol. 2003 May;23(10):3456-67. [Article] Choi YB, Ko JK, Shin J: The transcriptional corepressor, PELP1, recruits HDAC2 and masks histones using two separate domains. J Biol Chem. 2004 Dec 3;279(49):50930-41. Epub 2004 Sep 27. [Article] Castet A, Boulahtouf A, Versini G, Bonnet S, Augereau P, Vignon F, Khochbin S, Jalaguier S, Cavailles V: Multiple domains of the Receptor-Interacting Protein 140 contribute to transcription inhibition. Nucleic Acids Res. 2004 Apr 1;32(6):1957-66. Print 2004. [Article] Gray SG, Iglesias AH, Lizcano F, Villanueva R, Camelo S, Jingu H, Teh BT, Koibuchi N, Chin WW, Kokkotou E, Dangond F: Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein. J Biol Chem. 2005 Aug 5;280(31):28507-18. Epub 2005 May 31. [Article] Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M: Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006 Nov 3;127(3):635-48. [Article] Viiri KM, Korkeamaki H, Kukkonen MK, Nieminen LK, Lindfors K, Peterson P, Maki M, Kainulainen H, Lohi O: SAP30L interacts with members of the Sin3A corepressor complex and targets Sin3A to the nucleolus. Nucleic Acids Res. 2006 Jul 4;34(11):3288-98. Print 2006. [Article] Daub H, Olsen JV, Bairlein M, Gnad F, Oppermann FS, Korner R, Greff Z, Keri G, Stemmann O, Mann M: Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol Cell. 2008 Aug 8;31(3):438-48. doi: 10.1016/j.molcel.2008.07.007. [Article] Mulligan P, Westbrook TF, Ottinger M, Pavlova N, Chang B, Macia E, Shi YJ, Barretina J, Liu J, Howley PM, Elledge SJ, Shi Y: CDYL bridges REST and histone methyltransferases for gene repression and suppression of cellular transformation. Mol Cell. 2008 Dec 5;32(5):718-26. doi: 10.1016/j.molcel.2008.10.025. [Article] Mendez LM, Polo JM, Yu JJ, Krupski M, Ding BB, Melnick A, Ye BH: CtBP is an essential corepressor for BCL6 autoregulation. Mol Cell Biol. 2008 Apr;28(7):2175-86. doi: 10.1128/MCB.01400-07. Epub 2008 Jan 22. [Article] Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP: A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7. doi: 10.1073/pnas.0805139105. Epub 2008 Jul 31. [Article] Zhao WM, Coppinger JA, Seki A, Cheng XL, Yates JR 3rd, Fang G: RCS1, a substrate of APC/C, controls the metaphase to anaphase transition. Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13415-20. doi: 10.1073/pnas.0709227105. Epub 2008 Aug 29. [Article] Gauci S, Helbig AO, Slijper M, Krijgsveld J, Heck AJ, Mohammed S: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal Chem. 2009 Jun 1;81(11):4493-501. doi: 10.1021/ac9004309. [Article] Kajiwara Y, Akram A, Katsel P, Haroutunian V, Schmeidler J, Beecham G, Haines JL, Pericak-Vance MA, Buxbaum JD: FE65 binds Teashirt, inhibiting expression of the primate-specific caspase-4. PLoS One. 2009;4(4):e5071. doi: 10.1371/journal.pone.0005071. Epub 2009 Apr 3. [Article] Oh YM, Kwon YE, Kim JM, Bae SJ, Lee BK, Yoo SJ, Chung CH, Deshaies RJ, Seol JH: Chfr is linked to tumour metastasis through the downregulation of HDAC1. Nat Cell Biol. 2009 Mar;11(3):295-302. doi: 10.1038/ncb1837. Epub 2009 Feb 1. [Article] Mayya V, Lundgren DH, Hwang SI, Rezaul K, Wu L, Eng JK, Rodionov V, Han DK: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal. 2009 Aug 18;2(84):ra46. doi: 10.1126/scisignal.2000007. [Article] Olsen JV, Vermeulen M, Santamaria A, Kumar C, Miller ML, Jensen LJ, Gnad F, Cox J, Jensen TS, Nigg EA, Brunak S, Mann M: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3. doi: 10.1126/scisignal.2000475. [Article] Burkard TR, Planyavsky M, Kaupe I, Breitwieser FP, Burckstummer T, Bennett KL, Superti-Furga G, Colinge J: Initial characterization of the human central proteome. BMC Syst Biol. 2011 Jan 26;5:17. doi: 10.1186/1752-0509-5-17. [Article] Cong L, Pakala SB, Ohshiro K, Li DQ, Kumar R: SUMOylation and SUMO-interacting motif (SIM) of metastasis tumor antigen 1 (MTA1) synergistically regulate its transcriptional repressor function. J Biol Chem. 2011 Dec 23;286(51):43793-808. doi: 10.1074/jbc.M111.267237. Epub 2011 Sep 29. [Article] Sathyan KM, Shen Z, Tripathi V, Prasanth KV, Prasanth SG: A BEN-domain-containing protein associates with heterochromatin and represses transcription. J Cell Sci. 2011 Sep 15;124(Pt 18):3149-63. doi: 10.1242/jcs.086603. [Article] Rowbotham SP, Barki L, Neves-Costa A, Santos F, Dean W, Hawkes N, Choudhary P, Will WR, Webster J, Oxley D, Green CM, Varga-Weisz P, Mermoud JE: Maintenance of silent chromatin through replication requires SWI/SNF-like chromatin remodeler SMARCAD1. Mol Cell. 2011 May 6;42(3):285-96. doi: 10.1016/j.molcel.2011.02.036. [Article] Rigbolt KT, Prokhorova TA, Akimov V, Henningsen J, Johansen PT, Kratchmarova I, Kassem M, Mann M, Olsen JV, Blagoev B: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci Signal. 2011 Mar 15;4(164):rs3. doi: 10.1126/scisignal.2001570. [Article] Xuan C, Wang Q, Han X, Duan Y, Li L, Shi L, Wang Y, Shan L, Yao Z, Shang Y: RBB, a novel transcription repressor, represses the transcription of HDM2 oncogene. Oncogene. 2013 Aug 8;32(32):3711-21. doi: 10.1038/onc.2012.386. Epub 2012 Aug 27. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Hendriks IA, D'Souza RC, Yang B, Verlaan-de Vries M, Mann M, Vertegaal AC: Uncovering global SUMOylation signaling networks in a site-specific manner. Nat Struct Mol Biol. 2014 Oct;21(10):927-36. doi: 10.1038/nsmb.2890. Epub 2014 Sep 14. [Article] Liu J, Xu D, Wang H, Zhang Y, Chang Y, Zhang J, Wang J, Li C, Liu H, Zhao M, Lin C, Zhan Q, Huang C, Qian H: The subcellular distribution and function of MTA1 in cancer differentiation. Oncotarget. 2014 Jul 15;5(13):5153-64. [Article] Bressi JC, Jennings AJ, Skene R, Wu Y, Melkus R, De Jong R, O'Connell S, Grimshaw CE, Navre M, Gangloff AR: Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides. Bioorg Med Chem Lett. 2010 May 15;20(10):3142-5. doi: 10.1016/j.bmcl.2010.03.091. Epub 2010 Mar 30. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB02546Vorinostatapproved, investigationalyesinhibitorDetailsDB05223PracinostatinvestigationalunknownDetailsDB11830MocetinostatinvestigationalunknownDetailsDB00227Lovastatinapproved, investigationalnoinhibitorDetailsDB01303OxtriphyllineapprovedyesactivatorDetailsDB00277TheophyllineapprovedyesactivatorDetailsDB01223AminophyllineapprovedyesactivatorDetailsDB00313Valproic acidapproved, investigationalunknowninhibitorDetailsDB06176Romidepsinapproved, investigationalyesantagonistinhibitorDetailsDB09091Tixocortolapproved, withdrawnyesstimulatorDetailsDB00641SimvastatinapprovedunknowninhibitorDetailsDB00175PravastatinapprovedunknowninhibitorDetailsDB01095FluvastatinapprovedunknowninhibitorDetailsDB01076AtorvastatinapprovedunknowninhibitorDetailsDB05015Belinostatapproved, investigationalyesinhibitorDetailsDB06603Panobinostatapproved, investigationalyesinhibitorDetailsDB02546Vorinostatapproved, investigationalunknowninhibitorDetailsDB12847PyroxamideinvestigationalunknowninhibitorDetailsDB00313Valproic acidapproved, investigationalunknowninhibitorDetailsDB11841EntinostatinvestigationalyesinhibitorDetailsDB06819Phenylbutyric acidapproved, investigationalunknowninhibitorDetailsDB12645GivinostatinvestigationalunknowninhibitorDetailsDB06176Romidepsinapproved, investigationalunknowninhibitorDetailsDB01262Decitabineapproved, investigationalunknowninhibitorDetailsDB12565AbexinostatinvestigationalunknowninhibitorDetailsDB03766Propanoic acidapproved, vet_approvedunknowninhibitorDetails"
                    }
                },
                {
                    "Label": "Nuclear receptor subfamily 1 group I member 3",
                    "Detailed Info": {
                        "Name": "Nuclear receptor subfamily 1 group I member 3",
                        "Synonyms": "CAR\nConstitutive activator of retinoid response\nConstitutive active response\nConstitutive androstane receptor\nOrphan nuclear receptor MB67",
                        "Gene Name": "NR1I3",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0007375|Nuclear receptor subfamily 1 group I member 3\nMASREDELRNCVVCGDQATGYHFNALTCEGCKGFFRRTVSKSIGPTCPFAGSCEVSKTQR\nRHCPACRLQKCLDAGMRKDMILSAEALALRRAKQAQRRAQQTPVQLSKEQEELIRTLLGA\nHTRHMGTMFEQFVQFRPPAHLFIHHQPLPTLAPVLPLVTHFADINTFMVLQVIKFTKDLP\nVFRSLPIEDQISLLKGAAVEICHIVLNTTFCLQTQNFLCGPLRYTIEDGARVSPTVGFQV\nEFLELLFHFHGTLRKLQLQEPEYVLLAAMALFSPDRPGVTQRDEIDQLQEEMALTLQSYI\nKGQQRRPRDRFLYAKLLGLLAELRSINEAYGYQIQHIQGLSAMMPLLQEICS",
                        "Number of residues": "352",
                        "Molecular Weight": "39942.145",
                        "Theoretical pI": "8.26",
                        "GO Classification": "Functionsandrogen receptor activity / DNA binding / RNA polymerase II regulatory region sequence-specific DNA binding / RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding / thyroid hormone receptor activity / transcription coactivator activity / transcription factor activity, sequence-specific DNA binding / transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding / zinc ion bindingProcessesandrogen receptor signaling pathway / gene expression / intracellular receptor signaling pathway / negative regulation of transcription, DNA-templated / osteoblast differentiation / positive regulation of transcription from RNA polymerase II promoter / signal transduction / transcription initiation from RNA polymerase II promoterComponentscytoplasm / cytoskeleton / cytosol / nucleoplasm / nucleus",
                        "General Function": "Zinc ion binding",
                        "Specific Function": "Binds and transactivates the retinoic acid response elements that control expression of the retinoic acid receptor beta 2 and alcohol dehydrogenase 3 genes. Transactivates both the phenobarbital responsive element module of the human CYP2B6 gene and the CYP3A4 xenobiotic response element.",
                        "Pfam Domain Function": "Hormone_recep (PF00104)\nzf-C4 (PF00105)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Nucleus",
                        "Gene sequence": ">lcl|BSEQ0019481|Nuclear receptor subfamily 1 group I member 3 (NR1I3)\nATGGCCAGTAGGGAAGATGAGCTGAGGAACTGTGTGGTATGTGGGGACCAAGCCACAGGC\nTACCACTTTAATGCGCTGACTTGTGAGGGCTGCAAGGGTTTCTTCAGGAGAACAGTCAGC\nAAAAGCATTGGTCCCACCTGCCCCTTTGCTGGAAGCTGTGAAGTCAGCAAGACTCAGAGG\nCGCCACTGCCCAGCCTGCAGGTTGCAGAAGTGCTTAGATGCTGGCATGAGGAAAGACATG\nATACTGTCGGCAGAAGCCCTGGCATTGCGGCGAGCAAAGCAGGCCCAGCGGCGGGCACAG\nCAAACACCTGTGCAACTGAGTAAGGAGCAAGAAGAGCTGATCCGGACACTCCTGGGGGCC\nCACACCCGCCACATGGGCACCATGTTTGAACAGTTTGTGCAGTTTAGGCCTCCAGCTCAT\nCTGTTCATCCATCACCAGCCCTTGCCCACCCTGGCCCCTGTGCTGCCTCTGGTCACACAC\nTTCGCAGACATCAACACTTTCATGGTACTGCAAGTCATCAAGTTTACTAAGGACCTGCCC\nGTCTTCCGTTCCCTGCCCATTGAAGACCAGATCTCCCTTCTCAAGGGAGCAGCTGTGGAA\nATCTGTCACATCGTACTCAATACCACTTTCTGTCTCCAAACACAAAACTTCCTCTGCGGG\nCCTCTTCGCTACACAATTGAAGATGGAGCCCGTGTGGGGTTCCAGGTAGAGTTTTTGGAG\nTTGCTCTTTCACTTCCATGGAACACTACGAAAACTGCAGCTCCAAGAGCCTGAGTATGTG\nCTCTTGGCTGCCATGGCCCTCTTCTCTCCTGCTCCCTATCTTACAGACCGACCTGGAGTT\nACCCAGAGAGATGAGATTGATCAGCTGCAAGAGGAGATGGCACTGACTCTGCAAAGCTAC\nATCAAGGGCCAGCAGCGAAGGCCCCGGGATCGCTCACCTGGAACACCCTGGATACACTGG\nAGTGGGAAAATGCTGGGACCAAAGATTGGGCCGGGTTCAAAGGGAGCCCAGTGGTTGCAA\nTGA",
                        "Chromosome Location": "1",
                        "Locus": "1q23.3",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ14994UniProtKB Entry NameNR1I3_HUMANGenBank Protein ID458542GenBank Gene IDZ30425HGNC IDHGNC:7969",
                        "General References": "Baes M, Gulick T, Choi HS, Martinoli MG, Simha D, Moore DD: A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol Cell Biol. 1994 Mar;14(3):1544-52. [Article] Lamba JK, Lamba V, Yasuda K, Lin YS, Assem M, Thompson E, Strom S, Schuetz E: Expression of constitutive androstane receptor splice variants in human tissues and their functional consequences. J Pharmacol Exp Ther. 2004 Nov;311(2):811-21. Epub 2004 Jun 11. [Article] Gregory SG, Barlow KF, McLay KE, Kaul R, Swarbreck D, Dunham A, Scott CE, Howe KL, Woodfine K, Spencer CC, Jones MC, Gillson C, Searle S, Zhou Y, Kokocinski F, McDonald L, Evans R, Phillips K, Atkinson A, Cooper R, Jones C, Hall RE, Andrews TD, Lloyd C, Ainscough R, Almeida JP, Ambrose KD, Anderson F, Andrew RW, Ashwell RI, Aubin K, Babbage AK, Bagguley CL, Bailey J, Beasley H, Bethel G, Bird CP, Bray-Allen S, Brown JY, Brown AJ, Buckley D, Burton J, Bye J, Carder C, Chapman JC, Clark SY, Clarke G, Clee C, Cobley V, Collier RE, Corby N, Coville GJ, Davies J, Deadman R, Dunn M, Earthrowl M, Ellington AG, Errington H, Frankish A, Frankland J, French L, Garner P, Garnett J, Gay L, Ghori MR, Gibson R, Gilby LM, Gillett W, Glithero RJ, Grafham DV, Griffiths C, Griffiths-Jones S, Grocock R, Hammond S, Harrison ES, Hart E, Haugen E, Heath PD, Holmes S, Holt K, Howden PJ, Hunt AR, Hunt SE, Hunter G, Isherwood J, James R, Johnson C, Johnson D, Joy A, Kay M, Kershaw JK, Kibukawa M, Kimberley AM, King A, Knights AJ, Lad H, Laird G, Lawlor S, Leongamornlert DA, Lloyd DM, Loveland J, Lovell J, Lush MJ, Lyne R, Martin S, Mashreghi-Mohammadi M, Matthews L, Matthews NS, McLaren S, Milne S, Mistry S, Moore MJ, Nickerson T, O'Dell CN, Oliver K, Palmeiri A, Palmer SA, Parker A, Patel D, Pearce AV, Peck AI, Pelan S, Phelps K, Phillimore BJ, Plumb R, Rajan J, Raymond C, Rouse G, Saenphimmachak C, Sehra HK, Sheridan E, Shownkeen R, Sims S, Skuce CD, Smith M, Steward C, Subramanian S, Sycamore N, Tracey A, Tromans A, Van Helmond Z, Wall M, Wallis JM, White S, Whitehead SL, Wilkinson JE, Willey DL, Williams H, Wilming L, Wray PW, Wu Z, Coulson A, Vaudin M, Sulston JE, Durbin R, Hubbard T, Wooster R, Dunham I, Carter NP, McVean G, Ross MT, Harrow J, Olson MV, Beck S, Rogers J, Bentley DR, Banerjee R, Bryant SP, Burford DC, Burrill WD, Clegg SM, Dhami P, Dovey O, Faulkner LM, Gribble SM, Langford CF, Pandian RD, Porter KM, Prigmore E: The DNA sequence and biological annotation of human chromosome 1. Nature. 2006 May 18;441(7091):315-21. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Choi HS, Seol W, Moore DD: A component of the 26S proteasome binds on orphan member of the nuclear hormone receptor superfamily. J Steroid Biochem Mol Biol. 1996 Jan;56(1-6 Spec No):23-30. [Article] Kobayashi K, Sueyoshi T, Inoue K, Moore R, Negishi M: Cytoplasmic accumulation of the nuclear receptor CAR by a tetratricopeptide repeat protein in HepG2 cells. Mol Pharmacol. 2003 Nov;64(5):1069-75. [Article] Mutoh S, Osabe M, Inoue K, Moore R, Pedersen L, Perera L, Rebolloso Y, Sueyoshi T, Negishi M: Dephosphorylation of threonine 38 is required for nuclear translocation and activation of human xenobiotic receptor CAR (NR1I3). J Biol Chem. 2009 Dec 11;284(50):34785-92. doi: 10.1074/jbc.M109.048108. Epub 2009 Oct 26. [Article] Xu RX, Lambert MH, Wisely BB, Warren EN, Weinert EE, Waitt GM, Williams JD, Collins JL, Moore LB, Willson TM, Moore JT: A structural basis for constitutive activity in the human CAR/RXRalpha heterodimer. Mol Cell. 2004 Dec 22;16(6):919-28. [Article] Ikeda S, Kurose K, Ozawa S, Sai K, Hasegawa R, Komamura K, Ueno K, Kamakura S, Kitakaze M, Tomoike H, Nakajima T, Matsumoto K, Saito H, Goto Y, Kimura H, Katoh M, Sugai K, Minami N, Shirao K, Tamura T, Yamamoto N, Minami H, Ohtsu A, Yoshida T, Saijo N, Saito Y, Sawada J: Twenty-six novel single nucleotide polymorphisms and their frequencies of the NR1I3 (CAR) gene in a Japanese population. Drug Metab Pharmacokinet. 2003;18(6):413-8. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB0188916,17-Androstene-3-OlexperimentalunknownDetailsDB075573,20-PregnanedioneexperimentalunknownDetailsDB01708Prasteroneapproved, investigational, nutraceuticalunknownactivatorDetailsDB00737Meclizineapprovedunknowninverse agonistDetailsDB04540Cholesterolapproved, investigationalunknownDetailsDB00366Doxylamineapproved, vet_approvedunknownDetailsDB07931HexestrolwithdrawnunknownDetailsDB01026Ketoconazoleapproved, investigationalunknownDetailsDB01620PheniramineapprovedunknownDetailsDB04824Phenolphthaleinapproved, withdrawnunknownDetailsDB02709ResveratrolinvestigationalunknownDetailsDB08604Triclosanapproved, investigationalunknowninverse agonistDetailsDB01076AtorvastatinapprovedunknownligandDetails"
                    }
                }
            ],
            "enzymes": [
                {
                    "Label": "Cytochrome P450 3A4",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 3A4",
                        "Synonyms": "1,8-cineole 2-exo-monooxygenase\n1.14.13.-\nAlbendazole monooxygenase\nAlbendazole sulfoxidase\nCholesterol 25-hydroxylase\nCYP3A3\nCYPIIIA3\nCYPIIIA4\nCytochrome P450 3A3\nCytochrome P450 HLp\nCytochrome P450 NF-25\nCytochrome P450-PCN1\nNifedipine oxidase\nQuinine 3-monooxygenase\nTaurochenodeoxycholate 6-alpha-hydroxylase",
                        "Gene Name": "CYP3A4",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0021936|Cytochrome P450 3A4\nMALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMF\nDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISI\nAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYS\nMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICV\nFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSI\nIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVV\nNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFS\nKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLG\nGLLQPEKPVVLKVESRDGTVSGA",
                        "Number of residues": "503",
                        "Molecular Weight": "57342.67",
                        "Theoretical pI": "8.25",
                        "GO Classification": "Functionsalbendazole monooxygenase activity / aromatase activity / caffeine oxidase activity / enzyme binding / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity / oxygen binding / quinine 3-monooxygenase activity / steroid binding / steroid hydroxylase activity / taurochenodeoxycholate 6alpha-hydroxylase activity / testosterone 6-beta-hydroxylase activity / vitamin D 24-hydroxylase activity / vitamin D3 25-hydroxylase activityProcessesalkaloid catabolic process / androgen metabolic process / calcitriol biosynthetic process from calciol / drug catabolic process / drug metabolic process / exogenous drug catabolic process / heterocycle metabolic process / lipid metabolic process / monoterpenoid metabolic process / oxidation-reduction process / oxidative demethylation / small molecule metabolic process / steroid catabolic process / steroid metabolic process / vitamin D metabolic process / xenobiotic metabolic processComponentscytoplasm / endoplasmic reticulum membrane / integral component of membrane / intracellular membrane-bounded organelle",
                        "General Function": "Vitamin d3 25-hydroxylase activity",
                        "Specific Function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation reactions (e.g. caffeine 8-oxidation, omeprazole sulphoxidation, midazolam 1'-hydroxylation and midazolam 4-hydroxylation) of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,8-cineole 2-exo-monooxygenase. The enzyme also hydroxylates etoposide (PubMed:11159812). Catalyzes 4-beta-hydroxylation of cholesterol. May catalyze 25-hydroxylation of cholesterol in vitro (PubMed:21576599).",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "2-22",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0021937|Cytochrome P450 3A4 (CYP3A4)\nATGGCTCTCATCCCAGACTTGGCCATGGAAACCTGGCTTCTCCTGGCTGTCAGCCTGGTG\nCTCCTCTATCTATATGGAACCCATTCACATGGACTTTTTAAGAAGCTTGGAATTCCAGGG\nCCCACACCTCTGCCTTTTTTGGGAAATATTTTGTCCTACCATAAGGGCTTTTGTATGTTT\nGACATGGAATGTCATAAAAAGTATGGAAAAGTGTGGGGCTTTTATGATGGTCAACAGCCT\nGTGCTGGCTATCACAGATCCTGACATGATCAAAACAGTGCTAGTGAAAGAATGTTATTCT\nGTCTTCACAAACCGGAGGCCTTTTGGTCCAGTGGGATTTATGAAAAGTGCCATCTCTATA\nGCTGAGGATGAAGAATGGAAGAGATTACGATCATTGCTGTCTCCAACCTTCACCAGTGGA\nAAACTCAAGGAGATGGTCCCTATCATTGCCCAGTATGGAGATGTGTTGGTGAGAAATCTG\nAGGCGGGAAGCAGAGACAGGCAAGCCTGTCACCTTGAAAGACGTCTTTGGGGCCTACAGC\nATGGATGTGATCACTAGCACATCATTTGGAGTGAACATCGACTCTCTCAACAATCCACAA\nGACCCCTTTGTGGAAAACACCAAGAAGCTTTTAAGATTTGATTTTTTGGATCCATTCTTT\nCTCTCAATAATCTTTCCATTCCTCATCCCAATTCTTGAAGTATTAAATATCTGTGTGTTT\nCCAAGAGAAGTTACAAATTTTTTAAGAAAATCTGTAAAAAGGATGAAAGAAAGTCGCCTC\nGAAGATACACAAAAGCACCGAGTGGATTTCCTTCAGCTGATGATTGACTCTCAGAATTCA\nAAAGAAACTGAGTCCCACAAAGCTCTGTCCGATCTGGAGCTCGTGGCCCAATCAATTATC\nTTTATTTTTGCTGGCTATGAAACCACGAGCAGTGTTCTCTCCTTCATTATGTATGAACTG\nGCCACTCACCCTGATGTCCAGCAGAAACTGCAGGAGGAAATTGATGCAGTTTTACCCAAT\nAAGGCACCACCCACCTATGATACTGTGCTACAGATGGAGTATCTTGACATGGTGGTGAAT\nGAAACGCTCAGATTATTCCCAATTGCTATGAGACTTGAGAGGGTCTGCAAAAAAGATGTT\nGAGATCAATGGGATGTTCATTCCCAAAGGGGTGGTGGTGATGATTCCAAGCTATGCTCTT\nCACCGTGACCCAAAGTACTGGACAGAGCCTGAGAAGTTCCTCCCTGAAAGATTCAGCAAG\nAAGAACAAGGACAACATAGATCCTTACATATACACACCCTTTGGAAGTGGACCCAGAAAC\nTGCATTGGCATGAGGTTTGCTCTCATGAACATGAAACTTGCTCTAATCAGAGTCCTTCAG\nAACTTCTCCTTCAAACCTTGTAAAGAAACACAGATCCCCCTGAAATTAAGCTTAGGAGGA\nCTTCTTCAACCAGAAAAACCCGTTGTTCTAAAGGTTGAGTCAAGGGATGGCACCGTAAGT\nGGAGCCTGA",
                        "Chromosome Location": "7",
                        "Locus": "7q21.1",
                        "External Identifiers": "ResourceLinkUniProtKB IDP08684UniProtKB Entry NameCP3A4_HUMANGenBank Gene IDM18907GenAtlas IDCYP3A4HGNC IDHGNC:2637",
                        "General References": "Molowa DT, Schuetz EG, Wrighton SA, Watkins PB, Kremers P, Mendez-Picon G, Parker GA, Guzelian PS: Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver. Proc Natl Acad Sci U S A. 1986 Jul;83(14):5311-5. [Article] Gonzalez FJ, Schmid BJ, Umeno M, Mcbride OW, Hardwick JP, Meyer UA, Gelboin HV, Idle JR: Human P450PCN1: sequence, chromosome localization, and direct evidence through cDNA expression that P450PCN1 is nifedipine oxidase. DNA. 1988 Mar;7(2):79-86. [Article] Beaune PH, Umbenhauer DR, Bork RW, Lloyd RS, Guengerich FP: Isolation and sequence determination of a cDNA clone related to human cytochrome P-450 nifedipine oxidase. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8064-8. [Article] Spurr NK, Gough AC, Stevenson K, Wolf CR: The human cytochrome P450 CYP3 locus: assignment to chromosome 7q22-qter. Hum Genet. 1989 Jan;81(2):171-4. [Article] Bork RW, Muto T, Beaune PH, Srivastava PK, Lloyd RS, Guengerich FP: Characterization of mRNA species related to human liver cytochrome P-450 nifedipine oxidase and the regulation of catalytic activity. J Biol Chem. 1989 Jan 15;264(2):910-9. [Article] Chen Q, Wu J, Yu Y: [Establishment of transgenic cell line CHL-3A4 and its metabolic activation]. Zhonghua Yu Fang Yi Xue Za Zhi. 1998 Sep;32(5):281-4. [Article] Gellner K, Eiselt R, Hustert E, Arnold H, Koch I, Haberl M, Deglmann CJ, Burk O, Buntefuss D, Escher S, Bishop C, Koebe HG, Brinkmann U, Klenk HP, Kleine K, Meyer UA, Wojnowski L: Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics. 2001 Mar;11(2):111-21. [Article] Hsieh KP, Lin YY, Cheng CL, Lai ML, Lin MS, Siest JP, Huang JD: Novel mutations of CYP3A4 in Chinese. Drug Metab Dispos. 2001 Mar;29(3):268-73. [Article] Komori M, Hashizume T, Ohi H, Miura T, Kitada M, Nagashima K, Kamataki T: Cytochrome P-450 in human liver microsomes: high-performance liquid chromatographic isolation of three forms and their characterization. J Biochem. 1988 Dec;104(6):912-6. [Article] Watkins PB, Wrighton SA, Maurel P, Schuetz EG, Mendez-Picon G, Parker GA, Guzelian PS: Identification of an inducible form of cytochrome P-450 in human liver. Proc Natl Acad Sci U S A. 1985 Sep;82(18):6310-4. [Article] Aoyama T, Yamano S, Waxman DJ, Lapenson DP, Meyer UA, Fischer V, Tyndale R, Inaba T, Kalow W, Gelboin HV, et al.: Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. J Biol Chem. 1989 Jun 25;264(18):10388-95. [Article] Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP: Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther. 1994 Jul;270(1):414-23. [Article] Kolars JC, Lown KS, Schmiedlin-Ren P, Ghosh M, Fang C, Wrighton SA, Merion RM, Watkins PB: CYP3A gene expression in human gut epithelium. Pharmacogenetics. 1994 Oct;4(5):247-59. [Article] Zhang H, Coville PF, Walker RJ, Miners JO, Birkett DJ, Wanwimolruk S: Evidence for involvement of human CYP3A in the 3-hydroxylation of quinine. Br J Clin Pharmacol. 1997 Mar;43(3):245-52. [Article] Zhao XJ, Kawashiro T, Ishizaki T: Mutual inhibition between quinine and etoposide by human liver microsomes. Evidence for cytochrome P4503A4 involvement in their major metabolic pathways. Drug Metab Dispos. 1998 Feb;26(2):188-91. [Article] Miyazawa M, Shindo M, Shimada T: Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes. Drug Metab Dispos. 2001 Feb;29(2):200-5. [Article] Finta C, Zaphiropoulos PG: Intergenic mRNA molecules resulting from trans-splicing. J Biol Chem. 2002 Feb 22;277(8):5882-90. Epub 2001 Nov 28. [Article] Dauchy S, Dutheil F, Weaver RJ, Chassoux F, Daumas-Duport C, Couraud PO, Scherrmann JM, De Waziers I, Decleves X: ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J Neurochem. 2008 Dec;107(6):1518-28. doi: 10.1111/j.1471-4159.2008.05720.x. [Article] Agarwal V, Kommaddi RP, Valli K, Ryder D, Hyde TM, Kleinman JE, Strobel HW, Ravindranath V: Drug metabolism in human brain: high levels of cytochrome P4503A43 in brain and metabolism of anti-anxiety drug alprazolam to its active metabolite. PLoS One. 2008 Jun 11;3(6):e2337. doi: 10.1371/journal.pone.0002337. [Article] Pabarcus MK, Hoe N, Sadeghi S, Patterson C, Wiertz E, Correia MA: CYP3A4 ubiquitination by gp78 (the tumor autocrine motility factor receptor, AMFR) and CHIP E3 ligases. Arch Biochem Biophys. 2009 Mar 1;483(1):66-74. doi: 10.1016/j.abb.2008.12.001. Epub 2008 Dec 10. [Article] Dutheil F, Dauchy S, Diry M, Sazdovitch V, Cloarec O, Mellottee L, Bieche I, Ingelman-Sundberg M, Flinois JP, de Waziers I, Beaune P, Decleves X, Duyckaerts C, Loriot MA: Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function. Drug Metab Dispos. 2009 Jul;37(7):1528-38. doi: 10.1124/dmd.109.027011. Epub 2009 Apr 9. [Article] Honda A, Miyazaki T, Ikegami T, Iwamoto J, Maeda T, Hirayama T, Saito Y, Teramoto T, Matsuzaki Y: Cholesterol 25-hydroxylation activity of CYP3A. J Lipid Res. 2011 Aug;52(8):1509-16. doi: 10.1194/jlr.M014084. Epub 2011 May 16. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Yano JK, Wester MR, Schoch GA, Griffin KJ, Stout CD, Johnson EF: The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-A resolution. J Biol Chem. 2004 Sep 10;279(37):38091-4. Epub 2004 Jul 16. [Article] Williams PA, Cosme J, Vinkovic DM, Ward A, Angove HC, Day PJ, Vonrhein C, Tickle IJ, Jhoti H: Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone. Science. 2004 Jul 30;305(5684):683-6. Epub 2004 Jul 15. [Article] Sata F, Sapone A, Elizondo G, Stocker P, Miller VP, Zheng W, Raunio H, Crespi CL, Gonzalez FJ: CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activity. Clin Pharmacol Ther. 2000 Jan;67(1):48-56. [Article] Dai D, Tang J, Rose R, Hodgson E, Bienstock RJ, Mohrenweiser HW, Goldstein JA: Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos. J Pharmacol Exp Ther. 2001 Dec;299(3):825-31. [Article] Eiselt R, Domanski TL, Zibat A, Mueller R, Presecan-Siedel E, Hustert E, Zanger UM, Brockmoller J, Klenk HP, Meyer UA, Khan KK, He YA, Halpert JR, Wojnowski L: Identification and functional characterization of eight CYP3A4 protein variants. Pharmacogenetics. 2001 Jul;11(5):447-58. [Article] Lamba JK, Lin YS, Thummel K, Daly A, Watkins PB, Strom S, Zhang J, Schuetz EG: Common allelic variants of cytochrome P4503A4 and their prevalence in different populations. Pharmacogenetics. 2002 Mar;12(2):121-32. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB05478Pradefovir mesylateinvestigationalunknownDetailsDB00180Flunisolideapproved, investigationalunknownsubstrateinducerDetailsDB00185CevimelineapprovedunknownsubstrateDetailsDB00188Bortezomibapproved, investigationalnosubstrateDetailsDB00196Fluconazoleapproved, investigationalunknowninhibitorDetailsDB00204Dofetilideapproved, investigationalunknownsubstrateDetailsDB00213PantoprazoleapprovedunknownsubstrateDetailsDB00216Eletriptanapproved, investigationalunknownsubstrateDetailsDB00220NelfinavirapprovednosubstrateinhibitorDetailsDB00224IndinavirapprovedunknownsubstrateinhibitorDetailsDB00227Lovastatinapproved, investigationalunknownsubstrateinhibitorDetailsDB00234Reboxetineapproved, experimentalunknownsubstrateinhibitorDetailsDB00238NevirapineapprovedunknownsubstrateinducerDetailsDB00243Ranolazineapproved, investigationalnosubstrateinhibitorDetailsDB00246ZiprasidoneapprovedunknownsubstrateDetailsDB00270Isradipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00280DisopyramideapprovedunknownsubstrateDetailsDB00286Conjugated estrogensapprovednosubstrateDetailsDB00294Etonogestrelapproved, investigationalnosubstrateDetailsDB00297Bupivacaineapproved, investigationalunknownsubstrateDetailsDB00307Bexaroteneapproved, investigationalunknownsubstrateinducerDetailsDB00309Vindesineapproved, investigationalunknownsubstrateDetailsDB00317Gefitinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00320Dihydroergotamineapproved, investigationalunknownsubstrateinhibitorDetailsDB00324Fluorometholoneapproved, investigationalunknownsubstrateinducerDetailsDB00342Terfenadineapproved, withdrawnunknownsubstrateinhibitorDetailsDB00343Diltiazemapproved, investigationalunknownsubstrateinhibitorDetailsDB00346Alfuzosinapproved, investigationalunknownsubstrateDetailsDB00361Vinorelbineapproved, investigationalnosubstrateDetailsDB00365Grepafloxacinapproved, investigational, withdrawnunknownsubstrateDetailsDB00370MirtazapineapprovedunknownsubstrateinhibitorDetailsDB00381AmlodipineapprovednosubstrateDetailsDB00393Nimodipineapproved, investigationalunknownsubstrateDetailsDB00398Sorafenibapproved, investigationalunknownsubstrateinhibitorDetailsDB00401NisoldipineapprovedunknownsubstrateDetailsDB00402Eszopicloneapproved, investigationalunknownsubstrateDetailsDB00404Alprazolamapproved, illicit, investigationalunknownsubstrateDetailsDB00425ZolpidemapprovedunknownsubstrateDetailsDB00443Betamethasoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00455Loratadineapproved, investigationalnosubstrateinhibitorDetailsDB00468QuinineapprovedunknownsubstrateinhibitorinducerDetailsDB00470Dronabinolapproved, illicitnosubstrateinhibitorDetailsDB00471MontelukastapprovedunknownsubstrateDetailsDB00490Buspironeapproved, investigationalunknownsubstrateDetailsDB00496Darifenacinapproved, investigationalunknownsubstrateDetailsDB00518Albendazoleapproved, vet_approvedunknownsubstrateDetailsDB00528Lercanidipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00533Rofecoxibapproved, investigational, withdrawnunknownsubstrateinducerDetailsDB00539Toremifeneapproved, investigationalunknownsubstrateinhibitorDetailsDB00541Vincristineapproved, investigationalunknownsubstrateDetailsDB00559Bosentanapproved, investigationalunknownsubstrateinducerDetailsDB00570VinblastineapprovedunknownsubstrateinhibitorinducerDetailsDB00582VoriconazoleapprovedunknownsubstrateinhibitorDetailsDB00588Fluticasone propionateapprovedunknownsubstrateinhibitorDetailsDB00593EthosuximideapprovedunknownsubstrateDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknownsubstrateinducerDetailsDB00604Cisaprideapproved, investigational, withdrawnunknownsubstrateDetailsDB00615Rifabutinapproved, investigationalunknownsubstrateinducerDetailsDB00619ImatinibapprovednosubstrateinhibitorDetailsDB00622Nicardipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00624Testosteroneapproved, investigationalunknownsubstrateinducerDetailsDB00625Efavirenzapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00635Prednisoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00636Clofibrateapproved, investigationalunknownsubstrateinducerDetailsDB00637Astemizoleapproved, withdrawnunknownsubstrateinhibitorDetailsDB00641SimvastatinapprovedunknownsubstrateDetailsDB00673Aprepitantapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00674GalantamineapprovednosubstrateDetailsDB00675TamoxifenapprovedunknownsubstrateinhibitorinducerDetailsDB00678LosartanapprovedunknownsubstrateinhibitorDetailsDB00683Midazolamapproved, illicitunknownsubstrateinhibitorDetailsDB00696ErgotamineapprovedunknownsubstrateinhibitorDetailsDB00700EplerenoneapprovedunknownsubstrateDetailsDB00701Amprenavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00705DelavirdineapprovedunknownsubstrateinhibitorDetailsDB00731Nateglinideapproved, investigationalunknownsubstrateDetailsDB00736Esomeprazoleapproved, investigationalunknownsubstrateDetailsDB00741Hydrocortisoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00744Zileutonapproved, investigational, withdrawnunknownsubstrateDetailsDB00745Modafinilapproved, investigationalunknownsubstrateinducerDetailsDB00757Dolasetronapproved, investigationalunknownsubstrateDetailsDB00758ClopidogrelapprovednosubstrateDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateinhibitorDetailsDB00769HydrocortamateapprovedunknowninducerDetailsDB00773EtoposideapprovedunknownsubstrateinhibitorinducerDetailsDB00778Roxithromycinapproved, investigational, withdrawnnosubstrateinhibitorDetailsDB00802Alfentanilapproved, illicitunknownsubstrateDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB00820Tadalafilapproved, investigationalnosubstrateDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00834Mifepristoneapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00836LoperamideapprovedunknownsubstrateinhibitorDetailsDB00843DonepezilapprovedunknownsubstrateDetailsDB00860Prednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB00862VardenafilapprovedunknownsubstrateinhibitorDetailsDB00864Tacrolimusapproved, investigationalunknownsubstrateDetailsDB00872Conivaptanapproved, investigationalunknownsubstrateinhibitorDetailsDB00877Sirolimusapproved, investigationalnosubstrateDetailsDB00889Granisetronapproved, investigationalunknownsubstrateDetailsDB00897Triazolamapproved, investigationalunknownsubstrateDetailsDB00904Ondansetronapproved, withdrawnunknownsubstrateDetailsDB00906Tiagabineapproved, investigationalunknownsubstrateDetailsDB00907Cocaineapproved, illicitunknownsubstrateDetailsDB00909Zonisamideapproved, investigationalunknownsubstrateDetailsDB00910Paricalcitolapproved, investigationalunknownsubstrateDetailsDB00911Tinidazoleapproved, investigationalunknownsubstrateDetailsDB00918Almotriptanapproved, investigationalunknownsubstrateDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00932Tipranavirapproved, investigationalunknownsubstrateinhibitorDetailsDB00938SalmeterolapprovedunknownsubstrateDetailsDB00956Hydrocodoneapproved, illicit, investigationalunknownsubstrateDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB00962Zaleplonapproved, illicit, investigationalunknownsubstrateDetailsDB00976TelithromycinapprovedunknownsubstrateinhibitorDetailsDB00977EthinylestradiolapprovedunknownsubstrateDetailsDB00990Exemestaneapproved, investigationalunknownsubstrateDetailsDB00997Doxorubicinapproved, investigationalnosubstrateinhibitorDetailsDB01002Levobupivacaineapproved, investigationalunknownsubstrateDetailsDB01006Letrozoleapproved, investigationalunknownsubstrateDetailsDB01008Busulfanapproved, investigationalunknownsubstrateDetailsDB01012CinacalcetapprovedunknownsubstrateDetailsDB01023Felodipineapproved, investigationalunknownsubstrateDetailsDB01026Ketoconazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB01045RifampicinapprovedunknowninducerDetailsDB01054Nitrendipineapproved, investigationalunknownsubstrateDetailsDB01062Oxybutyninapproved, investigationalunknownsubstrateinhibitorDetailsDB01068Clonazepamapproved, illicitunknownsubstrateDetailsDB01072Atazanavirapproved, investigationalnosubstrateinhibitorDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB01100PimozideapprovedunknownsubstrateDetailsDB01105Sibutramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB01114ChlorpheniramineapprovedunknownsubstrateDetailsDB01115NifedipineapprovedunknownsubstrateinhibitorinducerDetailsDB01129Rabeprazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB01132Pioglitazoneapproved, investigationalunknownsubstrateinducerDetailsDB01149Nefazodoneapproved, withdrawnunknownsubstrateinhibitorDetailsDB01166Cilostazolapproved, investigationalunknownsubstrateDetailsDB01167Itraconazoleapproved, investigationalnosubstrateinhibitorDetailsDB01175EscitalopramapprovednosubstrateDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB01190Clindamycinapproved, vet_approvedunknownsubstrateinhibitorDetailsDB01200Bromocriptineapproved, investigational, withdrawnnosubstrateinhibitorDetailsDB01206Lomustineapproved, investigationalunknowninhibitorDetailsDB01211ClarithromycinapprovedunknownsubstrateinhibitorDetailsDB01215Estazolamapproved, illicitunknownsubstrateDetailsDB01216FinasterideapprovedunknownsubstrateDetailsDB01218HalofantrineapprovedunknownsubstrateDetailsDB01222BudesonideapprovednosubstrateinducerDetailsDB01224QuetiapineapprovedunknownsubstrateDetailsDB01227Levacetylmethadolapproved, investigational, withdrawnunknownsubstrateDetailsDB01229Paclitaxelapproved, vet_approvedunknownsubstrateinducerDetailsDB01232Saquinavirapproved, investigationalunknownsubstrateinhibitorDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB01238Aripiprazoleapproved, investigationalnosubstrateDetailsDB01254Dasatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB01256RetapamulinapprovedunknownsubstrateDetailsDB01261Sitagliptinapproved, investigationalunknownsubstrateDetailsDB01259Lapatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB01264DarunavirapprovedunknownsubstrateinhibitorDetailsDB01268Sunitinibapproved, investigationalnosubstrateinhibitorDetailsDB01263Posaconazoleapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB01388Mibefradilinvestigational, withdrawnunknownsubstrateinhibitorDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknowninducerDetailsDB01601LopinavirapprovedunknownsubstrateinhibitorDetailsDB01411PranlukastinvestigationalnosubstrateDetailsDB01410Ciclesonideapproved, investigationalnosubstrateDetailsDB00969Alosetronapproved, withdrawnunknownsubstrateDetailsDB04835Maravirocapproved, investigationalunknownsubstrateDetailsDB01409TiotropiumapprovedunknownsubstrateDetailsDB01591SolifenacinapprovednosubstrateDetailsDB01011Metyraponeapproved, investigationalunknowninhibitorinducerDetailsDB00377Palonosetronapproved, investigationalunknownsubstrateDetailsDB04856DexloxiglumideinvestigationalunknownsubstrateDetailsDB04886Calanolide AinvestigationalunknownsubstrateDetailsDB00580Valdecoxibapproved, investigational, withdrawnunknownsubstrateDetailsDB06144Sertindoleapproved, investigational, withdrawnunknownsubstrateDetailsDB04977PlitidepsininvestigationalunknownsubstrateDetailsDB04905TesmilifeneinvestigationalunknownsubstrateinhibitorinducerDetailsDB00333MethadoneapprovedunknownsubstrateinhibitorinducerDetailsDB04934RifalazilinvestigationalunknownsubstrateDetailsDB04957AzimilideinvestigationalunknownsubstrateDetailsDB00199Erythromycinapproved, investigational, vet_approvednosubstrateinhibitorDetailsDB01628Etoricoxibapproved, investigationalunknownsubstrateinhibitorDetailsDB00564Carbamazepineapproved, investigationalunknownsubstrateinducerDetailsDB06155Rimonabantapproved, investigationalunknownsubstrateDetailsDB06267Udenafilapproved, investigationalunknownsubstrateDetailsDB06287TemsirolimusapprovedunknownsubstrateDetailsDB06442AvasimibeinvestigationalunknowninducerDetailsDB08502CapravirineinvestigationalunknownsubstrateDetailsDB06652VicrivirocinvestigationalunknownsubstrateDetailsDB06685LaquinimodinvestigationalunknownsubstrateDetailsDB01095FluvastatinapprovedunknownsubstrateinhibitorDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateDetailsDB00248CabergolineapprovedunknownsubstrateDetailsDB00589Lisurideapproved, investigationalunknownsubstrateDetailsDB01186Pergolideapproved, investigational, vet_approved, withdrawnunknowninhibitorDetailsDB05271RotigotineapprovedunknownsubstrateDetailsDB00439Cerivastatinapproved, withdrawnunknownsubstrateinhibitorinducerDetailsDB00257Clotrimazoleapproved, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00734Risperidoneapproved, investigationalunknownsubstrateDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB01037Selegilineapproved, investigational, vet_approvedunknownsubstrateDetailsDB01159Halothaneapproved, vet_approvedunknownsubstrateDetailsDB01181IfosfamideapprovedunknownsubstrateinhibitorinducerDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB00814Meloxicamapproved, vet_approvedunknownsubstrateDetailsDB00908Quinidineapproved, investigationalunknownsubstrateinhibitorDetailsDB00656Trazodoneapproved, investigationalunknownsubstrateDetailsDB00176Fluvoxamineapproved, investigationalunknownsubstrateinhibitorDetailsDB00321AmitriptylineapprovedunknownsubstrateDetailsDB00540NortriptylineapprovedunknownsubstrateDetailsDB00215CitalopramapprovednosubstrateinhibitorDetailsDB00924CyclobenzaprineapprovedunknownsubstrateDetailsDB00472Fluoxetineapproved, vet_approvednosubstrateinhibitorDetailsDB01104SertralineapprovedunknownsubstrateinhibitorDetailsDB06148Mianserinapproved, investigationalunknownsubstrateDetailsDB01435Antipyrineapproved, investigationalunknownsubstrateDetailsDB01118Amiodaroneapproved, investigationalnosubstrateinhibitorDetailsDB00250Dapsoneapproved, investigationalunknownsubstrateDetailsDB00531Cyclophosphamideapproved, investigationalunknownsubstrateinducerDetailsDB05109Trabectedinapproved, investigationalunknownsubstrateDetailsDB00946Phenprocoumonapproved, investigationalunknownsubstrateDetailsDB00682WarfarinapprovedunknownsubstrateinducerDetailsDB00285VenlafaxineapprovedunknownsubstrateDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB00972AzelastineapprovedunknownsubstrateinhibitorDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00661VerapamilapprovedunknownsubstrateinhibitorDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateinducerDetailsDB00201CaffeineapprovedunknownsubstrateDetailsDB00318Codeineapproved, illicitunknownsubstrateDetailsDB00514DextromethorphanapprovedunknownsubstrateDetailsDB01248Docetaxelapproved, investigationalunknownsubstrateinhibitorDetailsDB00502HaloperidolapprovedunknownsubstrateinhibitorDetailsDB00281Lidocaineapproved, vet_approvedunknownsubstrateDetailsDB00571Propranololapproved, investigationalunknownsubstrateDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00446Chloramphenicolapproved, vet_approved, withdrawnunknowninhibitorDetailsDB00537Ciprofloxacinapproved, investigationalunknowninhibitorDetailsDB01059NorfloxacinapprovedunknowninhibitorDetailsDB06403Ambrisentanapproved, investigationalunknownsubstrateDetailsDB06413Armodafinilapproved, investigationalunknowninducerDetailsDB00865Benzphetamineapproved, illicitunknownsubstrateDetailsDB00612BisoprololapprovedunknownsubstrateDetailsDB00136Calcitriolapproved, nutraceuticalunknownsubstrateinducerDetailsDB00608Chloroquineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00349Clobazamapproved, illicitnosubstrateinducerDetailsDB00628Clorazepic acidapproved, illicitunknownsubstrateDetailsDB01396Digitoxinapproved, investigationalunknownsubstrateDetailsDB04855DronedaroneapprovedunknownsubstrateinhibitorDetailsDB04574Estrone sulfateapprovedunknownsubstrateDetailsDB06414EtravirineapprovedunknownsubstrateinducerDetailsDB01590EverolimusapprovedunknownsubstrateDetailsDB00949FelbamateapprovedunknownsubstrateinducerDetailsDB06702FesoterodineapprovedunknownsubstrateDetailsDB00690Flurazepamapproved, illicit, investigationalunknownsubstrateDetailsDB00499Flutamideapproved, investigationalunknownsubstrateDetailsDB01018Guanfacineapproved, investigationalunknownsubstrateDetailsDB04845Ixabepiloneapproved, investigationalunknownsubstrateDetailsDB00448Lansoprazoleapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00367Levonorgestrelapproved, investigationalunknownsubstrateDetailsDB00358Mefloquineapproved, investigationalunknownsubstrateinhibitorDetailsDB04868Nilotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB06712Nilvadipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00497Oxycodoneapproved, illicit, investigationalunknownsubstrateDetailsDB06589PazopanibapprovedunknownsubstrateinhibitorDetailsDB01621Pipotiazineapproved, investigationalunknownsubstrateDetailsDB01058Praziquantelapproved, investigational, vet_approvedunknownsubstrateDetailsDB01087PrimaquineapprovedunknownsubstrateinhibitorDetailsDB00647Dextropropoxypheneapproved, illicit, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00912Repaglinideapproved, investigationalunknownsubstrateDetailsDB06228RivaroxabanapprovedunknownsubstrateDetailsDB06176Romidepsinapproved, investigationalunknownsubstrateDetailsDB06207SilodosinapprovedunknownsubstrateDetailsDB00706Tamsulosinapproved, investigationalunknownsubstrateDetailsDB00444TeniposideapprovedunknownsubstrateinhibitorDetailsDB00759Tetracyclineapproved, vet_approved, withdrawnunknownsubstrateinhibitorDetailsDB00277TheophyllineapprovedunknownsubstrateDetailsDB01036Tolterodineapproved, investigationalunknownsubstrateDetailsDB06212TolvaptanapprovedunknownsubstrateDetailsDB00193Tramadolapproved, investigationalunknownsubstrateDetailsDB00440Trimethoprimapproved, vet_approvedunknownsubstrateDetailsDB01198ZopicloneapprovedunknownsubstrateDetailsDB00357Aminoglutethimideapproved, investigationalunknowninducerDetailsDB01320Fosphenytoinapproved, investigationalunknownsubstrateinducerDetailsDB00607Nafcillinapproved, investigationalunknowninducerDetailsDB00776OxcarbazepineapprovedunknowninhibitorinducerDetailsDB00312Pentobarbitalapproved, investigational, vet_approvedunknowninducerDetailsDB01174Phenobarbitalapproved, investigationalunknowninducerDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinducerDetailsDB00794Primidoneapproved, vet_approvedunknowninducerDetailsDB01201Rifapentineapproved, investigationalunknownsubstrateinducerDetailsDB01394ColchicineapprovedunknownsubstrateinhibitorDetailsDB01253ErgometrineapprovedunknownsubstrateDetailsDB01221Ketamineapproved, vet_approvedunknownsubstrateinducerDetailsDB00353MethylergometrineapprovedunknownsubstrateinhibitorDetailsDB06335SaxagliptinapprovedunknownsubstrateDetailsDB00708Sufentanilapproved, investigationalunknownsubstrateDetailsDB01128BicalutamideapprovedunknownsubstrateinhibitorDetailsDB01151Desipramineapproved, investigationalunknowninhibitorDetailsDB00916MetronidazoleapprovedunknowninhibitorDetailsDB06268Sitaxentanapproved, investigational, withdrawnunknowninhibitorDetailsDB01424Aminophenazoneapproved, withdrawnunknownsubstrateDetailsDB00363ClozapineapprovednosubstrateinhibitorinducerDetailsDB00420Promazineapproved, vet_approvedunknownsubstrateDetailsDB01136Carvedilolapproved, investigationalunknownsubstrateDetailsDB00549Zafirlukastapproved, investigationalunknownsubstrateinhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00482Celecoxibapproved, investigationalunknownsubstrateDetailsDB01016GlyburideapprovedunknownsubstrateinhibitorDetailsDB01138SulfinpyrazoneapprovedunknownsubstrateinducerDetailsDB06739SeratrodastexperimentalunknownsubstrateinducerDetailsDB06738KetobemidoneinvestigationalunknownsubstrateDetailsDB01242Clomipramineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00655EstroneapprovednosubstrateDetailsDB00458ImipramineapprovedunknownsubstrateDetailsDB00546AdinazolamexperimentalunknownsubstrateDetailsDB00231Temazepamapproved, investigationalunknownsubstrateDetailsDB03701VanoxerineinvestigationalunknownsubstrateDetailsDB00169Cholecalciferolapproved, nutraceuticalunknownsubstrateDetailsDB01192Oxymorphoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB01173OrphenadrineapprovedunknownsubstrateinhibitorDetailsDB06772CabazitaxelapprovedunknownsubstrateDetailsDB02709ResveratrolinvestigationalnoinhibitorDetailsDB06700Desvenlafaxineapproved, investigationalnosubstrateinhibitorDetailsDB06697ArtemetherapprovedunknownsubstrateinducerDetailsDB06708LumefantrineapprovedunknownsubstrateDetailsDB00819Acetazolamideapproved, vet_approvedunknowninhibitorDetailsDB06742Ambroxolapproved, investigationalunknownsubstrateDetailsDB01223AminophyllineapprovedunknownsubstrateDetailsDB00278Argatrobanapproved, investigationalunknownsubstrateDetailsDB01169Arsenic trioxideapproved, investigationalunknowninhibitorDetailsDB00207AzithromycinapprovedunknownsubstrateinhibitorDetailsDB01393Bezafibrateapproved, investigationalunknownsubstrateDetailsDB04794Bifonazoleapproved, investigationalunknowninhibitorDetailsDB01194BrinzolamideapprovednosubstrateDetailsDB00520CaspofunginapprovedunknowninhibitorDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknowninducerDetailsDB00356ChlorzoxazoneapprovedunknownsubstrateinhibitorDetailsDB00845Clofazimineapproved, investigationalunknowninhibitorDetailsDB06470ClomethiazoleinvestigationalunknownsubstrateDetailsDB01559Clotiazepamapproved, illicitunknownsubstrateDetailsDB00987Cytarabineapproved, investigationalunknownsubstrateDetailsDB01406DanazolapprovedunknowninhibitorDetailsDB00694DaunorubicinapprovedunknownsubstrateinhibitorDetailsDB01093Dimethyl sulfoxideapproved, vet_approvedunknowninhibitorDetailsDB00822DisulfiramapprovedunknownsubstrateDetailsDB00254Doxycyclineapproved, investigational, vet_approvedunknowninhibitorDetailsDB01127EconazoleapprovednoinhibitorDetailsDB00751Epinastineapproved, investigationalunknownsubstrateDetailsDB00668Epinephrineapproved, vet_approvedunknowninhibitorDetailsDB01196Estramustineapproved, investigationalunknownsubstrateDetailsDB00898EthanolapprovedunknownsubstrateinhibitorinducerDetailsDB01466Ethylmorphineexperimental, illicitunknownsubstrateDetailsDB00301Flucloxacillinapproved, investigationalunknownsubstrateinducerDetailsDB01544Flunitrazepamapproved, illicitunknownsubstrateDetailsDB00947Fulvestrantapproved, investigationalunknownsubstrateDetailsDB01275HydralazineapprovednoinhibitorDetailsDB00724Imiquimodapproved, investigationalunknownsubstrateDetailsDB01029Irbesartanapproved, investigationalnoinhibitorDetailsDB00602Ivermectinapproved, investigational, vet_approvednosubstrateDetailsDB01103QuinacrineinvestigationalunknownsubstrateDetailsDB01071MequitazineexperimentalunknowninhibitorDetailsDB04817Metamizoleapproved, investigational, withdrawnunknowninducerDetailsDB04833Methaqualoneillicit, withdrawnunknownsubstrateDetailsDB01028Methoxyfluraneapproved, investigational, vet_approved, withdrawnunknownsubstrateDetailsDB06710MethyltestosteroneapprovedunknownsubstrateDetailsDB00379Mexiletineapproved, investigationalunknownsubstrateDetailsDB01204Mitoxantroneapproved, investigationalunknowninhibitorDetailsDB00295Morphineapproved, investigationalnosubstrateDetailsDB01183Naloxoneapproved, vet_approvedunknownsubstrateinhibitorDetailsDB02701Nicotinamideapproved, investigationalunknowninhibitorDetailsDB00184NicotineapprovedunknownsubstrateDetailsDB01595NitrazepamapprovedunknownsubstrateDetailsDB00768OlopatadineapprovednosubstrateDetailsDB00316AcetaminophenapprovedunknownsubstrateinducerDetailsDB01074Perhexilineapproved, investigationalunknownsubstrateDetailsDB00850PerphenazineapprovedunknownsubstrateDetailsDB00454MeperidineapprovedunknownsubstrateinducerDetailsDB03783PhenacetinwithdrawnunknownsubstrateDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB00812Phenylbutazoneapproved, vet_approvedunknowninducerDetailsDB01085Pilocarpineapproved, investigationalunknowninhibitorDetailsDB01588Prazepamapproved, illicitunknownsubstrateDetailsDB01032Probenecidapproved, investigationalunknowninducerDetailsDB01182PropafenoneapprovedunknownsubstrateDetailsDB01589Quazepamapproved, illicitnosubstrateDetailsDB00481Raloxifeneapproved, investigationalunknowninhibitorDetailsDB00863Ranitidineapproved, withdrawnunknowninhibitorDetailsDB01220Rifaximinapproved, investigationalunknownsubstrateinducerDetailsDB00296RopivacaineapprovedunknownsubstrateDetailsDB01698Rutinapproved, experimental, investigationalunknowninducerDetailsDB01001Salbutamolapproved, vet_approvedunknowninhibitorDetailsDB01236Sevofluraneapproved, vet_approvedunknownsubstrateDetailsDB00359Sulfadiazineapproved, investigational, vet_approvedunknownsubstrateDetailsDB01015SulfamethoxazoleapprovedunknownsubstrateDetailsDB01349TasosartanexperimentalunknownsubstrateDetailsDB00763MethimazoleapprovedunknowninhibitorDetailsDB04572Thiotepaapproved, investigationalunknownsubstrateDetailsDB01007TioconazoleapprovedunknowninhibitorDetailsDB00273TopiramateapprovedunknowninducerDetailsDB00347TrimethadioneapprovedunknownsubstrateDetailsDB13179TroleandomycinapprovedunknownsubstrateinhibitorDetailsDB00313Valproic acidapproved, investigationalunknowninhibitorDetailsDB01392Yohimbineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00495ZidovudineapprovedunknownsubstrateDetailsDB04828ZomepiracwithdrawnunknownsubstrateDetailsDB01380Cortisone acetateapproved, investigationalunknownsubstrateinducerDetailsDB01384ParamethasoneexperimentalunknownsubstrateinhibitorinducerDetailsDB01587KetazolamapprovedunknownsubstrateinhibitorDetailsDB08811TofisopamexperimentalunknowninhibitorDetailsDB00617ParamethadioneapprovedunknownsubstrateDetailsDB00755Tretinoinapproved, investigational, nutraceuticalunknownsubstrateDetailsDB00980Ramelteonapproved, investigationalunknownsubstrateDetailsDB04946IloperidoneapprovedunknownsubstrateDetailsDB01418Acenocoumarolapproved, investigationalunknownsubstrateDetailsDB06684VilazodoneapprovedunknownsubstrateDetailsDB00255Diethylstilbestrolapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00575ClonidineapprovedunknownsubstrateDetailsDB00973EzetimibeapprovedunknowninhibitorDetailsDB00400Griseofulvinapproved, investigational, vet_approvedunknowninducerDetailsDB00808IndapamideapprovedunknownsubstrateDetailsDB05521Telaprevirapproved, withdrawnunknownsubstrateinhibitorDetailsDB08820IvacaftorapprovednosubstrateinhibitorDetailsDB06634CasopitantinvestigationalunknownDetailsDB04975BanoxantroneinvestigationalunknownsubstrateDetailsDB05039IndacaterolapprovedunknownsubstrateDetailsDB08816TicagrelorapprovedunknownsubstrateinhibitorDetailsDB06774CapsaicinapprovedunknowninhibitorDetailsDB06174Noscapineapproved, investigationalunknowninhibitorDetailsDB01333CefradineapprovedunknowninducerDetailsDB06777Chenodeoxycholic acidapprovedunknownsubstrateDetailsDB00856Chlorphenesinapproved, experimentalunknowninducerDetailsDB04920Clevidipineapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB01764DalfopristinapprovedunknowninhibitorDetailsDB01609Deferasiroxapproved, investigationalunknowninducerDetailsDB00485Dicloxacillinapproved, investigational, vet_approvedunknowninducerDetailsDB06370IndisulaminvestigationalunknowninhibitorDetailsDB01083Orlistatapproved, investigationalunknowninducerDetailsDB00239OxiconazoleapprovedunknowninducerDetailsDB00082PegvisomantapprovedunknowninducerDetailsDB06762PinacidilapprovedunknownsubstrateDetailsDB01369QuinupristinapprovedunknowninhibitorDetailsDB00337Pimecrolimusapproved, investigationalunknownsubstrateDetailsDB00041AldesleukinapprovedunknowninhibitorDetailsDB06605ApixabanapprovednosubstrateDetailsDB08827Lomitapideapproved, investigationalnosubstrateDetailsDB08828Vismodegibapproved, investigationalnosubstrateDetailsDB00620Triamcinoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB08864RilpivirineapprovednosubstrateinhibitorinducerDetailsDB06209PrasugrelapprovednosubstrateDetailsDB06216AsenapineapprovedunknownsubstrateDetailsDB00435Nitric OxideapprovedunknowninhibitorDetailsDB08867UlipristalapprovednosubstrateDetailsDB08815Lurasidoneapproved, investigationalunknownsubstrateDetailsDB08870Brentuximab vedotinapproved, investigationalnosubstrateinhibitorDetailsDB04871Lorcaserinapproved, withdrawnnosubstrateDetailsDB05294VandetanibapprovedunknownsubstrateDetailsDB08873Boceprevirapproved, withdrawnunknownsubstrateinhibitorDetailsDB08875Cabozantinibapproved, investigationalnosubstrateDetailsDB08877RuxolitinibapprovedunknownsubstrateDetailsDB05812AbirateroneapprovedunknownsubstrateinhibitorDetailsDB08881VemurafenibapprovedunknownsubstrateinducerDetailsDB08882LinagliptinapprovedunknownsubstrateinhibitorDetailsDB08883PerampanelapprovednosubstrateinducerDetailsDB08865Crizotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB06626Axitinibapproved, investigationalnosubstrateDetailsDB08893MirabegronapprovednosubstrateDetailsDB06237AvanafilapprovedunknownsubstrateDetailsDB08896RegorafenibapprovedunknownsubstrateinhibitorDetailsDB08899EnzalutamideapprovednosubstrateinducerDetailsDB08895Tofacitinibapproved, investigationalnosubstrateDetailsDB06616BosutinibapprovednosubstrateinhibitorDetailsDB08901Ponatinibapproved, investigationalunknownsubstrateDetailsDB08903BedaquilineapprovednosubstrateDetailsDB06201RufinamideapprovedunknowninducerDetailsDB08906Fluticasone furoateapprovednosubstrateinhibitorinducerDetailsDB08907CanagliflozinapprovedunknownsubstrateDetailsDB06203AlogliptinapprovedunknownsubstrateDetailsDB04938Ospemifeneapproved, investigationalunknownsubstrateDetailsDB08910PomalidomideapprovedunknownsubstrateDetailsDB08911TrametinibapprovedunknownsubstrateinducerDetailsDB08912Dabrafenibapproved, investigationalnosubstrateinhibitorinducerDetailsDB05773Trastuzumab emtansineapproved, investigationalunknownsubstrateDetailsDB08833Taurochenodeoxycholic acidexperimentalunknownsubstrateDetailsDB01142Doxepinapproved, investigationalnosubstrateDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB08918Levomilnacipranapproved, investigationalunknownsubstrateDetailsDB08932MacitentanapprovednosubstrateDetailsDB08933LuliconazoleapprovednoinhibitorDetailsDB06292DapagliflozinapprovednosubstrateDetailsDB09039Eliglustatapproved, investigationalnosubstrateDetailsDB05676Apremilastapproved, investigationalnosubstrateDetailsDB09049NaloxegolapprovedunknownsubstrateDetailsDB09053IbrutinibapprovedunknownsubstrateDetailsDB00951Isoniazidapproved, investigationalunknownDetailsDB09074OlaparibapprovedunknownsubstrateinhibitorDetailsDB09078Lenvatinibapproved, investigationalnosubstrateinhibitorinducerDetailsDB09073Palbociclibapproved, investigationalnosubstrateinhibitorDetailsDB09054IdelalisibapprovednosubstrateinhibitorinducerDetailsDB09068Vortioxetineapproved, investigationalnosubstrateDetailsDB09082VilanterolapprovednosubstrateDetailsDB09083IvabradineapprovednosubstrateDetailsDB09026Aliskirenapproved, investigationalnosubstrateDetailsDB09101ElvitegravirapprovednosubstrateinhibitorDetailsDB06016Cariprazineapproved, investigationalnosubstrateinhibitorinducerDetailsDB08439ParecoxibapprovedunknownsubstrateDetailsDB09128Brexpiprazoleapproved, investigationalnosubstrateDetailsDB09291Rolapitantapproved, investigationalnosubstrateDetailsDB04908Flibanserinapproved, investigationalnosubstrateDetailsDB09102Daclatasvirapproved, investigationalunknownsubstrateDetailsDB09143Sonidegibapproved, investigationalunknownsubstrateDetailsDB06636Isavuconazoniumapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB06603Panobinostatapproved, investigationalunknownsubstrateDetailsDB05239Cobimetinibapproved, investigationalnosubstrateinhibitorDetailsDB09570Ixazomibapproved, investigationalunknownsubstrateDetailsDB09330OsimertinibapprovednosubstrateinhibitorinducerDetailsDB11362SelexipagapprovednosubstrateDetailsDB09119Eslicarbazepine acetateapprovednoinducerDetailsDB06789Hydroxyprogesterone caproateapproved, investigationalunknownsubstrateDetailsDB08931RiociguatapprovedunknownsubstrateDetailsDB09183DasabuvirapprovednosubstrateDetailsDB09297Paritaprevirapproved, investigationalnosubstrateDetailsDB09317Synthetic Conjugated Estrogens, AapprovednosubstrateDetailsDB09318Synthetic Conjugated Estrogens, BapprovednosubstrateDetailsDB09389NorgestrelapprovedunknownsubstrateDetailsDB11581Venetoclaxapproved, investigationalnosubstrateinhibitorDetailsDB09280LumacaftorapprovednoinducerDetailsDB01323St. John's Wortapproved, investigational, nutraceuticalunknownsubstrateinduceractivatorDetailsDB09381Esterified estrogensapprovedunknownsubstrateDetailsDB00957Norgestimateapproved, investigationalunknownsubstrateinducerDetailsDB04911Oritavancinapproved, investigationalunknowninhibitorinducerDetailsDB06717FosaprepitantapprovedunknownsubstrateinhibitorinducerDetailsDB00648MitotaneapprovedunknowninducerDetailsDB08909Glycerol phenylbutyrateapprovedunknowninducerDetailsDB09048Netupitantapproved, investigationalnosubstrateinhibitorDetailsDB12332Rucaparibapproved, investigationalnosubstrateinhibitorDetailsDB11921Deflazacortapproved, investigationalnosubstrateinducerDetailsDB11737Icotinibexperimental, investigationalunknownsubstrateDetailsDB06654Safinamideapproved, investigationalunknownsubstrateDetailsDB12161Deutetrabenazineapproved, investigationalnosubstrateDetailsDB09555Dexchlorpheniramine maleateapprovedunknownsubstrateDetailsDB11613Velpatasvirapproved, investigationalnosubstrateDetailsDB05541Brivaracetamapproved, investigationalnosubstrateDetailsDB11915Valbenazineapproved, investigationalnosubstrateDetailsDB06670OdanacatibinvestigationalnosubstrateDetailsDB05351Dexlansoprazoleapproved, investigationalunknownsubstrateDetailsDB06290SimeprevirapprovedunknownsubstrateinhibitorDetailsDB11575GrazoprevirapprovednosubstrateinhibitorDetailsDB11943Delafloxacinapproved, investigationalunknowninducerDetailsDB01685TopiroxostatexperimentalunknowninhibitorDetailsDB08922PerospironeexperimentalunknownsubstrateDetailsDB09118StiripentolapprovedunknownsubstrateinhibitorinducerDetailsDB09166EtizolamexperimentalunknownsubstrateDetailsDB11614RupatadineapprovednosubstrateDetailsDB09262ImidafenacininvestigationalnosubstrateDetailsDB00143Glutathioneapproved, investigational, nutraceuticalunknownDetailsDB09238Manidipineapproved, investigationalunknownsubstrateinhibitorDetailsDB09123DienogestapprovedunknownsubstrateDetailsDB11828Neratinibapproved, investigationalunknownsubstrateDetailsDB12026Voxilaprevirapproved, investigationalnosubstrateDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB06412Oxymetholoneapproved, illicitunknowninhibitorDetailsDB00503Ritonavirapproved, investigationalunknownsubstrateinhibitorDetailsDB06595Midostaurinapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB11574ElbasvirapprovedunknownsubstrateDetailsDB12483Copanlisibapproved, investigationalnosubstrateDetailsDB11767Sarilumabapproved, investigationalnoinhibitorinducerDetailsDB12001Abemaciclibapproved, investigationalunknownsubstrateinhibitorDetailsDB12267Brigatinibapproved, investigationalnosubstrateDetailsDB11817Baricitinibapproved, investigationalunknownsubstrateDetailsDB13074Macimorelinapproved, investigationalunknownsubstrateDetailsDB09223BlonanserininvestigationalnosubstrateDetailsDB09236Lacidipineapproved, investigationalunknownsubstrateDetailsDB09061Cannabidiolapproved, investigationalunknownsubstrateinhibitorDetailsDB13943Testosterone cypionateapprovedunknownsubstrateinhibitorinducerDetailsDB13944Testosterone enanthateapprovedunknownsubstrateinhibitorinducerDetailsDB13946Testosterone undecanoateapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13941Piperaquineapproved, experimental, investigationalunknownsubstrateinhibitorDetailsDB01420Testosterone propionateapproved, investigational, vet_approved, withdrawnnosubstrateDetailsDB09195LorpiprazoleapprovednosubstrateDetailsDB11799Bictegravirapproved, investigationalunknownsubstrateDetailsDB11901Apalutamideapproved, investigationalnosubstrateinducerDetailsDB09225Zotepineapproved, investigational, withdrawnnosubstrateDetailsDB09230AzelnidipineinvestigationalunknownsubstrateDetailsDB09231BenidipineexperimentalnosubstrateinhibitorDetailsDB09235EfonidipineexperimentalunknownsubstrateinhibitorDetailsDB11642Pitolisantapproved, investigationalunknownsubstrateinducerDetailsDB11633Isavuconazoleapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB09237Levamlodipineapproved, investigationalunknownsubstrateDetailsDB11712Tezacaftorapproved, investigationalnosubstrateinhibitorinducerDetailsDB11130Opiumapproved, illicitnosubstrateDetailsDB11251Tocopherolapproved, investigationalnosubstrateDetailsDB14003alpha-Tocopherol acetateapprovednosubstrateDetailsDB11586Asunaprevirapproved, investigational, withdrawnnosubstrateinducerDetailsDB13975Black cohoshexperimentalnoinhibitorDetailsDB12278Propiverineapproved, investigationalnosubstrateDetailsDB14011NabiximolsinvestigationalunknownsubstrateDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorDetailsDB11641Vinflunineapproved, investigationalnosubstrateDetailsDB11635TocofersolanapprovednosubstrateDetailsDB11637Delamanidapproved, investigationalnosubstrateDetailsDB13746Bioallethrinapproved, experimentalnosubstrateDetailsDB14019FosnetupitantapprovedunknownsubstrateinhibitorDetailsDB12010Fostamatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB01049Ergoloid mesylateapprovednosubstrateDetailsDB11274Dihydro-alpha-ergocryptineapprovednosubstrateDetailsDB13293Ipecacapproved, withdrawnnosubstrateDetailsDB11198Peppermint oilapproved, investigationalunknowninhibitorDetailsDB13456MidecamycinexperimentalnosubstrateinhibitorDetailsDB12532Oxetacaineapproved, investigationalnoinhibitorDetailsDB11672Curcuminapproved, investigationalunknowninhibitorDetailsDB11779DanoprevirinvestigationalnoinhibitorDetailsDB09289TianeptineinvestigationalnosubstrateDetailsDB01357MestranolapprovednosubstrateDetailsDB04829Lysergic acid diethylamideillicit, investigational, withdrawnnosubstrateDetailsDB00247MethysergideapprovednosubstrateDetailsDB13399TergurideexperimentalnosubstrateDetailsDB14185Aripiprazole lauroxilapproved, investigationalunknownsubstrateDetailsDB11718Encorafenibapproved, investigationalnosubstrateinhibitorinducerDetailsDB14538Hydrocortisone aceponateexperimental, vet_approvedunknownsubstrateinducerDetailsDB14539Hydrocortisone acetateapproved, vet_approvedunknownsubstrateinducerDetailsDB14540Hydrocortisone butyrateapproved, vet_approvedunknownsubstrateinducerDetailsDB14541Hydrocortisone cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB14542Hydrocortisone phosphateapproved, vet_approvedunknownsubstrateDetailsDB14543Hydrocortisone probutateapproved, vet_approvedunknownsubstrateinducerDetailsDB14544Hydrocortisone valerateapproved, vet_approvedunknownsubstrateinducerDetailsDB14568Ivosidenibapproved, investigationalunknownsubstrateinducerDetailsDB126293,5-diiodothyropropionic acidinvestigationalnosubstrateDetailsDB014565-androstenedioneexperimental, illicitnosubstrateDetailsDB00240AlclometasoneapprovednosubstrateDetailsDB04630Aldosteroneexperimental, investigationalnosubstrateDetailsDB00288AmcinonideapprovednosubstrateinducerDetailsDB01536Androstenedioneexperimental, illicitnosubstrateDetailsDB00394Beclomethasone dipropionateapproved, investigationalnosubstrateinducerDetailsDB11750Clobetasolapproved, experimental, investigationalnosubstrateinducerDetailsDB01013Clobetasol propionateapprovednosubstrateinducerDetailsDB13158ClobetasoneapprovednosubstrateDetailsDB04652CorticosteroneexperimentalnosubstrateDetailsDB01285Corticotropinapproved, investigational, vet_approvednosubstrateinducerDetailsDB04839Cyproterone acetateapproved, investigationalnosubstrateinhibitorDetailsDB11636NomegestrolapprovednosubstrateDetailsDB13981Nomegestrol acetateapproved, investigationalnosubstrateDetailsDB00304DesogestrelapprovednosubstrateDetailsDB01260Desonideapproved, investigationalnosubstrateinducerDetailsDB06780Desoxycorticosterone acetateapprovednosubstrateDetailsDB01134Desoxycorticosterone pivalateexperimental, vet_approvednosubstrateDetailsDB11487Dexamethasone isonicotinatevet_approvednosubstrateinhibitorinducerDetailsDB09095Difluocortoloneapproved, investigational, withdrawnnosubstrateinducerDetailsDB06781DifluprednateapprovednosubstrateDetailsDB00378Dydrogesteroneapproved, investigational, withdrawnnosubstrateDetailsDB03515EquileninexperimentalnosubstrateDetailsDB02187EquilinexperimentalnosubstrateDetailsDB13866EtynodiolexperimentalnosubstrateDetailsDB00823Ethynodiol diacetateapprovednosubstrateDetailsDB00687Fludrocortisoneapproved, investigationalunknownsubstrateDetailsDB00663Flumethasoneapproved, vet_approvednosubstrateDetailsDB00591Fluocinolone acetonideapproved, investigational, vet_approvednosubstrateinducerDetailsDB01047Fluocinonideapproved, investigationalnosubstrateinducerDetailsDB08971Fluocortoloneapproved, withdrawnnosubstrateinducerDetailsDB08970FluprednideneexperimentalnosubstrateinducerDetailsDB09378FluprednisoloneapprovednosubstrateDetailsDB00846FlurandrenolideapprovednosubstrateDetailsDB13867Fluticasoneapproved, experimentalnosubstrateinhibitorinducerDetailsDB08905Formestaneapproved, investigational, withdrawnnoinducerDetailsDB06730GestodeneinvestigationalnosubstrateinhibitorDetailsDB11619GestrinoneapprovednosubstrateDetailsDB06786Halcinonideapproved, investigational, withdrawnnosubstrateDetailsDB05212HE3286investigationalnosubstrateDetailsDB14545Hydrocortisone succinateapprovedunknownsubstrateinducerDetailsDB14570HydroxyprogesteroneexperimentalnosubstrateDetailsDB01583LiotrixapprovednosubstrateDetailsDB14596Loteprednol etabonateapprovedunknownsubstrateDetailsDB12474Lynestrenolapproved, investigationalnosubstrateDetailsDB09124Medrogestoneapproved, withdrawnnosubstrateDetailsDB00253MedrysoneapprovednosubstrateinducerDetailsDB00351Megestrol acetateapproved, investigational, vet_approvednosubstrateDetailsDB11529Melengestrolvet_approvednosubstrateDetailsDB09383Meprednisoneapproved, investigationalnosubstrateinducerDetailsDB00764MometasoneexperimentalnosubstrateinducerDetailsDB14512Mometasone furoateapproved, investigational, vet_approvednosubstrateinducerDetailsDB06713Norelgestrominapproved, investigationalnosubstrateDetailsDB09371NorethynodrelapprovednosubstrateDetailsDB01130Prednicarbateapproved, investigationalnosubstrateDetailsDB13208PrednylideneexperimentalnosubstrateinducerDetailsDB02789Pregnenoloneapproved, experimentalnosubstrateDetailsDB13602PromegestoneexperimentalnosubstrateDetailsDB00896RimexoloneapprovednosubstrateinducerDetailsDB01117AtovaquoneapprovednosubstrateDetailsDB11753Rifamycinapproved, investigationalnoinhibitorinducerDetailsDB13528ChlormadinoneexperimentalnosubstrateDetailsDB13857DemegestoneexperimentalnosubstrateDetailsDB13685QuingestanolexperimentalnosubstrateDetailsDB14055(S)-Warfarinexperimental, investigationalnosubstrateDetailsDB13347DiphenadioneexperimentalnosubstrateDetailsDB08794Ethyl biscoumacetatewithdrawnunknownsubstrateDetailsDB01483BarbitalillicitnoinducerDetailsDB01154Thiamylalapproved, vet_approvednosubstrateinducerDetailsDB09229AranidipineexperimentalnosubstrateDetailsDB09227BarnidipineexperimentalnosubstrateinhibitorDetailsDB13488BencyclaneexperimentalnosubstrateDetailsDB01244Bepridilapproved, withdrawnnosubstrateDetailsDB08838AgmatineexperimentalnosubstrateDetailsDB11960CarboxyamidotriazoleinvestigationalnosubstrateDetailsDB13835CaroverineexperimentalnosubstrateDetailsDB09232CilnidipineinvestigationalnosubstrateDetailsDB00568Cinnarizineapproved, investigationalnosubstrateDetailsDB04838CyclandelateapprovednosubstrateDetailsDB09234DarodipineexperimentalnosubstrateDetailsDB14068DexniguldipineexperimentalnosubstrateDetailsDB14063DexverapamilexperimentalnosubstrateDetailsDB06446DotarizineinvestigationalnosubstrateDetailsDB14064EmopamilexperimentalnosubstrateDetailsDB08992EperisoneinvestigationalnosubstrateDetailsDB08980FendilinewithdrawnnosubstrateDetailsDB13961Fish oilapproved, nutraceuticalnosubstrateDetailsDB04841FlunarizineapprovednosubstrateDetailsDB04842Fluspirileneapproved, investigationalnosubstrateDetailsDB12923GallopamilinvestigationalnosubstrateDetailsDB13766Lidoflazineapproved, experimentalnosubstrateDetailsDB14065LomerizineexperimentalnosubstrateDetailsDB00825LevomentholapprovednosubstrateDetailsDB12092NaftopidilinvestigationalnosubstrateDetailsDB09239NiguldipineexperimentalnosubstrateDetailsDB09240NiludipineexperimentalnosubstrateDetailsDB04743Nimesulideapproved, investigational, withdrawnnosubstrateDetailsDB06152NylidrinapprovednosubstrateDetailsDB13500Otiloniumexperimental, investigationalnosubstrateDetailsDB13791PenfluridolexperimentalnosubstrateDetailsDB09090PinaveriumapprovednosubstrateDetailsDB04825Prenylamineapproved, withdrawnnosubstrateDetailsDB13725TerodilineexperimentalnosubstrateDetailsDB12093TetrahydropalmatineinvestigationalnosubstrateDetailsDB14066TetrandrineexperimentalnosubstrateDetailsDB09216Tolfenamic acidapproved, investigationalnosubstrateDetailsDB07615TranilastinvestigationalnosubstrateDetailsDB09089TrimebutineapprovednosubstrateDetailsDB05885SeletracetaminvestigationalnosubstrateDetailsDB12131VinpocetineinvestigationalnosubstrateDetailsDB13950WIN 55212-2experimentalnosubstrateinhibitorDetailsDB040706-Deoxyerythronolide BexperimentalnoinhibitorDetailsDB06318AVE9633investigationalnoinhibitorDetailsDB07348Brefeldin AexperimentalnoinhibitorDetailsDB11752Bryostatin 1investigationalnoinhibitorDetailsDB01152Candicidinapproved, withdrawnnoinhibitorDetailsDB11383Carbomycinvet_approvednoinhibitorDetailsDB06419CethromycininvestigationalnosubstrateinhibitorDetailsDB06342Coltuximab ravtansineinvestigationalnoinhibitorDetailsDB00954DirithromycinexperimentalnoinhibitorDetailsDB11400Doramectinvet_approvednoinhibitorDetailsDB12266EpofolateinvestigationalnoinhibitorDetailsDB01873Epothilone DinvestigationalnoinhibitorDetailsDB11405Eprinomectinvet_approvednoinhibitorDetailsDB13338FlurithromycinexperimentalnoinhibitorDetailsDB05814GPI-1485investigationalnoinhibitorDetailsDB09309KitasamycinexperimentalnoinhibitorDetailsDB05903KOS-1584investigationalnoinhibitorDetailsDB12089Lorvotuzumab mertansineinvestigationalnoinhibitorDetailsDB13287MiocamycinapprovednoinhibitorDetailsDB12489Mirvetuximab soravtansineapproved, investigationalnosubstrateinhibitorDetailsDB06587MitemcinalinvestigationalnoinhibitorDetailsDB11442Oleandomycinvet_approvednoinhibitorDetailsDB03010Patupiloneexperimental, investigationalnoinhibitorDetailsDB06233RidaforolimusinvestigationalnoinhibitorDetailsDB13409RokitamycinexperimentalnoinhibitorDetailsDB12391SagopiloneinvestigationalnoinhibitorDetailsDB11459Selamectinvet_approvednoinhibitorDetailsDB09308SolithromycininvestigationalnoinhibitorDetailsDB11470Tildipirosinvet_approvednoinhibitorDetailsDB01241GemfibrozilapprovedunknownsubstrateDetailsDB06791LanreotideapprovednoinhibitorDetailsDB00104Octreotideapproved, investigationalnoinhibitorDetailsDB06663PasireotideapprovednoinhibitorDetailsDB09099Somatostatinapproved, investigationalnoinhibitorDetailsDB04894Vapreotideexperimental, investigationalnoinhibitorDetailsDB12781BalaglitazoneinvestigationalnosubstrateDetailsDB09201CiglitazoneexperimentalnosubstrateDetailsDB09198LobeglitazoneexperimentalnosubstrateDetailsDB09199NetoglitazoneexperimentalnosubstrateDetailsDB09200Rivoglitazoneexperimental, investigationalnosubstrateDetailsDB00412Rosiglitazoneapproved, investigationalnosubstrateinducerDetailsDB09063CeritinibapprovednosubstrateinhibitorDetailsDB06469LestaurtinibinvestigationalnoinhibitorDetailsDB11805SaracatinibinvestigationalnoinhibitorDetailsDB11703Acalabrutinibapproved, investigationalunknownsubstrateinhibitorDetailsDB01267PaliperidoneapprovedunknownsubstrateDetailsDB01645GenisteininvestigationalunknowninducerDetailsDB05928DovitinibinvestigationalunknowninhibitorDetailsDB08496(R)-warfarinexperimentalunknownsubstrateDetailsDB119196-O-benzylguanineinvestigationalnosubstrateDetailsDB14583Segesterone acetateapproved, experimental, investigationalunknownsubstrateDetailsDB00563MethotrexateapprovednosubstrateDetailsDB04884DapoxetineinvestigationalnosubstrateinhibitorDetailsDB08953Indalpineinvestigational, withdrawnnosubstrateinhibitorDetailsDB00715Paroxetineapproved, investigationalnosubstrateinhibitorDetailsDB04832Zimelidineapproved, withdrawnnoinhibitorDetailsDB04896Milnacipranapproved, investigationalnosubstrateinhibitorDetailsDB02703Fusidic acidapproved, investigationalunknownsubstrateinhibitorDetailsDB11730Ribociclibapproved, investigationalnosubstrateinhibitorDetailsDB09079NintedanibapprovednosubstrateDetailsDB14634Fluprednidene acetateexperimentalnoinducerDetailsDB14637Fluprednisolone acetateexperimentalnosubstrateDetailsDB01656RoflumilastapprovednosubstrateDetailsDB09034Suvorexantapproved, investigationalnosubstrateDetailsDB09071Tasimelteonapproved, investigationalnosubstrateDetailsDB09030VorapaxarapprovednosubstrateDetailsDB01624Zuclopenthixolapproved, investigationalnosubstrateDetailsDB13385DihydroergocryptineexperimentalnosubstrateDetailsDB11273DihydroergocornineapprovednosubstrateDetailsDB13345Dihydroergocristineapproved, experimentalnosubstrateDetailsDB06218LacosamideapprovednosubstrateDetailsDB12329Eravacyclineapproved, investigationalunknownsubstrateDetailsDB06458RemacemideinvestigationalnoinhibitorDetailsDB08874FidaxomicinapprovednoinhibitorDetailsDB11742Ebastineapproved, investigationalnosubstrateDetailsDB09036Siltuximabapproved, investigationalnoinducerDetailsDB06273TocilizumabapprovednoinducerDetailsDB12301Doravirineapproved, investigationalunknownsubstrateDetailsDB11952Duvelisibapproved, investigationalnosubstrateDetailsDB13997Baloxavir marboxilapproved, investigationalnosubstrateinhibitorDetailsDB00186LorazepamapprovednosubstrateDetailsDB125159-aminocamptothecininvestigationalnosubstrateDetailsDB12952Methylprednisoneapproved, investigationalnosubstrateDetailsDB04861Nebivololapproved, investigationalunknownsubstrateDetailsDB11963Dacomitinibapproved, investigationalnosubstrateDetailsDB12141Gilteritinibapproved, investigationalnosubstrateDetailsDB14723Larotrectinibapproved, investigationalunknownsubstrateDetailsDB125371,2-Benzodiazepineapproved, investigationalunknownsubstrateDetailsDB09017Brotizolaminvestigational, withdrawnunknownsubstrateDetailsDB11094Vitamin Dapproved, nutraceutical, vet_approvednosubstrateDetailsDB01352Aprobarbitalexperimental, illicitunknowninducerDetailsDB00590DoxazosinapprovednosubstrateDetailsDB05482SN-38investigationalunknownsubstrateinhibitorDetailsDB06480PrucaloprideapprovednosubstrateDetailsDB11978Glasdegibapproved, investigationalunknownsubstrateDetailsDB12582PiperineinvestigationalunknowninhibitorDetailsDB00191Phentermineapproved, illicitnosubstrateDetailsDB12245Triclabendazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00264Metoprololapproved, investigationalnosubstrateDetailsDB11823Esketamineapproved, investigationalunknownsubstrateinducerDetailsDB00163Vitamin Eapproved, nutraceutical, vet_approvedunknownsubstrateinducerDetailsDB12371Siponimodapproved, investigationalunknownsubstrateDetailsDB12147Erdafitinibapproved, investigationalnosubstrateinhibitorinducerDetailsDB09299Tenofovir alafenamideapprovednosubstrateDetailsDB00982IsotretinoinapprovedunknownsubstrateDetailsDB12015Alpelisibapproved, investigationalunknownsubstrateDetailsDB12240Polatuzumab vedotinapproved, investigationalnosubstrateDetailsDB00905Bimatoprostapproved, investigationalunknownsubstrateDetailsDB11942Selinexorapproved, investigationalunknownsubstrateDetailsDB14669Betamethasone phosphateapproved, vet_approvedunknownsubstrateinducerDetailsDB14652Clocortolone acetateexperimentalunknowninducerDetailsDB13843CloprednolexperimentalunknowninducerDetailsDB14681CortisoneexperimentalunknowninducerDetailsDB13003CortivazolinvestigationalunknowninducerDetailsDB13728HalometasoneexperimentalunknowninducerDetailsDB14659Melengestrol acetateexperimentalunknowninducerDetailsDB14644Methylprednisolone hemisuccinateapprovedunknowninducerDetailsDB14633Prednisolone hemisuccinateexperimentalunknowninducerDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknownsubstrateinducerDetailsDB14646Prednisone acetateapproved, experimental, investigationalunknowninducerDetailsDB02520DitiocarbexperimentalunknowninhibitorDetailsDB06731SeproxetineinvestigationalunknowninhibitorDetailsDB00627Niacinapproved, investigational, nutraceuticalunknowninhibitorDetailsDB06282LevocetirizineapprovedunknownsubstrateDetailsDB09173ButyrfentanylillicitunknownsubstrateDetailsDB12978Pexidartinibapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB01551Dihydrocodeineapproved, illicitunknownsubstrateDetailsDB05154PretomanidapprovedunknownsubstrateDetailsDB01395DrospirenoneapprovedunknownsubstrateDetailsDB01611HydroxychloroquineapprovedunknownsubstrateDetailsDB11986Entrectinibapproved, investigationalunknownsubstrateDetailsDB12500Fedratinibapproved, investigationalunknownsubstrateDetailsDB12825Lefamulinapproved, investigationalunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknownsubstrateDetailsDB01319FosamprenavirapprovedunknownsubstrateinhibitorDetailsDB01050IbuprofenapprovednosubstrateDetailsDB15489MexazolamexperimentalunknownsubstrateDetailsDB00334Olanzapineapproved, investigationalunknowninhibitorDetailsDB09288PropacetamolexperimentalunknownsubstrateinducerDetailsDB01233Metoclopramideapproved, investigationalunknownsubstrateDetailsDB11761Tenapanorapproved, investigationalunknownsubstrateDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB14600Edetate disodium anhydrousapproved, vet_approvedunknowninhibitorDetailsDB01217Anastrozoleapproved, investigationalunknownsubstrateinhibitorDetailsDB14575EslicarbazepineapprovedunknowninducerDetailsDB12808Trifaroteneapproved, investigationalunknownsubstrateDetailsDB15444Elexacaftorapproved, investigationalnosubstrateinhibitorDetailsDB15566Prednisolone acetateapproved, vet_approvedunknownsubstrateinducerDetailsDB00557HydroxyzineapprovednosubstrateDetailsDB14240Echinaceaapproved, experimentalunknowninducerDetailsDB11560Lesinuradapproved, investigationalunknowninducerDetailsDB15035Zanubrutinibapproved, investigationalnosubstrateDetailsDB01381Ginkgo bilobaapproved, investigational, nutraceuticalunknowninhibitorinducerDetailsDB13879Glecaprevirapproved, investigationalunknowninhibitorDetailsDB14975Voxelotorapproved, investigationalunknownsubstrateDetailsDB00717NorethisteroneapprovedunknownsubstrateDetailsDB06119Cenobamateapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB13007Enfortumab vedotinapproved, investigationalunknownsubstrateDetailsDB14962Trastuzumab deruxtecanapproved, investigationalunknownsubstrateDetailsDB11951Lemborexantapproved, investigationalunknownsubstrateDetailsDB12941Darolutamideapproved, investigationalunknownsubstrateDetailsDB06077Lumateperoneapproved, investigationalnosubstrateDetailsDB15091Upadacitinibapproved, investigationalnosubstrateDetailsDB15328Ubrogepantapproved, investigationalunknownsubstrateDetailsDB15233Avapritinibapproved, investigationalunknownsubstrateDetailsDB12887Tazemetostatapproved, investigationalunknownsubstrateDetailsDB12457Rimegepantapproved, investigationalnosubstrateinhibitorDetailsDB13609UmifenovirinvestigationalunknownsubstrateDetailsDB11837Osilodrostatapproved, investigationalunknownsubstrateinhibitorDetailsDB14678Norethindrone enanthateexperimentalunknownsubstrateDetailsDB09241Methylene blueapproved, investigationalunknowninhibitorDetailsDB12612Ozanimodapproved, investigationalunknownsubstrateDetailsDB14598Edetate calcium disodium anhydrousapprovedunknowninhibitorDetailsDB11689Selumetinibapproved, investigationalnosubstrateDetailsDB15102Pemigatinibapproved, investigationalnosubstrateDetailsDB14761Remdesivirapproved, investigationalunknownsubstrateinhibitorDetailsDB11791Capmatinibapproved, investigationalunknownsubstrateDetailsDB15685Selpercatinibapproved, investigationalunknownsubstrateDetailsDB14840RipretinibapprovedunknownsubstrateDetailsDB00714Apomorphineapproved, investigationalunknownDetailsDB12674Lurbinectedinapproved, investigationalunknownsubstrateDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB05015Belinostatapproved, investigationalunknownsubstrateDetailsDB11796Fostemsavirapproved, investigationalunknownsubstrateDetailsDB11932Abametapirapproved, investigationalnoinhibitorDetailsDB15305Risdiplamapproved, investigationalunknownsubstrateDetailsDB14881Oliceridineapproved, investigationalnosubstrateDetailsDB12499Clascoteroneapproved, investigationalnoinhibitorDetailsDB15822Pralsetinibapproved, investigationalnosubstrateinhibitorinducerDetailsDB06448Lonafarnibapproved, investigationalunknownsubstrateinhibitorDetailsDB15982BerotralstatapprovednoinhibitorDetailsDB06137Tirbanibulinapproved, investigationalnosubstrateinhibitorDetailsDB14895Vibegronapproved, investigationalnosubstrateDetailsDB00475Chlordiazepoxideapproved, illicit, investigationalunknownsubstrateDetailsDB00752Tranylcypromineapproved, investigationalunknowninhibitorDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB05667Levoketoconazoleapproved, investigationalnosubstrateinhibitorinducerDetailsDB00476DuloxetineapprovedunknowninhibitorDetailsDB11693Voclosporinapproved, investigationalunknownsubstrateinhibitorDetailsDB15133Tepotinibapproved, investigationalnosubstrateinhibitorDetailsDB00747Scopolamineapproved, investigationalnosubstrateDetailsDB00330EthambutolapprovedunknowninhibitorDetailsDB14989Umbralisibapproved, investigational, withdrawnunknownsubstrateDetailsDB14984Casimersenapproved, investigationalnoinhibitorDetailsDB00545Pyridostigmineapproved, investigationalnoinducerDetailsDB11800Tivozanibapproved, investigationalunknownsubstrateDetailsDB12016Ponesimodapproved, investigationalunknownsubstrateDetailsDB08995Diosminapproved, investigationalunknowninhibitorDetailsDB05316Pimavanserinapproved, investigationalunknownsubstrateDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownsubstrateDetailsDB12235Estetrolapproved, investigationalunknownsubstrateDetailsDB16222Loncastuximab tesirineapproved, investigationalunknownDetailsDB11886Infigratinibapproved, investigationalnosubstrateDetailsDB12471Ibrexafungerpapproved, investigationalunknownsubstrateinhibitorDetailsDB12543Samidorphanapproved, investigationalnosubstrateDetailsDB16165Finerenoneapproved, investigationalunknownsubstrateDetailsDB16703Belumosudilapproved, investigationalnosubstrateDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB15463Belzutifanapproved, investigationalnosubstrateDetailsDB12265Fexinidazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB16390Mobocertinibapproved, investigationalunknownsubstrateDetailsDB16732Tisotumab vedotinapprovednosubstrateDetailsDB16098Atogepantapproved, investigationalnosubstrateDetailsDB16226Maralixibatapproved, investigationalnoinhibitorDetailsDB15011Avacopanapproved, investigationalnosubstrateinhibitorinducerDetailsDB12597Asciminibapproved, investigationalnosubstrateinhibitorDetailsDB06234Maribavirapproved, investigationalnosubstrateDetailsDB16691Nirmatrelvirapproved, investigationalnosubstrateinhibitorDetailsDB15031DaridorexantapprovednosubstrateDetailsDB12713Sotagliflozinapproved, investigationalnosubstrateinhibitorinducerDetailsDB14973Abrocitinibapproved, investigationalnosubstrateDetailsDB05467Palovaroteneapproved, investigationalnosubstrateinducerDetailsDB16236Mitapivatapproved, investigationalnosubstrateinducerDetailsDB12834SecnidazoleapprovedunknownsubstrateinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknownsubstrateinhibitorDetailsDB00486Nabiloneapproved, investigationalunknownsubstrateinhibitorDetailsDB06230Nalmefeneapproved, investigational, withdrawnnosubstrateDetailsDB11697Pacritinibapproved, investigationalnosubstrateinhibitorinducerDetailsDB05087Ganaxoloneapproved, investigationalnosubstrateDetailsDB01041Thalidomideapproved, investigational, withdrawnnosubstrateinducerDetailsDB14921Mavacamtenapproved, investigationalnosubstrateinducerDetailsDB09185Viloxazineapproved, investigational, withdrawnnoinhibitorDetailsDB00951Isoniazidapproved, investigationalunknowninhibitorDetailsDB12020Tecovirimatapproved, investigationalnoinducerDetailsDB06083Tapinarofapproved, investigationalnosubstrateDetailsDB01024Mycophenolic acidapproved, investigationalunknownsubstrateDetailsDB10534GrapefruitapprovedunknowninhibitorDetailsDB04951Pirfenidoneapproved, investigationalunknowninhibitorDetailsDB15673Lenacapavirapproved, investigationalnosubstrateinhibitorDetailsDB12095Telotristat ethylapproved, investigationalnoinhibitorinducerDetailsDB15149Futibatinibapproved, investigationalnosubstrateDetailsDB17083LinzagolixapprovednosubstrateDetailsDB11739Vonoprazanapproved, investigationalunknownsubstrateDetailsDB09065CobicistatapprovedyesinhibitorDetailsDB16267Olutasidenibapproved, investigationalnosubstrateinducerDetailsDB15568Adagrasibapproved, investigationalunknownsubstrateinhibitorDetailsDB12236Bexagliflozinapproved, investigationalunknownsubstrateDetailsDB17472Pirtobrutinibapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB06374Elacestrantapproved, investigationalunknownsubstrateDetailsDB11682Daprodustatapproved, investigationalnosubstrateDetailsDB09065CobicistatapprovednosubstrateDetailsDB12548Sparsentanapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB12513Omaveloxoloneapproved, investigationalunknownsubstrateinducerDetailsDB15688Zavegepantapproved, investigationalunknownsubstrateDetailsDB06045Trofinetideapproved, investigationalunknowninhibitorDetailsDB16217Leniolisibapproved, investigationalnosubstrateDetailsDB12255Vadadustatapproved, investigationalunknowndownregulatorDetailsDB14924Ritlecitinibapproved, investigationalunknownsubstrateinhibitorDetailsDB12874Quizartinibapproved, investigationalnosubstrateDetailsDB15490Zuranoloneapproved, experimentalnosubstrateDetailsDB11763Momelotinibapproved, investigationalunknownsubstrateDetailsDB12184GepironeinvestigationalnosubstrateDetailsDB14766EtrasimodapprovednosubstrateDetailsDB15114Vamoroloneapproved, investigationalnosubstrateinducerDetailsDB12218Capivasertibapproved, investigationalnosubstrateDetailsDB16826RepotrectinibinvestigationalnosubstrateinhibitorinducerDetailsDB11679FruquintinibinvestigationalnosubstrateDetailsDB00176Fluvoxamineapproved, investigationalunknowninhibitorDetailsDB00599Thiopentalapproved, vet_approvedunknownsubstrateDetailsDB08930DolutegravirapprovednosubstrateDetailsDB06595Midostaurinapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB13174RheinexperimentalunknowninhibitorDetailsDB11994Diacereinapproved, investigationalunknowninhibitorDetailsDB11605MyrrhapprovedunknowninducerDetailsDB11691Naldemedineapproved, investigationalnosubstrateDetailsDB13878Pibrentasvirapproved, investigationalunknowninhibitorDetailsDB13879Glecaprevirapproved, investigationalunknownsubstrateinhibitorDetailsDB09205Moxisylyteapproved, investigationalnosubstrateDetailsDB09568Omega-3-carboxylic acidsapproved, investigationalnosubstrateDetailsDB01601LopinavirapprovednoinhibitorDetailsDB01149Nefazodoneapproved, withdrawnnoinhibitorDetailsDB13141Ambroxol acefyllinateexperimental, investigationalnosubstrateDetailsDB11792MirodenafilinvestigationalunknownsubstrateDetailsDB11979Elagolixapproved, investigationalnosubstrateDetailsDB08865Crizotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB11703Acalabrutinibapproved, investigationalunknownsubstrateDetailsDB12267Brigatinibapproved, investigationalunknowninducerDetailsDB12307ForetinibinvestigationalunknownsubstrateDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB00593EthosuximideapprovedunknownsubstrateDetailsDB01201Rifapentineapproved, investigationalunknowninducerDetailsDB00643Mebendazoleapproved, vet_approvedunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknowninhibitorDetailsDB00334Olanzapineapproved, investigationalunknowninhibitorDetailsDB09212LoxoprofenapprovedunknownsubstrateDetailsDB00635Prednisoneapproved, vet_approvedunknowninducerDetailsDB01222BudesonideapprovedunknownsubstrateinducerDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB11951Lemborexantapproved, investigationalunknowninhibitorinducerDetailsDB12887Tazemetostatapproved, investigationalunknownsubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninducerDetailsDB11652Tucatinibapproved, investigationalunknownsubstrateDetailsDB15035Zanubrutinibapproved, investigationalunknownsubstrateDetailsDB15685Selpercatinibapproved, investigationalunknowninhibitorDetailsDB00409Remoxiprideapproved, withdrawnunknowninhibitorDetailsDB15305Risdiplamapproved, investigationalunknowninhibitorDetailsDB06448Lonafarnibapproved, investigationalnosubstrateinhibitorDetailsDB11853Relugolixapproved, investigationalunknownsubstrateinducerDetailsDB01586Ursodeoxycholic acidapproved, investigationalunknowninducerDetailsDB11742Ebastineapproved, investigationalunknownsubstrateDetailsDB15569Sotorasibapproved, investigationalunknownsubstrateDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB00647Dextropropoxypheneapproved, illicit, investigational, withdrawnunknowninhibitorDetailsDB00333MethadoneapprovednoinhibitorDetailsDB01167Itraconazoleapproved, investigationalnoinhibitorDetailsDB16536Birch bark extractapproved, experimentalunknowninhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateinhibitorDetails"
                    }
                },
                {
                    "Label": "Cytochrome P450 3A5",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 3A5",
                        "Synonyms": "1.14.14.1\nCYPIIIA5\nCytochrome P450 HLp2\nCytochrome P450-PCN3",
                        "Gene Name": "CYP3A5",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0004639|Cytochrome P450 3A5\nMDLIPNLAVETWLLLAVSLVLLYLYGTRTHGLFKRLGIPGPTPLPLLGNVLSYRQGLWKF\nDTECYKKYGKMWGTYEGQLPVLAITDPDVIRTVLVKECYSVFTNRRSLGPVGFMKSAISL\nAEDEEWKRIRSLLSPTFTSGKLKEMFPIIAQYGDVLVRNLRREAEKGKPVTLKDIFGAYS\nMDVITGTSFGVNIDSLNNPQDPFVESTKKFLKFGFLDPLFLSIILFPFLTPVFEALNVSL\nFPKDTINFLSKSVNRMKKSRLNDKQKHRLDFLQLMIDSQNSKETESHKALSDLELAAQSI\nIFIFAGYETTSSVLSFTLYELATHPDVQQKLQKEIDAVLPNKAPPTYDAVVQMEYLDMVV\nNETLRLFPVAIRLERTCKKDVEINGVFIPKGSMVVIPTYALHHDPKYWTEPEEFRPERFS\nKKKDSIDPYIYTPFGTGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLDTQG\nLLQPEKPIVLKVDSRDGTLSGE",
                        "Number of residues": "502",
                        "Molecular Weight": "57108.065",
                        "Theoretical pI": "9.09",
                        "GO Classification": "Functionsaromatase activity / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity / oxygen bindingProcessesalkaloid catabolic process / drug catabolic process / oxidative demethylation / small molecule metabolic process / steroid metabolic process / xenobiotic metabolic processComponentsendoplasmic reticulum membrane / intracellular membrane-bounded organelle",
                        "General Function": "Oxygen binding",
                        "Specific Function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0016766|Cytochrome P450 3A5 (CYP3A5)\nATGGACCTCATCCCAAATTTGGCGGTGGAAACCTGGCTTCTCCTGGCTGTCAGCCTGGTG\nCTCCTCTATCTATATGGGACCCGTACACATGGACTTTTTAAGAGACTGGGAATTCCAGGG\nCCCACACCTCTGCCTTTGTTGGGAAATGTTTTGTCCTATCGTCAGGGTCTCTGGAAATTT\nGACACAGAGTGCTATAAAAAGTATGGAAAAATGTGGGGAACGTATGAAGGTCAACTCCCT\nGTGCTGGCCATCACAGATCCCGACGTGATCAGAACAGTGCTAGTGAAAGAATGTTATTCT\nGTCTTCACAAATCGAAGGTCTTTAGGCCCAGTGGGATTTATGAAAAGTGCCATCTCTTTA\nGCTGAGGATGAAGAATGGAAGAGAATACGGTCATTGCTGTCTCCAACCTTCACCAGCGGA\nAAACTCAAGGAGATGTTCCCCATCATTGCCCAGTATGGAGATGTATTGGTGAGAAACTTG\nAGGCGGGAAGCAGAGAAAGGCAAGCCTGTCACCTTGAAAGACATCTTTGGGGCCTACAGC\nATGGATGTGATTACTGGCACATCATTTGGAGTGAACATCGACTCTCTCAACAATCCACAA\nGACCCCTTTGTGGAGAGCACTAAGAAGTTCCTAAAATTTGGTTTCTTAGATCCATTATTT\nCTCTCAATAATACTCTTTCCATTCCTTACCCCAGTTTTTGAAGCATTAAATGTCTCTCTG\nTTTCCAAAAGATACCATAAATTTTTTAAGTAAATCTGTAAACAGAATGAAGAAAAGTCGC\nCTCAACGACAAACAAAAGCACCGACTAGATTTCCTTCAGCTGATGATTGACTCCCAGAAT\nTCGAAAGAAACTGAGTCCCACAAAGCTCTGTCTGATCTGGAGCTCGCAGCCCAGTCAATA\nATCTTCATTTTTGCTGGCTATGAAACCACCAGCAGTGTTCTTTCCTTCACTTTATATGAA\nCTGGCCACTCACCCTGATGTCCAGCAGAAACTGCAAAAGGAGATTGATGCAGTTTTGCCC\nAATAAGGCACCACCTACCTATGATGCCGTGGTACAGATGGAGTACCTTGACATGGTGGTG\nAATGAAACACTCAGATTATTCCCAGTTGCTATTAGACTTGAGAGGACTTGCAAGAAAGAT\nGTTGAAATCAATGGGGTATTCATTCCCAAAGGGTCAATGGTGGTGATTCCAACTTATGCT\nCTTCACCATGACCCAAAGTACTGGACAGAGCCTGAGGAGTTCCGCCCTGAAAGGTTCAGT\nAAGAAGAAGGACAGCATAGATCCTTACATATACACACCCTTTGGAACTGGACCCAGAAAC\nTGCATTGGCATGAGGTTTGCTCTCATGAACATGAAACTTGCTCTAATCAGAGTCCTTCAG\nAACTTCTCCTTCAAACCTTGTAAAGAAACACAGATCCCCTTGAAATTAGACACGCAAGGA\nCTTCTTCAACCAGAAAAACCCATTGTTCTAAAGGTGGATTCAAGAGATGGAACCCTAAGT\nGGAGAATGA",
                        "Chromosome Location": "7",
                        "Locus": "7q21.1",
                        "External Identifiers": "ResourceLinkUniProtKB IDP20815UniProtKB Entry NameCP3A5_HUMANGenBank Protein ID181346GenBank Gene IDJ04813GenAtlas IDCYP3A5HGNC IDHGNC:2638",
                        "General References": "Aoyama T, Yamano S, Waxman DJ, Lapenson DP, Meyer UA, Fischer V, Tyndale R, Inaba T, Kalow W, Gelboin HV, et al.: Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. J Biol Chem. 1989 Jun 25;264(18):10388-95. [Article] Schuetz JD, Molowa DT, Guzelian PS: Characterization of a cDNA encoding a new member of the glucocorticoid-responsive cytochromes P450 in human liver. Arch Biochem Biophys. 1989 Nov 1;274(2):355-65. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Scherer SW, Cheung J, MacDonald JR, Osborne LR, Nakabayashi K, Herbrick JA, Carson AR, Parker-Katiraee L, Skaug J, Khaja R, Zhang J, Hudek AK, Li M, Haddad M, Duggan GE, Fernandez BA, Kanematsu E, Gentles S, Christopoulos CC, Choufani S, Kwasnicka D, Zheng XH, Lai Z, Nusskern D, Zhang Q, Gu Z, Lu F, Zeesman S, Nowaczyk MJ, Teshima I, Chitayat D, Shuman C, Weksberg R, Zackai EH, Grebe TA, Cox SR, Kirkpatrick SJ, Rahman N, Friedman JM, Heng HH, Pelicci PG, Lo-Coco F, Belloni E, Shaffer LG, Pober B, Morton CC, Gusella JF, Bruns GA, Korf BR, Quade BJ, Ligon AH, Ferguson H, Higgins AW, Leach NT, Herrick SR, Lemyre E, Farra CG, Kim HG, Summers AM, Gripp KW, Roberts W, Szatmari P, Winsor EJ, Grzeschik KH, Teebi A, Minassian BA, Kere J, Armengol L, Pujana MA, Estivill X, Wilson MD, Koop BF, Tosi S, Moore GE, Boright AP, Zlotorynski E, Kerem B, Kroisel PM, Petek E, Oscier DG, Mould SJ, Dohner H, Dohner K, Rommens JM, Vincent JB, Venter JC, Li PW, Mural RJ, Adams MD, Tsui LC: Human chromosome 7: DNA sequence and biology. Science. 2003 May 2;300(5620):767-72. Epub 2003 Apr 10. [Article] Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, Wagner-McPherson C, Layman D, Maas J, Jaeger S, Walker R, Wylie K, Sekhon M, Becker MC, O'Laughlin MD, Schaller ME, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Cordes M, Du H, Sun H, Edwards J, Bradshaw-Cordum H, Ali J, Andrews S, Isak A, Vanbrunt A, Nguyen C, Du F, Lamar B, Courtney L, Kalicki J, Ozersky P, Bielicki L, Scott K, Holmes A, Harkins R, Harris A, Strong CM, Hou S, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Leonard S, Rohlfing T, Rock SM, Tin-Wollam AM, Abbott A, Minx P, Maupin R, Strowmatt C, Latreille P, Miller N, Johnson D, Murray J, Woessner JP, Wendl MC, Yang SP, Schultz BR, Wallis JW, Spieth J, Bieri TA, Nelson JO, Berkowicz N, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Bedell JA, Mardis ER, Clifton SW, Chissoe SL, Marra MA, Raymond C, Haugen E, Gillett W, Zhou Y, James R, Phelps K, Iadanoto S, Bubb K, Simms E, Levy R, Clendenning J, Kaul R, Kent WJ, Furey TS, Baertsch RA, Brent MR, Keibler E, Flicek P, Bork P, Suyama M, Bailey JA, Portnoy ME, Torrents D, Chinwalla AT, Gish WR, Eddy SR, McPherson JD, Olson MV, Eichler EE, Green ED, Waterston RH, Wilson RK: The DNA sequence of human chromosome 7. Nature. 2003 Jul 10;424(6945):157-64. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Gellner K, Eiselt R, Hustert E, Arnold H, Koch I, Haberl M, Deglmann CJ, Burk O, Buntefuss D, Escher S, Bishop C, Koebe HG, Brinkmann U, Klenk HP, Kleine K, Meyer UA, Wojnowski L: Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics. 2001 Mar;11(2):111-21. [Article] Schuetz JD, Schuetz EG, Thottassery JV, Guzelian PS, Strom S, Sun D: Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells. Mol Pharmacol. 1996 Jan;49(1):63-72. [Article] Jounaidi Y, Guzelian PS, Maurel P, Vilarem MJ: Sequence of the 5'-flanking region of CYP3A5: comparative analysis with CYP3A4 and CYP3A7. Biochem Biophys Res Commun. 1994 Dec 30;205(3):1741-7. [Article] Finta C, Zaphiropoulos PG: Intergenic mRNA molecules resulting from trans-splicing. J Biol Chem. 2002 Feb 22;277(8):5882-90. Epub 2001 Nov 28. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Jounaidi Y, Hyrailles V, Gervot L, Maurel P: Detection of CYP3A5 allelic variant: a candidate for the polymorphic expression of the protein? Biochem Biophys Res Commun. 1996 Apr 16;221(2):466-70. [Article] Chou FC, Tzeng SJ, Huang JD: Genetic polymorphism of cytochrome P450 3A5 in Chinese. Drug Metab Dispos. 2001 Sep;29(9):1205-9. [Article] Lee SJ, Usmani KA, Chanas B, Ghanayem B, Xi T, Hodgson E, Mohrenweiser HW, Goldstein JA: Genetic findings and functional studies of human CYP3A5 single nucleotide polymorphisms in different ethnic groups. Pharmacogenetics. 2003 Aug;13(8):461-72. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00224IndinavirapprovedunknownsubstrateinhibitorDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinducerDetailsDB00468QuinineapprovedunknownsubstrateDetailsDB00541Vincristineapproved, investigationalnosubstrateDetailsDB00661VerapamilapprovedunknownsubstrateinhibitorDetailsDB00683Midazolamapproved, illicitunknownsubstrateDetailsDB00694DaunorubicinapprovedunknowninducerDetailsDB00758ClopidogrelapprovednosubstrateDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateDetailsDB00834Mifepristoneapproved, investigationalunknownsubstrateDetailsDB00864Tacrolimusapproved, investigationalunknownsubstrateDetailsDB01026Ketoconazoleapproved, investigationalnoinhibitorDetailsDB01232Saquinavirapproved, investigationalunknownsubstrateinhibitorDetailsDB13179TroleandomycinapprovedunknowninhibitorDetailsDB04856DexloxiglumideinvestigationalunknownsubstrateDetailsDB04957AzimilideinvestigationalunknownsubstrateDetailsDB06267Udenafilapproved, investigationalunknownsubstrateDetailsDB06287TemsirolimusapprovedunknownsubstrateinhibitorDetailsDB00802Alfentanilapproved, illicitunknownsubstrateDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateDetailsDB01181IfosfamideapprovedunknownsubstrateDetailsDB00321AmitriptylineapprovedunknownsubstrateDetailsDB00540NortriptylineapprovedunknownsubstrateDetailsDB00619ImatinibapprovednosubstrateinhibitorDetailsDB00675TamoxifenapprovedunknownsubstrateDetailsDB01041Thalidomideapproved, investigational, withdrawnnosubstrateinducerDetailsDB00220NelfinavirapprovednosubstrateinhibitorDetailsDB00238NevirapineapprovedunknownsubstrateDetailsDB06652VicrivirocinvestigationalunknownsubstrateDetailsDB00972AzelastineapprovedunknownsubstrateDetailsDB01211ClarithromycinapprovedunknownsubstrateinhibitorDetailsDB00404Alprazolamapproved, illicit, investigationalunknownsubstrateDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB00897Triazolamapproved, investigationalunknownsubstrateDetailsDB00604Cisaprideapproved, investigational, withdrawnunknownsubstrateDetailsDB00637Astemizoleapproved, withdrawnunknownsubstrateDetailsDB01114ChlorpheniramineapprovedunknownsubstrateDetailsDB00342Terfenadineapproved, withdrawnunknownsubstrateDetailsDB00381AmlodipineapprovedunknownsubstrateinhibitorDetailsDB00343Diltiazemapproved, investigationalunknownsubstrateinhibitorDetailsDB01023Felodipineapproved, investigationalunknownsubstrateDetailsDB00528Lercanidipineapproved, investigationalunknownsubstrateDetailsDB00401NisoldipineapprovedunknownsubstrateDetailsDB01054Nitrendipineapproved, investigationalunknownsubstrateDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB00439Cerivastatinapproved, withdrawnunknownsubstrateDetailsDB00641SimvastatinapprovedunknownsubstrateDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00741Hydrocortisoneapproved, vet_approvedunknownsubstrateDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateDetailsDB00624Testosteroneapproved, investigationalunknownsubstrateDetailsDB01238Aripiprazoleapproved, investigationalnosubstrateDetailsDB00490Buspironeapproved, investigationalunknownsubstrateDetailsDB01166Cilostazolapproved, investigationalunknownsubstrateDetailsDB00250Dapsoneapproved, investigationalunknownsubstrateDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB01248Docetaxelapproved, investigationalunknownsubstrateDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB00700EplerenoneapprovedunknownsubstrateDetailsDB01216FinasterideapprovedunknownsubstrateDetailsDB00502HaloperidolapprovedunknownsubstrateDetailsDB00281Lidocaineapproved, vet_approvedunknownsubstrateDetailsDB00731Nateglinideapproved, investigationalunknownsubstrateDetailsDB00904Ondansetronapproved, withdrawnunknownsubstrateDetailsDB01100PimozideapprovedunknownsubstrateDetailsDB00571Propranololapproved, investigationalunknownsubstrateDetailsDB01224QuetiapineapprovedunknownsubstrateDetailsDB00938SalmeterolapprovedunknownsubstrateDetailsDB00877Sirolimusapproved, investigationalnosubstrateDetailsDB00398Sorafenibapproved, investigationalunknownsubstrateDetailsDB01268Sunitinibapproved, investigationalunknownsubstrateDetailsDB01229Paclitaxelapproved, vet_approvedunknownsubstrateDetailsDB00656Trazodoneapproved, investigationalunknownsubstrateDetailsDB00962Zaleplonapproved, illicit, investigationalunknownsubstrateDetailsDB01167Itraconazoleapproved, investigationalnoinhibitorDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00446Chloramphenicolapproved, vet_approved, withdrawnunknowninhibitorDetailsDB00537Ciprofloxacinapproved, investigationalunknowninhibitorDetailsDB00705DelavirdineapprovedunknowninhibitorDetailsDB06730GestodeneinvestigationalunknowninhibitorDetailsDB01388Mibefradilinvestigational, withdrawnunknowninhibitorDetailsDB06731SeproxetineinvestigationalunknowninhibitorDetailsDB00582VoriconazoleapprovedunknownsubstrateinhibitorDetailsDB00313Valproic acidapproved, investigationalunknownsubstrateDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB06772CabazitaxelapprovedunknownsubstrateDetailsDB06697ArtemetherapprovedunknownsubstrateDetailsDB00701Amprenavirapproved, investigationalunknownsubstrateDetailsDB00278Argatrobanapproved, investigationalunknownsubstrateDetailsDB00394Beclomethasone dipropionateapproved, investigationalunknowninducerDetailsDB00564Carbamazepineapproved, investigationalunknownsubstrateinducerDetailsDB00608Chloroquineapproved, investigational, vet_approvednosubstrateDetailsDB00822DisulfiramapprovedunknownsubstrateDetailsDB00655EstroneapprovedunknownsubstrateDetailsDB00773EtoposideapprovedunknownsubstrateDetailsDB00499Flutamideapproved, investigationalunknownsubstrateDetailsDB01218HalofantrineapprovedunknownsubstrateDetailsDB01103QuinacrineinvestigationalnosubstrateDetailsDB00745Modafinilapproved, investigationalnosubstrateinducerDetailsDB00622Nicardipineapproved, investigationalunknowninhibitorDetailsDB00776OxcarbazepineapprovednoinhibitorinducerDetailsDB01062Oxybutyninapproved, investigationalunknownsubstrateDetailsDB00497Oxycodoneapproved, illicit, investigationalunknownsubstrateDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB01174Phenobarbitalapproved, investigationalnoinducerDetailsDB01058Praziquantelapproved, investigational, vet_approvedunknownsubstrateDetailsDB00206Reserpineapproved, investigational, withdrawnunknowninducerDetailsDB00444TeniposideapprovednosubstrateDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknowninhibitorDetailsDB00862VardenafilapprovedunknownsubstrateDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateDetailsDB00588Fluticasone propionateapprovedunknownsubstrateinhibitorDetailsDB00738Pentamidineapproved, investigationalunknownsubstrateDetailsDB00755Tretinoinapproved, investigational, nutraceuticalnosubstrateDetailsDB01254Dasatinibapproved, investigationalunknownsubstrateDetailsDB01259Lapatinibapproved, investigationalunknownsubstrateDetailsDB04946IloperidoneapprovedunknownsubstrateDetailsDB06176Romidepsinapproved, investigationalunknownsubstrateDetailsDB06335SaxagliptinapprovedunknownsubstrateDetailsDB06413Armodafinilapproved, investigationalunknowninducerDetailsDB00575ClonidineapprovedunknownsubstrateDetailsDB06419CethromycininvestigationalunknownsubstrateDetailsDB08873Boceprevirapproved, withdrawnunknownsubstrateinhibitorDetailsDB06228RivaroxabanapprovedunknownsubstrateDetailsDB08883PerampanelapprovednosubstrateDetailsDB08865Crizotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB06605ApixabanapprovedunknownsubstrateDetailsDB06626Axitinibapproved, investigationalnosubstrateDetailsDB08899EnzalutamideapprovednosubstrateinducerDetailsDB08901Ponatinibapproved, investigationalunknownsubstrateDetailsDB05773Trastuzumab emtansineapproved, investigationalunknownsubstrateDetailsDB00531Cyclophosphamideapproved, investigationalunknownsubstrateDetailsDB01095FluvastatinapprovedunknownsubstrateDetailsDB00472Fluoxetineapproved, vet_approvedunknownsubstrateDetailsDB00317Gefitinibapproved, investigationalunknownsubstrateDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB09053IbrutinibapprovedunknownsubstrateDetailsDB09068Vortioxetineapproved, investigationalnosubstrateDetailsDB09102Daclatasvirapproved, investigationalunknownsubstrateDetailsDB06403Ambrisentanapproved, investigationalnosubstrateDetailsDB06789Hydroxyprogesterone caproateapproved, investigationalunknownsubstrateDetailsDB09297Paritaprevirapproved, investigationalnosubstrateDetailsDB12161Deutetrabenazineapproved, investigationalnosubstrateDetailsDB11915Valbenazineapproved, investigationalnosubstrateDetailsDB08820IvacaftorapprovednosubstrateinhibitorDetailsDB09054IdelalisibapprovednosubstrateinhibitorDetailsDB09065CobicistatapprovednosubstrateDetailsDB06412Oxymetholoneapproved, illicitunknowninhibitorDetailsDB00503Ritonavirapproved, investigationalunknownsubstrateinhibitorDetailsDB06595Midostaurinapproved, investigationalunknowninducerDetailsDB11574ElbasvirapprovedunknownsubstrateDetailsDB12483Copanlisibapproved, investigationalnosubstrateDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB09061Cannabidiolapproved, investigationalunknownsubstrateinhibitorDetailsDB13943Testosterone cypionateapprovedunknownsubstrateDetailsDB13944Testosterone enanthateapprovedunknownsubstrateDetailsDB13946Testosterone undecanoateapproved, investigationalunknownsubstrateDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateDetailsDB09231BenidipineexperimentalnosubstrateDetailsDB11633Isavuconazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB11712Tezacaftorapproved, investigationalnosubstrateinducerDetailsDB11586Asunaprevirapproved, investigational, withdrawnnosubstrateinducerDetailsDB14011NabiximolsinvestigationalunknownsubstrateDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorDetailsDB00625Efavirenzapproved, investigationalunknowninducerDetailsDB00199Erythromycinapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB14185Aripiprazole lauroxilapproved, investigationalunknownsubstrateDetailsDB14538Hydrocortisone aceponateexperimental, vet_approvedunknownsubstrateDetailsDB14539Hydrocortisone acetateapproved, vet_approvedunknownsubstrateDetailsDB14540Hydrocortisone butyrateapproved, vet_approvedunknownsubstrateDetailsDB14541Hydrocortisone cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB14542Hydrocortisone phosphateapproved, vet_approvedunknownsubstrateDetailsDB14543Hydrocortisone probutateapproved, vet_approvedunknownsubstrateDetailsDB14544Hydrocortisone valerateapproved, vet_approvedunknownsubstrateDetailsDB01222BudesonideapprovednoinducerDetailsDB06654Safinamideapproved, investigationalunknowninhibitorDetailsDB11703Acalabrutinibapproved, investigationalunknowninhibitorDetailsDB01267PaliperidoneapprovedunknownsubstrateDetailsDB11737Icotinibexperimental, investigationalunknownsubstrateinducerDetailsDB00909Zonisamideapproved, investigationalnosubstrateDetailsDB09256Tegafurapproved, investigationalunknownsubstrateDetailsDB12301Doravirineapproved, investigationalunknownsubstrateDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateDetailsDB09074OlaparibapprovedunknownsubstrateinhibitorDetailsDB00455Loratadineapproved, investigationalunknownsubstrateDetailsDB13867Fluticasoneapproved, experimentalunknownsubstrateinhibitorinducerDetailsDB08906Fluticasone furoateapprovednosubstrateinhibitorinducerDetailsDB01126Dutasterideapproved, investigationalnosubstrateDetailsDB00905Bimatoprostapproved, investigationalunknownsubstrateDetailsDB00916MetronidazoleapprovedunknownsubstrateDetailsDB00288AmcinonideapprovedunknowninducerDetailsDB00443Betamethasoneapproved, vet_approvedunknowninducerDetailsDB14669Betamethasone phosphateapproved, vet_approvedunknowninducerDetailsDB11750Clobetasolapproved, experimental, investigationalunknowninducerDetailsDB01013Clobetasol propionateapprovedunknowninducerDetailsDB14652Clocortolone acetateexperimentalunknowninducerDetailsDB13843CloprednolexperimentalunknowninducerDetailsDB14681CortisoneexperimentalunknowninducerDetailsDB01380Cortisone acetateapproved, investigationalunknowninducerDetailsDB13003CortivazolinvestigationalunknowninducerDetailsDB11921Deflazacortapproved, investigationalunknowninducerDetailsDB11487Dexamethasone isonicotinatevet_approvedunknowninducerDetailsDB09095Difluocortoloneapproved, investigational, withdrawnunknowninducerDetailsDB01047Fluocinonideapproved, investigationalunknowninducerDetailsDB08971Fluocortoloneapproved, withdrawnunknowninducerDetailsDB00324Fluorometholoneapproved, investigationalunknowninducerDetailsDB08970FluprednideneexperimentalunknowninducerDetailsDB14634Fluprednidene acetateexperimentalunknowninducerDetailsDB13728HalometasoneexperimentalunknowninducerDetailsDB00253MedrysoneapprovedunknowninducerDetailsDB14659Melengestrol acetateexperimentalunknowninducerDetailsDB09383Meprednisoneapproved, investigationalunknowninducerDetailsDB14644Methylprednisolone hemisuccinateapprovedunknowninducerDetailsDB00764MometasoneexperimentalunknowninducerDetailsDB14512Mometasone furoateapproved, investigational, vet_approvednoinducerDetailsDB01384ParamethasoneexperimentalunknowninducerDetailsDB14633Prednisolone hemisuccinateexperimentalunknowninducerDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninducerDetailsDB00635Prednisoneapproved, vet_approvedunknowninducerDetailsDB14646Prednisone acetateapproved, experimental, investigationalunknowninducerDetailsDB13208PrednylideneexperimentalunknowninducerDetailsDB00896RimexoloneapprovedunknowninducerDetailsDB00620Triamcinoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB01045RifampicinapprovedunknowninducerDetailsDB00196Fluconazoleapproved, investigationalunknowninhibitorDetailsDB02520DitiocarbexperimentalunknowninhibitorDetailsDB00367Levonorgestrelapproved, investigationalunknownsubstrateDetailsDB01016GlyburideapprovedunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknownsubstrateDetailsDB09061Cannabidiolapproved, investigationalunknowninhibitorDetailsDB11761Tenapanorapproved, investigationalunknownsubstrateDetailsDB14011NabiximolsinvestigationalunknowninhibitorDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB04855DronedaroneapprovedunknownsubstrateinhibitorDetailsDB01217Anastrozoleapproved, investigationalunknownsubstrateDetailsDB15444Elexacaftorapproved, investigationalnosubstrateDetailsDB00557HydroxyzineapprovednosubstrateDetailsDB06119Cenobamateapproved, investigationalunknownsubstrateinhibitorDetailsDB11951Lemborexantapproved, investigationalunknownsubstrateDetailsDB01115NifedipineapprovedunknownsubstrateDetailsDB01190Clindamycinapproved, vet_approvedunknownsubstrateDetailsDB00977EthinylestradiolapprovedunknownsubstrateDetailsDB13609UmifenovirinvestigationalunknownsubstrateDetailsDB11837Osilodrostatapproved, investigationalunknowninhibitorDetailsDB09241Methylene blueapproved, investigationalunknowninhibitorDetailsDB11689Selumetinibapproved, investigationalnosubstrateDetailsDB00845Clofazimineapproved, investigationalunknowninhibitorDetailsDB00714Apomorphineapproved, investigationalunknownsubstrateDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB15822Pralsetinibapproved, investigationalnoinhibitorinducerDetailsDB06448Lonafarnibapproved, investigationalnosubstrateinhibitorDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB05667Levoketoconazoleapproved, investigationalnoinhibitorinducerDetailsDB14984Casimersenapproved, investigationalnoinhibitorDetailsDB12016Ponesimodapproved, investigationalunknownsubstrateDetailsDB05316Pimavanserinapproved, investigationalunknownsubstrateDetailsDB08816TicagrelorapprovedunknownsubstrateactivatorDetailsDB16222Loncastuximab tesirineapproved, investigationalunknownsubstrateDetailsDB12543Samidorphanapproved, investigationalnosubstrateDetailsDB12265Fexinidazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB16390Mobocertinibapproved, investigationalunknownsubstrateDetailsDB12834SecnidazoleapprovedunknownsubstrateDetailsDB00470Dronabinolapproved, illicitnoinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknowninhibitorDetailsDB06230Nalmefeneapproved, investigational, withdrawnnosubstrateDetailsDB05087Ganaxoloneapproved, investigationalnosubstrateDetailsDB06016Cariprazineapproved, investigationalnoinducerDetailsDB09185Viloxazineapproved, investigational, withdrawnnoinhibitorDetailsDB14921Mavacamtenapproved, investigationalnosubstrateDetailsDB01024Mycophenolic acidapproved, investigationalunknownsubstrateDetailsDB11739Vonoprazanapproved, investigationalunknownsubstrateDetailsDB05239Cobimetinibapproved, investigationalnoDetailsDB12240Polatuzumab vedotinapproved, investigationalnosubstrateDetailsDB17472Pirtobrutinibapproved, investigationalunknowninducerDetailsDB00349Clobazamapproved, illicitnosubstrateDetailsDB09065CobicistatapprovedyesinhibitorDetailsDB16217Leniolisibapproved, investigationalnosubstrateDetailsDB12874Quizartinibapproved, investigationalnosubstrateDetailsDB05812AbirateroneapprovedunknowninhibitorDetailsDB11718Encorafenibapproved, investigationalnoinhibitorDetailsDB01072Atazanavirapproved, investigationalunknowninhibitorDetailsDB15114Vamoroloneapproved, investigationalnosubstrateDetailsDB16826RepotrectinibinvestigationalunknownDetailsDB11679FruquintinibinvestigationalnosubstrateDetailsDB00176Fluvoxamineapproved, investigationalunknowninhibitorDetailsDB00599Thiopentalapproved, vet_approvedunknownsubstrateDetailsDB08930DolutegravirapprovednosubstrateDetailsDB06595Midostaurinapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB13174RheinexperimentalunknowninhibitorDetailsDB11994Diacereinapproved, investigationalunknowninhibitorDetailsDB11605MyrrhapprovedunknowninducerDetailsDB11691Naldemedineapproved, investigationalnosubstrateDetailsDB13878Pibrentasvirapproved, investigationalunknowninhibitorDetailsDB13879Glecaprevirapproved, investigationalunknownsubstrateinhibitorDetailsDB09205Moxisylyteapproved, investigationalnosubstrateDetailsDB09568Omega-3-carboxylic acidsapproved, investigationalnosubstrateDetailsDB01601LopinavirapprovednoinhibitorDetailsDB01149Nefazodoneapproved, withdrawnnoinhibitorDetailsDB13141Ambroxol acefyllinateexperimental, investigationalnosubstrateDetailsDB11792MirodenafilinvestigationalunknownsubstrateDetailsDB11979Elagolixapproved, investigationalnosubstrateDetailsDB08865Crizotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB11703Acalabrutinibapproved, investigationalunknownsubstrateDetailsDB12267Brigatinibapproved, investigationalunknowninducerDetailsDB12307ForetinibinvestigationalunknownsubstrateDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB00593EthosuximideapprovedunknownsubstrateDetailsDB01201Rifapentineapproved, investigationalunknowninducerDetailsDB00643Mebendazoleapproved, vet_approvedunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknowninhibitorDetailsDB00334Olanzapineapproved, investigationalunknowninhibitorDetailsDB09212LoxoprofenapprovedunknownsubstrateDetailsDB00635Prednisoneapproved, vet_approvedunknowninducerDetailsDB01222BudesonideapprovedunknownsubstrateinducerDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB11951Lemborexantapproved, investigationalunknowninhibitorinducerDetailsDB12887Tazemetostatapproved, investigationalunknownsubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninducerDetailsDB11652Tucatinibapproved, investigationalunknownsubstrateDetailsDB15035Zanubrutinibapproved, investigationalunknownsubstrateDetailsDB15685Selpercatinibapproved, investigationalunknowninhibitorDetailsDB00409Remoxiprideapproved, withdrawnunknowninhibitorDetailsDB15305Risdiplamapproved, investigationalunknowninhibitorDetailsDB06448Lonafarnibapproved, investigationalnosubstrateinhibitorDetailsDB11853Relugolixapproved, investigationalunknownsubstrateinducerDetailsDB01586Ursodeoxycholic acidapproved, investigationalunknowninducerDetailsDB11742Ebastineapproved, investigationalunknownsubstrateDetailsDB15569Sotorasibapproved, investigationalunknownsubstrateDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB00647Dextropropoxypheneapproved, illicit, investigational, withdrawnunknowninhibitorDetailsDB00333MethadoneapprovednoinhibitorDetailsDB01167Itraconazoleapproved, investigationalnoinhibitorDetailsDB16536Birch bark extractapproved, experimentalunknowninhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateinhibitorDetails"
                    }
                },
                {
                    "Label": "Cytochrome P450 3A7",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 3A7",
                        "Synonyms": "1.14.14.1\nCYPIIIA7\nCytochrome P450-HFLA",
                        "Gene Name": "CYP3A7",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0006949|Cytochrome P450 3A7\nMDLIPNLAVETWLLLAVSLILLYLYGTRTHGLFKKLGIPGPTPLPFLGNALSFRKGYWTF\nDMECYKKYRKVWGIYDCQQPMLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKNAISI\nAEDEEWKRIRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKHVFGAYS\nMDVITSTSFGVSIDSLNNPQDPFVENTKKLLRFNPLDPFVLSIKVFPFLTPILEALNITV\nFPRKVISFLTKSVKQIKEGRLKETQKHRVDFLQLMIDSQNSKDSETHKALSDLELMAQSI\nIFIFAGYETTSSVLSFIIYELATHPDVQQKVQKEIDTVLPNKAPPTYDTVLQLEYLDMVV\nNETLRLFPVAMRLERVCKKDVEINGMFIPKGVVVMIPSYVLHHDPKYWREPEKFLPERFS\nKKNKDNIDPYIYTPFGSGPRNCIGMRFALVNMKLALVRVLQNFSFKPCKETQIPLKLRFG\nGLLLTEKPIVLKAESRDETVSGA",
                        "Number of residues": "503",
                        "Molecular Weight": "57525.03",
                        "Theoretical pI": "9.59",
                        "GO Classification": "Functionsaromatase activity / heme binding / iron ion binding / monooxygenase activity / oxygen bindingProcessessmall molecule metabolic process / xenobiotic metabolic processComponentsendoplasmic reticulum membrane",
                        "General Function": "Oxygen binding",
                        "Specific Function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0019448|Cytochrome P450 3A7 (CYP3A7)\nATGGATCTCATCCCAAACTTGGCCGTGGAAACCTGGCTTCTCCTGGCTGTCAGCCTGATA\nCTCCTCTATCTATATGGAACCCGTACACATGGACTTTTTAAGAAGCTTGGAATTCCAGGG\nCCCACACCTCTGCCTTTTTTGGGAAATGCTTTGTCCTTCCGTAAGGGCTATTGGACGTTT\nGACATGGAATGTTATAAAAAGTATAGAAAAGTCTGGGGTATTTATGACTGTCAACAGCCT\nATGCTGGCTATCACAGATCCCGACATGATCAAAACAGTGCTAGTGAAAGAATGTTATTCT\nGTCTTCACAAACCGGAGGCCTTTCGGGCCAGTGGGATTTATGAAAAATGCCATCTCTATA\nGCTGAGGATGAAGAATGGAAGAGAATACGATCATTGCTGTCTCCAACATTCACCAGCGGA\nAAACTCAAGGAGATGGTCCCTATCATTGCCCAGTATGGAGATGTGTTGGTGAGAAATCTG\nAGGCGGGAAGCAGAGACAGGCAAGCCTGTCACCTTGAAACACGTCTTTGGGGCCTACAGC\nATGGATGTGATCACTAGCACATCATTTGGAGTGAGCATCGACTCTCTCAACAATCCACAA\nGACCCCTTTGTGGAAAACACCAAGAAGCTTTTAAGATTTAATCCATTAGATCCATTCGTT\nCTCTCAATAAAAGTCTTTCCATTCCTTACCCCAATTCTTGAAGCATTAAATATCACTGTG\nTTTCCAAGAAAAGTTATAAGTTTTCTAACAAAATCTGTAAAACAGATAAAAGAAGGTCGC\nCTCAAAGAGACACAAAAGCACCGAGTGGATTTCCTTCAGCTGATGATTGACTCTCAGAAT\nTCAAAAGACTCTGAGACCCACAAAGCTCTGTCTGATCTGGAGCTCATGGCCCAATCAATT\nATCTTTATTTTTGCTGGCTATGAAACCACGAGCAGTGTTCTCTCCTTCATTATATATGAA\nCTGGCCACTCACCCTGATGTCCAGCAGAAAGTGCAGAAGGAAATTGATACAGTTTTACCC\nAATAAGGCACCACCCACCTATGATACTGTGCTACAGTTGGAGTATCTTGACATGGTGGTG\nAATGAAACACTCAGATTATTCCCAGTTGCTATGAGACTTGAGAGGGTCTGCAAAAAAGAT\nGTTGAAATCAATGGGATGTTTATTCCCAAAGGGGTGGTGGTGATGATTCCAAGCTATGTT\nCTTCATCATGACCCAAAGTACTGGACAGAGCCTGAGAAGTTCCTCCCTGAAAGGTTCAGT\nAAAAAGAACAAGGACAACATAGATCCTTACATATACACACCCTTTGGAAGTGGACCCAGA\nAACTGCATTGGCATGAGGTTTGCTCTCGTGAACATGAAACTTGCTCTAGTCAGAGTCCTT\nCAGAACTTCTCCTTCAAACCTTGTAAAGAAACACAGATCCCCCTGAAATTACGCTTTGGA\nGGACTTCTTCTAACAGAAAAACCCATTGTTCTAAAGGCTGAGTCAAGGGATGAGACCTTT\nGTAGATATGGAGCCCATTCACATGGACTTTTTAAGAAGCTTGGCATTCCAGGGCCCACAC\nCTCTGCTTTTTTTGGGAACTACTTTGTCCTACCATCAGATCCCGCTGA",
                        "Chromosome Location": "7",
                        "Locus": "7q21-q22.1",
                        "External Identifiers": "ResourceLinkUniProtKB IDP24462UniProtKB Entry NameCP3A7_HUMANGenBank Protein ID220149GenBank Gene IDD00408HGNC IDHGNC:2640",
                        "General References": "Komori M, Nishio K, Ohi H, Kitada M, Kamataki T: Molecular cloning and sequence analysis of cDNA containing the entire coding region for human fetal liver cytochrome P-450. J Biochem. 1989 Feb;105(2):161-3. [Article] Finta C, Zaphiropoulos PG: The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons. Gene. 2000 Dec 30;260(1-2):13-23. [Article] Gellner K, Eiselt R, Hustert E, Arnold H, Koch I, Haberl M, Deglmann CJ, Burk O, Buntefuss D, Escher S, Bishop C, Koebe HG, Brinkmann U, Klenk HP, Kleine K, Meyer UA, Wojnowski L: Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics. 2001 Mar;11(2):111-21. [Article] Scherer SW, Cheung J, MacDonald JR, Osborne LR, Nakabayashi K, Herbrick JA, Carson AR, Parker-Katiraee L, Skaug J, Khaja R, Zhang J, Hudek AK, Li M, Haddad M, Duggan GE, Fernandez BA, Kanematsu E, Gentles S, Christopoulos CC, Choufani S, Kwasnicka D, Zheng XH, Lai Z, Nusskern D, Zhang Q, Gu Z, Lu F, Zeesman S, Nowaczyk MJ, Teshima I, Chitayat D, Shuman C, Weksberg R, Zackai EH, Grebe TA, Cox SR, Kirkpatrick SJ, Rahman N, Friedman JM, Heng HH, Pelicci PG, Lo-Coco F, Belloni E, Shaffer LG, Pober B, Morton CC, Gusella JF, Bruns GA, Korf BR, Quade BJ, Ligon AH, Ferguson H, Higgins AW, Leach NT, Herrick SR, Lemyre E, Farra CG, Kim HG, Summers AM, Gripp KW, Roberts W, Szatmari P, Winsor EJ, Grzeschik KH, Teebi A, Minassian BA, Kere J, Armengol L, Pujana MA, Estivill X, Wilson MD, Koop BF, Tosi S, Moore GE, Boright AP, Zlotorynski E, Kerem B, Kroisel PM, Petek E, Oscier DG, Mould SJ, Dohner H, Dohner K, Rommens JM, Vincent JB, Venter JC, Li PW, Mural RJ, Adams MD, Tsui LC: Human chromosome 7: DNA sequence and biology. Science. 2003 May 2;300(5620):767-72. Epub 2003 Apr 10. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Wrighton SA, Vandenbranden M: Isolation and characterization of human fetal liver cytochrome P450HLp2: a third member of the P450III gene family. Arch Biochem Biophys. 1989 Jan;268(1):144-51. [Article] Komori M, Nishio K, Fujitani T, Ohi H, Kitada M, Mima S, Itahashi K, Kamataki T: Isolation of a new human fetal liver cytochrome P450 cDNA clone: evidence for expression of a limited number of forms of cytochrome P450 in human fetal livers. Arch Biochem Biophys. 1989 Jul;272(1):219-25. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00199Erythromycinapproved, investigational, vet_approvednosubstrateinhibitorDetailsDB00908Quinidineapproved, investigationalunknownsubstrateDetailsDB00404Alprazolamapproved, illicit, investigationalunknownsubstrateDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB00897Triazolamapproved, investigationalunknownsubstrateDetailsDB00224IndinavirapprovedunknowninhibitorDetailsDB00220NelfinavirapprovednoinhibitorDetailsDB01232Saquinavirapproved, investigationalunknownsubstrateinhibitorDetailsDB00604Cisaprideapproved, investigational, withdrawnunknownsubstrateDetailsDB00637Astemizoleapproved, withdrawnunknownsubstrateDetailsDB01114ChlorpheniramineapprovedunknownsubstrateDetailsDB00342Terfenadineapproved, withdrawnunknownsubstrateDetailsDB00343Diltiazemapproved, investigationalunknownsubstrateinhibitorDetailsDB01023Felodipineapproved, investigationalunknownsubstrateDetailsDB00528Lercanidipineapproved, investigationalunknownsubstrateDetailsDB00401NisoldipineapprovedunknownsubstrateDetailsDB01054Nitrendipineapproved, investigationalunknownsubstrateDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB00439Cerivastatinapproved, withdrawnunknownsubstrateDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00741Hydrocortisoneapproved, vet_approvedunknownsubstrateDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00624Testosteroneapproved, investigationalunknownsubstrateDetailsDB00802Alfentanilapproved, illicitunknownsubstrateDetailsDB01238Aripiprazoleapproved, investigationalnosubstrateDetailsDB00490Buspironeapproved, investigationalunknownsubstrateDetailsDB01166Cilostazolapproved, investigationalunknownsubstrateDetailsDB00250Dapsoneapproved, investigationalunknownsubstrateDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB00514DextromethorphanapprovedunknownsubstrateDetailsDB01248Docetaxelapproved, investigationalunknownsubstrateDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB01216FinasterideapprovedunknownsubstrateDetailsDB00619ImatinibapprovednosubstrateinhibitorDetailsDB00502HaloperidolapprovedunknownsubstrateDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateDetailsDB01227Levacetylmethadolapproved, investigational, withdrawnunknownsubstrateDetailsDB00281Lidocaineapproved, vet_approvedunknownsubstrateDetailsDB00333MethadoneapprovedunknownsubstrateDetailsDB00731Nateglinideapproved, investigationalunknownsubstrateDetailsDB00904Ondansetronapproved, withdrawnunknownsubstrateDetailsDB01100PimozideapprovedunknownsubstrateDetailsDB00571Propranololapproved, investigationalunknownsubstrateDetailsDB00468QuinineapprovedunknownsubstrateDetailsDB00938SalmeterolapprovedunknownsubstrateDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateDetailsDB00877Sirolimusapproved, investigationalnosubstrateDetailsDB00398Sorafenibapproved, investigationalunknownsubstrateDetailsDB01268Sunitinibapproved, investigationalunknownsubstrateDetailsDB00675TamoxifenapprovedunknownsubstrateDetailsDB01229Paclitaxelapproved, vet_approvedunknownsubstrateDetailsDB06287TemsirolimusapprovedunknownsubstrateDetailsDB00656Trazodoneapproved, investigationalunknownsubstrateDetailsDB00541Vincristineapproved, investigationalunknownsubstrateDetailsDB00962Zaleplonapproved, illicit, investigationalunknownsubstrateDetailsDB01167Itraconazoleapproved, investigationalnoinhibitorDetailsDB00446Chloramphenicolapproved, vet_approved, withdrawnunknowninhibitorDetailsDB00537Ciprofloxacinapproved, investigationalunknowninhibitorDetailsDB00705DelavirdineapprovedunknowninhibitorDetailsDB06730GestodeneinvestigationalunknowninhibitorDetailsDB01388Mibefradilinvestigational, withdrawnunknowninhibitorDetailsDB06731SeproxetineinvestigationalunknowninhibitorDetailsDB00582VoriconazoleapprovedunknownsubstrateinhibitorDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB00257Clotrimazoleapproved, vet_approvedunknowninducerDetailsDB00458ImipramineapprovedunknownsubstrateDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinducerDetailsDB01058Praziquantelapproved, investigational, vet_approvedunknownsubstrateDetailsDB01045RifampicinapprovedunknowninducerDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknowninhibitorDetailsDB00588Fluticasone propionateapprovedunknownsubstrateDetailsDB00755Tretinoinapproved, investigational, nutraceuticalunknownsubstrateDetailsDB04946IloperidoneapprovedunknownsubstrateDetailsDB01708Prasteroneapproved, investigational, nutraceuticalunknownsubstrateinhibitorDetailsDB05804Prasterone sulfateinvestigationalunknownsubstrateDetailsDB01174Phenobarbitalapproved, investigationalnoinducerDetailsDB09102Daclatasvirapproved, investigationalunknownsubstrateDetailsDB09054IdelalisibapprovednosubstrateinhibitorDetailsDB09065CobicistatapprovednosubstrateDetailsDB06412Oxymetholoneapproved, illicitnoinhibitorDetailsDB00503Ritonavirapproved, investigationalnosubstrateinhibitorDetailsDB06595Midostaurinapproved, investigationalunknowninducerDetailsDB11574ElbasvirapprovedunknownsubstrateDetailsDB12483Copanlisibapproved, investigationalnosubstrateDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB13943Testosterone cypionateapprovedunknownsubstrateDetailsDB13944Testosterone enanthateapprovedunknownsubstrateDetailsDB13946Testosterone undecanoateapproved, investigationalunknownsubstrateDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateDetailsDB14009Medical Cannabisexperimental, investigationalunknowninhibitorDetailsDB00625Efavirenzapproved, investigationalunknowninducerDetailsDB13179TroleandomycinapprovedunknowninhibitorDetailsDB14185Aripiprazole lauroxilapproved, investigationalunknownsubstrateDetailsDB14538Hydrocortisone aceponateexperimental, vet_approvedunknownsubstrateDetailsDB14539Hydrocortisone acetateapproved, vet_approvedunknownsubstrateDetailsDB14540Hydrocortisone butyrateapproved, vet_approvedunknownsubstrateDetailsDB14541Hydrocortisone cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB14542Hydrocortisone phosphateapproved, vet_approvedunknownsubstrateDetailsDB14543Hydrocortisone probutateapproved, vet_approvedunknownsubstrateDetailsDB14544Hydrocortisone valerateapproved, vet_approvedunknownsubstrateDetailsDB13867Fluticasoneapproved, experimentalunknownsubstrateDetailsDB08906Fluticasone furoateapprovednosubstrateDetailsDB00916MetronidazoleapprovedunknownsubstrateDetailsDB00683Midazolamapproved, illicitunknownsubstrateDetailsDB00238NevirapineapprovedunknownsubstrateDetailsDB01016GlyburideapprovedunknownsubstrateDetailsDB00620Triamcinoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB09061Cannabidiolapproved, investigationalunknowninhibitorDetailsDB14011NabiximolsinvestigationalunknowninhibitorDetailsDB01224QuetiapineapprovedunknownDetailsDB00443Betamethasoneapproved, vet_approvedunknownDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB15305Risdiplamapproved, investigationalunknownsubstrateDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB01059NorfloxacinapprovednoinhibitorDetailsDB16390Mobocertinibapproved, investigationalunknownsubstrateDetailsDB09061Cannabidiolapproved, investigationalnoinhibitorDetailsDB00470Dronabinolapproved, illicitnoinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknowninhibitorDetailsDB00349Clobazamapproved, illicitnosubstrateDetailsDB09065CobicistatapprovedyesinhibitorDetailsDB12874Quizartinibapproved, investigationalnosubstrateDetailsDB11718Encorafenibapproved, investigationalnoinhibitorDetailsDB01072Atazanavirapproved, investigationalnoinhibitorDetailsDB11679FruquintinibinvestigationalnosubstrateDetailsDB00176Fluvoxamineapproved, investigationalunknowninhibitorDetailsDB00599Thiopentalapproved, vet_approvedunknownsubstrateDetailsDB08930DolutegravirapprovednosubstrateDetailsDB06595Midostaurinapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB13174RheinexperimentalunknowninhibitorDetailsDB11994Diacereinapproved, investigationalunknowninhibitorDetailsDB11605MyrrhapprovedunknowninducerDetailsDB11691Naldemedineapproved, investigationalnosubstrateDetailsDB13878Pibrentasvirapproved, investigationalunknowninhibitorDetailsDB13879Glecaprevirapproved, investigationalunknownsubstrateinhibitorDetailsDB09205Moxisylyteapproved, investigationalnosubstrateDetailsDB09568Omega-3-carboxylic acidsapproved, investigationalnosubstrateDetailsDB01601LopinavirapprovednoinhibitorDetailsDB01149Nefazodoneapproved, withdrawnnoinhibitorDetailsDB13141Ambroxol acefyllinateexperimental, investigationalnosubstrateDetailsDB11792MirodenafilinvestigationalunknownsubstrateDetailsDB11979Elagolixapproved, investigationalnosubstrateDetailsDB08865Crizotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB11703Acalabrutinibapproved, investigationalunknownsubstrateDetailsDB12267Brigatinibapproved, investigationalunknowninducerDetailsDB12307ForetinibinvestigationalunknownsubstrateDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB00593EthosuximideapprovedunknownsubstrateDetailsDB01201Rifapentineapproved, investigationalunknowninducerDetailsDB00643Mebendazoleapproved, vet_approvedunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknowninhibitorDetailsDB00334Olanzapineapproved, investigationalunknowninhibitorDetailsDB09212LoxoprofenapprovedunknownsubstrateDetailsDB00635Prednisoneapproved, vet_approvedunknowninducerDetailsDB01222BudesonideapprovedunknownsubstrateinducerDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB11951Lemborexantapproved, investigationalunknowninhibitorinducerDetailsDB12887Tazemetostatapproved, investigationalunknownsubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninducerDetailsDB11652Tucatinibapproved, investigationalunknownsubstrateDetailsDB15035Zanubrutinibapproved, investigationalunknownsubstrateDetailsDB15685Selpercatinibapproved, investigationalunknowninhibitorDetailsDB00409Remoxiprideapproved, withdrawnunknowninhibitorDetailsDB15305Risdiplamapproved, investigationalunknowninhibitorDetailsDB06448Lonafarnibapproved, investigationalnosubstrateinhibitorDetailsDB11853Relugolixapproved, investigationalunknownsubstrateinducerDetailsDB01586Ursodeoxycholic acidapproved, investigationalunknowninducerDetailsDB11742Ebastineapproved, investigationalunknownsubstrateDetailsDB15569Sotorasibapproved, investigationalunknownsubstrateDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB00647Dextropropoxypheneapproved, illicit, investigational, withdrawnunknowninhibitorDetailsDB00333MethadoneapprovednoinhibitorDetailsDB01167Itraconazoleapproved, investigationalnoinhibitorDetailsDB16536Birch bark extractapproved, experimentalunknowninhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateinhibitorDetails"
                    }
                },
                {
                    "Label": "Cytochrome P450 2C8",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 2C8",
                        "Synonyms": "1.14.14.1\nCYPIIC8\nCytochrome P450 form 1\nCytochrome P450 IIC2\nCytochrome P450 MP-12\nCytochrome P450 MP-20\nS-mephenytoin 4-hydroxylase",
                        "Gene Name": "CYP2C8",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0005650|Cytochrome P450 2C8\nMEPFVVLVLCLSFMLLFSLWRQSCRRRKLPPGPTPLPIIGNMLQIDVKDICKSFTNFSKV\nYGPVFTVYFGMNPIVVFHGYEAVKEALIDNGEEFSGRGNSPISQRITKGLGIISSNGKRW\nKEIRRFSLTTLRNFGMGKRSIEDRVQEEAHCLVEELRKTKASPCDPTFILGCAPCNVICS\nVVFQKRFDYKDQNFLTLMKRFNENFRILNSPWIQVCNNFPLLIDCFPGTHNKVLKNVALT\nRSYIREKVKEHQASLDVNNPRDFIDCFLIKMEQEKDNQKSEFNIENLVGTVADLFVAGTE\nTTSTTLRYGLLLLLKHPEVTAKVQEEIDHVIGRHRSPCMQDRSHMPYTDAVVHEIQRYSD\nLVPTGVPHAVTTDTKFRNYLIPKGTTIMALLTSVLHDDKEFPNPNIFDPGHFLDKNGNFK\nKSDYFMPFSAGKRICAGEGLARMELFLFLTTILQNFNLKSVDDLKNLNTTAVTKGIVSLP\nPSYQICFIPV",
                        "Number of residues": "490",
                        "Molecular Weight": "55824.275",
                        "Theoretical pI": "8.62",
                        "GO Classification": "Functionsarachidonic acid epoxygenase activity / aromatase activity / caffeine oxidase activity / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen / oxygen binding / steroid hydroxylase activityProcessesarachidonic acid metabolic process / drug metabolic process / epoxygenase P450 pathway / exogenous drug catabolic process / omega-hydroxylase P450 pathway / organic acid metabolic process / oxidation-reduction process / oxidative demethylation / small molecule metabolic process / xenobiotic metabolic processComponentscytoplasm / endoplasmic reticulum membrane / intracellular membrane-bounded organelle",
                        "General Function": "Steroid hydroxylase activity",
                        "Specific Function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. In the epoxidation of arachidonic acid it generates only 14,15- and 11,12-cis-epoxyeicosatrienoic acids. It is the principal enzyme responsible for the metabolism the anti-cancer drug paclitaxel (taxol).",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0021338|Cytochrome P450 2C8 (CYP2C8)\nATGGAACCTTTTGTGGTCCTGGTGCTGTGTCTCTCTTTTATGCTTCTCTTTTCACTCTGG\nAGACAGAGCTGTAGGAGAAGGAAGCTCCCTCCTGGCCCCACTCCTCTTCCTATTATTGGA\nAATATGCTACAGATAGATGTTAAGGACATCTGCAAATCTTTCACCAATTTCTCAAAAGTC\nTATGGTCCTGTGTTCACCGTGTATTTTGGCATGAATCCCATAGTGGTGTTTCATGGATAT\nGAGGCAGTGAAGGAAGCCCTGATTGATAATGGAGAGGAGTTTTCTGGAAGAGGCAATTCC\nCCAATATCTCAAAGAATTACTAAAGGACTTGGAATCATTTCCAGCAATGGAAAGAGATGG\nAAGGAGATCCGGCGTTTCTCCCTCACAACCTTGCGGAATTTTGGGATGGGGAAGAGGAGC\nATTGAGGACCGTGTTCAAGAGGAAGCTCACTGCCTTGTGGAGGAGTTGAGAAAAACCAAG\nGCTTCACCCTGTGATCCCACTTTCATCCTGGGCTGTGCTCCCTGCAATGTGATCTGCTCC\nGTTGTTTTCCAGAAACGATTTGATTATAAAGATCAGAATTTTCTCACCCTGATGAAAAGA\nTTCAATGAAAACTTCAGGATTCTGAACTCCCCATGGATCCAGGTCTGCAATAATTTCCCT\nCTACTCATTGATTGTTTCCCAGGAACTCACAACAAAGTGCTTAAAAATGTTGCTCTTACA\nCGAAGTTACATTAGGGAGAAAGTAAAAGAACACCAAGCATCACTGGATGTTAACAATCCT\nCGGGACTTTATCGATTGCTTCCTGATCAAAATGGAGCAGGAAAAGGACAACCAAAAGTCA\nGAATTCAATATTGAAAACTTGGTTGGCACTGTAGCTGATCTATTTGTTGCTGGAACAGAG\nACAACAAGCACCACTCTGAGATATGGACTCCTGCTCCTGCTGAAGCACCCAGAGGTCACA\nGCTAAAGTCCAGGAAGAGATTGATCATGTAATTGGCAGACACAGGAGCCCCTGCATGCAG\nGATAGGAGCCACATGCCTTACACTGATGCTGTAGTGCACGAGATCCAGAGATACAGTGAC\nCTTGTCCCCACCGGTGTGCCCCATGCAGTGACCACTGATACTAAGTTCAGAAACTACCTC\nATCCCCAAGGGCACAACCATAATGGCATTACTGACTTCCGTGCTACATGATGACAAAGAA\nTTTCCTAATCCAAATATCTTTGACCCTGGCCACTTTCTAGATAAGAATGGCAACTTTAAG\nAAAAGTGACTACTTCATGCCTTTCTCAGCAGGAAAACGAATTTGTGCAGGAGAAGGACTT\nGCCCGCATGGAGCTATTTTTATTTCTAACCACAATTTTACAGAACTTTAACCTGAAATCT\nGTTGATGATTTAAAGAACCTCAATACTACTGCAGTTACCAAAGGGATTGTTTCTCTGCCA\nCCCTCATACCAGATCTGCTTCATCCCTGTCTGA",
                        "Chromosome Location": "10",
                        "Locus": "10q23.33",
                        "External Identifiers": "ResourceLinkUniProtKB IDP10632UniProtKB Entry NameCP2C8_HUMANGenBank Gene IDM17397GenAtlas IDCYP2C8HGNC IDHGNC:2622",
                        "General References": "Okino ST, Quattrochi LC, Pendurthi UR, McBride OW, Tukey RH: Characterization of multiple human cytochrome P-450 1 cDNAs. The chromosomal localization of the gene and evidence for alternate RNA splicing. J Biol Chem. 1987 Nov 25;262(33):16072-9. [Article] Kimura S, Pastewka J, Gelboin HV, Gonzalez FJ: cDNA and amino acid sequences of two members of the human P450IIC gene subfamily. Nucleic Acids Res. 1987 Dec 10;15(23):10053-4. [Article] Romkes M, Faletto MB, Blaisdell JA, Raucy JL, Goldstein JA: Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. Biochemistry. 1991 Apr 2;30(13):3247-55. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Deloukas P, Earthrowl ME, Grafham DV, Rubenfield M, French L, Steward CA, Sims SK, Jones MC, Searle S, Scott C, Howe K, Hunt SE, Andrews TD, Gilbert JG, Swarbreck D, Ashurst JL, Taylor A, Battles J, Bird CP, Ainscough R, Almeida JP, Ashwell RI, Ambrose KD, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Bates K, Beasley H, Bray-Allen S, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Cahill P, Camire D, Carter NP, Chapman JC, Clark SY, Clarke G, Clee CM, Clegg S, Corby N, Coulson A, Dhami P, Dutta I, Dunn M, Faulkner L, Frankish A, Frankland JA, Garner P, Garnett J, Gribble S, Griffiths C, Grocock R, Gustafson E, Hammond S, Harley JL, Hart E, Heath PD, Ho TP, Hopkins B, Horne J, Howden PJ, Huckle E, Hynds C, Johnson C, Johnson D, Kana A, Kay M, Kimberley AM, Kershaw JK, Kokkinaki M, Laird GK, Lawlor S, Lee HM, Leongamornlert DA, Laird G, Lloyd C, Lloyd DM, Loveland J, Lovell J, McLaren S, McLay KE, McMurray A, Mashreghi-Mohammadi M, Matthews L, Milne S, Nickerson T, Nguyen M, Overton-Larty E, Palmer SA, Pearce AV, Peck AI, Pelan S, Phillimore B, Porter K, Rice CM, Rogosin A, Ross MT, Sarafidou T, Sehra HK, Shownkeen R, Skuce CD, Smith M, Standring L, Sycamore N, Tester J, Thorpe A, Torcasso W, Tracey A, Tromans A, Tsolas J, Wall M, Walsh J, Wang H, Weinstock K, West AP, Willey DL, Whitehead SL, Wilming L, Wray PW, Young L, Chen Y, Lovering RC, Moschonas NK, Siebert R, Fechtel K, Bentley D, Durbin R, Hubbard T, Doucette-Stamm L, Beck S, Smith DR, Rogers J: The DNA sequence and comparative analysis of human chromosome 10. Nature. 2004 May 27;429(6990):375-81. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Ged C, Beaune P: Isolation of the human cytochrome P-450 IIC8 gene: multiple glucocorticoid responsive elements in the 5' region. Biochim Biophys Acta. 1991 Mar 26;1088(3):433-5. [Article] Zeldin DC, DuBois RN, Falck JR, Capdevila JH: Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform. Arch Biochem Biophys. 1995 Sep 10;322(1):76-86. [Article] Ged C, Umbenhauer DR, Bellew TM, Bork RW, Srivastava PK, Shinriki N, Lloyd RS, Guengerich FP: Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 (S)-mephenytoin 4'-hydroxylase. Biochemistry. 1988 Sep 6;27(18):6929-40. [Article] Shephard EA, Phillips IR, Santisteban I, Palmer CN, Povey S: Cloning, expression and chromosomal localization of a member of the human cytochrome P450IIC gene sub-family. Ann Hum Genet. 1989 Jan;53(Pt 1):23-31. [Article] Kolyada AY: Sequence of a human liver cytochrome P-450 cDNA clone. Nucleic Acids Res. 1990 Sep 25;18(18):5550. [Article] Ishikawa C, Ozaki H, Nakajima T, Ishii T, Kanai S, Anjo S, Shirai K, Inoue I: A frameshift variant of CYP2C8 was identified in a patient who suffered from rhabdomyolysis after administration of cerivastatin. J Hum Genet. 2004;49(10):582-5. Epub 2004 Sep 9. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Schoch GA, Yano JK, Wester MR, Griffin KJ, Stout CD, Johnson EF: Structure of human microsomal cytochrome P450 2C8. Evidence for a peripheral fatty acid binding site. J Biol Chem. 2004 Mar 5;279(10):9497-503. Epub 2003 Dec 15. [Article] Schoch GA, Yano JK, Sansen S, Dansette PM, Stout CD, Johnson EF: Determinants of cytochrome P450 2C8 substrate binding: structures of complexes with montelukast, troglitazone, felodipine, and 9-cis-retinoic acid. J Biol Chem. 2008 Jun 20;283(25):17227-37. doi: 10.1074/jbc.M802180200. Epub 2008 Apr 15. [Article] Dai D, Zeldin DC, Blaisdell JA, Chanas B, Coulter SJ, Ghanayem BI, Goldstein JA: Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid. Pharmacogenetics. 2001 Oct;11(7):597-607. [Article] Bahadur N, Leathart JB, Mutch E, Steimel-Crespi D, Dunn SA, Gilissen R, Houdt JV, Hendrickx J, Mannens G, Bohets H, Williams FM, Armstrong M, Crespi CL, Daly AK: CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6alpha-hydroxylase activity in human liver microsomes. Biochem Pharmacol. 2002 Dec 1;64(11):1579-89. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB03796Palmitic AcidapprovedunknownDetailsDB00214TorasemideapprovedunknownsubstrateDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinducerDetailsDB00412Rosiglitazoneapproved, investigationalunknownsubstrateinhibitorDetailsDB00439Cerivastatinapproved, withdrawnunknownsubstrateinhibitorDetailsDB00564Carbamazepineapproved, investigationalunknownsubstrateinducerDetailsDB00682WarfarinapprovedunknownsubstrateDetailsDB00755Tretinoinapproved, investigational, nutraceuticalunknownsubstrateDetailsDB00912Repaglinideapproved, investigationalunknownsubstrateDetailsDB01118Amiodaroneapproved, investigationalnosubstrateDetailsDB01132Pioglitazoneapproved, investigationalunknownsubstrateinhibitorDetailsDB01198ZopicloneapprovedunknownsubstrateDetailsDB01229Paclitaxelapproved, vet_approvedunknownsubstrateDetailsDB01261Sitagliptinapproved, investigationalunknownsubstrateDetailsDB01259Lapatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00227Lovastatinapproved, investigationalunknownsubstrateDetailsDB00440Trimethoprimapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00471MontelukastapprovedunknownsubstrateinhibitorDetailsDB00549Zafirlukastapproved, investigationalunknowninhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknownsubstrateDetailsDB00613Amodiaquineapproved, investigationalunknownsubstrateDetailsDB00622Nicardipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00641SimvastatinapprovedunknownsubstrateinhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB01045RifampicinapprovedunknowninhibitorinducerDetailsDB01124Tolbutamideapproved, investigationalunknownsubstrateinhibitorDetailsDB01241GemfibrozilapprovedunknowninhibitorDetailsDB01424Aminophenazoneapproved, withdrawnunknownsubstrateDetailsDB01095FluvastatinapprovedunknownsubstrateinhibitorDetailsDB01023Felodipineapproved, investigationalunknowninhibitorDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00796Candesartan cilexetilapprovedunknowninhibitorDetailsDB00257Clotrimazoleapproved, vet_approvedunknowninhibitorDetailsDB00764MometasoneexperimentalnoinhibitorDetailsDB00938SalmeterolapprovedunknowninhibitorDetailsDB00481Raloxifeneapproved, investigationalunknowninhibitorDetailsDB01039FenofibrateapprovedunknowninhibitorDetailsDB00503Ritonavirapproved, investigationalunknowninhibitorinducerDetailsDB00451LevothyroxineapprovedunknowninhibitorDetailsDB00675TamoxifenapprovedunknowninhibitorDetailsDB00455Loratadineapproved, investigationalunknownsubstrateinhibitorDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB01062Oxybutyninapproved, investigationalunknowninhibitorDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknowninhibitorDetailsDB00977EthinylestradiolapprovedunknownsubstrateinhibitorDetailsDB00421SpironolactoneapprovedunknowninhibitorDetailsDB01029Irbesartanapproved, investigationalunknownsubstrateinhibitorDetailsDB01181IfosfamideapprovedunknownsubstrateinducerDetailsDB01115NifedipineapprovedunknowninhibitorDetailsDB00468QuinineapprovedunknownsubstrateinhibitorDetailsDB01435Antipyrineapproved, investigationalunknownsubstrateDetailsDB00250Dapsoneapproved, investigationalunknownsubstrateDetailsDB00946Phenprocoumonapproved, investigationalunknownsubstrateDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00972AzelastineapprovedunknownsubstrateDetailsDB00398Sorafenibapproved, investigationalunknownsubstrateinhibitorDetailsDB01174Phenobarbitalapproved, investigationalunknowninducerDetailsDB01201Rifapentineapproved, investigationalunknowninducerDetailsDB00418Secobarbitalapproved, vet_approvedunknowninducerDetailsDB06210EltrombopagapprovedunknownsubstrateinhibitorDetailsDB04868Nilotinibapproved, investigationalunknowninhibitorinducerDetailsDB00661VerapamilapprovedunknownsubstrateinhibitorDetailsDB01050IbuprofenapprovedunknownsubstrateDetailsDB00788Naproxenapproved, vet_approvedunknownsubstrateDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB00333MethadoneapprovedunknownsubstrateDetailsDB00201CaffeineapprovedunknownsubstrateDetailsDB04725LicofeloneinvestigationalunknownsubstrateinhibitorDetailsDB06739SeratrodastexperimentalunknownsubstrateDetailsDB00402Eszopicloneapproved, investigationalunknownsubstrateDetailsDB08607(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONEexperimentalunknownDetailsDB06772CabazitaxelapprovedunknownsubstrateDetailsDB01583LiotrixapprovedunknowninhibitorDetailsDB00321AmitriptylineapprovedunknownsubstrateinhibitorDetailsDB00381AmlodipineapprovedunknowninhibitorDetailsDB01076AtorvastatinapprovednosubstrateinhibitorDetailsDB01393Bezafibrateapproved, investigationalunknowninhibitorDetailsDB00608Chloroquineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00604Cisaprideapproved, investigational, withdrawnunknownsubstrateDetailsDB00758ClopidogrelapprovednoinhibitorDetailsDB00363ClozapineapprovednosubstrateDetailsDB00907Cocaineapproved, illicitunknowndownregulatorDetailsDB01394ColchicineapprovedunknowninhibitorDetailsDB00169Cholecalciferolapproved, nutraceuticalunknowninhibitorDetailsDB00531Cyclophosphamideapproved, investigationalunknownsubstrateinducerDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknowninducerDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB00343Diltiazemapproved, investigationalunknownsubstrateDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00544FluorouracilapprovedunknownsubstrateDetailsDB01218HalofantrineapprovedunknownsubstrateDetailsDB00741Hydrocortisoneapproved, vet_approvedunknowninducerDetailsDB00951Isoniazidapproved, investigationalunknowninhibitorDetailsDB01221Ketamineapproved, vet_approvedunknownsubstrateDetailsDB06738KetobemidoneinvestigationalunknownsubstrateDetailsDB01009Ketoprofenapproved, vet_approvedunknowninhibitorDetailsDB00448Lansoprazoleapproved, investigationalunknownsubstrateDetailsDB00281Lidocaineapproved, vet_approvedunknownsubstrateDetailsDB00784Mefenamic acidapprovedunknowninhibitorDetailsDB00814Meloxicamapproved, vet_approvedunknownsubstrateDetailsDB00532Mephenytoinapproved, investigational, withdrawnunknownsubstrateDetailsDB00916MetronidazoleapprovedunknowninhibitorDetailsDB00295Morphineapproved, investigationalnosubstrateDetailsDB00184NicotineapprovedunknownsubstrateDetailsDB06712Nilvadipineapproved, investigationalunknowninhibitorDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknownsubstrateDetailsDB00850PerphenazineapprovedunknownsubstrateDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB00554Piroxicamapproved, investigationalunknownsubstrateDetailsDB01032Probenecidapproved, investigationalunknowninducerDetailsDB00818Propofolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00205Pyrimethamineapproved, investigational, vet_approvedunknowninhibitorDetailsDB00533Rofecoxibapproved, investigational, withdrawnunknowninhibitorDetailsDB01232Saquinavirapproved, investigationalunknowninhibitorDetailsDB01037Selegilineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00359Sulfadiazineapproved, investigational, vet_approvedunknownsubstrateDetailsDB06729SulfaphenazoleapprovedunknowninhibitorDetailsDB01138SulfinpyrazoneapprovedunknowninhibitorDetailsDB00799Tazaroteneapproved, investigationalunknownsubstrateDetailsDB01079Tegaserodapproved, investigational, withdrawnunknowninhibitorDetailsDB00342Terfenadineapproved, withdrawnunknowninhibitorDetailsDB00624Testosteroneapproved, investigationalunknownsubstrateDetailsDB00208TiclopidineapprovedunknowninhibitorDetailsDB00897Triazolamapproved, investigationalunknowninhibitorDetailsDB00347TrimethadioneapprovedunknownsubstrateDetailsDB13179TroleandomycinapprovedunknowninhibitorDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00617ParamethadioneapprovedunknownsubstrateDetailsDB06589PazopanibapprovedunknownsubstrateinhibitorDetailsDB00255Diethylstilbestrolapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00836LoperamideapprovedunknownsubstrateDetailsDB00918Almotriptanapproved, investigationalunknownsubstrateDetailsDB05229BeraprostinvestigationalunknownsubstrateDetailsDB06510MuraglitazarinvestigationalunknownsubstrateDetailsDB06770Benzyl alcoholapprovedunknownsubstrateDetailsDB08860PitavastatinapprovedunknownsubstrateDetailsDB05812AbirateroneapprovedunknowninhibitorDetailsDB06605ApixabanapprovedunknownsubstrateDetailsDB08828Vismodegibapproved, investigationalunknowninhibitorDetailsDB08896RegorafenibapprovedunknowninhibitorDetailsDB08899EnzalutamideapprovednosubstrateinhibitorDetailsDB08901Ponatinibapproved, investigationalunknownsubstrateDetailsDB08911TrametinibapprovedunknowninhibitorDetailsDB08912Dabrafenibapproved, investigationalnosubstrateinhibitorDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB08918Levomilnacipranapproved, investigationalunknownsubstrateDetailsDB00951Isoniazidapproved, investigationalunknownDetailsDB09080OlodaterolapprovednosubstrateDetailsDB09054IdelalisibapprovednoinhibitorDetailsDB09068Vortioxetineapproved, investigationalnosubstrateDetailsDB09280LumacaftorapprovednoinhibitorinducerDetailsDB09570Ixazomibapproved, investigationalunknownsubstrateDetailsDB11362SelexipagapprovednosubstrateDetailsDB08931RiociguatapprovedunknownsubstrateDetailsDB09183DasabuvirapprovednosubstrateDetailsDB09296Ombitasvirapproved, investigationalnosubstrateDetailsDB00482Celecoxibapproved, investigationalunknownsubstrateDetailsDB00625Efavirenzapproved, investigationalunknowninhibitorDetailsDB01129Rabeprazoleapproved, investigationalunknowninhibitorDetailsDB08880TeriflunomideapprovedunknowninhibitorDetailsDB05219Crisaboroleapproved, investigationalnoinhibitorDetailsDB06595Midostaurinapproved, investigationalunknowninhibitorinducerDetailsDB05015Belinostatapproved, investigationalunknowninhibitorDetailsDB11613Velpatasvirapproved, investigationalnosubstrateDetailsDB06670OdanacatibinvestigationalnosubstrateDetailsDB01685TopiroxostatexperimentalunknowninhibitorDetailsDB08922PerospironeexperimentalunknownsubstrateDetailsDB12026Voxilaprevirapproved, investigationalnosubstrateDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB13919CandesartanexperimentalunknowninhibitorDetailsDB12070Letermovirapproved, investigationalnoinhibitorDetailsDB12267Brigatinibapproved, investigationalnosubstrateDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB13943Testosterone cypionateapprovedunknownsubstrateDetailsDB13944Testosterone enanthateapprovedunknownsubstrateDetailsDB13946Testosterone undecanoateapproved, investigationalunknownsubstrateDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateDetailsDB11901Apalutamideapproved, investigationalnosubstrateDetailsDB11633Isavuconazoleapproved, investigationalunknowninhibitorinducerDetailsDB11632Opicaponeapproved, investigationalnoinhibitorDetailsDB13746Bioallethrinapproved, experimentalnosubstrateDetailsDB00486Nabiloneapproved, investigationalnosubstrateinhibitorDetailsDB11995Avatrombopagapproved, investigationalunknowninducerDetailsDB00973EzetimibeapprovedunknowninhibitorDetailsDB14512Mometasone furoateapproved, investigational, vet_approvednoinhibitorDetailsDB14538Hydrocortisone aceponateexperimental, vet_approvedunknowninducerDetailsDB14539Hydrocortisone acetateapproved, vet_approvedunknowninducerDetailsDB14540Hydrocortisone butyrateapproved, vet_approvedunknowninducerDetailsDB14541Hydrocortisone cypionateapproved, investigational, vet_approvedunknowninducerDetailsDB14542Hydrocortisone phosphateapproved, vet_approvedunknowninducerDetailsDB14543Hydrocortisone probutateapproved, vet_approvedunknowninducerDetailsDB14544Hydrocortisone valerateapproved, vet_approvedunknowninducerDetailsDB14568Ivosidenibapproved, investigationalunknowninducerDetailsDB14545Hydrocortisone succinateapprovedunknowninducerDetailsDB11979Elagolixapproved, investigationalnosubstrateDetailsDB13867Fluticasoneapproved, experimentalnoinhibitorDetailsDB08906Fluticasone furoateapprovednoinhibitorDetailsDB00588Fluticasone propionateapprovednoinhibitorDetailsDB00615Rifabutinapproved, investigationalnoinducerDetailsDB11753Rifamycinapproved, investigationalnoinhibitorDetailsDB01220Rifaximinapproved, investigationalnoinducerDetailsDB12781BalaglitazoneinvestigationalnosubstrateinhibitorDetailsDB09201CiglitazoneexperimentalnosubstrateinhibitorDetailsDB09198LobeglitazoneexperimentalnosubstrateinhibitorDetailsDB09199NetoglitazoneexperimentalnosubstrateinhibitorDetailsDB09200Rivoglitazoneexperimental, investigationalnosubstrateinhibitorDetailsDB06616BosutinibapprovedunknowninhibitorDetailsDB08875Cabozantinibapproved, investigationalunknowninhibitorDetailsDB01645GenisteininvestigationalunknowninhibitorDetailsDB09078Lenvatinibapproved, investigationalunknowninhibitorDetailsDB01072Atazanavirapproved, investigationalnoinhibitorDetailsDB08496(R)-warfarinexperimentalunknownsubstrateDetailsDB14055(S)-Warfarinexperimental, investigationalunknownsubstrateDetailsDB09256Tegafurapproved, investigationalunknownsubstrateDetailsDB00307Bexaroteneapproved, investigationalnoinhibitorDetailsDB01357MestranolapprovednosubstrateDetailsDB01609Deferasiroxapproved, investigationalunknowninhibitorDetailsDB00908Quinidineapproved, investigationalnoinhibitorDetailsDB00834Mifepristoneapproved, investigationalunknowninhibitorDetailsDB08881VemurafenibapprovedunknowninhibitorDetailsDB09213Dexibuprofenapproved, investigationalnosubstrateDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateDetailsDB00619ImatinibapprovednosubstrateDetailsDB11978Glasdegibapproved, investigationalnosubstrateDetailsDB12245Triclabendazoleapproved, investigationalunknowninhibitorDetailsDB00465KetorolacapprovedunknownsubstrateDetailsDB12015Alpelisibapproved, investigationalunknowninhibitorDetailsDB11757Istradefyllineapproved, investigationalunknownsubstrateDetailsDB00678LosartanapprovednoinhibitorDetailsDB08502CapravirineinvestigationalunknownsubstrateDetailsDB01217Anastrozoleapproved, investigationalunknownsubstrateinhibitorDetailsDB12808Trifaroteneapproved, investigationalunknownsubstrateDetailsDB12001Abemaciclibapproved, investigationalunknowninhibitorDetailsDB15444Elexacaftorapproved, investigationalnoinhibitorDetailsDB00635Prednisoneapproved, vet_approvedunknowninducerDetailsDB06119Cenobamateapproved, investigationalunknowninducerDetailsDB01222BudesonideapprovedunknowninducerDetailsDB00959Methylprednisoloneapproved, vet_approvedunknowninducerDetailsDB06077Lumateperoneapproved, investigationalnosubstrateDetailsDB15328Ubrogepantapproved, investigationalunknowninhibitorDetailsDB01060Amoxicillinapproved, vet_approvedunknowninhibitorDetailsDB12466Favipiravirapproved, investigationalunknowninhibitorDetailsDB00443Betamethasoneapproved, vet_approvedunknowninducerDetailsDB09241Methylene blueapproved, investigationalunknowninhibitorDetailsDB12612Ozanimodapproved, investigationalunknownsubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninducerDetailsDB11689Selumetinibapproved, investigationalnosubstrateDetailsDB11652Tucatinibapproved, investigationalunknownsubstrateDetailsDB14761Remdesivirapproved, investigationalunknownsubstrateDetailsDB01611HydroxychloroquineapprovedunknownsubstrateDetailsDB15685Selpercatinibapproved, investigationalunknowninhibitorDetailsDB14840RipretinibapprovednoinhibitorDetailsDB00845Clofazimineapproved, investigationalunknowninhibitorDetailsDB00714Apomorphineapproved, investigationalunknownsubstrateDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknowninducerDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB12499Clascoteroneapproved, investigationalnoinhibitorDetailsDB15822Pralsetinibapproved, investigationalnoinhibitorinducerDetailsDB06448Lonafarnibapproved, investigationalnosubstrateinhibitorDetailsDB15935Lumasiranapproved, investigationalnoinhibitorDetailsDB06137Tirbanibulinapproved, investigationalnosubstrateinhibitorDetailsDB11853Relugolixapproved, investigationalunknownsubstrateDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB08864RilpivirineapprovedunknowninhibitorDetailsDB15133Tepotinibapproved, investigationalunknownsubstrateDetailsDB04854FebuxostatapprovednosubstrateDetailsDB08822Azilsartan medoxomilapproved, investigationalnosubstrateDetailsDB15569Sotorasibapproved, investigationalunknowninducerDetailsDB12471Ibrexafungerpapproved, investigationalunknowninhibitorDetailsDB12543Samidorphanapproved, investigationalnosubstrateDetailsDB12151Brincidofovirapproved, investigationalnoinhibitorDetailsDB16165Finerenoneapproved, investigationalunknownsubstrateDetailsDB16703Belumosudilapproved, investigationalnosubstrateDetailsDB08932MacitentanapprovednosubstrateDetailsDB05667Levoketoconazoleapproved, investigationalnoinhibitorDetailsDB05467Palovaroteneapproved, investigationalnosubstrateDetailsDB04847Roxadustatapproved, investigationalunknownsubstrateDetailsDB16236Mitapivatapproved, investigationalnosubstrateinducerDetailsDB09061Cannabidiolapproved, investigationalunknownsubstrateinhibitorDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorDetailsDB14921Mavacamtenapproved, investigationalnosubstrateDetailsDB12020Tecovirimatapproved, investigationalnoinducerDetailsDB00374Treprostinilapproved, investigationalunknownsubstrateDetailsDB01024Mycophenolic acidapproved, investigationalunknownsubstrateDetailsDB16536Birch bark extractapproved, experimentalunknowninhibitorDetailsDB09118StiripentolapprovedunknowninhibitorDetailsDB13997Baloxavir marboxilapproved, investigationalunknowninhibitorDetailsDB12095Telotristat ethylapproved, investigationalnoinhibitorDetailsDB17083LinzagolixapprovednosubstrateinhibitorDetailsDB16267Olutasidenibapproved, investigationalnosubstrateinducerDetailsDB15568Adagrasibapproved, investigationalunknownsubstrateDetailsDB17449Anacaulaseapproved, investigationalunknowninhibitorDetailsDB12236Bexagliflozinapproved, investigationalunknownsubstrateDetailsDB17472Pirtobrutinibapproved, investigationalunknowninhibitorDetailsDB11682Daprodustatapproved, investigationalnosubstrateinhibitorDetailsDB00349Clobazamapproved, illicitnosubstrateDetailsDB12513Omaveloxoloneapproved, investigationalunknownsubstrateinducerDetailsDB00862VardenafilapprovedunknowninhibitorDetailsDB11712Tezacaftorapproved, investigationalnoinhibitorDetailsDB01194BrinzolamideapprovednosubstrateDetailsDB12255Vadadustatapproved, investigationalunknowninhibitorDetailsDB14924Ritlecitinibapproved, investigationalunknownsubstrateDetailsDB11763Momelotinibapproved, investigationalunknownsubstrateDetailsDB14766EtrasimodapprovednosubstrateDetailsDB11718Encorafenibapproved, investigationalnoinhibitorDetailsDB15114Vamoroloneapproved, investigationalnosubstrateDetailsDB16826RepotrectinibinvestigationalnoinducerDetailsDB11679FruquintinibinvestigationalnosubstrateDetails"
                    }
                },
                {
                    "Label": "Cytochrome P450 2D6",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 2D6",
                        "Synonyms": "1.14.14.1\nCholesterol 25-hydroxylase\nCYP2DL1\nCYPIID6\nCytochrome P450-DB1\nDebrisoquine 4-hydroxylase",
                        "Gene Name": "CYP2D6",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0004641|Cytochrome P450 2D6\nMGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVDFQNTPYCFDQ\nLRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVF\nLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDK\nAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKV\nLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVA\nDLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVI\nHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHF\nLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGV\nFAFLVSPSPYELCAVPR",
                        "Number of residues": "497",
                        "Molecular Weight": "55768.94",
                        "Theoretical pI": "7.26",
                        "GO Classification": "Functionsarachidonic acid epoxygenase activity / aromatase activity / drug binding / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity / oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen / oxygen binding / steroid hydroxylase activityProcessesalkaloid catabolic process / alkaloid metabolic process / arachidonic acid metabolic process / coumarin metabolic process / drug catabolic process / drug metabolic process / exogenous drug catabolic process / heterocycle metabolic process / isoquinoline alkaloid metabolic process / monoterpenoid metabolic process / negative regulation of binding / negative regulation of cellular organofluorine metabolic process / oxidation-reduction process / oxidative demethylation / small molecule metabolic process / steroid metabolic process / xenobiotic metabolic processComponentscytoplasm / endoplasmic reticulum / endoplasmic reticulum membrane / mitochondrion",
                        "General Function": "Steroid hydroxylase activity",
                        "Specific Function": "Responsible for the metabolism of many drugs and environmental chemicals that it oxidizes. It is involved in the metabolism of drugs such as antiarrhythmics, adrenoceptor antagonists, and tricyclic antidepressants.",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0019275|Cytochrome P450 2D6 (CYP2D6)\nATGGGGCTAGAAGCACTGGTGCCCCTGGCCGTGATAGTGGCCATCTTCCTGCTCCTGGTG\nGACCTGATGCACCGGCGCCAACGCTGGGCTGCACGCTACCCACCAGGCCCCCTGCCACTG\nCCCGGGCTGGGCAACCTGCTGCATGTGGACTTCCAGAACACACCATACTGCTTCGACCAG\nTTGCGGCGCCGCTTCGGGGACGTGTTCAGCCTGCAGCTGGCCTGGACGCCGGTGGTCGTG\nCTCAATGGGCTGGCGGCCGTGCGCGAGGCGCTGGTGACCCACGGCGAGGACACCGCCGAC\nCGCCCGCCTGTGCCCATCACCCAGATCCTGGGTTTCGGGCCGCGTTCCCAAGGGGTGTTC\nCTGGCGCGCTATGGGCCCGCGTGGCGCGAGCAGAGGCGCTTCTCCGTGTCCACCTTGCGC\nAACTTGGGCCTGGGCAAGAAGTCGCTGGAGCAGTGGGTGACCGAGGAGGCCGCCTGCCTT\nTGTGCCGCCTTCGCCAACCACTCCGGACGCCCCTTTCGCCCCAACGGTCTCTTGGACAAA\nGCCGTGAGCAACGTGATCGCCTCCCTCACCTGCGGGCGCCGCTTCGAGTACGACGACCCT\nCGCTTCCTCAGGCTGCTGGACCTAGCTCAGGAGGGACTGAAGGAGGAGTCGGGCTTTCTG\nCGCGAGGTGCTGAATGCTGTCCCCGTCCTCCTGCATATCCCAGCGCTGGCTGGCAAGGTC\nCTACGCTTCCAAAAGGCTTTCCTGACCCAGCTGGATGAGCTGCTAACTGAGCACAGGATG\nACCTGGGACCCAGCCCAGCCCCCCCGAGACCTGACTGAGGCCTTCCTGGCAGAGATGGAG\nAAGGCCAAGGGGAACCCTGAGAGCAGCTTCAATGATGAGAACCTGCGCATAGTGGTGGCT\nGACCTGTTCTCTGCCGGGATGGTGACCACCTCGACCACGCTGGCCTGGGGCCTCCTGCTC\nATGATCCTACATCCGGATGTGCAGCGCCGTGTCCAACAGGAGATCGACGACGTGATAGGG\nCAGGTGCGGCGACCAGAGATGGGTGACCAGGCTCACATGCCCTACACCACTGCCGTGATT\nCATGAGGTGCAGCGCTTTGGGGACATCGTCCCCCTGGGTGTGACCCATATGACATCCCGT\nGACATCGAAGTACAGGGCTTCCGCATCCCTAAGGGAACGACACTCATCACCAACCTGTCA\nTCGGTGCTGAAGGATGAGGCCGTCTGGGAGAAGCCCTTCCGCTTCCACCCCGAACACTTC\nCTGGATGCCCAGGGCCACTTTGTGAAGCCGGAGGCCTTCCTGCCTTTCTCAGCAGGCCGC\nCGTGCATGCCTCGGGGAGCCCCTGGCCCGCATGGAGCTCTTCCTCTTCTTCACCTCCCTG\nCTGCAGCACTTCAGCTTCTCGGTGCCCACTGGACAGCCCCGGCCCAGCCACCATGGTGTC\nTTTGCTTTCCTGGTGAGCCCATCCCCCTATGAGCTTTGTGCTGTGCCCCGCTAG",
                        "Chromosome Location": "22",
                        "Locus": "22q13.1",
                        "External Identifiers": "ResourceLinkUniProtKB IDP10635UniProtKB Entry NameCP2D6_HUMANGenBank Protein ID181350GenBank Gene IDM20403GenAtlas IDCYP2D6HGNC IDHGNC:2625",
                        "General References": "Gonzalez FJ, Vilbois F, Hardwick JP, McBride OW, Nebert DW, Gelboin HV, Meyer UA: Human debrisoquine 4-hydroxylase (P450IID1): cDNA and deduced amino acid sequence and assignment of the CYP2D locus to chromosome 22. Genomics. 1988 Feb;2(2):174-9. [Article] Gonzalez FJ, Skoda RC, Kimura S, Umeno M, Zanger UM, Nebert DW, Gelboin HV, Hardwick JP, Meyer UA: Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature. 1988 Feb 4;331(6155):442-6. [Article] Kimura S, Umeno M, Skoda RC, Meyer UA, Gonzalez FJ: The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene. Am J Hum Genet. 1989 Dec;45(6):889-904. [Article] Gaedigk A, Bhathena A, Ndjountche L, Pearce RE, Abdel-Rahman SM, Alander SW, Bradford LD, Rogan PK, Leeder JS: Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans. Pharmacogenomics J. 2005;5(3):173-82. [Article] Dunham I, Shimizu N, Roe BA, Chissoe S, Hunt AR, Collins JE, Bruskiewich R, Beare DM, Clamp M, Smink LJ, Ainscough R, Almeida JP, Babbage A, Bagguley C, Bailey J, Barlow K, Bates KN, Beasley O, Bird CP, Blakey S, Bridgeman AM, Buck D, Burgess J, Burrill WD, O'Brien KP, et al.: The DNA sequence of human chromosome 22. Nature. 1999 Dec 2;402(6761):489-95. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Honda A, Miyazaki T, Ikegami T, Iwamoto J, Maeda T, Hirayama T, Saito Y, Teramoto T, Matsuzaki Y: Cholesterol 25-hydroxylation activity of CYP3A. J Lipid Res. 2011 Aug;52(8):1509-16. doi: 10.1194/jlr.M014084. Epub 2011 May 16. [Article] Rowland P, Blaney FE, Smyth MG, Jones JJ, Leydon VR, Oxbrow AK, Lewis CJ, Tennant MG, Modi S, Eggleston DS, Chenery RJ, Bridges AM: Crystal structure of human cytochrome P450 2D6. J Biol Chem. 2006 Mar 17;281(11):7614-22. Epub 2005 Dec 13. [Article] Tyndale R, Aoyama T, Broly F, Matsunaga T, Inaba T, Kalow W, Gelboin HV, Meyer UA, Gonzalez FJ: Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: possible association with the poor metabolizer phenotype. Pharmacogenetics. 1991 Oct;1(1):26-32. [Article] Yokota H, Tamura S, Furuya H, Kimura S, Watanabe M, Kanazawa I, Kondo I, Gonzalez FJ: Evidence for a new variant CYP2D6 allele CYP2D6J in a Japanese population associated with lower in vivo rates of sparteine metabolism. Pharmacogenetics. 1993 Oct;3(5):256-63. [Article] Evert B, Griese EU, Eichelbaum M: A missense mutation in exon 6 of the CYP2D6 gene leading to a histidine 324 to proline exchange is associated with the poor metabolizer phenotype of sparteine. Naunyn Schmiedebergs Arch Pharmacol. 1994 Oct;350(4):434-9. [Article] Daly AK, Leathart JB, London SJ, Idle JR: An inactive cytochrome P450 CYP2D6 allele containing a deletion and a base substitution. Hum Genet. 1995 Mar;95(3):337-41. [Article] Masimirembwa C, Persson I, Bertilsson L, Hasler J, Ingelman-Sundberg M: A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: association with diminished debrisoquine hydroxylase activity. Br J Clin Pharmacol. 1996 Dec;42(6):713-9. [Article] Marez D, Legrand M, Sabbagh N, Lo-Guidice JM, Boone P, Broly F: An additional allelic variant of the CYP2D6 gene causing impaired metabolism of sparteine. Hum Genet. 1996 May;97(5):668-70. [Article] Marez D, Legrand M, Sabbagh N, Lo Guidice JM, Spire C, Lafitte JJ, Meyer UA, Broly F: Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution. Pharmacogenetics. 1997 Jun;7(3):193-202. [Article] Wang SL, Lai MD, Huang JD: G169R mutation diminishes the metabolic activity of CYP2D6 in Chinese. Drug Metab Dispos. 1999 Mar;27(3):385-8. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article] Dai DP, Geng PW, Wang SH, Cai J, Hu LM, Nie JJ, Hu JH, Hu GX, Cai JP: In vitro functional assessment of 22 newly identified CYP2D6 allelic variants in the Chinese population. Basic Clin Pharmacol Toxicol. 2015 Jul;117(1):39-43. doi: 10.1111/bcpt.12363. Epub 2015 Jan 14. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00176Fluvoxamineapproved, investigationalunknownsubstrateinhibitorDetailsDB00182Amphetamineapproved, illicit, investigationalunknownsubstrateDetailsDB00185CevimelineapprovedunknownsubstrateDetailsDB00193Tramadolapproved, investigationalunknownsubstrateDetailsDB00243Ranolazineapproved, investigationalnosubstrateinhibitorDetailsDB00264Metoprololapproved, investigationalunknownsubstrateinhibitorDetailsDB00281Lidocaineapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00285VenlafaxineapprovedunknownsubstrateinhibitorDetailsDB00289AtomoxetineapprovedunknownsubstrateDetailsDB00318Codeineapproved, illicitunknownsubstrateDetailsDB00370MirtazapineapprovedunknownsubstrateDetailsDB00373TimololapprovedunknownsubstrateDetailsDB00379Mexiletineapproved, investigationalunknownsubstrateDetailsDB00433Prochlorperazineapproved, vet_approvedunknownsubstrateDetailsDB00454MeperidineapprovedunknownsubstrateDetailsDB00476DuloxetineapprovedunknownsubstrateinhibitorDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00496Darifenacinapproved, investigationalunknownsubstrateinhibitorDetailsDB00497Oxycodoneapproved, illicit, investigationalunknownsubstrateDetailsDB00502HaloperidolapprovedunknownsubstrateinhibitorDetailsDB00503Ritonavirapproved, investigationalunknownsubstrateinhibitorDetailsDB00514DextromethorphanapprovedunknownsubstrateDetailsDB00521CarteololapprovedunknownsubstrateDetailsDB00557HydroxyzineapprovednoinhibitorDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00575ClonidineapprovedunknownsubstrateDetailsDB00623FluphenazineapprovedunknowninhibitorDetailsDB00647Dextropropoxypheneapproved, illicit, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00656Trazodoneapproved, investigationalunknownsubstrateinhibitorDetailsDB00674GalantamineapprovednosubstrateDetailsDB00675TamoxifenapprovedunknownsubstrateinhibitorDetailsDB00679Thioridazineapproved, withdrawnunknownsubstrateinhibitorDetailsDB00699Nicergolineapproved, investigationalunknownsubstrateDetailsDB00715Paroxetineapproved, investigationalunknownsubstrateinhibitorDetailsDB00734Risperidoneapproved, investigationalunknownsubstrateinhibitorDetailsDB00757Dolasetronapproved, investigationalunknownsubstrateDetailsDB00805MinaprineapprovedunknownsubstrateDetailsDB00843DonepezilapprovedunknownsubstrateDetailsDB00850PerphenazineapprovedunknownsubstrateinhibitorDetailsDB00863Ranitidineapproved, withdrawnunknowninhibitorDetailsDB00866Alprenololexperimental, withdrawnunknownsubstrateDetailsDB00904Ondansetronapproved, withdrawnunknownsubstrateDetailsDB00914Phenforminapproved, investigational, withdrawnunknownsubstrateDetailsDB00918Almotriptanapproved, investigationalunknownsubstrateDetailsDB00934Maprotilineapproved, investigationalunknownsubstrateDetailsDB00956Hydrocodoneapproved, illicit, investigationalunknownsubstrateDetailsDB00960Pindololapproved, investigationalunknownsubstrateinhibitorDetailsDB01012CinacalcetapprovedunknowninhibitorDetailsDB01035ProcainamideapprovedunknownsubstrateDetailsDB01036Tolterodineapproved, investigationalunknownsubstrateDetailsDB01069Promethazineapproved, investigationalunknownsubstrateinhibitorDetailsDB01074Perhexilineapproved, investigationalunknownsubstrateinhibitorDetailsDB01114ChlorpheniramineapprovedunknownsubstrateinhibitorDetailsDB01136Carvedilolapproved, investigationalunknownsubstrateDetailsDB01142Doxepinapproved, investigationalnosubstrateinhibitorDetailsDB01151Desipramineapproved, investigationalunknownsubstrateinhibitorDetailsDB01193Acebutololapproved, investigationalunknownsubstrateinhibitorDetailsDB01195Flecainideapproved, withdrawnunknownsubstrateinhibitorDetailsDB01228Encainideapproved, investigational, withdrawnunknownsubstrateDetailsDB01233Metoclopramideapproved, investigationalunknownsubstrateinhibitorDetailsDB01242Clomipramineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB01171Moclobemideapproved, investigationalunknownsubstrateinhibitorDetailsDB01274Arformoterolapproved, investigationalunknownsubstrateDetailsDB01410Ciclesonideapproved, investigationalunknownsubstrateDetailsDB01466Ethylmorphineexperimental, illicitunknownsubstrateDetailsDB01409TiotropiumapprovednosubstrateDetailsDB01075Diphenhydramineapproved, investigationalunknownsubstrateinhibitorDetailsDB04840Debrisoquineapproved, investigationalunknownsubstrateDetailsDB00215CitalopramapprovednosubstrateinhibitorDetailsDB00234Reboxetineapproved, experimentalunknowninhibitorDetailsDB00257Clotrimazoleapproved, vet_approvedunknowninhibitorDetailsDB00317Gefitinibapproved, investigationalnosubstrateinhibitorDetailsDB00321AmitriptylineapprovedunknownsubstrateDetailsDB00342Terfenadineapproved, withdrawnunknownsubstrateinhibitorDetailsDB00343Diltiazemapproved, investigationalunknownsubstrateDetailsDB00356ChlorzoxazoneapprovedunknownsubstrateDetailsDB00363ClozapineapprovednosubstrateinhibitorDetailsDB00455Loratadineapproved, investigationalunknownsubstrateinhibitorDetailsDB00458ImipramineapprovedunknownsubstrateinhibitorDetailsDB00468QuinineapprovedunknownsubstrateinhibitorDetailsDB00482Celecoxibapproved, investigationalunknownsubstrateinhibitorDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00532Mephenytoinapproved, investigational, withdrawnunknownsubstrateDetailsDB00540NortriptylineapprovedunknownsubstrateinhibitorDetailsDB00613Amodiaquineapproved, investigationalunknowninhibitorDetailsDB00622Nicardipineapproved, investigationalunknowninhibitorDetailsDB00705DelavirdineapprovedunknownsubstrateinhibitorDetailsDB00726TrimipramineapprovedunknownsubstrateDetailsDB00752Tranylcypromineapproved, investigationalunknowninhibitorDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknowninhibitorDetailsDB00908Quinidineapproved, investigationalunknowninhibitorDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00933Mesoridazineapproved, investigationalunknownsubstrateDetailsDB00972AzelastineapprovedunknownsubstrateinhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB01071MequitazineexperimentalunknownsubstrateDetailsDB01104SertralineapprovedunknownsubstrateinhibitorDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB01115NifedipineapprovedunknowninhibitorDetailsDB01118Amiodaroneapproved, investigationalnoinhibitorDetailsDB01131ProguanilapprovednoinhibitorDetailsDB01149Nefazodoneapproved, withdrawnunknownsubstrateinhibitorDetailsDB01156BupropionapprovedunknowninhibitorDetailsDB01175EscitalopramapprovednosubstrateinhibitorDetailsDB01182PropafenoneapprovedunknownsubstrateinhibitorDetailsDB01191Dexfenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateinhibitorDetailsDB01192Oxymorphoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB01218HalofantrineapprovedunknowninhibitorDetailsDB01238Aripiprazoleapproved, investigationalnosubstrateDetailsDB01403Methotrimeprazineapproved, investigationalunknownsubstrateinhibitorDetailsDB01551Dihydrocodeineapproved, illicitunknownsubstrateDetailsDB00377Palonosetronapproved, investigationalunknownsubstrateDetailsDB04861Nebivololapproved, investigationalunknownsubstrateDetailsDB04889BicifadineinvestigationalunknownsubstrateDetailsDB015621-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidineexperimental, illicitunknowninhibitorDetailsDB06144Sertindoleapproved, investigational, withdrawnunknownsubstrateDetailsDB06148Mianserinapproved, investigationalunknownsubstrateDetailsDB04905TesmilifeneinvestigationalunknownsubstrateDetailsDB01624Zuclopenthixolapproved, investigationalunknownsubstrateDetailsDB00571Propranololapproved, investigationalunknownsubstrateinhibitorDetailsDB05271RotigotineapprovedunknownsubstrateinhibitorDetailsDB00472Fluoxetineapproved, vet_approvednosubstrateinhibitorDetailsDB01095FluvastatinapprovedunknownsubstrateDetailsDB01076AtorvastatinapprovednoinhibitorDetailsDB00439Cerivastatinapproved, withdrawnunknowninhibitorDetailsDB00619ImatinibapprovednosubstrateinhibitorDetailsDB00334Olanzapineapproved, investigationalnosubstrateinhibitorDetailsDB00792Tripelennamineapproved, vet_approvedunknowninhibitorDetailsDB00188Bortezomibapproved, investigationalunknownsubstrateDetailsDB05109Trabectedinapproved, investigationalunknownsubstrateDetailsDB00568Cinnarizineapproved, investigationalunknownsubstrateDetailsDB04841FlunarizineapprovedunknownsubstrateDetailsDB06726BufuralolexperimentalunknownsubstrateDetailsDB014724-Methoxyamphetamineexperimental, illicitunknownsubstrateDetailsDB03783PhenacetinwithdrawnunknownsubstrateDetailsDB06727Sparteineexperimental, withdrawnunknownsubstrateinhibitorDetailsDB00283Clemastineapproved, investigationalunknowninhibitorDetailsDB00907Cocaineapproved, illicitunknowninhibitorDetailsDB00997Doxorubicinapproved, investigationalnosubstrateinhibitorDetailsDB00333MethadoneapprovednosubstrateinhibitorDetailsDB01388Mibefradilinvestigational, withdrawnunknowninhibitorDetailsDB00211MidodrineapprovedunknownsubstrateDetailsDB00208TiclopidineapprovedunknownsubstrateinhibitorDetailsDB00543AmoxapineapprovedunknownsubstrateinhibitorDetailsDB00608Chloroquineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB04946IloperidoneapprovedunknownsubstrateDetailsDB01577Metamfetamineapproved, illicit, withdrawnunknownsubstrateDetailsDB01621Pipotiazineapproved, investigationalunknownsubstrateinhibitorDetailsDB00706Tamsulosinapproved, investigationalunknownsubstrateDetailsDB04844Tetrabenazineapproved, investigationalunknownsubstrateDetailsDB01601LopinavirapprovedunknownsubstrateDetailsDB00932Tipranavirapproved, investigationalunknownsubstrateinhibitorDetailsDB04855DronedaroneapprovedunknownsubstrateinhibitorDetailsDB00951Isoniazidapproved, investigationalunknowninhibitorDetailsDB06708LumefantrineapprovedunknowninhibitorDetailsDB04868Nilotinibapproved, investigationalunknowninhibitorDetailsDB01424Aminophenazoneapproved, withdrawnunknownsubstrateDetailsDB00238NevirapineapprovedunknownsubstrateinhibitorDetailsDB00216Eletriptanapproved, investigationalunknownsubstrateDetailsDB00425ZolpidemapprovedunknownsubstrateDetailsDB01628Etoricoxibapproved, investigationalunknowninhibitorDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateDetailsDB00316AcetaminophenapprovedunknownsubstrateDetailsDB00924CyclobenzaprineapprovedunknownsubstrateDetailsDB00381AmlodipineapprovedunknowninhibitorDetailsDB00701Amprenavirapproved, investigationalunknownsubstrateDetailsDB01429AprindineexperimentalunknownsubstrateDetailsDB00637Astemizoleapproved, withdrawnunknownsubstrateDetailsDB01244Bepridilapproved, withdrawnunknownsubstrateinhibitorDetailsDB00195Betaxololapproved, investigationalunknownsubstrateDetailsDB00810Biperidenapproved, investigationalunknowninhibitorDetailsDB00297Bupivacaineapproved, investigationalunknownsubstrateDetailsDB00490Buspironeapproved, investigationalunknownsubstrateDetailsDB00201CaffeineapprovedunknownsubstrateDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknowninhibitorDetailsDB00604Cisaprideapproved, investigational, withdrawnunknowninhibitorDetailsDB01093Dimethyl sulfoxideapproved, vet_approvedunknowninhibitorDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB00590DoxazosinapprovedunknownsubstrateDetailsDB00625Efavirenzapproved, investigationalunknowninhibitorDetailsDB00751Epinastineapproved, investigationalunknownsubstrateinhibitorDetailsDB01023Felodipineapproved, investigationalunknowninhibitorDetailsDB01611HydroxychloroquineapprovedunknownsubstrateinhibitorDetailsDB01177IdarubicinapprovedunknownsubstrateDetailsDB00224IndinavirapprovedunknowninhibitorDetailsDB00598LabetalolapprovedunknownsubstrateinhibitorDetailsDB00448Lansoprazoleapproved, investigationalunknowninhibitorDetailsDB00528Lercanidipineapproved, investigationalunknowninhibitorDetailsDB01206Lomustineapproved, investigationalunknowninhibitorDetailsDB06691Mepyramineapproved, vet_approvedunknowninhibitorDetailsDB01028Methoxyfluraneapproved, investigational, vet_approved, withdrawnunknownsubstrateDetailsDB00834Mifepristoneapproved, investigationalunknowninhibitorDetailsDB00731Nateglinideapproved, investigationalunknownsubstrateDetailsDB00220NelfinavirapprovednoinhibitorDetailsDB02701Nicotinamideapproved, investigationalunknowninhibitorDetailsDB00184NicotineapprovedunknownsubstrateDetailsDB00627Niacinapproved, investigational, nutraceuticalunknowninhibitorDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB01096OxamniquineapprovedunknownsubstrateinhibitorDetailsDB01580OxprenololapprovedunknownsubstrateinhibitorDetailsDB01062Oxybutyninapproved, investigationalunknowninhibitorDetailsDB00738Pentamidineapproved, investigationalunknownsubstrateDetailsDB01435Antipyrineapproved, investigationalunknownsubstrateDetailsDB01100PimozideapprovednoinhibitorDetailsDB00592Piperazineapproved, vet_approvedunknownsubstrateDetailsDB01087PrimaquineapprovedunknowninhibitorDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateDetailsDB01224QuetiapineapprovedunknownsubstrateDetailsDB00409Remoxiprideapproved, withdrawnunknownsubstrateDetailsDB00412Rosiglitazoneapproved, investigationalunknowninhibitorDetailsDB01232Saquinavirapproved, investigationalunknowninhibitorDetailsDB01037Selegilineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00641SimvastatinapprovedunknownsubstrateDetailsDB06729SulfaphenazoleapprovedunknowninhibitorDetailsDB01079Tegaserodapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00277TheophyllineapprovedunknownsubstrateDetailsDB00763MethimazoleapprovedunknowninhibitorDetailsDB01623ThiothixeneapprovedunknowninhibitorDetailsDB00209TrospiumapprovedunknowninhibitorDetailsDB00661VerapamilapprovedunknowninhibitorDetailsDB00570VinblastineapprovedunknowninhibitorDetailsDB00361Vinorelbineapproved, investigationalnoinhibitorDetailsDB01392Yohimbineapproved, investigational, vet_approvedunknownsubstrateDetailsDB06287TemsirolimusapprovedunknowninhibitorDetailsDB00398Sorafenibapproved, investigationalunknowninhibitorDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateDetailsDB01128BicalutamideapprovedunknowninhibitorDetailsDB01129Rabeprazoleapproved, investigationalunknowninhibitorDetailsDB01166Cilostazolapproved, investigationalunknownsubstrateDetailsDB06216AsenapineapprovedunknownsubstrateinhibitorDetailsDB06589PazopanibapprovedunknowninhibitorDetailsDB06702FesoterodineapprovedunknownsubstrateDetailsDB06684VilazodoneapprovedunknownsubstrateDetailsDB00836LoperamideapprovedunknownsubstrateDetailsDB06506RepinotaninvestigationalunknownsubstrateDetailsDB06770Benzyl alcoholapprovedunknownsubstrateDetailsDB04920Clevidipineapproved, investigationalunknownsubstrateDetailsDB00633Dexmedetomidineapproved, vet_approvedunknowninhibitorDetailsDB06370IndisulaminvestigationalunknowninhibitorDetailsDB06735EnclomipheneinvestigationalunknownsubstrateDetailsDB06204TapentadolapprovedunknownsubstrateDetailsDB04871Lorcaserinapproved, withdrawnnosubstrateinhibitorDetailsDB05812AbirateroneapprovedunknowninhibitorDetailsDB08881VemurafenibapprovedunknowninhibitorDetailsDB08893MirabegronapprovednosubstrateinhibitorDetailsDB08901Ponatinibapproved, investigationalunknownsubstrateDetailsDB06203AlogliptinapprovedunknownsubstrateDetailsDB08918Levomilnacipranapproved, investigationalunknownsubstrateDetailsDB06292DapagliflozinapprovednosubstrateDetailsDB09039Eliglustatapproved, investigationalnosubstrateinhibitorDetailsDB09048Netupitantapproved, investigationalnosubstrateDetailsDB09049NaloxegolapprovedunknowninhibitorDetailsDB09076UmeclidiniumapprovednosubstrateDetailsDB09065CobicistatapprovednosubstrateinhibitorDetailsDB09068Vortioxetineapproved, investigationalnosubstrateDetailsDB06016Cariprazineapproved, investigationalnosubstrateinhibitorDetailsDB00349Clobazamapproved, illicitnoinhibitorDetailsDB09128Brexpiprazoleapproved, investigationalnosubstrateDetailsDB09291Rolapitantapproved, investigationalnoinhibitorDetailsDB06678EsmirtazapineinvestigationalunknownsubstrateDetailsDB06603Panobinostatapproved, investigationalnoinhibitorDetailsDB09570Ixazomibapproved, investigationalunknownsubstrateDetailsDB06412Oxymetholoneapproved, illicitunknowninhibitorDetailsDB09183DasabuvirapprovednosubstrateDetailsDB06512DeramciclaneinvestigationalunknowninhibitorDetailsDB00022Peginterferon alfa-2bapprovedunknowninhibitorDetailsDB00494Entacaponeapproved, investigationalunknowninhibitorDetailsDB04938Ospemifeneapproved, investigationalunknowninhibitorDetailsDB06820SulconazoleapprovedunknowninhibitorDetailsDB08909Glycerol phenylbutyrateapprovedunknowninhibitorDetailsDB00420Promazineapproved, vet_approvedunknownsubstrateDetailsDB09118StiripentolapprovedunknowninhibitorDetailsDB12332Rucaparibapproved, investigationalnosubstrateinhibitorDetailsDB09555Dexchlorpheniramine maleateapprovednosubstrateinhibitorDetailsDB12161Deutetrabenazineapproved, investigationalnosubstrateDetailsDB06217Vernakalantapproved, investigationalunknownsubstrateinhibitorDetailsDB06595Midostaurinapproved, investigationalunknowninhibitorDetailsDB11915Valbenazineapproved, investigationalnosubstrateDetailsDB13174RheinexperimentalunknowninhibitorDetailsDB11994Diacereinapproved, investigationalunknowninhibitorDetailsDB08922PerospironeexperimentalunknownsubstrateDetailsDB09167DosulepinapprovedunknownsubstrateinhibitorDetailsDB11614RupatadineapprovednosubstrateDetailsDB09238Manidipineapproved, investigationalunknowninhibitorDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateDetailsDB09061Cannabidiolapproved, investigationalunknownsubstrateinhibitorDetailsDB11638Artenimolapproved, experimental, investigationalunknowninhibitorDetailsDB09195LorpiprazoleapprovednosubstrateDetailsDB09224MelperoneinvestigationalunknowninhibitorDetailsDB11642Pitolisantapproved, investigationalunknownsubstrateinhibitorDetailsDB11633Isavuconazoleapproved, investigationalunknowninhibitorDetailsDB11130Opiumapproved, illicitnosubstrateDetailsDB09053IbrutinibapprovednosubstrateDetailsDB11586Asunaprevirapproved, investigational, withdrawnnosubstrateinhibitorDetailsDB140105-methoxy-N,N-dimethyltryptamineexperimental, illicitunknownsubstrateDetailsDB13975Black cohoshexperimentalnoinhibitorDetailsDB14011NabiximolsinvestigationalunknownsubstrateDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorDetailsDB13293Ipecacapproved, withdrawnnosubstrateDetailsDB04948Lofexidineapproved, investigationalnosubstrateDetailsDB11672Curcuminapproved, investigationalunknowninhibitorDetailsDB04829Lysergic acid diethylamideillicit, investigational, withdrawnnosubstrateDetailsDB14185Aripiprazole lauroxilapproved, investigationalunknownsubstrateDetailsDB11718Encorafenibapproved, investigationalnosubstrateinhibitorDetailsDB06608Tafenoquineapproved, investigationalnosubstrateDetailsDB11979Elagolixapproved, investigationalnosubstrateDetailsDB11785AnisodamineinvestigationalnosubstrateDetailsDB09204ArotinololinvestigationalnosubstrateDetailsDB00335AtenololapprovednosubstrateDetailsDB09013BefunololexperimentalnosubstrateDetailsDB01295BevantololexperimentalnosubstrateDetailsDB08807BopindololexperimentalnosubstrateDetailsDB12752BucindololinvestigationalnosubstrateDetailsDB08808BupranololexperimentalnosubstrateDetailsDB04846Celiprololapproved, investigationalnosubstrateDetailsDB13508CloranololexperimentalnosubstrateDetailsDB13757EpanololexperimentalnosubstrateDetailsDB13443EsatenololexperimentalnosubstrateDetailsDB00187Esmololapproved, withdrawnnosubstrateDetailsDB08952IndenololwithdrawnnosubstrateDetailsDB12212LandiololinvestigationalnosubstrateDetailsDB09351Levobetaxololapproved, investigationalnosubstrateDetailsDB01210LevobunololapprovednosubstrateDetailsDB13530MepindololexperimentalnosubstrateDetailsDB01214MetipranololapprovednosubstrateDetailsDB01359Penbutololapproved, investigationalnosubstrateDetailsDB01297PractololapprovednosubstrateDetailsDB00489SotalolapprovednosubstrateDetailsDB11770TalinololinvestigationalnosubstrateDetailsDB13775TertatololexperimentalnosubstrateDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB06654Safinamideapproved, investigationalunknowninhibitorDetailsDB04818IproniazidwithdrawnunknowninhibitorDetailsDB01267PaliperidoneapprovedunknownsubstrateDetailsDB09078Lenvatinibapproved, investigationalunknowninhibitorDetailsDB08864RilpivirineapprovedunknowninhibitorDetailsDB04911Oritavancinapproved, investigationalunknowninhibitorinducerDetailsDB04884DapoxetineinvestigationalnosubstrateDetailsDB12693RitanserininvestigationalnoinhibitorDetailsDB02703Fusidic acidapproved, investigationalunknownsubstrateinhibitorDetailsDB09288PropacetamolexperimentalnosubstrateDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB11963Dacomitinibapproved, investigationalunknownsubstrateinhibitorDetailsDB14025ClinafloxacininvestigationalunknowninhibitorDetailsDB01323St. John's Wortapproved, investigational, nutraceuticalnoinhibitorDetailsDB01454Midomafetamineexperimental, illicit, investigationalnosubstrateDetailsDB11855Revefenacinapproved, investigationalnosubstrateDetailsDB12245Triclabendazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB01576Dextroamphetamineapproved, illicitnosubstrateDetailsDB06700Desvenlafaxineapproved, investigationalnoinhibitorDetailsDB00737MeclizineapprovednosubstrateDetailsDB01591SolifenacinapprovedunknownsubstrateDetailsDB13679Dexchlorpheniramineexperimental, investigationalunknownsubstrateinhibitorDetailsDB12523Mizolastineapproved, investigationalunknowninhibitorDetailsDB01173OrphenadrineapprovedunknowninhibitorDetailsDB09173ButyrfentanylillicitunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknownsubstrateDetailsDB04957AzimilideinvestigationalunknownsubstrateDetailsDB09061Cannabidiolapproved, investigationalunknowninhibitorDetailsDB14011NabiximolsinvestigationalunknownsubstrateinhibitorDetailsDB01590EverolimusapprovedunknowninhibitorDetailsDB12001Abemaciclibapproved, investigationalunknowninhibitorDetailsDB11732Lasmiditanapproved, investigationalnoinhibitorDetailsDB15444Elexacaftorapproved, investigationalnoinhibitorDetailsDB15091Upadacitinibapproved, investigationalunknownsubstrateDetailsDB00252Phenytoinapproved, vet_approvednosubstrateDetailsDB15328Ubrogepantapproved, investigationalunknowninhibitorDetailsDB00983Formoterolapproved, investigationalunknownsubstrateDetailsDB01264DarunavirapprovedunknowninhibitorDetailsDB13609UmifenovirinvestigationalunknownsubstrateDetailsDB11837Osilodrostatapproved, investigationalunknownsubstrateinhibitorDetailsDB12500Fedratinibapproved, investigationalunknowninhibitorDetailsDB09241Methylene blueapproved, investigationalunknownsubstrateinhibitorDetailsDB14761Remdesivirapproved, investigationalunknownsubstrateDetailsDB14840RipretinibapprovedunknownsubstrateDetailsDB00845Clofazimineapproved, investigationalunknowninhibitorDetailsDB14881Oliceridineapproved, investigationalunknownsubstrateDetailsDB12499Clascoteroneapproved, investigationalnoinhibitorDetailsDB15822Pralsetinibapproved, investigationalnosubstrateDetailsDB15982BerotralstatapprovednoinhibitorDetailsDB04951Pirfenidoneapproved, investigationalunknownsubstrateinhibitorDetailsDB06137Tirbanibulinapproved, investigationalnoinhibitorDetailsDB00549Zafirlukastapproved, investigationalunknowninhibitorDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB00745Modafinilapproved, investigationalunknowninducerDetailsDB00330EthambutolapprovedunknowninhibitorDetailsDB01086Benzocaineapproved, investigationalunknownsubstrateDetailsDB05316Pimavanserinapproved, investigationalunknownsubstrateDetailsDB11753Rifamycinapproved, investigationalunknowninhibitorDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownsubstrateDetailsDB15119Ropeginterferon alfa-2bapproved, investigationalnoinhibitorDetailsDB12151Brincidofovirapproved, investigationalnoinhibitorDetailsDB16703Belumosudilapproved, investigationalnosubstrateinhibitorDetailsDB12265Fexinidazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00602Ivermectinapproved, investigational, vet_approvednosubstrateDetailsDB12713Sotagliflozinapproved, investigationalnoinhibitorDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB00470Dronabinolapproved, illicitnoinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknowninhibitorDetailsDB05087Ganaxoloneapproved, investigationalnosubstrateDetailsDB09185Viloxazineapproved, investigational, withdrawnnosubstrateinhibitorDetailsDB14921Mavacamtenapproved, investigationalnoDetailsDB06083Tapinarofapproved, investigationalnosubstrateDetailsDB16650Deucravacitinibapproved, investigationalunknownsubstrateDetailsDB12095Telotristat ethylapproved, investigationalnoinhibitorDetailsDB15149Futibatinibapproved, investigationalnosubstrateDetailsDB11739Vonoprazanapproved, investigationalunknownsubstrateDetailsDB05239Cobimetinibapproved, investigationalnoinhibitorDetailsDB02709ResveratrolinvestigationalnoinhibitorDetailsDB15568Adagrasibapproved, investigationalunknownsubstrateinhibitorDetailsDB12236Bexagliflozinapproved, investigationalunknownsubstrateDetailsDB17472Pirtobrutinibapproved, investigationalunknowninhibitorDetailsDB15688Zavegepantapproved, investigationalunknownsubstrateDetailsDB00862VardenafilapprovedunknowninhibitorDetailsDB16217Leniolisibapproved, investigationalnosubstrateDetailsDB00953RizatriptanapprovednoinhibitorDetailsDB11712Tezacaftorapproved, investigationalnoinhibitorDetails"
                    }
                },
                {
                    "Label": "Cytochrome P450 2C9",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 2C9",
                        "Synonyms": "(R)-limonene 6-monooxygenase\n(S)-limonene 6-monooxygenase\n(S)-limonene 7-monooxygenase\n1.14.13.-\nCholesterol 25-hydroxylase\nCYP2C10\nCYPIIC9\nCytochrome P-450MP\nCytochrome P450 MP-4\nCytochrome P450 MP-8\nCytochrome P450 PB-1\nS-mephenytoin 4-hydroxylase",
                        "Gene Name": "CYP2C9",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0005471|Cytochrome P450 2C9\nMDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDISKSLTNLSKV\nYGPVFTLYFGLKPIVVLHGYEAVKEALIDLGEEFSGRGIFPLAERANRGFGIVFSNGKKW\nKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICS\nIIFHKRFDYKDQQFLNLMEKLNENIKILSSPWIQICNNFSPIIDYFPGTHNKLLKNVAFM\nKSYILEKVKEHQESMDMNNPQDFIDCFLMKMEKEKHNQPSEFTIESLENTAVDLFGAGTE\nTTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRSHMPYTDAVVHEVQRYID\nLLPTSLPHAVTCDIKFRNYLIPKGTTILISLTSVLHDNKEFPNPEMFDPHHFLDEGGNFK\nKSKYFMPFSAGKRICVGEALAGMELFLFLTSILQNFNLKSLVDPKNLDTTPVVNGFASVP\nPFYQLCFIPV",
                        "Number of residues": "490",
                        "Molecular Weight": "55627.365",
                        "Theoretical pI": "7.99",
                        "GO Classification": "Functions(R)-limonene 6-monooxygenase activity / (S)-limonene 6-monooxygenase activity / (S)-limonene 7-monooxygenase activity / arachidonic acid epoxygenase activity / aromatase activity / caffeine oxidase activity / drug binding / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity / oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen / oxygen binding / steroid hydroxylase activityProcessesarachidonic acid metabolic process / cellular amide metabolic process / drug catabolic process / drug metabolic process / epoxygenase P450 pathway / exogenous drug catabolic process / monocarboxylic acid metabolic process / monoterpenoid metabolic process / omega-hydroxylase P450 pathway / oxidation-reduction process / oxidative demethylation / small molecule metabolic process / steroid metabolic process / urea metabolic process / xenobiotic metabolic processComponentscytoplasm / endoplasmic reticulum membrane / intracellular membrane-bounded organelle",
                        "General Function": "Steroid hydroxylase activity",
                        "Specific Function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. This enzyme contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S-warfarin, diclofenac, phenytoin, tolbutamide and losartan.",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0016893|Cytochrome P450 2C9 (CYP2C9)\nATGGATTCTCTTGTGGTCCTTGTGCTCTGTCTCTCATGTTTGCTTCTCCTTTCACTCTGG\nAGACAGAGCTCTGGGAGAGGAAAACTCCCTCCTGGCCCCACTCCTCTCCCAGTGATTGGA\nAATATCCTACAGATAGGTATTAAGGACATCAGCAAATCCTTAACCAATCTCTCAAAGGTC\nTATGGCCCTGTGTTCACTCTGTATTTTGGCCTGAAACCCATAGTGGTGCTGCATGGATAT\nGAAGCAGTGAAGGAAGCCCTGATTGATCTTGGAGAGGAGTTTTCTGGAAGAGGCATTTTC\nCCACTGGCTGAAAGAGCTAACAGAGGATTTGGAATTGTTTTCAGCAATGGAAAGAAATGG\nAAGGAGATCCGGCGTTTCTCCCTCATGACGCTGCGGAATTTTGGGATGGGGAAGAGGAGC\nATTGAGGACCGTGTTCAAGAGGAAGCCCGCTGCCTTGTGGAGGAGTTGAGAAAAACCAAG\nGCCTCACCCTGTGATCCCACTTTCATCCTGGGCTGTGCTCCCTGCAATGTGATCTGCTCC\nATTATTTTCCATAAACGTTTTGATTATAAAGATCAGCAATTTCTTAACTTAATGGAAAAG\nTTGAATGAAAACATCAAGATTTTGAGCAGCCCCTGGATCCAGATCTGCAATAATTTTTCT\nCCTATCATTGATTACTTCCCGGGAACTCACAACAAATTACTTAAAAACGTTGCTTTTATG\nAAAAGTTATATTTTGGAAAAAGTAAAAGAACACCAAGAATCAATGGACATGAACAACCCT\nCAGGACTTTATTGATTGCTTCCTGATGAAAATGGAGAAGGAAAAGCACAACCAACCATCT\nGAATTTACTATTGAAAGCTTGGAAAACACTGCAGTTGACTTGTTTGGAGCTGGGACAGAG\nACGACAAGCACAACCCTGAGATATGCTCTCCTTCTCCTGCTGAAGCACCCAGAGGTCACA\nGCTAAAGTCCAGGAAGAGATTGAACGTGTGATTGGCAGAAACCGGAGCCCCTGCATGCAA\nGACAGGAGCCACATGCCCTACACAGATGCTGTGGTGCACGAGGTCCAGAGATACATTGAC\nCTTCTCCCCACCAGCCTGCCCCATGCAGTGACCTGTGACATTAAATTCAGAAACTATCTC\nATTCCCAAGGGCACAACCATATTAATTTCCCTGACTTCTGTGCTACATGACAACAAAGAA\nTTTCCCAACCCAGAGATGTTTGACCCTCATCACTTTCTGGATGAAGGTGGCAATTTTAAG\nAAAAGTAAATACTTCATGCCTTTCTCAGCAGGAAAACGGATTTGTGTGGGAGAAGCCCTG\nGCCGGCATGGAGCTGTTTTTATTCCTGACCTCCATTTTACAGAACTTTAACCTGAAATCT\nCTGGTTGACCCAAAGAACCTTGACACCACTCCAGTTGTCAATGGATTTGCCTCTGTGCCG\nCCCTTCTACCAGCTGTGCTTCATTCCTGTCTGA",
                        "Chromosome Location": "10",
                        "Locus": "10q24",
                        "External Identifiers": "ResourceLinkUniProtKB IDP11712UniProtKB Entry NameCP2C9_HUMANGenBank Gene IDAY341248GenAtlas IDCYP2C9HGNC IDHGNC:2623",
                        "General References": "Meehan RR, Gosden JR, Rout D, Hastie ND, Friedberg T, Adesnik M, Buckland R, van Heyningen V, Fletcher J, Spurr NK, et al.: Human cytochrome P-450 PB-1: a multigene family involved in mephenytoin and steroid oxidations that maps to chromosome 10. Am J Hum Genet. 1988 Jan;42(1):26-37. [Article] Kimura S, Pastewka J, Gelboin HV, Gonzalez FJ: cDNA and amino acid sequences of two members of the human P450IIC gene subfamily. Nucleic Acids Res. 1987 Dec 10;15(23):10053-4. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Deloukas P, Earthrowl ME, Grafham DV, Rubenfield M, French L, Steward CA, Sims SK, Jones MC, Searle S, Scott C, Howe K, Hunt SE, Andrews TD, Gilbert JG, Swarbreck D, Ashurst JL, Taylor A, Battles J, Bird CP, Ainscough R, Almeida JP, Ashwell RI, Ambrose KD, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Bates K, Beasley H, Bray-Allen S, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Cahill P, Camire D, Carter NP, Chapman JC, Clark SY, Clarke G, Clee CM, Clegg S, Corby N, Coulson A, Dhami P, Dutta I, Dunn M, Faulkner L, Frankish A, Frankland JA, Garner P, Garnett J, Gribble S, Griffiths C, Grocock R, Gustafson E, Hammond S, Harley JL, Hart E, Heath PD, Ho TP, Hopkins B, Horne J, Howden PJ, Huckle E, Hynds C, Johnson C, Johnson D, Kana A, Kay M, Kimberley AM, Kershaw JK, Kokkinaki M, Laird GK, Lawlor S, Lee HM, Leongamornlert DA, Laird G, Lloyd C, Lloyd DM, Loveland J, Lovell J, McLaren S, McLay KE, McMurray A, Mashreghi-Mohammadi M, Matthews L, Milne S, Nickerson T, Nguyen M, Overton-Larty E, Palmer SA, Pearce AV, Peck AI, Pelan S, Phillimore B, Porter K, Rice CM, Rogosin A, Ross MT, Sarafidou T, Sehra HK, Shownkeen R, Skuce CD, Smith M, Standring L, Sycamore N, Tester J, Thorpe A, Torcasso W, Tracey A, Tromans A, Tsolas J, Wall M, Walsh J, Wang H, Weinstock K, West AP, Willey DL, Whitehead SL, Wilming L, Wray PW, Young L, Chen Y, Lovering RC, Moschonas NK, Siebert R, Fechtel K, Bentley D, Durbin R, Hubbard T, Doucette-Stamm L, Beck S, Smith DR, Rogers J: The DNA sequence and comparative analysis of human chromosome 10. Nature. 2004 May 27;429(6990):375-81. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Yasumori T, Kawano S, Nagata K, Shimada M, Yamazoe Y, Kato R: Nucleotide sequence of a human liver cytochrome P-450 related to the rat male specific form. J Biochem. 1987 Nov;102(5):1075-82. [Article] Umbenhauer DR, Martin MV, Lloyd RS, Guengerich FP: Cloning and sequence determination of a complementary DNA related to human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylase. Biochemistry. 1987 Feb 24;26(4):1094-9. [Article] Ged C, Umbenhauer DR, Bellew TM, Bork RW, Srivastava PK, Shinriki N, Lloyd RS, Guengerich FP: Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 (S)-mephenytoin 4'-hydroxylase. Biochemistry. 1988 Sep 6;27(18):6929-40. [Article] Ohgiya S, Komori M, Ohi H, Shiramatsu K, Shinriki N, Kamataki T: Six-base deletion occurring in messages of human cytochrome P-450 in the CYP2C subfamily results in reduction of tolbutamide hydroxylase activity. Biochem Int. 1992 Sep;27(6):1073-81. [Article] Shimada T, Misono KS, Guengerich FP: Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction. J Biol Chem. 1986 Jan 15;261(2):909-21. [Article] Komori M, Hashizume T, Ohi H, Miura T, Kitada M, Nagashima K, Kamataki T: Cytochrome P-450 in human liver microsomes: high-performance liquid chromatographic isolation of three forms and their characterization. J Biochem. 1988 Dec;104(6):912-6. [Article] Srivastava PK, Yun CH, Beaune PH, Ged C, Guengerich FP: Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes. Mol Pharmacol. 1991 Jul;40(1):69-79. [Article] Haining RL, Hunter AP, Veronese ME, Trager WF, Rettie AE: Allelic variants of human cytochrome P450 2C9: baculovirus-mediated expression, purification, structural characterization, substrate stereoselectivity, and prochiral selectivity of the wild-type and I359L mutant forms. Arch Biochem Biophys. 1996 Sep 15;333(2):447-58. [Article] Sandhu P, Baba T, Guengerich FP: Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity. Arch Biochem Biophys. 1993 Nov 1;306(2):443-50. [Article] Miyazawa M, Shindo M, Shimada T: Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes. Drug Metab Dispos. 2002 May;30(5):602-7. [Article] Honda A, Miyazaki T, Ikegami T, Iwamoto J, Maeda T, Hirayama T, Saito Y, Teramoto T, Matsuzaki Y: Cholesterol 25-hydroxylation activity of CYP3A. J Lipid Res. 2011 Aug;52(8):1509-16. doi: 10.1194/jlr.M014084. Epub 2011 May 16. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Williams PA, Cosme J, Ward A, Angove HC, Matak Vinkovic D, Jhoti H: Crystal structure of human cytochrome P450 2C9 with bound warfarin. Nature. 2003 Jul 24;424(6947):464-8. Epub 2003 Jul 13. [Article] Stubbins MJ, Harries LW, Smith G, Tarbit MH, Wolf CR: Genetic analysis of the human cytochrome P450 CYP2C9 locus. Pharmacogenetics. 1996 Oct;6(5):429-39. [Article] Bhasker CR, Miners JO, Coulter S, Birkett DJ: Allelic and functional variability of cytochrome P4502C9. Pharmacogenetics. 1997 Feb;7(1):51-8. [Article] Imai J, Ieiri I, Mamiya K, Miyahara S, Furuumi H, Nanba E, Yamane M, Fukumaki Y, Ninomiya H, Tashiro N, Otsubo K, Higuchi S: Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locus. Pharmacogenetics. 2000 Feb;10(1):85-9. [Article] Dickmann LJ, Rettie AE, Kneller MB, Kim RB, Wood AJ, Stein CM, Wilkinson GR, Schwarz UI: Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans. Mol Pharmacol. 2001 Aug;60(2):382-7. [Article] Higashi MK, Veenstra DL, Kondo LM, Wittkowsky AK, Srinouanprachanh SL, Farin FM, Rettie AE: Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy. JAMA. 2002 Apr 3;287(13):1690-8. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB03317Ferroheme CexperimentalunknownDetailsDB00196Fluconazoleapproved, investigationalunknowninhibitorDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateinhibitorDetailsDB00222GlimepirideapprovedunknownsubstrateDetailsDB00250Dapsoneapproved, investigationalunknownsubstrateinducerDetailsDB00327Hydromorphoneapproved, illicitnosubstrateDetailsDB00469TenoxicamapprovedunknownsubstrateDetailsDB00470Dronabinolapproved, illicitnosubstrateinhibitorinducerDetailsDB00471MontelukastapprovedunknownsubstrateDetailsDB00472Fluoxetineapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00482Celecoxibapproved, investigationalunknownsubstrateDetailsDB00549Zafirlukastapproved, investigationalunknownsubstrateinhibitorDetailsDB00559Bosentanapproved, investigationalunknownsubstrateinducerDetailsDB00580Valdecoxibapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00582VoriconazoleapprovedunknownsubstrateinhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknownsubstrateDetailsDB00617ParamethadioneapprovedunknownsubstrateDetailsDB00675TamoxifenapprovedunknownsubstrateinhibitorDetailsDB00678LosartanapprovedunknownsubstrateDetailsDB00682WarfarinapprovedunknownsubstrateinducerDetailsDB00712Flurbiprofenapproved, investigationalunknownsubstrateDetailsDB00731Nateglinideapproved, investigationalunknownsubstrateDetailsDB00744Zileutonapproved, investigational, withdrawnunknownsubstrateDetailsDB00749Etodolacapproved, investigational, vet_approvedunknownsubstrateDetailsDB00784Mefenamic acidapprovedunknownsubstrateinhibitorDetailsDB00814Meloxicamapproved, vet_approvedunknownsubstrateDetailsDB00870Suprofenapproved, withdrawnunknownsubstrateinhibitorDetailsDB00916MetronidazoleapprovedunknowninhibitorDetailsDB00946Phenprocoumonapproved, investigationalunknownsubstrateDetailsDB01015SulfamethoxazoleapprovedunknownsubstrateinhibitorDetailsDB01029Irbesartanapproved, investigationalunknownsubstrateDetailsDB01050IbuprofenapprovedunknownsubstrateDetailsDB01067Glipizideapproved, investigationalunknownsubstrateDetailsDB01095FluvastatinapprovedunknownsubstrateinhibitorDetailsDB01104SertralineapprovedunknownsubstrateinhibitorDetailsDB01136Carvedilolapproved, investigationalunknownsubstrateDetailsDB01283Lumiracoxibapproved, investigationalunknownsubstrateDetailsDB00969Alosetronapproved, withdrawnnosubstrateDetailsDB00176Fluvoxamineapproved, investigationalnoinhibitorDetailsDB00214TorasemideapprovedunknownsubstrateinhibitorDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinhibitorinducerDetailsDB00412Rosiglitazoneapproved, investigationalunknownsubstrateinhibitorDetailsDB00448Lansoprazoleapproved, investigationalunknowninhibitorinducerDetailsDB00503Ritonavirapproved, investigationalunknowninducerDetailsDB00532Mephenytoinapproved, investigational, withdrawnunknownsubstrateDetailsDB00673Aprepitantapproved, investigationalunknowninhibitorinducerDetailsDB00705DelavirdineapprovedunknowninhibitorDetailsDB01016GlyburideapprovedunknownsubstrateinhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB01118Amiodaroneapproved, investigationalunknowninhibitorDetailsDB01124Tolbutamideapproved, investigationalunknownsubstrateDetailsDB01241GemfibrozilapprovedunknowninhibitorDetailsDB01381Ginkgo bilobaapproved, investigational, nutraceuticalunknowninhibitorDetailsDB01418Acenocoumarolapproved, investigationalunknownsubstrateDetailsDB04856DexloxiglumideinvestigationalunknownsubstrateinhibitorDetailsDB06442AvasimibeinvestigationalunknowninhibitorDetailsDB01098RosuvastatinapprovednosubstrateDetailsDB01065Melatoninapproved, nutraceutical, vet_approvedunknownsubstrateDetailsDB00796Candesartan cilexetilapprovedunknownsubstrateDetailsDB00641SimvastatinapprovedunknowninhibitorDetailsDB01076AtorvastatinapprovednoinhibitorDetailsDB00439Cerivastatinapproved, withdrawnunknowninhibitorDetailsDB01072Atazanavirapproved, investigationalnosubstrateinhibitorDetailsDB01181IfosfamideapprovedunknownsubstrateDetailsDB00619ImatinibapprovednosubstrateinhibitorDetailsDB00468QuinineapprovedunknownsubstrateDetailsDB01142Doxepinapproved, investigationalnosubstrateDetailsDB00321AmitriptylineapprovedunknownsubstrateDetailsDB04557Arachidonic AcidexperimentalunknownsubstrateDetailsDB01045RifampicinapprovedunknowninducerDetailsDB01174Phenobarbitalapproved, investigationalunknownsubstrateinducerDetailsDB00404Alprazolamapproved, illicit, investigationalunknownsubstrateDetailsDB00363ClozapineapprovednosubstrateDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB01357MestranolapprovedunknownsubstrateDetailsDB00788Naproxenapproved, vet_approvedunknownsubstrateDetailsDB00531Cyclophosphamideapproved, investigationalunknownsubstrateDetailsDB01355HexobarbitalexperimentalunknownsubstrateDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00554Piroxicamapproved, investigationalunknownsubstrateDetailsDB00208TiclopidineapprovedunknowninhibitorDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknownsubstrateDetailsDB00715Paroxetineapproved, investigationalunknowninhibitorDetailsDB01435Antipyrineapproved, investigationalunknownsubstrateDetailsDB00177Valsartanapproved, investigationalunknownsubstrateDetailsDB00188Bortezomibapproved, investigationalnosubstrateinhibitorDetailsDB01041Thalidomideapproved, investigational, withdrawnnosubstrateDetailsDB05109Trabectedinapproved, investigationalunknownsubstrateDetailsDB00313Valproic acidapproved, investigationalunknownsubstrateinhibitorDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00238NevirapineapprovedunknowninducerDetailsDB06652VicrivirocinvestigationalunknownsubstrateDetailsDB00972AzelastineapprovedunknownsubstrateinhibitorDetailsDB00568Cinnarizineapproved, investigationalunknownsubstrateDetailsDB04841FlunarizineapprovedunknownsubstrateDetailsDB01075Diphenhydramineapproved, investigationalunknownsubstrateDetailsDB06725Lornoxicamapproved, investigationalunknownsubstrateDetailsDB01039FenofibrateapprovedunknowninhibitorDetailsDB00951Isoniazidapproved, investigationalunknowninhibitorDetailsDB00812Phenylbutazoneapproved, vet_approvedunknownsubstrateinhibitorDetailsDB06729SulfaphenazoleapprovedunknowninhibitorDetailsDB00444TeniposideapprovedunknowninhibitorDetailsDB06414EtravirineapprovedunknownsubstrateinhibitorDetailsDB01320Fosphenytoinapproved, investigationalunknownsubstrateinducerDetailsDB01221Ketamineapproved, vet_approvedunknownsubstrateDetailsDB00359Sulfadiazineapproved, investigational, vet_approvedunknowninhibitorDetailsDB01138SulfinpyrazoneapprovedunknowninhibitorDetailsDB00263Sulfisoxazoleapproved, vet_approvedunknowninhibitorDetailsDB01198ZopicloneapprovedunknownsubstrateDetailsDB00564Carbamazepineapproved, investigationalunknowninducerDetailsDB00794Primidoneapproved, vet_approvedunknownsubstrateinducerDetailsDB01201Rifapentineapproved, investigationalunknowninducerDetailsDB00418Secobarbitalapproved, vet_approvedunknowninducerDetailsDB00625Efavirenzapproved, investigationalunknowninhibitorDetailsDB01097Leflunomideapproved, investigationalunknownsubstrateinhibitorDetailsDB04868Nilotinibapproved, investigationalunknowninhibitorDetailsDB00398Sorafenibapproved, investigationalunknowninhibitorDetailsDB01101Capecitabineapproved, investigationalnodownregulatorDetailsDB00544FluorouracilapprovedunknowninhibitorDetailsDB06268Sitaxentanapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00752Tranylcypromineapproved, investigationalunknowninhibitorDetailsDB01424Aminophenazoneapproved, withdrawnunknownsubstrateDetailsDB00216Eletriptanapproved, investigationalunknownsubstrateDetailsDB00758ClopidogrelapprovednosubstrateinhibitorDetailsDB00843DonepezilapprovedunknownsubstrateDetailsDB00661VerapamilapprovedunknownsubstrateinhibitorDetailsDB00425ZolpidemapprovedunknownsubstrateDetailsDB01036Tolterodineapproved, investigationalunknownsubstrateDetailsDB00328Indomethacinapproved, investigationalunknownsubstrateDetailsDB00936Salicylic acidapproved, investigational, vet_approvedunknownsubstrateDetailsDB01628Etoricoxibapproved, investigationalunknownsubstrateinhibitorDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB00818Propofolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00672Chlorpropamideapproved, investigationalunknownsubstrateDetailsDB01120GliclazideapprovedunknownsubstrateDetailsDB00201CaffeineapprovedunknownsubstrateDetailsDB00514DextromethorphanapprovedunknownsubstrateDetailsDB01009Ketoprofenapproved, vet_approvedunknownsubstrateinhibitorDetailsDB04725LicofeloneinvestigationalunknownsubstrateDetailsDB06737ZaltoprofenexperimentalunknownsubstrateDetailsDB06739SeratrodastexperimentalunknownsubstrateDetailsDB06738KetobemidoneinvestigationalunknownsubstrateDetailsDB06736Aceclofenacapproved, investigationalunknownsubstrateDetailsDB08798SulfamoxoleexperimentalunknowninhibitorDetailsDB06697ArtemetherapprovedunknownsubstrateDetailsDB00945Acetylsalicylic acidapproved, vet_approvedunknownsubstrateDetailsDB00613Amodiaquineapproved, investigationalunknowninhibitorDetailsDB00701Amprenavirapproved, investigationalunknownsubstrateDetailsDB01117AtovaquoneapprovedunknowninhibitorDetailsDB01156BupropionapprovedunknownsubstrateDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00604Cisaprideapproved, investigational, withdrawnunknowninhibitorDetailsDB00257Clotrimazoleapproved, vet_approvedunknowninhibitorDetailsDB01176CyclizineapprovedunknowninhibitorDetailsDB00266DicoumarolapprovedunknownsubstrateDetailsDB00757Dolasetronapproved, investigationalunknownsubstrateDetailsDB00869DorzolamideapprovednosubstrateDetailsDB00668Epinephrineapproved, vet_approvedunknowninhibitorDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00655EstroneapprovedunknownsubstrateDetailsDB00898EthanolapprovedunknowninhibitorDetailsDB01023Felodipineapproved, investigationalunknowninhibitorDetailsDB01195Flecainideapproved, withdrawnunknowninhibitorDetailsDB01544Flunitrazepamapproved, illicitunknownsubstrateDetailsDB00502HaloperidolapprovedunknownsubstrateDetailsDB01159Halothaneapproved, vet_approvedunknownsubstrateDetailsDB01177IdarubicinapprovedunknownsubstrateDetailsDB00281Lidocaineapproved, vet_approvedunknownsubstrateDetailsDB01601LopinavirapprovedunknowninhibitorinducerDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknowninhibitorDetailsDB00333MethadoneapprovedunknownsubstrateDetailsDB01028Methoxyfluraneapproved, investigational, vet_approved, withdrawnunknownsubstrateDetailsDB01171Moclobemideapproved, investigationalunknownsubstrateDetailsDB00745Modafinilapproved, investigationalunknowninhibitorinducerDetailsDB00184NicotineapprovedunknownsubstrateDetailsDB00904Ondansetronapproved, withdrawnunknownsubstrateDetailsDB00850PerphenazineapprovedunknownsubstrateDetailsDB03783PhenacetinwithdrawnunknownsubstrateDetailsDB01411PranlukastinvestigationalnoinhibitorDetailsDB01131ProguanilapprovedunknownsubstrateDetailsDB01069Promethazineapproved, investigationalunknowninhibitorDetailsDB01589Quazepamapproved, illicitnosubstrateDetailsDB00908Quinidineapproved, investigationalunknownsubstrateinhibitorDetailsDB00533Rofecoxibapproved, investigational, withdrawnunknownsubstrateDetailsDB01037Selegilineapproved, investigational, vet_approvedunknownsubstrateDetailsDB06150Sulfadimethoxineapproved, vet_approved, withdrawnunknowninhibitorDetailsDB00576Sulfamethizoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB00891SulfapyridineapprovedunknowninhibitorDetailsDB00231Temazepamapproved, investigationalunknownsubstrateDetailsDB00624Testosteroneapproved, investigationalunknownsubstrateDetailsDB00763MethimazoleapprovedunknowninhibitorDetailsDB00323Tolcaponeapproved, withdrawnnoinhibitorDetailsDB00347TrimethadioneapprovedunknownsubstrateDetailsDB00726TrimipramineapprovedunknownsubstrateDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB04898Ximelagatranapproved, investigational, withdrawnunknownsubstrateDetailsDB00495ZidovudineapprovedunknownsubstrateDetailsDB00755Tretinoinapproved, investigational, nutraceuticalunknownsubstrateDetailsDB01128BicalutamideapprovedunknowninhibitorDetailsDB01129Rabeprazoleapproved, investigationalunknowninhibitorDetailsDB01274Arformoterolapproved, investigationalunknownsubstrateDetailsDB04574Estrone sulfateapprovedunknownsubstrateinhibitorDetailsDB06413Armodafinilapproved, investigationalnoinhibitorDetailsDB00255Diethylstilbestrolapproved, investigational, withdrawnunknowninhibitorDetailsDB00420Promazineapproved, vet_approvedunknownsubstrateDetailsDB06594Agomelatineapproved, investigationalunknowninhibitorDetailsDB04831Tienilic acidwithdrawnunknowninhibitorDetailsDB06174Noscapineapproved, investigationalunknowninhibitorDetailsDB04920Clevidipineapproved, investigationalunknowninhibitorDetailsDB06370IndisulaminvestigationalunknownsubstrateDetailsDB06803Niclosamideapproved, investigational, vet_approvedunknownsubstrateDetailsDB00515CisplatinapprovedunknowninhibitorDetailsDB06820SulconazoleapprovedunknowninhibitorDetailsDB01154Thiamylalapproved, vet_approvedunknownsubstrateDetailsDB08828Vismodegibapproved, investigationalnosubstrateinhibitorDetailsDB00374Treprostinilapproved, investigationalunknownsubstrateDetailsDB06204TapentadolapprovedunknownsubstrateDetailsDB06209PrasugrelapprovednosubstrateDetailsDB08860PitavastatinapprovedunknownsubstrateDetailsDB08875Cabozantinibapproved, investigationalnosubstrateDetailsDB06605ApixabanapprovedunknownsubstrateDetailsDB08896RegorafenibapprovedunknowninhibitorDetailsDB08899EnzalutamideapprovednoinducerDetailsDB04938Ospemifeneapproved, investigationalunknownsubstrateDetailsDB00317Gefitinibapproved, investigationalunknowninhibitorDetailsDB06292DapagliflozinapprovednosubstrateDetailsDB09048Netupitantapproved, investigationalnosubstrateDetailsDB09080OlodaterolapprovednosubstrateDetailsDB09068Vortioxetineapproved, investigationalnosubstrateDetailsDB08439ParecoxibapprovedunknownsubstrateDetailsDB09280LumacaftorapprovednoinhibitorinducerDetailsDB09570Ixazomibapproved, investigationalunknownsubstrateDetailsDB11560Lesinuradapproved, investigationalnosubstrateDetailsDB05812AbirateroneapprovedunknowninhibitorDetailsDB08816TicagrelorapprovedunknowninhibitorinducerDetailsDB09063CeritinibapprovedunknowninhibitorDetailsDB00322FloxuridineapprovedunknowninhibitorDetailsDB05219Crisaboroleapproved, investigationalnoinhibitorDetailsDB06595Midostaurinapproved, investigationalunknowninhibitorinducerDetailsDB05015Belinostatapproved, investigationalunknowninhibitorDetailsDB05541Brivaracetamapproved, investigationalnosubstrateDetailsDB11611LifitegrastapprovednoinhibitorDetailsDB13174RheinexperimentalunknowninhibitorDetailsDB11994Diacereinapproved, investigationalunknowninhibitorDetailsDB03756Doconexentapproved, investigationalunknownsubstrateinhibitorDetailsDB11943Delafloxacinapproved, investigationalunknowninducerDetailsDB01685TopiroxostatexperimentalunknowninhibitorDetailsDB09120Zucapsaicinapproved, investigationalunknowninhibitorDetailsDB09118StiripentolapprovedunknowninhibitorDetailsDB09198LobeglitazoneexperimentalnoinhibitorDetailsDB09167DosulepinapprovedunknowninhibitorDetailsDB11614RupatadineapprovednosubstrateDetailsDB12319Benzbromaroneinvestigational, withdrawnunknowninhibitorDetailsDB09238Manidipineapproved, investigationalunknowninhibitorDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB13919CandesartanexperimentalunknownsubstrateinhibitorDetailsDB12070Letermovirapproved, investigationalnoinducerDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB09061Cannabidiolapproved, investigationalnosubstrateinhibitorDetailsDB13943Testosterone cypionateapprovedunknownsubstrateDetailsDB13944Testosterone enanthateapprovedunknownsubstrateDetailsDB13946Testosterone undecanoateapproved, investigationalunknownsubstrateDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13941Piperaquineapproved, experimental, investigationalunknownsubstrateDetailsDB11901Apalutamideapproved, investigationalnoinducerDetailsDB11633Isavuconazoleapproved, investigationalunknowninhibitorinducerDetailsDB11586Asunaprevirapproved, investigational, withdrawnnosubstrateDetailsDB13975Black cohoshexperimentalnoinhibitorDetailsDB14011NabiximolsinvestigationalnosubstrateDetailsDB14009Medical Cannabisexperimental, investigationalnosubstrateinhibitorinducerDetailsDB13746Bioallethrinapproved, experimentalnosubstrateDetailsDB00486Nabiloneapproved, investigationalnosubstrateinhibitorDetailsDB14033Acetyl sulfisoxazoleapproved, vet_approvedunknowninhibitorDetailsDB11995Avatrombopagapproved, investigationalunknowninducerDetailsDB11672Curcuminapproved, investigationalnoinhibitorDetailsDB00949FelbamateapprovedunknowninhibitorDetailsDB13136Fluindioneapproved, investigationalunknownsubstrateDetailsDB14568Ivosidenibapproved, investigationalunknowninducerDetailsDB12474Lynestrenolapproved, investigationalnosubstrateDetailsDB00615Rifabutinapproved, investigationalnoinducerDetailsDB11753Rifamycinapproved, investigationalnoinhibitorinducerDetailsDB04818IproniazidwithdrawnunknowninhibitorDetailsDB01645GenisteininvestigationalunknowninhibitorDetailsDB09078Lenvatinibapproved, investigationalunknowninhibitorDetailsDB08881VemurafenibapprovedunknowninhibitorDetailsDB00839Tolazamideapproved, investigationalunknownsubstrateDetailsDB00414Acetohexamideapproved, investigational, withdrawnunknownsubstrateDetailsDB01251Gliquidoneapproved, investigationalunknownsubstrateDetailsDB01289GlisoxepideinvestigationalunknownsubstrateDetailsDB08962Glibornurideinvestigational, withdrawnunknownsubstrateDetailsDB13406CarbutamideexperimentalunknownsubstrateDetailsDB13675MetahexamideexperimentalunknownsubstrateDetailsDB08496(R)-warfarinexperimentalunknownsubstrateDetailsDB14055(S)-Warfarinexperimental, investigationalunknownsubstrateDetailsDB00022Peginterferon alfa-2bapprovedunknowninducerDetailsDB04911Oritavancinapproved, investigationalunknowninhibitorDetailsDB06717FosaprepitantapprovedunknowninducerDetailsDB09288PropacetamolexperimentalnosubstrateDetailsDB14635Curcumin sulfateexperimentalnoinhibitorDetailsDB01080VigabatrinapprovedunknowninducerDetailsDB06218LacosamideapprovednosubstrateDetailsDB09213Dexibuprofenapproved, investigationalnosubstrateDetailsDB08912Dabrafenibapproved, investigationalnosubstrateinhibitorinducerDetailsDB00834Mifepristoneapproved, investigationalnoinhibitorDetailsDB00980Ramelteonapproved, investigationalnosubstrateDetailsDB00440Trimethoprimapproved, vet_approvedunknownsubstrateDetailsDB04665CoumarinexperimentalnosubstrateDetailsDB14025ClinafloxacininvestigationalunknowninhibitorDetailsDB06731SeproxetineinvestigationalunknowninhibitorDetailsDB00621Oxandroloneapproved, investigationalunknowninhibitorDetailsDB11963Dacomitinibapproved, investigationalnosubstrateDetailsDB00220NelfinavirapprovednoinducerDetailsDB07615TranilastinvestigationalnosubstrateDetailsDB12245Triclabendazoleapproved, investigationalunknownsubstrateDetailsDB11823Esketamineapproved, investigationalunknownsubstrateDetailsDB00465KetorolacapprovedunknownsubstrateDetailsDB00304DesogestrelapprovednosubstrateDetailsDB00455Loratadineapproved, investigationalunknownsubstrateDetailsDB12371Siponimodapproved, investigationalunknownsubstrateDetailsDB00334Olanzapineapproved, investigationalnoinhibitorDetailsDB12147Erdafitinibapproved, investigationalnosubstrateDetailsDB00476DuloxetineapprovedunknownsubstrateDetailsDB00461NabumetoneapprovednosubstrateDetailsDB12015Alpelisibapproved, investigationalunknowninducerDetailsDB00590DoxazosinapprovedunknownsubstrateDetailsDB01032Probenecidapproved, investigationalunknowninhibitorDetailsDB12978Pexidartinibapproved, investigationalunknowninhibitorDetailsDB11757Istradefyllineapproved, investigationalunknownsubstrateDetailsDB00622Nicardipineapproved, investigationalnoinhibitorDetailsDB01137Levofloxacinapproved, investigationalnoinhibitorDetailsDB08502CapravirineinvestigationalunknownsubstrateDetailsDB01217Anastrozoleapproved, investigationalunknowninhibitorDetailsDB12808Trifaroteneapproved, investigationalunknownsubstrateDetailsDB12001Abemaciclibapproved, investigationalunknowninhibitorDetailsDB15444Elexacaftorapproved, investigationalnoinhibitorDetailsDB14975Voxelotorapproved, investigationalunknownsubstrateDetailsDB00635Prednisoneapproved, vet_approvedunknowninducerDetailsDB00741Hydrocortisoneapproved, vet_approvedunknowninducerDetailsDB01222BudesonideapprovedunknowninducerDetailsDB00959Methylprednisoloneapproved, vet_approvedunknowninducerDetailsDB15328Ubrogepantapproved, investigationalunknowninhibitorDetailsDB15233Avapritinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00983Formoterolapproved, investigationalunknownsubstrateDetailsDB01115NifedipineapprovedunknowninhibitorinducerDetailsDB00957Norgestimateapproved, investigationalunknownsubstrateDetailsDB00977EthinylestradiolapprovedunknownsubstrateDetailsDB12457Rimegepantapproved, investigationalnosubstrateDetailsDB13609UmifenovirinvestigationalunknownsubstrateDetailsDB00443Betamethasoneapproved, vet_approvedunknowninducerDetailsDB09241Methylene blueapproved, investigationalunknowninhibitorDetailsDB11689Selumetinibapproved, investigationalnosubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninducerDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB14881Oliceridineapproved, investigationalunknownsubstrateDetailsDB12499Clascoteroneapproved, investigationalnoinhibitorDetailsDB15822Pralsetinibapproved, investigationalnoinhibitorinducerDetailsDB06448Lonafarnibapproved, investigationalnosubstrateDetailsDB04951Pirfenidoneapproved, investigationalunknownsubstrateinhibitorDetailsDB06137Tirbanibulinapproved, investigationalnoinhibitorDetailsDB11632Opicaponeapproved, investigationalnoinhibitorDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB08864RilpivirineapprovedunknowninhibitorDetailsDB00330EthambutolapprovedunknowninhibitorDetailsDB14989Umbralisibapproved, investigational, withdrawnunknownsubstrateDetailsDB08877RuxolitinibapprovednosubstrateDetailsDB14984Casimersenapproved, investigationalnoinhibitorDetailsDB06237AvanafilapprovedunknownsubstrateDetailsDB04854FebuxostatapprovednosubstrateDetailsDB08995Diosminapproved, investigationalunknowninhibitorDetailsDB08822Azilsartan medoxomilapproved, investigationalnosubstrateDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownDetailsDB15569Sotorasibapproved, investigationalunknowninducerDetailsDB12151Brincidofovirapproved, investigationalnoinhibitorDetailsDB15011Avacopanapproved, investigationalnoinhibitorDetailsDB12597Asciminibapproved, investigationalnoinhibitorDetailsDB08932MacitentanapprovednosubstrateDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB14973Abrocitinibapproved, investigationalnosubstrateDetailsDB16236Mitapivatapproved, investigationalnosubstrateinducerDetailsDB14737Cannabinolexperimental, investigationalunknownsubstrateinhibitorDetailsDB06016Cariprazineapproved, investigationalnoinhibitorDetailsDB14921Mavacamtenapproved, investigationalnosubstrateinducerDetailsDB06083Tapinarofapproved, investigationalnosubstrateDetailsDB15133Tepotinibapproved, investigationalnoinhibitorDetailsDB00285VenlafaxineapprovednosubstrateDetailsDB12095Telotristat ethylapproved, investigationalnoinhibitorDetailsDB15149Futibatinibapproved, investigationalnosubstrateDetailsDB17083LinzagolixapprovednosubstrateDetailsDB11739Vonoprazanapproved, investigationalunknownsubstrateDetailsDB16267Olutasidenibapproved, investigationalnosubstrateinducerDetailsDB02709ResveratrolinvestigationalunknowninhibitorDetailsDB15568Adagrasibapproved, investigationalunknownsubstrateinhibitorDetailsDB17449Anacaulaseapproved, investigationalunknowninhibitorDetailsDB17472Pirtobrutinibapproved, investigationalunknowninhibitorDetailsDB06374Elacestrantapproved, investigationalunknownsubstrateDetailsDB00349Clobazamapproved, illicitnoinhibitorDetailsDB12548Sparsentanapproved, investigationalunknowninducerDetailsDB00381AmlodipineapprovednoinhibitorDetailsDB00862VardenafilapprovedunknownsubstrateinhibitorDetailsDB08820IvacaftorapprovednoinhibitorDetailsDB11712Tezacaftorapproved, investigationalnoDetailsDB01194BrinzolamideapprovedunknownsubstrateDetailsDB15669Fezolinetantapproved, investigationalnosubstrateDetailsDB12255Vadadustatapproved, investigationalunknowninhibitorDetailsDB14924Ritlecitinibapproved, investigationalunknownsubstrateDetailsDB11763Momelotinibapproved, investigationalunknownsubstrateDetailsDB14766EtrasimodapprovednosubstrateDetailsDB11718Encorafenibapproved, investigationalnoinhibitorinducerDetailsDB16826RepotrectinibinvestigationalnoinducerDetailsDB11679FruquintinibinvestigationalnosubstrateDetails"
                    }
                },
                {
                    "Label": "Cytochrome P450 2C19",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 2C19",
                        "Synonyms": "(R)-limonene 6-monooxygenase\n(S)-limonene 6-monooxygenase\n(S)-limonene 7-monooxygenase\n1.14.13.-\nCYPIIC17\nCYPIIC19\nCytochrome P450-11A\nCytochrome P450-254C\nMephenytoin 4-hydroxylase",
                        "Gene Name": "CYP2C19",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0020694|Cytochrome P450 2C19\nMDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDVSKSLTNLSKI\nYGPVFTLYFGLERMVVLHGYEVVKEALIDLGEEFSGRGHFPLAERANRGFGIVFSNGKRW\nKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICS\nIIFQKRFDYKDQQFLNLMEKLNENIRIVSTPWIQICNNFPTIIDYFPGTHNKLLKNLAFM\nESDILEKVKEHQESMDINNPRDFIDCFLIKMEKEKQNQQSEFTIENLVITAADLLGAGTE\nTTSTTLRYALLLLLKHPEVTAKVQEEIERVVGRNRSPCMQDRGHMPYTDAVVHEVQRYID\nLIPTSLPHAVTCDVKFRNYLIPKGTTILTSLTSVLHDNKEFPNPEMFDPRHFLDEGGNFK\nKSNYFMPFSAGKRICVGEGLARMELFLFLTFILQNFNLKSLIDPKDLDTTPVVNGFASVP\nPFYQLCFIPV",
                        "Number of residues": "490",
                        "Molecular Weight": "55930.545",
                        "Theoretical pI": "7.42",
                        "GO Classification": "Functions(R)-limonene 6-monooxygenase activity / (S)-limonene 6-monooxygenase activity / (S)-limonene 7-monooxygenase activity / arachidonic acid epoxygenase activity / enzyme binding / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity / oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen / oxygen binding / steroid hydroxylase activityProcessesarachidonic acid metabolic process / drug metabolic process / epoxygenase P450 pathway / exogenous drug catabolic process / heterocycle metabolic process / monoterpenoid metabolic process / omega-hydroxylase P450 pathway / oxidation-reduction process / small molecule metabolic process / steroid metabolic process / xenobiotic metabolic processComponentscytoplasm / endoplasmic reticulum membrane / intracellular membrane-bounded organelle",
                        "General Function": "Steroid hydroxylase activity",
                        "Specific Function": "Responsible for the metabolism of a number of therapeutic agents such as the anticonvulsant drug S-mephenytoin, omeprazole, proguanil, certain barbiturates, diazepam, propranolol, citalopram and imipramine.",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0020695|Cytochrome P450 2C19 (CYP2C19)\nATGGATCCTTTTGTGGTCCTTGTGCTCTGTCTCTCATGTTTGCTTCTCCTTTCAATCTGG\nAGACAGAGCTCTGGGAGAGGAAAACTCCCTCCTGGCCCCACTCCTCTCCCAGTGATTGGA\nAATATCCTACAGATAGATATTAAGGATGTCAGCAAATCCTTAACCAATCTCTCAAAAATC\nTATGGCCCTGTGTTCACTCTGTATTTTGGCCTGGAACGCATGGTGGTGCTGCATGGATAT\nGAAGTGGTGAAGGAAGCCCTGATTGATCTTGGAGAGGAGTTTTCTGGAAGAGGCCATTTC\nCCACTGGCTGAAAGAGCTAACAGAGGATTTGGAATCGTTTTCAGCAATGGAAAGAGATGG\nAAGGAGATCCGGCGTTTCTCCCTCATGACGCTGCGGAATTTTGGGATGGGGAAGAGGAGC\nATTGAGGACCGTGTTCAAGAGGAAGCCCGCTGCCTTGTGGAGGAGTTGAGAAAAACCAAG\nGCTTCACCCTGTGATCCCACTTTCATCCTGGGCTGTGCTCCCTGCAATGTGATCTGCTCC\nATTATTTTCCAGAAACGTTTCGATTATAAAGATCAGCAATTTCTTAACTTGATGGAAAAA\nTTGAATGAAAACATCAGGATTGTAAGCACCCCCTGGATCCAGATATGCAATAATTTTCCC\nACTATCATTGATTATTTCCCGGGAACCCATAACAAATTACTTAAAAACCTTGCTTTTATG\nGAAAGTGATATTTTGGAGAAAGTAAAAGAACACCAAGAATCGATGGACATCAACAACCCT\nCGGGACTTTATTGATTGCTTCCTGATCAAAATGGAGAAGGAAAAGCAAAACCAACAGTCT\nGAATTCACTATTGAAAACTTGGTAATCACTGCAGCTGACTTACTTGGAGCTGGGACAGAG\nACAACAAGCACAACCCTGAGATATGCTCTCCTTCTCCTGCTGAAGCACCCAGAGGTCACA\nGCTAAAGTCCAGGAAGAGATTGAACGTGTCATTGGCAGAAACCGGAGCCCCTGCATGCAG\nGACAGGGGCCACATGCCCTACACAGATGCTGTGGTGCACGAGGTCCAGAGATACATCGAC\nCTCATCCCCACCAGCCTGCCCCATGCAGTGACCTGTGACGTTAAATTCAGAAACTACCTC\nATTCCCAAGGGCACAACCATATTAACTTCCCTCACTTCTGTGCTACATGACAACAAAGAA\nTTTCCCAACCCAGAGATGTTTGACCCTCGTCACTTTCTGGATGAAGGTGGAAATTTTAAG\nAAAAGTAACTACTTCATGCCTTTCTCAGCAGGAAAACGGATTTGTGTGGGAGAGGGCCTG\nGCCCGCATGGAGCTGTTTTTATTCCTGACCTTCATTTTACAGAACTTTAACCTGAAATCT\nCTGATTGACCCAAAGGACCTTGACACAACTCCTGTTGTCAATGGATTTGCTTCTGTCCCG\nCCCTTCTATCAGCTGTGCTTCATTCCTGTCTGA",
                        "Chromosome Location": "10",
                        "Locus": "10q24.1-q24.3",
                        "External Identifiers": "ResourceLinkUniProtKB IDP33261UniProtKB Entry NameCP2CJ_HUMANGenBank Protein ID181344GenBank Gene IDM61854HGNC IDHGNC:2621",
                        "General References": "Romkes M, Faletto MB, Blaisdell JA, Raucy JL, Goldstein JA: Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. Biochemistry. 1991 Apr 2;30(13):3247-55. [Article] Romkes M, Faletto MB, Blaisdell JA, Raucy JL, Goldstein JA: Cloning and expression of complementary DNAs for multiple members of the human cytochrome PH50IIC subfamily. Biochemistry. 1993 Feb 9;32(5):1390. [Article] Deloukas P, Earthrowl ME, Grafham DV, Rubenfield M, French L, Steward CA, Sims SK, Jones MC, Searle S, Scott C, Howe K, Hunt SE, Andrews TD, Gilbert JG, Swarbreck D, Ashurst JL, Taylor A, Battles J, Bird CP, Ainscough R, Almeida JP, Ashwell RI, Ambrose KD, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Bates K, Beasley H, Bray-Allen S, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Cahill P, Camire D, Carter NP, Chapman JC, Clark SY, Clarke G, Clee CM, Clegg S, Corby N, Coulson A, Dhami P, Dutta I, Dunn M, Faulkner L, Frankish A, Frankland JA, Garner P, Garnett J, Gribble S, Griffiths C, Grocock R, Gustafson E, Hammond S, Harley JL, Hart E, Heath PD, Ho TP, Hopkins B, Horne J, Howden PJ, Huckle E, Hynds C, Johnson C, Johnson D, Kana A, Kay M, Kimberley AM, Kershaw JK, Kokkinaki M, Laird GK, Lawlor S, Lee HM, Leongamornlert DA, Laird G, Lloyd C, Lloyd DM, Loveland J, Lovell J, McLaren S, McLay KE, McMurray A, Mashreghi-Mohammadi M, Matthews L, Milne S, Nickerson T, Nguyen M, Overton-Larty E, Palmer SA, Pearce AV, Peck AI, Pelan S, Phillimore B, Porter K, Rice CM, Rogosin A, Ross MT, Sarafidou T, Sehra HK, Shownkeen R, Skuce CD, Smith M, Standring L, Sycamore N, Tester J, Thorpe A, Torcasso W, Tracey A, Tromans A, Tsolas J, Wall M, Walsh J, Wang H, Weinstock K, West AP, Willey DL, Whitehead SL, Wilming L, Wray PW, Young L, Chen Y, Lovering RC, Moschonas NK, Siebert R, Fechtel K, Bentley D, Durbin R, Hubbard T, Doucette-Stamm L, Beck S, Smith DR, Rogers J: The DNA sequence and comparative analysis of human chromosome 10. Nature. 2004 May 27;429(6990):375-81. [Article] Wrighton SA, Stevens JC, Becker GW, VandenBranden M: Isolation and characterization of human liver cytochrome P450 2C19: correlation between 2C19 and S-mephenytoin 4'-hydroxylation. Arch Biochem Biophys. 1993 Oct;306(1):240-5. [Article] Miyazawa M, Shindo M, Shimada T: Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes. Drug Metab Dispos. 2002 May;30(5):602-7. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Reynald RL, Sansen S, Stout CD, Johnson EF: Structural characterization of human cytochrome P450 2C19: active site differences between P450s 2C8, 2C9, and 2C19. J Biol Chem. 2012 Dec 28;287(53):44581-91. doi: 10.1074/jbc.M112.424895. Epub 2012 Nov 1. [Article] de Morais SM, Wilkinson GR, Blaisdell J, Nakamura K, Meyer UA, Goldstein JA: The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J Biol Chem. 1994 Jun 3;269(22):15419-22. [Article] De Morais SM, Wilkinson GR, Blaisdell J, Meyer UA, Nakamura K, Goldstein JA: Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Mol Pharmacol. 1994 Oct;46(4):594-8. [Article] Xiao ZS, Goldstein JA, Xie HG, Blaisdell J, Wang W, Jiang CH, Yan FX, He N, Huang SL, Xu ZH, Zhou HH: Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele. J Pharmacol Exp Ther. 1997 Apr;281(1):604-9. [Article] Ibeanu GC, Goldstein JA, Meyer U, Benhamou S, Bouchardy C, Dayer P, Ghanayem BI, Blaisdell J: Identification of new human CYP2C19 alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian poor metabolizer of mephenytoin. J Pharmacol Exp Ther. 1998 Sep;286(3):1490-5. [Article] Ibeanu GC, Blaisdell J, Ghanayem BI, Beyeler C, Benhamou S, Bouchardy C, Wilkinson GR, Dayer P, Daly AK, Goldstein JA: An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in Caucasians. Pharmacogenetics. 1998 Apr;8(2):129-35. [Article] Ibeanu GC, Blaisdell J, Ferguson RJ, Ghanayem BI, Brosen K, Benhamou S, Bouchardy C, Wilkinson GR, Dayer P, Goldstein JA: A novel transversion in the intron 5 donor splice junction of CYP2C19 and a sequence polymorphism in exon 3 contribute to the poor metabolizer phenotype for the anticonvulsant drug S-mephenytoin. J Pharmacol Exp Ther. 1999 Aug;290(2):635-40. [Article] Blaisdell J, Mohrenweiser H, Jackson J, Ferguson S, Coulter S, Chanas B, Xi T, Ghanayem B, Goldstein JA: Identification and functional characterization of new potentially defective alleles of human CYP2C19. Pharmacogenetics. 2002 Dec;12(9):703-11. [Article] Morita J, Kobayashi K, Wanibuchi A, Kimura M, Irie S, Ishizaki T, Chiba K: A novel single nucleotide polymorphism (SNP) of the CYP2C19 gene in a Japanese subject with lowered capacity of mephobarbital 4'-hydroxylation. Drug Metab Pharmacokinet. 2004 Jun;19(3):236-8. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article] Fukushima-Uesaka H, Saito Y, Maekawa K, Ozawa S, Hasegawa R, Kajio H, Kuzuya N, Yasuda K, Kawamoto M, Kamatani N, Suzuki K, Yanagawa T, Tohkin M, Sawada J: Genetic variations and haplotypes of CYP2C19 in a Japanese population. Drug Metab Pharmacokinet. 2005 Aug;20(4):300-7. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00188Bortezomibapproved, investigationalnosubstrateinhibitorDetailsDB00213PantoprazoleapprovedunknownsubstrateinhibitorDetailsDB00215CitalopramapprovednosubstrateinhibitorDetailsDB00220NelfinavirapprovednosubstrateinducerDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinducerDetailsDB00273TopiramateapprovedunknowninhibitorDetailsDB00328Indomethacinapproved, investigationalunknownsubstrateinhibitorDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00349Clobazamapproved, illicitnosubstrateDetailsDB00395CarisoprodolapprovedunknownsubstrateDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00420Promazineapproved, vet_approvedunknownsubstrateDetailsDB00444TeniposideapprovedunknownsubstrateDetailsDB00448Lansoprazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00546AdinazolamexperimentalunknownsubstrateDetailsDB00582VoriconazoleapprovedunknownsubstrateinhibitorDetailsDB00665Nilutamideapproved, investigationalunknownsubstrateinhibitorDetailsDB00679Thioridazineapproved, withdrawnunknownsubstrateDetailsDB00736Esomeprazoleapproved, investigationalnosubstrateinhibitorDetailsDB00738Pentamidineapproved, investigationalunknownsubstrateDetailsDB00794Primidoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00849MethylphenobarbitalapprovedunknownsubstrateDetailsDB00949FelbamateapprovedunknowninhibitorDetailsDB01018Guanfacineapproved, investigationalunknownsubstrateDetailsDB01104SertralineapprovedunknownsubstrateinhibitorDetailsDB01124Tolbutamideapproved, investigationalunknownsubstrateDetailsDB01129Rabeprazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB01131ProguanilapprovedunknownsubstrateDetailsDB01166Cilostazolapproved, investigationalunknownsubstrateDetailsDB01171Moclobemideapproved, investigationalunknownsubstrateinhibitorDetailsDB01174Phenobarbitalapproved, investigationalunknownsubstrateinducerDetailsDB01274Arformoterolapproved, investigationalunknownsubstrateDetailsDB01320Fosphenytoinapproved, investigationalunknownsubstrateDetailsDB01544Flunitrazepamapproved, illicitunknownsubstrateDetailsDB00176Fluvoxamineapproved, investigationalnoinhibitorDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknowninhibitorDetailsDB00208TiclopidineapprovedunknownsubstrateinhibitorDetailsDB00321AmitriptylineapprovedunknownsubstrateinhibitorDetailsDB00343Diltiazemapproved, investigationalunknownsubstrateDetailsDB00455Loratadineapproved, investigationalnosubstrateinhibitorDetailsDB00458ImipramineapprovedunknownsubstrateinhibitorDetailsDB00503Ritonavirapproved, investigationalnoinducerDetailsDB00532Mephenytoinapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknownsubstrateDetailsDB00622Nicardipineapproved, investigationalunknowninhibitorDetailsDB00625Efavirenzapproved, investigationalunknowninducerDetailsDB00745Modafinilapproved, investigationalunknowninhibitorDetailsDB00752Tranylcypromineapproved, investigationalunknowninhibitorDetailsDB00776OxcarbazepineapprovedunknowninhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB01041Thalidomideapproved, investigational, withdrawnnosubstrateinhibitorDetailsDB01424Aminophenazoneapproved, withdrawnunknownsubstrateDetailsDB00333MethadoneapprovedunknownsubstrateDetailsDB06442AvasimibeinvestigationalunknowninhibitorDetailsDB01065Melatoninapproved, nutraceutical, vet_approvedunknownsubstrateDetailsDB01076AtorvastatinapprovednoinhibitorDetailsDB01095FluvastatinapprovedunknowninhibitorDetailsDB00196Fluconazoleapproved, investigationalunknowninhibitorDetailsDB00619ImatinibapprovednosubstrateDetailsDB00468QuinineapprovedunknownsubstrateinhibitorDetailsDB01142Doxepinapproved, investigationalnosubstrateDetailsDB01435Antipyrineapproved, investigationalunknownsubstrateDetailsDB00250Dapsoneapproved, investigationalunknownsubstrateDetailsDB00675TamoxifenapprovedunknownsubstrateDetailsDB05109Trabectedinapproved, investigationalunknownsubstrateDetailsDB01418Acenocoumarolapproved, investigationalunknownsubstrateDetailsDB00682WarfarinapprovedunknownsubstrateinhibitorDetailsDB00540NortriptylineapprovedunknownsubstrateDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00972AzelastineapprovedunknownsubstrateinhibitorDetailsDB01075Diphenhydramineapproved, investigationalunknownsubstrateDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00446Chloramphenicolapproved, vet_approved, withdrawnunknowninhibitorDetailsDB01242Clomipramineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00758ClopidogrelapprovednosubstrateDetailsDB00531Cyclophosphamideapproved, investigationalunknownsubstrateDetailsDB01355HexobarbitalexperimentalunknownsubstrateDetailsDB00571Propranololapproved, investigationalunknownsubstrateDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00472Fluoxetineapproved, vet_approvedunknownsubstrateinhibitorDetailsDB06403Ambrisentanapproved, investigationalunknownsubstrateDetailsDB01175EscitalopramapprovednosubstrateDetailsDB06414EtravirineapprovedunknownsubstrateinhibitorDetailsDB01181IfosfamideapprovedunknownsubstrateDetailsDB05246MethsuximideapprovedunknownsubstrateinhibitorDetailsDB00726TrimipramineapprovedunknownsubstrateDetailsDB00357Aminoglutethimideapproved, investigationalunknowninducerDetailsDB00564Carbamazepineapproved, investigationalunknowninhibitorinducerDetailsDB01601LopinavirapprovedunknowninhibitorDetailsDB01045RifampicinapprovedunknowninducerDetailsDB06413Armodafinilapproved, investigationalunknowninhibitorDetailsDB00705DelavirdineapprovedunknowninhibitorDetailsDB01241GemfibrozilapprovedunknowninhibitorDetailsDB00951Isoniazidapproved, investigationalunknowninhibitorDetailsDB06268Sitaxentanapproved, investigational, withdrawnunknowninhibitorDetailsDB00216Eletriptanapproved, investigationalunknownsubstrateDetailsDB00363ClozapineapprovednosubstrateinhibitorDetailsDB00425ZolpidemapprovedunknownsubstrateDetailsDB01036Tolterodineapproved, investigationalunknownsubstrateDetailsDB01283Lumiracoxibapproved, investigationalunknownsubstrateDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateinhibitorDetailsDB00672Chlorpropamideapproved, investigationalunknownsubstrateDetailsDB01120GliclazideapprovedunknownsubstrateDetailsDB01016GlyburideapprovedunknownsubstrateDetailsDB06739SeratrodastexperimentalunknownsubstrateDetailsDB06697ArtemetherapprovedunknownsubstrateinducerDetailsDB00945Acetylsalicylic acidapproved, vet_approvedunknowninducerDetailsDB01118Amiodaroneapproved, investigationalunknownsubstrateinhibitorDetailsDB00701Amprenavirapproved, investigationalunknowninhibitorDetailsDB00673Aprepitantapproved, investigationalunknownsubstrateinhibitorDetailsDB00289AtomoxetineapprovedunknownsubstrateDetailsDB01558Bromazepamapproved, illicit, investigationalunknownsubstrateDetailsDB00297Bupivacaineapproved, investigationalunknownsubstrateDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknowninhibitorDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknowninhibitorDetailsDB00604Cisaprideapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB06470ClomethiazoleinvestigationalunknownsubstrateDetailsDB01559Clotiazepamapproved, illicitunknownsubstrateDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknowninducerDetailsDB00514DextromethorphanapprovedunknownsubstrateDetailsDB01093Dimethyl sulfoxideapproved, vet_approvedunknowninhibitorDetailsDB00590DoxazosinapprovedunknownsubstrateDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00898EthanolapprovedunknowninhibitorDetailsDB01628Etoricoxibapproved, investigationalunknowninhibitorDetailsDB00502HaloperidolapprovedunknownsubstrateDetailsDB01050IbuprofenapprovedunknownsubstrateDetailsDB06738KetobemidoneinvestigationalunknownsubstrateDetailsDB00678LosartanapprovedunknowninhibitorDetailsDB01043Memantineapproved, investigationalunknowninhibitorDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB00184NicotineapprovedunknownsubstrateDetailsDB06712Nilvadipineapproved, investigationalunknowninhibitorDetailsDB00717NorethisteroneapprovedunknownsubstrateinducerDetailsDB00334Olanzapineapproved, investigationalunknowninhibitorDetailsDB00312Pentobarbitalapproved, investigational, vet_approvedunknownsubstrateDetailsDB00850PerphenazineapprovedunknownsubstrateDetailsDB00454MeperidineapprovedunknownsubstrateDetailsDB03783PhenacetinwithdrawnunknownsubstrateDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB01058Praziquantelapproved, investigational, vet_approvedunknownsubstrateDetailsDB00635Prednisoneapproved, vet_approvedunknowninducerDetailsDB00818Propofolapproved, investigational, vet_approvedunknownsubstrateDetailsDB01589Quazepamapproved, illicitnosubstrateDetailsDB01224QuetiapineapprovedunknownsubstrateDetailsDB01037Selegilineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00966Telmisartanapproved, investigationalunknowninhibitorDetailsDB00624Testosteroneapproved, investigationalunknownsubstrateDetailsDB00763MethimazoleapprovedunknowninhibitorDetailsDB00373TimololapprovedunknownsubstrateDetailsDB01007TioconazoleapprovedunknowninhibitorDetailsDB00347TrimethadioneapprovedunknownsubstrateDetailsDB00313Valproic acidapproved, investigationalunknownsubstrateinhibitorDetailsDB00661VerapamilapprovedunknownsubstrateDetailsDB00549Zafirlukastapproved, investigationalunknowninhibitorDetailsDB00909Zonisamideapproved, investigationalunknownsubstrateinhibitorDetailsDB00398Sorafenibapproved, investigationalunknowninhibitorDetailsDB00932Tipranavirapproved, investigationalunknownsubstrateinhibitorDetailsDB00980Ramelteonapproved, investigationalunknownsubstrateDetailsDB01128BicalutamideapprovedunknowninhibitorDetailsDB01259Lapatinibapproved, investigationalunknownsubstrateDetailsDB01621Pipotiazineapproved, investigationalunknownsubstrateDetailsDB00918Almotriptanapproved, investigationalunknownsubstrateDetailsDB04920Clevidipineapproved, investigationalunknowninhibitorDetailsDB00109Enfuvirtideapproved, investigationalunknownsubstrateDetailsDB00239OxiconazoleapprovedunknownsubstrateDetailsDB06204TapentadolapprovedunknownsubstrateDetailsDB06209PrasugrelapprovednosubstrateDetailsDB04871Lorcaserinapproved, withdrawnnosubstrateDetailsDB08864RilpivirineapprovedunknownsubstrateinhibitorDetailsDB06605ApixabanapprovedunknownsubstrateDetailsDB06626Axitinibapproved, investigationalnosubstrateDetailsDB08828Vismodegibapproved, investigationalunknowninhibitorDetailsDB08899EnzalutamideapprovednoinducerDetailsDB08895Tofacitinibapproved, investigationalnosubstrateDetailsDB04938Ospemifeneapproved, investigationalunknownsubstrateDetailsDB00317Gefitinibapproved, investigationalunknowninhibitorDetailsDB08918Levomilnacipranapproved, investigationalunknownsubstrateDetailsDB08932MacitentanapprovednosubstrateDetailsDB08933LuliconazoleapprovednoinhibitorDetailsDB09049NaloxegolapprovedunknowninhibitorDetailsDB00951Isoniazidapproved, investigationalunknownDetailsDB09054IdelalisibapprovednoinhibitorDetailsDB09068Vortioxetineapproved, investigationalnosubstrateDetailsDB09280LumacaftorapprovednoinducerDetailsDB09570Ixazomibapproved, investigationalunknownsubstrateDetailsDB06176Romidepsinapproved, investigationalunknownsubstrateDetailsDB09119Eslicarbazepine acetateapprovednoinhibitorDetailsDB06789Hydroxyprogesterone caproateapproved, investigationalunknowninducerDetailsDB05812AbirateroneapprovedunknowninhibitorDetailsDB09118StiripentolapprovedunknownsubstrateinhibitorDetailsDB06595Midostaurinapproved, investigationalunknowninhibitorinducerDetailsDB05541Brivaracetamapproved, investigationalnosubstrateDetailsDB05351Dexlansoprazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB01685TopiroxostatexperimentalunknowninhibitorDetailsDB09120Zucapsaicinapproved, investigationalunknowninhibitorDetailsDB09198LobeglitazoneexperimentalnoinhibitorDetailsDB09167DosulepinapprovedunknowninhibitorDetailsDB09166EtizolamexperimentalunknownsubstrateDetailsDB11614RupatadineapprovednosubstrateDetailsDB12319Benzbromaroneinvestigational, withdrawnunknowninhibitorDetailsDB09238Manidipineapproved, investigationalunknowninhibitorDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB12070Letermovirapproved, investigationalnoinducerDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB09061Cannabidiolapproved, investigationalunknownsubstrateinhibitorDetailsDB13943Testosterone cypionateapprovedunknownsubstrateDetailsDB13944Testosterone enanthateapprovedunknownsubstrateDetailsDB13946Testosterone undecanoateapproved, investigationalunknownsubstrateDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateDetailsDB11638Artenimolapproved, experimental, investigationalunknowninhibitorDetailsDB13941Piperaquineapproved, experimental, investigationalunknownsubstrateinhibitorDetailsDB11901Apalutamideapproved, investigationalnoinducerDetailsDB11633Isavuconazoleapproved, investigationalunknowninhibitorDetailsDB11586Asunaprevirapproved, investigational, withdrawnnosubstrateDetailsDB14011NabiximolsinvestigationalunknownsubstrateDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorDetailsDB11632Opicaponeapproved, investigationalnoinducerDetailsDB13746Bioallethrinapproved, experimentalnosubstrateDetailsDB04948Lofexidineapproved, investigationalnosubstrateDetailsDB00598LabetalolapprovedunknownsubstrateDetailsDB11967Binimetinibapproved, investigationalnosubstrateDetailsDB11718Encorafenibapproved, investigationalnosubstrateDetailsDB12474Lynestrenolapproved, investigationalnosubstrateinhibitorDetailsDB00615Rifabutinapproved, investigationalnoinducerDetailsDB01201Rifapentineapproved, investigationalnoinducerDetailsDB01220Rifaximinapproved, investigationalnoinducerDetailsDB11753Rifamycinapproved, investigationalnoinhibitorDetailsDB01483BarbitalillicitnosubstrateinducerDetailsDB00418Secobarbitalapproved, vet_approvednoinducerDetailsDB00599Thiopentalapproved, vet_approvednosubstrateDetailsDB06654Safinamideapproved, investigationalunknowninhibitorDetailsDB09078Lenvatinibapproved, investigationalunknowninhibitorDetailsDB05928DovitinibinvestigationalunknowninhibitorDetailsDB08496(R)-warfarinexperimentalunknownsubstrateDetailsDB14055(S)-Warfarinexperimental, investigationalunknownsubstrateDetailsDB04911Oritavancinapproved, investigationalunknowninhibitorDetailsDB06218LacosamideapprovedunknownsubstrateDetailsDB13762DexrabeprazoleexperimentalunknownsubstrateDetailsDB12319Benzbromaroneinvestigational, withdrawnunknowninhibitorDetailsDB09213Dexibuprofenapproved, investigationalunknownsubstrateDetailsDB00518Albendazoleapproved, vet_approvednosubstrateDetailsDB14025ClinafloxacininvestigationalunknowninhibitorDetailsDB06731SeproxetineinvestigationalunknowninhibitorDetailsDB14575EslicarbazepineapprovedunknowninhibitorDetailsDB01323St. John's Wortapproved, investigational, nutraceuticalnosubstrateinducerDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateDetailsDB12245Triclabendazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB11823Esketamineapproved, investigationalunknownsubstrateDetailsDB06684VilazodoneapprovedunknownsubstrateDetailsDB12015Alpelisibapproved, investigationalunknowninhibitorDetailsDB00977EthinylestradiolapprovedunknowninhibitorDetailsDB06730GestodeneinvestigationalunknowninhibitorDetailsDB00641SimvastatinapprovedunknownsubstrateDetailsDB00227Lovastatinapproved, investigationalunknownsubstrateDetailsDB00715Paroxetineapproved, investigationalunknownsubstrateDetailsDB00956Hydrocodoneapproved, illicit, investigationalunknownsubstrateDetailsDB04861Nebivololapproved, investigationalunknownsubstrateDetailsDB12500Fedratinibapproved, investigationalunknownsubstrateDetailsDB08502CapravirineinvestigationalunknownsubstrateDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB01039FenofibrateapprovedunknowninhibitorDetailsDB15444Elexacaftorapproved, investigationalnoinhibitorDetailsDB14975Voxelotorapproved, investigationalunknownsubstrateDetailsDB00741Hydrocortisoneapproved, vet_approvedunknowninducerDetailsDB06119Cenobamateapproved, investigationalunknownsubstrateinhibitorDetailsDB01222BudesonideapprovedunknowninducerDetailsDB00959Methylprednisoloneapproved, vet_approvedunknowninducerDetailsDB15328Ubrogepantapproved, investigationalunknowninhibitorDetailsDB00983Formoterolapproved, investigationalunknownsubstrateDetailsDB01006Letrozoleapproved, investigationalunknowninhibitorDetailsDB11837Osilodrostatapproved, investigationalunknowninhibitorDetailsDB00443Betamethasoneapproved, vet_approvedunknowninducerDetailsDB09241Methylene blueapproved, investigationalunknownsubstrateinhibitorDetailsDB11689Selumetinibapproved, investigationalnosubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninducerDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknowninducerDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB14881Oliceridineapproved, investigationalunknownsubstrateDetailsDB12499Clascoteroneapproved, investigationalnoinhibitorDetailsDB15093Somapacitanapproved, investigationalunknowninhibitorDetailsDB06448Lonafarnibapproved, investigationalnosubstrateinhibitorDetailsDB04951Pirfenidoneapproved, investigationalunknownsubstrateinhibitorDetailsDB06137Tirbanibulinapproved, investigationalnoinhibitorDetailsDB00935Oxymetazolineapproved, investigationalnosubstrateDetailsDB08912Dabrafenibapproved, investigationalnosubstrateinhibitorinducerDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB00476DuloxetineapprovedunknowninhibitorDetailsDB00052Somatotropinapproved, investigationalunknowninhibitorDetailsDB00330EthambutolapprovedunknowninhibitorDetailsDB14984Casimersenapproved, investigationalnoinhibitorDetailsDB01086Benzocaineapproved, investigationalunknownsubstrateDetailsDB08896RegorafenibapprovedunknowninhibitorDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownsubstrateDetailsDB05271RotigotineapprovednoinhibitorDetailsDB01183Naloxoneapproved, vet_approvedunknownsubstrateDetailsDB12543Samidorphanapproved, investigationalnosubstrateDetailsDB12151Brincidofovirapproved, investigationalnoinhibitorDetailsDB16703Belumosudilapproved, investigationalnoinhibitorDetailsDB15463Belzutifanapproved, investigationalnosubstrateDetailsDB12265Fexinidazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB16220Lonapegsomatropinapproved, investigationalunknowninhibitorDetailsDB16349VicagrelinvestigationalunknownsubstrateDetailsDB12597Asciminibapproved, investigationalnoinhibitorDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB14973Abrocitinibapproved, investigationalnosubstrateDetailsDB05467Palovaroteneapproved, investigationalnosubstrateDetailsDB16236Mitapivatapproved, investigationalnoinducerDetailsDB12834SecnidazoleapprovedunknowninhibitorDetailsDB00470Dronabinolapproved, illicitnosubstrateinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknownsubstrateDetailsDB11697Pacritinibapproved, investigationalnoinhibitorDetailsDB05087Ganaxoloneapproved, investigationalnosubstrateDetailsDB06016Cariprazineapproved, investigationalnoinhibitorDetailsDB14921Mavacamtenapproved, investigationalnosubstrateinducerDetailsDB12020Tecovirimatapproved, investigationalnoinhibitorDetailsDB06083Tapinarofapproved, investigationalnosubstrateDetailsDB00285VenlafaxineapprovednosubstrateDetailsDB12095Telotristat ethylapproved, investigationalnoinhibitorDetailsDB11739Vonoprazanapproved, investigationalunknownsubstrateinhibitorDetailsDB16267Olutasidenibapproved, investigationalnosubstrateDetailsDB02709ResveratrolinvestigationalnoinhibitorDetailsDB17472Pirtobrutinibapproved, investigationalunknowninhibitorinducerDetailsDB12548Sparsentanapproved, investigationalunknowninducerDetailsDB00381AmlodipineapprovednoinhibitorDetailsDB00862VardenafilapprovedunknowninhibitorDetailsDB11712Tezacaftorapproved, investigationalnoinhibitorDetailsDB15669Fezolinetantapproved, investigationalnosubstrateDetailsDB06700Desvenlafaxineapproved, investigationalnosubstrateDetailsDB11763Momelotinibapproved, investigationalunknownsubstrateDetailsDB14766EtrasimodapprovednosubstrateDetailsDB16826RepotrectinibinvestigationalnoinducerDetailsDB11679FruquintinibinvestigationalnosubstrateDetails"
                    }
                },
                {
                    "Label": "Cytochrome P450 2B6",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 2B6",
                        "Synonyms": "1,4-cineole 2-exo-monooxygenase\n1.14.13.-\nCYPIIB6\nCytochrome P450 IIB1",
                        "Gene Name": "CYP2B6",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0006839|Cytochrome P450 2B6\nMELSVLLFLALLTGLLLLLVQRHPNTHDRLPPGPRPLPLLGNLLQMDRRGLLKSFLRFRE\nKYGDVFTVHLGPRPVVMLCGVEAIREALVDKAEAFSGRGKIAMVDPFFRGYGVIFANGNR\nWKVLRRFSVTTMRDFGMGKRSVEERIQEEAQCLIEELRKSKGALMDPTFLFQSITANIIC\nSIVFGKRFHYQDQEFLKMLNLFYQTFSLISSVFGQLFELFSGFLKYFPGAHRQVYKNLQE\nINAYIGHSVEKHRETLDPSAPKDLIDTYLLHMEKEKSNAHSEFSHQNLNLNTLSLFFAGT\nETTSTTLRYGFLLMLKYPHVAERVYREIEQVIGPHRPPELHDRAKMPYTEAVIYEIQRFS\nDLLPMGVPHIVTQHTSFRGYIIPKDTEVFLILSTALHDPHYFEKPDAFNPDHFLDANGAL\nKKTEAFIPFSLGKRICLGEGIARAELFLFFTTILQNFSMASPVAPEDIDLTPQECGVGKI\nPPTYQIRFLPR",
                        "Number of residues": "491",
                        "Molecular Weight": "56277.81",
                        "Theoretical pI": "8.44",
                        "GO Classification": "Functionsarachidonic acid epoxygenase activity / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen / oxygen binding / steroid hydroxylase activityProcessescellular ketone metabolic process / drug metabolic process / epoxygenase P450 pathway / exogenous drug catabolic process / oxidation-reduction process / small molecule metabolic process / steroid metabolic process / xenobiotic metabolic processComponentscytoplasm / endoplasmic reticulum membrane / intracellular membrane-bounded organelle",
                        "General Function": "Steroid hydroxylase activity",
                        "Specific Function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,4-cineole 2-exo-monooxygenase.",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0019435|Cytochrome P450 2B6 (CYP2B6)\nATGGAACTCAGCGTCCTCCTCTTCCTTGCACTCCTCACAGGACTCTTGCTACTCCTGGTT\nCAGCGCCACCCTAACACCCATGACCGCCTCCCACCAGGGCCCCGCCCTCTGCCCCTTTTG\nGGAAACCTTCTGCAGATGGATAGAAGAGGCCTACTCAAATCCTTTCTGAGGTTCCGAGAG\nAAATATGGGGACGTCTTCACGGTACACCTGGGACCGAGGCCCGTGGTCATGCTGTGTGGA\nGTAGAGGCCATACGGGAGGCCCTTGTGGACAAGGCTGAGGCCTTCTCTGGCCGGGGAAAA\nATCGCCATGGTCGACCCATTCTTCCGGGGATATGGTGTGATCTTTGCCAATGGAAACCGC\nTGGAAGGTGCTTCGGCGATTCTCTGTGACCACTATGAGGGACTTCGGGATGGGAAAGCGG\nAGTGTGGAGGAGCGGATTCAGGAGGAGGCTCAGTGTCTGATAGAGGAGCTTCGGAAATCC\nAAGGGGGCCCTCATGGACCCCACCTTCCTCTTCCAGTCCATTACCGCCAACATCATCTGC\nTCCATCGTCTTTGGAAAACGATTCCACTACCAAGATCAAGAGTTCCTGAAGATGCTGAAC\nTTGTTCTACCAGACTTTTTCACTCATCAGCTCTGTATTCGGCCAGCTGTTTGAGCTCTTC\nTCTGGCTTCTTGAAATACTTTCCTGGGGCACACAGGCAAGTTTACAAAAACCTGCAGGAA\nATCAATGCTTACATTGGCCACAGTGTGGAGAAGCACCGTGAAACCCTGGACCCCAGCGCC\nCCCAAGGACCTCATCGACACCTACCTGCTCCACATGGAAAAAGAGAAATCCAACGCACAC\nAGTGAATTCAGCCACCAGAACCTCAACCTCAACACGCTCTCGCTCTTCTTTGCTGGCACT\nGAGACCACCAGCACCACTCTCCGCTACGGCTTCCTGCTCATGCTCAAATACCCTCATGTT\nGCAGAGAGAGTCTACAGGGAGATTGAACAGGTGATTGGCCCACATCGCCCTCCAGAGCTT\nCATGACCGAGCCAAAATGCCATACACAGAGGCAGTCATCTATGAGATTCAGAGATTTTCC\nGACCTTCTCCCCATGGGTGTGCCCCACATTGTCACCCAACACACCAGCTTCCGAGGGTAC\nATCATCCCCAAGGACACAGAAGTATTTCTCATCCTGAGCACTGCTCTCCATGACCCACAC\nTACTTTGAAAAACCAGACGCCTTCAATCCTGACCACTTTCTGGATGCCAATGGGGCACTG\nAAAAAGACTGAAGCTTTTATCCCCTTCTCCTTAGGGAAGCGGATTTGTCTTGGTGAAGGC\nATCGCCCGTGCGGAATTGTTCCTCTTCTTCACCACCATCCTCCAGAACTTCTCCATGGCC\nAGCCCCGTGGCCCCAGAAGACATCGATCTGACACCCCAGGAGTGTGGTGTGGGCAAAATA\nCCCCCAACATACCAGATCCGCTTCCTGCCCCGCTGA",
                        "Chromosome Location": "19",
                        "Locus": "19q13.2",
                        "External Identifiers": "ResourceLinkUniProtKB IDP20813UniProtKB Entry NameCP2B6_HUMANGenBank Protein ID181296GenBank Gene IDM29874HGNC IDHGNC:2615",
                        "General References": "Yamano S, Nhamburo PT, Aoyama T, Meyer UA, Inaba T, Kalow W, Gelboin HV, McBride OW, Gonzalez FJ: cDNA cloning and sequence and cDNA-directed expression of human P450 IIB1: identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liver. Biochemistry. 1989 Sep 5;28(18):7340-8. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Grimwood J, Gordon LA, Olsen A, Terry A, Schmutz J, Lamerdin J, Hellsten U, Goodstein D, Couronne O, Tran-Gyamfi M, Aerts A, Altherr M, Ashworth L, Bajorek E, Black S, Branscomb E, Caenepeel S, Carrano A, Caoile C, Chan YM, Christensen M, Cleland CA, Copeland A, Dalin E, Dehal P, Denys M, Detter JC, Escobar J, Flowers D, Fotopulos D, Garcia C, Georgescu AM, Glavina T, Gomez M, Gonzales E, Groza M, Hammon N, Hawkins T, Haydu L, Ho I, Huang W, Israni S, Jett J, Kadner K, Kimball H, Kobayashi A, Larionov V, Leem SH, Lopez F, Lou Y, Lowry S, Malfatti S, Martinez D, McCready P, Medina C, Morgan J, Nelson K, Nolan M, Ovcharenko I, Pitluck S, Pollard M, Popkie AP, Predki P, Quan G, Ramirez L, Rash S, Retterer J, Rodriguez A, Rogers S, Salamov A, Salazar A, She X, Smith D, Slezak T, Solovyev V, Thayer N, Tice H, Tsai M, Ustaszewska A, Vo N, Wagner M, Wheeler J, Wu K, Xie G, Yang J, Dubchak I, Furey TS, DeJong P, Dickson M, Gordon D, Eichler EE, Pennacchio LA, Richardson P, Stubbs L, Rokhsar DS, Myers RM, Rubin EM, Lucas SM: The DNA sequence and biology of human chromosome 19. Nature. 2004 Apr 1;428(6982):529-35. [Article] Miles JS, McLaren AW, Wolf CR: Alternative splicing in the human cytochrome P450IIB6 gene generates a high level of aberrant messages. Nucleic Acids Res. 1989 Oct 25;17(20):8241-55. [Article] Thum T, Borlak J: Gene expression in distinct regions of the heart. Lancet. 2000 Mar 18;355(9208):979-83. [Article] Miyazawa M, Shindo M, Shimada T: Roles of cytochrome P450 3A enzymes in the 2-hydroxylation of 1,4-cineole, a monoterpene cyclic ether, by rat and human liver microsomes. Xenobiotica. 2001 Oct;31(10):713-23. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Gay SC, Shah MB, Talakad JC, Maekawa K, Roberts AG, Wilderman PR, Sun L, Yang JY, Huelga SC, Hong WX, Zhang Q, Stout CD, Halpert JR: Crystal structure of a cytochrome P450 2B6 genetic variant in complex with the inhibitor 4-(4-chlorophenyl)imidazole at 2.0-A resolution. Mol Pharmacol. 2010 Apr;77(4):529-38. doi: 10.1124/mol.109.062570. Epub 2010 Jan 8. [Article] Shah MB, Pascual J, Zhang Q, Stout CD, Halpert JR: Structures of cytochrome P450 2B6 bound to 4-benzylpyridine and 4-(4-nitrobenzyl)pyridine: insight into inhibitor binding and rearrangement of active site side chains. Mol Pharmacol. 2011 Dec;80(6):1047-55. doi: 10.1124/mol.111.074427. Epub 2011 Aug 29. [Article] Shah MB, Wilderman PR, Pascual J, Zhang Q, Stout CD, Halpert JR: Conformational adaptation of human cytochrome P450 2B6 and rabbit cytochrome P450 2B4 revealed upon binding multiple amlodipine molecules. Biochemistry. 2012 Sep 18;51(37):7225-38. doi: 10.1021/bi300894z. Epub 2012 Sep 4. [Article] Haas DW, Ribaudo HJ, Kim RB, Tierney C, Wilkinson GR, Gulick RM, Clifford DB, Hulgan T, Marzolini C, Acosta EP: Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study. AIDS. 2004 Dec 3;18(18):2391-400. [Article] Carr DF, la Porte CJ, Pirmohamed M, Owen A, Cortes CP: Haplotype structure of CYP2B6 and association with plasma efavirenz concentrations in a Chilean HIV cohort. J Antimicrob Chemother. 2010 Sep;65(9):1889-93. doi: 10.1093/jac/dkq260. Epub 2010 Jul 17. [Article] Elens L, Vandercam B, Yombi JC, Lison D, Wallemacq P, Haufroid V: Influence of host genetic factors on efavirenz plasma and intracellular pharmacokinetics in HIV-1-infected patients. Pharmacogenomics. 2010 Sep;11(9):1223-34. doi: 10.2217/pgs.10.94. [Article] Ariyoshi N, Miyazaki M, Toide K, Sawamura Yi, Kamataki T: A single nucleotide polymorphism of CYP2b6 found in Japanese enhances catalytic activity by autoactivation. Biochem Biophys Res Commun. 2001 Mar;281(5):1256-60. [Article] Lang T, Klein K, Fischer J, Nussler AK, Neuhaus P, Hofmann U, Eichelbaum M, Schwab M, Zanger UM: Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics. 2001 Jul;11(5):399-415. [Article] Jinno H, Tanaka-Kagawa T, Ohno A, Makino Y, Matsushima E, Hanioka N, Ando M: Functional characterization of cytochrome P450 2B6 allelic variants. Drug Metab Dispos. 2003 Apr;31(4):398-403. [Article] Saito S, Iida A, Sekine A, Kawauchi S, Higuchi S, Ogawa C, Nakamura Y: Catalog of 680 variations among eight cytochrome p450 ( CYP) genes, nine esterase genes, and two other genes in the Japanese population. J Hum Genet. 2003;48(5):249-70. Epub 2003 Apr 29. [Article] Lamba V, Lamba J, Yasuda K, Strom S, Davila J, Hancock ML, Fackenthal JD, Rogan PK, Ring B, Wrighton SA, Schuetz EG: Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression. J Pharmacol Exp Ther. 2003 Dec;307(3):906-22. Epub 2003 Oct 9. [Article] Lang T, Klein K, Richter T, Zibat A, Kerb R, Eichelbaum M, Schwab M, Zanger UM: Multiple novel nonsynonymous CYP2B6 gene polymorphisms in Caucasians: demonstration of phenotypic null alleles. J Pharmacol Exp Ther. 2004 Oct;311(1):34-43. Epub 2004 Jun 9. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB029744-(4-Chlorophenyl)ImidazoleexperimentalunknownDetailsDB04664Cyclohexyl-pentyl-maltosideexperimentalunknownDetailsDB04794Bifonazoleapproved, investigationalunknownDetailsDB00333MethadoneapprovedunknownsubstrateinducerDetailsDB00531Cyclophosphamideapproved, investigationalunknownsubstrateinducerDetailsDB00532Mephenytoinapproved, investigational, withdrawnunknownsubstrateDetailsDB00625Efavirenzapproved, investigationalunknownsubstrateinducerDetailsDB01104SertralineapprovedunknownsubstrateinhibitorDetailsDB01156BupropionapprovedunknownsubstrateDetailsDB01181IfosfamideapprovedunknownsubstrateDetailsDB00184NicotineapprovedunknownsubstrateDetailsDB00208TiclopidineapprovedunknowninhibitorDetailsDB00220NelfinavirapprovednoinhibitorDetailsDB00238NevirapineapprovedunknownsubstrateinducerDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinducerDetailsDB00454MeperidineapprovednosubstrateDetailsDB00503Ritonavirapproved, investigationalnoinhibitorinducerDetailsDB00564Carbamazepineapproved, investigationalunknownsubstrateinducerDetailsDB00758ClopidogrelapprovednosubstrateinhibitorDetailsDB00818Propofolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00849MethylphenobarbitalapprovedunknownsubstrateDetailsDB01037Selegilineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB01043Memantineapproved, investigationalunknowninhibitorDetailsDB01173OrphenadrineapprovedunknowninhibitorDetailsDB00381AmlodipineapprovedunknownsubstrateinhibitorDetailsDB00675TamoxifenapprovedunknownsubstrateinhibitorDetailsDB00313Valproic acidapproved, investigationalunknownsubstrateDetailsDB00568Cinnarizineapproved, investigationalunknownsubstrateDetailsDB00398Sorafenibapproved, investigationalunknowninhibitorDetailsDB04572Thiotepaapproved, investigationalunknowninhibitorDetailsDB01174Phenobarbitalapproved, investigationalunknowninducerDetailsDB01045RifampicinapprovedunknowninducerDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateDetailsDB01069Promethazineapproved, investigationalunknownsubstrateDetailsDB01221Ketamineapproved, vet_approvedunknownsubstrateDetailsDB01320Fosphenytoinapproved, investigationalunknowninducerDetailsDB01151Desipramineapproved, investigationalunknowninhibitorDetailsDB00997Doxorubicinapproved, investigationalnoinhibitorDetailsDB00257Clotrimazoleapproved, vet_approvedunknowninhibitorinducerDetailsDB01167Itraconazoleapproved, investigationalnoinhibitorDetailsDB00481Raloxifeneapproved, investigationalunknowninhibitorDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB00641SimvastatinapprovedunknowninhibitorinducerDetailsDB00439Cerivastatinapproved, withdrawnunknowninducerDetailsDB01076AtorvastatinapprovednoinducerDetailsDB06739SeratrodastexperimentalunknownsubstrateDetailsDB00514DextromethorphanapprovedunknownsubstrateDetailsDB03575PhencyclidineillicitunknowninhibitorDetailsDB00865Benzphetamineapproved, illicitunknownsubstrateDetailsDB083691-(biphenyl-4-ylmethyl)-1H-imidazoleexperimentalunknownDetailsDB06697ArtemetherapprovedunknownsubstrateinducerDetailsDB00321AmitriptylineapprovedunknownsubstrateDetailsDB00701Amprenavirapproved, investigationalunknowninhibitorDetailsDB00604Cisaprideapproved, investigational, withdrawnunknownsubstrateDetailsDB00349Clobazamapproved, illicitnosubstrateDetailsDB06470ClomethiazoleinvestigationalunknownsubstrateDetailsDB01559Clotiazepamapproved, illicitunknownsubstrateDetailsDB01394ColchicineapprovedunknowninhibitorDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknowninducerDetailsDB00586Diclofenacapproved, vet_approvedunknownsubstrateDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB00751Epinastineapproved, investigationalunknownsubstrateDetailsDB00655EstroneapprovedunknownsubstrateDetailsDB00898EthanolapprovedunknowninhibitorDetailsDB01466Ethylmorphineexperimental, illicitunknownsubstrateDetailsDB01544Flunitrazepamapproved, illicitunknownsubstrateDetailsDB00472Fluoxetineapproved, vet_approvedunknownsubstrateDetailsDB00176Fluvoxamineapproved, investigationalunknowninhibitorDetailsDB01159Halothaneapproved, vet_approvedunknownsubstrateDetailsDB00458ImipramineapprovedunknownsubstrateDetailsDB00753Isofluraneapproved, vet_approvedunknownsubstrateinducerDetailsDB06738KetobemidoneinvestigationalunknownsubstrateDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB00281Lidocaineapproved, vet_approvedunknownsubstrateDetailsDB01601LopinavirapprovedunknowninhibitorDetailsDB00772Malathionapproved, investigationalunknownsubstrateDetailsDB04817Metamizoleapproved, investigational, withdrawnunknowninducerDetailsDB01028Methoxyfluraneapproved, investigational, vet_approved, withdrawnunknownsubstrateDetailsDB06710MethyltestosteroneapprovedunknownsubstrateDetailsDB00379Mexiletineapproved, investigationalunknownsubstrateDetailsDB06148Mianserinapproved, investigationalunknownsubstrateDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB00745Modafinilapproved, investigationalunknowninhibitorinducerDetailsDB00622Nicardipineapproved, investigationalunknowninducerDetailsDB01115NifedipineapprovedunknowninducerDetailsDB00715Paroxetineapproved, investigationalunknowninhibitorDetailsDB01074Perhexilineapproved, investigationalunknownsubstrateDetailsDB04930Permethrinapproved, investigationalunknownsubstrateinducerDetailsDB01435Antipyrineapproved, investigationalunknownsubstrateDetailsDB00908Quinidineapproved, investigationalunknowninhibitorDetailsDB00296RopivacaineapprovednosubstrateDetailsDB00778Roxithromycinapproved, investigational, withdrawnnoinhibitorDetailsDB01236Sevofluraneapproved, vet_approvedunknownsubstrateDetailsDB06729SulfaphenazoleapprovedunknowninhibitorDetailsDB01138SulfinpyrazoneapprovedunknowninducerDetailsDB00231Temazepamapproved, investigationalunknownsubstrateDetailsDB00624Testosteroneapproved, investigationalunknownsubstrateDetailsDB00763MethimazoleapprovedunknowninhibitorDetailsDB00193Tramadolapproved, investigationalunknownsubstrateDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknowninducerDetailsDB00661VerapamilapprovedunknownsubstrateactivatorDetailsDB00755Tretinoinapproved, investigational, nutraceuticalunknownsubstrateDetailsDB04868Nilotinibapproved, investigationalunknowninducerDetailsDB06413Armodafinilapproved, investigationalunknowninducerDetailsDB00836LoperamideapprovedunknownsubstrateDetailsDB04975BanoxantroneinvestigationalunknownsubstrateDetailsDB00435Nitric OxideapprovedunknowninhibitorDetailsDB00515CisplatinapprovedunknowninhibitorDetailsDB06209PrasugrelapprovednosubstrateDetailsDB04871Lorcaserinapproved, withdrawnnosubstrateDetailsDB08864RilpivirineapprovedunknowninhibitorDetailsDB08896RegorafenibapprovedunknowninhibitorDetailsDB08899EnzalutamideapprovednoinhibitorDetailsDB04938Ospemifeneapproved, investigationalunknownsubstrateDetailsDB09074OlaparibapprovedunknowninducerDetailsDB09054IdelalisibapprovednoinducerDetailsDB09068Vortioxetineapproved, investigationalnosubstrateDetailsDB09280LumacaftorapprovednoinducerDetailsDB09570Ixazomibapproved, investigationalunknownsubstrateDetailsDB06176Romidepsinapproved, investigationalunknownsubstrateDetailsDB08865Crizotinibapproved, investigationalunknowninhibitorDetailsDB05219Crisaboroleapproved, investigationalnoinhibitorDetailsDB06595Midostaurinapproved, investigationalunknowninducerDetailsDB11613Velpatasvirapproved, investigationalnosubstrateDetailsDB05541Brivaracetamapproved, investigationalnosubstrateDetailsDB09238Manidipineapproved, investigationalunknowninhibitorDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB12070Letermovirapproved, investigationalnoinducerDetailsDB13943Testosterone cypionateapprovedunknownsubstrateDetailsDB13944Testosterone enanthateapprovedunknownsubstrateDetailsDB13946Testosterone undecanoateapproved, investigationalunknownsubstrateDetailsDB13941Piperaquineapproved, experimental, investigationalunknowninhibitorDetailsDB11642Pitolisantapproved, investigationalunknowninducerDetailsDB11633Isavuconazoleapproved, investigationalunknowninducerDetailsDB11586Asunaprevirapproved, investigational, withdrawnnosubstrateDetailsDB11672Curcuminapproved, investigationalunknowninhibitorDetailsDB13132ArtemisinininvestigationalnosubstrateinducerDetailsDB00582VoriconazoleapprovedunknowninhibitorDetailsDB14568Ivosidenibapproved, investigationalunknowninducerDetailsDB00615Rifabutinapproved, investigationalnoinducerDetailsDB11753Rifamycinapproved, investigationalnoinhibitorinducerDetailsDB01201Rifapentineapproved, investigationalnoinducerDetailsDB08883PerampanelapprovedunknownsubstrateinducerDetailsDB09078Lenvatinibapproved, investigationalunknowninhibitorDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB01095FluvastatinapprovedunknowninducerDetailsDB08912Dabrafenibapproved, investigationalnoinhibitorinducerDetailsDB08881VemurafenibapprovedunknowninducerDetailsDB12130Lorlatinibapproved, investigationalunknowninducerDetailsDB12245Triclabendazoleapproved, investigationalunknowninhibitorDetailsDB11823Esketamineapproved, investigationalunknownsubstrateinducerDetailsDB00455Loratadineapproved, investigationalunknownsubstrateDetailsDB12978Pexidartinibapproved, investigationalunknowninhibitorinducerDetailsDB00956Hydrocodoneapproved, illicit, investigationalunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknownsubstrateDetailsDB00972AzelastineapprovedunknowninhibitorDetailsDB04856DexloxiglumideinvestigationalunknownsubstrateDetailsDB12808Trifaroteneapproved, investigationalunknownsubstrateDetailsDB12001Abemaciclibapproved, investigationalunknowninhibitorDetailsDB15444Elexacaftorapproved, investigationalnoinhibitorDetailsDB15035Zanubrutinibapproved, investigationalnoinducerDetailsDB14975Voxelotorapproved, investigationalunknownsubstrateDetailsDB00635Prednisoneapproved, vet_approvedunknowninducerDetailsDB00741Hydrocortisoneapproved, vet_approvedunknowninducerDetailsDB06119Cenobamateapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB01222BudesonideapprovedunknowninducerDetailsDB00959Methylprednisoloneapproved, vet_approvedunknowninducerDetailsDB11951Lemborexantapproved, investigationalunknowninducerDetailsDB00957Norgestimateapproved, investigationalunknownsubstrateDetailsDB11837Osilodrostatapproved, investigationalunknownsubstrateDetailsDB00443Betamethasoneapproved, vet_approvedunknowninducerDetailsDB09241Methylene blueapproved, investigationalunknowninhibitorDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninducerDetailsDB00714Apomorphineapproved, investigationalunknownsubstrateDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknowninducerDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB11932Abametapirapproved, investigationalunknowninhibitorDetailsDB12499Clascoteroneapproved, investigationalnoinhibitorDetailsDB06137Tirbanibulinapproved, investigationalnoinhibitorDetailsDB11853Relugolixapproved, investigationalunknownDetailsDB11632Opicaponeapproved, investigationalnoinhibitorDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB00476DuloxetineapprovedunknowninhibitorDetailsDB01086Benzocaineapproved, investigationalunknownsubstrateDetailsDB08822Azilsartan medoxomilapproved, investigationalnosubstrateDetailsDB00412Rosiglitazoneapproved, investigationalunknowninducerDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownsubstrateDetailsDB08816TicagrelorapprovedunknowninducerDetailsDB15569Sotorasibapproved, investigationalunknowninducerDetailsDB12151Brincidofovirapproved, investigationalnoinhibitorDetailsDB12265Fexinidazoleapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB15011Avacopanapproved, investigationalnoinducerDetailsDB05667Levoketoconazoleapproved, investigationalnoinhibitorDetailsDB14973Abrocitinibapproved, investigationalnosubstrateDetailsDB16236Mitapivatapproved, investigationalnoinducerDetailsDB09061Cannabidiolapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00470Dronabinolapproved, illicitnoinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknowninhibitorDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorinducerDetailsDB05087Ganaxoloneapproved, investigationalnosubstrateDetailsDB01041Thalidomideapproved, investigational, withdrawnnosubstrateinducerDetailsDB14921Mavacamtenapproved, investigationalnoinducerDetailsDB09185Viloxazineapproved, investigational, withdrawnnoinhibitorDetailsDB12020Tecovirimatapproved, investigationalnoinducerDetailsDB09118StiripentolapprovedunknowninhibitorinducerDetailsDB13997Baloxavir marboxilapproved, investigationalunknowninhibitorDetailsDB16650Deucravacitinibapproved, investigationalunknownsubstrateDetailsDB12095Telotristat ethylapproved, investigationalnoinducerDetailsDB09499Thiosulfuric acidapproved, investigationalunknowninducerDetailsDB11739Vonoprazanapproved, investigationalunknownsubstrateDetailsDB02709ResveratrolinvestigationalnoinhibitorDetailsDB15568Adagrasibapproved, investigationalunknownsubstrateDetailsDB16267Olutasidenibapproved, investigationalunknowninducerDetailsDB17472Pirtobrutinibapproved, investigationalunknowninhibitorinducerDetailsDB12548Sparsentanapproved, investigationalunknowninducerDetailsDB11712Tezacaftorapproved, investigationalnoinhibitorDetailsDB01194BrinzolamideapprovedunknownsubstrateDetailsDB12255Vadadustatapproved, investigationalunknowninducerDetailsDB05467Palovaroteneapproved, investigationalnoinducerDetailsDB11763Momelotinibapproved, investigationalunknowninhibitorDetailsDB11718Encorafenibapproved, investigationalnoinhibitorinducerDetailsDB16826RepotrectinibinvestigationalnoinducerDetails"
                    }
                },
                {
                    "Label": "UDP-glucuronosyltransferase 1-1",
                    "Detailed Info": {
                        "Name": "UDP-glucuronosyltransferase 1-1",
                        "Synonyms": "2.4.1.17\nBilirubin-specific UDPGT isozyme 1\nGNT1\nhUG-BR1\nUDP-glucuronosyltransferase 1-A\nUDP-glucuronosyltransferase 1A1\nUDPGT 1-1\nUGT-1A\nUGT1\nUGT1A",
                        "Gene Name": "UGT1A1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0006823|UDP-glucuronosyltransferase 1-1\nMAVESQGGRPLVLGLLLCVLGPVVSHAGKILLIPVDGSHWLSMLGAIQQLQQRGHEIVVL\nAPDASLYIRDGAFYTLKTYPVPFQREDVKESFVSLGHNVFENDSFLQRVIKTYKKIKKDS\nAMLLSGCSHLLHNKELMASLAESSFDVMLTDPFLPCSPIVAQYLSLPTVFFLHALPCSLE\nFEATQCPNPFSYVPRPLSSHSDHMTFLQRVKNMLIAFSQNFLCDVVYSPYATLASEFLQR\nEVTVQDLLSSASVWLFRSDFVKDYPRPIMPNMVFVGGINCLHQNPLSQEFEAYINASGEH\nGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDL\nLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTS\nEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHD\nLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH",
                        "Number of residues": "533",
                        "Molecular Weight": "59590.91",
                        "Theoretical pI": "8.09",
                        "GO Classification": "Functionsenzyme binding / enzyme inhibitor activity / glucuronosyltransferase activity / protein heterodimerization activity / protein homodimerization activity / retinoic acid binding / steroid bindingProcessesacute-phase response / bilirubin conjugation / biphenyl catabolic process / cellular glucuronidation / cellular response to ethanol / cellular response to glucocorticoid stimulus / cellular response to hormone stimulus / digestion / drug metabolic process / estrogen metabolic process / flavone metabolic process / flavonoid biosynthetic process / flavonoid glucuronidation / heme catabolic process / heterocycle metabolic process / liver development / negative regulation of catalytic activity / negative regulation of cellular glucuronidation / negative regulation of fatty acid metabolic process / negative regulation of glucuronosyltransferase activity / negative regulation of steroid metabolic process / organ regeneration / porphyrin-containing compound metabolic process / response to drug / response to lipopolysaccharide / response to nutrient / response to starvation / retinoic acid metabolic process / small molecule metabolic process / steroid metabolic process / xenobiotic glucuronidation / xenobiotic metabolic processComponentscytochrome complex / endoplasmic reticulum / endoplasmic reticulum chaperone complex / endoplasmic reticulum membrane / integral component of plasma membrane",
                        "General Function": "Steroid binding",
                        "Specific Function": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isoform glucuronidates bilirubin IX-alpha to form both the IX-alpha-C8 and IX-alpha-C12 monoconjugates and diconjugate. Is also able to catalyze the glucuronidation of 17beta-estradiol, 17alpha-ethinylestradiol, 1-hydroxypyrene, 4-methylumbelliferone, 1-naphthol, paranitrophenol, scopoletin, and umbelliferone. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1.",
                        "Pfam Domain Function": "UDPGT (PF00201)",
                        "Transmembrane Regions": "491-507",
                        "Cellular Location": "Microsome",
                        "Gene sequence": ">lcl|BSEQ0021360|UDP-glucuronosyltransferase 1-1 (UGT1A1)\nATGGCTGTGGAGTCCCAGGGCGGACGCCCACTTGTCCTGGGCCTGCTGCTGTGTGTGCTG\nGGCCCAGTGGTGTCCCATGCTGGGAAGATACTGTTGATCCCAGTGGATGGCAGCCACTGG\nCTGAGCATGCTTGGGGCCATCCAGCAGCTGCAGCAGAGGGGACATGAAATAGTTGTCCTA\nGCACCTGACGCCTCGTTGTACATCAGAGACGGAGCATTTTACACCTTGAAGACGTACCCT\nGTGCCATTCCAAAGGGAGGATGTGAAAGAGTCTTTTGTTAGTCTCGGGCATAATGTTTTT\nGAGAATGATTCTTTCCTGCAGCGTGTGATCAAAACATACAAGAAAATAAAAAAGGACTCT\nGCTATGCTTTTGTCTGGCTGTTCCCACTTACTGCACAACAAGGAGCTCATGGCCTCCCTG\nGCAGAAAGCAGCTTTGATGTCATGCTGACGGACCCTTTCCTTCCTTGCAGCCCCATCGTG\nGCCCAGTACCTGTCTCTGCCCACTGTATTCTTCTTGCATGCACTGCCATGCAGCCTGGAA\nTTTGAGGCTACCCAGTGCCCCAACCCATTCTCCTACGTGCCCAGGCCTCTCTCCTCTCAT\nTCAGATCACATGACCTTCCTGCAGCGGGTGAAGAACATGCTCATTGCCTTTTCACAGAAC\nTTTCTGTGCGACGTGGTTTATTCCCCGTATGCAACCCTTGCCTCAGAATTCCTTCAGAGA\nGAGGTGACTGTCCAGGACCTATTGAGCTCTGCATCTGTCTGGCTGTTTAGAAGTGACTTT\nGTGAAGGATTACCCTAGGCCCATCATGCCCAATATGGTTTTTGTTGGTGGAATCAACTGC\nCTTCACCAAAATCCACTATCCCAGGAATTTGAAGCCTACATTAATGCTTCTGGAGAACAT\nGGAATTGTGGTTTTCTCTTTGGGATCAATGGTCTCAGAAATTCCAGAGAAGAAAGCTATG\nGCAATTGCTGATGCTTTGGGCAAAATCCCTCAGACAGTCCTGTGGCGGTACACTGGAACC\nCGACCATCGAATCTTGCGAACAACACGATACTTGTTAAGTGGCTACCCCAAAACGATCTG\nCTTGGTCACCCGATGACCCGTGCCTTTATCACCCATGCTGGTTCCCATGGTGTTTATGAA\nAGCATATGCAATGGCGTTCCCATGGTGATGATGCCCTTGTTTGGTGATCAGATGGACAAT\nGCAAAGCGCATGGAGACTAAGGGAGCTGGAGTGACCCTGAATGTTCTGGAAATGACTTCT\nGAAGATTTAGAAAATGCTCTAAAAGCAGTCATCAATGACAAAAGTTACAAGGAGAACATC\nATGCGCCTCTCCAGCCTTCACAAGGACCGCCCGGTGGAGCCGCTGGACCTGGCCGTGTTC\nTGGGTGGAGTTTGTGATGAGGCACAAGGGCGCGCCACACCTGCGCCCCGCAGCCCACGAC\nCTCACCTGGTACCAGTACCATTCCTTGGACGTGATTGGTTTCCTCTTGGCCGTCGTGCTG\nACAGTGGCCTTCATCACCTTTAAATGTTGTGCTTATGGCTACCGGAAATGCTTGGGGAAA\nAAAGGGCGAGTTAAGAAAGCCCACAAATCCAAGACCCATTGA",
                        "Chromosome Location": "2",
                        "Locus": "2q37",
                        "External Identifiers": "ResourceLinkUniProtKB IDP22309UniProtKB Entry NameUD11_HUMANGenBank Protein ID184473GenBank Gene IDM57899HGNC IDHGNC:12530",
                        "General References": "Ritter JK, Crawford JM, Owens IS: Cloning of two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells. J Biol Chem. 1991 Jan 15;266(2):1043-7. [Article] Ritter JK, Chen F, Sheen YY, Tran HM, Kimura S, Yeatman MT, Owens IS: A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem. 1992 Feb 15;267(5):3257-61. [Article] Gong QH, Cho JW, Huang T, Potter C, Gholami N, Basu NK, Kubota S, Carvalho S, Pennington MW, Owens IS, Popescu NC: Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics. 2001 Jun;11(4):357-68. [Article] Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article] Meunier L, Usherwood YK, Chung KT, Hendershot LM: A subset of chaperones and folding enzymes form multiprotein complexes in endoplasmic reticulum to bind nascent proteins. Mol Biol Cell. 2002 Dec;13(12):4456-69. [Article] Levesque E, Girard H, Journault K, Lepine J, Guillemette C: Regulation of the UGT1A1 bilirubin-conjugating pathway: role of a new splicing event at the UGT1A locus. Hepatology. 2007 Jan;45(1):128-38. [Article] Udomuksorn W, Elliot DJ, Lewis BC, Mackenzie PI, Yoovathaworn K, Miners JO: Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates. Pharmacogenet Genomics. 2007 Dec;17(12):1017-29. [Article] Girard H, Levesque E, Bellemare J, Journault K, Caillier B, Guillemette C: Genetic diversity at the UGT1 locus is amplified by a novel 3' alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity. Pharmacogenet Genomics. 2007 Dec;17(12):1077-89. [Article] Tang L, Singh R, Liu Z, Hu M: Structure and concentration changes affect characterization of UGT isoform-specific metabolism of isoflavones. Mol Pharm. 2009 Sep-Oct;6(5):1466-82. doi: 10.1021/mp8002557. [Article] Sneitz N, Bakker CT, de Knegt RJ, Halley DJ, Finel M, Bosma PJ: Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants. Hum Mutat. 2010 Jan;31(1):52-9. doi: 10.1002/humu.21133. [Article] Johnson AD, Kavousi M, Smith AV, Chen MH, Dehghan A, Aspelund T, Lin JP, van Duijn CM, Harris TB, Cupples LA, Uitterlinden AG, Launer L, Hofman A, Rivadeneira F, Stricker B, Yang Q, O'Donnell CJ, Gudnason V, Witteman JC: Genome-wide association meta-analysis for total serum bilirubin levels. Hum Mol Genet. 2009 Jul 15;18(14):2700-10. doi: 10.1093/hmg/ddp202. Epub 2009 May 4. [Article] Chen R, Jiang X, Sun D, Han G, Wang F, Ye M, Wang L, Zou H: Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009 Feb;8(2):651-61. doi: 10.1021/pr8008012. [Article] Bellemare J, Rouleau M, Girard H, Harvey M, Guillemette C: Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro. Drug Metab Dispos. 2010 Oct;38(10):1785-9. doi: 10.1124/dmd.110.034835. Epub 2010 Jul 7. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Bosma PJ, Chowdhury JR, Huang TJ, Lahiri P, Elferink RP, Van Es HH, Lederstein M, Whitington PF, Jansen PL, Chowdhury NR: Mechanisms of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I. FASEB J. 1992 Jul;6(10):2859-63. [Article] Aono S, Yamada Y, Keino H, Hanada N, Nakagawa T, Sasaoka Y, Yazawa T, Sato H, Koiwai O: Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II. Biochem Biophys Res Commun. 1993 Dec 30;197(3):1239-44. [Article] Moghrabi N, Clarke DJ, Boxer M, Burchell B: Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2. Genomics. 1993 Oct;18(1):171-3. [Article] Ritter JK, Yeatman MT, Kaiser C, Gridelli B, Owens IS: A phenylalanine codon deletion at the UGT1 gene complex locus of a Crigler-Najjar type I patient generates a pH-sensitive bilirubin UDP-glucuronosyltransferase. J Biol Chem. 1993 Nov 5;268(31):23573-9. [Article] Labrune P, Myara A, Hadchouel M, Ronchi F, Bernard O, Trivin F, Chowdhury NR, Chowdhury JR, Munnich A, Odievre M: Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases. Hum Genet. 1994 Dec;94(6):693-7. [Article] Erps LT, Ritter JK, Hersh JH, Blossom D, Martin NC, Owens IS: Identification of two single base substitutions in the UGT1 gene locus which abolish bilirubin uridine diphosphate glucuronosyltransferase activity in vitro. J Clin Invest. 1994 Feb;93(2):564-70. [Article] Seppen J, Bosma PJ, Goldhoorn BG, Bakker CT, Chowdhury JR, Chowdhury NR, Jansen PL, Oude Elferink RP: Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase. J Clin Invest. 1994 Dec;94(6):2385-91. [Article] Aono S, Adachi Y, Uyama E, Yamada Y, Keino H, Nanno T, Koiwai O, Sato H: Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome. Lancet. 1995 Apr 15;345(8955):958-9. [Article] Seppen J, Steenken E, Lindhout D, Bosma PJ, Elferink RP: A mutation which disrupts the hydrophobic core of the signal peptide of bilirubin UDP-glucuronosyltransferase, an endoplasmic reticulum membrane protein, causes Crigler-Najjar type II. FEBS Lett. 1996 Jul 29;390(3):294-8. [Article] Ciotti M, Chen F, Rubaltelli FF, Owens IS: Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease. Biochim Biophys Acta. 1998 Jul 1;1407(1):40-50. [Article] Yamamoto K, Soeda Y, Kamisako T, Hosaka H, Fukano M, Sato H, Fujiyama Y, Adachi Y, Satoh Y, Bamba T: Analysis of bilirubin uridine 5'-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II. J Hum Genet. 1998;43(2):111-4. [Article] Maruo Y, Sato H, Yamano T, Doida Y, Shimada M: Gilbert syndrome caused by a homozygous missense mutation (Tyr486Asp) of bilirubin UDP-glucuronosyltransferase gene. J Pediatr. 1998 Jun;132(6):1045-7. [Article] Kadakol A, Ghosh SS, Sappal BS, Sharma G, Chowdhury JR, Chowdhury NR: Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype. Hum Mutat. 2000 Oct;16(4):297-306. [Article] Maruo Y, Nishizawa K, Sato H, Sawa H, Shimada M: Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene. Pediatrics. 2000 Nov;106(5):E59. [Article] Kadakol A, Sappal BS, Ghosh SS, Lowenheim M, Chowdhury A, Chowdhury S, Santra A, Arias IM, Chowdhury JR, Chowdhury NR: Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus. J Med Genet. 2001 Apr;38(4):244-9. [Article] Labrune P, Myara A, Chalas J, Le Bihan B, Capel L, Francoual J: Association of a homozygous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome. Hum Mutat. 2002 Nov;20(5):399-401. [Article] Sutomo R, Laosombat V, Sadewa AH, Yokoyama N, Nakamura H, Matsuo M, Nishio H: Novel missense mutation of the UGT1A1 gene in Thai siblings with Gilbert's syndrome. Pediatr Int. 2002 Aug;44(4):427-32. [Article] Ohnishi A, Emi Y: Rapid proteasomal degradation of translocation-deficient UDP-glucuronosyltransferase 1A1 proteins in patients with Crigler-Najjar type II. Biochem Biophys Res Commun. 2003 Oct 24;310(3):735-41. [Article] Servedio V, d'Apolito M, Maiorano N, Minuti B, Torricelli F, Ronchi F, Zancan L, Perrotta S, Vajro P, Boschetto L, Iolascon A: Spectrum of UGT1A1 mutations in Crigler-Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation. Hum Mutat. 2005 Mar;25(3):325. [Article] D'Apolito M, Marrone A, Servedio V, Vajro P, De Falco L, Iolascon A: Seven novel mutations of the UGT1A1 gene in patients with unconjugated hyperbilirubinemia. Haematologica. 2007 Jan;92(1):133-4. [Article] Khan S, Irfan M, Sher G, Zubaida B, Alvi MA, Yasinzai M, Naeem M: UGT1A1 gene mutations in Pakistani children suffering from inherited nonhemolytic unconjugated hyperbilirubinemias. Ann Hum Genet. 2013 Nov;77(6):482-7. doi: 10.1111/ahg.12039. Epub 2013 Aug 29. [Article] Minucci A, Canu G, Gentile L, Cimino V, Giardina B, Zuppi C, Capoluongo E: Identification of a novel mutation in UDP-glucuronosyltransferase (UGT1A1) gene in a child with neonatal unconjugated hyperbilirubinemia. Clin Biochem. 2013 Jan;46(1-2):170-2. doi: 10.1016/j.clinbiochem.2012.10.007. Epub 2012 Oct 22. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB01024Mycophenolic acidapproved, investigationalunknownsubstrateDetailsDB01048Abacavirapproved, investigationalunknownsubstrateDetailsDB00173Adenineapproved, nutraceuticalunknowninhibitorDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknownsubstrateDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00818Propofolapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00973EzetimibeapprovedunknownsubstrateDetailsDB01045RifampicinapprovedunknowninducerDetailsDB00678LosartanapprovedunknownsubstrateDetailsDB00712Flurbiprofenapproved, investigationalunknownsubstrateinhibitorDetailsDB00328Indomethacinapproved, investigationalunknownsubstrateinhibitorDetailsDB00870Suprofenapproved, withdrawnunknownsubstrateDetailsDB06741GavestinelinvestigationalunknownsubstrateDetailsDB04868Nilotinibapproved, investigationalunknowninhibitorDetailsDB06210EltrombopagapprovedunknownsubstrateinhibitorDetailsDB00295Morphineapproved, investigationalnosubstrateDetailsDB05039IndacaterolapprovedunknownsubstrateDetailsDB06510MuraglitazarinvestigationalunknownsubstrateDetailsDB00704Naltrexoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB06817RaltegravirapprovedunknownsubstrateDetailsDB04953Ezogabineapproved, investigationalunknownsubstrateDetailsDB01420Testosterone propionateapproved, investigational, vet_approved, withdrawnunknowninducerDetailsDB06589PazopanibapprovedunknowninhibitorDetailsDB06626Axitinibapproved, investigationalnosubstrateDetailsDB08896RegorafenibapprovedunknowninhibitorDetailsDB00316AcetaminophenapprovedunknownsubstrateDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB00227Lovastatinapproved, investigationalnosubstrateDetailsDB00641SimvastatinapprovedunknownsubstrateDetailsDB01544Flunitrazepamapproved, illicitunknowninhibitorDetailsDB00530Erlotinibapproved, investigationalunknowninhibitorDetailsDB00773EtoposideapprovedunknownsubstrateDetailsDB01095FluvastatinapprovedunknownsubstrateDetailsDB00398Sorafenibapproved, investigationalunknowninhibitorDetailsDB08930DolutegravirapprovednosubstrateDetailsDB09101ElvitegravirapprovednosubstrateDetailsDB09183DasabuvirapprovedunknowninhibitorDetailsDB05015Belinostatapproved, investigationalunknownsubstrateDetailsDB11943Delafloxacinapproved, investigationalnosubstrateDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB13878Pibrentasvirapproved, investigationalunknowninhibitorDetailsDB13879Glecaprevirapproved, investigationalunknowninhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB11827Ertugliflozinapproved, investigationalnoinhibitorDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateDetailsDB11799Bictegravirapproved, investigationalunknownsubstrateDetailsDB12010Fostamatinibapproved, investigationalunknowninhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB00224IndinavirapprovedunknowninhibitorDetailsDB00564Carbamazepineapproved, investigationalnoinducerDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinducerDetailsDB01174Phenobarbitalapproved, investigationalnoinducerDetailsDB00932Tipranavirapproved, investigationalnoinducerDetailsDB00220NelfinavirapprovednoinducerDetailsDB00625Efavirenzapproved, investigationalnoinducerDetailsDB00906Tiagabineapproved, investigationalnosubstrateDetailsDB00313Valproic acidapproved, investigationalnosubstrateinhibitorDetailsDB00909Zonisamideapproved, investigationalnosubstrateDetailsDB01136Carvedilolapproved, investigationalnosubstrateDetailsDB03496Alvocidibexperimental, investigationalnosubstrateDetailsDB00695Furosemideapproved, vet_approvednosubstrateDetailsDB01241GemfibrozilapprovednosubstrateinhibitorDetailsDB01067Glipizideapproved, investigationalnosubstrateDetailsDB00451LevothyroxineapprovednosubstrateDetailsDB00916MetronidazoleapprovednosubstrateDetailsDB01183Naloxoneapproved, vet_approvednosubstrateDetailsDB00481Raloxifeneapproved, investigationalnosubstrateDetailsDB00193Tramadolapproved, investigationalnosubstrateDetailsDB00495ZidovudineapprovednosubstrateinducerDetailsDB09298Silibininexperimental, investigationalnoinhibitorDetailsDB09276Sodium aurothiomalateapproved, investigationalnoinhibitorDetailsDB00977EthinylestradiolapprovednosubstrateinducerDetailsDB00439Cerivastatinapproved, withdrawnnosubstrateDetailsDB00947Fulvestrantapproved, investigationalnosubstrateDetailsDB01009Ketoprofenapproved, vet_approvednosubstrateDetailsDB11967Binimetinibapproved, investigationalnosubstrateDetailsDB01072Atazanavirapproved, investigationalnoinhibitorDetailsDB12020Tecovirimatapproved, investigationalunknownsubstrateDetailsDB02703Fusidic acidapproved, investigationalunknownsubstrateDetailsDB09288PropacetamolexperimentalnosubstrateDetailsDB01609Deferasiroxapproved, investigationalunknownsubstrateinhibitorDetailsDB14575EslicarbazepineapprovedunknownsubstrateDetailsDB09213Dexibuprofenapproved, investigationalunknownsubstrateDetailsDB09119Eslicarbazepine acetateapprovedunknownsubstrateDetailsDB11963Dacomitinibapproved, investigationalnoinhibitorDetailsDB01032Probenecidapproved, investigationalnoinhibitorDetailsDB00350Minoxidilapproved, investigationalnosubstrateDetailsDB00279Liothyronineapproved, vet_approvednosubstrateDetailsDB00304DesogestrelapprovednoinducerDetailsDB00598LabetalolapprovedunknownsubstrateDetailsDB12978Pexidartinibapproved, investigationalunknowninhibitorDetailsDB09297Paritaprevirapproved, investigationalunknowninhibitorDetailsDB09079NintedanibapprovedunknownsubstrateDetailsDB00455Loratadineapproved, investigationalunknownDetailsDB06077Lumateperoneapproved, investigationalnosubstrateDetailsDB15328Ubrogepantapproved, investigationalunknowninhibitorDetailsDB00957Norgestimateapproved, investigationalunknownsubstrateDetailsDB11689Selumetinibapproved, investigationalnosubstrateDetailsDB12893Sacituzumab govitecanapproved, investigationalnosubstrateDetailsDB15456Vericiguatapproved, investigationalunknownsubstrateDetailsDB09296Ombitasvirapproved, investigationalunknowninhibitorDetailsDB11751Cabotegravirapproved, investigationalunknownsubstrateDetailsDB04854FebuxostatapprovednosubstrateDetailsDB12016Ponesimodapproved, investigationalunknownsubstrateDetailsDB08804Nandrolone decanoateapproved, illicitunknownsubstrateDetailsDB16703Belumosudilapproved, investigationalnoinhibitorDetailsDB12597Asciminibapproved, investigationalnoinhibitorDetailsDB12713Sotagliflozinapproved, investigationalnosubstrateDetailsDB16236Mitapivatapproved, investigationalnoinducerDetailsDB09074OlaparibapprovedunknowninhibitorDetailsDB08912Dabrafenibapproved, investigationalnoinhibitorDetailsDB15673Lenacapavirapproved, investigationalnosubstrateDetailsDB00470Dronabinolapproved, illicitnosubstrateDetailsDB12243Edaravoneapproved, investigationalnosubstrateDetailsDB12236Bexagliflozinapproved, investigationalunknownsubstrateDetailsDB00349Clobazamapproved, illicitnoupregulatorDetailsDB12255Vadadustatapproved, investigationalunknownsubstrateinducerDetailsDB12874Quizartinibapproved, investigationalnoinhibitorDetailsDB06700Desvenlafaxineapproved, investigationalnosubstrateDetailsDB11763Momelotinibapproved, investigationalunknowninhibitorinducerDetailsDB11718Encorafenibapproved, investigationalnoinhibitorDetailsDB16826RepotrectinibinvestigationalnoinhibitorDetailsDB00555Lamotrigineapproved, investigationalunknownsubstrateDetailsDB00503Ritonavirapproved, investigationalnoinducerDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB00794Primidoneapproved, vet_approvedunknowninducerDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB00714Apomorphineapproved, investigationalunknownsubstrateDetailsDB11796Fostemsavirapproved, investigationalunknownsubstrateDetailsDB00871TerbutalineapprovedunknownsubstrateDetailsDB00960Pindololapproved, investigationalunknownsubstrateDetailsDB12471Ibrexafungerpapproved, investigationalunknownsubstrateDetails"
                    }
                },
                {
                    "Label": "UDP-glucuronosyltransferase 1-3",
                    "Detailed Info": {
                        "Name": "UDP-glucuronosyltransferase 1-3",
                        "Synonyms": "2.4.1.17\nGNT1\nUDP-glucuronosyltransferase 1-C\nUDP-glucuronosyltransferase 1A3\nUDPGT 1-3\nUGT-1C\nUGT1\nUGT1C",
                        "Gene Name": "UGT1A3",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0007065|UDP-glucuronosyltransferase 1-3\nMATGLQVPLPWLATGLLLLLSVQPWAESGKVLVVPIDGSHWLSMREVLRELHARGHQAVV\nLTPEVNMHIKEENFFTLTTYAISWTQDEFDRHVLGHTQLYFETEHFLKKFFRSMAMLNNM\nSLVYHRSCVELLHNEALIRHLNATSFDVVLTDPVNLCAAVLAKYLSIPTVFFLRNIPCDL\nDFKGTQCPNPSSYIPRLLTTNSDHMTFMQRVKNMLYPLALSYICHAFSAPYASLASELFQ\nREVSVVDILSHASVWLFRGDFVMDYPRPIMPNMVFIGGINCANRKPLSQEFEAYINASGE\nHGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQND\nLLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMT\nSEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAH\nDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH",
                        "Number of residues": "534",
                        "Molecular Weight": "60337.835",
                        "Theoretical pI": "8.28",
                        "GO Classification": "Functionsenzyme binding / glucuronosyltransferase activity / protein heterodimerization activity / protein homodimerization activity / retinoic acid bindingProcessescellular glucuronidation / cellular response to hormone stimulus / flavonoid biosynthetic process / flavonoid glucuronidation / metabolic process / negative regulation of cellular glucuronidation / negative regulation of fatty acid metabolic process / negative regulation of glucuronosyltransferase activity / retinoic acid metabolic process / xenobiotic glucuronidationComponentsendoplasmic reticulum / endoplasmic reticulum membrane / integral component of membrane",
                        "General Function": "Retinoic acid binding",
                        "Specific Function": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1.",
                        "Pfam Domain Function": "UDPGT (PF00201)",
                        "Transmembrane Regions": "492-508",
                        "Cellular Location": "Microsome",
                        "Gene sequence": ">lcl|BSEQ0017182|UDP-glucuronosyltransferase 1-3 (UGT1A3)\nATGGCCACAGGACTCCAGGTTCCCCTGCCGTGGCTGGCCACAGGACTGCTGCTTCTCCTC\nAGTGTCCAGCCCTGGGCTGAGAGTGGAAAGGTGTTGGTGGTGCCCATTGATGGCAGCCAC\nTGGCTCAGCATGCGGGAGGTCTTGCGGGAGCTCCATGCCAGAGGCCACCAGGCAGTGGTC\nCTCACCCCAGAGGTGAATATGCACATCAAAGAAGAGAACTTTTTCACCCTGACAACCTAT\nGCCATTTCGTGGACCCAGGATGAATTTGATCGCCATGTGCTGGGCCACACTCAACTGTAC\nTTTGAAACAGAACATTTTCTGAAGAAATTTTTCAGAAGTATGGCAATGTTGAACAATATG\nTCTTTGGTCTATCATAGGTCTTGTGTGGAGCTACTACATAATGAGGCCCTGATCAGGCAC\nCTGAATGCTACTTCCTTTGATGTGGTTTTAACAGACCCCGTTAACCTCTGCGCGGCAGTG\nCTGGCTAAGTACCTGTCGATTCCTACTGTGTTTTTTTTGAGGAACATTCCATGTGATTTA\nGACTTTAAGGGCACACAGTGTCCAAACCCTTCCTCCTATATTCCTAGATTACTAACAACC\nAATTCAGACCACATGACATTCATGCAAAGGGTCAAGAACATGCTCTACCCTCTGGCCCTG\nTCCTACATTTGCCATGCTTTTTCTGCTCCTTATGCAAGCCTTGCCTCTGAGCTTTTTCAG\nAGAGAGGTGTCAGTGGTGGATATTCTCAGTCATGCATCTGTGTGGCTGTTCCGAGGGGAC\nTTTGTGATGGACTACCCCAGGCCAATCATGCCCAACATGGTCTTCATTGGGGGCATCAAC\nTGTGCCAACAGGAAGCCACTATCTCAGGAATTTGAAGCCTACATTAATGCTTCTGGAGAA\nCATGGAATTGTGGTTTTCTCTTTGGGATCAATGGTCTCAGAAATTCCAGAGAAGAAAGCT\nATGGCAATTGCTGATGCTTTGGGCAAAATCCCTCAGACAGTCCTGTGGCGGTACACTGGA\nACCCGACCATCGAATCTTGCGAACAACACGATACTTGTTAAGTGGCTACCCCAAAACGAT\nCTGCTTGGTCACCCGATGACCCGTGCCTTTATCACCCATGCTGGTTCCCATGGTGTTTAT\nGAAAGCATATGCAATGGCGTTCCCATGGTGATGATGCCCTTGTTTGGTGATCAGATGGAC\nAATGCAAAGCGCATGGAGACTAAGGGAGCTGGAGTGACCCTGAATGTTCTGGAAATGACT\nTCTGAAGATTTAGAAAATGCTCTAAAAGCAGTCATCAATGACAAAAGTTACAAGGAGAAC\nATCATGCGCCTCTCCAGCCTTCACAAGGACCGCCCGGTGGAGCCGCTGGACCTGGCCGTG\nTTCTGGGTGGAGTTTGTGATGAGGCACAAGGGCGCGCCACACCTGCGCCCCGCAGCCCAC\nGACCTCACCTGGTACCAGTACCATTCCTTGGACGTGATTGGTTTCCTCTTGGCCGTCGTG\nCTGACAGTGGCCTTCATCACCTTTAAATGTTGTGCTTATGGCTACCGGAAATGCTTGGGG\nAAAAAAGGGCGAGTTAAGAAAGCCCACAAATCCAAGACCCATTGA",
                        "Chromosome Location": "2",
                        "Locus": "2q37",
                        "External Identifiers": "ResourceLinkUniProtKB IDP35503UniProtKB Entry NameUD13_HUMANGenBank Protein ID340135GenBank Gene IDM84127HGNC IDHGNC:12535",
                        "General References": "Ritter JK, Chen F, Sheen YY, Tran HM, Kimura S, Yeatman MT, Owens IS: A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem. 1992 Feb 15;267(5):3257-61. [Article] Gong QH, Cho JW, Huang T, Potter C, Gholami N, Basu NK, Kubota S, Carvalho S, Pennington MW, Owens IS, Popescu NC: Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics. 2001 Jun;11(4):357-68. [Article] Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article] Alonen A, Finel M, Kostiainen R: The human UDP-glucuronosyltransferase UGT1A3 is highly selective towards N2 in the tetrazole ring of losartan, candesartan, and zolarsartan. Biochem Pharmacol. 2008 Sep 15;76(6):763-72. doi: 10.1016/j.bcp.2008.07.006. Epub 2008 Jul 12. [Article] Bellemare J, Rouleau M, Girard H, Harvey M, Guillemette C: Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro. Drug Metab Dispos. 2010 Oct;38(10):1785-9. doi: 10.1124/dmd.110.034835. Epub 2010 Jul 7. [Article] Girard H, Levesque E, Bellemare J, Journault K, Caillier B, Guillemette C: Genetic diversity at the UGT1 locus is amplified by a novel 3' alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity. Pharmacogenet Genomics. 2007 Dec;17(12):1077-89. [Article] Chen R, Jiang X, Sun D, Han G, Wang F, Ye M, Wang L, Zou H: Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009 Feb;8(2):651-61. doi: 10.1021/pr8008012. [Article] Menard V, Girard H, Harvey M, Perusse L, Guillemette C: Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. Hum Mutat. 2009 Apr;30(4):677-87. doi: 10.1002/humu.20946. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00796Candesartan cilexetilapprovedunknownsubstrateDetailsDB01029Irbesartanapproved, investigationalunknownsubstrateDetailsDB00678LosartanapprovedunknownsubstrateDetailsDB00749Etodolacapproved, investigational, vet_approvedunknownsubstrateDetailsDB00712Flurbiprofenapproved, investigationalunknownsubstrateDetailsDB01050IbuprofenapprovedunknownsubstrateDetailsDB00327Hydromorphoneapproved, illicitnosubstrateDetailsDB01252MitiglinideinvestigationalunknownsubstrateDetailsDB04725LicofeloneinvestigationalunknownsubstrateDetailsDB06741GavestinelinvestigationalunknownsubstrateDetailsDB06210EltrombopagapprovedunknownsubstrateDetailsDB06403Ambrisentanapproved, investigationalunknownsubstrateDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknownsubstrateDetailsDB00295Morphineapproved, investigationalnosubstrateDetailsDB00973EzetimibeapprovedunknownsubstrateDetailsDB06510MuraglitazarinvestigationalunknownsubstrateDetailsDB00434CyproheptadineapprovedunknownsubstrateDetailsDB04953Ezogabineapproved, investigationalunknownsubstrateDetailsDB08860PitavastatinapprovedunknownsubstrateDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB00227Lovastatinapproved, investigationalunknownsubstrateDetailsDB00641SimvastatinapprovedunknownsubstrateDetailsDB01544Flunitrazepamapproved, illicitunknowninhibitorDetailsDB01095FluvastatinapprovedunknownsubstrateDetailsDB00313Valproic acidapproved, investigationalunknownsubstrateDetailsDB11943Delafloxacinapproved, investigationalnosubstrateDetailsDB11691Naldemedineapproved, investigationalnosubstrateDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateDetailsDB13919CandesartanexperimentalunknownsubstrateDetailsDB12070Letermovirapproved, investigationalnosubstrateDetailsDB06230Nalmefeneapproved, investigational, withdrawnnosubstrateDetailsDB08930DolutegravirapprovednosubstrateDetailsDB05928DovitinibinvestigationalunknowninhibitorDetailsDB01609Deferasiroxapproved, investigationalunknowninhibitorDetailsDB09213Dexibuprofenapproved, investigationalunknownsubstrateDetailsDB13997Baloxavir marboxilapproved, investigationalnosubstrateDetailsDB00966Telmisartanapproved, investigationalunknownsubstrateDetailsDB01241GemfibrozilapprovedunknownsubstrateinhibitorDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateDetailsDB00788Naproxenapproved, vet_approvedunknownsubstrateDetailsDB00586Diclofenacapproved, vet_approvedunknownsubstrateDetailsDB00455Loratadineapproved, investigationalunknownDetailsDB01217Anastrozoleapproved, investigationalunknownsubstrateDetailsDB00977EthinylestradiolapprovedunknownDetailsDB11689Selumetinibapproved, investigationalnoDetailsDB09038EmpagliflozinapprovedunknownsubstrateDetailsDB00920KetotifenapprovedunknownsubstrateDetailsDB04854FebuxostatapprovednosubstrateDetailsDB08893MirabegronapprovednosubstrateDetailsDB08804Nandrolone decanoateapproved, illicitunknownsubstrateDetailsDB12020Tecovirimatapproved, investigationalunknownsubstrateDetailsDB00470Dronabinolapproved, illicitnosubstrateDetailsDB06700Desvenlafaxineapproved, investigationalnosubstrateDetailsDB15114Vamoroloneapproved, investigationalnosubstrateDetailsDB00555Lamotrigineapproved, investigationalunknownsubstrateDetailsDB00503Ritonavirapproved, investigationalnoinducerDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB00794Primidoneapproved, vet_approvedunknowninducerDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB00714Apomorphineapproved, investigationalunknownsubstrateDetailsDB11796Fostemsavirapproved, investigationalunknownsubstrateDetailsDB00871TerbutalineapprovedunknownsubstrateDetailsDB00960Pindololapproved, investigationalunknownsubstrateDetailsDB12471Ibrexafungerpapproved, investigationalunknownsubstrateDetails"
                    }
                }
            ],
            "carriers": [
                {
                    "Label": "Serum albumin",
                    "Detailed Info": {
                        "Name": "Serum albumin",
                        "Synonyms": "Serum albumin precursor",
                        "Gene Name": "ALB",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0001058|Serum albumin\nMKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPF\nEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEP\nERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLF\nFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAV\nARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLK\nECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYAR\nRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFE\nQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVV\nLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTL\nSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLV\nAASQAALGL",
                        "Number of residues": "609",
                        "Molecular Weight": "69365.94",
                        "Theoretical pI": "6.21",
                        "GO Classification": "Functionsantioxidant activity / chaperone binding / copper ion binding / DNA binding / drug binding / fatty acid binding / pyridoxal phosphate binding / toxic substance bindingProcessesbile acid and bile salt transport / bile acid metabolic process / blood coagulation / cellular response to starvation / hemolysis by symbiont of host erythrocytes / lipoprotein metabolic process / maintenance of mitochondrion location / negative regulation of apoptotic process / negative regulation of programmed cell death / platelet activation / platelet degranulation / receptor-mediated endocytosis / retina homeostasis / small molecule metabolic process / sodium-independent organic anion transport / transmembrane transport / transportComponentsblood microparticle / endoplasmic reticulum / extracellular exosome / extracellular region / extracellular space / Golgi apparatus / myelin sheath / nucleus / platelet alpha granule lumen / protein complex",
                        "General Function": "Toxic substance binding",
                        "Specific Function": "Serum albumin, the main protein of plasma, has a good binding capacity for water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin and drugs. Its main function is the regulation of the colloidal osmotic pressure of blood. Major zinc transporter in plasma, typically binds about 80% of all plasma zinc.",
                        "Pfam Domain Function": "Serum_albumin (PF00273)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Secreted",
                        "Gene sequence": ">lcl|BSEQ0010372|Serum albumin (ALB)\nATGAAGTGGGTAACCTTTATTTCCCTTCTTTTTCTCTTTAGCTCGGCTTATTCCAGGGGT\nGTGTTTCGTCGAGATGCACACAAGAGTGAGGTTGCTCATCGGTTTAAAGATTTGGGAGAA\nGAAAATTTCAAAGCCTTGGTGTTGATTGCCTTTGCTCAGTATCTTCAGCAGTGTCCATTT\nGAAGATCATGTAAAATTAGTGAATGAAGTAACTGAATTTGCAAAAACATGTGTTGCTGAT\nGAGTCAGCTGAAAATTGTGACAAATCACTTCATACCCTTTTTGGAGACAAATTATGCACA\nGTTGCAACTCTTCGTGAAACCTATGGTGAAATGGCTGACTGCTGTGCAAAACAAGAACCT\nGAGAGAAATGAATGCTTCTTGCAACACAAAGATGACAACCCAAACCTCCCCCGATTGGTG\nAGACCAGAGGTTGATGTGATGTGCACTGCTTTTCATGACAATGAAGAGACATTTTTGAAA\nAAATACTTATATGAAATTGCCAGAAGACATCCTTACTTTTATGCCCCGGAACTCCTTTTC\nTTTGCTAAAAGGTATAAAGCTGCTTTTACAGAATGTTGCCAAGCTGCTGATAAAGCTGCC\nTGCCTGTTGCCAAAGCTCGATGAACTTCGGGATGAAGGGAAGGCTTCGTCTGCCAAACAG\nAGACTCAAGTGTGCCAGTCTCCAAAAATTTGGAGAAAGAGCTTTCAAAGCATGGGCAGTA\nGCTCGCCTGAGCCAGAGATTTCCCAAAGCTGAGTTTGCAGAAGTTTCCAAGTTAGTGACA\nGATCTTACCAAAGTCCACACGGAATGCTGCCATGGAGATCTGCTTGAATGTGCTGATGAC\nAGGGCGGACCTTGCCAAGTATATCTGTGAAAATCAAGATTCGATCTCCAGTAAACTGAAG\nGAATGCTGTGAAAAACCTCTGTTGGAAAAATCCCACTGCATTGCCGAAGTGGAAAATGAT\nGAGATGCCTGCTGACTTGCCTTCATTAGCTGCTGATTTTGTTGAAAGTAAGGATGTTTGC\nAAAAACTATGCTGAGGCAAAGGATGTCTTCCTGGGCATGTTTTTGTATGAATATGCAAGA\nAGGCATCCTGATTACTCTGTCGTGCTGCTGCTGAGACTTGCCAAGACATATGAAACCACT\nCTAGAGAAGTGCTGTGCCGCTGCAGATCCTCATGAATGCTATGCCAAAGTGTTCGATGAA\nTTTAAACCTCTTGTGGAAGAGCCTCAGAATTTAATCAAACAAAATTGTGAGCTTTTTGAG\nCAGCTTGGAGAGTACAAATTCCAGAATGCGCTATTAGTTCGTTACACCAAGAAAGTACCC\nCAAGTGTCAACTCCAACTCTTGTAGAGGTCTCAAGAAACCTAGGAAAAGTGGGCAGCAAA\nTGTTGTAAACATCCTGAAGCAAAAAGAATGCCCTGTGCAGAAGACTATCTATCCGTGGTC\nCTGAACCAGTTATGTGTGTTGCATGAGAAAACGCCAGTAAGTGACAGAGTCACCAAATGC\nTGCACAGAATCCTTGGTGAACAGGCGACCATGCTTTTCAGCTCTGGAAGTCGATGAAACA\nTACGTTCCCAAAGAGTTTAATGCTGAAACATTCACCTTCCATGCAGATATATGCACACTT\nTCTGAGAAGGAGAGACAAATCAAGAAACAAACTGCACTTGTTGAGCTCGTGAAACACAAG\nCCCAAGGCAACAAAAGAGCAACTGAAAGCTGTTATGGATGATTTCGCAGCTTTTGTAGAG\nAAGTGCTGCAAGGCTGACGATAAGGAGACCTGCTTTGCCGAGGAGGGTAAAAAACTTGTT\nGCTGCAAGTCAAGCTGCCTTAGGCTTATAA",
                        "Chromosome Location": "4",
                        "Locus": "4q11-q13",
                        "External Identifiers": "ResourceLinkUniProtKB IDP02768UniProtKB Entry NameALBU_HUMANGenBank Protein ID28590GenBank Gene IDV00494GenAtlas IDALBHGNC IDHGNC:399",
                        "General References": "Lawn RM, Adelman J, Bock SC, Franke AE, Houck CM, Najarian RC, Seeburg PH, Wion KL: The sequence of human serum albumin cDNA and its expression in E. coli. Nucleic Acids Res. 1981 Nov 25;9(22):6103-114. [Article] Dugaiczyk A, Law SW, Dennison OE: Nucleotide sequence and the encoded amino acids of human serum albumin mRNA. Proc Natl Acad Sci U S A. 1982 Jan;79(1):71-5. [Article] Minghetti PP, Ruffner DE, Kuang WJ, Dennison OE, Hawkins JW, Beattie WG, Dugaiczyk A: Molecular structure of the human albumin gene is revealed by nucleotide sequence within q11-22 of chromosome 4. J Biol Chem. 1986 May 25;261(15):6747-57. [Article] Yu Y, Zhang C, Zhou G, Wu S, Qu X, Wei H, Xing G, Dong C, Zhai Y, Wan J, Ouyang S, Li L, Zhang S, Zhou K, Zhang Y, Wu C, He F: Gene expression profiling in human fetal liver and identification of tissue- and developmental-stage-specific genes through compiled expression profiles and efficient cloning of full-length cDNAs. Genome Res. 2001 Aug;11(8):1392-403. [Article] Bechtel S, Rosenfelder H, Duda A, Schmidt CP, Ernst U, Wellenreuther R, Mehrle A, Schuster C, Bahr A, Blocker H, Heubner D, Hoerlein A, Michel G, Wedler H, Kohrer K, Ottenwalder B, Poustka A, Wiemann S, Schupp I: The full-ORF clone resource of the German cDNA Consortium. BMC Genomics. 2007 Oct 31;8:399. [Article] Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Clark HF, Gurney AL, Abaya E, Baker K, Baldwin D, Brush J, Chen J, Chow B, Chui C, Crowley C, Currell B, Deuel B, Dowd P, Eaton D, Foster J, Grimaldi C, Gu Q, Hass PE, Heldens S, Huang A, Kim HS, Klimowski L, Jin Y, Johnson S, Lee J, Lewis L, Liao D, Mark M, Robbie E, Sanchez C, Schoenfeld J, Seshagiri S, Simmons L, Singh J, Smith V, Stinson J, Vagts A, Vandlen R, Watanabe C, Wieand D, Woods K, Xie MH, Yansura D, Yi S, Yu G, Yuan J, Zhang M, Zhang Z, Goddard A, Wood WI, Godowski P, Gray A: The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res. 2003 Oct;13(10):2265-70. Epub 2003 Sep 15. [Article] Urano Y, Watanabe K, Sakai M, Tamaoki T: The human albumin gene. Characterization of the 5' and 3' flanking regions and the polymorphic gene transcripts. J Biol Chem. 1986 Mar 5;261(7):3244-51. [Article] Meloun B, Moravek L, Kostka V: Complete amino acid sequence of human serum albumin. FEBS Lett. 1975 Oct 15;58(1):134-7. [Article] Corbett JM, Wheeler CH, Baker CS, Yacoub MH, Dunn MJ: The human myocardial two-dimensional gel protein database: update 1994. Electrophoresis. 1994 Nov;15(11):1459-65. [Article] Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, Thomas GR, Vandekerckhove J: Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol. 2003 May;21(5):566-9. Epub 2003 Mar 31. [Article] Mogard MH, Kobayashi R, Chen CF, Lee TD, Reeve JR Jr, Shively JE, Walsh JH: The amino acid sequence of kinetensin, a novel peptide isolated from pepsin-treated human plasma: homology with human serum albumin, neurotensin and angiotensin. Biochem Biophys Res Commun. 1986 May 14;136(3):983-8. [Article] Carraway RE, Mitra SP, Cochrane DE: Structure of a biologically active neurotensin-related peptide obtained from pepsin-treated albumin(s). J Biol Chem. 1987 May 5;262(13):5968-73. [Article] Walker JE: Lysine residue 199 of human serum albumin is modified by acetylsalicyclic acid. FEBS Lett. 1976 Jul 15;66(2):173-5. [Article] Lapolla A, Fedele D, Reitano R, Arico NC, Seraglia R, Traldi P, Marotta E, Tonani R: Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides. J Am Soc Mass Spectrom. 2004 Apr;15(4):496-509. [Article] Jacobsen C: Lysine residue 240 of human serum albumin is involved in high-affinity binding of bilirubin. Biochem J. 1978 May 1;171(2):453-9. [Article] Garlick RL, Mazer JS: The principal site of nonenzymatic glycosylation of human serum albumin in vivo. J Biol Chem. 1983 May 25;258(10):6142-6. [Article] Shaklai N, Garlick RL, Bunn HF: Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J Biol Chem. 1984 Mar 25;259(6):3812-7. [Article] Iberg N, Fluckiger R: Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites. J Biol Chem. 1986 Oct 15;261(29):13542-5. [Article] Watkins S, Madison J, Galliano M, Minchiotti L, Putnam FW: A nucleotide insertion and frameshift cause analbuminemia in an Italian family. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2275-9. [Article] Lu J, Stewart AJ, Sadler PJ, Pinheiro TJ, Blindauer CA: Albumin as a zinc carrier: properties of its high-affinity zinc-binding site. Biochem Soc Trans. 2008 Dec;36(Pt 6):1317-21. doi: 10.1042/BST0361317. [Article] Han G, Ye M, Zhou H, Jiang X, Feng S, Jiang X, Tian R, Wan D, Zou H, Gu J: Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography. Proteomics. 2008 Apr;8(7):1346-61. doi: 10.1002/pmic.200700884. [Article] Mayya V, Lundgren DH, Hwang SI, Rezaul K, Wu L, Eng JK, Rodionov V, Han DK: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal. 2009 Aug 18;2(84):ra46. doi: 10.1126/scisignal.2000007. [Article] Burkard TR, Planyavsky M, Kaupe I, Breitwieser FP, Burckstummer T, Bennett KL, Superti-Furga G, Colinge J: Initial characterization of the human central proteome. BMC Syst Biol. 2011 Jan 26;5:17. doi: 10.1186/1752-0509-5-17. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Tagliabracci VS, Wiley SE, Guo X, Kinch LN, Durrant E, Wen J, Xiao J, Cui J, Nguyen KB, Engel JL, Coon JJ, Grishin N, Pinna LA, Pagliarini DJ, Dixon JE: A Single Kinase Generates the Majority of the Secreted Phosphoproteome. Cell. 2015 Jun 18;161(7):1619-32. doi: 10.1016/j.cell.2015.05.028. [Article] Vaca Jacome AS, Rabilloud T, Schaeffer-Reiss C, Rompais M, Ayoub D, Lane L, Bairoch A, Van Dorsselaer A, Carapito C: N-terminome analysis of the human mitochondrial proteome. Proteomics. 2015 Jul;15(14):2519-24. doi: 10.1002/pmic.201400617. Epub 2015 Jun 8. [Article] Carter DC, He XM, Munson SH, Twigg PD, Gernert KM, Broom MB, Miller TY: Three-dimensional structure of human serum albumin. Science. 1989 Jun 9;244(4909):1195-8. [Article] Carter DC, He XM: Structure of human serum albumin. Science. 1990 Jul 20;249(4966):302-3. [Article] He XM, Carter DC: Atomic structure and chemistry of human serum albumin. Nature. 1992 Jul 16;358(6383):209-15. [Article] Curry S, Mandelkow H, Brick P, Franks N: Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Biol. 1998 Sep;5(9):827-35. [Article] Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K: Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng. 1999 Jun;12(6):439-46. [Article] Bhattacharya AA, Curry S, Franks NP: Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures. J Biol Chem. 2000 Dec 8;275(49):38731-8. [Article] Petitpas I, Grune T, Bhattacharya AA, Curry S: Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. J Mol Biol. 2001 Dec 14;314(5):955-60. [Article] Brennan SO, Herbert P: Albumin Canterbury (313 Lys----Asn). A point mutation in the second domain of serum albumin. Biochim Biophys Acta. 1987 Apr 8;912(2):191-7. [Article] Takahashi N, Takahashi Y, Blumberg BS, Putnam FW: Amino acid substitutions in genetic variants of human serum albumin and in sequences inferred from molecular cloning. Proc Natl Acad Sci U S A. 1987 Jul;84(13):4413-7. [Article] Takahashi N, Takahashi Y, Isobe T, Putnam FW, Fujita M, Satoh C, Neel JV: Amino acid substitutions in inherited albumin variants from Amerindian and Japanese populations. Proc Natl Acad Sci U S A. 1987 Nov;84(22):8001-5. [Article] Arai K, Ishioka N, Huss K, Madison J, Putnam FW: Identical structural changes in inherited albumin variants from different populations. Proc Natl Acad Sci U S A. 1989 Jan;86(2):434-8. [Article] Arai K, Madison J, Huss K, Ishioka N, Satoh C, Fujita M, Neel JV, Sakurabayashi I, Putnam FW: Point substitutions in Japanese alloalbumins. Proc Natl Acad Sci U S A. 1989 Aug;86(16):6092-6. [Article] Arai K, Madison J, Shimizu A, Putnam FW: Point substitutions in albumin genetic variants from Asia. Proc Natl Acad Sci U S A. 1990 Jan;87(1):497-501. [Article] Brennan SO, Myles T, Peach RJ, Donaldson D, George PM: Albumin Redhill (-1 Arg, 320 Ala----Thr): a glycoprotein variant of human serum albumin whose precursor has an aberrant signal peptidase cleavage site. Proc Natl Acad Sci U S A. 1990 Jan;87(1):26-30. [Article] Galliano M, Minchiotti L, Porta F, Rossi A, Ferri G, Madison J, Watkins S, Putnam FW: Mutations in genetic variants of human serum albumin found in Italy. Proc Natl Acad Sci U S A. 1990 Nov;87(22):8721-5. [Article] Watkins S, Madison J, Davis E, Sakamoto Y, Galliano M, Minchiotti L, Putnam FW: A donor splice mutation and a single-base deletion produce two carboxyl-terminal variants of human serum albumin. Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):5959-63. [Article] Madison J, Arai K, Sakamoto Y, Feld RD, Kyle RA, Watkins S, Davis E, Matsuda Y, Amaki I, Putnam FW: Genetic variants of serum albumin in Americans and Japanese. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9853-7. [Article] Peach RJ, Brennan SO: Structural characterization of a glycoprotein variant of human serum albumin: albumin Casebrook (494 Asp----Asn). Biochim Biophys Acta. 1991 Jul 26;1097(1):49-54. [Article] Minchiotti L, Galliano M, Stoppini M, Ferri G, Crespeau H, Rochu D, Porta F: Two alloalbumins with identical electrophoretic mobility are produced by differently charged amino acid substitutions. Biochim Biophys Acta. 1992 Mar 12;1119(3):232-8. [Article] Carlson J, Sakamoto Y, Laurell CB, Madison J, Watkins S, Putnam FW: Alloalbuminemia in Sweden: structural study and phenotypic distribution of nine albumin variants. Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8225-9. [Article] Minchiotti L, Galliano M, Zapponi MC, Tenni R: The structural characterization and bilirubin-binding properties of albumin Herborn, a [Lys240-->Glu] albumin mutant. Eur J Biochem. 1993 Jun 1;214(2):437-44. [Article] Brennan SO, Fellowes AP: Albumin Hawkes Bay; a low level variant caused by loss of a sulphydryl group at position 177. Biochim Biophys Acta. 1993 Aug 4;1182(1):46-50. [Article] Galliano M, Minchiotti L, Iadarola P, Stoppini M, Giagnoni P, Watkins S, Madison J, Putnam FW: Protein and DNA sequence analysis of a 'private' genetic variant: albumin Ortonovo (Glu-505-->Lys). Biochim Biophys Acta. 1993 Nov 25;1225(1):27-32. [Article] Madison J, Galliano M, Watkins S, Minchiotti L, Porta F, Rossi A, Putnam FW: Genetic variants of human serum albumin in Italy: point mutants and a carboxyl-terminal variant. Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6476-80. [Article] Sunthornthepvarakul T, Angkeow P, Weiss RE, Hayashi Y, Refetoff S: An identical missense mutation in the albumin gene results in familial dysalbuminemic hyperthyroxinemia in 8 unrelated families. Biochem Biophys Res Commun. 1994 Jul 29;202(2):781-7. [Article] Rushbrook JI, Becker E, Schussler GC, Divino CM: Identification of a human serum albumin species associated with familial dysalbuminemic hyperthyroxinemia. J Clin Endocrinol Metab. 1995 Feb;80(2):461-7. [Article] Wada N, Chiba H, Shimizu C, Kijima H, Kubo M, Koike T: A novel missense mutation in codon 218 of the albumin gene in a distinct phenotype of familial dysalbuminemic hyperthyroxinemia in a Japanese kindred. J Clin Endocrinol Metab. 1997 Oct;82(10):3246-50. [Article] Sunthornthepvarakul T, Likitmaskul S, Ngowngarmratana S, Angsusingha K, Kitvitayasak S, Scherberg NH, Refetoff S: Familial dysalbuminemic hypertriiodothyroninemia: a new, dominantly inherited albumin defect. J Clin Endocrinol Metab. 1998 May;83(5):1448-54. [Article] Spahr CS, Davis MT, McGinley MD, Robinson JH, Bures EJ, Beierle J, Mort J, Courchesne PL, Chen K, Wahl RC, Yu W, Luethy R, Patterson SD: Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry. I. Profiling an unfractionated tryptic digest. Proteomics. 2001 Jan;1(1):93-107. [Article] Minchiotti L, Campagnoli M, Rossi A, Cosulich ME, Monti M, Pucci P, Kragh-Hansen U, Granel B, Disdier P, Weiller PJ, Galliano M: A nucleotide insertion and frameshift cause albumin Kenitra, an extended and O-glycosylated mutant of human serum albumin with two additional disulfide bridges. Eur J Biochem. 2001 Jan;268(2):344-52. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00070Hyaluronidase (ovine)approved, investigationalunknowninhibitorDetailsDB00137Luteinapproved, investigational, nutraceuticalunknownDetailsDB00459AcitretinapprovedunknownDetailsDB00576Sulfamethizoleapproved, investigational, vet_approvedunknownDetailsDB00743Gadobenic acidapproved, investigationalunknownbinderDetailsDB00815Sodium lauryl sulfateexperimentalunknownbinderDetailsDB00936Salicylic acidapproved, investigational, vet_approvednoother/unknownDetailsDB00946Phenprocoumonapproved, investigationalnobinderregulatorDetailsDB00995Auranofinapproved, investigationalunknownDetailsDB01120GliclazideapprovedunknownDetailsDB01328Cefonicidapproved, investigationalnoother/unknownDetailsDB01329Cefoperazoneapproved, investigationalnoother/unknownDetailsDB01396Digitoxinapproved, investigationalnoDetailsDB03017Lauric acidapproved, experimentalunknownDetailsDB03193Stearic acidapproved, experimentalunknownDetailsDB03600Capric acidexperimentalnoDetailsDB03796Palmitic AcidapprovedunknownDetailsDB04224Oleic Acidapproved, investigational, vet_approvedunknownDetailsDB04557Arachidonic AcidexperimentalnoDetailsDB04711IodipamideapprovedunknownbinderDetailsDB06412Oxymetholoneapproved, illicitunknownDetailsDB01197Captoprilapprovednoother/unknownDetailsDB01050IbuprofenapprovednobinderDetailsDB00563MethotrexateapprovednobinderDetailsDB00451LevothyroxineapprovednoDetailsDB00279Liothyronineapproved, vet_approvedunknownDetailsDB00605Sulindacapproved, investigationalunknownDetailsDB00749Etodolacapproved, investigational, vet_approvedunknownDetailsDB00861Diflunisalapproved, investigationalunknownDetailsDB01009Ketoprofenapproved, vet_approvedunknownDetailsDB00586Diclofenacapproved, vet_approvedunknownDetailsDB00783Estradiolapproved, investigational, vet_approvednoDetailsDB00655EstroneapprovednoDetailsDB00624Testosteroneapproved, investigationalnobinderDetailsDB01307Insulin detemirapprovednobinderDetailsDB01418Acenocoumarolapproved, investigationalnoDetailsDB00802Alfentanilapproved, illicitunknownDetailsDB00818Propofolapproved, investigational, vet_approvednoDetailsDB00228Enfluraneapproved, investigational, vet_approvedunknownbinderDetailsDB00753Isofluraneapproved, vet_approvedunknownDetailsDB01189DesfluraneapprovedunknownbinderDetailsDB01159Halothaneapproved, vet_approvedunknownDetailsDB01236Sevofluraneapproved, vet_approvedunknownbinderDetailsDB00252Phenytoinapproved, vet_approvedunknownDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknownDetailsDB00540NortriptylineapprovednobinderDetailsDB00321AmitriptylineapprovednobinderDetailsDB00903Etacrynic acidapproved, investigationalunknownDetailsDB00695Furosemideapproved, vet_approvednobinderDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvednoDetailsDB00682WarfarinapprovednobinderregulatorDetailsDB00554Piroxicamapproved, investigationalunknownDetailsDB00573FenoprofenapprovedunknownDetailsDB00328Indomethacinapproved, investigationalunknownDetailsDB03585Oxyphenbutazoneapproved, withdrawnunknownDetailsDB00544FluorouracilapprovednoDetailsDB01232Saquinavirapproved, investigationalunknownDetailsDB01032Probenecidapproved, investigationalnoDetailsDB01044Gatifloxacinapproved, investigational, withdrawnunknownother/unknownDetailsDB01068Clonazepamapproved, illicitnoDetailsDB01147Cloxacillinapproved, investigational, vet_approvednobinderDetailsDB01327Cefazolinapprovedunknownother/unknownDetailsDB00931Metacyclineapproved, investigationalnoDetailsDB01015SulfamethoxazoleapprovednosubstrateDetailsDB00415Ampicillinapproved, vet_approvednoother/unknownDetailsDB00567Cephalexinapproved, investigational, vet_approvednobinderDetailsDB00759Tetracyclineapproved, vet_approved, withdrawnnoDetailsDB01212Ceftriaxoneapprovednoother/unknownDetailsDB01330CefotetanapprovednoDetailsDB00274Cefmetazoleapproved, investigationalnoDetailsDB00495ZidovudineapprovednoDetailsDB01397Magnesium salicylateexperimentalnoDetailsDB00788Naproxenapproved, vet_approvednoDetailsDB00334Olanzapineapproved, investigationalnobinderDetailsDB01056Tocainideapprovednoother/unknownDetailsDB01320Fosphenytoinapproved, investigationalnoother/unknownDetailsDB00712Flurbiprofenapproved, investigationalnoother/unknownDetailsDB07402AzapropazonewithdrawnunknownDetailsDB075173-CARBOXY-4-METHYL-5-PROPYL-2-FURANPROPIONICexperimentalunknownDetailsDB07992Indoxyl sulfateexperimentalunknownDetailsDB08231Myristic acidexperimentalunknownDetailsDB08496(R)-warfarinexperimentalunknownDetailsDB08735R,S-Warfarin alcoholexperimentalunknownDetailsDB08736S,R-Warfarin alcoholexperimentalunknownDetailsDB00430CefpiramideapprovedunknownDetailsDB01583LiotrixapprovedunknownDetailsDB01294Bismuth subsalicylateapproved, vet_approvednobinderDetailsDB00456Cefalotinapproved, investigational, vet_approvedunknownbinderDetailsDB01581Sulfamerazineapproved, vet_approvedunknownDetailsDB01582Sulfamethazineapproved, investigational, vet_approvedunknownDetailsDB01587KetazolamapprovedunknownDetailsDB01614Acepromazineexperimental, vet_approvedunknownDetailsDB01621Pipotiazineapproved, investigationalunknownDetailsDB04574Estrone sulfateapprovedunknownDetailsDB06710MethyltestosteroneapprovedunknownDetailsDB01622ThioproperazineexperimentalunknownDetailsDB01623ThiothixeneapprovedunknownDetailsDB06705Gadofosveset trisodiumapprovedunknownsubstrateDetailsDB00454MeperidineapprovedunknownbinderDetailsDB01016GlyburideapprovedunknownbinderDetailsDB00912Repaglinideapproved, investigationalunknownDetailsDB00731Nateglinideapproved, investigationalunknownDetailsDB08867UlipristalapprovednosubstrateDetailsDB05294VandetanibapprovedunknownbinderDetailsDB05521Telaprevirapproved, withdrawnnosubstrateDetailsDB05812AbirateroneapprovedunknownbinderDetailsDB08881VemurafenibapprovedunknownsubstrateDetailsDB08828Vismodegibapproved, investigationalunknownbinderDetailsDB08893MirabegronapprovednobinderDetailsDB00635Prednisoneapproved, vet_approvedunknownsubstrateDetailsDB08899EnzalutamideapprovednobinderDetailsDB08820IvacaftorapprovednocarrierDetailsDB00776OxcarbazepineapprovedunknownsubstrateDetailsDB06201RufinamideapprovedunknownsubstrateDetailsDB06716Fospropofolapproved, illicit, investigationalunknownsubstrateDetailsDB04855DronedaroneapprovednobinderDetailsDB06209PrasugrelapprovedunknownsubstrateDetailsDB08860PitavastatinapprovedunknownsubstrateDetailsDB01183Naloxoneapproved, vet_approvedunknownbinderDetailsDB01242Clomipramineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateDetailsDB00472Fluoxetineapproved, vet_approvedunknownsubstrateDetailsDB00317Gefitinibapproved, investigationalunknownsubstrateDetailsDB00619ImatinibapprovednobinderDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateDetailsDB00678LosartanapprovedunknownsubstrateDetailsDB00412Rosiglitazoneapproved, investigationalunknownsubstrateDetailsDB01098RosuvastatinapprovedunknownsubstrateDetailsDB00864Tacrolimusapproved, investigationalunknownsubstrateDetailsDB00717NorethisteroneapprovedunknownsubstrateDetailsDB08931RiociguatapprovedunknownsubstrateDetailsDB08895Tofacitinibapproved, investigationalunknownDetailsDB08932MacitentanapprovednobinderDetailsDB06290SimeprevirapprovednobinderDetailsDB00493CefotaximeapprovedunknownDetailsDB09280LumacaftorapprovednocarrierDetailsDB09130Copperapproved, investigationalnobinderDetailsDB11093Calcium citrateapproved, investigationalnosubstrateDetailsDB11348Calcium PhosphateapprovednosubstrateDetailsDB11575GrazoprevirapprovednosubstrateDetailsDB11943Delafloxacinapproved, investigationalnosubstrateDetailsDB01685TopiroxostatexperimentalunknownbinderDetailsDB09093Chlortetracyclineapproved, investigational, vet_approvednoDetailsDB06796Mangafodipirapproved, investigational, withdrawnunknownbinderDetailsDB09262ImidafenacininvestigationalnosubstrateDetailsDB00276Amsacrineapproved, investigationalunknownDetailsDB11359GuaiacolapprovedunknownDetailsDB03255Phenolapproved, experimentalunknownDetailsDB06728AnilineexperimentalunknownDetailsDB06713Norelgestrominapproved, investigationalunknownDetailsDB01370Aluminiumapproved, investigationalunknownDetailsDB13014HypericininvestigationalunknownDetailsDB01057EchothiophateapprovedunknownDetailsDB11397Dichlorvosvet_approvedunknownDetailsDB00677Isoflurophateapproved, investigational, withdrawnunknownDetailsDB00943Zalcitabineapproved, investigationalunknownDetailsDB01072Atazanavirapproved, investigationalnobinderDetailsDB00649Stavudineapproved, investigationalunknownDetailsDB00900DidanosineapprovedunknownDetailsDB00625Efavirenzapproved, investigationalunknownDetailsDB00879Emtricitabineapproved, investigationalunknownbinderDetailsDB00220NelfinavirapprovednobinderDetailsDB00238NevirapineapprovedunknownDetailsDB00503Ritonavirapproved, investigationalunknownsubstrateDetailsDB00709Lamivudineapproved, investigationalunknownDetailsDB04216Quercetinexperimental, investigationalunknownDetailsDB00997Doxorubicinapproved, investigationalunknownDetailsDB04816Dantronapproved, investigational, withdrawnunknownDetailsDB00755Tretinoinapproved, investigational, nutraceuticalunknownbinderDetailsDB00515CisplatinapprovedunknownDetailsDB00162Vitamin Aapproved, nutraceutical, vet_approvedunknownbinderDetailsDB04690CamptothecinexperimentalunknownDetailsDB02709ResveratrolinvestigationalunknownDetailsDB00744Zileutonapproved, investigational, withdrawnunknownDetailsDB04539GlyphosateexperimentalunknownDetailsDB11590ThimerosalapprovedunknownDetailsDB05134TanespimycininvestigationalunknownDetailsDB01124Tolbutamideapproved, investigationalunknownDetailsDB01276Exenatideapproved, investigationalunknownDetailsDB00414Acetohexamideapproved, investigational, withdrawnunknownDetailsDB00458ImipramineapprovedunknownDetailsDB00159Icosapentapproved, nutraceuticalnobinderDetailsDB00951Isoniazidapproved, investigationalunknownDetailsDB01104SertralineapprovedunknownbinderDetailsDB09383Meprednisoneapproved, investigationalunknownDetailsDB00266DicoumarolapprovedunknownDetailsDB04828ZomepiracwithdrawnunknownDetailsDB00500TolmetinapprovedunknownDetailsDB11217ArbutinapprovedunknownDetailsDB09526Hydroquinoneapproved, investigationalunknownDetailsDB00784Mefenamic acidapprovedunknownDetailsDB00313Valproic acidapproved, investigationalunknownDetailsDB01169Arsenic trioxideapproved, investigationalnosubstrateDetailsDB11828Neratinibapproved, investigationalnosubstrateDetailsDB00607Nafcillinapproved, investigationalunknownDetailsDB12483Copanlisibapproved, investigationalunknownsubstrateDetailsDB00512VancomycinapprovednosubstrateDetailsDB12001Abemaciclibapproved, investigationalunknownbinderDetailsDB08864RilpivirineapprovednobinderDetailsDB13928Semaglutideapproved, investigationalnosubstrateDetailsDB09087Potassium alumapprovedunknownbinderDetailsDB09223BlonanserininvestigationalnosubstrateDetailsDB09236Lacidipineapproved, investigationalunknownbinderDetailsDB09124Medrogestoneapproved, withdrawnnobinderDetailsDB11827Ertugliflozinapproved, investigationalnobinderDetailsDB09139Technetium Tc-99m oxidronateapprovednobinderDetailsDB13943Testosterone cypionateapprovednoother/unknownDetailsDB13944Testosterone enanthateapprovednoother/unknownDetailsDB13946Testosterone undecanoateapproved, investigationalnobinderDetailsDB13952Estradiol acetateapproved, investigational, vet_approvednoDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvednoDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvednoDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvednoDetailsDB13956Estradiol valerateapproved, investigational, vet_approvednoDetailsDB11638Artenimolapproved, experimental, investigationalunknownligandDetailsDB01420Testosterone propionateapproved, investigational, vet_approved, withdrawnnosubstrateDetailsDB09195LorpiprazoleapprovednosubstrateDetailsDB09204ArotinololinvestigationalnosubstrateDetailsDB08814Triflusalapproved, investigationalnosubstrateDetailsDB09229AranidipineexperimentalnobinderDetailsDB09333Iopodic acidapproved, investigational, withdrawnnosubstrateDetailsDB09347Acetrizoic acidwithdrawnnobinderDetailsDB09348Propiolactoneapproved, withdrawnnobinderDetailsDB11130Opiumapproved, illicitnobinderDetailsDB06778Cupric sulfateapprovedunknownDetailsDB09053IbrutinibapprovednosubstrateDetailsDB11182Rose bengalapproved, investigationalunknownbinderDetailsDB13967Patent BlueapprovedyesbinderDetailsDB13909Bismuth subgallateapprovedunknowncarrierDetailsDB09418Potassium perchlorateapproved, investigationalunknownbinderDetailsDB11641Vinflunineapproved, investigationalnosubstrateDetailsDB13421Edoxudineapproved, investigational, withdrawnnobinderDetailsDB11134Cupric oxideapprovedunknownbinderDetailsDB11148Butambenapproved, withdrawnnosubstrateDetailsDB11637Delamanidapproved, investigationalunknownsubstrateDetailsDB13751Glycyrrhizic acidapproved, experimentalnobinderDetailsDB12965Silverapproved, investigationalunknownbinderDetailsDB14185Aripiprazole lauroxilapproved, investigationalunknownbinderDetailsDB14481Calcium phosphate dihydrateapprovednoDetailsDB14517Aluminium phosphateapproved, investigationalunknownDetailsDB14518Aluminum acetateapproved, investigationalunknownDetailsDB00432Trifluridineapproved, investigationalunknownbinderDetailsDB14582Patisiranapproved, investigationalunknownligandDetailsDB09213Dexibuprofenapproved, investigationalnoDetailsDB12455Omadacyclineapproved, investigationalunknownDetailsDB12836Grapiprantinvestigational, vet_approvednosubstrateDetailsDB11753Rifamycinapproved, investigationalnosubstrateDetailsDB11963Dacomitinibapproved, investigationalnobinderDetailsDB11855Revefenacinapproved, investigationalnobinderDetailsDB12141Gilteritinibapproved, investigationalnobinderDetailsDB06480PrucaloprideapprovedunknownbinderDetailsDB11978Glasdegibapproved, investigationalnobinderDetailsDB00214TorasemideapprovedunknownsubstrateDetailsDB00227Lovastatinapproved, investigationalnosubstrateDetailsDB09564Insulin degludecapprovednobinderDetailsDB00245BenzatropineapprovednobinderDetailsDB00264Metoprololapproved, investigationalnobinderDetailsDB00286Conjugated estrogensapprovednobinderDetailsDB00289AtomoxetineapprovednobinderDetailsDB00294Etonogestrelapproved, investigationalnobinderDetailsDB00295Morphineapproved, investigationalnobinderDetailsDB00310ChlorthalidoneapprovednoDetailsDB00304DesogestrelapprovednobinderDetailsDB00327Hydromorphoneapproved, illicitnobinderDetailsDB09073Palbociclibapproved, investigationalnobinderDetailsDB00332Ipratropiumapproved, experimentalnobinderDetailsDB01142Doxepinapproved, investigationalnobinderDetailsDB01076AtorvastatinapprovednobinderDetailsDB06655LiraglutideapprovedunknownbinderDetailsDB01235LevodopaapprovedunknownbinderDetailsDB01238Aripiprazoleapproved, investigationalunknownbinderDetailsDB00404Alprazolamapproved, illicit, investigationalunknownbinderDetailsDB00421SpironolactoneapprovedunknownbinderDetailsDB00335AtenololapprovednosubstrateDetailsDB01126Dutasterideapproved, investigationalnobinderDetailsDB09299Tenofovir alafenamideapprovednobinderDetailsDB00343Diltiazemapproved, investigationalnobinderDetailsDB14126Tenofovirexperimental, investigationalnobinderDetailsDB00476DuloxetineapprovedunknownligandDetailsDB00497Oxycodoneapproved, illicit, investigationalunknownbinderDetailsDB00481Raloxifeneapproved, investigationalnobinderDetailsDB00537Ciprofloxacinapproved, investigationalunknownbinderDetailsDB00461NabumetoneapprovedunknownDetailsDB00982IsotretinoinapprovedunknownbinderDetailsDB00584Enalaprilapproved, vet_approvednobinderDetailsDB01067Glipizideapproved, investigationalnobinderDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedunknownbinderDetailsDB00737MeclizineapprovednobinderDetailsDB00768OlopatadineapprovednobinderDetailsDB00571Propranololapproved, investigationalunknownDetailsDB00575ClonidineapprovedunknownbinderDetailsDB00787AcyclovirapprovedunknownbinderDetailsDB00490Buspironeapproved, investigationalunknownbinderDetailsDB01029Irbesartanapproved, investigationalunknownbinderDetailsDB06282LevocetirizineapprovedunknownbinderDetailsDB00598LabetalolapprovedunknownsubstrateDetailsDB01026Ketoconazoleapproved, investigationalunknownligandDetailsDB00675TamoxifenapprovedunknownsubstrateDetailsDB12978Pexidartinibapproved, investigationalunknownbinderDetailsDB01136Carvedilolapproved, investigationalunknownbinderDetailsDB04861Nebivololapproved, investigationalunknownbinderDetailsDB01611HydroxychloroquineapprovedunknownbinderDetailsDB01045RifampicinapprovedunknownligandDetailsDB01394ColchicineapprovedunknownbinderDetailsDB00333MethadoneapprovednoDetailsDB11757Istradefyllineapproved, investigationalunknownbinderDetailsDB00620Triamcinoloneapproved, vet_approvedunknownbinderDetailsDB00924CyclobenzaprineapprovedunknownsubstrateDetailsDB00881Quinaprilapproved, investigationalunknownbinderDetailsDB09079NintedanibapprovedunknownsubstrateDetailsDB00999Hydrochlorothiazideapproved, vet_approvedunknownbinderDetailsDB01241GemfibrozilapprovedunknownbinderDetailsDB01039FenofibrateapprovedunknownbinderDetailsDB01062Oxybutyninapproved, investigationalunknownbinderDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknownbinderDetailsDB01275HydralazineapprovedunknownbinderDetailsDB01195Flecainideapproved, withdrawnunknownbinderDetailsDB00687Fludrocortisoneapproved, investigationalunknownsubstrateDetailsDB00316AcetaminophenapprovedunknownbinderDetailsDB00278Argatrobanapproved, investigationalunknownbinderDetailsDB06216AsenapineapprovedunknownbinderDetailsDB15444Elexacaftorapproved, investigationalunknownsubstrateDetailsDB00860Prednisoloneapproved, vet_approvedunknownbinderDetailsDB15566Prednisolone acetateapproved, vet_approvedunknownbinderDetailsDB11703Acalabrutinibapproved, investigationalunknownbinderDetailsDB14513Magnesiumapproved, experimental, investigationalunknownDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknownbinderDetailsDB00661VerapamilapprovedunknownsubstrateDetailsDB00273TopiramateapprovedunknownbinderDetailsDB06119Cenobamateapproved, investigationalunknownbinderDetailsDB01222BudesonideapprovedunknownbinderDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknownbinderDetailsDB00950Fexofenadineapproved, investigationalunknownsubstrateDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownbinderDetailsDB09237Levamlodipineapproved, investigationalunknownbinderDetailsDB12941Darolutamideapproved, investigationalunknownbinderDetailsDB14879Cefiderocolapproved, investigationalnoligandDetailsDB00852PseudoephedrineapprovedunknownbinderDetailsDB00983Formoterolapproved, investigationalunknownsubstrateDetailsDB00993AzathioprineapprovedunknownbinderDetailsDB00557HydroxyzineapprovedunknownsubstrateregulatorDetailsDB01118Amiodaroneapproved, investigationalunknownbinderDetailsDB01069Promethazineapproved, investigationalunknownbinderDetailsDB01115NifedipineapprovedunknownbinderDetailsDB01132Pioglitazoneapproved, investigationalunknownsubstrateDetailsDB00814Meloxicamapproved, vet_approvedunknownDetailsDB00938SalmeterolapprovedunknownbinderDetailsDB00878Chlorhexidineapproved, vet_approved, withdrawnunknownsubstrateDetailsDB01006Letrozoleapproved, investigationalunknownbinderDetailsDB00246ZiprasidoneapprovedunknownDetailsDB01060Amoxicillinapproved, vet_approvedunknownbinderDetailsDB01137Levofloxacinapproved, investigationalunknownsubstrateDetailsDB09100Thyroid, porcineapprovedunknownbinderDetailsDB01013Clobetasol propionateapprovedunknownbinderDetailsDB00957Norgestimateapproved, investigationalunknownbinderDetailsDB00977EthinylestradiolapprovedunknownbinderDetailsDB00555Lamotrigineapproved, investigationalunknownsubstrateDetailsDB01264DarunavirapprovedunknownsubstrateDetailsDB00608Chloroquineapproved, investigational, vet_approvedunknownbinderDetailsDB12466Favipiravirapproved, investigationalunknowncarrierDetailsDB01601LopinavirapprovedunknownsubstrateDetailsDB14999Human interferon betaapproved, investigationalunknownbinderDetailsDB00126Ascorbic acidapproved, nutraceuticalunknownbinderDetailsDB00443Betamethasoneapproved, vet_approvedunknownDetailsDB05382Iodineapproved, investigationalunknownbinderDetailsDB11642Pitolisantapproved, investigationalnobinderDetailsDB00152Thiamineapproved, investigational, nutraceutical, vet_approvedunknownbinderDetailsDB00165Pyridoxineapproved, investigational, nutraceutical, vet_approvedunknownbinderDetailsDB00595Oxytetracyclineapproved, investigational, vet_approvedunknownbinderDetailsDB00870Suprofenapproved, withdrawnunknownbinderDetailsDB00774Hydroflumethiazideapproved, investigational, withdrawnunknownbinderDetailsDB09241Methylene blueapproved, investigationalunknownbinderDetailsDB15534Colchiceineapproved, experimentalunknownsubstrateDetailsDB01053Benzylpenicillinapproved, vet_approvedunknownbinderDetailsDB01324PolythiazideapprovedunknownbinderDetailsDB07565Chloramphenicol succinateapprovedunknownbinderDetailsDB01914D-glucoseapproved, investigational, vet_approvedunknownbinderDetailsDB14533Zinc chlorideapproved, investigationalunknownbinderDetailsDB11689Selumetinibapproved, investigationalunknowncarrierDetailsDB04911Oritavancinapproved, investigationalunknownbinderDetailsDB14548Zinc sulfate, unspecified formapproved, experimentalunknownbinderDetailsDB00734Risperidoneapproved, investigationalunknownbinderDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknownbinderDetailsDB01364EphedrineapprovedunknownbinderDetailsDB00237Butabarbitalapproved, illicitunknownbinderDetailsDB01133Tiludronic acidapproved, investigational, vet_approvedunknownbinderDetailsDB14840RipretinibapprovedunknownbinderDetailsDB00845Clofazimineapproved, investigationalunknownbinderDetailsDB00842OxazepamapprovedunknownbinderDetailsDB00714Apomorphineapproved, investigationalunknownbinderDetailsDB09274Artesunateapproved, investigationalunknownbinderDetailsDB15690Fluoroestradiol F-18approvedunknownbinderDetailsDB00808IndapamideapprovedunknownbinderDetailsDB08816TicagrelorapprovedunknownbinderDetailsDB14669Betamethasone phosphateapproved, vet_approvedunknownbinderDetailsDB12674Lurbinectedinapproved, investigationalunknownbinderDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknownbinderDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknownbinderDetailsDB00104Octreotideapproved, investigationalunknownbinderDetailsDB11677Triheptanoinapproved, investigationalunknownbinderDetailsDB12404Remimazolamapproved, investigationalunknownbinderDetailsDB11796Fostemsavirapproved, investigationalunknowncarrierDetailsDB15305Risdiplamapproved, investigationalunknownbinderDetailsDB11820Nifurtimoxapproved, investigationalunknownbinderDetailsDB00847Cysteamineapproved, investigationalunknownbinderDetailsDB15093Somapacitanapproved, investigationalunknownbinderDetailsDB00908Quinidineapproved, investigationalunknownbinderDetailsDB15935Lumasiranapproved, investigationalnobinderDetailsDB04951Pirfenidoneapproved, investigationalunknownbinderDetailsDB11853Relugolixapproved, investigationalunknownbinderDetailsDB01380Cortisone acetateapproved, investigationalunknownbinderDetailsDB15248Bulevirtideapproved, investigationalunknownbinderDetailsDB00501Cimetidineapproved, investigationalunknownsubstrateDetailsDB15456Vericiguatapproved, investigationalunknownbinderDetailsDB11751Cabotegravirapproved, investigationalunknownbinderDetailsDB15133Tepotinibapproved, investigationalunknownbinderDetailsDB06151Acetylcysteineapproved, investigationalunknownbinderDetailsDB00346Alfuzosinapproved, investigationalunknownbinderDetailsDB00376TrihexyphenidylapprovedunknownbinderDetailsDB00391Sulpirideapproved, investigationalnobinderDetailsDB01083Orlistatapproved, investigationalunknownbinderDetailsDB08877RuxolitinibapprovedunknownbinderDetailsDB00640Adenosineapproved, investigationalunknownbinderDetailsDB00853Temozolomideapproved, investigationalnobinderDetailsDB06237AvanafilapprovedunknownbinderDetailsDB04854FebuxostatapprovedunknownbinderDetailsDB01086Benzocaineapproved, investigationalunknownbinderDetailsDB11800Tivozanibapproved, investigationalunknownbinderDetailsDB00080Daptomycinapproved, investigationalnobinderDetailsDB00434CyproheptadineapprovedunknownbinderDetailsDB00083Botulinum toxin type Aapproved, investigationalunknownbinderDetailsDB00968MethyldopaapprovednobinderDetailsDB08995Diosminapproved, investigationalunknownbinderDetailsDB08822Azilsartan medoxomilapproved, investigationalnobinderDetailsDB00438CeftazidimeapprovednobinderDetailsDB09069Trimetazidineapproved, investigationalunknownbinderDetailsDB00601Linezolidapproved, investigationalnobinderDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownbinderDetailsDB12235Estetrolapproved, investigationalunknownbinderDetailsDB01064Isoprenalineapproved, investigationalunknownbinderDetailsDB12471Ibrexafungerpapproved, investigationalunknownbinderDetailsDB06695Dabigatran etexilateapprovedunknownbinderDetailsDB16165Finerenoneapproved, investigationalunknownbinderDetailsDB16703Belumosudilapproved, investigationalnobinderDetailsDB00877Sirolimusapproved, investigationalnobinderDetailsDB06234Maribavirapproved, investigationalnobinderDetailsDB14973Abrocitinibapproved, investigationalnobinderDetailsDB15575Padeliporfinapproved, experimentalunknownbinderDetailsDB09070Tiboloneapproved, investigationalunknownbinderDetailsDB04847Roxadustatapproved, investigationalunknownbinderDetailsDB09074OlaparibapprovedunknownbinderDetailsDB15171Tirzepatideapproved, investigationalunknownbinderDetailsDB13959Medium-chain triglyceridesapprovedunknownbinderDetailsDB06813Pralatrexateapproved, investigationalnobinderDetailsDB00342Terfenadineapproved, withdrawnunknownbinderregulatorDetailsDB13514Pranoprofenexperimental, investigationalnoregulatorDetailsDB00427TriprolidineapprovedunknownbinderregulatorDetailsDB00485Dicloxacillinapproved, investigational, vet_approvedunknownbinderregulatorDetailsDB01173OrphenadrineapprovedunknownbinderregulatorDetailsDB01619PhenindamineapprovedunknownbinderregulatorDetailsDB00792Tripelennamineapproved, vet_approvedunknownbinderregulatorDetailsDB08912Dabrafenibapproved, investigationalnobinderDetailsDB16699Vutrisiranapproved, investigationalunknownligandDetailsDB06150Sulfadimethoxineapproved, vet_approved, withdrawnunknownsubstrateDetailsDB00254Doxycyclineapproved, investigational, vet_approvedunknownsubstratebinderDetailsDB08936ChlorcyclizineapprovedunknownregulatorDetailsDB00568Cinnarizineapproved, investigationalunknownregulatorDetailsDB01176CyclizineapprovedunknownregulatorDetailsDB00366Doxylamineapproved, vet_approvedunknownregulatorDetailsDB00850PerphenazineapprovedunknownregulatorDetailsDB01024Mycophenolic acidapproved, investigationalunknownbinderDetailsDB08865Crizotinibapproved, investigationalunknownbinderDetailsDB13310OrmeloxifeneexperimentalunknownbinderDetailsDB00758ClopidogrelapprovednobinderDetailsDB15149Futibatinibapproved, investigationalnobinderDetailsDB08930DolutegravirapprovednobinderDetailsDB17083LinzagolixapprovednobinderDetailsDB11739Vonoprazanapproved, investigationalunknownbinderDetailsDB11793Niraparibapproved, investigationalunknownbinderDetailsDB00642Pemetrexedapproved, investigationalnobinderDetailsDB12243Edaravoneapproved, investigationalnobinderDetailsDB00795SulfasalazineapprovednobinderDetailsDB00303Ertapenemapproved, investigationalnobinderDetailsDB01119DiazoxideapprovedunknownbinderDetailsDB01101Capecitabineapproved, investigationalnobinderDetailsDB00363ClozapineapprovednobinderDetailsDB00349Clobazamapproved, illicitnobinderDetailsDB00770Alprostadilapproved, investigationalunknownbinderDetailsDB00683Midazolamapproved, illicitnobinderDetailsDB11901Apalutamideapproved, investigationalnobinderDetailsDB09128Brexpiprazoleapproved, investigationalnosubstrateDetailsDB08906Fluticasone furoateapprovednobinderDetailsDB12255Vadadustatapproved, investigationalunknownbinderDetailsDB09076UmeclidiniumapprovednobinderDetailsDB01005HydroxyureaapprovednobinderDetailsDB00526Oxaliplatinapproved, investigationalnobinderDetailsDB06772CabazitaxelapprovedunknownbinderDetailsDB12874Quizartinibapproved, investigationalnobinderDetailsDB01042MelphalanapprovedunknownbinderDetailsDB08903BedaquilineapprovednobinderDetailsDB11718Encorafenibapproved, investigationalnobinderDetailsDB11967Binimetinibapproved, investigationalnobinderDetails"
                    }
                }
            ],
            "transporters": [
                {
                    "Label": "P-glycoprotein 1",
                    "Detailed Info": {
                        "Name": "Multidrug resistance protein 1",
                        "Synonyms": "3.6.3.44\nATP-binding cassette sub-family B member 1\nMDR1\nP-glycoprotein 1\nPGY1",
                        "Gene Name": "ABCB1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0037114|Multidrug resistance protein 1\nMDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLYMVVGTLAAII\nHGAGLPLMMLVFGEMTDIFANAGNLEDLMSNITNRSDINDTGFFMNLEEDMTRYAYYYSG\nIGAGVLVAAYIQVSFWCLAAGRQIHKIRKQFFHAIMRQEIGWFDVHDVGELNTRLTDDVS\nKINEGIGDKIGMFFQSMATFFTGFIVGFTRGWKLTLVILAISPVLGLSAAVWAKILSSFT\nDKELLAYAKAGAVAEEVLAAIRTVIAFGGQKKELERYNKNLEEAKRIGIKKAITANISIG\nAAFLLIYASYALAFWYGTTLVLSGEYSIGQVLTVFFSVLIGAFSVGQASPSIEAFANARG\nAAYEIFKIIDNKPSIDSYSKSGHKPDNIKGNLEFRNVHFSYPSRKEVKILKGLNLKVQSG\nQTVALVGNSGCGKSTTVQLMQRLYDPTEGMVSVDGQDIRTINVRFLREIIGVVSQEPVLF\nATTIAENIRYGRENVTMDEIEKAVKEANAYDFIMKLPHKFDTLVGERGAQLSGGQKQRIA\nIARALVRNPKILLLDEATSALDTESEAVVQVALDKARKGRTTIVIAHRLSTVRNADVIAG\nFDDGVIVEKGNHDELMKEKGIYFKLVTMQTAGNEVELENAADESKSEIDALEMSSNDSRS\nSLIRKRSTRRSVRGSQAQDRKLSTKEALDESIPPVSFWRIMKLNLTEWPYFVVGVFCAII\nNGGLQPAFAIIFSKIIGVFTRIDDPETKRQNSNLFSLLFLALGIISFITFFLQGFTFGKA\nGEILTKRLRYMVFRSMLRQDVSWFDDPKNTTGALTTRLANDAAQVKGAIGSRLAVITQNI\nANLGTGIIISFIYGWQLTLLLLAIVPIIAIAGVVEMKMLSGQALKDKKELEGSGKIATEA\nIENFRTVVSLTQEQKFEHMYAQSLQVPYRNSLRKAHIFGITFSFTQAMMYFSYAGCFRFG\nAYLVAHKLMSFEDVLLVFSAVVFGAMAVGQVSSFAPDYAKAKISAAHIIMIIEKTPLIDS\nYSTEGLMPNTLEGNVTFGEVVFNYPTRPDIPVLQGLSLEVKKGQTLALVGSSGCGKSTVV\nQLLERFYDPLAGKVLLDGKEIKRLNVQWLRAHLGIVSQEPILFDCSIAENIAYGDNSRVV\nSQEEIVRAAKEANIHAFIESLPNKYSTKVGDKGTQLSGGQKQRIAIARALVRQPHILLLD\nEATSALDTESEKVVQEALDKAREGRTCIVIAHRLSTIQNADLIVVFQNGRVKEHGTHQQL\nLAQKGIYFSMVSVQAGTKRQ",
                        "Number of residues": "1280",
                        "Molecular Weight": "141477.255",
                        "Theoretical pI": "9.44",
                        "GO Classification": "FunctionsATP binding / ATPase activity, coupled to transmembrane movement of substances / transporter activity / xenobiotic-transporting ATPase activityProcessesdrug transmembrane transport / G2/M transition of mitotic cell cycle / response to drug / small molecule metabolic process / stem cell proliferation / transmembrane transport / transportComponentscell surface / extracellular exosome / integral component of membrane / membrane / plasma membrane",
                        "General Function": "Xenobiotic-transporting atpase activity",
                        "Specific Function": "Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells.",
                        "Pfam Domain Function": "ABC_tran (PF00005)\nABC_membrane (PF00664)",
                        "Transmembrane Regions": "45-67\n117-137\n187-208\n216-236\n293-316\n331-352\n712-732\n757-777\n833-853\n855-874\n935-957\n974-995",
                        "Cellular Location": "Cell membrane",
                        "Gene sequence": ">lcl|BSEQ0016291|Multidrug resistance protein 1 (ABCB1)\nATGGATCTTGAAGGGGACCGCAATGGAGGAGCAAAGAAGAAGAACTTTTTTAAACTGAAC\nAATAAAAGTGAAAAAGATAAGAAGGAAAAGAAACCAACTGTCAGTGTATTTTCAATGTTT\nCGCTATTCAAATTGGCTTGACAAGTTGTATATGGTGGTGGGAACTTTGGCTGCCATCATC\nCATGGGGCTGGACTTCCTCTCATGATGCTGGTGTTTGGAGAAATGACAGATATCTTTGCA\nAATGCAGGAAATTTAGAAGATCTGATGTCAAACATCACTAATAGAAGTGATATCAATGAT\nACAGGGTTCTTCATGAATCTGGAGGAAGACATGACCAGGTATGCCTATTATTACAGTGGA\nATTGGTGCTGGGGTGCTGGTTGCTGCTTACATTCAGGTTTCATTTTGGTGCCTGGCAGCT\nGGAAGACAAATACACAAAATTAGAAAACAGTTTTTTCATGCTATAATGCGACAGGAGATA\nGGCTGGTTTGATGTGCACGATGTTGGGGAGCTTAACACCCGACTTACAGATGATGTCTCC\nAAGATTAATGAAGGAATTGGTGACAAAATTGGAATGTTCTTTCAGTCAATGGCAACATTT\nTTCACTGGGTTTATAGTAGGATTTACACGTGGTTGGAAGCTAACCCTTGTGATTTTGGCC\nATCAGTCCTGTTCTTGGACTGTCAGCTGCTGTCTGGGCAAAGATACTATCTTCATTTACT\nGATAAAGAACTCTTAGCGTATGCAAAAGCTGGAGCAGTAGCTGAAGAGGTCTTGGCAGCA\nATTAGAACTGTGATTGCATTTGGAGGACAAAAGAAAGAACTTGAAAGGTACAACAAAAAT\nTTAGAAGAAGCTAAAAGAATTGGGATAAAGAAAGCTATTACAGCCAATATTTCTATAGGT\nGCTGCTTTCCTGCTGATCTATGCATCTTATGCTCTGGCCTTCTGGTATGGGACCACCTTG\nGTCCTCTCAGGGGAATATTCTATTGGACAAGTACTCACTGTATTCTTTTCTGTATTAATT\nGGGGCTTTTAGTGTTGGACAGGCATCTCCAAGCATTGAAGCATTTGCAAATGCAAGAGGA\nGCAGCTTATGAAATCTTCAAGATAATTGATAATAAGCCAAGTATTGACAGCTATTCGAAG\nAGTGGGCACAAACCAGATAATATTAAGGGAAATTTGGAATTCAGAAATGTTCACTTCAGT\nTACCCATCTCGAAAAGAAGTTAAGATCTTGAAGGGTCTGAACCTGAAGGTGCAGAGTGGG\nCAGACGGTGGCCCTGGTTGGAAACAGTGGCTGTGGGAAGAGCACAACAGTCCAGCTGATG\nCAGAGGCTCTATGACCCCACAGAGGGGATGGTCAGTGTTGATGGACAGGATATTAGGACC\nATAAATGTAAGGTTTCTACGGGAAATCATTGGTGTGGTGAGTCAGGAACCTGTATTGTTT\nGCCACCACGATAGCTGAAAACATTCGCTATGGCCGTGAAAATGTCACCATGGATGAGATT\nGAGAAAGCTGTCAAGGAAGCCAATGCCTATGACTTTATCATGAAACTGCCTCATAAATTT\nGACACCCTGGTTGGAGAGAGAGGGGCCCAGTTGAGTGGTGGGCAGAAGCAGAGGATCGCC\nATTGCACGTGCCCTGGTTCGCAACCCCAAGATCCTCCTGCTGGATGAGGCCACGTCAGCC\nTTGGACACAGAAAGCGAAGCAGTGGTTCAGGTGGCTCTGGATAAGGCCAGAAAAGGTCGG\nACCACCATTGTGATAGCTCATCGTTTGTCTACAGTTCGTAATGCTGACGTCATCGCTGGT\nTTCGATGATGGAGTCATTGTGGAGAAAGGAAATCATGATGAACTCATGAAAGAGAAAGGC\nATTTACTTCAAACTTGTCACAATGCAGACAGCAGGAAATGAAGTTGAATTAGAAAATGCA\nGCTGATGAATCCAAAAGTGAAATTGATGCCTTGGAAATGTCTTCAAATGATTCAAGATCC\nAGTCTAATAAGAAAAAGATCAACTCGTAGGAGTGTCCGTGGATCACAAGCCCAAGACAGA\nAAGCTTAGTACCAAAGAGGCTCTGGATGAAAGTATACCTCCAGTTTCCTTTTGGAGGATT\nATGAAGCTAAATTTAACTGAATGGCCTTATTTTGTTGTTGGTGTATTTTGTGCCATTATA\nAATGGAGGCCTGCAACCAGCATTTGCAATAATATTTTCAAAGATTATAGGGGTTTTTACA\nAGAATTGATGATCCTGAAACAAAACGACAGAATAGTAACTTGTTTTCACTATTGTTTCTA\nGCCCTTGGAATTATTTCTTTTATTACATTTTTCCTTCAGGGTTTCACATTTGGCAAAGCT\nGGAGAGATCCTCACCAAGCGGCTCCGATACATGGTTTTCCGATCCATGCTCAGACAGGAT\nGTGAGTTGGTTTGATGACCCTAAAAACACCACTGGAGCATTGACTACCAGGCTCGCCAAT\nGATGCTGCTCAAGTTAAAGGGGCTATAGGTTCCAGGCTTGCTGTAATTACCCAGAATATA\nGCAAATCTTGGGACAGGAATAATTATATCCTTCATCTATGGTTGGCAACTAACACTGTTA\nCTCTTAGCAATTGTACCCATCATTGCAATAGCAGGAGTTGTTGAAATGAAAATGTTGTCT\nGGACAAGCACTGAAAGATAAGAAAGAACTAGAAGGTTCTGGGAAGATCGCTACTGAAGCA\nATAGAAAACTTCCGAACCGTTGTTTCTTTGACTCAGGAGCAGAAGTTTGAACATATGTAT\nGCTCAGAGTTTGCAGGTACCATACAGAAACTCTTTGAGGAAAGCACACATCTTTGGAATT\nACATTTTCCTTCACCCAGGCAATGATGTATTTTTCCTATGCTGGATGTTTCCGGTTTGGA\nGCCTACTTGGTGGCACATAAACTCATGAGCTTTGAGGATGTTCTGTTAGTATTTTCAGCT\nGTTGTCTTTGGTGCCATGGCCGTGGGGCAAGTCAGTTCATTTGCTCCTGACTATGCCAAA\nGCCAAAATATCAGCAGCCCACATCATCATGATCATTGAAAAAACCCCTTTGATTGACAGC\nTACAGCACGGAAGGCCTAATGCCGAACACATTGGAAGGAAATGTCACATTTGGTGAAGTT\nGTATTCAACTATCCCACCCGACCGGACATCCCAGTGCTTCAGGGACTGAGCCTGGAGGTG\nAAGAAGGGCCAGACGCTGGCTCTGGTGGGCAGCAGTGGCTGTGGGAAGAGCACAGTGGTC\nCAGCTCCTGGAGCGGTTCTACGACCCCTTGGCAGGGAAAGTGCTGCTTGATGGCAAAGAA\nATAAAGCGACTGAATGTTCAGTGGCTCCGAGCACACCTGGGCATCGTGTCCCAGGAGCCC\nATCCTGTTTGACTGCAGCATTGCTGAGAACATTGCCTATGGAGACAACAGCCGGGTGGTG\nTCACAGGAAGAGATTGTGAGGGCAGCAAAGGAGGCCAACATACATGCCTTCATCGAGTCA\nCTGCCTAATAAATATAGCACTAAAGTAGGAGACAAAGGAACTCAGCTCTCTGGTGGCCAG\nAAACAACGCATTGCCATAGCTCGTGCCCTTGTTAGACAGCCTCATATTTTGCTTTTGGAT\nGAAGCCACGTCAGCTCTGGATACAGAAAGTGAAAAGGTTGTCCAAGAAGCCCTGGACAAA\nGCCAGAGAAGGCCGCACCTGCATTGTGATTGCTCACCGCCTGTCCACCATCCAGAATGCA\nGACTTAATAGTGGTGTTTCAGAATGGCAGAGTCAAGGAGCATGGCACGCATCAGCAGCTG\nCTGGCACAGAAAGGCATCTATTTTTCAATGGTCAGTGTCCAGGCTGGAACAAAGCGCCAG\nTGA",
                        "Chromosome Location": "7",
                        "Locus": "7q21.1",
                        "External Identifiers": "ResourceLinkUniProtKB IDP08183UniProtKB Entry NameMDR1_HUMANGenBank Protein ID307180GenBank Gene IDM14758GenAtlas IDABCB1HGNC IDHGNC:40",
                        "General References": "Chen CJ, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, Roninson IB: Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell. 1986 Nov 7;47(3):381-9. [Article] Chen CJ, Clark D, Ueda K, Pastan I, Gottesman MM, Roninson IB: Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins. J Biol Chem. 1990 Jan 5;265(1):506-14. [Article] Chen G, Duran GE, Steger KA, Lacayo NJ, Jaffrezou JP, Dumontet C, Sikic BI: Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins. J Biol Chem. 1997 Feb 28;272(9):5974-82. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, Wagner-McPherson C, Layman D, Maas J, Jaeger S, Walker R, Wylie K, Sekhon M, Becker MC, O'Laughlin MD, Schaller ME, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Cordes M, Du H, Sun H, Edwards J, Bradshaw-Cordum H, Ali J, Andrews S, Isak A, Vanbrunt A, Nguyen C, Du F, Lamar B, Courtney L, Kalicki J, Ozersky P, Bielicki L, Scott K, Holmes A, Harkins R, Harris A, Strong CM, Hou S, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Leonard S, Rohlfing T, Rock SM, Tin-Wollam AM, Abbott A, Minx P, Maupin R, Strowmatt C, Latreille P, Miller N, Johnson D, Murray J, Woessner JP, Wendl MC, Yang SP, Schultz BR, Wallis JW, Spieth J, Bieri TA, Nelson JO, Berkowicz N, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Bedell JA, Mardis ER, Clifton SW, Chissoe SL, Marra MA, Raymond C, Haugen E, Gillett W, Zhou Y, James R, Phelps K, Iadanoto S, Bubb K, Simms E, Levy R, Clendenning J, Kaul R, Kent WJ, Furey TS, Baertsch RA, Brent MR, Keibler E, Flicek P, Bork P, Suyama M, Bailey JA, Portnoy ME, Torrents D, Chinwalla AT, Gish WR, Eddy SR, McPherson JD, Olson MV, Eichler EE, Green ED, Waterston RH, Wilson RK: The DNA sequence of human chromosome 7. Nature. 2003 Jul 10;424(6945):157-64. [Article] Gekeler V, Weger S, Probst H: mdr1/P-glycoprotein gene segments analyzed from various human leukemic cell lines exhibiting different multidrug resistance profiles. Biochem Biophys Res Commun. 1990 Jun 15;169(2):796-802. [Article] Kioka N, Tsubota J, Kakehi Y, Komano T, Gottesman MM, Pastan I, Ueda K: P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance. Biochem Biophys Res Commun. 1989 Jul 14;162(1):224-31. [Article] Kerb R, Hoffmeyer S, Brinkmann U: ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2. Pharmacogenomics. 2001 Feb;2(1):51-64. [Article] Begley GS, Horvath AR, Taylor JC, Higgins CF: Cytoplasmic domains of the transporter associated with antigen processing and P-glycoprotein interact with subunits of the proteasome. Mol Immunol. 2005 Jan;42(1):137-41. [Article] Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP: A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7. doi: 10.1073/pnas.0805139105. Epub 2008 Jul 31. [Article] Burkard TR, Planyavsky M, Kaupe I, Breitwieser FP, Burckstummer T, Bennett KL, Superti-Furga G, Colinge J: Initial characterization of the human central proteome. BMC Syst Biol. 2011 Jan 26;5:17. doi: 10.1186/1752-0509-5-17. [Article] Katayama K, Yamaguchi M, Noguchi K, Sugimoto Y: Protein phosphatase complex PP5/PPP2R3C dephosphorylates P-glycoprotein/ABCB1 and down-regulates the expression and function. Cancer Lett. 2014 Apr 1;345(1):124-31. doi: 10.1016/j.canlet.2013.12.007. Epub 2013 Dec 11. [Article] Choi KH, Chen CJ, Kriegler M, Roninson IB: An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene. Cell. 1988 May 20;53(4):519-29. [Article] Mickley LA, Lee JS, Weng Z, Zhan Z, Alvarez M, Wilson W, Bates SE, Fojo T: Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors. Blood. 1998 Mar 1;91(5):1749-56. [Article] Decleves X, Chevillard S, Charpentier C, Vielh P, Laplanche JL: A new polymorphism (N21D) in the exon 2 of the human MDR1 gene encoding the P-glycoprotein. Hum Mutat. 2000 May;15(5):486. [Article] Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M, Brinkmann U: Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3473-8. [Article] Cascorbi I, Gerloff T, Johne A, Meisel C, Hoffmeyer S, Schwab M, Schaeffeler E, Eichelbaum M, Brinkmann U, Roots I: Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther. 2001 Mar;69(3):169-74. [Article] Honda T, Dan Y, Koyabu N, Ieiri I, Otsubo K, Higuchi S, Ohtani H, Sawada Y: Polymorphism of MDR1 gene in healthy japanese subjects: a novel SNP with an amino acid substitution (Glu108Lys). Drug Metab Pharmacokinet. 2002;17(5):479-81. [Article] Itoda M, Saito Y, Komamura K, Ueno K, Kamakura S, Ozawa S, Sawada J: Twelve novel single nucleotide polymorphisms in ABCB1/MDR1 among Japanese patients with ventricular tachycardia who were administered amiodarone. Drug Metab Pharmacokinet. 2002;17(6):566-71. [Article] Saito S, Iida A, Sekine A, Miura Y, Ogawa C, Kawauchi S, Higuchi S, Nakamura Y: Three hundred twenty-six genetic variations in genes encoding nine members of ATP-binding cassette, subfamily B (ABCB/MDR/TAP), in the Japanese population. J Hum Genet. 2002;47(1):38-50. [Article] Brant SR, Panhuysen CI, Nicolae D, Reddy DM, Bonen DK, Karaliukas R, Zhang L, Swanson E, Datta LW, Moran T, Ravenhill G, Duerr RH, Achkar JP, Karban AS, Cho JH: MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet. 2003 Dec;73(6):1282-92. Epub 2003 Nov 7. [Article] Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE: The consensus coding sequences of human breast and colorectal cancers. Science. 2006 Oct 13;314(5797):268-74. Epub 2006 Sep 7. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00171ATPinvestigational, nutraceuticalunknownDetailsDB00778Roxithromycinapproved, investigational, withdrawnunknownDetailsDB04881ElacridarinvestigationalunknownDetailsDB04905TesmilifeneinvestigationalyesinducerDetailsDB05449FM-VP4investigationalunknownDetailsDB06240TariquidarinvestigationalunknownDetailsDB06191ZosuquidarinvestigationalyesinhibitorDetailsDB00661VerapamilapprovedunknownsubstrateinhibitorDetailsDB01232Saquinavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00220NelfinavirapprovednosubstrateinhibitorinducerDetailsDB00224IndinavirapprovedunknownsubstrateinhibitorinducerDetailsDB00701Amprenavirapproved, investigationalunknownsubstrateinducerDetailsDB01045RifampicinapprovedunknowninducerDetailsDB00206Reserpineapproved, investigational, withdrawnunknownsubstrateinhibitorinducerDetailsDB01115NifedipineapprovedunknownsubstrateinducerDetailsDB00834Mifepristoneapproved, investigationalunknowninhibitorinducerDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00257Clotrimazoleapproved, vet_approvedunknowninhibitorinducerDetailsDB00564Carbamazepineapproved, investigationalunknowninducerDetailsDB00656Trazodoneapproved, investigationalunknowninducerDetailsDB01149Nefazodoneapproved, withdrawnunknowninhibitorinducerDetailsDB00503Ritonavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00390DigoxinapprovedunknownsubstrateinhibitorinducerDetailsDB00279Liothyronineapproved, vet_approvedunknowninducerDetailsDB00451LevothyroxineapprovedunknowninducerDetailsDB00440Trimethoprimapproved, vet_approvedunknownsubstrateDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateinhibitorinducerDetailsDB02261Platelet Activating FactorexperimentalunknownsubstrateinducerDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00501Cimetidineapproved, investigationalunknownsubstrateinducerDetailsDB04630Aldosteroneexperimental, investigationalunknownsubstrateinducerDetailsDB00864Tacrolimusapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00877Sirolimusapproved, investigationalnosubstrateinhibitorinducerDetailsDB01174Phenobarbitalapproved, investigationalunknownsubstrateinducerDetailsDB00199Erythromycinapproved, investigational, vet_approvednosubstrateinhibitorDetailsDB01118Amiodaroneapproved, investigationalunknowninhibitorinducerDetailsDB01323St. John's Wortapproved, investigational, nutraceuticalunknowninducerDetailsDB00541Vincristineapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00570VinblastineapprovedunknownsubstrateinhibitorinducerDetailsDB02659Cholic AcidapprovedunknowninducerDetailsDB00675TamoxifenapprovedunknownsubstrateinhibitorinducerDetailsDB00428Streptozocinapproved, investigationalunknowninducerDetailsDB01204Mitoxantroneapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00997Doxorubicinapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00694DaunorubicinapprovedunknownsubstrateinhibitorinducerDetailsDB00908Quinidineapproved, investigationalunknownsubstrateinhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB01388Mibefradilinvestigational, withdrawnunknownsubstrateinhibitorDetailsDB04540Cholesterolapproved, investigationalunknowninhibitorDetailsDB00358Mefloquineapproved, investigationalunknownsubstrateinhibitorDetailsDB00622Nicardipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00381AmlodipineapprovedunknownsubstrateinhibitorDetailsDB00972AzelastineapprovedunknowninhibitorDetailsDB00863Ranitidineapproved, withdrawnunknownsubstrateinhibitorDetailsDB00773EtoposideapprovedunknownsubstrateinhibitorDetailsDB00333MethadoneapprovedunknowninhibitorDetailsDB00641SimvastatinapprovedunknowninhibitorDetailsDB00227Lovastatinapproved, investigationalunknowninhibitorDetailsDB01076AtorvastatinapprovednosubstrateinhibitorDetailsDB01229Paclitaxelapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00457PrazosinapprovedunknownsubstrateinhibitormodulatorDetailsDB01054Nitrendipineapproved, investigationalunknowninhibitorDetailsDB00975DipyridamoleapprovedunknownsubstrateinhibitorDetailsDB00343Diltiazemapproved, investigationalunknownsubstrateinhibitorDetailsDB01394ColchicineapprovedunknownsubstrateinducerDetailsDB01211ClarithromycinapprovedunknownsubstrateinhibitorDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00970Dactinomycinapproved, investigationalunknownsubstrateinhibitorDetailsDB13179TroleandomycinapprovedunknowninhibitorDetailsDB00831Trifluoperazineapproved, investigationalunknowninhibitorDetailsDB00342Terfenadineapproved, withdrawnunknowninhibitorDetailsDB00468QuinineapprovedunknownsubstrateinhibitorDetailsDB01167Itraconazoleapproved, investigationalunknowninhibitorDetailsDB00328Indomethacinapproved, investigationalunknownsubstrateinhibitorDetailsDB02587Colforsinexperimental, investigationalunknowninhibitorDetailsDB00623FluphenazineapprovedunknowninhibitorDetailsDB01023Felodipineapproved, investigationalunknowninhibitorDetailsDB01136Carvedilolapproved, investigationalunknowninhibitorDetailsDB00421SpironolactoneapprovedunknowninducerDetailsDB00281Lidocaineapproved, vet_approvedunknowninhibitorDetailsDB00537Ciprofloxacinapproved, investigationalunknownsubstrateDetailsDB00207AzithromycinapprovedunknownsubstrateinhibitorDetailsDB00316AcetaminophenapprovedunknownsubstrateinhibitorDetailsDB00196Fluconazoleapproved, investigationalunknowninhibitorDetailsDB00213PantoprazoleapprovedunknownsubstrateinhibitorDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00448Lansoprazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00678LosartanapprovedunknownsubstrateinhibitorDetailsDB00584Enalaprilapproved, vet_approvedunknowninhibitorDetailsDB00590DoxazosinapprovedunknowninhibitorDetailsDB01340CilazaprilapprovedunknowninhibitorDetailsDB01197CaptoprilapprovedunknowninhibitorDetailsDB00796Candesartan cilexetilapprovedunknowninhibitorDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB00696ErgotamineapprovedunknowninhibitorDetailsDB01253ErgometrineapprovedunknowninhibitorDetailsDB00320Dihydroergotamineapproved, investigationalunknowninhibitorDetailsDB01200Bromocriptineapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00836LoperamideapprovedunknownsubstrateDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedunknowninhibitorDetailsDB00802Alfentanilapproved, illicitunknowninhibitorDetailsDB00401NisoldipineapprovedunknowninhibitorDetailsDB04832Zimelidineapproved, withdrawnunknowninhibitorDetailsDB00382Tacrineapproved, investigational, withdrawnunknownsubstrateDetailsDB00669Sumatriptanapproved, investigationalunknownsubstrateDetailsDB01037Selegilineapproved, investigational, vet_approvedunknowninhibitorDetailsDB00458ImipramineapprovedunknownsubstrateDetailsDB00502HaloperidolapprovedunknownsubstrateinhibitorDetailsDB00176Fluvoxamineapproved, investigationalunknowninhibitorDetailsDB00690Flurazepamapproved, illicit, investigationalunknowninhibitorDetailsDB00472Fluoxetineapproved, vet_approvedunknowninhibitorDetailsDB01142Doxepinapproved, investigationalunknownsubstrateDetailsDB01151Desipramineapproved, investigationalunknowninhibitorDetailsDB01242Clomipramineapproved, investigational, vet_approvedunknowninhibitorDetailsDB01239Chlorprothixeneapproved, experimental, investigational, withdrawnunknowninhibitorDetailsDB00490Buspironeapproved, investigationalunknowninhibitorDetailsDB01100PimozideapprovedunknowninhibitorDetailsDB00295Morphineapproved, investigationalnosubstrateDetailsDB00602Ivermectinapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00741Hydrocortisoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00637Astemizoleapproved, withdrawnunknowninhibitorDetailsDB00508Triflupromazineapproved, vet_approvedunknowninhibitorDetailsDB00344ProtriptylineapprovedunknowninhibitorDetailsDB01069Promethazineapproved, investigationalunknowninhibitorDetailsDB01244Bepridilapproved, withdrawnunknowninhibitorDetailsDB00455Loratadineapproved, investigationalnosubstrateinhibitorDetailsDB00967Desloratadineapproved, investigationalunknowninhibitorDetailsDB00285VenlafaxineapprovedunknownsubstrateinhibitorDetailsDB01104SertralineapprovedunknowninhibitorDetailsDB00234Reboxetineapproved, experimentalunknowninhibitorDetailsDB00715Paroxetineapproved, investigationalunknowninhibitorDetailsDB00215CitalopramapprovedunknownsubstrateinhibitorDetailsDB01196Estramustineapproved, investigationalunknowninhibitorDetailsDB04348Taurocholic acidapproved, experimentalunknownsubstrateinhibitorDetailsDB00875Flupentixolapproved, investigational, withdrawnunknowninhibitorDetailsDB00351Megestrol acetateapproved, investigational, vet_approvedunknowninhibitorDetailsDB02010StaurosporineexperimentalunknowninhibitorDetailsDB01103QuinacrineinvestigationalunknowninhibitorDetailsDB01645GenisteininvestigationalunknowninhibitorDetailsDB04216Quercetinexperimental, investigationalunknowninhibitorDetailsDB01137Levofloxacinapproved, investigationalunknownsubstrateinhibitorDetailsDB03467NaringeninexperimentalunknowndownregulatorDetailsDB01016GlyburideapprovedunknowninhibitorDetailsDB00950Fexofenadineapproved, investigationalunknownsubstrateDetailsDB00726TrimipramineapprovedunknownsubstrateDetailsDB00571Propranololapproved, investigationalunknownsubstrateDetailsDB00635Prednisoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00276Amsacrineapproved, investigationalunknowninhibitorDetailsDB00027Gramicidin DapprovedunknownsubstrateinhibitorDetailsDB01086Benzocaineapproved, investigationalunknowninhibitorDetailsDB01601LopinavirapprovedunknowninhibitorinducerDetailsDB00520CaspofunginapprovedunknowninhibitorDetailsDB00175PravastatinapprovednosubstrateDetailsDB00619ImatinibapprovednosubstrateinhibitorDetailsDB00398Sorafenibapproved, investigationalunknownsubstrateinhibitorDetailsDB01268Sunitinibapproved, investigationalunknowninhibitorDetailsDB01162TerazosinapprovedunknowninhibitorDetailsDB00470Dronabinolapproved, illicitunknowninhibitorDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknowninhibitorDetailsDB00966Telmisartanapproved, investigationalunknowninhibitorDetailsDB01254Dasatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00317Gefitinibapproved, investigationalunknownsubstrateinhibitorDetailsDB04868Nilotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00655EstroneapprovedunknownsubstrateinducerDetailsDB01259Lapatinibapproved, investigationalunknowninhibitorDetailsDB01263Posaconazoleapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00365Grepafloxacinapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB01396Digitoxinapproved, investigationalunknownsubstrateDetailsDB01208Sparfloxacinapproved, investigational, withdrawnunknownsubstrateDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB01224QuetiapineapprovedunknownsubstrateDetailsDB00334Olanzapineapproved, investigationalnosubstrateDetailsDB00363ClozapineapprovedunknownsubstrateDetailsDB01183Naloxoneapproved, vet_approvedunknownsubstrateDetailsDB04690CamptothecinexperimentalunknownsubstrateDetailsDB00860Prednisoloneapproved, vet_approvedunknownsubstrateDetailsDB01193Acebutololapproved, investigationalunknownsubstrateDetailsDB01050IbuprofenapprovedunknownsubstrateDetailsDB00945Acetylsalicylic acidapproved, vet_approvedunknownsubstrateinducermodulatorDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB00443Betamethasoneapproved, vet_approvedunknownsubstrateDetailsDB00539Toremifeneapproved, investigationalunknownsubstrateDetailsDB00255Diethylstilbestrolapproved, investigational, withdrawnunknownsubstrateDetailsDB00882Clomifeneapproved, investigationalunknownsubstrateDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstratedownregulatorregulatorDetailsDB01248Docetaxelapproved, investigationalunknownsubstrateDetailsDB00563MethotrexateapprovedunknownsubstrateDetailsDB00373TimololapprovedunknownsubstrateDetailsDB01203NadololapprovedunknownsubstrateDetailsDB00523Alitretinoinapproved, investigationalunknownsubstrateDetailsDB01339Vecuroniumapproved, investigationalunknownsubstrateDetailsDB04840Debrisoquineapproved, investigationalunknownsubstrateDetailsDB00441GemcitabineapprovednosubstrateDetailsDB01030Topotecanapproved, investigationalunknownsubstrateDetailsDB02901Stanoloneillicit, investigationalunknownsubstrateDetailsDB00751Epinastineapproved, investigationalunknownsubstrateDetailsDB00717NorethisteroneapprovedunknowninhibitorDetailsDB04573Estriolapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB03203SphingosineexperimentalunknownsubstrateDetailsDB00439Cerivastatinapproved, withdrawnunknownsubstrateDetailsDB00286Conjugated estrogensapprovedunknownsubstrateDetailsDB01202LevetiracetamapprovedunknownsubstrateDetailsDB00252Phenytoinapproved, vet_approvedunknownsubstrateDetailsDB00585NizatidineapprovedunknownsubstrateDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00555Lamotrigineapproved, investigationalunknownsubstrateinhibitorDetailsDB01261Sitagliptinapproved, investigationalunknownsubstrateDetailsDB01072Atazanavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB01169Arsenic trioxideapproved, investigationalunknowninhibitorDetailsDB06772CabazitaxelapprovedunknownsubstrateinhibitorDetailsDB01583LiotrixapprovedunknowninducerDetailsDB06287TemsirolimusapprovedunknownsubstrateinhibitorDetailsDB01587KetazolamapprovedunknownsubstrateDetailsDB04877VoacamineexperimentalunknowninhibitorDetailsDB00977EthinylestradiolapprovedunknownsubstrateDetailsDB01182PropafenoneapprovedunknowninhibitorDetailsDB00216Eletriptanapproved, investigationalunknownsubstrateDetailsDB04855DronedaroneapprovednoinhibitorDetailsDB06176Romidepsinapproved, investigationalunknownsubstrateDetailsDB06207SilodosinapprovedunknownsubstrateDetailsDB06414EtravirineapprovedunknowninhibitorDetailsDB06228RivaroxabanapprovedunknownsubstrateDetailsDB06695Dabigatran etexilateapprovedunknownsubstrateDetailsDB00973EzetimibeapprovedunknownsubstrateDetailsDB06702FesoterodineapprovedunknownsubstrateDetailsDB06212TolvaptanapprovednosubstrateinhibitorDetailsDB08860PitavastatinapprovedunknownsubstrateDetailsDB06589PazopanibapprovedunknownsubstrateDetailsDB08864RilpivirineapprovedunknowninhibitorDetailsDB08873Boceprevirapproved, withdrawnunknowninhibitorDetailsDB05521Telaprevirapproved, withdrawnunknownsubstrateinhibitorDetailsDB08874FidaxomicinapprovednosubstrateDetailsDB05039IndacaterolapprovedunknownsubstrateDetailsDB00349Clobazamapproved, illicitnosubstrateDetailsDB08882LinagliptinapprovedunknownsubstrateDetailsDB08827Lomitapideapproved, investigationalnoinhibitorDetailsDB08816TicagrelorapprovedunknownsubstrateinhibitorDetailsDB08865Crizotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB06605ApixabanapprovedunknownsubstrateDetailsDB06626Axitinibapproved, investigationalnosubstrateinhibitorDetailsDB08828Vismodegibapproved, investigationalunknownsubstrateDetailsDB08889Carfilzomibapproved, investigationalunknownsubstrateinhibitorDetailsDB08893MirabegronapprovedunknownsubstrateinhibitorDetailsDB08896RegorafenibapprovedunknownsubstrateinhibitorDetailsDB08899EnzalutamideapprovednoinhibitorDetailsDB08820IvacaftorapprovednoinhibitorDetailsDB06616BosutinibapprovednosubstrateDetailsDB08901Ponatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB08906Fluticasone furoateapprovednosubstrateinducerDetailsDB08907CanagliflozinapprovedunknownsubstrateinhibitorDetailsDB08910PomalidomideapprovedunknownsubstrateDetailsDB00480LenalidomideapprovednosubstrateDetailsDB08912Dabrafenibapproved, investigationalnosubstrateDetailsDB05773Trastuzumab emtansineapproved, investigationalunknownsubstrateDetailsDB00495ZidovudineapprovedunknownsubstrateDetailsDB00758ClopidogrelapprovednosubstrateDetailsDB08916AfatinibapprovedunknownsubstrateinhibitorDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateDetailsDB00709Lamivudineapproved, investigationalunknownsubstrateDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB08918Levomilnacipranapproved, investigationalunknownsubstrateDetailsDB06290SimeprevirapprovedunknownsubstrateinhibitorDetailsDB08934SofosbuvirapprovednosubstrateDetailsDB06292DapagliflozinapprovedunknownsubstrateDetailsDB09076UmeclidiniumapprovednosubstrateDetailsDB09075EdoxabanapprovednosubstrateDetailsDB09063CeritinibapprovednosubstrateDetailsDB09078Lenvatinibapproved, investigationalnosubstrateinhibitorDetailsDB09079NintedanibapprovednosubstrateinhibitorDetailsDB09054IdelalisibapprovednosubstrateinhibitorDetailsDB09065CobicistatapprovedunknowninhibitorDetailsDB09291Rolapitantapproved, investigationalnoinhibitorDetailsDB09102Daclatasvirapproved, investigationalunknownsubstrateinhibitorDetailsDB06636Isavuconazoniumapproved, investigationalnoinhibitorDetailsDB06603Panobinostatapproved, investigationalnosubstrateDetailsDB09330OsimertinibapprovednosubstrateDetailsDB11362SelexipagapprovednosubstrateDetailsDB06403Ambrisentanapproved, investigationalunknownsubstrateDetailsDB09296Ombitasvirapproved, investigationalnosubstrateDetailsDB11574ElbasvirapprovednosubstrateinhibitorDetailsDB11575GrazoprevirapprovednosubstrateDetailsDB09161Technetium Tc-99m sestamibiapproved, investigationalnosubstrateDetailsDB11581Venetoclaxapproved, investigationalnosubstrateinhibitorDetailsDB05015Belinostatapproved, investigationalunknownsubstrateDetailsDB11613Velpatasvirapproved, investigationalnosubstrateinhibitorDetailsDB09027LedipasvirapprovednosubstratetransporterDetailsDB09198LobeglitazoneexperimentalnoDetailsDB09031Miltefosineapproved, investigationalunknownDetailsDB09280LumacaftorapprovednoinhibitorinducerDetailsDB11828Neratinibapproved, investigationalunknowninhibitorDetailsDB12026Voxilaprevirapproved, investigationalnosubstrateinhibitorDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB05889Inotuzumab ozogamicinapproved, investigationalunknownsubstrateDetailsDB13878Pibrentasvirapproved, investigationalunknownsubstrateinhibitorDetailsDB13879Glecaprevirapproved, investigationalunknownsubstrateinhibitorDetailsDB12483Copanlisibapproved, investigationalunknownsubstrateDetailsDB12001Abemaciclibapproved, investigationalunknownsubstrateinhibitorDetailsDB12364Betrixabanapproved, investigationalnosubstrateDetailsDB13919CandesartanexperimentalunknowninhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateinhibitorDetailsDB12332Rucaparibapproved, investigationalnosubstrateinhibitorDetailsDB09270Ubidecarenoneapproved, investigational, nutraceuticalnosubstrateDetailsDB11827Ertugliflozinapproved, investigationalnosubstrateDetailsDB13943Testosterone cypionateapprovedunknowninhibitorDetailsDB13944Testosterone enanthateapprovedunknowninhibitorDetailsDB13946Testosterone undecanoateapproved, investigationalunknowninhibitorDetailsDB09160Technetium Tc-99m tetrofosminapprovednobinderDetailsDB13951Stanolone acetateexperimentalunknownsubstrateDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateDetailsDB01420Testosterone propionateapproved, investigational, vet_approved, withdrawnnosubstrateDetailsDB11901Apalutamideapproved, investigationalunknowninducerDetailsDB11633Isavuconazoleapproved, investigationalunknowninhibitorDetailsDB11251Tocopherolapproved, investigationalnotransporterDetailsDB14003alpha-Tocopherol acetateapprovednosubstrateDetailsDB09099Somatostatinapproved, investigationalunknownsubstrateDetailsDB11635TocofersolanapprovedunknownantagonistDetailsDB11641Vinflunineapproved, investigationalnosubstrateDetailsDB11672Curcuminapproved, investigationalunknowninhibitorDetailsDB11995Avatrombopagapproved, investigationalunknownsubstrateDetailsDB09297Paritaprevirapproved, investigationalunknownsubstrateDetailsDB09183DasabuvirapprovedunknownsubstrateDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedunknownDetailsDB14062Concanamycin AexperimentalyesinhibitorDetailsDB14061HycanthoneexperimentalyesinhibitorDetailsDB14063DexverapamilexperimentalyesinhibitorDetailsDB14064EmopamilexperimentalyesinhibitorDetailsDB14065LomerizineexperimentalyesinhibitorDetailsDB14066TetrandrineexperimentalunknowninhibitorDetailsDB14067Dofequidarexperimental, investigationalunknowninhibitorDetailsDB14068DexniguldipineexperimentalunknowninhibitorDetailsDB14069ONT-093investigationalyesinhibitorDetailsDB14070HM-30181experimentalyesinhibitorDetailsDB14071DesmethylsertralineexperimentalunknowninhibitorDetailsDB14072Reversin 121experimentalyesinhibitorDetailsDB14146LoxicodegolinvestigationalunknownDetailsDB14538Hydrocortisone aceponateexperimental, vet_approvedunknownDetailsDB14539Hydrocortisone acetateapproved, vet_approvedunknownDetailsDB14540Hydrocortisone butyrateapproved, vet_approvedunknownDetailsDB14541Hydrocortisone cypionateapproved, investigational, vet_approvedunknownDetailsDB14542Hydrocortisone phosphateapproved, vet_approvedunknownDetailsDB14543Hydrocortisone probutateapproved, vet_approvedunknownDetailsDB14544Hydrocortisone valerateapproved, vet_approvedunknownDetailsDB14568Ivosidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB11979Elagolixapproved, investigationalunknownsubstrateinhibitorDetailsDB13867Fluticasoneapproved, experimentalnosubstrateDetailsDB00608Chloroquineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00613Amodiaquineapproved, investigationalunknowninhibitorDetailsDB01087PrimaquineapprovedunknowninhibitorDetailsDB01611HydroxychloroquineapprovedunknowninhibitorDetailsDB01267PaliperidoneapprovedunknownsubstrateinhibitorDetailsDB05928DovitinibinvestigationalunknowninhibitorDetailsDB13125Lusutrombopagapproved, investigationalunknownsubstrateDetailsDB14635Curcumin sulfateexperimentalunknownDetailsDB14641Estriol tripropionateexperimentalunknownDetailsDB11952Duvelisibapproved, investigationalnosubstrateDetailsDB09213Dexibuprofenapproved, investigationalunknownDetailsDB11760Talazoparibapproved, investigationalunknownsubstrateDetailsDB12455Omadacyclineapproved, investigationalunknownsubstrateDetailsDB12836Grapiprantinvestigational, vet_approvednosubstrateDetailsDB12035Sarecyclineapproved, investigationalunknowninhibitorDetailsDB11753Rifamycinapproved, investigationalnosubstrateinhibitorDetailsDB11963Dacomitinibapproved, investigationalnosubstrateinhibitorDetailsDB11855Revefenacinapproved, investigationalnosubstrateDetailsDB12141Gilteritinibapproved, investigationalnosubstrateDetailsDB14126Tenofovirexperimental, investigationalnosubstrateDetailsDB00300Tenofovir disoproxilapproved, investigationalunknownsubstrateinhibitorDetailsDB09299Tenofovir alafenamideapprovedunknownsubstrateDetailsDB01264DarunavirapprovedunknownsubstrateinhibitorinducerDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateinhibitorDetailsDB00862VardenafilapprovedunknownsubstrateinhibitorDetailsDB00776OxcarbazepineapprovedunknownsubstrateDetailsDB00248CabergolineapprovednosubstrateDetailsDB06480PrucaloprideapprovednosubstrateDetailsDB00734Risperidoneapproved, investigationalunknownsubstrateDetailsDB01117AtovaquoneapprovednoinhibitorDetailsDB00788Naproxenapproved, vet_approvednoinhibitorDetailsDB00615Rifabutinapproved, investigationalunknowninducerDetailsDB12582PiperineinvestigationalunknowninhibitorDetailsDB11978Glasdegibapproved, investigationalnosubstrateinhibitorDetailsDB09074OlaparibapprovednosubstrateinhibitorDetailsDB00243Ranolazineapproved, investigationalnosubstrateinhibitorDetailsDB00321AmitriptylineapprovedunknownsubstrateDetailsDB00341CetirizineapprovednosubstrateinhibitorDetailsDB09073Palbociclibapproved, investigationalnosubstrateinhibitorDetailsDB01079Tegaserodapproved, investigational, withdrawnunknownsubstrateDetailsDB13867Fluticasoneapproved, experimentalunknownsubstrateDetailsDB12147Erdafitinibapproved, investigationalnosubstrateinhibitorDetailsDB00736Esomeprazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00476DuloxetineapprovedunknowninhibitorDetailsDB00481Raloxifeneapproved, investigationalunknownsubstrateDetailsDB12015Alpelisibapproved, investigationalunknowninhibitorDetailsDB11712Tezacaftorapproved, investigationalnosubstrateinhibitorDetailsDB00768OlopatadineapprovednosubstrateDetailsDB00698Nitrofurantoinapproved, vet_approvedunknownsubstrateDetailsDB00451LevothyroxineapprovednoinducerDetailsDB00394Beclomethasone dipropionateapproved, investigationalunknownsubstrateinducerDetailsDB00612BisoprololapprovedunknownsubstrateinhibitorDetailsDB00916MetronidazoleapprovedunknowninhibitorDetailsDB00482Celecoxibapproved, investigationalunknownsubstrateDetailsDB11986Entrectinibapproved, investigationalunknownsubstrateinhibitorDetailsDB12500Fedratinibapproved, investigationalunknownsubstrateinhibitorDetailsDB12825Lefamulinapproved, investigationalunknownsubstrateDetailsDB01222BudesonideapprovednosubstrateDetailsDB11757Istradefyllineapproved, investigationalunknowninhibitorDetailsDB01233Metoclopramideapproved, investigationalunknownsubstrateDetailsDB01175EscitalopramapprovedunknownsubstrateDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknowninhibitorDetailsDB01217Anastrozoleapproved, investigationalunknownsubstrateDetailsDB01195Flecainideapproved, withdrawnunknownsubstrateDetailsDB01418Acenocoumarolapproved, investigationalunknownsubstrateDetailsDB05676Apremilastapproved, investigationalunknownsubstrateDetailsDB11732Lasmiditanapproved, investigationalunknownsubstrateinhibitorDetailsDB11586Asunaprevirapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB15444Elexacaftorapproved, investigationalnosubstrateinhibitorDetailsDB15566Prednisolone acetateapproved, vet_approvedunknownsubstrateDetailsDB15035Zanubrutinibapproved, investigationalnosubstrateDetailsDB00273TopiramateapprovedunknownsubstrateDetailsDB09237Levamlodipineapproved, investigationalunknownsubstrateDetailsDB14962Trastuzumab deruxtecanapproved, investigationalnosubstrateDetailsDB13007Enfortumab vedotinapproved, investigationalunknownsubstrateDetailsDB11951Lemborexantapproved, investigationalunknownsubstrateDetailsDB12941Darolutamideapproved, investigationalunknownsubstrateDetailsDB15091Upadacitinibapproved, investigationalnosubstrateinhibitorDetailsDB15328Ubrogepantapproved, investigationalunknownsubstrateDetailsDB15233Avapritinibapproved, investigationalunknowninhibitormodulatorDetailsDB00993AzathioprineapprovedunknownsubstrateDetailsDB00557HydroxyzineapprovedunknownsubstrateDetailsDB11077Polyethylene glycol 400approvedunknowninhibitorDetailsDB12887Tazemetostatapproved, investigationalunknownsubstrateDetailsDB01006Letrozoleapproved, investigationalunknownsubstrateDetailsDB00246ZiprasidoneapprovedunknownDetailsDB01190Clindamycinapproved, vet_approvedunknownsubstrateDetailsDB09287Polyethylene glycolapproved, vet_approvednoinhibitorDetailsDB00957Norgestimateapproved, investigationalunknowninhibitorDetailsDB11770TalinololinvestigationalunknownsubstrateDetailsDB04881ElacridarinvestigationalunknowninhibitorDetailsDB00932Tipranavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB11869ValspodarinvestigationalunknowninhibitorDetailsDB00518Albendazoleapproved, vet_approvednosubstrateDetailsDB05239Cobimetinibapproved, investigationalnosubstrateDetailsDB06670OdanacatibinvestigationalunknownsubstrateDetailsDB04877VoacamineexperimentalnoinhibitorDetailsDB08930DolutegravirapprovednosubstrateDetailsDB00586Diclofenacapproved, vet_approvedunknowninducerDetailsDB11817Baricitinibapproved, investigationalunknownsubstrateDetailsDB11363Alectinibapproved, investigationalunknowninhibitorDetailsDB14723Larotrectinibapproved, investigationalunknownsubstrateDetailsDB00588Fluticasone propionateapprovedunknownsubstrateDetailsDB11430Monensinexperimental, vet_approvedunknownsubstrateDetailsDB03825Rhodamine 6GexperimentalunknownsubstrateDetailsDB09239NiguldipineexperimentalunknowninhibitorDetailsDB04851BiricodarinvestigationalunknowninhibitorDetailsDB06240TariquidarinvestigationalunknowninhibitorDetailsDB12799LaniquidarinvestigationalunknowninhibitorDetailsDB12923GallopamilinvestigationalunknowninhibitorDetailsDB06420AnnamycininvestigationalunknownDetailsDB00540NortriptylineapprovedunknownsubstrateDetailsDB00454MeperidineapprovedunknownsubstrateDetailsDB00652Pentazocineapproved, vet_approvedunknownsubstrateDetailsDB00818Propofolapproved, investigational, vet_approvedunknowninducerDetailsDB01590EverolimusapprovedunknownsubstrateinhibitorDetailsDB01212CeftriaxoneapprovedunknowninhibitorDetailsDB00872Conivaptanapproved, investigationalunknowninhibitorDetailsDB11544Salinomycinvet_approvedunknowninhibitorDetailsDB00909Zonisamideapproved, investigationalunknowninhibitorDetailsDB14057ValinomycinexperimentalunknownsubstrateinhibitorDetailsDB04908Flibanserinapproved, investigationalunknowninhibitorDetailsDB09039Eliglustatapproved, investigationalnosubstrateinhibitorDetailsDB01128BicalutamideapprovedunknowninhibitorDetailsDB00648MitotaneapprovedunknowninhibitorDetailsDB06448Lonafarnibapproved, investigationalnosubstrateinhibitorDetailsDB04960TipifarnibinvestigationalunknowninhibitorDetailsDB09048Netupitantapproved, investigationalunknowninhibitorDetailsDB09034Suvorexantapproved, investigationalunknownDetailsDB09030VorapaxarapprovedunknownDetailsDB05294VandetanibapprovedunknowninhibitorDetailsDB14062Concanamycin AexperimentalunknowninhibitorDetailsDB14061HycanthoneexperimentalunknowninhibitorDetailsDB08881VemurafenibapprovedunknownsubstrateinhibitorDetailsDB14063DexverapamilexperimentalunknowninhibitorDetailsDB14064EmopamilexperimentalunknowninhibitorDetailsDB14065LomerizineexperimentalunknowninhibitorDetailsDB14066TetrandrineexperimentalunknowninhibitorDetailsDB14069ONT-093investigationalunknowninhibitorDetailsDB14067Dofequidarexperimental, investigationalunknowninhibitorDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknowninhibitorDetailsDB12457Rimegepantapproved, investigationalunknownsubstrateDetailsDB12466Favipiravirapproved, investigationalunknowninhibitorDetailsDB00253MedrysoneapprovedunknownsubstrateDetailsDB09241Methylene blueapproved, investigationalunknownsubstrateinhibitorDetailsDB12612Ozanimodapproved, investigationalunknownsubstrateDetailsDB08868Fingolimodapproved, investigationalnoinhibitorDetailsDB07565Chloramphenicol succinateapprovedunknownsubstrateDetailsDB11689Selumetinibapproved, investigationalunknownsubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknownsubstrateinducerDetailsDB11652Tucatinibapproved, investigationalunknownsubstrateDetailsDB15102Pemigatinibapproved, investigationalnosubstrateinhibitorDetailsDB00315Zolmitriptanapproved, investigationalnoDetailsDB14761Remdesivirapproved, investigationalunknownsubstrateDetailsDB11791Capmatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB04845Ixabepiloneapproved, investigationalunknownsubstrateinhibitorDetailsDB15685Selpercatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB14840RipretinibapprovedunknownsubstrateinhibitorDetailsDB00845Clofazimineapproved, investigationalunknownsubstrateinhibitorDetailsDB09038EmpagliflozinapprovedunknownsubstrateDetailsDB06419CethromycininvestigationalunknownsubstrateinhibitorDetailsDB00674GalantamineapprovednoinhibitorDetailsDB09026Aliskirenapproved, investigationalnosubstrateDetailsDB09274Artesunateapproved, investigationalunknownsubstrateDetailsDB00188Bortezomibapproved, investigationalnosubstrateDetailsDB14669Betamethasone phosphateapproved, vet_approvedunknownsubstrateinducerDetailsDB12674Lurbinectedinapproved, investigationalunknownsubstrateinhibitorDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00104Octreotideapproved, investigationalunknownsubstrateDetailsDB11796Fostemsavirapproved, investigationalunknownsubstrateDetailsDB15719Belantamab mafodotinapprovedunknownsubstrateDetailsDB15305Risdiplamapproved, investigationalunknownsubstrateDetailsDB15822Pralsetinibapproved, investigationalnosubstrateinhibitorDetailsDB14845Filgotinibapproved, investigationalunknownsubstrateDetailsDB15982BerotralstatapprovednosubstrateinhibitorDetailsDB11853Relugolixapproved, investigationalunknownsubstrateinhibitorDetailsDB14895Vibegronapproved, investigationalnosubstrateDetailsDB01380Cortisone acetateapproved, investigationalunknownsubstrateinducerDetailsDB11632Opicaponeapproved, investigationalnosubstrateDetailsDB15456Vericiguatapproved, investigationalunknownsubstrateDetailsDB11751Cabotegravirapproved, investigationalunknownsubstrateDetailsDB11693Voclosporinapproved, investigationalunknownsubstrateinhibitorDetailsDB15133Tepotinibapproved, investigationalnosubstrateinhibitorDetailsDB00052Somatotropinapproved, investigationalunknownsubstrateDetailsDB00346Alfuzosinapproved, investigationalunknownsubstrateDetailsDB15442Trilaciclibapproved, investigationalunknownsubstrateDetailsDB14989Umbralisibapproved, investigational, withdrawnunknowninhibitorDetailsDB00391Sulpirideapproved, investigationalunknownsubstrateDetailsDB00853Temozolomideapproved, investigationalnosubstrateDetailsDB06237AvanafilapprovedunknownsubstrateDetailsDB11800Tivozanibapproved, investigationalunknownsubstrateDetailsDB00080Daptomycinapproved, investigationalnosubstrateDetailsDB06288Amisulprideapproved, investigationalnosubstrateDetailsDB08995Diosminapproved, investigationalunknowninhibitorDetailsDB04876Vildagliptinapproved, investigationalnosubstrateDetailsDB08822Azilsartan medoxomilapproved, investigationalnoinhibitorDetailsDB00360Sapropterinapproved, investigationalunknowninhibitorDetailsDB05667Levoketoconazoleapproved, investigationalnoinhibitorDetailsDB16222Loncastuximab tesirineapproved, investigationalunknownsubstrateDetailsDB15569Sotorasibapproved, investigationalunknowninhibitorDetailsDB11886Infigratinibapproved, investigationalnosubstrateinhibitorDetailsDB12471Ibrexafungerpapproved, investigationalunknownsubstratetransporterDetailsDB16703Belumosudilapproved, investigationalnosubstrateinhibitorDetailsDB16261Odevixibatapproved, investigationalunknownsubstrateDetailsDB15463Belzutifanapproved, investigationalnosubstrateDetailsDB16220Lonapegsomatropinapproved, investigationalunknownsubstrateDetailsDB16390Mobocertinibapproved, investigationalunknownsubstrateinhibitorDetailsDB16732Tisotumab vedotinapprovednosubstrateDetailsDB16098Atogepantapproved, investigationalnosubstrateDetailsDB08931RiociguatapprovednosubstrateDetailsDB15011Avacopanapproved, investigationalnosubstrateDetailsDB12597Asciminibapproved, investigationalnosubstrateinhibitorDetailsDB06234Maribavirapproved, investigationalnoinhibitorDetailsDB16691Nirmatrelvirapproved, investigationalnosubstrateinhibitorDetailsDB12713Sotagliflozinapproved, investigationalnoinhibitorDetailsDB14973Abrocitinibapproved, investigationalunknowninhibitorDetailsDB16236Mitapivatapproved, investigationalnosubstrateinhibitorDetailsDB09061Cannabidiolapproved, investigationalnoinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknowninhibitorDetailsDB14009Medical Cannabisexperimental, investigationalunknowninhibitorDetailsDB11697Pacritinibapproved, investigationalnoinhibitorDetailsDB06016Cariprazineapproved, investigationalunknowninhibitorDetailsDB16407AzvudineinvestigationalunknownactivatorregulatorDetailsDB12541SAR-405838investigationalnosubstrateDetailsDB00661VerapamilapprovedunknowninhibitorblockerDetailsDB09118StiripentolapprovedunknowninhibitorDetailsDB04951Pirfenidoneapproved, investigationalunknowninhibitorDetailsDB13997Baloxavir marboxilapproved, investigationalunknownsubstrateinhibitorDetailsDB15673Lenacapavirapproved, investigationalnosubstrateDetailsDB16650Deucravacitinibapproved, investigationalunknownsubstrateDetailsDB12095Telotristat ethylapproved, investigationalnosubstrateinhibitorDetailsDB15149Futibatinibapproved, investigationalnosubstrateinhibitorDetailsDB11739Vonoprazanapproved, investigationalunknowninhibitorDetailsDB11793Niraparibapproved, investigationalnosubstrateDetailsDB12489Mirvetuximab soravtansineapproved, investigationalnosubstrateDetailsDB16267Olutasidenibapproved, investigationalnoinhibitorDetailsDB12240Polatuzumab vedotinapproved, investigationalnosubstrateDetailsDB15568Adagrasibapproved, investigationalunknowninhibitorDetailsDB12236Bexagliflozinapproved, investigationalunknownsubstrateDetailsDB17472Pirtobrutinibapproved, investigationalunknownsubstrateinhibitorDetailsDB06374Elacestrantapproved, investigationalunknowninhibitorDetailsDB00683Midazolamapproved, illicitnosubstrateDetailsDB12548Sparsentanapproved, investigationalunknownsubstrateinhibitorDetailsDB15688Zavegepantapproved, investigationalunknownsubstrateDetailsDB16217Leniolisibapproved, investigationalnosubstrateDetailsDB01238Aripiprazoleapproved, investigationalunknowninhibitorDetailsDB09082VilanterolapprovednosubstrateDetailsDB12874Quizartinibapproved, investigationalnosubstrateinhibitorDetailsDB11763Momelotinibapproved, investigationalunknownsubstrateDetailsDB11718Encorafenibapproved, investigationalnosubstrateinhibitorDetailsDB15097Gefapixantapproved, investigationalnosubstrateDetailsDB11967Binimetinibapproved, investigationalnosubstrateDetailsDB16826RepotrectinibinvestigationalnosubstrateinhibitorDetails"
                    }
                },
                {
                    "Label": "Solute carrier organic anion transporter family member 1A2",
                    "Detailed Info": {
                        "Name": "Solute carrier organic anion transporter family member 1A2",
                        "Synonyms": "OATP\nOATP-1\nOATP-A\nOATP1\nOATP1A2\nOrganic anion-transporting polypeptide 1\nSLC21A3\nSodium-independent organic anion transporter\nSolute carrier family 21 member 3",
                        "Gene Name": "SLCO1A2",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0007000|Solute carrier organic anion transporter family member 1A2\nMGETEKRIETHRIRCLSKLKMFLLAITCAFVSKTLSGSYMNSMLTQIERQFNIPTSLVGF\nINGSFEIGNLLLIIFVSYFGTKLHRPIMIGIGCVVMGLGCFLKSLPHFLMNQYEYESTVS\nVSGNLSSNSFLCMENGTQILRPTQDPSECTKEVKSLMWVYVLVGNIVRGMGETPILPLGI\nSYIEDFAKFENSPLYIGLVETGAIIGPLIGLLLASFCANVYVDTGFVNTDDLIITPTDTR\nWVGAWWFGFLICAGVNVLTAIPFFFLPNTLPKEGLETNADIIKNENEDKQKEEVKKEKYG\nITKDFLPFMKSLSCNPIYMLFILVSVIQFNAFVNMISFMPKYLEQQYGISSSDAIFLMGI\nYNLPPICIGYIIGGLIMKKFKITVKQAAHIGCWLSLLEYLLYFLSFLMTCENSSVVGINT\nSYEGIPQDLYVENDIFADCNVDCNCPSKIWDPVCGNNGLSYLSACLAGCETSIGTGINMV\nFQNCSCIQTSGNSSAVLGLCDKGPDCSLMLQYFLILSAMSSFIYSLAAIPGYMVLLRCMK\nSEEKSLGVGLHTFCTRVFAGIPAPIYFGALMDSTCLHWGTLKCGESGACRIYDSTTFRYI\nYLGLPAALRGSSFVPALIILILLRKCHLPGENASSGTELIETKVKGKENECKDIYQKSTV\nLKDDELKTKL",
                        "Number of residues": "670",
                        "Molecular Weight": "74144.105",
                        "Theoretical pI": "5.75",
                        "GO Classification": "Functionsbile acid transmembrane transporter activity / organic anion transmembrane transporter activity / sodium-independent organic anion transmembrane transporter activityProcessesanion transmembrane transport / bile acid and bile salt transport / bile acid metabolic process / mitophagy in response to mitochondrial depolarization / organic anion transport / small molecule metabolic process / sodium-independent organic anion transport / transmembrane transportComponentsintegral component of plasma membrane / plasma membrane",
                        "General Function": "Sodium-independent organic anion transmembrane transporter activity",
                        "Specific Function": "Mediates the Na(+)-independent transport of organic anions such as sulfobromophthalein (BSP) and conjugated (taurocholate) and unconjugated (cholate) bile acids (By similarity). Selectively inhibited by the grapefruit juice component naringin.",
                        "Pfam Domain Function": "Kazal_2 (PF07648)\nOATP (PF03137)",
                        "Transmembrane Regions": "21-40\n60-80\n87-111\n156-184\n204-224\n243-267\n312-333\n354-377\n382-405\n514-536\n546-571\n606-623",
                        "Cellular Location": "Cell membrane",
                        "Gene sequence": ">lcl|BSEQ0012532|Solute carrier organic anion transporter family member 1A2 (SLCO1A2)\nATGGGAGAAACTGAGAAAAGAATTGAAACCCATAGAATAAGATGTCTTTCCAAGTTGAAG\nATGTTTCTGTTGGCAATAACATGTGCATTTGTATCCAAAACACTGTCTGGATCTTATATG\nAATTCCATGCTCACACAAATAGAGAGACAATTCAACATCCCAACATCTCTAGTTGGATTC\nATTAATGGAAGCTTTGAGATTGGAAATCTTTTGTTGATTATATTTGTGAGTTATTTTGGA\nACCAAACTGCATAGACCTATAATGATTGGCATTGGATGTGTGGTTATGGGCTTAGGCTGT\nTTCTTAAAATCACTACCTCATTTCCTCATGAACCAATATGAATATGAATCTACAGTTTCA\nGTTTCAGGCAACTTGTCCTCAAACAGTTTCTTGTGTATGGAAAATGGAACCCAGATTTTA\nAGACCAACGCAGGATCCATCAGAGTGTACAAAGGAAGTTAAATCATTAATGTGGGTGTAC\nGTCCTAGTAGGCAATATTGTACGTGGAATGGGTGAAACTCCCATCCTGCCTTTGGGTATT\nTCCTATATAGAAGATTTTGCCAAATTTGAAAATTCTCCTTTATATATTGGGCTTGTAGAA\nACAGGAGCTATTATTGGTCCTTTGATTGGACTTTTGTTGGCATCATTCTGTGCAAATGTT\nTATGTTGACACTGGATTTGTGAACACAGATGATCTGATCATAACTCCCACTGACACTCGT\nTGGGTCGGTGCATGGTGGTTTGGCTTTCTGATTTGTGCAGGAGTTAACGTGCTCACTGCC\nATTCCTTTTTTCTTTTTGCCCAACACACTTCCAAAGGAAGGACTAGAGACTAATGCTGAC\nATCATTAAAAATGAAAATGAAGACAAACAAAAAGAAGAGGTCAAGAAGGAAAAATATGGA\nATCACTAAAGATTTTCTACCTTTCATGAAAAGTCTTTCCTGCAATCCAATTTATATGCTT\nTTCATACTTGTAAGTGTGATACAGTTCAATGCATTCGTTAACATGATCTCCTTCATGCCT\nAAATACCTAGAACAGCAATATGGAATATCATCTTCAGATGCAATCTTTCTAATGGGTATT\nTATAACTTACCTCCAATATGTATTGGATATATAATTGGTGGTTTAATTATGAAGAAGTTC\nAAGATTACTGTCAAACAAGCTGCCCACATAGGATGTTGGTTATCCTTACTTGAGTATCTT\nCTCTATTTTTTATCTTTTCTCATGACTTGTGAAAATTCTTCAGTTGTTGGAATAAATACC\nTCTTATGAAGGAATTCCACAAGATTTATATGTGGAAAATGACATCTTTGCTGATTGCAAT\nGTGGATTGCAACTGTCCATCTAAAATATGGGATCCTGTGTGTGGAAACAATGGCTTGTCA\nTATCTGTCAGCTTGTCTTGCTGGTTGTGAGACATCCATTGGAACGGGAATAAACATGGTG\nTTCCAAAATTGCAGCTGTATTCAAACATCAGGAAATTCATCTGCAGTTCTTGGGCTGTGC\nGACAAAGGACCTGACTGTTCCTTGATGCTCCAGTACTTCCTAATCTTGTCAGCGATGAGC\nAGTTTCATTTATTCTTTGGCTGCCATACCTGGATATATGGTTCTCTTGAGGTGTATGAAA\nTCTGAAGAGAAGTCCCTTGGTGTGGGATTACATACATTTTGCACAAGAGTATTTGCTGGC\nATTCCTGCACCTATATATTTTGGCGCTTTAATGGATTCCACATGTTTACACTGGGGAACT\nTTGAAATGTGGTGAGTCAGGGGCATGCAGGATATATGATTCCACCACCTTCAGATACATC\nTACCTCGGATTGCCGGCAGCACTAAGAGGATCAAGCTTTGTTCCAGCCTTAATCATCTTA\nATTCTTTTGAGGAAGTGTCATCTACCTGGTGAAAATGCCTCTTCAGGAACAGAGCTTATA\nGAGACAAAAGTCAAAGGGAAGGAAAATGAGTGCAAAGATATATACCAAAAGTCCACGGTT\nTTGAAAGATGATGAATTGAAAACTAAATTGTAA",
                        "Chromosome Location": "12",
                        "Locus": "12p12",
                        "External Identifiers": "ResourceLinkUniProtKB IDP46721UniProtKB Entry NameSO1A2_HUMANGenBank Protein ID885978GenBank Gene IDU21943HGNC IDHGNC:10956",
                        "General References": "Kullak-Ublick GA, Hagenbuch B, Stieger B, Schteingart CD, Hofmann AF, Wolkoff AW, Meier PJ: Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology. 1995 Oct;109(4):1274-82. [Article] Konig J, Cui Y, Nies AT, Keppler D: Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J Biol Chem. 2000 Jul 28;275(30):23161-8. [Article] Speek M: Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes. Mol Cell Biol. 2001 Mar;21(6):1973-85. [Article] Bailey DG, Dresser GK, Leake BF, Kim RB: Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice. Clin Pharmacol Ther. 2007 Apr;81(4):495-502. doi: 10.1038/sj.clpt.6100104. Epub 2007 Feb 14. [Article] Lee W, Glaeser H, Smith LH, Roberts RL, Moeckel GW, Gervasini G, Leake BF, Kim RB: Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): implications for altered drug disposition and central nervous system drug entry. J Biol Chem. 2005 Mar 11;280(10):9610-7. Epub 2005 Jan 4. [Article] Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE: The consensus coding sequences of human breast and colorectal cancers. Science. 2006 Oct 13;314(5797):268-74. Epub 2006 Sep 7. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB04348Taurocholic acidapproved, experimentalunknownsubstrateinhibitorinducerDetailsDB01586Ursodeoxycholic acidapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB02659Cholic AcidapprovedunknownsubstrateinhibitorinducerDetailsDB00669Sumatriptanapproved, investigationalunknowninducerDetailsDB01183Naloxoneapproved, vet_approvedunknowninhibitorDetailsDB00286Conjugated estrogensapprovedunknownsubstrateinhibitorDetailsDB00908Quinidineapproved, investigationalunknowninhibitorDetailsDB01045RifampicinapprovedunknowninhibitorDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknowninhibitorDetailsDB00661VerapamilapprovedunknowninhibitorDetailsDB01232Saquinavirapproved, investigationalunknowninhibitorDetailsDB00503Ritonavirapproved, investigationalunknowninhibitorDetailsDB00220NelfinavirapprovednoinhibitorDetailsDB00227Lovastatinapproved, investigationalunknowninhibitorDetailsDB00224IndinavirapprovedunknowninhibitorDetailsDB01032Probenecidapproved, investigationalunknowninhibitorDetailsDB01124Tolbutamideapproved, investigationalunknowninhibitorDetailsDB00468QuinineapprovedunknowninhibitorDetailsDB00788Naproxenapproved, vet_approvedunknowninhibitorDetailsDB01009Ketoprofenapproved, vet_approvedunknowninhibitorDetailsDB00328Indomethacinapproved, investigationalunknownsubstrateinhibitorDetailsDB01050IbuprofenapprovedunknowninhibitorDetailsDB01016GlyburideapprovedunknowninhibitorDetailsDB02123Glycochenodeoxycholic AcidexperimentalunknownsubstrateinhibitorDetailsDB03619Deoxycholic acidapprovedunknownsubstrateinhibitorDetailsDB00421SpironolactoneapprovedunknowninhibitorDetailsDB00741Hydrocortisoneapproved, vet_approvedunknowninhibitorDetailsDB04630Aldosteroneexperimental, investigationalunknowninhibitorDetailsDB00655EstroneapprovedunknowninhibitorDetailsDB04573Estriolapproved, investigational, vet_approvedunknowninhibitorDetailsDB00635Prednisoneapproved, vet_approvedunknowninhibitorDetailsDB00860Prednisoloneapproved, vet_approvedunknowninhibitorDetailsDB01396Digitoxinapproved, investigationalunknowninhibitorDetailsDB01092OuabainapprovedunknownsubstrateinhibitorDetailsDB00641SimvastatinapprovedunknowninhibitorDetailsDB00175PravastatinapprovednosubstrateDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB00584Enalaprilapproved, vet_approvedunknownsubstrateDetailsDB00917DinoprostoneapprovedunknownsubstrateDetailsDB00279Liothyronineapproved, vet_approvedunknownsubstrateDetailsDB00950Fexofenadineapproved, investigationalunknownsubstrateDetailsDB00728RocuroniumapprovedunknownsubstrateDetailsDB00390DigoxinapprovedunknownsubstrateDetailsDB00563MethotrexateapprovedunknownsubstrateDetailsDB00887BumetanideapprovedunknownsubstrateDetailsDB01583LiotrixapprovedunknownsubstrateDetailsDB06710MethyltestosteroneapprovedunknowninhibitorinducerDetailsDB02691Glycocholic acidexperimental, investigationalunknownDetailsDB05804Prasterone sulfateinvestigationalunknownDetailsDB00451LevothyroxineapprovedunknownsubstrateDetailsDB00291ChlorambucilapprovedunknownDetailsDB08833Taurochenodeoxycholic acidexperimentalunknownDetailsDB08834Tauroursodeoxycholic acidapproved, investigationalunknownsubstrateDetailsDB08836Temocaprilexperimental, investigationalunknownDetailsDB01098RosuvastatinapprovedunknownDetailsDB08893MirabegronapprovedunknownsubstrateDetailsDB11611LifitegrastapprovedunknownsubstrateDetailsDB11591Bilastineapproved, investigationalnosubstrateDetailsDB13943Testosterone cypionateapprovedunknowninhibitorinducerDetailsDB13944Testosterone enanthateapprovedunknowninhibitorinducerDetailsDB13946Testosterone undecanoateapproved, investigationalunknowninhibitorinducerDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknowninhibitorDetailsDB01590EverolimusapprovedunknowninhibitorDetailsDB14538Hydrocortisone aceponateexperimental, vet_approvedunknownDetailsDB14539Hydrocortisone acetateapproved, vet_approvedunknownDetailsDB14540Hydrocortisone butyrateapproved, vet_approvedunknownDetailsDB14541Hydrocortisone cypionateapproved, investigational, vet_approvedunknownDetailsDB14542Hydrocortisone phosphateapproved, vet_approvedunknownDetailsDB14543Hydrocortisone probutateapproved, vet_approvedunknownDetailsDB14544Hydrocortisone valerateapproved, vet_approvedunknownDetailsDB14641Estriol tripropionateexperimentalunknownDetailsDB09213Dexibuprofenapproved, investigationalunknownDetailsDB11753Rifamycinapproved, investigationalnoinhibitorDetailsDB00199Erythromycinapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB01611HydroxychloroquineapprovedunknowninhibitorDetailsDB15566Prednisolone acetateapproved, vet_approvedunknowninhibitorDetailsDB01222BudesonideapprovedunknownsubstrateDetailsDB01137Levofloxacinapproved, investigationalunknownsubstrateDetailsDB00977EthinylestradiolapprovedunknowninhibitorDetailsDB00253MedrysoneapprovedunknownsubstrateDetailsDB01708Prasteroneapproved, investigational, nutraceuticalunknownsubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninhibitorDetailsDB14669Betamethasone phosphateapproved, vet_approvedunknowninhibitorDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknowninhibitorDetailsDB01380Cortisone acetateapproved, investigationalunknowninhibitorDetailsDB08912Dabrafenibapproved, investigationalnosubstrateDetailsDB00619ImatinibapprovednosubstrateDetailsDB01005HydroxyureaapprovednosubstrateDetails"
                    }
                },
                {
                    "Label": "Solute carrier organic anion transporter family member 1B1",
                    "Detailed Info": {
                        "Name": "Solute carrier organic anion transporter family member 1B1",
                        "Synonyms": "Liver-specific organic anion transporter 1\nLST-1\nLST1\nOATP-2\nOATP-C\nOATP1B1\nOATP2\nOATPC\nSLC21A6\nSodium-independent organic anion-transporting polypeptide 2\nSolute carrier family 21 member 6",
                        "Gene Name": "SLCO1B1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0010701|Solute carrier organic anion transporter family member 1B1\nMDQNQHLNKTAEAQPSENKKTRYCNGLKMFLAALSLSFIAKTLGAIIMKSSIIHIERRFE\nISSSLVGFIDGSFEIGNLLVIVFVSYFGSKLHRPKLIGIGCFIMGIGGVLTALPHFFMGY\nYRYSKETNINSSENSTSTLSTCLINQILSLNRASPEIVGKGCLKESGSYMWIYVFMGNML\nRGIGETPIVPLGLSYIDDFAKEGHSSLYLGILNAIAMIGPIIGFTLGSLFSKMYVDIGYV\nDLSTIRITPTDSRWVGAWWLNFLVSGLFSIISSIPFFFLPQTPNKPQKERKASLSLHVLE\nTNDEKDQTANLTNQGKNITKNVTGFFQSFKSILTNPLYVMFVLLTLLQVSSYIGAFTYVF\nKYVEQQYGQPSSKANILLGVITIPIFASGMFLGGYIIKKFKLNTVGIAKFSCFTAVMSLS\nFYLLYFFILCENKSVAGLTMTYDGNNPVTSHRDVPLSYCNSDCNCDESQWEPVCGNNGIT\nYISPCLAGCKSSSGNKKPIVFYNCSCLEVTGLQNRNYSAHLGECPRDDACTRKFYFFVAI\nQVLNLFFSALGGTSHVMLIVKIVQPELKSLALGFHSMVIRALGGILAPIYFGALIDTTCI\nKWSTNNCGTRGSCRTYNSTSFSRVYLGLSSMLRVSSLVLYIILIYAMKKKYQEKDINASE\nNGSVMDEANLESLNKNKHFVPSAGADSETHC",
                        "Number of residues": "691",
                        "Molecular Weight": "76447.99",
                        "Theoretical pI": "8.68",
                        "GO Classification": "Functionsbile acid transmembrane transporter activity / sodium-independent organic anion transmembrane transporter activityProcessesanion transmembrane transport / bile acid and bile salt transport / bile acid metabolic process / organic anion transport / small molecule metabolic process / sodium-independent organic anion transport / transmembrane transportComponentsbasolateral plasma membrane / integral component of plasma membrane / membrane / plasma membrane",
                        "General Function": "Sodium-independent organic anion transmembrane transporter activity",
                        "Specific Function": "Mediates the Na(+)-independent uptake of organic anions such as pravastatin, taurocholate, methotrexate, dehydroepiandrosterone sulfate, 17-beta-glucuronosyl estradiol, estrone sulfate, prostaglandin E2, thromboxane B2, leukotriene C3, leukotriene E4, thyroxine and triiodothyronine. Involved in the clearance of bile acids and organic anions from the liver.",
                        "Pfam Domain Function": "Kazal_2 (PF07648)\nOATP (PF03137)",
                        "Transmembrane Regions": "29-48\n68-88\n95-119\n169-197\n217-237\n256-280\n332-353\n374-397\n402-425\n538-560\n570-595\n630-647",
                        "Cellular Location": "Basolateral cell membrane",
                        "Gene sequence": ">lcl|BSEQ0010702|Solute carrier organic anion transporter family member 1B1 (SLCO1B1)\nATGGACCAAAATCAACATTTGAATAAAACAGCAGAGGCACAACCTTCAGAGAATAAGAAA\nACAAGATACTGCAATGGATTGAAGATGTTCTTGGCAGCTCTGTCACTCAGCTTTATTGCT\nAAGACACTAGGTGCAATTATTATGAAAAGTTCCATCATTCATATAGAACGGAGATTTGAG\nATATCCTCTTCTCTTGTTGGTTTTATTGACGGAAGCTTTGAAATTGGAAATTTGCTTGTG\nATTGTATTTGTGAGTTACTTTGGATCCAAACTACATAGACCAAAGTTAATTGGAATCGGT\nTGTTTCATTATGGGAATTGGAGGTGTTTTGACTGCTTTGCCACATTTCTTCATGGGATAT\nTACAGGTATTCTAAAGAAACTAATATCAATTCATCAGAAAATTCAACATCGACCTTATCC\nACTTGTTTAATTAATCAAATTTTATCACTCAATAGAGCATCACCTGAGATAGTGGGAAAA\nGGTTGTTTAAAGGAATCTGGGTCATACATGTGGATATATGTGTTCATGGGTAATATGCTT\nCGTGGAATAGGGGAGACTCCCATAGTACCATTGGGGCTTTCTTACATTGATGATTTCGCT\nAAAGAAGGACATTCTTCTTTGTATTTAGGTATATTGAATGCAATAGCAATGATTGGTCCA\nATCATTGGCTTTACCCTGGGATCTCTGTTTTCTAAAATGTACGTGGATATTGGATATGTA\nGATCTAAGCACTATCAGGATAACTCCTACTGATTCTCGATGGGTTGGAGCTTGGTGGCTT\nAATTTCCTTGTGTCTGGACTATTCTCCATTATTTCTTCCATACCATTCTTTTTCTTGCCC\nCAAACTCCAAATAAACCACAAAAAGAAAGAAAAGCTTCACTGTCTTTGCATGTGCTGGAA\nACAAATGATGAAAAGGATCAAACAGCTAATTTGACCAATCAAGGAAAAAATATTACCAAA\nAATGTGACTGGTTTTTTCCAGTCTTTTAAAAGCATCCTTACTAATCCCCTGTATGTTATG\nTTTGTGCTTTTGACGTTGTTACAAGTAAGCAGCTATATTGGTGCTTTTACTTATGTCTTC\nAAATACGTAGAGCAACAGTATGGTCAGCCTTCATCTAAGGCTAACATCTTATTGGGAGTC\nATAACCATACCTATTTTTGCAAGTGGAATGTTTTTAGGAGGATATATCATTAAAAAATTC\nAAACTGAACACCGTTGGAATTGCCAAATTCTCATGTTTTACTGCTGTGATGTCATTGTCC\nTTTTACCTATTATATTTTTTCATACTCTGTGAAAACAAATCAGTTGCCGGACTAACCATG\nACCTATGATGGAAATAATCCAGTGACATCTCATAGAGATGTACCACTTTCTTATTGCAAC\nTCAGACTGCAATTGTGATGAAAGTCAATGGGAACCAGTCTGTGGAAACAATGGAATAACT\nTACATCTCACCCTGTCTAGCAGGTTGCAAATCTTCAAGTGGCAATAAAAAGCCTATAGTG\nTTTTACAACTGCAGTTGTTTGGAAGTAACTGGTCTCCAGAACAGAAATTACTCAGCCCAT\nTTGGGTGAATGCCCAAGAGATGATGCTTGTACAAGGAAATTTTACTTTTTTGTTGCAATA\nCAAGTCTTGAATTTATTTTTCTCTGCACTTGGAGGCACCTCACATGTCATGCTGATTGTT\nAAAATTGTTCAACCTGAATTGAAATCACTTGCACTGGGTTTCCACTCAATGGTTATACGA\nGCACTAGGAGGAATTCTAGCTCCAATATATTTTGGGGCTCTGATTGATACAACGTGTATA\nAAGTGGTCCACCAACAACTGTGGCACACGTGGGTCATGTAGGACATATAATTCCACATCA\nTTTTCAAGGGTCTACTTGGGCTTGTCTTCAATGTTAAGAGTCTCATCACTTGTTTTATAT\nATTATATTAATTTATGCCATGAAGAAAAAATATCAAGAGAAAGATATCAATGCATCAGAA\nAATGGAAGTGTCATGGATGAAGCAAACTTAGAATCCTTAAATAAAAATAAACATTTTGTC\nCCTTCTGCTGGGGCAGATAGTGAAACACATTGTTAA",
                        "Chromosome Location": "12",
                        "Locus": "12p",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ9Y6L6UniProtKB Entry NameSO1B1_HUMANGenBank Protein ID5051630GenBank Gene IDAF060500GenAtlas IDSLCO1B1HGNC IDHGNC:10959",
                        "General References": "Abe T, Kakyo M, Tokui T, Nakagomi R, Nishio T, Nakai D, Nomura H, Unno M, Suzuki M, Naitoh T, Matsuno S, Yawo H: Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J Biol Chem. 1999 Jun 11;274(24):17159-63. [Article] Hsiang B, Zhu Y, Wang Z, Wu Y, Sasseville V, Yang WP, Kirchgessner TG: A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters. J Biol Chem. 1999 Dec 24;274(52):37161-8. [Article] Konig J, Cui Y, Nies AT, Keppler D: A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am J Physiol Gastrointest Liver Physiol. 2000 Jan;278(1):G156-64. [Article] Konig J, Cui Y, Nies AT, Keppler D: Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J Biol Chem. 2000 Jul 28;275(30):23161-8. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] van de Steeg E, Stranecky V, Hartmannova H, Noskova L, Hrebicek M, Wagenaar E, van Esch A, de Waart DR, Oude Elferink RP, Kenworthy KE, Sticova E, al-Edreesi M, Knisely AS, Kmoch S, Jirsa M, Schinkel AH: Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver. J Clin Invest. 2012 Feb;122(2):519-28. doi: 10.1172/JCI59526. Epub 2012 Jan 9. [Article] Yao J, Hong W, Huang J, Zhan K, Huang H, Hong M: N-Glycosylation dictates proper processing of organic anion transporting polypeptide 1B1. PLoS One. 2012;7(12):e52563. doi: 10.1371/journal.pone.0052563. Epub 2012 Dec 20. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Tirona RG, Leake BF, Merino G, Kim RB: Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans. J Biol Chem. 2001 Sep 21;276(38):35669-75. Epub 2001 Jul 26. [Article] Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23. [Article] Nozawa T, Nakajima M, Tamai I, Noda K, Nezu J, Sai Y, Tsuji A, Yokoi T: Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis. J Pharmacol Exp Ther. 2002 Aug;302(2):804-13. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB04348Taurocholic acidapproved, experimentalunknownsubstrateinhibitorinducerDetailsDB02659Cholic AcidapprovedunknownsubstrateinhibitorinducerDetailsDB00199Erythromycinapproved, investigational, vet_approvednosubstrateinhibitorDetailsDB01045RifampicinapprovedunknowninhibitorDetailsDB00286Conjugated estrogensapprovedunknownsubstrateinhibitorDetailsDB00655EstroneapprovedunknowninhibitorDetailsDB00783Estradiolapproved, investigational, vet_approvedunknowninhibitorDetailsDB01232Saquinavirapproved, investigationalunknowninhibitorDetailsDB00503Ritonavirapproved, investigationalunknowninhibitorDetailsDB00220NelfinavirapprovednoinhibitorDetailsDB00224IndinavirapprovedunknowninhibitorDetailsDB01892HyperforinnutraceuticalunknowninhibitorDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00908Quinidineapproved, investigationalunknowninhibitorDetailsDB00583Levocarnitineapproved, investigationalunknowninhibitorDetailsDB00877Sirolimusapproved, investigationalnoinhibitorDetailsDB00641SimvastatinapprovedunknownsubstrateinhibitorDetailsDB00227Lovastatinapproved, investigationalunknownsubstrateinhibitorDetailsDB01076AtorvastatinapprovednosubstrateinhibitorDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknowninhibitorDetailsDB00412Rosiglitazoneapproved, investigationalunknowninhibitorDetailsDB01132Pioglitazoneapproved, investigationalunknowninhibitorDetailsDB00762Irinotecanapproved, investigationalunknowninhibitorDetailsDB00520CaspofunginapprovedunknowninhibitorDetailsDB00175PravastatinapprovednosubstrateDetailsDB01393Bezafibrateapproved, investigationalunknowninhibitorDetailsDB06151Acetylcysteineapproved, investigationalunknowninhibitorDetailsDB00661VerapamilapprovedunknowninhibitorDetailsDB00917DinoprostoneapprovedunknownsubstrateDetailsDB01053Benzylpenicillinapproved, vet_approvedunknownsubstrateDetailsDB00563MethotrexateapprovedunknownsubstrateDetailsDB00279Liothyronineapproved, vet_approvedunknownsubstrateDetailsDB00439Cerivastatinapproved, withdrawnunknownsubstrateinhibitorDetailsDB00275Olmesartanapproved, investigationalunknownsubstrateDetailsDB00669Sumatriptanapproved, investigationalunknownsubstrateDetailsDB01092OuabainapprovedunknownsubstrateinhibitorDetailsDB00390DigoxinapprovedunknownsubstrateinhibitorDetailsDB00859PenicillamineapprovedunknownsubstrateDetailsDB00177Valsartanapproved, investigationalunknownsubstrateinhibitorDetailsDB06721GimatecaninvestigationalunknownsubstrateDetailsDB01583LiotrixapprovedunknownsubstrateDetailsDB06210EltrombopagapprovedunknowninhibitorDetailsDB00973EzetimibeapprovedunknownsubstrateDetailsDB02691Glycocholic acidexperimental, investigationalunknownDetailsDB05804Prasterone sulfateinvestigationalunknownDetailsDB00451LevothyroxineapprovedunknowninhibitorDetailsDB00509Dextrothyroxineapproved, investigationalunknownDetailsDB00950Fexofenadineapproved, investigationalunknownsubstrateDetailsDB08855Leukotriene C4experimental, investigationalunknownDetailsDB08856DADLEexperimentalunknownDetailsDB08857Bamet-UD2experimentalunknownDetailsDB08858cis-Diamminechlorocholylglycinateplatinum(II)experimentalunknownDetailsDB01095FluvastatinapprovedunknownsubstrateinhibitorDetailsDB08860PitavastatinapprovedunknownsubstrateinhibitorDetailsDB06589PazopanibapprovedunknowninhibitorDetailsDB06772CabazitaxelapprovedunknowninhibitorDetailsDB08864RilpivirineapprovedunknowninhibitorDetailsDB08884Gadoxetic acidapprovedunknownsubstrateDetailsDB06626Axitinibapproved, investigationalnosubstrateinhibitorDetailsDB08912Dabrafenibapproved, investigationalnosubstrateinhibitorDetailsDB00912Repaglinideapproved, investigationalunknownsubstrateDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB01098RosuvastatinapprovedunknownsubstrateinhibitorDetailsDB06290SimeprevirapprovedunknownsubstrateinhibitorDetailsDB04850PosizolidinvestigationalunknowninhibitorDetailsDB01211ClarithromycinapprovedunknownDetailsDB09054IdelalisibapprovednoinhibitorDetailsDB09272Eluxadolineapproved, investigationalunknownsubstrateinhibitorDetailsDB09292SacubitrilapprovedunknowninhibitorDetailsDB09102Daclatasvirapproved, investigationalunknowninhibitorDetailsDB05239Cobimetinibapproved, investigationalnoweak inhibitorDetailsDB11362SelexipagapprovednosubstrateDetailsDB06403Ambrisentanapproved, investigationalunknownsubstrateDetailsDB11575GrazoprevirapprovednosubstrateDetailsDB09137Technetium Tc-99m mebrofeninapprovednosubstrateDetailsDB13139Levosalbutamolapproved, investigationalnosubstrateDetailsDB13153Levomenolapproved, experimentalunknownsubstrateDetailsDB11613Velpatasvirapproved, investigationalnoinhibitortransporterDetailsDB05521Telaprevirapproved, withdrawnunknowninhibitorDetailsDB09198LobeglitazoneexperimentalnoinhibitorDetailsDB12026Voxilaprevirapproved, investigationalnosubstrateinhibitorDetailsDB13874Enasidenibapproved, investigationalunknowninhibitorDetailsDB13878Pibrentasvirapproved, investigationalunknowninhibitorDetailsDB13879Glecaprevirapproved, investigationalunknownsubstrateinhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateinhibitorDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknowninhibitorDetailsDB11901Apalutamideapproved, investigationalunknowninducerDetailsDB09297Paritaprevirapproved, investigationalunknownsubstrateinhibitorDetailsDB00975DipyridamoleapprovedunknowninhibitorDetailsDB01072Atazanavirapproved, investigationalunknowninhibitorDetailsDB00541Vincristineapproved, investigationalunknowninhibitorDetailsDB12319Benzbromaroneinvestigational, withdrawnunknowninhibitorDetailsDB08862Cholecystokininapproved, investigationalunknownsubstrateinhibitorDetailsDB00255Diethylstilbestrolapproved, investigational, withdrawnunknowninhibitorDetailsDB01645GenisteininvestigationalunknowninhibitorDetailsDB00602Ivermectinapproved, investigational, vet_approvedunknowninhibitorDetailsDB01115NifedipineapprovedunknowninhibitorDetailsDB01051Novobiocinapproved, investigational, vet_approved, withdrawnunknowninhibitorDetailsDB00646Nystatinapproved, vet_approvedunknowninhibitorDetailsDB11869ValspodarinvestigationalunknowninhibitorDetailsDB00206Reserpineapproved, investigational, withdrawnunknowninhibitorDetailsDB09298Silibininexperimental, investigationalunknowninhibitorDetailsDB00795SulfasalazineapprovednoinhibitorDetailsDB00932Tipranavirapproved, investigationalunknowninhibitorDetailsDB01601LopinavirapprovedunknowninhibitorDetailsDB01264DarunavirapprovedunknowninhibitorDetailsDB00328Indomethacinapproved, investigationalunknowninhibitorDetailsDB00701Amprenavirapproved, investigationalunknowninhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknowninhibitorDetailsDB04216Quercetinexperimental, investigationalunknowninhibitorDetailsDB00622Nicardipineapproved, investigationalunknowninhibitorDetailsDB00396Progesteroneapproved, vet_approvedunknowninhibitorDetailsDB00570VinblastineapprovedunknowninhibitorDetailsDB00468QuinineapprovedunknowninhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB13919CandesartanexperimentalunknowninhibitorDetailsDB09065CobicistatapprovedunknowninhibitorDetailsDB00976TelithromycinapprovedunknowninhibitorDetailsDB01590EverolimusapprovedunknowninhibitorDetailsDB00203Sildenafilapproved, investigationalunknowninhibitorDetailsDB00864Tacrolimusapproved, investigationalunknowninhibitorDetailsDB00398Sorafenibapproved, investigationalunknowninhibitorDetailsDB04868Nilotinibapproved, investigationalunknowninhibitorDetailsDB11586Asunaprevirapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB11979Elagolixapproved, investigationalunknownsubstrateDetailsDB13867Fluticasoneapproved, experimentalnoinhibitorDetailsDB08906Fluticasone furoateapprovednoinhibitorDetailsDB00588Fluticasone propionateapprovednoinhibitorDetailsDB09078Lenvatinibapproved, investigationalunknowninhibitorDetailsDB05928DovitinibinvestigationalunknowninhibitorDetailsDB08880TeriflunomideapprovedunknowninhibitorDetailsDB02703Fusidic acidapproved, investigationalunknownDetailsDB11753Rifamycinapproved, investigationalnoinhibitorDetailsDB11581Venetoclaxapproved, investigationalunknowninhibitorDetailsDB11855Revefenacinapproved, investigationalnosubstrateDetailsDB09279FimasartaninvestigationalunknownsubstrateDetailsDB00834Mifepristoneapproved, investigationalnoinhibitorDetailsDB00257Clotrimazoleapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00214TorasemideapprovednosubstrateDetailsDB13867Fluticasoneapproved, experimentalunknowninhibitorDetailsDB09299Tenofovir alafenamideapprovednosubstrateDetailsDB00481Raloxifeneapproved, investigationalunknownsubstrateDetailsDB00394Beclomethasone dipropionateapproved, investigationalunknowninhibitorDetailsDB12978Pexidartinibapproved, investigationalunknowninhibitorDetailsDB12500Fedratinibapproved, investigationalunknowninhibitorDetailsDB11757Istradefyllineapproved, investigationalunknowninhibitorDetailsDB01241GemfibrozilapprovedunknowninhibitorDetailsDB04855DronedaroneapprovednoinhibitorDetailsDB15444Elexacaftorapproved, investigationalnoinhibitorDetailsDB14962Trastuzumab deruxtecanapproved, investigationalunknownDetailsDB15091Upadacitinibapproved, investigationalnoinhibitorDetailsDB15328Ubrogepantapproved, investigationalunknownsubstrateinhibitorDetailsDB01211ClarithromycinapprovedunknowninhibitorDetailsDB12941Darolutamideapproved, investigationalunknowninhibitorDetailsDB00588Fluticasone propionateapprovedunknowninhibitorDetailsDB12457Rimegepantapproved, investigationalunknowninhibitorDetailsDB11837Osilodrostatapproved, investigationalunknowninhibitorDetailsDB11936Bempedoic acidapproved, investigationalunknowninhibitorDetailsDB01708Prasteroneapproved, investigational, nutraceuticalunknownsubstrateDetailsDB14761Remdesivirapproved, investigationalunknownsubstrateinhibitorDetailsDB09038EmpagliflozinapprovedunknownsubstrateDetailsDB09274Artesunateapproved, investigationalunknowninhibitorDetailsDB12674Lurbinectedinapproved, investigationalunknowninhibitorDetailsDB11796Fostemsavirapproved, investigationalunknowninhibitorDetailsDB15719Belantamab mafodotinapprovedunknownsubstrateDetailsDB15822Pralsetinibapproved, investigationalnoinhibitorDetailsDB06448Lonafarnibapproved, investigationalnoinhibitorDetailsDB06137Tirbanibulinapproved, investigationalnoinhibitorDetailsDB11632Opicaponeapproved, investigationalnoinhibitorDetailsDB08995Diosminapproved, investigationalunknowninhibitorDetailsDB11886Infigratinibapproved, investigationalnoinhibitorDetailsDB12151Brincidofovirapproved, investigationalnosubstrateinhibitorDetailsDB16703Belumosudilapproved, investigationalnoinhibitorDetailsDB15463Belzutifanapproved, investigationalnosubstrateDetailsDB12265Fexinidazoleapproved, investigationalunknowninhibitorDetailsDB16098Atogepantapproved, investigationalnosubstrateinhibitorDetailsDB06176Romidepsinapproved, investigationalnoinhibitorDetailsDB12597Asciminibapproved, investigationalunknowninhibitorDetailsDB15413Pafolacianineapproved, investigationalnosubstrateDetailsDB12713Sotagliflozinapproved, investigationalnoinhibitorDetailsDB15575Padeliporfinapproved, experimentalunknowninhibitorDetailsDB04847Roxadustatapproved, investigationalunknowninhibitorDetailsDB17083LinzagolixapprovednosubstrateinhibitorDetailsDB16267Olutasidenibapproved, investigationalnoinhibitorDetailsDB00244MesalazineapprovednosubstrateDetailsDB11682Daprodustatapproved, investigationalnoinhibitorDetailsDB06045Trofinetideapproved, investigationalunknowninhibitorDetailsDB16217Leniolisibapproved, investigationalnoinhibitorDetailsDB11712Tezacaftorapproved, investigationalnosubstrateinhibitorDetailsDB01005HydroxyureaapprovednosubstrateDetailsDB05812AbirateroneapprovedunknowninhibitorDetailsDB05467Palovaroteneapproved, investigationalnoinhibitorDetailsDB11763Momelotinibapproved, investigationalunknownsubstrateDetailsDB11718Encorafenibapproved, investigationalnoinhibitorDetailsDB12218Capivasertibapproved, investigationalnoinhibitorDetailsDB16826RepotrectinibinvestigationalnoinhibitorDetails"
                    }
                },
                {
                    "Label": "Multidrug resistance-associated protein 4",
                    "Detailed Info": {
                        "Name": "Multidrug resistance-associated protein 4",
                        "Synonyms": "ATP-binding cassette sub-family C member 4\nMOAT-B\nMRP/cMOAT-related ABC transporter\nMRP4\nMulti-specific organic anion transporter B",
                        "Gene Name": "ABCC4",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0037136|Multidrug resistance-associated protein 4\nMLPVYQEVKPNPLQDANLCSRVFFWWLNPLFKIGHKRRLEEDDMYSVLPEDRSQHLGEEL\nQGFWDKEVLRAENDAQKPSLTRAIIKCYWKSYLVLGIFTLIEESAKVIQPIFLGKIINYF\nENYDPMDSVALNTAYAYATVLTFCTLILAILHHLYFYHVQCAGMRLRVAMCHMIYRKALR\nLSNMAMGKTTTGQIVNLLSNDVNKFDQVTVFLHFLWAGPLQAIAVTALLWMEIGISCLAG\nMAVLIILLPLQSCFGKLFSSLRSKTATFTDARIRTMNEVITGIRIIKMYAWEKSFSNLIT\nNLRKKEISKILRSSCLRGMNLASFFSASKIIVFVTFTTYVLLGSVITASRVFVAVTLYGA\nVRLTVTLFFPSAIERVSEAIVSIRRIQTFLLLDEISQRNRQLPSDGKKMVHVQDFTAFWD\nKASETPTLQGLSFTVRPGELLAVVGPVGAGKSSLLSAVLGELAPSHGLVSVHGRIAYVSQ\nQPWVFSGTLRSNILFGKKYEKERYEKVIKACALKKDLQLLEDGDLTVIGDRGTTLSGGQK\nARVNLARAVYQDADIYLLDDPLSAVDAEVSRHLFELCICQILHEKITILVTHQLQYLKAA\nSQILILKDGKMVQKGTYTEFLKSGIDFGSLLKKDNEESEQPPVPGTPTLRNRTFSESSVW\nSQQSSRPSLKDGALESQDTENVPVTLSEENRSEGKVGFQAYKNYFRAGAHWIVFIFLILL\nNTAAQVAYVLQDWWLSYWANKQSMLNVTVNGGGNVTEKLDLNWYLGIYSGLTVATVLFGI\nARSLLVFYVLVNSSQTLHNKMFESILKAPVLFFDRNPIGRILNRFSKDIGHLDDLLPLTF\nLDFIQTLLQVVGVVSVAVAVIPWIAIPLVPLGIIFIFLRRYFLETSRDVKRLESTTRSPV\nFSHLSSSLQGLWTIRAYKAEERCQELFDAHQDLHSEAWFLFLTTSRWFAVRLDAICAMFV\nIIVAFGSLILAKTLDAGQVGLALSYALTLMGMFQWCVRQSAEVENMMISVERVIEYTDLE\nKEAPWEYQKRPPPAWPHEGVIIFDNVNFMYSPGGPLVLKHLTALIKSQEKVGIVGRTGAG\nKSSLISALFRLSEPEGKIWIDKILTTEIGLHDLRKKMSIIPQEPVLFTGTMRKNLDPFNE\nHTDEELWNALQEVQLKETIEDLPGKMDTELAESGSNFSVGQRQLVCLARAILRKNQILII\nDEATANVDPRTDELIQKKIREKFAHCTVLTIAHRLNTIIDSDKIMVLDSGRLKEYDEPYV\nLLQNKESLFYKMVQQLGKAEAAALTETAKQVYFKRNYPHIGHTDHMVTNTSNGQPSTLTI\nFETAL",
                        "Number of residues": "1325",
                        "Molecular Weight": "149525.33",
                        "Theoretical pI": "8.39",
                        "GO Classification": "Functions15-hydroxyprostaglandin dehydrogenase (NAD+) activity / ATP binding / ATPase activity, coupled to transmembrane movement of substancesProcessesblood coagulation / oxidation-reduction process / platelet activation / platelet degranulation / transmembrane transportComponentsbasolateral plasma membrane / integral component of membrane / membrane / plasma membrane / platelet dense granule membrane",
                        "General Function": "Atpase activity, coupled to transmembrane movement of substances",
                        "Specific Function": "May be an organic anion pump relevant to cellular detoxification.",
                        "Pfam Domain Function": "ABC_tran (PF00005)\nABC_membrane (PF00664)",
                        "Transmembrane Regions": "93-113\n136-156\n207-227\n228-248\n328-348\n351-371\n440-460\n710-730\n771-791\n836-856\n858-878\n954-974\n977-997\n1038-1058",
                        "Cellular Location": "Membrane",
                        "Gene sequence": ">lcl|BSEQ0010828|Multidrug resistance-associated protein 4 (ABCC4)\nATGCTGCCCGTGTACCAGGAGGTGAAGCCCAACCCGCTGCAGGACGCGAACCTCTGCTCA\nCGCGTGTTCTTCTGGTGGCTCAATCCCTTGTTTAAAATTGGCCATAAACGGAGATTAGAG\nGAAGATGATATGTATTCAGTGCTGCCAGAAGACCGCTCACAGCACCTTGGAGAGGAGTTG\nCAAGGGTTCTGGGATAAAGAAGTTTTAAGAGCTGAGAATGACGCACAGAAGCCTTCTTTA\nACAAGAGCAATCATAAAGTGTTACTGGAAATCTTATTTAGTTTTGGGAATTTTTACGTTA\nATTGAGGAAAGTGCCAAAGTAATCCAGCCCATATTTTTGGGAAAAATTATTAATTATTTT\nGAAAATTATGATCCCATGGATTCTGTGGCTTTGAACACAGCGTACGCCTATGCCACGGTG\nCTGACTTTTTGCACGCTCATTTTGGCTATACTGCATCACTTATATTTTTATCACGTTCAG\nTGTGCTGGGATGAGGTTACGAGTAGCCATGTGCCATATGATTTATCGGAAGGCACTTCGT\nCTTAGTAACATGGCCATGGGGAAGACAACCACAGGCCAGATAGTCAATCTGCTGTCCAAT\nGATGTGAACAAGTTTGATCAGGTGACAGTGTTCTTACACTTCCTGTGGGCAGGACCACTG\nCAGGCGATTGCAGTGACTGCCCTACTCTGGATGGAGATAGGAATATCGTGCCTTGCTGGG\nATGGCAGTTCTAATCATTCTCCTGCCCTTGCAAAGCTGTTTTGGGAAGTTGTTCTCATCA\nCTGAGGAGTAAAACTGCAACTTTCACGGATGCCAGGATCAGGACCATGAATGAAGTTATA\nACTGGTATAAGGATAATAAAAATGTACGCCTGGGAAAAGTCATTTTCAAATCTTATTACC\nAATTTGAGAAAGAAGGAGATTTCCAAGATTCTGAGAAGTTCCTGCCTCAGAGGGATGAAT\nTTGGCTTCATTTTTCAGTGCAAGCAAAATCATCGTGTTTGTGACCTTCACCACCTACGTG\nCTCCTCGGCAGTGTGATCACAGCCAGCCGCGTGTTCGTGGCAGTGACGCTGTATGGGGCT\nGTGCGGCTGACGGTTACCCTCTTCTTCCCCTCAGCCATTGAGAGGGTGTCAGAGGCAATC\nGTCAGCATCCGAAGAATCCAGACCTTTTTGCTACTTGATGAGATATCACAGCGCAACCGT\nCAGCTGCCGTCAGATGGTAAAAAGATGGTGCATGTGCAGGATTTTACTGCTTTTTGGGAT\nAAGGCATCAGAGACCCCAACTCTACAAGGCCTTTCCTTTACTGTCAGACCTGGCGAATTG\nTTAGCTGTGGTCGGCCCCGTGGGAGCAGGGAAGTCATCACTGTTAAGTGCCGTGCTCGGG\nGAATTGGCCCCAAGTCACGGGCTGGTCAGCGTGCATGGAAGAATTGCCTATGTGTCTCAG\nCAGCCCTGGGTGTTCTCGGGAACTCTGAGGAGTAATATTTTATTTGGGAAGAAATACGAA\nAAGGAACGATATGAAAAAGTCATAAAGGCTTGTGCTCTGAAAAAGGATTTACAGCTGTTG\nGAGGATGGTGATCTGACTGTGATAGGAGATCGGGGAACCACGCTGAGTGGAGGGCAGAAA\nGCACGGGTAAACCTTGCAAGAGCAGTGTATCAAGATGCTGACATCTATCTCCTGGACGAT\nCCTCTCAGTGCAGTAGATGCGGAAGTTAGCAGACACTTGTTCGAACTGTGTATTTGTCAA\nATTTTGCATGAGAAGATCACAATTTTAGTGACTCATCAGTTGCAGTACCTCAAAGCTGCA\nAGTCAGATTCTGATATTGAAAGATGGTAAAATGGTGCAGAAGGGGACTTACACTGAGTTC\nCTAAAATCTGGTATAGATTTTGGCTCCCTTTTAAAGAAGGATAATGAGGAAAGTGAACAA\nCCTCCAGTTCCAGGAACTCCCACACTAAGGAATCGTACCTTCTCAGAGTCTTCGGTTTGG\nTCTCAACAATCTTCTAGACCCTCCTTGAAAGATGGTGCTCTGGAGAGCCAAGATACAGAG\nAATGTCCCAGTTACACTATCAGAGGAGAACCGTTCTGAAGGAAAAGTTGGTTTTCAGGCC\nTATAAGAATTACTTCAGAGCTGGTGCTCACTGGATTGTCTTCATTTTCCTTATTCTCCTA\nAACACTGCAGCTCAGGTTGCCTATGTGCTTCAAGATTGGTGGCTTTCATACTGGGCAAAC\nAAACAAAGTATGCTAAATGTCACTGTAAATGGAGGAGGAAATGTAACCGAGAAGCTAGAT\nCTTAACTGGTACTTAGGAATTTATTCAGGTTTAACTGTAGCTACCGTTCTTTTTGGCATA\nGCAAGATCTCTATTGGTATTCTACGTCCTTGTTAACTCTTCACAAACTTTGCACAACAAA\nATGTTTGAGTCAATTCTGAAAGCTCCGGTATTATTCTTTGATAGAAATCCAATAGGAAGA\nATTTTAAATCGTTTCTCCAAAGACATTGGACACTTGGATGATTTGCTGCCGCTGACGTTT\nTTAGATTTCATCCAGAGATGGGATCTCGCTGTGTTGTCCTGGCTGGTCTCAAACTCCTAG",
                        "Chromosome Location": "13",
                        "Locus": "13q32",
                        "External Identifiers": "ResourceLinkUniProtKB IDO15439UniProtKB Entry NameMRP4_HUMANGenBank Protein ID3335173GenBank Gene IDAF071202GenAtlas IDABCC4HGNC IDHGNC:55",
                        "General References": "Lee K, Belinsky MG, Bell DW, Testa JR, Kruh GD: Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter. Cancer Res. 1998 Jul 1;58(13):2741-7. [Article] Adachi M, Sampath J, Lan LB, Sun D, Hargrove P, Flatley R, Tatum A, Edwards MZ, Wezeman M, Matherly L, Drake R, Schuetz J: Expression of MRP4 confers resistance to ganciclovir and compromises bystander cell killing. J Biol Chem. 2002 Oct 11;277(41):38998-9004. Epub 2002 Jun 24. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Dunham A, Matthews LH, Burton J, Ashurst JL, Howe KL, Ashcroft KJ, Beare DM, Burford DC, Hunt SE, Griffiths-Jones S, Jones MC, Keenan SJ, Oliver K, Scott CE, Ainscough R, Almeida JP, Ambrose KD, Andrews DT, Ashwell RI, Babbage AK, Bagguley CL, Bailey J, Bannerjee R, Barlow KF, Bates K, Beasley H, Bird CP, Bray-Allen S, Brown AJ, Brown JY, Burrill W, Carder C, Carter NP, Chapman JC, Clamp ME, Clark SY, Clarke G, Clee CM, Clegg SC, Cobley V, Collins JE, Corby N, Coville GJ, Deloukas P, Dhami P, Dunham I, Dunn M, Earthrowl ME, Ellington AG, Faulkner L, Frankish AG, Frankland J, French L, Garner P, Garnett J, Gilbert JG, Gilson CJ, Ghori J, Grafham DV, Gribble SM, Griffiths C, Hall RE, Hammond S, Harley JL, Hart EA, Heath PD, Howden PJ, Huckle EJ, Hunt PJ, Hunt AR, Johnson C, Johnson D, Kay M, Kimberley AM, King A, Laird GK, Langford CJ, Lawlor S, Leongamornlert DA, Lloyd DM, Lloyd C, Loveland JE, Lovell J, Martin S, Mashreghi-Mohammadi M, McLaren SJ, McMurray A, Milne S, Moore MJ, Nickerson T, Palmer SA, Pearce AV, Peck AI, Pelan S, Phillimore B, Porter KM, Rice CM, Searle S, Sehra HK, Shownkeen R, Skuce CD, Smith M, Steward CA, Sycamore N, Tester J, Thomas DW, Tracey A, Tromans A, Tubby B, Wall M, Wallis JM, West AP, Whitehead SL, Willey DL, Wilming L, Wray PW, Wright MW, Young L, Coulson A, Durbin R, Hubbard T, Sulston JE, Beck S, Bentley DR, Rogers J, Ross MT: The DNA sequence and analysis of human chromosome 13. Nature. 2004 Apr 1;428(6982):522-8. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Kool M, de Haas M, Scheffer GL, Scheper RJ, van Eijk MJ, Juijn JA, Baas F, Borst P: Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 1997 Aug 15;57(16):3537-47. [Article] Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M: Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006 Nov 3;127(3):635-48. [Article] Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP: A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7. doi: 10.1073/pnas.0805139105. Epub 2008 Jul 31. [Article] Mayya V, Lundgren DH, Hwang SI, Rezaul K, Wu L, Eng JK, Rodionov V, Han DK: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal. 2009 Aug 18;2(84):ra46. doi: 10.1126/scisignal.2000007. [Article] Olsen JV, Vermeulen M, Santamaria A, Kumar C, Miller ML, Jensen LJ, Gnad F, Cox J, Jensen TS, Nigg EA, Brunak S, Mann M: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3. doi: 10.1126/scisignal.2000475. [Article] Burkard TR, Planyavsky M, Kaupe I, Breitwieser FP, Burckstummer T, Bennett KL, Superti-Furga G, Colinge J: Initial characterization of the human central proteome. BMC Syst Biol. 2011 Jan 26;5:17. doi: 10.1186/1752-0509-5-17. [Article] Hayashi H, Naoi S, Nakagawa T, Nishikawa T, Fukuda H, Imajoh-Ohmi S, Kondo A, Kubo K, Yabuki T, Hattori A, Hirouchi M, Sugiyama Y: Sorting nexin 27 interacts with multidrug resistance-associated protein 4 (MRP4) and mediates internalization of MRP4. J Biol Chem. 2012 Apr 27;287(18):15054-65. doi: 10.1074/jbc.M111.337931. Epub 2012 Mar 12. [Article] Janke D, Mehralivand S, Strand D, Godtel-Armbrust U, Habermeier A, Gradhand U, Fischer C, Toliat MR, Fritz P, Zanger UM, Schwab M, Fromm MF, Nurnberg P, Wojnowski L, Closs EI, Lang T: 6-mercaptopurine and 9-(2-phosphonyl-methoxyethyl) adenine (PMEA) transport altered by two missense mutations in the drug transporter gene ABCC4. Hum Mutat. 2008 May;29(5):659-69. doi: 10.1002/humu.20694. [Article] Yuasa I, Umetsu K, Matsusue A, Nishimukai H, Harihara S, Fukumori Y, Saitou N, Jin F, Chattopadhyay PK, Henke L, Henke J: A Japanese-specific allele in the GALNT11 gene. Leg Med (Tokyo). 2010 Jul;12(4):208-11. doi: 10.1016/j.legalmed.2010.04.001. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00563MethotrexateapprovedunknownsubstrateinhibitorDetailsDB02527Cyclic adenosine monophosphateexperimentalunknownsubstrateinhibitorDetailsDB01032Probenecidapproved, investigationalunknowninhibitorDetailsDB00975DipyridamoleapprovedunknowninhibitorDetailsDB00661VerapamilapprovedunknowninhibitorDetailsDB01138SulfinpyrazoneapprovedunknowninhibitorDetailsDB00203Sildenafilapproved, investigationalunknowninhibitorDetailsDB00158Folic acidapproved, nutraceutical, vet_approvedunknowninhibitorDetailsDB04348Taurocholic acidapproved, experimentalunknowninhibitorDetailsDB00286Conjugated estrogensapprovedunknowninhibitorDetailsDB01586Ursodeoxycholic acidapproved, investigationalunknowninhibitorDetailsDB02659Cholic AcidapprovedunknowninhibitorDetailsDB00533Rofecoxibapproved, investigational, withdrawnunknowninhibitorDetailsDB01009Ketoprofenapproved, vet_approvedunknowninhibitorDetailsDB00328Indomethacinapproved, investigationalunknowninhibitorDetailsDB01050IbuprofenapprovedunknowninhibitorDetailsDB00712Flurbiprofenapproved, investigationalunknowninhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknowninhibitorDetailsDB00482Celecoxibapproved, investigationalunknowninhibitorDetailsDB00352TioguanineapprovedunknowninhibitorDetailsDB00398Sorafenibapproved, investigationalunknowninhibitorDetailsDB01268Sunitinibapproved, investigationalunknowninhibitorDetailsDB01033MercaptopurineapprovedunknownsubstrateDetailsDB00143Glutathioneapproved, investigational, nutraceuticalunknownsubstrateDetailsDB00917DinoprostoneapprovedunknownsubstrateDetailsDB00770Alprostadilapproved, investigationalunknownsubstrateDetailsDB00718Adefovir dipivoxilapproved, investigationalunknownsubstrateDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB01098RosuvastatinapprovedunknownsubstrateDetailsDB00198OseltamivirapprovedunknownsubstrateDetailsDB00814Meloxicamapproved, vet_approvedunknownbinderDetailsDB01327CefazolinapprovedunknownsubstrateDetailsDB00731Nateglinideapproved, investigationalunknownsubstrateDetailsDB08884Gadoxetic acidapprovedunknownsubstrateDetailsDB00495ZidovudineapprovedunknownsubstrateDetailsDB00544FluorouracilapprovedunknownsubstrateDetailsDB00709Lamivudineapproved, investigationalunknownsubstrateDetailsDB00300Tenofovir disoproxilapproved, investigationalunknownsubstrateDetailsDB00171ATPinvestigational, nutraceuticalunknownDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB13146Fluciclovine (18F)approvednosubstrateDetailsDB09213Dexibuprofenapproved, investigationalunknownDetailsDB09299Tenofovir alafenamideapprovednosubstrateDetailsDB14126Tenofovirexperimental, investigationalnosubstrateDetailsDB00481Raloxifeneapproved, investigationalunknownsubstrateDetailsDB00999Hydrochlorothiazideapproved, vet_approvedunknownsubstrateDetailsDB01069Promethazineapproved, investigationalunknowninhibitorDetailsDB01708Prasteroneapproved, investigational, nutraceuticalunknownsubstrateDetailsDB14761Remdesivirapproved, investigationalunknowninhibitorDetailsDB00619ImatinibapprovednosubstrateDetails"
                    }
                },
                {
                    "Label": "Multidrug resistance-associated protein 5",
                    "Detailed Info": {
                        "Name": "Multidrug resistance-associated protein 5",
                        "Synonyms": "ATP-binding cassette sub-family C member 5\nMOAT-C\nMRP5\nMulti-specific organic anion transporter C\npABC11\nSMRP",
                        "Gene Name": "ABCC5",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0006995|Multidrug resistance-associated protein 5\nMKDIDIGKEYIIPSPGYRSVRERTSTSGTHRDREDSKFRRTRPLECQDALETAARAEGLS\nLDASMHSQLRILDEEHPKGKYHHGLSALKPIRTTSKHQHPVDNAGLFSCMTFSWLSSLAR\nVAHKKGELSMEDVWSLSKHESSDVNCRRLERLWQEELNEVGPDAASLRRVVWIFCRTRLI\nLSIVCLMITQLAGFSGPAFMVKHLLEYTQATESNLQYSLLLVLGLLLTEIVRSWSLALTW\nALNYRTGVRLRGAILTMAFKKILKLKNIKEKSLGELINICSNDGQRMFEAAAVGSLLAGG\nPVVAILGMIYNVIILGPTGFLGSAVFILFYPAMMFASRLTAYFRRKCVAATDERVQKMNE\nVLTYIKFIKMYAWVKAFSQSVQKIREEERRILEKAGYFQSITVGVAPIVVVIASVVTFSV\nHMTLGFDLTAAQAFTVVTVFNSMTFALKVTPFSVKSLSEASVAVDRFKSLFLMEEVHMIK\nNKPASPHIKIEMKNATLAWDSSHSSIQNSPKLTPKMKKDKRASRGKKEKVRQLQRTEHQA\nVLAEQKGHLLLDSDERPSPEEEEGKHIHLGHLRLQRTLHSIDLEIQEGKLVGICGSVGSG\nKTSLISAILGQMTLLEGSIAISGTFAYVAQQAWILNATLRDNILFGKEYDEERYNSVLNS\nCCLRPDLAILPSSDLTEIGERGANLSGGQRQRISLARALYSDRSIYILDDPLSALDAHVG\nNHIFNSAIRKHLKSKTVLFVTHQLQYLVDCDEVIFMKEGCITERGTHEELMNLNGDYATI\nFNNLLLGETPPVEINSKKETSGSQKKSQDKGPKTGSVKKEKAVKPEEGQLVQLEEKGQGS\nVPWSVYGVYIQAAGGPLAFLVIMALFMLNVGSTAFSTWWLSYWIKQGSGNTTVTRGNETS\nVSDSMKDNPHMQYYASIYALSMAVMLILKAIRGVVFVKGTLRASSRLHDELFRRILRSPM\nKFFDTTPTGRILNRFSKDMDEVDVRLPFQAEMFIQNVILVFFCVGMIAGVFPWFLVAVGP\nLVILFSVLHIVSRVLIRELKRLDNITQSPFLSHITSSIQGLATIHAYNKGQEFLHRYQEL\nLDDNQAPFFLFTCAMRWLAVRLDLISIALITTTGLMIVLMHGQIPPAYAGLAISYAVQLT\nGLFQFTVRLASETEARFTSVERINHYIKTLSLEAPARIKNKAPSPDWPQEGEVTFENAEM\nRYRENLPLVLKKVSFTIKPKEKIGIVGRTGSGKSSLGMALFRLVELSGGCIKIDGVRISD\nIGLADLRSKLSIIPQEPVLFSGTVRSNLDPFNQYTEDQIWDALERTHMKECIAQLPLKLE\nSEVMENGDNFSVGERQLLCIARALLRHCKILILDEATAAMDTETDLLIQETIREAFADCT\nMLTIAHRLHTVLGSDRIMVLAQGQVVEFDTPSVLLSNDSSRFYAMFAAAENKVAVKG",
                        "Number of residues": "1437",
                        "Molecular Weight": "160658.8",
                        "Theoretical pI": "8.89",
                        "GO Classification": "FunctionsATP binding / ATPase activity, coupled to transmembrane movement of substances / organic anion transmembrane transporter activityProcessescarbohydrate metabolic process / glycosaminoglycan metabolic process / hyaluronan biosynthetic process / hyaluronan metabolic process / small molecule metabolic process / transmembrane transport / transportComponentsintegral component of plasma membrane / membrane / plasma membrane",
                        "General Function": "Organic anion transmembrane transporter activity",
                        "Specific Function": "Acts as a multispecific organic anion pump which can transport nucleotide analogs.",
                        "Pfam Domain Function": "ABC_tran (PF00005)\nABC_membrane (PF00664)",
                        "Transmembrane Regions": "179-199\n219-239\n296-316\n317-337\n400-420\n434-454\n608-628\n848-868\n917-937\n997-1017\n1018-1038\n1104-1124\n1127-1147",
                        "Cellular Location": "Membrane",
                        "Gene sequence": ">lcl|BSEQ0012531|Multidrug resistance-associated protein 5 (ABCC5)\nATGAAGGATATCGACATAGGAAAAGAGTATATCATCCCCAGTCCTGGGTATAGAAGTGTG\nAGGGAGAGAACCAGCACTTCTGGGACGCACAGAGACCGTGAAGATTCCAAGTTCAGGAGA\nACTCGACCGTTGGAATGCCAAGATGCCTTGGAAACAGCAGCCCGAGCCGAGGGCCTCTCT\nCTTGATGCCTCCATGCATTCTCAGCTCAGAATCCTGGATGAGGAGCATCCCAAGGGAAAG\nTACCATCATGGCTTGAGTGCTCTGAAGCCCATCCGGACTACTTCCAAACACCAGCACCCA\nGTGGACAATGCTGGGCTTTTTTCCTGTATGACTTTTTCGTGGCTTTCTTCTCTGGCCCGT\nGTGGCCCACAAGAAGGGGGAGCTCTCAATGGAAGACGTGTGGTCTCTGTCCAAGCACGAG\nTCTTCTGACGTGAACTGCAGAAGACTAGAGAGACTGTGGCAAGAAGAGCTGAATGAAGTT\nGGGCCAGACGCTGCTTCCCTGCGAAGGGTTGTGTGGATCTTCTGCCGCACCAGGCTCATC\nCTGTCCATCGTGTGCCTGATGATCACGCAGCTGGCTGGCTTCAGTGGACCAAATTTTCAG\nGATGGCTGTATTCTGCGGTCAGAATGA",
                        "Chromosome Location": "3",
                        "Locus": "3q27",
                        "External Identifiers": "ResourceLinkUniProtKB IDO15440UniProtKB Entry NameMRP5_HUMANGenBank Protein ID4140698GenBank Gene IDAF104942HGNC IDHGNC:56",
                        "General References": "Belinsky MG, Bain LJ, Balsara BB, Testa JR, Kruh GD: Characterization of MOAT-C and MOAT-D, new members of the MRP/cMOAT subfamily of transporter proteins. J Natl Cancer Inst. 1998 Nov 18;90(22):1735-41. [Article] McAleer MA, Breen MA, White NL, Matthews N: pABC11 (also known as MOAT-C and MRP5), a member of the ABC family of proteins, has anion transporter activity but does not confer multidrug resistance when overexpressed in human embryonic kidney 293 cells. J Biol Chem. 1999 Aug 13;274(33):23541-8. [Article] Suzuki T, Sasaki H, Kuh HJ, Agui M, Tatsumi Y, Tanabe S, Terada M, Saijo N, Nishio K: Detailed structural analysis on both human MRP5 and mouse mrp5 transcripts. Gene. 2000 Jan 25;242(1-2):167-73. [Article] Wijnholds J, Mol CA, van Deemter L, de Haas M, Scheffer GL, Baas F, Beijnen JH, Scheper RJ, Hatse S, De Clercq E, Balzarini J, Borst P: Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7476-81. [Article] Stojic J, Stohr H, Weber BH: Three novel ABCC5 splice variants in human retina and their role as regulators of ABCC5 gene expression. BMC Mol Biol. 2007 May 23;8:42. [Article] Muzny DM, Scherer SE, Kaul R, Wang J, Yu J, Sudbrak R, Buhay CJ, Chen R, Cree A, Ding Y, Dugan-Rocha S, Gill R, Gunaratne P, Harris RA, Hawes AC, Hernandez J, Hodgson AV, Hume J, Jackson A, Khan ZM, Kovar-Smith C, Lewis LR, Lozado RJ, Metzker ML, Milosavljevic A, Miner GR, Morgan MB, Nazareth LV, Scott G, Sodergren E, Song XZ, Steffen D, Wei S, Wheeler DA, Wright MW, Worley KC, Yuan Y, Zhang Z, Adams CQ, Ansari-Lari MA, Ayele M, Brown MJ, Chen G, Chen Z, Clendenning J, Clerc-Blankenburg KP, Chen R, Chen Z, Davis C, Delgado O, Dinh HH, Dong W, Draper H, Ernst S, Fu G, Gonzalez-Garay ML, Garcia DK, Gillett W, Gu J, Hao B, Haugen E, Havlak P, He X, Hennig S, Hu S, Huang W, Jackson LR, Jacob LS, Kelly SH, Kube M, Levy R, Li Z, Liu B, Liu J, Liu W, Lu J, Maheshwari M, Nguyen BV, Okwuonu GO, Palmeiri A, Pasternak S, Perez LM, Phelps KA, Plopper FJ, Qiang B, Raymond C, Rodriguez R, Saenphimmachak C, Santibanez J, Shen H, Shen Y, Subramanian S, Tabor PE, Verduzco D, Waldron L, Wang J, Wang J, Wang Q, Williams GA, Wong GK, Yao Z, Zhang J, Zhang X, Zhao G, Zhou J, Zhou Y, Nelson D, Lehrach H, Reinhardt R, Naylor SL, Yang H, Olson M, Weinstock G, Gibbs RA: The DNA sequence, annotation and analysis of human chromosome 3. Nature. 2006 Apr 27;440(7088):1194-8. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Suzuki T, Nishio K, Sasaki H, Kurokawa H, Saito-Ohara F, Ikeuchi T, Tanabe S, Terada M, Saijo N: cDNA cloning of a short type of multidrug resistance protein homologue, SMRP, from a human lung cancer cell line. Biochem Biophys Res Commun. 1997 Sep 29;238(3):790-4. [Article] Kool M, de Haas M, Scheffer GL, Scheper RJ, van Eijk MJ, Juijn JA, Baas F, Borst P: Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 1997 Aug 15;57(16):3537-47. [Article] Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP: A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7. doi: 10.1073/pnas.0805139105. Epub 2008 Jul 31. [Article] Olsen JV, Vermeulen M, Santamaria A, Kumar C, Miller ML, Jensen LJ, Gnad F, Cox J, Jensen TS, Nigg EA, Brunak S, Mann M: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3. doi: 10.1126/scisignal.2000475. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB01045RifampicinapprovedunknowninducerDetailsDB00515CisplatinapprovedunknowninducerDetailsDB01138SulfinpyrazoneapprovedunknowninhibitorDetailsDB00203Sildenafilapproved, investigationalunknowninhibitorDetailsDB01032Probenecidapproved, investigationalunknowninhibitorDetailsDB02527Cyclic adenosine monophosphateexperimentalunknowninhibitorDetailsDB00975DipyridamoleapprovedunknowninhibitorDetailsDB00917DinoprostoneapprovedunknowninhibitorDetailsDB00770Alprostadilapproved, investigationalunknowninhibitorDetailsDB00718Adefovir dipivoxilapproved, investigationalunknownsubstrateDetailsDB01033MercaptopurineapprovedunknownsubstrateDetailsDB00143Glutathioneapproved, investigational, nutraceuticalunknownsubstrateDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB00495ZidovudineapprovedunknownsubstrateDetailsDB00544FluorouracilapprovedunknownsubstrateDetailsDB11672Curcuminapproved, investigationalunknowninhibitorDetailsDB14635Curcumin sulfateexperimentalunknownDetailsDB08818Hyaluronic acidapproved, vet_approvedunknownsubstrateDetailsDB00642Pemetrexedapproved, investigationalnoDetails"
                    }
                },
                {
                    "Label": "Multidrug resistance-associated protein 1",
                    "Detailed Info": {
                        "Name": "Multidrug resistance-associated protein 1",
                        "Synonyms": "ATP-binding cassette sub-family C member 1\nLeukotriene C(4) transporter\nLTC4 transporter\nMRP\nMRP1",
                        "Gene Name": "ABCC1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0037076|Multidrug resistance-associated protein 1\nMALRGFCSADGSDPLWDWNVTWNTSNPDFTKCFQNTVLVWVPCFYLWACFPFYFLYLSRH\nDRGYIQMTPLNKTKTALGFLLWIVCWADLFYSFWERSRGIFLAPVFLVSPTLLGITMLLA\nTFLIQLERRKGVQSSGIMLTFWLVALVCALAILRSKIMTALKEDAQVDLFRDITFYVYFS\nLLLIQLVLSCFSDRSPLFSETIHDPNPCPESSASFLSRITFWWITGLIVRGYRQPLEGSD\nLWSLNKEDTSEQVVPVLVKNWKKECAKTRKQPVKVVYSSKDPAQPKESSKVDANEEVEAL\nIVKSPQKEWNPSLFKVLYKTFGPYFLMSFFFKAIHDLMMFSGPQILKLLIKFVNDTKAPD\nWQGYFYTVLLFVTACLQTLVLHQYFHICFVSGMRIKTAVIGAVYRKALVITNSARKSSTV\nGEIVNLMSVDAQRFMDLATYINMIWSAPLQVILALYLLWLNLGPSVLAGVAVMVLMVPVN\nAVMAMKTKTYQVAHMKSKDNRIKLMNEILNGIKVLKLYAWELAFKDKVLAIRQEELKVLK\nKSAYLSAVGTFTWVCTPFLVALCTFAVYVTIDENNILDAQTAFVSLALFNILRFPLNILP\nMVISSIVQASVSLKRLRIFLSHEELEPDSIERRPVKDGGGTNSITVRNATFTWARSDPPT\nLNGITFSIPEGALVAVVGQVGCGKSSLLSALLAEMDKVEGHVAIKGSVAYVPQQAWIQND\nSLRENILFGCQLEEPYYRSVIQACALLPDLEILPSGDRTEIGEKGVNLSGGQKQRVSLAR\nAVYSNADIYLFDDPLSAVDAHVGKHIFENVIGPKGMLKNKTRILVTHSMSYLPQVDVIIV\nMSGGKISEMGSYQELLARDGAFAEFLRTYASTEQEQDAEENGVTGVSGPGKEAKQMENGM\nLVTDSAGKQLQRQLSSSSSYSGDISRHHNSTAELQKAEAKKEETWKLMEADKAQTGQVKL\nSVYWDYMKAIGLFISFLSIFLFMCNHVSALASNYWLSLWTDDPIVNGTQEHTKVRLSVYG\nALGISQGIAVFGYSMAVSIGGILASRCLHVDLLHSILRSPMSFFERTPSGNLVNRFSKEL\nDTVDSMIPEVIKMFMGSLFNVIGACIVILLATPIAAIIIPPLGLIYFFVQRFYVASSRQL\nKRLESVSRSPVYSHFNETLLGVSVIRAFEEQERFIHQSDLKVDENQKAYYPSIVANRWLA\nVRLECVGNCIVLFAALFAVISRHSLSAGLVGLSVSYSLQVTTYLNWLVRMSSEMETNIVA\nVERLKEYSETEKEAPWQIQETAPPSSWPQVGRVEFRNYCLRYREDLDFVLRHINVTINGG\nEKVGIVGRTGAGKSSLTLGLFRINESAEGEIIIDGINIAKIGLHDLRFKITIIPQDPVLF\nSGSLRMNLDPFSQYSDEEVWTSLELAHLKDFVSALPDKLDHECAEGGENLSVGQRQLVCL\nARALLRKTKILVLDEATAAVDLETDDLIQSTIRTQFEDCTVLTIAHRLNTIMDYTRVIVL\nDKGEIQEYGAPSDLLQQRGLFYSMAKDAGLV",
                        "Number of residues": "1531",
                        "Molecular Weight": "171589.5",
                        "Theoretical pI": "7.11",
                        "GO Classification": "FunctionsATP binding / ATPase activity / ATPase activity, coupled to transmembrane movement of substances / transporter activityProcessesarachidonic acid metabolic process / cobalamin metabolic process / leukotriene metabolic process / response to drug / small molecule metabolic process / transmembrane transport / transport / vitamin metabolic process / water-soluble vitamin metabolic processComponentsbasolateral plasma membrane / extracellular exosome / integral component of plasma membrane / membrane / plasma membrane",
                        "General Function": "Transporter activity",
                        "Specific Function": "Mediates export of organic anions and drugs from the cytoplasm. Mediates ATP-dependent transport of glutathione and glutathione conjugates, leukotriene C4, estradiol-17-beta-o-glucuronide, methotrexate, antiviral drugs and other xenobiotics. Confers resistance to anticancer drugs. Hydrolyzes ATP with low efficiency.",
                        "Pfam Domain Function": "ABC_tran (PF00005)\nABC_membrane (PF00664)",
                        "Transmembrane Regions": "34-54\n75-95\n101-121\n134-154\n173-193\n317-337\n364-384\n441-461\n465-485\n548-568\n591-611\n968-988\n1026-1046\n1090-1110\n1112-1132\n1204-1224\n1227-1247",
                        "Cellular Location": "Cell membrane",
                        "Gene sequence": ">lcl|BSEQ0010554|Multidrug resistance-associated protein 1 (ABCC1)\nATGGCGCTCCGGGGCTTCTGCAGCGCCGATGGCTCCGACCCGCTCTGGGACTGGAATGTC\nACGTGGAATACCAGCAACCCCGACTTCACCAAGTGCTTTCAGAACACGGTCCTCGTGTGG\nGTGCCTTGTTTTTACCTCTGGGCCTGTTTCCCCTTCTACTTCCTCTATCTCTCCCGACAT\nGACCGAGGCTACATTCAGATGACACCTCTCAACAAAACCAAAACTGCCTTGGGATTTTTG\nCTGTGGATCGTCTGCTGGGCAGACCTCTTCTACTCTTTCTGGGAAAGAAGTCGGGGCATA\nTTCCTGGCCCCAGTGTTTCTGGTCAGCCCAACTCTCTTGGGCATCACCATGCTGCTTGCT\nACCTTTTTAATTCAGCTGGAGAGGAGGAAGGGAGTTCAGTCTTCAGGGATCATGCTCACT\nTTCTGGCTGGTAGCCCTAGTGTGTGCCCTAGCCATCCTGAGATCCAAAATTATGACAGCC\nTTAAAAGAGGATGCCCAGGTGGACCTGTTTCGTGACATCACTTTCTACGTCTACTTTTCC\nCTCTTACTCATTCAGCTCGTCTTGTCCTGTTTCTCAGATCGCTCACCCCTGTTCTCGGAA\nACCATCCACGACCCTAATCCCTGCCCAGAGTCCAGCGCTTCCTTCCTGTCGAGGATCACC\nTTCTGGTGGATCACAGGGTTGATTGTCCGGGGCTACCGCCAGCCCCTGGAGGGCAGTGAC\nCTCTGGTCCTTAAACAAGGAGGACACGTCGGAACAAGTCGTGCCTGTTTTGGTAAAGAAC\nTGGAAGAAGGAATGCGCCAAGACTAGGAAGCAGCCGGTGAAGGTTGTGTACTCCTCCAAG\nGATCCTGCCCAGCCGAAAGAGAGTTCCAAGGTGGATGCGAATGAGGAGGTGGAGGCTTTG\nATCGTCAAGTCCCCACAGAAGGAGTGGAACCCCTCTCTGTTTAAGGTGTTATACAAGACC\nTTTGGGCCCTACTTCCTCATGAGCTTCTTCTTCAAGGCCATCCACGACCTGATGATGTTT\nTCCGGGCCGCAGATCTTAAAGTTGCTCATCAAGTTCGTGAATGACACGAAGGCCCCAGAC\nTGGCAGGGCTACTTCTACACCGTGCTGCTGTTTGTCACTGCCTGCCTGCAGACCCTCGTG\nCTGCACCAGTACTTCCACATCTGCTTCGTCAGTGGCATGAGGATCAAGACCGCTGTCATT\nGGGGCTGTCTATCGGAAGGCCCTGGTGATCACCAATTCAGCCAGAAAATCCTCCACGGTC\nGGGGAGATTGTCAACCTCATGTCTGTGGACGCTCAGAGGTTCATGGACTTGGCCACGTAC\nATTAACATGATCTGGTCAGCCCCCCTGCAAGTCATCCTTGCTCTCTACCTCCTGTGGCTG\nAATCTGGGCCCTTCCGTCCTGGCTGGAGTGGCGGTGATGGTCCTCATGGTGCCCGTCAAT\nGCTGTGATGGCGATGAAGACCAAGACGTATCAGGTGGCCCACATGAAGAGCAAAGACAAT\nCGGATCAAGCTGATGAACGAAATTCTCAATGGGATCAAAGTGCTAAAGCTTTATGCCTGG\nGAGCTGGCATTCAAGGACAAGGTGCTGGCCATCAGGCAGGAGGAGCTGAAGGTGCTGAAG\nAAGTCTGCCTACCTGTCAGCCGTGGGCACCTTCACCTGGGTCTGCACGCCCTTTCTGGTG\nGCCTTGTGCACATTTGCCGTCTACGTGACCATTGACGAGAACAACATCCTGGATGCCCAG\nACAGCCTTCGTGTCTTTGGCCTTGTTCAACATCCTCCGGTTTCCCCTGAACATTCTCCCC\nATGGTCATCAGCAGCATCGTGCAGGCGAGTGTCTCCCTCAAACGCCTGAGGATCTTTCTC\nTCCCATGAGGAGCTGGAACCTGACAGCATCGAGCGACGGCCTGTCAAAGACGGCGGGGGC\nACGAACAGCATCACCGTGAGGAATGCCACATTCACCTGGGCCAGGAGCGACCCTCCCACA\nCTGAATGGCATCACCTTCTCCATCCCCGAAGGTGCTTTGGTGGCCGTGGTGGGCCAGGTG\nGGCTGCGGAAAGTCGTCCCTGCTCTCAGCCCTCTTGGCTGAGATGGACAAAGTGGAGGGG\nCACGTGGCTATCAAGGGCTCCGTGGCCTATGTGCCACAGCAGGCCTGGATTCAGAATGAT\nTCTCTCCGAGAAAACATCCTTTTTGGATGTCAGCTGGAGGAACCATATTACAGGTCCGTG\nATACAGGCCTGTGCCCTCCTCCCAGACCTGGAAATCCTGCCCAGTGGGGATCGGACAGAG\nATTGGCGAGAAGGGCGTGAACCTGTCTGGGGGCCAGAAGCAGCGCGTGAGCCTGGCCCGG\nGCCGTGTACTCCAACGCTGACATTTACCTCTTCGATGATCCCCTCTCAGCAGTGGATGCC\nCATGTGGGAAAACACATCTTTGAAAATGTGATTGGCCCCAAGGGGATGCTGAAGAACAAG\nACGCGGATCTTGGTCACGCACAGCATGAGCTACTTGCCGCAGGTGGACGTCATCATCGTC\nATGAGTGGCGGCAAGATCTCTGAGATGGGCTCCTACCAGGAGCTGCTGGCTCGAGACGGC\nGCCTTCGCTGAGTTCCTGCGTACCTATGCCAGCACAGAGCAGGAGCAGGATGCAGAGGAG\nAACGGGGTCACGGGCGTCAGCGGTCCAGGGAAGGAAGCAAAGCAAATGGAGAATGGCATG\nCTGGTGACGGACAGTGCAGGGAAGCAACTGCAGAGACAGCTCAGCAGCTCCTCCTCCTAT\nAGTGGGGACATCAGCAGGCACCACAACAGCACCGCAGAACTGCAGAAAGCTGAGGCCAAG\nAAGGAGGAGACCTGGAAGCTGATGGAGGCTGACAAGGCGCAGACAGGGCAGGTCAAGCTT\nTCCGTGTACTGGGACTACATGAAGGCCATCGGACTCTTCATCTCCTTCCTCAGCATCTTC\nCTTTTCATGTGTAACCATGTGTCCGCGCTGGCTTCCAACTATTGGCTCAGCCTCTGGACT\nGATGACCCCATCGTCAACGGGACTCAGGAGCACACGAAAGTCCGGCTGAGCGTCTATGGA\nGCCCTGGGCATTTCACAAGGGATCGCCGTGTTTGGCTACTCCATGGCCGTGTCCATCGGG\nGGGATCTTGGCTTCCCGCTGTCTGCACGTGGACCTGCTGCACAGCATCCTGCGGTCACCC\nATGAGCTTCTTTGAGCGGACCCCCAGTGGGAACCTGGTGAACCGCTTCTCCAAGGAGCTG\nGACACAGTGGACTCCATGATCCCGGAGGTCATCAAGATGTTCATGGGCTCCCTGTTCAAC\nGTCATTGGTGCCTGCATCGTTATCCTGCTGGCCACGCCCATCGCCGCCATCATCATCCCG\nCCCCTTGGCCTCATCTACTTCTTCGTCCAGAGGTTCTACGTGGCTTCCTCCCGGCAGCTG\nAAGCGCCTCGAGTCGGTCAGCCGCTCCCCGGTCTATTCCCATTTCAACGAGACCTTGCTG\nGGGGTCAGCGTCATTCGAGCCTTCGAGGAGCAGGAGCGCTTCATCCACCAGAGTGACCTG\nAAGGTGGACGAGAACCAGAAGGCCTATTACCCCAGCATCGTGGCCAACAGGTGGCTGGCC\nGTGCGGCTGGAGTGTGTGGGCAACTGCATCGTTCTGTTTGCTGCCCTGTTTGCGGTGATC\nTCCAGGCACAGCCTCAGTGCTGGCTTGGTGGGCCTCTCAGTGTCTTACTCATTGCAGGTC\nACCACGTACTTGAACTGGCTGGTTCGGATGTCATCTGAAATGGAAACCAACATCGTGGCC\nGTGGAGAGGCTCAAGGAGTATTCAGAGACTGAGAAGGAGGCGCCCTGGCAAATCCAGGAG\nACAGCTCCGCCCAGCAGCTGGCCCCAGGTGGGCCGAGTGGAATTCCGGAACTACTGCCTG\nCGCTACCGAGAGGACCTGGACTTCGTTCTCAGGCACATCAATGTCACGATCAATGGGGGA\nGAAAAGGTCGGCATCGTGGGGCGGACGGGAGCTGGGAAGTCGTCCCTGACCCTGGGCTTA\nTTTCGGATCAACGAGTCTGCCGAAGGAGAGATCATCATCGATGGCATCAACATCGCCAAG\nATCGGCCTGCACGACCTCCGCTTCAAGATCACCATCATCCCCCAGGACCCTGTTTTGTTT\nTCGGGTTCCCTCCGAATGAACCTGGACCCATTCAGCCAGTACTCGGATGAAGAAGTCTGG\nACGTCCCTGGAGCTGGCCCACCTGAAGGACTTCGTGTCAGCCCTTCCTGACAAGCTAGAC\nCATGAATGTGCAGAAGGCGGGGAGAACCTCAGTGTCGGGCAGCGCCAGCTTGTGTGCCTA\nGCCCGGGCCCTGCTGAGGAAGACGAAGATCCTTGTGTTGGATGAGGCCACGGCAGCCGTG\nGACCTGGAAACGGACGACCTCATCCAGTCCACCATCCGGACACAGTTCGAGGACTGCACC\nGTCCTCACCATCGCCCACCGGCTCAACACCATCATGGACTACACAAGGGTGATCGTCTTG\nGACAAAGGAGAAATCCAGGAGTACGGCGCCCCATCGGACCTCCTGCAGCAGAGAGGTCTT\nTTCTACAGCATGGCCAAAGACGCCGGCTTGGTGTGA",
                        "Chromosome Location": "16",
                        "Locus": "16p13.1",
                        "External Identifiers": "ResourceLinkUniProtKB IDP33527UniProtKB Entry NameMRP1_HUMANGenBank Protein ID1835659GenBank Gene IDL05628GenAtlas IDABCC1HGNC IDHGNC:51",
                        "General References": "Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, Deeley RG: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 1992 Dec 4;258(5088):1650-4. [Article] Cole SP, Deeley RG: Multidrug resistance-associated protein: sequence correction. Science. 1993 May 14;260(5110):879. [Article] Grant CE, Kurz EU, Cole SP, Deeley RG: Analysis of the intron-exon organization of the human multidrug-resistance protein gene (MRP) and alternative splicing of its mRNA. Genomics. 1997 Oct 15;45(2):368-78. [Article] Martin J, Han C, Gordon LA, Terry A, Prabhakar S, She X, Xie G, Hellsten U, Chan YM, Altherr M, Couronne O, Aerts A, Bajorek E, Black S, Blumer H, Branscomb E, Brown NC, Bruno WJ, Buckingham JM, Callen DF, Campbell CS, Campbell ML, Campbell EW, Caoile C, Challacombe JF, Chasteen LA, Chertkov O, Chi HC, Christensen M, Clark LM, Cohn JD, Denys M, Detter JC, Dickson M, Dimitrijevic-Bussod M, Escobar J, Fawcett JJ, Flowers D, Fotopulos D, Glavina T, Gomez M, Gonzales E, Goodstein D, Goodwin LA, Grady DL, Grigoriev I, Groza M, Hammon N, Hawkins T, Haydu L, Hildebrand CE, Huang W, Israni S, Jett J, Jewett PB, Kadner K, Kimball H, Kobayashi A, Krawczyk MC, Leyba T, Longmire JL, Lopez F, Lou Y, Lowry S, Ludeman T, Manohar CF, Mark GA, McMurray KL, Meincke LJ, Morgan J, Moyzis RK, Mundt MO, Munk AC, Nandkeshwar RD, Pitluck S, Pollard M, Predki P, Parson-Quintana B, Ramirez L, Rash S, Retterer J, Ricke DO, Robinson DL, Rodriguez A, Salamov A, Saunders EH, Scott D, Shough T, Stallings RL, Stalvey M, Sutherland RD, Tapia R, Tesmer JG, Thayer N, Thompson LS, Tice H, Torney DC, Tran-Gyamfi M, Tsai M, Ulanovsky LE, Ustaszewska A, Vo N, White PS, Williams AL, Wills PL, Wu JR, Wu K, Yang J, Dejong P, Bruce D, Doggett NA, Deaven L, Schmutz J, Grimwood J, Richardson P, Rokhsar DS, Eichler EE, Gilna P, Lucas SM, Myers RM, Rubin EM, Pennacchio LA: The sequence and analysis of duplication-rich human chromosome 16. Nature. 2004 Dec 23;432(7020):988-94. [Article] Loftus BJ, Kim UJ, Sneddon VP, Kalush F, Brandon R, Fuhrmann J, Mason T, Crosby ML, Barnstead M, Cronin L, Deslattes Mays A, Cao Y, Xu RX, Kang HL, Mitchell S, Eichler EE, Harris PC, Venter JC, Adams MD: Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. Genomics. 1999 Sep 15;60(3):295-308. [Article] Hipfner DR, Almquist KC, Leslie EM, Gerlach JH, Grant CE, Deeley RG, Cole SP: Membrane topology of the multidrug resistance protein (MRP). A study of glycosylation-site mutants reveals an extracytosolic NH2 terminus. J Biol Chem. 1997 Sep 19;272(38):23623-30. [Article] Kast C, Gros P: Topology mapping of the amino-terminal half of multidrug resistance-associated protein by epitope insertion and immunofluorescence. J Biol Chem. 1997 Oct 17;272(42):26479-87. [Article] Kast C, Gros P: Epitope insertion favors a six transmembrane domain model for the carboxy-terminal portion of the multidrug resistance-associated protein. Biochemistry. 1998 Feb 24;37(8):2305-13. [Article] Sjolinder M, Tornhamre S, Claesson HE, Hydman J, Lindgren J: Characterization of a leukotriene C4 export mechanism in human platelets: possible involvement of multidrug resistance-associated protein 1. J Lipid Res. 1999 Mar;40(3):439-46. [Article] Robbiani DF, Finch RA, Jager D, Muller WA, Sartorelli AC, Randolph GJ: The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell. 2000 Nov 22;103(5):757-68. [Article] Cui L, Hou YX, Riordan JR, Chang XB: Mutations of the Walker B motif in the first nucleotide binding domain of multidrug resistance protein MRP1 prevent conformational maturation. Arch Biochem Biophys. 2001 Aug 1;392(1):153-61. [Article] Ito K, Olsen SL, Qiu W, Deeley RG, Cole SP: Mutation of a single conserved tryptophan in multidrug resistance protein 1 (MRP1/ABCC1) results in loss of drug resistance and selective loss of organic anion transport. J Biol Chem. 2001 May 11;276(19):15616-24. Epub 2001 Feb 21. [Article] Zhang DW, Cole SP, Deeley RG: Identification of an amino acid residue in multidrug resistance protein 1 critical for conferring resistance to anthracyclines. J Biol Chem. 2001 Apr 20;276(16):13231-9. Epub 2001 Jan 23. [Article] Situ D, Haimeur A, Conseil G, Sparks KE, Zhang D, Deeley RG, Cole SP: Mutational analysis of ionizable residues proximal to the cytoplasmic interface of membrane spanning domain 3 of the multidrug resistance protein, MRP1 (ABCC1): glutamate 1204 is important for both the expression and catalytic activity of the transporter. J Biol Chem. 2004 Sep 10;279(37):38871-80. Epub 2004 Jun 18. [Article] Zhang DW, Nunoya K, Vasa M, Gu HM, Theis A, Cole SP, Deeley RG: Transmembrane helix 11 of multidrug resistance protein 1 (MRP1/ABCC1): identification of polar amino acids important for substrate specificity and binding of ATP at nucleotide binding domain 1. Biochemistry. 2004 Jul 27;43(29):9413-25. [Article] Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M: Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006 Nov 3;127(3):635-48. [Article] Conseil G, Deeley RG, Cole SP: Functional importance of three basic residues clustered at the cytosolic interface of transmembrane helix 15 in the multidrug and organic anion transporter MRP1 (ABCC1). J Biol Chem. 2006 Jan 6;281(1):43-50. Epub 2005 Oct 17. [Article] Daub H, Olsen JV, Bairlein M, Gnad F, Oppermann FS, Korner R, Greff Z, Keri G, Stemmann O, Mann M: Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol Cell. 2008 Aug 8;31(3):438-48. doi: 10.1016/j.molcel.2008.07.007. [Article] Gauci S, Helbig AO, Slijper M, Krijgsveld J, Heck AJ, Mohammed S: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal Chem. 2009 Jun 1;81(11):4493-501. doi: 10.1021/ac9004309. [Article] Mayya V, Lundgren DH, Hwang SI, Rezaul K, Wu L, Eng JK, Rodionov V, Han DK: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal. 2009 Aug 18;2(84):ra46. doi: 10.1126/scisignal.2000007. [Article] Olsen JV, Vermeulen M, Santamaria A, Kumar C, Miller ML, Jensen LJ, Gnad F, Cox J, Jensen TS, Nigg EA, Brunak S, Mann M: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3. doi: 10.1126/scisignal.2000475. [Article] Burkard TR, Planyavsky M, Kaupe I, Breitwieser FP, Burckstummer T, Bennett KL, Superti-Furga G, Colinge J: Initial characterization of the human central proteome. BMC Syst Biol. 2011 Jan 26;5:17. doi: 10.1186/1752-0509-5-17. [Article] Rigbolt KT, Prokhorova TA, Akimov V, Henningsen J, Johansen PT, Kratchmarova I, Kassem M, Mann M, Olsen JV, Blagoev B: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci Signal. 2011 Mar 15;4(164):rs3. doi: 10.1126/scisignal.2001570. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Ramaen O, Leulliot N, Sizun C, Ulryck N, Pamlard O, Lallemand JY, Tilbeurgh Hv, Jacquet E: Structure of the human multidrug resistance protein 1 nucleotide binding domain 1 bound to Mg2+/ATP reveals a non-productive catalytic site. J Mol Biol. 2006 Jun 16;359(4):940-9. Epub 2006 May 2. [Article] Le Saux O, Urban Z, Tschuch C, Csiszar K, Bacchelli B, Quaglino D, Pasquali-Ronchetti I, Pope FM, Richards A, Terry S, Bercovitch L, de Paepe A, Boyd CD: Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum. Nat Genet. 2000 Jun;25(2):223-7. [Article] Ringpfeil F, Lebwohl MG, Christiano AM, Uitto J: Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc Natl Acad Sci U S A. 2000 May 23;97(11):6001-6. [Article] Conrad S, Kauffmann HM, Ito K, Deeley RG, Cole SP, Schrenk D: Identification of human multidrug resistance protein 1 (MRP1) mutations and characterization of a G671V substitution. J Hum Genet. 2001;46(11):656-63. [Article] Perdu J, Germain DP: Identification of novel polymorphisms in the pM5 and MRP1 (ABCC1) genes at locus 16p13.1 and exclusion of both genes as responsible for pseudoxanthoma elasticum. Hum Mutat. 2001;17(1):74-5. [Article] Ito S, Ieiri I, Tanabe M, Suzuki A, Higuchi S, Otsubo K: Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects. Pharmacogenetics. 2001 Mar;11(2):175-84. [Article] Ley TJ, Mardis ER, Ding L, Fulton B, McLellan MD, Chen K, Dooling D, Dunford-Shore BH, McGrath S, Hickenbotham M, Cook L, Abbott R, Larson DE, Koboldt DC, Pohl C, Smith S, Hawkins A, Abbott S, Locke D, Hillier LW, Miner T, Fulton L, Magrini V, Wylie T, Glasscock J, Conyers J, Sander N, Shi X, Osborne JR, Minx P, Gordon D, Chinwalla A, Zhao Y, Ries RE, Payton JE, Westervelt P, Tomasson MH, Watson M, Baty J, Ivanovich J, Heath S, Shannon WD, Nagarajan R, Walter MJ, Link DC, Graubert TA, DiPersio JF, Wilson RK: DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature. 2008 Nov 6;456(7218):66-72. doi: 10.1038/nature07485. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB01138SulfinpyrazoneapprovedyesinhibitorDetailsDB04851BiricodarinvestigationalunknownDetailsDB00503Ritonavirapproved, investigationalunknowninhibitorinducerDetailsDB04216Quercetinexperimental, investigationalunknowninhibitorinducerDetailsDB00570VinblastineapprovedunknownsubstrateinhibitorinducerDetailsDB01174Phenobarbitalapproved, investigationalunknowninducerDetailsDB04348Taurocholic acidapproved, experimentalunknowninhibitorinducerDetailsDB02659Cholic AcidapprovedunknowninducerDetailsDB01165OfloxacinapprovedunknowninhibitorDetailsDB01138SulfinpyrazoneapprovedunknowninhibitorDetailsDB00328Indomethacinapproved, investigationalunknowninhibitorDetailsDB00286Conjugated estrogensapprovedunknowninhibitorDetailsDB01016GlyburideapprovedunknowninhibitorDetailsDB03467NaringeninexperimentalunknowninhibitorDetailsDB02375MyricetinexperimentalunknowninhibitorDetailsDB00709Lamivudineapproved, investigationalunknowninhibitorDetailsDB00224IndinavirapprovedunknowninhibitorDetailsDB00701Amprenavirapproved, investigationalunknowninhibitorDetailsDB01645GenisteininvestigationalunknowninhibitorDetailsDB01032Probenecidapproved, investigationalunknowninhibitorDetailsDB01050IbuprofenapprovedunknowninhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknowninhibitorDetailsDB00541Vincristineapproved, investigationalunknownsubstrateinhibitorDetailsDB00997Doxorubicinapproved, investigationalunknownsubstrateinhibitorDetailsDB00694DaunorubicinapprovedunknownsubstrateinhibitorDetailsDB01229Paclitaxelapproved, vet_approvedunknowninhibitorDetailsDB00143Glutathioneapproved, investigational, nutraceuticalunknownsubstrateinhibitorDetailsDB00563MethotrexateapprovedunknownsubstrateinhibitorDetailsDB01177IdarubicinapprovedunknowninhibitorDetailsDB00773EtoposideapprovedunknownsubstrateinhibitorDetailsDB00396Progesteroneapproved, vet_approvedunknowninhibitorDetailsDB00834Mifepristoneapproved, investigationalunknowninhibitorDetailsDB01045RifampicinapprovedunknowninhibitorDetailsDB00602Ivermectinapproved, investigational, vet_approvedunknowninhibitorDetailsDB01204Mitoxantroneapproved, investigationalunknownsubstrateinhibitorDetailsDB05294VandetanibapprovedunknowninhibitorDetailsDB00345Aminohippuric acidapproved, investigationalunknownsubstrateDetailsDB00365Grepafloxacinapproved, investigational, withdrawnunknownsubstrateDetailsDB00693FluoresceinapprovedunknownsubstrateDetailsDB01232Saquinavirapproved, investigationalunknownsubstrateDetailsDB00445EpirubicinapprovedunknownsubstrateDetailsDB03825Rhodamine 6GexperimentalunknownsubstrateDetailsDB00970Dactinomycinapproved, investigationalunknownsubstrateDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateDetailsDB00399Zoledronic acidapprovedunknownsubstrateDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB01072Atazanavirapproved, investigationalunknownsubstrateinhibitorDetailsDB06335SaxagliptinapprovedunknownsubstrateDetailsDB05812AbirateroneapprovedunknowninhibitorDetailsDB08881VemurafenibapprovedunknownsubstrateinhibitorDetailsDB01248Docetaxelapproved, investigationalunknownsubstrateDetailsDB09161Technetium Tc-99m sestamibiapproved, investigationalnosubstrateDetailsDB00171ATPinvestigational, nutraceuticalunknownDetailsDB08855Leukotriene C4experimental, investigationalunknownDetailsDB06176Romidepsinapproved, investigationalunknownDetailsDB13783Acemetacinapproved, investigationalnosubstrateDetailsDB09061Cannabidiolapproved, investigationalunknowninhibitorDetailsDB14011NabiximolsinvestigationalunknowninhibitorDetailsDB14009Medical Cannabisexperimental, investigationalunknowninhibitorDetailsDB09213Dexibuprofenapproved, investigationalunknownDetailsDB00115Cyanocobalaminapproved, nutraceuticalunknownDetailsDB00661VerapamilapprovedunknowninhibitorDetailsDB14962Trastuzumab deruxtecanapproved, investigationalunknownsubstrateDetailsDB08868Fingolimodapproved, investigationalunknowninhibitorinducerDetailsDB01708Prasteroneapproved, investigational, nutraceuticalunknownsubstrateDetailsDB00845Clofazimineapproved, investigationalunknowninhibitorDetailsDB15719Belantamab mafodotinapprovedunknownsubstrateDetailsDB00470Dronabinolapproved, illicitunknowninhibitorDetailsDB14737Cannabinolexperimental, investigationalunknowninhibitorDetailsDB04851BiricodarinvestigationalunknownmodulatorDetailsDB00499Flutamideapproved, investigationalunknownsubstrateDetailsDB00619ImatinibapprovednosubstrateinhibitorDetails"
                    }
                },
                {
                    "Label": "Solute carrier organic anion transporter family member 2B1",
                    "Detailed Info": {
                        "Name": "Solute carrier organic anion transporter family member 2B1",
                        "Synonyms": "KIAA0880\nOATP-B\nOATP-RP2\nOATP2B1\nOATPB\nOATPRP2\nOrganic anion transporter B\nOrganic anion transporter polypeptide-related protein 2\nSLC21A9\nSolute carrier family 21 member 9",
                        "Gene Name": "SLCO2B1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0037115|Solute carrier organic anion transporter family member 2B1\nMGPRIGPAGEVPQVPDKETKATMGTENTPGGKASPDPQDVRPSVFHNIKLFVLCHSLLQL\nAQLMISGYLKSSISTVEKRFGLSSQTSGLLASFNEVGNTALIVFVSYFGSRVHRPRMIGY\nGAILVALAGLLMTLPHFISEPYRYDNTSPEDMPQDFKASLCLPTTSAPASAPSNGNCSSY\nTETQHLSVVGIMFVAQTLLGVGGVPIQPFGISYIDDFAHNSNSPLYLGILFAVTMMGPGL\nAFGLGSLMLRLYVDINQMPEGGISLTIKDPRWVGAWWLGFLIAAGAVALAAIPYFFFPKE\nMPKEKRELQFRRKVLAVTDSPARKGKDSPSKQSPGESTKKQDGLVQIAPNLTVIQFIKVF\nPRVLLQTLRHPIFLLVVLSQVCLSSMAAGMAIFLPKFLERQFSITASYANLLIGCLSFPS\nVIVGIVVGGVLVKRLHLGPVGCGALCLLGMLLCLFFSLPLFFIGCSSHQIAGITHQTSAH\nPGLELSPSCMEACSCPLDGFNPVCDPSTRVEYITPCHAGCSSWVVQDALDNSQVFYTNCS\nCVVEGNPVLAGSCDSTCSHLVVPFLLLVSLGSALACLTHTPSFMLILRGVKKEDKTLAVG\nIQFMFLRILAWMPSPVIHGSAIDTTCVHWALSCGRRAVCRYYNNDLLRNRFIGLQFFFKT\nGSVICFALVLAVLRQQDKEARTKESRSSPAVEQQLLVSGPGKKPEDSRV",
                        "Number of residues": "709",
                        "Molecular Weight": "76709.98",
                        "Theoretical pI": "8.39",
                        "GO Classification": "Functionsbile acid transmembrane transporter activity / organic anion transmembrane transporter activity / sodium-independent organic anion transmembrane transporter activityProcessesanion transmembrane transport / bile acid and bile salt transport / sodium-independent organic anion transport / transmembrane transportComponentsintegral component of plasma membrane / plasma membrane",
                        "General Function": "Sodium-independent organic anion transmembrane transporter activity",
                        "Specific Function": "Mediates the Na(+)-independent transport of organic anions such as taurocholate, the prostaglandins PGD2, PGE1, PGE2, leukotriene C4, thromboxane B2 and iloprost.",
                        "Pfam Domain Function": "OATP (PF03137)",
                        "Transmembrane Regions": "50-69\n89-109\n116-140\n186-215\n235-255\n274-298\n367-388\n409-432\n437-460\n565-587\n597-622\n656-673",
                        "Cellular Location": "Cell membrane",
                        "Gene sequence": ">lcl|BSEQ0010728|Solute carrier organic anion transporter family member 2B1 (SLCO2B1)\nATGGGCACAGAAAACACACCTGGAGGCAAAGCCAGCCCAGACCCTCAGGACGTGCGGCCA\nAGTGTGTTCCATAACATCAAGCTGTTCGTTCTGTGCCACAGCCTGCTGCAGCTGGCGCAG\nCTCATGATCTCCGGCTACCTAAAGAGCTCCATCTCCACAGTGGAGAAGCGCTTCGGCCTC\nTCCAGCCAGACGTCGGGGCTGCTGGCCTCCTTCAACGAGGTGGGGAACACAGCCTTGATT\nGTGTTTGTGAGCTATTTTGGCAGCCGGGTGCACCGACCCCGAATGATTGGCTATGGGGCT\nATCCTTGTGGCCCTGGCGGGCCTGCTCATGACTCTCCCGCACTTCATCTCGGAGCCATAC\nCGCTACGACAACACCAGCCCTGAGGATATGCCACAGGACTTCAAGGCTTCCCTGTGCCTG\nCCCACAACCTCGGCCCCAGCCTCGGCCCCCTCCAATGGCAACTGCTCAAGCTACACAGAA\nACCCAGCATCTGAGTGTGGTGGGGATCATGTTCGTGGCACAGACCCTGCTGGGCGTGGGC\nGGGGTGCCCATTCAGCCCTTTGGCATCTCCTACATCGATGACTTTGCCCACAACAGCAAC\nTCGCCCCTCTACCTCGGGATCCTGTTTGCAGTGACCATGATGGGGCCAGGCCTGGCCTTT\nGGGCTGGGCAGCCTCATGCTGCGCCTTTATGTGGACATTAACCAGATGCCAGAAGGTGGT\nATCAGCCTGACCATAAAGGACCCCCGATGGGTGGGTGCCTGGTGGCTGGGTTTCCTCATC\nGCTGCCGGTGCAGTGGCCCTGGCTGCCATCCCCTACTTCTTCTTCCCCAAGGAAATGCCC\nAAGGAAAAACGTGAGCTTCAGTTTCGGCGAAAGGTCTTAGCAGTCACAGACTCACCTGCC\nAGGAAGGGCAAGGACTCTCCCTCTAAGCAGAGCCCTGGGGAGTCCACGAAGAAGCAGGAT\nGGCCTAGTCCAGATTGCACCAAACCTGACTGTGATCCAGTTCATTAAAGTCTTCCCCAGG\nGTGCTGCTGCAGACCCTACGCCACCCCATCTTCCTGCTGGTGGTCCTGTCCCAGGTATGC\nTTGTCATCCATGGCTGCGGGCATGGCCACCTTCCTGCCCAAGTTCCTGGAGCGCCAGTTT\nTCCATCACAGCCTCCTACGCCAACCTGCTCATCGGCTGCCTCTCCTTCCCTTCGGTCATC\nGTGGGCATCGTGGTGGGTGGCGTCCTGGTCAAGCGGCTCCACCTGGGCCCTGTGGGATGC\nGGTGCCCTTTGCCTGCTGGGGATGCTGCTGTGCCTCTTCTTCAGCCTGCCGCTCTTCTTT\nATCGGCTGCTCCAGCCACCAGATTGCGGGCATCACACACCAGACCAGTGCCCACCCTGGG\nCTGGAGCTGTCTCCAAGCTGCATGGAGGCCTGCTCCTGCCCATTGGACGGCTTTAACCCT\nGTCTGCGACCCCAGCACTCGTGTGGAATACATCACACCCTGCCACGCAGGCTGCTCAAGC\nTGGGTGGTCCAGGATGCTCTGGACAACAGCCAGGTTTTCTACACCAACTGCAGCTGCGTG\nGTGGAGGGCAACCCCGTGCTGGCAGGATCCTGCGACTCAACGTGCAGCCATCTGGTGGTG\nCCCTTCCTGCTCCTGGTCAGCCTGGGCTCGGCCCTGGCCTGTCTCACCCACACACCCTCC\nTTCATGCTCATCCTAAGAGGAGTGAAGAAAGAAGACAAGACTTTGGCTGTGGGCATCCAG\nTTCATGTTCCTGAGGATTTTGGCCTGGATGCCCAGCCCCGTGATCCACGGCAGCGCCATC\nGACACCACCTGTGTGCACTGGGCCCTGAGCTGTGGGCGTCGAGCTGTCTGTCGCTACTAC\nAATAATGACCTGCTCCGAAACCGGTTCATCGGCCTCCAGTTCTTCTTCAAAACAGGTTCT\nGTGATCTGCTTCGCCTTAGTTTTGGCTGTCCTGAGGCAGCAGGACAAAGAGGCAAGGACC\nAAAGAGAGCAGATCCAGCCCTGCCGTAGAGCAGCAATTGCTAGTGTCGGGGCCAGGGAAG\nAAGCCAGAGGATTCCCGAGTGTGA",
                        "Chromosome Location": "11",
                        "Locus": "11q13",
                        "External Identifiers": "ResourceLinkUniProtKB IDO94956UniProtKB Entry NameSO2B1_HUMANGenBank Protein ID5006263GenBank Gene IDAB026256GenAtlas IDSLCO2B1HGNC IDHGNC:10962",
                        "General References": "Tamai I, Nezu J, Uchino H, Sai Y, Oku A, Shimane M, Tsuji A: Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Commun. 2000 Jun 24;273(1):251-60. [Article] Nagase T, Ishikawa K, Suyama M, Kikuno R, Hirosawa M, Miyajima N, Tanaka A, Kotani H, Nomura N, Ohara O: Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res. 1998 Dec 31;5(6):355-64. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Bechtel S, Rosenfelder H, Duda A, Schmidt CP, Ernst U, Wellenreuther R, Mehrle A, Schuster C, Bahr A, Blocker H, Heubner D, Hoerlein A, Michel G, Wedler H, Kohrer K, Ottenwalder B, Poustka A, Wiemann S, Schupp I: The full-ORF clone resource of the German cDNA Consortium. BMC Genomics. 2007 Oct 31;8:399. [Article] Taylor TD, Noguchi H, Totoki Y, Toyoda A, Kuroki Y, Dewar K, Lloyd C, Itoh T, Takeda T, Kim DW, She X, Barlow KF, Bloom T, Bruford E, Chang JL, Cuomo CA, Eichler E, FitzGerald MG, Jaffe DB, LaButti K, Nicol R, Park HS, Seaman C, Sougnez C, Yang X, Zimmer AR, Zody MC, Birren BW, Nusbaum C, Fujiyama A, Hattori M, Rogers J, Lander ES, Sakaki Y: Human chromosome 11 DNA sequence and analysis including novel gene identification. Nature. 2006 Mar 23;440(7083):497-500. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Hanggi E, Grundschober AF, Leuthold S, Meier PJ, St-Pierre MV: Functional analysis of the extracellular cysteine residues in the human organic anion transporting polypeptide, OATP2B1. Mol Pharmacol. 2006 Sep;70(3):806-17. Epub 2006 Jun 5. [Article] Knauer MJ, Girdwood AJ, Kim RB, Tirona RG: Transport function and transcriptional regulation of a liver-enriched human organic anion transporting polypeptide 2B1 transcriptional start site variant. Mol Pharmacol. 2013 Jun;83(6):1218-28. doi: 10.1124/mol.112.083618. Epub 2013 Mar 26. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE: The consensus coding sequences of human breast and colorectal cancers. Science. 2006 Oct 13;314(5797):268-74. Epub 2006 Sep 7. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00655EstroneapprovedunknowninhibitorDetailsDB01045RifampicinapprovedunknowninhibitorDetailsDB02746Phthalic AcidexperimentalunknowninhibitorDetailsDB03902Oxalic AcidexperimentalunknowninhibitorDetailsDB00627Niacinapproved, investigational, nutraceuticalunknowninhibitorDetailsDB04398Lactic acidapproved, vet_approvedunknownsubstrateinhibitorDetailsDB04272Citric acidapproved, nutraceutical, vet_approvedunknowninhibitorDetailsDB03793Benzoic acidapproved, investigationalunknowninhibitorDetailsDB03166Acetic acidapprovedunknownsubstrateinhibitorDetailsDB04216Quercetinexperimental, investigationalunknowninhibitorDetailsDB03467NaringeninexperimentalunknowninhibitorDetailsDB00770Alprostadilapproved, investigationalunknownsubstrateinhibitorDetailsDB00175PravastatinapprovednosubstrateDetailsDB00917DinoprostoneapprovedunknownsubstrateDetailsDB01053Benzylpenicillinapproved, vet_approvedunknownsubstrateDetailsDB00286Conjugated estrogensapprovedunknownsubstrateDetailsDB04348Taurocholic acidapproved, experimentalunknownsubstrateDetailsDB00950Fexofenadineapproved, investigationalunknownsubstrateDetailsDB01124Tolbutamideapproved, investigationalunknownsubstrateDetailsDB01050IbuprofenapprovedunknownsubstrateDetailsDB00936Salicylic acidapproved, investigational, vet_approvedunknownsubstrateDetailsDB01016GlyburideapprovedunknownsubstrateDetailsDB01088Iloprostapproved, investigationalunknownsubstrateDetailsDB00471MontelukastapprovedunknownsubstrateDetailsDB05804Prasterone sulfateinvestigationalunknownDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB01095FluvastatinapprovedunknownDetailsDB01098RosuvastatinapprovedunknownDetailsDB08860PitavastatinapprovedunknownsubstrateDetailsDB11613Velpatasvirapproved, investigationalnoinhibitortransporterDetailsDB11611LifitegrastapprovedunknownsubstrateDetailsDB06290SimeprevirapprovedunknownsubstrateDetailsDB05521Telaprevirapproved, withdrawnunknowninhibitorDetailsDB11591Bilastineapproved, investigationalunknowninhibitorDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknowninhibitorDetailsDB11660Latanoprostene bunodapproved, investigationalunknownsubstrateDetailsDB12319Benzbromaroneinvestigational, withdrawnunknowninhibitorDetailsDB08862Cholecystokininapproved, investigationalunknowninhibitorDetailsDB00255Diethylstilbestrolapproved, investigational, withdrawnunknownsubstrateDetailsDB00975DipyridamoleapprovedunknowninhibitorDetailsDB00530Erlotinibapproved, investigationalunknowninhibitorDetailsDB01645GenisteininvestigationalunknowninhibitorDetailsDB01167Itraconazoleapproved, investigationalunknowninhibitorDetailsDB00451LevothyroxineapprovedunknowninhibitorDetailsDB01149Nefazodoneapproved, withdrawnunknowninhibitorDetailsDB00220NelfinavirapprovednoinhibitorDetailsDB01051Novobiocinapproved, investigational, vet_approved, withdrawnunknowninhibitorDetailsDB00554Piroxicamapproved, investigationalunknowninhibitorDetailsDB00206Reserpineapproved, investigational, withdrawnunknowninhibitorDetailsDB09298Silibininexperimental, investigationalunknowninhibitorDetailsDB00795SulfasalazineapprovednoinhibitorDetailsDB00759Tetracyclineapproved, vet_approved, withdrawnunknowninhibitorDetailsDB00932Tipranavirapproved, investigationalunknowninhibitorDetailsDB00313Valproic acidapproved, investigationalunknowninhibitorDetailsDB00224IndinavirapprovedunknowninhibitorDetailsDB01232Saquinavirapproved, investigationalunknowninhibitorDetailsDB00503Ritonavirapproved, investigationalunknowninhibitorDetailsDB11586Asunaprevirapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB05928DovitinibinvestigationalunknowninhibitorDetailsDB09213Dexibuprofenapproved, investigationalunknownDetailsDB11753Rifamycinapproved, investigationalnoinhibitorDetailsDB00641SimvastatinapprovedunknownDetailsDB00227Lovastatinapproved, investigationalunknownDetailsDB12978Pexidartinibapproved, investigationalunknowninhibitorDetailsDB01241GemfibrozilapprovedunknowninhibitorDetailsDB01072Atazanavirapproved, investigationalnoinhibitorDetailsDB01708Prasteroneapproved, investigational, nutraceuticalunknownsubstrateDetailsDB11632Opicaponeapproved, investigationalnosubstrateDetailsDB08995Diosminapproved, investigationalunknownDetailsDB16226Maralixibatapproved, investigationalunknowninhibitorDetailsDB11761Tenapanorapproved, investigationalunknowninhibitorDetailsDB00244MesalazineapprovedunknownsubstrateDetailsDB06374Elacestrantapproved, investigationalunknownsubstrateDetails"
                    }
                },
                {
                    "Label": "Solute carrier organic anion transporter family member 1B3",
                    "Detailed Info": {
                        "Name": "Solute carrier organic anion transporter family member 1B3",
                        "Synonyms": "Liver-specific organic anion transporter 2\nLST-2\nLST2\nOATP-8\nOATP1B3\nOATP8\nOrganic anion transporter 8\nOrganic anion-transporting polypeptide 8\nSLC21A8\nSolute carrier family 21 member 8",
                        "Gene Name": "SLCO1B3",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0007032|Solute carrier organic anion transporter family member 1B3\nMDQHQHLNKTAESASSEKKKTRRCNGFKMFLAALSFSYIAKALGGIIMKISITQIERRFD\nISSSLAGLIDGSFEIGNLLVIVFVSYFGSKLHRPKLIGIGCLLMGTGSILTSLPHFFMGY\nYRYSKETHINPSENSTSSLSTCLINQTLSFNGTSPEIVEKDCVKESGSHMWIYVFMGNML\nRGIGETPIVPLGISYIDDFAKEGHSSLYLGSLNAIGMIGPVIGFALGSLFAKMYVDIGYV\nDLSTIRITPKDSRWVGAWWLGFLVSGLFSIISSIPFFFLPKNPNKPQKERKISLSLHVLK\nTNDDRNQTANLTNQGKNVTKNVTGFFQSLKSILTNPLYVIFLLLTLLQVSSFIGSFTYVF\nKYMEQQYGQSASHANFLLGIITIPTVATGMFLGGFIIKKFKLSLVGIAKFSFLTSMISFL\nFQLLYFPLICESKSVAGLTLTYDGNNSVASHVDVPLSYCNSECNCDESQWEPVCGNNGIT\nYLSPCLAGCKSSSGIKKHTVFYNCSCVEVTGLQNRNYSAHLGECPRDNTCTRKFFIYVAI\nQVINSLFSATGGTTFILLTVKIVQPELKALAMGFQSMVIRTLGGILAPIYFGALIDKTCM\nKWSTNSCGAQGACRIYNSVFFGRVYLGLSIALRFPALVLYIVFIFAMKKKFQGKDTKASD\nNERKVMDEANLEFLNNGEHFVPSAGTDSKTCNLDMQDNAAAN",
                        "Number of residues": "702",
                        "Molecular Weight": "77402.175",
                        "Theoretical pI": "8.95",
                        "GO Classification": "Functionsbile acid transmembrane transporter activity / organic anion transmembrane transporter activity / sodium-independent organic anion transmembrane transporter activityProcessesanion transmembrane transport / bile acid and bile salt transport / bile acid metabolic process / organic anion transport / small molecule metabolic process / sodium-independent organic anion transport / transmembrane transportComponentsbasolateral plasma membrane / integral component of plasma membrane / plasma membrane",
                        "General Function": "Sodium-independent organic anion transmembrane transporter activity",
                        "Specific Function": "Mediates the Na(+)-independent uptake of organic anions such as 17-beta-glucuronosyl estradiol, taurocholate, triiodothyronine (T3), leukotriene C4, dehydroepiandrosterone sulfate (DHEAS), methotrexate and sulfobromophthalein (BSP). Involved in the clearance of bile acids and organic anions from the liver.",
                        "Pfam Domain Function": "Kazal_2 (PF07648)\nOATP (PF03137)",
                        "Transmembrane Regions": "29-48\n68-88\n95-119\n169-197\n217-237\n256-280\n332-353\n374-397\n402-425\n538-560\n570-595\n630-647",
                        "Cellular Location": "Basolateral cell membrane",
                        "Gene sequence": ">lcl|BSEQ0012544|Solute carrier organic anion transporter family member 1B3 (SLCO1B3)\nATGGACCAACATCAACATTTGAATAAAACAGCAGAGTCAGCATCTTCAGAGAAAAAGAAA\nACAAGACGCTGCAATGGATTCAAGATGTTCTTGGCAGCCCTGTCATTCAGCTATATTGCT\nAAAGCACTAGGTGGAATCATTATGAAAATTTCCATCACTCAAATAGAAAGGAGATTTGAC\nATATCCTCTTCTCTTGCTGGTTTAATTGATGGAAGCTTTGAAATTGGAAATTTGCTTGTG\nATTGTATTTGTAAGTTACTTTGGATCTAAACTACACAGACCGAAGTTAATTGGAATTGGT\nTGTCTCCTTATGGGAACTGGAAGTATTTTGACATCTTTACCACATTTCTTCATGGGATAT\nTATAGGTATTCTAAAGAAACCCATATTAATCCATCAGAAAATTCAACATCAAGTTTATCA\nACCTGTTTAATTAATCAAACCTTATCATTCAATGGAACATCACCTGAGATAGTAGAAAAA\nGATTGTGTAAAGGAATCTGGGTCACACATGTGGATCTATGTCTTCATGGGGAATATGCTT\nCGTGGCATAGGGGAAACCCCCATAGTACCATTGGGGATTTCATACATTGATGATTTTGCA\nAAAGAAGGACATTCTTCCTTGTATTTAGGTAGTTTGAATGCAATAGGAATGATTGGTCCA\nGTCATTGGCTTTGCACTGGGATCTCTGTTTGCTAAAATGTACGTGGATATTGGATATGTA\nGATCTGAGCACTATCAGAATAACTCCTAAGGACTCTCGTTGGGTTGGAGCTTGGTGGCTT\nGGTTTCCTTGTGTCTGGACTATTTTCCATTATTTCTTCCATACCATTTTTTTTCTTGCCG\nAAAAATCCAAATAAACCACAAAAAGAAAGAAAAATTTCACTATCATTGCATGTGCTGAAA\nACAAATGATGATAGAAATCAAACAGCTAATTTGACCAACCAAGGAAAAAATGTTACCAAA\nAATGTGACTGGTTTTTTCCAGTCTTTGAAAAGCATCCTTACCAATCCCCTGTATGTTATA\nTTTCTGCTTTTGACATTGTTACAAGTAAGCAGCTTTATTGGTTCTTTTACTTACGTCTTT\nAAATATATGGAGCAACAGTACGGTCAGTCTGCATCTCATGCTAACTTTTTGTTGGGAATC\nATAACCATTCCTACGGTTGCAACTGGAATGTTTTTAGGAGGATTTATCATTAAAAAATTC\nAAATTGTCTTTAGTTGGAATTGCCAAATTTTCATTTCTTACTTCGATGATATCCTTCTTG\nTTTCAACTTCTATATTTCCCTCTAATCTGCGAAAGCAAATCAGTTGCCGGCCTAACCTTG\nACCTATGATGGAAATAATTCAGTGGCATCTCATGTAGATGTACCACTTTCTTATTGCAAC\nTCAGAGTGCAATTGTGATGAAAGTCAGTGGGAACCAGTCTGTGGGAACAATGGAATAACT\nTACCTGTCACCTTGTCTAGCAGGATGCAAATCCTCAAGTGGTATTAAAAAGCATACAGTG\nTTTTATAACTGTAGTTGTGTGGAAGTAACTGGTCTCCAGAACAGAAATTACTCAGCACAC\nTTGGGTGAATGCCCAAGAGATAATACTTGTACAAGGAAATTTTTCATCTATGTTGCAATT\nCAAGTCATAAACTCTTTGTTCTCTGCAACAGGAGGTACCACATTTATCTTGTTGACTGTG\nAAGATTGTTCAACCTGAATTGAAAGCACTTGCAATGGGTTTCCAGTCAATGGTTATAAGA\nACACTAGGAGGAATTCTAGCTCCAATATATTTTGGGGCTCTGATTGATAAAACATGTATG\nAAGTGGTCCACCAACAGCTGTGGAGCACAAGGAGCTTGTAGGATATATAATTCCGTATTT\nTTTGGAAGGGTCTACTTGGGCTTATCTATAGCTTTAAGATTCCCAGCACTTGTTTTATAT\nATTGTTTTCATTTTTGCTATGAAGAAAAAATTTCAAGGAAAAGATACCAAGGCATCGGAC\nAATGAAAGAAAAGTAATGGATGAAGCAAACTTAGAATTCTTAAATAATGGTGAACATTTT\nGTACCTTCTGCTGGAACAGATAGTAAAACATGTAATTTGGACATGCAAGACAATGCTGCT\nGCCAACTAA",
                        "Chromosome Location": "12",
                        "Locus": "12p12",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ9NPD5UniProtKB Entry NameSO1B3_HUMANGenBank Protein ID9187497GenBank Gene IDAJ251506HGNC IDHGNC:10961",
                        "General References": "Konig J, Cui Y, Nies AT, Keppler D: Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J Biol Chem. 2000 Jul 28;275(30):23161-8. [Article] Abe T, Unno M, Onogawa T, Tokui T, Kondo TN, Nakagomi R, Adachi H, Fujiwara K, Okabe M, Suzuki T, Nunoki K, Sato E, Kakyo M, Nishio T, Sugita J, Asano N, Tanemoto M, Seki M, Date F, Ono K, Kondo Y, Shiiba K, Suzuki M, Ohtani H, Shimosegawa T, Iinuma K, Nagura H, Ito S, Matsuno S: LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology. 2001 Jun;120(7):1689-99. [Article] Scherer SE, Muzny DM, Buhay CJ, Chen R, Cree A, Ding Y, Dugan-Rocha S, Gill R, Gunaratne P, Harris RA, Hawes AC, Hernandez J, Hodgson AV, Hume J, Jackson A, Khan ZM, Kovar-Smith C, Lewis LR, Lozado RJ, Metzker ML, Milosavljevic A, Miner GR, Montgomery KT, Morgan MB, Nazareth LV, Scott G, Sodergren E, Song XZ, Steffen D, Lovering RC, Wheeler DA, Worley KC, Yuan Y, Zhang Z, Adams CQ, Ansari-Lari MA, Ayele M, Brown MJ, Chen G, Chen Z, Clerc-Blankenburg KP, Davis C, Delgado O, Dinh HH, Draper H, Gonzalez-Garay ML, Havlak P, Jackson LR, Jacob LS, Kelly SH, Li L, Li Z, Liu J, Liu W, Lu J, Maheshwari M, Nguyen BV, Okwuonu GO, Pasternak S, Perez LM, Plopper FJ, Santibanez J, Shen H, Tabor PE, Verduzco D, Waldron L, Wang Q, Williams GA, Zhang J, Zhou J, Allen CC, Amin AG, Anyalebechi V, Bailey M, Barbaria JA, Bimage KE, Bryant NP, Burch PE, Burkett CE, Burrell KL, Calderon E, Cardenas V, Carter K, Casias K, Cavazos I, Cavazos SR, Ceasar H, Chacko J, Chan SN, Chavez D, Christopoulos C, Chu J, Cockrell R, Cox CD, Dang M, Dathorne SR, David R, Davis CM, Davy-Carroll L, Deshazo DR, Donlin JE, D'Souza L, Eaves KA, Egan A, Emery-Cohen AJ, Escotto M, Flagg N, Forbes LD, Gabisi AM, Garza M, Hamilton C, Henderson N, Hernandez O, Hines S, Hogues ME, Huang M, Idlebird DG, Johnson R, Jolivet A, Jones S, Kagan R, King LM, Leal B, Lebow H, Lee S, LeVan JM, Lewis LC, London P, Lorensuhewa LM, Loulseged H, Lovett DA, Lucier A, Lucier RL, Ma J, Madu RC, Mapua P, Martindale AD, Martinez E, Massey E, Mawhiney S, Meador MG, Mendez S, Mercado C, Mercado IC, Merritt CE, Miner ZL, Minja E, Mitchell T, Mohabbat F, Mohabbat K, Montgomery B, Moore N, Morris S, Munidasa M, Ngo RN, Nguyen NB, Nickerson E, Nwaokelemeh OO, Nwokenkwo S, Obregon M, Oguh M, Oragunye N, Oviedo RJ, Parish BJ, Parker DN, Parrish J, Parks KL, Paul HA, Payton BA, Perez A, Perrin W, Pickens A, Primus EL, Pu LL, Puazo M, Quiles MM, Quiroz JB, Rabata D, Reeves K, Ruiz SJ, Shao H, Sisson I, Sonaike T, Sorelle RP, Sutton AE, Svatek AF, Svetz LA, Tamerisa KS, Taylor TR, Teague B, Thomas N, Thorn RD, Trejos ZY, Trevino BK, Ukegbu ON, Urban JB, Vasquez LI, Vera VA, Villasana DM, Wang L, Ward-Moore S, Warren JT, Wei X, White F, Williamson AL, Wleczyk R, Wooden HS, Wooden SH, Yen J, Yoon L, Yoon V, Zorrilla SE, Nelson D, Kucherlapati R, Weinstock G, Gibbs RA: The finished DNA sequence of human chromosome 12. Nature. 2006 Mar 16;440(7082):346-51. [Article] van de Steeg E, Stranecky V, Hartmannova H, Noskova L, Hrebicek M, Wagenaar E, van Esch A, de Waart DR, Oude Elferink RP, Kenworthy KE, Sticova E, al-Edreesi M, Knisely AS, Kmoch S, Jirsa M, Schinkel AH: Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver. J Clin Invest. 2012 Feb;122(2):519-28. doi: 10.1172/JCI59526. Epub 2012 Jan 9. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE: The consensus coding sequences of human breast and colorectal cancers. Science. 2006 Oct 13;314(5797):268-74. Epub 2006 Sep 7. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB01045RifampicinapprovedunknownsubstrateinhibitorDetailsDB01132Pioglitazoneapproved, investigationalunknowninhibitorDetailsDB04348Taurocholic acidapproved, experimentalunknownsubstrateDetailsDB00286Conjugated estrogensapprovedunknownsubstrateDetailsDB02659Cholic AcidapprovedunknownsubstrateDetailsDB00279Liothyronineapproved, vet_approvedunknownsubstrateDetailsDB01092OuabainapprovedunknownsubstrateDetailsDB00563MethotrexateapprovedunknownsubstrateDetailsDB00520CaspofunginapprovedunknownsubstrateDetailsDB00275Olmesartanapproved, investigationalunknownsubstrateDetailsDB00177Valsartanapproved, investigationalunknownsubstrateDetailsDB01583LiotrixapprovedunknownsubstrateDetailsDB06176Romidepsinapproved, investigationalunknowninhibitorDetailsDB08855Leukotriene C4experimental, investigationalunknownDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownDetailsDB02691Glycocholic acidexperimental, investigationalunknownDetailsDB05804Prasterone sulfateinvestigationalunknownDetailsDB00451LevothyroxineapprovedunknowninhibitorDetailsDB08861DPDPEexperimentalunknownDetailsDB08862Cholecystokininapproved, investigationalunknownsubstrateDetailsDB00950Fexofenadineapproved, investigationalunknownsubstrateDetailsDB01095FluvastatinapprovedunknownsubstrateDetailsDB08860PitavastatinapprovedunknownsubstrateDetailsDB01098RosuvastatinapprovedunknownDetailsDB06772CabazitaxelapprovedunknowninhibitorDetailsDB08864RilpivirineapprovedunknowninhibitorDetailsDB08884Gadoxetic acidapprovedunknownsubstrateDetailsDB08912Dabrafenibapproved, investigationalnosubstrateinhibitorDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB00175PravastatinapprovednosubstrateDetailsDB01229Paclitaxelapproved, vet_approvedunknownsubstrateDetailsDB01248Docetaxelapproved, investigationalunknownsubstrateDetailsDB01211ClarithromycinapprovedunknownDetailsDB09054IdelalisibapprovednoinhibitorDetailsDB09292SacubitrilapprovedunknowninhibitorDetailsDB09102Daclatasvirapproved, investigationalunknowninhibitorDetailsDB05239Cobimetinibapproved, investigationalnoinhibitorDetailsDB11362SelexipagapprovednosubstrateDetailsDB06403Ambrisentanapproved, investigationalunknownsubstrateDetailsDB11575GrazoprevirapprovednosubstrateDetailsDB09137Technetium Tc-99m mebrofeninapprovednosubstrateDetailsDB13154ParachlorophenolapprovedunknownsubstrateDetailsDB13139Levosalbutamolapproved, investigationalnosubstrateDetailsDB13153Levomenolapproved, experimentalunknownsubstrateDetailsDB11613Velpatasvirapproved, investigationalnoinhibitortransporterDetailsDB06290SimeprevirapprovedunknownsubstrateinhibitorDetailsDB06749Ginsenoside Rb1nutraceuticalunknowninhibitorDetailsDB06750Ginsenoside Rg1nutraceuticalunknownDetailsDB05016Atalurenapproved, investigationalnoinhibitorDetailsDB12026Voxilaprevirapproved, investigationalnosubstrateinhibitorDetailsDB13874Enasidenibapproved, investigationalunknowninhibitorDetailsDB13878Pibrentasvirapproved, investigationalunknowninhibitorDetailsDB13879Glecaprevirapproved, investigationalunknownsubstrateinhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateinhibitorDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB11817Baricitinibapproved, investigationalunknowninhibitorDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownDetailsDB09297Paritaprevirapproved, investigationalunknownsubstrateinhibitorDetailsDB00975DipyridamoleapprovedunknowninhibitorDetailsDB01072Atazanavirapproved, investigationalunknowninhibitorDetailsDB00541Vincristineapproved, investigationalunknowninhibitorDetailsDB09142SincalideapprovednosubstrateDetailsDB00602Ivermectinapproved, investigational, vet_approvedunknowninhibitorDetailsDB01149Nefazodoneapproved, withdrawnunknowninhibitorDetailsDB00220NelfinavirapprovednoinhibitorDetailsDB01051Novobiocinapproved, investigational, vet_approved, withdrawnunknowninhibitorDetailsDB00646Nystatinapproved, vet_approvedunknowninhibitorDetailsDB11869ValspodarinvestigationalunknowninhibitorDetailsDB09298Silibininexperimental, investigationalunknowninhibitorDetailsDB00795SulfasalazineapprovednoinhibitorDetailsDB00932Tipranavirapproved, investigationalunknowninhibitorDetailsDB09065CobicistatapprovedunknowninhibitorDetailsDB00199Erythromycinapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB01601LopinavirapprovedunknowninhibitorDetailsDB00976TelithromycinapprovedunknowninhibitorDetailsDB01590EverolimusapprovedunknowninhibitorDetailsDB11586Asunaprevirapproved, investigational, withdrawnunknowninhibitorDetailsDB05928DovitinibinvestigationalunknowninhibitorDetailsDB11753Rifamycinapproved, investigationalnoinhibitorDetailsDB11855Revefenacinapproved, investigationalnosubstrateDetailsDB00091Cyclosporineapproved, investigational, vet_approvednoinhibitorDetailsDB00834Mifepristoneapproved, investigationalnoinhibitorDetailsDB00257Clotrimazoleapproved, vet_approvedunknowninducerDetailsDB00396Progesteroneapproved, vet_approvedunknowninducerDetailsDB13946Testosterone undecanoateapproved, investigationalunknownsubstrateDetailsDB09299Tenofovir alafenamideapprovednosubstrateDetailsDB00481Raloxifeneapproved, investigationalunknownsubstrateDetailsDB11942Selinexorapproved, investigationalunknowninhibitorDetailsDB00394Beclomethasone dipropionateapproved, investigationalunknowninhibitorDetailsDB00641SimvastatinapprovedunknownDetailsDB00227Lovastatinapproved, investigationalunknownDetailsDB12978Pexidartinibapproved, investigationalunknowninhibitorDetailsDB12500Fedratinibapproved, investigationalunknowninhibitorDetailsDB11757Istradefyllineapproved, investigationalunknowninhibitorDetailsDB01241GemfibrozilapprovedunknowninhibitorDetailsDB04855DronedaroneapprovednoinhibitorDetailsDB00624Testosteroneapproved, investigationalunknownsubstrateDetailsDB15444Elexacaftorapproved, investigationalnoinhibitorDetailsDB14962Trastuzumab deruxtecanapproved, investigationalunknownsubstrateDetailsDB15328Ubrogepantapproved, investigationalunknownsubstrateinhibitorDetailsDB01211ClarithromycinapprovedunknowninhibitorDetailsDB12941Darolutamideapproved, investigationalunknowninhibitorDetailsDB12457Rimegepantapproved, investigationalunknowninhibitorDetailsDB11936Bempedoic acidapproved, investigationalunknownsubstrateinhibitorDetailsDB00503Ritonavirapproved, investigationalunknowninhibitorDetailsDB01708Prasteroneapproved, investigational, nutraceuticalunknownsubstrateDetailsDB14761Remdesivirapproved, investigationalunknowninhibitorDetailsDB09038EmpagliflozinapprovedunknownsubstrateDetailsDB00188Bortezomibapproved, investigationalnoinhibitorDetailsDB12674Lurbinectedinapproved, investigationalunknowninhibitorDetailsDB11796Fostemsavirapproved, investigationalunknowninhibitorDetailsDB15719Belantamab mafodotinapprovedunknownsubstrateDetailsDB15822Pralsetinibapproved, investigationalnoinhibitorDetailsDB06448Lonafarnibapproved, investigationalnoinhibitorDetailsDB06137Tirbanibulinapproved, investigationalnoinhibitorDetailsDB11632Opicaponeapproved, investigationalnosubstrateDetailsDB09078Lenvatinibapproved, investigationalunknowninhibitorDetailsDB08995Diosminapproved, investigationalunknownDetailsDB11886Infigratinibapproved, investigationalnoinhibitorDetailsDB12471Ibrexafungerpapproved, investigationalunknowninhibitorDetailsDB12151Brincidofovirapproved, investigationalnosubstrateDetailsDB15463Belzutifanapproved, investigationalnosubstrateDetailsDB12265Fexinidazoleapproved, investigationalunknowninhibitorDetailsDB16098Atogepantapproved, investigationalnosubstrateinhibitorDetailsDB12597Asciminibapproved, investigationalnoinhibitorDetailsDB15413Pafolacianineapproved, investigationalnosubstrateDetailsDB12713Sotagliflozinapproved, investigationalnoinhibitorDetailsDB15575Padeliporfinapproved, experimentalunknowninhibitorDetailsDB06813Pralatrexateapproved, investigationalnosubstrateDetailsDB00619ImatinibapprovednosubstrateDetailsDB16650Deucravacitinibapproved, investigationalunknowninhibitorDetailsDB17083LinzagolixapprovedunknownsubstrateinhibitorDetailsDB16267Olutasidenibapproved, investigationalnoinhibitorDetailsDB00244MesalazineapprovednosubstrateDetailsDB11682Daprodustatapproved, investigationalnoinhibitorDetailsDB12548Sparsentanapproved, investigationalunknowninhibitorDetailsDB15688Zavegepantapproved, investigationalunknownsubstrateDetailsDB06045Trofinetideapproved, investigationalunknowninhibitorDetailsDB16217Leniolisibapproved, investigationalnoinhibitorDetailsDB11712Tezacaftorapproved, investigationalnoinhibitorDetailsDB01005HydroxyureaapprovedunknownDetailsDB05467Palovaroteneapproved, investigationalnoinhibitorDetailsDB11763Momelotinibapproved, investigationalunknownsubstrateDetailsDB11718Encorafenibapproved, investigationalnoinhibitorDetailsDB12218Capivasertibapproved, investigationalnoinhibitorDetails"
                    }
                },
                {
                    "Label": "Canalicular multispecific organic anion transporter 1",
                    "Detailed Info": {
                        "Name": "Canalicular multispecific organic anion transporter 1",
                        "Synonyms": "ATP-binding cassette sub-family C member 2\nCanalicular multidrug resistance protein\nCMOAT\nCMOAT1\nCMRP\nMRP2\nMultidrug resistance-associated protein 2",
                        "Gene Name": "ABCC2",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0010748|Canalicular multispecific organic anion transporter 1\nMLEKFCNSTFWNSSFLDSPEADLPLCFEQTVLVWIPLGYLWLLAPWQLLHVYKSRTKRSS\nTTKLYLAKQVFVGFLLILAAIELALVLTEDSGQATVPAVRYTNPSLYLGTWLLVLLIQYS\nRQWCVQKNSWFLSLFWILSILCGTFQFQTLIRTLLQGDNSNLAYSCLFFISYGFQILILI\nFSAFSENNESSNNPSSIASFLSSITYSWYDSIILKGYKRPLTLEDVWEVDEEMKTKTLVS\nKFETHMKRELQKARRALQRRQEKSSQQNSGARLPGLNKNQSQSQDALVLEDVEKKKKKSG\nTKKDVPKSWLMKALFKTFYMVLLKSFLLKLVNDIFTFVSPQLLKLLISFASDRDTYLWIG\nYLCAILLFTAALIQSFCLQCYFQLCFKLGVKVRTAIMASVYKKALTLSNLARKEYTVGET\nVNLMSVDAQKLMDVTNFMHMLWSSVLQIVLSIFFLWRELGPSVLAGVGVMVLVIPINAIL\nSTKSKTIQVKNMKNKDKRLKIMNEILSGIKILKYFAWEPSFRDQVQNLRKKELKNLLAFS\nQLQCVVIFVFQLTPVLVSVVTFSVYVLVDSNNILDAQKAFTSITLFNILRFPLSMLPMMI\nSSMLQASVSTERLEKYLGGDDLDTSAIRHDCNFDKAMQFSEASFTWEHDSEATVRDVNLD\nIMAGQLVAVIGPVGSGKSSLISAMLGEMENVHGHITIKGTTAYVPQQSWIQNGTIKDNIL\nFGTEFNEKRYQQVLEACALLPDLEMLPGGDLAEIGEKGINLSGGQKQRISLARATYQNLD\nIYLLDDPLSAVDAHVGKHIFNKVLGPNGLLKGKTRLLVTHSMHFLPQVDEIVVLGNGTIV\nEKGSYSALLAKKGEFAKNLKTFLRHTGPEEEATVHDGSEEEDDDYGLISSVEEIPEDAAS\nITMRRENSFRRTLSRSSRSNGRHLKSLRNSLKTRNVNSLKEDEELVKGQKLIKKEFIETG\nKVKFSIYLEYLQAIGLFSIFFIILAFVMNSVAFIGSNLWLSAWTSDSKIFNSTDYPASQR\nDMRVGVYGALGLAQGIFVFIAHFWSAFGFVHASNILHKQLLNNILRAPMRFFDTTPTGRI\nVNRFAGDISTVDDTLPQSLRSWITCFLGIISTLVMICMATPVFTIIVIPLGIIYVSVQMF\nYVSTSRQLRRLDSVTRSPIYSHFSETVSGLPVIRAFEHQQRFLKHNEVRIDTNQKCVFSW\nITSNRWLAIRLELVGNLTVFFSALMMVIYRDTLSGDTVGFVLSNALNITQTLNWLVRMTS\nEIETNIVAVERITEYTKVENEAPWVTDKRPPPDWPSKGKIQFNNYQVRYRPELDLVLRGI\nTCDIGSMEKIGVVGRTGAGKSSLTNCLFRILEAAGGQIIIDGVDIASIGLHDLREKLTII\nPQDPILFSGSLRMNLDPFNNYSDEEIWKALELAHLKSFVASLQLGLSHEVTEAGGNLSIG\nQRQLLCLGRALLRKSKILVLDEATAAVDLETDNLIQTTIQNEFAHCTVITIAHRLHTIMD\nSDKVMVLDNGKIIECGSPEELLQIPGPFYFMAKEAGIENVNSTKF",
                        "Number of residues": "1545",
                        "Molecular Weight": "174205.64",
                        "Theoretical pI": "8.46",
                        "GO Classification": "FunctionsATP binding / ATPase activity, coupled to transmembrane movement of substances / organic anion transmembrane transporter activityProcessescellular chloride ion homeostasis / drug transmembrane transport / prostaglandin transport / response to arsenic-containing substance / response to estrogen / response to heat / response to methotrexate / response to oxidative stress / thyroid hormone transport / transmembrane transport / transportComponentsapical plasma membrane / cell surface / integral component of plasma membrane / plasma membrane",
                        "General Function": "Organic anion transmembrane transporter activity",
                        "Specific Function": "Mediates hepatobiliary excretion of numerous organic anions. May function as a cellular cisplatin transporter.",
                        "Pfam Domain Function": "ABC_tran (PF00005)\nABC_membrane (PF00664)",
                        "Transmembrane Regions": "28-48\n69-89\n94-114\n127-147\n166-186\n314-334\n361-381\n438-458\n462-482\n545-565\n588-608\n972-992\n1034-1054\n1098-1118\n1120-1140\n1212-1232\n1235-1255",
                        "Cellular Location": "Apical cell membrane",
                        "Gene sequence": ">lcl|BSEQ0010749|Canalicular multispecific organic anion transporter 1 (ABCC2)\nATGCTGGAGAAGTTCTGCAACTCTACTTTTTGGAATTCCTCATTCCTGGACAGTCCGGAG\nGCAGACCTGCCACTTTGTTTTGAGCAAACTGTTCTGGTGTGGATTCCCTTGGGCTTCCTA\nTGGCTCCTGGCCCCCTGGCAGCTTCTCCACGTGTATAAATCCAGGACCAAGAGATCCTCT\nACCACCAAACTCTATCTTGCTAAGCAGGTATTCGTTGGTTTTCTTCTTATTCTAGCAGCC\nATAGAGCTGGCCCTTGTACTCACAGAAGACTCTGGACAAGCCACAGTCCCTGCTGTTCGA\nTATACCAATCCAAGCCTCTACCTAGGCACATGGCTCCTGGTTTTGCTGATCCAATACAGC\nAGACAATGGTGTGTACAGAAAAACTCCTGGTTCCTGTCCCTATTCTGGATTCTCTCGATA\nCTCTGTGGCACTTTCCAATTTCAGACTCTGATCCGGACACTCTTACAGGGTGACAATTCT\nAATCTAGCCTACTCCTGCCTGTTCTTCATCTCCTACGGATTCCAGATCCTGATCCTGATC\nTTTTCAGCATTTTCAGAAAATAATGAGTCATCAAATAATCCATCATCCATAGCTTCATTC\nCTGAGTAGCATTACCTACAGCTGGTATGACAGCATCATTCTGAAAGGCTACAAGCGTCCT\nCTGACACTCGAGGATGTCTGGGAAGTTGATGAAGAGATGAAAACCAAGACATTAGTGAGC\nAAGTTTGAAACGCACATGAAGAGAGAGCTGCAGAAAGCCAGGCGGGCACTCCAGAGACGG\nCAGGAGAAGAGCTCCCAGCAGAACTCTGGAGCCAGGCTGCCTGGCTTGAACAAGAATCAG\nAGTCAAAGCCAAGATGCCCTTGTCCTGGAAGATGTTGAAAAGAAAAAAAAGAAGTCTGGG\nACCAAAAAAGATGTTCCAAAATCCTGGTTGATGAAGGCTCTGTTCAAAACTTTCTACATG\nGTGCTCCTGAAATCATTCCTACTGAAGCTAGTGAATGACATCTTCACGTTTGTGAGTCCT\nCAGCTGCTGAAATTGCTGATCTCCTTTGCAAGTGACCGTGACACATATTTGTGGATTGGA\nTATCTCTGTGCAATCCTCTTATTCACTGCGGCTCTCATTCAGTCTTTCTGCCTTCAGTGT\nTATTTCCAACTGTGCTTCAAGCTGGGTGTAAAAGTACGGACAGCTATCATGGCTTCTGTA\nTATAAGAAGGCATTGACCCTATCCAACTTGGCCAGGAAGGAGTACACCGTTGGAGAAACA\nGTGAACCTGATGTCTGTGGATGCCCAGAAGCTCATGGATGTGACCAACTTCATGCACATG\nCTGTGGTCAAGTGTTCTACAGATTGTCTTATCTATCTTCTTCCTATGGAGAGAGTTGGGA\nCCCTCAGTCTTAGCAGGTGTTGGGGTGATGGTGCTTGTAATCCCAATTAATGCGATACTG\nTCCACCAAGAGTAAGACCATTCAGGTCAAAAATATGAAGAATAAAGACAAACGTTTAAAG\nATCATGAATGAGATTCTTAGTGGAATCAAGATCCTGAAATATTTTGCCTGGGAACCTTCA\nTTCAGAGACCAAGTACAAAACCTCCGGAAGAAAGAGCTCAAGAACCTGCTGGCCTTTAGT\nCAACTACAGTGTGTAGTAATATTCGTCTTCCAGTTAACTCCAGTCCTGGTATCTGTGGTC\nACATTTTCTGTTTATGTCCTGGTGGATAGCAACAATATTTTGGATGCACAAAAGGCCTTC\nACCTCCATTACCCTCTTCAATATCCTGCGCTTTCCCCTGAGCATGCTTCCCATGATGATC\nTCCTCCATGCTCCAGGCCAGTGTTTCCACAGAGCGGCTAGAGAAGTACTTGGGAGGGGAT\nGACTTGGACACATCTGCCATTCGACATGACTGCAATTTTGACAAAGCCATGCAGTTTTCT\nGAGGCCTCCTTTACCTGGGAACATGATTCGGAAGCCACAGTCCGAGATGTGAACCTGGAC\nATTATGGCAGGCCAACTTGTGGCTGTGATAGGCCCTGTCGGCTCTGGGAAATCCTCCTTG\nATATCAGCCATGCTGGGAGAAATGGAAAATGTCCACGGGCACATCACCATCAAGGGCACC\nACTGCCTATGTCCCACAGCAGTCCTGGATTCAGAATGGCACCATAAAGGACAACATCCTT\nTTTGGAACAGAGTTTAATGAAAAGAGGTACCAGCAAGTACTGGAGGCCTGTGCTCTCCTC\nCCAGACTTGGAAATGCTGCCTGGAGGAGATTTGGCTGAGATTGGAGAGAAGGGTATAAAT\nCTTAGTGGGGGTCAGAAGCAGCGGATCAGCCTGGCCAGAGCTACCTACCAAAATTTAGAC\nATCTATCTTCTAGATGACCCCCTGTCTGCAGTGGATGCTCATGTAGGAAAACATATTTTT\nAATAAGGTCTTGGGCCCCAATGGCCTGTTGAAAGGCAAGACTCGACTCTTGGTTACACAT\nAGCATGCACTTTCTTCCTCAAGTGGATGAGATTGTAGTTCTGGGGAATGGAACAATTGTA\nGAGAAAGGATCCTACAGTGCTCTCCTGGCCAAAAAAGGAGAGTTTGCTAAGAATCTGAAG\nACATTTCTAAGACATACAGGCCCTGAAGAGGAAGCCACAGTCCATGATGGCAGTGAAGAA\nGAAGACGATGACTATGGGCTGATATCCAGTGTGGAAGAGATCCCCGAAGATGCAGCCTCC\nATAACCATGAGAAGAGAGAACAGCTTTCGTCGAACACTTAGCCGCAGTTCTAGGTCCAAT\nGGCAGGCATCTGAAGTCCCTGAGAAACTCCTTGAAAACTCGGAATGTGAATAGCCTGAAG\nGAAGACGAAGAACTAGTGAAAGGACAAAAACTAATTAAGAAGGAATTCATAGAAACTGGA\nAAGGTGAAGTTCTCCATCTACCTGGAGTACCTACAAGCAATAGGATTGTTTTCGATATTC\nTTCATCATCCTTGCGTTTGTGATGAATTCTGTGGCTTTTATTGGATCCAACCTCTGGCTC\nAGTGCTTGGACCAGTGACTCTAAAATCTTCAATAGCACCGACTATCCAGCATCTCAGAGG\nGACATGAGAGTTGGAGTCTACGGAGCTCTGGGATTAGCCCAAGGTATATTTGTGTTCATA\nGCACATTTCTGGAGTGCCTTTGGTTTCGTCCATGCATCAAATATCTTGCACAAGCAACTG\nCTGAACAATATCCTTCGAGCACCTATGAGATTTTTTGACACAACACCCACAGGCCGGATT\nGTGAACAGGTTTGCCGGCGATATTTCCACAGTGGATGACACCCTGCCTCAGTCCTTGCGC\nAGCTGGATTACATGCTTCCTGGGGATAATCAGCACCCTTGTCATGATCTGCATGGCCACT\nCCTGTCTTCACCATCATCGTCATTCCTCTTGGCATTATTTATGTATCTGTTCAGATGTTT\nTATGTGTCTACCTCCCGCCAGCTGAGGCGTCTGGACTCTGTCACCAGGTCCCCAATCTAC\nTCTCACTTCAGCGAGACCGTATCAGGTTTGCCAGTTATCCGTGCCTTTGAGCACCAGCAG\nCGATTTCTGAAACACAATGAGGTGAGGATTGACACCAACCAGAAATGTGTCTTTTCCTGG\nATCACCTCCAACAGGTGGCTTGCAATTCGCCTGGAGCTGGTTGGGAACCTGACTGTCTTC\nTTTTCAGCCTTGATGATGGTTATTTATAGAGATACCCTAAGTGGGGACACTGTTGGCTTT\nGTTCTGTCCAATGCACTCAATATCACACAAACCCTGAACTGGCTGGTGAGGATGACATCA\nGAAATAGAGACCAACATTGTGGCTGTTGAGCGAATAACTGAGTACACAAAAGTGGAAAAT\nGAGGCACCCTGGGTGACTGATAAGAGGCCTCCGCCAGATTGGCCCAGCAAAGGCAAGATC\nCAGTTTAACAACTACCAAGTGCGGTACCGACCTGAGCTGGATCTGGTCCTCAGAGGGATC\nACTTGTGACATCGGTAGCATGGAGAAGATTGGTGTGGTGGGCAGGACAGGAGCTGGAAAG\nTCATCCCTCACAAACTGCCTCTTCAGAATCTTAGAGGCTGCCGGTGGTCAGATTATCATT\nGATGGAGTAGATATTGCTTCCATTGGGCTCCACGACCTCCGAGAGAAGCTGACCATCATC\nCCCCAGGACCCCATCCTGTTCTCTGGAAGCCTGAGGATGAATCTCGACCCTTTCAACAAC\nTACTCAGATGAGGAGATTTGGAAGGCCTTGGAGCTGGCTCACCTCAAGTCTTTTGTGGCC\nAGCCTGCAACTTGGGTTATCCCACGAAGTGACAGAGGCTGGTGGCAACCTGAGCATAGGC\nCAGAGGCAGCTGCTGTGCCTGGGCAGGGCTCTGCTTCGGAAATCCAAGATCCTGGTCCTG\nGATGAGGCCACTGCTGCGGTGGATCTAGAGACAGACAACCTCATTCAGACGACCATCCAA\nAACGAGTTCGCCCACTGCACAGTGATCACCATCGCCCACAGGCTGCACACCATCATGGAC\nAGTGACAAGGTAATGGTCCTAGACAACGGGAAGATTATAGAGTGCGGCAGCCCTGAAGAA\nCTGCTACAAATCCCTGGACCCTTTTACTTTATGGCTAAGGAAGCTGGCATTGAGAATGTG\nAACAGCACAAAATTCTAG",
                        "Chromosome Location": "10",
                        "Locus": "10q24",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ92887UniProtKB Entry NameMRP2_HUMANGenBank Protein ID1764162GenBank Gene IDU63970GenAtlas IDABCC2HGNC IDHGNC:53",
                        "General References": "Taniguchi K, Wada M, Kohno K, Nakamura T, Kawabe T, Kawakami M, Kagotani K, Okumura K, Akiyama S, Kuwano M: A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res. 1996 Sep 15;56(18):4124-9. [Article] Buchler M, Konig J, Brom M, Kartenbeck J, Spring H, Horie T, Keppler D: cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem. 1996 Jun 21;271(25):15091-8. [Article] Tsujii H, Konig J, Rost D, Stockel B, Leuschner U, Keppler D: Exon-intron organization of the human multidrug-resistance protein 2 (MRP2) gene mutated in Dubin-Johnson syndrome. Gastroenterology. 1999 Sep;117(3):653-60. [Article] Deloukas P, Earthrowl ME, Grafham DV, Rubenfield M, French L, Steward CA, Sims SK, Jones MC, Searle S, Scott C, Howe K, Hunt SE, Andrews TD, Gilbert JG, Swarbreck D, Ashurst JL, Taylor A, Battles J, Bird CP, Ainscough R, Almeida JP, Ashwell RI, Ambrose KD, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Bates K, Beasley H, Bray-Allen S, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Cahill P, Camire D, Carter NP, Chapman JC, Clark SY, Clarke G, Clee CM, Clegg S, Corby N, Coulson A, Dhami P, Dutta I, Dunn M, Faulkner L, Frankish A, Frankland JA, Garner P, Garnett J, Gribble S, Griffiths C, Grocock R, Gustafson E, Hammond S, Harley JL, Hart E, Heath PD, Ho TP, Hopkins B, Horne J, Howden PJ, Huckle E, Hynds C, Johnson C, Johnson D, Kana A, Kay M, Kimberley AM, Kershaw JK, Kokkinaki M, Laird GK, Lawlor S, Lee HM, Leongamornlert DA, Laird G, Lloyd C, Lloyd DM, Loveland J, Lovell J, McLaren S, McLay KE, McMurray A, Mashreghi-Mohammadi M, Matthews L, Milne S, Nickerson T, Nguyen M, Overton-Larty E, Palmer SA, Pearce AV, Peck AI, Pelan S, Phillimore B, Porter K, Rice CM, Rogosin A, Ross MT, Sarafidou T, Sehra HK, Shownkeen R, Skuce CD, Smith M, Standring L, Sycamore N, Tester J, Thorpe A, Torcasso W, Tracey A, Tromans A, Tsolas J, Wall M, Walsh J, Wang H, Weinstock K, West AP, Willey DL, Whitehead SL, Wilming L, Wray PW, Young L, Chen Y, Lovering RC, Moschonas NK, Siebert R, Fechtel K, Bentley D, Durbin R, Hubbard T, Doucette-Stamm L, Beck S, Smith DR, Rogers J: The DNA sequence and comparative analysis of human chromosome 10. Nature. 2004 May 27;429(6990):375-81. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Keppler D, Konig J: Hepatic secretion of conjugated drugs and endogenous substances. Semin Liver Dis. 2000;20(3):265-72. [Article] Ito K, Oleschuk CJ, Westlake C, Vasa MZ, Deeley RG, Cole SP: Mutation of Trp1254 in the multispecific organic anion transporter, multidrug resistance protein 2 (MRP2) (ABCC2), alters substrate specificity and results in loss of methotrexate transport activity. J Biol Chem. 2001 Oct 12;276(41):38108-14. Epub 2001 Aug 10. [Article] Daub H, Olsen JV, Bairlein M, Gnad F, Oppermann FS, Korner R, Greff Z, Keri G, Stemmann O, Mann M: Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol Cell. 2008 Aug 8;31(3):438-48. doi: 10.1016/j.molcel.2008.07.007. [Article] Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP: A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7. doi: 10.1073/pnas.0805139105. Epub 2008 Jul 31. [Article] Olsen JV, Vermeulen M, Santamaria A, Kumar C, Miller ML, Jensen LJ, Gnad F, Cox J, Jensen TS, Nigg EA, Brunak S, Mann M: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3. doi: 10.1126/scisignal.2000475. [Article] Burkard TR, Planyavsky M, Kaupe I, Breitwieser FP, Burckstummer T, Bennett KL, Superti-Furga G, Colinge J: Initial characterization of the human central proteome. BMC Syst Biol. 2011 Jan 26;5:17. doi: 10.1186/1752-0509-5-17. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Wada M, Toh S, Taniguchi K, Nakamura T, Uchiumi T, Kohno K, Yoshida I, Kimura A, Sakisaka S, Adachi Y, Kuwano M: Mutations in the canilicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome. Hum Mol Genet. 1998 Feb;7(2):203-7. [Article] Toh S, Wada M, Uchiumi T, Inokuchi A, Makino Y, Horie Y, Adachi Y, Sakisaka S, Kuwano M: Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome. Am J Hum Genet. 1999 Mar;64(3):739-46. [Article] Keitel V, Kartenbeck J, Nies AT, Spring H, Brom M, Keppler D: Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome. Hepatology. 2000 Dec;32(6):1317-28. [Article] Mor-Cohen R, Zivelin A, Rosenberg N, Shani M, Muallem S, Seligsohn U: Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome. J Biol Chem. 2001 Oct 5;276(40):36923-30. Epub 2001 Jul 26. [Article] Ito S, Ieiri I, Tanabe M, Suzuki A, Higuchi S, Otsubo K: Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects. Pharmacogenetics. 2001 Mar;11(2):175-84. [Article] Arlanov R, Porter A, Strand D, Brough R, Karpova D, Kerb R, Wojnowski L, Schwab M, Lang T: Functional characterization of protein variants of the human multidrug transporter ABCC2 by a novel targeted expression system in fibrosarcoma cells. Hum Mutat. 2012 Apr;33(4):750-62. doi: 10.1002/humu.22041. Epub 2012 Feb 28. [Article] Okada H, Kusaka T, Fuke N, Kunikata J, Kondo S, Iwase T, Nan W, Hirota T, Ieiri I, Itoh S: Neonatal Dubin-Johnson syndrome: novel compound heterozygous mutation in the ABCC2 gene. Pediatr Int. 2014 Oct;56(5):e62-4. doi: 10.1111/ped.12404. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00171ATPinvestigational, nutraceuticalunknownDetailsDB01138SulfinpyrazoneapprovedyesinhibitorDetailsDB00503Ritonavirapproved, investigationalunknownsubstrateDetailsDB01892HyperforinnutraceuticalunknowninducerDetailsDB01586Ursodeoxycholic acidapproved, investigationalunknowninducerDetailsDB01045RifampicinapprovedunknowninducerDetailsDB01169Arsenic trioxideapproved, investigationalunknowninducerDetailsDB01174Phenobarbitalapproved, investigationalunknowninducerDetailsDB00515CisplatinapprovedunknowninducerDetailsDB04216Quercetinexperimental, investigationalunknowninducerDetailsDB04348Taurocholic acidapproved, experimentalunknowninducerDetailsDB02659Cholic AcidapprovedunknowninducerDetailsDB01115NifedipineapprovedunknowninducerDetailsDB00977EthinylestradiolapprovedunknowninhibitorinducerDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknowninducerDetailsDB00570VinblastineapprovedunknownsubstrateinhibitorinducerDetailsDB00421SpironolactoneapprovedunknowninducerDetailsDB00876EprosartanapprovedunknowninducerDetailsDB00275Olmesartanapproved, investigationalunknownsubstrateinducerDetailsDB01138SulfinpyrazoneapprovedunknownsubstrateinhibitorDetailsDB00541Vincristineapproved, investigationalunknownsubstrateinhibitorDetailsDB00206Reserpineapproved, investigational, withdrawnunknowninhibitorDetailsDB00908Quinidineapproved, investigationalunknowninhibitorDetailsDB00773EtoposideapprovedunknownsubstrateinhibitorDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknowninhibitorDetailsDB01032Probenecidapproved, investigationalunknownsubstrateinhibitorDetailsDB00143Glutathioneapproved, investigational, nutraceuticalunknownsubstrateinhibitorDetailsDB00695Furosemideapproved, vet_approvedunknowninhibitorDetailsDB00175PravastatinapprovednosubstrateDetailsDB00602Ivermectinapproved, investigational, vet_approvedunknowninhibitorDetailsDB01016GlyburideapprovedunknowninhibitorDetailsDB00328Indomethacinapproved, investigationalunknownsubstrateinhibitorDetailsDB00563MethotrexateapprovedunknownsubstrateinhibitorDetailsDB02703Fusidic acidapproved, investigationalunknowninhibitorDetailsDB01208Sparfloxacinapproved, investigational, withdrawnunknowninhibitorDetailsDB00978Lomefloxacinapproved, investigationalunknowninhibitorDetailsDB00365Grepafloxacinapproved, investigational, withdrawnunknowninhibitorDetailsDB01165OfloxacinapprovedunknowninhibitorDetailsDB00116Tetrahydrofolic acidnutraceuticalunknowninhibitorDetailsDB047895-methyltetrahydrofolic acidinvestigational, nutraceuticalunknowninhibitorDetailsDB04100Tricarbonyl(1,10-phenanthroline)rhenium(1+)experimentalunknowninhibitorDetailsDB01411PranlukastinvestigationalunknowninhibitorDetailsDB00398Sorafenibapproved, investigationalunknowninhibitorDetailsDB01268Sunitinibapproved, investigationalunknowninhibitorDetailsDB00966Telmisartanapproved, investigationalunknowninhibitorDetailsDB00345Aminohippuric acidapproved, investigationalunknownsubstrateinhibitorDetailsDB01232Saquinavirapproved, investigationalunknownsubstrateDetailsDB00224IndinavirapprovedunknownsubstrateDetailsDB00286Conjugated estrogensapprovedunknownsubstrateDetailsDB00439Cerivastatinapproved, withdrawnunknownsubstrateDetailsDB00252Phenytoinapproved, vet_approvedunknownsubstrateDetailsDB00067VasopressinapprovedunknownsubstrateDetailsDB00795SulfasalazineapprovednosubstrateDetailsDB00957Norgestimateapproved, investigationalunknowninhibitorDetailsDB00973EzetimibeapprovedunknownsubstrateDetailsDB08860PitavastatinapprovedunknownsubstrateDetailsDB08884Gadoxetic acidapprovedunknownsubstrateDetailsDB08907CanagliflozinapprovedunknownsubstrateDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB00227Lovastatinapproved, investigationalunknownsubstrateDetailsDB00641SimvastatinapprovedunknownsubstrateDetailsDB00564Carbamazepineapproved, investigationalunknownsubstrateDetailsDB00997Doxorubicinapproved, investigationalunknownsubstrateDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateDetailsDB00709Lamivudineapproved, investigationalunknownDetailsDB00958CarboplatinapprovedunknownsubstrateDetailsDB00526Oxaliplatinapproved, investigationalnosubstrateDetailsDB00675TamoxifenapprovedunknownsubstrateDetailsDB00300Tenofovir disoproxilapproved, investigationalunknownsubstrateDetailsDB01229Paclitaxelapproved, vet_approvedunknownsubstrateDetailsDB01248Docetaxelapproved, investigationalunknownsubstrateDetailsDB09272Eluxadolineapproved, investigationalunknownsubstrateDetailsDB09060AvibactamapprovednosubstrateDetailsDB09374Indocyanine green acid formapproved, investigationalnosubstrateDetailsDB06290SimeprevirapprovedunknownsubstrateinhibitorDetailsDB01095FluvastatinapprovednosubstrateDetailsDB01098RosuvastatinapprovednosubstrateDetailsDB12070Letermovirapproved, investigationalnoinhibitorDetailsDB14642LypressinapprovedunknownDetailsDB00177Valsartanapproved, investigationalunknownsubstrateDetailsDB00207AzithromycinapprovedunknownsubstrateinhibitorDetailsDB00199Erythromycinapproved, investigational, vet_approvedunknownsubstrateDetailsDB00481Raloxifeneapproved, investigationalunknownsubstrateDetailsDB00698Nitrofurantoinapproved, vet_approvedunknownDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownDetailsDB00950Fexofenadineapproved, investigationalunknownsubstrateDetailsDB11770TalinololinvestigationalunknownsubstrateDetailsDB06813Pralatrexateapproved, investigationalnosubstrateinhibitorDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknowninducerDetailsDB00104Octreotideapproved, investigationalunknownsubstrateinhibitorDetailsDB15719Belantamab mafodotinapprovedunknownsubstrateDetailsDB06448Lonafarnibapproved, investigationalnoinhibitorDetailsDB00798Gentamicinapproved, vet_approvednosubstrateDetailsDB12151Brincidofovirapproved, investigationalnoinhibitorDetailsDB12713Sotagliflozinapproved, investigationalnoinhibitorDetailsDB16407AzvudineinvestigationalunknownregulatorDetailsDB00619ImatinibapprovednosubstrateDetails"
                    }
                },
                {
                    "Label": "Bile salt export pump",
                    "Detailed Info": {
                        "Name": "Bile salt export pump",
                        "Synonyms": "ATP-binding cassette sub-family B member 11\nBSEP",
                        "Gene Name": "ABCB11",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0010492|Bile salt export pump\nMSDSVILRSIKKFGEENDGFESDKSYNNDKKSRLQDEKKGDGVRVGFFQLFRFSSSTDIW\nLMFVGSLCAFLHGIAQPGVLLIFGTMTDVFIDYDVELQELQIPGKACVNNTIVWTNSSLN\nQNMTNGTRCGLLNIESEMIKFASYYAGIAVAVLITGYIQICFWVIAAARQIQKMRKFYFR\nRIMRMEIGWFDCNSVGELNTRFSDDINKINDAIADQMALFIQRMTSTICGFLLGFFRGWK\nLTLVIISVSPLIGIGAATIGLSVSKFTDYELKAYAKAGVVADEVISSMRTVAAFGGEKRE\nVERYEKNLVFAQRWGIRKGIVMGFFTGFVWCLIFLCYALAFWYGSTLVLDEGEYTPGTLV\nQIFLSVIVGALNLGNASPCLEAFATGRAAATSIFETIDRKPIIDCMSEDGYKLDRIKGEI\nEFHNVTFHYPSRPEVKILNDLNMVIKPGEMTALVGPSGAGKSTALQLIQRFYDPCEGMVT\nVDGHDIRSLNIQWLRDQIGIVEQEPVLFSTTIAENIRYGREDATMEDIVQAAKEANAYNF\nIMDLPQQFDTLVGEGGGQMSGGQKQRVAIARALIRNPKILLLDMATSALDNESEAMVQEV\nLSKIQHGHTIISVAHRLSTVRAADTIIGFEHGTAVERGTHEELLERKGVYFTLVTLQSQG\nNQALNEEDIKDATEDDMLARTFSRGSYQDSLRASIRQRSKSQLSYLVHEPPLAVVDHKST\nYEEDRKDKDIPVQEEVEPAPVRRILKFSAPEWPYMLVGSVGAAVNGTVTPLYAFLFSQIL\nGTFSIPDKEEQRSQINGVCLLFVAMGCVSLFTQFLQGYAFAKSGELLTKRLRKFGFRAML\nGQDIAWFDDLRNSPGALTTRLATDASQVQGAAGSQIGMIVNSFTNVTVAMIIAFSFSWKL\nSLVILCFFPFLALSGATQTRMLTGFASRDKQALEMVGQITNEALSNIRTVAGIGKERRFI\nEALETELEKPFKTAIQKANIYGFCFAFAQCIMFIANSASYRYGGYLISNEGLHFSYVFRV\nISAVVLSATALGRAFSYTPSYAKAKISAARFFQLLDRQPPISVYNTAGEKWDNFQGKIDF\nVDCKFTYPSRPDSQVLNGLSVSISPGQTLAFVGSSGCGKSTSIQLLERFYDPDQGKVMID\nGHDSKKVNVQFLRSNIGIVSQEPVLFACSIMDNIKYGDNTKEIPMERVIAAAKQAQLHDF\nVMSLPEKYETNVGSQGSQLSRGEKQRIAIARAIVRDPKILLLDEATSALDTESEKTVQVA\nLDKAREGRTCIVIAHRLSTIQNADIIAVMAQGVVIEKGTHEELMAQKGAYYKLVTTGSPI\nS",
                        "Number of residues": "1321",
                        "Molecular Weight": "146405.83",
                        "Theoretical pI": "6.52",
                        "GO Classification": "FunctionsATP binding / bile acid-exporting ATPase activity / canalicular bile acid transmembrane transporter activity / sodium-exporting ATPase activity, phosphorylative mechanism / transporter activityProcessesbile acid and bile salt transport / bile acid biosynthetic process / bile acid metabolic process / canalicular bile acid transport / small molecule metabolic process / sodium ion transmembrane transport / transportComponentsapical part of cell / extracellular exosome / integral component of plasma membrane / intercellular canaliculus / membrane / plasma membrane",
                        "General Function": "Transporter activity",
                        "Specific Function": "Involved in the ATP-dependent secretion of bile salts into the canaliculus of hepatocytes.",
                        "Pfam Domain Function": "ABC_tran (PF00005)\nABC_membrane (PF00664)",
                        "Transmembrane Regions": "63-83\n148-168\n216-236\n241-261\n320-340\n354-374\n756-776\n795-815\n870-890\n891-911\n980-1000\n1012-1032",
                        "Cellular Location": "Membrane",
                        "Gene sequence": ">lcl|BSEQ0010493|Bile salt export pump (ABCB11)\nATGTCTGACTCAGTAATTCTTCGAAGTATAAAGAAATTTGGAGAGGAGAATGATGGTTTT\nGAGTCAGATAAATCATATAATAATGATAAGAAATCAAGGTTACAAGATGAGAAGAAAGGT\nGATGGCGTTAGAGTTGGCTTCTTTCAATTGTTTCGGTTTTCTTCATCAACTGACATTTGG\nCTGATGTTTGTGGGAAGTTTGTGTGCATTTCTCCATGGAATAGCCCAGCCAGGCGTGCTA\nCTCATTTTTGGCACAATGACAGATGTTTTTATTGACTACGACGTTGAGTTACAAGAACTC\nCAGATTCCAGGAAAAGCATGTGTGAATAACACCATTGTATGGACTAACAGTTCCCTCAAC\nCAGAACATGACAAATGGAACACGTTGTGGGTTGCTGAACATCGAGAGCGAAATGATCAAA\nTTTGCCAGTTACTATGCTGGAATTGCTGTCGCAGTACTTATCACAGGATATATTCAAATA\nTGCTTTTGGGTCATTGCCGCAGCTCGTCAGATACAGAAAATGAGAAAATTTTACTTTAGG\nAGAATAATGAGAATGGAAATAGGGTGGTTTGACTGCAATTCAGTGGGGGAGCTGAATACA\nAGATTCTCTGATGATATTAATAAAATCAATGATGCCATAGCTGACCAAATGGCCCTTTTC\nATTCAGCGCATGACCTCGACCATCTGTGGTTTCCTGTTGGGATTTTTCAGGGGTTGGAAA\nCTGACCTTGGTTATTATTTCTGTCAGCCCTCTCATTGGGATTGGAGCAGCCACCATTGGT\nCTGAGTGTGTCCAAGTTTACGGACTATGAGCTGAAGGCCTATGCCAAAGCAGGGGTGGTG\nGCTGATGAAGTCATTTCATCAATGAGAACAGTGGCTGCTTTTGGTGGTGAGAAAAGAGAG\nGTTGAAAGGTATGAGAAAAATCTTGTGTTCGCCCAGCGTTGGGGAATTAGAAAAGGAATA\nGTGATGGGATTCTTTACTGGATTCGTGTGGTGTCTCATCTTTTTGTGTTATGCACTGGCC\nTTCTGGTACGGCTCCACACTTGTCCTGGATGAAGGAGAATATACACCAGGAACCCTTGTC\nCAGATTTTCCTCAGTGTCATAGTAGGAGCTTTAAATCTTGGCAATGCCTCTCCTTGTTTG\nGAAGCCTTTGCAACTGGACGTGCAGCAGCCACCAGCATTTTTGAGACAATAGACAGGAAA\nCCCATCATTGACTGCATGTCAGAAGATGGTTACAAGTTGGATCGAATCAAGGGTGAAATT\nGAATTCCATAATGTGACCTTCCATTATCCTTCCAGACCAGAGGTGAAGATTCTAAATGAC\nCTCAACATGGTCATTAAACCAGGGGAAATGACAGCTCTGGTAGGACCCAGTGGAGCTGGA\nAAAAGTACAGCACTGCAACTCATTCAGCGATTCTATGACCCCTGTGAAGGAATGGTGACC\nGTGGATGGCCATGACATTCGCTCTCTTAACATTCAGTGGCTTAGAGATCAGATTGGGATA\nGTGGAGCAAGAGCCAGTTCTGTTCTCTACCACCATTGCAGAAAATATTCGCTATGGCAGA\nGAAGATGCAACAATGGAAGACATAGTCCAAGCTGCCAAGGAGGCCAATGCCTACAACTTC\nATCATGGACCTGCCACAGCAATTTGACACCCTTGTTGGAGAAGGAGGAGGCCAGATGAGT\nGGTGGCCAGAAACAAAGGGTAGCTATCGCCAGAGCCCTCATCCGAAATCCCAAGATTCTG\nCTTTTGGACATGGCCACCTCAGCTCTGGACAATGAGAGTGAAGCCATGGTGCAAGAAGTG\nCTGAGTAAGATTCAGCATGGGCACACAATCATTTCAGTTGCTCATCGCTTGTCTACGGTC\nAGAGCTGCAGATACCATCATTGGTTTTGAACATGGCACTGCAGTGGAAAGAGGGACCCAT\nGAAGAATTACTGGAAAGGAAAGGTGTTTACTTCACTCTAGTGACTTTGCAAAGCCAGGGA\nAATCAAGCTCTTAATGAAGAGGACATAAAGGATGCAACTGAAGATGACATGCTTGCGAGG\nACCTTTAGCAGAGGGAGCTACCAGGATAGTTTAAGGGCTTCCATCCGGCAACGCTCCAAG\nTCTCAGCTTTCTTACCTGGTGCACGAACCTCCATTAGCTGTTGTAGATCATAAGTCTACC\nTATGAAGAAGATAGAAAGGACAAGGACATTCCTGTGCAGGAAGAAGTTGAACCTGCCCCA\nGTTAGGAGGATTCTGAAATTCAGTGCTCCAGAATGGCCCTACATGCTGGTAGGGTCTGTG\nGGTGCAGCTGTGAACGGGACAGTCACACCCTTGTATGCCTTTTTATTCAGCCAGATTCTT\nGGGACTTTTTCAATTCCTGATAAAGAGGAACAAAGGTCACAGATCAATGGTGTGTGCCTA\nCTTTTTGTAGCAATGGGCTGTGTATCTCTTTTCACCCAATTTCTACAGGGATATGCCTTT\nGCTAAATCTGGGGAGCTCCTAACAAAAAGGCTACGTAAATTTGGTTTCAGGGCAATGCTG\nGGGCAAGATATTGCCTGGTTTGATGACCTCAGAAATAGCCCTGGAGCATTGACAACAAGA\nCTTGCTACAGATGCTTCCCAAGTTCAAGGGGCTGCCGGCTCTCAGATCGGGATGATAGTC\nAATTCCTTCACTAACGTCACTGTGGCCATGATCATTGCCTTCTCCTTTAGCTGGAAGCTG\nAGCCTGGTCATCTTGTGCTTCTTCCCCTTCTTGGCTTTATCAGGAGCCACACAGACCAGG\nATGTTGACAGGATTTGCCTCTCGAGATAAGCAGGCCCTGGAGATGGTGGGACAGATTACA\nAATGAAGCCCTCAGTAACATCCGCACTGTTGCTGGAATTGGAAAGGAGAGGCGGTTCATT\nGAAGCACTTGAGACTGAGCTGGAGAAGCCCTTCAAGACAGCCATTCAGAAAGCCAATATT\nTACGGATTCTGCTTTGCCTTTGCCCAGTGCATCATGTTTATTGCGAATTCTGCTTCCTAC\nAGATATGGAGGTTACTTAATCTCCAATGAGGGGCTCCATTTCAGCTATGTGTTCAGGGTG\nATCTCTGCAGTTGTACTGAGTGCAACAGCTCTTGGAAGAGCCTTCTCTTACACCCCAAGT\nTATGCAAAAGCTAAAATATCAGCTGCACGCTTTTTTCAACTGCTGGACCGACAACCCCCA\nATCAGTGTATACAATACTGCAGGTGAAAAATGGGACAACTTCCAGGGGAAGATTGATTTT\nGTTGATTGTAAATTTACATATCCTTCTCGACCTGACTCGCAAGTTCTGAATGGTCTCTCA\nGTGTCGATTAGTCCAGGGCAGACACTGGCGTTTGTTGGGAGCAGTGGATGTGGCAAAAGC\nACTAGCATTCAGCTGTTGGAACGTTTCTATGATCCTGATCAAGGGAAGGTGATGATAGAT\nGGTCATGACAGCAAAAAAGTAAATGTCCAGTTCCTCCGCTCAAACATTGGAATTGTTTCC\nCAGGAACCAGTGTTGTTTGCCTGTAGCATAATGGACAATATCAAGTATGGAGACAACACC\nAAAGAAATTCCCATGGAAAGAGTCATAGCAGCTGCAAAACAGGCTCAGCTGCATGATTTT\nGTCATGTCACTCCCAGAGAAATATGAAACTAACGTTGGGTCCCAGGGGTCTCAACTCTCT\nAGAGGGGAGAAACAACGCATTGCTATTGCTCGGGCCATTGTACGAGATCCTAAAATCTTG\nCTACTAGATGAAGCCACTTCTGCCTTAGACACAGAAAGTGAAAAGACGGTGCAGGTTGCT\nCTAGACAAAGCCAGAGAGGGTCGGACCTGCATTGTCATTGCCCATCGCTTGTCCACCATC\nCAGAACGCGGATATCATTGCTGTCATGGCACAGGGGGTGGTGATTGAAAAGGGGACCCAT\nGAAGAACTGATGGCCCAAAAAGGAGCCTACTACAAACTAGTCACCACTGGATCCCCCATC\nAGTTGA",
                        "Chromosome Location": "2",
                        "Locus": "2q24",
                        "External Identifiers": "ResourceLinkUniProtKB IDO95342UniProtKB Entry NameABCBB_HUMANGenBank Protein ID3873243GenBank Gene IDAF091582GenAtlas IDABCB11HGNC IDHGNC:42",
                        "General References": "Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H, Sokal E, Dahan K, Childs S, Ling V, Tanner MS, Kagalwalla AF, Nemeth A, Pawlowska J, Baker A, Mieli-Vergani G, Freimer NB, Gardiner RM, Thompson RJ: A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet. 1998 Nov;20(3):233-8. [Article] Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article] Mochizuki K, Kagawa T, Numari A, Harris MJ, Itoh J, Watanabe N, Mine T, Arias IM: Two N-linked glycans are required to maintain the transport activity of the bile salt export pump (ABCB11) in MDCK II cells. Am J Physiol Gastrointest Liver Physiol. 2007 Mar;292(3):G818-28. Epub 2006 Nov 2. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Jansen PL, Strautnieks SS, Jacquemin E, Hadchouel M, Sokal EM, Hooiveld GJ, Koning JH, De Jager-Krikken A, Kuipers F, Stellaard F, Bijleveld CM, Gouw A, Van Goor H, Thompson RJ, Muller M: Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology. 1999 Dec;117(6):1370-9. [Article] Saito S, Iida A, Sekine A, Miura Y, Ogawa C, Kawauchi S, Higuchi S, Nakamura Y: Three hundred twenty-six genetic variations in genes encoding nine members of ATP-binding cassette, subfamily B (ABCB/MDR/TAP), in the Japanese population. J Hum Genet. 2002;47(1):38-50. [Article] Chen HL, Chang PS, Hsu HC, Ni YH, Hsu HY, Lee JH, Jeng YM, Shau WY, Chang MH: FIC1 and BSEP defects in Taiwanese patients with chronic intrahepatic cholestasis with low gamma-glutamyltranspeptidase levels. J Pediatr. 2002 Jan;140(1):119-24. [Article] van Mil SW, van der Woerd WL, van der Brugge G, Sturm E, Jansen PL, Bull LN, van den Berg IE, Berger R, Houwen RH, Klomp LW: Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology. 2004 Aug;127(2):379-84. [Article] Pauli-Magnus C, Lang T, Meier Y, Zodan-Marin T, Jung D, Breymann C, Zimmermann R, Kenngott S, Beuers U, Reichel C, Kerb R, Penger A, Meier PJ, Kullak-Ublick GA: Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. Pharmacogenetics. 2004 Feb;14(2):91-102. [Article] Noe J, Kullak-Ublick GA, Jochum W, Stieger B, Kerb R, Haberl M, Mullhaupt B, Meier PJ, Pauli-Magnus C: Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis. J Hepatol. 2005 Sep;43(3):536-43. [Article] Lang T, Haberl M, Jung D, Drescher A, Schlagenhaufer R, Keil A, Mornhinweg E, Stieger B, Kullak-Ublick GA, Kerb R: Genetic variability, haplotype structures, and ethnic diversity of hepatic transporters MDR3 (ABCB4) and bile salt export pump (ABCB11). Drug Metab Dispos. 2006 Sep;34(9):1582-99. Epub 2006 Jun 8. [Article] Meier Y, Pauli-Magnus C, Zanger UM, Klein K, Schaeffeler E, Nussler AK, Nussler N, Eichelbaum M, Meier PJ, Stieger B: Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver. Hepatology. 2006 Jul;44(1):62-74. [Article] Lang C, Meier Y, Stieger B, Beuers U, Lang T, Kerb R, Kullak-Ublick GA, Meier PJ, Pauli-Magnus C: Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury. Pharmacogenet Genomics. 2007 Jan;17(1):47-60. [Article] Hu G, He P, Liu Z, Chen Q, Zheng B, Zhang Q: Diagnosis of ABCB11 gene mutations in children with intrahepatic cholestasis using high resolution melting analysis and direct sequencing. Mol Med Rep. 2014 Sep;10(3):1264-74. doi: 10.3892/mmr.2014.2349. Epub 2014 Jun 20. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00171ATPinvestigational, nutraceuticalunknownDetailsDB01016GlyburideapprovedunknowninhibitorDetailsDB01586Ursodeoxycholic acidapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB03619Deoxycholic acidapprovedunknowninducerDetailsDB04348Taurocholic acidapproved, experimentalunknownsubstrateinducerDetailsDB02659Cholic AcidapprovedunknownsubstrateinhibitorinducerDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknowninducerDetailsDB01174Phenobarbitalapproved, investigationalunknowninducerDetailsDB00977EthinylestradiolapprovedunknowninhibitorDetailsDB01045RifampicinapprovedunknowninhibitorDetailsDB02123Glycochenodeoxycholic AcidexperimentalunknownsubstrateinhibitorDetailsDB01016GlyburideapprovedunknownsubstrateinhibitorDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00206Reserpineapproved, investigational, withdrawnunknowninhibitorDetailsDB00570VinblastineapprovednosubstrateinhibitorDetailsDB00396Progesteroneapproved, vet_approvedunknowninhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknowninhibitorDetailsDB01229Paclitaxelapproved, vet_approvednosubstrateinhibitorDetailsDB02703Fusidic acidapproved, investigationalunknowninhibitorDetailsDB00559Bosentanapproved, investigationalunknowninhibitorDetailsDB00997Doxorubicinapproved, investigationalunknownsubstrateDetailsDB00693FluoresceinapprovedunknownsubstrateDetailsDB00541Vincristineapproved, investigationalunknownsubstrateDetailsDB00390DigoxinapprovedunknownsubstrateDetailsDB00175PravastatinapprovednosubstrateDetailsDB01098RosuvastatinapprovedunknownsubstrateDetailsDB06290SimeprevirapprovedunknowninhibitorDetailsDB12070Letermovirapproved, investigationalunknowninhibitorDetailsDB00932Tipranavirapproved, investigationalunknownsubstrateinhibitorDetailsDB00257Clotrimazoleapproved, vet_approvedunknownsubstrateinhibitorDetailsDB09078Lenvatinibapproved, investigationalunknowninhibitorDetailsDB00966Telmisartanapproved, investigationalnosubstrateDetailsDB09374Indocyanine green acid formapproved, investigationalnosubstrateDetailsDB01149Nefazodoneapproved, withdrawnnosubstrateDetailsDB01232Saquinavirapproved, investigationalnosubstrateDetailsDB01601LopinavirapprovednoinhibitorDetailsDB00503Ritonavirapproved, investigationalnoinhibitorDetailsDB00834Mifepristoneapproved, investigationalnosubstrateDetailsDB00455Loratadineapproved, investigationalunknownsubstrateDetailsDB13345Dihydroergocristineapproved, experimentalnosubstrateDetailsDB12319Benzbromaroneinvestigational, withdrawnnosubstrateDetailsDB00622Nicardipineapproved, investigationalnosubstrateDetailsDB00227Lovastatinapproved, investigationalnosubstrateDetailsDB01023Felodipineapproved, investigationalnosubstrateDetailsDB00255Diethylstilbestrolapproved, investigational, withdrawnnosubstrateDetailsDB00678LosartanapprovednosubstrateDetailsDB00222GlimepirideapprovednosubstrateDetailsDB00822DisulfiramapprovednosubstrateDetailsDB00641SimvastatinapprovednosubstrateDetailsDB00421SpironolactoneapprovednosubstrateDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB00439Cerivastatinapproved, withdrawnnosubstrateDetailsDB00270Isradipineapproved, investigationalnosubstrateDetailsDB00973EzetimibeapprovednosubstrateDetailsDB00975DipyridamoleapprovednosubstrateDetailsDB08860PitavastatinapprovednosubstrateDetailsDB01039FenofibrateapprovednosubstrateDetailsDB01072Atazanavirapproved, investigationalnosubstrateDetailsDB00912Repaglinideapproved, investigationalnosubstrateDetailsDB01138SulfinpyrazoneapprovednosubstrateDetailsDB00243Ranolazineapproved, investigationalnosubstrateDetailsDB00412Rosiglitazoneapproved, investigationalnosubstrateDetailsDB00220NelfinavirapprovednosubstrateDetailsDB01222BudesonideapprovednosubstrateDetailsDB00224IndinavirapprovednosubstrateDetailsDB00482Celecoxibapproved, investigationalnoinhibitorDetailsDB00833CefaclorapprovednosubstrateDetailsDB05804Prasterone sulfateinvestigationalnosubstrateDetailsDB00637Astemizoleapproved, withdrawnnosubstrateDetailsDB01118Amiodaroneapproved, investigationalnosubstrateinhibitorDetailsDB00911Tinidazoleapproved, investigationalnosubstrateDetailsDB12712PilsicainideinvestigationalnosubstrateDetailsDB00698Nitrofurantoinapproved, vet_approvednosubstrateDetailsDB00619ImatinibapprovednosubstrateDetailsDB00328Indomethacinapproved, investigationalnosubstrateDetailsDB00176Fluvoxamineapproved, investigationalnosubstrateDetailsDB01165OfloxacinapprovednosubstrateDetailsDB01067Glipizideapproved, investigationalnosubstrateDetailsDB00275Olmesartanapproved, investigationalnoinhibitorDetailsDB00335AtenololapprovednosubstrateDetailsDB00625Efavirenzapproved, investigationalnosubstrateDetailsDB00342Terfenadineapproved, withdrawnnosubstrateDetailsDB01211ClarithromycinapprovednosubstrateDetailsDB13751Glycyrrhizic acidapproved, experimentalnosubstrateDetailsDB00572Atropineapproved, vet_approvednosubstrateDetailsDB00301Flucloxacillinapproved, investigationalnosubstrateDetailsDB01054Nitrendipineapproved, investigationalnosubstrateDetailsDB00199Erythromycinapproved, investigational, vet_approvednosubstrateinhibitorDetailsDB00586Diclofenacapproved, vet_approvednosubstrateDetailsDB01115NifedipineapprovednoinhibitorDetailsDB01015SulfamethoxazoleapprovednoinhibitorDetailsDB00788Naproxenapproved, vet_approvednosubstrateDetailsDB00477Chlorpromazineapproved, investigational, vet_approvednoinhibitorDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00908Quinidineapproved, investigationalnoinhibitorDetailsDB00675TamoxifenapprovednoinhibitorDetailsDB14057ValinomycinexperimentalnoinhibitorDetailsDB05990Obeticholic acidapprovedunknowninhibitorinducerDetailsDB14761Remdesivirapproved, investigationalunknowninhibitorDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknowninducerDetailsDB15719Belantamab mafodotinapprovedunknownsubstrateDetailsDB15822Pralsetinibapproved, investigationalnoinhibitorDetailsDB11886Infigratinibapproved, investigationalnoinhibitorDetailsDB12151Brincidofovirapproved, investigationalnoinhibitorDetailsDB15233Avapritinibapproved, investigationalunknowninhibitorDetailsDB06176Romidepsinapproved, investigationalnoinhibitorDetailsDB08834Tauroursodeoxycholic acidapproved, investigationalunknownregulatorDetailsDB15133Tepotinibapproved, investigationalnoinhibitorDetailsDB05467Palovaroteneapproved, investigationalnoinhibitorDetails"
                    }
                }
            ]
        },
        "Disease Information": {
            "Anginal Pain": null,
            "Cardiovascular Complications": null,
            "Cardiovascular Disease": "Cardiovascular disease (CVD) is any disease involving the heart or blood vessels.[3] CVDs constitute a class of diseases that includes: coronary artery diseases (e.g. angina, heart attack), heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, thromboembolic disease, and venous thrombosis.[3][4]\n",
            "Coronary Artery Disease": "Coronary artery disease (CAD), also called coronary heart disease (CHD), ischemic heart disease (IHD),[13] myocardial ischemia,[14] or simply heart disease, involves the reduction of blood flow to the heart muscle due to build-up of atherosclerotic plaque in the arteries of the heart.[5][6][15] It is the most common of the cardiovascular diseases.[16] Types include stable angina, unstable angina, and myocardial infarction.[17] A common symptom is chest pain or discomfort which may travel into the shoulder, arm, back, neck, or jaw.[4] Occasionally it may feel like heartburn. Usually symptoms occur with exercise or emotional stress, last less than a few minutes, and improve with rest.[4] Shortness of breath may also occur and sometimes no symptoms are present.[4] In many cases, the first sign is a heart attack.[5] Other complications include heart failure or an abnormal heartbeat.[5]\n",
            "Coronary artery thrombosis": null,
            "Dysbetalipoproteinemia": null,
            "Fredrickson Type III lipidemia": null,
            "Heterozygous Familial Hypercholesterolemia": "Familial hypercholesterolemia (FH) is a genetic disorder characterized by high cholesterol levels, specifically very high levels of low-density lipoprotein cholesterol (LDL cholesterol), in the blood and early cardiovascular diseases. The most common mutations diminish the number of functional LDL receptors in the liver or produce abnormal LDL receptors that never go to the cell surface to function properly (abnormal trafficking).[citation needed] Since the underlying body biochemistry is slightly different in individuals with FH, their high cholesterol levels are less responsive to the kinds of cholesterol control methods which are usually more effective in people without FH (such as dietary modification and statin tablets). Nevertheless, treatment (including higher statin doses) is usually effective.\n",
            "High Cholesterol": "Hypercholesterolemia, also called high cholesterol, is the presence of high levels of cholesterol in the blood.[1] It is a form of hyperlipidemia (high levels of lipids in the blood), hyperlipoproteinemia (high levels of lipoproteins in the blood), and dyslipidemia (any abnormalities of lipid and lipoprotein levels in the blood).[1]\n",
            "Homozygous Familial Hypercholesterolaemia": null,
            "Hospitalizations": null,
            "Hypertension, Essential Hypertension": null,
            "Hypertriglyceridemias": null,
            "Mixed Dyslipidemias": null,
            "Mixed Hyperlipidemia": null,
            "Myocardial Infarction": "A myocardial infarction (MI), commonly known as a heart attack, occurs when blood flow decreases or stops in one of the coronary arteries of the heart, causing infarction (tissue death) to the heart muscle.[1] The most common symptom is chest pain or discomfort which may travel into the shoulder, arm, back, neck or jaw.[1] Often it occurs in the center or left side of the chest and lasts for more than a few minutes.[1] The discomfort may occasionally feel like heartburn.[1] Other symptoms may include shortness of breath, nausea, feeling faint, a cold sweat, feeling tired, and decreased level of consciousness.[1] About 30% of people have atypical symptoms.[8] Women more often present without chest pain and instead have neck pain, arm pain or feel tired.[11] Among those over 75 years old, about 5% have had an MI with little or no history of symptoms.[12] An MI may cause heart failure, an irregular heartbeat, cardiogenic shock or cardiac arrest.[3][4]\n",
            "Non-familial hypercholesterolemia": null,
            "Nonfatal Myocardial Infarction": null,
            "Postoperative Thromboembolism": null,
            "Primary Hypercholesterolemia": null,
            "Stroke": "Stroke (brain attack) is a medical condition in which poor blood flow to the brain causes cell death.[5] There are two main types of stroke: ischemic, due to lack of blood flow, and hemorrhagic, due to bleeding.[5] Both cause parts of the brain to stop functioning properly.[5]\n",
            "Thrombosis": "Thrombosis (from Ancient Greek \u03b8\u03c1\u03cc\u03bc\u03b2\u03c9\u03c3\u03b9\u03c2 thr\u00f3mb\u014dsis \"clotting\") is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system. When a blood vessel (a vein or an artery) is injured, the body uses platelets (thrombocytes) and fibrin to form a blood clot to prevent blood loss.  Even when a blood vessel is not injured, blood clots may form in the body under certain conditions. A clot, or a piece of the clot, that breaks free and begins to travel around the body is known as an embolus.[1][2]\n",
            "Transient Ischemic Attack": "A transient ischemic attack (TIA), commonly known as a mini-stroke, is a minor stroke whose noticeable symptoms usually end in less than an hour.  TIA causes the same symptoms associated with strokes, such as weakness or numbness on one side of the body, sudden dimming or loss of vision, difficulty speaking or understanding language, slurred speech, or confusion.\n",
            "Elevation of serum triglyceride levels": null,
            "Heterozygous familial hyperlipidemia": null,
            "Non-familial hyperlipidemia": null,
            "Primary Hyperlipidemia": null,
            "Revascularization procedures": null
        }
    },
    "MORPHINE SULFATE": {
        "Active Ingredients": {
            "MORPHINE SULFATE": "CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O.CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O.OS(=O)(=O)O"
        },
        "Drug Information": {
            "Identification": {
                "Summary": "Morphine is an opioid agonist used for the relief of moderate to severe acute and chronic pain.",
                "Brand Names": "Arymo, Avinza, Doloral, Duramorph, Embeda, Infumorph, Kadian, M-ediat, M-eslon, MSIR, Mitigo, Ms Contin, Statex",
                "Generic Name": "Morphine",
                "DrugBank Accession Number": "DB00295",
                "Background": "Morphine, the main alkaloid of opium, was first obtained from poppy seeds in 1805.1 It is a potent analgesic, though its use is limited due to tolerance, withdrawal, and the risk of abuse.2 Morphine is still routinely used today, though there are a number of semi-synthetic opioids of varying strength such as codeine, fentanyl, methadone, hydrocodone, hydromorphone, meperidine, and oxycodone.\nMorphine was granted FDA approval in 1941.13",
                "Type": "Small Molecule",
                "Groups": "Approved, Investigational",
                "Structure": "3DDownload MOLSDF3D-SDFPDBSMILESInChI\n\n\n Similar StructuresStructure for Morphine (DB00295)\u00d7 Close",
                "Weight": "Average: 285.3377 Monoisotopic: 285.136493479",
                "Chemical Formula": "C17H19NO3",
                "Synonyms": "(\u2212)-morphine(5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol(5alpha,6alpha)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol(5R,6S,9R,13S,14R)-4,5-epoxy-N-methyl-7-morphinen-3,6-diol(5\u03b1,6\u03b1)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol(5\u03b1,6\u03b1)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diolAnhydrous morphineMorfinaMorphiaMorphinMorphineMorphinumMorphium",
                "External IDs": "IDS-NM-009\nN02AA01"
            },
            "Pharmacology": {
                "Indication": "Morphine is used for the management of chronic, moderate to severe pain.2\nOpiods, including morphine, are effective for the short term management of pain. Patients taking opioids long term may need to be monitored for the development of physical dependence, addiction disorder, and drug abuse.11\nReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See how",
                "Associated Conditions": "Chronic Pain\nSevere Pain",
                "Contraindications & Blackbox Warnings": "Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events with our Clinical APILearn more",
                "Pharmacodynamics": "Morphine binding to opioid receptors blocks transmission of nociceptive signals, signals pain-modulating neurons in the spinal cord, and inhibits primary afferent nociceptors to the dorsal horn sensory projection cells.1\nMorphine has a time to onset of 6-30 minutes.1 Excess consumption of morphine and other opioids can lead to changes in synaptic neuroplasticity, including changes in neuron density, changes at postsynaptic sites, and changes at dendritic terminals.3\nIntravenous morphine's analgesic effect is sex dependent. The EC50 in men is 76ng/mL and in women is 22ng/mL.5\nMorphine-6-glucuronide is 22 times less potent than morphine in eliciting pupil constriction.5",
                "Mechanism of action": "Morphine-6-glucuronide is responsible for approximately 85% of the response observed by morphine administration.4 Morphine and its metabolites act as agonists of the mu and kappa opioid receptors.1 The mu-opioid receptor is integral to morphine's effects on the ventral tegmental area of the brain. Morphine's activation of the reward pathway is mediated by agonism of the delta-opioid receptor in the nucleus accumbens,2 while modification of the respiratory system and addiction disorder are mediated by agonism of the mu-opioid receptor.3\nTargetActionsOrganismAMu-type opioid receptoragonistregulatorHumansAKappa-type opioid receptoragonistHumansADelta-type opioid receptoragonistHumansULymphocyte antigen 96activatorHumans",
                "Absorption": "Morphine is absorbed in the alkaline environments of the upper intestine and rectal mucosa.6 The bioavailability of morphine is 80-100%.8 There is significant first-pass metabolism, therefore oral doses are 6 times larger than parenteral doses to achieve the same effect. Morphine reaches steady-state concentrations after 24-48 hours.1 Parenteral morphine has a Tmax of 15 minutes and oral morphine has a Tmax of 90 minutes, with a Cmax of 283nmol/L.7,8 The AUC of morphine is 225-290nmol*h/L.8",
                "Volume of distribution": "The volume of distribution of morphine is 5.31L/kg.6 Morphine-6-glucuronide has a volume of distribution of 3.61L/kg.6",
                "Protein binding": "Morphine is 35% protein bound, the metabolite morphine-3-glucuronide is 10% protein bound, and morphine-6-glucuronide is 15% protein bound.4",
                "Metabolism": "Morphine is 90% metabolized by glucuronidation by UGT2B7 and sulfation at positions 3 and 6.4 Morphine can also be metabolized to codeine, normorphine, and morphine ethereal sulfate.6\nHover over products below to view reaction partnersMorphine\n\n\nMorphine glucuronide\n\n\nmorphine-3-glucuronide\n\n\nNormorphine\n\n\nCodeine\n\n\nMorphine ethereal sulfate",
                "Route of elimination": "70-80% of an administered dose is excreted within 48 hours.6 Morphine is predominantly eliminated in the urine with 2-10% of a dose recovered as the unchanged parent drug.4 7-10% of a dose of morphine is eliminated in the feces.13",
                "Half-life": "Morphine has a half life of 2-3 hours.5",
                "Clearance": "The apparent clearance of intravenous or subcutaneous morphine is 1600 mL/min.8",
                "Adverse Effects": "Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support & research outcomes with our structured adverse effects data.See a data sample",
                "Toxicity": "The LD50 is 0.78\u00b5g/mL in males and 0.98\u00b5g/mL in females.9\nPatients experiencing an overdose present with respiratory depression, somnolence, skeletal muscle flaccidity, cold and clammy skin, miosis, and mydriasis. Symptoms of overdose can progress to pulmonary edema, bradycardia, hypotension, cardiac arrest, and death.12 Treat overdose with symptomatic and supportive treatment which may include the use of oxygen, vasopressors, and naloxone.12",
                "Pathways": "PathwayCategoryMorphine Action PathwayDrug actionCodeine Action PathwayDrug actionHeroin Metabolism PathwayDrug metabolismHeroin Action PathwayDrug actionCodeine Metabolism PathwayDrug metabolismMorphine Metabolism PathwayDrug metabolism",
                "Pharmacogenomic Effects/ADRs": "Interacting Gene/EnzymeAllele nameGenotype(s)Defining Change(s)Type(s)DescriptionDetailsMultidrug resistance protein 1---(T;T) / (C;T)T AlleleEffect Directly StudiedPatients with this genotype may have an increased analgesic response to morphine.DetailsMu-type opioid receptor---(A;A)A AlleleEffect Directly StudiedPatients with this genotype may have an increased analgesic response to morphine.Details"
            },
            "Interactions": {
                "Drug Interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. ApprovedVet approvedNutraceuticalIllicitWithdrawnInvestigationalExperimentalAll DrugsDrugInteractionIntegrate drug-drug interactions in your software\n\n\n1,2-BenzodiazepineThe risk or severity of adverse effects can be increased when Morphine is combined with 1,2-Benzodiazepine.AbaloparatideThe risk or severity of adverse effects can be increased when Morphine is combined with Abaloparatide.AbametapirThe serum concentration of Morphine can be increased when it is combined with Abametapir.AbataceptThe metabolism of Morphine can be increased when combined with Abatacept.AbemaciclibThe serum concentration of Abemaciclib can be increased when it is combined with Morphine.AbirateroneThe metabolism of Morphine can be decreased when combined with Abiraterone.AbrocitinibThe serum concentration of Morphine can be increased when it is combined with Abrocitinib.AcebutololThe risk or severity of adverse effects can be increased when Morphine is combined with Acebutolol.AcetazolamideThe risk or severity of CNS depression can be increased when Morphine is combined with Acetazolamide.AcetophenazineThe risk or severity of hypotension and CNS depression can be increased when Acetophenazine is combined with Morphine.Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more",
                "Food Interactions": "Avoid alcohol. Concomitant use may lead to profound sedation, respiratory depression, coma, and death.\nTake with or without food. There is no significant different in the AUC or Cmax of oral extended release tablets when taken with or without food."
            },
            "Products": {
                "": "Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access now  Access drug product information from over 10 global regions.Access now",
                "Product Ingredients": "IngredientUNIICASInChI KeyMorphine acetateVEO43W5229596-15-6CLDOGJORCNORLA-VYKNHSEDSA-NMorphine hydrochlorideJ28GE0ROVX52-26-6XCKKIKBIPZJUET-VYKNHSEDSA-NMorphine hydrochloride trihydrateQ5F3AS69LF6055-06-7XELXKCKNPPSFNN-BJWPBXOKSA-NMorphine mesylateQXB8THK8QY335328-17-1MHEMFNFIWLUDDJ-VYKNHSEDSA-NMorphine nitrateDV2P23JCWV596-16-7VHBDDUMTLJSZDR-VYKNHSEDSA-NMorphine phosphate1LQ9207LZE596-17-8KZSZGTYWWBPNKB-VYKNHSEDSA-NMorphine sulfateDY70C97N3064-31-3USAHOPJHPJHUNS-IFCNUISUSA-NMorphine sulfate pentahydrateX3P646A2J06211-15-0GRVOTVYEFDAHCL-RTSZDRIGSA-NMorphine tartrateU3NSU23LHD302-31-8SVTKSKRNLMAUKF-HAIKCVHQSA-N",
                "International/Other Brands": "Kapanol (Mayne Pharma/Glaxo) / MSIR (Purdue Pharma) / Oramorph (Boeringher Ingelheim)",
                "Brand Name Prescription Products": "NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImageArymo ERTablet, film coated, extended release30 mg/1OralZyla Life Sciences US Inc.2017-02-01Not applicableUSArymo ERTablet, film coated, extended release15 mg/1OralZyla Life Sciences US Inc.2017-02-01Not applicableUSArymo ERTablet, film coated, extended release60 mg/1OralZyla Life Sciences US Inc.2017-02-01Not applicableUSAvinzaCapsule, extended release60 mg/1OralPfizer Laboratories Div Pfizer Inc.2002-03-202017-01-31USAvinzaCapsule, extended release120 mg/1OralLake Erie Medical Dba Quality Care Produts Llc2011-10-252015-06-01USAvinzaCapsule, extended release60 mg/1OralLigand Pharmaceuticals Incorporated2006-08-08Not applicableUSAvinzaCapsule, extended release120 mg/1OralPhysicians Total Care, Inc.2004-10-152012-06-30USAvinzaCapsule, extended release30 mg/1Oralbryant ranch prepack2002-03-202010-07-15USAvinzaCapsule, extended release60 mg/1OralStat Rx USA2002-03-20Not applicableUSAvinzaCapsule, extended release90 mg/1OralPfizer Laboratories Div Pfizer Inc.2002-03-202017-01-31US",
                "Generic Prescription Products": "NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImageAstramorphInjection1 mg/1mLEpidural; Intrathecal; IntravenousAstra Zeneca Lp1990-10-012012-06-30USAstramorphInjection0.5 mg/1mLEpidural; Intrathecal; IntravenousAstra Zeneca Lp1990-10-012012-08-31USAstramorphInjection1 mg/1mLEpidural; Intrathecal; IntravenousAstra Zeneca Lp1990-09-302013-03-31USAstramorphInjection1 mg/1mLEpidural; Intrathecal; IntravenousAstra Zeneca Lp1990-10-012013-04-30USAstramorphInjection0.5 mg/1mLEpidural; Intrathecal; IntravenousAstra Zeneca Lp1990-10-012013-02-28USAstramorphInjection0.5 mg/1mLEpidural; Intrathecal; IntravenousAstra Zeneca Lp1990-10-012012-11-30USAstramorph PFInjection, solution0.5 mg/1mLEpidural; Intrathecal; IntravenousFresenius Kabi2009-09-282013-05-10USAstramorph PFInjection, solution1 mg/1mLEpidural; Intrathecal; IntravenousFresenius Kabi2009-09-282013-05-10USBar-morphine SRTablet, extended release60 mgOralBard Pharmaceuticals (1990) IncNot applicableNot applicableCanadaBar-morphine SRTablet, extended release200 mgOralBard Pharmaceuticals (1990) IncNot applicableNot applicableCanada",
                "Mixture Products": "NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImageEmbedaMorphine sulfate pentahydrate (60 mg/1) + Naltrexone hydrochloride (2.4 mg/1)Capsule, extended releaseOralPfizer Laboratories Div Pfizer Inc2009-08-13Not applicableUSEmbedaMorphine sulfate pentahydrate (20 mg/1) + Naltrexone hydrochloride (0.8 mg/1)Capsule, extended releaseOralPfizer Laboratories Div Pfizer Inc2009-08-13Not applicableUSEmbedaMorphine sulfate pentahydrate (100 mg/1) + Naltrexone hydrochloride (4 mg/1)Capsule, extended releaseOralPfizer Laboratories Div Pfizer Inc2009-08-13Not applicableUSEmbedaMorphine sulfate pentahydrate (50 mg/1) + Naltrexone hydrochloride (2 mg/1)Capsule, extended releaseOralPfizer Laboratories Div Pfizer Inc2009-08-13Not applicableUSEmbedaMorphine sulfate pentahydrate (20 mg/1) + Naltrexone hydrochloride (.8 mg/1)Capsule, extended releaseOralStat Rx USA2009-08-13Not applicableUSEmbedaMorphine sulfate pentahydrate (80 mg/1) + Naltrexone hydrochloride (3.2 mg/1)Capsule, extended releaseOralPfizer Laboratories Div Pfizer Inc2009-08-13Not applicableUSEmbedaMorphine sulfate pentahydrate (30 mg/1) + Naltrexone hydrochloride (1.2 mg/1)Capsule, extended releaseOralPfizer Laboratories Div Pfizer Inc2009-08-13Not applicableUS",
                "Unapproved/Other Products": "NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImageMORFIN HIDROKLORUR 0,01 GR/1 ML 1MLX10 AMPULMorphine hydrochloride (0.01 g/ml)SolutionIntramuscular; Intravenous; SubcutaneousOSEL \u0130LA\u00c7 SAN. VE T\u0130C. A.\u015e.2020-08-14Not applicableTurkeyMorphine SulfateMorphine sulfate pentahydrate (10 mg/1mL)InjectionIntramuscular; Intravenous; SubcutaneousPhysicians Total Care, Inc.2003-03-112011-06-30USMorphine SulfateMorphine sulfate pentahydrate (1 mg/1mL)Injection, solutionEpidural; Intramuscular; Intrathecal; IntravenousCantrell Drug Company2013-09-092017-12-06USMorphine SulfateMorphine sulfate pentahydrate (10 mg/1mL)Injection, solutionIntravenousHospira, Inc.1997-06-092014-03-01USMorphine SulfateMorphine sulfate pentahydrate (15 mg/1mL)InjectionIntramuscular; Intravenous; SubcutaneousBaxter Laboratories2002-12-022013-10-31USMorphine SulfateMorphine sulfate pentahydrate (30 mg/1)TabletOralGlenmark Generics, Inc. USA2006-08-012009-06-26USMorphine SulfateMorphine sulfate pentahydrate (25 mg/1mL)Injection, solutionIntravenousHospira, Inc.1991-04-112015-09-01USMorphine SulfateMorphine sulfate pentahydrate (15 mg/1mL)InjectionIntramuscular; Intravenous; SubcutaneousWest-Ward Pharmaceuticals Corp.1971-01-012017-05-31USMorphine SulfateMorphine sulfate pentahydrate (8 mg/1mL)Injection, solutionIntravenousHospira, Inc.1997-06-092013-10-01USMorphine SulfateMorphine sulfate pentahydrate (5 mg/1mL)InjectionIntramuscular; Intravenous; SubcutaneousBaxter Laboratories2002-12-022013-10-31US"
            },
            "Categories": {
                "ATC Codes": "A07DA52 \u2014 Morphine, combinationsA07DA \u2014 AntipropulsivesA07D \u2014 ANTIPROPULSIVESA07 \u2014 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTSA \u2014 ALIMENTARY TRACT AND METABOLISMN02AA51 \u2014 Morphine, combinationsN02AA \u2014 Natural opium alkaloidsN02A \u2014 OPIOIDSN02 \u2014 ANALGESICSN \u2014 NERVOUS SYSTEMN02AA01 \u2014 MorphineN02AA \u2014 Natural opium alkaloidsN02A \u2014 OPIOIDSN02 \u2014 ANALGESICSN \u2014 NERVOUS SYSTEMN02AG01 \u2014 Morphine and antispasmodicsN02AG \u2014 Opioids in combination with antispasmodicsN02A \u2014 OPIOIDSN02 \u2014 ANALGESICSN \u2014 NERVOUS SYSTEM",
                "Drug Categories": "Alkaloids\nAnalgesics\nAnesthetics\nCentral Nervous System Agents\nCentral Nervous System Depressants\nCytochrome P-450 CYP2C8 Substrates\nCytochrome P-450 CYP3A Substrates\nCytochrome P-450 CYP3A4 Substrates\nCytochrome P-450 Substrates\nHeterocyclic Compounds, Fused-Ring\nHigh-risk opioids\nHypotensive Agents\nNarcotics\nNatural Opium Alkaloids\nNervous System\nNeuraxial Anesthetics\nOpiate Agonists\nOpiate Alkaloids\nOpioid Agonist\nOpioids\nP-glycoprotein substrates\nPeripheral Nervous System Agents\nPhenanthrenes\nSensory System Agents\nSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome\nUGT1A1 Substrates\nUGT1A3 substrates\nUGT2B7 substrates",
                "Chemical TaxonomyProvided by Classyfire": "DescriptionThis compound belongs to the class of organic compounds known as morphinans. These are polycyclic compounds with a four-ring skeleton with three condensed six-member rings forming a partially hydrogenated phenanthrene moiety, one of which is aromatic while the two others are alicyclic.KingdomOrganic compoundsSuper ClassAlkaloids and derivativesClassMorphinansSub ClassNot AvailableDirect ParentMorphinansAlternative ParentsPhenanthrenes and derivatives / Tetralins / Coumarans / Aralkylamines / Alkyl aryl ethers / 1-hydroxy-2-unsubstituted benzenoids / Piperidines / Trialkylamines / Secondary alcohols / Oxacyclic compounds / Azacyclic compounds / Organopnictogen compounds / Hydrocarbon derivatives\n\n\n show 3 moreSubstituents1-hydroxy-2-unsubstituted benzenoid / Alcohol / Alkyl aryl ether / Amine / Aralkylamine / Aromatic heteropolycyclic compound / Azacycle / Benzenoid / Coumaran / Ether / Hydrocarbon derivative / Morphinan / Organic nitrogen compound / Organic oxygen compound / Organoheterocyclic compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Oxacycle / Phenanthrene / Piperidine / Secondary alcohol / Tertiary aliphatic amine / Tertiary amine / Tetralin\n\n\n show 15 moreMolecular FrameworkAromatic heteropolycyclic compoundsExternal Descriptorsmorphinane alkaloid, organic heteropentacyclic compound (CHEBI:17303)  / Alkaloids, Isoquinoline alkaloids (C01516)",
                "Description": "This compound belongs to the class of organic compounds known as morphinans. These are polycyclic compounds with a four-ring skeleton with three condensed six-member rings forming a partially hydrogenated phenanthrene moiety, one of which is aromatic while the two others are alicyclic.",
                "Kingdom": "Organic compounds",
                "Super Class": "Alkaloids and derivatives",
                "Class": "Morphinans",
                "Sub Class": "Not Available",
                "Direct Parent": "Morphinans",
                "Alternative Parents": "Phenanthrenes and derivatives / Tetralins / Coumarans / Aralkylamines / Alkyl aryl ethers / 1-hydroxy-2-unsubstituted benzenoids / Piperidines / Trialkylamines / Secondary alcohols / Oxacyclic compounds / Azacyclic compounds / Organopnictogen compounds / Hydrocarbon derivatives\n\n\n show 3 more",
                "Substituents": "1-hydroxy-2-unsubstituted benzenoid / Alcohol / Alkyl aryl ether / Amine / Aralkylamine / Aromatic heteropolycyclic compound / Azacycle / Benzenoid / Coumaran / Ether / Hydrocarbon derivative / Morphinan / Organic nitrogen compound / Organic oxygen compound / Organoheterocyclic compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Oxacycle / Phenanthrene / Piperidine / Secondary alcohol / Tertiary aliphatic amine / Tertiary amine / Tetralin\n\n\n show 15 more",
                "Molecular Framework": "Aromatic heteropolycyclic compounds",
                "External Descriptors": "morphinane alkaloid, organic heteropentacyclic compound (CHEBI:17303)  / Alkaloids, Isoquinoline alkaloids (C01516)",
                "Affected organisms": "Humans and other mammals"
            },
            "Chemical Identifiers": {
                "UNII": "76I7G6D29C",
                "CAS number": "57-27-2",
                "InChI Key": "BQJCRHHNABKAKU-KBQPJGBKSA-N",
                "InChI": "InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1",
                "IUPAC Name": "(1S,5R,13R,14S,17R)-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10,15-tetraene-10,14-diol",
                "SMILES": "[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O"
            },
            "References": {
                "Synthesis Reference": "US4764615",
                "General References": "Pacifici GM: Metabolism and pharmacokinetics of morphine in neonates: A review. Clinics (Sao Paulo). 2016 Aug;71(8):474-80. doi: 10.6061/clinics/2016(08)11. [Article] Kim J, Ham S, Hong H, Moon C, Im HI: Brain Reward Circuits in Morphine Addiction. Mol Cells. 2016 Sep;39(9):645-53. doi: 10.14348/molcells.2016.0137. Epub 2016 Aug 9. [Article] Beltran-Campos V, Silva-Vera M, Garcia-Campos ML, Diaz-Cintra S: Effects of morphine on brain plasticity. Neurologia. 2015 Apr;30(3):176-80. doi: 10.1016/j.nrl.2014.08.004. Epub 2014 Nov 11. [Article] Klimas R, Mikus G: Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide. Br J Anaesth. 2014 Dec;113(6):935-44. doi: 10.1093/bja/aeu186. Epub 2014 Jul 1. [Article] Lotsch J: Pharmacokinetic-pharmacodynamic modeling of opioids. J Pain Symptom Manage. 2005 May;29(5 Suppl):S90-103. doi: 10.1016/j.jpainsymman.2005.01.012. [Article] Hoskin PJ, Hanks GW: Morphine: pharmacokinetics and clinical practice. Br J Cancer. 1990 Nov;62(5):705-7. [Article] Glare PA, Walsh TD: Clinical pharmacokinetics of morphine. Ther Drug Monit. 1991 Jan;13(1):1-23. [Article] Stuart-Harris R, Joel SP, McDonald P, Currow D, Slevin ML: The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine. Br J Clin Pharmacol. 2000 Mar;49(3):207-14. [Article] Shigeev S: Severity of opiate intoxication to gender and age. Soud Lek. 2007 Jan;52(1):21-4. [Article] FDA approvals [Link] NIH [Link] FDA Approved Drug Products: Infumorph Morphine Sulfate Injection [Link] FDA Approved Drug Products: Morphine Sulfate Oral Tablets [Link] FDA Approved Drug Products: Morphine Sulfate Oral Solution [Link] FDA Approved Drug Products: MS Contin (Morphine Sulfate) Oral Extended Release Tablet [Link] FDA Approved Drug Products: Kadian (Morphine Sulfate) Oral Extended Release Capsules [Link]",
                "External Links": "Human Metabolome DatabaseHMDB0014440KEGG DrugD08233KEGG CompoundC01516PubChem Compound5288826PubChem Substance46505161ChemSpider4450907BindingDB50000092RxNav7052ChEBI17303ChEMBLCHEMBL70ZINCZINC000003812983Therapeutic Targets DatabaseDAP000071PharmGKBPA450550PDBe LigandMOIRxListRxList Drug PageDrugs.comDrugs.com Drug PagePDRhealthPDRhealth Drug PageWikipediaMorphine",
                "Human Metabolome Database": "HMDB0014440",
                "KEGG Drug": "D08233",
                "KEGG Compound": "C01516",
                "PubChem Compound": "5288826",
                "PubChem Substance": "46505161",
                "ChemSpider": "4450907",
                "BindingDB": "50000092",
                "RxNav": "7052",
                "ChEBI": "17303",
                "ChEMBL": "CHEMBL70",
                "ZINC": "ZINC000003812983",
                "Therapeutic Targets Database": "DAP000071",
                "PharmGKB": "PA450550",
                "PDBe Ligand": "MOI",
                "RxList": "RxList Drug Page",
                "Drugs.com": "Drugs.com Drug Page",
                "PDRhealth": "PDRhealth Drug Page",
                "Wikipedia": "Morphine",
                "PDB Entries": "1q0y / 7u62 / 8ef6",
                "FDA label": "Download (277 KB)",
                "MSDS": "Download (52.6 KB)"
            },
            "Clinical Trials": {
                "Clinical Trials": "PhaseStatusPurposeConditionsCount4Active Not RecruitingPreventionPain / Postpartum Depression14Active Not RecruitingTreatmentChronic Pain14Active Not RecruitingTreatmentOpioids Use / Postoperative pain14CompletedNot AvailableAbdominal Pain14CompletedNot AvailableAcute Coronary Syndrome (ACS)14CompletedBasic ScienceChronic Lower Back Pain (CLBP)14CompletedBasic ScienceHealthy Subjects (HS)14CompletedBasic SciencePain14CompletedBasic SciencePharyngeal Dysfunction / Pharyngeal Swallowing14CompletedDiagnosticAbdominal Cancer1"
            },
            "Pharmacoeconomics": {
                "Manufacturers": "King pharmaceuticals inc\nActavis elizabeth llc\nEkr therapeutics inc\nApp pharmaceuticals llc\nBaxter healthcare corp anesthesia and critical care\nHospira inc\nMallinckrodt chemical inc\nMeridian medical technologies inc\nWatson laboratories inc\nRoxane laboratories inc\nClonmel healthcare ltd\nEndo pharmaceuticals inc\nKv pharmaceutical co\nMallinckrodt inc\nPurdue pharma lp\nXanodyne pharmaceutics inc\nActavis",
                "Packagers": "Actavis Group\nAlpharma Pharmaceuticals LLC\nAmphastar Pharmaceuticals\nApotex Inc.\nAPP Pharmaceuticals\nAstraZeneca Inc.\nBarr Pharmaceuticals\nBaxter International Inc.\nBlenheim Pharmacal\nBristol-Myers Squibb Co.\nBryant Ranch Prepack\nCardinal Health\nCerovene Inc.\nCody Laboratories Inc.\nD.M. Graham Laboratories Inc.\nDispensing Solutions\nDiversified Healthcare Services Inc.\nEdenbridge Pharmaceuticals LLC\nEKR Therapeutics Inc.\nElan Pharmaceuticals Inc.\nEndo Pharmaceuticals Inc.\nEthex Corp.\nG & W Labs\nGlenmark Generics Ltd.\nHi Tech Pharmacal Co. Inc.\nHospira Inc.\nIde Interstate\nKing Pharmaceuticals Inc.\nKV Pharmaceutical Co.\nLake Erie Medical and Surgical Supply\nLannett Co. Inc.\nLehigh Valley Technologies Inc.\nLigand Pharmaceuticals Inc.\nMallinckrodt Inc.\nMarathon Pharmaceuticals\nMckesson Corp.\nMeridian Medical Technologies Inc.\nNovartis AG\nNucare Pharmaceuticals Inc.\nP F Laboratories Inc.\nPacira Pharmaceuticals Inc.\nPaddock Labs\nPharmakon\nPharmedium\nPhysicians Total Care Inc.\nPurdue Pharma LP\nQuality Care\nRanbaxy Laboratories\nRoxane Labs\nStat Rx Usa\nTercica Inc.\nUpsher Smith Laboratories\nWatson Pharmaceuticals\nWockhardt Ltd.\nXanodyne Pharmaceuticals Inc.",
                "Dosage Forms": "FormRouteStrengthTabletOral10.000 mgInjectionEpidural; Intrathecal; Intravenous0.5 mg/1mLInjectionEpidural; Intrathecal; Intravenous1 mg/1mLCapsule, coated, extended releaseOral60 mg/1Capsule, extended releaseOral120 mg/1Capsule, extended releaseOral30 mg/1Capsule, extended releaseOral45 mg/1Capsule, extended releaseOral60 mg/1Capsule, extended releaseOral75 mg/1Capsule, extended releaseOral90 mg/1SolutionParenteral2.500 mgTablet, film coatedOralInjectionIntramuscular; Subcutaneous10 mg/mlInjectionIntramuscular; Subcutaneous15 mg/mlInjection, lipid complexEpidural10 mg/1mLInjection, lipid complexEpidural15 mg/1.5mLInjection, lipid complexEpidural20 mg/2mLSyrupOral5 mg / mLCapsule, extended releaseOralSolutionOral0.600 gSolutionIntravenous250.000 mgTabletOral30.00 mgInjection, solutionEpidural; Intrathecal10 mg/1mLInjection, solutionEpidural; Intrathecal25 mg/1mLCapsule, extended releaseOral10 mg/1Capsule, extended releaseOral100 mg/1Capsule, extended releaseOral130 mg/1Capsule, extended releaseOral150 mg/1Capsule, extended releaseOral20 mg/1Capsule, extended releaseOral200 mg/1Capsule, extended releaseOral40 mg/1Capsule, extended releaseOral50 mg/1Capsule, extended releaseOral50 mgCapsule, extended releaseOral70 mg/1Capsule, extended releaseOral80 mg/1Capsule, extended releaseOralCapsuleOral10 mgCapsuleOral20 mgCapsuleOral30 mgCapsuleOral5 mgCapsule, extended releaseOral10 mgCapsule, extended releaseOral100 mgCapsule, extended releaseOral15 mgCapsule, extended releaseOral200 mgCapsule, extended releaseOral30 mgCapsule, extended releaseOral60 mgCapsule, coated pellets10 mgCapsule, coated pellets100 mgCapsule, coated pellets30 mgCapsule, coated pellets60 mgSuppositoryRectal10 mgTabletOral20 mgTabletOral40 mgSyrupOral50 mg / mLTabletOral60 mgInjectionEpidural; Intrathecal200 mg/20mLInjectionEpidural; Intrathecal500 mg/20mLTabletOral15 mgTabletOral30 mgTablet, film coatedOral15 mgSolutionIntramuscular; Intravenous; Subcutaneous0.01 g/mlSolutionIntramuscular; Intravenous; Subcutaneous0.02 g/mlInjectionSolutionOral30 mgInjection, solutionEpidural; Intramuscular; Intravenous; Subcutaneous10 MG/MLInjection, solutionEpidural; Intramuscular; Intravenous; Subcutaneous100 MG/5MLInjection, solutionEpidural; Intramuscular; Intravenous; Subcutaneous100 MG/10MLInjection, solutionEpidural; Intramuscular; Intravenous; Subcutaneous20 MG/MLInjection, solutionEpidural; Intramuscular; Intravenous; Subcutaneous200 MG/10MLInjection, solutionEpidural; Intramuscular; Intravenous; Subcutaneous50 MG/5MLInjection, solutionParenteral10 MG/MLInjection, solutionParenteral100 MG/5MLInjection, solutionParenteral100 MG/10MLInjection, solutionParenteral200 MG/10MLInjection, solutionParenteral50 MG/5MLSolutionEpidural0.01 GSolutionEpidural0.02 GInjection, solutionParenteral20 MG/MLInjection, solutionIntramuscular; Intravenous; SubcutaneousTablet, extended releaseOral20 MGTablet, extended releaseOral45 MGSolutionIntramuscular; Intravenous; Subcutaneous25 mg / mLSolutionIntramuscular; Intravenous; Subcutaneous0.01 grSolutionIntramuscular; Intravenous; Subcutaneous0.02 grSolutionIntramuscular; Intravenous; Subcutaneous50 mg / mLTabletOralSolutionEpidural; Intravenous; Subcutaneous0.5 mg / mLSolutionEpidural; Intravenous; Subcutaneous1 mg / mLInjectionIntramuscular10 mg/0.7mLInjectionIntramuscular; Intravenous; Subcutaneous10 mg/1mLInjectionIntramuscular; Intravenous; Subcutaneous15 mg/1mLInjectionIntramuscular; Intravenous; Subcutaneous5 mg/1mLInjectionIntramuscular; Intravenous; Subcutaneous8 mg/1mLInjectionIntravenous1 mg/1mLInjectionIntravenous1 mg/30mLInjectionIntravenous10 mg/1mLInjectionIntravenous4 mg/1mLInjectionIntravenous8 mg/1mLInjectionParenteral1 mg/1mLInjection, solutionEpidural; Intramuscular; Intrathecal; Intravenous1 mg/1mLInjection, solutionEpidural; Intramuscular; Intrathecal; Intravenous2 mg/1mLInjection, solutionEpidural; Intraspinal; Intrathecal; Intravenous; Subarachnoid0.5 mg/1mLInjection, solutionEpidural; Intraspinal; Intrathecal; Intravenous; Subarachnoid1 mg/1mLInjection, solutionEpidural; Intrathecal; Intravenous0.5 mg/1mLInjection, solutionEpidural; Intrathecal; Intravenous1 mg/1mLInjection, solutionIntramuscular; Intravenous10 mg/1mLInjection, solutionIntramuscular; Intravenous2 mg/1mLInjection, solutionIntramuscular; Intravenous4 mg/1mLInjection, solutionIntramuscular; Intravenous5 mg/1mLInjection, solutionIntramuscular; Intravenous8 mg/1mLInjection, solutionIntrathecal40 mg/1mLInjection, solutionIntrathecal; Intravenous0.5 mg/1mLInjection, solutionIntravenous0.5 mg/1mLInjection, solutionIntravenous1 mg/1mLInjection, solutionIntravenous10 mg/1mLInjection, solutionIntravenous15 mg/1mLInjection, solutionIntravenous2 mg/1mLInjection, solutionIntravenous25 mg/1mLInjection, solutionIntravenous4 mg/1mLInjection, solutionIntravenous5 mg/1mLInjection, solutionIntravenous50 mg/1mLInjection, solutionIntravenous8 mg/1mLInjection, solutionIntravenous; Subcutaneous10 mg/10mLInjection, solutionIntravenous; Subcutaneous30 mg/30mLInjection, solution, concentrateIntravenous25 mg/1mLInjection, solution, concentrateIntravenous50 mg/1mLPowderNot applicable1 g/1gSolutionOral10 mg/5mLSolutionOral10 mg/0.5mLSolutionOral20 mg/5mLSolutionOral20 mg/1mLSolution, concentrateOral100 mg/5mLSolution, concentrateOral20 mg/1mLSuppositoryRectal10 mg/1SuppositoryRectal20 mg/1SuppositoryRectal30 mg/1SuppositoryRectal5 mg/1TabletOral15 mg/1TabletOral30 mg/1Tablet, extended releaseOral100 mg/1Tablet, extended releaseOral15 mg/1Tablet, extended releaseOral200 mg/1Tablet, extended releaseOral30 mg/1Tablet, extended releaseOral60 mg/1Tablet, film coatedOral100 mg/1Tablet, film coatedOral15 mg/1Tablet, film coatedOral200 mg/1Tablet, film coatedOral30 mg/1Tablet, film coatedOral60 mg/1Tablet, film coated, extended releaseOral100 mg/1Tablet, film coated, extended releaseOral15 mg/1Tablet, film coated, extended releaseOral200 mg/1Tablet, film coated, extended releaseOral30 mg/1Tablet, film coated, extended releaseOral60 mg/1TabletOral200 mg/1LiquidIntramuscular; Intravenous; Subcutaneous10 mg / mLLiquidIntramuscular; Intravenous; Subcutaneous15 mg / mLSolutionIntravenous; Subcutaneous1 mg / mLSolutionIntravenous; Subcutaneous2 mg / mLSolutionIntravenous; Subcutaneous5 mg / mLSolutionIntramuscular; Intravenous; Subcutaneous1 mg / mLSolutionIntramuscular; Intravenous; Subcutaneous10 mg / mLSolutionIntramuscular; Intravenous; Subcutaneous15 mg / mLSolutionIntramuscular; Intravenous; Subcutaneous2 mg / mLLiquidIntramuscular; Intravenous; Subcutaneous2 mg / mLSolutionIntravenous1 mg / mLSolutionIntravenous100 mg / 100 mLSolutionIntravenous5 mg / mLSolutionIntravenous50 mg / 50 mLSolutionIntramuscular; Intravenous; Subcutaneous10 mg / 1 mLSolutionIntramuscular; Intravenous; Subcutaneous2 mg / 1 mLSolutionIntramuscular; Intravenous; Subcutaneous4 mg / 1 mLSolutionIntramuscular; Intravenous; Subcutaneous5 mg / 1 mLSolutionIntramuscular; Intravenous; Subcutaneous8 mg / 1 mLSolutionOral100 mg/5mLLiquidIntravenous; Subcutaneous1 mg / mLLiquidIntramuscular; Intravenous; Subcutaneous25 mg / mLLiquidIntramuscular; Intravenous; Subcutaneous50 mg / mLLiquidIntravenous; Subcutaneous2 mg / mLLiquidIntravenous25 mg / mLLiquidIntravenous50 mg / mLLiquidIntravenous1.1 mg / mLInjectionIntramuscular; Intravenous15 mg/1mlInjectionParenteral15 mg/1mlSolutionEpidural0.5 mg / mLSolutionEpidural1 mg / mLInjection, solutionEpidural; Intramuscular; Intrathecal; Intravenous; Subcutaneous10 mgInjectionIntramuscular; Intravenous10 MG/MLInjectionParenteral10 MG/MLGranule, for suspensionOral100 MGGranule, for suspensionOral20 MGGranule, for suspensionOral200 MGGranule, for suspensionOral30 MGGranule, for suspensionOral60 MGTablet, extended releaseOral100 mgTablet, extended releaseOral15 mgTablet, extended releaseOral200 mgTablet, extended releaseOral30 mgTablet, extended releaseOral60 mgSuppository, extended releaseRectal100 mg / supSuppository, extended releaseRectal200 mg / supSuppository, extended releaseRectal30 mg / supSuppository, extended releaseRectal60 mg / supTablet, extended releaseOral5 mg / tabCapsule, extended releaseOral120 mg / srcCapsule, extended releaseOral150 mg / srcCapsule, extended releaseOral200 mg / srcCapsule, extended releaseOral30 mg / srcCapsule, extended releaseOral60 mg / srcCapsule, extended releaseOral90 mg / srcSuppositoryRectal10 mg / supSuppositoryRectal20 mg / supSuppositoryRectal30 mg / supTablet, multilayer, extended releaseOral10 mgTablet, multilayer, extended releaseOral20 mgTablet, multilayer, extended releaseOral30 mgTablet, multilayer, extended releaseOral5 mgGranule, delayed releaseOral100 mgGranule, delayed releaseOral20 mgGranule, delayed releaseOral30 mgGranule, delayed releaseOral60 mgTablet, extended releaseOral10 MGTablet, film coatedOral10 mgTablet, film coatedOral100 mgTablet, film coatedOral30 mgTablet, film coatedOral60 mgTablet, extended releaseOralCapsuleOralTinctureOral10 mg/1mLTinctureOral10 mg / mLSolutionOral1 g/100mLSolutionOral10 mg/1mLSolutionOral10 g/1000mLSolutionOral20 MG/MLSolutionOral30 MG/5MLSyrupOral2 MG/MLSolutionOralSolution / dropsOralTabletOral100 mg/1TabletOral60 mg/1Tablet, extended releaseOral100 mg / tabLiquidOral2 mg/5mLInjectionIntramuscular; IntravenousSyrupOral10 mg / mLSyrupOral20 mg / mLSolution / dropsOral50 mg / mLSolution / dropsOral20 mg / mLSuppositoryRectal20 mgSuppositoryRectal30 mgSuppositoryRectal5 mgSyrupOral1 mg/mlSyrupOral1 mg / mLTabletOral10 mgTabletOral5 mgTabletOral25 mgTabletOral50 mgSolutionEpidural; Intramuscular; Intrathecal; Intravenous; Subcutaneous10 mg/mlInjectionParenteralCapsule, extended releaseOral120 mgCapsule, extended releaseOral20 mgCapsule, extended releaseOral40 mg",
                "Prices": "Unit descriptionCostUnitDepodur 15 mg/1.5 ml vial618.18USD mlRoxanol 20 mg/ml Solution 120ml Bottle95.98USD bottleMorphine Sulfate 20 mg/5ml Solution 500ml Bottle65.05USD bottleApokyn 30 mg/3 ml cartridge52.48USD mlMorphine Sulfate 10 mg/5ml Solution 500ml Bottle38.55USD bottleKadian er 200 mg capsule35.43USD capsuleKadian er 100 mg capsule23.01USD capsuleRoxanol 20 mg/ml Solution 30ml Bottle22.99USD bottleMorphine Sulfate 10 mg/5ml Solution 100ml Bottle21.99USD bottleOramorph sr 60 mg tablet21.76USD tabletMs contin 200 mg tablet21.5USD tabletKadian er 80 mg capsule18.66USD capsuleRoxanol 20 mg/ml Solution 240ml Bottle17.99USD bottleAvinza 90 mg capsule17.56USD capsuleOramorph sr 100 mg tablet17.16USD tabletKadian 100 mg 24 Hour Capsule16.93USD capsuleMS Contin 200 mg 12 Hour tablet16.32USD tabletKadian 100 mg capsule sr16.25USD capsuleKadian er 60 mg capsule14.31USD capsuleAVINza 90 mg 24 Hour Capsule13.21USD capsuleKadian 80 mg capsule sr12.96USD capsuleAvinza 120 mg capsule12.07USD capsuleKadian er 50 mg capsule11.76USD capsuleMs contin 100 mg tablet11.75USD tabletAvinza 60 mg capsule11.58USD capsuleAVINza 120 mg 24 Hour Capsule11.33USD capsuleAvinza 75 mg capsule10.79USD capsuleMorphine sulfate powder10.61USD gAvinza 45 mg capsule10.22USD capsuleKadian 60 mg 24 Hour Capsule9.06USD capsuleMorphine Sulfate CR 200 mg 12 Hour tablet8.97USD tabletMS Contin 100 mg 12 Hour tablet8.89USD tabletMorphine sulf 30 mg suppository8.44USD suppositoryAVINza 60 mg 24 Hour Capsule8.36USD capsuleMs contin 60 mg tablet7.95USD tabletInfumorph 10 mg/ml ampul p-f7.8USD mlKadian 50 mg 24 Hour Capsule7.71USD capsuleKadian er 30 mg capsule7.13USD capsuleOramorph sr 30 mg tablet6.83USD tabletMorphine sulf 20 mg suppository6.71USD suppositoryKadian er 10 mg capsule6.35USD capsuleMorphine sulf 10 mg suppository6.25USD suppositoryAvinza 30 mg capsule6.0USD capsuleMS Contin 60 mg 12 Hour tablet5.71USD tabletKadian er 20 mg capsule5.69USD capsuleMs Contin 200 mg Sustained-Release Tablet5.62USD tabletKadian 30 mg 24 Hour Capsule4.8USD capsuleKadian 20 mg 24 Hour Capsule4.76USD capsuleAVINza 30 mg 24 Hour Capsule4.47USD capsuleMorphine sulf 5 mg suppository4.45USD suppositoryMorphine Sulfate CR 100 mg 12 Hour tablet4.33USD tabletM-Eslon 200 mg Extended-Release Capsule4.3USD capsuleOramorph sr 15 mg tablet4.12USD tabletMs contin cr 30 mg tablet4.09USD tabletKadian 10 mg capsule sr4.05USD capsuleMorphine Hp 50 50 mg/ml4.01USD mlKadian 10 mg 24 Hour Capsule4.0USD capsuleMs contin 15 mg tablet3.58USD tabletMS Contin 30 mg 12 Hour tablet3.26USD tabletNovo-Morphine Sr 200 mg Sustained-Release Tablet3.09USD tabletPms-Morphine Sulfate Sr 200 mg Sustained-Release Tablet3.09USD tabletMs Contin 100 mg Sustained-Release Tablet3.02USD tabletMorphine Sulfate CR 60 mg 12 Hour tablet3.0USD tabletMorphine Hp 25 25 mg/ml2.9USD mlStatex 30 mg Suppository2.55USD suppositoryKadian 100 mg Sustained-Release Capsule2.35USD capsuleStatex 20 mg Suppository2.32USD suppositoryMorphine Lp Epidural 1 mg/ml2.24USD mlM-Eslon 100 mg Extended-Release Capsule2.15USD capsuleMS Contin 15 mg 12 Hour tablet2.13USD tabletMs Contin 60 mg Sustained-Release Tablet1.98USD tabletStatex 10 mg Suppository1.95USD suppositoryMorph sulf 5 mg/0.25 ml vial1.83USD vialStatex 5 mg Suppository1.75USD suppositoryNovo-Morphine Sr 100 mg Sustained-Release Tablet1.66USD tabletPms-Morphine Sulfate Sr 100 mg Sustained-Release Tablet1.66USD tabletMorphine Sulfate CR 30 mg 12 Hour tablet1.63USD tabletMorphine 8 mg/ml ampule1.56USD mlKadian 50 mg Sustained-Release Capsule1.35USD capsuleDuramorph 0.5 mg/ml ampul1.31USD mlAstramorph-pf 1 mg/ml ampul1.15USD mlMs Contin 30 mg Sustained-Release Tablet1.13USD tabletMorphine Lp Epidural 0.5 mg/ml1.12USD mlMorphine Sulfate 15 mg/ml1.03USD mlMorphine Sulfate 10 mg/ml1.02USD mlNovo-Morphine Sr 60 mg Sustained-Release Tablet1.01USD tabletPms-Morphine Sulfate Sr 60 mg Sustained-Release Tablet1.01USD tabletRatio-Morphine Sulfate Sr 60 mg Sustained-Release Tablet1.01USD tabletM-Eslon 60 mg Extended-Release Capsule1.0USD capsuleStatex 50 mg/ml Drops0.99USD mlMorphine Sulfate CR 15 mg 12 Hour tablet0.93USD tabletDuramorph 1 mg/ml ampul0.91USD mlM.O.S.-Sr 60 mg Sustained-Release Tablet0.89USD tabletMorphine 50 mg/25 ml-d5w syr0.86USD mlMorphine-ns 10 mg/ml syringe0.86USD mlMorphine-ns 5 mg/ml syringe0.8USD mlMs Contin 15 mg Sustained-Release Tablet0.75USD tabletMorphine 5 mg/ml vial0.74USD mlKadian 20 mg Sustained-Release Capsule0.73USD capsuleAstramorph-pf 0.5 mg/ml amp0.72USD mlMorphine Sulfate 15 mg tablet0.65USD tabletMorphine Sulfate 30 mg tablet0.65USD tabletMorphine 1 mg/ml vial p-f0.6USD mlMorphine-ns 1 mg/ml syringe0.58USD mlNovo-Morphine Sr 30 mg Sustained-Release Tablet0.57USD tabletPms-Morphine Sulfate Sr 30 mg Sustained-Release Tablet0.57USD tabletRatio-Morphine Sulfate Sr 30 mg Sustained-Release Tablet0.57USD tabletM-Eslon 30 mg Extended-Release Capsule0.56USD capsuleMorphine 0.5 mg/ml vial0.55USD mlMorphine sulfate 50 mg/ml vial0.55USD mlMorphine sulfate ir 30 mg tablet0.55USD tabletRatio-Morphine 20 mg/ml Syrup0.55USD syrupStatex 20 mg/ml Drops0.52USD mlM.O.S.-Sr 30 mg Sustained-Release Tablet0.51USD tabletMorphine 1 mg/ml syringe0.48USD mlMorphine 10 mg/ml vial0.48USD mlMs.Ir 30 mg Tablet0.48USD tabletMorphine sulfate 25 mg/ml vial0.43USD mlMorphine sulf 1 mg/ml vial0.4USD mlM.O.S. Sulfate 50 mg Tablet0.39USD tabletStatex 50 mg Tablet0.39USD tabletKadian 10 mg Sustained-Release Capsule0.38USD capsuleM-Eslon 15 mg Extended-Release Capsule0.38USD capsuleMs.Ir 20 mg Tablet0.38USD tabletNovo-Morphine Sr 15 mg Sustained-Release Tablet0.37USD tabletPms-Morphine Sulfate Sr 15 mg Sustained-Release Tablet0.37USD tabletRatio-Morphine Sulfate Sr 15 mg Sustained-Release Tablet0.37USD tabletM-Eslon 10 mg Extended-Release Capsule0.33USD capsuleMorphine sulfate ir 15 mg tablet0.32USD tabletMorphine 15 mg/ml vial0.3USD mlMorphine-ns 25 mg/25 ml syr0.26USD mlM.O.S. Sulfate 25 mg Tablet0.25USD tabletStatex 25 mg Tablet0.25USD tabletMs.Ir 10 mg Tablet0.21USD tabletRatio-Morphine 10 mg/ml Syrup0.19USD syrupM.O.S. Sulfate 10 mg Tablet0.19USD tabletStatex 10 mg Tablet0.19USD tabletMorphine-ns 5 mg/ml0.16USD mlMorphine-ns 55 mg/55 ml syr0.14USD mlMs.Ir 5 mg Tablet0.14USD tabletM.O.S. Sulfate 5 mg Tablet0.12USD tabletStatex 5 mg Tablet0.12USD tabletMorphine 1 mg/ml-d5w 100 ml0.1USD mlMorphine-ns 150 mg/150 ml0.1USD mlStatex 5 mg/ml Syrup0.08USD mlMorphine 1 mg/ml-d5w 250 ml0.06USD mlRatio-Morphine 5 mg/ml Syrup0.05USD syrupRatio-Morphine 1 mg/ml Syrup0.02USD syrupStatex 1 mg/ml Syrup0.02USD ml  DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.",
                "Patents": "Patent NumberPediatric ExtensionApprovedExpires (estimated)RegionUS5378474No1995-01-032010-03-23USCA2065210No2000-08-292012-04-06CanadaCA2128591No1999-03-232014-07-21CanadaUS6066339No2000-05-232017-11-25USUS5931809No1999-08-032015-07-14USUS5962016No1999-10-052017-01-31USUS6193998No2001-02-272016-09-01USUS5997899No1999-12-072016-09-01USUS6241999No2001-06-052016-09-01USUS5807572No1998-09-152015-09-15USUS5891467No1999-04-062017-01-31USUS6171613No2001-01-092016-10-01USUS8685443No2014-04-012025-07-03USUS8158156No2012-04-172027-06-19USUS7682633No2010-03-232027-06-19USUS8623418No2014-01-072029-11-07USUS8685444No2014-04-012025-07-03USUS8846104No2014-09-302027-06-19USUS7815934No2010-10-192027-12-12USUS7682634No2010-03-232027-06-19USUS8877247No2014-11-042027-06-19USUS9192608No2015-11-242034-03-12USUS9072781No2015-07-072034-03-12USUS9248229No2016-02-022034-03-12USUS7955619No2011-06-072028-08-12USUS9044402No2015-06-022033-07-01USUS9549899No2017-01-242033-07-01USUS10314788No2019-06-112028-08-12US"
            },
            "Properties": {
                "State": "Solid",
                "Experimental Properties": "PropertyValueSourcemelting point (\u00b0C)255 \u00b0CMSDSboiling point (\u00b0C)190\u00baCLide DR. CRC Handbook of Chemistry. 2004 water solubility149 mg/L (at 20 \u00b0C)MSDSlogP0.87Agilent Technology. LC/MS/MS Analysis of Opiates. pKa8.21 (at 25 \u00b0C)Agilent Technology. LC/MS/MS Analysis of Opiates.",
                "Predicted Properties": "PropertyValueSourceWater Solubility10.2 mg/mLALOGPSlogP0.99ALOGPSlogP0.9ChemaxonlogS-1.4ALOGPSpKa (Strongest Acidic)10.26ChemaxonpKa (Strongest Basic)9.12ChemaxonPhysiological Charge1ChemaxonHydrogen Acceptor Count4ChemaxonHydrogen Donor Count2ChemaxonPolar Surface Area52.93 \u00c52ChemaxonRotatable Bond Count0ChemaxonRefractivity80.12 m3\u00b7mol-1ChemaxonPolarizability29.94 \u00c53ChemaxonNumber of Rings5ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxon",
                "Predicted ADMET Features": "PropertyValueProbabilityHuman Intestinal Absorption+0.9971Blood Brain Barrier+0.9882Caco-2 permeable+0.8867P-glycoprotein substrateSubstrate0.8787P-glycoprotein inhibitor INon-inhibitor0.8782P-glycoprotein inhibitor IINon-inhibitor0.956Renal organic cation transporterInhibitor0.6221CYP450 2C9 substrateNon-substrate0.7451CYP450 2D6 substrateSubstrate0.8919CYP450 3A4 substrateSubstrate0.7375CYP450 1A2 substrateNon-inhibitor0.5191CYP450 2C9 inhibitorNon-inhibitor0.9046CYP450 2D6 inhibitorNon-inhibitor0.647CYP450 2C19 inhibitorNon-inhibitor0.8155CYP450 3A4 inhibitorNon-inhibitor0.9176CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.7503Ames testNon AMES toxic0.9132CarcinogenicityNon-carcinogens0.9634BiodegradationNot ready biodegradable0.9944Rat acute toxicity2.8989 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.8367hERG inhibition (predictor II)Non-inhibitor0.874  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)"
            },
            "Spectra": {
                "Mass Spec (NIST)": "Download (9.42 KB)",
                "Spectra": "SpectrumSpectrum TypeSplash KeyPredicted GC-MS Spectrum - GC-MSPredicted GC-MSNot AvailableGC-MS Spectrum - EI-BGC-MSsplash10-00li-8970000000-28acaf307ce4bc5aabf1GC-MS Spectrum - CI-BGC-MSsplash10-014i-0090000000-b9cf42b077ae0fa5b50dPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableLC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-000i-0090000000-98125212ed8e73f219e1LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-000i-0090000000-e9f7be236d827a716c1bLC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-000i-0290000000-5066e10cd96a2c376676LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0kui-0930000000-793deeb91de6d2459cbeLC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-100r-0900000000-f775c77035946f746daaLC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0ufr-0390000000-660ff44516f98e346016LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-000i-0090000000-22857c8ef81e65ad6bd3LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-000i-0090000000-c5194c99a9e7f30ea0c8LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-000i-0090000000-1980ff8ab9e654f16fe1LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-000i-0690000000-efa51d970eaf96d3b982LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0pc9-0920000000-64a693f2f51c03129c94LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-100r-0900000000-49174c3db4b1c1847080LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-000i-0090000000-3cc8784093ef460d3030LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-000i-0090000000-4bc885836f18b77696f3LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-000i-0090000000-4a16648c3e86669f2446LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-000i-0690000000-f41b2f804790e9ad8f1dLC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0pc9-0920000000-69393fc6563baf39d91fLC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-100r-0900000000-467f39309be5edfa4c01LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0ufr-0390000000-bd9670761ff2a7dafc55"
            },
            "Interested in using DrugBank in a commercial product or application?": {},
            "Stay up-to-date with the latest from DrugBank!": {},
            "Thank you for subscribing!": {}
        },
        "Additional Information": {
            "targets": [
                {
                    "Label": "Mu-type opioid receptor",
                    "Detailed Info": {
                        "Name": "Mu-type opioid receptor",
                        "Synonyms": "hMOP\nM-OR-1\nMOP\nMOR1\nMu opiate receptor\nMu opioid receptor",
                        "Gene Name": "OPRM1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0001536|Mu-type opioid receptor\nMDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCP\nPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALAT\nSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDF\nRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFI\nFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHI\nYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNI\nEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP",
                        "Number of residues": "400",
                        "Molecular Weight": "44778.855",
                        "Theoretical pI": "8.29",
                        "GO Classification": "Functionsbeta-endorphin receptor activity / G-protein alpha-subunit binding / G-protein beta-subunit binding / G-protein coupled receptor activity / morphine receptor activity / neuropeptide binding / voltage-gated calcium channel activityProcessesadenylate cyclase-activating dopamine receptor signaling pathway / adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway / behavioral response to ethanol / calcium ion transmembrane transport / cellular response to morphine / cellular response to stress / G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger / locomotory behavior / negative regulation of adenylate cyclase activity / negative regulation of cAMP-mediated signaling / negative regulation of cell proliferation / negative regulation of cytosolic calcium ion concentration / negative regulation of nitric oxide biosynthetic process / negative regulation of Wnt protein secretion / neuropeptide signaling pathway / opioid receptor signaling pathway / phospholipase C-activating G-protein coupled receptor signaling pathway / positive regulation of cAMP-mediated signaling / positive regulation of cytosolic calcium ion concentration / positive regulation of ERK1 and ERK2 cascade / positive regulation of neurogenesis / positive regulation of nitric oxide biosynthetic process / regulation of N-methyl-D-aspartate selective glutamate receptor activity / sensory perception / sensory perception of pain / synaptic transmissionComponentscytosol / endoplasmic reticulum / Golgi apparatus / integral component of plasma membrane / neuron projection / plasma membrane",
                        "General Function": "Voltage-gated calcium channel activity",
                        "Specific Function": "Receptor for endogenous opioids such as beta-endorphin and endomorphin. Receptor for natural and synthetic opioids including morphine, heroin, DAMGO, fentanyl, etorphine, buprenorphin and methadone. Agonist binding to the receptor induces coupling to an inactive GDP-bound heterotrimeric G-protein complex and subsequent exchange of GDP for GTP in the G-protein alpha subunit leading to dissociation of the G-protein complex with the free GTP-bound G-protein alpha and the G-protein beta-gamma dimer activating downstream cellular effectors. The agonist- and cell type-specific activity is predominantly coupled to pertussis toxin-sensitive G(i) and G(o) G alpha proteins, GNAI1, GNAI2, GNAI3 and GNAO1 isoforms Alpha-1 and Alpha-2, and to a lesser extend to pertussis toxin-insensitive G alpha proteins GNAZ and GNA15. They mediate an array of downstream cellular responses, including inhibition of adenylate cyclase activity and both N-type and L-type calcium channels, activation of inward rectifying potassium channels, mitogen-activated protein kinase (MAPK), phospholipase C (PLC), phosphoinositide/protein kinase (PKC), phosphoinositide 3-kinase (PI3K) and regulation of NF-kappa-B. Also couples to adenylate cyclase stimulatory G alpha proteins. The selective temporal coupling to G-proteins and subsequent signaling can be regulated by RGSZ proteins, such as RGS9, RGS17 and RGS4. Phosphorylation by members of the GPRK subfamily of Ser/Thr protein kinases and association with beta-arrestins is involved in short-term receptor desensitization. Beta-arrestins associate with the GPRK-phosphorylated receptor and uncouple it from the G-protein thus terminating signal transduction. The phosphorylated receptor is internalized through endocytosis via clathrin-coated pits which involves beta-arrestins. The activation of the ERK pathway occurs either in a G-protein-dependent or a beta-arrestin-dependent manner and is regulated by agonist-specific receptor phosphorylation. Acts as a class A G-protein coupled receptor (GPCR) which dissociates from beta-arrestin at or near the plasma membrane and undergoes rapid recycling. Receptor down-regulation pathways are varying with the agonist and occur dependent or independent of G-protein coupling. Endogenous ligands induce rapid desensitization, endocytosis and recycling whereas morphine induces only low desensitization and endocytosis. Heterooligomerization with other GPCRs can modulate agonist binding, signaling and trafficking properties. Involved in neurogenesis. Isoform 12 couples to GNAS and is proposed to be involved in excitatory effects. Isoform 16 and isoform 17 do not bind agonists but may act through oligomerization with binding-competent OPRM1 isoforms and reduce their ligand binding activity.",
                        "Pfam Domain Function": "7tm_1 (PF00001)",
                        "Transmembrane Regions": "69-93\n107-131\n143-165\n186-207\n231-255\n284-307\n315-338",
                        "Cellular Location": "Cell membrane",
                        "Gene sequence": ">lcl|BSEQ0021649|Mu-type opioid receptor (OPRM1)\nATGGACAGCAGCGCTGCCCCCACGAACGCCAGCAATTGCACTGATGCCTTGGCGTACTCA\nAGTTGCTCCCCAGCACCCAGCCCCGGTTCCTGGGTCAACTTGTCCCACTTAGATGGCAAC\nCTGTCCGACCCATGCGGTCCGAACCGCACCGACCTGGGCGGGAGAGACAGCCTGTGCCCT\nCCGACCGGCAGTCCCTCCATGATCACGGCCATCACGATCATGGCCCTCTACTCCATCGTG\nTGCGTGGTGGGGCTCTTCGGAAACTTCCTGGTCATGTATGTGATTGTCAGATACACCAAG\nATGAAGACTGCCACCAACATCTACATTTTCAACCTTGCTCTGGCAGATGCCTTAGCCACC\nAGTACCCTGCCCTTCCAGAGTGTGAATTACCTAATGGGAACATGGCCATTTGGAACCATC\nCTTTGCAAGATAGTGATCTCCATAGATTACTATAACATGTTCACCAGCATATTCACCCTC\nTGCACCATGAGTGTTGATCGATACATTGCAGTCTGCCACCCTGTCAAGGCCTTAGATTTC\nCGTACTCCCCGAAATGCCAAAATTATCAATGTCTGCAACTGGATCCTCTCTTCAGCCATT\nGGTCTTCCTGTAATGTTCATGGCTACAACAAAATACAGGCAAGGTTCCATAGATTGTACA\nCTAACATTCTCTCATCCAACCTGGTACTGGGAAAACCTGCTGAAGATCTGTGTTTTCATC\nTTCGCCTTCATTATGCCAGTGCTCATCATTACCGTGTGCTATGGACTGATGATCTTGCGC\nCTCAAGAGTGTCCGCATGCTCTCTGGCTCCAAAGAAAAGGACAGGAATCTTCGAAGGATC\nACCAGGATGGTGCTGGTGGTGGTGGCTGTGTTCATCGTCTGCTGGACTCCCATTCACATT\nTACGTCATCATTAAAGCCTTGGTTACAATCCCAGAAACTACGTTCCAGACTGTTTCTTGG\nCACTTCTGCATTGCTCTAGGTTACACAAACAGCTGCCTCAACCCAGTCCTTTATGCATTT\nCTGGATGAAAACTTCAAACGATGCTTCAGAGAGTTCTGTATCCCAACCTCTTCCAACATT\nGAGCAACAAAACTCCACTCGAATTCGTCAGAACACTAGAGACCACCCCTCCACGGCCAAT\nACAGTGGATAGAACTAATCATCAGCTAGAAAATCTGGAAGCAGAAACTGCTCCGTTGCCC\nTAA",
                        "Chromosome Location": "6",
                        "Locus": "6q24-q25",
                        "External Identifiers": "ResourceLinkUniProtKB IDP35372UniProtKB Entry NameOPRM_HUMANGenBank Protein ID452073GenBank Gene IDL25119GenAtlas IDOPRM1HGNC IDHGNC:8156",
                        "General References": "Wang JB, Johnson PS, Persico AM, Hawkins AL, Griffin CA, Uhl GR: Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. FEBS Lett. 1994 Jan 31;338(2):217-22. [Article] Bare LA, Mansson E, Yang D: Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain. FEBS Lett. 1994 Nov 7;354(2):213-6. [Article] Mestek A, Hurley JH, Bye LS, Campbell AD, Chen Y, Tian M, Liu J, Schulman H, Yu L: The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. J Neurosci. 1995 Mar;15(3 Pt 2):2396-406. [Article] Pan YX, Xu J, Mahurter L, Xu M, Gilbert AK, Pasternak GW: Identification and characterization of two new human mu opioid receptor splice variants, hMOR-1O and hMOR-1X. Biochem Biophys Res Commun. 2003 Feb 21;301(4):1057-61. [Article] Cadet P, Mantione KJ, Stefano GB: Molecular identification and functional expression of mu 3, a novel alternatively spliced variant of the human mu opiate receptor gene. J Immunol. 2003 May 15;170(10):5118-23. [Article] Pan L, Xu J, Yu R, Xu MM, Pan YX, Pasternak GW: Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene, Oprm. Neuroscience. 2005;133(1):209-20. [Article] Xu J, Xu M, Hurd YL, Pasternak GW, Pan YX: Isolation and characterization of new exon 11-associated N-terminal splice variants of the human mu opioid receptor gene. J Neurochem. 2009 Feb;108(4):962-72. doi: 10.1111/j.1471-4159.2008.05833.x. Epub 2008 Dec 10. [Article] Shabalina SA, Zaykin DV, Gris P, Ogurtsov AY, Gauthier J, Shibata K, Tchivileva IE, Belfer I, Mishra B, Kiselycznyk C, Wallace MR, Staud R, Spiridonov NA, Max MB, Goldman D, Fillingim RB, Maixner W, Diatchenko L: Expansion of the human mu-opioid receptor gene architecture: novel functional variants. Hum Mol Genet. 2009 Mar 15;18(6):1037-51. doi: 10.1093/hmg/ddn439. Epub 2008 Dec 22. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Mungall AJ, Palmer SA, Sims SK, Edwards CA, Ashurst JL, Wilming L, Jones MC, Horton R, Hunt SE, Scott CE, Gilbert JG, Clamp ME, Bethel G, Milne S, Ainscough R, Almeida JP, Ambrose KD, Andrews TD, Ashwell RI, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Barker DJ, Barlow KF, Bates K, Beare DM, Beasley H, Beasley O, Bird CP, Blakey S, Bray-Allen S, Brook J, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Carder C, Carter NP, Chapman JC, Clark SY, Clark G, Clee CM, Clegg S, Cobley V, Collier RE, Collins JE, Colman LK, Corby NR, Coville GJ, Culley KM, Dhami P, Davies J, Dunn M, Earthrowl ME, Ellington AE, Evans KA, Faulkner L, Francis MD, Frankish A, Frankland J, French L, Garner P, Garnett J, Ghori MJ, Gilby LM, Gillson CJ, Glithero RJ, Grafham DV, Grant M, Gribble S, Griffiths C, Griffiths M, Hall R, Halls KS, Hammond S, Harley JL, Hart EA, Heath PD, Heathcott R, Holmes SJ, Howden PJ, Howe KL, Howell GR, Huckle E, Humphray SJ, Humphries MD, Hunt AR, Johnson CM, Joy AA, Kay M, Keenan SJ, Kimberley AM, King A, Laird GK, Langford C, Lawlor S, Leongamornlert DA, Leversha M, Lloyd CR, Lloyd DM, Loveland JE, Lovell J, Martin S, Mashreghi-Mohammadi M, Maslen GL, Matthews L, McCann OT, McLaren SJ, McLay K, McMurray A, Moore MJ, Mullikin JC, Niblett D, Nickerson T, Novik KL, Oliver K, Overton-Larty EK, Parker A, Patel R, Pearce AV, Peck AI, Phillimore B, Phillips S, Plumb RW, Porter KM, Ramsey Y, Ranby SA, Rice CM, Ross MT, Searle SM, Sehra HK, Sheridan E, Skuce CD, Smith S, Smith M, Spraggon L, Squares SL, Steward CA, Sycamore N, Tamlyn-Hall G, Tester J, Theaker AJ, Thomas DW, Thorpe A, Tracey A, Tromans A, Tubby B, Wall M, Wallis JM, West AP, White SS, Whitehead SL, Whittaker H, Wild A, Willey DJ, Wilmer TE, Wood JM, Wray PW, Wyatt JC, Young L, Younger RM, Bentley DR, Coulson A, Durbin R, Hubbard T, Sulston JE, Dunham I, Rogers J, Beck S: The DNA sequence and analysis of human chromosome 6. Nature. 2003 Oct 23;425(6960):805-11. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Uhl GR, Sora I, Wang Z: The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses. Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7752-5. [Article] Chuang TK, Killam KF Jr, Chuang LF, Kung HF, Sheng WS, Chao CC, Yu L, Chuang RY: Mu opioid receptor gene expression in immune cells. Biochem Biophys Res Commun. 1995 Nov 22;216(3):922-30. [Article] Koch T, Brandenburg LO, Schulz S, Liang Y, Klein J, Hollt V: ADP-ribosylation factor-dependent phospholipase D2 activation is required for agonist-induced mu-opioid receptor endocytosis. J Biol Chem. 2003 Mar 14;278(11):9979-85. Epub 2003 Jan 7. [Article] Zhang P, Johnson PS, Zollner C, Wang W, Wang Z, Montes AE, Seidleck BK, Blaschak CJ, Surratt CK: Mutation of human mu opioid receptor extracellular \"disulfide cysteine\" residues alters ligand binding but does not prevent receptor targeting to the cell plasma membrane. Brain Res Mol Brain Res. 1999 Oct 1;72(2):195-204. [Article] Wang D, Sadee W, Quillan JM: Calmodulin binding to G protein-coupling domain of opioid receptors. J Biol Chem. 1999 Jul 30;274(31):22081-8. [Article] Law PY, Wong YH, Loh HH: Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol. 2000;40:389-430. [Article] Wang D, Surratt CK, Sadee W: Calmodulin regulation of basal and agonist-stimulated G protein coupling by the mu-opioid receptor (OP(3)) in morphine-pretreated cell. J Neurochem. 2000 Aug;75(2):763-71. [Article] Suzuki S, Chuang LF, Yau P, Doi RH, Chuang RY: Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells. Exp Cell Res. 2002 Nov 1;280(2):192-200. [Article] Massotte D, Brillet K, Kieffer B, Milligan G: Agonists activate Gi1 alpha or Gi2 alpha fused to the human mu opioid receptor differently. J Neurochem. 2002 Jun;81(6):1372-82. [Article] Feng GJ, Kellett E, Scorer CA, Wilde J, White JH, Milligan G: Selective interactions between helix VIII of the human mu-opioid receptors and the C terminus of periplakin disrupt G protein activation. J Biol Chem. 2003 Aug 29;278(35):33400-7. Epub 2003 Jun 16. [Article] Onoprishvili I, Andria ML, Kramer HK, Ancevska-Taneva N, Hiller JM, Simon EJ: Interaction between the mu opioid receptor and filamin A is involved in receptor regulation and trafficking. Mol Pharmacol. 2003 Nov;64(5):1092-100. [Article] Wang D, Sun X, Bohn LM, Sadee W: Opioid receptor homo- and heterodimerization in living cells by quantitative bioluminescence resonance energy transfer. Mol Pharmacol. 2005 Jun;67(6):2173-84. Epub 2005 Mar 18. [Article] Pascal G, Milligan G: Functional complementation and the analysis of opioid receptor homodimerization. Mol Pharmacol. 2005 Sep;68(3):905-15. Epub 2005 Jun 20. [Article] Choi HS, Kim CS, Hwang CK, Song KY, Wang W, Qiu Y, Law PY, Wei LN, Loh HH: The opioid ligand binding of human mu-opioid receptor is modulated by novel splice variants of the receptor. Biochem Biophys Res Commun. 2006 May 19;343(4):1132-40. Epub 2006 Mar 23. [Article] Ancevska-Taneva N, Onoprishvili I, Andria ML, Hiller JM, Simon EJ: A member of the heat shock protein 40 family, hlj1, binds to the carboxyl tail of the human mu opioid receptor. Brain Res. 2006 Apr 7;1081(1):28-33. Epub 2006 Mar 20. [Article] Roumy M, Lorenzo C, Mazeres S, Bouchet S, Zajac JM, Mollereau C: Physical association between neuropeptide FF and micro-opioid receptors as a possible molecular basis for anti-opioid activity. J Biol Chem. 2007 Mar 16;282(11):8332-42. Epub 2007 Jan 15. [Article] Lopez A, Salome L: Membrane functional organisation and dynamic of mu-opioid receptors. Cell Mol Life Sci. 2009 Jul;66(13):2093-108. doi: 10.1007/s00018-009-0008-4. Epub 2009 Mar 20. [Article] Talbot JN, Skifter DA, Bianchi E, Monaghan DT, Toews ML, Murrin LC: Regulation of mu opioid receptor internalization by the scaffold protein RanBPM. Neurosci Lett. 2009 Dec 11;466(3):154-8. doi: 10.1016/j.neulet.2009.09.048. Epub 2009 Sep 27. [Article] Jin J, Kittanakom S, Wong V, Reyes BA, Van Bockstaele EJ, Stagljar I, Berrettini W, Levenson R: Interaction of the mu-opioid receptor with GPR177 (Wntless) inhibits Wnt secretion: potential implications for opioid dependence. BMC Neurosci. 2010 Mar 9;11:33. doi: 10.1186/1471-2202-11-33. [Article] Gris P, Gauthier J, Cheng P, Gibson DG, Gris D, Laur O, Pierson J, Wentworth S, Nackley AG, Maixner W, Diatchenko L: A novel alternatively spliced isoform of the mu-opioid receptor: functional antagonism. Mol Pain. 2010 Jun 2;6:33. doi: 10.1186/1744-8069-6-33. [Article] Bergen AW, Kokoszka J, Peterson R, Long JC, Virkkunen M, Linnoila M, Goldman D: Mu opioid receptor gene variants: lack of association with alcohol dependence. Mol Psychiatry. 1997 Oct-Nov;2(6):490-4. [Article] Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L, Gong J, Schluger J, Strong JA, Leal SM, Tischfield JA, Kreek MJ, Yu L: Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9608-13. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00193Tramadolapproved, investigationalyesagonistDetailsDB00295Morphineapproved, investigationalyesagonistregulatorDetailsDB00318Codeineapproved, illicityesagonistregulatorDetailsDB00327Hydromorphoneapproved, illicityesagonistDetailsDB00504Levallorphanapprovedyespartial agonistDetailsDB00647Dextropropoxypheneapproved, illicit, investigational, withdrawnyesagonistDetailsDB00652Pentazocineapproved, vet_approvedyesantagonistDetailsDB00704Naltrexoneapproved, investigational, vet_approvedyesantagonistDetailsDB00708Sufentanilapproved, investigationalyesagonistDetailsDB00802Alfentanilapproved, illicityesagonistDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedyesagonistDetailsDB00854LevorphanolapprovedyesagonistDetailsDB00899RemifentanilapprovedyesagonistDetailsDB00913Anileridineapproved, illicityesagonistDetailsDB00956Hydrocodoneapproved, illicit, investigationalyesagonistDetailsDB01081Diphenoxylateapproved, illicityesagonistDetailsDB01183Naloxoneapproved, vet_approvedyesantagonistDetailsDB01192Oxymorphoneapproved, investigational, vet_approvedyesagonistDetailsDB01209Dezocineapproved, investigationalyesagonistDetailsDB01227Levacetylmethadolapproved, investigational, withdrawnyesagonistDetailsDB00333MethadoneapprovedyesagonistDetailsDB00611Butorphanolapproved, illicit, vet_approvedyesantagonistDetailsDB00836LoperamideapprovedyesagonistDetailsDB00844NalbuphineapprovedyesantagonistDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedyespartial agonistDetailsDB01497Etorphineillicit, vet_approvedyesagonistDetailsDB01535Carfentanilillicit, investigational, vet_approvedyesagonistDetailsDB014393-Methylthiofentanylexperimental, illicityesagonistDetailsDB01444Dimethylthiambuteneexperimental, illicityesagonistDetailsDB01452Diamorphineapproved, illicit, investigationalyesagonistDetailsDB015713-MethylfentanylillicityesagonistDetailsDB05046V1003investigationalunknownDetailsDB01433Methadyl acetateexperimental, illicityesagonistDetailsDB00497Oxycodoneapproved, illicit, investigationalyesagonistDetailsDB05492Epicept NP-1investigationalunknownDetailsDB05509LI-301investigationalunknownDetailsDB06204TapentadolapprovedunknownagonistDetailsDB06230Nalmefeneapproved, investigational, withdrawnyesantagonistDetailsDB06409Morphine glucuronideinvestigationalunknownDetailsDB06274Alvimopanapproved, investigationalyesantagonistDetailsDB01466Ethylmorphineexperimental, illicityesagonistDetailsDB01565Dihydromorphineexperimental, illicityesagonistDetailsDB01548Diprenorphineillicit, vet_approvedyesantagonistDetailsDB00904Ondansetronapproved, withdrawnunknownother/unknownDetailsDB06800MethylnaltrexoneapprovedyesantagonistDetailsDB06738KetobemidoneinvestigationalyesagonistDetailsDB00514DextromethorphanapprovedunknownagonistregulatorDetailsDB00454MeperidineapprovedunknownagonistDetailsDB00321AmitriptylineapprovedunknownbinderDetailsDB01221Ketamineapproved, vet_approvedunknownbinderDetailsDB09049NaloxegolapprovedyesantagonistDetailsDB09272Eluxadolineapproved, investigationalyesagonistDetailsDB09089TrimebutineapprovedyesagonistDetailsDB11691Naldemedineapproved, investigationalyesantagonistDetailsDB09061Cannabidiolapproved, investigationalunknownDetailsDB09209Pholcodineapproved, illicityesantagonistDetailsDB11130Opiumapproved, illicityesagonistDetailsDB14011NabiximolsinvestigationalunknownDetailsDB14009Medical Cannabisexperimental, investigationalunknownDetailsDB11186Pentoxyverineapproved, investigational, withdrawnunknownantagonistDetailsDB09289TianeptineinvestigationalyesagonistDetailsDB14146LoxicodegolinvestigationalyesagonistDetailsDB09173ButyrfentanylillicityesagonistDetailsDB01238Aripiprazoleapproved, investigationalunknownligandDetailsDB12668MetenkefalininvestigationalunknownagonistDetailsDB14881Oliceridineapproved, investigationalyesagonistDetailsDB06288Amisulprideapproved, investigationalnoagonistDetailsDB12543Samidorphanapproved, investigationalyesantagonistDetails"
                    }
                },
                {
                    "Label": "Kappa-type opioid receptor",
                    "Detailed Info": {
                        "Name": "Kappa-type opioid receptor",
                        "Synonyms": "K-OR-1\nOPRK",
                        "Gene Name": "OPRK1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0001260|Kappa-type opioid receptor\nMDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPV\nIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYL\nMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINI\nCIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVL\nIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALG\nSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRV\nRNTVQDPAYLRDIDGMNKPV",
                        "Number of residues": "380",
                        "Molecular Weight": "42644.665",
                        "Theoretical pI": "7.79",
                        "GO Classification": "Functionsdynorphin receptor activity / neuropeptide binding / opioid receptor activityProcessesadenylate cyclase-inhibiting G-protein coupled receptor signaling pathway / adenylate cyclase-inhibiting opioid receptor signaling pathway / behavior / behavioral response to cocaine / cellular response to lipopolysaccharide / defense response to virus / eating behavior / estrous cycle / immune response / locomotory behavior / maternal behavior / negative regulation of luteinizing hormone secretion / neuropeptide signaling pathway / opioid receptor signaling pathway / phospholipase C-activating G-protein coupled receptor signaling pathway / positive regulation of dopamine secretion / positive regulation of locomotion / positive regulation of p38MAPK cascade / positive regulation of potassium ion transmembrane transport / regulation of aerobic respiration / regulation of energy homeostasis / regulation of saliva secretion / regulation of sensory perception of pain / response to acrylamide / response to estrogen / response to ethanol / response to insulin / response to morphine / response to radiation / sensory perception / sensory perception of pain / sensory perception of temperature stimulus / synaptic transmissionComponentsaxon terminus / dendrite / integral component of membrane / integral component of plasma membrane / neuron projection / perikaryon / plasma membrane / synapse",
                        "General Function": "Opioid receptor activity",
                        "Specific Function": "G-protein coupled opioid receptor that functions as receptor for endogenous alpha-neoendorphins and dynorphins, but has low affinity for beta-endorphins. Also functions as receptor for various synthetic opioids and for the psychoactive diterpene salvinorin A. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Plays a role in the perception of pain. Plays a role in mediating reduced physical activity upon treatment with synthetic opioids. Plays a role in the regulation of salivation in response to synthetic opioids. May play a role in arousal and regulation of autonomic and neuroendocrine functions.",
                        "Pfam Domain Function": "7tm_1 (PF00001)",
                        "Transmembrane Regions": "58-85\n96-119\n133-154\n174-196\n223-247\n275-296\n312-333",
                        "Cellular Location": "Cell membrane",
                        "Gene sequence": ">lcl|BSEQ0021645|Kappa-type opioid receptor (OPRK1)\nATGGACTCCCCGATCCAGATCTTCCGCGGGGAGCCGGGCCCTACCTGCGCCCCGAGCGCC\nTGCCTGCCCCCCAACAGCAGCGCCTGGTTTCCCGGCTGGGCCGAGCCCGACAGCAACGGC\nAGCGCCGGCTCGGAGGACGCGCAGCTGGAGCCCGCGCACATCTCCCCGGCCATCCCGGTC\nATCATCACGGCGGTCTACTCCGTAGTGTTCGTCGTGGGCTTGGTGGGCAACTCGCTGGTC\nATGTTCGTGATCATCCGATACACAAAGATGAAGACAGCAACCAACATTTACATATTTAAC\nCTGGCTTTGGCAGATGCTTTAGTTACTACAACCATGCCCTTTCAGAGTACGGTCTACTTG\nATGAATTCCTGGCCTTTTGGGGATGTGCTGTGCAAGATAGTAATTTCCATTGATTACTAC\nAACATGTTCACCAGCATCTTCACCTTGACCATGATGAGCGTGGACCGCTACATTGCCGTG\nTGCCACCCCGTGAAGGCTTTGGACTTCCGCACACCCTTGAAGGCAAAGATCATCAATATC\nTGCATCTGGCTGCTGTCGTCATCTGTTGGCATCTCTGCAATAGTCCTTGGAGGCACCAAA\nGTCAGGGAAGACGTCGATGTCATTGAGTGCTCCTTGCAGTTCCCAGATGATGACTACTCC\nTGGTGGGACCTCTTCATGAAGATCTGCGTCTTCATCTTTGCCTTCGTGATCCCTGTCCTC\nATCATCATCGTCTGCTACACCCTGATGATCCTGCGTCTCAAGAGCGTCCGGCTCCTTTCT\nGGCTCCCGAGAGAAAGATCGCAACCTGCGTAGGATCACCAGACTGGTCCTGGTGGTGGTG\nGCAGTCTTCGTCGTCTGCTGGACTCCCATTCACATATTCATCCTGGTGGAGGCTCTGGGG\nAGCACCTCCCACAGCACAGCTGCTCTCTCCAGCTATTACTTCTGCATCGCCTTAGGCTAT\nACCAACAGTAGCCTGAATCCCATTCTCTACGCCTTTCTTGATGAAAACTTCAAGCGGTGT\nTTCCGGGACTTCTGCTTTCCACTGAAGATGAGGATGGAGCGGCAGAGCACTAGCAGAGTC\nCGAAATACAGTTCAGGATCCTGCTTACCTGAGGGACATCGATGGGATGAATAAACCAGTA\nTGA",
                        "Chromosome Location": "8",
                        "Locus": "8q11.2",
                        "External Identifiers": "ResourceLinkUniProtKB IDP41145UniProtKB Entry NameOPRK_HUMANGenBank Protein ID532060GenBank Gene IDU11053GenAtlas IDOPRK1HGNC IDHGNC:8154",
                        "General References": "Mansson E, Bare L, Yang D: Isolation of a human kappa opioid receptor cDNA from placenta. Biochem Biophys Res Commun. 1994 Aug 15;202(3):1431-7. [Article] Simonin F, Gaveriaux-Ruff C, Befort K, Matthes H, Lannes B, Micheletti G, Mattei MG, Charron G, Bloch B, Kieffer B: kappa-Opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system. Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):7006-10. [Article] Zhu J, Chen C, Xue JC, Kunapuli S, DeRiel JK, Liu-Chen LY: Cloning of a human kappa opioid receptor from the brain. Life Sci. 1995;56(9):PL201-7. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Nusbaum C, Mikkelsen TS, Zody MC, Asakawa S, Taudien S, Garber M, Kodira CD, Schueler MG, Shimizu A, Whittaker CA, Chang JL, Cuomo CA, Dewar K, FitzGerald MG, Yang X, Allen NR, Anderson S, Asakawa T, Blechschmidt K, Bloom T, Borowsky ML, Butler J, Cook A, Corum B, DeArellano K, DeCaprio D, Dooley KT, Dorris L 3rd, Engels R, Glockner G, Hafez N, Hagopian DS, Hall JL, Ishikawa SK, Jaffe DB, Kamat A, Kudoh J, Lehmann R, Lokitsang T, Macdonald P, Major JE, Matthews CD, Mauceli E, Menzel U, Mihalev AH, Minoshima S, Murayama Y, Naylor JW, Nicol R, Nguyen C, O'Leary SB, O'Neill K, Parker SC, Polley A, Raymond CK, Reichwald K, Rodriguez J, Sasaki T, Schilhabel M, Siddiqui R, Smith CL, Sneddon TP, Talamas JA, Tenzin P, Topham K, Venkataraman V, Wen G, Yamazaki S, Young SK, Zeng Q, Zimmer AR, Rosenthal A, Birren BW, Platzer M, Shimizu N, Lander ES: DNA sequence and analysis of human chromosome 8. Nature. 2006 Jan 19;439(7074):331-5. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Wang JB, Johnson PS, Wu JM, Wang WF, Uhl GR: Human kappa opiate receptor second extracellular loop elevates dynorphin's affinity for human mu/kappa chimeras. J Biol Chem. 1994 Oct 21;269(42):25966-9. [Article] Li JG, Chen C, Liu-Chen LY: Ezrin-radixin-moesin-binding phosphoprotein-50/Na+/H+ exchanger regulatory factor (EBP50/NHERF) blocks U50,488H-induced down-regulation of the human kappa opioid receptor by enhancing its recycling rate. J Biol Chem. 2002 Jul 26;277(30):27545-52. Epub 2002 May 9. [Article] Chen C, Li JG, Chen Y, Huang P, Wang Y, Liu-Chen LY: GEC1 interacts with the kappa opioid receptor and enhances expression of the receptor. J Biol Chem. 2006 Mar 24;281(12):7983-93. Epub 2006 Jan 23. [Article] Li JG, Chen C, Liu-Chen LY: N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathway. Biochemistry. 2007 Sep 25;46(38):10960-70. Epub 2007 Aug 21. [Article] Wang YH, Sun JF, Tao YM, Chi ZQ, Liu JG: The role of kappa-opioid receptor activation in mediating antinociception and addiction. Acta Pharmacol Sin. 2010 Sep;31(9):1065-70. doi: 10.1038/aps.2010.138. Epub 2010 Aug 23. [Article] Bruchas MR, Chavkin C: Kinase cascades and ligand-directed signaling at the kappa opioid receptor. Psychopharmacology (Berl). 2010 Jun;210(2):137-47. doi: 10.1007/s00213-010-1806-y. Epub 2010 Apr 17. [Article] Wu H, Wacker D, Mileni M, Katritch V, Han GW, Vardy E, Liu W, Thompson AA, Huang XP, Carroll FI, Mascarella SW, Westkaemper RB, Mosier PD, Roth BL, Cherezov V, Stevens RC: Structure of the human kappa-opioid receptor in complex with JDTic. Nature. 2012 Mar 21;485(7398):327-32. doi: 10.1038/nature10939. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00454MeperidineapprovedyesDetailsDB00611Butorphanolapproved, illicit, vet_approvedyesagonistDetailsDB00844NalbuphineapprovedyesagonistDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedyesantagonistDetailsDB00318Codeineapproved, illicityesagonistDetailsDB00327Hydromorphoneapproved, illicityesagonistDetailsDB00647Dextropropoxypheneapproved, illicit, investigational, withdrawnyesantagonistDetailsDB01209Dezocineapproved, investigationalyesantagonistDetailsDB00652Pentazocineapproved, vet_approvedyesagonistDetailsDB00295Morphineapproved, investigationalyesagonistDetailsDB00370MirtazapineapprovedunknownagonistDetailsDB00704Naltrexoneapproved, investigational, vet_approvedyesantagonistDetailsDB015713-MethylfentanylillicityesagonistDetailsDB01497Etorphineillicit, vet_approvedyesagonistDetailsDB05046V1003investigationalunknownDetailsDB05104AsimadolineinvestigationalunknownDetailsDB05155CR665investigationalunknownDetailsDB05443ADL 10-0101investigationalunknownDetailsDB00497Oxycodoneapproved, illicit, investigationalyesagonistDetailsDB00193Tramadolapproved, investigationalunknownagonistDetailsDB06204TapentadolapprovedunknownagonistDetailsDB06409Morphine glucuronideinvestigationalunknownDetailsDB01452Diamorphineapproved, illicit, investigationalunknownagonistDetailsDB00708Sufentanilapproved, investigationalunknownDetailsDB01535Carfentanilillicit, investigational, vet_approvedunknownagonistDetailsDB00321AmitriptylineapprovedunknownagonistDetailsDB00854LevorphanolapprovedunknownagonistDetailsDB01565Dihydromorphineexperimental, illicitunknownagonistDetailsDB01183Naloxoneapproved, vet_approvedyesantagonistDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedunknownagonistDetailsDB00825LevomentholapprovedunknownagonistDetailsDB014393-Methylthiofentanylexperimental, illicityesagonistDetailsDB01548Diprenorphineillicit, vet_approvedunknownantagonistDetailsDB00836LoperamideapprovedunknownagonistDetailsDB06274Alvimopanapproved, investigationalunknownantagonistDetailsDB00899RemifentanilapprovedunknownagonistDetailsDB06800MethylnaltrexoneapprovednoantagonistDetailsDB06738KetobemidoneinvestigationalyesagonistDetailsDB00514DextromethorphanapprovedunknownagonistDetailsDB00396Progesteroneapproved, vet_approvedunknownactivatorpotentiatorDetailsDB01221Ketamineapproved, vet_approvedunknownagonistDetailsDB06148Mianserinapproved, investigationalunknownagonistDetailsDB09272Eluxadolineapproved, investigationalyesagonistDetailsDB06230Nalmefeneapproved, investigational, withdrawnyespartial agonistDetailsDB11691Naldemedineapproved, investigationalyesantagonistDetailsDB00555Lamotrigineapproved, investigationalunknowninhibitorDetailsDB09209Pholcodineapproved, illicityesantagonistDetailsDB11130Opiumapproved, illicityesagonistDetailsDB11186Pentoxyverineapproved, investigational, withdrawnunknownagonistDetailsDB14146LoxicodegolinvestigationalunknownagonistDetailsDB00289Atomoxetineapprovedunknownpartial agonistDetailsDB09173ButyrfentanylillicitunknownagonistDetailsDB01238Aripiprazoleapproved, investigationalunknownligandDetailsDB06288Amisulprideapproved, investigationalnoagonistDetailsDB12543Samidorphanapproved, investigationalunknownpartial agonistDetailsDB11938Difelikefalinapproved, investigationalyesagonistDetails"
                    }
                },
                {
                    "Label": "Delta-type opioid receptor",
                    "Detailed Info": {
                        "Name": "Delta-type opioid receptor",
                        "Synonyms": "D-OR-1\nOPRD",
                        "Gene Name": "OPRD1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0010290|Delta-type opioid receptor\nMEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVC\nAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELL\nCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVG\nVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRL\nRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAAL\nHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTAC\nTPSDGPGGGAAA",
                        "Number of residues": "372",
                        "Molecular Weight": "40368.235",
                        "Theoretical pI": "9.17",
                        "GO Classification": "Functionsenkephalin receptor activity / neuropeptide binding / opioid receptor activityProcessesadenylate cyclase-inhibiting G-protein coupled receptor signaling pathway / adult locomotory behavior / cellular response to growth factor stimulus / cellular response to hypoxia / cellular response to toxic substance / eating behavior / G-protein coupled receptor signaling pathway / G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger / immune response / negative regulation of gene expression / negative regulation of protein oligomerization / neuropeptide signaling pathway / opioid receptor signaling pathway / phospholipase C-activating G-protein coupled receptor signaling pathway / positive regulation of CREB transcription factor activity / positive regulation of peptidyl-serine phosphorylation / protein import into nucleus, translocation / regulation of calcium ion transport / regulation of mitochondrial membrane potential / regulation of sensory perception of pain / synaptic transmissionComponentsaxon terminus / cytoplasm / dendrite membrane / integral component of plasma membrane / intrinsic component of plasma membrane / membrane raft / neuron projection / plasma membrane / postsynaptic membrane / vesicle",
                        "General Function": "Opioid receptor activity",
                        "Specific Function": "G-protein coupled receptor that functions as receptor for endogenous enkephalins and for a subset of other opioids. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Plays a role in the perception of pain and in opiate-mediated analgesia. Plays a role in developing analgesic tolerance to morphine.",
                        "Pfam Domain Function": "7tm_1 (PF00001)",
                        "Transmembrane Regions": "48-75\n86-110\n123-144\n164-186\n207-238\n262-284\n300-321",
                        "Cellular Location": "Cell membrane",
                        "Gene sequence": ">lcl|BSEQ0010291|Delta-type opioid receptor (OPRD1)\nATGGAACCGGCCCCCTCCGCCGGCGCCGAGCTGCAGCCCCCGCTCTTCGCCAACGCCTCG\nGACGCCTACCCTAGCGCCTGCCCCAGCGCTGGCGCCAATGCGTCGGGGCCGCCAGGCGCG\nCGGAGCGCCTCGTCCCTCGCCCTGGCAATCGCCATCACCGCGCTCTACTCGGCCGTGTGC\nGCCGTGGGGCTGCTGGGCAACGTGCTTGTCATGTTCGGCATCGTCCGGTACACTAAGATG\nAAGACGGCCACCAACATCTACATCTTCAACCTGGCCTTAGCCGATGCGCTGGCCACCAGC\nACGCTGCCTTTCCAGAGTGCCAAGTACCTGATGGAGACGTGGCCCTTCGGCGAGCTGCTC\nTGCAAGGCTGTGCTCTCCATCGACTACTACAATATGTTCACCAGCATCTTCACGCTCACC\nATGATGAGTGTTGACCGCTACATCGCTGTCTGCCACCCTGTCAAGGCCCTGGACTTCCGC\nACGCCTGCCAAGGCCAAGCTGATCAACATCTGTATCTGGGTCCTGGCCTCAGGCGTTGGC\nGTGCCCATCATGGTCATGGCTGTGACCCGTCCCCGGGACGGGGCAGTGGTGTGCATGCTC\nCAGTTCCCCAGCCCCAGCTGGTACTGGGACACGGTGACCAAGATCTGCGTGTTCCTCTTC\nGCCTTCGTGGTGCCCATCCTCATCATCACCGTGTGCTATGGCCTCATGCTGCTGCGCCTG\nCGCAGTGTGCGCCTGCTGTCGGGCTCCAAGGAGAAGGACCGCAGCCTGCGGCGCATCACG\nCGCATGGTGCTGGTGGTTGTGGGCGCCTTCGTGGTGTGTTGGGCGCCCATCCACATCTTC\nGTCATCGTCTGGACGCTGGTGGACATCGACCGGCGCGACCCGCTGGTGGTGGCTGCGCTG\nCACCTGTGCATCGCGCTGGGCTACGCCAATAGCAGCCTCAACCCCGTGCTCTACGCTTTC\nCTCGACGAGAACTTCAAGCGCTGCTTCCGCCAGCTCTGCCGCAAGCCCTGCGGCCGCCCA\nGACCCCAGCAGCTTCAGCCGCGCCCGCGAAGCCACGGCCCGCGAGCGTGTCACCGCCTGC\nACCCCGTCCGATGGTCCCGGCGGTGGCGCTGCCGCCTGA",
                        "Chromosome Location": "1",
                        "Locus": "1p36.1-p34.3",
                        "External Identifiers": "ResourceLinkUniProtKB IDP41143UniProtKB Entry NameOPRD_HUMANGenBank Protein ID27545517GenBank Gene IDU07882GenAtlas IDOPRD1HGNC IDHGNC:8153",
                        "General References": "Knapp RJ, Malatynska E, Fang L, Li X, Babin E, Nguyen M, Santoro G, Varga EV, Hruby VJ, Roeske WR, et al.: Identification of a human delta opioid receptor: cloning and expression. Life Sci. 1994;54(25):PL463-9. [Article] Simonin F, Befort K, Gaveriaux-Ruff C, Matthes H, Nappey V, Lannes B, Micheletti G, Kieffer B: The human delta-opioid receptor: genomic organization, cDNA cloning, functional expression, and distribution in human brain. Mol Pharmacol. 1994 Dec;46(6):1015-21. [Article] Gregory SG, Barlow KF, McLay KE, Kaul R, Swarbreck D, Dunham A, Scott CE, Howe KL, Woodfine K, Spencer CC, Jones MC, Gillson C, Searle S, Zhou Y, Kokocinski F, McDonald L, Evans R, Phillips K, Atkinson A, Cooper R, Jones C, Hall RE, Andrews TD, Lloyd C, Ainscough R, Almeida JP, Ambrose KD, Anderson F, Andrew RW, Ashwell RI, Aubin K, Babbage AK, Bagguley CL, Bailey J, Beasley H, Bethel G, Bird CP, Bray-Allen S, Brown JY, Brown AJ, Buckley D, Burton J, Bye J, Carder C, Chapman JC, Clark SY, Clarke G, Clee C, Cobley V, Collier RE, Corby N, Coville GJ, Davies J, Deadman R, Dunn M, Earthrowl M, Ellington AG, Errington H, Frankish A, Frankland J, French L, Garner P, Garnett J, Gay L, Ghori MR, Gibson R, Gilby LM, Gillett W, Glithero RJ, Grafham DV, Griffiths C, Griffiths-Jones S, Grocock R, Hammond S, Harrison ES, Hart E, Haugen E, Heath PD, Holmes S, Holt K, Howden PJ, Hunt AR, Hunt SE, Hunter G, Isherwood J, James R, Johnson C, Johnson D, Joy A, Kay M, Kershaw JK, Kibukawa M, Kimberley AM, King A, Knights AJ, Lad H, Laird G, Lawlor S, Leongamornlert DA, Lloyd DM, Loveland J, Lovell J, Lush MJ, Lyne R, Martin S, Mashreghi-Mohammadi M, Matthews L, Matthews NS, McLaren S, Milne S, Mistry S, Moore MJ, Nickerson T, O'Dell CN, Oliver K, Palmeiri A, Palmer SA, Parker A, Patel D, Pearce AV, Peck AI, Pelan S, Phelps K, Phillimore BJ, Plumb R, Rajan J, Raymond C, Rouse G, Saenphimmachak C, Sehra HK, Sheridan E, Shownkeen R, Sims S, Skuce CD, Smith M, Steward C, Subramanian S, Sycamore N, Tracey A, Tromans A, Van Helmond Z, Wall M, Wallis JM, White S, Whitehead SL, Wilkinson JE, Willey DL, Williams H, Wilming L, Wray PW, Wu Z, Coulson A, Vaudin M, Sulston JE, Durbin R, Hubbard T, Wooster R, Dunham I, Carter NP, McVean G, Ross MT, Harrow J, Olson MV, Beck S, Rogers J, Bentley DR, Banerjee R, Bryant SP, Burford DC, Burrill WD, Clegg SM, Dhami P, Dovey O, Faulkner LM, Gribble SM, Langford CF, Pandian RD, Porter KM, Prigmore E: The DNA sequence and biological annotation of human chromosome 1. Nature. 2006 May 18;441(7091):315-21. [Article] Whistler JL, Enquist J, Marley A, Fong J, Gladher F, Tsuruda P, Murray SR, Von Zastrow M: Modulation of postendocytic sorting of G protein-coupled receptors. Science. 2002 Jul 26;297(5581):615-20. [Article] Simonin F, Karcher P, Boeuf JJ, Matifas A, Kieffer BL: Identification of a novel family of G protein-coupled receptor associated sorting proteins. J Neurochem. 2004 May;89(3):766-75. [Article] Leskela TT, Lackman JJ, Vierimaa MM, Kobayashi H, Bouvier M, Petaja-Repo UE: Cys-27 variant of human delta-opioid receptor modulates maturation and cell surface delivery of Phe-27 variant via heteromerization. J Biol Chem. 2012 Feb 10;287(7):5008-20. doi: 10.1074/jbc.M111.305656. Epub 2011 Dec 19. [Article] Agirregoitia E, Peralta L, Mendoza R, Exposito A, Ereno ED, Matorras R, Agirregoitia N: Expression and localization of opioid receptors during the maturation of human oocytes. Reprod Biomed Online. 2012 May;24(5):550-7. doi: 10.1016/j.rbmo.2012.02.007. Epub 2012 Feb 22. [Article] Gelernter J, Kranzler HR: Variant detection at the delta opioid receptor (OPRD1) locus and population genetics of a novel variant affecting protein sequence. Hum Genet. 2000 Jul;107(1):86-8. [Article] Decaillot FM, Befort K, Filliol D, Yue S, Walker P, Kieffer BL: Opioid receptor random mutagenesis reveals a mechanism for G protein-coupled receptor activation. Nat Struct Biol. 2003 Aug;10(8):629-36. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00318Codeineapproved, illicityesagonistDetailsDB00327Hydromorphoneapproved, illicityespartial agonistDetailsDB00647Dextropropoxypheneapproved, illicit, investigational, withdrawnyesagonistDetailsDB00844NalbuphineapprovedyesantagonistDetailsDB00956Hydrocodoneapproved, illicit, investigationalyesagonistDetailsDB00295Morphineapproved, investigationalyesagonistDetailsDB00611Butorphanolapproved, illicit, vet_approvedyesagonistDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedyesagonistDetailsDB01183Naloxoneapproved, vet_approvedyesantagonistDetailsDB01497Etorphineillicit, vet_approvedyesagonistDetailsDB01548Diprenorphineillicit, vet_approvedyesantagonistDetailsDB014393-Methylthiofentanylexperimental, illicityesagonistDetailsDB01444Dimethylthiambuteneexperimental, illicitunknownagonistDetailsDB00836LoperamideapprovedunknownagonistDetailsDB00704Naltrexoneapproved, investigational, vet_approvedyesantagonistDetailsDB015713-MethylfentanylillicityesagonistDetailsDB05050ADL5859investigationalunknownDetailsDB00497Oxycodoneapproved, illicit, investigationalyesagonistDetailsDB06204TapentadolapprovedunknownagonistDetailsDB06409Morphine glucuronideinvestigationalunknownDetailsDB01452Diamorphineapproved, illicit, investigationalunknownagonistDetailsDB00193Tramadolapproved, investigationalunknownagonistDetailsDB00333MethadoneapprovedyesagonistDetailsDB00708Sufentanilapproved, investigationalunknownagonistDetailsDB01535Carfentanilillicit, investigational, vet_approvedyesagonistDetailsDB01192Oxymorphoneapproved, investigational, vet_approvedunknownantagonistDetailsDB00321AmitriptylineapprovedunknownagonistDetailsDB01081Diphenoxylateapproved, illicitunknownagonistDetailsDB00854LevorphanolapprovedunknownagonistDetailsDB01565Dihydromorphineexperimental, illicitunknownagonistDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknownantagonistDetailsDB06274Alvimopanapproved, investigationalunknownantagonistDetailsDB00899RemifentanilapprovedunknownagonistDetailsDB06738KetobemidoneinvestigationalyesagonistDetailsDB00514DextromethorphanapprovedunknownagonistDetailsDB01221Ketamineapproved, vet_approvedunknownbinderDetailsDB09272Eluxadolineapproved, investigationalyesantagonistDetailsDB11691Naldemedineapproved, investigationalyesantagonistDetailsDB06230Nalmefeneapproved, investigational, withdrawnyesantagonistDetailsDB09061Cannabidiolapproved, investigationalunknownDetailsDB09209Pholcodineapproved, illicitunknownantagonistDetailsDB11130Opiumapproved, illicityesagonistDetailsDB14011NabiximolsinvestigationalunknownDetailsDB14009Medical Cannabisexperimental, investigationalunknownDetailsDB14146LoxicodegolinvestigationalunknownagonistDetailsDB09173ButyrfentanylillicitunknownagonistDetailsDB01238Aripiprazoleapproved, investigationalunknownligandDetailsDB12668MetenkefalininvestigationalunknownagonistDetailsDB06288Amisulprideapproved, investigationalnoagonistDetailsDB12543Samidorphanapproved, investigationalunknownpartial agonistDetails"
                    }
                },
                {
                    "Label": "Lymphocyte antigen 96",
                    "Detailed Info": {
                        "Name": "Lymphocyte antigen 96",
                        "Synonyms": "ESOP-1\nESOP1\nLy-96\nMD2\nProtein MD-2",
                        "Gene Name": "LY96",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0037270|Lymphocyte antigen 96\nMLPFLFFSTLFSSIFTEAQKQYWVCNSSDASISYTYCDKMQYPISINVNPCIELKRSKGL\nLHIFYIPRRDLKQLYFNLYITVNTMNLPKRKEVICRGSDDDYSFCRALKGETVNTTISFS\nFKGIKFSKGKYKCVVEAISGSPEEMLFCLEFVILHQPNSN",
                        "Number of residues": "160",
                        "Molecular Weight": "18545.345",
                        "Theoretical pI": "8.46",
                        "GO Classification": "Functionscoreceptor activity / lipopolysaccharide receptor activityProcessesactivation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway / apoptotic process / cell surface receptor signaling pathway / cellular defense response / detection of lipopolysaccharide / extrinsic apoptotic signaling pathway / I-kappaB kinase/NF-kappaB signaling / inflammatory response / innate immune response / lipopolysaccharide-mediated signaling pathway / MyD88-dependent toll-like receptor signaling pathway / MyD88-independent toll-like receptor signaling pathway / positive regulation of lipopolysaccharide-mediated signaling pathway / positive regulation of tumor necrosis factor production / programmed cell death / response to lipopolysaccharide / toll-like receptor 2 signaling pathway / toll-like receptor 3 signaling pathway / toll-like receptor 4 signaling pathway / toll-like receptor signaling pathway / toll-like receptor TLR1 / toll-like receptor TLR6 / TRIF-dependent toll-like receptor signaling pathwayComponentsendosome membrane / extracellular space / intrinsic component of plasma membrane / lipopolysaccharide receptor complex / plasma membrane",
                        "General Function": "Lipopolysaccharide receptor activity",
                        "Specific Function": "Binds bacterial lipopolysaccharide (LPS) (PubMed:17803912, PubMed:17569869). Cooperates with TLR4 in the innate immune response to bacterial lipopolysaccharide (LPS), and with TLR2 in the response to cell wall components from Gram-positive and Gram-negative bacteria (PubMed:11160242, PubMed:11593030). Enhances TLR4-dependent activation of NF-kappa-B (PubMed:10359581). Cells expressing both LY96 and TLR4, but not TLR4 alone, respond to LPS (PubMed:10359581).",
                        "Pfam Domain Function": "E1_DerP2_DerF2 (PF02221)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Secreted",
                        "Gene sequence": ">lcl|BSEQ0021698|Lymphocyte antigen 96 (LY96)\nATGTTACCATTTCTGTTTTTTTCCACCCTGTTTTCTTCCATATTTACTGAAGCTCAGAAG\nCAGTATTGGGTCTGCAACTCATCCGATGCAAGTATTTCATACACCTACTGTGGGAGAGAT\nTTAAAGCAATTATATTTCAATCTCTATATAACTGTCAACACCATGAATCTTCCAAAGCGC\nAAAGAAGTTATTTGCCGAGGATCTGATGACGATTACTCTTTTTGCAGAGCTCTGAAGGGA\nGAGACTGTGAATACAACAATATCATTCTCCTTCAAGGGAATAAAATTTTCTAAGGGAAAA\nTACAAATGTGTTGTTGAAGCTATTTCTGGGAGCCCAGAAGAAATGCTCTTTTGCTTGGAG\nTTTGTCATCCTACACCAACCTAATTCAAATTAG",
                        "Chromosome Location": "8",
                        "Locus": "8q21.11",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ9Y6Y9UniProtKB Entry NameLY96_HUMANGenBank Protein ID5051740GenBank Gene IDAB018549HGNC IDHGNC:17156",
                        "General References": "Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, Kimoto M: MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med. 1999 Jun 7;189(11):1777-82. [Article] Kato K, Morrison AM, Nakano T, Tashiro K, Honjo T: ESOP-1, a secreted protein expressed in the hematopoietic, nervous, and reproductive systems of embryonic and adult mice. Blood. 2000 Jul 1;96(1):362-4. [Article] Schromm AB, Lien E, Henneke P, Chow JC, Yoshimura A, Heine H, Latz E, Monks BG, Schwartz DA, Miyake K, Golenbock DT: Molecular genetic analysis of an endotoxin nonresponder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling. J Exp Med. 2001 Jul 2;194(1):79-88. [Article] Nakajima T, Ohtani H, Satta Y, Uno Y, Akari H, Ishida T, Kimura A: Natural selection in the TLR-related genes in the course of primate evolution. Immunogenetics. 2008 Dec;60(12):727-35. doi: 10.1007/s00251-008-0332-0. Epub 2008 Sep 23. [Article] Nusbaum C, Mikkelsen TS, Zody MC, Asakawa S, Taudien S, Garber M, Kodira CD, Schueler MG, Shimizu A, Whittaker CA, Chang JL, Cuomo CA, Dewar K, FitzGerald MG, Yang X, Allen NR, Anderson S, Asakawa T, Blechschmidt K, Bloom T, Borowsky ML, Butler J, Cook A, Corum B, DeArellano K, DeCaprio D, Dooley KT, Dorris L 3rd, Engels R, Glockner G, Hafez N, Hagopian DS, Hall JL, Ishikawa SK, Jaffe DB, Kamat A, Kudoh J, Lehmann R, Lokitsang T, Macdonald P, Major JE, Matthews CD, Mauceli E, Menzel U, Mihalev AH, Minoshima S, Murayama Y, Naylor JW, Nicol R, Nguyen C, O'Leary SB, O'Neill K, Parker SC, Polley A, Raymond CK, Reichwald K, Rodriguez J, Sasaki T, Schilhabel M, Siddiqui R, Smith CL, Sneddon TP, Talamas JA, Tenzin P, Topham K, Venkataraman V, Wen G, Yamazaki S, Young SK, Zeng Q, Zimmer AR, Rosenthal A, Birren BW, Platzer M, Shimizu N, Lander ES: DNA sequence and analysis of human chromosome 8. Nature. 2006 Jan 19;439(7074):331-5. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] da Silva Correia J, Soldau K, Christen U, Tobias PS, Ulevitch RJ: Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2. J Biol Chem. 2001 Jun 15;276(24):21129-35. Epub 2001 Mar 26. [Article] Dziarski R, Wang Q, Miyake K, Kirschning CJ, Gupta D: MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components. J Immunol. 2001 Feb 1;166(3):1938-44. [Article] Visintin A, Mazzoni A, Spitzer JA, Segal DM: Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12156-61. Epub 2001 Oct 2. [Article] Mullen GE, Kennedy MN, Visintin A, Mazzoni A, Leifer CA, Davies DR, Segal DM: The role of disulfide bonds in the assembly and function of MD-2. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3919-24. Epub 2003 Mar 17. [Article] Kim HM, Park BS, Kim JI, Kim SE, Lee J, Oh SC, Enkhbayar P, Matsushima N, Lee H, Yoo OJ, Lee JO: Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell. 2007 Sep 7;130(5):906-17. [Article] Ohto U, Fukase K, Miyake K, Satow Y: Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science. 2007 Jun 15;316(5831):1632-4. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB03017Lauric acidapproved, experimentalunknownDetailsDB02767(R)-3-hydroxytetradecanoic acidexperimentalunknownDetailsDB08231Myristic acidexperimentalunknownDetailsDB00295Morphineapproved, investigationalunknownactivatorDetails"
                    }
                }
            ],
            "enzymes": [
                {
                    "Label": "Cytochrome P450 2C8",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 2C8",
                        "Synonyms": "1.14.14.1\nCYPIIC8\nCytochrome P450 form 1\nCytochrome P450 IIC2\nCytochrome P450 MP-12\nCytochrome P450 MP-20\nS-mephenytoin 4-hydroxylase",
                        "Gene Name": "CYP2C8",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0005650|Cytochrome P450 2C8\nMEPFVVLVLCLSFMLLFSLWRQSCRRRKLPPGPTPLPIIGNMLQIDVKDICKSFTNFSKV\nYGPVFTVYFGMNPIVVFHGYEAVKEALIDNGEEFSGRGNSPISQRITKGLGIISSNGKRW\nKEIRRFSLTTLRNFGMGKRSIEDRVQEEAHCLVEELRKTKASPCDPTFILGCAPCNVICS\nVVFQKRFDYKDQNFLTLMKRFNENFRILNSPWIQVCNNFPLLIDCFPGTHNKVLKNVALT\nRSYIREKVKEHQASLDVNNPRDFIDCFLIKMEQEKDNQKSEFNIENLVGTVADLFVAGTE\nTTSTTLRYGLLLLLKHPEVTAKVQEEIDHVIGRHRSPCMQDRSHMPYTDAVVHEIQRYSD\nLVPTGVPHAVTTDTKFRNYLIPKGTTIMALLTSVLHDDKEFPNPNIFDPGHFLDKNGNFK\nKSDYFMPFSAGKRICAGEGLARMELFLFLTTILQNFNLKSVDDLKNLNTTAVTKGIVSLP\nPSYQICFIPV",
                        "Number of residues": "490",
                        "Molecular Weight": "55824.275",
                        "Theoretical pI": "8.62",
                        "GO Classification": "Functionsarachidonic acid epoxygenase activity / aromatase activity / caffeine oxidase activity / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen / oxygen binding / steroid hydroxylase activityProcessesarachidonic acid metabolic process / drug metabolic process / epoxygenase P450 pathway / exogenous drug catabolic process / omega-hydroxylase P450 pathway / organic acid metabolic process / oxidation-reduction process / oxidative demethylation / small molecule metabolic process / xenobiotic metabolic processComponentscytoplasm / endoplasmic reticulum membrane / intracellular membrane-bounded organelle",
                        "General Function": "Steroid hydroxylase activity",
                        "Specific Function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. In the epoxidation of arachidonic acid it generates only 14,15- and 11,12-cis-epoxyeicosatrienoic acids. It is the principal enzyme responsible for the metabolism the anti-cancer drug paclitaxel (taxol).",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0021338|Cytochrome P450 2C8 (CYP2C8)\nATGGAACCTTTTGTGGTCCTGGTGCTGTGTCTCTCTTTTATGCTTCTCTTTTCACTCTGG\nAGACAGAGCTGTAGGAGAAGGAAGCTCCCTCCTGGCCCCACTCCTCTTCCTATTATTGGA\nAATATGCTACAGATAGATGTTAAGGACATCTGCAAATCTTTCACCAATTTCTCAAAAGTC\nTATGGTCCTGTGTTCACCGTGTATTTTGGCATGAATCCCATAGTGGTGTTTCATGGATAT\nGAGGCAGTGAAGGAAGCCCTGATTGATAATGGAGAGGAGTTTTCTGGAAGAGGCAATTCC\nCCAATATCTCAAAGAATTACTAAAGGACTTGGAATCATTTCCAGCAATGGAAAGAGATGG\nAAGGAGATCCGGCGTTTCTCCCTCACAACCTTGCGGAATTTTGGGATGGGGAAGAGGAGC\nATTGAGGACCGTGTTCAAGAGGAAGCTCACTGCCTTGTGGAGGAGTTGAGAAAAACCAAG\nGCTTCACCCTGTGATCCCACTTTCATCCTGGGCTGTGCTCCCTGCAATGTGATCTGCTCC\nGTTGTTTTCCAGAAACGATTTGATTATAAAGATCAGAATTTTCTCACCCTGATGAAAAGA\nTTCAATGAAAACTTCAGGATTCTGAACTCCCCATGGATCCAGGTCTGCAATAATTTCCCT\nCTACTCATTGATTGTTTCCCAGGAACTCACAACAAAGTGCTTAAAAATGTTGCTCTTACA\nCGAAGTTACATTAGGGAGAAAGTAAAAGAACACCAAGCATCACTGGATGTTAACAATCCT\nCGGGACTTTATCGATTGCTTCCTGATCAAAATGGAGCAGGAAAAGGACAACCAAAAGTCA\nGAATTCAATATTGAAAACTTGGTTGGCACTGTAGCTGATCTATTTGTTGCTGGAACAGAG\nACAACAAGCACCACTCTGAGATATGGACTCCTGCTCCTGCTGAAGCACCCAGAGGTCACA\nGCTAAAGTCCAGGAAGAGATTGATCATGTAATTGGCAGACACAGGAGCCCCTGCATGCAG\nGATAGGAGCCACATGCCTTACACTGATGCTGTAGTGCACGAGATCCAGAGATACAGTGAC\nCTTGTCCCCACCGGTGTGCCCCATGCAGTGACCACTGATACTAAGTTCAGAAACTACCTC\nATCCCCAAGGGCACAACCATAATGGCATTACTGACTTCCGTGCTACATGATGACAAAGAA\nTTTCCTAATCCAAATATCTTTGACCCTGGCCACTTTCTAGATAAGAATGGCAACTTTAAG\nAAAAGTGACTACTTCATGCCTTTCTCAGCAGGAAAACGAATTTGTGCAGGAGAAGGACTT\nGCCCGCATGGAGCTATTTTTATTTCTAACCACAATTTTACAGAACTTTAACCTGAAATCT\nGTTGATGATTTAAAGAACCTCAATACTACTGCAGTTACCAAAGGGATTGTTTCTCTGCCA\nCCCTCATACCAGATCTGCTTCATCCCTGTCTGA",
                        "Chromosome Location": "10",
                        "Locus": "10q23.33",
                        "External Identifiers": "ResourceLinkUniProtKB IDP10632UniProtKB Entry NameCP2C8_HUMANGenBank Gene IDM17397GenAtlas IDCYP2C8HGNC IDHGNC:2622",
                        "General References": "Okino ST, Quattrochi LC, Pendurthi UR, McBride OW, Tukey RH: Characterization of multiple human cytochrome P-450 1 cDNAs. The chromosomal localization of the gene and evidence for alternate RNA splicing. J Biol Chem. 1987 Nov 25;262(33):16072-9. [Article] Kimura S, Pastewka J, Gelboin HV, Gonzalez FJ: cDNA and amino acid sequences of two members of the human P450IIC gene subfamily. Nucleic Acids Res. 1987 Dec 10;15(23):10053-4. [Article] Romkes M, Faletto MB, Blaisdell JA, Raucy JL, Goldstein JA: Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. Biochemistry. 1991 Apr 2;30(13):3247-55. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Deloukas P, Earthrowl ME, Grafham DV, Rubenfield M, French L, Steward CA, Sims SK, Jones MC, Searle S, Scott C, Howe K, Hunt SE, Andrews TD, Gilbert JG, Swarbreck D, Ashurst JL, Taylor A, Battles J, Bird CP, Ainscough R, Almeida JP, Ashwell RI, Ambrose KD, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Bates K, Beasley H, Bray-Allen S, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Cahill P, Camire D, Carter NP, Chapman JC, Clark SY, Clarke G, Clee CM, Clegg S, Corby N, Coulson A, Dhami P, Dutta I, Dunn M, Faulkner L, Frankish A, Frankland JA, Garner P, Garnett J, Gribble S, Griffiths C, Grocock R, Gustafson E, Hammond S, Harley JL, Hart E, Heath PD, Ho TP, Hopkins B, Horne J, Howden PJ, Huckle E, Hynds C, Johnson C, Johnson D, Kana A, Kay M, Kimberley AM, Kershaw JK, Kokkinaki M, Laird GK, Lawlor S, Lee HM, Leongamornlert DA, Laird G, Lloyd C, Lloyd DM, Loveland J, Lovell J, McLaren S, McLay KE, McMurray A, Mashreghi-Mohammadi M, Matthews L, Milne S, Nickerson T, Nguyen M, Overton-Larty E, Palmer SA, Pearce AV, Peck AI, Pelan S, Phillimore B, Porter K, Rice CM, Rogosin A, Ross MT, Sarafidou T, Sehra HK, Shownkeen R, Skuce CD, Smith M, Standring L, Sycamore N, Tester J, Thorpe A, Torcasso W, Tracey A, Tromans A, Tsolas J, Wall M, Walsh J, Wang H, Weinstock K, West AP, Willey DL, Whitehead SL, Wilming L, Wray PW, Young L, Chen Y, Lovering RC, Moschonas NK, Siebert R, Fechtel K, Bentley D, Durbin R, Hubbard T, Doucette-Stamm L, Beck S, Smith DR, Rogers J: The DNA sequence and comparative analysis of human chromosome 10. Nature. 2004 May 27;429(6990):375-81. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Ged C, Beaune P: Isolation of the human cytochrome P-450 IIC8 gene: multiple glucocorticoid responsive elements in the 5' region. Biochim Biophys Acta. 1991 Mar 26;1088(3):433-5. [Article] Zeldin DC, DuBois RN, Falck JR, Capdevila JH: Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform. Arch Biochem Biophys. 1995 Sep 10;322(1):76-86. [Article] Ged C, Umbenhauer DR, Bellew TM, Bork RW, Srivastava PK, Shinriki N, Lloyd RS, Guengerich FP: Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 (S)-mephenytoin 4'-hydroxylase. Biochemistry. 1988 Sep 6;27(18):6929-40. [Article] Shephard EA, Phillips IR, Santisteban I, Palmer CN, Povey S: Cloning, expression and chromosomal localization of a member of the human cytochrome P450IIC gene sub-family. Ann Hum Genet. 1989 Jan;53(Pt 1):23-31. [Article] Kolyada AY: Sequence of a human liver cytochrome P-450 cDNA clone. Nucleic Acids Res. 1990 Sep 25;18(18):5550. [Article] Ishikawa C, Ozaki H, Nakajima T, Ishii T, Kanai S, Anjo S, Shirai K, Inoue I: A frameshift variant of CYP2C8 was identified in a patient who suffered from rhabdomyolysis after administration of cerivastatin. J Hum Genet. 2004;49(10):582-5. Epub 2004 Sep 9. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Schoch GA, Yano JK, Wester MR, Griffin KJ, Stout CD, Johnson EF: Structure of human microsomal cytochrome P450 2C8. Evidence for a peripheral fatty acid binding site. J Biol Chem. 2004 Mar 5;279(10):9497-503. Epub 2003 Dec 15. [Article] Schoch GA, Yano JK, Sansen S, Dansette PM, Stout CD, Johnson EF: Determinants of cytochrome P450 2C8 substrate binding: structures of complexes with montelukast, troglitazone, felodipine, and 9-cis-retinoic acid. J Biol Chem. 2008 Jun 20;283(25):17227-37. doi: 10.1074/jbc.M802180200. Epub 2008 Apr 15. [Article] Dai D, Zeldin DC, Blaisdell JA, Chanas B, Coulter SJ, Ghanayem BI, Goldstein JA: Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid. Pharmacogenetics. 2001 Oct;11(7):597-607. [Article] Bahadur N, Leathart JB, Mutch E, Steimel-Crespi D, Dunn SA, Gilissen R, Houdt JV, Hendrickx J, Mannens G, Bohets H, Williams FM, Armstrong M, Crespi CL, Daly AK: CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6alpha-hydroxylase activity in human liver microsomes. Biochem Pharmacol. 2002 Dec 1;64(11):1579-89. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB03796Palmitic AcidapprovedunknownDetailsDB00214TorasemideapprovedunknownsubstrateDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinducerDetailsDB00412Rosiglitazoneapproved, investigationalunknownsubstrateinhibitorDetailsDB00439Cerivastatinapproved, withdrawnunknownsubstrateinhibitorDetailsDB00564Carbamazepineapproved, investigationalunknownsubstrateinducerDetailsDB00682WarfarinapprovedunknownsubstrateDetailsDB00755Tretinoinapproved, investigational, nutraceuticalunknownsubstrateDetailsDB00912Repaglinideapproved, investigationalunknownsubstrateDetailsDB01118Amiodaroneapproved, investigationalnosubstrateDetailsDB01132Pioglitazoneapproved, investigationalunknownsubstrateinhibitorDetailsDB01198ZopicloneapprovedunknownsubstrateDetailsDB01229Paclitaxelapproved, vet_approvedunknownsubstrateDetailsDB01261Sitagliptinapproved, investigationalunknownsubstrateDetailsDB01259Lapatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00227Lovastatinapproved, investigationalunknownsubstrateDetailsDB00440Trimethoprimapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00471MontelukastapprovedunknownsubstrateinhibitorDetailsDB00549Zafirlukastapproved, investigationalunknowninhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknownsubstrateDetailsDB00613Amodiaquineapproved, investigationalunknownsubstrateDetailsDB00622Nicardipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00641SimvastatinapprovedunknownsubstrateinhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB01045RifampicinapprovedunknowninhibitorinducerDetailsDB01124Tolbutamideapproved, investigationalunknownsubstrateinhibitorDetailsDB01241GemfibrozilapprovedunknowninhibitorDetailsDB01424Aminophenazoneapproved, withdrawnunknownsubstrateDetailsDB01095FluvastatinapprovedunknownsubstrateinhibitorDetailsDB01023Felodipineapproved, investigationalunknowninhibitorDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00796Candesartan cilexetilapprovedunknowninhibitorDetailsDB00257Clotrimazoleapproved, vet_approvedunknowninhibitorDetailsDB00764MometasoneexperimentalnoinhibitorDetailsDB00938SalmeterolapprovedunknowninhibitorDetailsDB00481Raloxifeneapproved, investigationalunknowninhibitorDetailsDB01039FenofibrateapprovedunknowninhibitorDetailsDB00503Ritonavirapproved, investigationalunknowninhibitorinducerDetailsDB00451LevothyroxineapprovedunknowninhibitorDetailsDB00675TamoxifenapprovedunknowninhibitorDetailsDB00455Loratadineapproved, investigationalunknownsubstrateinhibitorDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB01062Oxybutyninapproved, investigationalunknowninhibitorDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknowninhibitorDetailsDB00977EthinylestradiolapprovedunknownsubstrateinhibitorDetailsDB00421SpironolactoneapprovedunknowninhibitorDetailsDB01029Irbesartanapproved, investigationalunknownsubstrateinhibitorDetailsDB01181IfosfamideapprovedunknownsubstrateinducerDetailsDB01115NifedipineapprovedunknowninhibitorDetailsDB00468QuinineapprovedunknownsubstrateinhibitorDetailsDB01435Antipyrineapproved, investigationalunknownsubstrateDetailsDB00250Dapsoneapproved, investigationalunknownsubstrateDetailsDB00946Phenprocoumonapproved, investigationalunknownsubstrateDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00972AzelastineapprovedunknownsubstrateDetailsDB00398Sorafenibapproved, investigationalunknownsubstrateinhibitorDetailsDB01174Phenobarbitalapproved, investigationalunknowninducerDetailsDB01201Rifapentineapproved, investigationalunknowninducerDetailsDB00418Secobarbitalapproved, vet_approvedunknowninducerDetailsDB06210EltrombopagapprovedunknownsubstrateinhibitorDetailsDB04868Nilotinibapproved, investigationalunknowninhibitorinducerDetailsDB00661VerapamilapprovedunknownsubstrateinhibitorDetailsDB01050IbuprofenapprovedunknownsubstrateDetailsDB00788Naproxenapproved, vet_approvedunknownsubstrateDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB00333MethadoneapprovedunknownsubstrateDetailsDB00201CaffeineapprovedunknownsubstrateDetailsDB04725LicofeloneinvestigationalunknownsubstrateinhibitorDetailsDB06739SeratrodastexperimentalunknownsubstrateDetailsDB00402Eszopicloneapproved, investigationalunknownsubstrateDetailsDB08607(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONEexperimentalunknownDetailsDB06772CabazitaxelapprovedunknownsubstrateDetailsDB01583LiotrixapprovedunknowninhibitorDetailsDB00321AmitriptylineapprovedunknownsubstrateinhibitorDetailsDB00381AmlodipineapprovedunknowninhibitorDetailsDB01076AtorvastatinapprovednosubstrateinhibitorDetailsDB01393Bezafibrateapproved, investigationalunknowninhibitorDetailsDB00608Chloroquineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00604Cisaprideapproved, investigational, withdrawnunknownsubstrateDetailsDB00758ClopidogrelapprovednoinhibitorDetailsDB00363ClozapineapprovednosubstrateDetailsDB00907Cocaineapproved, illicitunknowndownregulatorDetailsDB01394ColchicineapprovedunknowninhibitorDetailsDB00169Cholecalciferolapproved, nutraceuticalunknowninhibitorDetailsDB00531Cyclophosphamideapproved, investigationalunknownsubstrateinducerDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknowninducerDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB00343Diltiazemapproved, investigationalunknownsubstrateDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00544FluorouracilapprovedunknownsubstrateDetailsDB01218HalofantrineapprovedunknownsubstrateDetailsDB00741Hydrocortisoneapproved, vet_approvedunknowninducerDetailsDB00951Isoniazidapproved, investigationalunknowninhibitorDetailsDB01221Ketamineapproved, vet_approvedunknownsubstrateDetailsDB06738KetobemidoneinvestigationalunknownsubstrateDetailsDB01009Ketoprofenapproved, vet_approvedunknowninhibitorDetailsDB00448Lansoprazoleapproved, investigationalunknownsubstrateDetailsDB00281Lidocaineapproved, vet_approvedunknownsubstrateDetailsDB00784Mefenamic acidapprovedunknowninhibitorDetailsDB00814Meloxicamapproved, vet_approvedunknownsubstrateDetailsDB00532Mephenytoinapproved, investigational, withdrawnunknownsubstrateDetailsDB00916MetronidazoleapprovedunknowninhibitorDetailsDB00295Morphineapproved, investigationalnosubstrateDetailsDB00184NicotineapprovedunknownsubstrateDetailsDB06712Nilvadipineapproved, investigationalunknowninhibitorDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknownsubstrateDetailsDB00850PerphenazineapprovedunknownsubstrateDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB00554Piroxicamapproved, investigationalunknownsubstrateDetailsDB01032Probenecidapproved, investigationalunknowninducerDetailsDB00818Propofolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00205Pyrimethamineapproved, investigational, vet_approvedunknowninhibitorDetailsDB00533Rofecoxibapproved, investigational, withdrawnunknowninhibitorDetailsDB01232Saquinavirapproved, investigationalunknowninhibitorDetailsDB01037Selegilineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00359Sulfadiazineapproved, investigational, vet_approvedunknownsubstrateDetailsDB06729SulfaphenazoleapprovedunknowninhibitorDetailsDB01138SulfinpyrazoneapprovedunknowninhibitorDetailsDB00799Tazaroteneapproved, investigationalunknownsubstrateDetailsDB01079Tegaserodapproved, investigational, withdrawnunknowninhibitorDetailsDB00342Terfenadineapproved, withdrawnunknowninhibitorDetailsDB00624Testosteroneapproved, investigationalunknownsubstrateDetailsDB00208TiclopidineapprovedunknowninhibitorDetailsDB00897Triazolamapproved, investigationalunknowninhibitorDetailsDB00347TrimethadioneapprovedunknownsubstrateDetailsDB13179TroleandomycinapprovedunknowninhibitorDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00617ParamethadioneapprovedunknownsubstrateDetailsDB06589PazopanibapprovedunknownsubstrateinhibitorDetailsDB00255Diethylstilbestrolapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00836LoperamideapprovedunknownsubstrateDetailsDB00918Almotriptanapproved, investigationalunknownsubstrateDetailsDB05229BeraprostinvestigationalunknownsubstrateDetailsDB06510MuraglitazarinvestigationalunknownsubstrateDetailsDB06770Benzyl alcoholapprovedunknownsubstrateDetailsDB08860PitavastatinapprovedunknownsubstrateDetailsDB05812AbirateroneapprovedunknowninhibitorDetailsDB06605ApixabanapprovedunknownsubstrateDetailsDB08828Vismodegibapproved, investigationalunknowninhibitorDetailsDB08896RegorafenibapprovedunknowninhibitorDetailsDB08899EnzalutamideapprovednosubstrateinhibitorDetailsDB08901Ponatinibapproved, investigationalunknownsubstrateDetailsDB08911TrametinibapprovedunknowninhibitorDetailsDB08912Dabrafenibapproved, investigationalnosubstrateinhibitorDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB08918Levomilnacipranapproved, investigationalunknownsubstrateDetailsDB00951Isoniazidapproved, investigationalunknownDetailsDB09080OlodaterolapprovednosubstrateDetailsDB09054IdelalisibapprovednoinhibitorDetailsDB09068Vortioxetineapproved, investigationalnosubstrateDetailsDB09280LumacaftorapprovednoinhibitorinducerDetailsDB09570Ixazomibapproved, investigationalunknownsubstrateDetailsDB11362SelexipagapprovednosubstrateDetailsDB08931RiociguatapprovedunknownsubstrateDetailsDB09183DasabuvirapprovednosubstrateDetailsDB09296Ombitasvirapproved, investigationalnosubstrateDetailsDB00482Celecoxibapproved, investigationalunknownsubstrateDetailsDB00625Efavirenzapproved, investigationalunknowninhibitorDetailsDB01129Rabeprazoleapproved, investigationalunknowninhibitorDetailsDB08880TeriflunomideapprovedunknowninhibitorDetailsDB05219Crisaboroleapproved, investigationalnoinhibitorDetailsDB06595Midostaurinapproved, investigationalunknowninhibitorinducerDetailsDB05015Belinostatapproved, investigationalunknowninhibitorDetailsDB11613Velpatasvirapproved, investigationalnosubstrateDetailsDB06670OdanacatibinvestigationalnosubstrateDetailsDB01685TopiroxostatexperimentalunknowninhibitorDetailsDB08922PerospironeexperimentalunknownsubstrateDetailsDB12026Voxilaprevirapproved, investigationalnosubstrateDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB13919CandesartanexperimentalunknowninhibitorDetailsDB12070Letermovirapproved, investigationalnoinhibitorDetailsDB12267Brigatinibapproved, investigationalnosubstrateDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB13943Testosterone cypionateapprovedunknownsubstrateDetailsDB13944Testosterone enanthateapprovedunknownsubstrateDetailsDB13946Testosterone undecanoateapproved, investigationalunknownsubstrateDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateDetailsDB11901Apalutamideapproved, investigationalnosubstrateDetailsDB11633Isavuconazoleapproved, investigationalunknowninhibitorinducerDetailsDB11632Opicaponeapproved, investigationalnoinhibitorDetailsDB13746Bioallethrinapproved, experimentalnosubstrateDetailsDB00486Nabiloneapproved, investigationalnosubstrateinhibitorDetailsDB11995Avatrombopagapproved, investigationalunknowninducerDetailsDB00973EzetimibeapprovedunknowninhibitorDetailsDB14512Mometasone furoateapproved, investigational, vet_approvednoinhibitorDetailsDB14538Hydrocortisone aceponateexperimental, vet_approvedunknowninducerDetailsDB14539Hydrocortisone acetateapproved, vet_approvedunknowninducerDetailsDB14540Hydrocortisone butyrateapproved, vet_approvedunknowninducerDetailsDB14541Hydrocortisone cypionateapproved, investigational, vet_approvedunknowninducerDetailsDB14542Hydrocortisone phosphateapproved, vet_approvedunknowninducerDetailsDB14543Hydrocortisone probutateapproved, vet_approvedunknowninducerDetailsDB14544Hydrocortisone valerateapproved, vet_approvedunknowninducerDetailsDB14568Ivosidenibapproved, investigationalunknowninducerDetailsDB14545Hydrocortisone succinateapprovedunknowninducerDetailsDB11979Elagolixapproved, investigationalnosubstrateDetailsDB13867Fluticasoneapproved, experimentalnoinhibitorDetailsDB08906Fluticasone furoateapprovednoinhibitorDetailsDB00588Fluticasone propionateapprovednoinhibitorDetailsDB00615Rifabutinapproved, investigationalnoinducerDetailsDB11753Rifamycinapproved, investigationalnoinhibitorDetailsDB01220Rifaximinapproved, investigationalnoinducerDetailsDB12781BalaglitazoneinvestigationalnosubstrateinhibitorDetailsDB09201CiglitazoneexperimentalnosubstrateinhibitorDetailsDB09198LobeglitazoneexperimentalnosubstrateinhibitorDetailsDB09199NetoglitazoneexperimentalnosubstrateinhibitorDetailsDB09200Rivoglitazoneexperimental, investigationalnosubstrateinhibitorDetailsDB06616BosutinibapprovedunknowninhibitorDetailsDB08875Cabozantinibapproved, investigationalunknowninhibitorDetailsDB01645GenisteininvestigationalunknowninhibitorDetailsDB09078Lenvatinibapproved, investigationalunknowninhibitorDetailsDB01072Atazanavirapproved, investigationalnoinhibitorDetailsDB08496(R)-warfarinexperimentalunknownsubstrateDetailsDB14055(S)-Warfarinexperimental, investigationalunknownsubstrateDetailsDB09256Tegafurapproved, investigationalunknownsubstrateDetailsDB00307Bexaroteneapproved, investigationalnoinhibitorDetailsDB01357MestranolapprovednosubstrateDetailsDB01609Deferasiroxapproved, investigationalunknowninhibitorDetailsDB00908Quinidineapproved, investigationalnoinhibitorDetailsDB00834Mifepristoneapproved, investigationalunknowninhibitorDetailsDB08881VemurafenibapprovedunknowninhibitorDetailsDB09213Dexibuprofenapproved, investigationalnosubstrateDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateDetailsDB00619ImatinibapprovednosubstrateDetailsDB11978Glasdegibapproved, investigationalnosubstrateDetailsDB12245Triclabendazoleapproved, investigationalunknowninhibitorDetailsDB00465KetorolacapprovedunknownsubstrateDetailsDB12015Alpelisibapproved, investigationalunknowninhibitorDetailsDB11757Istradefyllineapproved, investigationalunknownsubstrateDetailsDB00678LosartanapprovednoinhibitorDetailsDB08502CapravirineinvestigationalunknownsubstrateDetailsDB01217Anastrozoleapproved, investigationalunknownsubstrateinhibitorDetailsDB12808Trifaroteneapproved, investigationalunknownsubstrateDetailsDB12001Abemaciclibapproved, investigationalunknowninhibitorDetailsDB15444Elexacaftorapproved, investigationalnoinhibitorDetailsDB00635Prednisoneapproved, vet_approvedunknowninducerDetailsDB06119Cenobamateapproved, investigationalunknowninducerDetailsDB01222BudesonideapprovedunknowninducerDetailsDB00959Methylprednisoloneapproved, vet_approvedunknowninducerDetailsDB06077Lumateperoneapproved, investigationalnosubstrateDetailsDB15328Ubrogepantapproved, investigationalunknowninhibitorDetailsDB01060Amoxicillinapproved, vet_approvedunknowninhibitorDetailsDB12466Favipiravirapproved, investigationalunknowninhibitorDetailsDB00443Betamethasoneapproved, vet_approvedunknowninducerDetailsDB09241Methylene blueapproved, investigationalunknowninhibitorDetailsDB12612Ozanimodapproved, investigationalunknownsubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninducerDetailsDB11689Selumetinibapproved, investigationalnosubstrateDetailsDB11652Tucatinibapproved, investigationalunknownsubstrateDetailsDB14761Remdesivirapproved, investigationalunknownsubstrateDetailsDB01611HydroxychloroquineapprovedunknownsubstrateDetailsDB15685Selpercatinibapproved, investigationalunknowninhibitorDetailsDB14840RipretinibapprovednoinhibitorDetailsDB00845Clofazimineapproved, investigationalunknowninhibitorDetailsDB00714Apomorphineapproved, investigationalunknownsubstrateDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknowninducerDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB12499Clascoteroneapproved, investigationalnoinhibitorDetailsDB15822Pralsetinibapproved, investigationalnoinhibitorinducerDetailsDB06448Lonafarnibapproved, investigationalnosubstrateinhibitorDetailsDB15935Lumasiranapproved, investigationalnoinhibitorDetailsDB06137Tirbanibulinapproved, investigationalnosubstrateinhibitorDetailsDB11853Relugolixapproved, investigationalunknownsubstrateDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB08864RilpivirineapprovedunknowninhibitorDetailsDB15133Tepotinibapproved, investigationalunknownsubstrateDetailsDB04854FebuxostatapprovednosubstrateDetailsDB08822Azilsartan medoxomilapproved, investigationalnosubstrateDetailsDB15569Sotorasibapproved, investigationalunknowninducerDetailsDB12471Ibrexafungerpapproved, investigationalunknowninhibitorDetailsDB12543Samidorphanapproved, investigationalnosubstrateDetailsDB12151Brincidofovirapproved, investigationalnoinhibitorDetailsDB16165Finerenoneapproved, investigationalunknownsubstrateDetailsDB16703Belumosudilapproved, investigationalnosubstrateDetailsDB08932MacitentanapprovednosubstrateDetailsDB05667Levoketoconazoleapproved, investigationalnoinhibitorDetailsDB05467Palovaroteneapproved, investigationalnosubstrateDetailsDB04847Roxadustatapproved, investigationalunknownsubstrateDetailsDB16236Mitapivatapproved, investigationalnosubstrateinducerDetailsDB09061Cannabidiolapproved, investigationalunknownsubstrateinhibitorDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorDetailsDB14921Mavacamtenapproved, investigationalnosubstrateDetailsDB12020Tecovirimatapproved, investigationalnoinducerDetailsDB00374Treprostinilapproved, investigationalunknownsubstrateDetailsDB01024Mycophenolic acidapproved, investigationalunknownsubstrateDetailsDB16536Birch bark extractapproved, experimentalunknowninhibitorDetailsDB09118StiripentolapprovedunknowninhibitorDetailsDB13997Baloxavir marboxilapproved, investigationalunknowninhibitorDetailsDB12095Telotristat ethylapproved, investigationalnoinhibitorDetailsDB17083LinzagolixapprovednosubstrateinhibitorDetailsDB16267Olutasidenibapproved, investigationalnosubstrateinducerDetailsDB15568Adagrasibapproved, investigationalunknownsubstrateDetailsDB17449Anacaulaseapproved, investigationalunknowninhibitorDetailsDB12236Bexagliflozinapproved, investigationalunknownsubstrateDetailsDB17472Pirtobrutinibapproved, investigationalunknowninhibitorDetailsDB11682Daprodustatapproved, investigationalnosubstrateinhibitorDetailsDB00349Clobazamapproved, illicitnosubstrateDetailsDB12513Omaveloxoloneapproved, investigationalunknownsubstrateinducerDetailsDB00862VardenafilapprovedunknowninhibitorDetailsDB11712Tezacaftorapproved, investigationalnoinhibitorDetailsDB01194BrinzolamideapprovednosubstrateDetailsDB12255Vadadustatapproved, investigationalunknowninhibitorDetailsDB14924Ritlecitinibapproved, investigationalunknownsubstrateDetailsDB11763Momelotinibapproved, investigationalunknownsubstrateDetailsDB14766EtrasimodapprovednosubstrateDetailsDB11718Encorafenibapproved, investigationalnoinhibitorDetailsDB15114Vamoroloneapproved, investigationalnosubstrateDetailsDB16826RepotrectinibinvestigationalnoinducerDetailsDB11679FruquintinibinvestigationalnosubstrateDetails"
                    }
                },
                {
                    "Label": "Cytochrome P450 3A4",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 3A4",
                        "Synonyms": "1,8-cineole 2-exo-monooxygenase\n1.14.13.-\nAlbendazole monooxygenase\nAlbendazole sulfoxidase\nCholesterol 25-hydroxylase\nCYP3A3\nCYPIIIA3\nCYPIIIA4\nCytochrome P450 3A3\nCytochrome P450 HLp\nCytochrome P450 NF-25\nCytochrome P450-PCN1\nNifedipine oxidase\nQuinine 3-monooxygenase\nTaurochenodeoxycholate 6-alpha-hydroxylase",
                        "Gene Name": "CYP3A4",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0021936|Cytochrome P450 3A4\nMALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMF\nDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISI\nAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYS\nMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICV\nFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSI\nIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVV\nNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFS\nKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLG\nGLLQPEKPVVLKVESRDGTVSGA",
                        "Number of residues": "503",
                        "Molecular Weight": "57342.67",
                        "Theoretical pI": "8.25",
                        "GO Classification": "Functionsalbendazole monooxygenase activity / aromatase activity / caffeine oxidase activity / enzyme binding / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity / oxygen binding / quinine 3-monooxygenase activity / steroid binding / steroid hydroxylase activity / taurochenodeoxycholate 6alpha-hydroxylase activity / testosterone 6-beta-hydroxylase activity / vitamin D 24-hydroxylase activity / vitamin D3 25-hydroxylase activityProcessesalkaloid catabolic process / androgen metabolic process / calcitriol biosynthetic process from calciol / drug catabolic process / drug metabolic process / exogenous drug catabolic process / heterocycle metabolic process / lipid metabolic process / monoterpenoid metabolic process / oxidation-reduction process / oxidative demethylation / small molecule metabolic process / steroid catabolic process / steroid metabolic process / vitamin D metabolic process / xenobiotic metabolic processComponentscytoplasm / endoplasmic reticulum membrane / integral component of membrane / intracellular membrane-bounded organelle",
                        "General Function": "Vitamin d3 25-hydroxylase activity",
                        "Specific Function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation reactions (e.g. caffeine 8-oxidation, omeprazole sulphoxidation, midazolam 1'-hydroxylation and midazolam 4-hydroxylation) of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,8-cineole 2-exo-monooxygenase. The enzyme also hydroxylates etoposide (PubMed:11159812). Catalyzes 4-beta-hydroxylation of cholesterol. May catalyze 25-hydroxylation of cholesterol in vitro (PubMed:21576599).",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "2-22",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0021937|Cytochrome P450 3A4 (CYP3A4)\nATGGCTCTCATCCCAGACTTGGCCATGGAAACCTGGCTTCTCCTGGCTGTCAGCCTGGTG\nCTCCTCTATCTATATGGAACCCATTCACATGGACTTTTTAAGAAGCTTGGAATTCCAGGG\nCCCACACCTCTGCCTTTTTTGGGAAATATTTTGTCCTACCATAAGGGCTTTTGTATGTTT\nGACATGGAATGTCATAAAAAGTATGGAAAAGTGTGGGGCTTTTATGATGGTCAACAGCCT\nGTGCTGGCTATCACAGATCCTGACATGATCAAAACAGTGCTAGTGAAAGAATGTTATTCT\nGTCTTCACAAACCGGAGGCCTTTTGGTCCAGTGGGATTTATGAAAAGTGCCATCTCTATA\nGCTGAGGATGAAGAATGGAAGAGATTACGATCATTGCTGTCTCCAACCTTCACCAGTGGA\nAAACTCAAGGAGATGGTCCCTATCATTGCCCAGTATGGAGATGTGTTGGTGAGAAATCTG\nAGGCGGGAAGCAGAGACAGGCAAGCCTGTCACCTTGAAAGACGTCTTTGGGGCCTACAGC\nATGGATGTGATCACTAGCACATCATTTGGAGTGAACATCGACTCTCTCAACAATCCACAA\nGACCCCTTTGTGGAAAACACCAAGAAGCTTTTAAGATTTGATTTTTTGGATCCATTCTTT\nCTCTCAATAATCTTTCCATTCCTCATCCCAATTCTTGAAGTATTAAATATCTGTGTGTTT\nCCAAGAGAAGTTACAAATTTTTTAAGAAAATCTGTAAAAAGGATGAAAGAAAGTCGCCTC\nGAAGATACACAAAAGCACCGAGTGGATTTCCTTCAGCTGATGATTGACTCTCAGAATTCA\nAAAGAAACTGAGTCCCACAAAGCTCTGTCCGATCTGGAGCTCGTGGCCCAATCAATTATC\nTTTATTTTTGCTGGCTATGAAACCACGAGCAGTGTTCTCTCCTTCATTATGTATGAACTG\nGCCACTCACCCTGATGTCCAGCAGAAACTGCAGGAGGAAATTGATGCAGTTTTACCCAAT\nAAGGCACCACCCACCTATGATACTGTGCTACAGATGGAGTATCTTGACATGGTGGTGAAT\nGAAACGCTCAGATTATTCCCAATTGCTATGAGACTTGAGAGGGTCTGCAAAAAAGATGTT\nGAGATCAATGGGATGTTCATTCCCAAAGGGGTGGTGGTGATGATTCCAAGCTATGCTCTT\nCACCGTGACCCAAAGTACTGGACAGAGCCTGAGAAGTTCCTCCCTGAAAGATTCAGCAAG\nAAGAACAAGGACAACATAGATCCTTACATATACACACCCTTTGGAAGTGGACCCAGAAAC\nTGCATTGGCATGAGGTTTGCTCTCATGAACATGAAACTTGCTCTAATCAGAGTCCTTCAG\nAACTTCTCCTTCAAACCTTGTAAAGAAACACAGATCCCCCTGAAATTAAGCTTAGGAGGA\nCTTCTTCAACCAGAAAAACCCGTTGTTCTAAAGGTTGAGTCAAGGGATGGCACCGTAAGT\nGGAGCCTGA",
                        "Chromosome Location": "7",
                        "Locus": "7q21.1",
                        "External Identifiers": "ResourceLinkUniProtKB IDP08684UniProtKB Entry NameCP3A4_HUMANGenBank Gene IDM18907GenAtlas IDCYP3A4HGNC IDHGNC:2637",
                        "General References": "Molowa DT, Schuetz EG, Wrighton SA, Watkins PB, Kremers P, Mendez-Picon G, Parker GA, Guzelian PS: Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver. Proc Natl Acad Sci U S A. 1986 Jul;83(14):5311-5. [Article] Gonzalez FJ, Schmid BJ, Umeno M, Mcbride OW, Hardwick JP, Meyer UA, Gelboin HV, Idle JR: Human P450PCN1: sequence, chromosome localization, and direct evidence through cDNA expression that P450PCN1 is nifedipine oxidase. DNA. 1988 Mar;7(2):79-86. [Article] Beaune PH, Umbenhauer DR, Bork RW, Lloyd RS, Guengerich FP: Isolation and sequence determination of a cDNA clone related to human cytochrome P-450 nifedipine oxidase. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8064-8. [Article] Spurr NK, Gough AC, Stevenson K, Wolf CR: The human cytochrome P450 CYP3 locus: assignment to chromosome 7q22-qter. Hum Genet. 1989 Jan;81(2):171-4. [Article] Bork RW, Muto T, Beaune PH, Srivastava PK, Lloyd RS, Guengerich FP: Characterization of mRNA species related to human liver cytochrome P-450 nifedipine oxidase and the regulation of catalytic activity. J Biol Chem. 1989 Jan 15;264(2):910-9. [Article] Chen Q, Wu J, Yu Y: [Establishment of transgenic cell line CHL-3A4 and its metabolic activation]. Zhonghua Yu Fang Yi Xue Za Zhi. 1998 Sep;32(5):281-4. [Article] Gellner K, Eiselt R, Hustert E, Arnold H, Koch I, Haberl M, Deglmann CJ, Burk O, Buntefuss D, Escher S, Bishop C, Koebe HG, Brinkmann U, Klenk HP, Kleine K, Meyer UA, Wojnowski L: Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics. 2001 Mar;11(2):111-21. [Article] Hsieh KP, Lin YY, Cheng CL, Lai ML, Lin MS, Siest JP, Huang JD: Novel mutations of CYP3A4 in Chinese. Drug Metab Dispos. 2001 Mar;29(3):268-73. [Article] Komori M, Hashizume T, Ohi H, Miura T, Kitada M, Nagashima K, Kamataki T: Cytochrome P-450 in human liver microsomes: high-performance liquid chromatographic isolation of three forms and their characterization. J Biochem. 1988 Dec;104(6):912-6. [Article] Watkins PB, Wrighton SA, Maurel P, Schuetz EG, Mendez-Picon G, Parker GA, Guzelian PS: Identification of an inducible form of cytochrome P-450 in human liver. Proc Natl Acad Sci U S A. 1985 Sep;82(18):6310-4. [Article] Aoyama T, Yamano S, Waxman DJ, Lapenson DP, Meyer UA, Fischer V, Tyndale R, Inaba T, Kalow W, Gelboin HV, et al.: Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. J Biol Chem. 1989 Jun 25;264(18):10388-95. [Article] Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP: Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther. 1994 Jul;270(1):414-23. [Article] Kolars JC, Lown KS, Schmiedlin-Ren P, Ghosh M, Fang C, Wrighton SA, Merion RM, Watkins PB: CYP3A gene expression in human gut epithelium. Pharmacogenetics. 1994 Oct;4(5):247-59. [Article] Zhang H, Coville PF, Walker RJ, Miners JO, Birkett DJ, Wanwimolruk S: Evidence for involvement of human CYP3A in the 3-hydroxylation of quinine. Br J Clin Pharmacol. 1997 Mar;43(3):245-52. [Article] Zhao XJ, Kawashiro T, Ishizaki T: Mutual inhibition between quinine and etoposide by human liver microsomes. Evidence for cytochrome P4503A4 involvement in their major metabolic pathways. Drug Metab Dispos. 1998 Feb;26(2):188-91. [Article] Miyazawa M, Shindo M, Shimada T: Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes. Drug Metab Dispos. 2001 Feb;29(2):200-5. [Article] Finta C, Zaphiropoulos PG: Intergenic mRNA molecules resulting from trans-splicing. J Biol Chem. 2002 Feb 22;277(8):5882-90. Epub 2001 Nov 28. [Article] Dauchy S, Dutheil F, Weaver RJ, Chassoux F, Daumas-Duport C, Couraud PO, Scherrmann JM, De Waziers I, Decleves X: ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J Neurochem. 2008 Dec;107(6):1518-28. doi: 10.1111/j.1471-4159.2008.05720.x. [Article] Agarwal V, Kommaddi RP, Valli K, Ryder D, Hyde TM, Kleinman JE, Strobel HW, Ravindranath V: Drug metabolism in human brain: high levels of cytochrome P4503A43 in brain and metabolism of anti-anxiety drug alprazolam to its active metabolite. PLoS One. 2008 Jun 11;3(6):e2337. doi: 10.1371/journal.pone.0002337. [Article] Pabarcus MK, Hoe N, Sadeghi S, Patterson C, Wiertz E, Correia MA: CYP3A4 ubiquitination by gp78 (the tumor autocrine motility factor receptor, AMFR) and CHIP E3 ligases. Arch Biochem Biophys. 2009 Mar 1;483(1):66-74. doi: 10.1016/j.abb.2008.12.001. Epub 2008 Dec 10. [Article] Dutheil F, Dauchy S, Diry M, Sazdovitch V, Cloarec O, Mellottee L, Bieche I, Ingelman-Sundberg M, Flinois JP, de Waziers I, Beaune P, Decleves X, Duyckaerts C, Loriot MA: Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function. Drug Metab Dispos. 2009 Jul;37(7):1528-38. doi: 10.1124/dmd.109.027011. Epub 2009 Apr 9. [Article] Honda A, Miyazaki T, Ikegami T, Iwamoto J, Maeda T, Hirayama T, Saito Y, Teramoto T, Matsuzaki Y: Cholesterol 25-hydroxylation activity of CYP3A. J Lipid Res. 2011 Aug;52(8):1509-16. doi: 10.1194/jlr.M014084. Epub 2011 May 16. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Yano JK, Wester MR, Schoch GA, Griffin KJ, Stout CD, Johnson EF: The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-A resolution. J Biol Chem. 2004 Sep 10;279(37):38091-4. Epub 2004 Jul 16. [Article] Williams PA, Cosme J, Vinkovic DM, Ward A, Angove HC, Day PJ, Vonrhein C, Tickle IJ, Jhoti H: Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone. Science. 2004 Jul 30;305(5684):683-6. Epub 2004 Jul 15. [Article] Sata F, Sapone A, Elizondo G, Stocker P, Miller VP, Zheng W, Raunio H, Crespi CL, Gonzalez FJ: CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activity. Clin Pharmacol Ther. 2000 Jan;67(1):48-56. [Article] Dai D, Tang J, Rose R, Hodgson E, Bienstock RJ, Mohrenweiser HW, Goldstein JA: Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos. J Pharmacol Exp Ther. 2001 Dec;299(3):825-31. [Article] Eiselt R, Domanski TL, Zibat A, Mueller R, Presecan-Siedel E, Hustert E, Zanger UM, Brockmoller J, Klenk HP, Meyer UA, Khan KK, He YA, Halpert JR, Wojnowski L: Identification and functional characterization of eight CYP3A4 protein variants. Pharmacogenetics. 2001 Jul;11(5):447-58. [Article] Lamba JK, Lin YS, Thummel K, Daly A, Watkins PB, Strom S, Zhang J, Schuetz EG: Common allelic variants of cytochrome P4503A4 and their prevalence in different populations. Pharmacogenetics. 2002 Mar;12(2):121-32. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB05478Pradefovir mesylateinvestigationalunknownDetailsDB00180Flunisolideapproved, investigationalunknownsubstrateinducerDetailsDB00185CevimelineapprovedunknownsubstrateDetailsDB00188Bortezomibapproved, investigationalnosubstrateDetailsDB00196Fluconazoleapproved, investigationalunknowninhibitorDetailsDB00204Dofetilideapproved, investigationalunknownsubstrateDetailsDB00213PantoprazoleapprovedunknownsubstrateDetailsDB00216Eletriptanapproved, investigationalunknownsubstrateDetailsDB00220NelfinavirapprovednosubstrateinhibitorDetailsDB00224IndinavirapprovedunknownsubstrateinhibitorDetailsDB00227Lovastatinapproved, investigationalunknownsubstrateinhibitorDetailsDB00234Reboxetineapproved, experimentalunknownsubstrateinhibitorDetailsDB00238NevirapineapprovedunknownsubstrateinducerDetailsDB00243Ranolazineapproved, investigationalnosubstrateinhibitorDetailsDB00246ZiprasidoneapprovedunknownsubstrateDetailsDB00270Isradipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00280DisopyramideapprovedunknownsubstrateDetailsDB00286Conjugated estrogensapprovednosubstrateDetailsDB00294Etonogestrelapproved, investigationalnosubstrateDetailsDB00297Bupivacaineapproved, investigationalunknownsubstrateDetailsDB00307Bexaroteneapproved, investigationalunknownsubstrateinducerDetailsDB00309Vindesineapproved, investigationalunknownsubstrateDetailsDB00317Gefitinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00320Dihydroergotamineapproved, investigationalunknownsubstrateinhibitorDetailsDB00324Fluorometholoneapproved, investigationalunknownsubstrateinducerDetailsDB00342Terfenadineapproved, withdrawnunknownsubstrateinhibitorDetailsDB00343Diltiazemapproved, investigationalunknownsubstrateinhibitorDetailsDB00346Alfuzosinapproved, investigationalunknownsubstrateDetailsDB00361Vinorelbineapproved, investigationalnosubstrateDetailsDB00365Grepafloxacinapproved, investigational, withdrawnunknownsubstrateDetailsDB00370MirtazapineapprovedunknownsubstrateinhibitorDetailsDB00381AmlodipineapprovednosubstrateDetailsDB00393Nimodipineapproved, investigationalunknownsubstrateDetailsDB00398Sorafenibapproved, investigationalunknownsubstrateinhibitorDetailsDB00401NisoldipineapprovedunknownsubstrateDetailsDB00402Eszopicloneapproved, investigationalunknownsubstrateDetailsDB00404Alprazolamapproved, illicit, investigationalunknownsubstrateDetailsDB00425ZolpidemapprovedunknownsubstrateDetailsDB00443Betamethasoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00455Loratadineapproved, investigationalnosubstrateinhibitorDetailsDB00468QuinineapprovedunknownsubstrateinhibitorinducerDetailsDB00470Dronabinolapproved, illicitnosubstrateinhibitorDetailsDB00471MontelukastapprovedunknownsubstrateDetailsDB00490Buspironeapproved, investigationalunknownsubstrateDetailsDB00496Darifenacinapproved, investigationalunknownsubstrateDetailsDB00518Albendazoleapproved, vet_approvedunknownsubstrateDetailsDB00528Lercanidipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00533Rofecoxibapproved, investigational, withdrawnunknownsubstrateinducerDetailsDB00539Toremifeneapproved, investigationalunknownsubstrateinhibitorDetailsDB00541Vincristineapproved, investigationalunknownsubstrateDetailsDB00559Bosentanapproved, investigationalunknownsubstrateinducerDetailsDB00570VinblastineapprovedunknownsubstrateinhibitorinducerDetailsDB00582VoriconazoleapprovedunknownsubstrateinhibitorDetailsDB00588Fluticasone propionateapprovedunknownsubstrateinhibitorDetailsDB00593EthosuximideapprovedunknownsubstrateDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknownsubstrateinducerDetailsDB00604Cisaprideapproved, investigational, withdrawnunknownsubstrateDetailsDB00615Rifabutinapproved, investigationalunknownsubstrateinducerDetailsDB00619ImatinibapprovednosubstrateinhibitorDetailsDB00622Nicardipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00624Testosteroneapproved, investigationalunknownsubstrateinducerDetailsDB00625Efavirenzapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00635Prednisoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00636Clofibrateapproved, investigationalunknownsubstrateinducerDetailsDB00637Astemizoleapproved, withdrawnunknownsubstrateinhibitorDetailsDB00641SimvastatinapprovedunknownsubstrateDetailsDB00673Aprepitantapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00674GalantamineapprovednosubstrateDetailsDB00675TamoxifenapprovedunknownsubstrateinhibitorinducerDetailsDB00678LosartanapprovedunknownsubstrateinhibitorDetailsDB00683Midazolamapproved, illicitunknownsubstrateinhibitorDetailsDB00696ErgotamineapprovedunknownsubstrateinhibitorDetailsDB00700EplerenoneapprovedunknownsubstrateDetailsDB00701Amprenavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00705DelavirdineapprovedunknownsubstrateinhibitorDetailsDB00731Nateglinideapproved, investigationalunknownsubstrateDetailsDB00736Esomeprazoleapproved, investigationalunknownsubstrateDetailsDB00741Hydrocortisoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00744Zileutonapproved, investigational, withdrawnunknownsubstrateDetailsDB00745Modafinilapproved, investigationalunknownsubstrateinducerDetailsDB00757Dolasetronapproved, investigationalunknownsubstrateDetailsDB00758ClopidogrelapprovednosubstrateDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateinhibitorDetailsDB00769HydrocortamateapprovedunknowninducerDetailsDB00773EtoposideapprovedunknownsubstrateinhibitorinducerDetailsDB00778Roxithromycinapproved, investigational, withdrawnnosubstrateinhibitorDetailsDB00802Alfentanilapproved, illicitunknownsubstrateDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB00820Tadalafilapproved, investigationalnosubstrateDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00834Mifepristoneapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00836LoperamideapprovedunknownsubstrateinhibitorDetailsDB00843DonepezilapprovedunknownsubstrateDetailsDB00860Prednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB00862VardenafilapprovedunknownsubstrateinhibitorDetailsDB00864Tacrolimusapproved, investigationalunknownsubstrateDetailsDB00872Conivaptanapproved, investigationalunknownsubstrateinhibitorDetailsDB00877Sirolimusapproved, investigationalnosubstrateDetailsDB00889Granisetronapproved, investigationalunknownsubstrateDetailsDB00897Triazolamapproved, investigationalunknownsubstrateDetailsDB00904Ondansetronapproved, withdrawnunknownsubstrateDetailsDB00906Tiagabineapproved, investigationalunknownsubstrateDetailsDB00907Cocaineapproved, illicitunknownsubstrateDetailsDB00909Zonisamideapproved, investigationalunknownsubstrateDetailsDB00910Paricalcitolapproved, investigationalunknownsubstrateDetailsDB00911Tinidazoleapproved, investigationalunknownsubstrateDetailsDB00918Almotriptanapproved, investigationalunknownsubstrateDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00932Tipranavirapproved, investigationalunknownsubstrateinhibitorDetailsDB00938SalmeterolapprovedunknownsubstrateDetailsDB00956Hydrocodoneapproved, illicit, investigationalunknownsubstrateDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB00962Zaleplonapproved, illicit, investigationalunknownsubstrateDetailsDB00976TelithromycinapprovedunknownsubstrateinhibitorDetailsDB00977EthinylestradiolapprovedunknownsubstrateDetailsDB00990Exemestaneapproved, investigationalunknownsubstrateDetailsDB00997Doxorubicinapproved, investigationalnosubstrateinhibitorDetailsDB01002Levobupivacaineapproved, investigationalunknownsubstrateDetailsDB01006Letrozoleapproved, investigationalunknownsubstrateDetailsDB01008Busulfanapproved, investigationalunknownsubstrateDetailsDB01012CinacalcetapprovedunknownsubstrateDetailsDB01023Felodipineapproved, investigationalunknownsubstrateDetailsDB01026Ketoconazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB01045RifampicinapprovedunknowninducerDetailsDB01054Nitrendipineapproved, investigationalunknownsubstrateDetailsDB01062Oxybutyninapproved, investigationalunknownsubstrateinhibitorDetailsDB01068Clonazepamapproved, illicitunknownsubstrateDetailsDB01072Atazanavirapproved, investigationalnosubstrateinhibitorDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB01100PimozideapprovedunknownsubstrateDetailsDB01105Sibutramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB01114ChlorpheniramineapprovedunknownsubstrateDetailsDB01115NifedipineapprovedunknownsubstrateinhibitorinducerDetailsDB01129Rabeprazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB01132Pioglitazoneapproved, investigationalunknownsubstrateinducerDetailsDB01149Nefazodoneapproved, withdrawnunknownsubstrateinhibitorDetailsDB01166Cilostazolapproved, investigationalunknownsubstrateDetailsDB01167Itraconazoleapproved, investigationalnosubstrateinhibitorDetailsDB01175EscitalopramapprovednosubstrateDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB01190Clindamycinapproved, vet_approvedunknownsubstrateinhibitorDetailsDB01200Bromocriptineapproved, investigational, withdrawnnosubstrateinhibitorDetailsDB01206Lomustineapproved, investigationalunknowninhibitorDetailsDB01211ClarithromycinapprovedunknownsubstrateinhibitorDetailsDB01215Estazolamapproved, illicitunknownsubstrateDetailsDB01216FinasterideapprovedunknownsubstrateDetailsDB01218HalofantrineapprovedunknownsubstrateDetailsDB01222BudesonideapprovednosubstrateinducerDetailsDB01224QuetiapineapprovedunknownsubstrateDetailsDB01227Levacetylmethadolapproved, investigational, withdrawnunknownsubstrateDetailsDB01229Paclitaxelapproved, vet_approvedunknownsubstrateinducerDetailsDB01232Saquinavirapproved, investigationalunknownsubstrateinhibitorDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB01238Aripiprazoleapproved, investigationalnosubstrateDetailsDB01254Dasatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB01256RetapamulinapprovedunknownsubstrateDetailsDB01261Sitagliptinapproved, investigationalunknownsubstrateDetailsDB01259Lapatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB01264DarunavirapprovedunknownsubstrateinhibitorDetailsDB01268Sunitinibapproved, investigationalnosubstrateinhibitorDetailsDB01263Posaconazoleapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB01388Mibefradilinvestigational, withdrawnunknownsubstrateinhibitorDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknowninducerDetailsDB01601LopinavirapprovedunknownsubstrateinhibitorDetailsDB01411PranlukastinvestigationalnosubstrateDetailsDB01410Ciclesonideapproved, investigationalnosubstrateDetailsDB00969Alosetronapproved, withdrawnunknownsubstrateDetailsDB04835Maravirocapproved, investigationalunknownsubstrateDetailsDB01409TiotropiumapprovedunknownsubstrateDetailsDB01591SolifenacinapprovednosubstrateDetailsDB01011Metyraponeapproved, investigationalunknowninhibitorinducerDetailsDB00377Palonosetronapproved, investigationalunknownsubstrateDetailsDB04856DexloxiglumideinvestigationalunknownsubstrateDetailsDB04886Calanolide AinvestigationalunknownsubstrateDetailsDB00580Valdecoxibapproved, investigational, withdrawnunknownsubstrateDetailsDB06144Sertindoleapproved, investigational, withdrawnunknownsubstrateDetailsDB04977PlitidepsininvestigationalunknownsubstrateDetailsDB04905TesmilifeneinvestigationalunknownsubstrateinhibitorinducerDetailsDB00333MethadoneapprovedunknownsubstrateinhibitorinducerDetailsDB04934RifalazilinvestigationalunknownsubstrateDetailsDB04957AzimilideinvestigationalunknownsubstrateDetailsDB00199Erythromycinapproved, investigational, vet_approvednosubstrateinhibitorDetailsDB01628Etoricoxibapproved, investigationalunknownsubstrateinhibitorDetailsDB00564Carbamazepineapproved, investigationalunknownsubstrateinducerDetailsDB06155Rimonabantapproved, investigationalunknownsubstrateDetailsDB06267Udenafilapproved, investigationalunknownsubstrateDetailsDB06287TemsirolimusapprovedunknownsubstrateDetailsDB06442AvasimibeinvestigationalunknowninducerDetailsDB08502CapravirineinvestigationalunknownsubstrateDetailsDB06652VicrivirocinvestigationalunknownsubstrateDetailsDB06685LaquinimodinvestigationalunknownsubstrateDetailsDB01095FluvastatinapprovedunknownsubstrateinhibitorDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateDetailsDB00248CabergolineapprovedunknownsubstrateDetailsDB00589Lisurideapproved, investigationalunknownsubstrateDetailsDB01186Pergolideapproved, investigational, vet_approved, withdrawnunknowninhibitorDetailsDB05271RotigotineapprovedunknownsubstrateDetailsDB00439Cerivastatinapproved, withdrawnunknownsubstrateinhibitorinducerDetailsDB00257Clotrimazoleapproved, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00734Risperidoneapproved, investigationalunknownsubstrateDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB01037Selegilineapproved, investigational, vet_approvedunknownsubstrateDetailsDB01159Halothaneapproved, vet_approvedunknownsubstrateDetailsDB01181IfosfamideapprovedunknownsubstrateinhibitorinducerDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB00814Meloxicamapproved, vet_approvedunknownsubstrateDetailsDB00908Quinidineapproved, investigationalunknownsubstrateinhibitorDetailsDB00656Trazodoneapproved, investigationalunknownsubstrateDetailsDB00176Fluvoxamineapproved, investigationalunknownsubstrateinhibitorDetailsDB00321AmitriptylineapprovedunknownsubstrateDetailsDB00540NortriptylineapprovedunknownsubstrateDetailsDB00215CitalopramapprovednosubstrateinhibitorDetailsDB00924CyclobenzaprineapprovedunknownsubstrateDetailsDB00472Fluoxetineapproved, vet_approvednosubstrateinhibitorDetailsDB01104SertralineapprovedunknownsubstrateinhibitorDetailsDB06148Mianserinapproved, investigationalunknownsubstrateDetailsDB01435Antipyrineapproved, investigationalunknownsubstrateDetailsDB01118Amiodaroneapproved, investigationalnosubstrateinhibitorDetailsDB00250Dapsoneapproved, investigationalunknownsubstrateDetailsDB00531Cyclophosphamideapproved, investigationalunknownsubstrateinducerDetailsDB05109Trabectedinapproved, investigationalunknownsubstrateDetailsDB00946Phenprocoumonapproved, investigationalunknownsubstrateDetailsDB00682WarfarinapprovedunknownsubstrateinducerDetailsDB00285VenlafaxineapprovedunknownsubstrateDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB00972AzelastineapprovedunknownsubstrateinhibitorDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00661VerapamilapprovedunknownsubstrateinhibitorDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateinducerDetailsDB00201CaffeineapprovedunknownsubstrateDetailsDB00318Codeineapproved, illicitunknownsubstrateDetailsDB00514DextromethorphanapprovedunknownsubstrateDetailsDB01248Docetaxelapproved, investigationalunknownsubstrateinhibitorDetailsDB00502HaloperidolapprovedunknownsubstrateinhibitorDetailsDB00281Lidocaineapproved, vet_approvedunknownsubstrateDetailsDB00571Propranololapproved, investigationalunknownsubstrateDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00446Chloramphenicolapproved, vet_approved, withdrawnunknowninhibitorDetailsDB00537Ciprofloxacinapproved, investigationalunknowninhibitorDetailsDB01059NorfloxacinapprovedunknowninhibitorDetailsDB06403Ambrisentanapproved, investigationalunknownsubstrateDetailsDB06413Armodafinilapproved, investigationalunknowninducerDetailsDB00865Benzphetamineapproved, illicitunknownsubstrateDetailsDB00612BisoprololapprovedunknownsubstrateDetailsDB00136Calcitriolapproved, nutraceuticalunknownsubstrateinducerDetailsDB00608Chloroquineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00349Clobazamapproved, illicitnosubstrateinducerDetailsDB00628Clorazepic acidapproved, illicitunknownsubstrateDetailsDB01396Digitoxinapproved, investigationalunknownsubstrateDetailsDB04855DronedaroneapprovedunknownsubstrateinhibitorDetailsDB04574Estrone sulfateapprovedunknownsubstrateDetailsDB06414EtravirineapprovedunknownsubstrateinducerDetailsDB01590EverolimusapprovedunknownsubstrateDetailsDB00949FelbamateapprovedunknownsubstrateinducerDetailsDB06702FesoterodineapprovedunknownsubstrateDetailsDB00690Flurazepamapproved, illicit, investigationalunknownsubstrateDetailsDB00499Flutamideapproved, investigationalunknownsubstrateDetailsDB01018Guanfacineapproved, investigationalunknownsubstrateDetailsDB04845Ixabepiloneapproved, investigationalunknownsubstrateDetailsDB00448Lansoprazoleapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00367Levonorgestrelapproved, investigationalunknownsubstrateDetailsDB00358Mefloquineapproved, investigationalunknownsubstrateinhibitorDetailsDB04868Nilotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB06712Nilvadipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00497Oxycodoneapproved, illicit, investigationalunknownsubstrateDetailsDB06589PazopanibapprovedunknownsubstrateinhibitorDetailsDB01621Pipotiazineapproved, investigationalunknownsubstrateDetailsDB01058Praziquantelapproved, investigational, vet_approvedunknownsubstrateDetailsDB01087PrimaquineapprovedunknownsubstrateinhibitorDetailsDB00647Dextropropoxypheneapproved, illicit, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00912Repaglinideapproved, investigationalunknownsubstrateDetailsDB06228RivaroxabanapprovedunknownsubstrateDetailsDB06176Romidepsinapproved, investigationalunknownsubstrateDetailsDB06207SilodosinapprovedunknownsubstrateDetailsDB00706Tamsulosinapproved, investigationalunknownsubstrateDetailsDB00444TeniposideapprovedunknownsubstrateinhibitorDetailsDB00759Tetracyclineapproved, vet_approved, withdrawnunknownsubstrateinhibitorDetailsDB00277TheophyllineapprovedunknownsubstrateDetailsDB01036Tolterodineapproved, investigationalunknownsubstrateDetailsDB06212TolvaptanapprovedunknownsubstrateDetailsDB00193Tramadolapproved, investigationalunknownsubstrateDetailsDB00440Trimethoprimapproved, vet_approvedunknownsubstrateDetailsDB01198ZopicloneapprovedunknownsubstrateDetailsDB00357Aminoglutethimideapproved, investigationalunknowninducerDetailsDB01320Fosphenytoinapproved, investigationalunknownsubstrateinducerDetailsDB00607Nafcillinapproved, investigationalunknowninducerDetailsDB00776OxcarbazepineapprovedunknowninhibitorinducerDetailsDB00312Pentobarbitalapproved, investigational, vet_approvedunknowninducerDetailsDB01174Phenobarbitalapproved, investigationalunknowninducerDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinducerDetailsDB00794Primidoneapproved, vet_approvedunknowninducerDetailsDB01201Rifapentineapproved, investigationalunknownsubstrateinducerDetailsDB01394ColchicineapprovedunknownsubstrateinhibitorDetailsDB01253ErgometrineapprovedunknownsubstrateDetailsDB01221Ketamineapproved, vet_approvedunknownsubstrateinducerDetailsDB00353MethylergometrineapprovedunknownsubstrateinhibitorDetailsDB06335SaxagliptinapprovedunknownsubstrateDetailsDB00708Sufentanilapproved, investigationalunknownsubstrateDetailsDB01128BicalutamideapprovedunknownsubstrateinhibitorDetailsDB01151Desipramineapproved, investigationalunknowninhibitorDetailsDB00916MetronidazoleapprovedunknowninhibitorDetailsDB06268Sitaxentanapproved, investigational, withdrawnunknowninhibitorDetailsDB01424Aminophenazoneapproved, withdrawnunknownsubstrateDetailsDB00363ClozapineapprovednosubstrateinhibitorinducerDetailsDB00420Promazineapproved, vet_approvedunknownsubstrateDetailsDB01136Carvedilolapproved, investigationalunknownsubstrateDetailsDB00549Zafirlukastapproved, investigationalunknownsubstrateinhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00482Celecoxibapproved, investigationalunknownsubstrateDetailsDB01016GlyburideapprovedunknownsubstrateinhibitorDetailsDB01138SulfinpyrazoneapprovedunknownsubstrateinducerDetailsDB06739SeratrodastexperimentalunknownsubstrateinducerDetailsDB06738KetobemidoneinvestigationalunknownsubstrateDetailsDB01242Clomipramineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00655EstroneapprovednosubstrateDetailsDB00458ImipramineapprovedunknownsubstrateDetailsDB00546AdinazolamexperimentalunknownsubstrateDetailsDB00231Temazepamapproved, investigationalunknownsubstrateDetailsDB03701VanoxerineinvestigationalunknownsubstrateDetailsDB00169Cholecalciferolapproved, nutraceuticalunknownsubstrateDetailsDB01192Oxymorphoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB01173OrphenadrineapprovedunknownsubstrateinhibitorDetailsDB06772CabazitaxelapprovedunknownsubstrateDetailsDB02709ResveratrolinvestigationalnoinhibitorDetailsDB06700Desvenlafaxineapproved, investigationalnosubstrateinhibitorDetailsDB06697ArtemetherapprovedunknownsubstrateinducerDetailsDB06708LumefantrineapprovedunknownsubstrateDetailsDB00819Acetazolamideapproved, vet_approvedunknowninhibitorDetailsDB06742Ambroxolapproved, investigationalunknownsubstrateDetailsDB01223AminophyllineapprovedunknownsubstrateDetailsDB00278Argatrobanapproved, investigationalunknownsubstrateDetailsDB01169Arsenic trioxideapproved, investigationalunknowninhibitorDetailsDB00207AzithromycinapprovedunknownsubstrateinhibitorDetailsDB01393Bezafibrateapproved, investigationalunknownsubstrateDetailsDB04794Bifonazoleapproved, investigationalunknowninhibitorDetailsDB01194BrinzolamideapprovednosubstrateDetailsDB00520CaspofunginapprovedunknowninhibitorDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknowninducerDetailsDB00356ChlorzoxazoneapprovedunknownsubstrateinhibitorDetailsDB00845Clofazimineapproved, investigationalunknowninhibitorDetailsDB06470ClomethiazoleinvestigationalunknownsubstrateDetailsDB01559Clotiazepamapproved, illicitunknownsubstrateDetailsDB00987Cytarabineapproved, investigationalunknownsubstrateDetailsDB01406DanazolapprovedunknowninhibitorDetailsDB00694DaunorubicinapprovedunknownsubstrateinhibitorDetailsDB01093Dimethyl sulfoxideapproved, vet_approvedunknowninhibitorDetailsDB00822DisulfiramapprovedunknownsubstrateDetailsDB00254Doxycyclineapproved, investigational, vet_approvedunknowninhibitorDetailsDB01127EconazoleapprovednoinhibitorDetailsDB00751Epinastineapproved, investigationalunknownsubstrateDetailsDB00668Epinephrineapproved, vet_approvedunknowninhibitorDetailsDB01196Estramustineapproved, investigationalunknownsubstrateDetailsDB00898EthanolapprovedunknownsubstrateinhibitorinducerDetailsDB01466Ethylmorphineexperimental, illicitunknownsubstrateDetailsDB00301Flucloxacillinapproved, investigationalunknownsubstrateinducerDetailsDB01544Flunitrazepamapproved, illicitunknownsubstrateDetailsDB00947Fulvestrantapproved, investigationalunknownsubstrateDetailsDB01275HydralazineapprovednoinhibitorDetailsDB00724Imiquimodapproved, investigationalunknownsubstrateDetailsDB01029Irbesartanapproved, investigationalnoinhibitorDetailsDB00602Ivermectinapproved, investigational, vet_approvednosubstrateDetailsDB01103QuinacrineinvestigationalunknownsubstrateDetailsDB01071MequitazineexperimentalunknowninhibitorDetailsDB04817Metamizoleapproved, investigational, withdrawnunknowninducerDetailsDB04833Methaqualoneillicit, withdrawnunknownsubstrateDetailsDB01028Methoxyfluraneapproved, investigational, vet_approved, withdrawnunknownsubstrateDetailsDB06710MethyltestosteroneapprovedunknownsubstrateDetailsDB00379Mexiletineapproved, investigationalunknownsubstrateDetailsDB01204Mitoxantroneapproved, investigationalunknowninhibitorDetailsDB00295Morphineapproved, investigationalnosubstrateDetailsDB01183Naloxoneapproved, vet_approvedunknownsubstrateinhibitorDetailsDB02701Nicotinamideapproved, investigationalunknowninhibitorDetailsDB00184NicotineapprovedunknownsubstrateDetailsDB01595NitrazepamapprovedunknownsubstrateDetailsDB00768OlopatadineapprovednosubstrateDetailsDB00316AcetaminophenapprovedunknownsubstrateinducerDetailsDB01074Perhexilineapproved, investigationalunknownsubstrateDetailsDB00850PerphenazineapprovedunknownsubstrateDetailsDB00454MeperidineapprovedunknownsubstrateinducerDetailsDB03783PhenacetinwithdrawnunknownsubstrateDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB00812Phenylbutazoneapproved, vet_approvedunknowninducerDetailsDB01085Pilocarpineapproved, investigationalunknowninhibitorDetailsDB01588Prazepamapproved, illicitunknownsubstrateDetailsDB01032Probenecidapproved, investigationalunknowninducerDetailsDB01182PropafenoneapprovedunknownsubstrateDetailsDB01589Quazepamapproved, illicitnosubstrateDetailsDB00481Raloxifeneapproved, investigationalunknowninhibitorDetailsDB00863Ranitidineapproved, withdrawnunknowninhibitorDetailsDB01220Rifaximinapproved, investigationalunknownsubstrateinducerDetailsDB00296RopivacaineapprovedunknownsubstrateDetailsDB01698Rutinapproved, experimental, investigationalunknowninducerDetailsDB01001Salbutamolapproved, vet_approvedunknowninhibitorDetailsDB01236Sevofluraneapproved, vet_approvedunknownsubstrateDetailsDB00359Sulfadiazineapproved, investigational, vet_approvedunknownsubstrateDetailsDB01015SulfamethoxazoleapprovedunknownsubstrateDetailsDB01349TasosartanexperimentalunknownsubstrateDetailsDB00763MethimazoleapprovedunknowninhibitorDetailsDB04572Thiotepaapproved, investigationalunknownsubstrateDetailsDB01007TioconazoleapprovedunknowninhibitorDetailsDB00273TopiramateapprovedunknowninducerDetailsDB00347TrimethadioneapprovedunknownsubstrateDetailsDB13179TroleandomycinapprovedunknownsubstrateinhibitorDetailsDB00313Valproic acidapproved, investigationalunknowninhibitorDetailsDB01392Yohimbineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00495ZidovudineapprovedunknownsubstrateDetailsDB04828ZomepiracwithdrawnunknownsubstrateDetailsDB01380Cortisone acetateapproved, investigationalunknownsubstrateinducerDetailsDB01384ParamethasoneexperimentalunknownsubstrateinhibitorinducerDetailsDB01587KetazolamapprovedunknownsubstrateinhibitorDetailsDB08811TofisopamexperimentalunknowninhibitorDetailsDB00617ParamethadioneapprovedunknownsubstrateDetailsDB00755Tretinoinapproved, investigational, nutraceuticalunknownsubstrateDetailsDB00980Ramelteonapproved, investigationalunknownsubstrateDetailsDB04946IloperidoneapprovedunknownsubstrateDetailsDB01418Acenocoumarolapproved, investigationalunknownsubstrateDetailsDB06684VilazodoneapprovedunknownsubstrateDetailsDB00255Diethylstilbestrolapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00575ClonidineapprovedunknownsubstrateDetailsDB00973EzetimibeapprovedunknowninhibitorDetailsDB00400Griseofulvinapproved, investigational, vet_approvedunknowninducerDetailsDB00808IndapamideapprovedunknownsubstrateDetailsDB05521Telaprevirapproved, withdrawnunknownsubstrateinhibitorDetailsDB08820IvacaftorapprovednosubstrateinhibitorDetailsDB06634CasopitantinvestigationalunknownDetailsDB04975BanoxantroneinvestigationalunknownsubstrateDetailsDB05039IndacaterolapprovedunknownsubstrateDetailsDB08816TicagrelorapprovedunknownsubstrateinhibitorDetailsDB06774CapsaicinapprovedunknowninhibitorDetailsDB06174Noscapineapproved, investigationalunknowninhibitorDetailsDB01333CefradineapprovedunknowninducerDetailsDB06777Chenodeoxycholic acidapprovedunknownsubstrateDetailsDB00856Chlorphenesinapproved, experimentalunknowninducerDetailsDB04920Clevidipineapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB01764DalfopristinapprovedunknowninhibitorDetailsDB01609Deferasiroxapproved, investigationalunknowninducerDetailsDB00485Dicloxacillinapproved, investigational, vet_approvedunknowninducerDetailsDB06370IndisulaminvestigationalunknowninhibitorDetailsDB01083Orlistatapproved, investigationalunknowninducerDetailsDB00239OxiconazoleapprovedunknowninducerDetailsDB00082PegvisomantapprovedunknowninducerDetailsDB06762PinacidilapprovedunknownsubstrateDetailsDB01369QuinupristinapprovedunknowninhibitorDetailsDB00337Pimecrolimusapproved, investigationalunknownsubstrateDetailsDB00041AldesleukinapprovedunknowninhibitorDetailsDB06605ApixabanapprovednosubstrateDetailsDB08827Lomitapideapproved, investigationalnosubstrateDetailsDB08828Vismodegibapproved, investigationalnosubstrateDetailsDB00620Triamcinoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB08864RilpivirineapprovednosubstrateinhibitorinducerDetailsDB06209PrasugrelapprovednosubstrateDetailsDB06216AsenapineapprovedunknownsubstrateDetailsDB00435Nitric OxideapprovedunknowninhibitorDetailsDB08867UlipristalapprovednosubstrateDetailsDB08815Lurasidoneapproved, investigationalunknownsubstrateDetailsDB08870Brentuximab vedotinapproved, investigationalnosubstrateinhibitorDetailsDB04871Lorcaserinapproved, withdrawnnosubstrateDetailsDB05294VandetanibapprovedunknownsubstrateDetailsDB08873Boceprevirapproved, withdrawnunknownsubstrateinhibitorDetailsDB08875Cabozantinibapproved, investigationalnosubstrateDetailsDB08877RuxolitinibapprovedunknownsubstrateDetailsDB05812AbirateroneapprovedunknownsubstrateinhibitorDetailsDB08881VemurafenibapprovedunknownsubstrateinducerDetailsDB08882LinagliptinapprovedunknownsubstrateinhibitorDetailsDB08883PerampanelapprovednosubstrateinducerDetailsDB08865Crizotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB06626Axitinibapproved, investigationalnosubstrateDetailsDB08893MirabegronapprovednosubstrateDetailsDB06237AvanafilapprovedunknownsubstrateDetailsDB08896RegorafenibapprovedunknownsubstrateinhibitorDetailsDB08899EnzalutamideapprovednosubstrateinducerDetailsDB08895Tofacitinibapproved, investigationalnosubstrateDetailsDB06616BosutinibapprovednosubstrateinhibitorDetailsDB08901Ponatinibapproved, investigationalunknownsubstrateDetailsDB08903BedaquilineapprovednosubstrateDetailsDB06201RufinamideapprovedunknowninducerDetailsDB08906Fluticasone furoateapprovednosubstrateinhibitorinducerDetailsDB08907CanagliflozinapprovedunknownsubstrateDetailsDB06203AlogliptinapprovedunknownsubstrateDetailsDB04938Ospemifeneapproved, investigationalunknownsubstrateDetailsDB08910PomalidomideapprovedunknownsubstrateDetailsDB08911TrametinibapprovedunknownsubstrateinducerDetailsDB08912Dabrafenibapproved, investigationalnosubstrateinhibitorinducerDetailsDB05773Trastuzumab emtansineapproved, investigationalunknownsubstrateDetailsDB08833Taurochenodeoxycholic acidexperimentalunknownsubstrateDetailsDB01142Doxepinapproved, investigationalnosubstrateDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB08918Levomilnacipranapproved, investigationalunknownsubstrateDetailsDB08932MacitentanapprovednosubstrateDetailsDB08933LuliconazoleapprovednoinhibitorDetailsDB06292DapagliflozinapprovednosubstrateDetailsDB09039Eliglustatapproved, investigationalnosubstrateDetailsDB05676Apremilastapproved, investigationalnosubstrateDetailsDB09049NaloxegolapprovedunknownsubstrateDetailsDB09053IbrutinibapprovedunknownsubstrateDetailsDB00951Isoniazidapproved, investigationalunknownDetailsDB09074OlaparibapprovedunknownsubstrateinhibitorDetailsDB09078Lenvatinibapproved, investigationalnosubstrateinhibitorinducerDetailsDB09073Palbociclibapproved, investigationalnosubstrateinhibitorDetailsDB09054IdelalisibapprovednosubstrateinhibitorinducerDetailsDB09068Vortioxetineapproved, investigationalnosubstrateDetailsDB09082VilanterolapprovednosubstrateDetailsDB09083IvabradineapprovednosubstrateDetailsDB09026Aliskirenapproved, investigationalnosubstrateDetailsDB09101ElvitegravirapprovednosubstrateinhibitorDetailsDB06016Cariprazineapproved, investigationalnosubstrateinhibitorinducerDetailsDB08439ParecoxibapprovedunknownsubstrateDetailsDB09128Brexpiprazoleapproved, investigationalnosubstrateDetailsDB09291Rolapitantapproved, investigationalnosubstrateDetailsDB04908Flibanserinapproved, investigationalnosubstrateDetailsDB09102Daclatasvirapproved, investigationalunknownsubstrateDetailsDB09143Sonidegibapproved, investigationalunknownsubstrateDetailsDB06636Isavuconazoniumapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB06603Panobinostatapproved, investigationalunknownsubstrateDetailsDB05239Cobimetinibapproved, investigationalnosubstrateinhibitorDetailsDB09570Ixazomibapproved, investigationalunknownsubstrateDetailsDB09330OsimertinibapprovednosubstrateinhibitorinducerDetailsDB11362SelexipagapprovednosubstrateDetailsDB09119Eslicarbazepine acetateapprovednoinducerDetailsDB06789Hydroxyprogesterone caproateapproved, investigationalunknownsubstrateDetailsDB08931RiociguatapprovedunknownsubstrateDetailsDB09183DasabuvirapprovednosubstrateDetailsDB09297Paritaprevirapproved, investigationalnosubstrateDetailsDB09317Synthetic Conjugated Estrogens, AapprovednosubstrateDetailsDB09318Synthetic Conjugated Estrogens, BapprovednosubstrateDetailsDB09389NorgestrelapprovedunknownsubstrateDetailsDB11581Venetoclaxapproved, investigationalnosubstrateinhibitorDetailsDB09280LumacaftorapprovednoinducerDetailsDB01323St. John's Wortapproved, investigational, nutraceuticalunknownsubstrateinduceractivatorDetailsDB09381Esterified estrogensapprovedunknownsubstrateDetailsDB00957Norgestimateapproved, investigationalunknownsubstrateinducerDetailsDB04911Oritavancinapproved, investigationalunknowninhibitorinducerDetailsDB06717FosaprepitantapprovedunknownsubstrateinhibitorinducerDetailsDB00648MitotaneapprovedunknowninducerDetailsDB08909Glycerol phenylbutyrateapprovedunknowninducerDetailsDB09048Netupitantapproved, investigationalnosubstrateinhibitorDetailsDB12332Rucaparibapproved, investigationalnosubstrateinhibitorDetailsDB11921Deflazacortapproved, investigationalnosubstrateinducerDetailsDB11737Icotinibexperimental, investigationalunknownsubstrateDetailsDB06654Safinamideapproved, investigationalunknownsubstrateDetailsDB12161Deutetrabenazineapproved, investigationalnosubstrateDetailsDB09555Dexchlorpheniramine maleateapprovedunknownsubstrateDetailsDB11613Velpatasvirapproved, investigationalnosubstrateDetailsDB05541Brivaracetamapproved, investigationalnosubstrateDetailsDB11915Valbenazineapproved, investigationalnosubstrateDetailsDB06670OdanacatibinvestigationalnosubstrateDetailsDB05351Dexlansoprazoleapproved, investigationalunknownsubstrateDetailsDB06290SimeprevirapprovedunknownsubstrateinhibitorDetailsDB11575GrazoprevirapprovednosubstrateinhibitorDetailsDB11943Delafloxacinapproved, investigationalunknowninducerDetailsDB01685TopiroxostatexperimentalunknowninhibitorDetailsDB08922PerospironeexperimentalunknownsubstrateDetailsDB09118StiripentolapprovedunknownsubstrateinhibitorinducerDetailsDB09166EtizolamexperimentalunknownsubstrateDetailsDB11614RupatadineapprovednosubstrateDetailsDB09262ImidafenacininvestigationalnosubstrateDetailsDB00143Glutathioneapproved, investigational, nutraceuticalunknownDetailsDB09238Manidipineapproved, investigationalunknownsubstrateinhibitorDetailsDB09123DienogestapprovedunknownsubstrateDetailsDB11828Neratinibapproved, investigationalunknownsubstrateDetailsDB12026Voxilaprevirapproved, investigationalnosubstrateDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB06412Oxymetholoneapproved, illicitunknowninhibitorDetailsDB00503Ritonavirapproved, investigationalunknownsubstrateinhibitorDetailsDB06595Midostaurinapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB11574ElbasvirapprovedunknownsubstrateDetailsDB12483Copanlisibapproved, investigationalnosubstrateDetailsDB11767Sarilumabapproved, investigationalnoinhibitorinducerDetailsDB12001Abemaciclibapproved, investigationalunknownsubstrateinhibitorDetailsDB12267Brigatinibapproved, investigationalnosubstrateDetailsDB11817Baricitinibapproved, investigationalunknownsubstrateDetailsDB13074Macimorelinapproved, investigationalunknownsubstrateDetailsDB09223BlonanserininvestigationalnosubstrateDetailsDB09236Lacidipineapproved, investigationalunknownsubstrateDetailsDB09061Cannabidiolapproved, investigationalunknownsubstrateinhibitorDetailsDB13943Testosterone cypionateapprovedunknownsubstrateinhibitorinducerDetailsDB13944Testosterone enanthateapprovedunknownsubstrateinhibitorinducerDetailsDB13946Testosterone undecanoateapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13941Piperaquineapproved, experimental, investigationalunknownsubstrateinhibitorDetailsDB01420Testosterone propionateapproved, investigational, vet_approved, withdrawnnosubstrateDetailsDB09195LorpiprazoleapprovednosubstrateDetailsDB11799Bictegravirapproved, investigationalunknownsubstrateDetailsDB11901Apalutamideapproved, investigationalnosubstrateinducerDetailsDB09225Zotepineapproved, investigational, withdrawnnosubstrateDetailsDB09230AzelnidipineinvestigationalunknownsubstrateDetailsDB09231BenidipineexperimentalnosubstrateinhibitorDetailsDB09235EfonidipineexperimentalunknownsubstrateinhibitorDetailsDB11642Pitolisantapproved, investigationalunknownsubstrateinducerDetailsDB11633Isavuconazoleapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB09237Levamlodipineapproved, investigationalunknownsubstrateDetailsDB11712Tezacaftorapproved, investigationalnosubstrateinhibitorinducerDetailsDB11130Opiumapproved, illicitnosubstrateDetailsDB11251Tocopherolapproved, investigationalnosubstrateDetailsDB14003alpha-Tocopherol acetateapprovednosubstrateDetailsDB11586Asunaprevirapproved, investigational, withdrawnnosubstrateinducerDetailsDB13975Black cohoshexperimentalnoinhibitorDetailsDB12278Propiverineapproved, investigationalnosubstrateDetailsDB14011NabiximolsinvestigationalunknownsubstrateDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorDetailsDB11641Vinflunineapproved, investigationalnosubstrateDetailsDB11635TocofersolanapprovednosubstrateDetailsDB11637Delamanidapproved, investigationalnosubstrateDetailsDB13746Bioallethrinapproved, experimentalnosubstrateDetailsDB14019FosnetupitantapprovedunknownsubstrateinhibitorDetailsDB12010Fostamatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB01049Ergoloid mesylateapprovednosubstrateDetailsDB11274Dihydro-alpha-ergocryptineapprovednosubstrateDetailsDB13293Ipecacapproved, withdrawnnosubstrateDetailsDB11198Peppermint oilapproved, investigationalunknowninhibitorDetailsDB13456MidecamycinexperimentalnosubstrateinhibitorDetailsDB12532Oxetacaineapproved, investigationalnoinhibitorDetailsDB11672Curcuminapproved, investigationalunknowninhibitorDetailsDB11779DanoprevirinvestigationalnoinhibitorDetailsDB09289TianeptineinvestigationalnosubstrateDetailsDB01357MestranolapprovednosubstrateDetailsDB04829Lysergic acid diethylamideillicit, investigational, withdrawnnosubstrateDetailsDB00247MethysergideapprovednosubstrateDetailsDB13399TergurideexperimentalnosubstrateDetailsDB14185Aripiprazole lauroxilapproved, investigationalunknownsubstrateDetailsDB11718Encorafenibapproved, investigationalnosubstrateinhibitorinducerDetailsDB14538Hydrocortisone aceponateexperimental, vet_approvedunknownsubstrateinducerDetailsDB14539Hydrocortisone acetateapproved, vet_approvedunknownsubstrateinducerDetailsDB14540Hydrocortisone butyrateapproved, vet_approvedunknownsubstrateinducerDetailsDB14541Hydrocortisone cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB14542Hydrocortisone phosphateapproved, vet_approvedunknownsubstrateDetailsDB14543Hydrocortisone probutateapproved, vet_approvedunknownsubstrateinducerDetailsDB14544Hydrocortisone valerateapproved, vet_approvedunknownsubstrateinducerDetailsDB14568Ivosidenibapproved, investigationalunknownsubstrateinducerDetailsDB126293,5-diiodothyropropionic acidinvestigationalnosubstrateDetailsDB014565-androstenedioneexperimental, illicitnosubstrateDetailsDB00240AlclometasoneapprovednosubstrateDetailsDB04630Aldosteroneexperimental, investigationalnosubstrateDetailsDB00288AmcinonideapprovednosubstrateinducerDetailsDB01536Androstenedioneexperimental, illicitnosubstrateDetailsDB00394Beclomethasone dipropionateapproved, investigationalnosubstrateinducerDetailsDB11750Clobetasolapproved, experimental, investigationalnosubstrateinducerDetailsDB01013Clobetasol propionateapprovednosubstrateinducerDetailsDB13158ClobetasoneapprovednosubstrateDetailsDB04652CorticosteroneexperimentalnosubstrateDetailsDB01285Corticotropinapproved, investigational, vet_approvednosubstrateinducerDetailsDB04839Cyproterone acetateapproved, investigationalnosubstrateinhibitorDetailsDB11636NomegestrolapprovednosubstrateDetailsDB13981Nomegestrol acetateapproved, investigationalnosubstrateDetailsDB00304DesogestrelapprovednosubstrateDetailsDB01260Desonideapproved, investigationalnosubstrateinducerDetailsDB06780Desoxycorticosterone acetateapprovednosubstrateDetailsDB01134Desoxycorticosterone pivalateexperimental, vet_approvednosubstrateDetailsDB11487Dexamethasone isonicotinatevet_approvednosubstrateinhibitorinducerDetailsDB09095Difluocortoloneapproved, investigational, withdrawnnosubstrateinducerDetailsDB06781DifluprednateapprovednosubstrateDetailsDB00378Dydrogesteroneapproved, investigational, withdrawnnosubstrateDetailsDB03515EquileninexperimentalnosubstrateDetailsDB02187EquilinexperimentalnosubstrateDetailsDB13866EtynodiolexperimentalnosubstrateDetailsDB00823Ethynodiol diacetateapprovednosubstrateDetailsDB00687Fludrocortisoneapproved, investigationalunknownsubstrateDetailsDB00663Flumethasoneapproved, vet_approvednosubstrateDetailsDB00591Fluocinolone acetonideapproved, investigational, vet_approvednosubstrateinducerDetailsDB01047Fluocinonideapproved, investigationalnosubstrateinducerDetailsDB08971Fluocortoloneapproved, withdrawnnosubstrateinducerDetailsDB08970FluprednideneexperimentalnosubstrateinducerDetailsDB09378FluprednisoloneapprovednosubstrateDetailsDB00846FlurandrenolideapprovednosubstrateDetailsDB13867Fluticasoneapproved, experimentalnosubstrateinhibitorinducerDetailsDB08905Formestaneapproved, investigational, withdrawnnoinducerDetailsDB06730GestodeneinvestigationalnosubstrateinhibitorDetailsDB11619GestrinoneapprovednosubstrateDetailsDB06786Halcinonideapproved, investigational, withdrawnnosubstrateDetailsDB05212HE3286investigationalnosubstrateDetailsDB14545Hydrocortisone succinateapprovedunknownsubstrateinducerDetailsDB14570HydroxyprogesteroneexperimentalnosubstrateDetailsDB01583LiotrixapprovednosubstrateDetailsDB14596Loteprednol etabonateapprovedunknownsubstrateDetailsDB12474Lynestrenolapproved, investigationalnosubstrateDetailsDB09124Medrogestoneapproved, withdrawnnosubstrateDetailsDB00253MedrysoneapprovednosubstrateinducerDetailsDB00351Megestrol acetateapproved, investigational, vet_approvednosubstrateDetailsDB11529Melengestrolvet_approvednosubstrateDetailsDB09383Meprednisoneapproved, investigationalnosubstrateinducerDetailsDB00764MometasoneexperimentalnosubstrateinducerDetailsDB14512Mometasone furoateapproved, investigational, vet_approvednosubstrateinducerDetailsDB06713Norelgestrominapproved, investigationalnosubstrateDetailsDB09371NorethynodrelapprovednosubstrateDetailsDB01130Prednicarbateapproved, investigationalnosubstrateDetailsDB13208PrednylideneexperimentalnosubstrateinducerDetailsDB02789Pregnenoloneapproved, experimentalnosubstrateDetailsDB13602PromegestoneexperimentalnosubstrateDetailsDB00896RimexoloneapprovednosubstrateinducerDetailsDB01117AtovaquoneapprovednosubstrateDetailsDB11753Rifamycinapproved, investigationalnoinhibitorinducerDetailsDB13528ChlormadinoneexperimentalnosubstrateDetailsDB13857DemegestoneexperimentalnosubstrateDetailsDB13685QuingestanolexperimentalnosubstrateDetailsDB14055(S)-Warfarinexperimental, investigationalnosubstrateDetailsDB13347DiphenadioneexperimentalnosubstrateDetailsDB08794Ethyl biscoumacetatewithdrawnunknownsubstrateDetailsDB01483BarbitalillicitnoinducerDetailsDB01154Thiamylalapproved, vet_approvednosubstrateinducerDetailsDB09229AranidipineexperimentalnosubstrateDetailsDB09227BarnidipineexperimentalnosubstrateinhibitorDetailsDB13488BencyclaneexperimentalnosubstrateDetailsDB01244Bepridilapproved, withdrawnnosubstrateDetailsDB08838AgmatineexperimentalnosubstrateDetailsDB11960CarboxyamidotriazoleinvestigationalnosubstrateDetailsDB13835CaroverineexperimentalnosubstrateDetailsDB09232CilnidipineinvestigationalnosubstrateDetailsDB00568Cinnarizineapproved, investigationalnosubstrateDetailsDB04838CyclandelateapprovednosubstrateDetailsDB09234DarodipineexperimentalnosubstrateDetailsDB14068DexniguldipineexperimentalnosubstrateDetailsDB14063DexverapamilexperimentalnosubstrateDetailsDB06446DotarizineinvestigationalnosubstrateDetailsDB14064EmopamilexperimentalnosubstrateDetailsDB08992EperisoneinvestigationalnosubstrateDetailsDB08980FendilinewithdrawnnosubstrateDetailsDB13961Fish oilapproved, nutraceuticalnosubstrateDetailsDB04841FlunarizineapprovednosubstrateDetailsDB04842Fluspirileneapproved, investigationalnosubstrateDetailsDB12923GallopamilinvestigationalnosubstrateDetailsDB13766Lidoflazineapproved, experimentalnosubstrateDetailsDB14065LomerizineexperimentalnosubstrateDetailsDB00825LevomentholapprovednosubstrateDetailsDB12092NaftopidilinvestigationalnosubstrateDetailsDB09239NiguldipineexperimentalnosubstrateDetailsDB09240NiludipineexperimentalnosubstrateDetailsDB04743Nimesulideapproved, investigational, withdrawnnosubstrateDetailsDB06152NylidrinapprovednosubstrateDetailsDB13500Otiloniumexperimental, investigationalnosubstrateDetailsDB13791PenfluridolexperimentalnosubstrateDetailsDB09090PinaveriumapprovednosubstrateDetailsDB04825Prenylamineapproved, withdrawnnosubstrateDetailsDB13725TerodilineexperimentalnosubstrateDetailsDB12093TetrahydropalmatineinvestigationalnosubstrateDetailsDB14066TetrandrineexperimentalnosubstrateDetailsDB09216Tolfenamic acidapproved, investigationalnosubstrateDetailsDB07615TranilastinvestigationalnosubstrateDetailsDB09089TrimebutineapprovednosubstrateDetailsDB05885SeletracetaminvestigationalnosubstrateDetailsDB12131VinpocetineinvestigationalnosubstrateDetailsDB13950WIN 55212-2experimentalnosubstrateinhibitorDetailsDB040706-Deoxyerythronolide BexperimentalnoinhibitorDetailsDB06318AVE9633investigationalnoinhibitorDetailsDB07348Brefeldin AexperimentalnoinhibitorDetailsDB11752Bryostatin 1investigationalnoinhibitorDetailsDB01152Candicidinapproved, withdrawnnoinhibitorDetailsDB11383Carbomycinvet_approvednoinhibitorDetailsDB06419CethromycininvestigationalnosubstrateinhibitorDetailsDB06342Coltuximab ravtansineinvestigationalnoinhibitorDetailsDB00954DirithromycinexperimentalnoinhibitorDetailsDB11400Doramectinvet_approvednoinhibitorDetailsDB12266EpofolateinvestigationalnoinhibitorDetailsDB01873Epothilone DinvestigationalnoinhibitorDetailsDB11405Eprinomectinvet_approvednoinhibitorDetailsDB13338FlurithromycinexperimentalnoinhibitorDetailsDB05814GPI-1485investigationalnoinhibitorDetailsDB09309KitasamycinexperimentalnoinhibitorDetailsDB05903KOS-1584investigationalnoinhibitorDetailsDB12089Lorvotuzumab mertansineinvestigationalnoinhibitorDetailsDB13287MiocamycinapprovednoinhibitorDetailsDB12489Mirvetuximab soravtansineapproved, investigationalnosubstrateinhibitorDetailsDB06587MitemcinalinvestigationalnoinhibitorDetailsDB11442Oleandomycinvet_approvednoinhibitorDetailsDB03010Patupiloneexperimental, investigationalnoinhibitorDetailsDB06233RidaforolimusinvestigationalnoinhibitorDetailsDB13409RokitamycinexperimentalnoinhibitorDetailsDB12391SagopiloneinvestigationalnoinhibitorDetailsDB11459Selamectinvet_approvednoinhibitorDetailsDB09308SolithromycininvestigationalnoinhibitorDetailsDB11470Tildipirosinvet_approvednoinhibitorDetailsDB01241GemfibrozilapprovedunknownsubstrateDetailsDB06791LanreotideapprovednoinhibitorDetailsDB00104Octreotideapproved, investigationalnoinhibitorDetailsDB06663PasireotideapprovednoinhibitorDetailsDB09099Somatostatinapproved, investigationalnoinhibitorDetailsDB04894Vapreotideexperimental, investigationalnoinhibitorDetailsDB12781BalaglitazoneinvestigationalnosubstrateDetailsDB09201CiglitazoneexperimentalnosubstrateDetailsDB09198LobeglitazoneexperimentalnosubstrateDetailsDB09199NetoglitazoneexperimentalnosubstrateDetailsDB09200Rivoglitazoneexperimental, investigationalnosubstrateDetailsDB00412Rosiglitazoneapproved, investigationalnosubstrateinducerDetailsDB09063CeritinibapprovednosubstrateinhibitorDetailsDB06469LestaurtinibinvestigationalnoinhibitorDetailsDB11805SaracatinibinvestigationalnoinhibitorDetailsDB11703Acalabrutinibapproved, investigationalunknownsubstrateinhibitorDetailsDB01267PaliperidoneapprovedunknownsubstrateDetailsDB01645GenisteininvestigationalunknowninducerDetailsDB05928DovitinibinvestigationalunknowninhibitorDetailsDB08496(R)-warfarinexperimentalunknownsubstrateDetailsDB119196-O-benzylguanineinvestigationalnosubstrateDetailsDB14583Segesterone acetateapproved, experimental, investigationalunknownsubstrateDetailsDB00563MethotrexateapprovednosubstrateDetailsDB04884DapoxetineinvestigationalnosubstrateinhibitorDetailsDB08953Indalpineinvestigational, withdrawnnosubstrateinhibitorDetailsDB00715Paroxetineapproved, investigationalnosubstrateinhibitorDetailsDB04832Zimelidineapproved, withdrawnnoinhibitorDetailsDB04896Milnacipranapproved, investigationalnosubstrateinhibitorDetailsDB02703Fusidic acidapproved, investigationalunknownsubstrateinhibitorDetailsDB11730Ribociclibapproved, investigationalnosubstrateinhibitorDetailsDB09079NintedanibapprovednosubstrateDetailsDB14634Fluprednidene acetateexperimentalnoinducerDetailsDB14637Fluprednisolone acetateexperimentalnosubstrateDetailsDB01656RoflumilastapprovednosubstrateDetailsDB09034Suvorexantapproved, investigationalnosubstrateDetailsDB09071Tasimelteonapproved, investigationalnosubstrateDetailsDB09030VorapaxarapprovednosubstrateDetailsDB01624Zuclopenthixolapproved, investigationalnosubstrateDetailsDB13385DihydroergocryptineexperimentalnosubstrateDetailsDB11273DihydroergocornineapprovednosubstrateDetailsDB13345Dihydroergocristineapproved, experimentalnosubstrateDetailsDB06218LacosamideapprovednosubstrateDetailsDB12329Eravacyclineapproved, investigationalunknownsubstrateDetailsDB06458RemacemideinvestigationalnoinhibitorDetailsDB08874FidaxomicinapprovednoinhibitorDetailsDB11742Ebastineapproved, investigationalnosubstrateDetailsDB09036Siltuximabapproved, investigationalnoinducerDetailsDB06273TocilizumabapprovednoinducerDetailsDB12301Doravirineapproved, investigationalunknownsubstrateDetailsDB11952Duvelisibapproved, investigationalnosubstrateDetailsDB13997Baloxavir marboxilapproved, investigationalnosubstrateinhibitorDetailsDB00186LorazepamapprovednosubstrateDetailsDB125159-aminocamptothecininvestigationalnosubstrateDetailsDB12952Methylprednisoneapproved, investigationalnosubstrateDetailsDB04861Nebivololapproved, investigationalunknownsubstrateDetailsDB11963Dacomitinibapproved, investigationalnosubstrateDetailsDB12141Gilteritinibapproved, investigationalnosubstrateDetailsDB14723Larotrectinibapproved, investigationalunknownsubstrateDetailsDB125371,2-Benzodiazepineapproved, investigationalunknownsubstrateDetailsDB09017Brotizolaminvestigational, withdrawnunknownsubstrateDetailsDB11094Vitamin Dapproved, nutraceutical, vet_approvednosubstrateDetailsDB01352Aprobarbitalexperimental, illicitunknowninducerDetailsDB00590DoxazosinapprovednosubstrateDetailsDB05482SN-38investigationalunknownsubstrateinhibitorDetailsDB06480PrucaloprideapprovednosubstrateDetailsDB11978Glasdegibapproved, investigationalunknownsubstrateDetailsDB12582PiperineinvestigationalunknowninhibitorDetailsDB00191Phentermineapproved, illicitnosubstrateDetailsDB12245Triclabendazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00264Metoprololapproved, investigationalnosubstrateDetailsDB11823Esketamineapproved, investigationalunknownsubstrateinducerDetailsDB00163Vitamin Eapproved, nutraceutical, vet_approvedunknownsubstrateinducerDetailsDB12371Siponimodapproved, investigationalunknownsubstrateDetailsDB12147Erdafitinibapproved, investigationalnosubstrateinhibitorinducerDetailsDB09299Tenofovir alafenamideapprovednosubstrateDetailsDB00982IsotretinoinapprovedunknownsubstrateDetailsDB12015Alpelisibapproved, investigationalunknownsubstrateDetailsDB12240Polatuzumab vedotinapproved, investigationalnosubstrateDetailsDB00905Bimatoprostapproved, investigationalunknownsubstrateDetailsDB11942Selinexorapproved, investigationalunknownsubstrateDetailsDB14669Betamethasone phosphateapproved, vet_approvedunknownsubstrateinducerDetailsDB14652Clocortolone acetateexperimentalunknowninducerDetailsDB13843CloprednolexperimentalunknowninducerDetailsDB14681CortisoneexperimentalunknowninducerDetailsDB13003CortivazolinvestigationalunknowninducerDetailsDB13728HalometasoneexperimentalunknowninducerDetailsDB14659Melengestrol acetateexperimentalunknowninducerDetailsDB14644Methylprednisolone hemisuccinateapprovedunknowninducerDetailsDB14633Prednisolone hemisuccinateexperimentalunknowninducerDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknownsubstrateinducerDetailsDB14646Prednisone acetateapproved, experimental, investigationalunknowninducerDetailsDB02520DitiocarbexperimentalunknowninhibitorDetailsDB06731SeproxetineinvestigationalunknowninhibitorDetailsDB00627Niacinapproved, investigational, nutraceuticalunknowninhibitorDetailsDB06282LevocetirizineapprovedunknownsubstrateDetailsDB09173ButyrfentanylillicitunknownsubstrateDetailsDB12978Pexidartinibapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB01551Dihydrocodeineapproved, illicitunknownsubstrateDetailsDB05154PretomanidapprovedunknownsubstrateDetailsDB01395DrospirenoneapprovedunknownsubstrateDetailsDB01611HydroxychloroquineapprovedunknownsubstrateDetailsDB11986Entrectinibapproved, investigationalunknownsubstrateDetailsDB12500Fedratinibapproved, investigationalunknownsubstrateDetailsDB12825Lefamulinapproved, investigationalunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknownsubstrateDetailsDB01319FosamprenavirapprovedunknownsubstrateinhibitorDetailsDB01050IbuprofenapprovednosubstrateDetailsDB15489MexazolamexperimentalunknownsubstrateDetailsDB00334Olanzapineapproved, investigationalunknowninhibitorDetailsDB09288PropacetamolexperimentalunknownsubstrateinducerDetailsDB01233Metoclopramideapproved, investigationalunknownsubstrateDetailsDB11761Tenapanorapproved, investigationalunknownsubstrateDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB14600Edetate disodium anhydrousapproved, vet_approvedunknowninhibitorDetailsDB01217Anastrozoleapproved, investigationalunknownsubstrateinhibitorDetailsDB14575EslicarbazepineapprovedunknowninducerDetailsDB12808Trifaroteneapproved, investigationalunknownsubstrateDetailsDB15444Elexacaftorapproved, investigationalnosubstrateinhibitorDetailsDB15566Prednisolone acetateapproved, vet_approvedunknownsubstrateinducerDetailsDB00557HydroxyzineapprovednosubstrateDetailsDB14240Echinaceaapproved, experimentalunknowninducerDetailsDB11560Lesinuradapproved, investigationalunknowninducerDetailsDB15035Zanubrutinibapproved, investigationalnosubstrateDetailsDB01381Ginkgo bilobaapproved, investigational, nutraceuticalunknowninhibitorinducerDetailsDB13879Glecaprevirapproved, investigationalunknowninhibitorDetailsDB14975Voxelotorapproved, investigationalunknownsubstrateDetailsDB00717NorethisteroneapprovedunknownsubstrateDetailsDB06119Cenobamateapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB13007Enfortumab vedotinapproved, investigationalunknownsubstrateDetailsDB14962Trastuzumab deruxtecanapproved, investigationalunknownsubstrateDetailsDB11951Lemborexantapproved, investigationalunknownsubstrateDetailsDB12941Darolutamideapproved, investigationalunknownsubstrateDetailsDB06077Lumateperoneapproved, investigationalnosubstrateDetailsDB15091Upadacitinibapproved, investigationalnosubstrateDetailsDB15328Ubrogepantapproved, investigationalunknownsubstrateDetailsDB15233Avapritinibapproved, investigationalunknownsubstrateDetailsDB12887Tazemetostatapproved, investigationalunknownsubstrateDetailsDB12457Rimegepantapproved, investigationalnosubstrateinhibitorDetailsDB13609UmifenovirinvestigationalunknownsubstrateDetailsDB11837Osilodrostatapproved, investigationalunknownsubstrateinhibitorDetailsDB14678Norethindrone enanthateexperimentalunknownsubstrateDetailsDB09241Methylene blueapproved, investigationalunknowninhibitorDetailsDB12612Ozanimodapproved, investigationalunknownsubstrateDetailsDB14598Edetate calcium disodium anhydrousapprovedunknowninhibitorDetailsDB11689Selumetinibapproved, investigationalnosubstrateDetailsDB15102Pemigatinibapproved, investigationalnosubstrateDetailsDB14761Remdesivirapproved, investigationalunknownsubstrateinhibitorDetailsDB11791Capmatinibapproved, investigationalunknownsubstrateDetailsDB15685Selpercatinibapproved, investigationalunknownsubstrateDetailsDB14840RipretinibapprovedunknownsubstrateDetailsDB00714Apomorphineapproved, investigationalunknownDetailsDB12674Lurbinectedinapproved, investigationalunknownsubstrateDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB05015Belinostatapproved, investigationalunknownsubstrateDetailsDB11796Fostemsavirapproved, investigationalunknownsubstrateDetailsDB11932Abametapirapproved, investigationalnoinhibitorDetailsDB15305Risdiplamapproved, investigationalunknownsubstrateDetailsDB14881Oliceridineapproved, investigationalnosubstrateDetailsDB12499Clascoteroneapproved, investigationalnoinhibitorDetailsDB15822Pralsetinibapproved, investigationalnosubstrateinhibitorinducerDetailsDB06448Lonafarnibapproved, investigationalunknownsubstrateinhibitorDetailsDB15982BerotralstatapprovednoinhibitorDetailsDB06137Tirbanibulinapproved, investigationalnosubstrateinhibitorDetailsDB14895Vibegronapproved, investigationalnosubstrateDetailsDB00475Chlordiazepoxideapproved, illicit, investigationalunknownsubstrateDetailsDB00752Tranylcypromineapproved, investigationalunknowninhibitorDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB05667Levoketoconazoleapproved, investigationalnosubstrateinhibitorinducerDetailsDB00476DuloxetineapprovedunknowninhibitorDetailsDB11693Voclosporinapproved, investigationalunknownsubstrateinhibitorDetailsDB15133Tepotinibapproved, investigationalnosubstrateinhibitorDetailsDB00747Scopolamineapproved, investigationalnosubstrateDetailsDB00330EthambutolapprovedunknowninhibitorDetailsDB14989Umbralisibapproved, investigational, withdrawnunknownsubstrateDetailsDB14984Casimersenapproved, investigationalnoinhibitorDetailsDB00545Pyridostigmineapproved, investigationalnoinducerDetailsDB11800Tivozanibapproved, investigationalunknownsubstrateDetailsDB12016Ponesimodapproved, investigationalunknownsubstrateDetailsDB08995Diosminapproved, investigationalunknowninhibitorDetailsDB05316Pimavanserinapproved, investigationalunknownsubstrateDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownsubstrateDetailsDB12235Estetrolapproved, investigationalunknownsubstrateDetailsDB16222Loncastuximab tesirineapproved, investigationalunknownDetailsDB11886Infigratinibapproved, investigationalnosubstrateDetailsDB12471Ibrexafungerpapproved, investigationalunknownsubstrateinhibitorDetailsDB12543Samidorphanapproved, investigationalnosubstrateDetailsDB16165Finerenoneapproved, investigationalunknownsubstrateDetailsDB16703Belumosudilapproved, investigationalnosubstrateDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB15463Belzutifanapproved, investigationalnosubstrateDetailsDB12265Fexinidazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB16390Mobocertinibapproved, investigationalunknownsubstrateDetailsDB16732Tisotumab vedotinapprovednosubstrateDetailsDB16098Atogepantapproved, investigationalnosubstrateDetailsDB16226Maralixibatapproved, investigationalnoinhibitorDetailsDB15011Avacopanapproved, investigationalnosubstrateinhibitorinducerDetailsDB12597Asciminibapproved, investigationalnosubstrateinhibitorDetailsDB06234Maribavirapproved, investigationalnosubstrateDetailsDB16691Nirmatrelvirapproved, investigationalnosubstrateinhibitorDetailsDB15031DaridorexantapprovednosubstrateDetailsDB12713Sotagliflozinapproved, investigationalnosubstrateinhibitorinducerDetailsDB14973Abrocitinibapproved, investigationalnosubstrateDetailsDB05467Palovaroteneapproved, investigationalnosubstrateinducerDetailsDB16236Mitapivatapproved, investigationalnosubstrateinducerDetailsDB12834SecnidazoleapprovedunknownsubstrateinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknownsubstrateinhibitorDetailsDB00486Nabiloneapproved, investigationalunknownsubstrateinhibitorDetailsDB06230Nalmefeneapproved, investigational, withdrawnnosubstrateDetailsDB11697Pacritinibapproved, investigationalnosubstrateinhibitorinducerDetailsDB05087Ganaxoloneapproved, investigationalnosubstrateDetailsDB01041Thalidomideapproved, investigational, withdrawnnosubstrateinducerDetailsDB14921Mavacamtenapproved, investigationalnosubstrateinducerDetailsDB09185Viloxazineapproved, investigational, withdrawnnoinhibitorDetailsDB00951Isoniazidapproved, investigationalunknowninhibitorDetailsDB12020Tecovirimatapproved, investigationalnoinducerDetailsDB06083Tapinarofapproved, investigationalnosubstrateDetailsDB01024Mycophenolic acidapproved, investigationalunknownsubstrateDetailsDB10534GrapefruitapprovedunknowninhibitorDetailsDB04951Pirfenidoneapproved, investigationalunknowninhibitorDetailsDB15673Lenacapavirapproved, investigationalnosubstrateinhibitorDetailsDB12095Telotristat ethylapproved, investigationalnoinhibitorinducerDetailsDB15149Futibatinibapproved, investigationalnosubstrateDetailsDB17083LinzagolixapprovednosubstrateDetailsDB11739Vonoprazanapproved, investigationalunknownsubstrateDetailsDB09065CobicistatapprovedyesinhibitorDetailsDB16267Olutasidenibapproved, investigationalnosubstrateinducerDetailsDB15568Adagrasibapproved, investigationalunknownsubstrateinhibitorDetailsDB12236Bexagliflozinapproved, investigationalunknownsubstrateDetailsDB17472Pirtobrutinibapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB06374Elacestrantapproved, investigationalunknownsubstrateDetailsDB11682Daprodustatapproved, investigationalnosubstrateDetailsDB09065CobicistatapprovednosubstrateDetailsDB12548Sparsentanapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB12513Omaveloxoloneapproved, investigationalunknownsubstrateinducerDetailsDB15688Zavegepantapproved, investigationalunknownsubstrateDetailsDB06045Trofinetideapproved, investigationalunknowninhibitorDetailsDB16217Leniolisibapproved, investigationalnosubstrateDetailsDB12255Vadadustatapproved, investigationalunknowndownregulatorDetailsDB14924Ritlecitinibapproved, investigationalunknownsubstrateinhibitorDetailsDB12874Quizartinibapproved, investigationalnosubstrateDetailsDB15490Zuranoloneapproved, experimentalnosubstrateDetailsDB11763Momelotinibapproved, investigationalunknownsubstrateDetailsDB12184GepironeinvestigationalnosubstrateDetailsDB14766EtrasimodapprovednosubstrateDetailsDB15114Vamoroloneapproved, investigationalnosubstrateinducerDetailsDB12218Capivasertibapproved, investigationalnosubstrateDetailsDB16826RepotrectinibinvestigationalnosubstrateinhibitorinducerDetailsDB11679FruquintinibinvestigationalnosubstrateDetailsDB00176Fluvoxamineapproved, investigationalunknowninhibitorDetailsDB00599Thiopentalapproved, vet_approvedunknownsubstrateDetailsDB08930DolutegravirapprovednosubstrateDetailsDB06595Midostaurinapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB13174RheinexperimentalunknowninhibitorDetailsDB11994Diacereinapproved, investigationalunknowninhibitorDetailsDB11605MyrrhapprovedunknowninducerDetailsDB11691Naldemedineapproved, investigationalnosubstrateDetailsDB13878Pibrentasvirapproved, investigationalunknowninhibitorDetailsDB13879Glecaprevirapproved, investigationalunknownsubstrateinhibitorDetailsDB09205Moxisylyteapproved, investigationalnosubstrateDetailsDB09568Omega-3-carboxylic acidsapproved, investigationalnosubstrateDetailsDB01601LopinavirapprovednoinhibitorDetailsDB01149Nefazodoneapproved, withdrawnnoinhibitorDetailsDB13141Ambroxol acefyllinateexperimental, investigationalnosubstrateDetailsDB11792MirodenafilinvestigationalunknownsubstrateDetailsDB11979Elagolixapproved, investigationalnosubstrateDetailsDB08865Crizotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB11703Acalabrutinibapproved, investigationalunknownsubstrateDetailsDB12267Brigatinibapproved, investigationalunknowninducerDetailsDB12307ForetinibinvestigationalunknownsubstrateDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB00593EthosuximideapprovedunknownsubstrateDetailsDB01201Rifapentineapproved, investigationalunknowninducerDetailsDB00643Mebendazoleapproved, vet_approvedunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknowninhibitorDetailsDB00334Olanzapineapproved, investigationalunknowninhibitorDetailsDB09212LoxoprofenapprovedunknownsubstrateDetailsDB00635Prednisoneapproved, vet_approvedunknowninducerDetailsDB01222BudesonideapprovedunknownsubstrateinducerDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB11951Lemborexantapproved, investigationalunknowninhibitorinducerDetailsDB12887Tazemetostatapproved, investigationalunknownsubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninducerDetailsDB11652Tucatinibapproved, investigationalunknownsubstrateDetailsDB15035Zanubrutinibapproved, investigationalunknownsubstrateDetailsDB15685Selpercatinibapproved, investigationalunknowninhibitorDetailsDB00409Remoxiprideapproved, withdrawnunknowninhibitorDetailsDB15305Risdiplamapproved, investigationalunknowninhibitorDetailsDB06448Lonafarnibapproved, investigationalnosubstrateinhibitorDetailsDB11853Relugolixapproved, investigationalunknownsubstrateinducerDetailsDB01586Ursodeoxycholic acidapproved, investigationalunknowninducerDetailsDB11742Ebastineapproved, investigationalunknownsubstrateDetailsDB15569Sotorasibapproved, investigationalunknownsubstrateDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB00647Dextropropoxypheneapproved, illicit, investigational, withdrawnunknowninhibitorDetailsDB00333MethadoneapprovednoinhibitorDetailsDB01167Itraconazoleapproved, investigationalnoinhibitorDetailsDB16536Birch bark extractapproved, experimentalunknowninhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateinhibitorDetails"
                    }
                },
                {
                    "Label": "UDP-glucuronosyltransferase 2B7",
                    "Detailed Info": {
                        "Name": "UDP-glucuronosyltransferase 2B7",
                        "Synonyms": "2.4.1.17\n3,4-catechol estrogen-specific UDPGT\nUDP-glucuronosyltransferase 2B9\nUDPGT 2B7\nUDPGT 2B9\nUDPGTh-2\nUGTB2B9",
                        "Gene Name": "UGT2B7",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0012557|UDP-glucuronosyltransferase 2B7\nMSVKWTSVILLIQLSFCFSSGNCGKVLVWAAEYSHWMNIKTILDELIQRGHEVTVLASSA\nSILFDPNNSSALKIEIYPTSLTKTELENFIMQQIKRWSDLPKDTFWLYFSQVQEIMSIFG\nDITRKFCKDVVSNKKFMKKVQESRFDVIFADAIFPCSELLAELFNIPFVYSLSFSPGYTF\nEKHSGGFIFPPSYVPVVMSELTDQMTFMERVKNMIYVLYFDFWFEIFDMKKWDQFYSEVL\nGRPTTLSETMGKADVWLIRNSWNFQFPHPLLPNVDFVGGLHCKPAKPLPKEMEDFVQSSG\nENGVVVFSLGSMVSNMTEERANVIASALAQIPQKVLWRFDGNKPDTLGLNTRLYKWIPQN\nDLLGHPKTRAFITHGGANGIYEAIYHGIPMVGIPLFADQPDNIAHMKARGAAVRVDFNTM\nSSTDLLNALKRVINDPSYKENVMKLSRIQHDQPVKPLDRAVFWIEFVMRHKGAKHLRVAA\nHDLTWFQYHSLDVIGFLLVCVATVIFIVTKCCLFCFWKFARKAKKGKND",
                        "Number of residues": "529",
                        "Molecular Weight": "60694.12",
                        "Theoretical pI": "8.45",
                        "GO Classification": "Functionsglucuronosyltransferase activityProcessesandrogen metabolic process / cellular glucuronidation / cellular response to hormone stimulus / flavonoid biosynthetic process / flavonoid glucuronidation / lipid metabolic processComponentsendoplasmic reticulum membrane / extracellular exosome / integral component of membrane / intracellular membrane-bounded organelle / membrane",
                        "General Function": "Glucuronosyltransferase activity",
                        "Specific Function": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds.Its unique specificity for 3,4-catechol estrogens and estriol suggests it may play an important role in regulating the level and activity of these potent and active estrogen metabolites. Is also active with androsterone, hyodeoxycholic acid and tetrachlorocatechol (in vitro).",
                        "Pfam Domain Function": "UDPGT (PF00201)",
                        "Transmembrane Regions": "493-509",
                        "Cellular Location": "Microsome membrane",
                        "Gene sequence": ">lcl|BSEQ0012558|UDP-glucuronosyltransferase 2B7 (UGT2B7)\nATGTCTGTGAAATGGACTTCAGTAATTTTGCTAATACAACTGAGCTTTTGCTTTAGCTCT\nGGGAATTGTGGAAAGGTGCTGGTGTGGGCAGCAGAATACAGCCATTGGATGAATATAAAG\nACAATCCTGGATGAGCTTATTCAGAGAGGTCATGAGGTGACTGTACTGGCATCTTCAGCT\nTCCATTCTTTTTGATCCCAACAACTCATCCGCTCTTAAAATTGAAATTTATCCCACATCT\nTTAACTAAAACTGAGTTGGAGAATTTCATCATGCAACAGATTAAGAGATGGTCAGACCTT\nCCAAAAGATACATTTTGGTTATATTTTTCACAAGTACAGGAAATCATGTCAATATTTGGT\nGACATAACTAGAAAGTTCTGTAAAGATGTAGTTTCAAATAAGAAATTTATGAAAAAAGTA\nCAAGAGTCAAGATTTGACGTCATTTTTGCAGATGCTATTTTTCCCTGTAGTGAGCTGCTG\nGCTGAGCTATTTAACATACCCTTTGTGTACAGTCTCAGCTTCTCTCCTGGCTACACTTTT\nGAAAAGCATAGTGGAGGATTTATTTTCCCTCCTTCCTACGTACCTGTTGTTATGTCAGAA\nTTAACTGATCAAATGACTTTCATGGAGAGGGTAAAAAATATGATCTATGTGCTTTACTTT\nGACTTTTGGTTCGAAATATTTGACATGAAGAAGTGGGATCAGTTTTATAGTGAAGTTCTA\nGGAAGACCCACTACATTATCTGAGACAATGGGGAAAGCTGACGTATGGCTTATTCGAAAC\nTCCTGGAATTTTCAGTTTCCATATCCACTCTTACCAAATGTTGATTTTGTTGGAGGACTC\nCACTGCAAACCTGCCAAACCCCTGCCTAAGGAAATGGAAGACTTTGTACAGAGCTCTGGA\nGAAAATGGTGTTGTGGTGTTTTCTCTGGGGTCAATGGTCAGTAACATGACAGAAGAAAGG\nGCCAACGTAATTGCATCAGCCCTGGCCCAGATCCCACAAAAGGTTCTGTGGAGATTTGAT\nGGGAATAAACCAGATACCTTAGGTCTCAATACTCGGCTCTACAAGTGGATACCCCAGAAT\nGACCTTCTAGGTCATCCAAAGACCAGAGCTTTTATAACTCATGGTGGAGCCAATGGCATC\nTACGAGGCAATCTACCATGGGATCCCTATGGTGGGGATTCCATTGTTTGCCGATCAACCT\nGATAACATTGCTCACATGAAGGCCAGGGGAGCAGCTGTTAGAGTGGACTTCAACACAATG\nTCGAGTACAGACTTGCTGAATGCATTGAAGAGAGTAATTAATGATCCTTCATATAAAGAG\nAATGTTATGAAATTATCAAGAATTCAACATGATCAACCAGTGAAGCCCCTGGATCGAGCA\nGTCTTCTGGATTGAATTTGTCATGCGCCACAAAGGAGCTAAACACCTTCGGGTTGCAGCC\nCACGACCTCACCTGGTTCCAGTACCACTCTTTGGATGTGATTGGGTTCCTGCTGGTCTGT\nGTGGCAACTGTGATATTTATCGTCACAAAATGTTGTCTGTTTTGTTTCTGGAAGTTTGCT\nAGAAAAGCAAAGAAGGGAAAAAATGATTAG",
                        "Chromosome Location": "4",
                        "Locus": "4q13",
                        "External Identifiers": "ResourceLinkUniProtKB IDP16662UniProtKB Entry NameUD2B7_HUMANGenBank Protein ID340080GenBank Gene IDJ05428HGNC IDHGNC:12554",
                        "General References": "Ritter JK, Sheen YY, Owens IS: Cloning and expression of human liver UDP-glucuronosyltransferase in COS-1 cells. 3,4-catechol estrogens and estriol as primary substrates. J Biol Chem. 1990 May 15;265(14):7900-6. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Chen R, Jiang X, Sun D, Han G, Wang F, Ye M, Wang L, Zou H: Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009 Feb;8(2):651-61. doi: 10.1021/pr8008012. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Miley MJ, Zielinska AK, Keenan JE, Bratton SM, Radominska-Pandya A, Redinbo MR: Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7. J Mol Biol. 2007 Jun 1;369(2):498-511. Epub 2007 Mar 30. [Article] Bhasker CR, McKinnon W, Stone A, Lo AC, Kubota T, Ishizaki T, Miners JO: Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance. Pharmacogenetics. 2000 Nov;10(8):679-85. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00678LosartanapprovedunknownsubstrateDetailsDB00586Diclofenacapproved, vet_approvedunknownsubstrateDetailsDB00749Etodolacapproved, investigational, vet_approvedunknownsubstrateDetailsDB00712Flurbiprofenapproved, investigationalunknownsubstrateDetailsDB01050IbuprofenapprovedunknownsubstrateDetailsDB00788Naproxenapproved, vet_approvedunknownsubstrateDetailsDB01252MitiglinideinvestigationalunknownsubstrateDetailsDB06737ZaltoprofenexperimentalunknownsubstrateDetailsDB01544Flunitrazepamapproved, illicitunknowninhibitorDetailsDB06403Ambrisentanapproved, investigationalunknownsubstrateDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknownsubstrateDetailsDB00295Morphineapproved, investigationalnosubstrateDetailsDB00328Indomethacinapproved, investigationalunknownsubstrateinhibitorDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB00973EzetimibeapprovedunknownsubstrateDetailsDB01024Mycophenolic acidapproved, investigationalunknownsubstrateDetailsDB06777Chenodeoxycholic acidapprovedunknowninhibitorDetailsDB06235VadimezaninvestigationalunknownsubstrateDetailsDB00445EpirubicinapprovedunknownsubstrateDetailsDB06204TapentadolapprovedunknownsubstrateDetailsDB08860PitavastatinapprovedunknownsubstrateDetailsDB06695Dabigatran etexilateapprovedunknownsubstrateDetailsDB06207SilodosinapprovedunknownsubstrateDetailsDB00495ZidovudineapprovedunknownsubstrateDetailsDB00227Lovastatinapproved, investigationalunknownsubstrateDetailsDB00641SimvastatinapprovedunknownsubstrateDetailsDB00842OxazepamapprovedunknownsubstrateDetailsDB00564Carbamazepineapproved, investigationalunknownsubstrateDetailsDB00318Codeineapproved, illicitunknownsubstrateDetailsDB01095FluvastatinapprovedunknownsubstrateDetailsDB00313Valproic acidapproved, investigationalunknownsubstrateDetailsDB06292DapagliflozinapprovednosubstrateDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateDetailsDB06230Nalmefeneapproved, investigational, withdrawnnosubstrateDetailsDB13783Acemetacinapproved, investigationalnosubstrateDetailsDB11827Ertugliflozinapproved, investigationalnosubstrateDetailsDB11638Artenimolapproved, experimental, investigationalnosubstrateDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB05928DovitinibinvestigationalunknowninhibitorDetailsDB09213Dexibuprofenapproved, investigationalunknownsubstrateDetailsDB01174Phenobarbitalapproved, investigationalunknowninducerDetailsDB00465KetorolacapprovedunknownsubstrateDetailsDB00327Hydromorphoneapproved, illicitnosubstrateDetailsDB00598LabetalolapprovedunknownsubstrateDetailsDB00675TamoxifenapprovedunknownsubstrateDetailsDB01136Carvedilolapproved, investigationalunknownsubstrateDetailsDB01241GemfibrozilapprovedunknownsubstrateDetailsDB01217Anastrozoleapproved, investigationalunknownsubstrateDetailsDB09212LoxoprofenapprovedunknownsubstrateDetailsDB06119Cenobamateapproved, investigationalunknownsubstrateDetailsDB00983Formoterolapproved, investigationalunknownsubstrateDetailsDB01006Letrozoleapproved, investigationalunknownsubstrateDetailsDB00977EthinylestradiolapprovedunknownsubstrateDetailsDB13609UmifenovirinvestigationalunknowninhibitorDetailsDB11837Osilodrostatapproved, investigationalunknownsubstrateDetailsDB11936Bempedoic acidapproved, investigationalunknownsubstrateDetailsDB00870Suprofenapproved, withdrawnunknownsubstrateDetailsDB09038EmpagliflozinapprovedunknownsubstrateDetailsDB09274Artesunateapproved, investigationalunknownsubstrateDetailsDB00514DextromethorphanapprovedunknownsubstrateDetailsDB00784Mefenamic acidapprovedunknowninhibitorDetailsDB04854FebuxostatapprovednosubstrateDetailsDB12016Ponesimodapproved, investigationalunknownsubstrateDetailsDB08893MirabegronapprovednosubstrateDetailsDB12235Estetrolapproved, investigationalunknownsubstrateDetailsDB08804Nandrolone decanoateapproved, illicitunknownsubstrateDetailsDB12597Asciminibapproved, investigationalnosubstrateDetailsDB12713Sotagliflozinapproved, investigationalnosubstrateDetailsDB09061Cannabidiolapproved, investigationalnosubstrateinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknownsubstrateinducerDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorinducerDetailsDB12095Telotristat ethylapproved, investigationalnoinducerDetailsDB05239Cobimetinibapproved, investigationalnosubstrateDetailsDB12243Edaravoneapproved, investigationalnosubstrateDetailsDB00683Midazolamapproved, illicitnosubstrateDetailsDB00755Tretinoinapproved, investigational, nutraceuticalunknownsubstrateDetailsDB06045Trofinetideapproved, investigationalunknowninhibitorDetailsDB12255Vadadustatapproved, investigationalunknownsubstrateDetailsDB15114Vamoroloneapproved, investigationalnosubstrateDetailsDB12218Capivasertibapproved, investigationalnosubstrateDetailsDB00555Lamotrigineapproved, investigationalunknownsubstrateDetailsDB00503Ritonavirapproved, investigationalnoinducerDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB00794Primidoneapproved, vet_approvedunknowninducerDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB00714Apomorphineapproved, investigationalunknownsubstrateDetailsDB11796Fostemsavirapproved, investigationalunknownsubstrateDetailsDB00871TerbutalineapprovedunknownsubstrateDetailsDB00960Pindololapproved, investigationalunknownsubstrateDetailsDB12471Ibrexafungerpapproved, investigationalunknownsubstrateDetails"
                    }
                },
                {
                    "Label": "UDP-glucuronosyltransferase 1-1",
                    "Detailed Info": {
                        "Name": "UDP-glucuronosyltransferase 1-1",
                        "Synonyms": "2.4.1.17\nBilirubin-specific UDPGT isozyme 1\nGNT1\nhUG-BR1\nUDP-glucuronosyltransferase 1-A\nUDP-glucuronosyltransferase 1A1\nUDPGT 1-1\nUGT-1A\nUGT1\nUGT1A",
                        "Gene Name": "UGT1A1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0006823|UDP-glucuronosyltransferase 1-1\nMAVESQGGRPLVLGLLLCVLGPVVSHAGKILLIPVDGSHWLSMLGAIQQLQQRGHEIVVL\nAPDASLYIRDGAFYTLKTYPVPFQREDVKESFVSLGHNVFENDSFLQRVIKTYKKIKKDS\nAMLLSGCSHLLHNKELMASLAESSFDVMLTDPFLPCSPIVAQYLSLPTVFFLHALPCSLE\nFEATQCPNPFSYVPRPLSSHSDHMTFLQRVKNMLIAFSQNFLCDVVYSPYATLASEFLQR\nEVTVQDLLSSASVWLFRSDFVKDYPRPIMPNMVFVGGINCLHQNPLSQEFEAYINASGEH\nGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDL\nLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTS\nEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHD\nLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH",
                        "Number of residues": "533",
                        "Molecular Weight": "59590.91",
                        "Theoretical pI": "8.09",
                        "GO Classification": "Functionsenzyme binding / enzyme inhibitor activity / glucuronosyltransferase activity / protein heterodimerization activity / protein homodimerization activity / retinoic acid binding / steroid bindingProcessesacute-phase response / bilirubin conjugation / biphenyl catabolic process / cellular glucuronidation / cellular response to ethanol / cellular response to glucocorticoid stimulus / cellular response to hormone stimulus / digestion / drug metabolic process / estrogen metabolic process / flavone metabolic process / flavonoid biosynthetic process / flavonoid glucuronidation / heme catabolic process / heterocycle metabolic process / liver development / negative regulation of catalytic activity / negative regulation of cellular glucuronidation / negative regulation of fatty acid metabolic process / negative regulation of glucuronosyltransferase activity / negative regulation of steroid metabolic process / organ regeneration / porphyrin-containing compound metabolic process / response to drug / response to lipopolysaccharide / response to nutrient / response to starvation / retinoic acid metabolic process / small molecule metabolic process / steroid metabolic process / xenobiotic glucuronidation / xenobiotic metabolic processComponentscytochrome complex / endoplasmic reticulum / endoplasmic reticulum chaperone complex / endoplasmic reticulum membrane / integral component of plasma membrane",
                        "General Function": "Steroid binding",
                        "Specific Function": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isoform glucuronidates bilirubin IX-alpha to form both the IX-alpha-C8 and IX-alpha-C12 monoconjugates and diconjugate. Is also able to catalyze the glucuronidation of 17beta-estradiol, 17alpha-ethinylestradiol, 1-hydroxypyrene, 4-methylumbelliferone, 1-naphthol, paranitrophenol, scopoletin, and umbelliferone. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1.",
                        "Pfam Domain Function": "UDPGT (PF00201)",
                        "Transmembrane Regions": "491-507",
                        "Cellular Location": "Microsome",
                        "Gene sequence": ">lcl|BSEQ0021360|UDP-glucuronosyltransferase 1-1 (UGT1A1)\nATGGCTGTGGAGTCCCAGGGCGGACGCCCACTTGTCCTGGGCCTGCTGCTGTGTGTGCTG\nGGCCCAGTGGTGTCCCATGCTGGGAAGATACTGTTGATCCCAGTGGATGGCAGCCACTGG\nCTGAGCATGCTTGGGGCCATCCAGCAGCTGCAGCAGAGGGGACATGAAATAGTTGTCCTA\nGCACCTGACGCCTCGTTGTACATCAGAGACGGAGCATTTTACACCTTGAAGACGTACCCT\nGTGCCATTCCAAAGGGAGGATGTGAAAGAGTCTTTTGTTAGTCTCGGGCATAATGTTTTT\nGAGAATGATTCTTTCCTGCAGCGTGTGATCAAAACATACAAGAAAATAAAAAAGGACTCT\nGCTATGCTTTTGTCTGGCTGTTCCCACTTACTGCACAACAAGGAGCTCATGGCCTCCCTG\nGCAGAAAGCAGCTTTGATGTCATGCTGACGGACCCTTTCCTTCCTTGCAGCCCCATCGTG\nGCCCAGTACCTGTCTCTGCCCACTGTATTCTTCTTGCATGCACTGCCATGCAGCCTGGAA\nTTTGAGGCTACCCAGTGCCCCAACCCATTCTCCTACGTGCCCAGGCCTCTCTCCTCTCAT\nTCAGATCACATGACCTTCCTGCAGCGGGTGAAGAACATGCTCATTGCCTTTTCACAGAAC\nTTTCTGTGCGACGTGGTTTATTCCCCGTATGCAACCCTTGCCTCAGAATTCCTTCAGAGA\nGAGGTGACTGTCCAGGACCTATTGAGCTCTGCATCTGTCTGGCTGTTTAGAAGTGACTTT\nGTGAAGGATTACCCTAGGCCCATCATGCCCAATATGGTTTTTGTTGGTGGAATCAACTGC\nCTTCACCAAAATCCACTATCCCAGGAATTTGAAGCCTACATTAATGCTTCTGGAGAACAT\nGGAATTGTGGTTTTCTCTTTGGGATCAATGGTCTCAGAAATTCCAGAGAAGAAAGCTATG\nGCAATTGCTGATGCTTTGGGCAAAATCCCTCAGACAGTCCTGTGGCGGTACACTGGAACC\nCGACCATCGAATCTTGCGAACAACACGATACTTGTTAAGTGGCTACCCCAAAACGATCTG\nCTTGGTCACCCGATGACCCGTGCCTTTATCACCCATGCTGGTTCCCATGGTGTTTATGAA\nAGCATATGCAATGGCGTTCCCATGGTGATGATGCCCTTGTTTGGTGATCAGATGGACAAT\nGCAAAGCGCATGGAGACTAAGGGAGCTGGAGTGACCCTGAATGTTCTGGAAATGACTTCT\nGAAGATTTAGAAAATGCTCTAAAAGCAGTCATCAATGACAAAAGTTACAAGGAGAACATC\nATGCGCCTCTCCAGCCTTCACAAGGACCGCCCGGTGGAGCCGCTGGACCTGGCCGTGTTC\nTGGGTGGAGTTTGTGATGAGGCACAAGGGCGCGCCACACCTGCGCCCCGCAGCCCACGAC\nCTCACCTGGTACCAGTACCATTCCTTGGACGTGATTGGTTTCCTCTTGGCCGTCGTGCTG\nACAGTGGCCTTCATCACCTTTAAATGTTGTGCTTATGGCTACCGGAAATGCTTGGGGAAA\nAAAGGGCGAGTTAAGAAAGCCCACAAATCCAAGACCCATTGA",
                        "Chromosome Location": "2",
                        "Locus": "2q37",
                        "External Identifiers": "ResourceLinkUniProtKB IDP22309UniProtKB Entry NameUD11_HUMANGenBank Protein ID184473GenBank Gene IDM57899HGNC IDHGNC:12530",
                        "General References": "Ritter JK, Crawford JM, Owens IS: Cloning of two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells. J Biol Chem. 1991 Jan 15;266(2):1043-7. [Article] Ritter JK, Chen F, Sheen YY, Tran HM, Kimura S, Yeatman MT, Owens IS: A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem. 1992 Feb 15;267(5):3257-61. [Article] Gong QH, Cho JW, Huang T, Potter C, Gholami N, Basu NK, Kubota S, Carvalho S, Pennington MW, Owens IS, Popescu NC: Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics. 2001 Jun;11(4):357-68. [Article] Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article] Meunier L, Usherwood YK, Chung KT, Hendershot LM: A subset of chaperones and folding enzymes form multiprotein complexes in endoplasmic reticulum to bind nascent proteins. Mol Biol Cell. 2002 Dec;13(12):4456-69. [Article] Levesque E, Girard H, Journault K, Lepine J, Guillemette C: Regulation of the UGT1A1 bilirubin-conjugating pathway: role of a new splicing event at the UGT1A locus. Hepatology. 2007 Jan;45(1):128-38. [Article] Udomuksorn W, Elliot DJ, Lewis BC, Mackenzie PI, Yoovathaworn K, Miners JO: Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates. Pharmacogenet Genomics. 2007 Dec;17(12):1017-29. [Article] Girard H, Levesque E, Bellemare J, Journault K, Caillier B, Guillemette C: Genetic diversity at the UGT1 locus is amplified by a novel 3' alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity. Pharmacogenet Genomics. 2007 Dec;17(12):1077-89. [Article] Tang L, Singh R, Liu Z, Hu M: Structure and concentration changes affect characterization of UGT isoform-specific metabolism of isoflavones. Mol Pharm. 2009 Sep-Oct;6(5):1466-82. doi: 10.1021/mp8002557. [Article] Sneitz N, Bakker CT, de Knegt RJ, Halley DJ, Finel M, Bosma PJ: Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants. Hum Mutat. 2010 Jan;31(1):52-9. doi: 10.1002/humu.21133. [Article] Johnson AD, Kavousi M, Smith AV, Chen MH, Dehghan A, Aspelund T, Lin JP, van Duijn CM, Harris TB, Cupples LA, Uitterlinden AG, Launer L, Hofman A, Rivadeneira F, Stricker B, Yang Q, O'Donnell CJ, Gudnason V, Witteman JC: Genome-wide association meta-analysis for total serum bilirubin levels. Hum Mol Genet. 2009 Jul 15;18(14):2700-10. doi: 10.1093/hmg/ddp202. Epub 2009 May 4. [Article] Chen R, Jiang X, Sun D, Han G, Wang F, Ye M, Wang L, Zou H: Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009 Feb;8(2):651-61. doi: 10.1021/pr8008012. [Article] Bellemare J, Rouleau M, Girard H, Harvey M, Guillemette C: Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro. Drug Metab Dispos. 2010 Oct;38(10):1785-9. doi: 10.1124/dmd.110.034835. Epub 2010 Jul 7. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Bosma PJ, Chowdhury JR, Huang TJ, Lahiri P, Elferink RP, Van Es HH, Lederstein M, Whitington PF, Jansen PL, Chowdhury NR: Mechanisms of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I. FASEB J. 1992 Jul;6(10):2859-63. [Article] Aono S, Yamada Y, Keino H, Hanada N, Nakagawa T, Sasaoka Y, Yazawa T, Sato H, Koiwai O: Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II. Biochem Biophys Res Commun. 1993 Dec 30;197(3):1239-44. [Article] Moghrabi N, Clarke DJ, Boxer M, Burchell B: Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2. Genomics. 1993 Oct;18(1):171-3. [Article] Ritter JK, Yeatman MT, Kaiser C, Gridelli B, Owens IS: A phenylalanine codon deletion at the UGT1 gene complex locus of a Crigler-Najjar type I patient generates a pH-sensitive bilirubin UDP-glucuronosyltransferase. J Biol Chem. 1993 Nov 5;268(31):23573-9. [Article] Labrune P, Myara A, Hadchouel M, Ronchi F, Bernard O, Trivin F, Chowdhury NR, Chowdhury JR, Munnich A, Odievre M: Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases. Hum Genet. 1994 Dec;94(6):693-7. [Article] Erps LT, Ritter JK, Hersh JH, Blossom D, Martin NC, Owens IS: Identification of two single base substitutions in the UGT1 gene locus which abolish bilirubin uridine diphosphate glucuronosyltransferase activity in vitro. J Clin Invest. 1994 Feb;93(2):564-70. [Article] Seppen J, Bosma PJ, Goldhoorn BG, Bakker CT, Chowdhury JR, Chowdhury NR, Jansen PL, Oude Elferink RP: Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase. J Clin Invest. 1994 Dec;94(6):2385-91. [Article] Aono S, Adachi Y, Uyama E, Yamada Y, Keino H, Nanno T, Koiwai O, Sato H: Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome. Lancet. 1995 Apr 15;345(8955):958-9. [Article] Seppen J, Steenken E, Lindhout D, Bosma PJ, Elferink RP: A mutation which disrupts the hydrophobic core of the signal peptide of bilirubin UDP-glucuronosyltransferase, an endoplasmic reticulum membrane protein, causes Crigler-Najjar type II. FEBS Lett. 1996 Jul 29;390(3):294-8. [Article] Ciotti M, Chen F, Rubaltelli FF, Owens IS: Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease. Biochim Biophys Acta. 1998 Jul 1;1407(1):40-50. [Article] Yamamoto K, Soeda Y, Kamisako T, Hosaka H, Fukano M, Sato H, Fujiyama Y, Adachi Y, Satoh Y, Bamba T: Analysis of bilirubin uridine 5'-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II. J Hum Genet. 1998;43(2):111-4. [Article] Maruo Y, Sato H, Yamano T, Doida Y, Shimada M: Gilbert syndrome caused by a homozygous missense mutation (Tyr486Asp) of bilirubin UDP-glucuronosyltransferase gene. J Pediatr. 1998 Jun;132(6):1045-7. [Article] Kadakol A, Ghosh SS, Sappal BS, Sharma G, Chowdhury JR, Chowdhury NR: Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype. Hum Mutat. 2000 Oct;16(4):297-306. [Article] Maruo Y, Nishizawa K, Sato H, Sawa H, Shimada M: Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene. Pediatrics. 2000 Nov;106(5):E59. [Article] Kadakol A, Sappal BS, Ghosh SS, Lowenheim M, Chowdhury A, Chowdhury S, Santra A, Arias IM, Chowdhury JR, Chowdhury NR: Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus. J Med Genet. 2001 Apr;38(4):244-9. [Article] Labrune P, Myara A, Chalas J, Le Bihan B, Capel L, Francoual J: Association of a homozygous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome. Hum Mutat. 2002 Nov;20(5):399-401. [Article] Sutomo R, Laosombat V, Sadewa AH, Yokoyama N, Nakamura H, Matsuo M, Nishio H: Novel missense mutation of the UGT1A1 gene in Thai siblings with Gilbert's syndrome. Pediatr Int. 2002 Aug;44(4):427-32. [Article] Ohnishi A, Emi Y: Rapid proteasomal degradation of translocation-deficient UDP-glucuronosyltransferase 1A1 proteins in patients with Crigler-Najjar type II. Biochem Biophys Res Commun. 2003 Oct 24;310(3):735-41. [Article] Servedio V, d'Apolito M, Maiorano N, Minuti B, Torricelli F, Ronchi F, Zancan L, Perrotta S, Vajro P, Boschetto L, Iolascon A: Spectrum of UGT1A1 mutations in Crigler-Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation. Hum Mutat. 2005 Mar;25(3):325. [Article] D'Apolito M, Marrone A, Servedio V, Vajro P, De Falco L, Iolascon A: Seven novel mutations of the UGT1A1 gene in patients with unconjugated hyperbilirubinemia. Haematologica. 2007 Jan;92(1):133-4. [Article] Khan S, Irfan M, Sher G, Zubaida B, Alvi MA, Yasinzai M, Naeem M: UGT1A1 gene mutations in Pakistani children suffering from inherited nonhemolytic unconjugated hyperbilirubinemias. Ann Hum Genet. 2013 Nov;77(6):482-7. doi: 10.1111/ahg.12039. Epub 2013 Aug 29. [Article] Minucci A, Canu G, Gentile L, Cimino V, Giardina B, Zuppi C, Capoluongo E: Identification of a novel mutation in UDP-glucuronosyltransferase (UGT1A1) gene in a child with neonatal unconjugated hyperbilirubinemia. Clin Biochem. 2013 Jan;46(1-2):170-2. doi: 10.1016/j.clinbiochem.2012.10.007. Epub 2012 Oct 22. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB01024Mycophenolic acidapproved, investigationalunknownsubstrateDetailsDB01048Abacavirapproved, investigationalunknownsubstrateDetailsDB00173Adenineapproved, nutraceuticalunknowninhibitorDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknownsubstrateDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00818Propofolapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00973EzetimibeapprovedunknownsubstrateDetailsDB01045RifampicinapprovedunknowninducerDetailsDB00678LosartanapprovedunknownsubstrateDetailsDB00712Flurbiprofenapproved, investigationalunknownsubstrateinhibitorDetailsDB00328Indomethacinapproved, investigationalunknownsubstrateinhibitorDetailsDB00870Suprofenapproved, withdrawnunknownsubstrateDetailsDB06741GavestinelinvestigationalunknownsubstrateDetailsDB04868Nilotinibapproved, investigationalunknowninhibitorDetailsDB06210EltrombopagapprovedunknownsubstrateinhibitorDetailsDB00295Morphineapproved, investigationalnosubstrateDetailsDB05039IndacaterolapprovedunknownsubstrateDetailsDB06510MuraglitazarinvestigationalunknownsubstrateDetailsDB00704Naltrexoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB06817RaltegravirapprovedunknownsubstrateDetailsDB04953Ezogabineapproved, investigationalunknownsubstrateDetailsDB01420Testosterone propionateapproved, investigational, vet_approved, withdrawnunknowninducerDetailsDB06589PazopanibapprovedunknowninhibitorDetailsDB06626Axitinibapproved, investigationalnosubstrateDetailsDB08896RegorafenibapprovedunknowninhibitorDetailsDB00316AcetaminophenapprovedunknownsubstrateDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB00227Lovastatinapproved, investigationalnosubstrateDetailsDB00641SimvastatinapprovedunknownsubstrateDetailsDB01544Flunitrazepamapproved, illicitunknowninhibitorDetailsDB00530Erlotinibapproved, investigationalunknowninhibitorDetailsDB00773EtoposideapprovedunknownsubstrateDetailsDB01095FluvastatinapprovedunknownsubstrateDetailsDB00398Sorafenibapproved, investigationalunknowninhibitorDetailsDB08930DolutegravirapprovednosubstrateDetailsDB09101ElvitegravirapprovednosubstrateDetailsDB09183DasabuvirapprovedunknowninhibitorDetailsDB05015Belinostatapproved, investigationalunknownsubstrateDetailsDB11943Delafloxacinapproved, investigationalnosubstrateDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB13878Pibrentasvirapproved, investigationalunknowninhibitorDetailsDB13879Glecaprevirapproved, investigationalunknowninhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB11827Ertugliflozinapproved, investigationalnoinhibitorDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateDetailsDB11799Bictegravirapproved, investigationalunknownsubstrateDetailsDB12010Fostamatinibapproved, investigationalunknowninhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB00224IndinavirapprovedunknowninhibitorDetailsDB00564Carbamazepineapproved, investigationalnoinducerDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinducerDetailsDB01174Phenobarbitalapproved, investigationalnoinducerDetailsDB00932Tipranavirapproved, investigationalnoinducerDetailsDB00220NelfinavirapprovednoinducerDetailsDB00625Efavirenzapproved, investigationalnoinducerDetailsDB00906Tiagabineapproved, investigationalnosubstrateDetailsDB00313Valproic acidapproved, investigationalnosubstrateinhibitorDetailsDB00909Zonisamideapproved, investigationalnosubstrateDetailsDB01136Carvedilolapproved, investigationalnosubstrateDetailsDB03496Alvocidibexperimental, investigationalnosubstrateDetailsDB00695Furosemideapproved, vet_approvednosubstrateDetailsDB01241GemfibrozilapprovednosubstrateinhibitorDetailsDB01067Glipizideapproved, investigationalnosubstrateDetailsDB00451LevothyroxineapprovednosubstrateDetailsDB00916MetronidazoleapprovednosubstrateDetailsDB01183Naloxoneapproved, vet_approvednosubstrateDetailsDB00481Raloxifeneapproved, investigationalnosubstrateDetailsDB00193Tramadolapproved, investigationalnosubstrateDetailsDB00495ZidovudineapprovednosubstrateinducerDetailsDB09298Silibininexperimental, investigationalnoinhibitorDetailsDB09276Sodium aurothiomalateapproved, investigationalnoinhibitorDetailsDB00977EthinylestradiolapprovednosubstrateinducerDetailsDB00439Cerivastatinapproved, withdrawnnosubstrateDetailsDB00947Fulvestrantapproved, investigationalnosubstrateDetailsDB01009Ketoprofenapproved, vet_approvednosubstrateDetailsDB11967Binimetinibapproved, investigationalnosubstrateDetailsDB01072Atazanavirapproved, investigationalnoinhibitorDetailsDB12020Tecovirimatapproved, investigationalunknownsubstrateDetailsDB02703Fusidic acidapproved, investigationalunknownsubstrateDetailsDB09288PropacetamolexperimentalnosubstrateDetailsDB01609Deferasiroxapproved, investigationalunknownsubstrateinhibitorDetailsDB14575EslicarbazepineapprovedunknownsubstrateDetailsDB09213Dexibuprofenapproved, investigationalunknownsubstrateDetailsDB09119Eslicarbazepine acetateapprovedunknownsubstrateDetailsDB11963Dacomitinibapproved, investigationalnoinhibitorDetailsDB01032Probenecidapproved, investigationalnoinhibitorDetailsDB00350Minoxidilapproved, investigationalnosubstrateDetailsDB00279Liothyronineapproved, vet_approvednosubstrateDetailsDB00304DesogestrelapprovednoinducerDetailsDB00598LabetalolapprovedunknownsubstrateDetailsDB12978Pexidartinibapproved, investigationalunknowninhibitorDetailsDB09297Paritaprevirapproved, investigationalunknowninhibitorDetailsDB09079NintedanibapprovedunknownsubstrateDetailsDB00455Loratadineapproved, investigationalunknownDetailsDB06077Lumateperoneapproved, investigationalnosubstrateDetailsDB15328Ubrogepantapproved, investigationalunknowninhibitorDetailsDB00957Norgestimateapproved, investigationalunknownsubstrateDetailsDB11689Selumetinibapproved, investigationalnosubstrateDetailsDB12893Sacituzumab govitecanapproved, investigationalnosubstrateDetailsDB15456Vericiguatapproved, investigationalunknownsubstrateDetailsDB09296Ombitasvirapproved, investigationalunknowninhibitorDetailsDB11751Cabotegravirapproved, investigationalunknownsubstrateDetailsDB04854FebuxostatapprovednosubstrateDetailsDB12016Ponesimodapproved, investigationalunknownsubstrateDetailsDB08804Nandrolone decanoateapproved, illicitunknownsubstrateDetailsDB16703Belumosudilapproved, investigationalnoinhibitorDetailsDB12597Asciminibapproved, investigationalnoinhibitorDetailsDB12713Sotagliflozinapproved, investigationalnosubstrateDetailsDB16236Mitapivatapproved, investigationalnoinducerDetailsDB09074OlaparibapprovedunknowninhibitorDetailsDB08912Dabrafenibapproved, investigationalnoinhibitorDetailsDB15673Lenacapavirapproved, investigationalnosubstrateDetailsDB00470Dronabinolapproved, illicitnosubstrateDetailsDB12243Edaravoneapproved, investigationalnosubstrateDetailsDB12236Bexagliflozinapproved, investigationalunknownsubstrateDetailsDB00349Clobazamapproved, illicitnoupregulatorDetailsDB12255Vadadustatapproved, investigationalunknownsubstrateinducerDetailsDB12874Quizartinibapproved, investigationalnoinhibitorDetailsDB06700Desvenlafaxineapproved, investigationalnosubstrateDetailsDB11763Momelotinibapproved, investigationalunknowninhibitorinducerDetailsDB11718Encorafenibapproved, investigationalnoinhibitorDetailsDB16826RepotrectinibinvestigationalnoinhibitorDetailsDB00555Lamotrigineapproved, investigationalunknownsubstrateDetailsDB00503Ritonavirapproved, investigationalnoinducerDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB00794Primidoneapproved, vet_approvedunknowninducerDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB00714Apomorphineapproved, investigationalunknownsubstrateDetailsDB11796Fostemsavirapproved, investigationalunknownsubstrateDetailsDB00871TerbutalineapprovedunknownsubstrateDetailsDB00960Pindololapproved, investigationalunknownsubstrateDetailsDB12471Ibrexafungerpapproved, investigationalunknownsubstrateDetails"
                    }
                },
                {
                    "Label": "UDP-glucuronosyltransferase 1-8",
                    "Detailed Info": {
                        "Name": "UDP-glucuronosyltransferase 1-8",
                        "Synonyms": "2.4.1.17\nGNT1\nUDP-glucuronosyltransferase 1-H\nUDP-glucuronosyltransferase 1A8\nUDPGT 1-8\nUGT-1H\nUGT1\nUGT1H",
                        "Gene Name": "UGT1A8",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0007073|UDP-glucuronosyltransferase 1-8\nMARTGWTSPIPLCVSLLLTCGFAEAGKLLVVPMDGSHWFTMQSVVEKLILRGHEVVVVMP\nEVSWQLGKSLNCTVKTYSTSYTLEDLDREFMDFADAQWKAQVRSLFSLFLSSSNGFFNLF\nFSHCRSLFNDRKLVEYLKESSFDAVFLDPFDACGLIVAKYFSLPSVVFARGIACHYLEEG\nAQCPAPLSYVPRILLGFSDAMTFKERVRNHIMHLEEHLFCQYFSKNALEIASEILQTPVT\nAYDLYSHTSIWLLRTDFVLDYPKPVMPNMIFIGGINCHQGKPLPMEFEAYINASGEHGIV\nVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDLLGH\nPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTSEDL\nENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHDLTW\nYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH",
                        "Number of residues": "530",
                        "Molecular Weight": "59741.035",
                        "Theoretical pI": "7.73",
                        "GO Classification": "Functionsdrug binding / enzyme binding / enzyme inhibitor activity / fatty acid binding / glucuronosyltransferase activity / protein heterodimerization activity / protein homodimerization activity / retinoic acid binding / steroid bindingProcessescellular glucuronidation / cellular response to hormone stimulus / coumarin metabolic process / drug metabolic process / fatty acid metabolic process / flavone metabolic process / flavonoid biosynthetic process / flavonoid glucuronidation / negative regulation of catalytic activity / negative regulation of cellular glucuronidation / negative regulation of fatty acid metabolic process / negative regulation of glucuronosyltransferase activity / negative regulation of steroid metabolic process / retinoic acid metabolic process / steroid metabolic process / xenobiotic glucuronidationComponentsendoplasmic reticulum / endoplasmic reticulum membrane / integral component of membrane",
                        "General Function": "Steroid binding",
                        "Specific Function": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1.",
                        "Pfam Domain Function": "UDPGT (PF00201)",
                        "Transmembrane Regions": "488-504",
                        "Cellular Location": "Microsome",
                        "Gene sequence": ">lcl|BSEQ0021368|UDP-glucuronosyltransferase 1-8 (UGT1A8)\nATGGCTCGCACAGGGTGGACCAGCCCCATTCCCCTATGTGTTTCTCTGCTGCTGACCTGT\nGGCTTTGCTGAGGCAGGGAAGCTGCTGGTAGTGCCCATGGATGGGAGTCACTGGTTCACC\nATGCAGTCGGTGGTGGAGAAACTTATCCTCAGGGGGCATGAGGTGGTTGTAGTCATGCCA\nGAGGTGAGTTGGCAACTGGGAAAATCACTGAATTGCACAGTGAAGACTTACTCAACCTCA\nTACACTCTGGAGGATCTGGACCGGGAATTCATGGATTTCGCCGATGCTCAATGGAAAGCA\nCAAGTACGAAGTTTGTTTTCTCTATTTCTGAGTTCATCCAATGGTTTTTTTAACTTATTT\nTTTTCGCATTGCAGGAGTTTGTTTAATGACCGAAAATTAGTAGAATACTTAAAGGAGAGT\nTCTTTTGATGCGGTGTTTCTTGATCCTTTTGATGCCTGTGGCTTAATTGTTGCCAAATAT\nTTCTCCCTCCCCTCTGTGGTCTTCGCCAGGGGAATAGCTTGCCACTATCTTGAAGAAGGT\nGCACAGTGCCCTGCTCCTCTTTCCTATGTCCCCAGAATTCTCTTAGGGTTCTCAGATGCC\nATGACTTTCAAGGAGAGAGTACGGAACCACATCATGCACTTGGAGGAACATTTATTTTGC\nCAGTATTTTTCCAAAAATGCCCTAGAAATAGCCTCTGAAATTCTCCAAACACCTGTCACA\nGCATATGATCTCTACAGCCACACATCAATTTGGTTGTTGCGAACAGACTTTGTTTTGGAC\nTATCCCAAACCCGTGATGCCCAATATGATCTTCATTGGTGGTATCAACTGCCATCAGGGA\nAAGCCATTGCCTATGGAATTTGAAGCCTACATTAATGCTTCTGGAGAACATGGAATTGTG\nGTTTTCTCTTTGGGATCAATGGTCTCAGAAATTCCAGAGAAGAAAGCTATGGCAATTGCT\nGATGCTTTGGGCAAAATCCCTCAGACAGTCCTGTGGCGGTACACTGGAACCCGACCATCG\nAATCTTGCGAACAACACGATACTTGTTAAGTGGCTACCCCAAAACGATCTGCTTGGTCAC\nCCGATGACCCGTGCCTTTATCACCCATGCTGGTTCCCATGGTGTTTATGAAAGCATATGC\nAATGGCGTTCCCATGGTGATGATGCCCTTGTTTGGTGATCAGATGGACAATGCAAAGCGC\nATGGAGACTAAGGGAGCTGGAGTGACCCTGAATGTTCTGGAAATGACTTCTGAAGATTTA\nGAAAATGCTCTAAAAGCAGTCATCAATGACAAAAGTTACAAGGAGAACATCATGCGCCTC\nTCCAGCCTTCACAAGGACCGCCCGGTGGAGCCGCTGGACCTGGCCGTGTTCTGGGTGGAG\nTTTGTGATGAGGCACAAGGGCGCGCCACACCTGCGCCCCGCAGCCCACGACCTCACCTGG\nTACCAGTACCATTCCTTGGACGTGATTGGTTTCCTCTTGGCCGTCGTGCTGACAGTGGCC\nTTCATCACCTTTAAATGTTGTGCTTATGGCTACCGGAAATGCTTGGGGAAAAAAGGGCGA\nGTTAAGAAAGCCCACAAATCCAAGACCCATTGA",
                        "Chromosome Location": "2",
                        "Locus": "2q37",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ9HAW9UniProtKB Entry NameUD18_HUMANGenBank Protein ID2613044GenBank Gene IDAF030310HGNC IDHGNC:12540",
                        "General References": "Strassburg CP, Manns MP, Tukey RH: Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8. J Biol Chem. 1998 Apr 10;273(15):8719-26. [Article] Gong QH, Cho JW, Huang T, Potter C, Gholami N, Basu NK, Kubota S, Carvalho S, Pennington MW, Owens IS, Popescu NC: Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics. 2001 Jun;11(4):357-68. [Article] Huang YH, Galijatovic A, Nguyen N, Geske D, Beaton D, Green J, Green M, Peters WH, Tukey RH: Identification and functional characterization of UDP-glucuronosyltransferases UGT1A8*1, UGT1A8*2 and UGT1A8*3. Pharmacogenetics. 2002 Jun;12(4):287-97. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article] Chen R, Jiang X, Sun D, Han G, Wang F, Ye M, Wang L, Zou H: Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009 Feb;8(2):651-61. doi: 10.1021/pr8008012. [Article] Girard H, Levesque E, Bellemare J, Journault K, Caillier B, Guillemette C: Genetic diversity at the UGT1 locus is amplified by a novel 3' alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity. Pharmacogenet Genomics. 2007 Dec;17(12):1077-89. [Article] Tang L, Singh R, Liu Z, Hu M: Structure and concentration changes affect characterization of UGT isoform-specific metabolism of isoflavones. Mol Pharm. 2009 Sep-Oct;6(5):1466-82. doi: 10.1021/mp8002557. [Article] Bellemare J, Rouleau M, Girard H, Harvey M, Guillemette C: Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro. Drug Metab Dispos. 2010 Oct;38(10):1785-9. doi: 10.1124/dmd.110.034835. Epub 2010 Jul 7. [Article] Menard V, Girard H, Harvey M, Perusse L, Guillemette C: Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. Hum Mutat. 2009 Apr;30(4):677-87. doi: 10.1002/humu.20946. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00818Propofolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknownsubstrateDetailsDB00295Morphineapproved, investigationalnosubstrateDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB00861Diflunisalapproved, investigationalunknownsubstrateDetailsDB00313Valproic acidapproved, investigationalunknownsubstrateDetailsDB06230Nalmefeneapproved, investigational, withdrawnnosubstrateDetailsDB11633Isavuconazoleapproved, investigationalunknowninhibitorDetailsDB06401Bazedoxifeneapproved, investigationalunknownsubstrateDetailsDB00481Raloxifeneapproved, investigationalnosubstrateDetailsDB00788Naproxenapproved, vet_approvedunknownsubstrateDetailsDB09079NintedanibapprovedunknownsubstrateDetailsDB00983Formoterolapproved, investigationalunknownsubstrateDetailsDB09038EmpagliflozinapprovedunknownsubstrateDetailsDB08893MirabegronapprovednosubstrateDetailsDB14737Cannabinolexperimental, investigationalunknownsubstrateinhibitorDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorDetailsDB01024Mycophenolic acidapproved, investigationalunknownsubstrateDetailsDB12243Edaravoneapproved, investigationalnosubstrateDetailsDB17472Pirtobrutinibapproved, investigationalunknownsubstrateDetailsDB12255Vadadustatapproved, investigationalunknownsubstrateDetailsDB00555Lamotrigineapproved, investigationalunknownsubstrateDetailsDB00503Ritonavirapproved, investigationalnoinducerDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB00794Primidoneapproved, vet_approvedunknowninducerDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB00714Apomorphineapproved, investigationalunknownsubstrateDetailsDB11796Fostemsavirapproved, investigationalunknownsubstrateDetailsDB00871TerbutalineapprovedunknownsubstrateDetailsDB00960Pindololapproved, investigationalunknownsubstrateDetailsDB12471Ibrexafungerpapproved, investigationalunknownsubstrateDetails"
                    }
                },
                {
                    "Label": "UDP-glucuronosyltransferase 2B15",
                    "Detailed Info": {
                        "Name": "UDP-glucuronosyltransferase 2B15",
                        "Synonyms": "2.4.1.17\nHLUG4\nUDP-glucuronosyltransferase 2B8\nUDPGT 2B15\nUDPGT 2B8\nUDPGTh-3\nUGT2B8",
                        "Gene Name": "UGT2B15",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0017513|UDP-glucuronosyltransferase 2B15\nMSLKWTSVFLLIQLSCYFSSGSCGKVLVWPTEYSHWINMKTILEELVQRGHEVTVLTSSA\nSTLVNASKSSAIKLEVYPTSLTKNYLEDSLLKILDRWIYGVSKNTFWSYFSQLQELCWEY\nYDYSNKLCKDAVLNKKLMMKLQESKFDVILADALNPCGELLAELFNIPFLYSLRFSVGYT\nFEKNGGGFLFPPSYVPVVMSELSDQMIFMERIKNMIHMLYFDFWFQIYDLKKWDQFYSEV\nLGRPTTLFETMGKAEMWLIRTYWDFEFPRPFLPNVDFVGGLHCKPAKPLPKEMEEFVQSS\nGENGIVVFSLGSMISNMSEESANMIASALAQIPQKVLWRFDGKKPNTLGSNTRLYKWLPQ\nNDLLGHPKTKAFITHGGTNGIYEAIYHGIPMVGIPLFADQHDNIAHMKAKGAALSVDIRT\nMSSRDLLNALKSVINDPVYKENVMKLSRIHHDQPMKPLDRAVFWIEFVMRHKGAKHLRVA\nAHNLTWIQYHSLDVIAFLLACVATVIFIITKFCLFCFRKLAKKGKKKKRD",
                        "Number of residues": "530",
                        "Molecular Weight": "61035.815",
                        "Theoretical pI": "Not Available",
                        "GO Classification": "Functionsglucuronosyltransferase activityProcessescellular glucuronidation / cellular response to hormone stimulus / flavonoid biosynthetic process / flavonoid glucuronidation / steroid metabolic process / xenobiotic metabolic processComponentsendoplasmic reticulum membrane / integral component of membrane / intracellular membrane-bounded organelle",
                        "General Function": "Glucuronosyltransferase activity",
                        "Specific Function": "UDPGTs are of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isozyme displays activity toward several classes of xenobiotic substrates, including simple phenolic compounds, 7-hydroxylated coumarins, flavonoids, anthraquinones, and certain drugs and their hydroxylated metabolites. It also catalyzes the glucuronidation of endogenous estrogens and androgens.",
                        "Pfam Domain Function": "UDPGT (PF00201)",
                        "Transmembrane Regions": "495-515",
                        "Cellular Location": "Microsome membrane",
                        "Gene sequence": ">lcl|BSEQ0017514|UDP-glucuronosyltransferase 2B15 (UGT2B15)\nATGTCTCTGAAATGGACGTCAGTCTTTCTGCTGATACAGCTCAGTTGTTACTTTAGCTCT\nGGAAGCTGTGGAAAGGTGCTAGTGTGGCCCACAGAATACAGCCATTGGATAAATATGAAG\nACAATCCTGGAAGAGCTTGTTCAGAGGGGTCATGAGGTGACTGTGTTGACATCTTCGGCT\nTCTACTCTTGTCAATGCCAGTAAATCATCTGCTATTAAATTAGAAGTTTATCCTACATCT\nTTAACTAAAAATTATTTGGAAGATTCTCTTCTGAAAATTCTCGATAGATGGATATATGGT\nGTTTCAAAAAATACATTTTGGTCATATTTTTCACAATTACAAGAATTGTGTTGGGAATAT\nTATGACTACAGTAACAAGCTCTGTAAAGATGCAGTTTTGAATAAGAAACTTATGATGAAA\nCTACAAGAGTCAAAGTTTGATGTCATTCTGGCAGATGCCCTTAATCCCTGTGGTGAGCTA\nCTGGCTGAACTATTTAACATACCCTTTCTGTACAGTCTTCGATTCTCTGTTGGCTACACA\nTTTGAGAAGAATGGTGGAGGATTTCTGTTCCCTCCTTCCTATGTACCTGTTGTTATGTCA\nGAATTAAGTGATCAAATGATTTTCATGGAGAGGATAAAAAATATGATACATATGCTTTAT\nTTTGACTTTTGGTTTCAAATTTATGATCTGAAGAAGTGGGACCAGTTTTATAGTGAAGTT\nCTAGGAAGACCCACTACATTATTTGAGACAATGGGGAAAGCTGAAATGTGGCTCATTCGA\nACCTATTGGGATTTTGAATTTCCTCGCCCATTCTTACCAAATGTTGATTTTGTTGGAGGA\nCTTCACTGTAAACCAGCCAAACCCCTGCCTAAGGAAATGGAAGAGTTTGTGCAGAGCTCT\nGGAGAAAATGGTATTGTGGTGTTTTCTCTGGGGTCGATGATCAGTAACATGTCAGAAGAA\nAGTGCCAACATGATTGCATCAGCCCTTGCCCAGATCCCACAAAAGGTTCTATGGAGATTT\nGATGGCAAGAAGCCAAATACTTTAGGTTCCAATACTCGACTGTACAAGTGGTTACCCCAG\nAATGACCTTCTTGGTCATCCCAAAACCAAAGCTTTTATAACTCATGGTGGAACCAATGGC\nATCTATGAGGCGATCTACCATGGGATCCCTATGGTGGGCATTCCCTTGTTTGCGGATCAA\nCATGATAACATTGCTCACATGAAAGCCAAGGGAGCAGCCCTCAGTGTGGACATCAGGACC\nATGTCAAGTAGAGATTTGCTCAATGCATTGAAGTCAGTCATTAATGACCCTGTCTATAAA\nGAGAATGTCATGAAATTATCAAGAATTCATCATGACCAACCAATGAAGCCCCTGGATCGA\nGCAGTCTTCTGGATTGAGTTTGTCATGCGCCACAAAGGAGCCAAGCACCTTCGAGTCGCA\nGCTCACAACCTCACCTGGATCCAGTACCACTCTTTGGATGTGATAGCATTCCTGCTGGCC\nTGCGTGGCAACTGTGATATTTATCATCACAAAATTTTGCCTGTTTTGTTTCCGAAAGCTT\nGCCAAAAAAGGAAAGAAGAAGAAAAGAGATTAG",
                        "Chromosome Location": "4",
                        "Locus": "Not Available",
                        "External Identifiers": "ResourceLinkUniProtKB IDP54855UniProtKB Entry NameUDB15_HUMANHGNC IDHGNC:12546",
                        "General References": "Chen F, Ritter JK, Wang MG, McBride OW, Lubet RA, Owens IS: Characterization of a cloned human dihydrotestosterone/androstanediol UDP-glucuronosyltransferase and its comparison to other steroid isoforms. Biochemistry. 1993 Oct 12;32(40):10648-57. [Article] Green MD, Oturu EM, Tephly TR: Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates. Drug Metab Dispos. 1994 Sep-Oct;22(5):799-805. [Article] Levesque E, Beaulieu M, Green MD, Tephly TR, Belanger A, Hum DW: Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics. 1997 Aug;7(4):317-25. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article] Coffman BL, Tephly TR, Irshaid YM, Green MD, Smith C, Jackson MR, Wooster R, Burchell B: Characterization and primary sequence of a human hepatic microsomal estriol UDPglucuronosyltransferase. Arch Biochem Biophys. 1990 Aug 15;281(1):170-5. [Article] Chen R, Jiang X, Sun D, Han G, Wang F, Ye M, Wang L, Zou H: Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009 Feb;8(2):651-61. doi: 10.1021/pr8008012. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Toide K, Umeda S, Yamazaki H, Takahashi Y, Terauchi Y, Fujii T, Kamataki T: A major genotype in UDP-glucuronosyltransferase 2B15. Drug Metab Pharmacokinet. 2002;17(2):164-6. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknownsubstrateDetailsDB00295Morphineapproved, investigationalnosubstrateDetailsDB00973EzetimibeapprovedunknownsubstrateDetailsDB06695Dabigatran etexilateapprovedunknownsubstrateDetailsDB00316AcetaminophenapprovedunknownsubstrateDetailsDB00842OxazepamapprovedunknownsubstrateDetailsDB00186LorazepamapprovedunknownsubstrateDetailsDB00313Valproic acidapproved, investigationalunknownsubstrateDetailsDB11943Delafloxacinapproved, investigationalnosubstrateDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateDetailsDB09288PropacetamolexperimentalnosubstrateDetailsDB00455Loratadineapproved, investigationalunknownDetailsDB06077Lumateperoneapproved, investigationalnosubstrateDetailsDB00983Formoterolapproved, investigationalunknownsubstrateDetailsDB00783Estradiolapproved, investigational, vet_approvedunknowninducerDetailsDB00514DextromethorphanapprovedunknownsubstrateDetailsDB09185Viloxazineapproved, investigational, withdrawnnosubstrateDetailsDB06045Trofinetideapproved, investigationalunknowninhibitorDetailsDB06700Desvenlafaxineapproved, investigationalnosubstrateDetailsDB00555Lamotrigineapproved, investigationalunknownsubstrateDetailsDB00503Ritonavirapproved, investigationalnoinducerDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB00794Primidoneapproved, vet_approvedunknowninducerDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB00714Apomorphineapproved, investigationalunknownsubstrateDetailsDB11796Fostemsavirapproved, investigationalunknownsubstrateDetailsDB00871TerbutalineapprovedunknownsubstrateDetailsDB00960Pindololapproved, investigationalunknownsubstrateDetailsDB12471Ibrexafungerpapproved, investigationalunknownsubstrateDetails"
                    }
                },
                {
                    "Label": "UDP-glucuronosyltransferase 2B4",
                    "Detailed Info": {
                        "Name": "UDP-glucuronosyltransferase 2B4",
                        "Synonyms": "2.4.1.17\nHLUG25\nHyodeoxycholic acid-specific UDPGT\nUDPGT 2B4\nUDPGTh-1\nUGT2B11",
                        "Gene Name": "UGT2B4",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0007072|UDP-glucuronosyltransferase 2B4\nMSMKWTSALLLIQLSCYFSSGSCGKVLVWPTEFSHWMNIKTILDELVQRGHEVTVLASSA\nSISFDPNSPSTLKFEVYPVSLTKTEFEDIIKQLVKRWAELPKDTFWSYFSQVQEIMWTFN\nDILRKFCKDIVSNKKLMKKLQESRFDVVLADAVFPFGELLAELLKIPFVYSLRFSPGYAI\nEKHSGGLLFPPSYVPVVMSELSDQMTFIERVKNMIYVLYFEFWFQIFDMKKWDQFYSEVL\nGRPTTLSETMAKADIWLIRNYWDFQFPHPLLPNVEFVGGLHCKPAKPLPKEMEEFVQSSG\nENGVVVFSLGSMVSNTSEERANVIASALAKIPQKVLWRFDGNKPDTLGLNTRLYKWIPQN\nDLLGHPKTRAFITHGGANGIYEAIYHGIPMVGVPLFADQPDNIAHMKAKGAAVSLDFHTM\nSSTDLLNALKTVINDPLYKENAMKLSRIHHDQPVKPLDRAVFWIEFVMRHKGAKHLRVAA\nHDLTWFQYHSLDVTGFLLACVATVIFIITKCLFCVWKFVRTGKKGKRD",
                        "Number of residues": "528",
                        "Molecular Weight": "60512.035",
                        "Theoretical pI": "8.75",
                        "GO Classification": "Functionsglucuronosyltransferase activityProcessescellular glucuronidation / cellular response to hormone stimulus / estrogen catabolic process / flavonoid biosynthetic process / flavonoid glucuronidation / metabolic process / xenobiotic metabolic processComponentsendoplasmic reticulum membrane / integral component of membrane / intracellular membrane-bounded organelle",
                        "General Function": "Glucuronosyltransferase activity",
                        "Specific Function": "UDPGTs are of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isozyme is active on polyhydroxylated estrogens (such as estriol, 4-hydroxyestrone and 2-hydroxyestriol) and xenobiotics (such as 4-methylumbelliferone, 1-naphthol, 4-nitrophenol, 2-aminophenol, 4-hydroxybiphenyl and menthol). It is capable of 6 alpha-hydroxyglucuronidation of hyodeoxycholic acid.",
                        "Pfam Domain Function": "UDPGT (PF00201)",
                        "Transmembrane Regions": "493-509",
                        "Cellular Location": "Microsome membrane",
                        "Gene sequence": ">lcl|BSEQ0017183|UDP-glucuronosyltransferase 2B4 (UGT2B4)\nATGTCTATGAAATGGACTTCAGCTCTTCTGCTGATACAGCTGAGCTGTTACTTTAGCTCT\nGGGAGTTGTGGAAAGGTGCTGGTGTGGCCCACAGAATTCAGCCACTGGATGAATATAAAG\nACAATCCTGGATGAACTTGTCCAGAGAGGTCATGAGGTGACTGTATTGGCATCTTCAGCT\nTCCATTTCTTTCGATCCCAACAGCCCATCTACTCTTAAATTTGAAGTTTATCCTGTATCT\nTTAACTAAAACTGAGTTTGAGGATATTATCAAGCAGCTGGTTAAGAGATGGGCAGAACTT\nCCAAAAGACACATTTTGGTCATATTTTTCACAAGTACAAGAAATCATGTGGACATTTAAT\nGACATACTTAGAAAGTTCTGTAAGGATATAGTTTCAAATAAGAAACTTATGAAGAAACTA\nCAGGAGTCAAGATTTGATGTTGTTCTTGCAGATGCTGTTTTCCCCTTTGGTGAGCTGCTG\nGCCGAGTTACTTAAAATACCCTTTGTCTACAGCCTCCGCTTCTCTCCTGGCTACGCAATT\nGAAAAGCATAGTGGAGGACTTCTGTTCCCTCCTTCCTATGTGCCTGTTGTTATGTCAGAA\nCTAAGTGACCAAATGACTTTCATAGAGAGGGTAAAAAATATGATCTATGTGCTTTATTTT\nGAATTTTGGTTCCAAATATTTGACATGAAGAAGTGGGATCAGTTCTACAGTGAAGTTCTA\nGGAAGACCCACTACGTTATCTGAGACAATGGCAAAAGCTGACATATGGCTTATTCGAAAC\nTACTGGGATTTTCAATTTCCTCACCCACTCTTACCAAATGTTGAGTTCGTTGGAGGACTC\nCACTGCAAACCTGCCAAACCCCTACCGAAGGAAATGGAAGAGTTTGTCCAGAGCTCTGGA\nGAAAATGGTGTTGTGGTGTTTTCTCTGGGGTCGATGGTCAGTAACACGTCAGAAGAAAGG\nGCCAATGTAATTGCATCAGCCCTTGCCAAGATCCCACAAAAGGTTCTGTGGAGATTTGAT\nGGGAATAAACCAGATACTTTAGGACTCAATACTCGGCTGTACAAGTGGATACCCCAGAAT\nGATCTTCTTGATATAAAGAGAATGCTATGA",
                        "Chromosome Location": "4",
                        "Locus": "4q13",
                        "External Identifiers": "ResourceLinkUniProtKB IDP06133UniProtKB Entry NameUD2B4_HUMANGenBank Protein ID37589GenBank Gene IDY00317HGNC IDHGNC:12553",
                        "General References": "Jackson MR, McCarthy LR, Harding D, Wilson S, Coughtrie MW, Burchell B: Cloning of a human liver microsomal UDP-glucuronosyltransferase cDNA. Biochem J. 1987 Mar 1;242(2):581-8. [Article] Jin CJ, Miners JO, Lillywhite KJ, Mackenzie PI: cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily. Biochem Biophys Res Commun. 1993 Jul 15;194(1):496-503. [Article] Levesque E, Beaulieu M, Hum DW, Belanger A: Characterization and substrate specificity of UGT2B4 (E458): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics. 1999 Apr;9(2):207-16. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Chen R, Jiang X, Sun D, Han G, Wang F, Ye M, Wang L, Zou H: Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009 Feb;8(2):651-61. doi: 10.1021/pr8008012. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00712Flurbiprofenapproved, investigationalunknownsubstrateDetailsDB01050IbuprofenapprovedunknownsubstrateDetailsDB06741GavestinelinvestigationalunknownsubstrateDetailsDB00295Morphineapproved, investigationalnosubstrateDetailsDB08907CanagliflozinapprovedunknownsubstrateDetailsDB00318Codeineapproved, illicitunknownsubstrateDetailsDB06292DapagliflozinapprovednosubstrateDetailsDB09213Dexibuprofenapproved, investigationalunknownsubstrateDetailsDB00586Diclofenacapproved, vet_approvedunknownsubstrateDetailsDB01136Carvedilolapproved, investigationalunknownsubstrateDetailsDB01241GemfibrozilapprovedunknownsubstrateDetailsDB06119Cenobamateapproved, investigationalunknownsubstrateDetailsDB00514DextromethorphanapprovedunknownsubstrateDetailsDB08804Nandrolone decanoateapproved, illicitunknownsubstrateDetailsDB00647Dextropropoxypheneapproved, illicit, investigational, withdrawnunknowninhibitorDetailsDB00333MethadoneapprovednoinhibitorDetailsDB12095Telotristat ethylapproved, investigationalnoinducerDetailsDB00349Clobazamapproved, illicitunknowninhibitorDetailsDB00683Midazolamapproved, illicitnosubstrateDetailsDB06700Desvenlafaxineapproved, investigationalnosubstrateDetailsDB00555Lamotrigineapproved, investigationalunknownsubstrateDetailsDB00503Ritonavirapproved, investigationalnoinducerDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB00794Primidoneapproved, vet_approvedunknowninducerDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB00714Apomorphineapproved, investigationalunknownsubstrateDetailsDB11796Fostemsavirapproved, investigationalunknownsubstrateDetailsDB00871TerbutalineapprovedunknownsubstrateDetailsDB00960Pindololapproved, investigationalunknownsubstrateDetailsDB12471Ibrexafungerpapproved, investigationalunknownsubstrateDetails"
                    }
                },
                {
                    "Label": "UDP-glucuronosyltransferase 1-3",
                    "Detailed Info": {
                        "Name": "UDP-glucuronosyltransferase 1-3",
                        "Synonyms": "2.4.1.17\nGNT1\nUDP-glucuronosyltransferase 1-C\nUDP-glucuronosyltransferase 1A3\nUDPGT 1-3\nUGT-1C\nUGT1\nUGT1C",
                        "Gene Name": "UGT1A3",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0007065|UDP-glucuronosyltransferase 1-3\nMATGLQVPLPWLATGLLLLLSVQPWAESGKVLVVPIDGSHWLSMREVLRELHARGHQAVV\nLTPEVNMHIKEENFFTLTTYAISWTQDEFDRHVLGHTQLYFETEHFLKKFFRSMAMLNNM\nSLVYHRSCVELLHNEALIRHLNATSFDVVLTDPVNLCAAVLAKYLSIPTVFFLRNIPCDL\nDFKGTQCPNPSSYIPRLLTTNSDHMTFMQRVKNMLYPLALSYICHAFSAPYASLASELFQ\nREVSVVDILSHASVWLFRGDFVMDYPRPIMPNMVFIGGINCANRKPLSQEFEAYINASGE\nHGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQND\nLLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMT\nSEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAH\nDLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH",
                        "Number of residues": "534",
                        "Molecular Weight": "60337.835",
                        "Theoretical pI": "8.28",
                        "GO Classification": "Functionsenzyme binding / glucuronosyltransferase activity / protein heterodimerization activity / protein homodimerization activity / retinoic acid bindingProcessescellular glucuronidation / cellular response to hormone stimulus / flavonoid biosynthetic process / flavonoid glucuronidation / metabolic process / negative regulation of cellular glucuronidation / negative regulation of fatty acid metabolic process / negative regulation of glucuronosyltransferase activity / retinoic acid metabolic process / xenobiotic glucuronidationComponentsendoplasmic reticulum / endoplasmic reticulum membrane / integral component of membrane",
                        "General Function": "Retinoic acid binding",
                        "Specific Function": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1.",
                        "Pfam Domain Function": "UDPGT (PF00201)",
                        "Transmembrane Regions": "492-508",
                        "Cellular Location": "Microsome",
                        "Gene sequence": ">lcl|BSEQ0017182|UDP-glucuronosyltransferase 1-3 (UGT1A3)\nATGGCCACAGGACTCCAGGTTCCCCTGCCGTGGCTGGCCACAGGACTGCTGCTTCTCCTC\nAGTGTCCAGCCCTGGGCTGAGAGTGGAAAGGTGTTGGTGGTGCCCATTGATGGCAGCCAC\nTGGCTCAGCATGCGGGAGGTCTTGCGGGAGCTCCATGCCAGAGGCCACCAGGCAGTGGTC\nCTCACCCCAGAGGTGAATATGCACATCAAAGAAGAGAACTTTTTCACCCTGACAACCTAT\nGCCATTTCGTGGACCCAGGATGAATTTGATCGCCATGTGCTGGGCCACACTCAACTGTAC\nTTTGAAACAGAACATTTTCTGAAGAAATTTTTCAGAAGTATGGCAATGTTGAACAATATG\nTCTTTGGTCTATCATAGGTCTTGTGTGGAGCTACTACATAATGAGGCCCTGATCAGGCAC\nCTGAATGCTACTTCCTTTGATGTGGTTTTAACAGACCCCGTTAACCTCTGCGCGGCAGTG\nCTGGCTAAGTACCTGTCGATTCCTACTGTGTTTTTTTTGAGGAACATTCCATGTGATTTA\nGACTTTAAGGGCACACAGTGTCCAAACCCTTCCTCCTATATTCCTAGATTACTAACAACC\nAATTCAGACCACATGACATTCATGCAAAGGGTCAAGAACATGCTCTACCCTCTGGCCCTG\nTCCTACATTTGCCATGCTTTTTCTGCTCCTTATGCAAGCCTTGCCTCTGAGCTTTTTCAG\nAGAGAGGTGTCAGTGGTGGATATTCTCAGTCATGCATCTGTGTGGCTGTTCCGAGGGGAC\nTTTGTGATGGACTACCCCAGGCCAATCATGCCCAACATGGTCTTCATTGGGGGCATCAAC\nTGTGCCAACAGGAAGCCACTATCTCAGGAATTTGAAGCCTACATTAATGCTTCTGGAGAA\nCATGGAATTGTGGTTTTCTCTTTGGGATCAATGGTCTCAGAAATTCCAGAGAAGAAAGCT\nATGGCAATTGCTGATGCTTTGGGCAAAATCCCTCAGACAGTCCTGTGGCGGTACACTGGA\nACCCGACCATCGAATCTTGCGAACAACACGATACTTGTTAAGTGGCTACCCCAAAACGAT\nCTGCTTGGTCACCCGATGACCCGTGCCTTTATCACCCATGCTGGTTCCCATGGTGTTTAT\nGAAAGCATATGCAATGGCGTTCCCATGGTGATGATGCCCTTGTTTGGTGATCAGATGGAC\nAATGCAAAGCGCATGGAGACTAAGGGAGCTGGAGTGACCCTGAATGTTCTGGAAATGACT\nTCTGAAGATTTAGAAAATGCTCTAAAAGCAGTCATCAATGACAAAAGTTACAAGGAGAAC\nATCATGCGCCTCTCCAGCCTTCACAAGGACCGCCCGGTGGAGCCGCTGGACCTGGCCGTG\nTTCTGGGTGGAGTTTGTGATGAGGCACAAGGGCGCGCCACACCTGCGCCCCGCAGCCCAC\nGACCTCACCTGGTACCAGTACCATTCCTTGGACGTGATTGGTTTCCTCTTGGCCGTCGTG\nCTGACAGTGGCCTTCATCACCTTTAAATGTTGTGCTTATGGCTACCGGAAATGCTTGGGG\nAAAAAAGGGCGAGTTAAGAAAGCCCACAAATCCAAGACCCATTGA",
                        "Chromosome Location": "2",
                        "Locus": "2q37",
                        "External Identifiers": "ResourceLinkUniProtKB IDP35503UniProtKB Entry NameUD13_HUMANGenBank Protein ID340135GenBank Gene IDM84127HGNC IDHGNC:12535",
                        "General References": "Ritter JK, Chen F, Sheen YY, Tran HM, Kimura S, Yeatman MT, Owens IS: A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem. 1992 Feb 15;267(5):3257-61. [Article] Gong QH, Cho JW, Huang T, Potter C, Gholami N, Basu NK, Kubota S, Carvalho S, Pennington MW, Owens IS, Popescu NC: Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics. 2001 Jun;11(4):357-68. [Article] Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article] Alonen A, Finel M, Kostiainen R: The human UDP-glucuronosyltransferase UGT1A3 is highly selective towards N2 in the tetrazole ring of losartan, candesartan, and zolarsartan. Biochem Pharmacol. 2008 Sep 15;76(6):763-72. doi: 10.1016/j.bcp.2008.07.006. Epub 2008 Jul 12. [Article] Bellemare J, Rouleau M, Girard H, Harvey M, Guillemette C: Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro. Drug Metab Dispos. 2010 Oct;38(10):1785-9. doi: 10.1124/dmd.110.034835. Epub 2010 Jul 7. [Article] Girard H, Levesque E, Bellemare J, Journault K, Caillier B, Guillemette C: Genetic diversity at the UGT1 locus is amplified by a novel 3' alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity. Pharmacogenet Genomics. 2007 Dec;17(12):1077-89. [Article] Chen R, Jiang X, Sun D, Han G, Wang F, Ye M, Wang L, Zou H: Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009 Feb;8(2):651-61. doi: 10.1021/pr8008012. [Article] Menard V, Girard H, Harvey M, Perusse L, Guillemette C: Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. Hum Mutat. 2009 Apr;30(4):677-87. doi: 10.1002/humu.20946. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00796Candesartan cilexetilapprovedunknownsubstrateDetailsDB01029Irbesartanapproved, investigationalunknownsubstrateDetailsDB00678LosartanapprovedunknownsubstrateDetailsDB00749Etodolacapproved, investigational, vet_approvedunknownsubstrateDetailsDB00712Flurbiprofenapproved, investigationalunknownsubstrateDetailsDB01050IbuprofenapprovedunknownsubstrateDetailsDB00327Hydromorphoneapproved, illicitnosubstrateDetailsDB01252MitiglinideinvestigationalunknownsubstrateDetailsDB04725LicofeloneinvestigationalunknownsubstrateDetailsDB06741GavestinelinvestigationalunknownsubstrateDetailsDB06210EltrombopagapprovedunknownsubstrateDetailsDB06403Ambrisentanapproved, investigationalunknownsubstrateDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknownsubstrateDetailsDB00295Morphineapproved, investigationalnosubstrateDetailsDB00973EzetimibeapprovedunknownsubstrateDetailsDB06510MuraglitazarinvestigationalunknownsubstrateDetailsDB00434CyproheptadineapprovedunknownsubstrateDetailsDB04953Ezogabineapproved, investigationalunknownsubstrateDetailsDB08860PitavastatinapprovedunknownsubstrateDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB00227Lovastatinapproved, investigationalunknownsubstrateDetailsDB00641SimvastatinapprovedunknownsubstrateDetailsDB01544Flunitrazepamapproved, illicitunknowninhibitorDetailsDB01095FluvastatinapprovedunknownsubstrateDetailsDB00313Valproic acidapproved, investigationalunknownsubstrateDetailsDB11943Delafloxacinapproved, investigationalnosubstrateDetailsDB11691Naldemedineapproved, investigationalnosubstrateDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateDetailsDB13919CandesartanexperimentalunknownsubstrateDetailsDB12070Letermovirapproved, investigationalnosubstrateDetailsDB06230Nalmefeneapproved, investigational, withdrawnnosubstrateDetailsDB08930DolutegravirapprovednosubstrateDetailsDB05928DovitinibinvestigationalunknowninhibitorDetailsDB01609Deferasiroxapproved, investigationalunknowninhibitorDetailsDB09213Dexibuprofenapproved, investigationalunknownsubstrateDetailsDB13997Baloxavir marboxilapproved, investigationalnosubstrateDetailsDB00966Telmisartanapproved, investigationalunknownsubstrateDetailsDB01241GemfibrozilapprovedunknownsubstrateinhibitorDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateDetailsDB00788Naproxenapproved, vet_approvedunknownsubstrateDetailsDB00586Diclofenacapproved, vet_approvedunknownsubstrateDetailsDB00455Loratadineapproved, investigationalunknownDetailsDB01217Anastrozoleapproved, investigationalunknownsubstrateDetailsDB00977EthinylestradiolapprovedunknownDetailsDB11689Selumetinibapproved, investigationalnoDetailsDB09038EmpagliflozinapprovedunknownsubstrateDetailsDB00920KetotifenapprovedunknownsubstrateDetailsDB04854FebuxostatapprovednosubstrateDetailsDB08893MirabegronapprovednosubstrateDetailsDB08804Nandrolone decanoateapproved, illicitunknownsubstrateDetailsDB12020Tecovirimatapproved, investigationalunknownsubstrateDetailsDB00470Dronabinolapproved, illicitnosubstrateDetailsDB06700Desvenlafaxineapproved, investigationalnosubstrateDetailsDB15114Vamoroloneapproved, investigationalnosubstrateDetailsDB00555Lamotrigineapproved, investigationalunknownsubstrateDetailsDB00503Ritonavirapproved, investigationalnoinducerDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB00794Primidoneapproved, vet_approvedunknowninducerDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB00714Apomorphineapproved, investigationalunknownsubstrateDetailsDB11796Fostemsavirapproved, investigationalunknownsubstrateDetailsDB00871TerbutalineapprovedunknownsubstrateDetailsDB00960Pindololapproved, investigationalunknownsubstrateDetailsDB12471Ibrexafungerpapproved, investigationalunknownsubstrateDetails"
                    }
                }
            ],
            "carriers": [
                {
                    "Label": "Serum albumin",
                    "Detailed Info": {
                        "Name": "Serum albumin",
                        "Synonyms": "Serum albumin precursor",
                        "Gene Name": "ALB",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0001058|Serum albumin\nMKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPF\nEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEP\nERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLF\nFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAV\nARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLK\nECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYAR\nRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFE\nQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVV\nLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTL\nSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLV\nAASQAALGL",
                        "Number of residues": "609",
                        "Molecular Weight": "69365.94",
                        "Theoretical pI": "6.21",
                        "GO Classification": "Functionsantioxidant activity / chaperone binding / copper ion binding / DNA binding / drug binding / fatty acid binding / pyridoxal phosphate binding / toxic substance bindingProcessesbile acid and bile salt transport / bile acid metabolic process / blood coagulation / cellular response to starvation / hemolysis by symbiont of host erythrocytes / lipoprotein metabolic process / maintenance of mitochondrion location / negative regulation of apoptotic process / negative regulation of programmed cell death / platelet activation / platelet degranulation / receptor-mediated endocytosis / retina homeostasis / small molecule metabolic process / sodium-independent organic anion transport / transmembrane transport / transportComponentsblood microparticle / endoplasmic reticulum / extracellular exosome / extracellular region / extracellular space / Golgi apparatus / myelin sheath / nucleus / platelet alpha granule lumen / protein complex",
                        "General Function": "Toxic substance binding",
                        "Specific Function": "Serum albumin, the main protein of plasma, has a good binding capacity for water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin and drugs. Its main function is the regulation of the colloidal osmotic pressure of blood. Major zinc transporter in plasma, typically binds about 80% of all plasma zinc.",
                        "Pfam Domain Function": "Serum_albumin (PF00273)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Secreted",
                        "Gene sequence": ">lcl|BSEQ0010372|Serum albumin (ALB)\nATGAAGTGGGTAACCTTTATTTCCCTTCTTTTTCTCTTTAGCTCGGCTTATTCCAGGGGT\nGTGTTTCGTCGAGATGCACACAAGAGTGAGGTTGCTCATCGGTTTAAAGATTTGGGAGAA\nGAAAATTTCAAAGCCTTGGTGTTGATTGCCTTTGCTCAGTATCTTCAGCAGTGTCCATTT\nGAAGATCATGTAAAATTAGTGAATGAAGTAACTGAATTTGCAAAAACATGTGTTGCTGAT\nGAGTCAGCTGAAAATTGTGACAAATCACTTCATACCCTTTTTGGAGACAAATTATGCACA\nGTTGCAACTCTTCGTGAAACCTATGGTGAAATGGCTGACTGCTGTGCAAAACAAGAACCT\nGAGAGAAATGAATGCTTCTTGCAACACAAAGATGACAACCCAAACCTCCCCCGATTGGTG\nAGACCAGAGGTTGATGTGATGTGCACTGCTTTTCATGACAATGAAGAGACATTTTTGAAA\nAAATACTTATATGAAATTGCCAGAAGACATCCTTACTTTTATGCCCCGGAACTCCTTTTC\nTTTGCTAAAAGGTATAAAGCTGCTTTTACAGAATGTTGCCAAGCTGCTGATAAAGCTGCC\nTGCCTGTTGCCAAAGCTCGATGAACTTCGGGATGAAGGGAAGGCTTCGTCTGCCAAACAG\nAGACTCAAGTGTGCCAGTCTCCAAAAATTTGGAGAAAGAGCTTTCAAAGCATGGGCAGTA\nGCTCGCCTGAGCCAGAGATTTCCCAAAGCTGAGTTTGCAGAAGTTTCCAAGTTAGTGACA\nGATCTTACCAAAGTCCACACGGAATGCTGCCATGGAGATCTGCTTGAATGTGCTGATGAC\nAGGGCGGACCTTGCCAAGTATATCTGTGAAAATCAAGATTCGATCTCCAGTAAACTGAAG\nGAATGCTGTGAAAAACCTCTGTTGGAAAAATCCCACTGCATTGCCGAAGTGGAAAATGAT\nGAGATGCCTGCTGACTTGCCTTCATTAGCTGCTGATTTTGTTGAAAGTAAGGATGTTTGC\nAAAAACTATGCTGAGGCAAAGGATGTCTTCCTGGGCATGTTTTTGTATGAATATGCAAGA\nAGGCATCCTGATTACTCTGTCGTGCTGCTGCTGAGACTTGCCAAGACATATGAAACCACT\nCTAGAGAAGTGCTGTGCCGCTGCAGATCCTCATGAATGCTATGCCAAAGTGTTCGATGAA\nTTTAAACCTCTTGTGGAAGAGCCTCAGAATTTAATCAAACAAAATTGTGAGCTTTTTGAG\nCAGCTTGGAGAGTACAAATTCCAGAATGCGCTATTAGTTCGTTACACCAAGAAAGTACCC\nCAAGTGTCAACTCCAACTCTTGTAGAGGTCTCAAGAAACCTAGGAAAAGTGGGCAGCAAA\nTGTTGTAAACATCCTGAAGCAAAAAGAATGCCCTGTGCAGAAGACTATCTATCCGTGGTC\nCTGAACCAGTTATGTGTGTTGCATGAGAAAACGCCAGTAAGTGACAGAGTCACCAAATGC\nTGCACAGAATCCTTGGTGAACAGGCGACCATGCTTTTCAGCTCTGGAAGTCGATGAAACA\nTACGTTCCCAAAGAGTTTAATGCTGAAACATTCACCTTCCATGCAGATATATGCACACTT\nTCTGAGAAGGAGAGACAAATCAAGAAACAAACTGCACTTGTTGAGCTCGTGAAACACAAG\nCCCAAGGCAACAAAAGAGCAACTGAAAGCTGTTATGGATGATTTCGCAGCTTTTGTAGAG\nAAGTGCTGCAAGGCTGACGATAAGGAGACCTGCTTTGCCGAGGAGGGTAAAAAACTTGTT\nGCTGCAAGTCAAGCTGCCTTAGGCTTATAA",
                        "Chromosome Location": "4",
                        "Locus": "4q11-q13",
                        "External Identifiers": "ResourceLinkUniProtKB IDP02768UniProtKB Entry NameALBU_HUMANGenBank Protein ID28590GenBank Gene IDV00494GenAtlas IDALBHGNC IDHGNC:399",
                        "General References": "Lawn RM, Adelman J, Bock SC, Franke AE, Houck CM, Najarian RC, Seeburg PH, Wion KL: The sequence of human serum albumin cDNA and its expression in E. coli. Nucleic Acids Res. 1981 Nov 25;9(22):6103-114. [Article] Dugaiczyk A, Law SW, Dennison OE: Nucleotide sequence and the encoded amino acids of human serum albumin mRNA. Proc Natl Acad Sci U S A. 1982 Jan;79(1):71-5. [Article] Minghetti PP, Ruffner DE, Kuang WJ, Dennison OE, Hawkins JW, Beattie WG, Dugaiczyk A: Molecular structure of the human albumin gene is revealed by nucleotide sequence within q11-22 of chromosome 4. J Biol Chem. 1986 May 25;261(15):6747-57. [Article] Yu Y, Zhang C, Zhou G, Wu S, Qu X, Wei H, Xing G, Dong C, Zhai Y, Wan J, Ouyang S, Li L, Zhang S, Zhou K, Zhang Y, Wu C, He F: Gene expression profiling in human fetal liver and identification of tissue- and developmental-stage-specific genes through compiled expression profiles and efficient cloning of full-length cDNAs. Genome Res. 2001 Aug;11(8):1392-403. [Article] Bechtel S, Rosenfelder H, Duda A, Schmidt CP, Ernst U, Wellenreuther R, Mehrle A, Schuster C, Bahr A, Blocker H, Heubner D, Hoerlein A, Michel G, Wedler H, Kohrer K, Ottenwalder B, Poustka A, Wiemann S, Schupp I: The full-ORF clone resource of the German cDNA Consortium. BMC Genomics. 2007 Oct 31;8:399. [Article] Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Clark HF, Gurney AL, Abaya E, Baker K, Baldwin D, Brush J, Chen J, Chow B, Chui C, Crowley C, Currell B, Deuel B, Dowd P, Eaton D, Foster J, Grimaldi C, Gu Q, Hass PE, Heldens S, Huang A, Kim HS, Klimowski L, Jin Y, Johnson S, Lee J, Lewis L, Liao D, Mark M, Robbie E, Sanchez C, Schoenfeld J, Seshagiri S, Simmons L, Singh J, Smith V, Stinson J, Vagts A, Vandlen R, Watanabe C, Wieand D, Woods K, Xie MH, Yansura D, Yi S, Yu G, Yuan J, Zhang M, Zhang Z, Goddard A, Wood WI, Godowski P, Gray A: The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res. 2003 Oct;13(10):2265-70. Epub 2003 Sep 15. [Article] Urano Y, Watanabe K, Sakai M, Tamaoki T: The human albumin gene. Characterization of the 5' and 3' flanking regions and the polymorphic gene transcripts. J Biol Chem. 1986 Mar 5;261(7):3244-51. [Article] Meloun B, Moravek L, Kostka V: Complete amino acid sequence of human serum albumin. FEBS Lett. 1975 Oct 15;58(1):134-7. [Article] Corbett JM, Wheeler CH, Baker CS, Yacoub MH, Dunn MJ: The human myocardial two-dimensional gel protein database: update 1994. Electrophoresis. 1994 Nov;15(11):1459-65. [Article] Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, Thomas GR, Vandekerckhove J: Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol. 2003 May;21(5):566-9. Epub 2003 Mar 31. [Article] Mogard MH, Kobayashi R, Chen CF, Lee TD, Reeve JR Jr, Shively JE, Walsh JH: The amino acid sequence of kinetensin, a novel peptide isolated from pepsin-treated human plasma: homology with human serum albumin, neurotensin and angiotensin. Biochem Biophys Res Commun. 1986 May 14;136(3):983-8. [Article] Carraway RE, Mitra SP, Cochrane DE: Structure of a biologically active neurotensin-related peptide obtained from pepsin-treated albumin(s). J Biol Chem. 1987 May 5;262(13):5968-73. [Article] Walker JE: Lysine residue 199 of human serum albumin is modified by acetylsalicyclic acid. FEBS Lett. 1976 Jul 15;66(2):173-5. [Article] Lapolla A, Fedele D, Reitano R, Arico NC, Seraglia R, Traldi P, Marotta E, Tonani R: Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides. J Am Soc Mass Spectrom. 2004 Apr;15(4):496-509. [Article] Jacobsen C: Lysine residue 240 of human serum albumin is involved in high-affinity binding of bilirubin. Biochem J. 1978 May 1;171(2):453-9. [Article] Garlick RL, Mazer JS: The principal site of nonenzymatic glycosylation of human serum albumin in vivo. J Biol Chem. 1983 May 25;258(10):6142-6. [Article] Shaklai N, Garlick RL, Bunn HF: Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J Biol Chem. 1984 Mar 25;259(6):3812-7. [Article] Iberg N, Fluckiger R: Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites. J Biol Chem. 1986 Oct 15;261(29):13542-5. [Article] Watkins S, Madison J, Galliano M, Minchiotti L, Putnam FW: A nucleotide insertion and frameshift cause analbuminemia in an Italian family. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2275-9. [Article] Lu J, Stewart AJ, Sadler PJ, Pinheiro TJ, Blindauer CA: Albumin as a zinc carrier: properties of its high-affinity zinc-binding site. Biochem Soc Trans. 2008 Dec;36(Pt 6):1317-21. doi: 10.1042/BST0361317. [Article] Han G, Ye M, Zhou H, Jiang X, Feng S, Jiang X, Tian R, Wan D, Zou H, Gu J: Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography. Proteomics. 2008 Apr;8(7):1346-61. doi: 10.1002/pmic.200700884. [Article] Mayya V, Lundgren DH, Hwang SI, Rezaul K, Wu L, Eng JK, Rodionov V, Han DK: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal. 2009 Aug 18;2(84):ra46. doi: 10.1126/scisignal.2000007. [Article] Burkard TR, Planyavsky M, Kaupe I, Breitwieser FP, Burckstummer T, Bennett KL, Superti-Furga G, Colinge J: Initial characterization of the human central proteome. BMC Syst Biol. 2011 Jan 26;5:17. doi: 10.1186/1752-0509-5-17. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Tagliabracci VS, Wiley SE, Guo X, Kinch LN, Durrant E, Wen J, Xiao J, Cui J, Nguyen KB, Engel JL, Coon JJ, Grishin N, Pinna LA, Pagliarini DJ, Dixon JE: A Single Kinase Generates the Majority of the Secreted Phosphoproteome. Cell. 2015 Jun 18;161(7):1619-32. doi: 10.1016/j.cell.2015.05.028. [Article] Vaca Jacome AS, Rabilloud T, Schaeffer-Reiss C, Rompais M, Ayoub D, Lane L, Bairoch A, Van Dorsselaer A, Carapito C: N-terminome analysis of the human mitochondrial proteome. Proteomics. 2015 Jul;15(14):2519-24. doi: 10.1002/pmic.201400617. Epub 2015 Jun 8. [Article] Carter DC, He XM, Munson SH, Twigg PD, Gernert KM, Broom MB, Miller TY: Three-dimensional structure of human serum albumin. Science. 1989 Jun 9;244(4909):1195-8. [Article] Carter DC, He XM: Structure of human serum albumin. Science. 1990 Jul 20;249(4966):302-3. [Article] He XM, Carter DC: Atomic structure and chemistry of human serum albumin. Nature. 1992 Jul 16;358(6383):209-15. [Article] Curry S, Mandelkow H, Brick P, Franks N: Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Biol. 1998 Sep;5(9):827-35. [Article] Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K: Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng. 1999 Jun;12(6):439-46. [Article] Bhattacharya AA, Curry S, Franks NP: Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures. J Biol Chem. 2000 Dec 8;275(49):38731-8. [Article] Petitpas I, Grune T, Bhattacharya AA, Curry S: Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. J Mol Biol. 2001 Dec 14;314(5):955-60. [Article] Brennan SO, Herbert P: Albumin Canterbury (313 Lys----Asn). A point mutation in the second domain of serum albumin. Biochim Biophys Acta. 1987 Apr 8;912(2):191-7. [Article] Takahashi N, Takahashi Y, Blumberg BS, Putnam FW: Amino acid substitutions in genetic variants of human serum albumin and in sequences inferred from molecular cloning. Proc Natl Acad Sci U S A. 1987 Jul;84(13):4413-7. [Article] Takahashi N, Takahashi Y, Isobe T, Putnam FW, Fujita M, Satoh C, Neel JV: Amino acid substitutions in inherited albumin variants from Amerindian and Japanese populations. Proc Natl Acad Sci U S A. 1987 Nov;84(22):8001-5. [Article] Arai K, Ishioka N, Huss K, Madison J, Putnam FW: Identical structural changes in inherited albumin variants from different populations. Proc Natl Acad Sci U S A. 1989 Jan;86(2):434-8. [Article] Arai K, Madison J, Huss K, Ishioka N, Satoh C, Fujita M, Neel JV, Sakurabayashi I, Putnam FW: Point substitutions in Japanese alloalbumins. Proc Natl Acad Sci U S A. 1989 Aug;86(16):6092-6. [Article] Arai K, Madison J, Shimizu A, Putnam FW: Point substitutions in albumin genetic variants from Asia. Proc Natl Acad Sci U S A. 1990 Jan;87(1):497-501. [Article] Brennan SO, Myles T, Peach RJ, Donaldson D, George PM: Albumin Redhill (-1 Arg, 320 Ala----Thr): a glycoprotein variant of human serum albumin whose precursor has an aberrant signal peptidase cleavage site. Proc Natl Acad Sci U S A. 1990 Jan;87(1):26-30. [Article] Galliano M, Minchiotti L, Porta F, Rossi A, Ferri G, Madison J, Watkins S, Putnam FW: Mutations in genetic variants of human serum albumin found in Italy. Proc Natl Acad Sci U S A. 1990 Nov;87(22):8721-5. [Article] Watkins S, Madison J, Davis E, Sakamoto Y, Galliano M, Minchiotti L, Putnam FW: A donor splice mutation and a single-base deletion produce two carboxyl-terminal variants of human serum albumin. Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):5959-63. [Article] Madison J, Arai K, Sakamoto Y, Feld RD, Kyle RA, Watkins S, Davis E, Matsuda Y, Amaki I, Putnam FW: Genetic variants of serum albumin in Americans and Japanese. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9853-7. [Article] Peach RJ, Brennan SO: Structural characterization of a glycoprotein variant of human serum albumin: albumin Casebrook (494 Asp----Asn). Biochim Biophys Acta. 1991 Jul 26;1097(1):49-54. [Article] Minchiotti L, Galliano M, Stoppini M, Ferri G, Crespeau H, Rochu D, Porta F: Two alloalbumins with identical electrophoretic mobility are produced by differently charged amino acid substitutions. Biochim Biophys Acta. 1992 Mar 12;1119(3):232-8. [Article] Carlson J, Sakamoto Y, Laurell CB, Madison J, Watkins S, Putnam FW: Alloalbuminemia in Sweden: structural study and phenotypic distribution of nine albumin variants. Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8225-9. [Article] Minchiotti L, Galliano M, Zapponi MC, Tenni R: The structural characterization and bilirubin-binding properties of albumin Herborn, a [Lys240-->Glu] albumin mutant. Eur J Biochem. 1993 Jun 1;214(2):437-44. [Article] Brennan SO, Fellowes AP: Albumin Hawkes Bay; a low level variant caused by loss of a sulphydryl group at position 177. Biochim Biophys Acta. 1993 Aug 4;1182(1):46-50. [Article] Galliano M, Minchiotti L, Iadarola P, Stoppini M, Giagnoni P, Watkins S, Madison J, Putnam FW: Protein and DNA sequence analysis of a 'private' genetic variant: albumin Ortonovo (Glu-505-->Lys). Biochim Biophys Acta. 1993 Nov 25;1225(1):27-32. [Article] Madison J, Galliano M, Watkins S, Minchiotti L, Porta F, Rossi A, Putnam FW: Genetic variants of human serum albumin in Italy: point mutants and a carboxyl-terminal variant. Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6476-80. [Article] Sunthornthepvarakul T, Angkeow P, Weiss RE, Hayashi Y, Refetoff S: An identical missense mutation in the albumin gene results in familial dysalbuminemic hyperthyroxinemia in 8 unrelated families. Biochem Biophys Res Commun. 1994 Jul 29;202(2):781-7. [Article] Rushbrook JI, Becker E, Schussler GC, Divino CM: Identification of a human serum albumin species associated with familial dysalbuminemic hyperthyroxinemia. J Clin Endocrinol Metab. 1995 Feb;80(2):461-7. [Article] Wada N, Chiba H, Shimizu C, Kijima H, Kubo M, Koike T: A novel missense mutation in codon 218 of the albumin gene in a distinct phenotype of familial dysalbuminemic hyperthyroxinemia in a Japanese kindred. J Clin Endocrinol Metab. 1997 Oct;82(10):3246-50. [Article] Sunthornthepvarakul T, Likitmaskul S, Ngowngarmratana S, Angsusingha K, Kitvitayasak S, Scherberg NH, Refetoff S: Familial dysalbuminemic hypertriiodothyroninemia: a new, dominantly inherited albumin defect. J Clin Endocrinol Metab. 1998 May;83(5):1448-54. [Article] Spahr CS, Davis MT, McGinley MD, Robinson JH, Bures EJ, Beierle J, Mort J, Courchesne PL, Chen K, Wahl RC, Yu W, Luethy R, Patterson SD: Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry. I. Profiling an unfractionated tryptic digest. Proteomics. 2001 Jan;1(1):93-107. [Article] Minchiotti L, Campagnoli M, Rossi A, Cosulich ME, Monti M, Pucci P, Kragh-Hansen U, Granel B, Disdier P, Weiller PJ, Galliano M: A nucleotide insertion and frameshift cause albumin Kenitra, an extended and O-glycosylated mutant of human serum albumin with two additional disulfide bridges. Eur J Biochem. 2001 Jan;268(2):344-52. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00070Hyaluronidase (ovine)approved, investigationalunknowninhibitorDetailsDB00137Luteinapproved, investigational, nutraceuticalunknownDetailsDB00459AcitretinapprovedunknownDetailsDB00576Sulfamethizoleapproved, investigational, vet_approvedunknownDetailsDB00743Gadobenic acidapproved, investigationalunknownbinderDetailsDB00815Sodium lauryl sulfateexperimentalunknownbinderDetailsDB00936Salicylic acidapproved, investigational, vet_approvednoother/unknownDetailsDB00946Phenprocoumonapproved, investigationalnobinderregulatorDetailsDB00995Auranofinapproved, investigationalunknownDetailsDB01120GliclazideapprovedunknownDetailsDB01328Cefonicidapproved, investigationalnoother/unknownDetailsDB01329Cefoperazoneapproved, investigationalnoother/unknownDetailsDB01396Digitoxinapproved, investigationalnoDetailsDB03017Lauric acidapproved, experimentalunknownDetailsDB03193Stearic acidapproved, experimentalunknownDetailsDB03600Capric acidexperimentalnoDetailsDB03796Palmitic AcidapprovedunknownDetailsDB04224Oleic Acidapproved, investigational, vet_approvedunknownDetailsDB04557Arachidonic AcidexperimentalnoDetailsDB04711IodipamideapprovedunknownbinderDetailsDB06412Oxymetholoneapproved, illicitunknownDetailsDB01197Captoprilapprovednoother/unknownDetailsDB01050IbuprofenapprovednobinderDetailsDB00563MethotrexateapprovednobinderDetailsDB00451LevothyroxineapprovednoDetailsDB00279Liothyronineapproved, vet_approvedunknownDetailsDB00605Sulindacapproved, investigationalunknownDetailsDB00749Etodolacapproved, investigational, vet_approvedunknownDetailsDB00861Diflunisalapproved, investigationalunknownDetailsDB01009Ketoprofenapproved, vet_approvedunknownDetailsDB00586Diclofenacapproved, vet_approvedunknownDetailsDB00783Estradiolapproved, investigational, vet_approvednoDetailsDB00655EstroneapprovednoDetailsDB00624Testosteroneapproved, investigationalnobinderDetailsDB01307Insulin detemirapprovednobinderDetailsDB01418Acenocoumarolapproved, investigationalnoDetailsDB00802Alfentanilapproved, illicitunknownDetailsDB00818Propofolapproved, investigational, vet_approvednoDetailsDB00228Enfluraneapproved, investigational, vet_approvedunknownbinderDetailsDB00753Isofluraneapproved, vet_approvedunknownDetailsDB01189DesfluraneapprovedunknownbinderDetailsDB01159Halothaneapproved, vet_approvedunknownDetailsDB01236Sevofluraneapproved, vet_approvedunknownbinderDetailsDB00252Phenytoinapproved, vet_approvedunknownDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknownDetailsDB00540NortriptylineapprovednobinderDetailsDB00321AmitriptylineapprovednobinderDetailsDB00903Etacrynic acidapproved, investigationalunknownDetailsDB00695Furosemideapproved, vet_approvednobinderDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvednoDetailsDB00682WarfarinapprovednobinderregulatorDetailsDB00554Piroxicamapproved, investigationalunknownDetailsDB00573FenoprofenapprovedunknownDetailsDB00328Indomethacinapproved, investigationalunknownDetailsDB03585Oxyphenbutazoneapproved, withdrawnunknownDetailsDB00544FluorouracilapprovednoDetailsDB01232Saquinavirapproved, investigationalunknownDetailsDB01032Probenecidapproved, investigationalnoDetailsDB01044Gatifloxacinapproved, investigational, withdrawnunknownother/unknownDetailsDB01068Clonazepamapproved, illicitnoDetailsDB01147Cloxacillinapproved, investigational, vet_approvednobinderDetailsDB01327Cefazolinapprovedunknownother/unknownDetailsDB00931Metacyclineapproved, investigationalnoDetailsDB01015SulfamethoxazoleapprovednosubstrateDetailsDB00415Ampicillinapproved, vet_approvednoother/unknownDetailsDB00567Cephalexinapproved, investigational, vet_approvednobinderDetailsDB00759Tetracyclineapproved, vet_approved, withdrawnnoDetailsDB01212Ceftriaxoneapprovednoother/unknownDetailsDB01330CefotetanapprovednoDetailsDB00274Cefmetazoleapproved, investigationalnoDetailsDB00495ZidovudineapprovednoDetailsDB01397Magnesium salicylateexperimentalnoDetailsDB00788Naproxenapproved, vet_approvednoDetailsDB00334Olanzapineapproved, investigationalnobinderDetailsDB01056Tocainideapprovednoother/unknownDetailsDB01320Fosphenytoinapproved, investigationalnoother/unknownDetailsDB00712Flurbiprofenapproved, investigationalnoother/unknownDetailsDB07402AzapropazonewithdrawnunknownDetailsDB075173-CARBOXY-4-METHYL-5-PROPYL-2-FURANPROPIONICexperimentalunknownDetailsDB07992Indoxyl sulfateexperimentalunknownDetailsDB08231Myristic acidexperimentalunknownDetailsDB08496(R)-warfarinexperimentalunknownDetailsDB08735R,S-Warfarin alcoholexperimentalunknownDetailsDB08736S,R-Warfarin alcoholexperimentalunknownDetailsDB00430CefpiramideapprovedunknownDetailsDB01583LiotrixapprovedunknownDetailsDB01294Bismuth subsalicylateapproved, vet_approvednobinderDetailsDB00456Cefalotinapproved, investigational, vet_approvedunknownbinderDetailsDB01581Sulfamerazineapproved, vet_approvedunknownDetailsDB01582Sulfamethazineapproved, investigational, vet_approvedunknownDetailsDB01587KetazolamapprovedunknownDetailsDB01614Acepromazineexperimental, vet_approvedunknownDetailsDB01621Pipotiazineapproved, investigationalunknownDetailsDB04574Estrone sulfateapprovedunknownDetailsDB06710MethyltestosteroneapprovedunknownDetailsDB01622ThioproperazineexperimentalunknownDetailsDB01623ThiothixeneapprovedunknownDetailsDB06705Gadofosveset trisodiumapprovedunknownsubstrateDetailsDB00454MeperidineapprovedunknownbinderDetailsDB01016GlyburideapprovedunknownbinderDetailsDB00912Repaglinideapproved, investigationalunknownDetailsDB00731Nateglinideapproved, investigationalunknownDetailsDB08867UlipristalapprovednosubstrateDetailsDB05294VandetanibapprovedunknownbinderDetailsDB05521Telaprevirapproved, withdrawnnosubstrateDetailsDB05812AbirateroneapprovedunknownbinderDetailsDB08881VemurafenibapprovedunknownsubstrateDetailsDB08828Vismodegibapproved, investigationalunknownbinderDetailsDB08893MirabegronapprovednobinderDetailsDB00635Prednisoneapproved, vet_approvedunknownsubstrateDetailsDB08899EnzalutamideapprovednobinderDetailsDB08820IvacaftorapprovednocarrierDetailsDB00776OxcarbazepineapprovedunknownsubstrateDetailsDB06201RufinamideapprovedunknownsubstrateDetailsDB06716Fospropofolapproved, illicit, investigationalunknownsubstrateDetailsDB04855DronedaroneapprovednobinderDetailsDB06209PrasugrelapprovedunknownsubstrateDetailsDB08860PitavastatinapprovedunknownsubstrateDetailsDB01183Naloxoneapproved, vet_approvedunknownbinderDetailsDB01242Clomipramineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateDetailsDB00472Fluoxetineapproved, vet_approvedunknownsubstrateDetailsDB00317Gefitinibapproved, investigationalunknownsubstrateDetailsDB00619ImatinibapprovednobinderDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateDetailsDB00678LosartanapprovedunknownsubstrateDetailsDB00412Rosiglitazoneapproved, investigationalunknownsubstrateDetailsDB01098RosuvastatinapprovedunknownsubstrateDetailsDB00864Tacrolimusapproved, investigationalunknownsubstrateDetailsDB00717NorethisteroneapprovedunknownsubstrateDetailsDB08931RiociguatapprovedunknownsubstrateDetailsDB08895Tofacitinibapproved, investigationalunknownDetailsDB08932MacitentanapprovednobinderDetailsDB06290SimeprevirapprovednobinderDetailsDB00493CefotaximeapprovedunknownDetailsDB09280LumacaftorapprovednocarrierDetailsDB09130Copperapproved, investigationalnobinderDetailsDB11093Calcium citrateapproved, investigationalnosubstrateDetailsDB11348Calcium PhosphateapprovednosubstrateDetailsDB11575GrazoprevirapprovednosubstrateDetailsDB11943Delafloxacinapproved, investigationalnosubstrateDetailsDB01685TopiroxostatexperimentalunknownbinderDetailsDB09093Chlortetracyclineapproved, investigational, vet_approvednoDetailsDB06796Mangafodipirapproved, investigational, withdrawnunknownbinderDetailsDB09262ImidafenacininvestigationalnosubstrateDetailsDB00276Amsacrineapproved, investigationalunknownDetailsDB11359GuaiacolapprovedunknownDetailsDB03255Phenolapproved, experimentalunknownDetailsDB06728AnilineexperimentalunknownDetailsDB06713Norelgestrominapproved, investigationalunknownDetailsDB01370Aluminiumapproved, investigationalunknownDetailsDB13014HypericininvestigationalunknownDetailsDB01057EchothiophateapprovedunknownDetailsDB11397Dichlorvosvet_approvedunknownDetailsDB00677Isoflurophateapproved, investigational, withdrawnunknownDetailsDB00943Zalcitabineapproved, investigationalunknownDetailsDB01072Atazanavirapproved, investigationalnobinderDetailsDB00649Stavudineapproved, investigationalunknownDetailsDB00900DidanosineapprovedunknownDetailsDB00625Efavirenzapproved, investigationalunknownDetailsDB00879Emtricitabineapproved, investigationalunknownbinderDetailsDB00220NelfinavirapprovednobinderDetailsDB00238NevirapineapprovedunknownDetailsDB00503Ritonavirapproved, investigationalunknownsubstrateDetailsDB00709Lamivudineapproved, investigationalunknownDetailsDB04216Quercetinexperimental, investigationalunknownDetailsDB00997Doxorubicinapproved, investigationalunknownDetailsDB04816Dantronapproved, investigational, withdrawnunknownDetailsDB00755Tretinoinapproved, investigational, nutraceuticalunknownbinderDetailsDB00515CisplatinapprovedunknownDetailsDB00162Vitamin Aapproved, nutraceutical, vet_approvedunknownbinderDetailsDB04690CamptothecinexperimentalunknownDetailsDB02709ResveratrolinvestigationalunknownDetailsDB00744Zileutonapproved, investigational, withdrawnunknownDetailsDB04539GlyphosateexperimentalunknownDetailsDB11590ThimerosalapprovedunknownDetailsDB05134TanespimycininvestigationalunknownDetailsDB01124Tolbutamideapproved, investigationalunknownDetailsDB01276Exenatideapproved, investigationalunknownDetailsDB00414Acetohexamideapproved, investigational, withdrawnunknownDetailsDB00458ImipramineapprovedunknownDetailsDB00159Icosapentapproved, nutraceuticalnobinderDetailsDB00951Isoniazidapproved, investigationalunknownDetailsDB01104SertralineapprovedunknownbinderDetailsDB09383Meprednisoneapproved, investigationalunknownDetailsDB00266DicoumarolapprovedunknownDetailsDB04828ZomepiracwithdrawnunknownDetailsDB00500TolmetinapprovedunknownDetailsDB11217ArbutinapprovedunknownDetailsDB09526Hydroquinoneapproved, investigationalunknownDetailsDB00784Mefenamic acidapprovedunknownDetailsDB00313Valproic acidapproved, investigationalunknownDetailsDB01169Arsenic trioxideapproved, investigationalnosubstrateDetailsDB11828Neratinibapproved, investigationalnosubstrateDetailsDB00607Nafcillinapproved, investigationalunknownDetailsDB12483Copanlisibapproved, investigationalunknownsubstrateDetailsDB00512VancomycinapprovednosubstrateDetailsDB12001Abemaciclibapproved, investigationalunknownbinderDetailsDB08864RilpivirineapprovednobinderDetailsDB13928Semaglutideapproved, investigationalnosubstrateDetailsDB09087Potassium alumapprovedunknownbinderDetailsDB09223BlonanserininvestigationalnosubstrateDetailsDB09236Lacidipineapproved, investigationalunknownbinderDetailsDB09124Medrogestoneapproved, withdrawnnobinderDetailsDB11827Ertugliflozinapproved, investigationalnobinderDetailsDB09139Technetium Tc-99m oxidronateapprovednobinderDetailsDB13943Testosterone cypionateapprovednoother/unknownDetailsDB13944Testosterone enanthateapprovednoother/unknownDetailsDB13946Testosterone undecanoateapproved, investigationalnobinderDetailsDB13952Estradiol acetateapproved, investigational, vet_approvednoDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvednoDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvednoDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvednoDetailsDB13956Estradiol valerateapproved, investigational, vet_approvednoDetailsDB11638Artenimolapproved, experimental, investigationalunknownligandDetailsDB01420Testosterone propionateapproved, investigational, vet_approved, withdrawnnosubstrateDetailsDB09195LorpiprazoleapprovednosubstrateDetailsDB09204ArotinololinvestigationalnosubstrateDetailsDB08814Triflusalapproved, investigationalnosubstrateDetailsDB09229AranidipineexperimentalnobinderDetailsDB09333Iopodic acidapproved, investigational, withdrawnnosubstrateDetailsDB09347Acetrizoic acidwithdrawnnobinderDetailsDB09348Propiolactoneapproved, withdrawnnobinderDetailsDB11130Opiumapproved, illicitnobinderDetailsDB06778Cupric sulfateapprovedunknownDetailsDB09053IbrutinibapprovednosubstrateDetailsDB11182Rose bengalapproved, investigationalunknownbinderDetailsDB13967Patent BlueapprovedyesbinderDetailsDB13909Bismuth subgallateapprovedunknowncarrierDetailsDB09418Potassium perchlorateapproved, investigationalunknownbinderDetailsDB11641Vinflunineapproved, investigationalnosubstrateDetailsDB13421Edoxudineapproved, investigational, withdrawnnobinderDetailsDB11134Cupric oxideapprovedunknownbinderDetailsDB11148Butambenapproved, withdrawnnosubstrateDetailsDB11637Delamanidapproved, investigationalunknownsubstrateDetailsDB13751Glycyrrhizic acidapproved, experimentalnobinderDetailsDB12965Silverapproved, investigationalunknownbinderDetailsDB14185Aripiprazole lauroxilapproved, investigationalunknownbinderDetailsDB14481Calcium phosphate dihydrateapprovednoDetailsDB14517Aluminium phosphateapproved, investigationalunknownDetailsDB14518Aluminum acetateapproved, investigationalunknownDetailsDB00432Trifluridineapproved, investigationalunknownbinderDetailsDB14582Patisiranapproved, investigationalunknownligandDetailsDB09213Dexibuprofenapproved, investigationalnoDetailsDB12455Omadacyclineapproved, investigationalunknownDetailsDB12836Grapiprantinvestigational, vet_approvednosubstrateDetailsDB11753Rifamycinapproved, investigationalnosubstrateDetailsDB11963Dacomitinibapproved, investigationalnobinderDetailsDB11855Revefenacinapproved, investigationalnobinderDetailsDB12141Gilteritinibapproved, investigationalnobinderDetailsDB06480PrucaloprideapprovedunknownbinderDetailsDB11978Glasdegibapproved, investigationalnobinderDetailsDB00214TorasemideapprovedunknownsubstrateDetailsDB00227Lovastatinapproved, investigationalnosubstrateDetailsDB09564Insulin degludecapprovednobinderDetailsDB00245BenzatropineapprovednobinderDetailsDB00264Metoprololapproved, investigationalnobinderDetailsDB00286Conjugated estrogensapprovednobinderDetailsDB00289AtomoxetineapprovednobinderDetailsDB00294Etonogestrelapproved, investigationalnobinderDetailsDB00295Morphineapproved, investigationalnobinderDetailsDB00310ChlorthalidoneapprovednoDetailsDB00304DesogestrelapprovednobinderDetailsDB00327Hydromorphoneapproved, illicitnobinderDetailsDB09073Palbociclibapproved, investigationalnobinderDetailsDB00332Ipratropiumapproved, experimentalnobinderDetailsDB01142Doxepinapproved, investigationalnobinderDetailsDB01076AtorvastatinapprovednobinderDetailsDB06655LiraglutideapprovedunknownbinderDetailsDB01235LevodopaapprovedunknownbinderDetailsDB01238Aripiprazoleapproved, investigationalunknownbinderDetailsDB00404Alprazolamapproved, illicit, investigationalunknownbinderDetailsDB00421SpironolactoneapprovedunknownbinderDetailsDB00335AtenololapprovednosubstrateDetailsDB01126Dutasterideapproved, investigationalnobinderDetailsDB09299Tenofovir alafenamideapprovednobinderDetailsDB00343Diltiazemapproved, investigationalnobinderDetailsDB14126Tenofovirexperimental, investigationalnobinderDetailsDB00476DuloxetineapprovedunknownligandDetailsDB00497Oxycodoneapproved, illicit, investigationalunknownbinderDetailsDB00481Raloxifeneapproved, investigationalnobinderDetailsDB00537Ciprofloxacinapproved, investigationalunknownbinderDetailsDB00461NabumetoneapprovedunknownDetailsDB00982IsotretinoinapprovedunknownbinderDetailsDB00584Enalaprilapproved, vet_approvednobinderDetailsDB01067Glipizideapproved, investigationalnobinderDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedunknownbinderDetailsDB00737MeclizineapprovednobinderDetailsDB00768OlopatadineapprovednobinderDetailsDB00571Propranololapproved, investigationalunknownDetailsDB00575ClonidineapprovedunknownbinderDetailsDB00787AcyclovirapprovedunknownbinderDetailsDB00490Buspironeapproved, investigationalunknownbinderDetailsDB01029Irbesartanapproved, investigationalunknownbinderDetailsDB06282LevocetirizineapprovedunknownbinderDetailsDB00598LabetalolapprovedunknownsubstrateDetailsDB01026Ketoconazoleapproved, investigationalunknownligandDetailsDB00675TamoxifenapprovedunknownsubstrateDetailsDB12978Pexidartinibapproved, investigationalunknownbinderDetailsDB01136Carvedilolapproved, investigationalunknownbinderDetailsDB04861Nebivololapproved, investigationalunknownbinderDetailsDB01611HydroxychloroquineapprovedunknownbinderDetailsDB01045RifampicinapprovedunknownligandDetailsDB01394ColchicineapprovedunknownbinderDetailsDB00333MethadoneapprovednoDetailsDB11757Istradefyllineapproved, investigationalunknownbinderDetailsDB00620Triamcinoloneapproved, vet_approvedunknownbinderDetailsDB00924CyclobenzaprineapprovedunknownsubstrateDetailsDB00881Quinaprilapproved, investigationalunknownbinderDetailsDB09079NintedanibapprovedunknownsubstrateDetailsDB00999Hydrochlorothiazideapproved, vet_approvedunknownbinderDetailsDB01241GemfibrozilapprovedunknownbinderDetailsDB01039FenofibrateapprovedunknownbinderDetailsDB01062Oxybutyninapproved, investigationalunknownbinderDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknownbinderDetailsDB01275HydralazineapprovedunknownbinderDetailsDB01195Flecainideapproved, withdrawnunknownbinderDetailsDB00687Fludrocortisoneapproved, investigationalunknownsubstrateDetailsDB00316AcetaminophenapprovedunknownbinderDetailsDB00278Argatrobanapproved, investigationalunknownbinderDetailsDB06216AsenapineapprovedunknownbinderDetailsDB15444Elexacaftorapproved, investigationalunknownsubstrateDetailsDB00860Prednisoloneapproved, vet_approvedunknownbinderDetailsDB15566Prednisolone acetateapproved, vet_approvedunknownbinderDetailsDB11703Acalabrutinibapproved, investigationalunknownbinderDetailsDB14513Magnesiumapproved, experimental, investigationalunknownDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknownbinderDetailsDB00661VerapamilapprovedunknownsubstrateDetailsDB00273TopiramateapprovedunknownbinderDetailsDB06119Cenobamateapproved, investigationalunknownbinderDetailsDB01222BudesonideapprovedunknownbinderDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknownbinderDetailsDB00950Fexofenadineapproved, investigationalunknownsubstrateDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownbinderDetailsDB09237Levamlodipineapproved, investigationalunknownbinderDetailsDB12941Darolutamideapproved, investigationalunknownbinderDetailsDB14879Cefiderocolapproved, investigationalnoligandDetailsDB00852PseudoephedrineapprovedunknownbinderDetailsDB00983Formoterolapproved, investigationalunknownsubstrateDetailsDB00993AzathioprineapprovedunknownbinderDetailsDB00557HydroxyzineapprovedunknownsubstrateregulatorDetailsDB01118Amiodaroneapproved, investigationalunknownbinderDetailsDB01069Promethazineapproved, investigationalunknownbinderDetailsDB01115NifedipineapprovedunknownbinderDetailsDB01132Pioglitazoneapproved, investigationalunknownsubstrateDetailsDB00814Meloxicamapproved, vet_approvedunknownDetailsDB00938SalmeterolapprovedunknownbinderDetailsDB00878Chlorhexidineapproved, vet_approved, withdrawnunknownsubstrateDetailsDB01006Letrozoleapproved, investigationalunknownbinderDetailsDB00246ZiprasidoneapprovedunknownDetailsDB01060Amoxicillinapproved, vet_approvedunknownbinderDetailsDB01137Levofloxacinapproved, investigationalunknownsubstrateDetailsDB09100Thyroid, porcineapprovedunknownbinderDetailsDB01013Clobetasol propionateapprovedunknownbinderDetailsDB00957Norgestimateapproved, investigationalunknownbinderDetailsDB00977EthinylestradiolapprovedunknownbinderDetailsDB00555Lamotrigineapproved, investigationalunknownsubstrateDetailsDB01264DarunavirapprovedunknownsubstrateDetailsDB00608Chloroquineapproved, investigational, vet_approvedunknownbinderDetailsDB12466Favipiravirapproved, investigationalunknowncarrierDetailsDB01601LopinavirapprovedunknownsubstrateDetailsDB14999Human interferon betaapproved, investigationalunknownbinderDetailsDB00126Ascorbic acidapproved, nutraceuticalunknownbinderDetailsDB00443Betamethasoneapproved, vet_approvedunknownDetailsDB05382Iodineapproved, investigationalunknownbinderDetailsDB11642Pitolisantapproved, investigationalnobinderDetailsDB00152Thiamineapproved, investigational, nutraceutical, vet_approvedunknownbinderDetailsDB00165Pyridoxineapproved, investigational, nutraceutical, vet_approvedunknownbinderDetailsDB00595Oxytetracyclineapproved, investigational, vet_approvedunknownbinderDetailsDB00870Suprofenapproved, withdrawnunknownbinderDetailsDB00774Hydroflumethiazideapproved, investigational, withdrawnunknownbinderDetailsDB09241Methylene blueapproved, investigationalunknownbinderDetailsDB15534Colchiceineapproved, experimentalunknownsubstrateDetailsDB01053Benzylpenicillinapproved, vet_approvedunknownbinderDetailsDB01324PolythiazideapprovedunknownbinderDetailsDB07565Chloramphenicol succinateapprovedunknownbinderDetailsDB01914D-glucoseapproved, investigational, vet_approvedunknownbinderDetailsDB14533Zinc chlorideapproved, investigationalunknownbinderDetailsDB11689Selumetinibapproved, investigationalunknowncarrierDetailsDB04911Oritavancinapproved, investigationalunknownbinderDetailsDB14548Zinc sulfate, unspecified formapproved, experimentalunknownbinderDetailsDB00734Risperidoneapproved, investigationalunknownbinderDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknownbinderDetailsDB01364EphedrineapprovedunknownbinderDetailsDB00237Butabarbitalapproved, illicitunknownbinderDetailsDB01133Tiludronic acidapproved, investigational, vet_approvedunknownbinderDetailsDB14840RipretinibapprovedunknownbinderDetailsDB00845Clofazimineapproved, investigationalunknownbinderDetailsDB00842OxazepamapprovedunknownbinderDetailsDB00714Apomorphineapproved, investigationalunknownbinderDetailsDB09274Artesunateapproved, investigationalunknownbinderDetailsDB15690Fluoroestradiol F-18approvedunknownbinderDetailsDB00808IndapamideapprovedunknownbinderDetailsDB08816TicagrelorapprovedunknownbinderDetailsDB14669Betamethasone phosphateapproved, vet_approvedunknownbinderDetailsDB12674Lurbinectedinapproved, investigationalunknownbinderDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknownbinderDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknownbinderDetailsDB00104Octreotideapproved, investigationalunknownbinderDetailsDB11677Triheptanoinapproved, investigationalunknownbinderDetailsDB12404Remimazolamapproved, investigationalunknownbinderDetailsDB11796Fostemsavirapproved, investigationalunknowncarrierDetailsDB15305Risdiplamapproved, investigationalunknownbinderDetailsDB11820Nifurtimoxapproved, investigationalunknownbinderDetailsDB00847Cysteamineapproved, investigationalunknownbinderDetailsDB15093Somapacitanapproved, investigationalunknownbinderDetailsDB00908Quinidineapproved, investigationalunknownbinderDetailsDB15935Lumasiranapproved, investigationalnobinderDetailsDB04951Pirfenidoneapproved, investigationalunknownbinderDetailsDB11853Relugolixapproved, investigationalunknownbinderDetailsDB01380Cortisone acetateapproved, investigationalunknownbinderDetailsDB15248Bulevirtideapproved, investigationalunknownbinderDetailsDB00501Cimetidineapproved, investigationalunknownsubstrateDetailsDB15456Vericiguatapproved, investigationalunknownbinderDetailsDB11751Cabotegravirapproved, investigationalunknownbinderDetailsDB15133Tepotinibapproved, investigationalunknownbinderDetailsDB06151Acetylcysteineapproved, investigationalunknownbinderDetailsDB00346Alfuzosinapproved, investigationalunknownbinderDetailsDB00376TrihexyphenidylapprovedunknownbinderDetailsDB00391Sulpirideapproved, investigationalnobinderDetailsDB01083Orlistatapproved, investigationalunknownbinderDetailsDB08877RuxolitinibapprovedunknownbinderDetailsDB00640Adenosineapproved, investigationalunknownbinderDetailsDB00853Temozolomideapproved, investigationalnobinderDetailsDB06237AvanafilapprovedunknownbinderDetailsDB04854FebuxostatapprovedunknownbinderDetailsDB01086Benzocaineapproved, investigationalunknownbinderDetailsDB11800Tivozanibapproved, investigationalunknownbinderDetailsDB00080Daptomycinapproved, investigationalnobinderDetailsDB00434CyproheptadineapprovedunknownbinderDetailsDB00083Botulinum toxin type Aapproved, investigationalunknownbinderDetailsDB00968MethyldopaapprovednobinderDetailsDB08995Diosminapproved, investigationalunknownbinderDetailsDB08822Azilsartan medoxomilapproved, investigationalnobinderDetailsDB00438CeftazidimeapprovednobinderDetailsDB09069Trimetazidineapproved, investigationalunknownbinderDetailsDB00601Linezolidapproved, investigationalnobinderDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownbinderDetailsDB12235Estetrolapproved, investigationalunknownbinderDetailsDB01064Isoprenalineapproved, investigationalunknownbinderDetailsDB12471Ibrexafungerpapproved, investigationalunknownbinderDetailsDB06695Dabigatran etexilateapprovedunknownbinderDetailsDB16165Finerenoneapproved, investigationalunknownbinderDetailsDB16703Belumosudilapproved, investigationalnobinderDetailsDB00877Sirolimusapproved, investigationalnobinderDetailsDB06234Maribavirapproved, investigationalnobinderDetailsDB14973Abrocitinibapproved, investigationalnobinderDetailsDB15575Padeliporfinapproved, experimentalunknownbinderDetailsDB09070Tiboloneapproved, investigationalunknownbinderDetailsDB04847Roxadustatapproved, investigationalunknownbinderDetailsDB09074OlaparibapprovedunknownbinderDetailsDB15171Tirzepatideapproved, investigationalunknownbinderDetailsDB13959Medium-chain triglyceridesapprovedunknownbinderDetailsDB06813Pralatrexateapproved, investigationalnobinderDetailsDB00342Terfenadineapproved, withdrawnunknownbinderregulatorDetailsDB13514Pranoprofenexperimental, investigationalnoregulatorDetailsDB00427TriprolidineapprovedunknownbinderregulatorDetailsDB00485Dicloxacillinapproved, investigational, vet_approvedunknownbinderregulatorDetailsDB01173OrphenadrineapprovedunknownbinderregulatorDetailsDB01619PhenindamineapprovedunknownbinderregulatorDetailsDB00792Tripelennamineapproved, vet_approvedunknownbinderregulatorDetailsDB08912Dabrafenibapproved, investigationalnobinderDetailsDB16699Vutrisiranapproved, investigationalunknownligandDetailsDB06150Sulfadimethoxineapproved, vet_approved, withdrawnunknownsubstrateDetailsDB00254Doxycyclineapproved, investigational, vet_approvedunknownsubstratebinderDetailsDB08936ChlorcyclizineapprovedunknownregulatorDetailsDB00568Cinnarizineapproved, investigationalunknownregulatorDetailsDB01176CyclizineapprovedunknownregulatorDetailsDB00366Doxylamineapproved, vet_approvedunknownregulatorDetailsDB00850PerphenazineapprovedunknownregulatorDetailsDB01024Mycophenolic acidapproved, investigationalunknownbinderDetailsDB08865Crizotinibapproved, investigationalunknownbinderDetailsDB13310OrmeloxifeneexperimentalunknownbinderDetailsDB00758ClopidogrelapprovednobinderDetailsDB15149Futibatinibapproved, investigationalnobinderDetailsDB08930DolutegravirapprovednobinderDetailsDB17083LinzagolixapprovednobinderDetailsDB11739Vonoprazanapproved, investigationalunknownbinderDetailsDB11793Niraparibapproved, investigationalunknownbinderDetailsDB00642Pemetrexedapproved, investigationalnobinderDetailsDB12243Edaravoneapproved, investigationalnobinderDetailsDB00795SulfasalazineapprovednobinderDetailsDB00303Ertapenemapproved, investigationalnobinderDetailsDB01119DiazoxideapprovedunknownbinderDetailsDB01101Capecitabineapproved, investigationalnobinderDetailsDB00363ClozapineapprovednobinderDetailsDB00349Clobazamapproved, illicitnobinderDetailsDB00770Alprostadilapproved, investigationalunknownbinderDetailsDB00683Midazolamapproved, illicitnobinderDetailsDB11901Apalutamideapproved, investigationalnobinderDetailsDB09128Brexpiprazoleapproved, investigationalnosubstrateDetailsDB08906Fluticasone furoateapprovednobinderDetailsDB12255Vadadustatapproved, investigationalunknownbinderDetailsDB09076UmeclidiniumapprovednobinderDetailsDB01005HydroxyureaapprovednobinderDetailsDB00526Oxaliplatinapproved, investigationalnobinderDetailsDB06772CabazitaxelapprovedunknownbinderDetailsDB12874Quizartinibapproved, investigationalnobinderDetailsDB01042MelphalanapprovedunknownbinderDetailsDB08903BedaquilineapprovednobinderDetailsDB11718Encorafenibapproved, investigationalnobinderDetailsDB11967Binimetinibapproved, investigationalnobinderDetails"
                    }
                }
            ],
            "transporters": [
                {
                    "Label": "P-glycoprotein 1",
                    "Detailed Info": {
                        "Name": "Multidrug resistance protein 1",
                        "Synonyms": "3.6.3.44\nATP-binding cassette sub-family B member 1\nMDR1\nP-glycoprotein 1\nPGY1",
                        "Gene Name": "ABCB1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0037114|Multidrug resistance protein 1\nMDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLYMVVGTLAAII\nHGAGLPLMMLVFGEMTDIFANAGNLEDLMSNITNRSDINDTGFFMNLEEDMTRYAYYYSG\nIGAGVLVAAYIQVSFWCLAAGRQIHKIRKQFFHAIMRQEIGWFDVHDVGELNTRLTDDVS\nKINEGIGDKIGMFFQSMATFFTGFIVGFTRGWKLTLVILAISPVLGLSAAVWAKILSSFT\nDKELLAYAKAGAVAEEVLAAIRTVIAFGGQKKELERYNKNLEEAKRIGIKKAITANISIG\nAAFLLIYASYALAFWYGTTLVLSGEYSIGQVLTVFFSVLIGAFSVGQASPSIEAFANARG\nAAYEIFKIIDNKPSIDSYSKSGHKPDNIKGNLEFRNVHFSYPSRKEVKILKGLNLKVQSG\nQTVALVGNSGCGKSTTVQLMQRLYDPTEGMVSVDGQDIRTINVRFLREIIGVVSQEPVLF\nATTIAENIRYGRENVTMDEIEKAVKEANAYDFIMKLPHKFDTLVGERGAQLSGGQKQRIA\nIARALVRNPKILLLDEATSALDTESEAVVQVALDKARKGRTTIVIAHRLSTVRNADVIAG\nFDDGVIVEKGNHDELMKEKGIYFKLVTMQTAGNEVELENAADESKSEIDALEMSSNDSRS\nSLIRKRSTRRSVRGSQAQDRKLSTKEALDESIPPVSFWRIMKLNLTEWPYFVVGVFCAII\nNGGLQPAFAIIFSKIIGVFTRIDDPETKRQNSNLFSLLFLALGIISFITFFLQGFTFGKA\nGEILTKRLRYMVFRSMLRQDVSWFDDPKNTTGALTTRLANDAAQVKGAIGSRLAVITQNI\nANLGTGIIISFIYGWQLTLLLLAIVPIIAIAGVVEMKMLSGQALKDKKELEGSGKIATEA\nIENFRTVVSLTQEQKFEHMYAQSLQVPYRNSLRKAHIFGITFSFTQAMMYFSYAGCFRFG\nAYLVAHKLMSFEDVLLVFSAVVFGAMAVGQVSSFAPDYAKAKISAAHIIMIIEKTPLIDS\nYSTEGLMPNTLEGNVTFGEVVFNYPTRPDIPVLQGLSLEVKKGQTLALVGSSGCGKSTVV\nQLLERFYDPLAGKVLLDGKEIKRLNVQWLRAHLGIVSQEPILFDCSIAENIAYGDNSRVV\nSQEEIVRAAKEANIHAFIESLPNKYSTKVGDKGTQLSGGQKQRIAIARALVRQPHILLLD\nEATSALDTESEKVVQEALDKAREGRTCIVIAHRLSTIQNADLIVVFQNGRVKEHGTHQQL\nLAQKGIYFSMVSVQAGTKRQ",
                        "Number of residues": "1280",
                        "Molecular Weight": "141477.255",
                        "Theoretical pI": "9.44",
                        "GO Classification": "FunctionsATP binding / ATPase activity, coupled to transmembrane movement of substances / transporter activity / xenobiotic-transporting ATPase activityProcessesdrug transmembrane transport / G2/M transition of mitotic cell cycle / response to drug / small molecule metabolic process / stem cell proliferation / transmembrane transport / transportComponentscell surface / extracellular exosome / integral component of membrane / membrane / plasma membrane",
                        "General Function": "Xenobiotic-transporting atpase activity",
                        "Specific Function": "Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells.",
                        "Pfam Domain Function": "ABC_tran (PF00005)\nABC_membrane (PF00664)",
                        "Transmembrane Regions": "45-67\n117-137\n187-208\n216-236\n293-316\n331-352\n712-732\n757-777\n833-853\n855-874\n935-957\n974-995",
                        "Cellular Location": "Cell membrane",
                        "Gene sequence": ">lcl|BSEQ0016291|Multidrug resistance protein 1 (ABCB1)\nATGGATCTTGAAGGGGACCGCAATGGAGGAGCAAAGAAGAAGAACTTTTTTAAACTGAAC\nAATAAAAGTGAAAAAGATAAGAAGGAAAAGAAACCAACTGTCAGTGTATTTTCAATGTTT\nCGCTATTCAAATTGGCTTGACAAGTTGTATATGGTGGTGGGAACTTTGGCTGCCATCATC\nCATGGGGCTGGACTTCCTCTCATGATGCTGGTGTTTGGAGAAATGACAGATATCTTTGCA\nAATGCAGGAAATTTAGAAGATCTGATGTCAAACATCACTAATAGAAGTGATATCAATGAT\nACAGGGTTCTTCATGAATCTGGAGGAAGACATGACCAGGTATGCCTATTATTACAGTGGA\nATTGGTGCTGGGGTGCTGGTTGCTGCTTACATTCAGGTTTCATTTTGGTGCCTGGCAGCT\nGGAAGACAAATACACAAAATTAGAAAACAGTTTTTTCATGCTATAATGCGACAGGAGATA\nGGCTGGTTTGATGTGCACGATGTTGGGGAGCTTAACACCCGACTTACAGATGATGTCTCC\nAAGATTAATGAAGGAATTGGTGACAAAATTGGAATGTTCTTTCAGTCAATGGCAACATTT\nTTCACTGGGTTTATAGTAGGATTTACACGTGGTTGGAAGCTAACCCTTGTGATTTTGGCC\nATCAGTCCTGTTCTTGGACTGTCAGCTGCTGTCTGGGCAAAGATACTATCTTCATTTACT\nGATAAAGAACTCTTAGCGTATGCAAAAGCTGGAGCAGTAGCTGAAGAGGTCTTGGCAGCA\nATTAGAACTGTGATTGCATTTGGAGGACAAAAGAAAGAACTTGAAAGGTACAACAAAAAT\nTTAGAAGAAGCTAAAAGAATTGGGATAAAGAAAGCTATTACAGCCAATATTTCTATAGGT\nGCTGCTTTCCTGCTGATCTATGCATCTTATGCTCTGGCCTTCTGGTATGGGACCACCTTG\nGTCCTCTCAGGGGAATATTCTATTGGACAAGTACTCACTGTATTCTTTTCTGTATTAATT\nGGGGCTTTTAGTGTTGGACAGGCATCTCCAAGCATTGAAGCATTTGCAAATGCAAGAGGA\nGCAGCTTATGAAATCTTCAAGATAATTGATAATAAGCCAAGTATTGACAGCTATTCGAAG\nAGTGGGCACAAACCAGATAATATTAAGGGAAATTTGGAATTCAGAAATGTTCACTTCAGT\nTACCCATCTCGAAAAGAAGTTAAGATCTTGAAGGGTCTGAACCTGAAGGTGCAGAGTGGG\nCAGACGGTGGCCCTGGTTGGAAACAGTGGCTGTGGGAAGAGCACAACAGTCCAGCTGATG\nCAGAGGCTCTATGACCCCACAGAGGGGATGGTCAGTGTTGATGGACAGGATATTAGGACC\nATAAATGTAAGGTTTCTACGGGAAATCATTGGTGTGGTGAGTCAGGAACCTGTATTGTTT\nGCCACCACGATAGCTGAAAACATTCGCTATGGCCGTGAAAATGTCACCATGGATGAGATT\nGAGAAAGCTGTCAAGGAAGCCAATGCCTATGACTTTATCATGAAACTGCCTCATAAATTT\nGACACCCTGGTTGGAGAGAGAGGGGCCCAGTTGAGTGGTGGGCAGAAGCAGAGGATCGCC\nATTGCACGTGCCCTGGTTCGCAACCCCAAGATCCTCCTGCTGGATGAGGCCACGTCAGCC\nTTGGACACAGAAAGCGAAGCAGTGGTTCAGGTGGCTCTGGATAAGGCCAGAAAAGGTCGG\nACCACCATTGTGATAGCTCATCGTTTGTCTACAGTTCGTAATGCTGACGTCATCGCTGGT\nTTCGATGATGGAGTCATTGTGGAGAAAGGAAATCATGATGAACTCATGAAAGAGAAAGGC\nATTTACTTCAAACTTGTCACAATGCAGACAGCAGGAAATGAAGTTGAATTAGAAAATGCA\nGCTGATGAATCCAAAAGTGAAATTGATGCCTTGGAAATGTCTTCAAATGATTCAAGATCC\nAGTCTAATAAGAAAAAGATCAACTCGTAGGAGTGTCCGTGGATCACAAGCCCAAGACAGA\nAAGCTTAGTACCAAAGAGGCTCTGGATGAAAGTATACCTCCAGTTTCCTTTTGGAGGATT\nATGAAGCTAAATTTAACTGAATGGCCTTATTTTGTTGTTGGTGTATTTTGTGCCATTATA\nAATGGAGGCCTGCAACCAGCATTTGCAATAATATTTTCAAAGATTATAGGGGTTTTTACA\nAGAATTGATGATCCTGAAACAAAACGACAGAATAGTAACTTGTTTTCACTATTGTTTCTA\nGCCCTTGGAATTATTTCTTTTATTACATTTTTCCTTCAGGGTTTCACATTTGGCAAAGCT\nGGAGAGATCCTCACCAAGCGGCTCCGATACATGGTTTTCCGATCCATGCTCAGACAGGAT\nGTGAGTTGGTTTGATGACCCTAAAAACACCACTGGAGCATTGACTACCAGGCTCGCCAAT\nGATGCTGCTCAAGTTAAAGGGGCTATAGGTTCCAGGCTTGCTGTAATTACCCAGAATATA\nGCAAATCTTGGGACAGGAATAATTATATCCTTCATCTATGGTTGGCAACTAACACTGTTA\nCTCTTAGCAATTGTACCCATCATTGCAATAGCAGGAGTTGTTGAAATGAAAATGTTGTCT\nGGACAAGCACTGAAAGATAAGAAAGAACTAGAAGGTTCTGGGAAGATCGCTACTGAAGCA\nATAGAAAACTTCCGAACCGTTGTTTCTTTGACTCAGGAGCAGAAGTTTGAACATATGTAT\nGCTCAGAGTTTGCAGGTACCATACAGAAACTCTTTGAGGAAAGCACACATCTTTGGAATT\nACATTTTCCTTCACCCAGGCAATGATGTATTTTTCCTATGCTGGATGTTTCCGGTTTGGA\nGCCTACTTGGTGGCACATAAACTCATGAGCTTTGAGGATGTTCTGTTAGTATTTTCAGCT\nGTTGTCTTTGGTGCCATGGCCGTGGGGCAAGTCAGTTCATTTGCTCCTGACTATGCCAAA\nGCCAAAATATCAGCAGCCCACATCATCATGATCATTGAAAAAACCCCTTTGATTGACAGC\nTACAGCACGGAAGGCCTAATGCCGAACACATTGGAAGGAAATGTCACATTTGGTGAAGTT\nGTATTCAACTATCCCACCCGACCGGACATCCCAGTGCTTCAGGGACTGAGCCTGGAGGTG\nAAGAAGGGCCAGACGCTGGCTCTGGTGGGCAGCAGTGGCTGTGGGAAGAGCACAGTGGTC\nCAGCTCCTGGAGCGGTTCTACGACCCCTTGGCAGGGAAAGTGCTGCTTGATGGCAAAGAA\nATAAAGCGACTGAATGTTCAGTGGCTCCGAGCACACCTGGGCATCGTGTCCCAGGAGCCC\nATCCTGTTTGACTGCAGCATTGCTGAGAACATTGCCTATGGAGACAACAGCCGGGTGGTG\nTCACAGGAAGAGATTGTGAGGGCAGCAAAGGAGGCCAACATACATGCCTTCATCGAGTCA\nCTGCCTAATAAATATAGCACTAAAGTAGGAGACAAAGGAACTCAGCTCTCTGGTGGCCAG\nAAACAACGCATTGCCATAGCTCGTGCCCTTGTTAGACAGCCTCATATTTTGCTTTTGGAT\nGAAGCCACGTCAGCTCTGGATACAGAAAGTGAAAAGGTTGTCCAAGAAGCCCTGGACAAA\nGCCAGAGAAGGCCGCACCTGCATTGTGATTGCTCACCGCCTGTCCACCATCCAGAATGCA\nGACTTAATAGTGGTGTTTCAGAATGGCAGAGTCAAGGAGCATGGCACGCATCAGCAGCTG\nCTGGCACAGAAAGGCATCTATTTTTCAATGGTCAGTGTCCAGGCTGGAACAAAGCGCCAG\nTGA",
                        "Chromosome Location": "7",
                        "Locus": "7q21.1",
                        "External Identifiers": "ResourceLinkUniProtKB IDP08183UniProtKB Entry NameMDR1_HUMANGenBank Protein ID307180GenBank Gene IDM14758GenAtlas IDABCB1HGNC IDHGNC:40",
                        "General References": "Chen CJ, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, Roninson IB: Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell. 1986 Nov 7;47(3):381-9. [Article] Chen CJ, Clark D, Ueda K, Pastan I, Gottesman MM, Roninson IB: Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins. J Biol Chem. 1990 Jan 5;265(1):506-14. [Article] Chen G, Duran GE, Steger KA, Lacayo NJ, Jaffrezou JP, Dumontet C, Sikic BI: Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins. J Biol Chem. 1997 Feb 28;272(9):5974-82. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, Wagner-McPherson C, Layman D, Maas J, Jaeger S, Walker R, Wylie K, Sekhon M, Becker MC, O'Laughlin MD, Schaller ME, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Cordes M, Du H, Sun H, Edwards J, Bradshaw-Cordum H, Ali J, Andrews S, Isak A, Vanbrunt A, Nguyen C, Du F, Lamar B, Courtney L, Kalicki J, Ozersky P, Bielicki L, Scott K, Holmes A, Harkins R, Harris A, Strong CM, Hou S, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Leonard S, Rohlfing T, Rock SM, Tin-Wollam AM, Abbott A, Minx P, Maupin R, Strowmatt C, Latreille P, Miller N, Johnson D, Murray J, Woessner JP, Wendl MC, Yang SP, Schultz BR, Wallis JW, Spieth J, Bieri TA, Nelson JO, Berkowicz N, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Bedell JA, Mardis ER, Clifton SW, Chissoe SL, Marra MA, Raymond C, Haugen E, Gillett W, Zhou Y, James R, Phelps K, Iadanoto S, Bubb K, Simms E, Levy R, Clendenning J, Kaul R, Kent WJ, Furey TS, Baertsch RA, Brent MR, Keibler E, Flicek P, Bork P, Suyama M, Bailey JA, Portnoy ME, Torrents D, Chinwalla AT, Gish WR, Eddy SR, McPherson JD, Olson MV, Eichler EE, Green ED, Waterston RH, Wilson RK: The DNA sequence of human chromosome 7. Nature. 2003 Jul 10;424(6945):157-64. [Article] Gekeler V, Weger S, Probst H: mdr1/P-glycoprotein gene segments analyzed from various human leukemic cell lines exhibiting different multidrug resistance profiles. Biochem Biophys Res Commun. 1990 Jun 15;169(2):796-802. [Article] Kioka N, Tsubota J, Kakehi Y, Komano T, Gottesman MM, Pastan I, Ueda K: P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance. Biochem Biophys Res Commun. 1989 Jul 14;162(1):224-31. [Article] Kerb R, Hoffmeyer S, Brinkmann U: ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2. Pharmacogenomics. 2001 Feb;2(1):51-64. [Article] Begley GS, Horvath AR, Taylor JC, Higgins CF: Cytoplasmic domains of the transporter associated with antigen processing and P-glycoprotein interact with subunits of the proteasome. Mol Immunol. 2005 Jan;42(1):137-41. [Article] Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP: A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7. doi: 10.1073/pnas.0805139105. Epub 2008 Jul 31. [Article] Burkard TR, Planyavsky M, Kaupe I, Breitwieser FP, Burckstummer T, Bennett KL, Superti-Furga G, Colinge J: Initial characterization of the human central proteome. BMC Syst Biol. 2011 Jan 26;5:17. doi: 10.1186/1752-0509-5-17. [Article] Katayama K, Yamaguchi M, Noguchi K, Sugimoto Y: Protein phosphatase complex PP5/PPP2R3C dephosphorylates P-glycoprotein/ABCB1 and down-regulates the expression and function. Cancer Lett. 2014 Apr 1;345(1):124-31. doi: 10.1016/j.canlet.2013.12.007. Epub 2013 Dec 11. [Article] Choi KH, Chen CJ, Kriegler M, Roninson IB: An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene. Cell. 1988 May 20;53(4):519-29. [Article] Mickley LA, Lee JS, Weng Z, Zhan Z, Alvarez M, Wilson W, Bates SE, Fojo T: Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors. Blood. 1998 Mar 1;91(5):1749-56. [Article] Decleves X, Chevillard S, Charpentier C, Vielh P, Laplanche JL: A new polymorphism (N21D) in the exon 2 of the human MDR1 gene encoding the P-glycoprotein. Hum Mutat. 2000 May;15(5):486. [Article] Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M, Brinkmann U: Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3473-8. [Article] Cascorbi I, Gerloff T, Johne A, Meisel C, Hoffmeyer S, Schwab M, Schaeffeler E, Eichelbaum M, Brinkmann U, Roots I: Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther. 2001 Mar;69(3):169-74. [Article] Honda T, Dan Y, Koyabu N, Ieiri I, Otsubo K, Higuchi S, Ohtani H, Sawada Y: Polymorphism of MDR1 gene in healthy japanese subjects: a novel SNP with an amino acid substitution (Glu108Lys). Drug Metab Pharmacokinet. 2002;17(5):479-81. [Article] Itoda M, Saito Y, Komamura K, Ueno K, Kamakura S, Ozawa S, Sawada J: Twelve novel single nucleotide polymorphisms in ABCB1/MDR1 among Japanese patients with ventricular tachycardia who were administered amiodarone. Drug Metab Pharmacokinet. 2002;17(6):566-71. [Article] Saito S, Iida A, Sekine A, Miura Y, Ogawa C, Kawauchi S, Higuchi S, Nakamura Y: Three hundred twenty-six genetic variations in genes encoding nine members of ATP-binding cassette, subfamily B (ABCB/MDR/TAP), in the Japanese population. J Hum Genet. 2002;47(1):38-50. [Article] Brant SR, Panhuysen CI, Nicolae D, Reddy DM, Bonen DK, Karaliukas R, Zhang L, Swanson E, Datta LW, Moran T, Ravenhill G, Duerr RH, Achkar JP, Karban AS, Cho JH: MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet. 2003 Dec;73(6):1282-92. Epub 2003 Nov 7. [Article] Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE: The consensus coding sequences of human breast and colorectal cancers. Science. 2006 Oct 13;314(5797):268-74. Epub 2006 Sep 7. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00171ATPinvestigational, nutraceuticalunknownDetailsDB00778Roxithromycinapproved, investigational, withdrawnunknownDetailsDB04881ElacridarinvestigationalunknownDetailsDB04905TesmilifeneinvestigationalyesinducerDetailsDB05449FM-VP4investigationalunknownDetailsDB06240TariquidarinvestigationalunknownDetailsDB06191ZosuquidarinvestigationalyesinhibitorDetailsDB00661VerapamilapprovedunknownsubstrateinhibitorDetailsDB01232Saquinavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00220NelfinavirapprovednosubstrateinhibitorinducerDetailsDB00224IndinavirapprovedunknownsubstrateinhibitorinducerDetailsDB00701Amprenavirapproved, investigationalunknownsubstrateinducerDetailsDB01045RifampicinapprovedunknowninducerDetailsDB00206Reserpineapproved, investigational, withdrawnunknownsubstrateinhibitorinducerDetailsDB01115NifedipineapprovedunknownsubstrateinducerDetailsDB00834Mifepristoneapproved, investigationalunknowninhibitorinducerDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00257Clotrimazoleapproved, vet_approvedunknowninhibitorinducerDetailsDB00564Carbamazepineapproved, investigationalunknowninducerDetailsDB00656Trazodoneapproved, investigationalunknowninducerDetailsDB01149Nefazodoneapproved, withdrawnunknowninhibitorinducerDetailsDB00503Ritonavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00390DigoxinapprovedunknownsubstrateinhibitorinducerDetailsDB00279Liothyronineapproved, vet_approvedunknowninducerDetailsDB00451LevothyroxineapprovedunknowninducerDetailsDB00440Trimethoprimapproved, vet_approvedunknownsubstrateDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateinhibitorinducerDetailsDB02261Platelet Activating FactorexperimentalunknownsubstrateinducerDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00501Cimetidineapproved, investigationalunknownsubstrateinducerDetailsDB04630Aldosteroneexperimental, investigationalunknownsubstrateinducerDetailsDB00864Tacrolimusapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00877Sirolimusapproved, investigationalnosubstrateinhibitorinducerDetailsDB01174Phenobarbitalapproved, investigationalunknownsubstrateinducerDetailsDB00199Erythromycinapproved, investigational, vet_approvednosubstrateinhibitorDetailsDB01118Amiodaroneapproved, investigationalunknowninhibitorinducerDetailsDB01323St. John's Wortapproved, investigational, nutraceuticalunknowninducerDetailsDB00541Vincristineapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00570VinblastineapprovedunknownsubstrateinhibitorinducerDetailsDB02659Cholic AcidapprovedunknowninducerDetailsDB00675TamoxifenapprovedunknownsubstrateinhibitorinducerDetailsDB00428Streptozocinapproved, investigationalunknowninducerDetailsDB01204Mitoxantroneapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00997Doxorubicinapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00694DaunorubicinapprovedunknownsubstrateinhibitorinducerDetailsDB00908Quinidineapproved, investigationalunknownsubstrateinhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB01388Mibefradilinvestigational, withdrawnunknownsubstrateinhibitorDetailsDB04540Cholesterolapproved, investigationalunknowninhibitorDetailsDB00358Mefloquineapproved, investigationalunknownsubstrateinhibitorDetailsDB00622Nicardipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00381AmlodipineapprovedunknownsubstrateinhibitorDetailsDB00972AzelastineapprovedunknowninhibitorDetailsDB00863Ranitidineapproved, withdrawnunknownsubstrateinhibitorDetailsDB00773EtoposideapprovedunknownsubstrateinhibitorDetailsDB00333MethadoneapprovedunknowninhibitorDetailsDB00641SimvastatinapprovedunknowninhibitorDetailsDB00227Lovastatinapproved, investigationalunknowninhibitorDetailsDB01076AtorvastatinapprovednosubstrateinhibitorDetailsDB01229Paclitaxelapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00457PrazosinapprovedunknownsubstrateinhibitormodulatorDetailsDB01054Nitrendipineapproved, investigationalunknowninhibitorDetailsDB00975DipyridamoleapprovedunknownsubstrateinhibitorDetailsDB00343Diltiazemapproved, investigationalunknownsubstrateinhibitorDetailsDB01394ColchicineapprovedunknownsubstrateinducerDetailsDB01211ClarithromycinapprovedunknownsubstrateinhibitorDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00970Dactinomycinapproved, investigationalunknownsubstrateinhibitorDetailsDB13179TroleandomycinapprovedunknowninhibitorDetailsDB00831Trifluoperazineapproved, investigationalunknowninhibitorDetailsDB00342Terfenadineapproved, withdrawnunknowninhibitorDetailsDB00468QuinineapprovedunknownsubstrateinhibitorDetailsDB01167Itraconazoleapproved, investigationalunknowninhibitorDetailsDB00328Indomethacinapproved, investigationalunknownsubstrateinhibitorDetailsDB02587Colforsinexperimental, investigationalunknowninhibitorDetailsDB00623FluphenazineapprovedunknowninhibitorDetailsDB01023Felodipineapproved, investigationalunknowninhibitorDetailsDB01136Carvedilolapproved, investigationalunknowninhibitorDetailsDB00421SpironolactoneapprovedunknowninducerDetailsDB00281Lidocaineapproved, vet_approvedunknowninhibitorDetailsDB00537Ciprofloxacinapproved, investigationalunknownsubstrateDetailsDB00207AzithromycinapprovedunknownsubstrateinhibitorDetailsDB00316AcetaminophenapprovedunknownsubstrateinhibitorDetailsDB00196Fluconazoleapproved, investigationalunknowninhibitorDetailsDB00213PantoprazoleapprovedunknownsubstrateinhibitorDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00448Lansoprazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00678LosartanapprovedunknownsubstrateinhibitorDetailsDB00584Enalaprilapproved, vet_approvedunknowninhibitorDetailsDB00590DoxazosinapprovedunknowninhibitorDetailsDB01340CilazaprilapprovedunknowninhibitorDetailsDB01197CaptoprilapprovedunknowninhibitorDetailsDB00796Candesartan cilexetilapprovedunknowninhibitorDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB00696ErgotamineapprovedunknowninhibitorDetailsDB01253ErgometrineapprovedunknowninhibitorDetailsDB00320Dihydroergotamineapproved, investigationalunknowninhibitorDetailsDB01200Bromocriptineapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00836LoperamideapprovedunknownsubstrateDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedunknowninhibitorDetailsDB00802Alfentanilapproved, illicitunknowninhibitorDetailsDB00401NisoldipineapprovedunknowninhibitorDetailsDB04832Zimelidineapproved, withdrawnunknowninhibitorDetailsDB00382Tacrineapproved, investigational, withdrawnunknownsubstrateDetailsDB00669Sumatriptanapproved, investigationalunknownsubstrateDetailsDB01037Selegilineapproved, investigational, vet_approvedunknowninhibitorDetailsDB00458ImipramineapprovedunknownsubstrateDetailsDB00502HaloperidolapprovedunknownsubstrateinhibitorDetailsDB00176Fluvoxamineapproved, investigationalunknowninhibitorDetailsDB00690Flurazepamapproved, illicit, investigationalunknowninhibitorDetailsDB00472Fluoxetineapproved, vet_approvedunknowninhibitorDetailsDB01142Doxepinapproved, investigationalunknownsubstrateDetailsDB01151Desipramineapproved, investigationalunknowninhibitorDetailsDB01242Clomipramineapproved, investigational, vet_approvedunknowninhibitorDetailsDB01239Chlorprothixeneapproved, experimental, investigational, withdrawnunknowninhibitorDetailsDB00490Buspironeapproved, investigationalunknowninhibitorDetailsDB01100PimozideapprovedunknowninhibitorDetailsDB00295Morphineapproved, investigationalnosubstrateDetailsDB00602Ivermectinapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00741Hydrocortisoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00637Astemizoleapproved, withdrawnunknowninhibitorDetailsDB00508Triflupromazineapproved, vet_approvedunknowninhibitorDetailsDB00344ProtriptylineapprovedunknowninhibitorDetailsDB01069Promethazineapproved, investigationalunknowninhibitorDetailsDB01244Bepridilapproved, withdrawnunknowninhibitorDetailsDB00455Loratadineapproved, investigationalnosubstrateinhibitorDetailsDB00967Desloratadineapproved, investigationalunknowninhibitorDetailsDB00285VenlafaxineapprovedunknownsubstrateinhibitorDetailsDB01104SertralineapprovedunknowninhibitorDetailsDB00234Reboxetineapproved, experimentalunknowninhibitorDetailsDB00715Paroxetineapproved, investigationalunknowninhibitorDetailsDB00215CitalopramapprovedunknownsubstrateinhibitorDetailsDB01196Estramustineapproved, investigationalunknowninhibitorDetailsDB04348Taurocholic acidapproved, experimentalunknownsubstrateinhibitorDetailsDB00875Flupentixolapproved, investigational, withdrawnunknowninhibitorDetailsDB00351Megestrol acetateapproved, investigational, vet_approvedunknowninhibitorDetailsDB02010StaurosporineexperimentalunknowninhibitorDetailsDB01103QuinacrineinvestigationalunknowninhibitorDetailsDB01645GenisteininvestigationalunknowninhibitorDetailsDB04216Quercetinexperimental, investigationalunknowninhibitorDetailsDB01137Levofloxacinapproved, investigationalunknownsubstrateinhibitorDetailsDB03467NaringeninexperimentalunknowndownregulatorDetailsDB01016GlyburideapprovedunknowninhibitorDetailsDB00950Fexofenadineapproved, investigationalunknownsubstrateDetailsDB00726TrimipramineapprovedunknownsubstrateDetailsDB00571Propranololapproved, investigationalunknownsubstrateDetailsDB00635Prednisoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00276Amsacrineapproved, investigationalunknowninhibitorDetailsDB00027Gramicidin DapprovedunknownsubstrateinhibitorDetailsDB01086Benzocaineapproved, investigationalunknowninhibitorDetailsDB01601LopinavirapprovedunknowninhibitorinducerDetailsDB00520CaspofunginapprovedunknowninhibitorDetailsDB00175PravastatinapprovednosubstrateDetailsDB00619ImatinibapprovednosubstrateinhibitorDetailsDB00398Sorafenibapproved, investigationalunknownsubstrateinhibitorDetailsDB01268Sunitinibapproved, investigationalunknowninhibitorDetailsDB01162TerazosinapprovedunknowninhibitorDetailsDB00470Dronabinolapproved, illicitunknowninhibitorDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknowninhibitorDetailsDB00966Telmisartanapproved, investigationalunknowninhibitorDetailsDB01254Dasatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00317Gefitinibapproved, investigationalunknownsubstrateinhibitorDetailsDB04868Nilotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00655EstroneapprovedunknownsubstrateinducerDetailsDB01259Lapatinibapproved, investigationalunknowninhibitorDetailsDB01263Posaconazoleapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00365Grepafloxacinapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB01396Digitoxinapproved, investigationalunknownsubstrateDetailsDB01208Sparfloxacinapproved, investigational, withdrawnunknownsubstrateDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB01224QuetiapineapprovedunknownsubstrateDetailsDB00334Olanzapineapproved, investigationalnosubstrateDetailsDB00363ClozapineapprovedunknownsubstrateDetailsDB01183Naloxoneapproved, vet_approvedunknownsubstrateDetailsDB04690CamptothecinexperimentalunknownsubstrateDetailsDB00860Prednisoloneapproved, vet_approvedunknownsubstrateDetailsDB01193Acebutololapproved, investigationalunknownsubstrateDetailsDB01050IbuprofenapprovedunknownsubstrateDetailsDB00945Acetylsalicylic acidapproved, vet_approvedunknownsubstrateinducermodulatorDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB00443Betamethasoneapproved, vet_approvedunknownsubstrateDetailsDB00539Toremifeneapproved, investigationalunknownsubstrateDetailsDB00255Diethylstilbestrolapproved, investigational, withdrawnunknownsubstrateDetailsDB00882Clomifeneapproved, investigationalunknownsubstrateDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstratedownregulatorregulatorDetailsDB01248Docetaxelapproved, investigationalunknownsubstrateDetailsDB00563MethotrexateapprovedunknownsubstrateDetailsDB00373TimololapprovedunknownsubstrateDetailsDB01203NadololapprovedunknownsubstrateDetailsDB00523Alitretinoinapproved, investigationalunknownsubstrateDetailsDB01339Vecuroniumapproved, investigationalunknownsubstrateDetailsDB04840Debrisoquineapproved, investigationalunknownsubstrateDetailsDB00441GemcitabineapprovednosubstrateDetailsDB01030Topotecanapproved, investigationalunknownsubstrateDetailsDB02901Stanoloneillicit, investigationalunknownsubstrateDetailsDB00751Epinastineapproved, investigationalunknownsubstrateDetailsDB00717NorethisteroneapprovedunknowninhibitorDetailsDB04573Estriolapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB03203SphingosineexperimentalunknownsubstrateDetailsDB00439Cerivastatinapproved, withdrawnunknownsubstrateDetailsDB00286Conjugated estrogensapprovedunknownsubstrateDetailsDB01202LevetiracetamapprovedunknownsubstrateDetailsDB00252Phenytoinapproved, vet_approvedunknownsubstrateDetailsDB00585NizatidineapprovedunknownsubstrateDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00555Lamotrigineapproved, investigationalunknownsubstrateinhibitorDetailsDB01261Sitagliptinapproved, investigationalunknownsubstrateDetailsDB01072Atazanavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB01169Arsenic trioxideapproved, investigationalunknowninhibitorDetailsDB06772CabazitaxelapprovedunknownsubstrateinhibitorDetailsDB01583LiotrixapprovedunknowninducerDetailsDB06287TemsirolimusapprovedunknownsubstrateinhibitorDetailsDB01587KetazolamapprovedunknownsubstrateDetailsDB04877VoacamineexperimentalunknowninhibitorDetailsDB00977EthinylestradiolapprovedunknownsubstrateDetailsDB01182PropafenoneapprovedunknowninhibitorDetailsDB00216Eletriptanapproved, investigationalunknownsubstrateDetailsDB04855DronedaroneapprovednoinhibitorDetailsDB06176Romidepsinapproved, investigationalunknownsubstrateDetailsDB06207SilodosinapprovedunknownsubstrateDetailsDB06414EtravirineapprovedunknowninhibitorDetailsDB06228RivaroxabanapprovedunknownsubstrateDetailsDB06695Dabigatran etexilateapprovedunknownsubstrateDetailsDB00973EzetimibeapprovedunknownsubstrateDetailsDB06702FesoterodineapprovedunknownsubstrateDetailsDB06212TolvaptanapprovednosubstrateinhibitorDetailsDB08860PitavastatinapprovedunknownsubstrateDetailsDB06589PazopanibapprovedunknownsubstrateDetailsDB08864RilpivirineapprovedunknowninhibitorDetailsDB08873Boceprevirapproved, withdrawnunknowninhibitorDetailsDB05521Telaprevirapproved, withdrawnunknownsubstrateinhibitorDetailsDB08874FidaxomicinapprovednosubstrateDetailsDB05039IndacaterolapprovedunknownsubstrateDetailsDB00349Clobazamapproved, illicitnosubstrateDetailsDB08882LinagliptinapprovedunknownsubstrateDetailsDB08827Lomitapideapproved, investigationalnoinhibitorDetailsDB08816TicagrelorapprovedunknownsubstrateinhibitorDetailsDB08865Crizotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB06605ApixabanapprovedunknownsubstrateDetailsDB06626Axitinibapproved, investigationalnosubstrateinhibitorDetailsDB08828Vismodegibapproved, investigationalunknownsubstrateDetailsDB08889Carfilzomibapproved, investigationalunknownsubstrateinhibitorDetailsDB08893MirabegronapprovedunknownsubstrateinhibitorDetailsDB08896RegorafenibapprovedunknownsubstrateinhibitorDetailsDB08899EnzalutamideapprovednoinhibitorDetailsDB08820IvacaftorapprovednoinhibitorDetailsDB06616BosutinibapprovednosubstrateDetailsDB08901Ponatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB08906Fluticasone furoateapprovednosubstrateinducerDetailsDB08907CanagliflozinapprovedunknownsubstrateinhibitorDetailsDB08910PomalidomideapprovedunknownsubstrateDetailsDB00480LenalidomideapprovednosubstrateDetailsDB08912Dabrafenibapproved, investigationalnosubstrateDetailsDB05773Trastuzumab emtansineapproved, investigationalunknownsubstrateDetailsDB00495ZidovudineapprovedunknownsubstrateDetailsDB00758ClopidogrelapprovednosubstrateDetailsDB08916AfatinibapprovedunknownsubstrateinhibitorDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateDetailsDB00709Lamivudineapproved, investigationalunknownsubstrateDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB08918Levomilnacipranapproved, investigationalunknownsubstrateDetailsDB06290SimeprevirapprovedunknownsubstrateinhibitorDetailsDB08934SofosbuvirapprovednosubstrateDetailsDB06292DapagliflozinapprovedunknownsubstrateDetailsDB09076UmeclidiniumapprovednosubstrateDetailsDB09075EdoxabanapprovednosubstrateDetailsDB09063CeritinibapprovednosubstrateDetailsDB09078Lenvatinibapproved, investigationalnosubstrateinhibitorDetailsDB09079NintedanibapprovednosubstrateinhibitorDetailsDB09054IdelalisibapprovednosubstrateinhibitorDetailsDB09065CobicistatapprovedunknowninhibitorDetailsDB09291Rolapitantapproved, investigationalnoinhibitorDetailsDB09102Daclatasvirapproved, investigationalunknownsubstrateinhibitorDetailsDB06636Isavuconazoniumapproved, investigationalnoinhibitorDetailsDB06603Panobinostatapproved, investigationalnosubstrateDetailsDB09330OsimertinibapprovednosubstrateDetailsDB11362SelexipagapprovednosubstrateDetailsDB06403Ambrisentanapproved, investigationalunknownsubstrateDetailsDB09296Ombitasvirapproved, investigationalnosubstrateDetailsDB11574ElbasvirapprovednosubstrateinhibitorDetailsDB11575GrazoprevirapprovednosubstrateDetailsDB09161Technetium Tc-99m sestamibiapproved, investigationalnosubstrateDetailsDB11581Venetoclaxapproved, investigationalnosubstrateinhibitorDetailsDB05015Belinostatapproved, investigationalunknownsubstrateDetailsDB11613Velpatasvirapproved, investigationalnosubstrateinhibitorDetailsDB09027LedipasvirapprovednosubstratetransporterDetailsDB09198LobeglitazoneexperimentalnoDetailsDB09031Miltefosineapproved, investigationalunknownDetailsDB09280LumacaftorapprovednoinhibitorinducerDetailsDB11828Neratinibapproved, investigationalunknowninhibitorDetailsDB12026Voxilaprevirapproved, investigationalnosubstrateinhibitorDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB05889Inotuzumab ozogamicinapproved, investigationalunknownsubstrateDetailsDB13878Pibrentasvirapproved, investigationalunknownsubstrateinhibitorDetailsDB13879Glecaprevirapproved, investigationalunknownsubstrateinhibitorDetailsDB12483Copanlisibapproved, investigationalunknownsubstrateDetailsDB12001Abemaciclibapproved, investigationalunknownsubstrateinhibitorDetailsDB12364Betrixabanapproved, investigationalnosubstrateDetailsDB13919CandesartanexperimentalunknowninhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateinhibitorDetailsDB12332Rucaparibapproved, investigationalnosubstrateinhibitorDetailsDB09270Ubidecarenoneapproved, investigational, nutraceuticalnosubstrateDetailsDB11827Ertugliflozinapproved, investigationalnosubstrateDetailsDB13943Testosterone cypionateapprovedunknowninhibitorDetailsDB13944Testosterone enanthateapprovedunknowninhibitorDetailsDB13946Testosterone undecanoateapproved, investigationalunknowninhibitorDetailsDB09160Technetium Tc-99m tetrofosminapprovednobinderDetailsDB13951Stanolone acetateexperimentalunknownsubstrateDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateDetailsDB01420Testosterone propionateapproved, investigational, vet_approved, withdrawnnosubstrateDetailsDB11901Apalutamideapproved, investigationalunknowninducerDetailsDB11633Isavuconazoleapproved, investigationalunknowninhibitorDetailsDB11251Tocopherolapproved, investigationalnotransporterDetailsDB14003alpha-Tocopherol acetateapprovednosubstrateDetailsDB09099Somatostatinapproved, investigationalunknownsubstrateDetailsDB11635TocofersolanapprovedunknownantagonistDetailsDB11641Vinflunineapproved, investigationalnosubstrateDetailsDB11672Curcuminapproved, investigationalunknowninhibitorDetailsDB11995Avatrombopagapproved, investigationalunknownsubstrateDetailsDB09297Paritaprevirapproved, investigationalunknownsubstrateDetailsDB09183DasabuvirapprovedunknownsubstrateDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedunknownDetailsDB14062Concanamycin AexperimentalyesinhibitorDetailsDB14061HycanthoneexperimentalyesinhibitorDetailsDB14063DexverapamilexperimentalyesinhibitorDetailsDB14064EmopamilexperimentalyesinhibitorDetailsDB14065LomerizineexperimentalyesinhibitorDetailsDB14066TetrandrineexperimentalunknowninhibitorDetailsDB14067Dofequidarexperimental, investigationalunknowninhibitorDetailsDB14068DexniguldipineexperimentalunknowninhibitorDetailsDB14069ONT-093investigationalyesinhibitorDetailsDB14070HM-30181experimentalyesinhibitorDetailsDB14071DesmethylsertralineexperimentalunknowninhibitorDetailsDB14072Reversin 121experimentalyesinhibitorDetailsDB14146LoxicodegolinvestigationalunknownDetailsDB14538Hydrocortisone aceponateexperimental, vet_approvedunknownDetailsDB14539Hydrocortisone acetateapproved, vet_approvedunknownDetailsDB14540Hydrocortisone butyrateapproved, vet_approvedunknownDetailsDB14541Hydrocortisone cypionateapproved, investigational, vet_approvedunknownDetailsDB14542Hydrocortisone phosphateapproved, vet_approvedunknownDetailsDB14543Hydrocortisone probutateapproved, vet_approvedunknownDetailsDB14544Hydrocortisone valerateapproved, vet_approvedunknownDetailsDB14568Ivosidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB11979Elagolixapproved, investigationalunknownsubstrateinhibitorDetailsDB13867Fluticasoneapproved, experimentalnosubstrateDetailsDB00608Chloroquineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00613Amodiaquineapproved, investigationalunknowninhibitorDetailsDB01087PrimaquineapprovedunknowninhibitorDetailsDB01611HydroxychloroquineapprovedunknowninhibitorDetailsDB01267PaliperidoneapprovedunknownsubstrateinhibitorDetailsDB05928DovitinibinvestigationalunknowninhibitorDetailsDB13125Lusutrombopagapproved, investigationalunknownsubstrateDetailsDB14635Curcumin sulfateexperimentalunknownDetailsDB14641Estriol tripropionateexperimentalunknownDetailsDB11952Duvelisibapproved, investigationalnosubstrateDetailsDB09213Dexibuprofenapproved, investigationalunknownDetailsDB11760Talazoparibapproved, investigationalunknownsubstrateDetailsDB12455Omadacyclineapproved, investigationalunknownsubstrateDetailsDB12836Grapiprantinvestigational, vet_approvednosubstrateDetailsDB12035Sarecyclineapproved, investigationalunknowninhibitorDetailsDB11753Rifamycinapproved, investigationalnosubstrateinhibitorDetailsDB11963Dacomitinibapproved, investigationalnosubstrateinhibitorDetailsDB11855Revefenacinapproved, investigationalnosubstrateDetailsDB12141Gilteritinibapproved, investigationalnosubstrateDetailsDB14126Tenofovirexperimental, investigationalnosubstrateDetailsDB00300Tenofovir disoproxilapproved, investigationalunknownsubstrateinhibitorDetailsDB09299Tenofovir alafenamideapprovedunknownsubstrateDetailsDB01264DarunavirapprovedunknownsubstrateinhibitorinducerDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateinhibitorDetailsDB00862VardenafilapprovedunknownsubstrateinhibitorDetailsDB00776OxcarbazepineapprovedunknownsubstrateDetailsDB00248CabergolineapprovednosubstrateDetailsDB06480PrucaloprideapprovednosubstrateDetailsDB00734Risperidoneapproved, investigationalunknownsubstrateDetailsDB01117AtovaquoneapprovednoinhibitorDetailsDB00788Naproxenapproved, vet_approvednoinhibitorDetailsDB00615Rifabutinapproved, investigationalunknowninducerDetailsDB12582PiperineinvestigationalunknowninhibitorDetailsDB11978Glasdegibapproved, investigationalnosubstrateinhibitorDetailsDB09074OlaparibapprovednosubstrateinhibitorDetailsDB00243Ranolazineapproved, investigationalnosubstrateinhibitorDetailsDB00321AmitriptylineapprovedunknownsubstrateDetailsDB00341CetirizineapprovednosubstrateinhibitorDetailsDB09073Palbociclibapproved, investigationalnosubstrateinhibitorDetailsDB01079Tegaserodapproved, investigational, withdrawnunknownsubstrateDetailsDB13867Fluticasoneapproved, experimentalunknownsubstrateDetailsDB12147Erdafitinibapproved, investigationalnosubstrateinhibitorDetailsDB00736Esomeprazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00476DuloxetineapprovedunknowninhibitorDetailsDB00481Raloxifeneapproved, investigationalunknownsubstrateDetailsDB12015Alpelisibapproved, investigationalunknowninhibitorDetailsDB11712Tezacaftorapproved, investigationalnosubstrateinhibitorDetailsDB00768OlopatadineapprovednosubstrateDetailsDB00698Nitrofurantoinapproved, vet_approvedunknownsubstrateDetailsDB00451LevothyroxineapprovednoinducerDetailsDB00394Beclomethasone dipropionateapproved, investigationalunknownsubstrateinducerDetailsDB00612BisoprololapprovedunknownsubstrateinhibitorDetailsDB00916MetronidazoleapprovedunknowninhibitorDetailsDB00482Celecoxibapproved, investigationalunknownsubstrateDetailsDB11986Entrectinibapproved, investigationalunknownsubstrateinhibitorDetailsDB12500Fedratinibapproved, investigationalunknownsubstrateinhibitorDetailsDB12825Lefamulinapproved, investigationalunknownsubstrateDetailsDB01222BudesonideapprovednosubstrateDetailsDB11757Istradefyllineapproved, investigationalunknowninhibitorDetailsDB01233Metoclopramideapproved, investigationalunknownsubstrateDetailsDB01175EscitalopramapprovedunknownsubstrateDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknowninhibitorDetailsDB01217Anastrozoleapproved, investigationalunknownsubstrateDetailsDB01195Flecainideapproved, withdrawnunknownsubstrateDetailsDB01418Acenocoumarolapproved, investigationalunknownsubstrateDetailsDB05676Apremilastapproved, investigationalunknownsubstrateDetailsDB11732Lasmiditanapproved, investigationalunknownsubstrateinhibitorDetailsDB11586Asunaprevirapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB15444Elexacaftorapproved, investigationalnosubstrateinhibitorDetailsDB15566Prednisolone acetateapproved, vet_approvedunknownsubstrateDetailsDB15035Zanubrutinibapproved, investigationalnosubstrateDetailsDB00273TopiramateapprovedunknownsubstrateDetailsDB09237Levamlodipineapproved, investigationalunknownsubstrateDetailsDB14962Trastuzumab deruxtecanapproved, investigationalnosubstrateDetailsDB13007Enfortumab vedotinapproved, investigationalunknownsubstrateDetailsDB11951Lemborexantapproved, investigationalunknownsubstrateDetailsDB12941Darolutamideapproved, investigationalunknownsubstrateDetailsDB15091Upadacitinibapproved, investigationalnosubstrateinhibitorDetailsDB15328Ubrogepantapproved, investigationalunknownsubstrateDetailsDB15233Avapritinibapproved, investigationalunknowninhibitormodulatorDetailsDB00993AzathioprineapprovedunknownsubstrateDetailsDB00557HydroxyzineapprovedunknownsubstrateDetailsDB11077Polyethylene glycol 400approvedunknowninhibitorDetailsDB12887Tazemetostatapproved, investigationalunknownsubstrateDetailsDB01006Letrozoleapproved, investigationalunknownsubstrateDetailsDB00246ZiprasidoneapprovedunknownDetailsDB01190Clindamycinapproved, vet_approvedunknownsubstrateDetailsDB09287Polyethylene glycolapproved, vet_approvednoinhibitorDetailsDB00957Norgestimateapproved, investigationalunknowninhibitorDetailsDB11770TalinololinvestigationalunknownsubstrateDetailsDB04881ElacridarinvestigationalunknowninhibitorDetailsDB00932Tipranavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB11869ValspodarinvestigationalunknowninhibitorDetailsDB00518Albendazoleapproved, vet_approvednosubstrateDetailsDB05239Cobimetinibapproved, investigationalnosubstrateDetailsDB06670OdanacatibinvestigationalunknownsubstrateDetailsDB04877VoacamineexperimentalnoinhibitorDetailsDB08930DolutegravirapprovednosubstrateDetailsDB00586Diclofenacapproved, vet_approvedunknowninducerDetailsDB11817Baricitinibapproved, investigationalunknownsubstrateDetailsDB11363Alectinibapproved, investigationalunknowninhibitorDetailsDB14723Larotrectinibapproved, investigationalunknownsubstrateDetailsDB00588Fluticasone propionateapprovedunknownsubstrateDetailsDB11430Monensinexperimental, vet_approvedunknownsubstrateDetailsDB03825Rhodamine 6GexperimentalunknownsubstrateDetailsDB09239NiguldipineexperimentalunknowninhibitorDetailsDB04851BiricodarinvestigationalunknowninhibitorDetailsDB06240TariquidarinvestigationalunknowninhibitorDetailsDB12799LaniquidarinvestigationalunknowninhibitorDetailsDB12923GallopamilinvestigationalunknowninhibitorDetailsDB06420AnnamycininvestigationalunknownDetailsDB00540NortriptylineapprovedunknownsubstrateDetailsDB00454MeperidineapprovedunknownsubstrateDetailsDB00652Pentazocineapproved, vet_approvedunknownsubstrateDetailsDB00818Propofolapproved, investigational, vet_approvedunknowninducerDetailsDB01590EverolimusapprovedunknownsubstrateinhibitorDetailsDB01212CeftriaxoneapprovedunknowninhibitorDetailsDB00872Conivaptanapproved, investigationalunknowninhibitorDetailsDB11544Salinomycinvet_approvedunknowninhibitorDetailsDB00909Zonisamideapproved, investigationalunknowninhibitorDetailsDB14057ValinomycinexperimentalunknownsubstrateinhibitorDetailsDB04908Flibanserinapproved, investigationalunknowninhibitorDetailsDB09039Eliglustatapproved, investigationalnosubstrateinhibitorDetailsDB01128BicalutamideapprovedunknowninhibitorDetailsDB00648MitotaneapprovedunknowninhibitorDetailsDB06448Lonafarnibapproved, investigationalnosubstrateinhibitorDetailsDB04960TipifarnibinvestigationalunknowninhibitorDetailsDB09048Netupitantapproved, investigationalunknowninhibitorDetailsDB09034Suvorexantapproved, investigationalunknownDetailsDB09030VorapaxarapprovedunknownDetailsDB05294VandetanibapprovedunknowninhibitorDetailsDB14062Concanamycin AexperimentalunknowninhibitorDetailsDB14061HycanthoneexperimentalunknowninhibitorDetailsDB08881VemurafenibapprovedunknownsubstrateinhibitorDetailsDB14063DexverapamilexperimentalunknowninhibitorDetailsDB14064EmopamilexperimentalunknowninhibitorDetailsDB14065LomerizineexperimentalunknowninhibitorDetailsDB14066TetrandrineexperimentalunknowninhibitorDetailsDB14069ONT-093investigationalunknowninhibitorDetailsDB14067Dofequidarexperimental, investigationalunknowninhibitorDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknowninhibitorDetailsDB12457Rimegepantapproved, investigationalunknownsubstrateDetailsDB12466Favipiravirapproved, investigationalunknowninhibitorDetailsDB00253MedrysoneapprovedunknownsubstrateDetailsDB09241Methylene blueapproved, investigationalunknownsubstrateinhibitorDetailsDB12612Ozanimodapproved, investigationalunknownsubstrateDetailsDB08868Fingolimodapproved, investigationalnoinhibitorDetailsDB07565Chloramphenicol succinateapprovedunknownsubstrateDetailsDB11689Selumetinibapproved, investigationalunknownsubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknownsubstrateinducerDetailsDB11652Tucatinibapproved, investigationalunknownsubstrateDetailsDB15102Pemigatinibapproved, investigationalnosubstrateinhibitorDetailsDB00315Zolmitriptanapproved, investigationalnoDetailsDB14761Remdesivirapproved, investigationalunknownsubstrateDetailsDB11791Capmatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB04845Ixabepiloneapproved, investigationalunknownsubstrateinhibitorDetailsDB15685Selpercatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB14840RipretinibapprovedunknownsubstrateinhibitorDetailsDB00845Clofazimineapproved, investigationalunknownsubstrateinhibitorDetailsDB09038EmpagliflozinapprovedunknownsubstrateDetailsDB06419CethromycininvestigationalunknownsubstrateinhibitorDetailsDB00674GalantamineapprovednoinhibitorDetailsDB09026Aliskirenapproved, investigationalnosubstrateDetailsDB09274Artesunateapproved, investigationalunknownsubstrateDetailsDB00188Bortezomibapproved, investigationalnosubstrateDetailsDB14669Betamethasone phosphateapproved, vet_approvedunknownsubstrateinducerDetailsDB12674Lurbinectedinapproved, investigationalunknownsubstrateinhibitorDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00104Octreotideapproved, investigationalunknownsubstrateDetailsDB11796Fostemsavirapproved, investigationalunknownsubstrateDetailsDB15719Belantamab mafodotinapprovedunknownsubstrateDetailsDB15305Risdiplamapproved, investigationalunknownsubstrateDetailsDB15822Pralsetinibapproved, investigationalnosubstrateinhibitorDetailsDB14845Filgotinibapproved, investigationalunknownsubstrateDetailsDB15982BerotralstatapprovednosubstrateinhibitorDetailsDB11853Relugolixapproved, investigationalunknownsubstrateinhibitorDetailsDB14895Vibegronapproved, investigationalnosubstrateDetailsDB01380Cortisone acetateapproved, investigationalunknownsubstrateinducerDetailsDB11632Opicaponeapproved, investigationalnosubstrateDetailsDB15456Vericiguatapproved, investigationalunknownsubstrateDetailsDB11751Cabotegravirapproved, investigationalunknownsubstrateDetailsDB11693Voclosporinapproved, investigationalunknownsubstrateinhibitorDetailsDB15133Tepotinibapproved, investigationalnosubstrateinhibitorDetailsDB00052Somatotropinapproved, investigationalunknownsubstrateDetailsDB00346Alfuzosinapproved, investigationalunknownsubstrateDetailsDB15442Trilaciclibapproved, investigationalunknownsubstrateDetailsDB14989Umbralisibapproved, investigational, withdrawnunknowninhibitorDetailsDB00391Sulpirideapproved, investigationalunknownsubstrateDetailsDB00853Temozolomideapproved, investigationalnosubstrateDetailsDB06237AvanafilapprovedunknownsubstrateDetailsDB11800Tivozanibapproved, investigationalunknownsubstrateDetailsDB00080Daptomycinapproved, investigationalnosubstrateDetailsDB06288Amisulprideapproved, investigationalnosubstrateDetailsDB08995Diosminapproved, investigationalunknowninhibitorDetailsDB04876Vildagliptinapproved, investigationalnosubstrateDetailsDB08822Azilsartan medoxomilapproved, investigationalnoinhibitorDetailsDB00360Sapropterinapproved, investigationalunknowninhibitorDetailsDB05667Levoketoconazoleapproved, investigationalnoinhibitorDetailsDB16222Loncastuximab tesirineapproved, investigationalunknownsubstrateDetailsDB15569Sotorasibapproved, investigationalunknowninhibitorDetailsDB11886Infigratinibapproved, investigationalnosubstrateinhibitorDetailsDB12471Ibrexafungerpapproved, investigationalunknownsubstratetransporterDetailsDB16703Belumosudilapproved, investigationalnosubstrateinhibitorDetailsDB16261Odevixibatapproved, investigationalunknownsubstrateDetailsDB15463Belzutifanapproved, investigationalnosubstrateDetailsDB16220Lonapegsomatropinapproved, investigationalunknownsubstrateDetailsDB16390Mobocertinibapproved, investigationalunknownsubstrateinhibitorDetailsDB16732Tisotumab vedotinapprovednosubstrateDetailsDB16098Atogepantapproved, investigationalnosubstrateDetailsDB08931RiociguatapprovednosubstrateDetailsDB15011Avacopanapproved, investigationalnosubstrateDetailsDB12597Asciminibapproved, investigationalnosubstrateinhibitorDetailsDB06234Maribavirapproved, investigationalnoinhibitorDetailsDB16691Nirmatrelvirapproved, investigationalnosubstrateinhibitorDetailsDB12713Sotagliflozinapproved, investigationalnoinhibitorDetailsDB14973Abrocitinibapproved, investigationalunknowninhibitorDetailsDB16236Mitapivatapproved, investigationalnosubstrateinhibitorDetailsDB09061Cannabidiolapproved, investigationalnoinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknowninhibitorDetailsDB14009Medical Cannabisexperimental, investigationalunknowninhibitorDetailsDB11697Pacritinibapproved, investigationalnoinhibitorDetailsDB06016Cariprazineapproved, investigationalunknowninhibitorDetailsDB16407AzvudineinvestigationalunknownactivatorregulatorDetailsDB12541SAR-405838investigationalnosubstrateDetailsDB00661VerapamilapprovedunknowninhibitorblockerDetailsDB09118StiripentolapprovedunknowninhibitorDetailsDB04951Pirfenidoneapproved, investigationalunknowninhibitorDetailsDB13997Baloxavir marboxilapproved, investigationalunknownsubstrateinhibitorDetailsDB15673Lenacapavirapproved, investigationalnosubstrateDetailsDB16650Deucravacitinibapproved, investigationalunknownsubstrateDetailsDB12095Telotristat ethylapproved, investigationalnosubstrateinhibitorDetailsDB15149Futibatinibapproved, investigationalnosubstrateinhibitorDetailsDB11739Vonoprazanapproved, investigationalunknowninhibitorDetailsDB11793Niraparibapproved, investigationalnosubstrateDetailsDB12489Mirvetuximab soravtansineapproved, investigationalnosubstrateDetailsDB16267Olutasidenibapproved, investigationalnoinhibitorDetailsDB12240Polatuzumab vedotinapproved, investigationalnosubstrateDetailsDB15568Adagrasibapproved, investigationalunknowninhibitorDetailsDB12236Bexagliflozinapproved, investigationalunknownsubstrateDetailsDB17472Pirtobrutinibapproved, investigationalunknownsubstrateinhibitorDetailsDB06374Elacestrantapproved, investigationalunknowninhibitorDetailsDB00683Midazolamapproved, illicitnosubstrateDetailsDB12548Sparsentanapproved, investigationalunknownsubstrateinhibitorDetailsDB15688Zavegepantapproved, investigationalunknownsubstrateDetailsDB16217Leniolisibapproved, investigationalnosubstrateDetailsDB01238Aripiprazoleapproved, investigationalunknowninhibitorDetailsDB09082VilanterolapprovednosubstrateDetailsDB12874Quizartinibapproved, investigationalnosubstrateinhibitorDetailsDB11763Momelotinibapproved, investigationalunknownsubstrateDetailsDB11718Encorafenibapproved, investigationalnosubstrateinhibitorDetailsDB15097Gefapixantapproved, investigationalnosubstrateDetailsDB11967Binimetinibapproved, investigationalnosubstrateDetailsDB16826RepotrectinibinvestigationalnosubstrateinhibitorDetails"
                    }
                }
            ]
        },
        "Disease Information": {
            "Chronic Pain": null,
            "Severe Pain": null
        }
    },
    "PENICILLIN": {
        "Active Ingredients": {
            "PENICILLIN G POTASSIUM": "CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.[K+]"
        },
        "Drug Information": {
            "Identification": {
                "Summary": "Benzylpenicillin is a penicillin used for the treatment of infections caused by gram-positive cocci, in particular streptococcal infections. This form of penicillin is typically used in intravenous or long-acting injectable formulations due to poor oral absorption.",
                "Brand Names": "Bicillin, Bicillin L-A, Pfizerpen",
                "Generic Name": "Benzylpenicillin",
                "DrugBank Accession Number": "DB01053",
                "Background": "Benzylpenicillin (Penicillin G) is narrow spectrum antibiotic used to treat infections caused by susceptible bacteria. It is a natural penicillin antibiotic that is administered intravenously or intramuscularly due to poor oral absorption. Penicillin G may also be used in some cases as prophylaxis against susceptible organisms.\nNatural penicillins are considered the drugs of choice for several infections caused by susceptible gram positive aerobic organisms, such as Streptococcus pneumoniae, groups A, B, C and G streptococci, nonenterococcal group D streptococci, viridans group streptococci, and non-penicillinase producing staphylococcus. Aminoglycosides may be added for synergy against group B streptococcus (S. agalactiae), S. viridans, and Enterococcus faecalis. The natural penicillins may also be used as first or second line agents against susceptible gram positive aerobic bacilli such as Bacillus anthracis, Corynebacterium diphtheriae, and Erysipelothrix rhusiopathiae. Natural penicillins have limited activity against gram negative organisms; however, they may be used in some cases to treat infections caused by Neisseria meningitidis and Pasteurella. They are not generally used to treat anaerobic infections. Resistance patterns, susceptibility and treatment guidelines vary across regions.",
                "Type": "Small Molecule",
                "Groups": "Approved, Vet approved",
                "Structure": "3DDownload MOLSDF3D-SDFPDBSMILESInChI\n\n\n Similar StructuresStructure for Benzylpenicillin (DB01053)\u00d7 Close",
                "Weight": "Average: 334.39 Monoisotopic: 334.098727764",
                "Chemical Formula": "C16H18N2O4S",
                "Synonyms": "(2S,5R,6R)-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid6-(2-phenylacetamido)penicillanic acidBencilpenicilinaBensylpenicillinBenzyl benicillinBenzylpenicillinBenzylp\u00e9nicillineBenzylpenicillinic acidBenzylpenicillinumFree penicillin IIPCGPenicillin GPG"
            },
            "Pharmacology": {
                "Indication": "For use in the treatment of severe infections caused by penicillin G-susceptible microorganisms when rapid and high penicillin levels are required such as in the treatment of septicemia, meningitis, pericarditis, endocarditis and severe pneumonia.\nReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See how",
                "Associated Conditions": "Actinomycosis\nAcute Rheumatic Fever\nAnthrax\nBloodstream Infections (BSI)\nClostridium Botulinum Toxin Adverse Reaction\nDiphtheria\nEmpyema\nEndocarditis\nEndocarditis caused by Erysipelothrix infections\nFusospirochetosis\nGas Gangrene\nGonococcal infections\nGram-Negative Bacterial Infections\nHaverhill fever\nListeria infection\nMeningitis\nMeningococcal Meningitis\nPasteurella infections\nPericarditis\nPneumonia\nSyphilis\nTetanus\nRat bite fever",
                "Contraindications & Blackbox Warnings": "Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events with our Clinical APILearn more",
                "Pharmacodynamics": "Penicillin G is a penicillin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. The name \"penicillin\" can either refer to several variants of penicillin available, or to the group of antibiotics derived from the penicillins. Penicillin G has in vitro activity against gram-positive and gram-negative aerobic and anaerobic bacteria. The bactericidal activity of penicillin G results from the inhibition of cell wall synthesis and is mediated through penicillin G binding to penicillin binding proteins (PBPs). Penicillin G is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases.",
                "Mechanism of action": "By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, penicillin G inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that penicillin G interferes with an autolysin inhibitor.\nTargetActionsOrganismUPenicillin-binding protein 3inhibitorStaphylococcus aureus (strain USA300)USolute carrier family 22 member 8substrateinhibitorHumansUSolute carrier family 15 member 1substrateinhibitorHumansUSolute carrier family 15 member 2inhibitorHumans",
                "Absorption": "Rapidly absorbed following both intramuscular and subcutaneous injection. Initial blood levels following parenteral administration are high but transient. Oral absorption in fasting, healthy humans is only about 15-30% as it is very susceptible to acid-catalyzed hydrolysis.",
                "Volume of distribution": "0.53\u20130.67 L/kg in adults with normal renal function",
                "Protein binding": "Bind to serum proteins (45-68%), mainly albumin.",
                "Metabolism": "About 16-30% of an intramuscular dose is metabolized to penicilloic acid, an inactive metabolite. Small amounts of 6-aminopenicillanic acid have been recovered in the urine of patients on penicillin G. A small percentage of the drug appears to be hydroxylated into one or more active metabolites, which are also excreted via urine.\nHover over products below to view reaction partnersBenzylpenicillin\n\n\n6-aminopenicillanic acid\n\n\nPenicilloic acid",
                "Route of elimination": "Penicillin G is eliminated by the kidneys. Nonrenal clearance includes hepatic metabolism and, to a lesser extent, biliary excretion.",
                "Half-life": "In adults with normal renal function is reportedly 0.4\u20130.9 hours",
                "Clearance": "560ml/min in healthy humans",
                "Adverse Effects": "Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support & research outcomes with our structured adverse effects data.See a data sample",
                "Toxicity": "Oral LD50 in rat is 8900 mg/kg MSDS. Neurological adverse reactions, including convulsions, may occur with the attainment of high CSF levels of beta-lactams. Neutropenia can occur if high doses are administered consistently for over 2 weeks.",
                "Pathways": "Not Available",
                "Pharmacogenomic Effects/ADRs": "Not Available"
            },
            "Interactions": {
                "Drug Interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. ApprovedVet approvedNutraceuticalIllicitWithdrawnInvestigationalExperimentalAll DrugsDrugInteractionIntegrate drug-drug interactions in your software\n\n\nAcamprosateThe excretion of Acamprosate can be decreased when combined with Benzylpenicillin.AcemetacinAcemetacin may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.AcenocoumarolBenzylpenicillin may increase the anticoagulant activities of Acenocoumarol.AcetazolamideAcetazolamide may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.Acetyl sulfisoxazoleAcetyl sulfisoxazole may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.AcetylcysteineThe excretion of Benzylpenicillin can be decreased when combined with Acetylcysteine.Acetylsalicylic acidThe excretion of Benzylpenicillin can be decreased when combined with Acetylsalicylic acid.AcyclovirThe excretion of Benzylpenicillin can be decreased when combined with Acyclovir.Adefovir dipivoxilThe excretion of Adefovir dipivoxil can be decreased when combined with Benzylpenicillin.AllopurinolThe excretion of Allopurinol can be decreased when combined with Benzylpenicillin.Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more",
                "Food Interactions": "No interactions found."
            },
            "Products": {
                "": "Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access now  Access drug product information from over 10 global regions.Access now",
                "Product Ingredients": "IngredientUNIICASInChI KeyBenethamine penicillinO3S7RWT8R5751-84-8JAQPGQYDZJZOIN-LQDWTQKMSA-NBenzathine benzylpenicillinSSZ1S4I0US1538-09-6BVGLIYRKPOITBQ-ANPZCEIESA-NBenzylpenicillin benzathine hydrateRIT82F58GK41372-02-5WIDKTXGNSOORHA-CJHXQPGBSA-NBenzylpenicillin calciumZ1GL5S1Z1Z973-53-5PEWXRXAGXPYMIB-ANPZCEIESA-LBenzylpenicillin potassiumVL775ZTH4C113-98-4IYNDLOXRXUOGIU-LQDWTQKMSA-MBenzylpenicillin sodiumYS5LY7JF4N69-57-8FCPVYOBCFFNJFS-LQDWTQKMSA-M",
                "International/Other Brands": "Pentids",
                "Brand Name Prescription Products": "NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImageBicillin L-AInjection, suspension2400000 [iU]/4mLIntramuscularPhysicians Total Care, Inc.1994-06-142011-06-30USBicillin L-AInjection, suspension600000 [iU]/1mLIntramuscularPfizer Laboratories Div Pfizer Inc1952-06-27Not applicableUSBicillin L-AInjection, suspension2400000 [iU]/4mLIntramuscularPfizer Laboratories Div Pfizer Inc1952-06-27Not applicableUSBicillin L-AInjection, suspension600000 [iU]/1mLIntramuscularPhysicians Total Care, Inc.2008-08-272012-06-30USBicillin L-AInjection, suspension600000 [iU]/1mLIntramuscularA-S Medication Solutions1952-06-272022-12-31USBicillin L-ASuspension1200000 unit / 2 mLIntramuscularPfizer Canada Ulc2008-06-11Not applicableCanadaBicillin L-AInjection, suspension1200000 [iU]/2mLIntramuscularRemedy Repack2015-04-062015-11-11USBicillin L-AInjection, suspension1200000 [iU]/2mLIntramuscularPfizer Laboratories Div Pfizer Inc1952-06-27Not applicableUSBicillin L-AInjection, suspension1200000 [iU]/2mLIntramuscularA-S Medication Solutions1952-06-27Not applicableUSBicillin L-AInjection, suspension1200000 [iU]/2mLIntramuscularA S Medication Solutions1952-06-27Not applicableUS",
                "Generic Prescription Products": "NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImageBuffered Penicillin G PotassiumInjection, powder, for solution5000000 [iU]/1Intramuscular; IntravenousHF Acquisition Co LLC, DBA HealthFirst2020-01-29Not applicableUSNovo-pen G 500Tablet500000 unitOralNovopharm Limited1966-12-312005-08-10CanadaPenicillin G PotassiumInjection, powder, for solution20000000 [iU]/1Intramuscular; IntravenousSandoz Inc2001-08-30Not applicableUSPenicillin G PotassiumInjection, powder, for solution5000000 [iU]/1Intramuscular; IntravenousAthenex Pharmaceutical Division, Llc.2019-05-21Not applicableUSPenicillin G PotassiumInjection, powder, for solution1000000 [iU]/1Intramuscular; IntravenousWG Critical Care, LLC2012-05-10Not applicableUSPenicillin G PotassiumInjection, powder, for solution5000000 [iU]/1Intramuscular; IntravenousSandoz Inc2001-08-30Not applicableUSPenicillin G PotassiumPowder, for solution20000000 [iU]/1IntravenousFresenius Kabi USA, LLC2009-09-012016-04-19USPenicillin G PotassiumInjection, powder, for solution20000000 [iU]/1IntravenousWG Critical Care, LLC2012-05-10Not applicableUSPenicillin G PotassiumInjection, powder, for solution20000000 [iU]/1IntravenousAthenex Pharmaceutical Division, Llc.2019-05-21Not applicableUSPenicillin G PotassiumPowder, for solution5000000 [iU]/1Intramuscular; Intrapleural; Intrathecal; IntravenousFresenius Kabi USA, LLC2009-09-012011-12-12US",
                "Mixture Products": "NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImageBENZAPEN 6.3.3 IM ENJ TOZ ICEREN FLAKON, 1 ADETBenzathine benzylpenicillin (600 IU) + Benzylpenicillin sodium (300 IU) + Procaine benzylpenicillin (300 IU)Injection; PowderIntramuscularT\u00dcM-EK\u0130P \u0130LA\u00c7 A.\u015e.2020-08-14Not applicableTurkeyBENZAPEN 6.3.3 IM ENJ TOZ ICEREN FLAKON, 1 ADETBenzathine benzylpenicillin (600 IU) + Benzylpenicillin sodium (300 IU) + Procaine benzylpenicillin (300 IU)Injection; PowderIntramuscularT\u00dcM-EK\u0130P \u0130LA\u00c7 A.\u015e.2020-08-14Not applicableTurkeyBicillin A-P Injection PwsBenzylpenicillin benzathine hydrate (600000 unit / 2 mL) + Benzylpenicillin potassium (300000 unit / 2 mL) + Procaine benzylpenicillin (300000 unit / 2 mL)Powder, for solutionIntramuscularWyeth Ayerst Canada Inc.1995-12-311996-09-10CanadaBicillin A-P Injection PwsBenzylpenicillin benzathine hydrate (600000 unit / 2 mL) + Benzylpenicillin potassium (300000 unit / 2 mL) + Procaine benzylpenicillin (300000 unit / 2 mL)Powder, for solutionIntramuscularWyeth Ayerst Canada Inc.1995-12-311996-09-10CanadaBicillin C-R 900/300Benzylpenicillin benzathine hydrate (900000 [iU]/2mL) + Procaine benzylpenicillin (300000 [iU]/2mL)Injection, suspensionIntramuscularPfizer Laboratories Div Pfizer Inc1953-05-18Not applicableUSBicillin CRBenzylpenicillin benzathine hydrate (600000 [iU]/2mL) + Procaine benzylpenicillin (600000 [iU]/2mL)Injection, suspensionIntramuscularPhysicians Total Care, Inc.2008-08-28Not applicableUSBicillin CRBenzylpenicillin benzathine hydrate (600000 [iU]/2mL) + Procaine benzylpenicillin (600000 [iU]/2mL)Injection, suspensionIntramuscularPfizer Laboratories Div Pfizer Inc1953-05-18Not applicableUSBicillin CRBenzylpenicillin benzathine hydrate (600000 [iU]/2mL) + Procaine benzylpenicillin (600000 [iU]/2mL)Injection, suspensionIntramuscularA-S Medication Solutions1953-05-18Not applicableUSBicillin CRBenzylpenicillin benzathine hydrate (600000 [iU]/2mL) + Procaine benzylpenicillin (600000 [iU]/2mL)Injection, suspensionIntramuscularPfizer Laboratories Div Pfizer Inc1953-05-18Not applicableUSBicillin CRBenzylpenicillin benzathine hydrate (600000 [iU]/2mL) + Procaine benzylpenicillin (600000 [iU]/2mL)Injection, suspensionIntramuscularDispensing Solutions, Inc.1953-05-18Not applicableUS"
            },
            "Categories": {
                "ATC Codes": "J01CR50 \u2014 Combinations of penicillinsJ01CR \u2014 Combinations of penicillins, incl. beta-lactamase inhibitorsJ01C \u2014 BETA-LACTAM ANTIBACTERIALS, PENICILLINSJ01 \u2014 ANTIBACTERIALS FOR SYSTEMIC USEJ \u2014 ANTIINFECTIVES FOR SYSTEMIC USEJ01CE01 \u2014 BenzylpenicillinJ01CE \u2014 Beta-lactamase sensitive penicillinsJ01C \u2014 BETA-LACTAM ANTIBACTERIALS, PENICILLINSJ01 \u2014 ANTIBACTERIALS FOR SYSTEMIC USEJ \u2014 ANTIINFECTIVES FOR SYSTEMIC USES01AA14 \u2014 BenzylpenicillinS01AA \u2014 AntibioticsS01A \u2014 ANTIINFECTIVESS01 \u2014 OPHTHALMOLOGICALSS \u2014 SENSORY ORGANSJ01CE08 \u2014 Benzathine benzylpenicillinJ01CE \u2014 Beta-lactamase sensitive penicillinsJ01C \u2014 BETA-LACTAM ANTIBACTERIALS, PENICILLINSJ01 \u2014 ANTIBACTERIALS FOR SYSTEMIC USEJ \u2014 ANTIINFECTIVES FOR SYSTEMIC USE",
                "Drug Categories": "Amides\nAnti-Bacterial Agents\nAnti-Infective Agents\nAntibacterials for Systemic Use\nAntiinfectives for Systemic Use\nBeta-Lactam Antibacterials\nBeta-Lactamase Sensitive Penicillins\nbeta-Lactams\nHeterocyclic Compounds, Fused-Ring\nLactams\nNatural Penicillins\nOAT1/SLC22A6 inhibitors\nOAT3/SLC22A8 Inhibitors\nOAT3/SLC22A8 Substrates\nOATP1B1/SLCO1B1 Substrates\nOATP2B1/SLCO2B1 substrates\nOphthalmologicals\nPenicillin G\nPenicillins\nSensory Organs\nSulfur Compounds",
                "Chemical TaxonomyProvided by Classyfire": "DescriptionThis compound belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond.KingdomOrganic compoundsSuper ClassOrganic acids and derivativesClassCarboxylic acids and derivativesSub ClassAmino acids, peptides, and analoguesDirect ParentDipeptidesAlternative ParentsPenicillins / N-acyl-alpha amino acids and derivatives / Phenylacetamides / Thiazolidines / Tertiary carboxylic acid amides / Azetidines / Secondary carboxylic acid amides / Azacyclic compounds / Thiohemiaminal derivatives / Carboxylic acids / Dialkylthioethers / Monocarboxylic acids and derivatives / Hydrocarbon derivatives / Carbonyl compounds / Organopnictogen compounds / Organic oxides / Organonitrogen compounds\n\n\n show 7 moreSubstituentsAlpha-amino acid or derivatives / Alpha-dipeptide / Aromatic heteropolycyclic compound / Azacycle / Azetidine / Benzenoid / Beta-lactam / Carbonyl group / Carboxamide group / Carboxylic acid / Dialkylthioether / Hemithioaminal / Hydrocarbon derivative / Lactam / Monocarboxylic acid or derivatives / Monocyclic benzene moiety / N-acyl-alpha amino acid or derivatives / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organoheterocyclic compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Penam / Penicillin / Phenylacetamide / Secondary carboxylic acid amide / Tertiary carboxylic acid amide / Thiazolidine / Thioether\n\n\n show 21 moreMolecular FrameworkAromatic heteropolycyclic compoundsExternal Descriptorspenicillin (CHEBI:18208)  / penams (C05551)",
                "Description": "This compound belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond.",
                "Kingdom": "Organic compounds",
                "Super Class": "Organic acids and derivatives",
                "Class": "Carboxylic acids and derivatives",
                "Sub Class": "Amino acids, peptides, and analogues",
                "Direct Parent": "Dipeptides",
                "Alternative Parents": "Penicillins / N-acyl-alpha amino acids and derivatives / Phenylacetamides / Thiazolidines / Tertiary carboxylic acid amides / Azetidines / Secondary carboxylic acid amides / Azacyclic compounds / Thiohemiaminal derivatives / Carboxylic acids / Dialkylthioethers / Monocarboxylic acids and derivatives / Hydrocarbon derivatives / Carbonyl compounds / Organopnictogen compounds / Organic oxides / Organonitrogen compounds\n\n\n show 7 more",
                "Substituents": "Alpha-amino acid or derivatives / Alpha-dipeptide / Aromatic heteropolycyclic compound / Azacycle / Azetidine / Benzenoid / Beta-lactam / Carbonyl group / Carboxamide group / Carboxylic acid / Dialkylthioether / Hemithioaminal / Hydrocarbon derivative / Lactam / Monocarboxylic acid or derivatives / Monocyclic benzene moiety / N-acyl-alpha amino acid or derivatives / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organoheterocyclic compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Penam / Penicillin / Phenylacetamide / Secondary carboxylic acid amide / Tertiary carboxylic acid amide / Thiazolidine / Thioether\n\n\n show 21 more",
                "Molecular Framework": "Aromatic heteropolycyclic compounds",
                "External Descriptors": "penicillin (CHEBI:18208)  / penams (C05551)",
                "Affected organisms": "Enteric bacteria and other eubacteria\nStreptococcus pyogenes\nStaphylococcus aureus\nStaphylococcus epidermidis"
            },
            "Chemical Identifiers": {
                "UNII": "Q42T66VG0C",
                "CAS number": "61-33-6",
                "InChI Key": "JGSARLDLIJGVTE-MBNYWOFBSA-N",
                "InChI": "InChI=1S/C16H18N2O4S/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1",
                "IUPAC Name": "(2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",
                "SMILES": "[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O"
            },
            "References": {
                "Synthesis Reference": "Gunter Schumacher, Peter Buckel, \"Plasmids for the increased production of penicillin G amidase.\" U.S. Patent US5053335, issued May, 1984.\nUS5053335",
                "General References": "Eagle H, Newman E, Musselman AD, Robinson M, Birmingham M: THE RENAL CLEARANCE OF PENICILLINS F, G, K, AND X IN RABBITS AND MAN. J Clin Invest. 1947 Sep;26(5):903-18. [Article] article [Link] Webmd [Link] monograph [Link] FDA Approved Drug Products: Penicillin G Potassium Intravenous Injection [Link] FDA Approved Drug Products: Penicillin G Sodium Intravenous Injection [Link]",
                "External Links": "Human Metabolome DatabaseHMDB0015186KEGG DrugD02336KEGG CompoundC05551PubChem Compound5904PubChem Substance46506778ChemSpider5693BindingDB50022787RxNav7980ChEBI18208ChEMBLCHEMBL29ZINCZINC000003871701Therapeutic Targets DatabaseDNC001109PharmGKBPA450842PDBe LigandPNNRxListRxList Drug PageWikipediaBenzylpenicillin",
                "Human Metabolome Database": "HMDB0015186",
                "KEGG Drug": "D02336",
                "KEGG Compound": "C05551",
                "PubChem Compound": "5904",
                "PubChem Substance": "46506778",
                "ChemSpider": "5693",
                "BindingDB": "50022787",
                "RxNav": "7980",
                "ChEBI": "18208",
                "ChEMBL": "CHEMBL29",
                "ZINC": "ZINC000003871701",
                "Therapeutic Targets Database": "DNC001109",
                "PharmGKB": "PA450842",
                "PDBe Ligand": "PNN",
                "RxList": "RxList Drug Page",
                "Wikipedia": "Benzylpenicillin",
                "PDB Entries": "1fxv / 1gm7 / 1uob / 1uof / 3huo / 3kp2 / 5kmw",
                "MSDS": "Download (47.7 KB)"
            },
            "Clinical Trials": {
                "Clinical Trials": "PhaseStatusPurposeConditionsCount4CompletedDiagnosticPenicillin Allergy14CompletedTreatmentAcute Kidney Injury (AKI) / Neurologic toxicity / Sepsis14CompletedTreatmentBorreliosis / Early Lyme Disease / Erythema Chronicum Migrans / Lyme Disease14CompletedTreatmentInfant Bacterial Meningitis14CompletedTreatmentSyphilis24Not Yet RecruitingTreatmentBone and Joint Infections / Endovascular Infection / Gastrointestinal Tract Infections / Genitourinary tract infection / Pulmonary Infections / Skin and Soft Tissue Infections (SSTIs)14RecruitingDiagnosticPenicillin Allergy / Penicillin Reaction14RecruitingTreatmentBacteremia caused by Staphylococcus Aureus14RecruitingTreatmentComplicated Urinary Tract Infection / Infection / Pediatric Infectious Diseases14RecruitingTreatmentEarly Syphilis1"
            },
            "Pharmacoeconomics": {
                "Manufacturers": "Not Available",
                "Packagers": "APP Pharmaceuticals\nBaxter International Inc.\nC.O. Truxton Inc.\nKing Pharmaceuticals Inc.\nPfizer Inc.\nPhysicians Total Care Inc.\nSandoz",
                "Dosage Forms": "FormRouteStrengthInjection, powder, for solutionIntramuscularInjection; powderIntramuscularInjection1200.000 iuInjectionInjection2400.000 iuInjection, powder, for solutionInjection, solutionInjection, powder, for solution1000.000 UI/4MLInjection, powder, for solution1000.000 UIInjection, powder, for solutionIntramuscular; Intravenous0.6 gInjection, powder, for solutionIntramuscular; Intravenous3 gPowder, for solutionIntramuscularInjection, suspensionIntramuscularInjection, suspensionIntramuscular1200000 [iU]/2mLInjection, suspensionIntramuscular2400000 [iU]/4mLInjection, suspensionIntramuscular600000 [iU]/1mLSuspensionIntramuscular1200000 unit / 2 mLPowderIntramuscular2400000 IUPowderIntramuscular600000 IUInjection, solutionIntramuscularTabletOralInjection, powder, for solutionIntramuscularInjection, solutionIntramuscular; Intravenous1000.000 i.u.Injection, solutionIntramuscular; Intravenous1000.000 iuInjection, solutionIntramuscular; Intravenous500000 iuInjection, powder, for suspensionParenteral2400000 IUInjection, powder, for suspensionParenteral12000000 IUSuspensionOral250000 unit / 5 mLSuspensionOral500000 unit / 5 mLTabletOral500000 unit / tabTabletOral500000 unitInjection, powder, for solution5000000 IUInjection, powder, for solutionParenteral1200000 IUInjection, powder, for suspensionIntramuscular1200000 IUInjection, powder, for suspensionParenteral1200000 IUInjection, powder, for suspensionIntramuscular120000 IUInjection, powder, for suspensionIntramuscular240000 IUInjection, powder, for suspensionIntramuscular2.4 million IUInjection, powder, for suspensionIntramuscular2015 mgInjection, powder, for solutionIntramuscular100000 IUInjection, powder, for suspensionIntramuscular2400000 IUInjection, powder, for solutionParenteral5000000 IUInjection, powder, for solutionIntramuscular; Intravenous5000000 IUInjection, powder, for suspensionOral120000 IUInjection, powder, for solutionIntramuscular; Intravenous1000000 [iU]/1Injection, powder, for solutionIntramuscular; Intravenous20000000 [iU]/1Injection, powder, for solutionIntramuscular; Intravenous5000000 [iU]/1Injection, powder, for solutionIntravenous20000000 [iU]/1Injection, solutionIntravenous1000000 [iU]/50mLInjection, solutionIntravenous2000000 [iU]/50mLInjection, solutionIntravenous3000000 [iU]/50mLPowder, for solutionIntravenous10000000 unit / vialPowder, for solutionIntramuscular; Intravenous1000000 unit / vialPowder, for solutionIntramuscular; Intravenous; Topical5000000 unit / vialInjection, powder, for solutionIntramuscular; Intravenous5000000 [USP'U]/1Powder, for solutionIntramuscular; Intravenous10000000 unit / vialPowder, for solutionIntramuscular; Intravenous5000000 unit / vialPowder, for solutionIntramuscular; Intravenous; Topical10000000 unit / vialPowder, for solutionIntramuscular; Intravenous; Topical1000000 unit / vialInjection, powder, for solutionIntramuscular; Intravenous5,000,000 IU/vialInjection, powder, for solutionIntramuscular; Intravenous1000000 IUInjection, powder, for solutionIntramuscular; Intravenous10000000 IUInjection, powder, for solutionParenteralInjectionIntravenous500000 IUInjectionIntravenous1000000 IUInjectionIntramuscular; Intravenous1000.000 iuInjectionIntramuscular; IntravenousPowder, for solutionIntramuscular; Intrapleural; Intrathecal; Intravenous5000000 [iU]/1Powder, for solutionIntravenous20000000 [iU]/1Injection, powder, for solutionIntramuscular; Intravenous1 million IUInjectionIntramuscularInjection, powder, for suspensionParenteralInjectionIntramuscular; Intravenous1000000 IUInjectionIntramuscular; Intravenous500000 IUInjection, powder, for suspensionIntramuscular1200000 IU/4MLInjection, powder, for suspensionIntramuscular600000 UI/2.5MLInjection, suspensionIntramuscular1200000 IU/2.5MLPowderIntramuscular1200000 IUPowderIntramuscular600000 UIPowderIntramuscular1.2 MU/1vial",
                "Prices": "Unit descriptionCostUnitPenicillin gk 20 million unit160.26USD eachPenicillin g na 5 million unit47.91USD eachBicillin C-R (1200000) 2ml Syringe43.0USD syringePenicillin g k 5 million unit42.18USD eachPfizerpen 20 million unit vial23.41USD vialPenicillin G Sodium 10000000 iu/vial9.35USD vialPfizerpen 5 million unit vial7.99USD vialPenicillin G Sodium 5000000 iu/vial5.36USD vialPenicillin G Sodium 1000000 iu/vial2.52USD vialPen g k 3 million unit/50 ml0.27USD mlPen g k 2 million unit/50 ml0.26USD mlPen g k 1 million unit/50 ml0.25USD ml  DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.",
                "Patents": "Not Available"
            },
            "Properties": {
                "State": "Solid",
                "Experimental Properties": "PropertyValueSourcemelting point (\u00b0C)214-217 \u00b0CNot Availablewater solubilitySlightly soluble (210 mg/L)Not AvailablelogP1.83HANSCH,C ET AL. (1995)pKa2.74 (at 25 \u00b0C)MERCK INDEX (1996)",
                "Predicted Properties": "PropertyValueSourceWater Solubility0.285 mg/mLALOGPSlogP1.92ALOGPSlogP1.08ChemaxonlogS-3.1ALOGPSpKa (Strongest Acidic)3.53ChemaxonpKa (Strongest Basic)-2.8ChemaxonPhysiological Charge-1ChemaxonHydrogen Acceptor Count4ChemaxonHydrogen Donor Count2ChemaxonPolar Surface Area86.71 \u00c52ChemaxonRotatable Bond Count4ChemaxonRefractivity84.53 m3\u00b7mol-1ChemaxonPolarizability33.53 \u00c53ChemaxonNumber of Rings3ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxon",
                "Predicted ADMET Features": "PropertyValueProbabilityHuman Intestinal Absorption-0.9059Blood Brain Barrier-0.9954Caco-2 permeable-0.8956P-glycoprotein substrateSubstrate0.6253P-glycoprotein inhibitor INon-inhibitor0.9374P-glycoprotein inhibitor IINon-inhibitor0.9905Renal organic cation transporterNon-inhibitor0.9485CYP450 2C9 substrateNon-substrate0.7694CYP450 2D6 substrateNon-substrate0.845CYP450 3A4 substrateNon-substrate0.5133CYP450 1A2 substrateNon-inhibitor0.9046CYP450 2C9 inhibitorNon-inhibitor0.9187CYP450 2D6 inhibitorNon-inhibitor0.9295CYP450 2C19 inhibitorNon-inhibitor0.9026CYP450 3A4 inhibitorNon-inhibitor0.8802CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.96Ames testNon AMES toxic0.9193CarcinogenicityNon-carcinogens0.6267BiodegradationNot ready biodegradable0.989Rat acute toxicity1.6523 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9993hERG inhibition (predictor II)Non-inhibitor0.9223  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)"
            },
            "Spectra": {
                "Mass Spec (NIST)": "Not Available",
                "Spectra": "SpectrumSpectrum TypeSplash KeyPredicted GC-MS Spectrum - GC-MSPredicted GC-MSNot AvailablePredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available"
            },
            "Interested in using DrugBank in a commercial product or application?": {},
            "Stay up-to-date with the latest from DrugBank!": {},
            "Thank you for subscribing!": {}
        },
        "Additional Information": {
            "targets": [
                {
                    "Label": "Penicillin-binding protein 3",
                    "Detailed Info": {
                        "Name": "Penicillin-binding protein 3",
                        "Synonyms": "Not Available",
                        "Gene Name": "pbp3",
                        "Organism": "Staphylococcus aureus (strain USA300)",
                        "Amino acid sequence": ">lcl|BSEQ0009573|Penicillin-binding protein 3\nMLKRLKEKSNDEIVQNTINKRINFIFGVIIFIFAVLVLRLGYLQIAQGSHYKQIIKNDEN\nITVNESVPRGRILDRNGKVLVDNASKMAITYTRGRKTTQSEMLDTAEKLSKLIKMDTKKI\nTERDKKDFWIQLHPKKAKAMMTKEQAMLADGSIKQDQYDKQLLSKIGKSQLDELSSKDLQ\nVLAIFREMNAGTVLDPQMIKNEDVSEKEYAAVSQQLSKLPGVNTSMDWDRKYPYGDTLRG\nIFGDVSTPAEGIPKELTEHYLSKGYSRNDRVGKSYLEYQYEDVLRGKKKEMKYTTDKSGK\nVTSSEVLNPGARGQDLKLTIDIDLQKEVEALLDKQIKKLRSQGAKDMDNAMMVVQNPKNG\nDILALAGKQINKSGKMTDYDIGTFTSQFAVGSSVKGGTLLAGYQNKAIKVGETMVDEPLH\nFQGGLTKRSYFNKNGHVTINDKQALMHSSNVYMFKTALKLAGDPYYSGMALPSDISSPAQ\nKLRRGLNQVGLGVKTGIDLPNETRGQIEPLTNNPGNYLDLSIGQYDTYTPLQLSQYVSTI\nANDGYRIQPHIGLTIHESTNKDEVGPLKKKINGTVLNKVNNTEKEIKQIQEGFKMAFNDK\nDGTGYVSFKDTVVPTAGKTGTAEVFQNGEPRVNSTYIGYAPIDDPKLAFSIVYTNQPVPP\nPWLTGGDLGRDVINYYFKQLGKNDKNKDKDK",
                        "Number of residues": "691",
                        "Molecular Weight": "77250.74",
                        "Theoretical pI": "Not Available",
                        "GO Classification": "Functionspenicillin bindingComponentsintegral component of membrane",
                        "General Function": "Not Available",
                        "Specific Function": "Penicillin binding",
                        "Pfam Domain Function": "PBP_dimer (PF03717)\nTranspeptidase (PF00905)",
                        "Transmembrane Regions": "21-42",
                        "Cellular Location": "Not Available",
                        "Gene sequence": ">lcl|BSEQ0049973|Penicillin-binding protein 3 (pbp3)\nTTGTTAAAAAGACTAAAAGAAAAATCAAATGATGAAATCGTTCAAAATACAATTAACAAG\nAGAATTAACTTTATATTTGGTGTGATTATATTTATTTTTGCAGTACTAGTACTACGTTTA\nGGTTATTTACAAATCGCACAAGGCTCACATTATAAACAAATTATAAAAAATGATGAAAAC\nATTACAGTGAATGAGTCTGTGCCAAGAGGTCGTATTTTAGACAGAAATGGGAAAGTTTTA\nGTTGATAATGCTTCTAAAATGGCTATTACATATACTAGGGGTCGAAAAACAACACAATCG\nGAAATGTTGGATACGGCTGAAAAGTTATCAAAGCTAATCAAGATGGATACTAAGAAAATT\nACAGAACGTGATAAGAAAGATTTCTGGATTCAGTTGCATCCTAAAAAAGCAAAAGCAATG\nATGACAAAAGAACAAGCTATGTTAGCAGATGGAAGTATTAAACAAGATCAATATGATAAA\nCAACTGTTATCGAAAATCGGAAAATCACAATTAGATGAATTGTCTTCTAAAGATTTACAA\nGTTTTAGCTATTTTTCGAGAGATGAATGCAGGAACAGTTTTAGATCCACAAATGATAAAA\nAATGAAGATGTCAGTGAAAAAGAGTATGCAGCAGTTTCTCAGCAACTTTCCAAATTACCA\nGGTGTTAACACGTCTATGGATTGGGATAGAAAATATCCATATGGCGATACTTTAAGAGGT\nATATTCGGAGATGTATCGACACCTGCTGAAGGTATTCCAAAAGAATTGACAGAACATTAC\nTTATCCAAAGGATATTCACGCAATGATCGTGTTGGAAAATCTTACCTAGAATATCAATAT\nGAAGATGTATTGCGTGGTAAGAAGAAAGAAATGAAATACACAACGGACAAATCTGGTAAA\nGTTACATCTTCAGAAGTGTTAAATCCTGGCGCTCGCGGTCAAGATTTGAAATTAACGATC\nGATATAGATCTTCAAAAAGAAGTAGAAGCATTATTAGATAAACAAATTAAGAAGCTTCGC\nAGTCAAGGTGCCAAAGATATGGATAATGCAATGATGGTTGTACAAAATCCTAAAAATGGA\nGACATTCTTGCGCTTGCCGGAAAGCAGATTAATAAGAGTGGTAAAATGACTGATTATGAC\nATTGGTACGTTTACTTCTCAATTTGCGGTTGGATCTTCTGTAAAAGGTGGAACATTATTA\nGCCGGTTATCAGAATAAAGCTATCAAAGTTGGAGAAACAATGGTCGATGAACCATTACAT\nTTCCAAGGTGGTTTGACAAAACGATCATACTTCAATAAAAACGGGCATGTAACTATTAAT\nGATAAGCAAGCTTTGATGCATTCATCAAACGTATATATGTTTAAAACAGCATTAAAATTA\nGCGGGAGACCCTTATTATTCTGGTATGGCTTTACCTTCAGACATAAGTTCACCTGCCCAA\nAAGCTAAGAAGAGGATTAAATCAAGTAGGCTTAGGTGTGAAAACAGGGATAGATTTACCA\nAATGAAACAAGAGGTCAAATCGAACCATTAACAAATAATCCAGGTAATTATCTAGATTTA\nTCAATTGGTCAATATGATACCTATACACCATTACAATTATCACAATATGTTTCAACTATA\nGCGAATGATGGTTATAGAATACAGCCACACATTGGATTAACGATTCATGAATCAACTAAT\nAAAGATGAGGTTGGTCCACTCAAGAAGAAAATTAATGGCACTGTCTTGAACAAGGTTAAT\nAATACTGAAAAGGAAATCAAACAAATTCAAGAAGGATTCAAAATGGCATTTAATGATAAA\nGATGGTACTGGATATGTTAGTTTTAAAGATACAGTAGTACCTACTGCTGGTAAAACGGGT\nACCGCAGAAGTGTTCCAAAACGGAGAGCCAAGAGTTAACTCTACTTATATAGGATACGCG\nCCAATTGATGATCCAAAATTAGCGTTTTCAATTGTATATACAAATCAGCCTGTACCACCA\nCCATGGTTAACAGGTGGAGACTTAGGTAGAGATGTAATTAACTACTACTTTAAGCAGTTA\nGGTAAAAATGATAAAAATAAAGACAAAGACAAATAA",
                        "Chromosome Location": "Not Available",
                        "Locus": "Not Available",
                        "External Identifiers": "ResourceLinkUniProtKB IDA0A0H2XJ39UniProtKB Entry NameA0A0H2XJ39_STAA3",
                        "General References": "Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, Lin F, Lin J, Carleton HA, Mongodin EF, Sensabaugh GF, Perdreau-Remington F: Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet. 2006 Mar 4;367(9512):731-9. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB01053Benzylpenicillinapproved, vet_approvedunknowninhibitorDetails"
                    }
                },
                {
                    "Label": "Solute carrier family 22 member 8",
                    "Detailed Info": {
                        "Name": "Solute carrier family 22 member 8",
                        "Synonyms": "hOAT3\nOAT3\nOrganic anion transporter 3",
                        "Gene Name": "SLC22A8",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0007005|Solute carrier family 22 member 8\nMTFSEILDRVGSMGHFQFLHVAILGLPILNMANHNLLQIFTAATPVHHCRPPHNASTGPW\nVLPMGPNGKPERCLRFVHPPNASLPNDTQRAMEPCLDGWVYNSTKDSIVTEWDLVCNSNK\nLKEMAQSIFMAGILIGGLVLGDLSDRFGRRPILTCSYLLLAASGSGAAFSPTFPIYMVFR\nFLCGFGISGITLSTVILNVEWVPTRMRAIMSTALGYCYTFGQFILPGLAYAIPQWRWLQL\nTVSIPFFVFFLSSWWTPESIRWLVLSGKSSKALKILRRVAVFNGKKEEGERLSLEELKLN\nLQKEISLAKAKYTASDLFRIPMLRRMTFCLSLAWFATGFAYYSLAMGVEEFGVNLYILQI\nIFGGVDVPAKFITILSLSYLGRHTTQAAALLLAGGAILALTFVPLDLQTVRTVLAVFGKG\nCLSSSFSCLFLYTSELYPTVIRQTGMGVSNLWTRVGSMVSPLVKITGEVQPFIPNIIYGI\nTALLGGSAALFLPETLNQPLPETIEDLENWSLRAKKPKQEPEVEKASQRIPLQPHGPGLG\nSS",
                        "Number of residues": "542",
                        "Molecular Weight": "59855.585",
                        "Theoretical pI": "9.05",
                        "GO Classification": "Functionsinorganic anion exchanger activity / sodium-independent organic anion transmembrane transporter activityProcessesanion transmembrane transport / response to toxic substance / sodium-independent organic anion transport / transmembrane transportComponentsbasolateral plasma membrane / extracellular exosome / integral component of plasma membrane / plasma membrane",
                        "General Function": "Sodium-independent organic anion transmembrane transporter activity",
                        "Specific Function": "Plays an important role in the excretion/detoxification of endogenous and exogenous organic anions, especially from the brain and kidney. Involved in the transport basolateral of steviol, fexofenadine. Transports benzylpenicillin (PCG), estrone-3-sulfate (E1S), cimetidine (CMD), 2,4-dichloro-phenoxyacetate (2,4-D), p-amino-hippurate (PAH), acyclovir (ACV) and ochratoxin (OTA).",
                        "Pfam Domain Function": "Sugar_tr (PF00083)",
                        "Transmembrane Regions": "10-30\n124-144\n155-175\n177-197\n213-233\n237-257\n328-348\n355-375\n387-407\n412-432\n472-492",
                        "Cellular Location": "Basolateral cell membrane",
                        "Gene sequence": ">lcl|BSEQ0019450|Solute carrier family 22 member 8 (SLC22A8)\nATGACCTTCTCGGAGATCCTGGACCGTGTGGGAAGCATGGGCCATTTCCAGTTCCTGCAT\nGTAGCCATACTGGGCCTCCCGATCCTCAACATGGCCAACCACAACCTGCTGCAGATCTTC\nACAGCCGCCACCCCTGTCCACCACTGTCGCCCGCCCCACAATGCCTCCACAGGGCCTTGG\nGTGCTCCCCATGGGCCCAAATGGGAAGCCTGAGAGGTGCCTCCGTTTTGTACATCCGCCC\nAATGCCAGCCTGCCCAATGACACCCAGAGGGCCATGGAGCCATGCCTGGATGGCTGGGTC\nTACAACAGCACCAAGGACTCCATTGTGACAGAGTGGGACTTGGTGTGCAACTCCAACAAA\nCTGAAGGAGATGGCCCAGTCTATCTTCATGGCAGGTATACTGATTGGAGGGCTCGTGCTT\nGGAGACCTGTCTGACAGGTTTGGCCGCAGGCCCATCCTGACCTGCAGCTACCTGCTGCTG\nGCAGCCAGCGGCTCCGGTGCAGCCTTCAGCCCCACCTTCCCCATCTACATGGTCTTCCGC\nTTCCTGTGTGGCTTTGGCATCTCAGGCATTACCCTGAGCACCGTCATCTTGAATGTGGAA\nTGGGTGCCTACCCGGATGCGGGCCATCATGTCGACAGCACTCGGGTACTGCTACACCTTT\nGGCCAGTTCATTCTGCCCGGCCTGGCCTACGCCATCCCCCAGTGGCGTTGGCTGCAGTTA\nACTGTGTCCATTCCCTTCTTCGTCTTCTTCCTATCATCCTGGTGGACACCAGAGTCCATA\nCGCTGGTTGGTCTTGTCTGGAAAGTCCTCGAAGGCCCTGAAGATACTCCGGCGGGTGGCT\nGTCTTCAATGGCAAGAAGGAAGAGGGAGAAAGGCTCAGCTTGGAGGAGCTCAAACTCAAC\nCTGCAGAAGGAGATCTCCTTGGCCAAGGCCAAGTACACCGCAAGTGACCTGTTCCGGATA\nCCCATGCTGCGCCGCATGACCTTCTGTCTTTCCCTGGCCTGGTTTGCTACCGGTTTTGCC\nTACTATAGTTTGGCTATGGGTGTGGAAGAATTTGGAGTCAACCTCTACATCCTCCAGATC\nATCTTTGGTGGGGTCGATGTCCCAGCCAAGTTCATCACCATCCTCTCCTTAAGCTACCTG\nGGCCGGCATACCACTCAGGCCGCTGCCCTGCTCCTGGCAGGAGGGGCCATCTTGGCTCTC\nACCTTTGTGCCCTTGGACTTGCAGACCGTGAGGACAGTATTGGCTGTGTTTGGGAAGGGA\nTGCCTATCCAGCTCCTTCAGCTGCCTCTTCCTCTACACAAGTGAATTATACCCCACAGTC\nATCAGGCAAACAGGTATGGGCGTAAGTAACCTGTGGACCCGCGTGGGAAGCATGGTGTCC\nCCGCTGGTGAAAATCACGGGTGAGGTACAGCCCTTCATCCCCAATATCATCTACGGGATC\nACCGCCCTCCTCGGGGGCAGTGCTGCCCTCTTCCTGCCTGAGACCCTGAATCAGCCCTTG\nCCAGAGACTATCGAAGACCTGGAAAACTGGTCCCTGCGGGCAAAGAAGCCAAAGCAGGAG\nCCAGAGGTGGAAAAGGCCTCCCAGAGGATCCCTCTACAGCCTCACGGACCAGGCCTGGGC\nTCCAGCTGA",
                        "Chromosome Location": "11",
                        "Locus": "11q11",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ8TCC7UniProtKB Entry NameS22A8_HUMANGenBank Protein ID4378059GenBank Gene IDAF097491HGNC IDHGNC:10972",
                        "General References": "Race JE, Grassl SM, Williams WJ, Holtzman EJ: Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3). Biochem Biophys Res Commun. 1999 Feb 16;255(2):508-14. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Taylor TD, Noguchi H, Totoki Y, Toyoda A, Kuroki Y, Dewar K, Lloyd C, Itoh T, Takeda T, Kim DW, She X, Barlow KF, Bloom T, Bruford E, Chang JL, Cuomo CA, Eichler E, FitzGerald MG, Jaffe DB, LaButti K, Nicol R, Park HS, Seaman C, Sougnez C, Yang X, Zimmer AR, Zody MC, Birren BW, Nusbaum C, Fujiyama A, Hattori M, Rogers J, Lander ES, Sakaki Y: Human chromosome 11 DNA sequence and analysis including novel gene identification. Nature. 2006 Mar 23;440(7083):497-500. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Motohashi H, Sakurai Y, Saito H, Masuda S, Urakami Y, Goto M, Fukatsu A, Ogawa O, Inui K: Gene expression levels and immunolocalization of organic ion transporters in the human kidney. J Am Soc Nephrol. 2002 Apr;13(4):866-74. [Article] Bakhiya A, Bahn A, Burckhardt G, Wolff N: Human organic anion transporter 3 (hOAT3) can operate as an exchanger and mediate secretory urate flux. Cell Physiol Biochem. 2003;13(5):249-56. [Article] Srimaroeng C, Chatsudthipong V, Aslamkhan AG, Pritchard JB: Transport of the natural sweetener stevioside and its aglycone steviol by human organic anion transporter (hOAT1; SLC22A6) and hOAT3 (SLC22A8). J Pharmacol Exp Ther. 2005 May;313(2):621-8. Epub 2005 Jan 11. [Article] Tahara H, Shono M, Kusuhara H, Kinoshita H, Fuse E, Takadate A, Otagiri M, Sugiyama Y: Molecular cloning and functional analyses of OAT1 and OAT3 from cynomolgus monkey kidney. Pharm Res. 2005 Apr;22(4):647-60. Epub 2005 Apr 7. [Article] Tahara H, Kusuhara H, Maeda K, Koepsell H, Fuse E, Sugiyama Y: Inhibition of oat3-mediated renal uptake as a mechanism for drug-drug interaction between fexofenadine and probenecid. Drug Metab Dispos. 2006 May;34(5):743-7. doi: 10.1124/dmd.105.008375. Epub 2006 Feb 2. [Article] Nishizato Y, Ieiri I, Suzuki H, Kimura M, Kawabata K, Hirota T, Takane H, Irie S, Kusuhara H, Urasaki Y, Urae A, Higuchi S, Otsubo K, Sugiyama Y: Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics. Clin Pharmacol Ther. 2003 Jun;73(6):554-65. [Article] Erdman AR, Mangravite LM, Urban TJ, Lagpacan LL, Castro RA, de la Cruz M, Chan W, Huang CC, Johns SJ, Kawamoto M, Stryke D, Taylor TR, Carlson EJ, Ferrin TE, Brett CM, Burchard EG, Giacomini KM: The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics. Am J Physiol Renal Physiol. 2006 Apr;290(4):F905-12. Epub 2005 Nov 15. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB01032Probenecidapproved, investigationalyesinhibitorDetailsDB00624Testosteroneapproved, investigationalunknowninducerDetailsDB04348Taurocholic acidapproved, experimentalunknownsubstrateinhibitorDetailsDB00936Salicylic acidapproved, investigational, vet_approvedunknowninhibitorDetailsDB00908Quinidineapproved, investigationalunknowninhibitorDetailsDB01032Probenecidapproved, investigationalunknowninhibitorDetailsDB01053Benzylpenicillinapproved, vet_approvedunknownsubstrateinhibitorDetailsDB01092OuabainapprovedunknowninhibitorDetailsDB00328Indomethacinapproved, investigationalunknowninhibitorDetailsDB01050IbuprofenapprovedunknowninhibitorDetailsDB00536GuanidineapprovedunknowninhibitorDetailsDB03553Glutaric AcidexperimentalunknownsubstrateinhibitorDetailsDB00695Furosemideapproved, vet_approvedunknowninhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknowninhibitorDetailsDB02659Cholic AcidapprovedunknownsubstrateinhibitorDetailsDB00887BumetanideapprovedunknowninhibitorDetailsDB01597Cilastatinapproved, investigationalunknowninhibitorDetailsDB00554Piroxicamapproved, investigationalunknowninhibitorDetailsDB00345Aminohippuric acidapproved, investigationalunknownsubstrateinhibitorDetailsDB04519Caprylic acidinvestigationalunknowninhibitorDetailsDB00501Cimetidineapproved, investigationalunknownsubstrateinhibitorDetailsDB00168Aspartameinvestigational, nutraceuticalunknowninhibitorDetailsDB00759Tetracyclineapproved, vet_approved, withdrawnunknownsubstrateinhibitorDetailsDB00595Oxytetracyclineapproved, investigational, vet_approvedunknownsubstrateDetailsDB01004Ganciclovirapproved, investigationalunknowninhibitorDetailsDB00787AcyclovirapprovedunknownsubstrateinhibitorDetailsDB00917DinoprostoneapprovedunknownsubstrateinhibitorDetailsDB00456Cefalotinapproved, investigational, vet_approvedunknowninhibitorDetailsDB01329Cefoperazoneapproved, investigationalunknowninhibitorDetailsDB01327CefazolinapprovedunknowninhibitorDetailsDB01326Cefamandoleapproved, experimentalunknowninhibitorDetailsDB01140Cefadroxilapproved, vet_approved, withdrawnunknowninhibitorDetailsDB01212CeftriaxoneapprovedunknowninhibitorDetailsDB00493CefotaximeapprovedunknowninhibitorDetailsDB00812Phenylbutazoneapproved, vet_approvedunknowninhibitorDetailsDB01009Ketoprofenapproved, vet_approvedunknowninhibitorDetailsDB00175PravastatinapprovednosubstrateinhibitorDetailsDB00927FamotidineapprovednosubstrateinhibitorDetailsDB00279Liothyronineapproved, vet_approvedunknowninhibitorDetailsDB00563MethotrexateapprovedunknownsubstrateinhibitorDetailsDB00286Conjugated estrogensapprovedunknownsubstrateinhibitorDetailsDB00469TenoxicamapprovedunknowninhibitorDetailsDB00584Enalaprilapproved, vet_approvedunknowninhibitorDetailsDB01650trans-2-hydroxycinnamic acidexperimentalunknowninhibitorDetailsDB00567Cephalexinapproved, investigational, vet_approvedunknowninhibitorDetailsDB00313Valproic acidapproved, investigationalunknownsubstrateinhibitorDetailsDB01065Melatoninapproved, nutraceutical, vet_approvedunknowninhibitorDetailsDB03793Benzoic acidapproved, investigationalunknowninhibitorDetailsDB01033MercaptopurineapprovedunknownsubstrateinhibitorDetailsDB01051Novobiocinapproved, investigational, vet_approved, withdrawnunknowninhibitorDetailsDB00213PantoprazoleapprovedunknowninhibitorDetailsDB00139Succinic acidapproved, nutraceuticalunknownsubstrateDetailsDB02527Cyclic adenosine monophosphateexperimentalunknownsubstrateDetailsDB00577Valaciclovirapproved, investigationalunknownsubstrateDetailsDB03902Oxalic AcidexperimentalunknownsubstrateDetailsDB00863Ranitidineapproved, withdrawnunknownsubstrateDetailsDB00583Levocarnitineapproved, investigationalunknownsubstrateDetailsDB00437AllopurinolapprovedunknownsubstrateDetailsDB00198OseltamivirapprovedunknownsubstrateDetailsDB01583LiotrixapprovedunknowninhibitorDetailsDB01414Cefacetrileexperimental, vet_approvedunknownsubstrateinhibitorDetailsDB06710MethyltestosteroneapprovedunknowninducerDetailsDB00495ZidovudineapprovedunknownsubstrateinhibitorDetailsDB08844Uric acidinvestigationalunknownDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateDetailsDB05804Prasterone sulfateinvestigationalunknownDetailsDB01160Dinoprost tromethamineapproved, vet_approvedunknownDetailsDB04133Degraded CephaloridineexperimentalunknownDetailsDB08837Tetraethylammoniumexperimental, investigationalunknownDetailsDB06335SaxagliptinapprovedunknownsubstrateDetailsDB08912Dabrafenibapproved, investigationalnoinhibitorDetailsDB00300Tenofovir disoproxilapproved, investigationalunknownsubstrateDetailsDB00493CefotaximeapprovedunknownDetailsDB01212CeftriaxoneapprovedunknownDetailsDB01053Benzylpenicillinapproved, vet_approvedunknownsubstrateinhibitorDetailsDB09272Eluxadolineapproved, investigationalunknownsubstrateDetailsDB09060AvibactamapprovednosubstrateDetailsDB01685TopiroxostatexperimentalunknowninhibitorDetailsDB05016Atalurenapproved, investigationalnoinhibitorDetailsDB13874Enasidenibapproved, investigationalunknowninhibitorDetailsDB12070Letermovirapproved, investigationalunknowninhibitorDetailsDB08930DolutegravirapprovednoinhibitorDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB11817Baricitinibapproved, investigationalunknownsubstrateinhibitorDetailsDB13943Testosterone cypionateapprovedunknowninducerDetailsDB13944Testosterone enanthateapprovedunknowninducerDetailsDB13946Testosterone undecanoateapproved, investigationalunknowninducerDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownDetailsDB11901Apalutamideapproved, investigationalnoinhibitorDetailsDB11995Avatrombopagapproved, investigationalunknowninhibitorDetailsDB00655EstroneapprovedunknownsubstrateDetailsDB00833CefaclorapprovedunknownsubstrateinhibitorDetailsDB00535CefdinirapprovedunknownsubstrateDetailsDB00229Cefotiamapproved, investigationalunknownsubstrateinhibitorDetailsDB01415Ceftibutenapproved, investigationalunknownsubstrateinhibitorDetailsDB01332Ceftizoximeapproved, withdrawnunknownsubstrateinhibitorDetailsDB09008Cefaloridineexperimental, withdrawnunknownsubstrateinhibitorDetailsDB00741Hydrocortisoneapproved, vet_approvedunknownsubstrateDetailsDB12243Edaravoneapproved, investigationalnosubstrateDetailsDB00950Fexofenadineapproved, investigationalunknownsubstrateDetailsDB00650LeucovorinapprovedunknownsubstrateinhibitorDetailsDB00881Quinaprilapproved, investigationalunknownsubstrateDetailsDB01098RosuvastatinapprovedunknownsubstrateinhibitorDetailsDB01261Sitagliptinapproved, investigationalunknownsubstrateDetailsDB14538Hydrocortisone aceponateexperimental, vet_approvedunknownDetailsDB14539Hydrocortisone acetateapproved, vet_approvedunknownDetailsDB14540Hydrocortisone butyrateapproved, vet_approvedunknownDetailsDB14541Hydrocortisone cypionateapproved, investigational, vet_approvedunknownDetailsDB14542Hydrocortisone phosphateapproved, vet_approvedunknownDetailsDB14543Hydrocortisone probutateapproved, vet_approvedunknownDetailsDB14544Hydrocortisone valerateapproved, vet_approvedunknownDetailsDB14568Ivosidenibapproved, investigationalunknowninhibitorDetailsDB09078Lenvatinibapproved, investigationalunknowninhibitorDetailsDB00319PiperacillinapprovedunknownsubstrateDetailsDB01606TazobactamapprovedunknownsubstrateinhibitorDetailsDB01045RifampicinapprovedunknowninhibitorDetailsDB11751Cabotegravirapproved, investigationalunknowninhibitorDetailsDB09213Dexibuprofenapproved, investigationalunknownDetailsDB12866PradigastatinvestigationalunknowninhibitorDetailsDB00642Pemetrexedapproved, investigationalnosubstrateDetailsDB00448Lansoprazoleapproved, investigationalunknowninhibitorDetailsDB06211Doripenemapproved, investigationalnosubstrateDetailsDB00945Acetylsalicylic acidapproved, vet_approvedunknowninhibitorDetailsDB00736Esomeprazoleapproved, investigationalunknowninhibitorDetailsDB09299Tenofovir alafenamideapprovednosubstrateDetailsDB14126Tenofovirexperimental, investigationalnosubstrateDetailsDB00788Naproxenapproved, vet_approvedunknownDetailsDB12377Relebactamapproved, investigationalunknownsubstrateDetailsDB05154PretomanidapprovedunknowninhibitorDetailsDB00654Latanoprostapproved, investigationalunknowninhibitorDetailsDB00999Hydrochlorothiazideapproved, vet_approvedunknownsubstrateDetailsDB01241GemfibrozilapprovedunknowninhibitorDetailsDB04855DronedaroneapprovedunknowninhibitorDetailsDB01222BudesonideapprovedunknownsubstrateDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB11644Tafamidisapproved, investigationalunknowninhibitorDetailsDB12457Rimegepantapproved, investigationalunknowninhibitorDetailsDB12466Favipiravirapproved, investigationalunknowninhibitorDetailsDB11837Osilodrostatapproved, investigationalunknowninhibitorDetailsDB00253MedrysoneapprovedunknownsubstrateDetailsDB00774Hydroflumethiazideapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB01324PolythiazideapprovedunknownsubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknownsubstrateDetailsDB09038EmpagliflozinapprovedunknownsubstrateDetailsDB09274Artesunateapproved, investigationalunknowninhibitorDetailsDB14669Betamethasone phosphateapproved, vet_approvedunknownsubstrateDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknownsubstrateDetailsDB01380Cortisone acetateapproved, investigationalunknownsubstrateDetailsDB00601Linezolidapproved, investigationalnoinhibitorDetailsDB01147Cloxacillinapproved, investigational, vet_approvednosubstrateinhibitorDetailsDB12151Brincidofovirapproved, investigationalnoinhibitorDetailsDB12265Fexinidazoleapproved, investigationalunknowninhibitorDetailsDB14973Abrocitinibapproved, investigationalunknownsubstrateDetailsDB04847Roxadustatapproved, investigationalunknownsubstrateDetailsDB17083LinzagolixapprovednosubstrateinhibitorDetailsDB16267Olutasidenibapproved, investigationalnoinhibitorDetailsDB11682Daprodustatapproved, investigationalnosubstrateDetailsDB01250OlsalazineapprovedunknownupregulatorDetailsDB12548Sparsentanapproved, investigationalunknowninhibitorDetailsDB11712Tezacaftorapproved, investigationalnoinhibitorDetailsDB12255Vadadustatapproved, investigationalunknownsubstrateinhibitorDetailsDB11718Encorafenibapproved, investigationalnoinhibitorDetailsDB12218Capivasertibapproved, investigationalnoinhibitorDetails"
                    }
                },
                {
                    "Label": "Solute carrier family 15 member 1",
                    "Detailed Info": {
                        "Name": "Solute carrier family 15 member 1",
                        "Synonyms": "Intestinal H(+)/peptide cotransporter\nOligopeptide transporter, small intestine isoform\nPEPT1\nPeptide transporter 1",
                        "Gene Name": "SLC15A1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0010713|Solute carrier family 15 member 1\nMGMSKSHSFFGYPLSIFFIVVNEFCERFSYYGMRAILILYFTNFISWDDNLSTAIYHTFV\nALCYLTPILGALIADSWLGKFKTIVSLSIVYTIGQAVTSVSSINDLTDHNHDGTPDSLPV\nHVVLSLIGLALIALGTGGIKPCVSAFGGDQFEEGQEKQRNRFFSIFYLAINAGSLLSTII\nTPMLRVQQCGIHSKQACYPLAFGVPAALMAVALIVFVLGSGMYKKFKPQGNIMGKVAKCI\nGFAIKNRFRHRSKAFPKREHWLDWAKEKYDERLISQIKMVTRVMFLYIPLPMFWALFDQQ\nGSRWTLQATTMSGKIGALEIQPDQMQTVNAILIVIMVPIFDAVLYPLIAKCGFNFTSLKK\nMAVGMVLASMAFVVAAIVQVEIDKTLPVFPKGNEVQIKVLNIGNNTMNISLPGEMVTLGP\nMSQTNAFMTFDVNKLTRINISSPGSPVTAVTDDFKQGQRHTLLVWAPNHYQVVKDGLNQK\nPEKGENGIRFVNTFNELITITMSGKVYANISSYNASTYQFFPSGIKGFTISSTEIPPQCQ\nPNFNTFYLEFGSAYTYIVQRKNDSCPEVKVFEDISANTVNMALQIPQYFLLTCGEVVFSV\nTGLEFSYSQAPSNMKSVLQAGWLLTVAVGNIIVLIVAGAGQFSKQWAEYILFAALLLVVC\nVIFAIMARFYTYINPAEIEAQFDEDEKKNRLEKSNPYFMSGANSQKQM",
                        "Number of residues": "708",
                        "Molecular Weight": "78805.265",
                        "Theoretical pI": "8.64",
                        "GO Classification": "Functionspeptide / proton-dependent oligopeptide secondary active transmembrane transporter activityProcessesdigestion / ion transport / protein transport / proton transport / transmembrane transport / transportComponentsbrush border / integral component of plasma membrane / membrane / plasma membrane",
                        "General Function": "Proton-dependent oligopeptide secondary active transmembrane transporter activity",
                        "Specific Function": "Proton-coupled intake of oligopeptides of 2 to 4 amino acids with a preference for dipeptides. May constitute a major route for the absorption of protein digestion end-products.",
                        "Pfam Domain Function": "PTR2 (PF00854)",
                        "Transmembrane Regions": "1-21\n54-74\n83-103\n119-139\n162-182\n199-219\n277-297\n328-348\n362-382\n585-605\n620-640\n646-666",
                        "Cellular Location": "Membrane",
                        "Gene sequence": ">lcl|BSEQ0010714|Solute carrier family 15 member 1 (SLC15A1)\nATGGGAATGTCCAAATCACACAGTTTCTTTGGTTATCCCCTGAGCATCTTCTTCATCGTG\nGTCAATGAGTTTTGCGAAAGATTTTCCTACTATGGAATGCGAGCAATCCTGATTCTGTAC\nTTCACAAATTTCATCAGCTGGGATGATAACCTGTCCACCGCCATCTACCATACGTTTGTG\nGCTCTGTGCTACCTGACGCCAATTCTCGGAGCTCTTATCGCCGACTCGTGGCTGGGAAAG\nTTCAAGACCATTGTGTCGCTCTCCATTGTCTACACAATTGGACAAGCAGTCACCTCAGTA\nAGCTCCATTAATGACCTCACAGACCACAACCATGATGGCACCCCCGACAGCCTTCCTGTG\nCACGTGGTGCTGTCCTTGATCGGCCTGGCCCTGATAGCTCTCGGGACTGGAGGAATCAAA\nCCCTGTGTGTCTGCGTTTGGTGGAGATCAGTTTGAAGAGGGCCAGGAGAAACAAAGAAAC\nAGATTTTTTTCCATCTTTTACTTGGCTATTAATGCTGGAAGTTTGCTTTCCACAATCATC\nACACCCATGCTCAGAGTTCAACAATGTGGAATTCACAGTAAACAAGCTTGTTACCCACTG\nGCCTTTGGGGTTCCTGCTGCTCTCATGGCTGTAGCCCTGATTGTGTTTGTCCTTGGCAGT\nGGGATGTACAAGAAGTTCAAGCCACAGGGCAACATCATGGGTAAAGTGGCCAAGTGCATC\nGGTTTTGCCATCAAAAATAGATTTAGGCATCGGAGTAAGGCATTTCCCAAGAGGGAGCAC\nTGGCTGGACTGGGCTAAAGAGAAATACGATGAGCGGCTCATCTCCCAAATTAAGATGGTT\nACGAGGGTGATGTTCCTGTATATTCCACTCCCAATGTTCTGGGCCTTGTTTGACCAGCAG\nGGCTCCAGGTGGACACTGCAGGCAACAACTATGTCCGGGAAAATCGGAGCTCTTGAAATT\nCAGCCCGATCAGATGCAGACCGTGAACGCCATCCTGATCGTGATCATGGTCCCGATCTTC\nGATGCTGTGCTGTACCCTCTCATTGCAAAATGTGGCTTCAATTTCACCTCCTTGAAGAAG\nATGGCAGTTGGCATGGTCCTGGCCTCCATGGCCTTTGTGGTGGCTGCCATCGTGCAGGTG\nGAAATCGATAAAACTCTTCCAGTCTTCCCCAAAGGAAACGAAGTCCAAATTAAAGTTTTG\nAATATAGGAAACAATACCATGAATATATCTCTTCCTGGAGAGATGGTGACACTTGGCCCA\nATGTCTCAAACAAATGCATTTATGACTTTTGATGTAAACAAACTGACAAGGATAAACATT\nTCTTCTCCTGGATCACCAGTCACTGCTGTAACTGACGACTTCAAGCAGGGCCAACGCCAC\nACGCTTCTAGTGTGGGCCCCCAATCACTACCAGGTGGTAAAGGATGGTCTTAACCAGAAG\nCCAGAAAAAGGGGAAAATGGAATCAGATTTGTAAATACTTTTAACGAGCTCATCACCATC\nACAATGAGTGGGAAAGTTTATGCAAACATCAGCAGCTACAATGCCAGCACATACCAGTTT\nTTTCCTTCTGGCATAAAAGGCTTCACAATAAGCTCAACAGAGATTCCGCCACAATGTCAA\nCCTAATTTCAATACTTTCTACCTTGAATTTGGTAGTGCTTATACCTATATAGTCCAAAGG\nAAGAATGACAGCTGCCCTGAAGTGAAGGTGTTTGAAGATATTTCAGCCAACACAGTTAAC\nATGGCTCTGCAAATCCCGCAGTATTTTCTTCTCACCTGTGGCGAAGTGGTCTTCTCTGTC\nACGGGATTGGAATTCTCATATTCTCAGGCTCCTTCCAACATGAAGTCGGTGCTTCAGGCA\nGGATGGCTGCTGACCGTGGCTGTTGGCAACATCATTGTGCTCATCGTGGCAGGGGCAGGC\nCAGTTCAGCAAACAGTGGGCCGAGTACATTCTATTTGCCGCGTTGCTTCTGGTCGTCTGT\nGTAATTTTTGCCATCATGGCTCGGTTCTATACTTACATCAACCCAGCGGAGATCGAAGCT\nCAATTTGATGAGGATGAAAAGAAAAACAGACTGGAAAAGAGTAACCCATATTTCATGTCA\nGGGGCCAATTCACAGAAACAGATGTGA",
                        "Chromosome Location": "13",
                        "Locus": "13q33-q34",
                        "External Identifiers": "ResourceLinkUniProtKB IDP46059UniProtKB Entry NameS15A1_HUMANGenBank Protein ID773588GenBank Gene IDU13173GenAtlas IDSLC15A1HGNC IDHGNC:10920",
                        "General References": "Liang R, Fei YJ, Prasad PD, Ramamoorthy S, Han H, Yang-Feng TL, Hediger MA, Ganapathy V, Leibach FH: Human intestinal H+/peptide cotransporter. Cloning, functional expression, and chromosomal localization. J Biol Chem. 1995 Mar 24;270(12):6456-63. [Article] Dunham A, Matthews LH, Burton J, Ashurst JL, Howe KL, Ashcroft KJ, Beare DM, Burford DC, Hunt SE, Griffiths-Jones S, Jones MC, Keenan SJ, Oliver K, Scott CE, Ainscough R, Almeida JP, Ambrose KD, Andrews DT, Ashwell RI, Babbage AK, Bagguley CL, Bailey J, Bannerjee R, Barlow KF, Bates K, Beasley H, Bird CP, Bray-Allen S, Brown AJ, Brown JY, Burrill W, Carder C, Carter NP, Chapman JC, Clamp ME, Clark SY, Clarke G, Clee CM, Clegg SC, Cobley V, Collins JE, Corby N, Coville GJ, Deloukas P, Dhami P, Dunham I, Dunn M, Earthrowl ME, Ellington AG, Faulkner L, Frankish AG, Frankland J, French L, Garner P, Garnett J, Gilbert JG, Gilson CJ, Ghori J, Grafham DV, Gribble SM, Griffiths C, Hall RE, Hammond S, Harley JL, Hart EA, Heath PD, Howden PJ, Huckle EJ, Hunt PJ, Hunt AR, Johnson C, Johnson D, Kay M, Kimberley AM, King A, Laird GK, Langford CJ, Lawlor S, Leongamornlert DA, Lloyd DM, Lloyd C, Loveland JE, Lovell J, Martin S, Mashreghi-Mohammadi M, McLaren SJ, McMurray A, Milne S, Moore MJ, Nickerson T, Palmer SA, Pearce AV, Peck AI, Pelan S, Phillimore B, Porter KM, Rice CM, Searle S, Sehra HK, Shownkeen R, Skuce CD, Smith M, Steward CA, Sycamore N, Tester J, Thomas DW, Tracey A, Tromans A, Tubby B, Wall M, Wallis JM, West AP, Whitehead SL, Willey DL, Wilming L, Wray PW, Wright MW, Young L, Coulson A, Durbin R, Hubbard T, Sulston JE, Beck S, Bentley DR, Rogers J, Ross MT: The DNA sequence and analysis of human chromosome 13. Nature. 2004 Apr 1;428(6982):522-8. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Saito S, Iida A, Sekine A, Ogawa C, Kawauchi S, Higuchi S, Nakamura Y: Catalog of 238 variations among six human genes encoding solute carriers ( hSLCs) in the Japanese population. J Hum Genet. 2002;47(11):576-84. [Article] Anderle P, Nielsen CU, Pinsonneault J, Krog PL, Brodin B, Sadee W: Genetic variants of the human dipeptide transporter PEPT1. J Pharmacol Exp Ther. 2006 Feb;316(2):636-46. Epub 2005 Oct 28. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB01197CaptoprilapprovedunknowninhibitorDetailsDB01000CyclacillinapprovedunknowninhibitorDetailsDB01140Cefadroxilapproved, vet_approved, withdrawnunknownsubstrateinhibitorDetailsDB00567Cephalexinapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00447Loracarbefapproved, investigational, withdrawnunknowninhibitorDetailsDB00671Cefiximeapproved, investigationalunknownsubstrateinhibitorDetailsDB01060Amoxicillinapproved, vet_approvedunknowninhibitorDetailsDB00415Ampicillinapproved, vet_approvedunknowninhibitorDetailsDB01415Ceftibutenapproved, investigationalunknownsubstrateinhibitorDetailsDB00535CefdinirapprovedunknownsubstrateinhibitorDetailsDB00577Valaciclovirapproved, investigationalunknownsubstrateinhibitorDetailsDB00584Enalaprilapproved, vet_approvedunknownsubstrateinhibitorDetailsDB01333CefradineapprovedunknownsubstrateinhibitorDetailsDB00968MethyldopaapprovedunknowninhibitorDetailsDB01235LevodopaapprovedunknowninhibitorDetailsDB00833CefaclorapprovedunknowninhibitorDetailsDB01413Cefepimeapproved, investigationalunknowninhibitorDetailsDB01212CeftriaxoneapprovedunknowninhibitorDetailsDB00493CefotaximeapprovedunknowninhibitorDetailsDB01112CefuroximeapprovedunknowninhibitorDetailsDB01053Benzylpenicillinapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00456Cefalotinapproved, investigational, vet_approvedunknowninhibitorDetailsDB00274Cefmetazoleapproved, investigationalunknowninhibitorDetailsDB00713Oxacillinapproved, investigationalunknowninhibitorDetailsDB01147Cloxacillinapproved, investigational, vet_approvednoinhibitorDetailsDB00485Dicloxacillinapproved, investigational, vet_approvedunknowninhibitorDetailsDB03424UbenimexinvestigationalunknowninhibitorDetailsDB00855Aminolevulinic acidapprovedunknowninhibitorDetailsDB01016GlyburideapprovedunknowninhibitorDetailsDB01124Tolbutamideapproved, investigationalunknowninhibitorDetailsDB00731Nateglinideapproved, investigationalunknowninhibitorDetailsDB00672Chlorpropamideapproved, investigationalunknowninhibitorDetailsDB01332Ceftizoximeapproved, withdrawnunknownsubstrateDetailsDB00198OseltamivirapprovedunknownsubstrateDetailsDB00881Quinaprilapproved, investigationalunknownsubstrateDetailsDB00542Benazeprilapproved, investigationalunknownsubstrateDetailsDB01340CilazaprilapprovedunknownsubstrateDetailsDB00492FosinoprilapprovedunknownsubstrateDetailsDB00691MoexiprilapprovedunknownsubstrateDetailsDB00790PerindoprilapprovedunknownsubstrateDetailsDB00178RamiprilapprovedunknownsubstrateDetailsDB01348SpiraprilapprovedunknownsubstrateDetailsDB00519TrandolaprilapprovedunknownsubstrateDetailsDB08795AzidocillinexperimentalunknowninhibitorDetailsDB01610Valganciclovirapproved, investigationalunknownDetailsDB00211MidodrineapprovedunknownDetailsDB08836Temocaprilexperimental, investigationalunknownDetailsDB01095FluvastatinapprovedunknownsubstrateinhibitorDetailsDB00415Ampicillinapproved, vet_approvedunknownDetailsDB00493CefotaximeapprovedunknownDetailsDB00713Oxacillinapproved, investigationalunknownDetailsDB01053Benzylpenicillinapproved, vet_approvedunknownsubstrateinhibitorDetailsDB01212CeftriaxoneapprovedunknownDetailsDB00417Phenoxymethylpenicillinapproved, vet_approvedunknownDetailsDB03793Benzoic acidapproved, investigationalunknownDetailsDB01956Taurineapproved, nutraceuticalnosubstrateDetailsDB09213Dexibuprofenapproved, investigationalunknownDetailsDB01255Lisdexamfetamineapproved, investigationalunknownsubstrateDetailsDB00563MethotrexateapprovedunknownsubstrateDetailsDB00722Lisinoprilapproved, investigationalunknownsubstrateinhibitorDetails"
                    }
                },
                {
                    "Label": "Solute carrier family 15 member 2",
                    "Detailed Info": {
                        "Name": "Solute carrier family 15 member 2",
                        "Synonyms": "Kidney H(+)/peptide cotransporter\nOligopeptide transporter, kidney isoform\nPEPT2\nPeptide transporter 2",
                        "Gene Name": "SLC15A2",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0037126|Solute carrier family 15 member 2\nMNPFQKNESKETLFSPVSIEEVPPRPPSPPKKPSPTICGSNYPLSIAFIVVNEFCERFSY\nYGMKAVLILYFLYFLHWNEDTSTSIYHAFSSLCYFTPILGAAIADSWLGKFKTIIYLSLV\nYVLGHVIKSLGALPILGGQVVHTVLSLIGLSLIALGTGGIKPCVAAFGGDQFEEKHAEER\nTRYFSVFYLSINAGSLISTFITPMLRGDVQCFGEDCYALAFGVPGLLMVIALVVFAMGSK\nIYNKPPPEGNIVAQVFKCIWFAISNRFKNRSGDIPKRQHWLDWAAEKYPKQLIMDVKALT\nRVLFLYIPLPMFWALLDQQGSRWTLQAIRMNRNLGFFVLQPDQMQVLNPLLVLIFIPLFD\nFVIYRLVSKCGINFSSLRKMAVGMILACLAFAVAAAVEIKINEMAPAQPGPQEVFLQVLN\nLADDEVKVTVVGNENNSLLIESIKSFQKTPHYSKLHLKTKSQDFHFHLKYHNLSLYTEHS\nVQEKNWYSLVIREDGNSISSMMVKDTESRTTNGMTTVRFVNTLHKDVNISLSTDTSLNVG\nEDYGVSAYRTVQRGEYPAVHCRTEDKNFSLNLGLLDFGAAYLFVITNNTNQGLQAWKIED\nIPANKMSIAWQLPQYALVTAGEVMFSVTGLEFSYSQAPSSMKSVLQAAWLLTIAVGNIIV\nLVVAQFSGLVQWAEFILFSCLLLVICLIFSIMGYYYVPVKTEDMRGPADKHIPHIQGNMI\nKLETKKTKL",
                        "Number of residues": "729",
                        "Molecular Weight": "81782.77",
                        "Theoretical pI": "8.38",
                        "GO Classification": "Functionsantibiotic transporter activity / dipeptide transporter activity / high-affinity oligopeptide transporter activity / peptideProcessesdrug transport / ion transport / protein transport / proton transport / transmembrane transport / transportComponentsextracellular exosome / integral component of plasma membrane / plasma membrane",
                        "General Function": "Peptide:proton symporter activity",
                        "Specific Function": "Proton-coupled intake of oligopeptides of 2 to 4 amino acids with a preference for dipeptides.",
                        "Pfam Domain Function": "PTR2 (PF00854)",
                        "Transmembrane Regions": "58-78\n88-108\n115-135\n140-160\n184-204\n218-238\n296-316\n344-364\n381-401\n568-588\n612-632\n644-664\n675-695",
                        "Cellular Location": "Membrane",
                        "Gene sequence": ">lcl|BSEQ0010792|Solute carrier family 15 member 2 (SLC15A2)\nATGAATCCTTTCCAGAAAAATGAGTCCAAGGAAACTCTTTTTTCACCTGTCTCCATTGAA\nGAGGTACCACCTCGACCACCTAGCCCTCCAAAGAAGCCATCTCCGACAATCTGTGGCTCC\nAACTATCCACTGAGCATTGCCTTCATTGTGGTGAATGAATTCTGCGAGCGCTTTTCCTAT\nTATGGAATGAAAGCTGTGCTGATCCTGTATTTCCTGTATTTCCTGCACTGGAATGAAGAT\nACCTCCACATCTATATACCATGCCTTCAGCAGCCTCTGTTATTTTACTCCCATCCTGGGA\nGCAGCCATTGCTGACTCGTGGTTGGGAAAATTCAAAGTCCTATCATTGATCGGCCTGAGT\nCTAATAGCTTTGGGGACAGGAGGCATCAAACCCTGTGTGGCAGCTTTTGGTGGAGACCAG\nTTTGAAGAAAAACATGCAGAGGAACGGACTAGATACTTCTCAGTCTTCTACCTGTCCATC\nAATGCAGGGAGCTTGATTTCTACATTTATCACACCCATGCTGAGAGGAGATGTGCAATGT\nTTTGGAGAAGACTGCTATGCATTGGCTTTTGGAGTTCCAGGACTGCTCATGGTAATTGCA\nCTTGTTGTGTTTGCAATGGGAAGCAAAATATACAATAAACCACCCCCTGAAGGAAACATA\nGTGGCTCAAGTTTTCAAATGTATCTGGTTTGCTATTTCCAATCGTTTCAAGAACCGTTCT\nGGAGACATTCCAAAGCGACAGCACTGGCTAGACTGGGCGGCTGAGAAATATCCAAAGCAG\nCTCATTATGGATGTAAAGGCACTGACCAGGGTACTATTCCTTTATATCCCATTGCCCATG\nTTCTGGGCTCTTTTGGATCAGCAGGGTTCACGATGGACTTTGCAAGCCATCAGGATGAAT\nAGGAATTTGGGGTTTTTTGTGCTTCAGCCGGACCAGATGCAGGTTCTAAATCCCCTTCTG\nGTTCTTATCTTCATCCCGTTGTTTGACTTTGTCATTTATCGTCTGGTCTCCAAGTGTGGA\nATTAACTTCTCATCACTTAGGAAAATGGCTGTTGGTATGATCCTAGCATGCCTGGCATTT\nGCAGTTGCGGCAGCTGTAGAGATAAAAATAAATGAAATGGCCCCAGCCCAGCCAGGTCCC\nCAGGAGGTTTTCCTACAAGTCTTGAATCTGGCAGATGATGAGGTGAAGGTGACAGTGGTG\nGGAAATGAAAACAATTCTCTGTTGATAGAGTCCATCAAATCCTTTCAGAAAACACCACAC\nTATTCCAAACTGCACCTGAAAACAAAAAGCCAGGATTTTCACTTCCACCTGAAATATCAC\nAATTTGTCTCTCTACACTGAGCATTCTGTGCAGGAGAAGAACTGGTACAGTCTTGTCATT\nCGTGAAGATGGGAACAGTATCTCCAGCATGATGGTAAAGGATACAGAAAGCAGAACAACC\nAATGGGATGACAACCGTGAGGTTTGTTAACACTTTGCATAAAGATGTCAACATCTCCCTG\nAGTACAGATACCTCTCTCAATGTTGGTGAAGACTATGGTGTGTCTGCTTATAGAACTGTG\nCAAAGAGGAGAATACCCTGCAGTGCACTGTAGAACAGAAGATAAGAACTTTTCTCTGAAT\nTTGGGTCTTCTAGACTTTGGTGCAGCATATCTGTTTGTTATTACTAATAACACCAATCAG\nGGTCTTCAGGCCTGGAAGATTGAAGACATTCCAGCCAACAAAATGTCCATTGCGTGGCAG\nCTACCACAATATGCCCTGGTTACAGCTGGGGAGGTCATGTTCTCTGTCACAGGTCTTGAG\nTTTTCTTATTCTCAGGCTCCCTCTAGCATGAAATCTGTGCTCCAGGCAGCTTGGCTATTG\nACAATTGCAGTTGGGAATATCATCGTGCTTGTTGTGGCACAGTTCAGTGGCCTGGTACAG\nTGGGCCGAATTCATTTTGTTTTCCTGCCTCCTGCTGGTGATCTGCCTGATCTTCTCCATC\nATGGGCTACTACTATGTTCCTGTAAAGACAGAGGATATGCGGGGTCCAGCAGATAAGCAC\nATTCCTCACATCCAGGGGAACATGATCAAACTAGAGACCAAGAAGACAAAACTCTGA",
                        "Chromosome Location": "3",
                        "Locus": "3q13.33",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ16348UniProtKB Entry NameS15A2_HUMANGenBank Protein ID999213GenBank Gene IDS78203GenAtlas IDSLC15A2HGNC IDHGNC:10921",
                        "General References": "Liu W, Liang R, Ramamoorthy S, Fei YJ, Ganapathy ME, Hediger MA, Ganapathy V, Leibach FH: Molecular cloning of PEPT 2, a new member of the H+/peptide cotransporter family, from human kidney. Biochim Biophys Acta. 1995 May 4;1235(2):461-6. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Muzny DM, Scherer SE, Kaul R, Wang J, Yu J, Sudbrak R, Buhay CJ, Chen R, Cree A, Ding Y, Dugan-Rocha S, Gill R, Gunaratne P, Harris RA, Hawes AC, Hernandez J, Hodgson AV, Hume J, Jackson A, Khan ZM, Kovar-Smith C, Lewis LR, Lozado RJ, Metzker ML, Milosavljevic A, Miner GR, Morgan MB, Nazareth LV, Scott G, Sodergren E, Song XZ, Steffen D, Wei S, Wheeler DA, Wright MW, Worley KC, Yuan Y, Zhang Z, Adams CQ, Ansari-Lari MA, Ayele M, Brown MJ, Chen G, Chen Z, Clendenning J, Clerc-Blankenburg KP, Chen R, Chen Z, Davis C, Delgado O, Dinh HH, Dong W, Draper H, Ernst S, Fu G, Gonzalez-Garay ML, Garcia DK, Gillett W, Gu J, Hao B, Haugen E, Havlak P, He X, Hennig S, Hu S, Huang W, Jackson LR, Jacob LS, Kelly SH, Kube M, Levy R, Li Z, Liu B, Liu J, Liu W, Lu J, Maheshwari M, Nguyen BV, Okwuonu GO, Palmeiri A, Pasternak S, Perez LM, Phelps KA, Plopper FJ, Qiang B, Raymond C, Rodriguez R, Saenphimmachak C, Santibanez J, Shen H, Shen Y, Subramanian S, Tabor PE, Verduzco D, Waldron L, Wang J, Wang J, Wang Q, Williams GA, Wong GK, Yao Z, Zhang J, Zhang X, Zhao G, Zhou J, Zhou Y, Nelson D, Lehrach H, Reinhardt R, Naylor SL, Yang H, Olson M, Weinstock G, Gibbs RA: The DNA sequence, annotation and analysis of human chromosome 3. Nature. 2006 Apr 27;440(7088):1194-8. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB01000CyclacillinapprovedunknowninhibitorDetailsDB01140Cefadroxilapproved, vet_approved, withdrawnunknowninhibitorDetailsDB00567Cephalexinapproved, investigational, vet_approvedunknowninhibitorDetailsDB01415Ceftibutenapproved, investigationalunknowninhibitorDetailsDB00671Cefiximeapproved, investigationalunknowninhibitorDetailsDB00535CefdinirapprovedunknowninhibitorDetailsDB03424UbenimexinvestigationalunknownsubstrateinhibitorDetailsDB00855Aminolevulinic acidapprovedunknowninhibitorDetailsDB00447Loracarbefapproved, investigational, withdrawnunknowninhibitorDetailsDB01333CefradineapprovedunknowninhibitorDetailsDB00415Ampicillinapproved, vet_approvedunknowninhibitorDetailsDB01060Amoxicillinapproved, vet_approvedunknowninhibitorDetailsDB00577Valaciclovirapproved, investigationalunknownsubstrateinhibitorDetailsDB01016GlyburideapprovedunknowninhibitorDetailsDB01413Cefepimeapproved, investigationalunknowninhibitorDetailsDB01124Tolbutamideapproved, investigationalunknowninhibitorDetailsDB00731Nateglinideapproved, investigationalunknowninhibitorDetailsDB00672Chlorpropamideapproved, investigationalunknowninhibitorDetailsDB01212CeftriaxoneapprovedunknowninhibitorDetailsDB00493CefotaximeapprovedunknowninhibitorDetailsDB01112CefuroximeapprovedunknowninhibitorDetailsDB01053Benzylpenicillinapproved, vet_approvedunknowninhibitorDetailsDB00456Cefalotinapproved, investigational, vet_approvedunknowninhibitorDetailsDB00274Cefmetazoleapproved, investigationalunknowninhibitorDetailsDB00713Oxacillinapproved, investigationalunknowninhibitorDetailsDB01147Cloxacillinapproved, investigational, vet_approvednoinhibitorDetailsDB00485Dicloxacillinapproved, investigational, vet_approvedunknowninhibitorDetailsDB00833CefaclorapprovedunknowninhibitorDetailsDB00881Quinaprilapproved, investigationalunknownsubstrateDetailsDB00542Benazeprilapproved, investigationalunknownsubstrateDetailsDB01340CilazaprilapprovedunknownsubstrateDetailsDB00492FosinoprilapprovedunknownsubstrateDetailsDB00691MoexiprilapprovedunknownsubstrateDetailsDB00790PerindoprilapprovedunknownsubstrateDetailsDB00178RamiprilapprovedunknownsubstrateDetailsDB01348SpiraprilapprovedunknownsubstrateDetailsDB00519TrandolaprilapprovedunknownsubstrateDetailsDB08795AzidocillinexperimentalunknowninhibitorDetailsDB01610Valganciclovirapproved, investigationalunknownDetailsDB00415Ampicillinapproved, vet_approvedunknownDetailsDB00493CefotaximeapprovedunknownDetailsDB00713Oxacillinapproved, investigationalunknownDetailsDB01053Benzylpenicillinapproved, vet_approvedunknowninhibitorDetailsDB00781Polymyxin Bapproved, vet_approvedunknownDetailsDB00722Lisinoprilapproved, investigationalunknownsubstrateDetails"
                    }
                }
            ],
            "enzymes": [
                {
                    "Label": "Beta-lactamase TEM",
                    "Detailed Info": {
                        "Name": "Beta-lactamase TEM",
                        "Synonyms": "3.5.2.6\nIRT-4\nPenicillinase\nTEM-1\nTEM-16/CAZ-7\nTEM-2\nTEM-24/CAZ-6\nTEM-3\nTEM-4\nTEM-5\nTEM-6\nTEM-8/CAZ-2",
                        "Gene Name": "bla",
                        "Organism": "Escherichia coli",
                        "Amino acid sequence": ">lcl|BSEQ0022085|Beta-lactamase TEM\nMSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP\nEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL\nCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM\nPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS\nRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW",
                        "Number of residues": "286",
                        "Molecular Weight": "31514.865",
                        "Theoretical pI": "5.92",
                        "GO Classification": "Functionsbeta-lactamase activityProcessesbeta-lactam antibiotic catabolic process / response to antibiotic",
                        "General Function": "TEM-type are the most prevalent beta-lactamases in enterobacteria; they hydrolyze the beta-lactam bond in susceptible beta-lactam antibiotics, thus conferring resistance to penicillins and cephalosporins. TEM-3 and TEM-4 are capable of hydrolyzing cefotaxime and ceftazidime. TEM-5 is capable of hydrolyzing ceftazidime. TEM-6 is capable of hydrolyzing ceftazidime and aztreonam. TEM-8/CAZ-2, TEM-16/CAZ-7 and TEM-24/CAZ-6 are markedly active against ceftazidime. IRT-4 shows resistance to beta-lactamase inhibitors.",
                        "Specific Function": "Beta-lactamase activity",
                        "Pfam Domain Function": "Beta-lactamase (PF00144)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Cytoplasmic",
                        "Gene sequence": ">lcl|BSEQ0007458|1191 bp\nATGAAATCTAACAATGCGCTCATCGTCATCCTCGGCACCGTCACCCTGGATGCTGTAGGC\nATAGGCTTGGTTATGCCGGTACTGCCGGGCCTCTTGCGGGATATCGTCCATTCCGACAGC\nATCGCCAGTCACTATGGCGTGCTGCTAGCGCTATATGCGTTGATGCAATTTCTATGCGCA\nCCCGTTCTCGGAGCACTGTCCGACCGCTTTGGCCGCCGCCCAGTCCTGCTCGCTTCGCTA\nCTTGGAGCCACTATCGACTACGCGATCATGGCGACCACACCCGTCCTGTGGATCCTCTAC\nGCCGGACGCATCGTGGCCGGCATCACCGGCGCCACAGGTGCGGTTGCTGGCGCCTATATC\nGCCGACATCACCGATGGGGAAGATCGGGCTCGCCACTTCGGGCTCATGAGCGCTTGTTTC\nGGCGTGGGTATGGTGGCAGGCCCCGTGGCCGGGGGACTGTTGGGCGCCATCTCCTTGCAT\nGCACCATTCCTTGCGGCGGCGGTGCTCAACGGCCTCAACCTACTACTGGGCTGCTTCCTA\nATGCAGGAGTCGCATAAGGGAGAGCGTCGACCGATGCCCTTGAGAGCCTTCAACCCAGTC\nAGCTCCTTCCGGTGGGCGCGGGGCATGACTATCGTCGCCGCACTTATGACTGTCTTCTTT\nATCATGCAACTCGTAGGACAGGTGCCGGCAGCGCTCTGGGTCATTTTCGGCGAGGACCGC\nTTTCGCTGGAGCGCGACGATGATCGGCCTGTCGCTTGCGGTATTCGGAATCTTGCACGCC\nCTCGCTCAAGCCTTCGTCACTGGTCCCGCCACCAAACGTTTCGGCGAGAAGCAGGCCATT\nATCGCCGGCATGGCGGCCGACGCGCTGGGCTACGTCTTGCTGGCGTTCGCGACGCGAGGC\nTGGATGGCCTTCCCCATTATGATTCTTCTCGCTTCCGGCGGCATCGGGATGCCCGCGTTG\nCAGGCCATGCTGTCCAGGCAGGTAGATGACGACCATCAGGGACAGCTTCAAGGATCGCTC\nGCGGCTCTTACCAGCCTAACTTCGATCACTGGACCGCTGATCGTCACGGCGATTTATGCC\nGCCTCGGCGAGCACATGGAACGGGTTGGCATGGATTGTAGGCGCCGCCCTATACCTTGTC\nTGCCTCCCCGCGTTGCGTCGCGGTGCATGGAGCCGGGCCACCTCGACCTGA",
                        "Chromosome Location": "Not Available",
                        "Locus": "Not Available",
                        "External Identifiers": "ResourceLinkUniProtKB IDP62593UniProtKB Entry NameBLAT_ECOLXGenBank Protein ID208959GenBank Gene IDJ01749",
                        "General References": "Sutcliffe JG: Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc Natl Acad Sci U S A. 1978 Aug;75(8):3737-41. [Article] Sutcliffe JG: Complete nucleotide sequence of the Escherichia coli plasmid pBR322. Cold Spring Harb Symp Quant Biol. 1979;43 Pt 1:77-90. [Article] Ohtsubo H, Ryder TB, Maeda Y, Armstrong K, Ohtsubo E: DNA replication of the resistance plasmid R100 and its control. Adv Biophys. 1986;21:115-33. [Article] Ambler RP, Scott GK: Partial amino acid sequence of penicillinase coded by Escherichia coli plasmid R6K. Proc Natl Acad Sci U S A. 1978 Aug;75(8):3732-6. [Article] Mabilat C, Lourencao-Vital J, Goussard S, Courvalin P: A new example of physical linkage between Tn1 and Tn21: the antibiotic multiple-resistance region of plasmid pCFF04 encoding extended-spectrum beta-lactamase TEM-3. Mol Gen Genet. 1992 Oct;235(1):113-21. [Article] Sougakoff W, Petit A, Goussard S, Sirot D, Bure A, Courvalin P: Characterization of the plasmid genes blaT-4 and blaT-5 which encode the broad-spectrum beta-lactamases TEM-4 and TEM-5 in enterobacteriaceae. Gene. 1989 May 30;78(2):339-48. [Article] Goussard S, Sougakoff W, Mabilat C, Bauernfeind A, Courvalin P: An IS1-like element is responsible for high-level synthesis of extended-spectrum beta-lactamase TEM-6 in Enterobacteriaceae. J Gen Microbiol. 1991 Dec;137(12):2681-7. [Article] Chanal C, Poupart MC, Sirot D, Labia R, Sirot J, Cluzel R: Nucleotide sequences of CAZ-2, CAZ-6, and CAZ-7 beta-lactamase genes. Antimicrob Agents Chemother. 1992 Sep;36(9):1817-20. [Article] Brun T, Peduzzi J, Canica MM, Paul G, Nevot P, Barthelemy M, Labia R: Characterization and amino acid sequence of IRT-4, a novel TEM-type enzyme with a decreased susceptibility to beta-lactamase inhibitors. FEMS Microbiol Lett. 1994 Jul 1;120(1-2):111-7. [Article] Jelsch C, Lenfant F, Masson JM, Samama JP: Beta-lactamase TEM1 of E. coli. Crystal structure determination at 2.5 A resolution. FEBS Lett. 1992 Mar 9;299(2):135-42. [Article] Jelsch C, Mourey L, Masson JM, Samama JP: Crystal structure of Escherichia coli TEM1 beta-lactamase at 1.8 A resolution. Proteins. 1993 Aug;16(4):364-83. [Article] Strynadka NC, Jensen SE, Alzari PM, James MN: A potent new mode of beta-lactamase inhibition revealed by the 1.7 A X-ray crystallographic structure of the TEM-1-BLIP complex. Nat Struct Biol. 1996 Mar;3(3):290-7. [Article] Maveyraud L, Pratt RF, Samama JP: Crystal structure of an acylation transition-state analog of the TEM-1 beta-lactamase. Mechanistic implications for class A beta-lactamases. Biochemistry. 1998 Feb 24;37(8):2622-8. [Article] Swaren P, Golemi D, Cabantous S, Bulychev A, Maveyraud L, Mobashery S, Samama JP: X-ray structure of the Asn276Asp variant of the Escherichia coli TEM-1 beta-lactamase: direct observation of electrostatic modulation in resistance to inactivation by clavulanic acid. Biochemistry. 1999 Jul 27;38(30):9570-6. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB074641(R)-1-ACETAMIDO-2-(3-CARBOXY-2-HYDROXYPHENYL)ETHYL BORONIC ACIDexperimentalunknownDetailsDB026141(R)-1-Acetamido-2-(3-Carboxyphenyl)Ethyl Boronic AcidexperimentalunknownDetailsDB07466(1R)-2-PHENYLACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACIDexperimentalunknownDetailsDB04035Ceftazidime BATSIexperimentalunknownDetailsDB04037N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-AmineexperimentalunknownDetailsDB07599[(2-AMINO-ALPHA-METHOXYIMINO-4-THIAZOLYLACETYL)AMINO]METHYLBORONIC ACIDexperimentalunknownDetailsDB02642[[N-(Benzyloxycarbonyl)Amino]Methyl]PhosphateexperimentalunknownDetailsDB044303-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-AcrylonitrileexperimentalunknownDetailsDB02841[(2-Ethoxy-1-Naphthoyl)Amino]Methylboronic AcidexperimentalunknownDetailsDB085513-{(R)-(Dihydroxyboryl)[(2-thienylacetyl)amino]methyl}benzoic acidexperimentalunknownDetailsDB09060AvibactamapprovedyesinhibitorDetailsDB12107Vaborbactamapproved, investigationalyesinhibitorDetailsDB12377Relebactamapproved, investigationalyesinhibitorDetailsDB01598ImipenemapprovednosubstrateDetailsDB01053Benzylpenicillinapproved, vet_approvedunknownsubstrateDetails"
                    }
                }
            ],
            "carriers": [
                {
                    "Label": "Serum albumin",
                    "Detailed Info": {
                        "Name": "Serum albumin",
                        "Synonyms": "Serum albumin precursor",
                        "Gene Name": "ALB",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0001058|Serum albumin\nMKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPF\nEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEP\nERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLF\nFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAV\nARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLK\nECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYAR\nRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFE\nQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVV\nLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTL\nSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLV\nAASQAALGL",
                        "Number of residues": "609",
                        "Molecular Weight": "69365.94",
                        "Theoretical pI": "6.21",
                        "GO Classification": "Functionsantioxidant activity / chaperone binding / copper ion binding / DNA binding / drug binding / fatty acid binding / pyridoxal phosphate binding / toxic substance bindingProcessesbile acid and bile salt transport / bile acid metabolic process / blood coagulation / cellular response to starvation / hemolysis by symbiont of host erythrocytes / lipoprotein metabolic process / maintenance of mitochondrion location / negative regulation of apoptotic process / negative regulation of programmed cell death / platelet activation / platelet degranulation / receptor-mediated endocytosis / retina homeostasis / small molecule metabolic process / sodium-independent organic anion transport / transmembrane transport / transportComponentsblood microparticle / endoplasmic reticulum / extracellular exosome / extracellular region / extracellular space / Golgi apparatus / myelin sheath / nucleus / platelet alpha granule lumen / protein complex",
                        "General Function": "Toxic substance binding",
                        "Specific Function": "Serum albumin, the main protein of plasma, has a good binding capacity for water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin and drugs. Its main function is the regulation of the colloidal osmotic pressure of blood. Major zinc transporter in plasma, typically binds about 80% of all plasma zinc.",
                        "Pfam Domain Function": "Serum_albumin (PF00273)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Secreted",
                        "Gene sequence": ">lcl|BSEQ0010372|Serum albumin (ALB)\nATGAAGTGGGTAACCTTTATTTCCCTTCTTTTTCTCTTTAGCTCGGCTTATTCCAGGGGT\nGTGTTTCGTCGAGATGCACACAAGAGTGAGGTTGCTCATCGGTTTAAAGATTTGGGAGAA\nGAAAATTTCAAAGCCTTGGTGTTGATTGCCTTTGCTCAGTATCTTCAGCAGTGTCCATTT\nGAAGATCATGTAAAATTAGTGAATGAAGTAACTGAATTTGCAAAAACATGTGTTGCTGAT\nGAGTCAGCTGAAAATTGTGACAAATCACTTCATACCCTTTTTGGAGACAAATTATGCACA\nGTTGCAACTCTTCGTGAAACCTATGGTGAAATGGCTGACTGCTGTGCAAAACAAGAACCT\nGAGAGAAATGAATGCTTCTTGCAACACAAAGATGACAACCCAAACCTCCCCCGATTGGTG\nAGACCAGAGGTTGATGTGATGTGCACTGCTTTTCATGACAATGAAGAGACATTTTTGAAA\nAAATACTTATATGAAATTGCCAGAAGACATCCTTACTTTTATGCCCCGGAACTCCTTTTC\nTTTGCTAAAAGGTATAAAGCTGCTTTTACAGAATGTTGCCAAGCTGCTGATAAAGCTGCC\nTGCCTGTTGCCAAAGCTCGATGAACTTCGGGATGAAGGGAAGGCTTCGTCTGCCAAACAG\nAGACTCAAGTGTGCCAGTCTCCAAAAATTTGGAGAAAGAGCTTTCAAAGCATGGGCAGTA\nGCTCGCCTGAGCCAGAGATTTCCCAAAGCTGAGTTTGCAGAAGTTTCCAAGTTAGTGACA\nGATCTTACCAAAGTCCACACGGAATGCTGCCATGGAGATCTGCTTGAATGTGCTGATGAC\nAGGGCGGACCTTGCCAAGTATATCTGTGAAAATCAAGATTCGATCTCCAGTAAACTGAAG\nGAATGCTGTGAAAAACCTCTGTTGGAAAAATCCCACTGCATTGCCGAAGTGGAAAATGAT\nGAGATGCCTGCTGACTTGCCTTCATTAGCTGCTGATTTTGTTGAAAGTAAGGATGTTTGC\nAAAAACTATGCTGAGGCAAAGGATGTCTTCCTGGGCATGTTTTTGTATGAATATGCAAGA\nAGGCATCCTGATTACTCTGTCGTGCTGCTGCTGAGACTTGCCAAGACATATGAAACCACT\nCTAGAGAAGTGCTGTGCCGCTGCAGATCCTCATGAATGCTATGCCAAAGTGTTCGATGAA\nTTTAAACCTCTTGTGGAAGAGCCTCAGAATTTAATCAAACAAAATTGTGAGCTTTTTGAG\nCAGCTTGGAGAGTACAAATTCCAGAATGCGCTATTAGTTCGTTACACCAAGAAAGTACCC\nCAAGTGTCAACTCCAACTCTTGTAGAGGTCTCAAGAAACCTAGGAAAAGTGGGCAGCAAA\nTGTTGTAAACATCCTGAAGCAAAAAGAATGCCCTGTGCAGAAGACTATCTATCCGTGGTC\nCTGAACCAGTTATGTGTGTTGCATGAGAAAACGCCAGTAAGTGACAGAGTCACCAAATGC\nTGCACAGAATCCTTGGTGAACAGGCGACCATGCTTTTCAGCTCTGGAAGTCGATGAAACA\nTACGTTCCCAAAGAGTTTAATGCTGAAACATTCACCTTCCATGCAGATATATGCACACTT\nTCTGAGAAGGAGAGACAAATCAAGAAACAAACTGCACTTGTTGAGCTCGTGAAACACAAG\nCCCAAGGCAACAAAAGAGCAACTGAAAGCTGTTATGGATGATTTCGCAGCTTTTGTAGAG\nAAGTGCTGCAAGGCTGACGATAAGGAGACCTGCTTTGCCGAGGAGGGTAAAAAACTTGTT\nGCTGCAAGTCAAGCTGCCTTAGGCTTATAA",
                        "Chromosome Location": "4",
                        "Locus": "4q11-q13",
                        "External Identifiers": "ResourceLinkUniProtKB IDP02768UniProtKB Entry NameALBU_HUMANGenBank Protein ID28590GenBank Gene IDV00494GenAtlas IDALBHGNC IDHGNC:399",
                        "General References": "Lawn RM, Adelman J, Bock SC, Franke AE, Houck CM, Najarian RC, Seeburg PH, Wion KL: The sequence of human serum albumin cDNA and its expression in E. coli. Nucleic Acids Res. 1981 Nov 25;9(22):6103-114. [Article] Dugaiczyk A, Law SW, Dennison OE: Nucleotide sequence and the encoded amino acids of human serum albumin mRNA. Proc Natl Acad Sci U S A. 1982 Jan;79(1):71-5. [Article] Minghetti PP, Ruffner DE, Kuang WJ, Dennison OE, Hawkins JW, Beattie WG, Dugaiczyk A: Molecular structure of the human albumin gene is revealed by nucleotide sequence within q11-22 of chromosome 4. J Biol Chem. 1986 May 25;261(15):6747-57. [Article] Yu Y, Zhang C, Zhou G, Wu S, Qu X, Wei H, Xing G, Dong C, Zhai Y, Wan J, Ouyang S, Li L, Zhang S, Zhou K, Zhang Y, Wu C, He F: Gene expression profiling in human fetal liver and identification of tissue- and developmental-stage-specific genes through compiled expression profiles and efficient cloning of full-length cDNAs. Genome Res. 2001 Aug;11(8):1392-403. [Article] Bechtel S, Rosenfelder H, Duda A, Schmidt CP, Ernst U, Wellenreuther R, Mehrle A, Schuster C, Bahr A, Blocker H, Heubner D, Hoerlein A, Michel G, Wedler H, Kohrer K, Ottenwalder B, Poustka A, Wiemann S, Schupp I: The full-ORF clone resource of the German cDNA Consortium. BMC Genomics. 2007 Oct 31;8:399. [Article] Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Clark HF, Gurney AL, Abaya E, Baker K, Baldwin D, Brush J, Chen J, Chow B, Chui C, Crowley C, Currell B, Deuel B, Dowd P, Eaton D, Foster J, Grimaldi C, Gu Q, Hass PE, Heldens S, Huang A, Kim HS, Klimowski L, Jin Y, Johnson S, Lee J, Lewis L, Liao D, Mark M, Robbie E, Sanchez C, Schoenfeld J, Seshagiri S, Simmons L, Singh J, Smith V, Stinson J, Vagts A, Vandlen R, Watanabe C, Wieand D, Woods K, Xie MH, Yansura D, Yi S, Yu G, Yuan J, Zhang M, Zhang Z, Goddard A, Wood WI, Godowski P, Gray A: The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res. 2003 Oct;13(10):2265-70. Epub 2003 Sep 15. [Article] Urano Y, Watanabe K, Sakai M, Tamaoki T: The human albumin gene. Characterization of the 5' and 3' flanking regions and the polymorphic gene transcripts. J Biol Chem. 1986 Mar 5;261(7):3244-51. [Article] Meloun B, Moravek L, Kostka V: Complete amino acid sequence of human serum albumin. FEBS Lett. 1975 Oct 15;58(1):134-7. [Article] Corbett JM, Wheeler CH, Baker CS, Yacoub MH, Dunn MJ: The human myocardial two-dimensional gel protein database: update 1994. Electrophoresis. 1994 Nov;15(11):1459-65. [Article] Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, Thomas GR, Vandekerckhove J: Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol. 2003 May;21(5):566-9. Epub 2003 Mar 31. [Article] Mogard MH, Kobayashi R, Chen CF, Lee TD, Reeve JR Jr, Shively JE, Walsh JH: The amino acid sequence of kinetensin, a novel peptide isolated from pepsin-treated human plasma: homology with human serum albumin, neurotensin and angiotensin. Biochem Biophys Res Commun. 1986 May 14;136(3):983-8. [Article] Carraway RE, Mitra SP, Cochrane DE: Structure of a biologically active neurotensin-related peptide obtained from pepsin-treated albumin(s). J Biol Chem. 1987 May 5;262(13):5968-73. [Article] Walker JE: Lysine residue 199 of human serum albumin is modified by acetylsalicyclic acid. FEBS Lett. 1976 Jul 15;66(2):173-5. [Article] Lapolla A, Fedele D, Reitano R, Arico NC, Seraglia R, Traldi P, Marotta E, Tonani R: Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides. J Am Soc Mass Spectrom. 2004 Apr;15(4):496-509. [Article] Jacobsen C: Lysine residue 240 of human serum albumin is involved in high-affinity binding of bilirubin. Biochem J. 1978 May 1;171(2):453-9. [Article] Garlick RL, Mazer JS: The principal site of nonenzymatic glycosylation of human serum albumin in vivo. J Biol Chem. 1983 May 25;258(10):6142-6. [Article] Shaklai N, Garlick RL, Bunn HF: Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J Biol Chem. 1984 Mar 25;259(6):3812-7. [Article] Iberg N, Fluckiger R: Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites. J Biol Chem. 1986 Oct 15;261(29):13542-5. [Article] Watkins S, Madison J, Galliano M, Minchiotti L, Putnam FW: A nucleotide insertion and frameshift cause analbuminemia in an Italian family. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2275-9. [Article] Lu J, Stewart AJ, Sadler PJ, Pinheiro TJ, Blindauer CA: Albumin as a zinc carrier: properties of its high-affinity zinc-binding site. Biochem Soc Trans. 2008 Dec;36(Pt 6):1317-21. doi: 10.1042/BST0361317. [Article] Han G, Ye M, Zhou H, Jiang X, Feng S, Jiang X, Tian R, Wan D, Zou H, Gu J: Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography. Proteomics. 2008 Apr;8(7):1346-61. doi: 10.1002/pmic.200700884. [Article] Mayya V, Lundgren DH, Hwang SI, Rezaul K, Wu L, Eng JK, Rodionov V, Han DK: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal. 2009 Aug 18;2(84):ra46. doi: 10.1126/scisignal.2000007. [Article] Burkard TR, Planyavsky M, Kaupe I, Breitwieser FP, Burckstummer T, Bennett KL, Superti-Furga G, Colinge J: Initial characterization of the human central proteome. BMC Syst Biol. 2011 Jan 26;5:17. doi: 10.1186/1752-0509-5-17. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Tagliabracci VS, Wiley SE, Guo X, Kinch LN, Durrant E, Wen J, Xiao J, Cui J, Nguyen KB, Engel JL, Coon JJ, Grishin N, Pinna LA, Pagliarini DJ, Dixon JE: A Single Kinase Generates the Majority of the Secreted Phosphoproteome. Cell. 2015 Jun 18;161(7):1619-32. doi: 10.1016/j.cell.2015.05.028. [Article] Vaca Jacome AS, Rabilloud T, Schaeffer-Reiss C, Rompais M, Ayoub D, Lane L, Bairoch A, Van Dorsselaer A, Carapito C: N-terminome analysis of the human mitochondrial proteome. Proteomics. 2015 Jul;15(14):2519-24. doi: 10.1002/pmic.201400617. Epub 2015 Jun 8. [Article] Carter DC, He XM, Munson SH, Twigg PD, Gernert KM, Broom MB, Miller TY: Three-dimensional structure of human serum albumin. Science. 1989 Jun 9;244(4909):1195-8. [Article] Carter DC, He XM: Structure of human serum albumin. Science. 1990 Jul 20;249(4966):302-3. [Article] He XM, Carter DC: Atomic structure and chemistry of human serum albumin. Nature. 1992 Jul 16;358(6383):209-15. [Article] Curry S, Mandelkow H, Brick P, Franks N: Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Biol. 1998 Sep;5(9):827-35. [Article] Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K: Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng. 1999 Jun;12(6):439-46. [Article] Bhattacharya AA, Curry S, Franks NP: Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures. J Biol Chem. 2000 Dec 8;275(49):38731-8. [Article] Petitpas I, Grune T, Bhattacharya AA, Curry S: Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. J Mol Biol. 2001 Dec 14;314(5):955-60. [Article] Brennan SO, Herbert P: Albumin Canterbury (313 Lys----Asn). A point mutation in the second domain of serum albumin. Biochim Biophys Acta. 1987 Apr 8;912(2):191-7. [Article] Takahashi N, Takahashi Y, Blumberg BS, Putnam FW: Amino acid substitutions in genetic variants of human serum albumin and in sequences inferred from molecular cloning. Proc Natl Acad Sci U S A. 1987 Jul;84(13):4413-7. [Article] Takahashi N, Takahashi Y, Isobe T, Putnam FW, Fujita M, Satoh C, Neel JV: Amino acid substitutions in inherited albumin variants from Amerindian and Japanese populations. Proc Natl Acad Sci U S A. 1987 Nov;84(22):8001-5. [Article] Arai K, Ishioka N, Huss K, Madison J, Putnam FW: Identical structural changes in inherited albumin variants from different populations. Proc Natl Acad Sci U S A. 1989 Jan;86(2):434-8. [Article] Arai K, Madison J, Huss K, Ishioka N, Satoh C, Fujita M, Neel JV, Sakurabayashi I, Putnam FW: Point substitutions in Japanese alloalbumins. Proc Natl Acad Sci U S A. 1989 Aug;86(16):6092-6. [Article] Arai K, Madison J, Shimizu A, Putnam FW: Point substitutions in albumin genetic variants from Asia. Proc Natl Acad Sci U S A. 1990 Jan;87(1):497-501. [Article] Brennan SO, Myles T, Peach RJ, Donaldson D, George PM: Albumin Redhill (-1 Arg, 320 Ala----Thr): a glycoprotein variant of human serum albumin whose precursor has an aberrant signal peptidase cleavage site. Proc Natl Acad Sci U S A. 1990 Jan;87(1):26-30. [Article] Galliano M, Minchiotti L, Porta F, Rossi A, Ferri G, Madison J, Watkins S, Putnam FW: Mutations in genetic variants of human serum albumin found in Italy. Proc Natl Acad Sci U S A. 1990 Nov;87(22):8721-5. [Article] Watkins S, Madison J, Davis E, Sakamoto Y, Galliano M, Minchiotti L, Putnam FW: A donor splice mutation and a single-base deletion produce two carboxyl-terminal variants of human serum albumin. Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):5959-63. [Article] Madison J, Arai K, Sakamoto Y, Feld RD, Kyle RA, Watkins S, Davis E, Matsuda Y, Amaki I, Putnam FW: Genetic variants of serum albumin in Americans and Japanese. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9853-7. [Article] Peach RJ, Brennan SO: Structural characterization of a glycoprotein variant of human serum albumin: albumin Casebrook (494 Asp----Asn). Biochim Biophys Acta. 1991 Jul 26;1097(1):49-54. [Article] Minchiotti L, Galliano M, Stoppini M, Ferri G, Crespeau H, Rochu D, Porta F: Two alloalbumins with identical electrophoretic mobility are produced by differently charged amino acid substitutions. Biochim Biophys Acta. 1992 Mar 12;1119(3):232-8. [Article] Carlson J, Sakamoto Y, Laurell CB, Madison J, Watkins S, Putnam FW: Alloalbuminemia in Sweden: structural study and phenotypic distribution of nine albumin variants. Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8225-9. [Article] Minchiotti L, Galliano M, Zapponi MC, Tenni R: The structural characterization and bilirubin-binding properties of albumin Herborn, a [Lys240-->Glu] albumin mutant. Eur J Biochem. 1993 Jun 1;214(2):437-44. [Article] Brennan SO, Fellowes AP: Albumin Hawkes Bay; a low level variant caused by loss of a sulphydryl group at position 177. Biochim Biophys Acta. 1993 Aug 4;1182(1):46-50. [Article] Galliano M, Minchiotti L, Iadarola P, Stoppini M, Giagnoni P, Watkins S, Madison J, Putnam FW: Protein and DNA sequence analysis of a 'private' genetic variant: albumin Ortonovo (Glu-505-->Lys). Biochim Biophys Acta. 1993 Nov 25;1225(1):27-32. [Article] Madison J, Galliano M, Watkins S, Minchiotti L, Porta F, Rossi A, Putnam FW: Genetic variants of human serum albumin in Italy: point mutants and a carboxyl-terminal variant. Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6476-80. [Article] Sunthornthepvarakul T, Angkeow P, Weiss RE, Hayashi Y, Refetoff S: An identical missense mutation in the albumin gene results in familial dysalbuminemic hyperthyroxinemia in 8 unrelated families. Biochem Biophys Res Commun. 1994 Jul 29;202(2):781-7. [Article] Rushbrook JI, Becker E, Schussler GC, Divino CM: Identification of a human serum albumin species associated with familial dysalbuminemic hyperthyroxinemia. J Clin Endocrinol Metab. 1995 Feb;80(2):461-7. [Article] Wada N, Chiba H, Shimizu C, Kijima H, Kubo M, Koike T: A novel missense mutation in codon 218 of the albumin gene in a distinct phenotype of familial dysalbuminemic hyperthyroxinemia in a Japanese kindred. J Clin Endocrinol Metab. 1997 Oct;82(10):3246-50. [Article] Sunthornthepvarakul T, Likitmaskul S, Ngowngarmratana S, Angsusingha K, Kitvitayasak S, Scherberg NH, Refetoff S: Familial dysalbuminemic hypertriiodothyroninemia: a new, dominantly inherited albumin defect. J Clin Endocrinol Metab. 1998 May;83(5):1448-54. [Article] Spahr CS, Davis MT, McGinley MD, Robinson JH, Bures EJ, Beierle J, Mort J, Courchesne PL, Chen K, Wahl RC, Yu W, Luethy R, Patterson SD: Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry. I. Profiling an unfractionated tryptic digest. Proteomics. 2001 Jan;1(1):93-107. [Article] Minchiotti L, Campagnoli M, Rossi A, Cosulich ME, Monti M, Pucci P, Kragh-Hansen U, Granel B, Disdier P, Weiller PJ, Galliano M: A nucleotide insertion and frameshift cause albumin Kenitra, an extended and O-glycosylated mutant of human serum albumin with two additional disulfide bridges. Eur J Biochem. 2001 Jan;268(2):344-52. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00070Hyaluronidase (ovine)approved, investigationalunknowninhibitorDetailsDB00137Luteinapproved, investigational, nutraceuticalunknownDetailsDB00459AcitretinapprovedunknownDetailsDB00576Sulfamethizoleapproved, investigational, vet_approvedunknownDetailsDB00743Gadobenic acidapproved, investigationalunknownbinderDetailsDB00815Sodium lauryl sulfateexperimentalunknownbinderDetailsDB00936Salicylic acidapproved, investigational, vet_approvednoother/unknownDetailsDB00946Phenprocoumonapproved, investigationalnobinderregulatorDetailsDB00995Auranofinapproved, investigationalunknownDetailsDB01120GliclazideapprovedunknownDetailsDB01328Cefonicidapproved, investigationalnoother/unknownDetailsDB01329Cefoperazoneapproved, investigationalnoother/unknownDetailsDB01396Digitoxinapproved, investigationalnoDetailsDB03017Lauric acidapproved, experimentalunknownDetailsDB03193Stearic acidapproved, experimentalunknownDetailsDB03600Capric acidexperimentalnoDetailsDB03796Palmitic AcidapprovedunknownDetailsDB04224Oleic Acidapproved, investigational, vet_approvedunknownDetailsDB04557Arachidonic AcidexperimentalnoDetailsDB04711IodipamideapprovedunknownbinderDetailsDB06412Oxymetholoneapproved, illicitunknownDetailsDB01197Captoprilapprovednoother/unknownDetailsDB01050IbuprofenapprovednobinderDetailsDB00563MethotrexateapprovednobinderDetailsDB00451LevothyroxineapprovednoDetailsDB00279Liothyronineapproved, vet_approvedunknownDetailsDB00605Sulindacapproved, investigationalunknownDetailsDB00749Etodolacapproved, investigational, vet_approvedunknownDetailsDB00861Diflunisalapproved, investigationalunknownDetailsDB01009Ketoprofenapproved, vet_approvedunknownDetailsDB00586Diclofenacapproved, vet_approvedunknownDetailsDB00783Estradiolapproved, investigational, vet_approvednoDetailsDB00655EstroneapprovednoDetailsDB00624Testosteroneapproved, investigationalnobinderDetailsDB01307Insulin detemirapprovednobinderDetailsDB01418Acenocoumarolapproved, investigationalnoDetailsDB00802Alfentanilapproved, illicitunknownDetailsDB00818Propofolapproved, investigational, vet_approvednoDetailsDB00228Enfluraneapproved, investigational, vet_approvedunknownbinderDetailsDB00753Isofluraneapproved, vet_approvedunknownDetailsDB01189DesfluraneapprovedunknownbinderDetailsDB01159Halothaneapproved, vet_approvedunknownDetailsDB01236Sevofluraneapproved, vet_approvedunknownbinderDetailsDB00252Phenytoinapproved, vet_approvedunknownDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknownDetailsDB00540NortriptylineapprovednobinderDetailsDB00321AmitriptylineapprovednobinderDetailsDB00903Etacrynic acidapproved, investigationalunknownDetailsDB00695Furosemideapproved, vet_approvednobinderDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvednoDetailsDB00682WarfarinapprovednobinderregulatorDetailsDB00554Piroxicamapproved, investigationalunknownDetailsDB00573FenoprofenapprovedunknownDetailsDB00328Indomethacinapproved, investigationalunknownDetailsDB03585Oxyphenbutazoneapproved, withdrawnunknownDetailsDB00544FluorouracilapprovednoDetailsDB01232Saquinavirapproved, investigationalunknownDetailsDB01032Probenecidapproved, investigationalnoDetailsDB01044Gatifloxacinapproved, investigational, withdrawnunknownother/unknownDetailsDB01068Clonazepamapproved, illicitnoDetailsDB01147Cloxacillinapproved, investigational, vet_approvednobinderDetailsDB01327Cefazolinapprovedunknownother/unknownDetailsDB00931Metacyclineapproved, investigationalnoDetailsDB01015SulfamethoxazoleapprovednosubstrateDetailsDB00415Ampicillinapproved, vet_approvednoother/unknownDetailsDB00567Cephalexinapproved, investigational, vet_approvednobinderDetailsDB00759Tetracyclineapproved, vet_approved, withdrawnnoDetailsDB01212Ceftriaxoneapprovednoother/unknownDetailsDB01330CefotetanapprovednoDetailsDB00274Cefmetazoleapproved, investigationalnoDetailsDB00495ZidovudineapprovednoDetailsDB01397Magnesium salicylateexperimentalnoDetailsDB00788Naproxenapproved, vet_approvednoDetailsDB00334Olanzapineapproved, investigationalnobinderDetailsDB01056Tocainideapprovednoother/unknownDetailsDB01320Fosphenytoinapproved, investigationalnoother/unknownDetailsDB00712Flurbiprofenapproved, investigationalnoother/unknownDetailsDB07402AzapropazonewithdrawnunknownDetailsDB075173-CARBOXY-4-METHYL-5-PROPYL-2-FURANPROPIONICexperimentalunknownDetailsDB07992Indoxyl sulfateexperimentalunknownDetailsDB08231Myristic acidexperimentalunknownDetailsDB08496(R)-warfarinexperimentalunknownDetailsDB08735R,S-Warfarin alcoholexperimentalunknownDetailsDB08736S,R-Warfarin alcoholexperimentalunknownDetailsDB00430CefpiramideapprovedunknownDetailsDB01583LiotrixapprovedunknownDetailsDB01294Bismuth subsalicylateapproved, vet_approvednobinderDetailsDB00456Cefalotinapproved, investigational, vet_approvedunknownbinderDetailsDB01581Sulfamerazineapproved, vet_approvedunknownDetailsDB01582Sulfamethazineapproved, investigational, vet_approvedunknownDetailsDB01587KetazolamapprovedunknownDetailsDB01614Acepromazineexperimental, vet_approvedunknownDetailsDB01621Pipotiazineapproved, investigationalunknownDetailsDB04574Estrone sulfateapprovedunknownDetailsDB06710MethyltestosteroneapprovedunknownDetailsDB01622ThioproperazineexperimentalunknownDetailsDB01623ThiothixeneapprovedunknownDetailsDB06705Gadofosveset trisodiumapprovedunknownsubstrateDetailsDB00454MeperidineapprovedunknownbinderDetailsDB01016GlyburideapprovedunknownbinderDetailsDB00912Repaglinideapproved, investigationalunknownDetailsDB00731Nateglinideapproved, investigationalunknownDetailsDB08867UlipristalapprovednosubstrateDetailsDB05294VandetanibapprovedunknownbinderDetailsDB05521Telaprevirapproved, withdrawnnosubstrateDetailsDB05812AbirateroneapprovedunknownbinderDetailsDB08881VemurafenibapprovedunknownsubstrateDetailsDB08828Vismodegibapproved, investigationalunknownbinderDetailsDB08893MirabegronapprovednobinderDetailsDB00635Prednisoneapproved, vet_approvedunknownsubstrateDetailsDB08899EnzalutamideapprovednobinderDetailsDB08820IvacaftorapprovednocarrierDetailsDB00776OxcarbazepineapprovedunknownsubstrateDetailsDB06201RufinamideapprovedunknownsubstrateDetailsDB06716Fospropofolapproved, illicit, investigationalunknownsubstrateDetailsDB04855DronedaroneapprovednobinderDetailsDB06209PrasugrelapprovedunknownsubstrateDetailsDB08860PitavastatinapprovedunknownsubstrateDetailsDB01183Naloxoneapproved, vet_approvedunknownbinderDetailsDB01242Clomipramineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateDetailsDB00472Fluoxetineapproved, vet_approvedunknownsubstrateDetailsDB00317Gefitinibapproved, investigationalunknownsubstrateDetailsDB00619ImatinibapprovednobinderDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateDetailsDB00678LosartanapprovedunknownsubstrateDetailsDB00412Rosiglitazoneapproved, investigationalunknownsubstrateDetailsDB01098RosuvastatinapprovedunknownsubstrateDetailsDB00864Tacrolimusapproved, investigationalunknownsubstrateDetailsDB00717NorethisteroneapprovedunknownsubstrateDetailsDB08931RiociguatapprovedunknownsubstrateDetailsDB08895Tofacitinibapproved, investigationalunknownDetailsDB08932MacitentanapprovednobinderDetailsDB06290SimeprevirapprovednobinderDetailsDB00493CefotaximeapprovedunknownDetailsDB09280LumacaftorapprovednocarrierDetailsDB09130Copperapproved, investigationalnobinderDetailsDB11093Calcium citrateapproved, investigationalnosubstrateDetailsDB11348Calcium PhosphateapprovednosubstrateDetailsDB11575GrazoprevirapprovednosubstrateDetailsDB11943Delafloxacinapproved, investigationalnosubstrateDetailsDB01685TopiroxostatexperimentalunknownbinderDetailsDB09093Chlortetracyclineapproved, investigational, vet_approvednoDetailsDB06796Mangafodipirapproved, investigational, withdrawnunknownbinderDetailsDB09262ImidafenacininvestigationalnosubstrateDetailsDB00276Amsacrineapproved, investigationalunknownDetailsDB11359GuaiacolapprovedunknownDetailsDB03255Phenolapproved, experimentalunknownDetailsDB06728AnilineexperimentalunknownDetailsDB06713Norelgestrominapproved, investigationalunknownDetailsDB01370Aluminiumapproved, investigationalunknownDetailsDB13014HypericininvestigationalunknownDetailsDB01057EchothiophateapprovedunknownDetailsDB11397Dichlorvosvet_approvedunknownDetailsDB00677Isoflurophateapproved, investigational, withdrawnunknownDetailsDB00943Zalcitabineapproved, investigationalunknownDetailsDB01072Atazanavirapproved, investigationalnobinderDetailsDB00649Stavudineapproved, investigationalunknownDetailsDB00900DidanosineapprovedunknownDetailsDB00625Efavirenzapproved, investigationalunknownDetailsDB00879Emtricitabineapproved, investigationalunknownbinderDetailsDB00220NelfinavirapprovednobinderDetailsDB00238NevirapineapprovedunknownDetailsDB00503Ritonavirapproved, investigationalunknownsubstrateDetailsDB00709Lamivudineapproved, investigationalunknownDetailsDB04216Quercetinexperimental, investigationalunknownDetailsDB00997Doxorubicinapproved, investigationalunknownDetailsDB04816Dantronapproved, investigational, withdrawnunknownDetailsDB00755Tretinoinapproved, investigational, nutraceuticalunknownbinderDetailsDB00515CisplatinapprovedunknownDetailsDB00162Vitamin Aapproved, nutraceutical, vet_approvedunknownbinderDetailsDB04690CamptothecinexperimentalunknownDetailsDB02709ResveratrolinvestigationalunknownDetailsDB00744Zileutonapproved, investigational, withdrawnunknownDetailsDB04539GlyphosateexperimentalunknownDetailsDB11590ThimerosalapprovedunknownDetailsDB05134TanespimycininvestigationalunknownDetailsDB01124Tolbutamideapproved, investigationalunknownDetailsDB01276Exenatideapproved, investigationalunknownDetailsDB00414Acetohexamideapproved, investigational, withdrawnunknownDetailsDB00458ImipramineapprovedunknownDetailsDB00159Icosapentapproved, nutraceuticalnobinderDetailsDB00951Isoniazidapproved, investigationalunknownDetailsDB01104SertralineapprovedunknownbinderDetailsDB09383Meprednisoneapproved, investigationalunknownDetailsDB00266DicoumarolapprovedunknownDetailsDB04828ZomepiracwithdrawnunknownDetailsDB00500TolmetinapprovedunknownDetailsDB11217ArbutinapprovedunknownDetailsDB09526Hydroquinoneapproved, investigationalunknownDetailsDB00784Mefenamic acidapprovedunknownDetailsDB00313Valproic acidapproved, investigationalunknownDetailsDB01169Arsenic trioxideapproved, investigationalnosubstrateDetailsDB11828Neratinibapproved, investigationalnosubstrateDetailsDB00607Nafcillinapproved, investigationalunknownDetailsDB12483Copanlisibapproved, investigationalunknownsubstrateDetailsDB00512VancomycinapprovednosubstrateDetailsDB12001Abemaciclibapproved, investigationalunknownbinderDetailsDB08864RilpivirineapprovednobinderDetailsDB13928Semaglutideapproved, investigationalnosubstrateDetailsDB09087Potassium alumapprovedunknownbinderDetailsDB09223BlonanserininvestigationalnosubstrateDetailsDB09236Lacidipineapproved, investigationalunknownbinderDetailsDB09124Medrogestoneapproved, withdrawnnobinderDetailsDB11827Ertugliflozinapproved, investigationalnobinderDetailsDB09139Technetium Tc-99m oxidronateapprovednobinderDetailsDB13943Testosterone cypionateapprovednoother/unknownDetailsDB13944Testosterone enanthateapprovednoother/unknownDetailsDB13946Testosterone undecanoateapproved, investigationalnobinderDetailsDB13952Estradiol acetateapproved, investigational, vet_approvednoDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvednoDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvednoDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvednoDetailsDB13956Estradiol valerateapproved, investigational, vet_approvednoDetailsDB11638Artenimolapproved, experimental, investigationalunknownligandDetailsDB01420Testosterone propionateapproved, investigational, vet_approved, withdrawnnosubstrateDetailsDB09195LorpiprazoleapprovednosubstrateDetailsDB09204ArotinololinvestigationalnosubstrateDetailsDB08814Triflusalapproved, investigationalnosubstrateDetailsDB09229AranidipineexperimentalnobinderDetailsDB09333Iopodic acidapproved, investigational, withdrawnnosubstrateDetailsDB09347Acetrizoic acidwithdrawnnobinderDetailsDB09348Propiolactoneapproved, withdrawnnobinderDetailsDB11130Opiumapproved, illicitnobinderDetailsDB06778Cupric sulfateapprovedunknownDetailsDB09053IbrutinibapprovednosubstrateDetailsDB11182Rose bengalapproved, investigationalunknownbinderDetailsDB13967Patent BlueapprovedyesbinderDetailsDB13909Bismuth subgallateapprovedunknowncarrierDetailsDB09418Potassium perchlorateapproved, investigationalunknownbinderDetailsDB11641Vinflunineapproved, investigationalnosubstrateDetailsDB13421Edoxudineapproved, investigational, withdrawnnobinderDetailsDB11134Cupric oxideapprovedunknownbinderDetailsDB11148Butambenapproved, withdrawnnosubstrateDetailsDB11637Delamanidapproved, investigationalunknownsubstrateDetailsDB13751Glycyrrhizic acidapproved, experimentalnobinderDetailsDB12965Silverapproved, investigationalunknownbinderDetailsDB14185Aripiprazole lauroxilapproved, investigationalunknownbinderDetailsDB14481Calcium phosphate dihydrateapprovednoDetailsDB14517Aluminium phosphateapproved, investigationalunknownDetailsDB14518Aluminum acetateapproved, investigationalunknownDetailsDB00432Trifluridineapproved, investigationalunknownbinderDetailsDB14582Patisiranapproved, investigationalunknownligandDetailsDB09213Dexibuprofenapproved, investigationalnoDetailsDB12455Omadacyclineapproved, investigationalunknownDetailsDB12836Grapiprantinvestigational, vet_approvednosubstrateDetailsDB11753Rifamycinapproved, investigationalnosubstrateDetailsDB11963Dacomitinibapproved, investigationalnobinderDetailsDB11855Revefenacinapproved, investigationalnobinderDetailsDB12141Gilteritinibapproved, investigationalnobinderDetailsDB06480PrucaloprideapprovedunknownbinderDetailsDB11978Glasdegibapproved, investigationalnobinderDetailsDB00214TorasemideapprovedunknownsubstrateDetailsDB00227Lovastatinapproved, investigationalnosubstrateDetailsDB09564Insulin degludecapprovednobinderDetailsDB00245BenzatropineapprovednobinderDetailsDB00264Metoprololapproved, investigationalnobinderDetailsDB00286Conjugated estrogensapprovednobinderDetailsDB00289AtomoxetineapprovednobinderDetailsDB00294Etonogestrelapproved, investigationalnobinderDetailsDB00295Morphineapproved, investigationalnobinderDetailsDB00310ChlorthalidoneapprovednoDetailsDB00304DesogestrelapprovednobinderDetailsDB00327Hydromorphoneapproved, illicitnobinderDetailsDB09073Palbociclibapproved, investigationalnobinderDetailsDB00332Ipratropiumapproved, experimentalnobinderDetailsDB01142Doxepinapproved, investigationalnobinderDetailsDB01076AtorvastatinapprovednobinderDetailsDB06655LiraglutideapprovedunknownbinderDetailsDB01235LevodopaapprovedunknownbinderDetailsDB01238Aripiprazoleapproved, investigationalunknownbinderDetailsDB00404Alprazolamapproved, illicit, investigationalunknownbinderDetailsDB00421SpironolactoneapprovedunknownbinderDetailsDB00335AtenololapprovednosubstrateDetailsDB01126Dutasterideapproved, investigationalnobinderDetailsDB09299Tenofovir alafenamideapprovednobinderDetailsDB00343Diltiazemapproved, investigationalnobinderDetailsDB14126Tenofovirexperimental, investigationalnobinderDetailsDB00476DuloxetineapprovedunknownligandDetailsDB00497Oxycodoneapproved, illicit, investigationalunknownbinderDetailsDB00481Raloxifeneapproved, investigationalnobinderDetailsDB00537Ciprofloxacinapproved, investigationalunknownbinderDetailsDB00461NabumetoneapprovedunknownDetailsDB00982IsotretinoinapprovedunknownbinderDetailsDB00584Enalaprilapproved, vet_approvednobinderDetailsDB01067Glipizideapproved, investigationalnobinderDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedunknownbinderDetailsDB00737MeclizineapprovednobinderDetailsDB00768OlopatadineapprovednobinderDetailsDB00571Propranololapproved, investigationalunknownDetailsDB00575ClonidineapprovedunknownbinderDetailsDB00787AcyclovirapprovedunknownbinderDetailsDB00490Buspironeapproved, investigationalunknownbinderDetailsDB01029Irbesartanapproved, investigationalunknownbinderDetailsDB06282LevocetirizineapprovedunknownbinderDetailsDB00598LabetalolapprovedunknownsubstrateDetailsDB01026Ketoconazoleapproved, investigationalunknownligandDetailsDB00675TamoxifenapprovedunknownsubstrateDetailsDB12978Pexidartinibapproved, investigationalunknownbinderDetailsDB01136Carvedilolapproved, investigationalunknownbinderDetailsDB04861Nebivololapproved, investigationalunknownbinderDetailsDB01611HydroxychloroquineapprovedunknownbinderDetailsDB01045RifampicinapprovedunknownligandDetailsDB01394ColchicineapprovedunknownbinderDetailsDB00333MethadoneapprovednoDetailsDB11757Istradefyllineapproved, investigationalunknownbinderDetailsDB00620Triamcinoloneapproved, vet_approvedunknownbinderDetailsDB00924CyclobenzaprineapprovedunknownsubstrateDetailsDB00881Quinaprilapproved, investigationalunknownbinderDetailsDB09079NintedanibapprovedunknownsubstrateDetailsDB00999Hydrochlorothiazideapproved, vet_approvedunknownbinderDetailsDB01241GemfibrozilapprovedunknownbinderDetailsDB01039FenofibrateapprovedunknownbinderDetailsDB01062Oxybutyninapproved, investigationalunknownbinderDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknownbinderDetailsDB01275HydralazineapprovedunknownbinderDetailsDB01195Flecainideapproved, withdrawnunknownbinderDetailsDB00687Fludrocortisoneapproved, investigationalunknownsubstrateDetailsDB00316AcetaminophenapprovedunknownbinderDetailsDB00278Argatrobanapproved, investigationalunknownbinderDetailsDB06216AsenapineapprovedunknownbinderDetailsDB15444Elexacaftorapproved, investigationalunknownsubstrateDetailsDB00860Prednisoloneapproved, vet_approvedunknownbinderDetailsDB15566Prednisolone acetateapproved, vet_approvedunknownbinderDetailsDB11703Acalabrutinibapproved, investigationalunknownbinderDetailsDB14513Magnesiumapproved, experimental, investigationalunknownDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknownbinderDetailsDB00661VerapamilapprovedunknownsubstrateDetailsDB00273TopiramateapprovedunknownbinderDetailsDB06119Cenobamateapproved, investigationalunknownbinderDetailsDB01222BudesonideapprovedunknownbinderDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknownbinderDetailsDB00950Fexofenadineapproved, investigationalunknownsubstrateDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownbinderDetailsDB09237Levamlodipineapproved, investigationalunknownbinderDetailsDB12941Darolutamideapproved, investigationalunknownbinderDetailsDB14879Cefiderocolapproved, investigationalnoligandDetailsDB00852PseudoephedrineapprovedunknownbinderDetailsDB00983Formoterolapproved, investigationalunknownsubstrateDetailsDB00993AzathioprineapprovedunknownbinderDetailsDB00557HydroxyzineapprovedunknownsubstrateregulatorDetailsDB01118Amiodaroneapproved, investigationalunknownbinderDetailsDB01069Promethazineapproved, investigationalunknownbinderDetailsDB01115NifedipineapprovedunknownbinderDetailsDB01132Pioglitazoneapproved, investigationalunknownsubstrateDetailsDB00814Meloxicamapproved, vet_approvedunknownDetailsDB00938SalmeterolapprovedunknownbinderDetailsDB00878Chlorhexidineapproved, vet_approved, withdrawnunknownsubstrateDetailsDB01006Letrozoleapproved, investigationalunknownbinderDetailsDB00246ZiprasidoneapprovedunknownDetailsDB01060Amoxicillinapproved, vet_approvedunknownbinderDetailsDB01137Levofloxacinapproved, investigationalunknownsubstrateDetailsDB09100Thyroid, porcineapprovedunknownbinderDetailsDB01013Clobetasol propionateapprovedunknownbinderDetailsDB00957Norgestimateapproved, investigationalunknownbinderDetailsDB00977EthinylestradiolapprovedunknownbinderDetailsDB00555Lamotrigineapproved, investigationalunknownsubstrateDetailsDB01264DarunavirapprovedunknownsubstrateDetailsDB00608Chloroquineapproved, investigational, vet_approvedunknownbinderDetailsDB12466Favipiravirapproved, investigationalunknowncarrierDetailsDB01601LopinavirapprovedunknownsubstrateDetailsDB14999Human interferon betaapproved, investigationalunknownbinderDetailsDB00126Ascorbic acidapproved, nutraceuticalunknownbinderDetailsDB00443Betamethasoneapproved, vet_approvedunknownDetailsDB05382Iodineapproved, investigationalunknownbinderDetailsDB11642Pitolisantapproved, investigationalnobinderDetailsDB00152Thiamineapproved, investigational, nutraceutical, vet_approvedunknownbinderDetailsDB00165Pyridoxineapproved, investigational, nutraceutical, vet_approvedunknownbinderDetailsDB00595Oxytetracyclineapproved, investigational, vet_approvedunknownbinderDetailsDB00870Suprofenapproved, withdrawnunknownbinderDetailsDB00774Hydroflumethiazideapproved, investigational, withdrawnunknownbinderDetailsDB09241Methylene blueapproved, investigationalunknownbinderDetailsDB15534Colchiceineapproved, experimentalunknownsubstrateDetailsDB01053Benzylpenicillinapproved, vet_approvedunknownbinderDetailsDB01324PolythiazideapprovedunknownbinderDetailsDB07565Chloramphenicol succinateapprovedunknownbinderDetailsDB01914D-glucoseapproved, investigational, vet_approvedunknownbinderDetailsDB14533Zinc chlorideapproved, investigationalunknownbinderDetailsDB11689Selumetinibapproved, investigationalunknowncarrierDetailsDB04911Oritavancinapproved, investigationalunknownbinderDetailsDB14548Zinc sulfate, unspecified formapproved, experimentalunknownbinderDetailsDB00734Risperidoneapproved, investigationalunknownbinderDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknownbinderDetailsDB01364EphedrineapprovedunknownbinderDetailsDB00237Butabarbitalapproved, illicitunknownbinderDetailsDB01133Tiludronic acidapproved, investigational, vet_approvedunknownbinderDetailsDB14840RipretinibapprovedunknownbinderDetailsDB00845Clofazimineapproved, investigationalunknownbinderDetailsDB00842OxazepamapprovedunknownbinderDetailsDB00714Apomorphineapproved, investigationalunknownbinderDetailsDB09274Artesunateapproved, investigationalunknownbinderDetailsDB15690Fluoroestradiol F-18approvedunknownbinderDetailsDB00808IndapamideapprovedunknownbinderDetailsDB08816TicagrelorapprovedunknownbinderDetailsDB14669Betamethasone phosphateapproved, vet_approvedunknownbinderDetailsDB12674Lurbinectedinapproved, investigationalunknownbinderDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknownbinderDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknownbinderDetailsDB00104Octreotideapproved, investigationalunknownbinderDetailsDB11677Triheptanoinapproved, investigationalunknownbinderDetailsDB12404Remimazolamapproved, investigationalunknownbinderDetailsDB11796Fostemsavirapproved, investigationalunknowncarrierDetailsDB15305Risdiplamapproved, investigationalunknownbinderDetailsDB11820Nifurtimoxapproved, investigationalunknownbinderDetailsDB00847Cysteamineapproved, investigationalunknownbinderDetailsDB15093Somapacitanapproved, investigationalunknownbinderDetailsDB00908Quinidineapproved, investigationalunknownbinderDetailsDB15935Lumasiranapproved, investigationalnobinderDetailsDB04951Pirfenidoneapproved, investigationalunknownbinderDetailsDB11853Relugolixapproved, investigationalunknownbinderDetailsDB01380Cortisone acetateapproved, investigationalunknownbinderDetailsDB15248Bulevirtideapproved, investigationalunknownbinderDetailsDB00501Cimetidineapproved, investigationalunknownsubstrateDetailsDB15456Vericiguatapproved, investigationalunknownbinderDetailsDB11751Cabotegravirapproved, investigationalunknownbinderDetailsDB15133Tepotinibapproved, investigationalunknownbinderDetailsDB06151Acetylcysteineapproved, investigationalunknownbinderDetailsDB00346Alfuzosinapproved, investigationalunknownbinderDetailsDB00376TrihexyphenidylapprovedunknownbinderDetailsDB00391Sulpirideapproved, investigationalnobinderDetailsDB01083Orlistatapproved, investigationalunknownbinderDetailsDB08877RuxolitinibapprovedunknownbinderDetailsDB00640Adenosineapproved, investigationalunknownbinderDetailsDB00853Temozolomideapproved, investigationalnobinderDetailsDB06237AvanafilapprovedunknownbinderDetailsDB04854FebuxostatapprovedunknownbinderDetailsDB01086Benzocaineapproved, investigationalunknownbinderDetailsDB11800Tivozanibapproved, investigationalunknownbinderDetailsDB00080Daptomycinapproved, investigationalnobinderDetailsDB00434CyproheptadineapprovedunknownbinderDetailsDB00083Botulinum toxin type Aapproved, investigationalunknownbinderDetailsDB00968MethyldopaapprovednobinderDetailsDB08995Diosminapproved, investigationalunknownbinderDetailsDB08822Azilsartan medoxomilapproved, investigationalnobinderDetailsDB00438CeftazidimeapprovednobinderDetailsDB09069Trimetazidineapproved, investigationalunknownbinderDetailsDB00601Linezolidapproved, investigationalnobinderDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownbinderDetailsDB12235Estetrolapproved, investigationalunknownbinderDetailsDB01064Isoprenalineapproved, investigationalunknownbinderDetailsDB12471Ibrexafungerpapproved, investigationalunknownbinderDetailsDB06695Dabigatran etexilateapprovedunknownbinderDetailsDB16165Finerenoneapproved, investigationalunknownbinderDetailsDB16703Belumosudilapproved, investigationalnobinderDetailsDB00877Sirolimusapproved, investigationalnobinderDetailsDB06234Maribavirapproved, investigationalnobinderDetailsDB14973Abrocitinibapproved, investigationalnobinderDetailsDB15575Padeliporfinapproved, experimentalunknownbinderDetailsDB09070Tiboloneapproved, investigationalunknownbinderDetailsDB04847Roxadustatapproved, investigationalunknownbinderDetailsDB09074OlaparibapprovedunknownbinderDetailsDB15171Tirzepatideapproved, investigationalunknownbinderDetailsDB13959Medium-chain triglyceridesapprovedunknownbinderDetailsDB06813Pralatrexateapproved, investigationalnobinderDetailsDB00342Terfenadineapproved, withdrawnunknownbinderregulatorDetailsDB13514Pranoprofenexperimental, investigationalnoregulatorDetailsDB00427TriprolidineapprovedunknownbinderregulatorDetailsDB00485Dicloxacillinapproved, investigational, vet_approvedunknownbinderregulatorDetailsDB01173OrphenadrineapprovedunknownbinderregulatorDetailsDB01619PhenindamineapprovedunknownbinderregulatorDetailsDB00792Tripelennamineapproved, vet_approvedunknownbinderregulatorDetailsDB08912Dabrafenibapproved, investigationalnobinderDetailsDB16699Vutrisiranapproved, investigationalunknownligandDetailsDB06150Sulfadimethoxineapproved, vet_approved, withdrawnunknownsubstrateDetailsDB00254Doxycyclineapproved, investigational, vet_approvedunknownsubstratebinderDetailsDB08936ChlorcyclizineapprovedunknownregulatorDetailsDB00568Cinnarizineapproved, investigationalunknownregulatorDetailsDB01176CyclizineapprovedunknownregulatorDetailsDB00366Doxylamineapproved, vet_approvedunknownregulatorDetailsDB00850PerphenazineapprovedunknownregulatorDetailsDB01024Mycophenolic acidapproved, investigationalunknownbinderDetailsDB08865Crizotinibapproved, investigationalunknownbinderDetailsDB13310OrmeloxifeneexperimentalunknownbinderDetailsDB00758ClopidogrelapprovednobinderDetailsDB15149Futibatinibapproved, investigationalnobinderDetailsDB08930DolutegravirapprovednobinderDetailsDB17083LinzagolixapprovednobinderDetailsDB11739Vonoprazanapproved, investigationalunknownbinderDetailsDB11793Niraparibapproved, investigationalunknownbinderDetailsDB00642Pemetrexedapproved, investigationalnobinderDetailsDB12243Edaravoneapproved, investigationalnobinderDetailsDB00795SulfasalazineapprovednobinderDetailsDB00303Ertapenemapproved, investigationalnobinderDetailsDB01119DiazoxideapprovedunknownbinderDetailsDB01101Capecitabineapproved, investigationalnobinderDetailsDB00363ClozapineapprovednobinderDetailsDB00349Clobazamapproved, illicitnobinderDetailsDB00770Alprostadilapproved, investigationalunknownbinderDetailsDB00683Midazolamapproved, illicitnobinderDetailsDB11901Apalutamideapproved, investigationalnobinderDetailsDB09128Brexpiprazoleapproved, investigationalnosubstrateDetailsDB08906Fluticasone furoateapprovednobinderDetailsDB12255Vadadustatapproved, investigationalunknownbinderDetailsDB09076UmeclidiniumapprovednobinderDetailsDB01005HydroxyureaapprovednobinderDetailsDB00526Oxaliplatinapproved, investigationalnobinderDetailsDB06772CabazitaxelapprovedunknownbinderDetailsDB12874Quizartinibapproved, investigationalnobinderDetailsDB01042MelphalanapprovedunknownbinderDetailsDB08903BedaquilineapprovednobinderDetailsDB11718Encorafenibapproved, investigationalnobinderDetailsDB11967Binimetinibapproved, investigationalnobinderDetails"
                    }
                }
            ],
            "transporters": [
                {
                    "Label": "Solute carrier family 22 member 5",
                    "Detailed Info": {
                        "Name": "Solute carrier family 22 member 5",
                        "Synonyms": "High-affinity sodium-dependent carnitine cotransporter\nOCTN2\nOrganic cation/carnitine transporter 2",
                        "Gene Name": "SLC22A5",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0000212|Solute carrier family 22 member 5\nMRDYDEVTAFLGEWGPFQRLIFFLLSASIIPNGFTGLSSVFLIATPEHRCRVPDAANLSS\nAWRNHTVPLRLRDGREVPHSCRRYRLATIANFSALGLEPGRDVDLGQLEQESCLDGWEFS\nQDVYLSTIVTEWNLVCEDDWKAPLTISLFFVGVLLGSFISGQLSDRFGRKNVLFVTMGMQ\nTGFSFLQIFSKNFEMFVVLFVLVGMGQISNYVAAFVLGTEILGKSVRIIFSTLGVCIFYA\nFGYMVLPLFAYFIRDWRMLLVALTMPGVLCVALWWFIPESPRWLISQGRFEEAEVIIRKA\nAKANGIVVPSTIFDPSELQDLSSKKQQSHNILDLLRTWNIRMVTIMSIMLWMTISVGYFG\nLSLDTPNLHGDIFVNCFLSAMVEVPAYVLAWLLLQYLPRRYSMATALFLGGSVLLFMQLV\nPPDLYYLATVLVMVGKFGVTAAFSMVYVYTAELYPTVVRNMGVGVSSTASRLGSILSPYF\nVYLGAYDRFLPYILMGSLTILTAILTLFLPESFGTPLPDTIDQMLRVKGMKHRKTPSHTR\nMLKDGQERPTILKSTAF",
                        "Number of residues": "557",
                        "Molecular Weight": "62751.08",
                        "Theoretical pI": "8.04",
                        "GO Classification": "FunctionsATP binding / carnitine transmembrane transporter activity / cation / drug transmembrane transporter activity / PDZ domain binding / quaternary ammonium group transmembrane transporter activity / symporter activityProcessescarnitine metabolic process / carnitine transmembrane transport / carnitine transport / drug transmembrane transport / drug transport / modified amino acid transport / positive regulation of intestinal epithelial structure maintenance / quaternary ammonium group transport / quorum sensing involved in interaction with host / sodium ion transport / sodium-dependent organic cation transport / transmembrane transportComponentsapical plasma membrane / brush border membrane / extracellular exosome / integral component of plasma membrane / plasma membrane",
                        "General Function": "Symporter activity",
                        "Specific Function": "Sodium-ion dependent, high affinity carnitine transporter. Involved in the active cellular uptake of carnitine. Transports one sodium ion with one molecule of carnitine. Also transports organic cations such as tetraethylammonium (TEA) without the involvement of sodium. Also relative uptake activity ratio of carnitine to TEA is 11.3.",
                        "Pfam Domain Function": "Sugar_tr (PF00083)",
                        "Transmembrane Regions": "21-41\n143-163\n173-193\n198-218\n233-253\n258-278\n342-362\n374-394\n407-427\n431-451\n463-483\n489-509",
                        "Cellular Location": "Membrane",
                        "Gene sequence": ">lcl|BSEQ0009938|Solute carrier family 22 member 5 (SLC22A5)\nATGCGGGACTACGACGAGGTGACCGCCTTCCTGGGCGAGTGGGGGCCCTTCCAGCGCCTC\nATCTTCTTCCTGCTCAGCGCCAGCATCATCCCCAATGGCTTCACCGGCCTGTCCTCCGTG\nTTCCTGATAGCGACCCCGGAGCACCGCTGCCGGGTGCCGGACGCCGCGAACCTGAGCAGC\nGCCTGGCGCAACCACACTGTCCCACTGCGGCTGCGGGACGGCCGCGAGGTGCCCCACAGC\nTGCCGCCGCTACCGGCTCGCCACCATCGCCAACTTCTCGGCGCTTGGGCTGGAGCCGGGG\nCGCGACGTGGACCTGGGGCAGCTGGAGCAGGAGAGCTGTCTGGATGGCTGGGAGTTCAGT\nCAGGACGTCTACCTGTCCACCATTGTGACCGAGCAAGACAGTGGGGCCTACAATGCTATG\nAAAAACAGGATGGGAAAGAAGCCTGCTCTCTGCCTTCCTGCCCAGTGGAACCTGGTGTGT\nGAGGACGACTGGAAGGCCCCACTCACAATCTCCTTGTTCTTCGTGGGTGTGCTGTTGGGC\nTCCTTCATTTCAGGGCAGCTGTCAGACAGGTTTGGCCGGAAGAATGTGCTGTTCGTGACC\nATGGGCATGCAGACAGGCTTCAGCTTCCTGCAGATCTTCTCGAAGAATTTTGAGATGTTT\nGTCGTGCTGTTTGTCCTTGTAGGCATGGGCCAGATCTCCAACTATGTGGCAGCATTTGTC\nCTGGGGACAGAAATTCTTGGCAAGTCAGTTCGTATAATATTCTCTACGTTAGGAGTGTGC\nATATTTTATGCATTTGGCTACATGGTGCTGCCACTGTTTGCTTACTTCATCCGAGACTGG\nCGGATGCTGCTGGTGGCGCTGACGATGCCGGGGGTGCTATGCGTGGCACTCTGGTGGTTC\nATCCCTGAGTCCCCCCGATGGCTCATCTCTCAGGGACGATTTGAAGAGGCAGAGGTGATC\nATCCGCAAGGCTGCCAAAGCCAATGGGATTGTTGTGCCTTCCACTATCTTTGACCCGAGT\nGAGTTACAAGACCTAAGTTCCAAGAAGCAGCAGTCCCACAACATTCTGGATCTGCTTCGA\nACCTGGAATATCCGGATGGTCACCATCATGTCCATAATGCTGTGGATGACCATATCAGTG\nGGCTATTTTGGGCTTTCGCTTGATACTCCTAACTTGCATGGGGACATCTTTGTGAACTGC\nTTCCTTTCAGCGATGGTTGAAGTCCCAGCATATGTGTTGGCCTGGCTGCTGCTGCAATAT\nTTGCCCCGGCGCTATTCCATGGCCACTGCCCTCTTCCTGGGTGGCAGTGTCCTTCTCTTC\nATGCAGCTGGTACCCCCAGACTTGTATTATTTGGCTACAGTCCTGGTGATGGTGGGCAAG\nTTTGGAGTCACGGCTGCCTTTTCCATGGTCTACGTGTACACAGCCGAGCTGTATCCCACA\nGTGGTGAGAAACATGGGTGTGGGAGTCAGCTCCACAGCATCCCGCCTGGGCAGCATCCTG\nTCTCCCTACTTCGTTTACCTTGGTGCCTACGACCGCTTCCTGCCCTACATTCTCATGGGA\nAGTCTGACCATCCTGACAGCCATCCTCACCTTGTTTCTCCCAGAGAGCTTCGGTACCCCA\nCTCCCAGACACCATTGACCAGATGCTAAGAGTCAAAGGAATGAAACACAGAAAAACTCCA\nAGTCACACAAGGATGTTAAAAGATGGTCAAGAAAGGCCCACAATCCTTAAAAGCACAGCC\nTTCTAA",
                        "Chromosome Location": "5",
                        "Locus": "5q31",
                        "External Identifiers": "ResourceLinkUniProtKB IDO76082UniProtKB Entry NameS22A5_HUMANGenBank Protein ID3273741GenBank Gene IDAF057164GenAtlas IDSLC22A5HGNC IDHGNC:10969",
                        "General References": "Wu X, Prasad PD, Leibach FH, Ganapathy V: cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun. 1998 May 29;246(3):589-95. [Article] Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, Shimane M, Sai Y, Tsuji A: Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem. 1998 Aug 7;273(32):20378-82. [Article] Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N, Nikaido H, Sai Y, Koizumi A, Shoji Y, Takada G, Matsuishi T, Yoshino M, Kato H, Ohura T, Tsujimoto G, Hayakawa J, Shimane M, Tsuji A: Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet. 1999 Jan;21(1):91-4. [Article] Maekawa S, Mori D, Nishiya T, Takikawa O, Horinouchi T, Nishimoto A, Kajita E, Miwa S: OCTN2VT, a splice variant of OCTN2, does not transport carnitine because of the retention in the endoplasmic reticulum caused by insertion of 24 amino acids in the first extracellular loop of OCTN2. Biochim Biophys Acta. 2007 Jun;1773(6):1000-6. Epub 2007 Apr 19. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Schmutz J, Martin J, Terry A, Couronne O, Grimwood J, Lowry S, Gordon LA, Scott D, Xie G, Huang W, Hellsten U, Tran-Gyamfi M, She X, Prabhakar S, Aerts A, Altherr M, Bajorek E, Black S, Branscomb E, Caoile C, Challacombe JF, Chan YM, Denys M, Detter JC, Escobar J, Flowers D, Fotopulos D, Glavina T, Gomez M, Gonzales E, Goodstein D, Grigoriev I, Groza M, Hammon N, Hawkins T, Haydu L, Israni S, Jett J, Kadner K, Kimball H, Kobayashi A, Lopez F, Lou Y, Martinez D, Medina C, Morgan J, Nandkeshwar R, Noonan JP, Pitluck S, Pollard M, Predki P, Priest J, Ramirez L, Retterer J, Rodriguez A, Rogers S, Salamov A, Salazar A, Thayer N, Tice H, Tsai M, Ustaszewska A, Vo N, Wheeler J, Wu K, Yang J, Dickson M, Cheng JF, Eichler EE, Olsen A, Pennacchio LA, Rokhsar DS, Richardson P, Lucas SM, Myers RM, Rubin EM: The DNA sequence and comparative analysis of human chromosome 5. Nature. 2004 Sep 16;431(7006):268-74. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Wu X, Huang W, Prasad PD, Seth P, Rajan DP, Leibach FH, Chen J, Conway SJ, Ganapathy V: Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther. 1999 Sep;290(3):1482-92. [Article] Wollscheid B, Bausch-Fluck D, Henderson C, O'Brien R, Bibel M, Schiess R, Aebersold R, Watts JD: Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Nat Biotechnol. 2009 Apr;27(4):378-86. doi: 10.1038/nbt.1532. Epub 2009 Apr 6. [Article] Mayya V, Lundgren DH, Hwang SI, Rezaul K, Wu L, Eng JK, Rodionov V, Han DK: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal. 2009 Aug 18;2(84):ra46. doi: 10.1126/scisignal.2000007. [Article] Burwinkel B, Kreuder J, Schweitzer S, Vorgerd M, Gempel K, Gerbitz KD, Kilimann MW: Carnitine transporter OCTN2 mutations in systemic primary carnitine deficiency: a novel Arg169Gln mutation and a recurrent Arg282ter mutation associated with an unconventional splicing abnormality. Biochem Biophys Res Commun. 1999 Aug 2;261(2):484-7. [Article] Vaz FM, Scholte HR, Ruiter J, Hussaarts-Odijk LM, Pereira RR, Schweitzer S, de Klerk JB, Waterham HR, Wanders RJ: Identification of two novel mutations in OCTN2 of three patients with systemic carnitine deficiency. Hum Genet. 1999 Jul-Aug;105(1-2):157-61. [Article] Tang NL, Ganapathy V, Wu X, Hui J, Seth P, Yuen PM, Wanders RJ, Fok TF, Hjelm NM: Mutations of OCTN2, an organic cation/carnitine transporter, lead to deficient cellular carnitine uptake in primary carnitine deficiency. Hum Mol Genet. 1999 Apr;8(4):655-60. [Article] Koizumi A, Nozaki J, Ohura T, Kayo T, Wada Y, Nezu J, Ohashi R, Tamai I, Shoji Y, Takada G, Kibira S, Matsuishi T, Tsuji A: Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency. Hum Mol Genet. 1999 Nov;8(12):2247-54. [Article] Seth P, Wu X, Huang W, Leibach FH, Ganapathy V: Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function. J Biol Chem. 1999 Nov 19;274(47):33388-92. [Article] Mayatepek E, Nezu J, Tamai I, Oku A, Katsura M, Shimane M, Tsuji A: Two novel missense mutations of the OCTN2 gene (W283R and V446F) in a patient with primary systemic carnitine deficiency. Hum Mutat. 2000 Jan;15(1):118. [Article] Wang Y, Kelly MA, Cowan TM, Longo N: A missense mutation in the OCTN2 gene associated with residual carnitine transport activity. Hum Mutat. 2000;15(3):238-45. [Article] Wang Y, Taroni F, Garavaglia B, Longo N: Functional analysis of mutations in the OCTN2 transporter causing primary carnitine deficiency: lack of genotype-phenotype correlation. Hum Mutat. 2000 Nov;16(5):401-7. [Article] Wang Y, Korman SH, Ye J, Gargus JJ, Gutman A, Taroni F, Garavaglia B, Longo N: Phenotype and genotype variation in primary carnitine deficiency. Genet Med. 2001 Nov-Dec;3(6):387-92. [Article] Makhseed N, Vallance HD, Potter M, Waters PJ, Wong LT, Lillquist Y, Pasquali M, Amat di San Filippo C, Longo N: Carnitine transporter defect due to a novel mutation in the SLC22A5 gene presenting with peripheral neuropathy. J Inherit Metab Dis. 2004;27(6):778-80. [Article] Dobrowolski SF, McKinney JT, Amat di San Filippo C, Giak Sim K, Wilcken B, Longo N: Validation of dye-binding/high-resolution thermal denaturation for the identification of mutations in the SLC22A5 gene. Hum Mutat. 2005 Mar;25(3):306-13. [Article] Urban TJ, Gallagher RC, Brown C, Castro RA, Lagpacan LL, Brett CM, Taylor TR, Carlson EJ, Ferrin TE, Burchard EG, Packman S, Giacomini KM: Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5). Mol Pharmacol. 2006 Nov;70(5):1602-11. Epub 2006 Aug 24. [Article] Schimmenti LA, Crombez EA, Schwahn BC, Heese BA, Wood TC, Schroer RJ, Bentler K, Cederbaum S, Sarafoglou K, McCann M, Rinaldo P, Matern D, di San Filippo CA, Pasquali M, Berry SA, Longo N: Expanded newborn screening identifies maternal primary carnitine deficiency. Mol Genet Metab. 2007 Apr;90(4):441-5. Epub 2006 Nov 28. [Article] El-Hattab AW, Li FY, Shen J, Powell BR, Bawle EV, Adams DJ, Wahl E, Kobori JA, Graham B, Scaglia F, Wong LJ: Maternal systemic primary carnitine deficiency uncovered by newborn screening: clinical, biochemical, and molecular aspects. Genet Med. 2010 Jan;12(1):19-24. doi: 10.1097/GIM.0b013e3181c5e6f7. [Article] Li FY, El-Hattab AW, Bawle EV, Boles RG, Schmitt ES, Scaglia F, Wong LJ: Molecular spectrum of SLC22A5 (OCTN2) gene mutations detected in 143 subjects evaluated for systemic carnitine deficiency. Hum Mutat. 2010 Aug;31(8):E1632-51. doi: 10.1002/humu.21311. [Article] Lee NC, Tang NL, Chien YH, Chen CA, Lin SJ, Chiu PC, Huang AC, Hwu WL: Diagnoses of newborns and mothers with carnitine uptake defects through newborn screening. Mol Genet Metab. 2010 May;100(1):46-50. doi: 10.1016/j.ymgme.2009.12.015. Epub 2009 Dec 28. [Article] Rose EC, di San Filippo CA, Ndukwe Erlingsson UC, Ardon O, Pasquali M, Longo N: Genotype-phenotype correlation in primary carnitine deficiency. Hum Mutat. 2012 Jan;33(1):118-23. doi: 10.1002/humu.21607. Epub 2011 Oct 11. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00583Levocarnitineapproved, investigationalunknownDetailsDB01035ProcainamideapprovedunknowninhibitorDetailsDB00184NicotineapprovedunknowninhibitorDetailsDB01577Metamfetamineapproved, illicit, withdrawnunknowninhibitorDetailsDB00536GuanidineapprovedunknowninhibitorDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00122Cholineapproved, nutraceuticalunknowninhibitorDetailsDB00182Amphetamineapproved, illicit, investigationalunknownsubstrateDetailsDB01151Desipramineapproved, investigationalunknowninhibitorDetailsDB00661VerapamilapprovedunknowninhibitorDetailsDB00313Valproic acidapproved, investigationalunknowninhibitorDetailsDB01208Sparfloxacinapproved, investigational, withdrawnunknowninhibitorDetailsDB00468QuinineapprovedunknowninhibitorDetailsDB00908Quinidineapproved, investigationalunknowninhibitorDetailsDB01032Probenecidapproved, investigationalunknowninhibitorDetailsDB00345Aminohippuric acidapproved, investigationalunknowninhibitorDetailsDB01165OfloxacinapprovedunknowninhibitorDetailsDB01059NorfloxacinapprovedunknowninhibitorDetailsDB00627Niacinapproved, investigational, nutraceuticalunknowninhibitorDetailsDB00978Lomefloxacinapproved, investigationalunknowninhibitorDetailsDB00365Grepafloxacinapproved, investigational, withdrawnunknowninhibitorDetailsDB00695Furosemideapproved, vet_approvedunknowninhibitorDetailsDB00148Creatineapproved, investigational, nutraceuticalunknowninhibitorDetailsDB00575ClonidineapprovedunknowninhibitorDetailsDB00456Cefalotinapproved, investigational, vet_approvedunknowninhibitorDetailsDB00689CephaloglycinapprovedunknowninhibitorDetailsDB00125Arginineinvestigational, nutraceuticalunknowninhibitorDetailsDB04630Aldosteroneexperimental, investigationalunknowninhibitorDetailsDB00970Dactinomycinapproved, investigationalunknowninhibitorDetailsDB01053Benzylpenicillinapproved, vet_approvedunknowninhibitorDetailsDB01000CyclacillinapprovedunknowninhibitorDetailsDB01333CefradineapprovedunknowninhibitorDetailsDB00567Cephalexinapproved, investigational, vet_approvedunknowninhibitorDetailsDB00671Cefiximeapproved, investigationalunknowninhibitorDetailsDB01413Cefepimeapproved, investigationalunknowninhibitorDetailsDB00535CefdinirapprovedunknowninhibitorDetailsDB01140Cefadroxilapproved, vet_approved, withdrawnunknowninhibitorDetailsDB00415Ampicillinapproved, vet_approvedunknowninhibitorDetailsDB00152Thiamineapproved, investigational, nutraceutical, vet_approvedunknowninhibitorDetailsDB00368NorepinephrineapprovedunknowninhibitorDetailsDB00281Lidocaineapproved, vet_approvedunknowninhibitorDetailsDB05381Histamineapproved, investigationalunknowninhibitorDetailsDB00988DopamineapprovedunknowninhibitorDetailsDB01075Diphenhydramineapproved, investigationalunknowninhibitorDetailsDB03128Acetylcholineapproved, investigationalunknowninhibitorDetailsDB00583Levocarnitineapproved, investigationalunknownsubstrateDetailsDB00332Ipratropiumapproved, experimentalunknownsubstrateDetailsDB01409TiotropiumapprovedunknownsubstrateDetailsDB08795AzidocillinexperimentalunknowninhibitorDetailsDB08837Tetraethylammoniumexperimental, investigationalunknownDetailsDB06691Mepyramineapproved, vet_approvedunknownDetailsDB08842Acetylcarnitineapproved, investigationalunknownDetailsDB04133Degraded CephaloridineexperimentalunknownDetailsDB14006Choline salicylateapproved, nutraceuticalunknowninhibitorDetailsDB14754SolriamfetolapprovedunknownDetailsDB09237Levamlodipineapproved, investigationalunknowninhibitorDetailsDB00983Formoterolapproved, investigationalunknownsubstrateDetailsDB06709Methacholineapproved, investigationalnoinhibitorDetailsDB00871TerbutalineapprovedunknownsubstrateDetailsDB00619ImatinibapprovednosubstrateDetailsDB01005HydroxyureaapprovednosubstrateDetails"
                    }
                },
                {
                    "Label": "Solute carrier family 15 member 1",
                    "Detailed Info": {
                        "Name": "Solute carrier family 15 member 1",
                        "Synonyms": "Intestinal H(+)/peptide cotransporter\nOligopeptide transporter, small intestine isoform\nPEPT1\nPeptide transporter 1",
                        "Gene Name": "SLC15A1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0010713|Solute carrier family 15 member 1\nMGMSKSHSFFGYPLSIFFIVVNEFCERFSYYGMRAILILYFTNFISWDDNLSTAIYHTFV\nALCYLTPILGALIADSWLGKFKTIVSLSIVYTIGQAVTSVSSINDLTDHNHDGTPDSLPV\nHVVLSLIGLALIALGTGGIKPCVSAFGGDQFEEGQEKQRNRFFSIFYLAINAGSLLSTII\nTPMLRVQQCGIHSKQACYPLAFGVPAALMAVALIVFVLGSGMYKKFKPQGNIMGKVAKCI\nGFAIKNRFRHRSKAFPKREHWLDWAKEKYDERLISQIKMVTRVMFLYIPLPMFWALFDQQ\nGSRWTLQATTMSGKIGALEIQPDQMQTVNAILIVIMVPIFDAVLYPLIAKCGFNFTSLKK\nMAVGMVLASMAFVVAAIVQVEIDKTLPVFPKGNEVQIKVLNIGNNTMNISLPGEMVTLGP\nMSQTNAFMTFDVNKLTRINISSPGSPVTAVTDDFKQGQRHTLLVWAPNHYQVVKDGLNQK\nPEKGENGIRFVNTFNELITITMSGKVYANISSYNASTYQFFPSGIKGFTISSTEIPPQCQ\nPNFNTFYLEFGSAYTYIVQRKNDSCPEVKVFEDISANTVNMALQIPQYFLLTCGEVVFSV\nTGLEFSYSQAPSNMKSVLQAGWLLTVAVGNIIVLIVAGAGQFSKQWAEYILFAALLLVVC\nVIFAIMARFYTYINPAEIEAQFDEDEKKNRLEKSNPYFMSGANSQKQM",
                        "Number of residues": "708",
                        "Molecular Weight": "78805.265",
                        "Theoretical pI": "8.64",
                        "GO Classification": "Functionspeptide / proton-dependent oligopeptide secondary active transmembrane transporter activityProcessesdigestion / ion transport / protein transport / proton transport / transmembrane transport / transportComponentsbrush border / integral component of plasma membrane / membrane / plasma membrane",
                        "General Function": "Proton-dependent oligopeptide secondary active transmembrane transporter activity",
                        "Specific Function": "Proton-coupled intake of oligopeptides of 2 to 4 amino acids with a preference for dipeptides. May constitute a major route for the absorption of protein digestion end-products.",
                        "Pfam Domain Function": "PTR2 (PF00854)",
                        "Transmembrane Regions": "1-21\n54-74\n83-103\n119-139\n162-182\n199-219\n277-297\n328-348\n362-382\n585-605\n620-640\n646-666",
                        "Cellular Location": "Membrane",
                        "Gene sequence": ">lcl|BSEQ0010714|Solute carrier family 15 member 1 (SLC15A1)\nATGGGAATGTCCAAATCACACAGTTTCTTTGGTTATCCCCTGAGCATCTTCTTCATCGTG\nGTCAATGAGTTTTGCGAAAGATTTTCCTACTATGGAATGCGAGCAATCCTGATTCTGTAC\nTTCACAAATTTCATCAGCTGGGATGATAACCTGTCCACCGCCATCTACCATACGTTTGTG\nGCTCTGTGCTACCTGACGCCAATTCTCGGAGCTCTTATCGCCGACTCGTGGCTGGGAAAG\nTTCAAGACCATTGTGTCGCTCTCCATTGTCTACACAATTGGACAAGCAGTCACCTCAGTA\nAGCTCCATTAATGACCTCACAGACCACAACCATGATGGCACCCCCGACAGCCTTCCTGTG\nCACGTGGTGCTGTCCTTGATCGGCCTGGCCCTGATAGCTCTCGGGACTGGAGGAATCAAA\nCCCTGTGTGTCTGCGTTTGGTGGAGATCAGTTTGAAGAGGGCCAGGAGAAACAAAGAAAC\nAGATTTTTTTCCATCTTTTACTTGGCTATTAATGCTGGAAGTTTGCTTTCCACAATCATC\nACACCCATGCTCAGAGTTCAACAATGTGGAATTCACAGTAAACAAGCTTGTTACCCACTG\nGCCTTTGGGGTTCCTGCTGCTCTCATGGCTGTAGCCCTGATTGTGTTTGTCCTTGGCAGT\nGGGATGTACAAGAAGTTCAAGCCACAGGGCAACATCATGGGTAAAGTGGCCAAGTGCATC\nGGTTTTGCCATCAAAAATAGATTTAGGCATCGGAGTAAGGCATTTCCCAAGAGGGAGCAC\nTGGCTGGACTGGGCTAAAGAGAAATACGATGAGCGGCTCATCTCCCAAATTAAGATGGTT\nACGAGGGTGATGTTCCTGTATATTCCACTCCCAATGTTCTGGGCCTTGTTTGACCAGCAG\nGGCTCCAGGTGGACACTGCAGGCAACAACTATGTCCGGGAAAATCGGAGCTCTTGAAATT\nCAGCCCGATCAGATGCAGACCGTGAACGCCATCCTGATCGTGATCATGGTCCCGATCTTC\nGATGCTGTGCTGTACCCTCTCATTGCAAAATGTGGCTTCAATTTCACCTCCTTGAAGAAG\nATGGCAGTTGGCATGGTCCTGGCCTCCATGGCCTTTGTGGTGGCTGCCATCGTGCAGGTG\nGAAATCGATAAAACTCTTCCAGTCTTCCCCAAAGGAAACGAAGTCCAAATTAAAGTTTTG\nAATATAGGAAACAATACCATGAATATATCTCTTCCTGGAGAGATGGTGACACTTGGCCCA\nATGTCTCAAACAAATGCATTTATGACTTTTGATGTAAACAAACTGACAAGGATAAACATT\nTCTTCTCCTGGATCACCAGTCACTGCTGTAACTGACGACTTCAAGCAGGGCCAACGCCAC\nACGCTTCTAGTGTGGGCCCCCAATCACTACCAGGTGGTAAAGGATGGTCTTAACCAGAAG\nCCAGAAAAAGGGGAAAATGGAATCAGATTTGTAAATACTTTTAACGAGCTCATCACCATC\nACAATGAGTGGGAAAGTTTATGCAAACATCAGCAGCTACAATGCCAGCACATACCAGTTT\nTTTCCTTCTGGCATAAAAGGCTTCACAATAAGCTCAACAGAGATTCCGCCACAATGTCAA\nCCTAATTTCAATACTTTCTACCTTGAATTTGGTAGTGCTTATACCTATATAGTCCAAAGG\nAAGAATGACAGCTGCCCTGAAGTGAAGGTGTTTGAAGATATTTCAGCCAACACAGTTAAC\nATGGCTCTGCAAATCCCGCAGTATTTTCTTCTCACCTGTGGCGAAGTGGTCTTCTCTGTC\nACGGGATTGGAATTCTCATATTCTCAGGCTCCTTCCAACATGAAGTCGGTGCTTCAGGCA\nGGATGGCTGCTGACCGTGGCTGTTGGCAACATCATTGTGCTCATCGTGGCAGGGGCAGGC\nCAGTTCAGCAAACAGTGGGCCGAGTACATTCTATTTGCCGCGTTGCTTCTGGTCGTCTGT\nGTAATTTTTGCCATCATGGCTCGGTTCTATACTTACATCAACCCAGCGGAGATCGAAGCT\nCAATTTGATGAGGATGAAAAGAAAAACAGACTGGAAAAGAGTAACCCATATTTCATGTCA\nGGGGCCAATTCACAGAAACAGATGTGA",
                        "Chromosome Location": "13",
                        "Locus": "13q33-q34",
                        "External Identifiers": "ResourceLinkUniProtKB IDP46059UniProtKB Entry NameS15A1_HUMANGenBank Protein ID773588GenBank Gene IDU13173GenAtlas IDSLC15A1HGNC IDHGNC:10920",
                        "General References": "Liang R, Fei YJ, Prasad PD, Ramamoorthy S, Han H, Yang-Feng TL, Hediger MA, Ganapathy V, Leibach FH: Human intestinal H+/peptide cotransporter. Cloning, functional expression, and chromosomal localization. J Biol Chem. 1995 Mar 24;270(12):6456-63. [Article] Dunham A, Matthews LH, Burton J, Ashurst JL, Howe KL, Ashcroft KJ, Beare DM, Burford DC, Hunt SE, Griffiths-Jones S, Jones MC, Keenan SJ, Oliver K, Scott CE, Ainscough R, Almeida JP, Ambrose KD, Andrews DT, Ashwell RI, Babbage AK, Bagguley CL, Bailey J, Bannerjee R, Barlow KF, Bates K, Beasley H, Bird CP, Bray-Allen S, Brown AJ, Brown JY, Burrill W, Carder C, Carter NP, Chapman JC, Clamp ME, Clark SY, Clarke G, Clee CM, Clegg SC, Cobley V, Collins JE, Corby N, Coville GJ, Deloukas P, Dhami P, Dunham I, Dunn M, Earthrowl ME, Ellington AG, Faulkner L, Frankish AG, Frankland J, French L, Garner P, Garnett J, Gilbert JG, Gilson CJ, Ghori J, Grafham DV, Gribble SM, Griffiths C, Hall RE, Hammond S, Harley JL, Hart EA, Heath PD, Howden PJ, Huckle EJ, Hunt PJ, Hunt AR, Johnson C, Johnson D, Kay M, Kimberley AM, King A, Laird GK, Langford CJ, Lawlor S, Leongamornlert DA, Lloyd DM, Lloyd C, Loveland JE, Lovell J, Martin S, Mashreghi-Mohammadi M, McLaren SJ, McMurray A, Milne S, Moore MJ, Nickerson T, Palmer SA, Pearce AV, Peck AI, Pelan S, Phillimore B, Porter KM, Rice CM, Searle S, Sehra HK, Shownkeen R, Skuce CD, Smith M, Steward CA, Sycamore N, Tester J, Thomas DW, Tracey A, Tromans A, Tubby B, Wall M, Wallis JM, West AP, Whitehead SL, Willey DL, Wilming L, Wray PW, Wright MW, Young L, Coulson A, Durbin R, Hubbard T, Sulston JE, Beck S, Bentley DR, Rogers J, Ross MT: The DNA sequence and analysis of human chromosome 13. Nature. 2004 Apr 1;428(6982):522-8. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Saito S, Iida A, Sekine A, Ogawa C, Kawauchi S, Higuchi S, Nakamura Y: Catalog of 238 variations among six human genes encoding solute carriers ( hSLCs) in the Japanese population. J Hum Genet. 2002;47(11):576-84. [Article] Anderle P, Nielsen CU, Pinsonneault J, Krog PL, Brodin B, Sadee W: Genetic variants of the human dipeptide transporter PEPT1. J Pharmacol Exp Ther. 2006 Feb;316(2):636-46. Epub 2005 Oct 28. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB01197CaptoprilapprovedunknowninhibitorDetailsDB01000CyclacillinapprovedunknowninhibitorDetailsDB01140Cefadroxilapproved, vet_approved, withdrawnunknownsubstrateinhibitorDetailsDB00567Cephalexinapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00447Loracarbefapproved, investigational, withdrawnunknowninhibitorDetailsDB00671Cefiximeapproved, investigationalunknownsubstrateinhibitorDetailsDB01060Amoxicillinapproved, vet_approvedunknowninhibitorDetailsDB00415Ampicillinapproved, vet_approvedunknowninhibitorDetailsDB01415Ceftibutenapproved, investigationalunknownsubstrateinhibitorDetailsDB00535CefdinirapprovedunknownsubstrateinhibitorDetailsDB00577Valaciclovirapproved, investigationalunknownsubstrateinhibitorDetailsDB00584Enalaprilapproved, vet_approvedunknownsubstrateinhibitorDetailsDB01333CefradineapprovedunknownsubstrateinhibitorDetailsDB00968MethyldopaapprovedunknowninhibitorDetailsDB01235LevodopaapprovedunknowninhibitorDetailsDB00833CefaclorapprovedunknowninhibitorDetailsDB01413Cefepimeapproved, investigationalunknowninhibitorDetailsDB01212CeftriaxoneapprovedunknowninhibitorDetailsDB00493CefotaximeapprovedunknowninhibitorDetailsDB01112CefuroximeapprovedunknowninhibitorDetailsDB01053Benzylpenicillinapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00456Cefalotinapproved, investigational, vet_approvedunknowninhibitorDetailsDB00274Cefmetazoleapproved, investigationalunknowninhibitorDetailsDB00713Oxacillinapproved, investigationalunknowninhibitorDetailsDB01147Cloxacillinapproved, investigational, vet_approvednoinhibitorDetailsDB00485Dicloxacillinapproved, investigational, vet_approvedunknowninhibitorDetailsDB03424UbenimexinvestigationalunknowninhibitorDetailsDB00855Aminolevulinic acidapprovedunknowninhibitorDetailsDB01016GlyburideapprovedunknowninhibitorDetailsDB01124Tolbutamideapproved, investigationalunknowninhibitorDetailsDB00731Nateglinideapproved, investigationalunknowninhibitorDetailsDB00672Chlorpropamideapproved, investigationalunknowninhibitorDetailsDB01332Ceftizoximeapproved, withdrawnunknownsubstrateDetailsDB00198OseltamivirapprovedunknownsubstrateDetailsDB00881Quinaprilapproved, investigationalunknownsubstrateDetailsDB00542Benazeprilapproved, investigationalunknownsubstrateDetailsDB01340CilazaprilapprovedunknownsubstrateDetailsDB00492FosinoprilapprovedunknownsubstrateDetailsDB00691MoexiprilapprovedunknownsubstrateDetailsDB00790PerindoprilapprovedunknownsubstrateDetailsDB00178RamiprilapprovedunknownsubstrateDetailsDB01348SpiraprilapprovedunknownsubstrateDetailsDB00519TrandolaprilapprovedunknownsubstrateDetailsDB08795AzidocillinexperimentalunknowninhibitorDetailsDB01610Valganciclovirapproved, investigationalunknownDetailsDB00211MidodrineapprovedunknownDetailsDB08836Temocaprilexperimental, investigationalunknownDetailsDB01095FluvastatinapprovedunknownsubstrateinhibitorDetailsDB00415Ampicillinapproved, vet_approvedunknownDetailsDB00493CefotaximeapprovedunknownDetailsDB00713Oxacillinapproved, investigationalunknownDetailsDB01053Benzylpenicillinapproved, vet_approvedunknownsubstrateinhibitorDetailsDB01212CeftriaxoneapprovedunknownDetailsDB00417Phenoxymethylpenicillinapproved, vet_approvedunknownDetailsDB03793Benzoic acidapproved, investigationalunknownDetailsDB01956Taurineapproved, nutraceuticalnosubstrateDetailsDB09213Dexibuprofenapproved, investigationalunknownDetailsDB01255Lisdexamfetamineapproved, investigationalunknownsubstrateDetailsDB00563MethotrexateapprovedunknownsubstrateDetailsDB00722Lisinoprilapproved, investigationalunknownsubstrateinhibitorDetails"
                    }
                },
                {
                    "Label": "Solute carrier family 15 member 2",
                    "Detailed Info": {
                        "Name": "Solute carrier family 15 member 2",
                        "Synonyms": "Kidney H(+)/peptide cotransporter\nOligopeptide transporter, kidney isoform\nPEPT2\nPeptide transporter 2",
                        "Gene Name": "SLC15A2",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0037126|Solute carrier family 15 member 2\nMNPFQKNESKETLFSPVSIEEVPPRPPSPPKKPSPTICGSNYPLSIAFIVVNEFCERFSY\nYGMKAVLILYFLYFLHWNEDTSTSIYHAFSSLCYFTPILGAAIADSWLGKFKTIIYLSLV\nYVLGHVIKSLGALPILGGQVVHTVLSLIGLSLIALGTGGIKPCVAAFGGDQFEEKHAEER\nTRYFSVFYLSINAGSLISTFITPMLRGDVQCFGEDCYALAFGVPGLLMVIALVVFAMGSK\nIYNKPPPEGNIVAQVFKCIWFAISNRFKNRSGDIPKRQHWLDWAAEKYPKQLIMDVKALT\nRVLFLYIPLPMFWALLDQQGSRWTLQAIRMNRNLGFFVLQPDQMQVLNPLLVLIFIPLFD\nFVIYRLVSKCGINFSSLRKMAVGMILACLAFAVAAAVEIKINEMAPAQPGPQEVFLQVLN\nLADDEVKVTVVGNENNSLLIESIKSFQKTPHYSKLHLKTKSQDFHFHLKYHNLSLYTEHS\nVQEKNWYSLVIREDGNSISSMMVKDTESRTTNGMTTVRFVNTLHKDVNISLSTDTSLNVG\nEDYGVSAYRTVQRGEYPAVHCRTEDKNFSLNLGLLDFGAAYLFVITNNTNQGLQAWKIED\nIPANKMSIAWQLPQYALVTAGEVMFSVTGLEFSYSQAPSSMKSVLQAAWLLTIAVGNIIV\nLVVAQFSGLVQWAEFILFSCLLLVICLIFSIMGYYYVPVKTEDMRGPADKHIPHIQGNMI\nKLETKKTKL",
                        "Number of residues": "729",
                        "Molecular Weight": "81782.77",
                        "Theoretical pI": "8.38",
                        "GO Classification": "Functionsantibiotic transporter activity / dipeptide transporter activity / high-affinity oligopeptide transporter activity / peptideProcessesdrug transport / ion transport / protein transport / proton transport / transmembrane transport / transportComponentsextracellular exosome / integral component of plasma membrane / plasma membrane",
                        "General Function": "Peptide:proton symporter activity",
                        "Specific Function": "Proton-coupled intake of oligopeptides of 2 to 4 amino acids with a preference for dipeptides.",
                        "Pfam Domain Function": "PTR2 (PF00854)",
                        "Transmembrane Regions": "58-78\n88-108\n115-135\n140-160\n184-204\n218-238\n296-316\n344-364\n381-401\n568-588\n612-632\n644-664\n675-695",
                        "Cellular Location": "Membrane",
                        "Gene sequence": ">lcl|BSEQ0010792|Solute carrier family 15 member 2 (SLC15A2)\nATGAATCCTTTCCAGAAAAATGAGTCCAAGGAAACTCTTTTTTCACCTGTCTCCATTGAA\nGAGGTACCACCTCGACCACCTAGCCCTCCAAAGAAGCCATCTCCGACAATCTGTGGCTCC\nAACTATCCACTGAGCATTGCCTTCATTGTGGTGAATGAATTCTGCGAGCGCTTTTCCTAT\nTATGGAATGAAAGCTGTGCTGATCCTGTATTTCCTGTATTTCCTGCACTGGAATGAAGAT\nACCTCCACATCTATATACCATGCCTTCAGCAGCCTCTGTTATTTTACTCCCATCCTGGGA\nGCAGCCATTGCTGACTCGTGGTTGGGAAAATTCAAAGTCCTATCATTGATCGGCCTGAGT\nCTAATAGCTTTGGGGACAGGAGGCATCAAACCCTGTGTGGCAGCTTTTGGTGGAGACCAG\nTTTGAAGAAAAACATGCAGAGGAACGGACTAGATACTTCTCAGTCTTCTACCTGTCCATC\nAATGCAGGGAGCTTGATTTCTACATTTATCACACCCATGCTGAGAGGAGATGTGCAATGT\nTTTGGAGAAGACTGCTATGCATTGGCTTTTGGAGTTCCAGGACTGCTCATGGTAATTGCA\nCTTGTTGTGTTTGCAATGGGAAGCAAAATATACAATAAACCACCCCCTGAAGGAAACATA\nGTGGCTCAAGTTTTCAAATGTATCTGGTTTGCTATTTCCAATCGTTTCAAGAACCGTTCT\nGGAGACATTCCAAAGCGACAGCACTGGCTAGACTGGGCGGCTGAGAAATATCCAAAGCAG\nCTCATTATGGATGTAAAGGCACTGACCAGGGTACTATTCCTTTATATCCCATTGCCCATG\nTTCTGGGCTCTTTTGGATCAGCAGGGTTCACGATGGACTTTGCAAGCCATCAGGATGAAT\nAGGAATTTGGGGTTTTTTGTGCTTCAGCCGGACCAGATGCAGGTTCTAAATCCCCTTCTG\nGTTCTTATCTTCATCCCGTTGTTTGACTTTGTCATTTATCGTCTGGTCTCCAAGTGTGGA\nATTAACTTCTCATCACTTAGGAAAATGGCTGTTGGTATGATCCTAGCATGCCTGGCATTT\nGCAGTTGCGGCAGCTGTAGAGATAAAAATAAATGAAATGGCCCCAGCCCAGCCAGGTCCC\nCAGGAGGTTTTCCTACAAGTCTTGAATCTGGCAGATGATGAGGTGAAGGTGACAGTGGTG\nGGAAATGAAAACAATTCTCTGTTGATAGAGTCCATCAAATCCTTTCAGAAAACACCACAC\nTATTCCAAACTGCACCTGAAAACAAAAAGCCAGGATTTTCACTTCCACCTGAAATATCAC\nAATTTGTCTCTCTACACTGAGCATTCTGTGCAGGAGAAGAACTGGTACAGTCTTGTCATT\nCGTGAAGATGGGAACAGTATCTCCAGCATGATGGTAAAGGATACAGAAAGCAGAACAACC\nAATGGGATGACAACCGTGAGGTTTGTTAACACTTTGCATAAAGATGTCAACATCTCCCTG\nAGTACAGATACCTCTCTCAATGTTGGTGAAGACTATGGTGTGTCTGCTTATAGAACTGTG\nCAAAGAGGAGAATACCCTGCAGTGCACTGTAGAACAGAAGATAAGAACTTTTCTCTGAAT\nTTGGGTCTTCTAGACTTTGGTGCAGCATATCTGTTTGTTATTACTAATAACACCAATCAG\nGGTCTTCAGGCCTGGAAGATTGAAGACATTCCAGCCAACAAAATGTCCATTGCGTGGCAG\nCTACCACAATATGCCCTGGTTACAGCTGGGGAGGTCATGTTCTCTGTCACAGGTCTTGAG\nTTTTCTTATTCTCAGGCTCCCTCTAGCATGAAATCTGTGCTCCAGGCAGCTTGGCTATTG\nACAATTGCAGTTGGGAATATCATCGTGCTTGTTGTGGCACAGTTCAGTGGCCTGGTACAG\nTGGGCCGAATTCATTTTGTTTTCCTGCCTCCTGCTGGTGATCTGCCTGATCTTCTCCATC\nATGGGCTACTACTATGTTCCTGTAAAGACAGAGGATATGCGGGGTCCAGCAGATAAGCAC\nATTCCTCACATCCAGGGGAACATGATCAAACTAGAGACCAAGAAGACAAAACTCTGA",
                        "Chromosome Location": "3",
                        "Locus": "3q13.33",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ16348UniProtKB Entry NameS15A2_HUMANGenBank Protein ID999213GenBank Gene IDS78203GenAtlas IDSLC15A2HGNC IDHGNC:10921",
                        "General References": "Liu W, Liang R, Ramamoorthy S, Fei YJ, Ganapathy ME, Hediger MA, Ganapathy V, Leibach FH: Molecular cloning of PEPT 2, a new member of the H+/peptide cotransporter family, from human kidney. Biochim Biophys Acta. 1995 May 4;1235(2):461-6. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Muzny DM, Scherer SE, Kaul R, Wang J, Yu J, Sudbrak R, Buhay CJ, Chen R, Cree A, Ding Y, Dugan-Rocha S, Gill R, Gunaratne P, Harris RA, Hawes AC, Hernandez J, Hodgson AV, Hume J, Jackson A, Khan ZM, Kovar-Smith C, Lewis LR, Lozado RJ, Metzker ML, Milosavljevic A, Miner GR, Morgan MB, Nazareth LV, Scott G, Sodergren E, Song XZ, Steffen D, Wei S, Wheeler DA, Wright MW, Worley KC, Yuan Y, Zhang Z, Adams CQ, Ansari-Lari MA, Ayele M, Brown MJ, Chen G, Chen Z, Clendenning J, Clerc-Blankenburg KP, Chen R, Chen Z, Davis C, Delgado O, Dinh HH, Dong W, Draper H, Ernst S, Fu G, Gonzalez-Garay ML, Garcia DK, Gillett W, Gu J, Hao B, Haugen E, Havlak P, He X, Hennig S, Hu S, Huang W, Jackson LR, Jacob LS, Kelly SH, Kube M, Levy R, Li Z, Liu B, Liu J, Liu W, Lu J, Maheshwari M, Nguyen BV, Okwuonu GO, Palmeiri A, Pasternak S, Perez LM, Phelps KA, Plopper FJ, Qiang B, Raymond C, Rodriguez R, Saenphimmachak C, Santibanez J, Shen H, Shen Y, Subramanian S, Tabor PE, Verduzco D, Waldron L, Wang J, Wang J, Wang Q, Williams GA, Wong GK, Yao Z, Zhang J, Zhang X, Zhao G, Zhou J, Zhou Y, Nelson D, Lehrach H, Reinhardt R, Naylor SL, Yang H, Olson M, Weinstock G, Gibbs RA: The DNA sequence, annotation and analysis of human chromosome 3. Nature. 2006 Apr 27;440(7088):1194-8. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB01000CyclacillinapprovedunknowninhibitorDetailsDB01140Cefadroxilapproved, vet_approved, withdrawnunknowninhibitorDetailsDB00567Cephalexinapproved, investigational, vet_approvedunknowninhibitorDetailsDB01415Ceftibutenapproved, investigationalunknowninhibitorDetailsDB00671Cefiximeapproved, investigationalunknowninhibitorDetailsDB00535CefdinirapprovedunknowninhibitorDetailsDB03424UbenimexinvestigationalunknownsubstrateinhibitorDetailsDB00855Aminolevulinic acidapprovedunknowninhibitorDetailsDB00447Loracarbefapproved, investigational, withdrawnunknowninhibitorDetailsDB01333CefradineapprovedunknowninhibitorDetailsDB00415Ampicillinapproved, vet_approvedunknowninhibitorDetailsDB01060Amoxicillinapproved, vet_approvedunknowninhibitorDetailsDB00577Valaciclovirapproved, investigationalunknownsubstrateinhibitorDetailsDB01016GlyburideapprovedunknowninhibitorDetailsDB01413Cefepimeapproved, investigationalunknowninhibitorDetailsDB01124Tolbutamideapproved, investigationalunknowninhibitorDetailsDB00731Nateglinideapproved, investigationalunknowninhibitorDetailsDB00672Chlorpropamideapproved, investigationalunknowninhibitorDetailsDB01212CeftriaxoneapprovedunknowninhibitorDetailsDB00493CefotaximeapprovedunknowninhibitorDetailsDB01112CefuroximeapprovedunknowninhibitorDetailsDB01053Benzylpenicillinapproved, vet_approvedunknowninhibitorDetailsDB00456Cefalotinapproved, investigational, vet_approvedunknowninhibitorDetailsDB00274Cefmetazoleapproved, investigationalunknowninhibitorDetailsDB00713Oxacillinapproved, investigationalunknowninhibitorDetailsDB01147Cloxacillinapproved, investigational, vet_approvednoinhibitorDetailsDB00485Dicloxacillinapproved, investigational, vet_approvedunknowninhibitorDetailsDB00833CefaclorapprovedunknowninhibitorDetailsDB00881Quinaprilapproved, investigationalunknownsubstrateDetailsDB00542Benazeprilapproved, investigationalunknownsubstrateDetailsDB01340CilazaprilapprovedunknownsubstrateDetailsDB00492FosinoprilapprovedunknownsubstrateDetailsDB00691MoexiprilapprovedunknownsubstrateDetailsDB00790PerindoprilapprovedunknownsubstrateDetailsDB00178RamiprilapprovedunknownsubstrateDetailsDB01348SpiraprilapprovedunknownsubstrateDetailsDB00519TrandolaprilapprovedunknownsubstrateDetailsDB08795AzidocillinexperimentalunknowninhibitorDetailsDB01610Valganciclovirapproved, investigationalunknownDetailsDB00415Ampicillinapproved, vet_approvedunknownDetailsDB00493CefotaximeapprovedunknownDetailsDB00713Oxacillinapproved, investigationalunknownDetailsDB01053Benzylpenicillinapproved, vet_approvedunknowninhibitorDetailsDB00781Polymyxin Bapproved, vet_approvedunknownDetailsDB00722Lisinoprilapproved, investigationalunknownsubstrateDetails"
                    }
                },
                {
                    "Label": "Solute carrier family 22 member 6",
                    "Detailed Info": {
                        "Name": "Solute carrier family 22 member 6",
                        "Synonyms": "hOAT1\nhPAHT\nhROAT1\nOAT1\nOrganic anion transporter 1\nPAH transporter\nPAHT\nRenal organic anion transporter 1",
                        "Gene Name": "SLC22A6",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0037120|Solute carrier family 22 member 6\nMAFNDLLQQVGGVGRFQQIQVTLVVLPLLLMASHNTLQNFTAAIPTHHCRPPADANLSKN\nGGLEVWLPRDRQGQPESCLRFTSPQWGLPFLNGTEANGTGATEPCTDGWIYDNSTFPSTI\nVTEWDLVCSHRALRQLAQSLYMVGVLLGAMVFGYLADRLGRRKVLILNYLQTAVSGTCAA\nFAPNFPIYCAFRLLSGMALAGISLNCMTLNVEWMPIHTRACVGTLIGYVYSLGQFLLAGV\nAYAVPHWRHLQLLVSAPFFAFFIYSWFFIESARWHSSSGRLDLTLRALQRVARINGKREE\nGAKLSMEVLRASLQKELTMGKGQASAMELLRCPTLRHLFLCLSMLWFATSFAYYGLVMDL\nQGFGVSIYLIQVIFGAVDLPAKLVGFLVINSLGRRPAQMAALLLAGICILLNGVIPQDQS\nIVRTSLAVLGKGCLAASFNCIFLYTGELYPTMIRQTGMGMGSTMARVGSIVSPLVSMTAE\nLYPSMPLFIYGAVPVAASAVTVLLPETLGQPLPDTVQDLESRWAPTQKEAGIYPRKGKQT\nRQQQEHQKYMVPLQASAQEKNGL",
                        "Number of residues": "563",
                        "Molecular Weight": "61815.78",
                        "Theoretical pI": "8.78",
                        "GO Classification": "Functionschloride ion binding / inorganic anion exchanger activity / organic anion transmembrane transporter activity / sodium-independent organic anion transmembrane transporter activityProcessesalpha-ketoglutarate transport / anion transmembrane transport / organic anion transport / protein homooligomerization / renal tubular secretion / response to methotrexate / sodium-independent organic anion transport / transmembrane transportComponentsbasolateral plasma membrane / caveola / extracellular exosome / integral component of plasma membrane / plasma membrane / protein complex",
                        "General Function": "Sodium-independent organic anion transmembrane transporter activity",
                        "Specific Function": "Involved in the renal elimination of endogenous and exogenous organic anions. Functions as organic anion exchanger when the uptake of one molecule of organic anion is coupled with an efflux of one molecule of endogenous dicarboxylic acid (glutarate, ketoglutarate, etc). Mediates the sodium-independent uptake of 2,3-dimercapto-1-propanesulfonic acid (DMPS) (By similarity). Mediates the sodium-independent uptake of p-aminohippurate (PAH), ochratoxin (OTA), acyclovir (ACV), 3'-azido-3-'deoxythymidine (AZT), cimetidine (CMD), 2,4-dichloro-phenoxyacetate (2,4-D), hippurate (HA), indoleacetate (IA), indoxyl sulfate (IS) and 3-carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF), cidofovir, adefovir, 9-(2-phosphonylmethoxyethyl) guanine (PMEG), 9-(2-phosphonylmethoxyethyl) diaminopurine (PMEDAP) and edaravone sulfate. PAH uptake is inhibited by p-chloromercuribenzenesulphonate (PCMBS), diethyl pyrocarbonate (DEPC), sulindac, diclofenac, carprofen, glutarate and okadaic acid (By similarity). PAH uptake is inhibited by benzothiazolylcysteine (BTC), S-chlorotrifluoroethylcysteine (CTFC), cysteine S-conjugates S-dichlorovinylcysteine (DCVC), furosemide, steviol, phorbol 12-myristate 13-acetate (PMA), calcium ionophore A23187, benzylpenicillin, furosemide, indomethacin, bumetamide, losartan, probenecid, phenol red, urate, and alpha-ketoglutarate.",
                        "Pfam Domain Function": "Sugar_tr (PF00083)",
                        "Transmembrane Regions": "10-30\n136-156\n165-187\n191-213\n225-245\n249-269\n338-358\n369-389\n396-416\n426-446\n456-475\n485-505",
                        "Cellular Location": "Cell membrane",
                        "Gene sequence": ">lcl|BSEQ0010747|Solute carrier family 22 member 6 (SLC22A6)\nATGGCCTTTAATGACCTCCTGCAGCAGGTGGGGGGTGTCGGCCGCTTCCAGCAGATCCAG\nGTCACCCTGGTGGTCCTCCCCCTGCTCCTGATGGCTTCTCACAACACCCTGCAGAACTTC\nACTGCTGCCATCCCTACCCACCACTGCCGCCCGCCTGCCGATGCCAACCTCAGCAAGAAC\nGGGGGGCTGGAGGTCTGGCTGCCCCGGGACAGGCAGGGGCAGCCTGAGTCCTGCCTCCGC\nTTCACCTCCCCGCAGTGGGGACTGCCCTTTCTCAATGGCACAGAAGCCAATGGCACAGGG\nGCCACAGAGCCCTGCACCGATGGCTGGATCTATGACAACAGCACCTTCCCATCTACCATC\nGTGACTGAGTGGGACCTTGTGTGCTCTCACAGGGCCCTACGCCAGCTGGCCCAGTCCTTG\nTACATGGTGGGGGTGCTGCTCGGAGCCATGGTGTTCGGCTACCTTGCAGACAGGCTAGGC\nCGCCGGAAGGTACTCATCTTGAACTACCTGCAGACAGCTGTGTCAGGGACCTGCGCAGCC\nTTCGCACCCAACTTCCCCATCTACTGCGCCTTCCGGCTCCTCTCGGGCATGGCTCTGGCT\nGGCATCTCCCTCAACTGCATGACACTGAATGTGGAGTGGATGCCCATTCACACACGGGCC\nTGCGTGGGCACCTTGATTGGCTATGTCTACAGCCTGGGCCAGTTCCTCCTGGCTGGTGTG\nGCCTACGCTGTGCCCCACTGGCGCCACCTGCAGCTACTGGTCTCTGCGCCTTTTTTTGCC\nTTCTTCATCTACTCCTGGTTCTTCATTGAGTCGGCCCGCTGGCACTCCTCCTCCGGGAGG\nCTGGACCTCACCCTGAGGGCCCTGCAGAGAGTCGCCCGGATCAATGGGAAGCGGGAAGAA\nGGAGCCAAATTGAGTATGGAGGTACTCCGGGCCAGTCTGCAGAAGGAGCTGACCATGGGC\nAAAGGCCAGGCATCGGCCATGGAGCTGCTGCGCTGCCCCACCCTCCGCCACCTCTTCCTC\nTGCCTCTCCATGCTGTGGTTTGCCACTAGCTTTGCATACTATGGGCTGGTCATGGACCTG\nCAGGGCTTTGGAGTCAGCATCTACCTAATCCAGGTGATCTTTGGTGCTGTGGACCTGCCT\nGCCAAGCTTGTGGGCTTCCTTGTCATCAACTCCCTGGGTCGCCGGCCTGCCCAGATGGCT\nGCACTGCTGCTGGCAGGCATCTGCATCCTGCTCAATGGGGTGATACCCCAGGACCAGTCC\nATTGTCCGAACCTCTCTTGCTGTGCTGGGGAAGGGTTGTCTGGCTGCCTCCTTCAACTGC\nATCTTCCTGTATACTGGGGAACTGTATCCCACAATGATCCGGCAGACAGGCATGGGAATG\nGGCAGCACCATGGCCCGAGTGGGCAGCATCGTGAGCCCACTGGTGAGCATGACTGCCGAG\nCTCTACCCCTCCATGCCTCTCTTCATCTACGGTGCTGTTCCTGTGGCCGCCAGCGCTGTC\nACTGTCCTCCTGCCAGAGACCCTGGGCCAGCCACTGCCAGACACGGTGCAGGACCTGGAG\nAGCAGGTGGGCCCCCACTCAGAAAGAAGCAGGGATATATCCCAGGAAAGGGAAACAGACG\nCGACAGCAACAAGAGCACCAGAAGTATATGGTCCCACTGCAGGCCTCAGCACAAGAGAAG\nAATGGACTCTGA",
                        "Chromosome Location": "11",
                        "Locus": "Not Available",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ4U2R8UniProtKB Entry NameS22A6_HUMANGenBank Protein ID3831566GenBank Gene IDAF057039GenAtlas IDhROAT1HGNC IDHGNC:10970",
                        "General References": "Reid G, Wolff NA, Dautzenberg FM, Burckhardt G: Cloning of a human renal p-aminohippurate transporter, hROAT1. Kidney Blood Press Res. 1998;21(2-4):233-7. [Article] Hosoyamada M, Sekine T, Kanai Y, Endou H: Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am J Physiol. 1999 Jan;276(1 Pt 2):F122-8. [Article] Lu R, Chan BS, Schuster VL: Cloning of the human kidney PAH transporter: narrow substrate specificity and regulation by protein kinase C. Am J Physiol. 1999 Feb;276(2 Pt 2):F295-303. [Article] Race JE, Grassl SM, Williams WJ, Holtzman EJ: Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3). Biochem Biophys Res Commun. 1999 Feb 16;255(2):508-14. [Article] Cihlar T, Lin DC, Pritchard JB, Fuller MD, Mendel DB, Sweet DH: The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1. Mol Pharmacol. 1999 Sep;56(3):570-80. [Article] Bahn A, Prawitt D, Buttler D, Reid G, Enklaar T, Wolff NA, Ebbinghaus C, Hillemann A, Schulten HJ, Gunawan B, Fuzesi L, Zabel B, Burckhardt G: Genomic structure and in vivo expression of the human organic anion transporter 1 (hOAT1) gene. Biochem Biophys Res Commun. 2000 Aug 28;275(2):623-30. [Article] Taylor TD, Noguchi H, Totoki Y, Toyoda A, Kuroki Y, Dewar K, Lloyd C, Itoh T, Takeda T, Kim DW, She X, Barlow KF, Bloom T, Bruford E, Chang JL, Cuomo CA, Eichler E, FitzGerald MG, Jaffe DB, LaButti K, Nicol R, Park HS, Seaman C, Sougnez C, Yang X, Zimmer AR, Zody MC, Birren BW, Nusbaum C, Fujiyama A, Hattori M, Rogers J, Lander ES, Sakaki Y: Human chromosome 11 DNA sequence and analysis including novel gene identification. Nature. 2006 Mar 23;440(7083):497-500. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Groves CE, Munoz L, Bahn A, Burckhardt G, Wright SH: Interaction of cysteine conjugates with human and rabbit organic anion transporter 1. J Pharmacol Exp Ther. 2003 Feb;304(2):560-6. [Article] Tanaka K, Xu W, Zhou F, You G: Role of glycosylation in the organic anion transporter OAT1. J Biol Chem. 2004 Apr 9;279(15):14961-6. Epub 2004 Jan 28. [Article] Hong M, Zhou F, You G: Critical amino acid residues in transmembrane domain 1 of the human organic anion transporter hOAT1. J Biol Chem. 2004 Jul 23;279(30):31478-82. Epub 2004 May 15. [Article] Srimaroeng C, Chatsudthipong V, Aslamkhan AG, Pritchard JB: Transport of the natural sweetener stevioside and its aglycone steviol by human organic anion transporter (hOAT1; SLC22A6) and hOAT3 (SLC22A8). J Pharmacol Exp Ther. 2005 May;313(2):621-8. Epub 2005 Jan 11. [Article] Tahara H, Shono M, Kusuhara H, Kinoshita H, Fuse E, Takadate A, Otagiri M, Sugiyama Y: Molecular cloning and functional analyses of OAT1 and OAT3 from cynomolgus monkey kidney. Pharm Res. 2005 Apr;22(4):647-60. Epub 2005 Apr 7. [Article] Perry JL, Dembla-Rajpal N, Hall LA, Pritchard JB: A three-dimensional model of human organic anion transporter 1: aromatic amino acids required for substrate transport. J Biol Chem. 2006 Dec 8;281(49):38071-9. Epub 2006 Oct 11. [Article] Mizuno N, Takahashi T, Iwase Y, Kusuhara H, Niwa T, Sugiyama Y: Human organic anion transporters 1 (hOAT1/SLC22A6) and 3 (hOAT3/SLC22A8) transport edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and its sulfate conjugate. Drug Metab Dispos. 2007 Aug;35(8):1429-34. Epub 2007 May 14. [Article] Bleasby K, Hall LA, Perry JL, Mohrenweiser HW, Pritchard JB: Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6). J Pharmacol Exp Ther. 2005 Aug;314(2):923-31. Epub 2005 May 24. [Article] Xu G, Bhatnagar V, Wen G, Hamilton BA, Eraly SA, Nigam SK: Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)]. Kidney Int. 2005 Oct;68(4):1491-9. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00695Furosemideapproved, vet_approvedunknowninhibitorinducerDetailsDB00936Salicylic acidapproved, investigational, vet_approvedunknowninhibitorDetailsDB01032Probenecidapproved, investigationalunknownsubstrateinhibitorDetailsDB00345Aminohippuric acidapproved, investigationalunknownsubstrateinhibitorDetailsDB01009Ketoprofenapproved, vet_approvedunknowninhibitorDetailsDB03553Glutaric AcidexperimentalunknownsubstrateinhibitorDetailsDB00369CidofovirapprovedunknownsubstrateinhibitorDetailsDB01333CefradineapprovedunknowninhibitorDetailsDB00718Adefovir dipivoxilapproved, investigationalunknownsubstrateinhibitorDetailsDB00554Piroxicamapproved, investigationalunknowninhibitorDetailsDB03783PhenacetinwithdrawnunknowninhibitorDetailsDB00788Naproxenapproved, vet_approvedunknowninhibitorDetailsDB00328Indomethacinapproved, investigationalunknownsubstrateinhibitorDetailsDB01050IbuprofenapprovedunknowninhibitorDetailsDB00712Flurbiprofenapproved, investigationalunknowninhibitorDetailsDB00749Etodolacapproved, investigational, vet_approvedunknowninhibitorDetailsDB00861Diflunisalapproved, investigationalunknowninhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknowninhibitorDetailsDB01597Cilastatinapproved, investigationalunknowninhibitorDetailsDB01053Benzylpenicillinapproved, vet_approvedunknowninhibitorDetailsDB04519Caprylic acidinvestigationalunknowninhibitorDetailsDB00501Cimetidineapproved, investigationalunknownsubstrateinhibitorDetailsDB00168Aspartameinvestigational, nutraceuticalunknowninhibitorDetailsDB00759Tetracyclineapproved, vet_approved, withdrawnunknowninhibitorDetailsDB00595Oxytetracyclineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB01017Minocyclineapproved, investigationalunknowninhibitorDetailsDB00254Doxycyclineapproved, investigational, vet_approvedunknowninhibitorDetailsDB01004Ganciclovirapproved, investigationalunknowninhibitorDetailsDB00787AcyclovirapprovedunknownsubstrateinhibitorDetailsDB00917DinoprostoneapprovedunknownsubstrateinhibitorDetailsDB00456Cefalotinapproved, investigational, vet_approvedunknowninhibitorDetailsDB01212CeftriaxoneapprovedunknowninhibitorDetailsDB00493CefotaximeapprovedunknowninhibitorDetailsDB01329Cefoperazoneapproved, investigationalunknowninhibitorDetailsDB01327CefazolinapprovedunknownsubstrateinhibitorDetailsDB01326Cefamandoleapproved, experimentalunknowninhibitorDetailsDB01140Cefadroxilapproved, vet_approved, withdrawnunknowninhibitorDetailsDB00812Phenylbutazoneapproved, vet_approvedunknowninhibitorDetailsDB00563MethotrexateapprovedunknownsubstrateinhibitorDetailsDB00693FluoresceinapprovedunknownsubstrateinhibitorDetailsDB00678LosartanapprovedunknowninhibitorDetailsDB00999Hydrochlorothiazideapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00887BumetanideapprovedunknownsubstrateinhibitorDetailsDB00175PravastatinapprovednoinhibitorDetailsDB00520CaspofunginapprovedunknowninhibitorDetailsDB00605Sulindacapproved, investigationalunknowninhibitorDetailsDB00140Riboflavinapproved, investigational, nutraceutical, vet_approvedunknowninhibitorDetailsDB00158Folic acidapproved, nutraceutical, vet_approvedunknowninhibitorDetailsDB00584Enalaprilapproved, vet_approvedunknowninhibitorDetailsDB00821Carprofenapproved, vet_approved, withdrawnunknowninhibitorDetailsDB01197CaptoprilapprovedunknownsubstrateinhibitorDetailsDB01124Tolbutamideapproved, investigationalunknowninhibitorDetailsDB01060Amoxicillinapproved, vet_approvedunknowninhibitorDetailsDB00567Cephalexinapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00313Valproic acidapproved, investigationalunknowninhibitorDetailsDB00779Nalidixic acidapproved, investigationalunknowninhibitorDetailsDB00903Etacrynic acidapproved, investigationalunknowninhibitorDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00703MethazolamideapprovedunknowninhibitorDetailsDB00311EthoxzolamidewithdrawnunknowninhibitorDetailsDB00606CyclothiazideapprovedunknowninhibitorDetailsDB00880Chlorothiazideapproved, vet_approvedunknowninhibitorDetailsDB00819Acetazolamideapproved, vet_approvedunknowninhibitorDetailsDB02266Flufenamic acidapprovedunknowninhibitorDetailsDB00500TolmetinapprovedunknowninhibitorDetailsDB00945Acetylsalicylic acidapproved, vet_approvedunknowninhibitorDetailsDB01435Antipyrineapproved, investigationalunknowninhibitorDetailsDB03585Oxyphenbutazoneapproved, withdrawnunknowninhibitorDetailsDB00939Meclofenamic acidapproved, vet_approvedunknowninhibitorDetailsDB01424Aminophenazoneapproved, withdrawnunknowninhibitorDetailsDB00731Nateglinideapproved, investigationalunknowninhibitorDetailsDB00319PiperacillinapprovedunknowninhibitorDetailsDB01165OfloxacinapprovedunknowninhibitorDetailsDB01059NorfloxacinapprovedunknowninhibitorDetailsDB00607Nafcillinapproved, investigationalunknowninhibitorDetailsDB00827Cinoxacinapproved, investigational, withdrawnunknowninhibitorDetailsDB00446Chloramphenicolapproved, vet_approved, withdrawnunknowninhibitorDetailsDB00438CeftazidimeapprovedunknowninhibitorDetailsDB00578Carbenicillinapproved, investigationalunknowninhibitorDetailsDB00432Trifluridineapproved, investigationalunknownsubstrateinhibitorDetailsDB01016GlyburideapprovedunknowninhibitorDetailsDB04348Taurocholic acidapproved, experimentalunknownsubstrateinhibitorDetailsDB00529FoscarnetapprovedunknowninhibitorDetailsDB00672Chlorpropamideapproved, investigationalunknowninhibitorDetailsDB00229Cefotiamapproved, investigationalunknownsubstrateinhibitorDetailsDB01051Novobiocinapproved, investigational, vet_approved, withdrawnunknowninhibitorDetailsDB00286Conjugated estrogensapprovedunknownsubstrateDetailsDB02527Cyclic adenosine monophosphateexperimentalunknownsubstrateDetailsDB00709Lamivudineapproved, investigationalunknownsubstrateDetailsDB00365Grepafloxacinapproved, investigational, withdrawnunknownsubstrateDetailsDB00649Stavudineapproved, investigationalunknownsubstrateDetailsDB00943Zalcitabineapproved, investigationalunknownsubstrateDetailsDB00900DidanosineapprovedunknownsubstrateDetailsDB01032Probenecidapproved, investigationalyesinhibitorDetailsDB01237BromodiphenhydramineapprovedunknownDetailsDB01414Cefacetrileexperimental, vet_approvedunknownsubstrateinhibitorDetailsDB00654Latanoprostapproved, investigationalunknownsubstrateinhibitorDetailsDB00577Valaciclovirapproved, investigationalunknownDetailsDB08843GS 0573investigationalunknownDetailsDB00495ZidovudineapprovedunknownsubstrateDetailsDB02315Cyclic GMPexperimentalunknownDetailsDB08844Uric acidinvestigationalunknownDetailsDB01160Dinoprost tromethamineapproved, vet_approvedunknownDetailsDB06151Acetylcysteineapproved, investigationalunknownsubstrateDetailsDB08846Ellagic acidinvestigationalunknownsubstrateinhibitorDetailsDB04133Degraded CephaloridineexperimentalunknownDetailsDB00659Acamprosateapproved, investigationalunknownsubstrateDetailsDB08912Dabrafenibapproved, investigationalnoinhibitorDetailsDB00300Tenofovir disoproxilapproved, investigationalunknownsubstrateDetailsDB00493CefotaximeapprovedunknownDetailsDB01212CeftriaxoneapprovedunknownDetailsDB01685TopiroxostatexperimentalunknowninhibitorDetailsDB05016Atalurenapproved, investigationalnoinhibitorDetailsDB13874Enasidenibapproved, investigationalunknowninhibitorDetailsDB08930DolutegravirapprovednoinhibitorDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB11817Baricitinibapproved, investigationalunknowninhibitorDetailsDB00535CefdinirapprovedunknownsubstrateDetailsDB01415Ceftibutenapproved, investigationalunknownsubstrateDetailsDB01332Ceftizoximeapproved, withdrawnunknownsubstrateinhibitorDetailsDB09008Cefaloridineexperimental, withdrawnunknownsubstrateDetailsDB00155Citrullineinvestigational, nutraceuticalunknownsubstrateDetailsDB12243Edaravoneapproved, investigationalnosubstrateDetailsDB00770Alprostadilapproved, investigationalunknownsubstrateinhibitorDetailsDB09298Silibininexperimental, investigationalunknownsubstrateinhibitorDetailsDB09078Lenvatinibapproved, investigationalunknowninhibitorDetailsDB01606TazobactamapprovedunknownsubstrateinhibitorDetailsDB01045RifampicinapprovedunknowninhibitorDetailsDB11751Cabotegravirapproved, investigationalunknowninhibitorDetailsDB09213Dexibuprofenapproved, investigationalunknownDetailsDB09299Tenofovir alafenamideapprovednosubstrateDetailsDB14126Tenofovirexperimental, investigationalnosubstrateDetailsDB11757Istradefyllineapproved, investigationalunknowninhibitorDetailsDB15328Ubrogepantapproved, investigationalunknownsubstrateDetailsDB00927FamotidineapprovednosubstrateDetailsDB11644Tafamidisapproved, investigationalunknowninhibitorDetailsDB12466Favipiravirapproved, investigationalunknowninhibitorDetailsDB11837Osilodrostatapproved, investigationalunknowninhibitorDetailsDB00774Hydroflumethiazideapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB01324PolythiazideapprovedunknownsubstrateDetailsDB15822Pralsetinibapproved, investigationalnoinhibitorDetailsDB16628FosdenopterinapprovedunknowninhibitorDetailsDB00601Linezolidapproved, investigationalnoinhibitorDetailsDB12151Brincidofovirapproved, investigationalnoinhibitorDetailsDB12265Fexinidazoleapproved, investigationalunknowninhibitorDetailsDB16098Atogepantapproved, investigationalnosubstrateDetailsDB06176Romidepsinapproved, investigationalnoinhibitorDetailsDB15413Pafolacianineapproved, investigationalnosubstrateDetailsDB04847Roxadustatapproved, investigationalunknownsubstrateDetailsDB17083LinzagolixapprovednoinhibitorDetailsDB00642Pemetrexedapproved, investigationalnosubstrateDetailsDB11682Daprodustatapproved, investigationalnosubstrateDetailsDB01250OlsalazineapprovedunknownupregulatorDetailsDB12513Omaveloxoloneapproved, investigationalunknowninhibitorDetailsDB11712Tezacaftorapproved, investigationalnoinhibitorDetailsDB12255Vadadustatapproved, investigationalunknownsubstrateDetailsDB16704Durlobactamapproved, investigationalnosubstrateDetailsDB11718Encorafenibapproved, investigationalnoinhibitorDetails"
                    }
                },
                {
                    "Label": "Solute carrier family 22 member 8",
                    "Detailed Info": {
                        "Name": "Solute carrier family 22 member 8",
                        "Synonyms": "hOAT3\nOAT3\nOrganic anion transporter 3",
                        "Gene Name": "SLC22A8",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0007005|Solute carrier family 22 member 8\nMTFSEILDRVGSMGHFQFLHVAILGLPILNMANHNLLQIFTAATPVHHCRPPHNASTGPW\nVLPMGPNGKPERCLRFVHPPNASLPNDTQRAMEPCLDGWVYNSTKDSIVTEWDLVCNSNK\nLKEMAQSIFMAGILIGGLVLGDLSDRFGRRPILTCSYLLLAASGSGAAFSPTFPIYMVFR\nFLCGFGISGITLSTVILNVEWVPTRMRAIMSTALGYCYTFGQFILPGLAYAIPQWRWLQL\nTVSIPFFVFFLSSWWTPESIRWLVLSGKSSKALKILRRVAVFNGKKEEGERLSLEELKLN\nLQKEISLAKAKYTASDLFRIPMLRRMTFCLSLAWFATGFAYYSLAMGVEEFGVNLYILQI\nIFGGVDVPAKFITILSLSYLGRHTTQAAALLLAGGAILALTFVPLDLQTVRTVLAVFGKG\nCLSSSFSCLFLYTSELYPTVIRQTGMGVSNLWTRVGSMVSPLVKITGEVQPFIPNIIYGI\nTALLGGSAALFLPETLNQPLPETIEDLENWSLRAKKPKQEPEVEKASQRIPLQPHGPGLG\nSS",
                        "Number of residues": "542",
                        "Molecular Weight": "59855.585",
                        "Theoretical pI": "9.05",
                        "GO Classification": "Functionsinorganic anion exchanger activity / sodium-independent organic anion transmembrane transporter activityProcessesanion transmembrane transport / response to toxic substance / sodium-independent organic anion transport / transmembrane transportComponentsbasolateral plasma membrane / extracellular exosome / integral component of plasma membrane / plasma membrane",
                        "General Function": "Sodium-independent organic anion transmembrane transporter activity",
                        "Specific Function": "Plays an important role in the excretion/detoxification of endogenous and exogenous organic anions, especially from the brain and kidney. Involved in the transport basolateral of steviol, fexofenadine. Transports benzylpenicillin (PCG), estrone-3-sulfate (E1S), cimetidine (CMD), 2,4-dichloro-phenoxyacetate (2,4-D), p-amino-hippurate (PAH), acyclovir (ACV) and ochratoxin (OTA).",
                        "Pfam Domain Function": "Sugar_tr (PF00083)",
                        "Transmembrane Regions": "10-30\n124-144\n155-175\n177-197\n213-233\n237-257\n328-348\n355-375\n387-407\n412-432\n472-492",
                        "Cellular Location": "Basolateral cell membrane",
                        "Gene sequence": ">lcl|BSEQ0019450|Solute carrier family 22 member 8 (SLC22A8)\nATGACCTTCTCGGAGATCCTGGACCGTGTGGGAAGCATGGGCCATTTCCAGTTCCTGCAT\nGTAGCCATACTGGGCCTCCCGATCCTCAACATGGCCAACCACAACCTGCTGCAGATCTTC\nACAGCCGCCACCCCTGTCCACCACTGTCGCCCGCCCCACAATGCCTCCACAGGGCCTTGG\nGTGCTCCCCATGGGCCCAAATGGGAAGCCTGAGAGGTGCCTCCGTTTTGTACATCCGCCC\nAATGCCAGCCTGCCCAATGACACCCAGAGGGCCATGGAGCCATGCCTGGATGGCTGGGTC\nTACAACAGCACCAAGGACTCCATTGTGACAGAGTGGGACTTGGTGTGCAACTCCAACAAA\nCTGAAGGAGATGGCCCAGTCTATCTTCATGGCAGGTATACTGATTGGAGGGCTCGTGCTT\nGGAGACCTGTCTGACAGGTTTGGCCGCAGGCCCATCCTGACCTGCAGCTACCTGCTGCTG\nGCAGCCAGCGGCTCCGGTGCAGCCTTCAGCCCCACCTTCCCCATCTACATGGTCTTCCGC\nTTCCTGTGTGGCTTTGGCATCTCAGGCATTACCCTGAGCACCGTCATCTTGAATGTGGAA\nTGGGTGCCTACCCGGATGCGGGCCATCATGTCGACAGCACTCGGGTACTGCTACACCTTT\nGGCCAGTTCATTCTGCCCGGCCTGGCCTACGCCATCCCCCAGTGGCGTTGGCTGCAGTTA\nACTGTGTCCATTCCCTTCTTCGTCTTCTTCCTATCATCCTGGTGGACACCAGAGTCCATA\nCGCTGGTTGGTCTTGTCTGGAAAGTCCTCGAAGGCCCTGAAGATACTCCGGCGGGTGGCT\nGTCTTCAATGGCAAGAAGGAAGAGGGAGAAAGGCTCAGCTTGGAGGAGCTCAAACTCAAC\nCTGCAGAAGGAGATCTCCTTGGCCAAGGCCAAGTACACCGCAAGTGACCTGTTCCGGATA\nCCCATGCTGCGCCGCATGACCTTCTGTCTTTCCCTGGCCTGGTTTGCTACCGGTTTTGCC\nTACTATAGTTTGGCTATGGGTGTGGAAGAATTTGGAGTCAACCTCTACATCCTCCAGATC\nATCTTTGGTGGGGTCGATGTCCCAGCCAAGTTCATCACCATCCTCTCCTTAAGCTACCTG\nGGCCGGCATACCACTCAGGCCGCTGCCCTGCTCCTGGCAGGAGGGGCCATCTTGGCTCTC\nACCTTTGTGCCCTTGGACTTGCAGACCGTGAGGACAGTATTGGCTGTGTTTGGGAAGGGA\nTGCCTATCCAGCTCCTTCAGCTGCCTCTTCCTCTACACAAGTGAATTATACCCCACAGTC\nATCAGGCAAACAGGTATGGGCGTAAGTAACCTGTGGACCCGCGTGGGAAGCATGGTGTCC\nCCGCTGGTGAAAATCACGGGTGAGGTACAGCCCTTCATCCCCAATATCATCTACGGGATC\nACCGCCCTCCTCGGGGGCAGTGCTGCCCTCTTCCTGCCTGAGACCCTGAATCAGCCCTTG\nCCAGAGACTATCGAAGACCTGGAAAACTGGTCCCTGCGGGCAAAGAAGCCAAAGCAGGAG\nCCAGAGGTGGAAAAGGCCTCCCAGAGGATCCCTCTACAGCCTCACGGACCAGGCCTGGGC\nTCCAGCTGA",
                        "Chromosome Location": "11",
                        "Locus": "11q11",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ8TCC7UniProtKB Entry NameS22A8_HUMANGenBank Protein ID4378059GenBank Gene IDAF097491HGNC IDHGNC:10972",
                        "General References": "Race JE, Grassl SM, Williams WJ, Holtzman EJ: Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3). Biochem Biophys Res Commun. 1999 Feb 16;255(2):508-14. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Taylor TD, Noguchi H, Totoki Y, Toyoda A, Kuroki Y, Dewar K, Lloyd C, Itoh T, Takeda T, Kim DW, She X, Barlow KF, Bloom T, Bruford E, Chang JL, Cuomo CA, Eichler E, FitzGerald MG, Jaffe DB, LaButti K, Nicol R, Park HS, Seaman C, Sougnez C, Yang X, Zimmer AR, Zody MC, Birren BW, Nusbaum C, Fujiyama A, Hattori M, Rogers J, Lander ES, Sakaki Y: Human chromosome 11 DNA sequence and analysis including novel gene identification. Nature. 2006 Mar 23;440(7083):497-500. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Motohashi H, Sakurai Y, Saito H, Masuda S, Urakami Y, Goto M, Fukatsu A, Ogawa O, Inui K: Gene expression levels and immunolocalization of organic ion transporters in the human kidney. J Am Soc Nephrol. 2002 Apr;13(4):866-74. [Article] Bakhiya A, Bahn A, Burckhardt G, Wolff N: Human organic anion transporter 3 (hOAT3) can operate as an exchanger and mediate secretory urate flux. Cell Physiol Biochem. 2003;13(5):249-56. [Article] Srimaroeng C, Chatsudthipong V, Aslamkhan AG, Pritchard JB: Transport of the natural sweetener stevioside and its aglycone steviol by human organic anion transporter (hOAT1; SLC22A6) and hOAT3 (SLC22A8). J Pharmacol Exp Ther. 2005 May;313(2):621-8. Epub 2005 Jan 11. [Article] Tahara H, Shono M, Kusuhara H, Kinoshita H, Fuse E, Takadate A, Otagiri M, Sugiyama Y: Molecular cloning and functional analyses of OAT1 and OAT3 from cynomolgus monkey kidney. Pharm Res. 2005 Apr;22(4):647-60. Epub 2005 Apr 7. [Article] Tahara H, Kusuhara H, Maeda K, Koepsell H, Fuse E, Sugiyama Y: Inhibition of oat3-mediated renal uptake as a mechanism for drug-drug interaction between fexofenadine and probenecid. Drug Metab Dispos. 2006 May;34(5):743-7. doi: 10.1124/dmd.105.008375. Epub 2006 Feb 2. [Article] Nishizato Y, Ieiri I, Suzuki H, Kimura M, Kawabata K, Hirota T, Takane H, Irie S, Kusuhara H, Urasaki Y, Urae A, Higuchi S, Otsubo K, Sugiyama Y: Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics. Clin Pharmacol Ther. 2003 Jun;73(6):554-65. [Article] Erdman AR, Mangravite LM, Urban TJ, Lagpacan LL, Castro RA, de la Cruz M, Chan W, Huang CC, Johns SJ, Kawamoto M, Stryke D, Taylor TR, Carlson EJ, Ferrin TE, Brett CM, Burchard EG, Giacomini KM: The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics. Am J Physiol Renal Physiol. 2006 Apr;290(4):F905-12. Epub 2005 Nov 15. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB01032Probenecidapproved, investigationalyesinhibitorDetailsDB00624Testosteroneapproved, investigationalunknowninducerDetailsDB04348Taurocholic acidapproved, experimentalunknownsubstrateinhibitorDetailsDB00936Salicylic acidapproved, investigational, vet_approvedunknowninhibitorDetailsDB00908Quinidineapproved, investigationalunknowninhibitorDetailsDB01032Probenecidapproved, investigationalunknowninhibitorDetailsDB01053Benzylpenicillinapproved, vet_approvedunknownsubstrateinhibitorDetailsDB01092OuabainapprovedunknowninhibitorDetailsDB00328Indomethacinapproved, investigationalunknowninhibitorDetailsDB01050IbuprofenapprovedunknowninhibitorDetailsDB00536GuanidineapprovedunknowninhibitorDetailsDB03553Glutaric AcidexperimentalunknownsubstrateinhibitorDetailsDB00695Furosemideapproved, vet_approvedunknowninhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknowninhibitorDetailsDB02659Cholic AcidapprovedunknownsubstrateinhibitorDetailsDB00887BumetanideapprovedunknowninhibitorDetailsDB01597Cilastatinapproved, investigationalunknowninhibitorDetailsDB00554Piroxicamapproved, investigationalunknowninhibitorDetailsDB00345Aminohippuric acidapproved, investigationalunknownsubstrateinhibitorDetailsDB04519Caprylic acidinvestigationalunknowninhibitorDetailsDB00501Cimetidineapproved, investigationalunknownsubstrateinhibitorDetailsDB00168Aspartameinvestigational, nutraceuticalunknowninhibitorDetailsDB00759Tetracyclineapproved, vet_approved, withdrawnunknownsubstrateinhibitorDetailsDB00595Oxytetracyclineapproved, investigational, vet_approvedunknownsubstrateDetailsDB01004Ganciclovirapproved, investigationalunknowninhibitorDetailsDB00787AcyclovirapprovedunknownsubstrateinhibitorDetailsDB00917DinoprostoneapprovedunknownsubstrateinhibitorDetailsDB00456Cefalotinapproved, investigational, vet_approvedunknowninhibitorDetailsDB01329Cefoperazoneapproved, investigationalunknowninhibitorDetailsDB01327CefazolinapprovedunknowninhibitorDetailsDB01326Cefamandoleapproved, experimentalunknowninhibitorDetailsDB01140Cefadroxilapproved, vet_approved, withdrawnunknowninhibitorDetailsDB01212CeftriaxoneapprovedunknowninhibitorDetailsDB00493CefotaximeapprovedunknowninhibitorDetailsDB00812Phenylbutazoneapproved, vet_approvedunknowninhibitorDetailsDB01009Ketoprofenapproved, vet_approvedunknowninhibitorDetailsDB00175PravastatinapprovednosubstrateinhibitorDetailsDB00927FamotidineapprovednosubstrateinhibitorDetailsDB00279Liothyronineapproved, vet_approvedunknowninhibitorDetailsDB00563MethotrexateapprovedunknownsubstrateinhibitorDetailsDB00286Conjugated estrogensapprovedunknownsubstrateinhibitorDetailsDB00469TenoxicamapprovedunknowninhibitorDetailsDB00584Enalaprilapproved, vet_approvedunknowninhibitorDetailsDB01650trans-2-hydroxycinnamic acidexperimentalunknowninhibitorDetailsDB00567Cephalexinapproved, investigational, vet_approvedunknowninhibitorDetailsDB00313Valproic acidapproved, investigationalunknownsubstrateinhibitorDetailsDB01065Melatoninapproved, nutraceutical, vet_approvedunknowninhibitorDetailsDB03793Benzoic acidapproved, investigationalunknowninhibitorDetailsDB01033MercaptopurineapprovedunknownsubstrateinhibitorDetailsDB01051Novobiocinapproved, investigational, vet_approved, withdrawnunknowninhibitorDetailsDB00213PantoprazoleapprovedunknowninhibitorDetailsDB00139Succinic acidapproved, nutraceuticalunknownsubstrateDetailsDB02527Cyclic adenosine monophosphateexperimentalunknownsubstrateDetailsDB00577Valaciclovirapproved, investigationalunknownsubstrateDetailsDB03902Oxalic AcidexperimentalunknownsubstrateDetailsDB00863Ranitidineapproved, withdrawnunknownsubstrateDetailsDB00583Levocarnitineapproved, investigationalunknownsubstrateDetailsDB00437AllopurinolapprovedunknownsubstrateDetailsDB00198OseltamivirapprovedunknownsubstrateDetailsDB01583LiotrixapprovedunknowninhibitorDetailsDB01414Cefacetrileexperimental, vet_approvedunknownsubstrateinhibitorDetailsDB06710MethyltestosteroneapprovedunknowninducerDetailsDB00495ZidovudineapprovedunknownsubstrateinhibitorDetailsDB08844Uric acidinvestigationalunknownDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateDetailsDB05804Prasterone sulfateinvestigationalunknownDetailsDB01160Dinoprost tromethamineapproved, vet_approvedunknownDetailsDB04133Degraded CephaloridineexperimentalunknownDetailsDB08837Tetraethylammoniumexperimental, investigationalunknownDetailsDB06335SaxagliptinapprovedunknownsubstrateDetailsDB08912Dabrafenibapproved, investigationalnoinhibitorDetailsDB00300Tenofovir disoproxilapproved, investigationalunknownsubstrateDetailsDB00493CefotaximeapprovedunknownDetailsDB01212CeftriaxoneapprovedunknownDetailsDB01053Benzylpenicillinapproved, vet_approvedunknownsubstrateinhibitorDetailsDB09272Eluxadolineapproved, investigationalunknownsubstrateDetailsDB09060AvibactamapprovednosubstrateDetailsDB01685TopiroxostatexperimentalunknowninhibitorDetailsDB05016Atalurenapproved, investigationalnoinhibitorDetailsDB13874Enasidenibapproved, investigationalunknowninhibitorDetailsDB12070Letermovirapproved, investigationalunknowninhibitorDetailsDB08930DolutegravirapprovednoinhibitorDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB11817Baricitinibapproved, investigationalunknownsubstrateinhibitorDetailsDB13943Testosterone cypionateapprovedunknowninducerDetailsDB13944Testosterone enanthateapprovedunknowninducerDetailsDB13946Testosterone undecanoateapproved, investigationalunknowninducerDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownDetailsDB11901Apalutamideapproved, investigationalnoinhibitorDetailsDB11995Avatrombopagapproved, investigationalunknowninhibitorDetailsDB00655EstroneapprovedunknownsubstrateDetailsDB00833CefaclorapprovedunknownsubstrateinhibitorDetailsDB00535CefdinirapprovedunknownsubstrateDetailsDB00229Cefotiamapproved, investigationalunknownsubstrateinhibitorDetailsDB01415Ceftibutenapproved, investigationalunknownsubstrateinhibitorDetailsDB01332Ceftizoximeapproved, withdrawnunknownsubstrateinhibitorDetailsDB09008Cefaloridineexperimental, withdrawnunknownsubstrateinhibitorDetailsDB00741Hydrocortisoneapproved, vet_approvedunknownsubstrateDetailsDB12243Edaravoneapproved, investigationalnosubstrateDetailsDB00950Fexofenadineapproved, investigationalunknownsubstrateDetailsDB00650LeucovorinapprovedunknownsubstrateinhibitorDetailsDB00881Quinaprilapproved, investigationalunknownsubstrateDetailsDB01098RosuvastatinapprovedunknownsubstrateinhibitorDetailsDB01261Sitagliptinapproved, investigationalunknownsubstrateDetailsDB14538Hydrocortisone aceponateexperimental, vet_approvedunknownDetailsDB14539Hydrocortisone acetateapproved, vet_approvedunknownDetailsDB14540Hydrocortisone butyrateapproved, vet_approvedunknownDetailsDB14541Hydrocortisone cypionateapproved, investigational, vet_approvedunknownDetailsDB14542Hydrocortisone phosphateapproved, vet_approvedunknownDetailsDB14543Hydrocortisone probutateapproved, vet_approvedunknownDetailsDB14544Hydrocortisone valerateapproved, vet_approvedunknownDetailsDB14568Ivosidenibapproved, investigationalunknowninhibitorDetailsDB09078Lenvatinibapproved, investigationalunknowninhibitorDetailsDB00319PiperacillinapprovedunknownsubstrateDetailsDB01606TazobactamapprovedunknownsubstrateinhibitorDetailsDB01045RifampicinapprovedunknowninhibitorDetailsDB11751Cabotegravirapproved, investigationalunknowninhibitorDetailsDB09213Dexibuprofenapproved, investigationalunknownDetailsDB12866PradigastatinvestigationalunknowninhibitorDetailsDB00642Pemetrexedapproved, investigationalnosubstrateDetailsDB00448Lansoprazoleapproved, investigationalunknowninhibitorDetailsDB06211Doripenemapproved, investigationalnosubstrateDetailsDB00945Acetylsalicylic acidapproved, vet_approvedunknowninhibitorDetailsDB00736Esomeprazoleapproved, investigationalunknowninhibitorDetailsDB09299Tenofovir alafenamideapprovednosubstrateDetailsDB14126Tenofovirexperimental, investigationalnosubstrateDetailsDB00788Naproxenapproved, vet_approvedunknownDetailsDB12377Relebactamapproved, investigationalunknownsubstrateDetailsDB05154PretomanidapprovedunknowninhibitorDetailsDB00654Latanoprostapproved, investigationalunknowninhibitorDetailsDB00999Hydrochlorothiazideapproved, vet_approvedunknownsubstrateDetailsDB01241GemfibrozilapprovedunknowninhibitorDetailsDB04855DronedaroneapprovedunknowninhibitorDetailsDB01222BudesonideapprovedunknownsubstrateDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB11644Tafamidisapproved, investigationalunknowninhibitorDetailsDB12457Rimegepantapproved, investigationalunknowninhibitorDetailsDB12466Favipiravirapproved, investigationalunknowninhibitorDetailsDB11837Osilodrostatapproved, investigationalunknowninhibitorDetailsDB00253MedrysoneapprovedunknownsubstrateDetailsDB00774Hydroflumethiazideapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB01324PolythiazideapprovedunknownsubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknownsubstrateDetailsDB09038EmpagliflozinapprovedunknownsubstrateDetailsDB09274Artesunateapproved, investigationalunknowninhibitorDetailsDB14669Betamethasone phosphateapproved, vet_approvedunknownsubstrateDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknownsubstrateDetailsDB01380Cortisone acetateapproved, investigationalunknownsubstrateDetailsDB00601Linezolidapproved, investigationalnoinhibitorDetailsDB01147Cloxacillinapproved, investigational, vet_approvednosubstrateinhibitorDetailsDB12151Brincidofovirapproved, investigationalnoinhibitorDetailsDB12265Fexinidazoleapproved, investigationalunknowninhibitorDetailsDB14973Abrocitinibapproved, investigationalunknownsubstrateDetailsDB04847Roxadustatapproved, investigationalunknownsubstrateDetailsDB17083LinzagolixapprovednosubstrateinhibitorDetailsDB16267Olutasidenibapproved, investigationalnoinhibitorDetailsDB11682Daprodustatapproved, investigationalnosubstrateDetailsDB01250OlsalazineapprovedunknownupregulatorDetailsDB12548Sparsentanapproved, investigationalunknowninhibitorDetailsDB11712Tezacaftorapproved, investigationalnoinhibitorDetailsDB12255Vadadustatapproved, investigationalunknownsubstrateinhibitorDetailsDB11718Encorafenibapproved, investigationalnoinhibitorDetailsDB12218Capivasertibapproved, investigationalnoinhibitorDetails"
                    }
                },
                {
                    "Label": "Solute carrier family 22 member 4",
                    "Detailed Info": {
                        "Name": "Solute carrier family 22 member 4",
                        "Synonyms": "Ergothioneine transporter\nET transporter\nETT\nOCTN1\nOrganic cation/carnitine transporter 1\nUT2H",
                        "Gene Name": "SLC22A4",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0010533|Solute carrier family 22 member 4\nMRDYDEVIAFLGEWGPFQRLIFFLLSASIIPNGFNGMSVVFLAGTPEHRCRVPDAANLSS\nAWRNNSVPLRLRDGREVPHSCSRYRLATIANFSALGLEPGRDVDLGQLEQESCLDGWEFS\nQDVYLSTVVTEWNLVCEDNWKVPLTTSLFFVGVLLGSFVSGQLSDRFGRKNVLFATMAVQ\nTGFSFLQIFSISWEMFTVLFVIVGMGQISNYVVAFILGTEILGKSVRIIFSTLGVCTFFA\nVGYMLLPLFAYFIRDWRMLLLALTVPGVLCVPLWWFIPESPRWLISQRRFREAEDIIQKA\nAKMNNIAVPAVIFDSVEELNPLKQQKAFILDLFRTRNIAIMTIMSLLLWMLTSVGYFALS\nLDAPNLHGDAYLNCFLSALIEIPAYITAWLLLRTLPRRYIIAAVLFWGGGVLLFIQLVPV\nDYYFLSIGLVMLGKFGITSAFSMLYVFTAELYPTLVRNMAVGVTSTASRVGSIIAPYFVY\nLGAYNRMLPYIVMGSLTVLIGILTLFFPESLGMTLPETLEQMQKVKWFRSGKKTRDSMET\nEENPKVLITAF",
                        "Number of residues": "551",
                        "Molecular Weight": "62154.48",
                        "Theoretical pI": "7.27",
                        "GO Classification": "FunctionsATP binding / carnitine transmembrane transporter activity / cation / nucleotide binding / PDZ domain binding / quaternary ammonium group transmembrane transporter activity / secondary active organic cation transmembrane transporter activity / symporter activityProcessesbody fluid secretion / carnitine metabolic process / carnitine transmembrane transport / carnitine transport / modified amino acid transport / organic cation transport / quaternary ammonium group transport / sodium ion transport / transmembrane transport / triglyceride metabolic processComponentsapical plasma membrane / integral component of plasma membrane / mitochondrion / plasma membrane",
                        "General Function": "Symporter activity",
                        "Specific Function": "Sodium-ion dependent, low affinity carnitine transporter. Probably transports one sodium ion with one molecule of carnitine. Also transports organic cations such as tetraethylammonium (TEA) without the involvement of sodium. Relative uptake activity ratio of carnitine to TEA is 1.78. A key substrate of this transporter seems to be ergothioneine (ET).",
                        "Pfam Domain Function": "Sugar_tr (PF00083)",
                        "Transmembrane Regions": "21-41\n142-162\n172-192\n198-218\n233-253\n258-278\n338-358\n372-392\n400-420\n427-447\n461-481\n487-507",
                        "Cellular Location": "Membrane",
                        "Gene sequence": ">lcl|BSEQ0010534|Solute carrier family 22 member 4 (SLC22A4)\nATGCGGGACTACGACGAGGTGATCGCCTTCCTGGGCGAGTGGGGGCCCTTCCAGCGCCTC\nATCTTCTTCCTGCTCAGCGCCAGCATCATCCCCAATGGCTTCAATGGTATGTCAGTCGTG\nTTCCTGGCGGGGACCCCGGAGCACCGCTGTCGAGTGCCGGACGCCGCGAACCTGAGCAGC\nGCCTGGCGCAACAACAGTGTCCCGCTGCGGCTGCGGGACGGCCGCGAGGTGCCCCACAGC\nTGCAGCCGCTACCGGCTCGCCACCATCGCCAACTTCTCGGCGCTCGGGCTGGAGCCGGGG\nCGCGACGTGGACCTGGGGCAGCTGGAGCAGGAGAGCTGCCTGGATGGCTGGGAGTTCAGC\nCAGGACGTCTACCTGTCCACCGTCGTGACCGAGTGGAATCTGGTGTGTGAGGACAACTGG\nAAGGTGCCCCTCACCACCTCCCTGTTCTTCGTAGGCGTGCTCCTCGGCTCCTTCGTGTCC\nGGGCAGCTGTCAGACAGGTTTGGCAGGAAGAACGTTCTCTTCGCAACCATGGCTGTACAG\nACTGGCTTCAGCTTCCTGCAGATTTTCTCCATCAGCTGGGAGATGTTCACTGTGTTATTT\nGTCATCGTGGGCATGGGCCAGATCTCCAACTATGTGGTAGCCTTCATACTAGGAACAGAA\nATTCTTGGCAAGTCAGTTCGTATTATATTCTCTACATTAGGAGTGTGCACATTTTTTGCA\nGTTGGCTATATGCTGCTGCCACTGTTTGCTTACTTCATCAGAGACTGGCGGATGCTGCTG\nCTGGCGCTGACGGTGCCGGGAGTGCTGTGTGTCCCGCTGTGGTGGTTCATTCCTGAATCT\nCCCCGATGGCTGATATCCCAGAGAAGATTTAGAGAGGCTGAAGATATCATCCAAAAAGCT\nGCAAAAATGAACAACATAGCTGTACCAGCAGTGATATTTGATTCTGTGGAGGAGCTAAAT\nCCCCTGAAGCAGCAGAAAGCTTTCATTCTGGACCTGTTCAGGACTCGGAATATTGCCATA\nATGACCATTATGTCTTTGCTGCTATGGATGCTGACCTCAGTGGGTTACTTTGCTCTGTCT\nCTGGATGCTCCTAATTTACATGGAGATGCCTACCTGAACTGTTTCCTCTCTGCCTTGATT\nGAAATTCCAGCTTACATTACAGCCTGGCTGCTATTGCGAACCCTGCCCAGGCGTTATATC\nATAGCTGCAGTACTGTTCTGGGGAGGAGGTGTGCTTCTCTTCATTCAACTGGTACCTGTG\nGATTATTACTTCTTATCCATTGGTCTGGTCATGCTGGGAAAATTTGGGATCACCTCTGCT\nTTCTCCATGCTGTATGTCTTCACTGCTGAGCTCTACCCAACCCTGGTCAGGAACATGGCG\nGTGGGGGTCACATCCACGGCCTCCAGAGTGGGCAGCATCATTGCCCCCTACTTTGTTTAC\nCTCGGTGCTTACAACAGAATGCTGCCCTACATCGTCATGGGTAGTCTGACTGTCCTGATT\nGGAATCCTCACCCTTTTTTTCCCTGAAAGTTTGGGAATGACTCTTCCAGAAACCTTAGAG\nCAGATGCAGAAAGTGAAATGGTTCAGATCTGGGAAAAAAACAAGAGACTCAATGGAGACA\nGAAGAAAATCCCAAGGTTCTAATAACTGCATTCTGA",
                        "Chromosome Location": "5",
                        "Locus": "5q31.1",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ9H015UniProtKB Entry NameS22A4_HUMANGenBank Protein ID2605501GenBank Gene IDAB007448GenAtlas IDSLC22A4HGNC IDHGNC:10968",
                        "General References": "Tamai I, Yabuuchi H, Nezu J, Sai Y, Oku A, Shimane M, Tsuji A: Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett. 1997 Dec 8;419(1):107-11. [Article] Grundemann D, Harlfinger S, Golz S, Geerts A, Lazar A, Berkels R, Jung N, Rubbert A, Schomig E: Discovery of the ergothioneine transporter. Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5256-61. Epub 2005 Mar 28. [Article] Schmutz J, Martin J, Terry A, Couronne O, Grimwood J, Lowry S, Gordon LA, Scott D, Xie G, Huang W, Hellsten U, Tran-Gyamfi M, She X, Prabhakar S, Aerts A, Altherr M, Bajorek E, Black S, Branscomb E, Caoile C, Challacombe JF, Chan YM, Denys M, Detter JC, Escobar J, Flowers D, Fotopulos D, Glavina T, Gomez M, Gonzales E, Goodstein D, Grigoriev I, Groza M, Hammon N, Hawkins T, Haydu L, Israni S, Jett J, Kadner K, Kimball H, Kobayashi A, Lopez F, Lou Y, Martinez D, Medina C, Morgan J, Nandkeshwar R, Noonan JP, Pitluck S, Pollard M, Predki P, Priest J, Ramirez L, Retterer J, Rodriguez A, Rogers S, Salamov A, Salazar A, Thayer N, Tice H, Tsai M, Ustaszewska A, Vo N, Wheeler J, Wu K, Yang J, Dickson M, Cheng JF, Eichler EE, Olsen A, Pennacchio LA, Rokhsar DS, Richardson P, Lucas SM, Myers RM, Rubin EM: The DNA sequence and comparative analysis of human chromosome 5. Nature. 2004 Sep 16;431(7006):268-74. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Yabuuchi H, Tamai I, Nezu J, Sakamoto K, Oku A, Shimane M, Sai Y, Tsuji A: Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J Pharmacol Exp Ther. 1999 May;289(2):768-73. [Article] Tokuhiro S, Yamada R, Chang X, Suzuki A, Kochi Y, Sawada T, Suzuki M, Nagasaki M, Ohtsuki M, Ono M, Furukawa H, Nagashima M, Yoshino S, Mabuchi A, Sekine A, Saito S, Takahashi A, Tsunoda T, Nakamura Y, Yamamoto K: An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet. 2003 Dec;35(4):341-8. Epub 2003 Nov 9. [Article] Saito S, Iida A, Sekine A, Ogawa C, Kawauchi S, Higuchi S, Nakamura Y: Catalog of 238 variations among six human genes encoding solute carriers ( hSLCs) in the Japanese population. J Hum Genet. 2002;47(11):576-84. [Article] Kawasaki Y, Kato Y, Sai Y, Tsuji A: Functional characterization of human organic cation transporter OCTN1 single nucleotide polymorphisms in the Japanese population. J Pharm Sci. 2004 Dec;93(12):2920-6. [Article] Peltekova VD, Wintle RF, Rubin LA, Amos CI, Huang Q, Gu X, Newman B, Van Oene M, Cescon D, Greenberg G, Griffiths AM, St George-Hyslop PH, Siminovitch KA: Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet. 2004 May;36(5):471-5. Epub 2004 Apr 11. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00583Levocarnitineapproved, investigationalunknownDetailsDB00661VerapamilapprovedunknowninhibitorDetailsDB00127Spermineexperimental, nutraceuticalunknowninhibitorDetailsDB03566SpermidineexperimentalunknowninhibitorDetailsDB00468QuinineapprovedunknowninhibitorDetailsDB00908Quinidineapproved, investigationalunknowninhibitorDetailsDB01917PutrescineexperimentalunknowninhibitorDetailsDB01035ProcainamideapprovedunknowninhibitorDetailsDB01053Benzylpenicillinapproved, vet_approvedunknowninhibitorDetailsDB00345Aminohippuric acidapproved, investigationalunknowninhibitorDetailsDB01165OfloxacinapprovedunknowninhibitorDetailsDB00184NicotineapprovedunknowninhibitorDetailsDB00123Lysineapproved, nutraceuticalunknowninhibitorDetailsDB01137Levofloxacinapproved, investigationalunknowninhibitorDetailsDB00536GuanidineapprovedunknowninhibitorDetailsDB00575ClonidineapprovedunknowninhibitorDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00122Cholineapproved, nutraceuticalunknowninhibitorDetailsDB00583Levocarnitineapproved, investigationalunknownsubstrateinhibitorDetailsDB00125Arginineinvestigational, nutraceuticalunknowninhibitorDetailsDB00594AmilorideapprovedunknowninhibitorDetailsDB00458ImipramineapprovedunknowninhibitorDetailsDB01151Desipramineapproved, investigationalunknowninhibitorDetailsDB00987Cytarabineapproved, investigationalunknownsubstrateDetailsDB00332Ipratropiumapproved, experimentalunknownsubstrateDetailsDB01409TiotropiumapprovedunknownsubstrateDetailsDB08837Tetraethylammoniumexperimental, investigationalunknownDetailsDB06691Mepyramineapproved, vet_approvedunknownDetailsDB13943Testosterone cypionateapprovedunknownsubstrateDetailsDB13944Testosterone enanthateapprovedunknownsubstrateDetailsDB13946Testosterone undecanoateapproved, investigationalunknownsubstrateDetailsDB14006Choline salicylateapproved, nutraceuticalunknowninhibitorDetailsDB14754SolriamfetolapprovedunknownDetailsDB01043Memantineapproved, investigationalunknownDetailsDB00983Formoterolapproved, investigationalunknownsubstrateDetailsDB01005HydroxyureaapprovednosubstrateDetails"
                    }
                },
                {
                    "Label": "Solute carrier family 22 member 11",
                    "Detailed Info": {
                        "Name": "Solute carrier family 22 member 11",
                        "Synonyms": "OAT4\nOrganic anion transporter 4",
                        "Gene Name": "SLC22A11",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0001752|Solute carrier family 22 member 11\nMAFSKLLEQAGGVGLFQTLQVLTFILPCLMIPSQMLLENFSAAIPGHRCWTHMLDNGSAV\nSTNMTPKALLTISIPPGPNQGPHQCRRFRQPQWQLLDPNATATSWSEADTEPCVDGWVYD\nRSVFTSTIVAKWDLVCSSQGLKPLSQSIFMSGILVGSFIWGLLSYRFGRKPMLSWCCLQL\nAVAGTSTIFAPTFVIYCGLRFVAAFGMAGIFLSSLTLMVEWTTTSRRAVTMTVVGCAFSA\nGQAALGGLAFALRDWRTLQLAASVPFFAISLISWWLPESARWLIIKGKPDQALQELRKVA\nRINGHKEAKNLTIEVLMSSVKEEVASAKEPRSVLDLFCVPVLRWRSCAMLVVNFSLLISY\nYGLVFDLQSLGRDIFLLQALFGAVDFLGRATTALLLSFLGRRTIQAGSQAMAGLAILANM\nLVPQDLQTLRVVFAVLGKGCFGISLTCLTIYKAELFPTPVRMTADGILHTVGRLGAMMGP\nLILMSRQALPLLPPLLYGVISIASSLVVLFFLPETQGLPLPDTIQDLESQKSTAAQGNRQ\nEAVTVESTSL",
                        "Number of residues": "550",
                        "Molecular Weight": "59970.945",
                        "Theoretical pI": "8.71",
                        "GO Classification": "Functionsinorganic anion exchanger activity / organic anion transmembrane transporter activity / sodium-independent organic anion transmembrane transporter activityProcessesanion transmembrane transport / organic anion transport / sodium-independent organic anion transport / transmembrane transport / urate metabolic processComponentsapical plasma membrane / external side of plasma membrane / extracellular exosome / integral component of plasma membrane / plasma membrane",
                        "General Function": "Sodium-independent organic anion transmembrane transporter activity",
                        "Specific Function": "Mediates saturable uptake of estrone sulfate, dehydroepiandrosterone sulfate and related compounds.",
                        "Pfam Domain Function": "Sugar_tr (PF00083)",
                        "Transmembrane Regions": "11-31\n143-163\n175-195\n201-221\n232-252\n257-277\n347-367\n379-399\n403-423\n431-451\n464-484\n491-511",
                        "Cellular Location": "Cell membrane",
                        "Gene sequence": ">lcl|BSEQ0010620|Solute carrier family 22 member 11 (SLC22A11)\nATGGCGTTCTCGAAGCTCTTGGAGCAAGCCGGAGGCGTGGGCCTCTTCCAGACCCTGCAG\nGTGCTCACCTTCATCCTCCCCTGCCTCATGATACCTTCCCAGATGCTCCTGGAGAACTTC\nTCAGCCGCCATCCCAGGCCACCGATGCTGGACACACATGCTGGACAATGGCTCTGCGGTT\nTCCACAAACATGACCCCCAAGGCCCTTCTGACCATCTCCATCCCGCCAGGCCCCAACCAG\nGGGCCCCACCAGTGCCGCCGCTTCCGCCAGCCACAGTGGCAGCTCTTGGACCCCAATGCC\nACGGCCACCAGCTGGAGCGAAGCTGACACGGAGCCGTGTGTGGACGGCTGGGTCTATGAC\nCGCAGCGTCTTCACCTCCACCATCGTGGCCAAGTGGGACCTGGTGTGCAGCTCCCAGGGC\nTTGAAGCCCCTAAGCCAGTCCATCTTCATGTCCGGGATCCTGGTGGGCTCCTTTATCTGG\nGGCCTCCTCTCCTACCGGTTTGGGAGGAAGCCGATGCTGAGCTGGTGCTGCCTGCAGTTG\nGCCGTGGCGGGCACCAGCACCATCTTCGCCCCAACATTCGTCATCTACTGCGGCCTGCGG\nTTCGTGGCCGCTTTTGGGATGGCCGGCATCTTTCTGAGTTCACTGACACTGATGGTGGAG\nTGGACCACGACCAGCAGGAGGGCGGTCACCATGACGGTGGTGGGATGTGCCTTCAGCGCA\nGGCCAGGCGGCGCTGGGCGGCCTGGCCTTTGCCCTGCGGGACTGGAGGACTCTCCAGCTG\nGCAGCATCAGTGCCCTTCTTTGCCATCTCCCTGATATCCTGGTGGCTGCCAGAATCCGCC\nCGGTGGCTGATTATTAAGGGCAAACCAGACCAAGCACTTCAGGAGCTCAGAAAGGTGGCC\nAGGATAAATGGCCACAAGGAGGCCAAGAACCTGACCATAGAGGTGCTGATGTCCAGCGTG\nAAGGAGGAGGTGGCCTCTGCAAAGGAGCCGCGGTCGGTGCTGGACCTGTTCTGCGTGCCC\nGTGCTCCGCTGGAGGAGCTGCGCCATGCTGGTGGTGAAGATGACAGCAGATGGCATTCTG\nCATACAGTGGGCCGGCTGGGGGCTATGATGGGTCCCCTGATCCTGATGAGCCGCCAAGCC\nCTGCCCCTGCTGCCTCCTCTCCTCTATGGCGTTATCTCCATTGCTTCCAGCCTGGTTGTG\nCTGTTCTTCCTCCCGGAGACCCAGGGACTTCCGCTCCCTGACACTATCCAGGACCTGGAG\nAGCCAGAAATCAACAGCAGCCCAGGGCAACCGGCAAGAGGCCGTCACTGTGGAAAGTACC\nTCGCTCTAG",
                        "Chromosome Location": "11",
                        "Locus": "11q13.1",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ9NSA0UniProtKB Entry NameS22AB_HUMANGenBank Protein ID7707622GenBank Gene IDAB026116GenAtlas IDSLC22A11HGNC IDHGNC:18120",
                        "General References": "Cha SH, Sekine T, Kusuhara H, Yu E, Kim JY, Kim DK, Sugiyama Y, Kanai Y, Endou H: Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem. 2000 Feb 11;275(6):4507-12. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Taylor TD, Noguchi H, Totoki Y, Toyoda A, Kuroki Y, Dewar K, Lloyd C, Itoh T, Takeda T, Kim DW, She X, Barlow KF, Bloom T, Bruford E, Chang JL, Cuomo CA, Eichler E, FitzGerald MG, Jaffe DB, LaButti K, Nicol R, Park HS, Seaman C, Sougnez C, Yang X, Zimmer AR, Zody MC, Birren BW, Nusbaum C, Fujiyama A, Hattori M, Rogers J, Lander ES, Sakaki Y: Human chromosome 11 DNA sequence and analysis including novel gene identification. Nature. 2006 Mar 23;440(7083):497-500. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Zhou F, Pan Z, Ma J, You G: Mutational analysis of histidine residues in human organic anion transporter 4 (hOAT4). Biochem J. 2004 Nov 15;384(Pt 1):87-92. [Article] Zhou F, Tanaka K, Pan Z, Ma J, You G: The role of glycine residues in the function of human organic anion transporter 4. Mol Pharmacol. 2004 May;65(5):1141-7. [Article] Zhou F, Xu W, Hong M, Pan Z, Sinko PJ, Ma J, You G: The role of N-linked glycosylation in protein folding, membrane targeting, and substrate binding of human organic anion transporter hOAT4. Mol Pharmacol. 2005 Mar;67(3):868-76. Epub 2004 Dec 2. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB01032Probenecidapproved, investigationalyesinhibitorDetailsDB00759Tetracyclineapproved, vet_approved, withdrawnunknowninhibitorDetailsDB00595Oxytetracyclineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00917DinoprostoneapprovedunknowninhibitorDetailsDB00456Cefalotinapproved, investigational, vet_approvedunknowninhibitorDetailsDB01212CeftriaxoneapprovedunknowninhibitorDetailsDB00493CefotaximeapprovedunknowninhibitorDetailsDB01329Cefoperazoneapproved, investigationalunknowninhibitorDetailsDB01327CefazolinapprovedunknowninhibitorDetailsDB01326Cefamandoleapproved, experimentalunknowninhibitorDetailsDB01032Probenecidapproved, investigationalunknowninhibitorDetailsDB00554Piroxicamapproved, investigationalunknowninhibitorDetailsDB01053Benzylpenicillinapproved, vet_approvedunknowninhibitorDetailsDB00345Aminohippuric acidapproved, investigationalunknownsubstrateinhibitorDetailsDB04519Caprylic acidinvestigationalunknowninhibitorDetailsDB00328Indomethacinapproved, investigationalunknowninhibitorDetailsDB00168Aspartameinvestigational, nutraceuticalunknowninhibitorDetailsDB00812Phenylbutazoneapproved, vet_approvedunknowninhibitorDetailsDB01009Ketoprofenapproved, vet_approvedunknowninhibitorDetailsDB01050IbuprofenapprovedunknowninhibitorDetailsDB00936Salicylic acidapproved, investigational, vet_approvedunknowninhibitorDetailsDB03553Glutaric AcidexperimentalunknowninhibitorDetailsDB00695Furosemideapproved, vet_approvedunknowninhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknowninhibitorDetailsDB00887BumetanideapprovedunknowninhibitorDetailsDB00783Estradiolapproved, investigational, vet_approvedunknowninhibitorDetailsDB00175PravastatinapprovednosubstrateDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB01051Novobiocinapproved, investigational, vet_approved, withdrawnunknowninhibitorDetailsDB00563MethotrexateapprovedunknownsubstrateDetailsDB00286Conjugated estrogensapprovedunknownsubstrateDetailsDB00495ZidovudineapprovedunknownDetailsDB01160Dinoprost tromethamineapproved, vet_approvedunknownDetailsDB04133Degraded CephaloridineexperimentalunknownDetailsDB08846Ellagic acidinvestigationalunknownDetailsDB00493CefotaximeapprovedunknownDetailsDB01212CeftriaxoneapprovedunknownDetailsDB11560Lesinuradapproved, investigationalyesinhibitorDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknowninhibitorDetailsDB09213Dexibuprofenapproved, investigationalunknownDetailsDB12377Relebactamapproved, investigationalunknownsubstrateDetailsDB06282LevocetirizineapprovedunknownsubstrateDetailsDB00999Hydrochlorothiazideapproved, vet_approvedunknownsubstrateDetailsDB00642Pemetrexedapproved, investigationalnosubstrateDetails"
                    }
                },
                {
                    "Label": "Solute carrier organic anion transporter family member 2B1",
                    "Detailed Info": {
                        "Name": "Solute carrier organic anion transporter family member 2B1",
                        "Synonyms": "KIAA0880\nOATP-B\nOATP-RP2\nOATP2B1\nOATPB\nOATPRP2\nOrganic anion transporter B\nOrganic anion transporter polypeptide-related protein 2\nSLC21A9\nSolute carrier family 21 member 9",
                        "Gene Name": "SLCO2B1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0037115|Solute carrier organic anion transporter family member 2B1\nMGPRIGPAGEVPQVPDKETKATMGTENTPGGKASPDPQDVRPSVFHNIKLFVLCHSLLQL\nAQLMISGYLKSSISTVEKRFGLSSQTSGLLASFNEVGNTALIVFVSYFGSRVHRPRMIGY\nGAILVALAGLLMTLPHFISEPYRYDNTSPEDMPQDFKASLCLPTTSAPASAPSNGNCSSY\nTETQHLSVVGIMFVAQTLLGVGGVPIQPFGISYIDDFAHNSNSPLYLGILFAVTMMGPGL\nAFGLGSLMLRLYVDINQMPEGGISLTIKDPRWVGAWWLGFLIAAGAVALAAIPYFFFPKE\nMPKEKRELQFRRKVLAVTDSPARKGKDSPSKQSPGESTKKQDGLVQIAPNLTVIQFIKVF\nPRVLLQTLRHPIFLLVVLSQVCLSSMAAGMAIFLPKFLERQFSITASYANLLIGCLSFPS\nVIVGIVVGGVLVKRLHLGPVGCGALCLLGMLLCLFFSLPLFFIGCSSHQIAGITHQTSAH\nPGLELSPSCMEACSCPLDGFNPVCDPSTRVEYITPCHAGCSSWVVQDALDNSQVFYTNCS\nCVVEGNPVLAGSCDSTCSHLVVPFLLLVSLGSALACLTHTPSFMLILRGVKKEDKTLAVG\nIQFMFLRILAWMPSPVIHGSAIDTTCVHWALSCGRRAVCRYYNNDLLRNRFIGLQFFFKT\nGSVICFALVLAVLRQQDKEARTKESRSSPAVEQQLLVSGPGKKPEDSRV",
                        "Number of residues": "709",
                        "Molecular Weight": "76709.98",
                        "Theoretical pI": "8.39",
                        "GO Classification": "Functionsbile acid transmembrane transporter activity / organic anion transmembrane transporter activity / sodium-independent organic anion transmembrane transporter activityProcessesanion transmembrane transport / bile acid and bile salt transport / sodium-independent organic anion transport / transmembrane transportComponentsintegral component of plasma membrane / plasma membrane",
                        "General Function": "Sodium-independent organic anion transmembrane transporter activity",
                        "Specific Function": "Mediates the Na(+)-independent transport of organic anions such as taurocholate, the prostaglandins PGD2, PGE1, PGE2, leukotriene C4, thromboxane B2 and iloprost.",
                        "Pfam Domain Function": "OATP (PF03137)",
                        "Transmembrane Regions": "50-69\n89-109\n116-140\n186-215\n235-255\n274-298\n367-388\n409-432\n437-460\n565-587\n597-622\n656-673",
                        "Cellular Location": "Cell membrane",
                        "Gene sequence": ">lcl|BSEQ0010728|Solute carrier organic anion transporter family member 2B1 (SLCO2B1)\nATGGGCACAGAAAACACACCTGGAGGCAAAGCCAGCCCAGACCCTCAGGACGTGCGGCCA\nAGTGTGTTCCATAACATCAAGCTGTTCGTTCTGTGCCACAGCCTGCTGCAGCTGGCGCAG\nCTCATGATCTCCGGCTACCTAAAGAGCTCCATCTCCACAGTGGAGAAGCGCTTCGGCCTC\nTCCAGCCAGACGTCGGGGCTGCTGGCCTCCTTCAACGAGGTGGGGAACACAGCCTTGATT\nGTGTTTGTGAGCTATTTTGGCAGCCGGGTGCACCGACCCCGAATGATTGGCTATGGGGCT\nATCCTTGTGGCCCTGGCGGGCCTGCTCATGACTCTCCCGCACTTCATCTCGGAGCCATAC\nCGCTACGACAACACCAGCCCTGAGGATATGCCACAGGACTTCAAGGCTTCCCTGTGCCTG\nCCCACAACCTCGGCCCCAGCCTCGGCCCCCTCCAATGGCAACTGCTCAAGCTACACAGAA\nACCCAGCATCTGAGTGTGGTGGGGATCATGTTCGTGGCACAGACCCTGCTGGGCGTGGGC\nGGGGTGCCCATTCAGCCCTTTGGCATCTCCTACATCGATGACTTTGCCCACAACAGCAAC\nTCGCCCCTCTACCTCGGGATCCTGTTTGCAGTGACCATGATGGGGCCAGGCCTGGCCTTT\nGGGCTGGGCAGCCTCATGCTGCGCCTTTATGTGGACATTAACCAGATGCCAGAAGGTGGT\nATCAGCCTGACCATAAAGGACCCCCGATGGGTGGGTGCCTGGTGGCTGGGTTTCCTCATC\nGCTGCCGGTGCAGTGGCCCTGGCTGCCATCCCCTACTTCTTCTTCCCCAAGGAAATGCCC\nAAGGAAAAACGTGAGCTTCAGTTTCGGCGAAAGGTCTTAGCAGTCACAGACTCACCTGCC\nAGGAAGGGCAAGGACTCTCCCTCTAAGCAGAGCCCTGGGGAGTCCACGAAGAAGCAGGAT\nGGCCTAGTCCAGATTGCACCAAACCTGACTGTGATCCAGTTCATTAAAGTCTTCCCCAGG\nGTGCTGCTGCAGACCCTACGCCACCCCATCTTCCTGCTGGTGGTCCTGTCCCAGGTATGC\nTTGTCATCCATGGCTGCGGGCATGGCCACCTTCCTGCCCAAGTTCCTGGAGCGCCAGTTT\nTCCATCACAGCCTCCTACGCCAACCTGCTCATCGGCTGCCTCTCCTTCCCTTCGGTCATC\nGTGGGCATCGTGGTGGGTGGCGTCCTGGTCAAGCGGCTCCACCTGGGCCCTGTGGGATGC\nGGTGCCCTTTGCCTGCTGGGGATGCTGCTGTGCCTCTTCTTCAGCCTGCCGCTCTTCTTT\nATCGGCTGCTCCAGCCACCAGATTGCGGGCATCACACACCAGACCAGTGCCCACCCTGGG\nCTGGAGCTGTCTCCAAGCTGCATGGAGGCCTGCTCCTGCCCATTGGACGGCTTTAACCCT\nGTCTGCGACCCCAGCACTCGTGTGGAATACATCACACCCTGCCACGCAGGCTGCTCAAGC\nTGGGTGGTCCAGGATGCTCTGGACAACAGCCAGGTTTTCTACACCAACTGCAGCTGCGTG\nGTGGAGGGCAACCCCGTGCTGGCAGGATCCTGCGACTCAACGTGCAGCCATCTGGTGGTG\nCCCTTCCTGCTCCTGGTCAGCCTGGGCTCGGCCCTGGCCTGTCTCACCCACACACCCTCC\nTTCATGCTCATCCTAAGAGGAGTGAAGAAAGAAGACAAGACTTTGGCTGTGGGCATCCAG\nTTCATGTTCCTGAGGATTTTGGCCTGGATGCCCAGCCCCGTGATCCACGGCAGCGCCATC\nGACACCACCTGTGTGCACTGGGCCCTGAGCTGTGGGCGTCGAGCTGTCTGTCGCTACTAC\nAATAATGACCTGCTCCGAAACCGGTTCATCGGCCTCCAGTTCTTCTTCAAAACAGGTTCT\nGTGATCTGCTTCGCCTTAGTTTTGGCTGTCCTGAGGCAGCAGGACAAAGAGGCAAGGACC\nAAAGAGAGCAGATCCAGCCCTGCCGTAGAGCAGCAATTGCTAGTGTCGGGGCCAGGGAAG\nAAGCCAGAGGATTCCCGAGTGTGA",
                        "Chromosome Location": "11",
                        "Locus": "11q13",
                        "External Identifiers": "ResourceLinkUniProtKB IDO94956UniProtKB Entry NameSO2B1_HUMANGenBank Protein ID5006263GenBank Gene IDAB026256GenAtlas IDSLCO2B1HGNC IDHGNC:10962",
                        "General References": "Tamai I, Nezu J, Uchino H, Sai Y, Oku A, Shimane M, Tsuji A: Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Commun. 2000 Jun 24;273(1):251-60. [Article] Nagase T, Ishikawa K, Suyama M, Kikuno R, Hirosawa M, Miyajima N, Tanaka A, Kotani H, Nomura N, Ohara O: Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res. 1998 Dec 31;5(6):355-64. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Bechtel S, Rosenfelder H, Duda A, Schmidt CP, Ernst U, Wellenreuther R, Mehrle A, Schuster C, Bahr A, Blocker H, Heubner D, Hoerlein A, Michel G, Wedler H, Kohrer K, Ottenwalder B, Poustka A, Wiemann S, Schupp I: The full-ORF clone resource of the German cDNA Consortium. BMC Genomics. 2007 Oct 31;8:399. [Article] Taylor TD, Noguchi H, Totoki Y, Toyoda A, Kuroki Y, Dewar K, Lloyd C, Itoh T, Takeda T, Kim DW, She X, Barlow KF, Bloom T, Bruford E, Chang JL, Cuomo CA, Eichler E, FitzGerald MG, Jaffe DB, LaButti K, Nicol R, Park HS, Seaman C, Sougnez C, Yang X, Zimmer AR, Zody MC, Birren BW, Nusbaum C, Fujiyama A, Hattori M, Rogers J, Lander ES, Sakaki Y: Human chromosome 11 DNA sequence and analysis including novel gene identification. Nature. 2006 Mar 23;440(7083):497-500. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Hanggi E, Grundschober AF, Leuthold S, Meier PJ, St-Pierre MV: Functional analysis of the extracellular cysteine residues in the human organic anion transporting polypeptide, OATP2B1. Mol Pharmacol. 2006 Sep;70(3):806-17. Epub 2006 Jun 5. [Article] Knauer MJ, Girdwood AJ, Kim RB, Tirona RG: Transport function and transcriptional regulation of a liver-enriched human organic anion transporting polypeptide 2B1 transcriptional start site variant. Mol Pharmacol. 2013 Jun;83(6):1218-28. doi: 10.1124/mol.112.083618. Epub 2013 Mar 26. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE: The consensus coding sequences of human breast and colorectal cancers. Science. 2006 Oct 13;314(5797):268-74. Epub 2006 Sep 7. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00655EstroneapprovedunknowninhibitorDetailsDB01045RifampicinapprovedunknowninhibitorDetailsDB02746Phthalic AcidexperimentalunknowninhibitorDetailsDB03902Oxalic AcidexperimentalunknowninhibitorDetailsDB00627Niacinapproved, investigational, nutraceuticalunknowninhibitorDetailsDB04398Lactic acidapproved, vet_approvedunknownsubstrateinhibitorDetailsDB04272Citric acidapproved, nutraceutical, vet_approvedunknowninhibitorDetailsDB03793Benzoic acidapproved, investigationalunknowninhibitorDetailsDB03166Acetic acidapprovedunknownsubstrateinhibitorDetailsDB04216Quercetinexperimental, investigationalunknowninhibitorDetailsDB03467NaringeninexperimentalunknowninhibitorDetailsDB00770Alprostadilapproved, investigationalunknownsubstrateinhibitorDetailsDB00175PravastatinapprovednosubstrateDetailsDB00917DinoprostoneapprovedunknownsubstrateDetailsDB01053Benzylpenicillinapproved, vet_approvedunknownsubstrateDetailsDB00286Conjugated estrogensapprovedunknownsubstrateDetailsDB04348Taurocholic acidapproved, experimentalunknownsubstrateDetailsDB00950Fexofenadineapproved, investigationalunknownsubstrateDetailsDB01124Tolbutamideapproved, investigationalunknownsubstrateDetailsDB01050IbuprofenapprovedunknownsubstrateDetailsDB00936Salicylic acidapproved, investigational, vet_approvedunknownsubstrateDetailsDB01016GlyburideapprovedunknownsubstrateDetailsDB01088Iloprostapproved, investigationalunknownsubstrateDetailsDB00471MontelukastapprovedunknownsubstrateDetailsDB05804Prasterone sulfateinvestigationalunknownDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB01095FluvastatinapprovedunknownDetailsDB01098RosuvastatinapprovedunknownDetailsDB08860PitavastatinapprovedunknownsubstrateDetailsDB11613Velpatasvirapproved, investigationalnoinhibitortransporterDetailsDB11611LifitegrastapprovedunknownsubstrateDetailsDB06290SimeprevirapprovedunknownsubstrateDetailsDB05521Telaprevirapproved, withdrawnunknowninhibitorDetailsDB11591Bilastineapproved, investigationalunknowninhibitorDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknowninhibitorDetailsDB11660Latanoprostene bunodapproved, investigationalunknownsubstrateDetailsDB12319Benzbromaroneinvestigational, withdrawnunknowninhibitorDetailsDB08862Cholecystokininapproved, investigationalunknowninhibitorDetailsDB00255Diethylstilbestrolapproved, investigational, withdrawnunknownsubstrateDetailsDB00975DipyridamoleapprovedunknowninhibitorDetailsDB00530Erlotinibapproved, investigationalunknowninhibitorDetailsDB01645GenisteininvestigationalunknowninhibitorDetailsDB01167Itraconazoleapproved, investigationalunknowninhibitorDetailsDB00451LevothyroxineapprovedunknowninhibitorDetailsDB01149Nefazodoneapproved, withdrawnunknowninhibitorDetailsDB00220NelfinavirapprovednoinhibitorDetailsDB01051Novobiocinapproved, investigational, vet_approved, withdrawnunknowninhibitorDetailsDB00554Piroxicamapproved, investigationalunknowninhibitorDetailsDB00206Reserpineapproved, investigational, withdrawnunknowninhibitorDetailsDB09298Silibininexperimental, investigationalunknowninhibitorDetailsDB00795SulfasalazineapprovednoinhibitorDetailsDB00759Tetracyclineapproved, vet_approved, withdrawnunknowninhibitorDetailsDB00932Tipranavirapproved, investigationalunknowninhibitorDetailsDB00313Valproic acidapproved, investigationalunknowninhibitorDetailsDB00224IndinavirapprovedunknowninhibitorDetailsDB01232Saquinavirapproved, investigationalunknowninhibitorDetailsDB00503Ritonavirapproved, investigationalunknowninhibitorDetailsDB11586Asunaprevirapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB05928DovitinibinvestigationalunknowninhibitorDetailsDB09213Dexibuprofenapproved, investigationalunknownDetailsDB11753Rifamycinapproved, investigationalnoinhibitorDetailsDB00641SimvastatinapprovedunknownDetailsDB00227Lovastatinapproved, investigationalunknownDetailsDB12978Pexidartinibapproved, investigationalunknowninhibitorDetailsDB01241GemfibrozilapprovedunknowninhibitorDetailsDB01072Atazanavirapproved, investigationalnoinhibitorDetailsDB01708Prasteroneapproved, investigational, nutraceuticalunknownsubstrateDetailsDB11632Opicaponeapproved, investigationalnosubstrateDetailsDB08995Diosminapproved, investigationalunknownDetailsDB16226Maralixibatapproved, investigationalunknowninhibitorDetailsDB11761Tenapanorapproved, investigationalunknowninhibitorDetailsDB00244MesalazineapprovedunknownsubstrateDetailsDB06374Elacestrantapproved, investigationalunknownsubstrateDetails"
                    }
                },
                {
                    "Label": "Solute carrier organic anion transporter family member 4A1",
                    "Detailed Info": {
                        "Name": "Solute carrier organic anion transporter family member 4A1",
                        "Synonyms": "Colon organic anion transporter\nOATP-E\nOATP-RP1\nOATP1\nOATP4A1\nOATPE\nOATPRP1\nOrganic anion transporter polypeptide-related protein 1\nOrganic anion-transporting polypeptide E\nPOAT\nSLC21A12\nSodium-independent organic anion transporter E\nSolute carrier family 21 member 12",
                        "Gene Name": "SLCO4A1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0007026|Solute carrier organic anion transporter family member 4A1\nMPLHQLGDKPLTFPSPNSAMENGLDHTPPSRRASPGTPLSPGSLRSAAHSPLDTSKQPLC\nQLWAEKHGARGTHEVRYVSAGQSVACGWWAFAPPCLQVLNTPKGILFFLCAAAFLQGMTV\nNGFINTVITSLERRYDLHSYQSGLIASSYDIAACLCLTFVSYFGGSGHKPRWLGWGVLLM\nGTGSLVFALPHFTAGRYEVELDAGVRTCPANPGAVCADSTSGLSRYQLVFMLGQFLHGVG\nATPLYTLGVTYLDENVKSSCSPVYIAIFYTAAILGPAAGYLIGGALLNIYTEMGRRTELT\nTESPLWVGAWWVGFLGSGAAAFFTAVPILGYPRQLPGSQRYAVMRAAEMHQLKDSSRGEA\nSNPDFGKTIRDLPLSIWLLLKNPTFILLCLAGATEATLITGMSTFSPKFLESQFSLSASE\nAATLFGYLVVPAGGGGTFLGGFFVNKLRLRGSAVIKFCLFCTVVSLLGILVFSLHCPSVP\nMAGVTASYGGSLLPEGHLNLTAPCNAACSCQPEHYSPVCGSDGLMYFSLCHAGCPAATET\nNVDGQKVYRDCSCIPQNLSSGFGHATAGKCTSTCQRKPLLLVFIFVVIFFTFLSSIPALT\nATLRCVRDPQRSFALGIQWIVVRILGGIPGPIAFGWVIDKACLLWQDQCGQQGSCLVYQN\nSAMSRYILIMGLLYKVLGVLFFAIACFLYKPLSESSDGLETCLPSQSSAPDSATDSQLQS\nSV",
                        "Number of residues": "722",
                        "Molecular Weight": "77192.505",
                        "Theoretical pI": "7.85",
                        "GO Classification": "Functionssodium-independent organic anion transmembrane transporter activity / thyroid hormone transmembrane transporter activityProcessesanion transmembrane transport / sodium-independent organic anion transport / thyroid hormone metabolic process / thyroid hormone transport / transmembrane transportComponentsintegral component of plasma membrane / plasma membrane",
                        "General Function": "Thyroid hormone transmembrane transporter activity",
                        "Specific Function": "Mediates the Na(+)-independent transport of organic anions such as the thyroid hormones T3 (triiodo-L-thyronine), T4 (thyroxine) and rT3, and of estrone-3-sulfate and taurocholate.",
                        "Pfam Domain Function": "Kazal_2 (PF07648)\nOATP (PF03137)",
                        "Transmembrane Regions": "104-124\n144-164\n171-195\n223-253\n273-293\n308-332\n379-400\n421-444\n449-471\n581-603\n613-638\n672-689",
                        "Cellular Location": "Cell membrane",
                        "Gene sequence": ">lcl|BSEQ0012543|Solute carrier organic anion transporter family member 4A1 (SLCO4A1)\nATGCCCCTGCATCAGCTGGGGGACAAGCCGCTCACCTTCCCCAGCCCCAACTCAGCCATG\nGAAAACGGGCTTGACCACACCCCACCCAGCAGGAGGGCATCCCCGGGCACACCCCTGAGC\nCCCGGCTCCCTCCGCTCCGCTGCCCATAGCCCCCTGGACACCAGCAAGCAGCCCCTCTGC\nCAGCTCTGGGCCGAGAAGCATGGCGCCCGGGGGACCCATGAGGTGCGGTACGTCTCGGCC\nGGGCAGAGCGTGGCGTGCGGCTGGTGGGCCTTCGCACCGCCGTGCCTGCAGGTCCTCAAC\nACGCCCAAGGGCATCCTGTTCTTCCTGTGTGCGGCCGCATTCCTGCAGGGGATGACTGTG\nAATGGCTTCATCAACACAGTCATCACCTCCCTGGAGCGCCGCTATGACCTGCACAGCTAC\nCAGAGCGGGCTCATCGCCAGCTCCTACGACATTGCCGCCTGCCTCTGCCTCACCTTCGTC\nAGCTACTTCGGGGGCTCAGGGCACAAGCCGCGCTGGCTGGGCTGGGGCGTGCTGCTTATG\nGGCACGGGGTCGCTGGTGTTCGCGCTGCCCCACTTCACGGCTGGCCGCTATGAGGTGGAG\nTTGGACGCGGGTGTCAGGACGTGCCCTGCCAACCCCGGCGCGGTGTGTGCGGACAGCACC\nTCGGGCCTGTCCCGCTACCAGCTGGTCTTCATGCTGGGCCAGTTCCTGCATGGCGTGGGT\nGCCACACCCCTCTACACGCTGGGCGTCACCTACCTGGATGAGAACGTCAAGTCCAGCTGC\nTCGCCCGTCTACATTGCCATCTTCTACACAGCGGCCATCCTGGGCCCAGCTGCCGGCTAC\nCTGATTGGAGGTGCCCTGCTGAATATCTACACGGAAATGGGCCGACGGACGGAGCTGACC\nACCGAGAGCCCACTGTGGGTCGGCGCCTGGTGGGTCGGCTTCCTGGGCTCTGGGGCCGCT\nGCTTTCTTCACCGCCGTTCCCATCCTTGGTTACCCTCGGCAGCTGCCAGGCTCCCAGCGC\nTACGCGGTCATGAGAGCGGCGGAAATGCACCAGTTGAAGGACAGCAGCCGTGGGGAGGCG\nAGCAACCCGGACTTTGGGAAAACCATCAGAGACCTGCCTCTCTCCATCTGGCTCCTGCTG\nAAGAACCCCACGTTCATCCTGCTCTGCCTGGCCGGGGCCACCGAGGCCACTCTCATCACC\nGGCATGTCCACGTTCAGCCCCAAGTTCTTGGAGTCCCAGTTCAGCCTGAGTGCCTCAGAA\nGCTGCCACCTTGTTTGGGTACCTGGTGGTGCCAGCGGGTGGTGGCGGCACCTTCCTGGGC\nGGCTTCTTTGTGAACAAGCTCAGGCTCCGGGGCTCCGCGGTCATCAAGTTCTGCCTGTTC\nTGCACCGTTGTCAGCCTGCTGGGCATCCTCGTCTTCTCACTGCACTGCCCCAGTGTGCCC\nATGGCGGGCGTCACAGCCAGCTACGGCGGGAGCCTCCTGCCCGAAGGCCACCTGAACCTA\nACGGCTCCCTGCAACGCTGCCTGCAGCTGCCAGCCAGAACACTACAGCCCTGTGTGCGGC\nTCGGACGGCCTCATGTACTTCTCACTGTGCCACGCAGGGTGCCCTGCAGCCACGGAGACG\nAATGTGGACGGCCAGAAGGTGTACCGAGACTGTAGCTGTATCCCTCAGAATCTTTCCTCT\nGGTTTTGGCCATGCCACTGCAGGGAAATGCACTTCAACTTGTCAGAGAAAGCCCCTCCTT\nCTGGTTTTCATATTCGTTGTAATTTTCTTTACATTCCTCAGCAGCATTCCTGCACTAACG\nGCAACTCTACGATGTGTCCGTGACCCTCAGAGATCCTTTGCCCTGGGAATCCAGTGGATT\nGTAGTTAGAATACTAGGGGGCATCCCGGGGCCCATCGCCTTCGGCTGGGTGATCGACAAG\nGCCTGTCTGCTGTGGCAGGACCAGTGTGGCCAGCAGGGCTCCTGCTTGGTGTACCAGAAT\nTCGGCCATGAGCCGCTACATACTCATCATGGGGCTCCTGTACAAGGTGCTGGGCGTCCTC\nTTCTTTGCCATAGCCTGCTTCTTATACAAGCCCCTGTCGGAGTCTTCAGATGGCCTGGAA\nACTTGTCTGCCCAGCCAGTCCTCAGCCCCTGACAGTGCCACAGATAGCCAGCTCCAGAGC\nAGCGTCTGA",
                        "Chromosome Location": "20",
                        "Locus": "20q13.33",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ96BD0UniProtKB Entry NameSO4A1_HUMANGenBank Protein ID6683743GenBank Gene IDAB031051HGNC IDHGNC:10953",
                        "General References": "Tamai I, Nezu J, Uchino H, Sai Y, Oku A, Shimane M, Tsuji A: Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Commun. 2000 Jun 24;273(1):251-60. [Article] Fujiwara K, Adachi H, Nishio T, Unno M, Tokui T, Okabe M, Onogawa T, Suzuki T, Asano N, Tanemoto M, Seki M, Shiiba K, Suzuki M, Kondo Y, Nunoki K, Shimosegawa T, Iinuma K, Ito S, Matsuno S, Abe T: Identification of thyroid hormone transporters in humans: different molecules are involved in a tissue-specific manner. Endocrinology. 2001 May;142(5):2005-12. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Deloukas P, Matthews LH, Ashurst J, Burton J, Gilbert JG, Jones M, Stavrides G, Almeida JP, Babbage AK, Bagguley CL, Bailey J, Barlow KF, Bates KN, Beard LM, Beare DM, Beasley OP, Bird CP, Blakey SE, Bridgeman AM, Brown AJ, Buck D, Burrill W, Butler AP, Carder C, Carter NP, Chapman JC, Clamp M, Clark G, Clark LN, Clark SY, Clee CM, Clegg S, Cobley VE, Collier RE, Connor R, Corby NR, Coulson A, Coville GJ, Deadman R, Dhami P, Dunn M, Ellington AG, Frankland JA, Fraser A, French L, Garner P, Grafham DV, Griffiths C, Griffiths MN, Gwilliam R, Hall RE, Hammond S, Harley JL, Heath PD, Ho S, Holden JL, Howden PJ, Huckle E, Hunt AR, Hunt SE, Jekosch K, Johnson CM, Johnson D, Kay MP, Kimberley AM, King A, Knights A, Laird GK, Lawlor S, Lehvaslaiho MH, Leversha M, Lloyd C, Lloyd DM, Lovell JD, Marsh VL, Martin SL, McConnachie LJ, McLay K, McMurray AA, Milne S, Mistry D, Moore MJ, Mullikin JC, Nickerson T, Oliver K, Parker A, Patel R, Pearce TA, Peck AI, Phillimore BJ, Prathalingam SR, Plumb RW, Ramsay H, Rice CM, Ross MT, Scott CE, Sehra HK, Shownkeen R, Sims S, Skuce CD, Smith ML, Soderlund C, Steward CA, Sulston JE, Swann M, Sycamore N, Taylor R, Tee L, Thomas DW, Thorpe A, Tracey A, Tromans AC, Vaudin M, Wall M, Wallis JM, Whitehead SL, Whittaker P, Willey DL, Williams L, Williams SA, Wilming L, Wray PW, Hubbard T, Durbin RM, Bentley DR, Beck S, Rogers J: The DNA sequence and comparative analysis of human chromosome 20. Nature. 2001 Dec 20-27;414(6866):865-71. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Daub H, Olsen JV, Bairlein M, Gnad F, Oppermann FS, Korner R, Greff Z, Keri G, Stemmann O, Mann M: Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol Cell. 2008 Aug 8;31(3):438-48. doi: 10.1016/j.molcel.2008.07.007. [Article] Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP: A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7. doi: 10.1073/pnas.0805139105. Epub 2008 Jul 31. [Article] Olsen JV, Vermeulen M, Santamaria A, Kumar C, Miller ML, Jensen LJ, Gnad F, Cox J, Jensen TS, Nigg EA, Brunak S, Mann M: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3. doi: 10.1126/scisignal.2000475. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00279Liothyronineapproved, vet_approvedunknownsubstrateinhibitorDetailsDB04348Taurocholic acidapproved, experimentalunknowninhibitorDetailsDB00917DinoprostoneapprovedunknownsubstrateDetailsDB01053Benzylpenicillinapproved, vet_approvedunknownsubstrateDetailsDB00286Conjugated estrogensapprovedunknownsubstrateDetailsDB01583LiotrixapprovedunknownsubstrateinhibitorDetailsDB00451LevothyroxineapprovedunknownsubstrateDetailsDB00509Dextrothyroxineapproved, investigationalunknownDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownDetailsDB09100Thyroid, porcineapprovedunknownsubstrateDetails"
                    }
                },
                {
                    "Label": "Solute carrier organic anion transporter family member 3A1",
                    "Detailed Info": {
                        "Name": "Solute carrier organic anion transporter family member 3A1",
                        "Synonyms": "OATP-D\nOATP-RP3\nOATP3A1\nOATPD\nOATPRP3\nOrganic anion transporter polypeptide-related protein 3\nOrganic anion-transporting polypeptide D\nPGE1 transporter\nSLC21A11\nSodium-independent organic anion transporter D\nSolute carrier family 21 member 11",
                        "Gene Name": "SLCO3A1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0037253|Solute carrier organic anion transporter family member 3A1\nMQGKKPGGSSGGGRSGELQGDEAQRNKKKKKKVSCFSNIKIFLVSECALMLAQGTVGAYL\nVSVLTTLERRFNLQSADVGVIASSFEIGNLALILFVSYFGARGHRPRLIGCGGIVMALGA\nLLSALPEFLTHQYKYEAGEIRWGAEGRDVCAANGSGGDEGPDPDLICRNRTATNMMYLLL\nIGAQVLLGIGATPVQPLGVSYIDDHVRRKDSSLYIGILFTMLVFGPACGFILGSFCTKIY\nVDAVFIDTSNLDITPDDPRWIGAWWGGFLLCGALLFFSSLLMFGFPQSLPPHSEPAMESE\nQAMLSEREYERPKPSNGVLRHPLEPDSSASCFQQLRVIPKVTKHLLSNPVFTCIILAACM\nEIAVVAGFAAFLGKYLEQQFNLTTSSANQLLGMTAIPCACLGIFLGGLLVKKLSLSALGA\nIRMAMLVNLVSTACYVSFLFLGCDTGPVAGVTVPYGNSTAPGSALDPYSPCNNNCECQTD\nSFTPVCGADGITYLSACFAGCNSTNLTGCACLTTVPAENATVVPGKCPSPGCQEAFLTFL\nCVMCICSLIGAMAQTPSVIILIRTVSPELKSYALGVLFLLLRLLGFIPPPLIFGAGIDST\nCLFWSTFCGEQGACVLYDNVVYRYLYVSIAIALKSFAFILYTTTWQCLRKNYKRYIKNHE\nGGLSTSEFFASTLTLDNLGRDPVPANQTHRTKFIYNLEDHEWCENMESVL",
                        "Number of residues": "710",
                        "Molecular Weight": "76552.135",
                        "Theoretical pI": "6.71",
                        "GO Classification": "Functionssodium-independent organic anion transmembrane transporter activityProcessesanion transmembrane transport / prostaglandin transport / sodium-independent organic anion transport / transmembrane transportComponentsintegral component of plasma membrane / plasma membrane",
                        "General Function": "Sodium-independent organic anion transmembrane transporter activity",
                        "Specific Function": "Mediates the Na(+)-independent transport of organic anions such as estrone-3-sulfate (PubMed:10873595). Mediates transport of prostaglandins (PG) E1 and E2, thyroxine (T4), deltorphin II, BQ-123 and vasopressin, but not DPDPE (a derivative of enkephalin lacking an N-terminal tyrosine residue), estrone-3-sulfate, taurocholate, digoxin nor DHEAS (PubMed:16971491).",
                        "Pfam Domain Function": "Kazal_2 (PF07648)\nOATP (PF03137)",
                        "Transmembrane Regions": "41-60\n80-100\n107-131\n175-203\n223-243\n262-286\n345-366\n387-410\n415-438\n540-562\n572-597\n631-648",
                        "Cellular Location": "Cell membrane",
                        "Gene sequence": ">lcl|BSEQ0017177|Solute carrier organic anion transporter family member 3A1 (SLCO3A1)\nATGCAGGGGAAGAAGCCGGGCGGTTCGTCGGGCGGCGGCCGGAGCGGCGAGCTGCAGGGG\nGACGAGGCGCAGAGGAACAAGAAAAAGAAAAAGAAGGTGTCCTGCTTTTCCAACATCAAG\nATCTTCCTGGTGTCCGAGTGCGCCCTGATGCTGGCGCAGGGCACGGTGGGCGCCTACCTG\nGTGAGCGTCCTGACCACCCTGGAGCGTAGGTTCAACCTGCAGAGCGCTGACGTGGGTGTG\nATCGCTAGCAGCTTCGAGATCGGGAACCTGGCGCTCATCCTCTTCGTGAGCTACTTCGGG\nGCACGCGGGCACCGGCCGCGCCTGATCGGCTGCGGCGGCATCGTCATGGCGCTGGGCGCG\nCTGCTGTCGGCGCTGCCCGAGTTCCTGACCCACCAGTACAAGTACGAGGCGGGCGAGATC\nCGCTGGGGCGCCGAGGGCCGCGACGTCTGCGCAGCCAACGGCTCGGGCGGCGACGAGGGG\nCCCGACCCCGACCTCATCTGCCGCAACCGGACGGCTACCAACATGATGTACTTGCTGCTC\nATTGGGGCCCAGGTGCTCCTGGGCATCGGTGCTACCCCTGTGCAGCCCCTGGGCGTCTCC\nTACATCGACGACCACGTGCGGAGGAAGGACTCCTCGCTCTATATAGGAATCCTGTTCACG\nATGCTGGTATTTGGACCAGCCTGCGGGTTTATCCTGGGCTCTTTCTGTACCAAAATCTAC\nGTGGATGCGGTCTTCATTGACACAAGTAACCTGGACATCACTCCGGACGACCCCCGCTGG\nATCGGAGCCTGGTGGGGTGGCTTTCTGCTCTGCGGTGCCTTACTCTTCTTCTCTTCCCTC\nTTGATGTTTGGGTTTCCACAGTCCCTGCCCCCGCACTCAGAGCCCGCCATGGAAAGCGAG\nCAGGCCATGCTCTCCGAAAGAGAATACGAGAGACCCAAGCCCAGCAACGGGGTCCTGAGG\nCACCCCCTGGAGCCAGACAGCAGTGCCTCCTGTTTCCAGCAGCTGAGAGTGATCCCGAAG\nGTCACCAAGCACCTGCTCTCAAACCCTGTGTTCACCTGCATCATCCTGGCCGCCTGCATG\nGAGATTGCAGTGGTGGCTGGCTTCGCTGCCTTTTTGGGGAAGTACCTGGAGCAGCAGTTT\nAACCTCACCACCTCTTCTGCCAACCAGCTGCTTGGGATGACTGCGATCCCGTGTGCTTGT\nCTGGGTATCTTCCTGGGAGGTCTTTTGGTGAAGAAGCTCAGCCTGTCTGCCCTGGGGGCC\nATTCGGATGGCCATGCTCGTCAACCTGGTGTCCACTGCTTGCTACGTCTCCTTCCTCTTC\nCTGGGCTGCGACACTGGCCCTGTGGCTGGGGTTACTGTTCCCTATGGAAACAGCACAGCA\nCCTGGCTCAGCCCTGGACCCCTACTCGCCCTGCAATAATAACTGTGAATGCCAAACCGAT\nTCCTTCACTCCAGTGTGTGGGGCAGATGGCATCACCTACCTGTCTGCCTGCTTTGCTGGC\nTGCAACAGCACGAATCTCACGGGCTGTGCGTGCCTCACCACCGTCCCTGCTGAGAACGCA\nACCGTGGTTCCTGGAAAATGCCCCAGTCCTGGGTGCCAAGAGGCCTTCCTCACTTTCCTC\nTGTGTGATGTGTATCTGCAGCCTGATCGGTGCCATGGCACAGACACCCTCAGTCATCATC\nCTCATCAGGACAGTCAGCCCTGAACTCAAGTCTTACGCTTTGGGAGTTCTTTTTCTCCTC\nCTTCGTTTGTTGGGCTTCATCCCTCCACCCCTCATCTTCGGGGCTGGCATCGACTCCACC\nTGCCTGTTCTGGAGCACGTTCTGTGGGGAGCAAGGCGCCTGCGTCCTCTACGACAATGTG\nGTCTACCGATACCTGTATGTCAGCATCGCCATCGCGCTCAAATCCTTCGCCTTCATCCTG\nTACACCACCACGTGGCAGTGCCTGAGGAAAAACTATAAACGCTACATCAAAAACCACGAG\nGGCGGGCTGAGCACCAGCACAGAGTACCAAGACATTGAGACTGAGAAAACCTGCCCCGAA\nTCACATTCACCTTCAGAAGACTCCTTTGTGAGAAGCTGA",
                        "Chromosome Location": "15",
                        "Locus": "15q26",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ9UIG8UniProtKB Entry NameSO3A1_HUMANGenBank Protein ID6683741GenBank Gene IDAB031050HGNC IDHGNC:10952",
                        "General References": "Tamai I, Nezu J, Uchino H, Sai Y, Oku A, Shimane M, Tsuji A: Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Commun. 2000 Jun 24;273(1):251-60. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Zody MC, Garber M, Sharpe T, Young SK, Rowen L, O'Neill K, Whittaker CA, Kamal M, Chang JL, Cuomo CA, Dewar K, FitzGerald MG, Kodira CD, Madan A, Qin S, Yang X, Abbasi N, Abouelleil A, Arachchi HM, Baradarani L, Birditt B, Bloom S, Bloom T, Borowsky ML, Burke J, Butler J, Cook A, DeArellano K, DeCaprio D, Dorris L 3rd, Dors M, Eichler EE, Engels R, Fahey J, Fleetwood P, Friedman C, Gearin G, Hall JL, Hensley G, Johnson E, Jones C, Kamat A, Kaur A, Locke DP, Madan A, Munson G, Jaffe DB, Lui A, Macdonald P, Mauceli E, Naylor JW, Nesbitt R, Nicol R, O'Leary SB, Ratcliffe A, Rounsley S, She X, Sneddon KM, Stewart S, Sougnez C, Stone SM, Topham K, Vincent D, Wang S, Zimmer AR, Birren BW, Hood L, Lander ES, Nusbaum C: Analysis of the DNA sequence and duplication history of human chromosome 15. Nature. 2006 Mar 30;440(7084):671-5. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Huber RD, Gao B, Sidler Pfandler MA, Zhang-Fu W, Leuthold S, Hagenbuch B, Folkers G, Meier PJ, Stieger B: Characterization of two splice variants of human organic anion transporting polypeptide 3A1 isolated from human brain. Am J Physiol Cell Physiol. 2007 Feb;292(2):C795-806. Epub 2006 Sep 13. [Article] Van Damme P, Lasa M, Polevoda B, Gazquez C, Elosegui-Artola A, Kim DS, De Juan-Pardo E, Demeyer K, Hole K, Larrea E, Timmerman E, Prieto J, Arnesen T, Sherman F, Gevaert K, Aldabe R: N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12449-54. doi: 10.1073/pnas.1210303109. Epub 2012 Jul 18. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB04348Taurocholic acidapproved, experimentalunknowninhibitorDetailsDB00770Alprostadilapproved, investigationalunknownsubstrateinhibitorDetailsDB00345Aminohippuric acidapproved, investigationalunknowninhibitorDetailsDB00917DinoprostoneapprovedunknownsubstrateDetailsDB01053Benzylpenicillinapproved, vet_approvedunknownsubstrateDetailsDB00286Conjugated estrogensapprovedunknownsubstrateDetailsDB00563MethotrexateapprovedunknownsubstrateDetailsDB01088Iloprostapproved, investigationalunknownsubstrateDetailsDB01160Dinoprost tromethamineapproved, vet_approvedunknownDetailsDB06654Safinamideapproved, investigationalunknownsubstrateDetailsDB09198LobeglitazoneexperimentalnoinhibitorDetailsDB09100Thyroid, porcineapprovedunknownsubstrateDetails"
                    }
                },
                {
                    "Label": "Solute carrier organic anion transporter family member 1B1",
                    "Detailed Info": {
                        "Name": "Solute carrier organic anion transporter family member 1B1",
                        "Synonyms": "Liver-specific organic anion transporter 1\nLST-1\nLST1\nOATP-2\nOATP-C\nOATP1B1\nOATP2\nOATPC\nSLC21A6\nSodium-independent organic anion-transporting polypeptide 2\nSolute carrier family 21 member 6",
                        "Gene Name": "SLCO1B1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0010701|Solute carrier organic anion transporter family member 1B1\nMDQNQHLNKTAEAQPSENKKTRYCNGLKMFLAALSLSFIAKTLGAIIMKSSIIHIERRFE\nISSSLVGFIDGSFEIGNLLVIVFVSYFGSKLHRPKLIGIGCFIMGIGGVLTALPHFFMGY\nYRYSKETNINSSENSTSTLSTCLINQILSLNRASPEIVGKGCLKESGSYMWIYVFMGNML\nRGIGETPIVPLGLSYIDDFAKEGHSSLYLGILNAIAMIGPIIGFTLGSLFSKMYVDIGYV\nDLSTIRITPTDSRWVGAWWLNFLVSGLFSIISSIPFFFLPQTPNKPQKERKASLSLHVLE\nTNDEKDQTANLTNQGKNITKNVTGFFQSFKSILTNPLYVMFVLLTLLQVSSYIGAFTYVF\nKYVEQQYGQPSSKANILLGVITIPIFASGMFLGGYIIKKFKLNTVGIAKFSCFTAVMSLS\nFYLLYFFILCENKSVAGLTMTYDGNNPVTSHRDVPLSYCNSDCNCDESQWEPVCGNNGIT\nYISPCLAGCKSSSGNKKPIVFYNCSCLEVTGLQNRNYSAHLGECPRDDACTRKFYFFVAI\nQVLNLFFSALGGTSHVMLIVKIVQPELKSLALGFHSMVIRALGGILAPIYFGALIDTTCI\nKWSTNNCGTRGSCRTYNSTSFSRVYLGLSSMLRVSSLVLYIILIYAMKKKYQEKDINASE\nNGSVMDEANLESLNKNKHFVPSAGADSETHC",
                        "Number of residues": "691",
                        "Molecular Weight": "76447.99",
                        "Theoretical pI": "8.68",
                        "GO Classification": "Functionsbile acid transmembrane transporter activity / sodium-independent organic anion transmembrane transporter activityProcessesanion transmembrane transport / bile acid and bile salt transport / bile acid metabolic process / organic anion transport / small molecule metabolic process / sodium-independent organic anion transport / transmembrane transportComponentsbasolateral plasma membrane / integral component of plasma membrane / membrane / plasma membrane",
                        "General Function": "Sodium-independent organic anion transmembrane transporter activity",
                        "Specific Function": "Mediates the Na(+)-independent uptake of organic anions such as pravastatin, taurocholate, methotrexate, dehydroepiandrosterone sulfate, 17-beta-glucuronosyl estradiol, estrone sulfate, prostaglandin E2, thromboxane B2, leukotriene C3, leukotriene E4, thyroxine and triiodothyronine. Involved in the clearance of bile acids and organic anions from the liver.",
                        "Pfam Domain Function": "Kazal_2 (PF07648)\nOATP (PF03137)",
                        "Transmembrane Regions": "29-48\n68-88\n95-119\n169-197\n217-237\n256-280\n332-353\n374-397\n402-425\n538-560\n570-595\n630-647",
                        "Cellular Location": "Basolateral cell membrane",
                        "Gene sequence": ">lcl|BSEQ0010702|Solute carrier organic anion transporter family member 1B1 (SLCO1B1)\nATGGACCAAAATCAACATTTGAATAAAACAGCAGAGGCACAACCTTCAGAGAATAAGAAA\nACAAGATACTGCAATGGATTGAAGATGTTCTTGGCAGCTCTGTCACTCAGCTTTATTGCT\nAAGACACTAGGTGCAATTATTATGAAAAGTTCCATCATTCATATAGAACGGAGATTTGAG\nATATCCTCTTCTCTTGTTGGTTTTATTGACGGAAGCTTTGAAATTGGAAATTTGCTTGTG\nATTGTATTTGTGAGTTACTTTGGATCCAAACTACATAGACCAAAGTTAATTGGAATCGGT\nTGTTTCATTATGGGAATTGGAGGTGTTTTGACTGCTTTGCCACATTTCTTCATGGGATAT\nTACAGGTATTCTAAAGAAACTAATATCAATTCATCAGAAAATTCAACATCGACCTTATCC\nACTTGTTTAATTAATCAAATTTTATCACTCAATAGAGCATCACCTGAGATAGTGGGAAAA\nGGTTGTTTAAAGGAATCTGGGTCATACATGTGGATATATGTGTTCATGGGTAATATGCTT\nCGTGGAATAGGGGAGACTCCCATAGTACCATTGGGGCTTTCTTACATTGATGATTTCGCT\nAAAGAAGGACATTCTTCTTTGTATTTAGGTATATTGAATGCAATAGCAATGATTGGTCCA\nATCATTGGCTTTACCCTGGGATCTCTGTTTTCTAAAATGTACGTGGATATTGGATATGTA\nGATCTAAGCACTATCAGGATAACTCCTACTGATTCTCGATGGGTTGGAGCTTGGTGGCTT\nAATTTCCTTGTGTCTGGACTATTCTCCATTATTTCTTCCATACCATTCTTTTTCTTGCCC\nCAAACTCCAAATAAACCACAAAAAGAAAGAAAAGCTTCACTGTCTTTGCATGTGCTGGAA\nACAAATGATGAAAAGGATCAAACAGCTAATTTGACCAATCAAGGAAAAAATATTACCAAA\nAATGTGACTGGTTTTTTCCAGTCTTTTAAAAGCATCCTTACTAATCCCCTGTATGTTATG\nTTTGTGCTTTTGACGTTGTTACAAGTAAGCAGCTATATTGGTGCTTTTACTTATGTCTTC\nAAATACGTAGAGCAACAGTATGGTCAGCCTTCATCTAAGGCTAACATCTTATTGGGAGTC\nATAACCATACCTATTTTTGCAAGTGGAATGTTTTTAGGAGGATATATCATTAAAAAATTC\nAAACTGAACACCGTTGGAATTGCCAAATTCTCATGTTTTACTGCTGTGATGTCATTGTCC\nTTTTACCTATTATATTTTTTCATACTCTGTGAAAACAAATCAGTTGCCGGACTAACCATG\nACCTATGATGGAAATAATCCAGTGACATCTCATAGAGATGTACCACTTTCTTATTGCAAC\nTCAGACTGCAATTGTGATGAAAGTCAATGGGAACCAGTCTGTGGAAACAATGGAATAACT\nTACATCTCACCCTGTCTAGCAGGTTGCAAATCTTCAAGTGGCAATAAAAAGCCTATAGTG\nTTTTACAACTGCAGTTGTTTGGAAGTAACTGGTCTCCAGAACAGAAATTACTCAGCCCAT\nTTGGGTGAATGCCCAAGAGATGATGCTTGTACAAGGAAATTTTACTTTTTTGTTGCAATA\nCAAGTCTTGAATTTATTTTTCTCTGCACTTGGAGGCACCTCACATGTCATGCTGATTGTT\nAAAATTGTTCAACCTGAATTGAAATCACTTGCACTGGGTTTCCACTCAATGGTTATACGA\nGCACTAGGAGGAATTCTAGCTCCAATATATTTTGGGGCTCTGATTGATACAACGTGTATA\nAAGTGGTCCACCAACAACTGTGGCACACGTGGGTCATGTAGGACATATAATTCCACATCA\nTTTTCAAGGGTCTACTTGGGCTTGTCTTCAATGTTAAGAGTCTCATCACTTGTTTTATAT\nATTATATTAATTTATGCCATGAAGAAAAAATATCAAGAGAAAGATATCAATGCATCAGAA\nAATGGAAGTGTCATGGATGAAGCAAACTTAGAATCCTTAAATAAAAATAAACATTTTGTC\nCCTTCTGCTGGGGCAGATAGTGAAACACATTGTTAA",
                        "Chromosome Location": "12",
                        "Locus": "12p",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ9Y6L6UniProtKB Entry NameSO1B1_HUMANGenBank Protein ID5051630GenBank Gene IDAF060500GenAtlas IDSLCO1B1HGNC IDHGNC:10959",
                        "General References": "Abe T, Kakyo M, Tokui T, Nakagomi R, Nishio T, Nakai D, Nomura H, Unno M, Suzuki M, Naitoh T, Matsuno S, Yawo H: Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J Biol Chem. 1999 Jun 11;274(24):17159-63. [Article] Hsiang B, Zhu Y, Wang Z, Wu Y, Sasseville V, Yang WP, Kirchgessner TG: A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters. J Biol Chem. 1999 Dec 24;274(52):37161-8. [Article] Konig J, Cui Y, Nies AT, Keppler D: A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am J Physiol Gastrointest Liver Physiol. 2000 Jan;278(1):G156-64. [Article] Konig J, Cui Y, Nies AT, Keppler D: Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J Biol Chem. 2000 Jul 28;275(30):23161-8. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] van de Steeg E, Stranecky V, Hartmannova H, Noskova L, Hrebicek M, Wagenaar E, van Esch A, de Waart DR, Oude Elferink RP, Kenworthy KE, Sticova E, al-Edreesi M, Knisely AS, Kmoch S, Jirsa M, Schinkel AH: Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver. J Clin Invest. 2012 Feb;122(2):519-28. doi: 10.1172/JCI59526. Epub 2012 Jan 9. [Article] Yao J, Hong W, Huang J, Zhan K, Huang H, Hong M: N-Glycosylation dictates proper processing of organic anion transporting polypeptide 1B1. PLoS One. 2012;7(12):e52563. doi: 10.1371/journal.pone.0052563. Epub 2012 Dec 20. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Tirona RG, Leake BF, Merino G, Kim RB: Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans. J Biol Chem. 2001 Sep 21;276(38):35669-75. Epub 2001 Jul 26. [Article] Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23. [Article] Nozawa T, Nakajima M, Tamai I, Noda K, Nezu J, Sai Y, Tsuji A, Yokoi T: Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis. J Pharmacol Exp Ther. 2002 Aug;302(2):804-13. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB04348Taurocholic acidapproved, experimentalunknownsubstrateinhibitorinducerDetailsDB02659Cholic AcidapprovedunknownsubstrateinhibitorinducerDetailsDB00199Erythromycinapproved, investigational, vet_approvednosubstrateinhibitorDetailsDB01045RifampicinapprovedunknowninhibitorDetailsDB00286Conjugated estrogensapprovedunknownsubstrateinhibitorDetailsDB00655EstroneapprovedunknowninhibitorDetailsDB00783Estradiolapproved, investigational, vet_approvedunknowninhibitorDetailsDB01232Saquinavirapproved, investigationalunknowninhibitorDetailsDB00503Ritonavirapproved, investigationalunknowninhibitorDetailsDB00220NelfinavirapprovednoinhibitorDetailsDB00224IndinavirapprovedunknowninhibitorDetailsDB01892HyperforinnutraceuticalunknowninhibitorDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00908Quinidineapproved, investigationalunknowninhibitorDetailsDB00583Levocarnitineapproved, investigationalunknowninhibitorDetailsDB00877Sirolimusapproved, investigationalnoinhibitorDetailsDB00641SimvastatinapprovedunknownsubstrateinhibitorDetailsDB00227Lovastatinapproved, investigationalunknownsubstrateinhibitorDetailsDB01076AtorvastatinapprovednosubstrateinhibitorDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknowninhibitorDetailsDB00412Rosiglitazoneapproved, investigationalunknowninhibitorDetailsDB01132Pioglitazoneapproved, investigationalunknowninhibitorDetailsDB00762Irinotecanapproved, investigationalunknowninhibitorDetailsDB00520CaspofunginapprovedunknowninhibitorDetailsDB00175PravastatinapprovednosubstrateDetailsDB01393Bezafibrateapproved, investigationalunknowninhibitorDetailsDB06151Acetylcysteineapproved, investigationalunknowninhibitorDetailsDB00661VerapamilapprovedunknowninhibitorDetailsDB00917DinoprostoneapprovedunknownsubstrateDetailsDB01053Benzylpenicillinapproved, vet_approvedunknownsubstrateDetailsDB00563MethotrexateapprovedunknownsubstrateDetailsDB00279Liothyronineapproved, vet_approvedunknownsubstrateDetailsDB00439Cerivastatinapproved, withdrawnunknownsubstrateinhibitorDetailsDB00275Olmesartanapproved, investigationalunknownsubstrateDetailsDB00669Sumatriptanapproved, investigationalunknownsubstrateDetailsDB01092OuabainapprovedunknownsubstrateinhibitorDetailsDB00390DigoxinapprovedunknownsubstrateinhibitorDetailsDB00859PenicillamineapprovedunknownsubstrateDetailsDB00177Valsartanapproved, investigationalunknownsubstrateinhibitorDetailsDB06721GimatecaninvestigationalunknownsubstrateDetailsDB01583LiotrixapprovedunknownsubstrateDetailsDB06210EltrombopagapprovedunknowninhibitorDetailsDB00973EzetimibeapprovedunknownsubstrateDetailsDB02691Glycocholic acidexperimental, investigationalunknownDetailsDB05804Prasterone sulfateinvestigationalunknownDetailsDB00451LevothyroxineapprovedunknowninhibitorDetailsDB00509Dextrothyroxineapproved, investigationalunknownDetailsDB00950Fexofenadineapproved, investigationalunknownsubstrateDetailsDB08855Leukotriene C4experimental, investigationalunknownDetailsDB08856DADLEexperimentalunknownDetailsDB08857Bamet-UD2experimentalunknownDetailsDB08858cis-Diamminechlorocholylglycinateplatinum(II)experimentalunknownDetailsDB01095FluvastatinapprovedunknownsubstrateinhibitorDetailsDB08860PitavastatinapprovedunknownsubstrateinhibitorDetailsDB06589PazopanibapprovedunknowninhibitorDetailsDB06772CabazitaxelapprovedunknowninhibitorDetailsDB08864RilpivirineapprovedunknowninhibitorDetailsDB08884Gadoxetic acidapprovedunknownsubstrateDetailsDB06626Axitinibapproved, investigationalnosubstrateinhibitorDetailsDB08912Dabrafenibapproved, investigationalnosubstrateinhibitorDetailsDB00912Repaglinideapproved, investigationalunknownsubstrateDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB01098RosuvastatinapprovedunknownsubstrateinhibitorDetailsDB06290SimeprevirapprovedunknownsubstrateinhibitorDetailsDB04850PosizolidinvestigationalunknowninhibitorDetailsDB01211ClarithromycinapprovedunknownDetailsDB09054IdelalisibapprovednoinhibitorDetailsDB09272Eluxadolineapproved, investigationalunknownsubstrateinhibitorDetailsDB09292SacubitrilapprovedunknowninhibitorDetailsDB09102Daclatasvirapproved, investigationalunknowninhibitorDetailsDB05239Cobimetinibapproved, investigationalnoweak inhibitorDetailsDB11362SelexipagapprovednosubstrateDetailsDB06403Ambrisentanapproved, investigationalunknownsubstrateDetailsDB11575GrazoprevirapprovednosubstrateDetailsDB09137Technetium Tc-99m mebrofeninapprovednosubstrateDetailsDB13139Levosalbutamolapproved, investigationalnosubstrateDetailsDB13153Levomenolapproved, experimentalunknownsubstrateDetailsDB11613Velpatasvirapproved, investigationalnoinhibitortransporterDetailsDB05521Telaprevirapproved, withdrawnunknowninhibitorDetailsDB09198LobeglitazoneexperimentalnoinhibitorDetailsDB12026Voxilaprevirapproved, investigationalnosubstrateinhibitorDetailsDB13874Enasidenibapproved, investigationalunknowninhibitorDetailsDB13878Pibrentasvirapproved, investigationalunknowninhibitorDetailsDB13879Glecaprevirapproved, investigationalunknownsubstrateinhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateinhibitorDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknowninhibitorDetailsDB11901Apalutamideapproved, investigationalunknowninducerDetailsDB09297Paritaprevirapproved, investigationalunknownsubstrateinhibitorDetailsDB00975DipyridamoleapprovedunknowninhibitorDetailsDB01072Atazanavirapproved, investigationalunknowninhibitorDetailsDB00541Vincristineapproved, investigationalunknowninhibitorDetailsDB12319Benzbromaroneinvestigational, withdrawnunknowninhibitorDetailsDB08862Cholecystokininapproved, investigationalunknownsubstrateinhibitorDetailsDB00255Diethylstilbestrolapproved, investigational, withdrawnunknowninhibitorDetailsDB01645GenisteininvestigationalunknowninhibitorDetailsDB00602Ivermectinapproved, investigational, vet_approvedunknowninhibitorDetailsDB01115NifedipineapprovedunknowninhibitorDetailsDB01051Novobiocinapproved, investigational, vet_approved, withdrawnunknowninhibitorDetailsDB00646Nystatinapproved, vet_approvedunknowninhibitorDetailsDB11869ValspodarinvestigationalunknowninhibitorDetailsDB00206Reserpineapproved, investigational, withdrawnunknowninhibitorDetailsDB09298Silibininexperimental, investigationalunknowninhibitorDetailsDB00795SulfasalazineapprovednoinhibitorDetailsDB00932Tipranavirapproved, investigationalunknowninhibitorDetailsDB01601LopinavirapprovedunknowninhibitorDetailsDB01264DarunavirapprovedunknowninhibitorDetailsDB00328Indomethacinapproved, investigationalunknowninhibitorDetailsDB00701Amprenavirapproved, investigationalunknowninhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknowninhibitorDetailsDB04216Quercetinexperimental, investigationalunknowninhibitorDetailsDB00622Nicardipineapproved, investigationalunknowninhibitorDetailsDB00396Progesteroneapproved, vet_approvedunknowninhibitorDetailsDB00570VinblastineapprovedunknowninhibitorDetailsDB00468QuinineapprovedunknowninhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB13919CandesartanexperimentalunknowninhibitorDetailsDB09065CobicistatapprovedunknowninhibitorDetailsDB00976TelithromycinapprovedunknowninhibitorDetailsDB01590EverolimusapprovedunknowninhibitorDetailsDB00203Sildenafilapproved, investigationalunknowninhibitorDetailsDB00864Tacrolimusapproved, investigationalunknowninhibitorDetailsDB00398Sorafenibapproved, investigationalunknowninhibitorDetailsDB04868Nilotinibapproved, investigationalunknowninhibitorDetailsDB11586Asunaprevirapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB11979Elagolixapproved, investigationalunknownsubstrateDetailsDB13867Fluticasoneapproved, experimentalnoinhibitorDetailsDB08906Fluticasone furoateapprovednoinhibitorDetailsDB00588Fluticasone propionateapprovednoinhibitorDetailsDB09078Lenvatinibapproved, investigationalunknowninhibitorDetailsDB05928DovitinibinvestigationalunknowninhibitorDetailsDB08880TeriflunomideapprovedunknowninhibitorDetailsDB02703Fusidic acidapproved, investigationalunknownDetailsDB11753Rifamycinapproved, investigationalnoinhibitorDetailsDB11581Venetoclaxapproved, investigationalunknowninhibitorDetailsDB11855Revefenacinapproved, investigationalnosubstrateDetailsDB09279FimasartaninvestigationalunknownsubstrateDetailsDB00834Mifepristoneapproved, investigationalnoinhibitorDetailsDB00257Clotrimazoleapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00214TorasemideapprovednosubstrateDetailsDB13867Fluticasoneapproved, experimentalunknowninhibitorDetailsDB09299Tenofovir alafenamideapprovednosubstrateDetailsDB00481Raloxifeneapproved, investigationalunknownsubstrateDetailsDB00394Beclomethasone dipropionateapproved, investigationalunknowninhibitorDetailsDB12978Pexidartinibapproved, investigationalunknowninhibitorDetailsDB12500Fedratinibapproved, investigationalunknowninhibitorDetailsDB11757Istradefyllineapproved, investigationalunknowninhibitorDetailsDB01241GemfibrozilapprovedunknowninhibitorDetailsDB04855DronedaroneapprovednoinhibitorDetailsDB15444Elexacaftorapproved, investigationalnoinhibitorDetailsDB14962Trastuzumab deruxtecanapproved, investigationalunknownDetailsDB15091Upadacitinibapproved, investigationalnoinhibitorDetailsDB15328Ubrogepantapproved, investigationalunknownsubstrateinhibitorDetailsDB01211ClarithromycinapprovedunknowninhibitorDetailsDB12941Darolutamideapproved, investigationalunknowninhibitorDetailsDB00588Fluticasone propionateapprovedunknowninhibitorDetailsDB12457Rimegepantapproved, investigationalunknowninhibitorDetailsDB11837Osilodrostatapproved, investigationalunknowninhibitorDetailsDB11936Bempedoic acidapproved, investigationalunknowninhibitorDetailsDB01708Prasteroneapproved, investigational, nutraceuticalunknownsubstrateDetailsDB14761Remdesivirapproved, investigationalunknownsubstrateinhibitorDetailsDB09038EmpagliflozinapprovedunknownsubstrateDetailsDB09274Artesunateapproved, investigationalunknowninhibitorDetailsDB12674Lurbinectedinapproved, investigationalunknowninhibitorDetailsDB11796Fostemsavirapproved, investigationalunknowninhibitorDetailsDB15719Belantamab mafodotinapprovedunknownsubstrateDetailsDB15822Pralsetinibapproved, investigationalnoinhibitorDetailsDB06448Lonafarnibapproved, investigationalnoinhibitorDetailsDB06137Tirbanibulinapproved, investigationalnoinhibitorDetailsDB11632Opicaponeapproved, investigationalnoinhibitorDetailsDB08995Diosminapproved, investigationalunknowninhibitorDetailsDB11886Infigratinibapproved, investigationalnoinhibitorDetailsDB12151Brincidofovirapproved, investigationalnosubstrateinhibitorDetailsDB16703Belumosudilapproved, investigationalnoinhibitorDetailsDB15463Belzutifanapproved, investigationalnosubstrateDetailsDB12265Fexinidazoleapproved, investigationalunknowninhibitorDetailsDB16098Atogepantapproved, investigationalnosubstrateinhibitorDetailsDB06176Romidepsinapproved, investigationalnoinhibitorDetailsDB12597Asciminibapproved, investigationalunknowninhibitorDetailsDB15413Pafolacianineapproved, investigationalnosubstrateDetailsDB12713Sotagliflozinapproved, investigationalnoinhibitorDetailsDB15575Padeliporfinapproved, experimentalunknowninhibitorDetailsDB04847Roxadustatapproved, investigationalunknowninhibitorDetailsDB17083LinzagolixapprovednosubstrateinhibitorDetailsDB16267Olutasidenibapproved, investigationalnoinhibitorDetailsDB00244MesalazineapprovednosubstrateDetailsDB11682Daprodustatapproved, investigationalnoinhibitorDetailsDB06045Trofinetideapproved, investigationalunknowninhibitorDetailsDB16217Leniolisibapproved, investigationalnoinhibitorDetailsDB11712Tezacaftorapproved, investigationalnosubstrateinhibitorDetailsDB01005HydroxyureaapprovednosubstrateDetailsDB05812AbirateroneapprovedunknowninhibitorDetailsDB05467Palovaroteneapproved, investigationalnoinhibitorDetailsDB11763Momelotinibapproved, investigationalunknownsubstrateDetailsDB11718Encorafenibapproved, investigationalnoinhibitorDetailsDB12218Capivasertibapproved, investigationalnoinhibitorDetailsDB16826RepotrectinibinvestigationalnoinhibitorDetails"
                    }
                }
            ]
        },
        "Disease Information": {
            "Actinomycosis": "Actinomycosis is a rare infectious bacterial disease caused by Actinomyces species.[1] The name refers to ray-like appearance of the organisms in the granules. About 70% of infections are due to either Actinomyces israelii or A. gerencseriae.[1] Infection can also be caused by Streptomyces somaliensis and Propionibacterium propionicus. The condition is likely to be a polymicrobial anaerobic infection.[2]\n",
            "Acute Rheumatic Fever": "Rheumatic fever (RF) is an inflammatory disease that can involve the heart, joints, skin, and brain.[1] The disease typically develops two to four weeks after a streptococcal throat infection.[2] Signs and symptoms include fever, multiple painful joints, involuntary muscle movements, and occasionally a characteristic non-itchy rash known as erythema marginatum.[1] The heart is involved in about half of the cases.[1] Damage to the heart valves, known as rheumatic heart disease (RHD), usually occurs after repeated attacks but can sometimes occur after one.[1] The damaged valves may result in heart failure, atrial fibrillation and infection of the valves.[1]\n",
            "Anthrax": "Anthrax is an infection caused by the bacterium Bacillus anthracis.[2] Infection typically occurs by contact with the skin, inhalation, or intestinal absorption.[9] Symptom onset occurs between one day and more than two months after the infection is contracted.[1] The skin form presents with a small blister with surrounding swelling that often turns into a painless ulcer with a black center.[1] The inhalation form presents with fever, chest pain and shortness of breath.[1] The intestinal form presents with diarrhea (which may contain blood), abdominal pains, nausea and vomiting.[1]\n",
            "Bloodstream Infections": null,
            "Clostridium Botulinum Toxin Adverse Reaction": null,
            "Diphtheria": "Diphtheria is an infection caused by the bacterium Corynebacterium diphtheriae.[1] Most infections are asymptomatic or have a mild clinical course, but in some outbreaks, the lethality rate approaches 10%.[2]  Signs and symptoms may vary from mild to severe,[2] and usually start two to five days after exposure.[1] Symptoms often develop gradually, beginning with a sore throat and fever.[2] In severe cases, a grey or white patch develops in the throat,[1][2] which can block the airway, and create a barking cough similar to what is observed in croup.[2] The neck may also swell in part due to the enlargement of the facial lymph nodes.[1] Diphtheria can also involve the skin, eyes, or genitals, and can cause[1][2] complications, including myocarditis (which in itself can result in an abnormal heart rate), inflammation of nerves (which can result in paralysis), kidney problems, and bleeding problems due to low levels of platelets.[1]\n",
            "Empyema": "An empyema (/\u02cc\u025bmpa\u026a\u02c8i\u02d0m\u0259/) is a collection or gathering of pus within a naturally existing anatomical cavity. For example, pleural empyema is empyema of the pleural cavity. It must be differentiated from an abscess, which is a collection of pus in a newly formed cavity. The term is from Greek \u1f10\u03bc\u03c0\u03cd\u03b7\u03bc\u03b1, \"abscess\".\n",
            "Endocarditis": "Endocarditis is an inflammation of the inner layer of the heart, the endocardium. It usually involves the heart valves. Other structures that may be involved include the interventricular septum, the chordae tendineae, the mural endocardium, or the surfaces of intracardiac devices. Endocarditis is characterized by lesions, known as vegetations, which is a mass of platelets, fibrin, microcolonies of microorganisms, and scant inflammatory cells.[1] In the subacute form of infective endocarditis, the vegetation may also include a center of granulomatous tissue, which may fibrose or calcify.[2]\n",
            "Endocarditis caused by Erysipelothrix infections": null,
            "Fusospirochetosis": null,
            "Gas Gangrene": null,
            "Gonococcal infections": null,
            "Gram-Negative Bacterial Infections": null,
            "Haverhill fever": "Haverhill fever (or epidemic arthritic erythema) is a systemic illness caused by the bacterium Streptobacillus moniliformis, an organism common in rats and mice. If untreated, the illness can have a mortality rate of up to 13%. Among the two types of rat-bite fever, Haverhill fever caused by Streptobacillus moniliformis is most common in North America. The other type of infection caused by Spirillum minus is more common in Asia and is also known as Sodoku.[1]\n",
            "Listeria infection": "Listeriosis is a bacterial infection most commonly caused by Listeria monocytogenes,[1] although L.\u00a0ivanovii and L.\u00a0grayi have been reported in certain cases. Listeriosis can cause severe illness, including severe sepsis, meningitis, or encephalitis, sometimes resulting in lifelong harm and even death. Those at risk of severe illness are the elderly,  fetuses, newborns and those who are immunocompromised. In pregnant women it may cause stillbirth or spontaneous abortion, and preterm birth is common. Listeriosis may cause mild, self-limiting gastroenteritis and fever in anyone.[2]\n",
            "Meningitis": "Meningitis is acute or chronic inflammation of the protective membranes covering the brain and spinal cord, collectively called the meninges.[10] The most common symptoms are fever, intense headache, vomiting and neck stiffness and occasionally photophobia.[1]\n",
            "Meningococcal Meningitis": null,
            "Pasteurella infections": "P. aerogenes\nP. anatis\nP. avium\nP. bettyae\nP. caballi\nP. canis\nP. dagmatis\nP. gallicida\nP. gallinarum\nP. granulomatis\nP. langaaensis\nP. lymphangitidis\nP. mairii\nP. multocida\nP. oralis\nP. pneumotropica\nP. skyensis\nP. stomatis\nP. testudinis\nP. trehalosi\nP. ureae\nP. volantium\n",
            "Pericarditis": "Pericarditis is inflammation of the pericardium, the fibrous sac surrounding the heart.[8] Symptoms typically include sudden onset of sharp chest pain, which may also be felt in the shoulders, neck, or back.[1] The pain is typically less severe when sitting up and more severe when lying down or breathing deeply.[1] Other symptoms of pericarditis can include fever, weakness, palpitations, and shortness of breath.[1] The onset of symptoms can occasionally be gradual rather than sudden.[8]\n",
            "Pneumonia": "Pneumonia is an inflammatory condition of the lung primarily affecting the small air sacs known as alveoli.[3][14] Symptoms typically include some combination of productive or dry cough, chest pain, fever, and difficulty breathing.[15] The severity of the condition is variable.[15]\n",
            "Syphilis": "Syphilis (/\u02c8s\u026af\u0259l\u026as/) is a sexually transmitted infection caused by the bacterium Treponema pallidum subspecies pallidum.[1] The signs and symptoms of syphilis vary depending in which of the four stages it presents (primary, secondary, latent, and tertiary).[1][2] The primary stage classically presents with a single chancre (a firm, painless, non-itchy skin ulceration usually between 1\u00a0cm and 2\u00a0cm in diameter) though there may be multiple sores.[2] In secondary syphilis, a diffuse rash occurs, which frequently involves the palms of the hands and soles of the feet.[2] There may also be sores in the mouth or vagina.[2] In latent syphilis, which can last for years, there are few or no symptoms.[2] In tertiary syphilis, there are gummas (soft, non-cancerous growths), neurological problems, or heart symptoms.[3] Syphilis has been known as \"the great imitator\" as it may cause symptoms similar to many other diseases.[2][3]",
            "Tetanus": "Tetanus, also known as lockjaw, is a bacterial infection caused by Clostridium tetani and characterized by muscle spasms. In the most common type, the spasms begin in the jaw, and then progress to the rest of the body. Each spasm usually lasts for a few minutes. Spasms occur frequently for three to four weeks.[1] Some spasms may be severe enough to fracture bones.[2] Other symptoms of tetanus may include fever, sweating, headache, trouble swallowing, high blood pressure, and a fast heart rate. Onset of symptoms is typically 3 to 21 days following infection. Recovery may take months, but about 10% of cases prove to be fatal.[1]\n",
            "Rat bite fever": "Rat-bite fever (RBF) is an acute, febrile human illness caused by bacteria transmitted by rodents, in most cases, which is passed from rodent to human by the rodent's urine or mucous secretions. Alternative names for rat-bite fever include streptobacillary fever, streptobacillosis, spirillary fever, bogger, and epidemic arthritic erythema. It is a rare disease spread by infected rodents and caused by two specific types of bacteria:\n"
        }
    },
    "PROZAC": {
        "Active Ingredients": {
            "FLUOXETINE HYDROCHLORIDE": "CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F.Cl"
        },
        "Drug Information": {
            "Identification": {
                "Summary": "Fluoxetine is a selective serotonin reuptake inhibitor used to treat major depressive disorder, bulimia, OCD, premenstrual dysphoric disorder, panic disorder, and bipolar I.",
                "Brand Names": "Prozac, Sarafem, Symbyax",
                "Generic Name": "Fluoxetine",
                "DrugBank Accession Number": "DB00472",
                "Background": "Fluoxetine is a 2nd generation antidepressant categorized as a selective serotonin reuptake inhibitor (SSRI).2 It gained FDA approval in 1987 and although it was initially intended for the treatment of depression, today it is commonly prescribed to manage depression in addition to various other pathologies.13",
                "Type": "Small Molecule",
                "Groups": "Approved, Vet approved",
                "Structure": "3DDownload MOLSDF3D-SDFPDBSMILESInChI\n\n\n Similar StructuresStructure for Fluoxetine (DB00472)\u00d7 Close",
                "Weight": "Average: 309.3261 Monoisotopic: 309.134048818",
                "Chemical Formula": "C17H18F3NO",
                "Synonyms": "(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine(+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamineFluoxetinFluoxetinaFluox\u00e9tineFluoxetineFluoxetinum",
                "External IDs": "Lilly 103472\nLilly 110 140"
            },
            "Pharmacology": {
                "Indication": "Fluoxetine is indicated for both acute and maintenance treatment of major depressive disorder, obsessive compulsive disorder, and bulimia nervosa; however, it is only indicated for acute treatment of panic disorder independent of whether agoraphobia is present.12 Fluoxetine may also be used in combination with olanzapine to treat depression related to Bipolar I Disorder, and treatment resistant depression.12 Fluoxetine is additionally indicated for the treatment of female patients with premenstrual dysphoric disorder (PMDD).18\nReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See how",
                "Associated Conditions": "Alcohol Dependency\nAnorexia Nervosa (AN)\nBulimia Nervosa\nCataplexy\nDepression\nMajor Depressive Disorder (MDD)\nMajor depressive disorder, recurrent episode\nMyoclonus\nObesity\nObsessive Compulsive Disorder (OCD)\nPanic Disorder With Agoraphobia\nPanic disorder without agoraphobia\nPremature Ejaculation\nPremenstrual Dysphoric Disorder (PMDD)",
                "Associated Therapies": "Maintenance therapy",
                "Contraindications & Blackbox Warnings": "Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events with our Clinical APILearn more",
                "Pharmacodynamics": "Fluoxetine blocks the serotonin reuptake transporter in the presynaptic terminal, which ultimately results in sustained levels of 5-hydroxytryptamine (5-HT) in certain brain areas.13 However, fluoxetine binds with relatively poor affinity to 5-HT, dopaminergic, adrenergic, cholinergic, muscarinic, and histamine receptors which explains why it has a far more desirable adverse effect profile compared to earlier developed classes of antidepressants such as tricyclic antidepressants.132",
                "Mechanism of action": "The monoaminergic hypothesis of depression emerged in 1965 and linked depression with dysfunction of neurotransmitters such as noradrenaline and serotonin.13 Indeed, low levels of serotonin have been observed in the cerebrospinal fluid of patients diagnosed with depression.3 As a result of this hypothesis, drugs that modulate levels of serotonin such as fluoxetine were developed.13\nFluoxetine is a selective serotonin reuptake inhibitor (SSRI) and as the name suggests, it exerts it's therapeutic effect by inhibiting the presynaptic reuptake of the neurotransmitter serotonin.2 As a result, levels of 5-hydroxytryptamine (5-HT) are increased in various parts of the brain.13 Further, fluoxetine has high affinity for 5-HT transporters, weak affinity for noradrenaline transporters and no affinity for dopamine transporters indicating that it is 5-HT selective.13\nFluoxetine interacts to a degree with the 5-HT2C receptor and it has been suggested that through this mechanism, it is able to increase noradrenaline and dopamine levels in the prefrontal cortex.13\nTargetActionsOrganismASodium-dependent serotonin transporterinhibitorHumansU5-hydroxytryptamine receptor 2CantagonistHumansUNeuronal acetylcholine receptor subunit alpha-2antagonistHumansUNeuronal acetylcholine receptor subunit alpha-3antagonistHumansUNeuronal acetylcholine receptor subunit beta-4antagonistHumansUCyclin-dependent kinases regulatory subunit 1Not AvailableHumansUPotassium voltage-gated channel subfamily H member 2inhibitorHumans",
                "Absorption": "The oral bioavailability of fluoxetine is <90% as a result of hepatic first pass metabolism.13\nIn a bioequivalence study, the Cmax of fluoxetine 20 mg for the established reference formulation was 11.754 ng/mL while the Cmax for the proposed generic formulation was 11.786 ng/ml.11\nFluoxetine is very lipophilic and highly plasma protein bound, allowing the drug and it's active metabolite, norfluoxetine, to be distributed to the brain.13",
                "Volume of distribution": "The volume of distribution of fluoxetine and it's metabolite varies between 20 to 42 L/kg.6",
                "Protein binding": "Approximately 94% of fluoxetine is plasma protein bound.2",
                "Metabolism": "Fluoxetine is metabolized to norfluoxetine by CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP3A4, and CYP3A5 upon ingestion.138 Although all of the mentioned enzymes contribute to N-demethylation of fluoxetine, CYP2D6, CYP2C9 and CYP3A4 appear to be the major contributing enzymes for phase I metabolism.8 In addition, there is evidence to suggest that CYP2C19 and CYP3A4 mediate O-dealkylation of fluoxetine and norfluoxetine to produce para-trifluoromethylphenol which is subsequently metabolized to hippuric acid.910 Both fluoxetine and norfluoxetine undergo glucuronidation to facilitate excretion.13 \nNotably, both the parent drug and active metabolite inhibit CYP2D6 isozymes, and as a result patients who are being treated with fluoxetine are susceptible to drug interactions.1316\nHover over products below to view reaction partnersFluoxetine\n\n\nNorfluoxetine\n\n\n4-Trifluoromethylphenol\n\n\nHippuric acid\n\n\nNorfluoxetine alcohol\n\n\nNorfluoxetine acid\n\n\nNorfluoxetine glucuronide\n\n\n4-Trifluoromethylphenol\n\n\nHippuric acid\n\n\nFluoxetine glucuronide",
                "Route of elimination": "Fluoxetine is primarily eliminated in the urine.15",
                "Half-life": "The half life of fluoxetine is significant with the elimination half-life of the parent drug averaging 1-3 days after acute administration, and 4-6 days after chronic administration.12 Further, the elimination half life of it's active metabolite, norfluoxetine, ranges from 4-16 days after both acute and chronic administration.12 The half-life of fluoxetine should be considered when switching patients from fluoxetine to another antidepressant since marked accumulation occurs after chronic use.12 Fluoxetine's long half-life may even be beneficial when discontinuing the drug since the risk of withdrawal is minimized.13",
                "Clearance": "The clearance value of fluoxetine in healthy patients is reported to be 9.6 ml/min/kg.7",
                "Adverse Effects": "Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support & research outcomes with our structured adverse effects data.See a data sample",
                "Toxicity": "In a report that included 234 fluoxetine overdose cases, it was concluded that symptoms resulting from fluoxetine overdose were generally minor and short in duration.5 The most common overdose adverse effects included drowsiness, tremor, tachycardia, nausea and vomiting, and providing the patient with aggressive supportive care was the recommended intervention.45\nDespite this evidence, more severe adverse effects have been linked to fluoxetine ingestion although most of these reports involved co-ingestion with other substances or drugs as well as other factors.4 For example, there is a case report that details a patient who ingested 1400 mg of fluoxetine in a suicide attempt and as a result, experienced a generalized seizure three hours later.4 In a separate case, a 14 year old patient ingested 1.2 g of fluoxetine and subsequently experienced tonic/clonic seizures, symptoms consistent with serotonin syndrome, and rhabdomyolysis, although the patient did not experience sustained renal injury.6",
                "Pathways": "PathwayCategoryFluoxetine Metabolism PathwayDrug metabolismFluoxetine Action PathwayDrug action",
                "Pharmacogenomic Effects/ADRs": "Not Available"
            },
            "Interactions": {
                "Drug Interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. ApprovedVet approvedNutraceuticalIllicitWithdrawnInvestigationalExperimentalAll DrugsDrugInteractionIntegrate drug-drug interactions in your software\n\n\n1,2-BenzodiazepineThe serum concentration of 1,2-Benzodiazepine can be increased when it is combined with Fluoxetine.AbametapirThe serum concentration of Fluoxetine can be increased when it is combined with Abametapir.AbataceptThe metabolism of Fluoxetine can be increased when combined with Abatacept.AbciximabThe risk or severity of hemorrhage can be increased when Fluoxetine is combined with Abciximab.AbemaciclibThe metabolism of Abemaciclib can be decreased when combined with Fluoxetine.AbirateroneThe serum concentration of Fluoxetine can be increased when it is combined with Abiraterone.AbrocitinibThe metabolism of Abrocitinib can be decreased when combined with Fluoxetine.AcalabrutinibThe metabolism of Acalabrutinib can be decreased when combined with Fluoxetine.AcarboseThe risk or severity of hypoglycemia can be increased when Fluoxetine is combined with Acarbose.AcebutololThe serum concentration of Acebutolol can be increased when it is combined with Fluoxetine.Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more",
                "Food Interactions": "Avoid alcohol.\nTake with or without food."
            },
            "Products": {
                "": "Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access now  Access drug product information from over 10 global regions.Access now",
                "Product Ingredients": "IngredientUNIICASInChI KeyFluoxetine hydrochlorideI9W7N6B1KJ56296-78-7GIYXAJPCNFJEHY-UHFFFAOYSA-N",
                "Product Images": "PreviousNext",
                "International/Other Brands": "Adofen (Brainpharma) / Animex-On (Laboratorios) / Fluoxeren (Menarini) / Fontex (Lilly) / Ladose (Lilly)",
                "Brand Name Prescription Products": "NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImageAct FluoxetineCapsule20 mgOralDr. Reddy's Laboratories Inc2000-05-312023-06-27CanadaAct FluoxetineCapsule10 mgOralDr. Reddy's Laboratories Inc2000-05-312023-06-27CanadaAct FluoxetineCapsule40 mgOralDr. Reddy's Laboratories IncNot applicableNot applicableCanadaBci FluoxetineCapsule20 mgOralBaker Cummins IncNot applicableNot applicableCanadaFluoxetineSolution20 mg / 5 mLOralApotex CorporationNot applicableNot applicableCanadaFluoxetineCapsule20 mgOralApotex Corporation1996-12-31Not applicableCanadaFluoxetineCapsule10 mgOralSanis Health Inc2009-10-22Not applicableCanadaFluoxetineCapsule20 mgOralAltamed Pharma2020-03-05Not applicableCanadaFluoxetineCapsule10 mgOralApotex Corporation1996-12-31Not applicableCanadaFluoxetineCapsule20 mgOralMeliapharm Inc2010-06-112014-06-25Canada",
                "Generic Prescription Products": "NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImageAccel-fluoxetineCapsule20 mgOralAccel Pharma Inc2015-03-262018-03-29CanadaAccel-fluoxetineCapsule10 mgOralAccel Pharma Inc2015-03-262018-03-29CanadaAch-fluoxetineCapsule20 mgOralAccord Healthcare Inc2012-05-01Not applicableCanadaAch-fluoxetineCapsule10 mgOralAccord Healthcare Inc2012-10-10Not applicableCanadaAg-fluoxetineCapsule10 mgOralAngita Pharma Inc.2019-03-15Not applicableCanadaAg-fluoxetineCapsule20 mgOralAngita Pharma Inc.2019-03-15Not applicableCanadaApo-fluoxetineCapsule10 mgOralApotex Corporation1996-12-31Not applicableCanadaApo-fluoxetineSolution20 mg / 5 mLOralApotex Corporation1997-06-16Not applicableCanadaApo-fluoxetineCapsule20 mgOralApotex Corporation1996-12-31Not applicableCanadaAuro-fluoxetineCapsule20 mgOralAuro Pharma Inc2012-07-24Not applicableCanada",
                "Mixture Products": "NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImageFLUXOPIN 12 MG/25 MG KAPS\u00dcL ,30 KAPS\u00dcLFluoxetine hydrochloride (25 mg) + Olanzapine (12 mg)CapsuleOralDeva Holding A.S.2020-08-142018-10-26TurkeyFLUXOPIN 12 MG/50 MG KAPS\u00dcL ,30 KAPS\u00dcLFluoxetine hydrochloride (50 mg) + Olanzapine (12 mg)CapsuleOralDeva Holding A.S.2020-08-142018-10-26TurkeyFLUXOPIN 3 MG/25 MG KAPS\u00dcL ,30 KAPS\u00dcLFluoxetine hydrochloride (25 mg) + Olanzapine (3 mg)CapsuleOralDeva Holding A.S.2020-08-142018-10-26TurkeyFLUXOPIN 6 MG/25 MG KAPS\u00dcL ,30 KAPS\u00dcLFluoxetine hydrochloride (25 mg) + Olanzapine (6 mg)CapsuleOralDeva Holding A.S.2020-08-142018-10-26TurkeyFLUXOPIN 6 MG/50 MG KAPS\u00dcL ,30 KAPS\u00dcLFluoxetine hydrochloride (50 mg) + Olanzapine (6 mg)CapsuleOralDeva Holding A.S.2020-08-142018-10-26TurkeyOlanzapine and FluoxetineFluoxetine hydrochloride (25 mg/1) + Olanzapine (6 mg/1)CapsuleOralAvKARE2014-01-21Not applicableUSOlanzapine and FluoxetineFluoxetine hydrochloride (50 mg/1) + Olanzapine (12 mg/1)CapsuleOralPar Pharmaceutical, Inc.2012-11-26Not applicableUSOlanzapine and FluoxetineFluoxetine hydrochloride (50 mg/1) + Olanzapine (12 mg/1)CapsuleOralTeva Pharmaceuticals USA, Inc.2012-06-19Not applicableUSOlanzapine and FluoxetineFluoxetine hydrochloride (50 mg/1) + Olanzapine (6 mg/1)CapsuleOralSandoz Inc2012-11-30Not applicableUSOlanzapine and FluoxetineFluoxetine hydrochloride (25 mg/1) + Olanzapine (6 mg/1)CapsuleOralPar Pharmaceutical, Inc.2012-11-26Not applicableUS",
                "Unapproved/Other Products": "NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImageGaboxetineFluoxetine hydrochloride (10 mg/1) + Choline (125 mg/1)KitOralPhysician Therapeutics Llc2011-07-07Not applicableUSSentraflox AM-10Fluoxetine hydrochloride (10 mg/1) + Choline (250 mg/1)KitOralPhysician Therapeutics Llc2011-07-07Not applicableUSSentroxatineFluoxetine hydrochloride (10 mg/1) + Choline (250 mg/1)KitOralPhysician Therapeutics Llc2011-02-17Not applicableUS"
            },
            "Categories": {
                "ATC Codes": "N06CA03 \u2014 Fluoxetine and psycholepticsN06CA \u2014 Antidepressants in combination with psycholepticsN06C \u2014 PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATIONN06 \u2014 PSYCHOANALEPTICSN \u2014 NERVOUS SYSTEMN06AB03 \u2014 FluoxetineN06AB \u2014 Selective serotonin reuptake inhibitorsN06A \u2014 ANTIDEPRESSANTSN06 \u2014 PSYCHOANALEPTICSN \u2014 NERVOUS SYSTEM",
                "Drug Categories": "Agents that reduce seizure threshold\nAmines\nAnticholinergic Agents\nAntidepressive Agents\nAntidepressive Agents Indicated for Depression\nAntidepressive Agents, Second-Generation\nCentral Nervous System Agents\nCentral Nervous System Depressants\nCytochrome P-450 CYP1A2 Inhibitors\nCytochrome P-450 CYP1A2 Inhibitors (strength unknown)\nCytochrome P-450 CYP1A2 Substrates\nCytochrome P-450 CYP2B6 Substrates\nCytochrome P-450 CYP2C19 Inhibitors\nCytochrome P-450 CYP2C19 Inhibitors (strong)\nCytochrome P-450 CYP2C19 Substrates\nCytochrome P-450 CYP2C9 Inhibitors\nCytochrome P-450 CYP2C9 Inhibitors (moderate)\nCytochrome P-450 CYP2C9 Inhibitors (strength unknown)\nCytochrome P-450 CYP2C9 Substrates\nCytochrome P-450 CYP2D6 Inhibitors\nCytochrome P-450 CYP2D6 Inhibitors (strong)\nCytochrome P-450 CYP2D6 Substrates\nCytochrome P-450 CYP3A Inhibitors\nCytochrome P-450 CYP3A Substrates\nCytochrome P-450 CYP3A4 Inhibitors\nCytochrome P-450 CYP3A4 Inhibitors (weak)\nCytochrome P-450 CYP3A4 Substrates\nCytochrome P-450 CYP3A5 Substrates\nCytochrome P-450 Enzyme Inhibitors\nCytochrome P-450 Substrates\nEnzyme Inhibitors\nHighest Risk QTc-Prolonging Agents\nHypoglycemia-Associated Agents\nMembrane Transport Modulators\nNervous System\nNeurotransmitter Agents\nNeurotransmitter Uptake Inhibitors\nNicotinic Antagonists\nP-glycoprotein inhibitors\nPropylamines\nPsychoanaleptics\nPsychotropic Drugs\nQTc Prolonging Agents\nSelective Serotonin Reuptake Inhibitors\nSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome\nSerotonin 5-HT2 Receptor Antagonists\nSerotonin 5-HT2C Receptor Antagonists\nSerotonin Agents\nSerotonin Modulators\nSerotonin Receptor Antagonists\nVasodilating Agents",
                "Chemical TaxonomyProvided by Classyfire": "DescriptionThis compound belongs to the class of organic compounds known as trifluoromethylbenzenes. These are organofluorine compounds that contain a benzene ring substituted with one or more trifluoromethyl groups.KingdomOrganic compoundsSuper ClassBenzenoidsClassBenzene and substituted derivativesSub ClassTrifluoromethylbenzenesDirect ParentTrifluoromethylbenzenesAlternative ParentsPhenoxy compounds / Phenol ethers / Aralkylamines / Alkyl aryl ethers / Dialkylamines / Organopnictogen compounds / Organofluorides / Hydrocarbon derivatives / Alkyl fluoridesSubstituentsAlkyl aryl ether / Alkyl fluoride / Alkyl halide / Amine / Aralkylamine / Aromatic homomonocyclic compound / Ether / Hydrocarbon derivative / Organic nitrogen compound / Organic oxygen compoundMolecular FrameworkAromatic homomonocyclic compoundsExternal Descriptorsaromatic ether, secondary amino compound, (trifluoromethyl)benzenes (CHEBI:86990)",
                "Description": "This compound belongs to the class of organic compounds known as trifluoromethylbenzenes. These are organofluorine compounds that contain a benzene ring substituted with one or more trifluoromethyl groups.",
                "Kingdom": "Organic compounds",
                "Super Class": "Benzenoids",
                "Class": "Benzene and substituted derivatives",
                "Sub Class": "Trifluoromethylbenzenes",
                "Direct Parent": "Trifluoromethylbenzenes",
                "Alternative Parents": "Phenoxy compounds / Phenol ethers / Aralkylamines / Alkyl aryl ethers / Dialkylamines / Organopnictogen compounds / Organofluorides / Hydrocarbon derivatives / Alkyl fluorides",
                "Substituents": "Alkyl aryl ether / Alkyl fluoride / Alkyl halide / Amine / Aralkylamine / Aromatic homomonocyclic compound / Ether / Hydrocarbon derivative / Organic nitrogen compound / Organic oxygen compound",
                "Molecular Framework": "Aromatic homomonocyclic compounds",
                "External Descriptors": "aromatic ether, secondary amino compound, (trifluoromethyl)benzenes (CHEBI:86990)",
                "Affected organisms": "Humans and other mammals"
            },
            "Chemical Identifiers": {
                "UNII": "01K63SUP8D",
                "CAS number": "54910-89-3",
                "InChI Key": "RTHCYVBBDHJXIQ-UHFFFAOYSA-N",
                "InChI": "InChI=1S/C17H18F3NO/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20/h2-10,16,21H,11-12H2,1H3",
                "IUPAC Name": "methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})amine",
                "SMILES": "CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1"
            },
            "References": {
                "Synthesis Reference": "Eduard Schwartz, Joseph Kaspi, Zinovi Itov, Gidon Pilarski, \"Production of fluoxetine and new intermediates.\" U.S. Patent US5225585, issued October, 1990.\nUS5225585",
                "General References": "Wong DT, Bymaster FP, Engleman EA: Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci. 1995;57(5):411-41. [Article] Sommi RW, Crismon ML, Bowden CL: Fluoxetine: a serotonin-specific, second-generation antidepressant. Pharmacotherapy. 1987 Jan-Feb;7(1):1-15. [Article] Sohel AJ, Molla M: Fluoxetine . [Article] Suchard JR: Fluoxetine overdose-induced seizure. West J Emerg Med. 2008 Aug;9(3):154-6. [Article] Borys DJ, Setzer SC, Ling LJ, Reisdorf JJ, Day LC, Krenzelok EP: Acute fluoxetine overdose: a report of 234 cases. Am J Emerg Med. 1992 Mar;10(2):115-20. [Article] Lee-Kelland R, Zehra S, Mappa P: Fluoxetine overdose in a teenager resulting in serotonin syndrome, seizure and delayed onset rhabdomyolysis. BMJ Case Rep. 2018 Oct 8;2018. pii: bcr-2018-225529. doi: 10.1136/bcr-2018-225529. [Article] Schenker S, Bergstrom RF, Wolen RL, Lemberger L: Fluoxetine disposition and elimination in cirrhosis. Clin Pharmacol Ther. 1988 Sep;44(3):353-9. doi: 10.1038/clpt.1988.161. [Article] Margolis JM, O'Donnell JP, Mankowski DC, Ekins S, Obach RS: (R)-, (S)-, and racemic fluoxetine N-demethylation by human cytochrome P450 enzymes. Drug Metab Dispos. 2000 Oct;28(10):1187-91. [Article] Liu ZQ, Zhu B, Tan YF, Tan ZR, Wang LS, Huang SL, Shu Y, Zhou HH: O-Dealkylation of fluoxetine in relation to CYP2C19 gene dose and involvement of CYP3A4 in human liver microsomes. J Pharmacol Exp Ther. 2002 Jan;300(1):105-11. doi: 10.1124/jpet.300.1.105. [Article] Crifasi JA, Le NX, Long C: Simultaneous identification and quantitation of fluoxetine and its metabolite, norfluoxetine, in biological samples by GC-MS. J Anal Toxicol. 1997 Oct;21(6):415-9. doi: 10.1093/jat/21.6.415. [Article] Shi S, Liu Y, Wu J, Li Z, Zhao Y, Zhong D, Zeng F: Comparative bioavailability and tolerability of a single 20-mg dose of two fluoxetine hydrochloride dispersible tablet formulations in fasting, healthy Chinese male volunteers: an open-label, randomized-sequence, two-period crossover study. Clin Ther. 2010 Oct;32(11):1977-86. doi: 10.1016/j.clinthera.2010.10.003. [Article] FDA Approved Drug Products: Prozac (fluoxetine) oral capsules [Link] Fluoxetine: A case history of its discovery and preclinical development [Link] The Distribution of Fluoxetine in Human Fluids and Tissues [Link] DailyMed - Fluoxetine [Link] Flockhart Table of Drug Interactions [Link] Health Canada Product Monograph: Fluoxetine oral capsules [Link] FDA Approved Drug Products: Sarafem (fluoxetine hydrochloride) tablets for oral use [Link] DailyMed Label: PROZAC (fluoxetine capsules) for oral use [Link]",
                "External Links": "Human Metabolome DatabaseHMDB0014615KEGG DrugD00823PubChem Compound3386PubChem Substance46507902ChemSpider3269BindingDB30130RxNav4493ChEBI86990ChEMBLCHEMBL41Therapeutic Targets DatabaseDAP000186PharmGKBPA449673Guide to PharmacologyGtP Drug PageRxListRxList Drug PageDrugs.comDrugs.com Drug PageWikipediaFluoxetine",
                "Human Metabolome Database": "HMDB0014615",
                "KEGG Drug": "D00823",
                "PubChem Compound": "3386",
                "PubChem Substance": "46507902",
                "ChemSpider": "3269",
                "BindingDB": "30130",
                "RxNav": "4493",
                "ChEBI": "86990",
                "ChEMBL": "CHEMBL41",
                "Therapeutic Targets Database": "DAP000186",
                "PharmGKB": "PA449673",
                "Guide to Pharmacology": "GtP Drug Page",
                "RxList": "RxList Drug Page",
                "Drugs.com": "Drugs.com Drug Page",
                "Wikipedia": "Fluoxetine",
                "MSDS": "Download (76.7 KB)"
            },
            "Clinical Trials": {
                "Clinical Trials": "PhaseStatusPurposeConditionsCount4Active Not RecruitingTreatmentDepressive Disorder14CompletedBasic ScienceBipolar Disorder (BD)14CompletedBasic ScienceMajor Depressive Disorder (MDD)14CompletedDiagnosticMajor Depressive Disorder (MDD)14CompletedHealth Services ResearchHealthy Subjects (HS)14CompletedHealth Services ResearchObsessive Compulsive Disorder (OCD)14CompletedOtherHealthy Controls / Major Depressive Disorder (MDD)14CompletedTreatmentAlcohol Dependency / Depression14CompletedTreatmentAlcohol Related Disorders / Marijuana Abuse / Substance Related Disorders14CompletedTreatmentAnorexia Nervosa (AN) / Eating Disorders1"
            },
            "Pharmacoeconomics": {
                "Manufacturers": "Barr laboratories inc\nDr reddys laboratories ltd\nEli lilly and co\nMutual pharmacal co\nWatson laboratories inc\nAlembic ltd\nAlphapharm party ltd\nAurobindo pharma ltd\nBeijing double crane pharmaceutical co ltd\nCarlsbad technology inc\nDr reddys laboratories inc\nIvax pharmaceuticals inc sub teva pharmaceuticals usa\nLandela pharmaceutical\nMallinckrodt inc\nMylan pharmaceuticals inc\nPar pharmaceutical inc\nPliva inc\nRanbaxy laboratories ltd\nSandoz inc\nTeva pharmaceuticals usa inc\nWockhardt ltd\nLilly research laboratories div eli lilly and co\nActavis mid atlantic llc\nAurobindo pharma usa inc\nHi tech pharmacal co inc\nLannett holdings inc\nNovex pharma\nPharmaceutical assoc inc div beach products\nSilarx pharmaceuticals inc\nWockhardt eu operations (swiss) ag\nWarner chilcott inc",
                "Packagers": "Advanced Pharmaceutical Services Inc.\nAlphapharm Party Ltd.\nAmerisource Health Services Corp.\nAmneal Pharmaceuticals\nApotex Inc.\nAQ Pharmaceuticals Inc.\nA-S Medication Solutions LLC\nAtlantic Biologicals Corporation\nAurobindo Pharma Ltd.\nBarr Pharmaceuticals\nBlenheim Pharmacal\nBryant Ranch Prepack\nCardinal Health\nCaremark LLC\nCarlsbad Technology Inc.\nComprehensive Consultant Services Inc.\nCorepharma LLC\nCoupler Enterprises Inc.\nD.M. Graham Laboratories Inc.\nDHHS Program Support Center Supply Service Center\nDispensing Solutions\nDiversified Healthcare Services Inc.\nDoctor Reddys Laboratories Ltd.\nDSM Corp.\nEli Lilly & Co.\nEon Labs\nGolden State Medical Supply Inc.\nH.J. Harkins Co. Inc.\nHeartland Repack Services LLC\nInnoviant Pharmacy Inc.\nIvax Pharmaceuticals\nKaiser Foundation Hospital\nKeltman Pharmaceuticals Inc.\nLake Erie Medical and Surgical Supply\nLegacy Pharmaceuticals Packaging LLC\nLiberty Pharmaceuticals\nLilly Del Caribe Inc.\nMajor Pharmaceuticals\nMallinckrodt Inc.\nMedvantx Inc.\nMurfreesboro Pharmaceutical Nursing Supply\nMylan\nNorthstar Rx LLC\nNorwich Pharmaceuticals Inc.\nNovex Pharma\nNovopharm Ltd.\nNucare Pharmaceuticals Inc.\nOhm Laboratories Inc.\nPalmetto Pharmaceuticals Inc.\nPar Pharmaceuticals\nPCA LLC\nPD-Rx Pharmaceuticals Inc.\nPharmaceutical Association\nPharmaceutical Utilization Management Program VA Inc.\nPharmedix\nPharmpak Inc.\nPhysician Partners Ltd.\nPhysicians Total Care Inc.\nPliva Inc.\nPreferred Pharmaceuticals Inc.\nPrepackage Specialists\nPrepak Systems Inc.\nPromex Medical Inc.\nPrx Pharmaceuticals\nRanbaxy Laboratories\nRebel Distributors Corp.\nRemedy Repack\nResource Optimization and Innovation LLC\nSandhills Packaging Inc.\nSandoz\nSilarx Pharmaceuticals\nSouthwood Pharmaceuticals\nSpectrum Pharmaceuticals\nSt Mary's Medical Park Pharmacy\nStat Rx Usa\nTeva Pharmaceutical Industries Ltd.\nTya Pharmaceuticals\nUDL Laboratories\nVa Cmop Dallas\nVangard Labs Inc.\nWarner Chilcott Co. Inc.\nWC Pharmaceuticals\nWockhardt Ltd.\nXactdose Inc.",
                "Dosage Forms": "FormRouteStrengthTabletOral22.357 mgCapsuleOral20.000 mgTablet, solubleOralCapsuleOral22.400 mgTabletOral22.40 mgCapsuleOralTabletOralCapsuleOral20 mgSolutionOral0.4 gTablet, film coatedOralSolutionOralTabletOral10 MGTabletOral40 MGTablet, film coatedOral20 MGTablet, film coatedOral40 MGSyrupOral0.421 gCapsule, coatedOral20 mgTablet, orally disintegratingOral20 MGTablet, coatedOral20 mgCapsuleNot applicable20 mg/1CapsuleOral20 mg/1LiquidOral20 mg/5mLTablet, film coatedOral60 mg/1CapsuleOral10 mg/1CapsuleOral22.36 MGCapsuleOral22.4 MgCapsuleOral40 mg/1Capsule, delayed releaseOral90 mg/1Capsule, delayed release pelletsOral90 mg/1For solutionOral20 mg/5mLTabletOral10 mg/1TabletOral20 mg/1TabletOral22.36 MGTabletOral60 mg/1Tablet, coatedOral10 mg/1Tablet, coatedOral20 mg/1Tablet, film coatedOral10 mg/1Tablet, film coatedOral20 mg/1CapsuleOral40 mgTabletOral20.000 mgCapsule, gelatin coatedOralSyrupOral0.4 gSolutionOral20 mg / 5 mLCapsuleOralCapsuleOral20.00 mgCapsuleOral60 mgCapsuleOral20.0000 mgSolutionOral20 mg/5mLTablet, for suspensionOral20 MGCapsuleOral22.360 mgTablet, solubleOral20 mgCapsuleOral10 mgCapsule, coatedOral90 mgLiquidOral20 mg / 5 mLTabletOral15 mg/1KitOralCapsuleOral10 mg / capCapsuleOral20 mg / capTabletOral20.00 mgSolutionOral448 mgTabletOral20 mg",
                "Prices": "Unit descriptionCostUnitPROzac 20 mg/5ml Solution 120ml Bottle266.51USD bottlePROzac Weekly 1 Package = 4 capsule (90 mg) Disp Pack140.77USD dispSarafem 7 10 mg tablet Box61.08USD boxSarafem 7 20 mg tablet Each Box Contains 7 tablet59.55USD boxProzac weekly 90 mg capsule34.5USD capsulePROzac 40 mg capsule13.89USD capsuleFluoxetine hcl powder8.32USD gSarafem 10 mg tablet7.91USD tabletSarafem 15 mg tablet7.91USD tabletSarafem 20 mg tablet7.91USD tabletPROzac 20 mg capsule6.95USD capsulePROzac 10 mg capsule6.77USD capsuleFLUoxetine HCl 40 mg capsule5.54USD capsulePROzac 10 mg tablet4.31USD tabletFluoxetine hcl 20 mg tablet4.26USD tabletRapiflux 20 mg tablet3.11USD tabletFLUoxetine HCl 20 mg capsule2.77USD capsuleFluoxetine hcl 10 mg tablet2.72USD tabletFLUoxetine HCl 10 mg capsule2.7USD capsuleFxt 40 40 mg Capsule2.3USD capsuleProzac 10 mg Capsule2.02USD capsuleProzac 20 mg Capsule2.02USD capsuleApo-Fluoxetine 10 mg Capsule1.13USD capsuleCo Fluoxetine 10 mg Capsule1.13USD capsuleMylan-Fluoxetine 10 mg Capsule1.13USD capsuleNovo-Fluoxetine 10 mg Capsule1.13USD capsuleNu-Fluoxetine 10 mg Capsule1.13USD capsulePhl-Fluoxetine 10 mg Capsule1.13USD capsulePms-Fluoxetine 10 mg Capsule1.13USD capsuleRatio-Fluoxetine Hydrochloride 10 mg Capsule1.13USD capsuleSandoz Fluoxetine 10 mg Capsule1.13USD capsuleApo-Fluoxetine 20 mg Capsule1.06USD capsuleCo Fluoxetine 20 mg Capsule1.06USD capsuleMylan-Fluoxetine 20 mg Capsule1.06USD capsuleNovo-Fluoxetine 20 mg Capsule1.06USD capsuleNu-Fluoxetine 20 mg Capsule1.06USD capsulePhl-Fluoxetine 20 mg Capsule1.06USD capsulePms-Fluoxetine 20 mg Capsule1.06USD capsuleRatio-Fluoxetine Hydrochloride 20 mg Capsule1.06USD capsuleSandoz Fluoxetine 20 mg Capsule1.06USD capsuleFLUoxetine HCl 20 mg/5ml Solution1.03USD mlApo-Fluoxetine 4 mg/ml Liquid0.61USD liquid  DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.",
                "Patents": "Patent NumberPediatric ExtensionApprovedExpires (estimated)RegionUS6960577No2005-11-012017-11-01USUS5910319Yes1999-06-082017-11-29USUS5985322Yes1999-11-162017-11-29USUSRE39030No2006-03-212017-05-29USUS5945416No1999-08-312017-03-24US"
            },
            "Properties": {
                "State": "Solid",
                "Experimental Properties": "PropertyValueSourcemelting point (\u00b0C)193 - 197 \u00b0CMSDSboiling point (\u00b0C)395.1\u00b0C at 760 mmHghttps://www.lookchem.com/Fluoxetine/water solubilityinsolublehttps://www.lookchem.com/Fluoxetine/logP4.05ADLARD,M ET AL. (1995)",
                "Predicted Properties": "PropertyValueSourceWater Solubility0.0017 mg/mLALOGPSlogP4.09ALOGPSlogP4.17ChemaxonlogS-5.3ALOGPSpKa (Strongest Basic)9.8ChemaxonPhysiological Charge1ChemaxonHydrogen Acceptor Count2ChemaxonHydrogen Donor Count1ChemaxonPolar Surface Area21.26 \u00c52ChemaxonRotatable Bond Count7ChemaxonRefractivity80.37 m3\u00b7mol-1ChemaxonPolarizability30.33 \u00c53ChemaxonNumber of Rings2ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleYesChemaxonMDDR-like RuleNoChemaxon",
                "Predicted ADMET Features": "PropertyValueProbabilityHuman Intestinal Absorption+1.0Blood Brain Barrier+0.983Caco-2 permeable+0.8867P-glycoprotein substrateSubstrate0.5899P-glycoprotein inhibitor IInhibitor0.8565P-glycoprotein inhibitor IIInhibitor0.5459Renal organic cation transporterInhibitor0.5633CYP450 2C9 substrateNon-substrate0.7475CYP450 2D6 substrateSubstrate0.8918CYP450 3A4 substrateSubstrate0.5754CYP450 1A2 substrateInhibitor0.9107CYP450 2C9 inhibitorNon-inhibitor0.907CYP450 2D6 inhibitorInhibitor0.8932CYP450 2C19 inhibitorInhibitor0.8993CYP450 3A4 inhibitorInhibitor0.7959CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.7149Ames testNon AMES toxic0.7105CarcinogenicityNon-carcinogens0.8089BiodegradationNot ready biodegradable0.9868Rat acute toxicity2.6048 LD50, mol/kg Not applicablehERG inhibition (predictor I)Strong inhibitor0.6058hERG inhibition (predictor II)Inhibitor0.8467  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)"
            },
            "Spectra": {
                "Mass Spec (NIST)": "Not Available",
                "Spectra": "SpectrumSpectrum TypeSplash KeyPredicted GC-MS Spectrum - GC-MSPredicted GC-MSNot AvailableMass Spectrum (Electron Ionization)MSsplash10-0006-9200000000-dcf68dbfd090c7fdfe11Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableLC-MS/MS Spectrum - LC-ESI-qTof , PositiveLC-MS/MSNot AvailableLC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-03di-0009000000-ed61090013f0dc5f5c5aLC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-014i-0190000000-e9bcd2accdf5b7e40a88LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-014i-0590000000-04b1d4265cb156217f40LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-014i-0790000000-5c42b9a9a2cd0c4114aaLC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0gb9-0960000000-88822d2fb3e7c0cdc0b3LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0002-0900000000-6b560941c92823b7901cLC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-03di-0109000000-1531c1e1630dcb42b497LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0006-9000000000-53199cfe3b343ae81afdLC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-03di-0109000000-0e790a7e6032e51bfeb3LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-00kf-9800000000-64d39c4a4fcc7f8b6f47LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-00kf-9700000000-e516356ce3eca65bece8LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0002-0900000000-6b560941c92823b7901cLC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0zgi-1390000000-84c6bc70aefcd3758f31LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0f7o-6940000000-a424e26ecc7465229968LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0a4m-0390000000-9b7253cd5718aa434e46LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0a4m-0290000000-d88f8004205c7223aa9fMS/MS Spectrum - , positiveLC-MS/MSsplash10-01t9-0592000000-92a48c620c961fdb430fLC-MS/MS Spectrum - LC-ESI-QFT , positiveLC-MS/MSsplash10-03di-0409000000-03f5678c6178e634f254LC-MS/MS Spectrum - LC-ESI-QFT , positiveLC-MS/MSsplash10-014l-4900000000-2940e7bc3f6a559e61fcLC-MS/MS Spectrum - LC-ESI-QFT , positiveLC-MS/MSsplash10-014l-5900000000-c904d50adb4d1ea90abdLC-MS/MS Spectrum - LC-ESI-QFT , positiveLC-MS/MSsplash10-014l-5900000000-5cbc74ddfe414085c9bdLC-MS/MS Spectrum - LC-ESI-QFT , positiveLC-MS/MSsplash10-0002-0900000000-6b560941c92823b7901cLC-MS/MS Spectrum - LC-ESI-QFT , positiveLC-MS/MSsplash10-0002-0900000000-f5f65bd85fe3483260bb"
            },
            "Interested in using DrugBank in a commercial product or application?": {},
            "Stay up-to-date with the latest from DrugBank!": {},
            "Thank you for subscribing!": {}
        },
        "Additional Information": {
            "targets": [
                {
                    "Label": "Sodium-dependent serotonin transporter",
                    "Detailed Info": {
                        "Name": "Sodium-dependent serotonin transporter",
                        "Synonyms": "5HT transporter\n5HTT\nHTT\nSERT\nSolute carrier family 6 member 4",
                        "Gene Name": "SLC6A4",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0001494|Sodium-dependent serotonin transporter\nMETTPLNSQKQLSACEDGEDCQENGVLQKVVPTPGDKVESGQISNGYSAVPSPGAGDDTR\nHSIPATTTTLVAELHQGERETWGKKVDFLLSVIGYAVDLGNVWRFPYICYQNGGGAFLLP\nYTIMAIFGGIPLFYMELALGQYHRNGCISIWRKICPIFKGIGYAICIIAFYIASYYNTIM\nAWALYYLISSFTDQLPWTSCKNSWNTGNCTNYFSEDNITWTLHSTSPAEEFYTRHVLQIH\nRSKGLQDLGGISWQLALCIMLIFTVIYFSIWKGVKTSGKVVWVTATFPYIILSVLLVRGA\nTLPGAWRGVLFYLKPNWQKLLETGVWIDAAAQIFFSLGPGFGVLLAFASYNKFNNNCYQD\nALVTSVVNCMTSFVSGFVIFTVLGYMAEMRNEDVSEVAKDAGPSLLFITYAEAIANMPAS\nTFFAIIFFLMLITLGLDSTFAGLEGVITAVLDEFPHVWAKRRERFVLAVVITCFFGSLVT\nLTFGGAYVVKLLEEYATGPAVLTVALIEAVAVSWFYGITQFCRDVKEMLGFSPGWFWRIC\nWVAISPLFLLFIICSFLMSPPQLRLFQYNYPYWSIILGYCIGTSSFICIPTYIAYRLIIT\nPGTFKERIIKSITPETPTEIPCGDIRLNAV",
                        "Number of residues": "630",
                        "Molecular Weight": "70324.165",
                        "Theoretical pI": "6.17",
                        "GO Classification": "Functionsactin filament binding / cocaine binding / monoamine transmembrane transporter activity / Rab GTPase binding / serotonin / serotonin transmembrane transporter activityProcessesbrain morphogenesis / cellular response to cGMP / cellular response to retinoic acid / circadian rhythm / memory / monoamine transport / negative regulation of cerebellar granule cell precursor proliferation / negative regulation of neuron differentiation / negative regulation of organ growth / negative regulation of synaptic transmission, dopaminergic / positive regulation of cell cycle / positive regulation of gene expression / protein homooligomerization / protein oligomerization / response to drug / response to estradiol / response to hypoxia / response to nutrient / response to toxic substance / serotonin transport / serotonin uptake / social behavior / sperm ejaculation / synaptic transmission / thalamus development / vasoconstrictionComponentscytosol / endomembrane system / endosome membrane / integral component of plasma membrane / membrane raft / neuron projection / plasma membrane",
                        "General Function": "Serotonin:sodium symporter activity",
                        "Specific Function": "Serotonin transporter whose primary function in the central nervous system involves the regulation of serotonergic signaling via transport of serotonin molecules from the synaptic cleft back into the pre-synaptic terminal for re-utilization. Plays a key role in mediating regulation of the availability of serotonin to other receptors of serotonergic systems. Terminates the action of serotonin and recycles it in a sodium-dependent manner.",
                        "Pfam Domain Function": "SNF (PF00209)\n5HT_transport_N (PF03491)",
                        "Transmembrane Regions": "88-108\n116-135\n160-180\n253-271\n280-297\n333-350\n362-383\n417-436\n464-482\n498-518\n539-558\n577-595",
                        "Cellular Location": "Cell membrane",
                        "Gene sequence": ">lcl|BSEQ0021275|Sodium-dependent serotonin transporter (SLC6A4)\nATGGAGACGACGCCCTTGAATTCTCAGAAGCAGCTATCAGCGTGTGAAGATGGAGAAGAT\nTGTCAGGAAAACGGAGTTCTACAGAAGGTTGTTCCCACCCCAGGGGACAAAGTGGAGTCC\nGGGCAAATATCCAATGGGTACTCAGCAGTTCCAAGTCCTGGTGCGGGAGATGACACACGG\nCACTCTATCCCAGCGACCACCACCACCCTAGTGGCTGAGCTTCATCAAGGGGAACGGGAG\nACCTGGGGCAAGAAGGTGGATTTCCTTCTCTCAGTGATTGGCTATGCTGTGGACCTGGGC\nAATGTCTGGCGCTTCCCCTACATATGTTACCAGAATGGAGGGGGGGCATTCCTCCTCCCC\nTACACCATCATGGCCATTTTTGGGGGAATCCCGCTCTTTTACATGGAGCTCGCACTGGGA\nCAGTACCACCGAAATGGATGCATTTCAATATGGAGGAAAATCTGCCCGATTTTCAAAGGG\nATTGGTTATGCCATCTGCATCATTGCCTTTTACATTGCTTCCTACTACAACACCATCATG\nGCCTGGGCGCTATACTACCTCATCTCCTCCTTCACGGACCAGCTGCCCTGGACCAGCTGC\nAAGAACTCCTGGAACACTGGCAACTGCACCAATTACTTCTCCGAGGACAACATCACCTGG\nACCCTCCATTCCACGTCCCCTGCTGAAGAATTTTACACGCGCCACGTCCTGCAGATCCAC\nCGGTCTAAGGGGCTCCAGGACCTGGGGGGCATCAGCTGGCAGCTGGCCCTCTGCATCATG\nCTGATCTTCACTGTTATCTACTTCAGCATCTGGAAAGGCGTCAAGACCTCTGGCAAGGTG\nGTGTGGGTGACAGCCACCTTCCCTTATATCATCCTTTCTGTCCTGCTGGTGAGGGGTGCC\nACCCTCCCTGGAGCCTGGAGGGGTGTTCTCTTCTACTTGAAACCCAATTGGCAGAAACTC\nCTGGAGACAGGGGTGTGGATAGATGCAGCCGCTCAGATCTTCTTCTCTCTTGGTCCGGGC\nTTTGGGGTCCTGCTGGCTTTTGCTAGCTACAACAAGTTCAACAACAACTGCTACCAAGAT\nGCCCTGGTGACCAGCGTGGTGAACTGCATGACGAGCTTCGTTTCGGGATTTGTCATCTTC\nACAGTGCTCGGTTACATGGCTGAGATGAGGAATGAAGATGTGTCTGAGGTGGCCAAAGAC\nGCAGGTCCCAGCCTCCTCTTCATCACGTATGCAGAAGCGATAGCCAACATGCCAGCGTCC\nACTTTCTTTGCCATCATCTTCTTTCTGATGTTAATCACGCTGGGCTTGGACAGCACGTTT\nGCAGGCTTGGAGGGGGTGATCACGGCTGTGCTGGATGAGTTCCCACACGTCTGGGCCAAG\nCGCCGGGAGCGGTTCGTGCTCGCCGTGGTCATCACCTGCTTCTTTGGATCCCTGGTCACC\nCTGACTTTTGGAGGGGCCTACGTGGTGAAGCTGCTGGAGGAGTATGCCACGGGGCCCGCA\nGTGCTCACTGTCGCGCTGATCGAAGCAGTCGCTGTGTCTTGGTTCTATGGCATCACTCAG\nTTCTGCAGGGACGTGAAGGAAATGCTCGGCTTCAGCCCGGGGTGGTTCTGGAGGATCTGC\nTGGGTGGCCATCAGCCCTCTGTTTCTCCTGTTCATCATTTGCAGTTTTCTGATGAGCCCG\nCCACAACTACGACTTTTCCAATATAATTATCCTTACTGGAGTATCATCTTGGGTTACTGC\nATAGGAACCTCATCTTTCATTTGCATCCCCACATATATAGCTTATCGGTTGATCATCACT\nCCAGGGACATTTAAAGAGCGTATTATTAAAAGTATTACCCCAGAAACACCAACAGAAATT\nCCTTGTGGGGACATCCGCTTGAATGCTGTGTAA",
                        "Chromosome Location": "17",
                        "Locus": "17q11.1-q12",
                        "External Identifiers": "ResourceLinkUniProtKB IDP31645UniProtKB Entry NameSC6A4_HUMANGenBank Protein ID36433GenBank Gene IDX70697GenAtlas IDSLC6A4HGNC IDHGNC:11050",
                        "General References": "Lesch KP, Wolozin BL, Estler HC, Murphy DL, Riederer P: Isolation of a cDNA encoding the human brain serotonin transporter. J Neural Transm Gen Sect. 1993;91(1):67-72. [Article] Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS, Ganapathy V, Blakely RD: Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2542-6. [Article] Lesch KP, Wolozin BL, Murphy DL, Reiderer P: Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem. 1993 Jun;60(6):2319-22. [Article] Iceta R, Mesonero JE, Aramayona JJ, Alcalde AI: Molecular characterization and intracellular regulation of the human serotonin transporter in Caco-2 cells. J Physiol Pharmacol. 2006 Mar;57(1):119-30. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Carneiro AM, Blakely RD: Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter. J Biol Chem. 2006 Aug 25;281(34):24769-80. Epub 2006 Jun 27. [Article] Muller HK, Wiborg O, Haase J: Subcellular redistribution of the serotonin transporter by secretory carrier membrane protein 2. J Biol Chem. 2006 Sep 29;281(39):28901-9. Epub 2006 Jul 26. [Article] Brenner B, Harney JT, Ahmed BA, Jeffus BC, Unal R, Mehta JL, Kilic F: Plasma serotonin levels and the platelet serotonin transporter. J Neurochem. 2007 Jul;102(1):206-15. Epub 2007 May 15. [Article] Zhang YW, Gesmonde J, Ramamoorthy S, Rudnick G: Serotonin transporter phosphorylation by cGMP-dependent protein kinase is altered by a mutation associated with obsessive compulsive disorder. J Neurosci. 2007 Oct 3;27(40):10878-86. [Article] Ahmed BA, Jeffus BC, Bukhari SI, Harney JT, Unal R, Lupashin VV, van der Sluijs P, Kilic F: Serotonin transamidates Rab4 and facilitates its binding to the C terminus of serotonin transporter. J Biol Chem. 2008 Apr 4;283(14):9388-98. doi: 10.1074/jbc.M706367200. Epub 2008 Jan 28. [Article] Ahmed BA, Bukhari IA, Jeffus BC, Harney JT, Thyparambil S, Ziu E, Fraer M, Rusch NJ, Zimniak P, Lupashin V, Tang D, Kilic F: The cellular distribution of serotonin transporter is impeded on serotonin-altered vimentin network. PLoS One. 2009;4(3):e4730. doi: 10.1371/journal.pone.0004730. Epub 2009 Mar 9. [Article] Annamalai B, Mannangatti P, Arapulisamy O, Shippenberg TS, Jayanthi LD, Ramamoorthy S: Tyrosine phosphorylation of the human serotonin transporter: a role in the transporter stability and function. Mol Pharmacol. 2012 Jan;81(1):73-85. doi: 10.1124/mol.111.073171. Epub 2011 Oct 12. [Article] Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington J, Lipshutz R, Daley GQ, Lander ES: Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet. 1999 Jul;22(3):231-8. [Article] Ozaki N, Goldman D, Kaye WH, Plotnicov K, Greenberg BD, Lappalainen J, Rudnick G, Murphy DL: Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry. 2003 Nov;8(11):933-6. [Article] Kilic F, Murphy DL, Rudnick G: A human serotonin transporter mutation causes constitutive activation of transport activity. Mol Pharmacol. 2003 Aug;64(2):440-6. [Article] Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R: Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003 Jul 18;301(5631):386-9. [Article] Feinn R, Nellissery M, Kranzler HR: Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence. Am J Med Genet B Neuropsychiatr Genet. 2005 Feb 5;133B(1):79-84. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00176Fluvoxamineapproved, investigationalyesinhibitorDetailsDB00215CitalopramapprovedyesinhibitorDetailsDB00285VenlafaxineapprovedyesinhibitorDetailsDB00321AmitriptylineapprovedyesinhibitorDetailsDB00472Fluoxetineapproved, vet_approvedyesinhibitorDetailsDB00476DuloxetineapprovedyesinhibitorDetailsDB00540NortriptylineapprovedyesinhibitorDetailsDB00543AmoxapineapprovedyesinhibitorDetailsDB00715Paroxetineapproved, investigationalyesinhibitorDetailsDB00726TrimipramineapprovedyesinhibitorDetailsDB01104SertralineapprovedyesinhibitorbinderdownregulatorDetailsDB01105Sibutramineapproved, illicit, investigational, withdrawnyesinhibitorDetailsDB01142Doxepinapproved, investigationalyesinhibitorDetailsDB01175EscitalopramapprovedyesinhibitorDetailsDB01191Dexfenfluramineapproved, illicit, investigational, withdrawnyesinhibitorDetailsDB01242Clomipramineapproved, investigational, vet_approvedyesinhibitorDetailsDB00344ProtriptylineapprovedyesinhibitorDetailsDB00458ImipramineapprovedyesinhibitorDetailsDB00514DextromethorphanapprovedunknowninhibitorDetailsDB00656Trazodoneapproved, investigationalyesinhibitorDetailsDB00805MinaprineapprovedunknowninhibitorDetailsDB00907Cocaineapproved, illicityesinhibitorDetailsDB01149Nefazodoneapproved, withdrawnyesinhibitorDetailsDB01151Desipramineapproved, investigationalyesinhibitorDetailsDB01454Midomafetamineexperimental, illicit, investigationalyesnegative modulatorDetailsDB04832Zimelidineapproved, withdrawnunknownDetailsDB04836Amineptineillicit, withdrawnunknownDetailsDB01442MMDAexperimental, illicityesnegative modulatorDetailsDB00191Phentermineapproved, illicityesinhibitorDetailsDB04889BicifadineinvestigationalunknownDetailsDB04896Milnacipranapproved, investigationalyesinhibitorDetailsDB05422OPC-14523investigationalunknownDetailsDB05688CRx-119investigationalunknownDetailsDB00193Tramadolapproved, investigationalyesinhibitorDetailsDB12305DasotralineinvestigationalunknownDetailsDB06156TesofensineinvestigationalunknownDetailsDB05964AmitifadineinvestigationalunknownDetailsDB06148Mianserinapproved, investigationalunknowninhibitorDetailsDB00289AtomoxetineapprovedunknownbinderDetailsDB00661VerapamilapprovedunknownunknownDetailsDB00579Mazindolapproved, investigationalyesinhibitorDetailsDB01114ChlorpheniramineapprovedunknowninhibitorDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnyessubstrateinhibitorDetailsDB01079Tegaserodapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB06700Desvenlafaxineapproved, investigationalyesinhibitorDetailsDB06701Dexmethylphenidateapproved, investigationalunknowninhibitorDetailsDB00852PseudoephedrineapprovedyesinhibitorDetailsDB014724-Methoxyamphetamineexperimental, illicityesinhibitorDetailsDB01577Metamfetamineapproved, illicit, withdrawnyesnegative modulatorDetailsDB01363Ephedra sinica rootnutraceuticalyesnegative modulatorDetailsDB01454Midomafetamineexperimental, illicit, investigationalunknownDetailsDB06204TapentadolapprovedunknowninhibitorDetailsDB08918Levomilnacipranapproved, investigationalyesinhibitorDetailsDB00408LoxapineapprovedunknownbinderDetailsDB00182Amphetamineapproved, illicit, investigationalunknownbinderDetailsDB00988DopamineapprovedunknowninhibitorDetailsDB00454MeperidineapprovedunknownbinderDetailsDB09016Butriptylineapproved, withdrawnyesantagonistinhibitorDetailsDB09068Vortioxetineapproved, investigationalyesinhibitorDetailsDB09167DosulepinapprovedyesinhibitorDetailsDB08839Serotonininvestigational, nutraceuticalunknownDetailsDB09186NisoxetineexperimentalunknownDetailsDB04821Nomifensineapproved, withdrawnunknownDetailsDB09194EtoperidonewithdrawnnoinhibitorDetailsDB09195LorpiprazoleapprovedyesantagonistDetailsDB09225Zotepineapproved, investigational, withdrawnyesantagonistDetailsDB00245BenzatropineapprovednoinhibitorDetailsDB06684VilazodoneapprovedyesinhibitorDetailsDB00370MirtazapineapprovedunknownsubstrateinhibitorDetailsDB00924CyclobenzaprineapprovedunknowninhibitorDetailsDB01238Aripiprazoleapproved, investigationalunknownmodulatorDetailsDB06077Lumateperoneapproved, investigationalyesinhibitorDetailsDB00852PseudoephedrineapprovedunknowninhibitorDetailsDB00721Procaineapproved, investigational, vet_approvedunknowninhibitorDetails"
                    }
                },
                {
                    "Label": "5-hydroxytryptamine receptor 2C",
                    "Detailed Info": {
                        "Name": "5-hydroxytryptamine receptor 2C",
                        "Synonyms": "5-HT-1C\n5-HT-2C\n5-HT1C\n5-hydroxytryptamine receptor 1C\nHTR1C\nSerotonin receptor 2C",
                        "Gene Name": "HTR2C",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0001064|5-hydroxytryptamine receptor 2C\nMVNLRNAVHSFLVHLIGLLVWQCDISVSPVAAIVTDIFNTSDGGRFKFPDGVQNWPALSI\nVIIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYVW\nPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVWA\nISIGVSVPIPVIGLRDEEKVFVNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYCLTIYV\nLRRQALMLLHGHTEEPPGLSLDFLKCCKRNTAEEENSANPNQDQNARRRKKKERRPRGTM\nQAINNERKASKVLGIVFFVFLIMWCPFFITNILSVLCEKSCNQKLMEKLLNVFVWIGYVC\nSGINPLVYTLFNKIYRRAFSNYLRCNYKVEKKPPVRQIPRVAATALSGRELNVNIYRHTN\nEPVIEKASDNEPGIEMQVENLELPVNPSSVVSERISSV",
                        "Number of residues": "458",
                        "Molecular Weight": "51820.705",
                        "Theoretical pI": "9.11",
                        "GO Classification": "Functions1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding / drug binding / Gq/11-coupled serotonin receptor activity / serotonin binding / serotonin receptor activityProcessesbehavioral fear response / cellular calcium ion homeostasis / cGMP biosynthetic process / feeding behavior / locomotory behavior / phospholipase C-activating G-protein coupled receptor signaling pathway / phospholipase C-activating serotonin receptor signaling pathway / positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway / positive regulation of ERK1 and ERK2 cascade / positive regulation of fat cell differentiation / positive regulation of phosphatidylinositol biosynthetic process / regulation of appetite / regulation of corticotropin-releasing hormone secretion / regulation of neurological system process / release of sequestered calcium ion into cytosol / response to drug / serotonin receptor signaling pathway / synaptic transmissionComponentscytosol / integral component of plasma membrane / plasma membrane",
                        "General Function": "Serotonin receptor activity",
                        "Specific Function": "G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for various drugs and psychoactive substances, including ergot alkaloid derivatives, 1-2,5,-dimethoxy-4-iodophenyl-2-aminopropane (DOI) and lysergic acid diethylamide (LSD). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Beta-arrestin family members inhibit signaling via G proteins and mediate activation of alternative signaling pathways. Signaling activates a phosphatidylinositol-calcium second messenger system that modulates the activity of phosphatidylinositol 3-kinase and down-stream signaling cascades and promotes the release of Ca(2+) ions from intracellular stores. Regulates neuronal activity via the activation of short transient receptor potential calcium channels in the brain, and thereby modulates the activation of pro-opiomelacortin neurons and the release of CRH that then regulates the release of corticosterone. Plays a role in the regulation of appetite and eating behavior, responses to anxiogenic stimuli and stress. Plays a role in insulin sensitivity and glucose homeostasis.",
                        "Pfam Domain Function": "7tm_1 (PF00001)",
                        "Transmembrane Regions": "53-78\n90-110\n128-150\n171-193\n214-235\n312-333\n349-371",
                        "Cellular Location": "Cell membrane",
                        "Gene sequence": ">lcl|BSEQ0010373|5-hydroxytryptamine receptor 2C (HTR2C)\nATGGTGAACCTGAGGAATGCGGTGCATTCATTCCTTGTGCACCTAATTGGCCTATTGGTT\nTGGCAATGTGATATTTCTGTGAGCCCAGTAGCAGCTATAGTAACTGACATTTTCAATACC\nTCCGATGGTGGACGCTTCAAATTCCCAGACGGGGTACAAAACTGGCCAGCACTTTCAATC\nGTCATCATAATAATCATGACAATAGGTGGCAACATCCTTGTGATCATGGCAGTAAGCATG\nGAAAAGAAACTGCACAATGCCACCAATTACTTCTTAATGTCCCTAGCCATTGCTGATATG\nCTAGTGGGACTACTTGTCATGCCCCTGTCTCTCCTGGCAATCCTTTATGATTATGTCTGG\nCCACTACCTAGATATTTGTGCCCCGTCTGGATTTCTTTAGATGTTTTATTTTCAACAGCG\nTCCATCATGCACCTCTGCGCTATATCGCTGGATCGGTATGTAGCAATACGTAATCCTATT\nGAGCATAGCCGTTTCAATTCGCGGACTAAGGCCATCATGAAGATTGCTATTGTTTGGGCA\nATTTCTATAGGTGTATCAGTTCCTATCCCTGTGATTGGACTGAGGGACGAAGAAAAGGTG\nTTCGTGAACAACACGACGTGCGTGCTCAACGACCCAAATTTCGTTCTTATTGGGTCCTTC\nGTAGCTTTCTTCATACCGCTGACGATTATGGTGATTACGTATTGCCTGACCATCTACGTT\nCTGCGCCGACAAGCTTTGATGTTACTGCACGGCCACACCGAGGAACCGCCTGGACTAAGT\nCTGGATTTCCTGAAGTGCTGCAAGAGGAATACGGCCGAGGAAGAGAACTCTGCAAACCCT\nAACCAAGACCAGAACGCACGCCGAAGAAAGAAGAAGGAGAGACGTCCTAGGGGCACCATG\nCAGGCTATCAACAATGAAAGAAAAGCTTCGAAAGTCCTTGGGATTGTTTTCTTTGTGTTT\nCTGATCATGTGGTGCCCATTTTTCATTACCAATATTCTGTCTGTTCTTTGTGAGAAGTCC\nTGTAACCAAAAGCTCATGGAAAAGCTTCTGAATGTGTTTGTTTGGATTGGCTATGTTTGT\nTCAGGAATCAATCCTCTGGTGTATACTCTGTTCAACAAAATTTACCGAAGGGCATTCTCC\nAACTATTTGCGTTGCAATTATAAGGTAGAGAAAAAGCCTCCTGTCAGGCAGATTCCAAGA\nGTTGCCGCCACTGCTTTGTCTGGGAGGGAGCTTAATGTTAACATTTATCGGCATACCAAT\nGAACCGGTGATCGAGAAAGCCAGTGACAATGAGCCCGGTATAGAGATGCAAGTTGAGAAT\nTTAGAGTTACCAGTAAATCCCTCCAGTGTGGTTAGCGAAAGGATTAGCAGTGTGTGA",
                        "Chromosome Location": "X",
                        "Locus": "Xq24",
                        "External Identifiers": "ResourceLinkUniProtKB IDP28335UniProtKB Entry Name5HT2C_HUMANGenBank Protein ID338028GenBank Gene IDM81778GenAtlas IDHTR2CHGNC IDHGNC:5295",
                        "General References": "Saltzman AG, Morse B, Whitman MM, Ivanshchenko Y, Jaye M, Felder S: Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes. Biochem Biophys Res Commun. 1991 Dec 31;181(3):1469-78. [Article] Stam NJ, Vanderheyden P, van Alebeek C, Klomp J, de Boer T, van Delft AM, Olijve W: Genomic organisation and functional expression of the gene encoding the human serotonin 5-HT2C receptor. Eur J Pharmacol. 1994 Nov 15;269(3):339-48. [Article] Xie E, Zhu L, Zhao L, Chang LS: The human serotonin 5-HT2C receptor: complete cDNA, genomic structure, and alternatively spliced variant. Genomics. 1996 Aug 1;35(3):551-61. [Article] Niswender CM, Sanders-Bush E, Emeson RB: Identification and characterization of RNA editing events within the 5-HT2C receptor. Ann N Y Acad Sci. 1998 Dec 15;861:38-48. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Ross MT, Grafham DV, Coffey AJ, Scherer S, McLay K, Muzny D, Platzer M, Howell GR, Burrows C, Bird CP, Frankish A, Lovell FL, Howe KL, Ashurst JL, Fulton RS, Sudbrak R, Wen G, Jones MC, Hurles ME, Andrews TD, Scott CE, Searle S, Ramser J, Whittaker A, Deadman R, Carter NP, Hunt SE, Chen R, Cree A, Gunaratne P, Havlak P, Hodgson A, Metzker ML, Richards S, Scott G, Steffen D, Sodergren E, Wheeler DA, Worley KC, Ainscough R, Ambrose KD, Ansari-Lari MA, Aradhya S, Ashwell RI, Babbage AK, Bagguley CL, Ballabio A, Banerjee R, Barker GE, Barlow KF, Barrett IP, Bates KN, Beare DM, Beasley H, Beasley O, Beck A, Bethel G, Blechschmidt K, Brady N, Bray-Allen S, Bridgeman AM, Brown AJ, Brown MJ, Bonnin D, Bruford EA, Buhay C, Burch P, Burford D, Burgess J, Burrill W, Burton J, Bye JM, Carder C, Carrel L, Chako J, Chapman JC, Chavez D, Chen E, Chen G, Chen Y, Chen Z, Chinault C, Ciccodicola A, Clark SY, Clarke G, Clee CM, Clegg S, Clerc-Blankenburg K, Clifford K, Cobley V, Cole CG, Conquer JS, Corby N, Connor RE, David R, Davies J, Davis C, Davis J, Delgado O, Deshazo D, Dhami P, Ding Y, Dinh H, Dodsworth S, Draper H, Dugan-Rocha S, Dunham A, Dunn M, Durbin KJ, Dutta I, Eades T, Ellwood M, Emery-Cohen A, Errington H, Evans KL, Faulkner L, Francis F, Frankland J, Fraser AE, Galgoczy P, Gilbert J, Gill R, Glockner G, Gregory SG, Gribble S, Griffiths C, Grocock R, Gu Y, Gwilliam R, Hamilton C, Hart EA, Hawes A, Heath PD, Heitmann K, Hennig S, Hernandez J, Hinzmann B, Ho S, Hoffs M, Howden PJ, Huckle EJ, Hume J, Hunt PJ, Hunt AR, Isherwood J, Jacob L, Johnson D, Jones S, de Jong PJ, Joseph SS, Keenan S, Kelly S, Kershaw JK, Khan Z, Kioschis P, Klages S, Knights AJ, Kosiura A, Kovar-Smith C, Laird GK, Langford C, Lawlor S, Leversha M, Lewis L, Liu W, Lloyd C, Lloyd DM, Loulseged H, Loveland JE, Lovell JD, Lozado R, Lu J, Lyne R, Ma J, Maheshwari M, Matthews LH, McDowall J, McLaren S, McMurray A, Meidl P, Meitinger T, Milne S, Miner G, Mistry SL, Morgan M, Morris S, Muller I, Mullikin JC, Nguyen N, Nordsiek G, Nyakatura G, O'Dell CN, Okwuonu G, Palmer S, Pandian R, Parker D, Parrish J, Pasternak S, Patel D, Pearce AV, Pearson DM, Pelan SE, Perez L, Porter KM, Ramsey Y, Reichwald K, Rhodes S, Ridler KA, Schlessinger D, Schueler MG, Sehra HK, Shaw-Smith C, Shen H, Sheridan EM, Shownkeen R, Skuce CD, Smith ML, Sotheran EC, Steingruber HE, Steward CA, Storey R, Swann RM, Swarbreck D, Tabor PE, Taudien S, Taylor T, Teague B, Thomas K, Thorpe A, Timms K, Tracey A, Trevanion S, Tromans AC, d'Urso M, Verduzco D, Villasana D, Waldron L, Wall M, Wang Q, Warren J, Warry GL, Wei X, West A, Whitehead SL, Whiteley MN, Wilkinson JE, Willey DL, Williams G, Williams L, Williamson A, Williamson H, Wilming L, Woodmansey RL, Wray PW, Yen J, Zhang J, Zhou J, Zoghbi H, Zorilla S, Buck D, Reinhardt R, Poustka A, Rosenthal A, Lehrach H, Meindl A, Minx PJ, Hillier LW, Willard HF, Wilson RK, Waterston RH, Rice CM, Vaudin M, Coulson A, Nelson DL, Weinstock G, Sulston JE, Durbin R, Hubbard T, Gibbs RA, Beck S, Rogers J, Bentley DR: The DNA sequence of the human X chromosome. Nature. 2005 Mar 17;434(7031):325-37. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Becamel C, Figge A, Poliak S, Dumuis A, Peles E, Bockaert J, Lubbert H, Ullmer C: Interaction of serotonin 5-hydroxytryptamine type 2C receptors with PDZ10 of the multi-PDZ domain protein MUPP1. J Biol Chem. 2001 Apr 20;276(16):12974-82. Epub 2001 Jan 9. [Article] Schaerlinger B, Hickel P, Etienne N, Guesnier L, Maroteaux L: Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy. Br J Pharmacol. 2003 Sep;140(2):277-84. Epub 2003 Aug 11. [Article] Marion S, Oakley RH, Kim KM, Caron MG, Barak LS: A beta-arrestin binding determinant common to the second intracellular loops of rhodopsin family G protein-coupled receptors. J Biol Chem. 2006 Feb 3;281(5):2932-8. Epub 2005 Nov 30. [Article] Nichols DE, Nichols CD: Serotonin receptors. Chem Rev. 2008 May;108(5):1614-41. doi: 10.1021/cr078224o. Epub 2008 May 14. [Article] Cussac D, Boutet-Robinet E, Ailhaud MC, Newman-Tancredi A, Martel JC, Danty N, Rauly-Lestienne I: Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells. Eur J Pharmacol. 2008 Oct 10;594(1-3):32-8. doi: 10.1016/j.ejphar.2008.07.040. Epub 2008 Jul 30. [Article] Knauer CS, Campbell JE, Chio CL, Fitzgerald LW: Pharmacological characterization of mitogen-activated protein kinase activation by recombinant human 5-HT2C, 5-HT2A, and 5-HT2B receptors. Naunyn Schmiedebergs Arch Pharmacol. 2009 May;379(5):461-71. doi: 10.1007/s00210-008-0378-4. Epub 2008 Dec 5. [Article] Pytliak M, Vargova V, Mechirova V, Felsoci M: Serotonin receptors - from molecular biology to clinical applications. Physiol Res. 2011;60(1):15-25. Epub 2010 Oct 15. [Article] Jahnsen JA, Uhlen S: The N-terminal region of the human 5-HT(2)C receptor has as a cleavable signal peptide. Eur J Pharmacol. 2012 Jun 5;684(1-3):44-50. doi: 10.1016/j.ejphar.2012.03.043. Epub 2012 Apr 3. [Article] Lappalainen J, Zhang L, Dean M, Oz M, Ozaki N, Yu DH, Virkkunen M, Weight F, Linnoila M, Goldman D: Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2c receptor gene (HTR2C). Genomics. 1995 May 20;27(2):274-9. [Article] Samochowiec J, Smolka M, Winterer G, Rommelspacher H, Schmidt LG, Sander T: Association analysis between a Cys23Ser substitution polymorphism of the human 5-HT2c receptor gene and neuronal hyperexcitability. Am J Med Genet. 1999 Apr 16;88(2):126-30. [Article] Marshall SE, Bird TG, Hart K, Welsh KI: Unified approach to the analysis of genetic variation in serotonergic pathways. Am J Med Genet. 1999 Dec 15;88(6):621-7. [Article] Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington J, Lipshutz R, Daley GQ, Lander ES: Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet. 1999 Jul;22(3):231-8. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnyesagonistDetailsDB00246ZiprasidoneapprovedyesantagonistDetailsDB00334Olanzapineapproved, investigationalunknownantagonistDetailsDB00370MirtazapineapprovedunknownantagonistDetailsDB00420Promazineapproved, vet_approvedunknownantagonistDetailsDB00777PropiomazineapprovedunknownantagonistDetailsDB00805MinaprineapprovedyesantagonistDetailsDB01224QuetiapineapprovedunknownligandDetailsDB00193Tramadolapproved, investigationalunknownantagonistDetailsDB00363ClozapineapprovedunknownantagonistDetailsDB01191Dexfenfluramineapproved, illicit, investigational, withdrawnunknownagonistDetailsDB00247MethysergideapprovedyesantagonistDetailsDB04871Lorcaserinapproved, withdrawnunknownDetailsDB04884DapoxetineinvestigationalunknownDetailsDB06144Sertindoleapproved, investigational, withdrawnyesantagonistDetailsDB06148Mianserinapproved, investigationalunknownantagonistDetailsDB05492Epicept NP-1investigationalunknownDetailsDB06216AsenapineapprovedunknownantagonistDetailsDB06229OcaperidoneinvestigationalunknownDetailsDB12177EplivanserininvestigationalunknownDetailsDB06512Deramciclaneinvestigationalunknowninverse agonistDetailsDB06446DotarizineinvestigationalunknownDetailsDB06594Agomelatineapproved, investigationalyesantagonistDetailsDB01186Pergolideapproved, investigational, vet_approved, withdrawnunknownagonistDetailsDB01200Bromocriptineapproved, investigational, withdrawnunknownagonistDetailsDB00589Lisurideapproved, investigationalyesagonistDetailsDB00248CabergolineapprovedunknownagonistDetailsDB00714Apomorphineapproved, investigationalunknownagonistDetailsDB01267PaliperidoneapprovedyesantagonistDetailsDB01238Aripiprazoleapproved, investigationalunknownantagonistpartial agonistDetailsDB01403Methotrimeprazineapproved, investigationalunknownantagonistDetailsDB00656Trazodoneapproved, investigationalyesagonistDetailsDB00408LoxapineapprovedunknownantagonistDetailsDB00434CyproheptadineapprovedyesantagonistDetailsDB01392Yohimbineapproved, investigational, vet_approvedunknownantagonistDetailsDB01242Clomipramineapproved, investigational, vet_approvedyesantagonistDetailsDB01142Doxepinapproved, investigationalunknownantagonistDetailsDB01079Tegaserodapproved, investigational, withdrawnunknownantagonistDetailsDB01149Nefazodoneapproved, withdrawnyesantagonistDetailsDB01454Midomafetamineexperimental, illicit, investigationalunknownagonistDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknownbinderDetailsDB00458ImipramineapprovedunknownantagonistbinderDetailsDB00543AmoxapineapprovedunknownantagonistDetailsDB00540NortriptylineapprovedunknownantagonistdownregulatorDetailsDB00726TrimipramineapprovedunknownantagonistDetailsDB00696ErgotamineapprovedunknownagonistDetailsDB00321AmitriptylineapprovedunknownantagonistDetailsDB00934Maprotilineapproved, investigationalunknownbinderDetailsDB01151Desipramineapproved, investigationalunknownbinderDetailsDB09014CaptodiameexperimentalyesantagonistDetailsDB12163SarpogrelateinvestigationalunknownDetailsDB00623FluphenazineapprovedunknownDetailsDB00472Fluoxetineapproved, vet_approvedunknownantagonistDetailsDB015374-Bromo-2,5-dimethoxyphenethylamineexperimental, illicityespartial agonistDetailsDB09194EtoperidonewithdrawnyesagonistDetailsDB139402,5-Dimethoxy-4-ethylthioamphetamineexperimentalunknownagonistDetailsDB09195LorpiprazoleapprovedyesantagonistDetailsDB12110m-ChlorophenylpiperazineinvestigationalunknownagonistDetailsDB06153PizotifenapprovedunknownantagonistDetailsDB04948Lofexidineapproved, investigationalnoagonistDetailsDB14185Aripiprazole lauroxilapproved, investigationalunknownDetailsDB00502HaloperidolapprovedyesDetailsDB00924CyclobenzaprineapprovedunknownantagonistDetailsDB01175EscitalopramapprovedunknowninhibitorDetailsDB00734Risperidoneapproved, investigationalunknownantagonistDetailsDB00875Flupentixolapproved, investigational, withdrawnunknownantagonistDetailsDB05316Pimavanserinapproved, investigationalunknowninverse agonistDetailsDB00320Dihydroergotamineapproved, investigationalunknownagonistDetailsDB06016Cariprazineapproved, investigationalunknownantagonistDetailsDB09185Viloxazineapproved, investigational, withdrawnyesagonistDetailsDB13025TiaprideinvestigationalyesantagonistDetailsDB09304SetiptilineexperimentalunknownantagonistDetailsDB13345Dihydroergocristineapproved, experimentalyesantagonistDetailsDB01049Ergoloid mesylateapprovedyesantagonistagonistDetailsDB11273DihydroergocornineapprovedyesantagonistagonistDetailsDB12141Gilteritinibapproved, investigationalnoinhibitorDetailsDB00715Paroxetineapproved, investigationalunknownDetailsDB01239Chlorprothixeneapproved, experimental, investigational, withdrawnyesinhibitorDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknownbinderDetailsDB08804Nandrolone decanoateapproved, illicitunknownmodulatorDetailsDB01221Ketamineapproved, vet_approvedunknownantagonistDetailsDB06678Esmirtazapineinvestigationalunknowninverse agonistDetails"
                    }
                },
                {
                    "Label": "Neuronal acetylcholine receptor subunit alpha-2",
                    "Detailed Info": {
                        "Name": "Neuronal acetylcholine receptor subunit alpha-2",
                        "Synonyms": "Neuronal acetylcholine receptor subunit alpha-2 precursor",
                        "Gene Name": "CHRNA2",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0037067|Neuronal acetylcholine receptor subunit alpha-2\nMGPSCPVFLSFTKLSLWWLLLTPAGGEEAKRPPPRAPGDPLSSPSPTALPQGGSHTETED\nRLFKHLFRGYNRWARPVPNTSDVVIVRFGLSIAQLIDVDEKNQMMTTNVWLKQEWSDYKL\nRWNPTDFGNITSLRVPSEMIWIPDIVLYNNADGEFAVTHMTKAHLFSTGTVHWVPPAIYK\nSSCSIDVTFFPFDQQNCKMKFGSWTYDKAKIDLEQMEQTVDLKDYWESGEWAIVNATGTY\nNSKKYDCCAEIYPDVTYAFVIRRLPLFYTINLIIPCLLISCLTVLVFYLPSDCGEKITLC\nISVLLSLTVFLLLITEIIPSTSLVIPLIGEYLLFTMIFVTLSIVITVFVLNVHHRSPSTH\nTMPHWVRGALLGCVPRWLLMNRPPPPVELCHPLRLKLSPSYHWLESNVDAEEREVVVEEE\nDRWACAGHVAPSVGTLCSHGHLHSGASGPKAEALLQEGELLLSPHMQKALEGVHYIADHL\nRSEDADSSVKEDWKYVAMVIDRIFLWLFIIVCFLGTIGLFLPPFLAGMI",
                        "Number of residues": "529",
                        "Molecular Weight": "59764.82",
                        "Theoretical pI": "6.02",
                        "GO Classification": "Functionsacetylcholine binding / acetylcholine receptor activity / acetylcholine-activated cation-selective channel activity / drug bindingProcessescation transmembrane transport / ion transport / neurological system process / neuromuscular synaptic transmission / protein heterooligomerization / regulation of membrane potential / response to nicotine / signal transduction / synaptic transmission / synaptic transmission, cholinergicComponentsacetylcholine-gated channel complex / cell junction / integral component of membrane / neuron projection / plasma membrane / postsynaptic membrane / synapse",
                        "General Function": "Drug binding",
                        "Specific Function": "After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.",
                        "Pfam Domain Function": "Neur_chan_LBD (PF02931)\nNeur_chan_memb (PF02932)",
                        "Transmembrane Regions": "265-289\n297-315\n331-352\n503-521",
                        "Cellular Location": "Cell junction",
                        "Gene sequence": ">lcl|BSEQ0010520|Neuronal acetylcholine receptor subunit alpha-2 (CHRNA2)\nATGGGCCCCTCCTGTCCTGTGTTCCTGTCCTTCACAAAGCTCAGCCTGTGGTGGCTCCTT\nCTGACCCCAGCAGGTGGAGAGGAAGCTAAGCGCCCACCTCCCAGGGCTCCTGGAGACCCA\nCTCTCCTCTCCCAGTCCCACGGCATTGCCGCAGGGAGGCTCGCATACCGAGACTGAGGAC\nCGGCTCTTCAAACACCTCTTCCGGGGCTACAACCGCTGGGCGCGCCCGGTGCCCAACACT\nTCAGACGTGGTGATTGTGCGCTTTGGACTGTCCATCGCTCAGCTCATCGATGTGGATGAG\nAAGAACCAAATGATGACCACCAACGTCTGGCTAAAACAGGAGTGGAGCGACTACAAACTG\nCGCTGGAACCCCACTGATTTTGGCAACATCACATCTCTCAGGGTCCCTTCTGAGATGATC\nTGGATCCCCGACATTGTTCTCTACAACAATGCAGATGGGGAGTTTGCAGTGACCCACATG\nACCAAGGCCCACCTCTTCTCCACGGGCACTGTGCACTGGGTGCCCCCGGCCATCTACAAG\nAGCTCCTGCAGCATCGACGTCACCTTCTTCCCCTTCGACCAGCAGAACTGCAAGATGAAG\nTTTGGCTCCTGGACTTATGACAAGGCCAAGATCGACCTGGAGCAGATGGAGCAGACTGTG\nGACCTGAAGGACTACTGGGAGAGCGGCGAGTGGGCCATCGTCAATGCCACGGGCACCTAC\nAACAGCAAGAAGTACGACTGCTGCGCCGAGATCTACCCCGACGTCACCTACGCCTTCGTC\nATCCGGCGGCTGCCGCTCTTCTACACCATCAACCTCATCATCCCCTGCCTGCTCATCTCC\nTGCCTCACTGTGCTGGTCTTCTACCTGCCCTCCGACTGCGGCGAGAAGATCACGCTGTGC\nATTTCGGTGCTGCTGTCACTCACCGTCTTCCTGCTGCTCATCACTGAGATCATCCCGTCC\nACCTCGCTGGTCATCCCGCTCATCGGCGAGTACCTGCTGTTCACCATGATCTTCGTCACC\nCTGTCCATCGTCATCACCGTCTTCGTGCTCAATGTGCACCACCGCTCCCCCAGCACCCAC\nACCATGCCCCACTGGGTGCGGGGGGCCCTTCTGGGCTGTGTGCCCCGGTGGCTTCTGATG\nAACCGGCCCCCACCACCCGTGGAGCTCTGCCACCCCCTACGCCTGAAGCTCAGCCCCTCT\nTATCACTGGCTGGAGAGCAACGTGGATGCCGAGGAGAGGGAGGTGGTGGTGGAGGAGGAG\nGACAGATGGGCATGTGCAGGTCATGTGGCCCCCTCTGTGGGCACCCTCTGCAGCCACGGC\nCACCTGCACTCTGGGGCCTCAGGTCCCAAGGCTGAGGCTCTGCTGCAGGAGGGTGAGCTG\nCTGCTATCACCCCACATGCAGAAGGCACTGGAAGGTGTGCACTACATTGCCGACCACCTG\nCGGTCTGAGGATGCTGACTCTTCGGTGAAGGAGGACTGGAAGTATGTTGCCATGGTCATC\nGACAGGATCTTCCTCTGGCTGTTTATCATCGTCTGCTTCCTGGGGACCATCGGCCTCTTT\nCTGCCTCCGTTCCTAGCTGGAATGATCTGA",
                        "Chromosome Location": "8",
                        "Locus": "8p21",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ15822UniProtKB Entry NameACHA2_HUMANGenBank Protein ID1458110GenBank Gene IDU62431GenAtlas IDCHRNA2HGNC IDHGNC:1956",
                        "General References": "Elliott KJ, Ellis SB, Berckhan KJ, Urrutia A, Chavez-Noriega LE, Johnson EC, Velicelebi G, Harpold MM: Comparative structure of human neuronal alpha 2-alpha 7 and beta 2-beta 4 nicotinic acetylcholine receptor subunits and functional expression of the alpha 2, alpha 3, alpha 4, alpha 7, beta 2, and beta 4 subunits. J Mol Neurosci. 1996 Fall;7(3):217-28. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Nusbaum C, Mikkelsen TS, Zody MC, Asakawa S, Taudien S, Garber M, Kodira CD, Schueler MG, Shimizu A, Whittaker CA, Chang JL, Cuomo CA, Dewar K, FitzGerald MG, Yang X, Allen NR, Anderson S, Asakawa T, Blechschmidt K, Bloom T, Borowsky ML, Butler J, Cook A, Corum B, DeArellano K, DeCaprio D, Dooley KT, Dorris L 3rd, Engels R, Glockner G, Hafez N, Hagopian DS, Hall JL, Ishikawa SK, Jaffe DB, Kamat A, Kudoh J, Lehmann R, Lokitsang T, Macdonald P, Major JE, Matthews CD, Mauceli E, Menzel U, Mihalev AH, Minoshima S, Murayama Y, Naylor JW, Nicol R, Nguyen C, O'Leary SB, O'Neill K, Parker SC, Polley A, Raymond CK, Reichwald K, Rodriguez J, Sasaki T, Schilhabel M, Siddiqui R, Smith CL, Sneddon TP, Talamas JA, Tenzin P, Topham K, Venkataraman V, Wen G, Yamazaki S, Young SK, Zeng Q, Zimmer AR, Rosenthal A, Birren BW, Platzer M, Shimizu N, Lander ES: DNA sequence and analysis of human chromosome 8. Nature. 2006 Jan 19;439(7074):331-5. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Aridon P, Marini C, Di Resta C, Brilli E, De Fusco M, Politi F, Parrini E, Manfredi I, Pisano T, Pruna D, Curia G, Cianchetti C, Pasqualetti M, Becchetti A, Guerrini R, Casari G: Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear. Am J Hum Genet. 2006 Aug;79(2):342-50. Epub 2006 Jun 26. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00184NicotineapprovedunknownagonistDetailsDB00416Metocurine iodideapproved, withdrawnyesantagonistDetailsDB00483Gallamine triethiodideapprovedunknownantagonistDetailsDB00657Mecamylamineapproved, investigationalyesantagonistDetailsDB00728RocuroniumapprovedyesantagonistDetailsDB00732Atracurium besylateapprovedyesantagonistDetailsDB01135DoxacuriumapprovedyesantagonistDetailsDB01199TubocurarineapprovedyesantagonistDetailsDB01226MivacuriumapprovedyesantagonistDetailsDB01245Decamethoniumapprovedyespartial agonistDetailsDB00411CarbamoylcholineapprovedyesagonistDetailsDB00514DextromethorphanapprovedunknownantagonistDetailsDB01338PipecuroniumapprovedyesantagonistDetailsDB01337PancuroniumapprovedyesantagonistDetailsDB01336MetocurineapprovedyesantagonistDetailsDB05740RPI-78MinvestigationalunknownDetailsDB00721Procaineapproved, investigational, vet_approvedunknownantagonistDetailsDB01339Vecuroniumapproved, investigationalyesantagonistDetailsDB00898EthanolapprovedunknownDetailsDB07720EpibatidineexperimentalunknownagonistDetailsDB08960HexamethoniumexperimentalyesantagonistDetailsDB00472Fluoxetineapproved, vet_approvedunknownantagonistDetailsDB00237Butabarbitalapproved, illicitunknowninhibitorDetailsDB00202SuccinylcholineapprovedyesagonistDetailsDB00565Cisatracuriumapproved, investigationalyesantagonistDetails"
                    }
                },
                {
                    "Label": "Neuronal acetylcholine receptor subunit alpha-3",
                    "Detailed Info": {
                        "Name": "Neuronal acetylcholine receptor subunit alpha-3",
                        "Synonyms": "NACHRA3",
                        "Gene Name": "CHRNA3",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0006903|Neuronal acetylcholine receptor subunit alpha-3\nMGSGPLSLPLALSPPRLLLLLLLSLLPVARASEAEHRLFERLFEDYNEIIRPVANVSDPV\nIIHFEVSMSQLVKVDEVNQIMETNLWLKQIWNDYKLKWNPSDYGGAEFMRVPAQKIWKPD\nIVLYNNAVGDFQVDDKTKALLKYTGEVTWIPPAIFKSSCKIDVTYFPFDYQNCTMKFGSW\nSYDKAKIDLVLIGSSMNLKDYWESGEWAIIKAPGYKHDIKYNCCEEIYPDITYSLYIRRL\nPLFYTINLIIPCLLISFLTVLVFYLPSDCGEKVTLCISVLLSLTVFLLVITETIPSTSLV\nIPLIGEYLLFTMIFVTLSIVITVFVLNVHYRTPTTHTMPSWVKTVFLNLLPRVMFMTRPT\nSNEGNAQKPRPLYGAELSNLNCFSRAESKGCKEGYPCQDGMCGYCHHRRIKISNFSANLT\nRSSSSESVDAVLSLSALSPEIKEAIQSVKYIAENMKAQNEAKEIQDDWKYVAMVIDRIFL\nWVFTLVCILGTAGLFLQPLMAREDA",
                        "Number of residues": "505",
                        "Molecular Weight": "57479.54",
                        "Theoretical pI": "6.4",
                        "GO Classification": "Functionsacetylcholine binding / acetylcholine receptor activity / acetylcholine-activated cation-selective channel activity / drug binding / ligand-gated ion channel activityProcessesactivation of transmembrane receptor protein tyrosine kinase activity / behavioral response to nicotine / cation transmembrane transport / excitatory postsynaptic potential / heart development / ion transmembrane transport / ion transport / locomotory behavior / nervous system development / neurological system process / protein heterooligomerization / regulation of acetylcholine secretion, neurotransmission / regulation of dendrite morphogenesis / regulation of membrane potential / regulation of smooth muscle contraction / response to drug / response to inorganic substance / signal transduction / synaptic transmission / synaptic transmission involved in micturition / synaptic transmission, cholinergicComponentsacetylcholine-gated channel complex / cell junction / dendrite / integral component of membrane / neuron projection / neuronal cell body / plasma membrane / postsynaptic density / postsynaptic membrane / synapse",
                        "General Function": "Ligand-gated ion channel activity",
                        "Specific Function": "After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.",
                        "Pfam Domain Function": "Neur_chan_LBD (PF02931)\nNeur_chan_memb (PF02932)",
                        "Transmembrane Regions": "241-265\n273-291\n307-328\n478-497",
                        "Cellular Location": "Cell junction",
                        "Gene sequence": ">lcl|BSEQ0012491|Neuronal acetylcholine receptor subunit alpha-3 (CHRNA3)\nATGGGCTCTGGCCCGCTCTCGCTGCCCCTGGCGCTGTCGCCGCCGCGGCTGCTGCTGCTG\nCTGCTGCTGTCTCTGCTGCCAGTGGCCAGGGCCTCAGAGGCTGAGCACCGTCTATTTGAG\nCGGCTGTTTGAAGATTACAATGAGATCATCCGGCCTGTAGCCAACGTGTCTGACCCAGTC\nATCATCCATTTCGAGGTGTCCATGTCTCAGCTGGTGAAGGTGGATGAAGTAAACCAGATC\nATGGAGACCAACCTGTGGCTCAAGCAAATCTGGAATGACTACAAGCTGAAATGGAACCCC\nTCTGACTATGGTGGGGCAGAGTTCATGCGTGTCCCTGCACAGAAGATCTGGAAGCCAGAC\nATTGTGCTGTATAACAATGCTGTTGGGGATTTCCAGGTGGACGACAAGACCAAAGCCTTA\nCTCAAGTACACTGGGGAGGTGACTTGGATACCTCCGGCCATCTTTAAGAGCTCCTGTAAA\nATCGACGTGACCTACTTCCCGTTTGATTACCAAAACTGTACCATGAAGTTCGGTTCCTGG\nTCCTACGATAAGGCGAAAATCGATCTGGTCCTGATCGGCTCTTCCATGAACCTCAAGGAC\nTATTGGGAGAGCGGCGAGTGGGCCATCATCAAAGCCCCAGGCTACAAACACGACATCAAG\nTACAACTGCTGCGAGGAGATCTACCCCGACATCACATACTCGCTGTACATCCGGCGCCTG\nCCCTTGTTCTACACCATCAACCTCATCATCCCCTGCCTGCTCATCTCCTTCCTCACTGTG\nCTCGTCTTCTACCTGCCCTCCGACTGCGGTGAGAAGGTGACCCTGTGCATTTCTGTCCTC\nCTCTCCCTGACGGTGTTTCTCCTGGTGATCACTGAGACCATCCCTTCCACCTCGCTGGTC\nATCCCCCTGATTGGAGAGTACCTCCTGTTCACCATGATTTTTGTAACCTTGTCCATCGTC\nATCACCGTCTTCGTGCTCAACGTGCACTACAGAACCCCGACGACACACACAATGCCCTCA\nTGGGTGAAGACTGTATTCTTGAACCTGCTCCCCAGGGTCATGTTCATGACCAGGCCAACA\nAGCAACGAGGGCAACGCTCAGAAGCCGAGGCCCCTCTACGGTGCCGAGCTCTCAAATCTG\nAATTGCTTCAGCCGCGCAGAGTCCAAAGGCTGCAAGGAGGGCTACCCCTGCCAGGACGGG\nATGTGTGGTTACTGCCACCACCGCAGGATAAAAATCTCCAATTTCAGTGCTAACCTCACG\nAGAAGCTCTAGTTCTGAATCTGTTGATGCTGTGCTGTCCCTCTCTGCTTTGTCACCAGAA\nATCAAAGAAGCCATCCAAAGTGTCAAGTATATTGCTGAAAATATGAAAGCACAAAATGAA\nGCCAAAGAGATTCAAGATGATTGGAAGTATGTTGCCATGGTGATTGATCGTATTTTTCTG\nTGGGTTTTCACCCTGGTGTGCATTCTAGGGACAGCAGGATTGTTTCTGCAACCCCTGATG\nGCCAGGGAAGATGCATAA",
                        "Chromosome Location": "15",
                        "Locus": "15q24",
                        "External Identifiers": "ResourceLinkUniProtKB IDP32297UniProtKB Entry NameACHA3_HUMANGenBank Protein ID177898GenBank Gene IDM86383HGNC IDHGNC:1957",
                        "General References": "Fornasari D, Chini B, Tarroni P, Clementi F: Molecular cloning of human neuronal nicotinic receptor alpha 3-subunit. Neurosci Lett. 1990 Apr 6;111(3):351-6. [Article] Mihovilovic M, Roses AD: Expression of mRNAs in human thymus coding for the alpha 3 subunit of a neuronal acetylcholine receptor. Exp Neurol. 1991 Feb;111(2):175-80. [Article] Elliott KJ, Ellis SB, Berckhan KJ, Urrutia A, Chavez-Noriega LE, Johnson EC, Velicelebi G, Harpold MM: Comparative structure of human neuronal alpha 2-alpha 7 and beta 2-beta 4 nicotinic acetylcholine receptor subunits and functional expression of the alpha 2, alpha 3, alpha 4, alpha 7, beta 2, and beta 4 subunits. J Mol Neurosci. 1996 Fall;7(3):217-28. [Article] Groot Kormelink PJ, Luyten WH: Cloning and sequence of full-length cDNAs encoding the human neuronal nicotinic acetylcholine receptor (nAChR) subunits beta3 and beta4 and expression of seven nAChR subunits in the human neuroblastoma cell line SH-SY5Y and/or IMR-32. FEBS Lett. 1997 Jan 6;400(3):309-14. [Article] Rempel N, Heyers S, Engels H, Sleegers E, Steinlein OK: The structures of the human neuronal nicotinic acetylcholine receptor beta2- and alpha3-subunit genes (CHRNB2 and CHRNA3). Hum Genet. 1998 Dec;103(6):645-53. [Article] Lev-Lehman E, Bercovich D, Xu W, Stockton DW, Beaudet AL: Characterization of the human beta4 nAChR gene and polymorphisms in CHRNA3 and CHRNB4. J Hum Genet. 2001;46(7):362-6. [Article] Zody MC, Garber M, Sharpe T, Young SK, Rowen L, O'Neill K, Whittaker CA, Kamal M, Chang JL, Cuomo CA, Dewar K, FitzGerald MG, Kodira CD, Madan A, Qin S, Yang X, Abbasi N, Abouelleil A, Arachchi HM, Baradarani L, Birditt B, Bloom S, Bloom T, Borowsky ML, Burke J, Butler J, Cook A, DeArellano K, DeCaprio D, Dorris L 3rd, Dors M, Eichler EE, Engels R, Fahey J, Fleetwood P, Friedman C, Gearin G, Hall JL, Hensley G, Johnson E, Jones C, Kamat A, Kaur A, Locke DP, Madan A, Munson G, Jaffe DB, Lui A, Macdonald P, Mauceli E, Naylor JW, Nesbitt R, Nicol R, O'Leary SB, Ratcliffe A, Rounsley S, She X, Sneddon KM, Stewart S, Sougnez C, Stone SM, Topham K, Vincent D, Wang S, Zimmer AR, Birren BW, Hood L, Lander ES, Nusbaum C: Analysis of the DNA sequence and duplication history of human chromosome 15. Nature. 2006 Mar 30;440(7084):671-5. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Lansdell SJ, Gee VJ, Harkness PC, Doward AI, Baker ER, Gibb AJ, Millar NS: RIC-3 enhances functional expression of multiple nicotinic acetylcholine receptor subtypes in mammalian cells. Mol Pharmacol. 2005 Nov;68(5):1431-8. Epub 2005 Aug 24. [Article] Chanock SJ, Hunter DJ: Genomics: when the smoke clears ... Nature. 2008 Apr 3;452(7187):537-8. doi: 10.1038/452537a. [Article] Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Chen C, Goodman G, Field JK, Liloglou T, Xinarianos G, Cassidy A, McLaughlin J, Liu G, Narod S, Krokan HE, Skorpen F, Elvestad MB, Hveem K, Vatten L, Linseisen J, Clavel-Chapelon F, Vineis P, Bueno-de-Mesquita HB, Lund E, Martinez C, Bingham S, Rasmuson T, Hainaut P, Riboli E, Ahrens W, Benhamou S, Lagiou P, Trichopoulos D, Holcatova I, Merletti F, Kjaerheim K, Agudo A, Macfarlane G, Talamini R, Simonato L, Lowry R, Conway DI, Znaor A, Healy C, Zelenika D, Boland A, Delepine M, Foglio M, Lechner D, Matsuda F, Blanche H, Gut I, Heath S, Lathrop M, Brennan P: A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature. 2008 Apr 3;452(7187):633-7. doi: 10.1038/nature06885. [Article] Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, Manolescu A, Thorleifsson G, Stefansson H, Ingason A, Stacey SN, Bergthorsson JT, Thorlacius S, Gudmundsson J, Jonsson T, Jakobsdottir M, Saemundsdottir J, Olafsdottir O, Gudmundsson LJ, Bjornsdottir G, Kristjansson K, Skuladottir H, Isaksson HJ, Gudbjartsson T, Jones GT, Mueller T, Gottsater A, Flex A, Aben KK, de Vegt F, Mulders PF, Isla D, Vidal MJ, Asin L, Saez B, Murillo L, Blondal T, Kolbeinsson H, Stefansson JG, Hansdottir I, Runarsdottir V, Pola R, Lindblad B, van Rij AM, Dieplinger B, Haltmayer M, Mayordomo JI, Kiemeney LA, Matthiasson SE, Oskarsson H, Tyrfingsson T, Gudbjartsson DF, Gulcher JR, Jonsson S, Thorsteinsdottir U, Kong A, Stefansson K: A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature. 2008 Apr 3;452(7187):638-42. doi: 10.1038/nature06846. [Article] Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, Dong Q, Zhang Q, Gu X, Vijayakrishnan J, Sullivan K, Matakidou A, Wang Y, Mills G, Doheny K, Tsai YY, Chen WV, Shete S, Spitz MR, Houlston RS: Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet. 2008 May;40(5):616-22. doi: 10.1038/ng.109. Epub 2008 Apr 2. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00848Levamisoleapproved, investigational, vet_approved, withdrawnyesagonistDetailsDB00184NicotineapprovedunknownagonistDetailsDB01227Levacetylmethadolapproved, investigational, withdrawnunknownantagonistDetailsDB01273Vareniclineapproved, investigationalunknownpartial agonistDetailsDB01156BupropionapprovedunknownantagonistDetailsDB01090PentoliniumapprovedyesantagonistDetailsDB00514DextromethorphanapprovedunknownantagonistDetailsDB09028CytisineexperimentalunknownagonistDetailsDB00898EthanolapprovedunknownDetailsDB07720EpibatidineexperimentalunknownagonistDetailsDB05710GantacuriuminvestigationalyesantagonistDetailsDB00915AmantadineapprovedunknownantagonistDetailsDB00472Fluoxetineapproved, vet_approvedunknownantagonistDetailsDB00333MethadoneapprovedunknownantagonistDetailsDB00237Butabarbitalapproved, illicitunknowninhibitorDetailsDB00202SuccinylcholineapprovedyesagonistDetailsDB00565Cisatracuriumapproved, investigationalyesantagonistDetails"
                    }
                },
                {
                    "Label": "Neuronal acetylcholine receptor subunit beta-4",
                    "Detailed Info": {
                        "Name": "Neuronal acetylcholine receptor subunit beta-4",
                        "Synonyms": "Not Available",
                        "Gene Name": "CHRNB4",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0006901|Neuronal acetylcholine receptor subunit beta-4\nMRRAPSLVLFFLVALCGRGNCRVANAEEKLMDDLLNKTRYNNLIRPATSSSQLISIKLQL\nSLAQLISVNEREQIMTTNVWLKQEWTDYRLTWNSSRYEGVNILRIPAKRIWLPDIVLYNN\nADGTYEVSVYTNLIVRSNGSVLWLPPAIYKSACKIEVKYFPFDQQNCTLKFRSWTYDHTE\nIDMVLMTPTASMDDFTPSGEWDIVALPGRRTVNPQDPSYVDVTYDFIIKRKPLFYTINLI\nIPCVLTTLLAILVFYLPSDCGEKMTLCISVLLALTFFLLLISKIVPPTSLDVPLIGKYLM\nFTMVLVTFSIVTSVCVLNVHHRSPSTHTMAPWVKRCFLHKLPTFLFMKRPGPDSSPARAF\nPPSKSCVTKPEATATSTSPSNFYGNSMYFVNPASAASKSPAGSTPVAIPRDFWLRSSGRF\nRQDVQEALEGVSFIAQHMKNDDEDQSVVEDWKYVAMVVDRLFLWVFMFVCVLGTVGLFLP\nPLFQTHAASEGPYAAQRD",
                        "Number of residues": "498",
                        "Molecular Weight": "56378.985",
                        "Theoretical pI": "8.45",
                        "GO Classification": "Functionsacetylcholine binding / acetylcholine receptor activity / acetylcholine-activated cation-selective channel activity / drug binding / ligand-gated ion channel activityProcessesaction potential / behavioral response to nicotine / cation transmembrane transport / ion transmembrane transport / ion transport / locomotory behavior / neurological system process / positive regulation of transmission of nerve impulse / protein heterooligomerization / regulation of membrane potential / regulation of neurotransmitter secretion / regulation of smooth muscle contraction / response to nicotine / signal transduction / smooth muscle contraction / synaptic transmission / synaptic transmission involved in micturition / synaptic transmission, cholinergicComponentsacetylcholine-gated channel complex / cell junction / integral component of membrane / integral component of plasma membrane / neuron projection / plasma membrane / postsynaptic membrane / synapse",
                        "General Function": "Ligand-gated ion channel activity",
                        "Specific Function": "After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.",
                        "Pfam Domain Function": "Neur_chan_LBD (PF02931)\nNeur_chan_memb (PF02932)",
                        "Transmembrane Regions": "237-257\n266-286\n299-319\n461-481",
                        "Cellular Location": "Cell junction",
                        "Gene sequence": ">lcl|BSEQ0020698|Neuronal acetylcholine receptor subunit beta-4 (CHRNB4)\nATGAGGCGCGCGCCTTCCCTGGTCCTTTTCTTCCTGGTCGCCCTTTGCGGGCGCGGGAAC\nTGCCGCGTGGCCAATGCGGAGGAAAAGCTGATGGACGACCTTCTGAACAAAACCCGTTAC\nAATAACCTGATCCGCCCAGCCACCAGCTCCTCACAGCTCATCTCCATCAAGCTGCAGCTC\nTCCCTGGCCCAGCTTATCAGCGTGAATGAGCGAGAGCAGATCATGACCACCAATGTCTGG\nCTGAAACAGGAATGGACTGATTACCGCCTGACCTGGAACAGCTCCCGCTACGAGGGTGTG\nAACATCCTGAGGATCCCTGCAAAGCGCATCTGGTTGCCTGACATCGTGCTTTACAACAAC\nGCCGACGGGACCTATGAGGTGTCTGTCTACACCAACTTGATAGTCCGGTCCAACGGCAGC\nGTCCTGTGGCTGCCCCCTGCCATCTACAAGAGCGCCTGCAAGATTGAGGTGAAGTACTTT\nCCCTTCGACCAGCAGAACTGCACCCTCAAGTTCCGCTCCTGGACCTATGACCACACGGAG\nATAGACATGGTCCTCATGACGCCCACAGCCAGCATGGATGACTTTACTCCCAGTGGTGAG\nTGGGACATAGTGGCCCTCCCAGGGAGAAGGACAGTGAACCCACAAGACCCCAGCTACGTG\nGACGTGACTTACGACTTCATCATCAAGCGCAAGCCTCTGTTCTACACCATCAACCTCATC\nATCCCCTGCGTGCTCACCACCTTGCTGGCCATCCTCGTCTTCTACCTGCCATCCGACTGC\nGGCGAGAAGATGACACTGTGCATCTCAGTGCTGCTGGCACTGACATTCTTCCTGCTGCTC\nATCTCCAAGATCGTGCCACCCACCTCCCTCGATGTGCCTCTCATCGGCAAGTACCTCATG\nTTCACCATGGTGCTGGTCACCTTCTCCATCGTCACCAGCGTCTGTGTGCTCAATGTGCAC\nCACCGCTCGCCCAGCACCCACACCATGGCACCCTGGGTCAAGCGCTGCTTCCTGCACAAG\nCTGCCTACCTTCCTCTTCATGAAGCGCCCTGGCCCCGACAGCAGCCCGGCCAGAGCCTTC\nCCGCCCAGCAAGTCATGCGTGACCAAGCCCGAGGCCACCGCCACCTCCACCAGCCCCTCC\nAACTTCTATGGGAACTCCATGTACTTTGTGAACCCCGCCTCTGCAGCTTCCAAGTCTCCA\nGCCGGCTCTACCCCGGTGGCTATCCCCAGGGATTTCTGGCTGCGGTCCTCTGGGAGGTTC\nCGACAGGATGTGCAGGAGGCATTAGAAGGTGTCAGCTTCATCGCCCAGCACATGAAGAAT\nGACGATGAAGACCAGAGTGTCGTTGAGGACTGGAAGTACGTGGCTATGGTGGTGGACCGG\nCTGTTCCTGTGGGTGTTCATGTTTGTGTGCGTCCTGGGCACTGTGGGGCTCTTCCTACCG\nCCCCTCTTCCAGACCCATGCAGCTTCTGAGGGGCCCTACGCTGCCCAGCGTGACTGA",
                        "Chromosome Location": "15",
                        "Locus": "15q24",
                        "External Identifiers": "ResourceLinkUniProtKB IDP30926UniProtKB Entry NameACHB4_HUMANGenBank Protein ID1458126GenBank Gene IDU62439HGNC IDHGNC:1964",
                        "General References": "Elliott KJ, Ellis SB, Berckhan KJ, Urrutia A, Chavez-Noriega LE, Johnson EC, Velicelebi G, Harpold MM: Comparative structure of human neuronal alpha 2-alpha 7 and beta 2-beta 4 nicotinic acetylcholine receptor subunits and functional expression of the alpha 2, alpha 3, alpha 4, alpha 7, beta 2, and beta 4 subunits. J Mol Neurosci. 1996 Fall;7(3):217-28. [Article] Gerzanich V, Kuryatov A, Anand R, Lindstrom J: \"Orphan\" alpha6 nicotinic AChR subunit can form a functional heteromeric acetylcholine receptor. Mol Pharmacol. 1997 Feb;51(2):320-7. [Article] Groot Kormelink PJ, Luyten WH: Cloning and sequence of full-length cDNAs encoding the human neuronal nicotinic acetylcholine receptor (nAChR) subunits beta3 and beta4 and expression of seven nAChR subunits in the human neuroblastoma cell line SH-SY5Y and/or IMR-32. FEBS Lett. 1997 Jan 6;400(3):309-14. [Article] Lev-Lehman E, Bercovich D, Xu W, Stockton DW, Beaudet AL: Characterization of the human beta4 nAChR gene and polymorphisms in CHRNA3 and CHRNB4. J Hum Genet. 2001;46(7):362-6. [Article] Zody MC, Garber M, Sharpe T, Young SK, Rowen L, O'Neill K, Whittaker CA, Kamal M, Chang JL, Cuomo CA, Dewar K, FitzGerald MG, Kodira CD, Madan A, Qin S, Yang X, Abbasi N, Abouelleil A, Arachchi HM, Baradarani L, Birditt B, Bloom S, Bloom T, Borowsky ML, Burke J, Butler J, Cook A, DeArellano K, DeCaprio D, Dorris L 3rd, Dors M, Eichler EE, Engels R, Fahey J, Fleetwood P, Friedman C, Gearin G, Hall JL, Hensley G, Johnson E, Jones C, Kamat A, Kaur A, Locke DP, Madan A, Munson G, Jaffe DB, Lui A, Macdonald P, Mauceli E, Naylor JW, Nesbitt R, Nicol R, O'Leary SB, Ratcliffe A, Rounsley S, She X, Sneddon KM, Stewart S, Sougnez C, Stone SM, Topham K, Vincent D, Wang S, Zimmer AR, Birren BW, Hood L, Lander ES, Nusbaum C: Analysis of the DNA sequence and duplication history of human chromosome 15. Nature. 2006 Mar 30;440(7084):671-5. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Valor LM, Campos-Caro A, Carrasco-Serrano C, Ortiz JA, Ballesta JJ, Criado M: Transcription factors NF-Y and Sp1 are important determinants of the promoter activity of the bovine and human neuronal nicotinic receptor beta 4 subunit genes. J Biol Chem. 2002 Mar 15;277(11):8866-76. Epub 2001 Dec 12. [Article] Tarroni P, Rubboli F, Chini B, Zwart R, Oortgiesen M, Sher E, Clementi F: Neuronal-type nicotinic receptors in human neuroblastoma and small-cell lung carcinoma cell lines. FEBS Lett. 1992 Nov 2;312(1):66-70. [Article] Lansdell SJ, Gee VJ, Harkness PC, Doward AI, Baker ER, Gibb AJ, Millar NS: RIC-3 enhances functional expression of multiple nicotinic acetylcholine receptor subtypes in mammalian cells. Mol Pharmacol. 2005 Nov;68(5):1431-8. Epub 2005 Aug 24. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00184NicotineapprovedunknownagonistDetailsDB01227Levacetylmethadolapproved, investigational, withdrawnunknownother/unknownDetailsDB01090PentoliniumapprovedyesantagonistDetailsDB00514DextromethorphanapprovedunknownantagonistDetailsDB00898EthanolapprovedunknownDetailsDB07720EpibatidineexperimentalunknownagonistDetailsDB00472Fluoxetineapproved, vet_approvedunknownantagonistDetailsDB00237Butabarbitalapproved, illicitunknowninhibitorDetailsDB00202SuccinylcholineapprovedyesagonistDetailsDB00565Cisatracuriumapproved, investigationalyesantagonistDetails"
                    }
                },
                {
                    "Label": "Cyclin-dependent kinases regulatory subunit 1",
                    "Detailed Info": {
                        "Name": "Cyclin-dependent kinases regulatory subunit 1",
                        "Synonyms": "CKS-1\nCKS1",
                        "Gene Name": "CKS1B",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0013183|Cyclin-dependent kinases regulatory subunit 1\nMSHKQIYYSDKYDDEEFEYRHVMLPKDIAKLVPKTHLMSESEWRNLGVQQSQGWVHYMIH\nEPEPHILLFRRPLPKKPKK",
                        "Number of residues": "79",
                        "Molecular Weight": "9660.14",
                        "Theoretical pI": "Not Available",
                        "GO Classification": "Functionscyclin-dependent protein serine/threonine kinase regulator activityProcessescell division / cell proliferation / G1/S transition of mitotic cell cycle / mitotic cell cycle / regulation of cyclin-dependent protein serine/threonine kinase activityComponentsnucleoplasm",
                        "General Function": "Cyclin-dependent protein serine/threonine kinase regulator activity",
                        "Specific Function": "Binds to the catalytic subunit of the cyclin dependent kinases and is essential for their biological function.",
                        "Pfam Domain Function": "CKS (PF01111)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Not Available",
                        "Gene sequence": ">lcl|BSEQ0013184|Cyclin-dependent kinases regulatory subunit 1 (CKS1B)\nATGTCGCACAAACAAATTTACTATTCGGACAAATACGACGACGAGGAGTTTGAGTATCGA\nCATGTCATGCTGCCCAAGGACATAGCCAAGCTGGTCCCTAAAACCCATCTGATGTCTGAA\nTCTGAATGGAGGAATCTTGGCGTTCAGCAGAGTCAGGGATGGGTCCATTATATGATCCAT\nGAACCAGAACCTCACATCTTGCTGTTCCGGCGCCCACTACCCAAGAAACCAAAGAAATGA",
                        "Chromosome Location": "1",
                        "Locus": "Not Available",
                        "External Identifiers": "ResourceLinkUniProtKB IDP61024UniProtKB Entry NameCKS1_HUMANHGNC IDHGNC:19083",
                        "General References": "Richardson HE, Stueland CS, Thomas J, Russell P, Reed SI: Human cDNAs encoding homologs of the small p34Cdc28/Cdc2-associated protein of Saccharomyces cerevisiae and Schizosaccharomyces pombe. Genes Dev. 1990 Aug;4(8):1332-44. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Burkard TR, Planyavsky M, Kaupe I, Breitwieser FP, Burckstummer T, Bennett KL, Superti-Furga G, Colinge J: Initial characterization of the human central proteome. BMC Syst Biol. 2011 Jan 26;5:17. doi: 10.1186/1752-0509-5-17. [Article] Van Damme P, Lasa M, Polevoda B, Gazquez C, Elosegui-Artola A, Kim DS, De Juan-Pardo E, Demeyer K, Hole K, Larrea E, Timmerman E, Prieto J, Arnesen T, Sherman F, Gevaert K, Aldabe R: N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12449-54. doi: 10.1073/pnas.1210303109. Epub 2012 Jul 18. [Article] Arvai AS, Bourne Y, Hickey MJ, Tainer JA: Crystal structure of the human cell cycle protein CksHs1: single domain fold with similarity to kinase N-lobe domain. J Mol Biol. 1995 Jun 23;249(5):835-42. [Article] Bourne Y, Watson MH, Hickey MJ, Holmes W, Rocque W, Reed SI, Tainer JA: Crystal structure and mutational analysis of the human CDK2 kinase complex with cell cycle-regulatory protein CksHs1. Cell. 1996 Mar 22;84(6):863-74. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB026812,8-bis[oxido(oxo)vanadio]-1,1,1,3,5,5,7,7,9,9,9-undecaoxopentavanadoxane-2,8-diiumexperimentalunknownDetailsDB00472Fluoxetineapproved, vet_approvedunknownDetails"
                    }
                },
                {
                    "Label": "Potassium voltage-gated channel subfamily H member 2",
                    "Detailed Info": {
                        "Name": "Potassium voltage-gated channel subfamily H member 2",
                        "Synonyms": "Eag homolog\nEag-related protein 1\nERG\nERG-1\nERG1\nEther-a-go-go-related gene potassium channel 1\nEther-a-go-go-related protein 1\nH-ERG\nHERG\nhERG-1\nhERG1\nVoltage-gated potassium channel subunit Kv11.1",
                        "Gene Name": "KCNH2",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0000180|Potassium voltage-gated channel subfamily H member 2\nMPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVM\nQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDG\nAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSV\nRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSP\nPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPP\nRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIA\nPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIY\nTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANE\nEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLD\nRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSS\nGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVS\nAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGF\nPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALY\nFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLE\nVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTE\nQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSS\nPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTP\nSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSA\nVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPG\nQLGALTSQPLHRHGSDPGS",
                        "Number of residues": "1159",
                        "Molecular Weight": "126653.52",
                        "Theoretical pI": "7.97",
                        "GO Classification": "FunctionsC3HC4-type RING finger domain binding / delayed rectifier potassium channel activity / identical protein binding / inward rectifier potassium channel activity / phosphorelay sensor kinase activity / protein homodimerization activity / scaffold protein binding / ubiquitin protein ligase binding / voltage-gated potassium channel activity / voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarizationProcessescardiac muscle contraction / cellular response to drug / membrane depolarization during action potential / membrane repolarization during action potential / membrane repolarization during cardiac muscle cell action potential / negative regulation of potassium ion export / negative regulation of potassium ion transmembrane transport / positive regulation of potassium ion transmembrane transport / potassium ion export / potassium ion export across plasma membrane / potassium ion homeostasis / potassium ion transmembrane transport / regulation of heart rate by cardiac conduction / regulation of heart rate by hormone / regulation of membrane potential / regulation of membrane repolarization / regulation of potassium ion transmembrane transport / regulation of ventricular cardiac muscle cell membrane repolarization / synaptic transmission / ventricular cardiac muscle cell action potentialComponentscell surface / nuclear envelope / perinuclear region of cytoplasm / plasma membrane / voltage-gated potassium channel complex",
                        "General Function": "Voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization",
                        "Specific Function": "Pore-forming (alpha) subunit of voltage-gated inwardly rectifying potassium channel. Channel properties are modulated by cAMP and subunit assembly. Mediates the rapidly activating component of the delayed rectifying potassium current in heart (IKr). Isoforms USO have no channel activity by themself, but modulates channel characteristics by forming heterotetramers with other isoforms which are retained intracellularly and undergo ubiquitin-dependent degradation.",
                        "Pfam Domain Function": "Ion_trans (PF00520)\ncNMP_binding (PF00027)\nPAS_9 (PF13426)",
                        "Transmembrane Regions": "404-424\n451-471\n496-516\n521-541\n548-568\n639-659",
                        "Cellular Location": "Cell membrane",
                        "Gene sequence": ">lcl|BSEQ0021259|Potassium voltage-gated channel subfamily H member 2 (KCNH2)\nATGCCGGTGCGGAGGGGCCACGTCGCGCCGCAGAACACCTTCCTGGACACCATCATCCGC\nAAGTTTGAGGGCCAGAGCCGTAAGTTCATCATCGCCAACGCTCGGGTGGAGAACTGCGCC\nGTCATCTACTGCAACGACGGCTTCTGCGAGCTGTGCGGCTACTCGCGGGCCGAGGTGATG\nCAGCGACCCTGCACCTGCGACTTCCTGCACGGGCCGCGCACGCAGCGCCGCGCTGCCGCG\nCAGATCGCGCAGGCACTGCTGGGCGCCGAGGAGCGCAAAGTGGAAATCGCCTTCTACCGG\nAAAGATGGGAGCTGCTTCCTATGTCTGGTGGATGTGGTGCCCGTGAAGAACGAGGATGGG\nGCTGTCATCATGTTCATCCTCAATTTCGAGGTGGTGATGGAGAAGGACATGGTGGGGTCC\nCCGGCTCATGACACCAACCACCGGGGCCCCCCCACCAGCTGGCTGGCCCCAGGCCGCGCC\nAAGACCTTCCGCCTGAAGCTGCCCGCGCTGCTGGCGCTGACGGCCCGGGAGTCGTCGGTG\nCGGTCGGGCGGCGCGGGCGGCGCGGGCGCCCCGGGGGCCGTGGTGGTGGACGTGGACCTG\nACGCCCGCGGCACCCAGCAGCGAGTCGCTGGCCCTGGACGAAGTGACAGCCATGGACAAC\nCACGTGGCAGGGCTCGGGCCCGCGGAGGAGCGGCGTGCGCTGGTGGGTCCCGGCTCTCCG\nCCCCGCAGCGCGCCCGGCCAGCTCCCATCGCCCCGGGCGCACAGCCTCAACCCCGACGCC\nTCGGGCTCCAGCTGCAGCCTGGCCCGGACGCGCTCCCGAGAAAGCTGCGCCAGCGTGCGC\nCGCGCCTCGTCGGCCGACGACATCGAGGCCATGCGCGCCGGGGTGCTGCCCCCGCCACCG\nCGCCACGCCAGCACCGGGGCCATGCACCCACTGCGCAGCGGCTTGCTCAACTCCACCTCG\nGACTCCGACCTCGTGCGCTACCGCACCATTAGCAAGATTCCCCAAATCACCCTCAACTTT\nGTGGACCTCAAGGGCGACCCCTTCTTGGCTTCGCCCACCAGTGACCGTGAGATCATAGCA\nCCTAAGATAAAGGAGCGAACCCACAATGTCACTGAGAAGGTCACCCAGGTCCTGTCCCTG\nGGCGCCGACGTGCTGCCTGAGTACAAGCTGCAGGCACCGCGCATCCACCGCTGGACCATC\nCTGCATTACAGCCCCTTCAAGGCCGTGTGGGACTGGCTCATCCTGCTGCTGGTCATCTAC\nACGGCTGTCTTCACACCCTACTCGGCTGCCTTCCTGCTGAAGGAGACGGAAGAAGGCCCG\nCCTGCTACCGAGTGTGGCTACGCCTGCCAGCCGCTGGCTGTGGTGGACCTCATCGTGGAC\nATCATGTTCATTGTGGACATCCTCATCAACTTCCGCACCACCTACGTCAATGCCAACGAG\nGAGGTGGTCAGCCACCCCGGCCGCATCGCCGTCCACTACTTCAAGGGCTGGTTCCTCATC\nGACATGGTGGCCGCCATCCCCTTCGACCTGCTCATCTTCGGCTCTGGCTCTGAGGAGCTG\nATCGGGCTGCTGAAGACTGCGCGGCTGCTGCGGCTGGTGCGCGTGGCGCGGAAGCTGGAT\nCGCTACTCAGAGTACGGCGCGGCCGTGCTGTTCTTGCTCATGTGCACCTTTGCGCTCATC\nGCGCACTGGCTAGCCTGCATCTGGTACGCCATCGGCAACATGGAGCAGCCACACATGGAC\nTCACGCATCGGCTGGCTGCACAACCTGGGCGACCAGATAGGCAAACCCTACAACAGCAGC\nGGCCTGGGCGGCCCCTCCATCAAGGACAAGTATGTGACGGCGCTCTACTTCACCTTCAGC\nAGCCTCACCAGTGTGGGCTTCGGCAACGTCTCTCCCAACACCAACTCAGAGAAGATCTTC\nTCCATCTGCGTCATGCTCATTGGCTCCCTCATGTATGCTAGCATCTTCGGCAACGTGTCG\nGCCATCATCCAGCGGCTGTACTCGGGCACAGCCCGCTACCACACACAGATGCTGCGGGTG\nCGGGAGTTCATCCGCTTCCACCAGATCCCCAATCCCCTGCGCCAGCGCCTCGAGGAGTAC\nTTCCAGCACGCCTGGTCCTACACCAACGGCATCGACATGAACGCGGTGCTGAAGGGCTTC\nCCTGAGTGCCTGCAGGCTGACATCTGCCTGCACCTGAACCGCTCACTGCTGCAGCACTGC\nAAACCCTTCCGAGGGGCCACCAAGGGCTGCCTTCGGGCCCTGGCCATGAAGTTCAAGACC\nACACATGCACCGCCAGGGGACACACTGGTGCATGCTGGGGACCTGCTCACCGCCCTGTAC\nTTCATCTCCCGGGGCTCCATCGAGATCCTGCGGGGCGACGTCGTCGTGGCCATCCTGGGG\nAAGAATGACATCTTTGGGGAGCCTCTGAACCTGTATGCAAGGCCTGGCAAGTCGAACGGG\nGATGTGCGGGCCCTCACCTACTGTGACCTACACAAGATCCATCGGGACGACCTGCTGGAG\nGTGCTGGACATGTACCCTGAGTTCTCCGACCACTTCTGGTCCAGCCTGGAGATCACCTTC\nAACCTGCGAGATACCAACATGATCCCGGGCTCCCCCGGCAGTACGGAGTTAGAGGGTGGC\nTTCAGTCGGCAACGCAAGCGCAAGTTGTCCTTCCGCAGGCGCACGGACAAGGACACGGAG\nCAGCCAGGGGAGGTGTCGGCCTTGGGGCCGGGCCGGGCGGGGGCAGGGCCGAGTAGCCGG\nGGCCGGCCGGGGGGGCCGTGGGGGGAGAGCCCGTCCAGTGGCCCCTCCAGCCCTGAGAGC\nAGTGAGGATGAGGGCCCAGGCCGCAGCTCCAGCCCCCTCCGCCTGGTGCCCTTCTCCAGC\nCCCAGGCCCCCCGGAGAGCCGCCGGGTGGGGAGCCCCTGATGGAGGACTGCGAGAAGAGC\nAGCGACACTTGCAACCCCCTGTCAGGCGCCTTCTCAGGAGTGTCCAACATTTTCAGCTTC\nTGGGGGGACAGTCGGGGCCGCCAGTACCAGGAGCTCCCTCGATGCCCCGCCCCCACCCCC\nAGCCTCCTCAACATCCCCCTCTCCAGCCCGGGTCGGCGGCCCCGGGGCGACGTGGAGAGC\nAGGCTGGATGCCCTCCAGCGCCAGCTCAACAGGCTGGAGACCCGGCTGAGTGCAGACATG\nGCCACTGTCCTGCAGCTGCTACAGAGGCAGATGACGCTGGTCCCGCCCGCCTACAGTGCT\nGTGACCACCCCGGGGCCTGGCCCCACTTCCACATCCCCGCTGTTGCCCGTCAGCCCCCTC\nCCCACCCTCACCTTGGACTCGCTTTCTCAGGTTTCCCAGTTCATGGCGTGTGAGGAGCTG\nCCCCCGGGGGCCCCAGAGCTTCCCCAAGAAGGCCCCACACGACGCCTCTCCCTACCGGGC\nCAGCTGGGGGCCCTCACCTCCCAGCCCCTGCACAGACACGGCTCGGACCCGGGCAGTTAG",
                        "Chromosome Location": "7",
                        "Locus": "7q35-q36",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ12809UniProtKB Entry NameKCNH2_HUMANGenBank Protein ID487738GenBank Gene IDU04270GenAtlas IDKCNH2HGNC IDHGNC:6251",
                        "General References": "Warmke JW, Ganetzky B: A family of potassium channel genes related to eag in Drosophila and mammals. Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3438-42. [Article] Itoh T, Tanaka T, Nagai R, Kamiya T, Sawayama T, Nakayama T, Tomoike H, Sakurada H, Yazaki Y, Nakamura Y: Genomic organization and mutational analysis of HERG, a gene responsible for familial long QT syndrome. Hum Genet. 1998 Apr;102(4):435-9. [Article] Soejima H, Kawamoto S, Akai J, Miyoshi O, Arai Y, Morohka T, Matsuo S, Niikawa N, Kimura A, Okubo K, Mukai T: Isolation of novel heart-specific genes using the BodyMap database. Genomics. 2001 May 15;74(1):115-20. [Article] Crociani O, Guasti L, Balzi M, Becchetti A, Wanke E, Olivotto M, Wymore RS, Arcangeli A: Cell cycle-dependent expression of HERG1 and HERG1B isoforms in tumor cells. J Biol Chem. 2003 Jan 31;278(5):2947-55. Epub 2002 Nov 12. [Article] Guasti L, Crociani O, Redaelli E, Pillozzi S, Polvani S, Masselli M, Mello T, Galli A, Amedei A, Wymore RS, Wanke E, Arcangeli A: Identification of a posttranslational mechanism for the regulation of hERG1 K+ channel expression and hERG1 current density in tumor cells. Mol Cell Biol. 2008 Aug;28(16):5043-60. doi: 10.1128/MCB.00304-08. Epub 2008 Jun 16. [Article] Huffaker SJ, Chen J, Nicodemus KK, Sambataro F, Yang F, Mattay V, Lipska BK, Hyde TM, Song J, Rujescu D, Giegling I, Mayilyan K, Proust MJ, Soghoyan A, Caforio G, Callicott JH, Bertolino A, Meyer-Lindenberg A, Chang J, Ji Y, Egan MF, Goldberg TE, Kleinman JE, Lu B, Weinberger DR: A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia. Nat Med. 2009 May;15(5):509-18. doi: 10.1038/nm.1962. Epub 2009 May 3. [Article] Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, Wagner-McPherson C, Layman D, Maas J, Jaeger S, Walker R, Wylie K, Sekhon M, Becker MC, O'Laughlin MD, Schaller ME, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Cordes M, Du H, Sun H, Edwards J, Bradshaw-Cordum H, Ali J, Andrews S, Isak A, Vanbrunt A, Nguyen C, Du F, Lamar B, Courtney L, Kalicki J, Ozersky P, Bielicki L, Scott K, Holmes A, Harkins R, Harris A, Strong CM, Hou S, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Leonard S, Rohlfing T, Rock SM, Tin-Wollam AM, Abbott A, Minx P, Maupin R, Strowmatt C, Latreille P, Miller N, Johnson D, Murray J, Woessner JP, Wendl MC, Yang SP, Schultz BR, Wallis JW, Spieth J, Bieri TA, Nelson JO, Berkowicz N, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Bedell JA, Mardis ER, Clifton SW, Chissoe SL, Marra MA, Raymond C, Haugen E, Gillett W, Zhou Y, James R, Phelps K, Iadanoto S, Bubb K, Simms E, Levy R, Clendenning J, Kaul R, Kent WJ, Furey TS, Baertsch RA, Brent MR, Keibler E, Flicek P, Bork P, Suyama M, Bailey JA, Portnoy ME, Torrents D, Chinwalla AT, Gish WR, Eddy SR, McPherson JD, Olson MV, Eichler EE, Green ED, Waterston RH, Wilson RK: The DNA sequence of human chromosome 7. Nature. 2003 Jul 10;424(6945):157-64. [Article] London B, Trudeau MC, Newton KP, Beyer AK, Copeland NG, Gilbert DJ, Jenkins NA, Satler CA, Robertson GA: Two isoforms of the mouse ether-a-go-go-related gene coassemble to form channels with properties similar to the rapidly activating component of the cardiac delayed rectifier K+ current. Circ Res. 1997 Nov;81(5):870-8. [Article] Lees-Miller JP, Kondo C, Wang L, Duff HJ: Electrophysiological characterization of an alternatively processed ERG K+ channel in mouse and human hearts. Circ Res. 1997 Nov;81(5):719-26. [Article] Paulussen A, Yang P, Pangalos M, Verhasselt P, Marrannes R, Verfaille C, Vandenberk I, Crabbe R, Konings F, Luyten W, Armstrong M: Analysis of the human KCNH2(HERG) gene: identification and characterization of a novel mutation Y667X associated with long QT syndrome and a non-pathological 9 bp insertion. Hum Mutat. 2000 May;15(5):483. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Kupershmidt S, Snyders DJ, Raes A, Roden DM: A K+ channel splice variant common in human heart lacks a C-terminal domain required for expression of rapidly activating delayed rectifier current. J Biol Chem. 1998 Oct 16;273(42):27231-5. [Article] Gong Q, Anderson CL, January CT, Zhou Z: Role of glycosylation in cell surface expression and stability of HERG potassium channels. Am J Physiol Heart Circ Physiol. 2002 Jul;283(1):H77-84. [Article] Cui J, Melman Y, Palma E, Fishman GI, McDonald TV: Cyclic AMP regulates the HERG K(+) channel by dual pathways. Curr Biol. 2000 Jun 1;10(11):671-4. [Article] McDonald TV, Yu Z, Ming Z, Palma E, Meyers MB, Wang KW, Goldstein SA, Fishman GI: A minK-HERG complex regulates the cardiac potassium current I(Kr). Nature. 1997 Jul 17;388(6639):289-92. [Article] Abbott GW, Sesti F, Splawski I, Buck ME, Lehmann MH, Timothy KW, Keating MT, Goldstein SA: MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell. 1999 Apr 16;97(2):175-87. [Article] Gong Q, Jones MA, Zhou Z: Mechanisms of pharmacological rescue of trafficking-defective hERG mutant channels in human long QT syndrome. J Biol Chem. 2006 Feb 17;281(7):4069-74. Epub 2005 Dec 16. [Article] Mayya V, Lundgren DH, Hwang SI, Rezaul K, Wu L, Eng JK, Rodionov V, Han DK: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal. 2009 Aug 18;2(84):ra46. doi: 10.1126/scisignal.2000007. [Article] Morais Cabral JH, Lee A, Cohen SL, Chait BT, Li M, Mackinnon R: Crystal structure and functional analysis of the HERG potassium channel N terminus: a eukaryotic PAS domain. Cell. 1998 Nov 25;95(5):649-55. [Article] Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT: A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 1995 Mar 10;80(5):795-803. [Article] Satler CA, Walsh EP, Vesely MR, Plummer MH, Ginsburg GS, Jacob HJ: Novel missense mutation in the cyclic nucleotide-binding domain of HERG causes long QT syndrome. Am J Med Genet. 1996 Oct 2;65(1):27-35. [Article] Benson DW, MacRae CA, Vesely MR, Walsh EP, Seidman JG, Seidman CE, Satler CA: Missense mutation in the pore region of HERG causes familial long QT syndrome. Circulation. 1996 May 15;93(10):1791-5. [Article] Dausse E, Berthet M, Denjoy I, Andre-Fouet X, Cruaud C, Bennaceur M, Faure S, Coumel P, Schwartz K, Guicheney P: A mutation in HERG associated with notched T waves in long QT syndrome. J Mol Cell Cardiol. 1996 Aug;28(8):1609-15. [Article] Tanaka T, Nagai R, Tomoike H, Takata S, Yano K, Yabuta K, Haneda N, Nakano O, Shibata A, Sawayama T, Kasai H, Yazaki Y, Nakamura Y: Four novel KVLQT1 and four novel HERG mutations in familial long-QT syndrome. Circulation. 1997 Feb 4;95(3):565-7. [Article] Splawski I, Shen J, Timothy KW, Vincent GM, Lehmann MH, Keating MT: Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and KCNE1. Genomics. 1998 Jul 1;51(1):86-97. [Article] Satler CA, Vesely MR, Duggal P, Ginsburg GS, Beggs AH: Multiple different missense mutations in the pore region of HERG in patients with long QT syndrome. Hum Genet. 1998 Mar;102(3):265-72. [Article] Akimoto K, Furutani M, Imamura S, Furutani Y, Kasanuki H, Takao A, Momma K, Matsuoka R: Novel missense mutation (G601S) of HERG in a Japanese long QT syndrome family. Hum Mutat. 1998;Suppl 1:S184-6. [Article] Berthet M, Denjoy I, Donger C, Demay L, Hammoude H, Klug D, Schulze-Bahr E, Richard P, Funke H, Schwartz K, Coumel P, Hainque B, Guicheney P: C-terminal HERG mutations: the role of hypokalemia and a KCNQ1-associated mutation in cardiac event occurrence. Circulation. 1999 Mar 23;99(11):1464-70. [Article] Jongbloed RJ, Wilde AA, Geelen JL, Doevendans P, Schaap C, Van Langen I, van Tintelen JP, Cobben JM, Beaufort-Krol GC, Geraedts JP, Smeets HJ: Novel KCNQ1 and HERG missense mutations in Dutch long-QT families. Hum Mutat. 1999;13(4):301-10. [Article] Chen J, Zou A, Splawski I, Keating MT, Sanguinetti MC: Long QT syndrome-associated mutations in the Per-Arnt-Sim (PAS) domain of HERG potassium channels accelerate channel deactivation. J Biol Chem. 1999 Apr 9;274(15):10113-8. [Article] Yoshida H, Horie M, Otani H, Takano M, Tsuji K, Kubota T, Fukunami M, Sasayama S: Characterization of a novel missense mutation in the pore of HERG in a patient with long QT syndrome. J Cardiovasc Electrophysiol. 1999 Sep;10(9):1262-70. [Article] Larsen LA, Svendsen IH, Jensen AM, Kanters JK, Andersen PS, Moller M, Sorensen SA, Sandoe E, Jacobsen JR, Vuust J, Christiansen M: Long QT syndrome with a high mortality rate caused by a novel G572R missense mutation in KCNH2. Clin Genet. 2000 Feb;57(2):125-30. [Article] Splawski I, Shen J, Timothy KW, Lehmann MH, Priori S, Robinson JL, Moss AJ, Schwartz PJ, Towbin JA, Vincent GM, Keating MT: Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation. 2000 Sep 5;102(10):1178-85. [Article] Laitinen P, Fodstad H, Piippo K, Swan H, Toivonen L, Viitasalo M, Kaprio J, Kontula K: Survey of the coding region of the HERG gene in long QT syndrome reveals six novel mutations and an amino acid polymorphism with possible phenotypic effects. Hum Mutat. 2000 Jun;15(6):580-1. [Article] Kagan A, Yu Z, Fishman GI, McDonald TV: The dominant negative LQT2 mutation A561V reduces wild-type HERG expression. J Biol Chem. 2000 Apr 14;275(15):11241-8. [Article] Yoshida H, Horie M, Otani H, Kawashima T, Onishi Y, Sasayama S: Bradycardia-induced long QT syndrome caused by a de novo missense mutation in the S2-S3 inner loop of HERG. Am J Med Genet. 2001 Feb 1;98(4):348-52. [Article] Hayashi K, Shimizu M, Ino H, Yamaguchi M, Mabuchi H, Hoshi N, Higashida H: Characterization of a novel missense mutation E637K in the pore-S6 loop of HERG in a patient with long QT syndrome. Cardiovasc Res. 2002 Apr;54(1):67-76. [Article] Yang P, Kanki H, Drolet B, Yang T, Wei J, Viswanathan PC, Hohnloser SH, Shimizu W, Schwartz PJ, Stanton M, Murray KT, Norris K, George AL Jr, Roden DM: Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation. 2002 Apr 23;105(16):1943-8. [Article] Liu W, Yang J, Hu D, Kang C, Li C, Zhang S, Li P, Chen Z, Qin X, Ying K, Li Y, Li Y, Li Z, Cheng X, Li L, Qi Y, Chen S, Wang Q: KCNQ1 and KCNH2 mutations associated with long QT syndrome in a Chinese population. Hum Mutat. 2002 Dec;20(6):475-6. [Article] Paulussen A, Raes A, Matthijs G, Snyders DJ, Cohen N, Aerssens J: A novel mutation (T65P) in the PAS domain of the human potassium channel HERG results in the long QT syndrome by trafficking deficiency. J Biol Chem. 2002 Dec 13;277(50):48610-6. Epub 2002 Sep 26. [Article] Johnson WH Jr, Yang P, Yang T, Lau YR, Mostella BA, Wolff DJ, Roden DM, Benson DW: Clinical, genetic, and biophysical characterization of a homozygous HERG mutation causing severe neonatal long QT syndrome. Pediatr Res. 2003 May;53(5):744-8. Epub 2003 Mar 5. [Article] Brugada R, Hong K, Dumaine R, Cordeiro J, Gaita F, Borggrefe M, Menendez TM, Brugada J, Pollevick GD, Wolpert C, Burashnikov E, Matsuo K, Wu YS, Guerchicoff A, Bianchi F, Giustetto C, Schimpf R, Brugada P, Antzelevitch C: Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation. 2004 Jan 6;109(1):30-5. Epub 2003 Dec 15. [Article] Westenskow P, Splawski I, Timothy KW, Keating MT, Sanguinetti MC: Compound mutations: a common cause of severe long-QT syndrome. Circulation. 2004 Apr 20;109(15):1834-41. Epub 2004 Mar 29. [Article] Tester DJ, Will ML, Haglund CM, Ackerman MJ: Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm. 2005 May;2(5):507-17. [Article] Napolitano C, Priori SG, Schwartz PJ, Bloise R, Ronchetti E, Nastoli J, Bottelli G, Cerrone M, Leonardi S: Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. JAMA. 2005 Dec 21;294(23):2975-80. [Article] Hong K, Bjerregaard P, Gussak I, Brugada R: Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. J Cardiovasc Electrophysiol. 2005 Apr;16(4):394-6. [Article] Millat G, Chevalier P, Restier-Miron L, Da Costa A, Bouvagnet P, Kugener B, Fayol L, Gonzalez Armengod C, Oddou B, Chanavat V, Froidefond E, Perraudin R, Rousson R, Rodriguez-Lafrasse C: Spectrum of pathogenic mutations and associated polymorphisms in a cohort of 44 unrelated patients with long QT syndrome. Clin Genet. 2006 Sep;70(3):214-27. [Article] Kapplinger JD, Tester DJ, Salisbury BA, Carr JL, Harris-Kerr C, Pollevick GD, Wilde AA, Ackerman MJ: Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm. 2009 Sep;6(9):1297-303. doi: 10.1016/j.hrthm.2009.05.021. Epub 2009 Jun 23. [Article] Aidery P, Kisselbach J, Gaspar H, Baldea I, Schweizer PA, Becker R, Katus HA, Thomas D: Identification and functional characterization of the novel human ether-a-go-go-related gene (hERG) R744P mutant associated with hereditary long QT syndrome 2. Biochem Biophys Res Commun. 2012 Feb 24;418(4):830-5. doi: 10.1016/j.bbrc.2012.01.118. Epub 2012 Jan 30. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00308IbutilideapprovedyesinhibitorDetailsDB01182PropafenoneapprovedyesinhibitorDetailsDB00204Dofetilideapproved, investigationalyesinhibitorDetailsDB00276Amsacrineapproved, investigationalunknowninhibitorDetailsDB00489SotalolapprovedyesinhibitorDetailsDB00604Cisaprideapproved, investigational, withdrawnunknowninhibitorDetailsDB00637Astemizoleapproved, withdrawnunknowninhibitorDetailsDB00908Quinidineapproved, investigationalunknowninhibitorDetailsDB01100PimozideapprovedyesinhibitorDetailsDB01136Carvedilolapproved, investigationalunknowninhibitorDetailsDB01218HalofantrineapprovedyesinhibitorDetailsDB00342Terfenadineapproved, withdrawnunknowninhibitorDetailsDB00661VerapamilapprovedunknowninhibitorDetailsDB04855DronedaroneapprovedyesinhibitorDetailsDB04957AzimilideinvestigationalunknownDetailsDB06144Sertindoleapproved, investigational, withdrawnunknowninhibitorDetailsDB01162TerazosinapprovedunknowninhibitorDetailsDB00457PrazosinapprovedunknowninhibitorDetailsDB00679Thioridazineapproved, withdrawnunknowninhibitorDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknowninhibitorDetailsDB00458ImipramineapprovedunknowninhibitorDetailsDB01142Doxepinapproved, investigationalunknowninhibitorDetailsDB00537Ciprofloxacinapproved, investigationalunknownDetailsDB01211ClarithromycinapprovedunknownDetailsDB00199Erythromycinapproved, investigational, vet_approvednoinhibitorDetailsDB06217Vernakalantapproved, investigationalunknownblockerDetailsDB06457TecastemizoleinvestigationalunknownDetailsDB00455Loratadineapproved, investigationalunknownantagonistDetailsDB01244Bepridilapproved, withdrawnunknowninhibitorDetailsDB00280DisopyramideapprovedunknowninhibitorDetailsDB01195Flecainideapproved, withdrawnunknowninhibitorDetailsDB00472Fluoxetineapproved, vet_approvedunknowninhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB01035ProcainamideapprovedunknowninhibitorDetailsDB00675TamoxifenapprovedunknowninhibitorDetailsDB01074Perhexilineapproved, investigationalunknownDetailsDB11386Chlorobutanolapproved, investigational, vet_approvedunknownDetailsDB00176Fluvoxamineapproved, investigationalunknownDetailsDB01149Nefazodoneapproved, withdrawnunknownantagonistDetailsDB12364Betrixabanapproved, investigationalunknowninhibitorDetailsDB11642Pitolisantapproved, investigationalnoblockerDetailsDB11633Isavuconazoleapproved, investigationalnoinhibitorDetailsDB11090Potassium nitrateapprovedunknownagonistDetailsDB11186Pentoxyverineapproved, investigational, withdrawnunknowninhibitorDetailsDB00252Phenytoinapproved, vet_approvedyesinhibitorDetailsDB00557HydroxyzineapprovedunknowninhibitorDetailsDB00836LoperamideapprovednoblockerDetailsDB01118Amiodaroneapproved, investigationalyesinhibitorDetailsDB00590DoxazosinapprovedunknowninhibitorDetailsDB00321AmitriptylineapprovedunknownblockerDetailsDB06207SilodosinapprovedunknownblockerDetailsDB03701VanoxerineinvestigationalunknownblockerDetailsDB00228Enfluraneapproved, investigational, vet_approvedunknowninhibitoractivatorDetailsDB01069Promethazineapproved, investigationalunknowninducerDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetails"
                    }
                }
            ],
            "enzymes": [
                {
                    "Label": "Cytochrome P450 2B6",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 2B6",
                        "Synonyms": "1,4-cineole 2-exo-monooxygenase\n1.14.13.-\nCYPIIB6\nCytochrome P450 IIB1",
                        "Gene Name": "CYP2B6",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0006839|Cytochrome P450 2B6\nMELSVLLFLALLTGLLLLLVQRHPNTHDRLPPGPRPLPLLGNLLQMDRRGLLKSFLRFRE\nKYGDVFTVHLGPRPVVMLCGVEAIREALVDKAEAFSGRGKIAMVDPFFRGYGVIFANGNR\nWKVLRRFSVTTMRDFGMGKRSVEERIQEEAQCLIEELRKSKGALMDPTFLFQSITANIIC\nSIVFGKRFHYQDQEFLKMLNLFYQTFSLISSVFGQLFELFSGFLKYFPGAHRQVYKNLQE\nINAYIGHSVEKHRETLDPSAPKDLIDTYLLHMEKEKSNAHSEFSHQNLNLNTLSLFFAGT\nETTSTTLRYGFLLMLKYPHVAERVYREIEQVIGPHRPPELHDRAKMPYTEAVIYEIQRFS\nDLLPMGVPHIVTQHTSFRGYIIPKDTEVFLILSTALHDPHYFEKPDAFNPDHFLDANGAL\nKKTEAFIPFSLGKRICLGEGIARAELFLFFTTILQNFSMASPVAPEDIDLTPQECGVGKI\nPPTYQIRFLPR",
                        "Number of residues": "491",
                        "Molecular Weight": "56277.81",
                        "Theoretical pI": "8.44",
                        "GO Classification": "Functionsarachidonic acid epoxygenase activity / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen / oxygen binding / steroid hydroxylase activityProcessescellular ketone metabolic process / drug metabolic process / epoxygenase P450 pathway / exogenous drug catabolic process / oxidation-reduction process / small molecule metabolic process / steroid metabolic process / xenobiotic metabolic processComponentscytoplasm / endoplasmic reticulum membrane / intracellular membrane-bounded organelle",
                        "General Function": "Steroid hydroxylase activity",
                        "Specific Function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,4-cineole 2-exo-monooxygenase.",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0019435|Cytochrome P450 2B6 (CYP2B6)\nATGGAACTCAGCGTCCTCCTCTTCCTTGCACTCCTCACAGGACTCTTGCTACTCCTGGTT\nCAGCGCCACCCTAACACCCATGACCGCCTCCCACCAGGGCCCCGCCCTCTGCCCCTTTTG\nGGAAACCTTCTGCAGATGGATAGAAGAGGCCTACTCAAATCCTTTCTGAGGTTCCGAGAG\nAAATATGGGGACGTCTTCACGGTACACCTGGGACCGAGGCCCGTGGTCATGCTGTGTGGA\nGTAGAGGCCATACGGGAGGCCCTTGTGGACAAGGCTGAGGCCTTCTCTGGCCGGGGAAAA\nATCGCCATGGTCGACCCATTCTTCCGGGGATATGGTGTGATCTTTGCCAATGGAAACCGC\nTGGAAGGTGCTTCGGCGATTCTCTGTGACCACTATGAGGGACTTCGGGATGGGAAAGCGG\nAGTGTGGAGGAGCGGATTCAGGAGGAGGCTCAGTGTCTGATAGAGGAGCTTCGGAAATCC\nAAGGGGGCCCTCATGGACCCCACCTTCCTCTTCCAGTCCATTACCGCCAACATCATCTGC\nTCCATCGTCTTTGGAAAACGATTCCACTACCAAGATCAAGAGTTCCTGAAGATGCTGAAC\nTTGTTCTACCAGACTTTTTCACTCATCAGCTCTGTATTCGGCCAGCTGTTTGAGCTCTTC\nTCTGGCTTCTTGAAATACTTTCCTGGGGCACACAGGCAAGTTTACAAAAACCTGCAGGAA\nATCAATGCTTACATTGGCCACAGTGTGGAGAAGCACCGTGAAACCCTGGACCCCAGCGCC\nCCCAAGGACCTCATCGACACCTACCTGCTCCACATGGAAAAAGAGAAATCCAACGCACAC\nAGTGAATTCAGCCACCAGAACCTCAACCTCAACACGCTCTCGCTCTTCTTTGCTGGCACT\nGAGACCACCAGCACCACTCTCCGCTACGGCTTCCTGCTCATGCTCAAATACCCTCATGTT\nGCAGAGAGAGTCTACAGGGAGATTGAACAGGTGATTGGCCCACATCGCCCTCCAGAGCTT\nCATGACCGAGCCAAAATGCCATACACAGAGGCAGTCATCTATGAGATTCAGAGATTTTCC\nGACCTTCTCCCCATGGGTGTGCCCCACATTGTCACCCAACACACCAGCTTCCGAGGGTAC\nATCATCCCCAAGGACACAGAAGTATTTCTCATCCTGAGCACTGCTCTCCATGACCCACAC\nTACTTTGAAAAACCAGACGCCTTCAATCCTGACCACTTTCTGGATGCCAATGGGGCACTG\nAAAAAGACTGAAGCTTTTATCCCCTTCTCCTTAGGGAAGCGGATTTGTCTTGGTGAAGGC\nATCGCCCGTGCGGAATTGTTCCTCTTCTTCACCACCATCCTCCAGAACTTCTCCATGGCC\nAGCCCCGTGGCCCCAGAAGACATCGATCTGACACCCCAGGAGTGTGGTGTGGGCAAAATA\nCCCCCAACATACCAGATCCGCTTCCTGCCCCGCTGA",
                        "Chromosome Location": "19",
                        "Locus": "19q13.2",
                        "External Identifiers": "ResourceLinkUniProtKB IDP20813UniProtKB Entry NameCP2B6_HUMANGenBank Protein ID181296GenBank Gene IDM29874HGNC IDHGNC:2615",
                        "General References": "Yamano S, Nhamburo PT, Aoyama T, Meyer UA, Inaba T, Kalow W, Gelboin HV, McBride OW, Gonzalez FJ: cDNA cloning and sequence and cDNA-directed expression of human P450 IIB1: identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liver. Biochemistry. 1989 Sep 5;28(18):7340-8. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Grimwood J, Gordon LA, Olsen A, Terry A, Schmutz J, Lamerdin J, Hellsten U, Goodstein D, Couronne O, Tran-Gyamfi M, Aerts A, Altherr M, Ashworth L, Bajorek E, Black S, Branscomb E, Caenepeel S, Carrano A, Caoile C, Chan YM, Christensen M, Cleland CA, Copeland A, Dalin E, Dehal P, Denys M, Detter JC, Escobar J, Flowers D, Fotopulos D, Garcia C, Georgescu AM, Glavina T, Gomez M, Gonzales E, Groza M, Hammon N, Hawkins T, Haydu L, Ho I, Huang W, Israni S, Jett J, Kadner K, Kimball H, Kobayashi A, Larionov V, Leem SH, Lopez F, Lou Y, Lowry S, Malfatti S, Martinez D, McCready P, Medina C, Morgan J, Nelson K, Nolan M, Ovcharenko I, Pitluck S, Pollard M, Popkie AP, Predki P, Quan G, Ramirez L, Rash S, Retterer J, Rodriguez A, Rogers S, Salamov A, Salazar A, She X, Smith D, Slezak T, Solovyev V, Thayer N, Tice H, Tsai M, Ustaszewska A, Vo N, Wagner M, Wheeler J, Wu K, Xie G, Yang J, Dubchak I, Furey TS, DeJong P, Dickson M, Gordon D, Eichler EE, Pennacchio LA, Richardson P, Stubbs L, Rokhsar DS, Myers RM, Rubin EM, Lucas SM: The DNA sequence and biology of human chromosome 19. Nature. 2004 Apr 1;428(6982):529-35. [Article] Miles JS, McLaren AW, Wolf CR: Alternative splicing in the human cytochrome P450IIB6 gene generates a high level of aberrant messages. Nucleic Acids Res. 1989 Oct 25;17(20):8241-55. [Article] Thum T, Borlak J: Gene expression in distinct regions of the heart. Lancet. 2000 Mar 18;355(9208):979-83. [Article] Miyazawa M, Shindo M, Shimada T: Roles of cytochrome P450 3A enzymes in the 2-hydroxylation of 1,4-cineole, a monoterpene cyclic ether, by rat and human liver microsomes. Xenobiotica. 2001 Oct;31(10):713-23. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Gay SC, Shah MB, Talakad JC, Maekawa K, Roberts AG, Wilderman PR, Sun L, Yang JY, Huelga SC, Hong WX, Zhang Q, Stout CD, Halpert JR: Crystal structure of a cytochrome P450 2B6 genetic variant in complex with the inhibitor 4-(4-chlorophenyl)imidazole at 2.0-A resolution. Mol Pharmacol. 2010 Apr;77(4):529-38. doi: 10.1124/mol.109.062570. Epub 2010 Jan 8. [Article] Shah MB, Pascual J, Zhang Q, Stout CD, Halpert JR: Structures of cytochrome P450 2B6 bound to 4-benzylpyridine and 4-(4-nitrobenzyl)pyridine: insight into inhibitor binding and rearrangement of active site side chains. Mol Pharmacol. 2011 Dec;80(6):1047-55. doi: 10.1124/mol.111.074427. Epub 2011 Aug 29. [Article] Shah MB, Wilderman PR, Pascual J, Zhang Q, Stout CD, Halpert JR: Conformational adaptation of human cytochrome P450 2B6 and rabbit cytochrome P450 2B4 revealed upon binding multiple amlodipine molecules. Biochemistry. 2012 Sep 18;51(37):7225-38. doi: 10.1021/bi300894z. Epub 2012 Sep 4. [Article] Haas DW, Ribaudo HJ, Kim RB, Tierney C, Wilkinson GR, Gulick RM, Clifford DB, Hulgan T, Marzolini C, Acosta EP: Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study. AIDS. 2004 Dec 3;18(18):2391-400. [Article] Carr DF, la Porte CJ, Pirmohamed M, Owen A, Cortes CP: Haplotype structure of CYP2B6 and association with plasma efavirenz concentrations in a Chilean HIV cohort. J Antimicrob Chemother. 2010 Sep;65(9):1889-93. doi: 10.1093/jac/dkq260. Epub 2010 Jul 17. [Article] Elens L, Vandercam B, Yombi JC, Lison D, Wallemacq P, Haufroid V: Influence of host genetic factors on efavirenz plasma and intracellular pharmacokinetics in HIV-1-infected patients. Pharmacogenomics. 2010 Sep;11(9):1223-34. doi: 10.2217/pgs.10.94. [Article] Ariyoshi N, Miyazaki M, Toide K, Sawamura Yi, Kamataki T: A single nucleotide polymorphism of CYP2b6 found in Japanese enhances catalytic activity by autoactivation. Biochem Biophys Res Commun. 2001 Mar;281(5):1256-60. [Article] Lang T, Klein K, Fischer J, Nussler AK, Neuhaus P, Hofmann U, Eichelbaum M, Schwab M, Zanger UM: Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics. 2001 Jul;11(5):399-415. [Article] Jinno H, Tanaka-Kagawa T, Ohno A, Makino Y, Matsushima E, Hanioka N, Ando M: Functional characterization of cytochrome P450 2B6 allelic variants. Drug Metab Dispos. 2003 Apr;31(4):398-403. [Article] Saito S, Iida A, Sekine A, Kawauchi S, Higuchi S, Ogawa C, Nakamura Y: Catalog of 680 variations among eight cytochrome p450 ( CYP) genes, nine esterase genes, and two other genes in the Japanese population. J Hum Genet. 2003;48(5):249-70. Epub 2003 Apr 29. [Article] Lamba V, Lamba J, Yasuda K, Strom S, Davila J, Hancock ML, Fackenthal JD, Rogan PK, Ring B, Wrighton SA, Schuetz EG: Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression. J Pharmacol Exp Ther. 2003 Dec;307(3):906-22. Epub 2003 Oct 9. [Article] Lang T, Klein K, Richter T, Zibat A, Kerb R, Eichelbaum M, Schwab M, Zanger UM: Multiple novel nonsynonymous CYP2B6 gene polymorphisms in Caucasians: demonstration of phenotypic null alleles. J Pharmacol Exp Ther. 2004 Oct;311(1):34-43. Epub 2004 Jun 9. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB029744-(4-Chlorophenyl)ImidazoleexperimentalunknownDetailsDB04664Cyclohexyl-pentyl-maltosideexperimentalunknownDetailsDB04794Bifonazoleapproved, investigationalunknownDetailsDB00333MethadoneapprovedunknownsubstrateinducerDetailsDB00531Cyclophosphamideapproved, investigationalunknownsubstrateinducerDetailsDB00532Mephenytoinapproved, investigational, withdrawnunknownsubstrateDetailsDB00625Efavirenzapproved, investigationalunknownsubstrateinducerDetailsDB01104SertralineapprovedunknownsubstrateinhibitorDetailsDB01156BupropionapprovedunknownsubstrateDetailsDB01181IfosfamideapprovedunknownsubstrateDetailsDB00184NicotineapprovedunknownsubstrateDetailsDB00208TiclopidineapprovedunknowninhibitorDetailsDB00220NelfinavirapprovednoinhibitorDetailsDB00238NevirapineapprovedunknownsubstrateinducerDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinducerDetailsDB00454MeperidineapprovednosubstrateDetailsDB00503Ritonavirapproved, investigationalnoinhibitorinducerDetailsDB00564Carbamazepineapproved, investigationalunknownsubstrateinducerDetailsDB00758ClopidogrelapprovednosubstrateinhibitorDetailsDB00818Propofolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00849MethylphenobarbitalapprovedunknownsubstrateDetailsDB01037Selegilineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB01043Memantineapproved, investigationalunknowninhibitorDetailsDB01173OrphenadrineapprovedunknowninhibitorDetailsDB00381AmlodipineapprovedunknownsubstrateinhibitorDetailsDB00675TamoxifenapprovedunknownsubstrateinhibitorDetailsDB00313Valproic acidapproved, investigationalunknownsubstrateDetailsDB00568Cinnarizineapproved, investigationalunknownsubstrateDetailsDB00398Sorafenibapproved, investigationalunknowninhibitorDetailsDB04572Thiotepaapproved, investigationalunknowninhibitorDetailsDB01174Phenobarbitalapproved, investigationalunknowninducerDetailsDB01045RifampicinapprovedunknowninducerDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateDetailsDB01069Promethazineapproved, investigationalunknownsubstrateDetailsDB01221Ketamineapproved, vet_approvedunknownsubstrateDetailsDB01320Fosphenytoinapproved, investigationalunknowninducerDetailsDB01151Desipramineapproved, investigationalunknowninhibitorDetailsDB00997Doxorubicinapproved, investigationalnoinhibitorDetailsDB00257Clotrimazoleapproved, vet_approvedunknowninhibitorinducerDetailsDB01167Itraconazoleapproved, investigationalnoinhibitorDetailsDB00481Raloxifeneapproved, investigationalunknowninhibitorDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB00641SimvastatinapprovedunknowninhibitorinducerDetailsDB00439Cerivastatinapproved, withdrawnunknowninducerDetailsDB01076AtorvastatinapprovednoinducerDetailsDB06739SeratrodastexperimentalunknownsubstrateDetailsDB00514DextromethorphanapprovedunknownsubstrateDetailsDB03575PhencyclidineillicitunknowninhibitorDetailsDB00865Benzphetamineapproved, illicitunknownsubstrateDetailsDB083691-(biphenyl-4-ylmethyl)-1H-imidazoleexperimentalunknownDetailsDB06697ArtemetherapprovedunknownsubstrateinducerDetailsDB00321AmitriptylineapprovedunknownsubstrateDetailsDB00701Amprenavirapproved, investigationalunknowninhibitorDetailsDB00604Cisaprideapproved, investigational, withdrawnunknownsubstrateDetailsDB00349Clobazamapproved, illicitnosubstrateDetailsDB06470ClomethiazoleinvestigationalunknownsubstrateDetailsDB01559Clotiazepamapproved, illicitunknownsubstrateDetailsDB01394ColchicineapprovedunknowninhibitorDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknowninducerDetailsDB00586Diclofenacapproved, vet_approvedunknownsubstrateDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB00751Epinastineapproved, investigationalunknownsubstrateDetailsDB00655EstroneapprovedunknownsubstrateDetailsDB00898EthanolapprovedunknowninhibitorDetailsDB01466Ethylmorphineexperimental, illicitunknownsubstrateDetailsDB01544Flunitrazepamapproved, illicitunknownsubstrateDetailsDB00472Fluoxetineapproved, vet_approvedunknownsubstrateDetailsDB00176Fluvoxamineapproved, investigationalunknowninhibitorDetailsDB01159Halothaneapproved, vet_approvedunknownsubstrateDetailsDB00458ImipramineapprovedunknownsubstrateDetailsDB00753Isofluraneapproved, vet_approvedunknownsubstrateinducerDetailsDB06738KetobemidoneinvestigationalunknownsubstrateDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB00281Lidocaineapproved, vet_approvedunknownsubstrateDetailsDB01601LopinavirapprovedunknowninhibitorDetailsDB00772Malathionapproved, investigationalunknownsubstrateDetailsDB04817Metamizoleapproved, investigational, withdrawnunknowninducerDetailsDB01028Methoxyfluraneapproved, investigational, vet_approved, withdrawnunknownsubstrateDetailsDB06710MethyltestosteroneapprovedunknownsubstrateDetailsDB00379Mexiletineapproved, investigationalunknownsubstrateDetailsDB06148Mianserinapproved, investigationalunknownsubstrateDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB00745Modafinilapproved, investigationalunknowninhibitorinducerDetailsDB00622Nicardipineapproved, investigationalunknowninducerDetailsDB01115NifedipineapprovedunknowninducerDetailsDB00715Paroxetineapproved, investigationalunknowninhibitorDetailsDB01074Perhexilineapproved, investigationalunknownsubstrateDetailsDB04930Permethrinapproved, investigationalunknownsubstrateinducerDetailsDB01435Antipyrineapproved, investigationalunknownsubstrateDetailsDB00908Quinidineapproved, investigationalunknowninhibitorDetailsDB00296RopivacaineapprovednosubstrateDetailsDB00778Roxithromycinapproved, investigational, withdrawnnoinhibitorDetailsDB01236Sevofluraneapproved, vet_approvedunknownsubstrateDetailsDB06729SulfaphenazoleapprovedunknowninhibitorDetailsDB01138SulfinpyrazoneapprovedunknowninducerDetailsDB00231Temazepamapproved, investigationalunknownsubstrateDetailsDB00624Testosteroneapproved, investigationalunknownsubstrateDetailsDB00763MethimazoleapprovedunknowninhibitorDetailsDB00193Tramadolapproved, investigationalunknownsubstrateDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknowninducerDetailsDB00661VerapamilapprovedunknownsubstrateactivatorDetailsDB00755Tretinoinapproved, investigational, nutraceuticalunknownsubstrateDetailsDB04868Nilotinibapproved, investigationalunknowninducerDetailsDB06413Armodafinilapproved, investigationalunknowninducerDetailsDB00836LoperamideapprovedunknownsubstrateDetailsDB04975BanoxantroneinvestigationalunknownsubstrateDetailsDB00435Nitric OxideapprovedunknowninhibitorDetailsDB00515CisplatinapprovedunknowninhibitorDetailsDB06209PrasugrelapprovednosubstrateDetailsDB04871Lorcaserinapproved, withdrawnnosubstrateDetailsDB08864RilpivirineapprovedunknowninhibitorDetailsDB08896RegorafenibapprovedunknowninhibitorDetailsDB08899EnzalutamideapprovednoinhibitorDetailsDB04938Ospemifeneapproved, investigationalunknownsubstrateDetailsDB09074OlaparibapprovedunknowninducerDetailsDB09054IdelalisibapprovednoinducerDetailsDB09068Vortioxetineapproved, investigationalnosubstrateDetailsDB09280LumacaftorapprovednoinducerDetailsDB09570Ixazomibapproved, investigationalunknownsubstrateDetailsDB06176Romidepsinapproved, investigationalunknownsubstrateDetailsDB08865Crizotinibapproved, investigationalunknowninhibitorDetailsDB05219Crisaboroleapproved, investigationalnoinhibitorDetailsDB06595Midostaurinapproved, investigationalunknowninducerDetailsDB11613Velpatasvirapproved, investigationalnosubstrateDetailsDB05541Brivaracetamapproved, investigationalnosubstrateDetailsDB09238Manidipineapproved, investigationalunknowninhibitorDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB12070Letermovirapproved, investigationalnoinducerDetailsDB13943Testosterone cypionateapprovedunknownsubstrateDetailsDB13944Testosterone enanthateapprovedunknownsubstrateDetailsDB13946Testosterone undecanoateapproved, investigationalunknownsubstrateDetailsDB13941Piperaquineapproved, experimental, investigationalunknowninhibitorDetailsDB11642Pitolisantapproved, investigationalunknowninducerDetailsDB11633Isavuconazoleapproved, investigationalunknowninducerDetailsDB11586Asunaprevirapproved, investigational, withdrawnnosubstrateDetailsDB11672Curcuminapproved, investigationalunknowninhibitorDetailsDB13132ArtemisinininvestigationalnosubstrateinducerDetailsDB00582VoriconazoleapprovedunknowninhibitorDetailsDB14568Ivosidenibapproved, investigationalunknowninducerDetailsDB00615Rifabutinapproved, investigationalnoinducerDetailsDB11753Rifamycinapproved, investigationalnoinhibitorinducerDetailsDB01201Rifapentineapproved, investigationalnoinducerDetailsDB08883PerampanelapprovedunknownsubstrateinducerDetailsDB09078Lenvatinibapproved, investigationalunknowninhibitorDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB01095FluvastatinapprovedunknowninducerDetailsDB08912Dabrafenibapproved, investigationalnoinhibitorinducerDetailsDB08881VemurafenibapprovedunknowninducerDetailsDB12130Lorlatinibapproved, investigationalunknowninducerDetailsDB12245Triclabendazoleapproved, investigationalunknowninhibitorDetailsDB11823Esketamineapproved, investigationalunknownsubstrateinducerDetailsDB00455Loratadineapproved, investigationalunknownsubstrateDetailsDB12978Pexidartinibapproved, investigationalunknowninhibitorinducerDetailsDB00956Hydrocodoneapproved, illicit, investigationalunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknownsubstrateDetailsDB00972AzelastineapprovedunknowninhibitorDetailsDB04856DexloxiglumideinvestigationalunknownsubstrateDetailsDB12808Trifaroteneapproved, investigationalunknownsubstrateDetailsDB12001Abemaciclibapproved, investigationalunknowninhibitorDetailsDB15444Elexacaftorapproved, investigationalnoinhibitorDetailsDB15035Zanubrutinibapproved, investigationalnoinducerDetailsDB14975Voxelotorapproved, investigationalunknownsubstrateDetailsDB00635Prednisoneapproved, vet_approvedunknowninducerDetailsDB00741Hydrocortisoneapproved, vet_approvedunknowninducerDetailsDB06119Cenobamateapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB01222BudesonideapprovedunknowninducerDetailsDB00959Methylprednisoloneapproved, vet_approvedunknowninducerDetailsDB11951Lemborexantapproved, investigationalunknowninducerDetailsDB00957Norgestimateapproved, investigationalunknownsubstrateDetailsDB11837Osilodrostatapproved, investigationalunknownsubstrateDetailsDB00443Betamethasoneapproved, vet_approvedunknowninducerDetailsDB09241Methylene blueapproved, investigationalunknowninhibitorDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninducerDetailsDB00714Apomorphineapproved, investigationalunknownsubstrateDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknowninducerDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB11932Abametapirapproved, investigationalunknowninhibitorDetailsDB12499Clascoteroneapproved, investigationalnoinhibitorDetailsDB06137Tirbanibulinapproved, investigationalnoinhibitorDetailsDB11853Relugolixapproved, investigationalunknownDetailsDB11632Opicaponeapproved, investigationalnoinhibitorDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB00476DuloxetineapprovedunknowninhibitorDetailsDB01086Benzocaineapproved, investigationalunknownsubstrateDetailsDB08822Azilsartan medoxomilapproved, investigationalnosubstrateDetailsDB00412Rosiglitazoneapproved, investigationalunknowninducerDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownsubstrateDetailsDB08816TicagrelorapprovedunknowninducerDetailsDB15569Sotorasibapproved, investigationalunknowninducerDetailsDB12151Brincidofovirapproved, investigationalnoinhibitorDetailsDB12265Fexinidazoleapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB15011Avacopanapproved, investigationalnoinducerDetailsDB05667Levoketoconazoleapproved, investigationalnoinhibitorDetailsDB14973Abrocitinibapproved, investigationalnosubstrateDetailsDB16236Mitapivatapproved, investigationalnoinducerDetailsDB09061Cannabidiolapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00470Dronabinolapproved, illicitnoinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknowninhibitorDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorinducerDetailsDB05087Ganaxoloneapproved, investigationalnosubstrateDetailsDB01041Thalidomideapproved, investigational, withdrawnnosubstrateinducerDetailsDB14921Mavacamtenapproved, investigationalnoinducerDetailsDB09185Viloxazineapproved, investigational, withdrawnnoinhibitorDetailsDB12020Tecovirimatapproved, investigationalnoinducerDetailsDB09118StiripentolapprovedunknowninhibitorinducerDetailsDB13997Baloxavir marboxilapproved, investigationalunknowninhibitorDetailsDB16650Deucravacitinibapproved, investigationalunknownsubstrateDetailsDB12095Telotristat ethylapproved, investigationalnoinducerDetailsDB09499Thiosulfuric acidapproved, investigationalunknowninducerDetailsDB11739Vonoprazanapproved, investigationalunknownsubstrateDetailsDB02709ResveratrolinvestigationalnoinhibitorDetailsDB15568Adagrasibapproved, investigationalunknownsubstrateDetailsDB16267Olutasidenibapproved, investigationalunknowninducerDetailsDB17472Pirtobrutinibapproved, investigationalunknowninhibitorinducerDetailsDB12548Sparsentanapproved, investigationalunknowninducerDetailsDB11712Tezacaftorapproved, investigationalnoinhibitorDetailsDB01194BrinzolamideapprovedunknownsubstrateDetailsDB12255Vadadustatapproved, investigationalunknowninducerDetailsDB05467Palovaroteneapproved, investigationalnoinducerDetailsDB11763Momelotinibapproved, investigationalunknowninhibitorDetailsDB11718Encorafenibapproved, investigationalnoinhibitorinducerDetailsDB16826RepotrectinibinvestigationalnoinducerDetails"
                    }
                },
                {
                    "Label": "Cytochrome P450 3A5",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 3A5",
                        "Synonyms": "1.14.14.1\nCYPIIIA5\nCytochrome P450 HLp2\nCytochrome P450-PCN3",
                        "Gene Name": "CYP3A5",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0004639|Cytochrome P450 3A5\nMDLIPNLAVETWLLLAVSLVLLYLYGTRTHGLFKRLGIPGPTPLPLLGNVLSYRQGLWKF\nDTECYKKYGKMWGTYEGQLPVLAITDPDVIRTVLVKECYSVFTNRRSLGPVGFMKSAISL\nAEDEEWKRIRSLLSPTFTSGKLKEMFPIIAQYGDVLVRNLRREAEKGKPVTLKDIFGAYS\nMDVITGTSFGVNIDSLNNPQDPFVESTKKFLKFGFLDPLFLSIILFPFLTPVFEALNVSL\nFPKDTINFLSKSVNRMKKSRLNDKQKHRLDFLQLMIDSQNSKETESHKALSDLELAAQSI\nIFIFAGYETTSSVLSFTLYELATHPDVQQKLQKEIDAVLPNKAPPTYDAVVQMEYLDMVV\nNETLRLFPVAIRLERTCKKDVEINGVFIPKGSMVVIPTYALHHDPKYWTEPEEFRPERFS\nKKKDSIDPYIYTPFGTGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLDTQG\nLLQPEKPIVLKVDSRDGTLSGE",
                        "Number of residues": "502",
                        "Molecular Weight": "57108.065",
                        "Theoretical pI": "9.09",
                        "GO Classification": "Functionsaromatase activity / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity / oxygen bindingProcessesalkaloid catabolic process / drug catabolic process / oxidative demethylation / small molecule metabolic process / steroid metabolic process / xenobiotic metabolic processComponentsendoplasmic reticulum membrane / intracellular membrane-bounded organelle",
                        "General Function": "Oxygen binding",
                        "Specific Function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0016766|Cytochrome P450 3A5 (CYP3A5)\nATGGACCTCATCCCAAATTTGGCGGTGGAAACCTGGCTTCTCCTGGCTGTCAGCCTGGTG\nCTCCTCTATCTATATGGGACCCGTACACATGGACTTTTTAAGAGACTGGGAATTCCAGGG\nCCCACACCTCTGCCTTTGTTGGGAAATGTTTTGTCCTATCGTCAGGGTCTCTGGAAATTT\nGACACAGAGTGCTATAAAAAGTATGGAAAAATGTGGGGAACGTATGAAGGTCAACTCCCT\nGTGCTGGCCATCACAGATCCCGACGTGATCAGAACAGTGCTAGTGAAAGAATGTTATTCT\nGTCTTCACAAATCGAAGGTCTTTAGGCCCAGTGGGATTTATGAAAAGTGCCATCTCTTTA\nGCTGAGGATGAAGAATGGAAGAGAATACGGTCATTGCTGTCTCCAACCTTCACCAGCGGA\nAAACTCAAGGAGATGTTCCCCATCATTGCCCAGTATGGAGATGTATTGGTGAGAAACTTG\nAGGCGGGAAGCAGAGAAAGGCAAGCCTGTCACCTTGAAAGACATCTTTGGGGCCTACAGC\nATGGATGTGATTACTGGCACATCATTTGGAGTGAACATCGACTCTCTCAACAATCCACAA\nGACCCCTTTGTGGAGAGCACTAAGAAGTTCCTAAAATTTGGTTTCTTAGATCCATTATTT\nCTCTCAATAATACTCTTTCCATTCCTTACCCCAGTTTTTGAAGCATTAAATGTCTCTCTG\nTTTCCAAAAGATACCATAAATTTTTTAAGTAAATCTGTAAACAGAATGAAGAAAAGTCGC\nCTCAACGACAAACAAAAGCACCGACTAGATTTCCTTCAGCTGATGATTGACTCCCAGAAT\nTCGAAAGAAACTGAGTCCCACAAAGCTCTGTCTGATCTGGAGCTCGCAGCCCAGTCAATA\nATCTTCATTTTTGCTGGCTATGAAACCACCAGCAGTGTTCTTTCCTTCACTTTATATGAA\nCTGGCCACTCACCCTGATGTCCAGCAGAAACTGCAAAAGGAGATTGATGCAGTTTTGCCC\nAATAAGGCACCACCTACCTATGATGCCGTGGTACAGATGGAGTACCTTGACATGGTGGTG\nAATGAAACACTCAGATTATTCCCAGTTGCTATTAGACTTGAGAGGACTTGCAAGAAAGAT\nGTTGAAATCAATGGGGTATTCATTCCCAAAGGGTCAATGGTGGTGATTCCAACTTATGCT\nCTTCACCATGACCCAAAGTACTGGACAGAGCCTGAGGAGTTCCGCCCTGAAAGGTTCAGT\nAAGAAGAAGGACAGCATAGATCCTTACATATACACACCCTTTGGAACTGGACCCAGAAAC\nTGCATTGGCATGAGGTTTGCTCTCATGAACATGAAACTTGCTCTAATCAGAGTCCTTCAG\nAACTTCTCCTTCAAACCTTGTAAAGAAACACAGATCCCCTTGAAATTAGACACGCAAGGA\nCTTCTTCAACCAGAAAAACCCATTGTTCTAAAGGTGGATTCAAGAGATGGAACCCTAAGT\nGGAGAATGA",
                        "Chromosome Location": "7",
                        "Locus": "7q21.1",
                        "External Identifiers": "ResourceLinkUniProtKB IDP20815UniProtKB Entry NameCP3A5_HUMANGenBank Protein ID181346GenBank Gene IDJ04813GenAtlas IDCYP3A5HGNC IDHGNC:2638",
                        "General References": "Aoyama T, Yamano S, Waxman DJ, Lapenson DP, Meyer UA, Fischer V, Tyndale R, Inaba T, Kalow W, Gelboin HV, et al.: Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. J Biol Chem. 1989 Jun 25;264(18):10388-95. [Article] Schuetz JD, Molowa DT, Guzelian PS: Characterization of a cDNA encoding a new member of the glucocorticoid-responsive cytochromes P450 in human liver. Arch Biochem Biophys. 1989 Nov 1;274(2):355-65. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Scherer SW, Cheung J, MacDonald JR, Osborne LR, Nakabayashi K, Herbrick JA, Carson AR, Parker-Katiraee L, Skaug J, Khaja R, Zhang J, Hudek AK, Li M, Haddad M, Duggan GE, Fernandez BA, Kanematsu E, Gentles S, Christopoulos CC, Choufani S, Kwasnicka D, Zheng XH, Lai Z, Nusskern D, Zhang Q, Gu Z, Lu F, Zeesman S, Nowaczyk MJ, Teshima I, Chitayat D, Shuman C, Weksberg R, Zackai EH, Grebe TA, Cox SR, Kirkpatrick SJ, Rahman N, Friedman JM, Heng HH, Pelicci PG, Lo-Coco F, Belloni E, Shaffer LG, Pober B, Morton CC, Gusella JF, Bruns GA, Korf BR, Quade BJ, Ligon AH, Ferguson H, Higgins AW, Leach NT, Herrick SR, Lemyre E, Farra CG, Kim HG, Summers AM, Gripp KW, Roberts W, Szatmari P, Winsor EJ, Grzeschik KH, Teebi A, Minassian BA, Kere J, Armengol L, Pujana MA, Estivill X, Wilson MD, Koop BF, Tosi S, Moore GE, Boright AP, Zlotorynski E, Kerem B, Kroisel PM, Petek E, Oscier DG, Mould SJ, Dohner H, Dohner K, Rommens JM, Vincent JB, Venter JC, Li PW, Mural RJ, Adams MD, Tsui LC: Human chromosome 7: DNA sequence and biology. Science. 2003 May 2;300(5620):767-72. Epub 2003 Apr 10. [Article] Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, Wagner-McPherson C, Layman D, Maas J, Jaeger S, Walker R, Wylie K, Sekhon M, Becker MC, O'Laughlin MD, Schaller ME, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Cordes M, Du H, Sun H, Edwards J, Bradshaw-Cordum H, Ali J, Andrews S, Isak A, Vanbrunt A, Nguyen C, Du F, Lamar B, Courtney L, Kalicki J, Ozersky P, Bielicki L, Scott K, Holmes A, Harkins R, Harris A, Strong CM, Hou S, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Leonard S, Rohlfing T, Rock SM, Tin-Wollam AM, Abbott A, Minx P, Maupin R, Strowmatt C, Latreille P, Miller N, Johnson D, Murray J, Woessner JP, Wendl MC, Yang SP, Schultz BR, Wallis JW, Spieth J, Bieri TA, Nelson JO, Berkowicz N, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Bedell JA, Mardis ER, Clifton SW, Chissoe SL, Marra MA, Raymond C, Haugen E, Gillett W, Zhou Y, James R, Phelps K, Iadanoto S, Bubb K, Simms E, Levy R, Clendenning J, Kaul R, Kent WJ, Furey TS, Baertsch RA, Brent MR, Keibler E, Flicek P, Bork P, Suyama M, Bailey JA, Portnoy ME, Torrents D, Chinwalla AT, Gish WR, Eddy SR, McPherson JD, Olson MV, Eichler EE, Green ED, Waterston RH, Wilson RK: The DNA sequence of human chromosome 7. Nature. 2003 Jul 10;424(6945):157-64. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Gellner K, Eiselt R, Hustert E, Arnold H, Koch I, Haberl M, Deglmann CJ, Burk O, Buntefuss D, Escher S, Bishop C, Koebe HG, Brinkmann U, Klenk HP, Kleine K, Meyer UA, Wojnowski L: Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics. 2001 Mar;11(2):111-21. [Article] Schuetz JD, Schuetz EG, Thottassery JV, Guzelian PS, Strom S, Sun D: Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells. Mol Pharmacol. 1996 Jan;49(1):63-72. [Article] Jounaidi Y, Guzelian PS, Maurel P, Vilarem MJ: Sequence of the 5'-flanking region of CYP3A5: comparative analysis with CYP3A4 and CYP3A7. Biochem Biophys Res Commun. 1994 Dec 30;205(3):1741-7. [Article] Finta C, Zaphiropoulos PG: Intergenic mRNA molecules resulting from trans-splicing. J Biol Chem. 2002 Feb 22;277(8):5882-90. Epub 2001 Nov 28. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Jounaidi Y, Hyrailles V, Gervot L, Maurel P: Detection of CYP3A5 allelic variant: a candidate for the polymorphic expression of the protein? Biochem Biophys Res Commun. 1996 Apr 16;221(2):466-70. [Article] Chou FC, Tzeng SJ, Huang JD: Genetic polymorphism of cytochrome P450 3A5 in Chinese. Drug Metab Dispos. 2001 Sep;29(9):1205-9. [Article] Lee SJ, Usmani KA, Chanas B, Ghanayem B, Xi T, Hodgson E, Mohrenweiser HW, Goldstein JA: Genetic findings and functional studies of human CYP3A5 single nucleotide polymorphisms in different ethnic groups. Pharmacogenetics. 2003 Aug;13(8):461-72. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00224IndinavirapprovedunknownsubstrateinhibitorDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinducerDetailsDB00468QuinineapprovedunknownsubstrateDetailsDB00541Vincristineapproved, investigationalnosubstrateDetailsDB00661VerapamilapprovedunknownsubstrateinhibitorDetailsDB00683Midazolamapproved, illicitunknownsubstrateDetailsDB00694DaunorubicinapprovedunknowninducerDetailsDB00758ClopidogrelapprovednosubstrateDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateDetailsDB00834Mifepristoneapproved, investigationalunknownsubstrateDetailsDB00864Tacrolimusapproved, investigationalunknownsubstrateDetailsDB01026Ketoconazoleapproved, investigationalnoinhibitorDetailsDB01232Saquinavirapproved, investigationalunknownsubstrateinhibitorDetailsDB13179TroleandomycinapprovedunknowninhibitorDetailsDB04856DexloxiglumideinvestigationalunknownsubstrateDetailsDB04957AzimilideinvestigationalunknownsubstrateDetailsDB06267Udenafilapproved, investigationalunknownsubstrateDetailsDB06287TemsirolimusapprovedunknownsubstrateinhibitorDetailsDB00802Alfentanilapproved, illicitunknownsubstrateDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateDetailsDB01181IfosfamideapprovedunknownsubstrateDetailsDB00321AmitriptylineapprovedunknownsubstrateDetailsDB00540NortriptylineapprovedunknownsubstrateDetailsDB00619ImatinibapprovednosubstrateinhibitorDetailsDB00675TamoxifenapprovedunknownsubstrateDetailsDB01041Thalidomideapproved, investigational, withdrawnnosubstrateinducerDetailsDB00220NelfinavirapprovednosubstrateinhibitorDetailsDB00238NevirapineapprovedunknownsubstrateDetailsDB06652VicrivirocinvestigationalunknownsubstrateDetailsDB00972AzelastineapprovedunknownsubstrateDetailsDB01211ClarithromycinapprovedunknownsubstrateinhibitorDetailsDB00404Alprazolamapproved, illicit, investigationalunknownsubstrateDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB00897Triazolamapproved, investigationalunknownsubstrateDetailsDB00604Cisaprideapproved, investigational, withdrawnunknownsubstrateDetailsDB00637Astemizoleapproved, withdrawnunknownsubstrateDetailsDB01114ChlorpheniramineapprovedunknownsubstrateDetailsDB00342Terfenadineapproved, withdrawnunknownsubstrateDetailsDB00381AmlodipineapprovedunknownsubstrateinhibitorDetailsDB00343Diltiazemapproved, investigationalunknownsubstrateinhibitorDetailsDB01023Felodipineapproved, investigationalunknownsubstrateDetailsDB00528Lercanidipineapproved, investigationalunknownsubstrateDetailsDB00401NisoldipineapprovedunknownsubstrateDetailsDB01054Nitrendipineapproved, investigationalunknownsubstrateDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB00439Cerivastatinapproved, withdrawnunknownsubstrateDetailsDB00641SimvastatinapprovedunknownsubstrateDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00741Hydrocortisoneapproved, vet_approvedunknownsubstrateDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateDetailsDB00624Testosteroneapproved, investigationalunknownsubstrateDetailsDB01238Aripiprazoleapproved, investigationalnosubstrateDetailsDB00490Buspironeapproved, investigationalunknownsubstrateDetailsDB01166Cilostazolapproved, investigationalunknownsubstrateDetailsDB00250Dapsoneapproved, investigationalunknownsubstrateDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB01248Docetaxelapproved, investigationalunknownsubstrateDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB00700EplerenoneapprovedunknownsubstrateDetailsDB01216FinasterideapprovedunknownsubstrateDetailsDB00502HaloperidolapprovedunknownsubstrateDetailsDB00281Lidocaineapproved, vet_approvedunknownsubstrateDetailsDB00731Nateglinideapproved, investigationalunknownsubstrateDetailsDB00904Ondansetronapproved, withdrawnunknownsubstrateDetailsDB01100PimozideapprovedunknownsubstrateDetailsDB00571Propranololapproved, investigationalunknownsubstrateDetailsDB01224QuetiapineapprovedunknownsubstrateDetailsDB00938SalmeterolapprovedunknownsubstrateDetailsDB00877Sirolimusapproved, investigationalnosubstrateDetailsDB00398Sorafenibapproved, investigationalunknownsubstrateDetailsDB01268Sunitinibapproved, investigationalunknownsubstrateDetailsDB01229Paclitaxelapproved, vet_approvedunknownsubstrateDetailsDB00656Trazodoneapproved, investigationalunknownsubstrateDetailsDB00962Zaleplonapproved, illicit, investigationalunknownsubstrateDetailsDB01167Itraconazoleapproved, investigationalnoinhibitorDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00446Chloramphenicolapproved, vet_approved, withdrawnunknowninhibitorDetailsDB00537Ciprofloxacinapproved, investigationalunknowninhibitorDetailsDB00705DelavirdineapprovedunknowninhibitorDetailsDB06730GestodeneinvestigationalunknowninhibitorDetailsDB01388Mibefradilinvestigational, withdrawnunknowninhibitorDetailsDB06731SeproxetineinvestigationalunknowninhibitorDetailsDB00582VoriconazoleapprovedunknownsubstrateinhibitorDetailsDB00313Valproic acidapproved, investigationalunknownsubstrateDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB06772CabazitaxelapprovedunknownsubstrateDetailsDB06697ArtemetherapprovedunknownsubstrateDetailsDB00701Amprenavirapproved, investigationalunknownsubstrateDetailsDB00278Argatrobanapproved, investigationalunknownsubstrateDetailsDB00394Beclomethasone dipropionateapproved, investigationalunknowninducerDetailsDB00564Carbamazepineapproved, investigationalunknownsubstrateinducerDetailsDB00608Chloroquineapproved, investigational, vet_approvednosubstrateDetailsDB00822DisulfiramapprovedunknownsubstrateDetailsDB00655EstroneapprovedunknownsubstrateDetailsDB00773EtoposideapprovedunknownsubstrateDetailsDB00499Flutamideapproved, investigationalunknownsubstrateDetailsDB01218HalofantrineapprovedunknownsubstrateDetailsDB01103QuinacrineinvestigationalnosubstrateDetailsDB00745Modafinilapproved, investigationalnosubstrateinducerDetailsDB00622Nicardipineapproved, investigationalunknowninhibitorDetailsDB00776OxcarbazepineapprovednoinhibitorinducerDetailsDB01062Oxybutyninapproved, investigationalunknownsubstrateDetailsDB00497Oxycodoneapproved, illicit, investigationalunknownsubstrateDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB01174Phenobarbitalapproved, investigationalnoinducerDetailsDB01058Praziquantelapproved, investigational, vet_approvedunknownsubstrateDetailsDB00206Reserpineapproved, investigational, withdrawnunknowninducerDetailsDB00444TeniposideapprovednosubstrateDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknowninhibitorDetailsDB00862VardenafilapprovedunknownsubstrateDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateDetailsDB00588Fluticasone propionateapprovedunknownsubstrateinhibitorDetailsDB00738Pentamidineapproved, investigationalunknownsubstrateDetailsDB00755Tretinoinapproved, investigational, nutraceuticalnosubstrateDetailsDB01254Dasatinibapproved, investigationalunknownsubstrateDetailsDB01259Lapatinibapproved, investigationalunknownsubstrateDetailsDB04946IloperidoneapprovedunknownsubstrateDetailsDB06176Romidepsinapproved, investigationalunknownsubstrateDetailsDB06335SaxagliptinapprovedunknownsubstrateDetailsDB06413Armodafinilapproved, investigationalunknowninducerDetailsDB00575ClonidineapprovedunknownsubstrateDetailsDB06419CethromycininvestigationalunknownsubstrateDetailsDB08873Boceprevirapproved, withdrawnunknownsubstrateinhibitorDetailsDB06228RivaroxabanapprovedunknownsubstrateDetailsDB08883PerampanelapprovednosubstrateDetailsDB08865Crizotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB06605ApixabanapprovedunknownsubstrateDetailsDB06626Axitinibapproved, investigationalnosubstrateDetailsDB08899EnzalutamideapprovednosubstrateinducerDetailsDB08901Ponatinibapproved, investigationalunknownsubstrateDetailsDB05773Trastuzumab emtansineapproved, investigationalunknownsubstrateDetailsDB00531Cyclophosphamideapproved, investigationalunknownsubstrateDetailsDB01095FluvastatinapprovedunknownsubstrateDetailsDB00472Fluoxetineapproved, vet_approvedunknownsubstrateDetailsDB00317Gefitinibapproved, investigationalunknownsubstrateDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB09053IbrutinibapprovedunknownsubstrateDetailsDB09068Vortioxetineapproved, investigationalnosubstrateDetailsDB09102Daclatasvirapproved, investigationalunknownsubstrateDetailsDB06403Ambrisentanapproved, investigationalnosubstrateDetailsDB06789Hydroxyprogesterone caproateapproved, investigationalunknownsubstrateDetailsDB09297Paritaprevirapproved, investigationalnosubstrateDetailsDB12161Deutetrabenazineapproved, investigationalnosubstrateDetailsDB11915Valbenazineapproved, investigationalnosubstrateDetailsDB08820IvacaftorapprovednosubstrateinhibitorDetailsDB09054IdelalisibapprovednosubstrateinhibitorDetailsDB09065CobicistatapprovednosubstrateDetailsDB06412Oxymetholoneapproved, illicitunknowninhibitorDetailsDB00503Ritonavirapproved, investigationalunknownsubstrateinhibitorDetailsDB06595Midostaurinapproved, investigationalunknowninducerDetailsDB11574ElbasvirapprovedunknownsubstrateDetailsDB12483Copanlisibapproved, investigationalnosubstrateDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB09061Cannabidiolapproved, investigationalunknownsubstrateinhibitorDetailsDB13943Testosterone cypionateapprovedunknownsubstrateDetailsDB13944Testosterone enanthateapprovedunknownsubstrateDetailsDB13946Testosterone undecanoateapproved, investigationalunknownsubstrateDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateDetailsDB09231BenidipineexperimentalnosubstrateDetailsDB11633Isavuconazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB11712Tezacaftorapproved, investigationalnosubstrateinducerDetailsDB11586Asunaprevirapproved, investigational, withdrawnnosubstrateinducerDetailsDB14011NabiximolsinvestigationalunknownsubstrateDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorDetailsDB00625Efavirenzapproved, investigationalunknowninducerDetailsDB00199Erythromycinapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB14185Aripiprazole lauroxilapproved, investigationalunknownsubstrateDetailsDB14538Hydrocortisone aceponateexperimental, vet_approvedunknownsubstrateDetailsDB14539Hydrocortisone acetateapproved, vet_approvedunknownsubstrateDetailsDB14540Hydrocortisone butyrateapproved, vet_approvedunknownsubstrateDetailsDB14541Hydrocortisone cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB14542Hydrocortisone phosphateapproved, vet_approvedunknownsubstrateDetailsDB14543Hydrocortisone probutateapproved, vet_approvedunknownsubstrateDetailsDB14544Hydrocortisone valerateapproved, vet_approvedunknownsubstrateDetailsDB01222BudesonideapprovednoinducerDetailsDB06654Safinamideapproved, investigationalunknowninhibitorDetailsDB11703Acalabrutinibapproved, investigationalunknowninhibitorDetailsDB01267PaliperidoneapprovedunknownsubstrateDetailsDB11737Icotinibexperimental, investigationalunknownsubstrateinducerDetailsDB00909Zonisamideapproved, investigationalnosubstrateDetailsDB09256Tegafurapproved, investigationalunknownsubstrateDetailsDB12301Doravirineapproved, investigationalunknownsubstrateDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateDetailsDB09074OlaparibapprovedunknownsubstrateinhibitorDetailsDB00455Loratadineapproved, investigationalunknownsubstrateDetailsDB13867Fluticasoneapproved, experimentalunknownsubstrateinhibitorinducerDetailsDB08906Fluticasone furoateapprovednosubstrateinhibitorinducerDetailsDB01126Dutasterideapproved, investigationalnosubstrateDetailsDB00905Bimatoprostapproved, investigationalunknownsubstrateDetailsDB00916MetronidazoleapprovedunknownsubstrateDetailsDB00288AmcinonideapprovedunknowninducerDetailsDB00443Betamethasoneapproved, vet_approvedunknowninducerDetailsDB14669Betamethasone phosphateapproved, vet_approvedunknowninducerDetailsDB11750Clobetasolapproved, experimental, investigationalunknowninducerDetailsDB01013Clobetasol propionateapprovedunknowninducerDetailsDB14652Clocortolone acetateexperimentalunknowninducerDetailsDB13843CloprednolexperimentalunknowninducerDetailsDB14681CortisoneexperimentalunknowninducerDetailsDB01380Cortisone acetateapproved, investigationalunknowninducerDetailsDB13003CortivazolinvestigationalunknowninducerDetailsDB11921Deflazacortapproved, investigationalunknowninducerDetailsDB11487Dexamethasone isonicotinatevet_approvedunknowninducerDetailsDB09095Difluocortoloneapproved, investigational, withdrawnunknowninducerDetailsDB01047Fluocinonideapproved, investigationalunknowninducerDetailsDB08971Fluocortoloneapproved, withdrawnunknowninducerDetailsDB00324Fluorometholoneapproved, investigationalunknowninducerDetailsDB08970FluprednideneexperimentalunknowninducerDetailsDB14634Fluprednidene acetateexperimentalunknowninducerDetailsDB13728HalometasoneexperimentalunknowninducerDetailsDB00253MedrysoneapprovedunknowninducerDetailsDB14659Melengestrol acetateexperimentalunknowninducerDetailsDB09383Meprednisoneapproved, investigationalunknowninducerDetailsDB14644Methylprednisolone hemisuccinateapprovedunknowninducerDetailsDB00764MometasoneexperimentalunknowninducerDetailsDB14512Mometasone furoateapproved, investigational, vet_approvednoinducerDetailsDB01384ParamethasoneexperimentalunknowninducerDetailsDB14633Prednisolone hemisuccinateexperimentalunknowninducerDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninducerDetailsDB00635Prednisoneapproved, vet_approvedunknowninducerDetailsDB14646Prednisone acetateapproved, experimental, investigationalunknowninducerDetailsDB13208PrednylideneexperimentalunknowninducerDetailsDB00896RimexoloneapprovedunknowninducerDetailsDB00620Triamcinoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB01045RifampicinapprovedunknowninducerDetailsDB00196Fluconazoleapproved, investigationalunknowninhibitorDetailsDB02520DitiocarbexperimentalunknowninhibitorDetailsDB00367Levonorgestrelapproved, investigationalunknownsubstrateDetailsDB01016GlyburideapprovedunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknownsubstrateDetailsDB09061Cannabidiolapproved, investigationalunknowninhibitorDetailsDB11761Tenapanorapproved, investigationalunknownsubstrateDetailsDB14011NabiximolsinvestigationalunknowninhibitorDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB04855DronedaroneapprovedunknownsubstrateinhibitorDetailsDB01217Anastrozoleapproved, investigationalunknownsubstrateDetailsDB15444Elexacaftorapproved, investigationalnosubstrateDetailsDB00557HydroxyzineapprovednosubstrateDetailsDB06119Cenobamateapproved, investigationalunknownsubstrateinhibitorDetailsDB11951Lemborexantapproved, investigationalunknownsubstrateDetailsDB01115NifedipineapprovedunknownsubstrateDetailsDB01190Clindamycinapproved, vet_approvedunknownsubstrateDetailsDB00977EthinylestradiolapprovedunknownsubstrateDetailsDB13609UmifenovirinvestigationalunknownsubstrateDetailsDB11837Osilodrostatapproved, investigationalunknowninhibitorDetailsDB09241Methylene blueapproved, investigationalunknowninhibitorDetailsDB11689Selumetinibapproved, investigationalnosubstrateDetailsDB00845Clofazimineapproved, investigationalunknowninhibitorDetailsDB00714Apomorphineapproved, investigationalunknownsubstrateDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB15822Pralsetinibapproved, investigationalnoinhibitorinducerDetailsDB06448Lonafarnibapproved, investigationalnosubstrateinhibitorDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB05667Levoketoconazoleapproved, investigationalnoinhibitorinducerDetailsDB14984Casimersenapproved, investigationalnoinhibitorDetailsDB12016Ponesimodapproved, investigationalunknownsubstrateDetailsDB05316Pimavanserinapproved, investigationalunknownsubstrateDetailsDB08816TicagrelorapprovedunknownsubstrateactivatorDetailsDB16222Loncastuximab tesirineapproved, investigationalunknownsubstrateDetailsDB12543Samidorphanapproved, investigationalnosubstrateDetailsDB12265Fexinidazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB16390Mobocertinibapproved, investigationalunknownsubstrateDetailsDB12834SecnidazoleapprovedunknownsubstrateDetailsDB00470Dronabinolapproved, illicitnoinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknowninhibitorDetailsDB06230Nalmefeneapproved, investigational, withdrawnnosubstrateDetailsDB05087Ganaxoloneapproved, investigationalnosubstrateDetailsDB06016Cariprazineapproved, investigationalnoinducerDetailsDB09185Viloxazineapproved, investigational, withdrawnnoinhibitorDetailsDB14921Mavacamtenapproved, investigationalnosubstrateDetailsDB01024Mycophenolic acidapproved, investigationalunknownsubstrateDetailsDB11739Vonoprazanapproved, investigationalunknownsubstrateDetailsDB05239Cobimetinibapproved, investigationalnoDetailsDB12240Polatuzumab vedotinapproved, investigationalnosubstrateDetailsDB17472Pirtobrutinibapproved, investigationalunknowninducerDetailsDB00349Clobazamapproved, illicitnosubstrateDetailsDB09065CobicistatapprovedyesinhibitorDetailsDB16217Leniolisibapproved, investigationalnosubstrateDetailsDB12874Quizartinibapproved, investigationalnosubstrateDetailsDB05812AbirateroneapprovedunknowninhibitorDetailsDB11718Encorafenibapproved, investigationalnoinhibitorDetailsDB01072Atazanavirapproved, investigationalunknowninhibitorDetailsDB15114Vamoroloneapproved, investigationalnosubstrateDetailsDB16826RepotrectinibinvestigationalunknownDetailsDB11679FruquintinibinvestigationalnosubstrateDetailsDB00176Fluvoxamineapproved, investigationalunknowninhibitorDetailsDB00599Thiopentalapproved, vet_approvedunknownsubstrateDetailsDB08930DolutegravirapprovednosubstrateDetailsDB06595Midostaurinapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB13174RheinexperimentalunknowninhibitorDetailsDB11994Diacereinapproved, investigationalunknowninhibitorDetailsDB11605MyrrhapprovedunknowninducerDetailsDB11691Naldemedineapproved, investigationalnosubstrateDetailsDB13878Pibrentasvirapproved, investigationalunknowninhibitorDetailsDB13879Glecaprevirapproved, investigationalunknownsubstrateinhibitorDetailsDB09205Moxisylyteapproved, investigationalnosubstrateDetailsDB09568Omega-3-carboxylic acidsapproved, investigationalnosubstrateDetailsDB01601LopinavirapprovednoinhibitorDetailsDB01149Nefazodoneapproved, withdrawnnoinhibitorDetailsDB13141Ambroxol acefyllinateexperimental, investigationalnosubstrateDetailsDB11792MirodenafilinvestigationalunknownsubstrateDetailsDB11979Elagolixapproved, investigationalnosubstrateDetailsDB08865Crizotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB11703Acalabrutinibapproved, investigationalunknownsubstrateDetailsDB12267Brigatinibapproved, investigationalunknowninducerDetailsDB12307ForetinibinvestigationalunknownsubstrateDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB00593EthosuximideapprovedunknownsubstrateDetailsDB01201Rifapentineapproved, investigationalunknowninducerDetailsDB00643Mebendazoleapproved, vet_approvedunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknowninhibitorDetailsDB00334Olanzapineapproved, investigationalunknowninhibitorDetailsDB09212LoxoprofenapprovedunknownsubstrateDetailsDB00635Prednisoneapproved, vet_approvedunknowninducerDetailsDB01222BudesonideapprovedunknownsubstrateinducerDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB11951Lemborexantapproved, investigationalunknowninhibitorinducerDetailsDB12887Tazemetostatapproved, investigationalunknownsubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninducerDetailsDB11652Tucatinibapproved, investigationalunknownsubstrateDetailsDB15035Zanubrutinibapproved, investigationalunknownsubstrateDetailsDB15685Selpercatinibapproved, investigationalunknowninhibitorDetailsDB00409Remoxiprideapproved, withdrawnunknowninhibitorDetailsDB15305Risdiplamapproved, investigationalunknowninhibitorDetailsDB06448Lonafarnibapproved, investigationalnosubstrateinhibitorDetailsDB11853Relugolixapproved, investigationalunknownsubstrateinducerDetailsDB01586Ursodeoxycholic acidapproved, investigationalunknowninducerDetailsDB11742Ebastineapproved, investigationalunknownsubstrateDetailsDB15569Sotorasibapproved, investigationalunknownsubstrateDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB00647Dextropropoxypheneapproved, illicit, investigational, withdrawnunknowninhibitorDetailsDB00333MethadoneapprovednoinhibitorDetailsDB01167Itraconazoleapproved, investigationalnoinhibitorDetailsDB16536Birch bark extractapproved, experimentalunknowninhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateinhibitorDetails"
                    }
                },
                {
                    "Label": "Cytochrome P450 2C9",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 2C9",
                        "Synonyms": "(R)-limonene 6-monooxygenase\n(S)-limonene 6-monooxygenase\n(S)-limonene 7-monooxygenase\n1.14.13.-\nCholesterol 25-hydroxylase\nCYP2C10\nCYPIIC9\nCytochrome P-450MP\nCytochrome P450 MP-4\nCytochrome P450 MP-8\nCytochrome P450 PB-1\nS-mephenytoin 4-hydroxylase",
                        "Gene Name": "CYP2C9",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0005471|Cytochrome P450 2C9\nMDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDISKSLTNLSKV\nYGPVFTLYFGLKPIVVLHGYEAVKEALIDLGEEFSGRGIFPLAERANRGFGIVFSNGKKW\nKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICS\nIIFHKRFDYKDQQFLNLMEKLNENIKILSSPWIQICNNFSPIIDYFPGTHNKLLKNVAFM\nKSYILEKVKEHQESMDMNNPQDFIDCFLMKMEKEKHNQPSEFTIESLENTAVDLFGAGTE\nTTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRSHMPYTDAVVHEVQRYID\nLLPTSLPHAVTCDIKFRNYLIPKGTTILISLTSVLHDNKEFPNPEMFDPHHFLDEGGNFK\nKSKYFMPFSAGKRICVGEALAGMELFLFLTSILQNFNLKSLVDPKNLDTTPVVNGFASVP\nPFYQLCFIPV",
                        "Number of residues": "490",
                        "Molecular Weight": "55627.365",
                        "Theoretical pI": "7.99",
                        "GO Classification": "Functions(R)-limonene 6-monooxygenase activity / (S)-limonene 6-monooxygenase activity / (S)-limonene 7-monooxygenase activity / arachidonic acid epoxygenase activity / aromatase activity / caffeine oxidase activity / drug binding / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity / oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen / oxygen binding / steroid hydroxylase activityProcessesarachidonic acid metabolic process / cellular amide metabolic process / drug catabolic process / drug metabolic process / epoxygenase P450 pathway / exogenous drug catabolic process / monocarboxylic acid metabolic process / monoterpenoid metabolic process / omega-hydroxylase P450 pathway / oxidation-reduction process / oxidative demethylation / small molecule metabolic process / steroid metabolic process / urea metabolic process / xenobiotic metabolic processComponentscytoplasm / endoplasmic reticulum membrane / intracellular membrane-bounded organelle",
                        "General Function": "Steroid hydroxylase activity",
                        "Specific Function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. This enzyme contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S-warfarin, diclofenac, phenytoin, tolbutamide and losartan.",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0016893|Cytochrome P450 2C9 (CYP2C9)\nATGGATTCTCTTGTGGTCCTTGTGCTCTGTCTCTCATGTTTGCTTCTCCTTTCACTCTGG\nAGACAGAGCTCTGGGAGAGGAAAACTCCCTCCTGGCCCCACTCCTCTCCCAGTGATTGGA\nAATATCCTACAGATAGGTATTAAGGACATCAGCAAATCCTTAACCAATCTCTCAAAGGTC\nTATGGCCCTGTGTTCACTCTGTATTTTGGCCTGAAACCCATAGTGGTGCTGCATGGATAT\nGAAGCAGTGAAGGAAGCCCTGATTGATCTTGGAGAGGAGTTTTCTGGAAGAGGCATTTTC\nCCACTGGCTGAAAGAGCTAACAGAGGATTTGGAATTGTTTTCAGCAATGGAAAGAAATGG\nAAGGAGATCCGGCGTTTCTCCCTCATGACGCTGCGGAATTTTGGGATGGGGAAGAGGAGC\nATTGAGGACCGTGTTCAAGAGGAAGCCCGCTGCCTTGTGGAGGAGTTGAGAAAAACCAAG\nGCCTCACCCTGTGATCCCACTTTCATCCTGGGCTGTGCTCCCTGCAATGTGATCTGCTCC\nATTATTTTCCATAAACGTTTTGATTATAAAGATCAGCAATTTCTTAACTTAATGGAAAAG\nTTGAATGAAAACATCAAGATTTTGAGCAGCCCCTGGATCCAGATCTGCAATAATTTTTCT\nCCTATCATTGATTACTTCCCGGGAACTCACAACAAATTACTTAAAAACGTTGCTTTTATG\nAAAAGTTATATTTTGGAAAAAGTAAAAGAACACCAAGAATCAATGGACATGAACAACCCT\nCAGGACTTTATTGATTGCTTCCTGATGAAAATGGAGAAGGAAAAGCACAACCAACCATCT\nGAATTTACTATTGAAAGCTTGGAAAACACTGCAGTTGACTTGTTTGGAGCTGGGACAGAG\nACGACAAGCACAACCCTGAGATATGCTCTCCTTCTCCTGCTGAAGCACCCAGAGGTCACA\nGCTAAAGTCCAGGAAGAGATTGAACGTGTGATTGGCAGAAACCGGAGCCCCTGCATGCAA\nGACAGGAGCCACATGCCCTACACAGATGCTGTGGTGCACGAGGTCCAGAGATACATTGAC\nCTTCTCCCCACCAGCCTGCCCCATGCAGTGACCTGTGACATTAAATTCAGAAACTATCTC\nATTCCCAAGGGCACAACCATATTAATTTCCCTGACTTCTGTGCTACATGACAACAAAGAA\nTTTCCCAACCCAGAGATGTTTGACCCTCATCACTTTCTGGATGAAGGTGGCAATTTTAAG\nAAAAGTAAATACTTCATGCCTTTCTCAGCAGGAAAACGGATTTGTGTGGGAGAAGCCCTG\nGCCGGCATGGAGCTGTTTTTATTCCTGACCTCCATTTTACAGAACTTTAACCTGAAATCT\nCTGGTTGACCCAAAGAACCTTGACACCACTCCAGTTGTCAATGGATTTGCCTCTGTGCCG\nCCCTTCTACCAGCTGTGCTTCATTCCTGTCTGA",
                        "Chromosome Location": "10",
                        "Locus": "10q24",
                        "External Identifiers": "ResourceLinkUniProtKB IDP11712UniProtKB Entry NameCP2C9_HUMANGenBank Gene IDAY341248GenAtlas IDCYP2C9HGNC IDHGNC:2623",
                        "General References": "Meehan RR, Gosden JR, Rout D, Hastie ND, Friedberg T, Adesnik M, Buckland R, van Heyningen V, Fletcher J, Spurr NK, et al.: Human cytochrome P-450 PB-1: a multigene family involved in mephenytoin and steroid oxidations that maps to chromosome 10. Am J Hum Genet. 1988 Jan;42(1):26-37. [Article] Kimura S, Pastewka J, Gelboin HV, Gonzalez FJ: cDNA and amino acid sequences of two members of the human P450IIC gene subfamily. Nucleic Acids Res. 1987 Dec 10;15(23):10053-4. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Deloukas P, Earthrowl ME, Grafham DV, Rubenfield M, French L, Steward CA, Sims SK, Jones MC, Searle S, Scott C, Howe K, Hunt SE, Andrews TD, Gilbert JG, Swarbreck D, Ashurst JL, Taylor A, Battles J, Bird CP, Ainscough R, Almeida JP, Ashwell RI, Ambrose KD, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Bates K, Beasley H, Bray-Allen S, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Cahill P, Camire D, Carter NP, Chapman JC, Clark SY, Clarke G, Clee CM, Clegg S, Corby N, Coulson A, Dhami P, Dutta I, Dunn M, Faulkner L, Frankish A, Frankland JA, Garner P, Garnett J, Gribble S, Griffiths C, Grocock R, Gustafson E, Hammond S, Harley JL, Hart E, Heath PD, Ho TP, Hopkins B, Horne J, Howden PJ, Huckle E, Hynds C, Johnson C, Johnson D, Kana A, Kay M, Kimberley AM, Kershaw JK, Kokkinaki M, Laird GK, Lawlor S, Lee HM, Leongamornlert DA, Laird G, Lloyd C, Lloyd DM, Loveland J, Lovell J, McLaren S, McLay KE, McMurray A, Mashreghi-Mohammadi M, Matthews L, Milne S, Nickerson T, Nguyen M, Overton-Larty E, Palmer SA, Pearce AV, Peck AI, Pelan S, Phillimore B, Porter K, Rice CM, Rogosin A, Ross MT, Sarafidou T, Sehra HK, Shownkeen R, Skuce CD, Smith M, Standring L, Sycamore N, Tester J, Thorpe A, Torcasso W, Tracey A, Tromans A, Tsolas J, Wall M, Walsh J, Wang H, Weinstock K, West AP, Willey DL, Whitehead SL, Wilming L, Wray PW, Young L, Chen Y, Lovering RC, Moschonas NK, Siebert R, Fechtel K, Bentley D, Durbin R, Hubbard T, Doucette-Stamm L, Beck S, Smith DR, Rogers J: The DNA sequence and comparative analysis of human chromosome 10. Nature. 2004 May 27;429(6990):375-81. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Yasumori T, Kawano S, Nagata K, Shimada M, Yamazoe Y, Kato R: Nucleotide sequence of a human liver cytochrome P-450 related to the rat male specific form. J Biochem. 1987 Nov;102(5):1075-82. [Article] Umbenhauer DR, Martin MV, Lloyd RS, Guengerich FP: Cloning and sequence determination of a complementary DNA related to human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylase. Biochemistry. 1987 Feb 24;26(4):1094-9. [Article] Ged C, Umbenhauer DR, Bellew TM, Bork RW, Srivastava PK, Shinriki N, Lloyd RS, Guengerich FP: Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 (S)-mephenytoin 4'-hydroxylase. Biochemistry. 1988 Sep 6;27(18):6929-40. [Article] Ohgiya S, Komori M, Ohi H, Shiramatsu K, Shinriki N, Kamataki T: Six-base deletion occurring in messages of human cytochrome P-450 in the CYP2C subfamily results in reduction of tolbutamide hydroxylase activity. Biochem Int. 1992 Sep;27(6):1073-81. [Article] Shimada T, Misono KS, Guengerich FP: Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction. J Biol Chem. 1986 Jan 15;261(2):909-21. [Article] Komori M, Hashizume T, Ohi H, Miura T, Kitada M, Nagashima K, Kamataki T: Cytochrome P-450 in human liver microsomes: high-performance liquid chromatographic isolation of three forms and their characterization. J Biochem. 1988 Dec;104(6):912-6. [Article] Srivastava PK, Yun CH, Beaune PH, Ged C, Guengerich FP: Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes. Mol Pharmacol. 1991 Jul;40(1):69-79. [Article] Haining RL, Hunter AP, Veronese ME, Trager WF, Rettie AE: Allelic variants of human cytochrome P450 2C9: baculovirus-mediated expression, purification, structural characterization, substrate stereoselectivity, and prochiral selectivity of the wild-type and I359L mutant forms. Arch Biochem Biophys. 1996 Sep 15;333(2):447-58. [Article] Sandhu P, Baba T, Guengerich FP: Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity. Arch Biochem Biophys. 1993 Nov 1;306(2):443-50. [Article] Miyazawa M, Shindo M, Shimada T: Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes. Drug Metab Dispos. 2002 May;30(5):602-7. [Article] Honda A, Miyazaki T, Ikegami T, Iwamoto J, Maeda T, Hirayama T, Saito Y, Teramoto T, Matsuzaki Y: Cholesterol 25-hydroxylation activity of CYP3A. J Lipid Res. 2011 Aug;52(8):1509-16. doi: 10.1194/jlr.M014084. Epub 2011 May 16. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Williams PA, Cosme J, Ward A, Angove HC, Matak Vinkovic D, Jhoti H: Crystal structure of human cytochrome P450 2C9 with bound warfarin. Nature. 2003 Jul 24;424(6947):464-8. Epub 2003 Jul 13. [Article] Stubbins MJ, Harries LW, Smith G, Tarbit MH, Wolf CR: Genetic analysis of the human cytochrome P450 CYP2C9 locus. Pharmacogenetics. 1996 Oct;6(5):429-39. [Article] Bhasker CR, Miners JO, Coulter S, Birkett DJ: Allelic and functional variability of cytochrome P4502C9. Pharmacogenetics. 1997 Feb;7(1):51-8. [Article] Imai J, Ieiri I, Mamiya K, Miyahara S, Furuumi H, Nanba E, Yamane M, Fukumaki Y, Ninomiya H, Tashiro N, Otsubo K, Higuchi S: Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locus. Pharmacogenetics. 2000 Feb;10(1):85-9. [Article] Dickmann LJ, Rettie AE, Kneller MB, Kim RB, Wood AJ, Stein CM, Wilkinson GR, Schwarz UI: Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans. Mol Pharmacol. 2001 Aug;60(2):382-7. [Article] Higashi MK, Veenstra DL, Kondo LM, Wittkowsky AK, Srinouanprachanh SL, Farin FM, Rettie AE: Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy. JAMA. 2002 Apr 3;287(13):1690-8. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB03317Ferroheme CexperimentalunknownDetailsDB00196Fluconazoleapproved, investigationalunknowninhibitorDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateinhibitorDetailsDB00222GlimepirideapprovedunknownsubstrateDetailsDB00250Dapsoneapproved, investigationalunknownsubstrateinducerDetailsDB00327Hydromorphoneapproved, illicitnosubstrateDetailsDB00469TenoxicamapprovedunknownsubstrateDetailsDB00470Dronabinolapproved, illicitnosubstrateinhibitorinducerDetailsDB00471MontelukastapprovedunknownsubstrateDetailsDB00472Fluoxetineapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00482Celecoxibapproved, investigationalunknownsubstrateDetailsDB00549Zafirlukastapproved, investigationalunknownsubstrateinhibitorDetailsDB00559Bosentanapproved, investigationalunknownsubstrateinducerDetailsDB00580Valdecoxibapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00582VoriconazoleapprovedunknownsubstrateinhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknownsubstrateDetailsDB00617ParamethadioneapprovedunknownsubstrateDetailsDB00675TamoxifenapprovedunknownsubstrateinhibitorDetailsDB00678LosartanapprovedunknownsubstrateDetailsDB00682WarfarinapprovedunknownsubstrateinducerDetailsDB00712Flurbiprofenapproved, investigationalunknownsubstrateDetailsDB00731Nateglinideapproved, investigationalunknownsubstrateDetailsDB00744Zileutonapproved, investigational, withdrawnunknownsubstrateDetailsDB00749Etodolacapproved, investigational, vet_approvedunknownsubstrateDetailsDB00784Mefenamic acidapprovedunknownsubstrateinhibitorDetailsDB00814Meloxicamapproved, vet_approvedunknownsubstrateDetailsDB00870Suprofenapproved, withdrawnunknownsubstrateinhibitorDetailsDB00916MetronidazoleapprovedunknowninhibitorDetailsDB00946Phenprocoumonapproved, investigationalunknownsubstrateDetailsDB01015SulfamethoxazoleapprovedunknownsubstrateinhibitorDetailsDB01029Irbesartanapproved, investigationalunknownsubstrateDetailsDB01050IbuprofenapprovedunknownsubstrateDetailsDB01067Glipizideapproved, investigationalunknownsubstrateDetailsDB01095FluvastatinapprovedunknownsubstrateinhibitorDetailsDB01104SertralineapprovedunknownsubstrateinhibitorDetailsDB01136Carvedilolapproved, investigationalunknownsubstrateDetailsDB01283Lumiracoxibapproved, investigationalunknownsubstrateDetailsDB00969Alosetronapproved, withdrawnnosubstrateDetailsDB00176Fluvoxamineapproved, investigationalnoinhibitorDetailsDB00214TorasemideapprovedunknownsubstrateinhibitorDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinhibitorinducerDetailsDB00412Rosiglitazoneapproved, investigationalunknownsubstrateinhibitorDetailsDB00448Lansoprazoleapproved, investigationalunknowninhibitorinducerDetailsDB00503Ritonavirapproved, investigationalunknowninducerDetailsDB00532Mephenytoinapproved, investigational, withdrawnunknownsubstrateDetailsDB00673Aprepitantapproved, investigationalunknowninhibitorinducerDetailsDB00705DelavirdineapprovedunknowninhibitorDetailsDB01016GlyburideapprovedunknownsubstrateinhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB01118Amiodaroneapproved, investigationalunknowninhibitorDetailsDB01124Tolbutamideapproved, investigationalunknownsubstrateDetailsDB01241GemfibrozilapprovedunknowninhibitorDetailsDB01381Ginkgo bilobaapproved, investigational, nutraceuticalunknowninhibitorDetailsDB01418Acenocoumarolapproved, investigationalunknownsubstrateDetailsDB04856DexloxiglumideinvestigationalunknownsubstrateinhibitorDetailsDB06442AvasimibeinvestigationalunknowninhibitorDetailsDB01098RosuvastatinapprovednosubstrateDetailsDB01065Melatoninapproved, nutraceutical, vet_approvedunknownsubstrateDetailsDB00796Candesartan cilexetilapprovedunknownsubstrateDetailsDB00641SimvastatinapprovedunknowninhibitorDetailsDB01076AtorvastatinapprovednoinhibitorDetailsDB00439Cerivastatinapproved, withdrawnunknowninhibitorDetailsDB01072Atazanavirapproved, investigationalnosubstrateinhibitorDetailsDB01181IfosfamideapprovedunknownsubstrateDetailsDB00619ImatinibapprovednosubstrateinhibitorDetailsDB00468QuinineapprovedunknownsubstrateDetailsDB01142Doxepinapproved, investigationalnosubstrateDetailsDB00321AmitriptylineapprovedunknownsubstrateDetailsDB04557Arachidonic AcidexperimentalunknownsubstrateDetailsDB01045RifampicinapprovedunknowninducerDetailsDB01174Phenobarbitalapproved, investigationalunknownsubstrateinducerDetailsDB00404Alprazolamapproved, illicit, investigationalunknownsubstrateDetailsDB00363ClozapineapprovednosubstrateDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB01357MestranolapprovedunknownsubstrateDetailsDB00788Naproxenapproved, vet_approvedunknownsubstrateDetailsDB00531Cyclophosphamideapproved, investigationalunknownsubstrateDetailsDB01355HexobarbitalexperimentalunknownsubstrateDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00554Piroxicamapproved, investigationalunknownsubstrateDetailsDB00208TiclopidineapprovedunknowninhibitorDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknownsubstrateDetailsDB00715Paroxetineapproved, investigationalunknowninhibitorDetailsDB01435Antipyrineapproved, investigationalunknownsubstrateDetailsDB00177Valsartanapproved, investigationalunknownsubstrateDetailsDB00188Bortezomibapproved, investigationalnosubstrateinhibitorDetailsDB01041Thalidomideapproved, investigational, withdrawnnosubstrateDetailsDB05109Trabectedinapproved, investigationalunknownsubstrateDetailsDB00313Valproic acidapproved, investigationalunknownsubstrateinhibitorDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00238NevirapineapprovedunknowninducerDetailsDB06652VicrivirocinvestigationalunknownsubstrateDetailsDB00972AzelastineapprovedunknownsubstrateinhibitorDetailsDB00568Cinnarizineapproved, investigationalunknownsubstrateDetailsDB04841FlunarizineapprovedunknownsubstrateDetailsDB01075Diphenhydramineapproved, investigationalunknownsubstrateDetailsDB06725Lornoxicamapproved, investigationalunknownsubstrateDetailsDB01039FenofibrateapprovedunknowninhibitorDetailsDB00951Isoniazidapproved, investigationalunknowninhibitorDetailsDB00812Phenylbutazoneapproved, vet_approvedunknownsubstrateinhibitorDetailsDB06729SulfaphenazoleapprovedunknowninhibitorDetailsDB00444TeniposideapprovedunknowninhibitorDetailsDB06414EtravirineapprovedunknownsubstrateinhibitorDetailsDB01320Fosphenytoinapproved, investigationalunknownsubstrateinducerDetailsDB01221Ketamineapproved, vet_approvedunknownsubstrateDetailsDB00359Sulfadiazineapproved, investigational, vet_approvedunknowninhibitorDetailsDB01138SulfinpyrazoneapprovedunknowninhibitorDetailsDB00263Sulfisoxazoleapproved, vet_approvedunknowninhibitorDetailsDB01198ZopicloneapprovedunknownsubstrateDetailsDB00564Carbamazepineapproved, investigationalunknowninducerDetailsDB00794Primidoneapproved, vet_approvedunknownsubstrateinducerDetailsDB01201Rifapentineapproved, investigationalunknowninducerDetailsDB00418Secobarbitalapproved, vet_approvedunknowninducerDetailsDB00625Efavirenzapproved, investigationalunknowninhibitorDetailsDB01097Leflunomideapproved, investigationalunknownsubstrateinhibitorDetailsDB04868Nilotinibapproved, investigationalunknowninhibitorDetailsDB00398Sorafenibapproved, investigationalunknowninhibitorDetailsDB01101Capecitabineapproved, investigationalnodownregulatorDetailsDB00544FluorouracilapprovedunknowninhibitorDetailsDB06268Sitaxentanapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00752Tranylcypromineapproved, investigationalunknowninhibitorDetailsDB01424Aminophenazoneapproved, withdrawnunknownsubstrateDetailsDB00216Eletriptanapproved, investigationalunknownsubstrateDetailsDB00758ClopidogrelapprovednosubstrateinhibitorDetailsDB00843DonepezilapprovedunknownsubstrateDetailsDB00661VerapamilapprovedunknownsubstrateinhibitorDetailsDB00425ZolpidemapprovedunknownsubstrateDetailsDB01036Tolterodineapproved, investigationalunknownsubstrateDetailsDB00328Indomethacinapproved, investigationalunknownsubstrateDetailsDB00936Salicylic acidapproved, investigational, vet_approvedunknownsubstrateDetailsDB01628Etoricoxibapproved, investigationalunknownsubstrateinhibitorDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB00818Propofolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00672Chlorpropamideapproved, investigationalunknownsubstrateDetailsDB01120GliclazideapprovedunknownsubstrateDetailsDB00201CaffeineapprovedunknownsubstrateDetailsDB00514DextromethorphanapprovedunknownsubstrateDetailsDB01009Ketoprofenapproved, vet_approvedunknownsubstrateinhibitorDetailsDB04725LicofeloneinvestigationalunknownsubstrateDetailsDB06737ZaltoprofenexperimentalunknownsubstrateDetailsDB06739SeratrodastexperimentalunknownsubstrateDetailsDB06738KetobemidoneinvestigationalunknownsubstrateDetailsDB06736Aceclofenacapproved, investigationalunknownsubstrateDetailsDB08798SulfamoxoleexperimentalunknowninhibitorDetailsDB06697ArtemetherapprovedunknownsubstrateDetailsDB00945Acetylsalicylic acidapproved, vet_approvedunknownsubstrateDetailsDB00613Amodiaquineapproved, investigationalunknowninhibitorDetailsDB00701Amprenavirapproved, investigationalunknownsubstrateDetailsDB01117AtovaquoneapprovedunknowninhibitorDetailsDB01156BupropionapprovedunknownsubstrateDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00604Cisaprideapproved, investigational, withdrawnunknowninhibitorDetailsDB00257Clotrimazoleapproved, vet_approvedunknowninhibitorDetailsDB01176CyclizineapprovedunknowninhibitorDetailsDB00266DicoumarolapprovedunknownsubstrateDetailsDB00757Dolasetronapproved, investigationalunknownsubstrateDetailsDB00869DorzolamideapprovednosubstrateDetailsDB00668Epinephrineapproved, vet_approvedunknowninhibitorDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00655EstroneapprovedunknownsubstrateDetailsDB00898EthanolapprovedunknowninhibitorDetailsDB01023Felodipineapproved, investigationalunknowninhibitorDetailsDB01195Flecainideapproved, withdrawnunknowninhibitorDetailsDB01544Flunitrazepamapproved, illicitunknownsubstrateDetailsDB00502HaloperidolapprovedunknownsubstrateDetailsDB01159Halothaneapproved, vet_approvedunknownsubstrateDetailsDB01177IdarubicinapprovedunknownsubstrateDetailsDB00281Lidocaineapproved, vet_approvedunknownsubstrateDetailsDB01601LopinavirapprovedunknowninhibitorinducerDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknowninhibitorDetailsDB00333MethadoneapprovedunknownsubstrateDetailsDB01028Methoxyfluraneapproved, investigational, vet_approved, withdrawnunknownsubstrateDetailsDB01171Moclobemideapproved, investigationalunknownsubstrateDetailsDB00745Modafinilapproved, investigationalunknowninhibitorinducerDetailsDB00184NicotineapprovedunknownsubstrateDetailsDB00904Ondansetronapproved, withdrawnunknownsubstrateDetailsDB00850PerphenazineapprovedunknownsubstrateDetailsDB03783PhenacetinwithdrawnunknownsubstrateDetailsDB01411PranlukastinvestigationalnoinhibitorDetailsDB01131ProguanilapprovedunknownsubstrateDetailsDB01069Promethazineapproved, investigationalunknowninhibitorDetailsDB01589Quazepamapproved, illicitnosubstrateDetailsDB00908Quinidineapproved, investigationalunknownsubstrateinhibitorDetailsDB00533Rofecoxibapproved, investigational, withdrawnunknownsubstrateDetailsDB01037Selegilineapproved, investigational, vet_approvedunknownsubstrateDetailsDB06150Sulfadimethoxineapproved, vet_approved, withdrawnunknowninhibitorDetailsDB00576Sulfamethizoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB00891SulfapyridineapprovedunknowninhibitorDetailsDB00231Temazepamapproved, investigationalunknownsubstrateDetailsDB00624Testosteroneapproved, investigationalunknownsubstrateDetailsDB00763MethimazoleapprovedunknowninhibitorDetailsDB00323Tolcaponeapproved, withdrawnnoinhibitorDetailsDB00347TrimethadioneapprovedunknownsubstrateDetailsDB00726TrimipramineapprovedunknownsubstrateDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB04898Ximelagatranapproved, investigational, withdrawnunknownsubstrateDetailsDB00495ZidovudineapprovedunknownsubstrateDetailsDB00755Tretinoinapproved, investigational, nutraceuticalunknownsubstrateDetailsDB01128BicalutamideapprovedunknowninhibitorDetailsDB01129Rabeprazoleapproved, investigationalunknowninhibitorDetailsDB01274Arformoterolapproved, investigationalunknownsubstrateDetailsDB04574Estrone sulfateapprovedunknownsubstrateinhibitorDetailsDB06413Armodafinilapproved, investigationalnoinhibitorDetailsDB00255Diethylstilbestrolapproved, investigational, withdrawnunknowninhibitorDetailsDB00420Promazineapproved, vet_approvedunknownsubstrateDetailsDB06594Agomelatineapproved, investigationalunknowninhibitorDetailsDB04831Tienilic acidwithdrawnunknowninhibitorDetailsDB06174Noscapineapproved, investigationalunknowninhibitorDetailsDB04920Clevidipineapproved, investigationalunknowninhibitorDetailsDB06370IndisulaminvestigationalunknownsubstrateDetailsDB06803Niclosamideapproved, investigational, vet_approvedunknownsubstrateDetailsDB00515CisplatinapprovedunknowninhibitorDetailsDB06820SulconazoleapprovedunknowninhibitorDetailsDB01154Thiamylalapproved, vet_approvedunknownsubstrateDetailsDB08828Vismodegibapproved, investigationalnosubstrateinhibitorDetailsDB00374Treprostinilapproved, investigationalunknownsubstrateDetailsDB06204TapentadolapprovedunknownsubstrateDetailsDB06209PrasugrelapprovednosubstrateDetailsDB08860PitavastatinapprovedunknownsubstrateDetailsDB08875Cabozantinibapproved, investigationalnosubstrateDetailsDB06605ApixabanapprovedunknownsubstrateDetailsDB08896RegorafenibapprovedunknowninhibitorDetailsDB08899EnzalutamideapprovednoinducerDetailsDB04938Ospemifeneapproved, investigationalunknownsubstrateDetailsDB00317Gefitinibapproved, investigationalunknowninhibitorDetailsDB06292DapagliflozinapprovednosubstrateDetailsDB09048Netupitantapproved, investigationalnosubstrateDetailsDB09080OlodaterolapprovednosubstrateDetailsDB09068Vortioxetineapproved, investigationalnosubstrateDetailsDB08439ParecoxibapprovedunknownsubstrateDetailsDB09280LumacaftorapprovednoinhibitorinducerDetailsDB09570Ixazomibapproved, investigationalunknownsubstrateDetailsDB11560Lesinuradapproved, investigationalnosubstrateDetailsDB05812AbirateroneapprovedunknowninhibitorDetailsDB08816TicagrelorapprovedunknowninhibitorinducerDetailsDB09063CeritinibapprovedunknowninhibitorDetailsDB00322FloxuridineapprovedunknowninhibitorDetailsDB05219Crisaboroleapproved, investigationalnoinhibitorDetailsDB06595Midostaurinapproved, investigationalunknowninhibitorinducerDetailsDB05015Belinostatapproved, investigationalunknowninhibitorDetailsDB05541Brivaracetamapproved, investigationalnosubstrateDetailsDB11611LifitegrastapprovednoinhibitorDetailsDB13174RheinexperimentalunknowninhibitorDetailsDB11994Diacereinapproved, investigationalunknowninhibitorDetailsDB03756Doconexentapproved, investigationalunknownsubstrateinhibitorDetailsDB11943Delafloxacinapproved, investigationalunknowninducerDetailsDB01685TopiroxostatexperimentalunknowninhibitorDetailsDB09120Zucapsaicinapproved, investigationalunknowninhibitorDetailsDB09118StiripentolapprovedunknowninhibitorDetailsDB09198LobeglitazoneexperimentalnoinhibitorDetailsDB09167DosulepinapprovedunknowninhibitorDetailsDB11614RupatadineapprovednosubstrateDetailsDB12319Benzbromaroneinvestigational, withdrawnunknowninhibitorDetailsDB09238Manidipineapproved, investigationalunknowninhibitorDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB13919CandesartanexperimentalunknownsubstrateinhibitorDetailsDB12070Letermovirapproved, investigationalnoinducerDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB09061Cannabidiolapproved, investigationalnosubstrateinhibitorDetailsDB13943Testosterone cypionateapprovedunknownsubstrateDetailsDB13944Testosterone enanthateapprovedunknownsubstrateDetailsDB13946Testosterone undecanoateapproved, investigationalunknownsubstrateDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13941Piperaquineapproved, experimental, investigationalunknownsubstrateDetailsDB11901Apalutamideapproved, investigationalnoinducerDetailsDB11633Isavuconazoleapproved, investigationalunknowninhibitorinducerDetailsDB11586Asunaprevirapproved, investigational, withdrawnnosubstrateDetailsDB13975Black cohoshexperimentalnoinhibitorDetailsDB14011NabiximolsinvestigationalnosubstrateDetailsDB14009Medical Cannabisexperimental, investigationalnosubstrateinhibitorinducerDetailsDB13746Bioallethrinapproved, experimentalnosubstrateDetailsDB00486Nabiloneapproved, investigationalnosubstrateinhibitorDetailsDB14033Acetyl sulfisoxazoleapproved, vet_approvedunknowninhibitorDetailsDB11995Avatrombopagapproved, investigationalunknowninducerDetailsDB11672Curcuminapproved, investigationalnoinhibitorDetailsDB00949FelbamateapprovedunknowninhibitorDetailsDB13136Fluindioneapproved, investigationalunknownsubstrateDetailsDB14568Ivosidenibapproved, investigationalunknowninducerDetailsDB12474Lynestrenolapproved, investigationalnosubstrateDetailsDB00615Rifabutinapproved, investigationalnoinducerDetailsDB11753Rifamycinapproved, investigationalnoinhibitorinducerDetailsDB04818IproniazidwithdrawnunknowninhibitorDetailsDB01645GenisteininvestigationalunknowninhibitorDetailsDB09078Lenvatinibapproved, investigationalunknowninhibitorDetailsDB08881VemurafenibapprovedunknowninhibitorDetailsDB00839Tolazamideapproved, investigationalunknownsubstrateDetailsDB00414Acetohexamideapproved, investigational, withdrawnunknownsubstrateDetailsDB01251Gliquidoneapproved, investigationalunknownsubstrateDetailsDB01289GlisoxepideinvestigationalunknownsubstrateDetailsDB08962Glibornurideinvestigational, withdrawnunknownsubstrateDetailsDB13406CarbutamideexperimentalunknownsubstrateDetailsDB13675MetahexamideexperimentalunknownsubstrateDetailsDB08496(R)-warfarinexperimentalunknownsubstrateDetailsDB14055(S)-Warfarinexperimental, investigationalunknownsubstrateDetailsDB00022Peginterferon alfa-2bapprovedunknowninducerDetailsDB04911Oritavancinapproved, investigationalunknowninhibitorDetailsDB06717FosaprepitantapprovedunknowninducerDetailsDB09288PropacetamolexperimentalnosubstrateDetailsDB14635Curcumin sulfateexperimentalnoinhibitorDetailsDB01080VigabatrinapprovedunknowninducerDetailsDB06218LacosamideapprovednosubstrateDetailsDB09213Dexibuprofenapproved, investigationalnosubstrateDetailsDB08912Dabrafenibapproved, investigationalnosubstrateinhibitorinducerDetailsDB00834Mifepristoneapproved, investigationalnoinhibitorDetailsDB00980Ramelteonapproved, investigationalnosubstrateDetailsDB00440Trimethoprimapproved, vet_approvedunknownsubstrateDetailsDB04665CoumarinexperimentalnosubstrateDetailsDB14025ClinafloxacininvestigationalunknowninhibitorDetailsDB06731SeproxetineinvestigationalunknowninhibitorDetailsDB00621Oxandroloneapproved, investigationalunknowninhibitorDetailsDB11963Dacomitinibapproved, investigationalnosubstrateDetailsDB00220NelfinavirapprovednoinducerDetailsDB07615TranilastinvestigationalnosubstrateDetailsDB12245Triclabendazoleapproved, investigationalunknownsubstrateDetailsDB11823Esketamineapproved, investigationalunknownsubstrateDetailsDB00465KetorolacapprovedunknownsubstrateDetailsDB00304DesogestrelapprovednosubstrateDetailsDB00455Loratadineapproved, investigationalunknownsubstrateDetailsDB12371Siponimodapproved, investigationalunknownsubstrateDetailsDB00334Olanzapineapproved, investigationalnoinhibitorDetailsDB12147Erdafitinibapproved, investigationalnosubstrateDetailsDB00476DuloxetineapprovedunknownsubstrateDetailsDB00461NabumetoneapprovednosubstrateDetailsDB12015Alpelisibapproved, investigationalunknowninducerDetailsDB00590DoxazosinapprovedunknownsubstrateDetailsDB01032Probenecidapproved, investigationalunknowninhibitorDetailsDB12978Pexidartinibapproved, investigationalunknowninhibitorDetailsDB11757Istradefyllineapproved, investigationalunknownsubstrateDetailsDB00622Nicardipineapproved, investigationalnoinhibitorDetailsDB01137Levofloxacinapproved, investigationalnoinhibitorDetailsDB08502CapravirineinvestigationalunknownsubstrateDetailsDB01217Anastrozoleapproved, investigationalunknowninhibitorDetailsDB12808Trifaroteneapproved, investigationalunknownsubstrateDetailsDB12001Abemaciclibapproved, investigationalunknowninhibitorDetailsDB15444Elexacaftorapproved, investigationalnoinhibitorDetailsDB14975Voxelotorapproved, investigationalunknownsubstrateDetailsDB00635Prednisoneapproved, vet_approvedunknowninducerDetailsDB00741Hydrocortisoneapproved, vet_approvedunknowninducerDetailsDB01222BudesonideapprovedunknowninducerDetailsDB00959Methylprednisoloneapproved, vet_approvedunknowninducerDetailsDB15328Ubrogepantapproved, investigationalunknowninhibitorDetailsDB15233Avapritinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00983Formoterolapproved, investigationalunknownsubstrateDetailsDB01115NifedipineapprovedunknowninhibitorinducerDetailsDB00957Norgestimateapproved, investigationalunknownsubstrateDetailsDB00977EthinylestradiolapprovedunknownsubstrateDetailsDB12457Rimegepantapproved, investigationalnosubstrateDetailsDB13609UmifenovirinvestigationalunknownsubstrateDetailsDB00443Betamethasoneapproved, vet_approvedunknowninducerDetailsDB09241Methylene blueapproved, investigationalunknowninhibitorDetailsDB11689Selumetinibapproved, investigationalnosubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninducerDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB14881Oliceridineapproved, investigationalunknownsubstrateDetailsDB12499Clascoteroneapproved, investigationalnoinhibitorDetailsDB15822Pralsetinibapproved, investigationalnoinhibitorinducerDetailsDB06448Lonafarnibapproved, investigationalnosubstrateDetailsDB04951Pirfenidoneapproved, investigationalunknownsubstrateinhibitorDetailsDB06137Tirbanibulinapproved, investigationalnoinhibitorDetailsDB11632Opicaponeapproved, investigationalnoinhibitorDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB08864RilpivirineapprovedunknowninhibitorDetailsDB00330EthambutolapprovedunknowninhibitorDetailsDB14989Umbralisibapproved, investigational, withdrawnunknownsubstrateDetailsDB08877RuxolitinibapprovednosubstrateDetailsDB14984Casimersenapproved, investigationalnoinhibitorDetailsDB06237AvanafilapprovedunknownsubstrateDetailsDB04854FebuxostatapprovednosubstrateDetailsDB08995Diosminapproved, investigationalunknowninhibitorDetailsDB08822Azilsartan medoxomilapproved, investigationalnosubstrateDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownDetailsDB15569Sotorasibapproved, investigationalunknowninducerDetailsDB12151Brincidofovirapproved, investigationalnoinhibitorDetailsDB15011Avacopanapproved, investigationalnoinhibitorDetailsDB12597Asciminibapproved, investigationalnoinhibitorDetailsDB08932MacitentanapprovednosubstrateDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB14973Abrocitinibapproved, investigationalnosubstrateDetailsDB16236Mitapivatapproved, investigationalnosubstrateinducerDetailsDB14737Cannabinolexperimental, investigationalunknownsubstrateinhibitorDetailsDB06016Cariprazineapproved, investigationalnoinhibitorDetailsDB14921Mavacamtenapproved, investigationalnosubstrateinducerDetailsDB06083Tapinarofapproved, investigationalnosubstrateDetailsDB15133Tepotinibapproved, investigationalnoinhibitorDetailsDB00285VenlafaxineapprovednosubstrateDetailsDB12095Telotristat ethylapproved, investigationalnoinhibitorDetailsDB15149Futibatinibapproved, investigationalnosubstrateDetailsDB17083LinzagolixapprovednosubstrateDetailsDB11739Vonoprazanapproved, investigationalunknownsubstrateDetailsDB16267Olutasidenibapproved, investigationalnosubstrateinducerDetailsDB02709ResveratrolinvestigationalunknowninhibitorDetailsDB15568Adagrasibapproved, investigationalunknownsubstrateinhibitorDetailsDB17449Anacaulaseapproved, investigationalunknowninhibitorDetailsDB17472Pirtobrutinibapproved, investigationalunknowninhibitorDetailsDB06374Elacestrantapproved, investigationalunknownsubstrateDetailsDB00349Clobazamapproved, illicitnoinhibitorDetailsDB12548Sparsentanapproved, investigationalunknowninducerDetailsDB00381AmlodipineapprovednoinhibitorDetailsDB00862VardenafilapprovedunknownsubstrateinhibitorDetailsDB08820IvacaftorapprovednoinhibitorDetailsDB11712Tezacaftorapproved, investigationalnoDetailsDB01194BrinzolamideapprovedunknownsubstrateDetailsDB15669Fezolinetantapproved, investigationalnosubstrateDetailsDB12255Vadadustatapproved, investigationalunknowninhibitorDetailsDB14924Ritlecitinibapproved, investigationalunknownsubstrateDetailsDB11763Momelotinibapproved, investigationalunknownsubstrateDetailsDB14766EtrasimodapprovednosubstrateDetailsDB11718Encorafenibapproved, investigationalnoinhibitorinducerDetailsDB16826RepotrectinibinvestigationalnoinducerDetailsDB11679FruquintinibinvestigationalnosubstrateDetails"
                    }
                },
                {
                    "Label": "Cytochrome P450 2D6",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 2D6",
                        "Synonyms": "1.14.14.1\nCholesterol 25-hydroxylase\nCYP2DL1\nCYPIID6\nCytochrome P450-DB1\nDebrisoquine 4-hydroxylase",
                        "Gene Name": "CYP2D6",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0004641|Cytochrome P450 2D6\nMGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVDFQNTPYCFDQ\nLRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVF\nLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDK\nAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKV\nLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVA\nDLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVI\nHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHF\nLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGV\nFAFLVSPSPYELCAVPR",
                        "Number of residues": "497",
                        "Molecular Weight": "55768.94",
                        "Theoretical pI": "7.26",
                        "GO Classification": "Functionsarachidonic acid epoxygenase activity / aromatase activity / drug binding / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity / oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen / oxygen binding / steroid hydroxylase activityProcessesalkaloid catabolic process / alkaloid metabolic process / arachidonic acid metabolic process / coumarin metabolic process / drug catabolic process / drug metabolic process / exogenous drug catabolic process / heterocycle metabolic process / isoquinoline alkaloid metabolic process / monoterpenoid metabolic process / negative regulation of binding / negative regulation of cellular organofluorine metabolic process / oxidation-reduction process / oxidative demethylation / small molecule metabolic process / steroid metabolic process / xenobiotic metabolic processComponentscytoplasm / endoplasmic reticulum / endoplasmic reticulum membrane / mitochondrion",
                        "General Function": "Steroid hydroxylase activity",
                        "Specific Function": "Responsible for the metabolism of many drugs and environmental chemicals that it oxidizes. It is involved in the metabolism of drugs such as antiarrhythmics, adrenoceptor antagonists, and tricyclic antidepressants.",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0019275|Cytochrome P450 2D6 (CYP2D6)\nATGGGGCTAGAAGCACTGGTGCCCCTGGCCGTGATAGTGGCCATCTTCCTGCTCCTGGTG\nGACCTGATGCACCGGCGCCAACGCTGGGCTGCACGCTACCCACCAGGCCCCCTGCCACTG\nCCCGGGCTGGGCAACCTGCTGCATGTGGACTTCCAGAACACACCATACTGCTTCGACCAG\nTTGCGGCGCCGCTTCGGGGACGTGTTCAGCCTGCAGCTGGCCTGGACGCCGGTGGTCGTG\nCTCAATGGGCTGGCGGCCGTGCGCGAGGCGCTGGTGACCCACGGCGAGGACACCGCCGAC\nCGCCCGCCTGTGCCCATCACCCAGATCCTGGGTTTCGGGCCGCGTTCCCAAGGGGTGTTC\nCTGGCGCGCTATGGGCCCGCGTGGCGCGAGCAGAGGCGCTTCTCCGTGTCCACCTTGCGC\nAACTTGGGCCTGGGCAAGAAGTCGCTGGAGCAGTGGGTGACCGAGGAGGCCGCCTGCCTT\nTGTGCCGCCTTCGCCAACCACTCCGGACGCCCCTTTCGCCCCAACGGTCTCTTGGACAAA\nGCCGTGAGCAACGTGATCGCCTCCCTCACCTGCGGGCGCCGCTTCGAGTACGACGACCCT\nCGCTTCCTCAGGCTGCTGGACCTAGCTCAGGAGGGACTGAAGGAGGAGTCGGGCTTTCTG\nCGCGAGGTGCTGAATGCTGTCCCCGTCCTCCTGCATATCCCAGCGCTGGCTGGCAAGGTC\nCTACGCTTCCAAAAGGCTTTCCTGACCCAGCTGGATGAGCTGCTAACTGAGCACAGGATG\nACCTGGGACCCAGCCCAGCCCCCCCGAGACCTGACTGAGGCCTTCCTGGCAGAGATGGAG\nAAGGCCAAGGGGAACCCTGAGAGCAGCTTCAATGATGAGAACCTGCGCATAGTGGTGGCT\nGACCTGTTCTCTGCCGGGATGGTGACCACCTCGACCACGCTGGCCTGGGGCCTCCTGCTC\nATGATCCTACATCCGGATGTGCAGCGCCGTGTCCAACAGGAGATCGACGACGTGATAGGG\nCAGGTGCGGCGACCAGAGATGGGTGACCAGGCTCACATGCCCTACACCACTGCCGTGATT\nCATGAGGTGCAGCGCTTTGGGGACATCGTCCCCCTGGGTGTGACCCATATGACATCCCGT\nGACATCGAAGTACAGGGCTTCCGCATCCCTAAGGGAACGACACTCATCACCAACCTGTCA\nTCGGTGCTGAAGGATGAGGCCGTCTGGGAGAAGCCCTTCCGCTTCCACCCCGAACACTTC\nCTGGATGCCCAGGGCCACTTTGTGAAGCCGGAGGCCTTCCTGCCTTTCTCAGCAGGCCGC\nCGTGCATGCCTCGGGGAGCCCCTGGCCCGCATGGAGCTCTTCCTCTTCTTCACCTCCCTG\nCTGCAGCACTTCAGCTTCTCGGTGCCCACTGGACAGCCCCGGCCCAGCCACCATGGTGTC\nTTTGCTTTCCTGGTGAGCCCATCCCCCTATGAGCTTTGTGCTGTGCCCCGCTAG",
                        "Chromosome Location": "22",
                        "Locus": "22q13.1",
                        "External Identifiers": "ResourceLinkUniProtKB IDP10635UniProtKB Entry NameCP2D6_HUMANGenBank Protein ID181350GenBank Gene IDM20403GenAtlas IDCYP2D6HGNC IDHGNC:2625",
                        "General References": "Gonzalez FJ, Vilbois F, Hardwick JP, McBride OW, Nebert DW, Gelboin HV, Meyer UA: Human debrisoquine 4-hydroxylase (P450IID1): cDNA and deduced amino acid sequence and assignment of the CYP2D locus to chromosome 22. Genomics. 1988 Feb;2(2):174-9. [Article] Gonzalez FJ, Skoda RC, Kimura S, Umeno M, Zanger UM, Nebert DW, Gelboin HV, Hardwick JP, Meyer UA: Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature. 1988 Feb 4;331(6155):442-6. [Article] Kimura S, Umeno M, Skoda RC, Meyer UA, Gonzalez FJ: The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene. Am J Hum Genet. 1989 Dec;45(6):889-904. [Article] Gaedigk A, Bhathena A, Ndjountche L, Pearce RE, Abdel-Rahman SM, Alander SW, Bradford LD, Rogan PK, Leeder JS: Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans. Pharmacogenomics J. 2005;5(3):173-82. [Article] Dunham I, Shimizu N, Roe BA, Chissoe S, Hunt AR, Collins JE, Bruskiewich R, Beare DM, Clamp M, Smink LJ, Ainscough R, Almeida JP, Babbage A, Bagguley C, Bailey J, Barlow K, Bates KN, Beasley O, Bird CP, Blakey S, Bridgeman AM, Buck D, Burgess J, Burrill WD, O'Brien KP, et al.: The DNA sequence of human chromosome 22. Nature. 1999 Dec 2;402(6761):489-95. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Honda A, Miyazaki T, Ikegami T, Iwamoto J, Maeda T, Hirayama T, Saito Y, Teramoto T, Matsuzaki Y: Cholesterol 25-hydroxylation activity of CYP3A. J Lipid Res. 2011 Aug;52(8):1509-16. doi: 10.1194/jlr.M014084. Epub 2011 May 16. [Article] Rowland P, Blaney FE, Smyth MG, Jones JJ, Leydon VR, Oxbrow AK, Lewis CJ, Tennant MG, Modi S, Eggleston DS, Chenery RJ, Bridges AM: Crystal structure of human cytochrome P450 2D6. J Biol Chem. 2006 Mar 17;281(11):7614-22. Epub 2005 Dec 13. [Article] Tyndale R, Aoyama T, Broly F, Matsunaga T, Inaba T, Kalow W, Gelboin HV, Meyer UA, Gonzalez FJ: Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: possible association with the poor metabolizer phenotype. Pharmacogenetics. 1991 Oct;1(1):26-32. [Article] Yokota H, Tamura S, Furuya H, Kimura S, Watanabe M, Kanazawa I, Kondo I, Gonzalez FJ: Evidence for a new variant CYP2D6 allele CYP2D6J in a Japanese population associated with lower in vivo rates of sparteine metabolism. Pharmacogenetics. 1993 Oct;3(5):256-63. [Article] Evert B, Griese EU, Eichelbaum M: A missense mutation in exon 6 of the CYP2D6 gene leading to a histidine 324 to proline exchange is associated with the poor metabolizer phenotype of sparteine. Naunyn Schmiedebergs Arch Pharmacol. 1994 Oct;350(4):434-9. [Article] Daly AK, Leathart JB, London SJ, Idle JR: An inactive cytochrome P450 CYP2D6 allele containing a deletion and a base substitution. Hum Genet. 1995 Mar;95(3):337-41. [Article] Masimirembwa C, Persson I, Bertilsson L, Hasler J, Ingelman-Sundberg M: A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: association with diminished debrisoquine hydroxylase activity. Br J Clin Pharmacol. 1996 Dec;42(6):713-9. [Article] Marez D, Legrand M, Sabbagh N, Lo-Guidice JM, Boone P, Broly F: An additional allelic variant of the CYP2D6 gene causing impaired metabolism of sparteine. Hum Genet. 1996 May;97(5):668-70. [Article] Marez D, Legrand M, Sabbagh N, Lo Guidice JM, Spire C, Lafitte JJ, Meyer UA, Broly F: Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution. Pharmacogenetics. 1997 Jun;7(3):193-202. [Article] Wang SL, Lai MD, Huang JD: G169R mutation diminishes the metabolic activity of CYP2D6 in Chinese. Drug Metab Dispos. 1999 Mar;27(3):385-8. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article] Dai DP, Geng PW, Wang SH, Cai J, Hu LM, Nie JJ, Hu JH, Hu GX, Cai JP: In vitro functional assessment of 22 newly identified CYP2D6 allelic variants in the Chinese population. Basic Clin Pharmacol Toxicol. 2015 Jul;117(1):39-43. doi: 10.1111/bcpt.12363. Epub 2015 Jan 14. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00176Fluvoxamineapproved, investigationalunknownsubstrateinhibitorDetailsDB00182Amphetamineapproved, illicit, investigationalunknownsubstrateDetailsDB00185CevimelineapprovedunknownsubstrateDetailsDB00193Tramadolapproved, investigationalunknownsubstrateDetailsDB00243Ranolazineapproved, investigationalnosubstrateinhibitorDetailsDB00264Metoprololapproved, investigationalunknownsubstrateinhibitorDetailsDB00281Lidocaineapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00285VenlafaxineapprovedunknownsubstrateinhibitorDetailsDB00289AtomoxetineapprovedunknownsubstrateDetailsDB00318Codeineapproved, illicitunknownsubstrateDetailsDB00370MirtazapineapprovedunknownsubstrateDetailsDB00373TimololapprovedunknownsubstrateDetailsDB00379Mexiletineapproved, investigationalunknownsubstrateDetailsDB00433Prochlorperazineapproved, vet_approvedunknownsubstrateDetailsDB00454MeperidineapprovedunknownsubstrateDetailsDB00476DuloxetineapprovedunknownsubstrateinhibitorDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00496Darifenacinapproved, investigationalunknownsubstrateinhibitorDetailsDB00497Oxycodoneapproved, illicit, investigationalunknownsubstrateDetailsDB00502HaloperidolapprovedunknownsubstrateinhibitorDetailsDB00503Ritonavirapproved, investigationalunknownsubstrateinhibitorDetailsDB00514DextromethorphanapprovedunknownsubstrateDetailsDB00521CarteololapprovedunknownsubstrateDetailsDB00557HydroxyzineapprovednoinhibitorDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00575ClonidineapprovedunknownsubstrateDetailsDB00623FluphenazineapprovedunknowninhibitorDetailsDB00647Dextropropoxypheneapproved, illicit, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00656Trazodoneapproved, investigationalunknownsubstrateinhibitorDetailsDB00674GalantamineapprovednosubstrateDetailsDB00675TamoxifenapprovedunknownsubstrateinhibitorDetailsDB00679Thioridazineapproved, withdrawnunknownsubstrateinhibitorDetailsDB00699Nicergolineapproved, investigationalunknownsubstrateDetailsDB00715Paroxetineapproved, investigationalunknownsubstrateinhibitorDetailsDB00734Risperidoneapproved, investigationalunknownsubstrateinhibitorDetailsDB00757Dolasetronapproved, investigationalunknownsubstrateDetailsDB00805MinaprineapprovedunknownsubstrateDetailsDB00843DonepezilapprovedunknownsubstrateDetailsDB00850PerphenazineapprovedunknownsubstrateinhibitorDetailsDB00863Ranitidineapproved, withdrawnunknowninhibitorDetailsDB00866Alprenololexperimental, withdrawnunknownsubstrateDetailsDB00904Ondansetronapproved, withdrawnunknownsubstrateDetailsDB00914Phenforminapproved, investigational, withdrawnunknownsubstrateDetailsDB00918Almotriptanapproved, investigationalunknownsubstrateDetailsDB00934Maprotilineapproved, investigationalunknownsubstrateDetailsDB00956Hydrocodoneapproved, illicit, investigationalunknownsubstrateDetailsDB00960Pindololapproved, investigationalunknownsubstrateinhibitorDetailsDB01012CinacalcetapprovedunknowninhibitorDetailsDB01035ProcainamideapprovedunknownsubstrateDetailsDB01036Tolterodineapproved, investigationalunknownsubstrateDetailsDB01069Promethazineapproved, investigationalunknownsubstrateinhibitorDetailsDB01074Perhexilineapproved, investigationalunknownsubstrateinhibitorDetailsDB01114ChlorpheniramineapprovedunknownsubstrateinhibitorDetailsDB01136Carvedilolapproved, investigationalunknownsubstrateDetailsDB01142Doxepinapproved, investigationalnosubstrateinhibitorDetailsDB01151Desipramineapproved, investigationalunknownsubstrateinhibitorDetailsDB01193Acebutololapproved, investigationalunknownsubstrateinhibitorDetailsDB01195Flecainideapproved, withdrawnunknownsubstrateinhibitorDetailsDB01228Encainideapproved, investigational, withdrawnunknownsubstrateDetailsDB01233Metoclopramideapproved, investigationalunknownsubstrateinhibitorDetailsDB01242Clomipramineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB01171Moclobemideapproved, investigationalunknownsubstrateinhibitorDetailsDB01274Arformoterolapproved, investigationalunknownsubstrateDetailsDB01410Ciclesonideapproved, investigationalunknownsubstrateDetailsDB01466Ethylmorphineexperimental, illicitunknownsubstrateDetailsDB01409TiotropiumapprovednosubstrateDetailsDB01075Diphenhydramineapproved, investigationalunknownsubstrateinhibitorDetailsDB04840Debrisoquineapproved, investigationalunknownsubstrateDetailsDB00215CitalopramapprovednosubstrateinhibitorDetailsDB00234Reboxetineapproved, experimentalunknowninhibitorDetailsDB00257Clotrimazoleapproved, vet_approvedunknowninhibitorDetailsDB00317Gefitinibapproved, investigationalnosubstrateinhibitorDetailsDB00321AmitriptylineapprovedunknownsubstrateDetailsDB00342Terfenadineapproved, withdrawnunknownsubstrateinhibitorDetailsDB00343Diltiazemapproved, investigationalunknownsubstrateDetailsDB00356ChlorzoxazoneapprovedunknownsubstrateDetailsDB00363ClozapineapprovednosubstrateinhibitorDetailsDB00455Loratadineapproved, investigationalunknownsubstrateinhibitorDetailsDB00458ImipramineapprovedunknownsubstrateinhibitorDetailsDB00468QuinineapprovedunknownsubstrateinhibitorDetailsDB00482Celecoxibapproved, investigationalunknownsubstrateinhibitorDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00532Mephenytoinapproved, investigational, withdrawnunknownsubstrateDetailsDB00540NortriptylineapprovedunknownsubstrateinhibitorDetailsDB00613Amodiaquineapproved, investigationalunknowninhibitorDetailsDB00622Nicardipineapproved, investigationalunknowninhibitorDetailsDB00705DelavirdineapprovedunknownsubstrateinhibitorDetailsDB00726TrimipramineapprovedunknownsubstrateDetailsDB00752Tranylcypromineapproved, investigationalunknowninhibitorDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknowninhibitorDetailsDB00908Quinidineapproved, investigationalunknowninhibitorDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00933Mesoridazineapproved, investigationalunknownsubstrateDetailsDB00972AzelastineapprovedunknownsubstrateinhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB01071MequitazineexperimentalunknownsubstrateDetailsDB01104SertralineapprovedunknownsubstrateinhibitorDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB01115NifedipineapprovedunknowninhibitorDetailsDB01118Amiodaroneapproved, investigationalnoinhibitorDetailsDB01131ProguanilapprovednoinhibitorDetailsDB01149Nefazodoneapproved, withdrawnunknownsubstrateinhibitorDetailsDB01156BupropionapprovedunknowninhibitorDetailsDB01175EscitalopramapprovednosubstrateinhibitorDetailsDB01182PropafenoneapprovedunknownsubstrateinhibitorDetailsDB01191Dexfenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateinhibitorDetailsDB01192Oxymorphoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB01218HalofantrineapprovedunknowninhibitorDetailsDB01238Aripiprazoleapproved, investigationalnosubstrateDetailsDB01403Methotrimeprazineapproved, investigationalunknownsubstrateinhibitorDetailsDB01551Dihydrocodeineapproved, illicitunknownsubstrateDetailsDB00377Palonosetronapproved, investigationalunknownsubstrateDetailsDB04861Nebivololapproved, investigationalunknownsubstrateDetailsDB04889BicifadineinvestigationalunknownsubstrateDetailsDB015621-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidineexperimental, illicitunknowninhibitorDetailsDB06144Sertindoleapproved, investigational, withdrawnunknownsubstrateDetailsDB06148Mianserinapproved, investigationalunknownsubstrateDetailsDB04905TesmilifeneinvestigationalunknownsubstrateDetailsDB01624Zuclopenthixolapproved, investigationalunknownsubstrateDetailsDB00571Propranololapproved, investigationalunknownsubstrateinhibitorDetailsDB05271RotigotineapprovedunknownsubstrateinhibitorDetailsDB00472Fluoxetineapproved, vet_approvednosubstrateinhibitorDetailsDB01095FluvastatinapprovedunknownsubstrateDetailsDB01076AtorvastatinapprovednoinhibitorDetailsDB00439Cerivastatinapproved, withdrawnunknowninhibitorDetailsDB00619ImatinibapprovednosubstrateinhibitorDetailsDB00334Olanzapineapproved, investigationalnosubstrateinhibitorDetailsDB00792Tripelennamineapproved, vet_approvedunknowninhibitorDetailsDB00188Bortezomibapproved, investigationalunknownsubstrateDetailsDB05109Trabectedinapproved, investigationalunknownsubstrateDetailsDB00568Cinnarizineapproved, investigationalunknownsubstrateDetailsDB04841FlunarizineapprovedunknownsubstrateDetailsDB06726BufuralolexperimentalunknownsubstrateDetailsDB014724-Methoxyamphetamineexperimental, illicitunknownsubstrateDetailsDB03783PhenacetinwithdrawnunknownsubstrateDetailsDB06727Sparteineexperimental, withdrawnunknownsubstrateinhibitorDetailsDB00283Clemastineapproved, investigationalunknowninhibitorDetailsDB00907Cocaineapproved, illicitunknowninhibitorDetailsDB00997Doxorubicinapproved, investigationalnosubstrateinhibitorDetailsDB00333MethadoneapprovednosubstrateinhibitorDetailsDB01388Mibefradilinvestigational, withdrawnunknowninhibitorDetailsDB00211MidodrineapprovedunknownsubstrateDetailsDB00208TiclopidineapprovedunknownsubstrateinhibitorDetailsDB00543AmoxapineapprovedunknownsubstrateinhibitorDetailsDB00608Chloroquineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB04946IloperidoneapprovedunknownsubstrateDetailsDB01577Metamfetamineapproved, illicit, withdrawnunknownsubstrateDetailsDB01621Pipotiazineapproved, investigationalunknownsubstrateinhibitorDetailsDB00706Tamsulosinapproved, investigationalunknownsubstrateDetailsDB04844Tetrabenazineapproved, investigationalunknownsubstrateDetailsDB01601LopinavirapprovedunknownsubstrateDetailsDB00932Tipranavirapproved, investigationalunknownsubstrateinhibitorDetailsDB04855DronedaroneapprovedunknownsubstrateinhibitorDetailsDB00951Isoniazidapproved, investigationalunknowninhibitorDetailsDB06708LumefantrineapprovedunknowninhibitorDetailsDB04868Nilotinibapproved, investigationalunknowninhibitorDetailsDB01424Aminophenazoneapproved, withdrawnunknownsubstrateDetailsDB00238NevirapineapprovedunknownsubstrateinhibitorDetailsDB00216Eletriptanapproved, investigationalunknownsubstrateDetailsDB00425ZolpidemapprovedunknownsubstrateDetailsDB01628Etoricoxibapproved, investigationalunknowninhibitorDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateDetailsDB00316AcetaminophenapprovedunknownsubstrateDetailsDB00924CyclobenzaprineapprovedunknownsubstrateDetailsDB00381AmlodipineapprovedunknowninhibitorDetailsDB00701Amprenavirapproved, investigationalunknownsubstrateDetailsDB01429AprindineexperimentalunknownsubstrateDetailsDB00637Astemizoleapproved, withdrawnunknownsubstrateDetailsDB01244Bepridilapproved, withdrawnunknownsubstrateinhibitorDetailsDB00195Betaxololapproved, investigationalunknownsubstrateDetailsDB00810Biperidenapproved, investigationalunknowninhibitorDetailsDB00297Bupivacaineapproved, investigationalunknownsubstrateDetailsDB00490Buspironeapproved, investigationalunknownsubstrateDetailsDB00201CaffeineapprovedunknownsubstrateDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknowninhibitorDetailsDB00604Cisaprideapproved, investigational, withdrawnunknowninhibitorDetailsDB01093Dimethyl sulfoxideapproved, vet_approvedunknowninhibitorDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB00590DoxazosinapprovedunknownsubstrateDetailsDB00625Efavirenzapproved, investigationalunknowninhibitorDetailsDB00751Epinastineapproved, investigationalunknownsubstrateinhibitorDetailsDB01023Felodipineapproved, investigationalunknowninhibitorDetailsDB01611HydroxychloroquineapprovedunknownsubstrateinhibitorDetailsDB01177IdarubicinapprovedunknownsubstrateDetailsDB00224IndinavirapprovedunknowninhibitorDetailsDB00598LabetalolapprovedunknownsubstrateinhibitorDetailsDB00448Lansoprazoleapproved, investigationalunknowninhibitorDetailsDB00528Lercanidipineapproved, investigationalunknowninhibitorDetailsDB01206Lomustineapproved, investigationalunknowninhibitorDetailsDB06691Mepyramineapproved, vet_approvedunknowninhibitorDetailsDB01028Methoxyfluraneapproved, investigational, vet_approved, withdrawnunknownsubstrateDetailsDB00834Mifepristoneapproved, investigationalunknowninhibitorDetailsDB00731Nateglinideapproved, investigationalunknownsubstrateDetailsDB00220NelfinavirapprovednoinhibitorDetailsDB02701Nicotinamideapproved, investigationalunknowninhibitorDetailsDB00184NicotineapprovedunknownsubstrateDetailsDB00627Niacinapproved, investigational, nutraceuticalunknowninhibitorDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB01096OxamniquineapprovedunknownsubstrateinhibitorDetailsDB01580OxprenololapprovedunknownsubstrateinhibitorDetailsDB01062Oxybutyninapproved, investigationalunknowninhibitorDetailsDB00738Pentamidineapproved, investigationalunknownsubstrateDetailsDB01435Antipyrineapproved, investigationalunknownsubstrateDetailsDB01100PimozideapprovednoinhibitorDetailsDB00592Piperazineapproved, vet_approvedunknownsubstrateDetailsDB01087PrimaquineapprovedunknowninhibitorDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateDetailsDB01224QuetiapineapprovedunknownsubstrateDetailsDB00409Remoxiprideapproved, withdrawnunknownsubstrateDetailsDB00412Rosiglitazoneapproved, investigationalunknowninhibitorDetailsDB01232Saquinavirapproved, investigationalunknowninhibitorDetailsDB01037Selegilineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00641SimvastatinapprovedunknownsubstrateDetailsDB06729SulfaphenazoleapprovedunknowninhibitorDetailsDB01079Tegaserodapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00277TheophyllineapprovedunknownsubstrateDetailsDB00763MethimazoleapprovedunknowninhibitorDetailsDB01623ThiothixeneapprovedunknowninhibitorDetailsDB00209TrospiumapprovedunknowninhibitorDetailsDB00661VerapamilapprovedunknowninhibitorDetailsDB00570VinblastineapprovedunknowninhibitorDetailsDB00361Vinorelbineapproved, investigationalnoinhibitorDetailsDB01392Yohimbineapproved, investigational, vet_approvedunknownsubstrateDetailsDB06287TemsirolimusapprovedunknowninhibitorDetailsDB00398Sorafenibapproved, investigationalunknowninhibitorDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateDetailsDB01128BicalutamideapprovedunknowninhibitorDetailsDB01129Rabeprazoleapproved, investigationalunknowninhibitorDetailsDB01166Cilostazolapproved, investigationalunknownsubstrateDetailsDB06216AsenapineapprovedunknownsubstrateinhibitorDetailsDB06589PazopanibapprovedunknowninhibitorDetailsDB06702FesoterodineapprovedunknownsubstrateDetailsDB06684VilazodoneapprovedunknownsubstrateDetailsDB00836LoperamideapprovedunknownsubstrateDetailsDB06506RepinotaninvestigationalunknownsubstrateDetailsDB06770Benzyl alcoholapprovedunknownsubstrateDetailsDB04920Clevidipineapproved, investigationalunknownsubstrateDetailsDB00633Dexmedetomidineapproved, vet_approvedunknowninhibitorDetailsDB06370IndisulaminvestigationalunknowninhibitorDetailsDB06735EnclomipheneinvestigationalunknownsubstrateDetailsDB06204TapentadolapprovedunknownsubstrateDetailsDB04871Lorcaserinapproved, withdrawnnosubstrateinhibitorDetailsDB05812AbirateroneapprovedunknowninhibitorDetailsDB08881VemurafenibapprovedunknowninhibitorDetailsDB08893MirabegronapprovednosubstrateinhibitorDetailsDB08901Ponatinibapproved, investigationalunknownsubstrateDetailsDB06203AlogliptinapprovedunknownsubstrateDetailsDB08918Levomilnacipranapproved, investigationalunknownsubstrateDetailsDB06292DapagliflozinapprovednosubstrateDetailsDB09039Eliglustatapproved, investigationalnosubstrateinhibitorDetailsDB09048Netupitantapproved, investigationalnosubstrateDetailsDB09049NaloxegolapprovedunknowninhibitorDetailsDB09076UmeclidiniumapprovednosubstrateDetailsDB09065CobicistatapprovednosubstrateinhibitorDetailsDB09068Vortioxetineapproved, investigationalnosubstrateDetailsDB06016Cariprazineapproved, investigationalnosubstrateinhibitorDetailsDB00349Clobazamapproved, illicitnoinhibitorDetailsDB09128Brexpiprazoleapproved, investigationalnosubstrateDetailsDB09291Rolapitantapproved, investigationalnoinhibitorDetailsDB06678EsmirtazapineinvestigationalunknownsubstrateDetailsDB06603Panobinostatapproved, investigationalnoinhibitorDetailsDB09570Ixazomibapproved, investigationalunknownsubstrateDetailsDB06412Oxymetholoneapproved, illicitunknowninhibitorDetailsDB09183DasabuvirapprovednosubstrateDetailsDB06512DeramciclaneinvestigationalunknowninhibitorDetailsDB00022Peginterferon alfa-2bapprovedunknowninhibitorDetailsDB00494Entacaponeapproved, investigationalunknowninhibitorDetailsDB04938Ospemifeneapproved, investigationalunknowninhibitorDetailsDB06820SulconazoleapprovedunknowninhibitorDetailsDB08909Glycerol phenylbutyrateapprovedunknowninhibitorDetailsDB00420Promazineapproved, vet_approvedunknownsubstrateDetailsDB09118StiripentolapprovedunknowninhibitorDetailsDB12332Rucaparibapproved, investigationalnosubstrateinhibitorDetailsDB09555Dexchlorpheniramine maleateapprovednosubstrateinhibitorDetailsDB12161Deutetrabenazineapproved, investigationalnosubstrateDetailsDB06217Vernakalantapproved, investigationalunknownsubstrateinhibitorDetailsDB06595Midostaurinapproved, investigationalunknowninhibitorDetailsDB11915Valbenazineapproved, investigationalnosubstrateDetailsDB13174RheinexperimentalunknowninhibitorDetailsDB11994Diacereinapproved, investigationalunknowninhibitorDetailsDB08922PerospironeexperimentalunknownsubstrateDetailsDB09167DosulepinapprovedunknownsubstrateinhibitorDetailsDB11614RupatadineapprovednosubstrateDetailsDB09238Manidipineapproved, investigationalunknowninhibitorDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateDetailsDB09061Cannabidiolapproved, investigationalunknownsubstrateinhibitorDetailsDB11638Artenimolapproved, experimental, investigationalunknowninhibitorDetailsDB09195LorpiprazoleapprovednosubstrateDetailsDB09224MelperoneinvestigationalunknowninhibitorDetailsDB11642Pitolisantapproved, investigationalunknownsubstrateinhibitorDetailsDB11633Isavuconazoleapproved, investigationalunknowninhibitorDetailsDB11130Opiumapproved, illicitnosubstrateDetailsDB09053IbrutinibapprovednosubstrateDetailsDB11586Asunaprevirapproved, investigational, withdrawnnosubstrateinhibitorDetailsDB140105-methoxy-N,N-dimethyltryptamineexperimental, illicitunknownsubstrateDetailsDB13975Black cohoshexperimentalnoinhibitorDetailsDB14011NabiximolsinvestigationalunknownsubstrateDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorDetailsDB13293Ipecacapproved, withdrawnnosubstrateDetailsDB04948Lofexidineapproved, investigationalnosubstrateDetailsDB11672Curcuminapproved, investigationalunknowninhibitorDetailsDB04829Lysergic acid diethylamideillicit, investigational, withdrawnnosubstrateDetailsDB14185Aripiprazole lauroxilapproved, investigationalunknownsubstrateDetailsDB11718Encorafenibapproved, investigationalnosubstrateinhibitorDetailsDB06608Tafenoquineapproved, investigationalnosubstrateDetailsDB11979Elagolixapproved, investigationalnosubstrateDetailsDB11785AnisodamineinvestigationalnosubstrateDetailsDB09204ArotinololinvestigationalnosubstrateDetailsDB00335AtenololapprovednosubstrateDetailsDB09013BefunololexperimentalnosubstrateDetailsDB01295BevantololexperimentalnosubstrateDetailsDB08807BopindololexperimentalnosubstrateDetailsDB12752BucindololinvestigationalnosubstrateDetailsDB08808BupranololexperimentalnosubstrateDetailsDB04846Celiprololapproved, investigationalnosubstrateDetailsDB13508CloranololexperimentalnosubstrateDetailsDB13757EpanololexperimentalnosubstrateDetailsDB13443EsatenololexperimentalnosubstrateDetailsDB00187Esmololapproved, withdrawnnosubstrateDetailsDB08952IndenololwithdrawnnosubstrateDetailsDB12212LandiololinvestigationalnosubstrateDetailsDB09351Levobetaxololapproved, investigationalnosubstrateDetailsDB01210LevobunololapprovednosubstrateDetailsDB13530MepindololexperimentalnosubstrateDetailsDB01214MetipranololapprovednosubstrateDetailsDB01359Penbutololapproved, investigationalnosubstrateDetailsDB01297PractololapprovednosubstrateDetailsDB00489SotalolapprovednosubstrateDetailsDB11770TalinololinvestigationalnosubstrateDetailsDB13775TertatololexperimentalnosubstrateDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB06654Safinamideapproved, investigationalunknowninhibitorDetailsDB04818IproniazidwithdrawnunknowninhibitorDetailsDB01267PaliperidoneapprovedunknownsubstrateDetailsDB09078Lenvatinibapproved, investigationalunknowninhibitorDetailsDB08864RilpivirineapprovedunknowninhibitorDetailsDB04911Oritavancinapproved, investigationalunknowninhibitorinducerDetailsDB04884DapoxetineinvestigationalnosubstrateDetailsDB12693RitanserininvestigationalnoinhibitorDetailsDB02703Fusidic acidapproved, investigationalunknownsubstrateinhibitorDetailsDB09288PropacetamolexperimentalnosubstrateDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB11963Dacomitinibapproved, investigationalunknownsubstrateinhibitorDetailsDB14025ClinafloxacininvestigationalunknowninhibitorDetailsDB01323St. John's Wortapproved, investigational, nutraceuticalnoinhibitorDetailsDB01454Midomafetamineexperimental, illicit, investigationalnosubstrateDetailsDB11855Revefenacinapproved, investigationalnosubstrateDetailsDB12245Triclabendazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB01576Dextroamphetamineapproved, illicitnosubstrateDetailsDB06700Desvenlafaxineapproved, investigationalnoinhibitorDetailsDB00737MeclizineapprovednosubstrateDetailsDB01591SolifenacinapprovedunknownsubstrateDetailsDB13679Dexchlorpheniramineexperimental, investigationalunknownsubstrateinhibitorDetailsDB12523Mizolastineapproved, investigationalunknowninhibitorDetailsDB01173OrphenadrineapprovedunknowninhibitorDetailsDB09173ButyrfentanylillicitunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknownsubstrateDetailsDB04957AzimilideinvestigationalunknownsubstrateDetailsDB09061Cannabidiolapproved, investigationalunknowninhibitorDetailsDB14011NabiximolsinvestigationalunknownsubstrateinhibitorDetailsDB01590EverolimusapprovedunknowninhibitorDetailsDB12001Abemaciclibapproved, investigationalunknowninhibitorDetailsDB11732Lasmiditanapproved, investigationalnoinhibitorDetailsDB15444Elexacaftorapproved, investigationalnoinhibitorDetailsDB15091Upadacitinibapproved, investigationalunknownsubstrateDetailsDB00252Phenytoinapproved, vet_approvednosubstrateDetailsDB15328Ubrogepantapproved, investigationalunknowninhibitorDetailsDB00983Formoterolapproved, investigationalunknownsubstrateDetailsDB01264DarunavirapprovedunknowninhibitorDetailsDB13609UmifenovirinvestigationalunknownsubstrateDetailsDB11837Osilodrostatapproved, investigationalunknownsubstrateinhibitorDetailsDB12500Fedratinibapproved, investigationalunknowninhibitorDetailsDB09241Methylene blueapproved, investigationalunknownsubstrateinhibitorDetailsDB14761Remdesivirapproved, investigationalunknownsubstrateDetailsDB14840RipretinibapprovedunknownsubstrateDetailsDB00845Clofazimineapproved, investigationalunknowninhibitorDetailsDB14881Oliceridineapproved, investigationalunknownsubstrateDetailsDB12499Clascoteroneapproved, investigationalnoinhibitorDetailsDB15822Pralsetinibapproved, investigationalnosubstrateDetailsDB15982BerotralstatapprovednoinhibitorDetailsDB04951Pirfenidoneapproved, investigationalunknownsubstrateinhibitorDetailsDB06137Tirbanibulinapproved, investigationalnoinhibitorDetailsDB00549Zafirlukastapproved, investigationalunknowninhibitorDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB00745Modafinilapproved, investigationalunknowninducerDetailsDB00330EthambutolapprovedunknowninhibitorDetailsDB01086Benzocaineapproved, investigationalunknownsubstrateDetailsDB05316Pimavanserinapproved, investigationalunknownsubstrateDetailsDB11753Rifamycinapproved, investigationalunknowninhibitorDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownsubstrateDetailsDB15119Ropeginterferon alfa-2bapproved, investigationalnoinhibitorDetailsDB12151Brincidofovirapproved, investigationalnoinhibitorDetailsDB16703Belumosudilapproved, investigationalnosubstrateinhibitorDetailsDB12265Fexinidazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00602Ivermectinapproved, investigational, vet_approvednosubstrateDetailsDB12713Sotagliflozinapproved, investigationalnoinhibitorDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB00470Dronabinolapproved, illicitnoinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknowninhibitorDetailsDB05087Ganaxoloneapproved, investigationalnosubstrateDetailsDB09185Viloxazineapproved, investigational, withdrawnnosubstrateinhibitorDetailsDB14921Mavacamtenapproved, investigationalnoDetailsDB06083Tapinarofapproved, investigationalnosubstrateDetailsDB16650Deucravacitinibapproved, investigationalunknownsubstrateDetailsDB12095Telotristat ethylapproved, investigationalnoinhibitorDetailsDB15149Futibatinibapproved, investigationalnosubstrateDetailsDB11739Vonoprazanapproved, investigationalunknownsubstrateDetailsDB05239Cobimetinibapproved, investigationalnoinhibitorDetailsDB02709ResveratrolinvestigationalnoinhibitorDetailsDB15568Adagrasibapproved, investigationalunknownsubstrateinhibitorDetailsDB12236Bexagliflozinapproved, investigationalunknownsubstrateDetailsDB17472Pirtobrutinibapproved, investigationalunknowninhibitorDetailsDB15688Zavegepantapproved, investigationalunknownsubstrateDetailsDB00862VardenafilapprovedunknowninhibitorDetailsDB16217Leniolisibapproved, investigationalnosubstrateDetailsDB00953RizatriptanapprovednoinhibitorDetailsDB11712Tezacaftorapproved, investigationalnoinhibitorDetails"
                    }
                },
                {
                    "Label": "CYP2B protein",
                    "Detailed Info": {
                        "Name": "CYP2B protein",
                        "Synonyms": "CYP2B7\nCytochrome P450 2B7 short isoform",
                        "Gene Name": "CYP2B",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0010738|CYP2B protein\nMELSVLLFLALLTGLLLLLVQRHPNSHGTLPPGPRPLPLLGNLLQMDRRGLLKSFLRFRE\nKYGDVFTVHLGPRPVVMLCGVEAIREALVDNAEAFSGRGKIVIMDPVYQGYGMLFANGNR\nWKVLRRFSVTTMRDFGMGKRSVEERIQDEAQCLIEELRKSKGALVDPTFLFHSITANIIC\nSIIFGKRFHYQDQEFLKTLNLFCQSFLLISSISSQLFELFSGFLKYFPGAHRQVYKNLQE\nINAYIGHSVEKHRETLDPSAPRDLIDTYLLHMEKEKSNPHSEFSHQNLIINTLSLFFAGT\nETTSTTLRYGFLLMLKYPHVAERVYKEIEQVVGPHRPPALDDRAKMPYTEAVIREIQRFA\nDLLPMGVPHIVTQHTSF",
                        "Number of residues": "377",
                        "Molecular Weight": "43147.81",
                        "Theoretical pI": "9.03",
                        "GO Classification": "Functionsheme binding / iron ion binding / oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen",
                        "General Function": "Oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen",
                        "Specific Function": "Not Available",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Not Available",
                        "Gene sequence": ">lcl|BSEQ0002094|1134 bp\nATGGAGCTCAGCGTCCTCCTCTTCCTTGCACTCCTCACAGGCCTCTTGCTACTCCTGGTT\nCAGCGTCACCCTAACTCCCATGGCACCCTCCCACCAGGGCCCCGCCCTCTGCCCCTTTTG\nGGGAACCTTCTGCAGATGGACAGAAGAGGCCTACTCAAATCCTTTCTGAGGTTCCGAGAG\nAAATATGGGGACGTCTTCACGGTACACCTGGGACCGAGGCCCGTGGTCATGCTGTGTGGA\nGTAGAGGCCATACGGGAGGCCCTGGTGGACAACGCTGAGGCCTTCTCTGGCCGGGGAAAA\nATCGTCATCATGGACCCAGTCTACCAGGGATATGGCATGCTCTTTGCCAATGGAAACCGC\nTGGAAGGTGCTTCGGCGATTCTCTGTGACCACCATGAGGGACTTCGGGATGGGAAAGCGG\nAGTGTGGAGGAGCGGATTCAGGACGAGGCTCAGTGTCTGATAGAGGAACTTCGGAAATCC\nAAGGGAGCCCTCGTGGACCCCACCTTCCTCTTCCATTCCATTACCGCCAACATCATCTGC\nTCCATCATCTTTGGAAAACGCTTCCACTACCAAGATCAAGAGTTCCTGAAGACGCTGAAC\nTTGTTCTGCCAGAGTTTCTTACTCATCAGCTCTATATCCAGCCAGCTGTTTGAGCTCTTC\nTCTGGCTTCTTGAAATACTTTCCTGGGGCACACAGGCAAGTTTACAAAAACCTACAGGAA\nATCAATGCTTACATTGGCCACAGTGTGGAGAAGCACCGTGAAACCCTGGACCCCAGCGCC\nCCCAGGGACCTCATCGACACCTACCTGCTCCACATGGAAAAAGAGAAATCCAACCCACAC\nAGTGAATTCAGCCACCAGAACCTCATCATCAACACGCTCTCGCTCTTCTTTGCTGGCACT\nGAGACCACCAGCACCACTCTCCGCTACGGCTTCCTGCTCATGCTCAAATACCCTCATGTC\nGCAGAGAGAGTCTACAAGGAGATTGAACAGGTGGTTGGCCCACATCGCCCTCCAGCGCTT\nGATGACCGAGCCAAAATGCCATACACAGAGGCAGTCATCCGTGAGATTCAGAGATTTGCT\nGACCTTCTCCCCATGGGTGTGCCCCACATTGTCACCCAACACACCAGCTTCTGA",
                        "Chromosome Location": "Not Available",
                        "Locus": "19q13.2",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ14097UniProtKB Entry NameQ14097_HUMANGenBank Protein ID181294GenBank Gene IDM29873",
                        "General References": "Yamano S, Nhamburo PT, Aoyama T, Meyer UA, Inaba T, Kalow W, Gelboin HV, McBride OW, Gonzalez FJ: cDNA cloning and sequence and cDNA-directed expression of human P450 IIB1: identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liver. Biochemistry. 1989 Sep 5;28(18):7340-8. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB01149Nefazodoneapproved, withdrawnunknowninhibitorDetailsDB01104SertralineapprovedunknowninducerDetailsDB00472Fluoxetineapproved, vet_approvedunknowninducerDetailsDB00366Doxylamineapproved, vet_approvedunknowninducerDetailsDB11431Moxidectinapproved, investigational, vet_approvednosubstrateDetails"
                    }
                },
                {
                    "Label": "Cytochrome P450 1A2",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 1A2",
                        "Synonyms": "1.14.14.1\nCholesterol 25-hydroxylase\nCYPIA2\nCytochrome P(3)450\nCytochrome P450 4\nCytochrome P450-P3",
                        "Gene Name": "CYP1A2",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0004778|Cytochrome P450 1A2\nMALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPLLGHVLTLGKN\nPHLALSRMSQRYGDVLQIRIGSTPVLVLSRLDTIRQALVRQGDDFKGRPDLYTSTLITDG\nQSLTFSTDSGPVWAARRRLAQNALNTFSIASDPASSSSCYLEEHVSKEAKALISRLQELM\nAGPGHFDPYNQVVVSVANVIGAMCFGQHFPESSDEMLSLVKNTHEFVETASSGNPLDFFP\nILRYLPNPALQRFKAFNQRFLWFLQKTVQEHYQDFDKNSVRDITGALFKHSKKGPRASGN\nLIPQEKIVNLVNDIFGAGFDTVTTAISWSLMYLVTKPEIQRKIQKELDTVIGRERRPRLS\nDRPQLPYLEAFILETFRHSSFLPFTIPHSTTRDTTLNGFYIPKKCCVFVNQWQVNHDPEL\nWEDPSEFRPERFLTADGTAINKPLSEKMMLFGMGKRRCIGEVLAKWEIFLFLAILLQQLE\nFSVPPGVKVDLTPIYGLTMKHARCEHVQARRFSIN",
                        "Number of residues": "515",
                        "Molecular Weight": "58293.76",
                        "Theoretical pI": "9.43",
                        "GO Classification": "Functionsaromatase activity / caffeine oxidase activity / demethylase activity / electron carrier activity / enzyme binding / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity / oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenProcessesalkaloid metabolic process / arachidonic acid metabolic process / cellular respiration / cellular response to cadmium ion / dibenzo-p-dioxin metabolic process / drug catabolic process / drug metabolic process / epoxygenase P450 pathway / exogenous drug catabolic process / heterocycle metabolic process / hydrogen peroxide biosynthetic process / lung development / methylation / monocarboxylic acid metabolic process / monoterpenoid metabolic process / omega-hydroxylase P450 pathway / oxidation-reduction process / oxidative deethylation / oxidative demethylation / porphyrin-containing compound metabolic process / post-embryonic development / regulation of gene expression / response to estradiol / response to immobilization stress / response to lipopolysaccharide / small molecule metabolic process / steroid catabolic process / toxin biosynthetic process / xenobiotic metabolic processComponentsendoplasmic reticulum membrane / intracellular membrane-bounded organelle",
                        "General Function": "Oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen",
                        "Specific Function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Most active in catalyzing 2-hydroxylation. Caffeine is metabolized primarily by cytochrome CYP1A2 in the liver through an initial N3-demethylation. Also acts in the metabolism of aflatoxin B1 and acetaminophen. Participates in the bioactivation of carcinogenic aromatic and heterocyclic amines. Catalizes the N-hydroxylation of heterocyclic amines and the O-deethylation of phenacetin.",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0011742|Cytochrome P450 1A2 (CYP1A2)\nATGGCATTGTCCCAGTCTGTTCCCTTCTCGGCCACAGAGCTTCTCCTGGCCTCTGCCATC\nTTCTGCCTGGTATTCTGGGTGCTCAAGGGTTTGAGGCCTCGGGTCCCCAAAGGCCTGAAA\nAGTCCACCAGAGCCATGGGGCTGGCCCTTGCTCGGGCATGTGCTGACCCTGGGGAAGAAC\nCCGCACCTGGCACTGTCAAGGATGAGCCAGCGCTACGGGGACGTCCTGCAGATCCGCATT\nGGCTCCACGCCCGTGCTGGTGCTGAGCCGCCTGGACACCATCCGGCAGGCCCTGGTGCGG\nCAGGGCGACGATTTCAAGGGCCGGCCTGACCTCTACACCTCCACCCTCATCACTGATGGC\nCAGAGCTTGACCTTCAGCACAGACTCTGGACCGGTGTGGGCTGCCCGCCGGCGCCTGGCC\nCAGAATGCCCTCAACACCTTCTCCATCGCCTCTGACCCAGCTTCCTCATCCTCCTGCTAC\nCTGGAGGAGCATGTGAGCAAGGAGGCTAAGGCCCTGATCAGCAGGTTGCAGGAGCTGATG\nGCAGGGCCTGGGCACTTCGACCCTTACAATCAGGTGGTGGTGTCAGTGGCCAACGTCATT\nGGTGCCATGTGCTTCGGACAGCACTTCCCTGAGAGTAGCGATGAGATGCTCAGCCTCGTG\nAAGAACACTCATGAGTTCGTGGAGACTGCCTCCTCCGGGAACCCCCTGGACTTCTTCCCC\nATCCTTCGCTACCTGCCTAACCCTGCCCTGCAGAGGTTCAAGGCCTTCAACCAGAGGTTC\nCTGTGGTTCCTGCAGAAAACAGTCCAGGAGCACTATCAGGACTTTGACAAGAACAGTGTC\nCGGGACATCACGGGTGCCCTGTTCAAGCACAGCAAGAAGGGGCCTAGAGCCAGCGGCAAC\nCTCATCCCACAGGAGAAGATTGTCAACCTTGTCAATGACATCTTTGGAGCAGGATTTGAC\nACAGTCACCACAGCCATCTCCTGGAGCCTCATGTACCTTGTGACCAAGCCTGAGATACAG\nAGGAAGATCCAGAAGGAGCTGGACACTGTGATTGGCAGGGAGCGGCGGCCCCGGCTCTCT\nGACAGACCCCAGCTGCCCTACTTGGAGGCCTTCATCCTGGAGACCTTCCGACACTCCTCC\nTTCTTGCCCTTCACCATCCCCCACAGCACAACAAGGGACACAACGCTGAATGGCTTCTAC\nATCCCCAAGAAATGCTGTGTCTTCGTAAACCAGTGGCAGGTCAACCATGACCCAGAGCTG\nTGGGAGGACCCCTCTGAGTTCCGGCCTGAGCGGTTCCTCACCGCCGATGGCACTGCCATT\nAACAAGCCCTTGAGTGAGAAGATGATGCTGTTTGGCATGGGCAAGCGCCGGTGTATCGGG\nGAAGTCCTGGCCAAGTGGGAGATCTTCCTCTTCCTGGCCATCCTGCTACAGCAACTGGAG\nTTCAGCGTGCCGCCGGGCGTGAAAGTCGACCTGACCCCCATCTACGGGCTGACCATGAAG\nCACGCCCGCTGTGAACATGTCCAGGCGCGGCTGCGCTTCTCCATCAATTGA",
                        "Chromosome Location": "15",
                        "Locus": "15q24",
                        "External Identifiers": "ResourceLinkUniProtKB IDP05177UniProtKB Entry NameCP1A2_HUMANGenBank Gene IDZ00036GenAtlas IDCYP1A2HGNC IDHGNC:2596",
                        "General References": "Jaiswal AK, Nebert DW, Gonzalez FJ: Human P3(450): cDNA and complete amino acid sequence. Nucleic Acids Res. 1986 Aug 26;14(16):6773-4. [Article] Quattrochi LC, Pendurthi UR, Okino ST, Potenza C, Tukey RH: Human cytochrome P-450 4 mRNA and gene: part of a multigene family that contains Alu sequences in its mRNA. Proc Natl Acad Sci U S A. 1986 Sep;83(18):6731-5. [Article] Ikeya K, Jaiswal AK, Owens RA, Jones JE, Nebert DW, Kimura S: Human CYP1A2: sequence, gene structure, comparison with the mouse and rat orthologous gene, and differences in liver 1A2 mRNA expression. Mol Endocrinol. 1989 Sep;3(9):1399-408. [Article] Jaiswal AK, Nebert DW, McBride OW, Gonzalez FJ: Human P(3)450: cDNA and complete protein sequence, repetitive Alu sequences in the 3' nontranslated region, and localization of gene to chromosome 15. J Exp Pathol. 1987 Winter;3(1):1-17. [Article] Corchero J, Pimprale S, Kimura S, Gonzalez FJ: Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation. Pharmacogenetics. 2001 Feb;11(1):1-6. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Wrighton SA, Campanile C, Thomas PE, Maines SL, Watkins PB, Parker G, Mendez-Picon G, Haniu M, Shively JE, Levin W, et al.: Identification of a human liver cytochrome P-450 homologous to the major isosafrole-inducible cytochrome P-450 in the rat. Mol Pharmacol. 1986 Apr;29(4):405-10. [Article] Quattrochi LC, Okino ST, Pendurthi UR, Tukey RH: Cloning and isolation of human cytochrome P-450 cDNAs homologous to dioxin-inducible rabbit mRNAs encoding P-450 4 and P-450 6. DNA. 1985 Oct;4(5):395-400. [Article] Zhou H, Josephy PD, Kim D, Guengerich FP: Functional characterization of four allelic variants of human cytochrome P450 1A2. Arch Biochem Biophys. 2004 Feb 1;422(1):23-30. [Article] Honda A, Miyazaki T, Ikegami T, Iwamoto J, Maeda T, Hirayama T, Saito Y, Teramoto T, Matsuzaki Y: Cholesterol 25-hydroxylation activity of CYP3A. J Lipid Res. 2011 Aug;52(8):1509-16. doi: 10.1194/jlr.M014084. Epub 2011 May 16. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Sansen S, Yano JK, Reynald RL, Schoch GA, Griffin KJ, Stout CD, Johnson EF: Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2. J Biol Chem. 2007 May 11;282(19):14348-55. Epub 2007 Feb 20. [Article] Huang JD, Guo WC, Lai MD, Guo YL, Lambert GH: Detection of a novel cytochrome P-450 1A2 polymorphism (F21L) in Chinese. Drug Metab Dispos. 1999 Jan;27(1):98-101. [Article] Chevalier D, Cauffiez C, Allorge D, Lo-Guidice JM, Lhermitte M, Lafitte JJ, Broly F: Five novel natural allelic variants-951A>C, 1042G>A (D348N), 1156A>T (I386F), 1217G>A (C406Y) and 1291C>T (C431Y)-of the human CYP1A2 gene in a French Caucasian population. Hum Mutat. 2001 Apr;17(4):355-6. [Article] Murayama N, Soyama A, Saito Y, Nakajima Y, Komamura K, Ueno K, Kamakura S, Kitakaze M, Kimura H, Goto Y, Saitoh O, Katoh M, Ohnuma T, Kawai M, Sugai K, Ohtsuki T, Suzuki C, Minami N, Ozawa S, Sawada J: Six novel nonsynonymous CYP1A2 gene polymorphisms: catalytic activities of the naturally occurring variant enzymes. J Pharmacol Exp Ther. 2004 Jan;308(1):300-6. Epub 2003 Oct 16. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article] Soyama A, Saito Y, Hanioka N, Maekawa K, Komamura K, Kamakura S, Kitakaze M, Tomoike H, Ueno K, Goto Y, Kimura H, Katoh M, Sugai K, Saitoh O, Kawai M, Ohnuma T, Ohtsuki T, Suzuki C, Minami N, Kamatani N, Ozawa S, Sawada J: Single nucleotide polymorphisms and haplotypes of CYP1A2 in a Japanese population. Drug Metab Pharmacokinet. 2005 Feb;20(1):24-33. [Article] Jiang Z, Dalton TP, Jin L, Wang B, Tsuneoka Y, Shertzer HG, Deka R, Nebert DW: Toward the evaluation of function in genetic variability: characterizing human SNP frequencies and establishing BAC-transgenic mice carrying the human CYP1A1_CYP1A2 locus. Hum Mutat. 2005 Feb;25(2):196-206. [Article] Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H: Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA. 2006 Mar 8;295(10):1135-41. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00176Fluvoxamineapproved, investigationalunknownsubstrateinhibitorDetailsDB00188Bortezomibapproved, investigationalnosubstrateinhibitorDetailsDB00201CaffeineapprovedunknownsubstrateinhibitorDetailsDB00261AnagrelideapprovedunknownsubstrateinhibitorDetailsDB00268Ropiniroleapproved, investigationalunknownsubstrateDetailsDB00277TheophyllineapprovedunknownsubstrateDetailsDB00281Lidocaineapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00286Conjugated estrogensapprovedunknownsubstrateinhibitorDetailsDB00296RopivacaineapprovednosubstrateDetailsDB00315Zolmitriptanapproved, investigationalnosubstrateDetailsDB00316AcetaminophenapprovedunknownsubstrateDetailsDB00321AmitriptylineapprovedunknownsubstrateDetailsDB00334Olanzapineapproved, investigationalnosubstrateDetailsDB00363ClozapineapprovednosubstrateDetailsDB00365Grepafloxacinapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00370MirtazapineapprovedunknownsubstrateDetailsDB00379Mexiletineapproved, investigationalunknownsubstrateinhibitorDetailsDB00382Tacrineapproved, investigational, withdrawnunknownsubstrateDetailsDB00458ImipramineapprovedunknownsubstrateinhibitorDetailsDB00476DuloxetineapprovedunknownsubstrateinhibitorDetailsDB00499Flutamideapproved, investigationalunknownsubstrateDetailsDB00502HaloperidolapprovedunknownsubstrateDetailsDB00537Ciprofloxacinapproved, investigationalunknowninhibitorDetailsDB00540NortriptylineapprovedunknownsubstrateDetailsDB00544FluorouracilapprovedunknownsubstrateDetailsDB00571Propranololapproved, investigationalunknownsubstrateDetailsDB00655EstroneapprovedunknownsubstrateDetailsDB00661VerapamilapprovedunknownsubstrateDetailsDB00682WarfarinapprovedunknownsubstrateDetailsDB00697Tizanidineapproved, investigationalunknownsubstrateDetailsDB00740Riluzoleapproved, investigationalunknownsubstrateDetailsDB00744Zileutonapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00851Dacarbazineapproved, investigationalunknownsubstrateDetailsDB00863Ranitidineapproved, withdrawnunknownsubstrateinhibitorDetailsDB00904Ondansetronapproved, withdrawnunknownsubstrateinhibitorDetailsDB00924CyclobenzaprineapprovedunknownsubstrateDetailsDB00978Lomefloxacinapproved, investigationalunknownsubstrateinhibitorDetailsDB00980Ramelteonapproved, investigationalunknownsubstrateDetailsDB00998Frovatriptanapproved, investigationalunknownsubstrateDetailsDB01002Levobupivacaineapproved, investigationalunknownsubstrateDetailsDB01012CinacalcetapprovedunknownsubstrateDetailsDB01094HesperetinexperimentalunknownsubstrateDetailsDB01097Leflunomideapproved, investigationalunknownsubstrateDetailsDB01100PimozideapprovedunknownsubstrateDetailsDB01165OfloxacinapprovedunknowninhibitorDetailsDB01182PropafenoneapprovedunknownsubstrateinhibitorDetailsDB01242Clomipramineapproved, investigational, vet_approvednosubstrateDetailsDB00969Alosetronapproved, withdrawnunknownsubstrateinhibitorDetailsDB01367RasagilineapprovedunknownsubstrateDetailsDB00356ChlorzoxazoneapprovedunknownsubstrateDetailsDB00467Enoxacinapproved, investigationalunknowninhibitorDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00487PefloxacinapprovedunknowninhibitorDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00532Mephenytoinapproved, investigational, withdrawnunknownsubstrateDetailsDB00533Rofecoxibapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknownsubstrateDetailsDB00730Thiabendazoleapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00908Quinidineapproved, investigationalunknowninhibitorDetailsDB00972AzelastineapprovedunknownsubstrateDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB01045RifampicinapprovedunknowninducerDetailsDB01059NorfloxacinapprovedunknowninhibitorDetailsDB01418Acenocoumarolapproved, investigationalunknownsubstrateDetailsDB01424Aminophenazoneapproved, withdrawnunknownsubstrateDetailsDB00377Palonosetronapproved, investigationalunknownsubstrateDetailsDB05708GTS-21investigationalunknownsubstrateDetailsDB06442AvasimibeinvestigationalunknowninhibitorDetailsDB01065Melatoninapproved, nutraceutical, vet_approvedunknownsubstrateDetailsDB01115NifedipineapprovedunknownsubstrateinhibitorDetailsDB00619ImatinibapprovednosubstrateDetailsDB00468QuinineapprovedunknownsubstrateDetailsDB01142Doxepinapproved, investigationalnosubstrateDetailsDB00564Carbamazepineapproved, investigationalunknowninhibitorinducerDetailsDB00425ZolpidemapprovedunknownsubstrateDetailsDB00951Isoniazidapproved, investigationalunknowninhibitorDetailsDB00472Fluoxetineapproved, vet_approvedunknownsubstrateinhibitorDetailsDB01435Antipyrineapproved, investigationalunknownsubstrateDetailsDB01118Amiodaroneapproved, investigationalunknowninhibitorDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00568Cinnarizineapproved, investigationalunknownsubstrateDetailsDB04841FlunarizineapprovedunknownsubstrateDetailsDB00788Naproxenapproved, vet_approvedunknownsubstrateDetailsDB03783PhenacetinwithdrawnunknownsubstrateDetailsDB00553MethoxsalenapprovedunknowninhibitorDetailsDB01388Mibefradilinvestigational, withdrawnunknowninhibitorDetailsDB00745Modafinilapproved, investigationalunknowninducerDetailsDB00607Nafcillinapproved, investigationalunknowninducerDetailsDB06732beta-NaphthoflavoneexperimentalunknowninducerDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknowninducerDetailsDB01223AminophyllineapprovedunknownsubstrateDetailsDB06216AsenapineapprovedunknownsubstrateDetailsDB00195Betaxololapproved, investigationalunknownsubstrateDetailsDB04574Estrone sulfateapprovedunknownsubstrateDetailsDB00629Guanabenzapproved, investigationalunknownsubstrateDetailsDB01623ThiothixeneapprovedunknownsubstrateDetailsDB00831Trifluoperazineapproved, investigationalunknownsubstrateDetailsDB01174Phenobarbitalapproved, investigationalnoinducerDetailsDB01241GemfibrozilapprovedunknowninhibitorDetailsDB00752Tranylcypromineapproved, investigationalunknowninhibitorDetailsDB01087PrimaquineapprovedunknownsubstrateinducerDetailsDB00758ClopidogrelapprovednosubstrateDetailsDB00420Promazineapproved, vet_approvedunknownsubstrateinhibitorDetailsDB01136Carvedilolapproved, investigationalunknownsubstrateDetailsDB01628Etoricoxibapproved, investigationalunknownsubstrateDetailsDB01645GenisteininvestigationalunknownsubstrateinhibitorDetailsDB07453alpha-NaphthoflavoneexperimentalunknownDetailsDB02709ResveratrolinvestigationalnosubstrateinhibitorinducerDetailsDB00518Albendazoleapproved, vet_approvedunknowninducerDetailsDB01558Bromazepamapproved, illicit, investigationalunknownsubstrateDetailsDB00215CitalopramapprovednoinhibitorDetailsDB01151Desipramineapproved, investigationalunknownproduct ofDetailsDB01191Dexfenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB00625Efavirenzapproved, investigationalunknownsubstrateinhibitorDetailsDB00898EthanolapprovedunknownsubstrateDetailsDB00773EtoposideapprovedunknownsubstrateDetailsDB00400Griseofulvinapproved, investigational, vet_approvedunknowninducerDetailsDB01283Lumiracoxibapproved, investigationalunknownsubstrateDetailsDB00772Malathionapproved, investigationalunknownsubstrateDetailsDB00934Maprotilineapproved, investigationalunknownsubstrateDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorinducerDetailsDB00333MethadoneapprovedunknownsubstrateDetailsDB01028Methoxyfluraneapproved, investigational, vet_approved, withdrawnunknownsubstrateDetailsDB06148Mianserinapproved, investigationalunknownsubstrateDetailsDB00184NicotineapprovedunknownsubstrateinducerDetailsDB00806Pentoxifyllineapproved, investigationalunknownsubstrateDetailsDB00850PerphenazineapprovedunknownsubstrateDetailsDB00388PhenylephrineapprovedunknowninducerDetailsDB01058Praziquantelapproved, investigational, vet_approvedunknownsubstrateDetailsDB00818Propofolapproved, investigational, vet_approvedunknowninhibitorDetailsDB01129Rabeprazoleapproved, investigationalunknowninhibitorinducerDetailsDB00503Ritonavirapproved, investigationalunknowninducerDetailsDB00412Rosiglitazoneapproved, investigationalunknowninhibitorDetailsDB01037Selegilineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB01079Tegaserodapproved, investigational, withdrawnunknowninhibitorDetailsDB01405TemafloxacinwithdrawnunknownsubstrateinhibitorDetailsDB01412TheobromineinvestigationalunknownsubstrateDetailsDB00763MethimazoleapprovedunknowninhibitorDetailsDB00208TiclopidineapprovedunknowninhibitorDetailsDB06264TolperisoneinvestigationalunknownsubstrateDetailsDB00384TriamtereneapprovedunknownsubstrateDetailsDB00313Valproic acidapproved, investigationalunknowninhibitorDetailsDB00549Zafirlukastapproved, investigationalunknowninhibitorDetailsDB01303OxtriphyllineapprovedunknownsubstrateDetailsDB00398Sorafenibapproved, investigationalunknownsubstrateDetailsDB00418Secobarbitalapproved, vet_approvedunknowninducerDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateDetailsDB01166Cilostazolapproved, investigationalunknownsubstrateDetailsDB01254Dasatinibapproved, investigationalunknownsubstrateDetailsDB06210EltrombopagapprovedunknownsubstrateDetailsDB06413Armodafinilapproved, investigationalunknowninducerDetailsDB00575ClonidineapprovedunknownsubstrateDetailsDB06594Agomelatineapproved, investigationalunknownsubstrateDetailsDB06510MuraglitazarinvestigationalunknownsubstrateDetailsDB06770Benzyl alcoholapprovedunknownsubstrateDetailsDB06774CapsaicinapprovedunknownsubstrateinducerDetailsDB00633Dexmedetomidineapproved, vet_approvedunknowninhibitorDetailsDB06235VadimezaninvestigationalunknownsubstrateDetailsDB00461NabumetoneapprovedunknownsubstrateDetailsDB06803Niclosamideapproved, investigational, vet_approvedunknowninhibitorDetailsDB00435Nitric OxideapprovedunknowninhibitorDetailsDB06820SulconazoleapprovedunknowninhibitorDetailsDB00428Streptozocinapproved, investigationalunknowninducerDetailsDB06589PazopanibapprovedunknownsubstrateDetailsDB08867UlipristalapprovednosubstrateDetailsDB04871Lorcaserinapproved, withdrawnnosubstrateDetailsDB08881VemurafenibapprovedunknowninhibitorDetailsDB06605ApixabanapprovedunknownsubstrateDetailsDB06626Axitinibapproved, investigationalnosubstrateDetailsDB08910PomalidomideapprovedunknownsubstrateDetailsDB06290SimeprevirapprovednoinhibitorDetailsDB06292DapagliflozinapprovednosubstrateDetailsDB00951Isoniazidapproved, investigationalunknownDetailsDB05812AbirateroneapprovedunknowninhibitorDetailsDB09570Ixazomibapproved, investigationalunknownsubstrateDetailsDB09330OsimertinibapprovednoinducerDetailsDB06769Bendamustineapproved, investigationalnosubstrateDetailsDB00105Interferon alfa-2bapprovedunknowninhibitorDetailsDB05990Obeticholic acidapprovedunknowninhibitordownregulatorDetailsDB01173OrphenadrineapprovedunknowninhibitorDetailsDB00715Paroxetineapproved, investigationalunknownsubstrateinhibitorDetailsDB00008Peginterferon alfa-2aapproved, investigationalunknowninhibitorDetailsDB00022Peginterferon alfa-2bapprovedunknowninhibitorDetailsDB12332Rucaparibapproved, investigationalnosubstrateinhibitorinducerDetailsDB11737Icotinibexperimental, investigationalunknownsubstrateDetailsDB12161Deutetrabenazineapproved, investigationalnosubstrateDetailsDB06595Midostaurinapproved, investigationalunknowninhibitorinducerDetailsDB05015Belinostatapproved, investigationalunknowninducerDetailsDB13174RheinexperimentalunknowninhibitorDetailsDB11994Diacereinapproved, investigationalunknowninhibitorDetailsDB09120Zucapsaicinapproved, investigationalunknowninhibitorDetailsDB09118StiripentolapprovedunknownsubstrateinhibitorinducerDetailsDB09198LobeglitazoneexperimentalnoinhibitorDetailsDB09167DosulepinapprovedunknowninhibitorDetailsDB12026Voxilaprevirapproved, investigationalnosubstrateDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB09225Zotepineapproved, investigational, withdrawnnosubstrateDetailsDB11642Pitolisantapproved, investigationalunknowninducerDetailsDB13975Black cohoshexperimentalnoinhibitorDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorinducerDetailsDB11198Peppermint oilapproved, investigationalunknowninhibitorDetailsDB04948Lofexidineapproved, investigationalnosubstrateDetailsDB11672Curcuminapproved, investigationalunknowninhibitorDetailsDB00238NevirapineapprovedunknowninhibitorDetailsDB11967Binimetinibapproved, investigationalnosubstrateDetailsDB06654Safinamideapproved, investigationalunknowninhibitorDetailsDB08883PerampanelapprovedunknownsubstrateDetailsDB09078Lenvatinibapproved, investigationalunknowninhibitorDetailsDB05928DovitinibinvestigationalunknowninducerDetailsDB08496(R)-warfarinexperimentalunknownsubstrateDetailsDB141328-chlorotheophyllineexperimentalnosubstrateDetailsDB01320Fosphenytoinapproved, investigationalunknowninducerDetailsDB00993AzathioprineapprovednosubstrateDetailsDB14029FurafyllineexperimentalnoinhibitorDetailsDB04076HypoxanthineexperimentalnosubstrateDetailsDB12406LisofyllineinvestigationalnosubstrateDetailsDB02134XanthineexperimentalnosubstrateDetailsDB06771BesifloxacinapprovednoinhibitorDetailsDB00827Cinoxacinapproved, investigational, withdrawnnoinhibitorDetailsDB11511Difloxacinvet_approvednoinhibitorDetailsDB06160GarenoxacininvestigationalnoinhibitorDetailsDB01044Gatifloxacinapproved, investigational, withdrawnnoinhibitorDetailsDB01155Gemifloxacinapproved, investigationalnoinhibitorDetailsDB00218Moxifloxacinapproved, investigationalnoinhibitorDetailsDB06600NemonoxacininvestigationalnoinhibitorDetailsDB11443Orbifloxacinvet_approvednoinhibitorDetailsDB11774PazufloxacininvestigationalnoinhibitorDetailsDB13823Pipemidic acidexperimentalnoinhibitorDetailsDB11892PrulifloxacininvestigationalnoinhibitorDetailsDB00817Rosoxacinapproved, investigationalnoinhibitorDetailsDB13772RufloxacinexperimentalnoinhibitorDetailsDB11491Sarafloxacinvet_approved, withdrawnnoinhibitorDetailsDB13261Sitafloxacinexperimental, investigationalnoinhibitorDetailsDB01208Sparfloxacinapproved, investigational, withdrawnunknowninhibitorDetailsDB05488Technetium Tc-99m ciprofloxacininvestigationalnoinhibitorDetailsDB00685Trovafloxacinapproved, investigational, withdrawnnoinhibitorDetailsDB016678-azaguanineexperimentalnosubstrateDetailsDB043569-DeazaguanineexperimentalnosubstrateDetailsDB024899-MethylguanineexperimentalnosubstrateDetailsDB13573AcefyllineexperimentalnosubstrateDetailsDB13203BamifyllineexperimentalnosubstrateDetailsDB14018BromotheophyllineapprovednosubstrateDetailsDB13812BufyllineexperimentalnosubstrateDetailsDB09273DoxofyllineexperimentalnosubstrateDetailsDB13592EtamiphyllineexperimentalnosubstrateDetailsDB01482FenethyllineexperimentalnosubstrateDetailsDB13634PentifyllineexperimentalnosubstrateDetailsDB06479PropentofyllineinvestigationalunknownsubstrateDetailsDB13449ProxyphyllineexperimentalnosubstrateDetailsDB09256Tegafurapproved, investigationalunknownsubstrateDetailsDB09288PropacetamolexperimentalnosubstrateDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB00280DisopyramideapprovedunknownsubstrateDetailsDB00454MeperidineapprovedunknowninducerDetailsDB09290RamosetroninvestigationalunknownsubstrateDetailsDB09071Tasimelteonapproved, investigationalunknownsubstrateDetailsDB04951Pirfenidoneapproved, investigationalunknownsubstrateinhibitorDetailsDB12945Dihydralazineapproved, experimentalunknownsubstrateinhibitorDetailsDB11450Pimobendanvet_approvedunknownsubstrateDetailsDB08880TeriflunomideapprovedunknowninducerDetailsDB01609Deferasiroxapproved, investigationalunknowninhibitorDetailsDB08972FlumequinewithdrawnunknowninhibitorDetailsDB14025ClinafloxacininvestigationalunknowninhibitorDetailsDB11753Rifamycinapproved, investigationalnoinhibitorDetailsDB01056TocainideapprovednosubstrateinhibitorDetailsDB09185Viloxazineapproved, investigational, withdrawnnoinhibitorDetailsDB12245Triclabendazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00455Loratadineapproved, investigationalunknownsubstrateDetailsDB05676Apremilastapproved, investigationalunknownsubstrateDetailsDB11404Enrofloxacinvet_approvedunknowninhibitorDetailsDB00779Nalidixic acidapproved, investigationalunknowninhibitorDetailsDB05396Albinterferon Alfa-2BinvestigationalunknowninhibitorDetailsDB12814Cepeginterferon alfa-2BinvestigationalunknowninhibitorDetailsDB15119Ropeginterferon alfa-2bapproved, investigationalnoinhibitorDetailsDB09122Peginterferon beta-1aapprovedunknowndownregulatorDetailsDB00033Interferon gamma-1bapproved, investigationalunknowninhibitorDetailsDB00068Interferon beta-1bapprovedunknowninhibitorDetailsDB00060Interferon beta-1aapproved, investigationalunknowninhibitorDetailsDB00069Interferon alfacon-1approved, investigationalunknowninhibitorDetailsDB00018Interferon alfa-n3approved, investigationalunknowninhibitorDetailsDB00011Interferon alfa-n1approved, investigationalunknowninhibitorDetailsDB15131Interferon alfa-2cinvestigationalunknowninhibitorDetailsDB00034Interferon alfa-2aapproved, investigationalunknowninhibitorDetailsDB05258Interferon alfainvestigationalunknowninhibitorDetailsDB14999Human interferon betaapproved, investigationalunknowndownregulatorDetailsDB01306Insulin aspartapprovedunknowninducerDetailsDB09456Insulin beefapprovedunknowninducerDetailsDB09564Insulin degludecapprovednoinducerDetailsDB01307Insulin detemirapprovednoinducerDetailsDB00047Insulin glargineapprovedunknowninducerDetailsDB01309Insulin glulisineapprovedunknowninducerDetailsDB00030Insulin humanapproved, investigationalunknowninducerDetailsDB00046Insulin lisproapprovedunknowninducerDetailsDB11567Insulin peglisproinvestigationalunknowninducerDetailsDB00071Insulin porkapprovedunknowninducerDetailsDB05115NN344investigationalunknowninducerDetailsDB11568Insulin tregopilinvestigationalunknowninducerDetailsDB00675TamoxifenapprovedunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknownsubstrateDetailsDB01233Metoclopramideapproved, investigationalunknownsubstrateDetailsDB04889BicifadineinvestigationalunknownsubstrateDetailsDB09061Cannabidiolapproved, investigationalunknowninhibitorDetailsDB14011NabiximolsinvestigationalunknowninhibitorDetailsDB01217Anastrozoleapproved, investigationalunknowninhibitorDetailsDB01195Flecainideapproved, withdrawnunknownsubstrateDetailsDB12001Abemaciclibapproved, investigationalunknowninhibitorDetailsDB01072Atazanavirapproved, investigationalunknowninhibitorDetailsDB15444Elexacaftorapproved, investigationalnoinhibitorDetailsDB00717NorethisteroneapprovedunknownsubstrateDetailsDB06077Lumateperoneapproved, investigationalnosubstrateDetailsDB00252Phenytoinapproved, vet_approvednoinducerDetailsDB00794Primidoneapproved, vet_approvedunknowninducerDetailsDB00927FamotidineapprovednoinhibitorDetailsDB00977EthinylestradiolapprovedunknownsubstrateDetailsDB00440Trimethoprimapproved, vet_approvedunknownsubstrateDetailsDB13609UmifenovirinvestigationalunknownsubstrateDetailsDB01601LopinavirapprovedunknownsubstrateinhibitorDetailsDB11837Osilodrostatapproved, investigationalunknowninhibitorDetailsDB09241Methylene blueapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB11689Selumetinibapproved, investigationalnosubstrateDetailsDB11791Capmatinibapproved, investigationalunknowninhibitorDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB00409Remoxiprideapproved, withdrawnunknowninhibitorDetailsDB11932Abametapirapproved, investigationalnosubstrateinhibitorDetailsDB12499Clascoteroneapproved, investigationalnoinhibitorDetailsDB15093Somapacitanapproved, investigationalunknowninducerDetailsDB15822Pralsetinibapproved, investigationalnosubstrateDetailsDB06448Lonafarnibapproved, investigationalnosubstrateDetailsDB06137Tirbanibulinapproved, investigationalnoinhibitorDetailsDB08912Dabrafenibapproved, investigationalnoinhibitorDetailsDB11632Opicaponeapproved, investigationalnoinhibitorDetailsDB00784Mefenamic acidapprovedunknownsubstrateinhibitorDetailsDB00052Somatotropinapproved, investigationalunknowninducerDetailsDB00330EthambutolapprovedunknowninhibitorDetailsDB15442Trilaciclibapproved, investigationalunknowninducerDetailsDB14989Umbralisibapproved, investigational, withdrawnunknownsubstrateDetailsDB04854FebuxostatapprovednosubstrateDetailsDB01086Benzocaineapproved, investigationalunknownsubstrateDetailsDB11564Insulin argineexperimentalunknowninducerDetailsDB01381Ginkgo bilobaapproved, investigational, nutraceuticalnoinhibitorDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownsubstrateDetailsDB12151Brincidofovirapproved, investigationalnoinhibitorDetailsDB16703Belumosudilapproved, investigationalnoinhibitorDetailsDB12265Fexinidazoleapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB16220Lonapegsomatropinapproved, investigationalunknowninducerDetailsDB15011Avacopanapproved, investigationalnoinducerDetailsDB06234Maribavirapproved, investigationalnosubstrateDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB05667Levoketoconazoleapproved, investigationalnoinducerDetailsDB16236Mitapivatapproved, investigationalnosubstrateDetailsDB09061Cannabidiolapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00470Dronabinolapproved, illicitnoinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknowninhibitorDetailsDB11697Pacritinibapproved, investigationalnoinhibitorinducerDetailsDB06016Cariprazineapproved, investigationalnoinhibitorDetailsDB06083Tapinarofapproved, investigationalnosubstrateDetailsDB01656RoflumilastapprovednosubstrateDetailsDB16650Deucravacitinibapproved, investigationalunknownsubstrateDetailsDB11793Niraparibapproved, investigationalnoinducerDetailsDB16267Olutasidenibapproved, investigationalnosubstrateinducerDetailsDB15568Adagrasibapproved, investigationalunknownsubstrateDetailsDB17472Pirtobrutinibapproved, investigationalunknowninhibitorDetailsDB00349Clobazamapproved, illicitnosubstrateDetailsDB16217Leniolisibapproved, investigationalnosubstrateinhibitorDetailsDB11712Tezacaftorapproved, investigationalnoinhibitorDetailsDB15669Fezolinetantapproved, investigationalnosubstrateDetailsDB14924Ritlecitinibapproved, investigationalunknownsubstrateinhibitorDetailsDB11763Momelotinibapproved, investigationalunknownsubstrateDetailsDB11718Encorafenibapproved, investigationalnoinhibitorDetails"
                    }
                },
                {
                    "Label": "Cytochrome P450 3A4",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 3A4",
                        "Synonyms": "1,8-cineole 2-exo-monooxygenase\n1.14.13.-\nAlbendazole monooxygenase\nAlbendazole sulfoxidase\nCholesterol 25-hydroxylase\nCYP3A3\nCYPIIIA3\nCYPIIIA4\nCytochrome P450 3A3\nCytochrome P450 HLp\nCytochrome P450 NF-25\nCytochrome P450-PCN1\nNifedipine oxidase\nQuinine 3-monooxygenase\nTaurochenodeoxycholate 6-alpha-hydroxylase",
                        "Gene Name": "CYP3A4",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0021936|Cytochrome P450 3A4\nMALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMF\nDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISI\nAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYS\nMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICV\nFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSI\nIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVV\nNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFS\nKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLG\nGLLQPEKPVVLKVESRDGTVSGA",
                        "Number of residues": "503",
                        "Molecular Weight": "57342.67",
                        "Theoretical pI": "8.25",
                        "GO Classification": "Functionsalbendazole monooxygenase activity / aromatase activity / caffeine oxidase activity / enzyme binding / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity / oxygen binding / quinine 3-monooxygenase activity / steroid binding / steroid hydroxylase activity / taurochenodeoxycholate 6alpha-hydroxylase activity / testosterone 6-beta-hydroxylase activity / vitamin D 24-hydroxylase activity / vitamin D3 25-hydroxylase activityProcessesalkaloid catabolic process / androgen metabolic process / calcitriol biosynthetic process from calciol / drug catabolic process / drug metabolic process / exogenous drug catabolic process / heterocycle metabolic process / lipid metabolic process / monoterpenoid metabolic process / oxidation-reduction process / oxidative demethylation / small molecule metabolic process / steroid catabolic process / steroid metabolic process / vitamin D metabolic process / xenobiotic metabolic processComponentscytoplasm / endoplasmic reticulum membrane / integral component of membrane / intracellular membrane-bounded organelle",
                        "General Function": "Vitamin d3 25-hydroxylase activity",
                        "Specific Function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation reactions (e.g. caffeine 8-oxidation, omeprazole sulphoxidation, midazolam 1'-hydroxylation and midazolam 4-hydroxylation) of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,8-cineole 2-exo-monooxygenase. The enzyme also hydroxylates etoposide (PubMed:11159812). Catalyzes 4-beta-hydroxylation of cholesterol. May catalyze 25-hydroxylation of cholesterol in vitro (PubMed:21576599).",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "2-22",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0021937|Cytochrome P450 3A4 (CYP3A4)\nATGGCTCTCATCCCAGACTTGGCCATGGAAACCTGGCTTCTCCTGGCTGTCAGCCTGGTG\nCTCCTCTATCTATATGGAACCCATTCACATGGACTTTTTAAGAAGCTTGGAATTCCAGGG\nCCCACACCTCTGCCTTTTTTGGGAAATATTTTGTCCTACCATAAGGGCTTTTGTATGTTT\nGACATGGAATGTCATAAAAAGTATGGAAAAGTGTGGGGCTTTTATGATGGTCAACAGCCT\nGTGCTGGCTATCACAGATCCTGACATGATCAAAACAGTGCTAGTGAAAGAATGTTATTCT\nGTCTTCACAAACCGGAGGCCTTTTGGTCCAGTGGGATTTATGAAAAGTGCCATCTCTATA\nGCTGAGGATGAAGAATGGAAGAGATTACGATCATTGCTGTCTCCAACCTTCACCAGTGGA\nAAACTCAAGGAGATGGTCCCTATCATTGCCCAGTATGGAGATGTGTTGGTGAGAAATCTG\nAGGCGGGAAGCAGAGACAGGCAAGCCTGTCACCTTGAAAGACGTCTTTGGGGCCTACAGC\nATGGATGTGATCACTAGCACATCATTTGGAGTGAACATCGACTCTCTCAACAATCCACAA\nGACCCCTTTGTGGAAAACACCAAGAAGCTTTTAAGATTTGATTTTTTGGATCCATTCTTT\nCTCTCAATAATCTTTCCATTCCTCATCCCAATTCTTGAAGTATTAAATATCTGTGTGTTT\nCCAAGAGAAGTTACAAATTTTTTAAGAAAATCTGTAAAAAGGATGAAAGAAAGTCGCCTC\nGAAGATACACAAAAGCACCGAGTGGATTTCCTTCAGCTGATGATTGACTCTCAGAATTCA\nAAAGAAACTGAGTCCCACAAAGCTCTGTCCGATCTGGAGCTCGTGGCCCAATCAATTATC\nTTTATTTTTGCTGGCTATGAAACCACGAGCAGTGTTCTCTCCTTCATTATGTATGAACTG\nGCCACTCACCCTGATGTCCAGCAGAAACTGCAGGAGGAAATTGATGCAGTTTTACCCAAT\nAAGGCACCACCCACCTATGATACTGTGCTACAGATGGAGTATCTTGACATGGTGGTGAAT\nGAAACGCTCAGATTATTCCCAATTGCTATGAGACTTGAGAGGGTCTGCAAAAAAGATGTT\nGAGATCAATGGGATGTTCATTCCCAAAGGGGTGGTGGTGATGATTCCAAGCTATGCTCTT\nCACCGTGACCCAAAGTACTGGACAGAGCCTGAGAAGTTCCTCCCTGAAAGATTCAGCAAG\nAAGAACAAGGACAACATAGATCCTTACATATACACACCCTTTGGAAGTGGACCCAGAAAC\nTGCATTGGCATGAGGTTTGCTCTCATGAACATGAAACTTGCTCTAATCAGAGTCCTTCAG\nAACTTCTCCTTCAAACCTTGTAAAGAAACACAGATCCCCCTGAAATTAAGCTTAGGAGGA\nCTTCTTCAACCAGAAAAACCCGTTGTTCTAAAGGTTGAGTCAAGGGATGGCACCGTAAGT\nGGAGCCTGA",
                        "Chromosome Location": "7",
                        "Locus": "7q21.1",
                        "External Identifiers": "ResourceLinkUniProtKB IDP08684UniProtKB Entry NameCP3A4_HUMANGenBank Gene IDM18907GenAtlas IDCYP3A4HGNC IDHGNC:2637",
                        "General References": "Molowa DT, Schuetz EG, Wrighton SA, Watkins PB, Kremers P, Mendez-Picon G, Parker GA, Guzelian PS: Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver. Proc Natl Acad Sci U S A. 1986 Jul;83(14):5311-5. [Article] Gonzalez FJ, Schmid BJ, Umeno M, Mcbride OW, Hardwick JP, Meyer UA, Gelboin HV, Idle JR: Human P450PCN1: sequence, chromosome localization, and direct evidence through cDNA expression that P450PCN1 is nifedipine oxidase. DNA. 1988 Mar;7(2):79-86. [Article] Beaune PH, Umbenhauer DR, Bork RW, Lloyd RS, Guengerich FP: Isolation and sequence determination of a cDNA clone related to human cytochrome P-450 nifedipine oxidase. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8064-8. [Article] Spurr NK, Gough AC, Stevenson K, Wolf CR: The human cytochrome P450 CYP3 locus: assignment to chromosome 7q22-qter. Hum Genet. 1989 Jan;81(2):171-4. [Article] Bork RW, Muto T, Beaune PH, Srivastava PK, Lloyd RS, Guengerich FP: Characterization of mRNA species related to human liver cytochrome P-450 nifedipine oxidase and the regulation of catalytic activity. J Biol Chem. 1989 Jan 15;264(2):910-9. [Article] Chen Q, Wu J, Yu Y: [Establishment of transgenic cell line CHL-3A4 and its metabolic activation]. Zhonghua Yu Fang Yi Xue Za Zhi. 1998 Sep;32(5):281-4. [Article] Gellner K, Eiselt R, Hustert E, Arnold H, Koch I, Haberl M, Deglmann CJ, Burk O, Buntefuss D, Escher S, Bishop C, Koebe HG, Brinkmann U, Klenk HP, Kleine K, Meyer UA, Wojnowski L: Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics. 2001 Mar;11(2):111-21. [Article] Hsieh KP, Lin YY, Cheng CL, Lai ML, Lin MS, Siest JP, Huang JD: Novel mutations of CYP3A4 in Chinese. Drug Metab Dispos. 2001 Mar;29(3):268-73. [Article] Komori M, Hashizume T, Ohi H, Miura T, Kitada M, Nagashima K, Kamataki T: Cytochrome P-450 in human liver microsomes: high-performance liquid chromatographic isolation of three forms and their characterization. J Biochem. 1988 Dec;104(6):912-6. [Article] Watkins PB, Wrighton SA, Maurel P, Schuetz EG, Mendez-Picon G, Parker GA, Guzelian PS: Identification of an inducible form of cytochrome P-450 in human liver. Proc Natl Acad Sci U S A. 1985 Sep;82(18):6310-4. [Article] Aoyama T, Yamano S, Waxman DJ, Lapenson DP, Meyer UA, Fischer V, Tyndale R, Inaba T, Kalow W, Gelboin HV, et al.: Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. J Biol Chem. 1989 Jun 25;264(18):10388-95. [Article] Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP: Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther. 1994 Jul;270(1):414-23. [Article] Kolars JC, Lown KS, Schmiedlin-Ren P, Ghosh M, Fang C, Wrighton SA, Merion RM, Watkins PB: CYP3A gene expression in human gut epithelium. Pharmacogenetics. 1994 Oct;4(5):247-59. [Article] Zhang H, Coville PF, Walker RJ, Miners JO, Birkett DJ, Wanwimolruk S: Evidence for involvement of human CYP3A in the 3-hydroxylation of quinine. Br J Clin Pharmacol. 1997 Mar;43(3):245-52. [Article] Zhao XJ, Kawashiro T, Ishizaki T: Mutual inhibition between quinine and etoposide by human liver microsomes. Evidence for cytochrome P4503A4 involvement in their major metabolic pathways. Drug Metab Dispos. 1998 Feb;26(2):188-91. [Article] Miyazawa M, Shindo M, Shimada T: Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes. Drug Metab Dispos. 2001 Feb;29(2):200-5. [Article] Finta C, Zaphiropoulos PG: Intergenic mRNA molecules resulting from trans-splicing. J Biol Chem. 2002 Feb 22;277(8):5882-90. Epub 2001 Nov 28. [Article] Dauchy S, Dutheil F, Weaver RJ, Chassoux F, Daumas-Duport C, Couraud PO, Scherrmann JM, De Waziers I, Decleves X: ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J Neurochem. 2008 Dec;107(6):1518-28. doi: 10.1111/j.1471-4159.2008.05720.x. [Article] Agarwal V, Kommaddi RP, Valli K, Ryder D, Hyde TM, Kleinman JE, Strobel HW, Ravindranath V: Drug metabolism in human brain: high levels of cytochrome P4503A43 in brain and metabolism of anti-anxiety drug alprazolam to its active metabolite. PLoS One. 2008 Jun 11;3(6):e2337. doi: 10.1371/journal.pone.0002337. [Article] Pabarcus MK, Hoe N, Sadeghi S, Patterson C, Wiertz E, Correia MA: CYP3A4 ubiquitination by gp78 (the tumor autocrine motility factor receptor, AMFR) and CHIP E3 ligases. Arch Biochem Biophys. 2009 Mar 1;483(1):66-74. doi: 10.1016/j.abb.2008.12.001. Epub 2008 Dec 10. [Article] Dutheil F, Dauchy S, Diry M, Sazdovitch V, Cloarec O, Mellottee L, Bieche I, Ingelman-Sundberg M, Flinois JP, de Waziers I, Beaune P, Decleves X, Duyckaerts C, Loriot MA: Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function. Drug Metab Dispos. 2009 Jul;37(7):1528-38. doi: 10.1124/dmd.109.027011. Epub 2009 Apr 9. [Article] Honda A, Miyazaki T, Ikegami T, Iwamoto J, Maeda T, Hirayama T, Saito Y, Teramoto T, Matsuzaki Y: Cholesterol 25-hydroxylation activity of CYP3A. J Lipid Res. 2011 Aug;52(8):1509-16. doi: 10.1194/jlr.M014084. Epub 2011 May 16. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Yano JK, Wester MR, Schoch GA, Griffin KJ, Stout CD, Johnson EF: The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-A resolution. J Biol Chem. 2004 Sep 10;279(37):38091-4. Epub 2004 Jul 16. [Article] Williams PA, Cosme J, Vinkovic DM, Ward A, Angove HC, Day PJ, Vonrhein C, Tickle IJ, Jhoti H: Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone. Science. 2004 Jul 30;305(5684):683-6. Epub 2004 Jul 15. [Article] Sata F, Sapone A, Elizondo G, Stocker P, Miller VP, Zheng W, Raunio H, Crespi CL, Gonzalez FJ: CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activity. Clin Pharmacol Ther. 2000 Jan;67(1):48-56. [Article] Dai D, Tang J, Rose R, Hodgson E, Bienstock RJ, Mohrenweiser HW, Goldstein JA: Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos. J Pharmacol Exp Ther. 2001 Dec;299(3):825-31. [Article] Eiselt R, Domanski TL, Zibat A, Mueller R, Presecan-Siedel E, Hustert E, Zanger UM, Brockmoller J, Klenk HP, Meyer UA, Khan KK, He YA, Halpert JR, Wojnowski L: Identification and functional characterization of eight CYP3A4 protein variants. Pharmacogenetics. 2001 Jul;11(5):447-58. [Article] Lamba JK, Lin YS, Thummel K, Daly A, Watkins PB, Strom S, Zhang J, Schuetz EG: Common allelic variants of cytochrome P4503A4 and their prevalence in different populations. Pharmacogenetics. 2002 Mar;12(2):121-32. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB05478Pradefovir mesylateinvestigationalunknownDetailsDB00180Flunisolideapproved, investigationalunknownsubstrateinducerDetailsDB00185CevimelineapprovedunknownsubstrateDetailsDB00188Bortezomibapproved, investigationalnosubstrateDetailsDB00196Fluconazoleapproved, investigationalunknowninhibitorDetailsDB00204Dofetilideapproved, investigationalunknownsubstrateDetailsDB00213PantoprazoleapprovedunknownsubstrateDetailsDB00216Eletriptanapproved, investigationalunknownsubstrateDetailsDB00220NelfinavirapprovednosubstrateinhibitorDetailsDB00224IndinavirapprovedunknownsubstrateinhibitorDetailsDB00227Lovastatinapproved, investigationalunknownsubstrateinhibitorDetailsDB00234Reboxetineapproved, experimentalunknownsubstrateinhibitorDetailsDB00238NevirapineapprovedunknownsubstrateinducerDetailsDB00243Ranolazineapproved, investigationalnosubstrateinhibitorDetailsDB00246ZiprasidoneapprovedunknownsubstrateDetailsDB00270Isradipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00280DisopyramideapprovedunknownsubstrateDetailsDB00286Conjugated estrogensapprovednosubstrateDetailsDB00294Etonogestrelapproved, investigationalnosubstrateDetailsDB00297Bupivacaineapproved, investigationalunknownsubstrateDetailsDB00307Bexaroteneapproved, investigationalunknownsubstrateinducerDetailsDB00309Vindesineapproved, investigationalunknownsubstrateDetailsDB00317Gefitinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00320Dihydroergotamineapproved, investigationalunknownsubstrateinhibitorDetailsDB00324Fluorometholoneapproved, investigationalunknownsubstrateinducerDetailsDB00342Terfenadineapproved, withdrawnunknownsubstrateinhibitorDetailsDB00343Diltiazemapproved, investigationalunknownsubstrateinhibitorDetailsDB00346Alfuzosinapproved, investigationalunknownsubstrateDetailsDB00361Vinorelbineapproved, investigationalnosubstrateDetailsDB00365Grepafloxacinapproved, investigational, withdrawnunknownsubstrateDetailsDB00370MirtazapineapprovedunknownsubstrateinhibitorDetailsDB00381AmlodipineapprovednosubstrateDetailsDB00393Nimodipineapproved, investigationalunknownsubstrateDetailsDB00398Sorafenibapproved, investigationalunknownsubstrateinhibitorDetailsDB00401NisoldipineapprovedunknownsubstrateDetailsDB00402Eszopicloneapproved, investigationalunknownsubstrateDetailsDB00404Alprazolamapproved, illicit, investigationalunknownsubstrateDetailsDB00425ZolpidemapprovedunknownsubstrateDetailsDB00443Betamethasoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00455Loratadineapproved, investigationalnosubstrateinhibitorDetailsDB00468QuinineapprovedunknownsubstrateinhibitorinducerDetailsDB00470Dronabinolapproved, illicitnosubstrateinhibitorDetailsDB00471MontelukastapprovedunknownsubstrateDetailsDB00490Buspironeapproved, investigationalunknownsubstrateDetailsDB00496Darifenacinapproved, investigationalunknownsubstrateDetailsDB00518Albendazoleapproved, vet_approvedunknownsubstrateDetailsDB00528Lercanidipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00533Rofecoxibapproved, investigational, withdrawnunknownsubstrateinducerDetailsDB00539Toremifeneapproved, investigationalunknownsubstrateinhibitorDetailsDB00541Vincristineapproved, investigationalunknownsubstrateDetailsDB00559Bosentanapproved, investigationalunknownsubstrateinducerDetailsDB00570VinblastineapprovedunknownsubstrateinhibitorinducerDetailsDB00582VoriconazoleapprovedunknownsubstrateinhibitorDetailsDB00588Fluticasone propionateapprovedunknownsubstrateinhibitorDetailsDB00593EthosuximideapprovedunknownsubstrateDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknownsubstrateinducerDetailsDB00604Cisaprideapproved, investigational, withdrawnunknownsubstrateDetailsDB00615Rifabutinapproved, investigationalunknownsubstrateinducerDetailsDB00619ImatinibapprovednosubstrateinhibitorDetailsDB00622Nicardipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00624Testosteroneapproved, investigationalunknownsubstrateinducerDetailsDB00625Efavirenzapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00635Prednisoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00636Clofibrateapproved, investigationalunknownsubstrateinducerDetailsDB00637Astemizoleapproved, withdrawnunknownsubstrateinhibitorDetailsDB00641SimvastatinapprovedunknownsubstrateDetailsDB00673Aprepitantapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00674GalantamineapprovednosubstrateDetailsDB00675TamoxifenapprovedunknownsubstrateinhibitorinducerDetailsDB00678LosartanapprovedunknownsubstrateinhibitorDetailsDB00683Midazolamapproved, illicitunknownsubstrateinhibitorDetailsDB00696ErgotamineapprovedunknownsubstrateinhibitorDetailsDB00700EplerenoneapprovedunknownsubstrateDetailsDB00701Amprenavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00705DelavirdineapprovedunknownsubstrateinhibitorDetailsDB00731Nateglinideapproved, investigationalunknownsubstrateDetailsDB00736Esomeprazoleapproved, investigationalunknownsubstrateDetailsDB00741Hydrocortisoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00744Zileutonapproved, investigational, withdrawnunknownsubstrateDetailsDB00745Modafinilapproved, investigationalunknownsubstrateinducerDetailsDB00757Dolasetronapproved, investigationalunknownsubstrateDetailsDB00758ClopidogrelapprovednosubstrateDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateinhibitorDetailsDB00769HydrocortamateapprovedunknowninducerDetailsDB00773EtoposideapprovedunknownsubstrateinhibitorinducerDetailsDB00778Roxithromycinapproved, investigational, withdrawnnosubstrateinhibitorDetailsDB00802Alfentanilapproved, illicitunknownsubstrateDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB00820Tadalafilapproved, investigationalnosubstrateDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00834Mifepristoneapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00836LoperamideapprovedunknownsubstrateinhibitorDetailsDB00843DonepezilapprovedunknownsubstrateDetailsDB00860Prednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB00862VardenafilapprovedunknownsubstrateinhibitorDetailsDB00864Tacrolimusapproved, investigationalunknownsubstrateDetailsDB00872Conivaptanapproved, investigationalunknownsubstrateinhibitorDetailsDB00877Sirolimusapproved, investigationalnosubstrateDetailsDB00889Granisetronapproved, investigationalunknownsubstrateDetailsDB00897Triazolamapproved, investigationalunknownsubstrateDetailsDB00904Ondansetronapproved, withdrawnunknownsubstrateDetailsDB00906Tiagabineapproved, investigationalunknownsubstrateDetailsDB00907Cocaineapproved, illicitunknownsubstrateDetailsDB00909Zonisamideapproved, investigationalunknownsubstrateDetailsDB00910Paricalcitolapproved, investigationalunknownsubstrateDetailsDB00911Tinidazoleapproved, investigationalunknownsubstrateDetailsDB00918Almotriptanapproved, investigationalunknownsubstrateDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00932Tipranavirapproved, investigationalunknownsubstrateinhibitorDetailsDB00938SalmeterolapprovedunknownsubstrateDetailsDB00956Hydrocodoneapproved, illicit, investigationalunknownsubstrateDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB00962Zaleplonapproved, illicit, investigationalunknownsubstrateDetailsDB00976TelithromycinapprovedunknownsubstrateinhibitorDetailsDB00977EthinylestradiolapprovedunknownsubstrateDetailsDB00990Exemestaneapproved, investigationalunknownsubstrateDetailsDB00997Doxorubicinapproved, investigationalnosubstrateinhibitorDetailsDB01002Levobupivacaineapproved, investigationalunknownsubstrateDetailsDB01006Letrozoleapproved, investigationalunknownsubstrateDetailsDB01008Busulfanapproved, investigationalunknownsubstrateDetailsDB01012CinacalcetapprovedunknownsubstrateDetailsDB01023Felodipineapproved, investigationalunknownsubstrateDetailsDB01026Ketoconazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB01045RifampicinapprovedunknowninducerDetailsDB01054Nitrendipineapproved, investigationalunknownsubstrateDetailsDB01062Oxybutyninapproved, investigationalunknownsubstrateinhibitorDetailsDB01068Clonazepamapproved, illicitunknownsubstrateDetailsDB01072Atazanavirapproved, investigationalnosubstrateinhibitorDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB01100PimozideapprovedunknownsubstrateDetailsDB01105Sibutramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB01114ChlorpheniramineapprovedunknownsubstrateDetailsDB01115NifedipineapprovedunknownsubstrateinhibitorinducerDetailsDB01129Rabeprazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB01132Pioglitazoneapproved, investigationalunknownsubstrateinducerDetailsDB01149Nefazodoneapproved, withdrawnunknownsubstrateinhibitorDetailsDB01166Cilostazolapproved, investigationalunknownsubstrateDetailsDB01167Itraconazoleapproved, investigationalnosubstrateinhibitorDetailsDB01175EscitalopramapprovednosubstrateDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB01190Clindamycinapproved, vet_approvedunknownsubstrateinhibitorDetailsDB01200Bromocriptineapproved, investigational, withdrawnnosubstrateinhibitorDetailsDB01206Lomustineapproved, investigationalunknowninhibitorDetailsDB01211ClarithromycinapprovedunknownsubstrateinhibitorDetailsDB01215Estazolamapproved, illicitunknownsubstrateDetailsDB01216FinasterideapprovedunknownsubstrateDetailsDB01218HalofantrineapprovedunknownsubstrateDetailsDB01222BudesonideapprovednosubstrateinducerDetailsDB01224QuetiapineapprovedunknownsubstrateDetailsDB01227Levacetylmethadolapproved, investigational, withdrawnunknownsubstrateDetailsDB01229Paclitaxelapproved, vet_approvedunknownsubstrateinducerDetailsDB01232Saquinavirapproved, investigationalunknownsubstrateinhibitorDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB01238Aripiprazoleapproved, investigationalnosubstrateDetailsDB01254Dasatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB01256RetapamulinapprovedunknownsubstrateDetailsDB01261Sitagliptinapproved, investigationalunknownsubstrateDetailsDB01259Lapatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB01264DarunavirapprovedunknownsubstrateinhibitorDetailsDB01268Sunitinibapproved, investigationalnosubstrateinhibitorDetailsDB01263Posaconazoleapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB01388Mibefradilinvestigational, withdrawnunknownsubstrateinhibitorDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknowninducerDetailsDB01601LopinavirapprovedunknownsubstrateinhibitorDetailsDB01411PranlukastinvestigationalnosubstrateDetailsDB01410Ciclesonideapproved, investigationalnosubstrateDetailsDB00969Alosetronapproved, withdrawnunknownsubstrateDetailsDB04835Maravirocapproved, investigationalunknownsubstrateDetailsDB01409TiotropiumapprovedunknownsubstrateDetailsDB01591SolifenacinapprovednosubstrateDetailsDB01011Metyraponeapproved, investigationalunknowninhibitorinducerDetailsDB00377Palonosetronapproved, investigationalunknownsubstrateDetailsDB04856DexloxiglumideinvestigationalunknownsubstrateDetailsDB04886Calanolide AinvestigationalunknownsubstrateDetailsDB00580Valdecoxibapproved, investigational, withdrawnunknownsubstrateDetailsDB06144Sertindoleapproved, investigational, withdrawnunknownsubstrateDetailsDB04977PlitidepsininvestigationalunknownsubstrateDetailsDB04905TesmilifeneinvestigationalunknownsubstrateinhibitorinducerDetailsDB00333MethadoneapprovedunknownsubstrateinhibitorinducerDetailsDB04934RifalazilinvestigationalunknownsubstrateDetailsDB04957AzimilideinvestigationalunknownsubstrateDetailsDB00199Erythromycinapproved, investigational, vet_approvednosubstrateinhibitorDetailsDB01628Etoricoxibapproved, investigationalunknownsubstrateinhibitorDetailsDB00564Carbamazepineapproved, investigationalunknownsubstrateinducerDetailsDB06155Rimonabantapproved, investigationalunknownsubstrateDetailsDB06267Udenafilapproved, investigationalunknownsubstrateDetailsDB06287TemsirolimusapprovedunknownsubstrateDetailsDB06442AvasimibeinvestigationalunknowninducerDetailsDB08502CapravirineinvestigationalunknownsubstrateDetailsDB06652VicrivirocinvestigationalunknownsubstrateDetailsDB06685LaquinimodinvestigationalunknownsubstrateDetailsDB01095FluvastatinapprovedunknownsubstrateinhibitorDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateDetailsDB00248CabergolineapprovedunknownsubstrateDetailsDB00589Lisurideapproved, investigationalunknownsubstrateDetailsDB01186Pergolideapproved, investigational, vet_approved, withdrawnunknowninhibitorDetailsDB05271RotigotineapprovedunknownsubstrateDetailsDB00439Cerivastatinapproved, withdrawnunknownsubstrateinhibitorinducerDetailsDB00257Clotrimazoleapproved, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00734Risperidoneapproved, investigationalunknownsubstrateDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB01037Selegilineapproved, investigational, vet_approvedunknownsubstrateDetailsDB01159Halothaneapproved, vet_approvedunknownsubstrateDetailsDB01181IfosfamideapprovedunknownsubstrateinhibitorinducerDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB00814Meloxicamapproved, vet_approvedunknownsubstrateDetailsDB00908Quinidineapproved, investigationalunknownsubstrateinhibitorDetailsDB00656Trazodoneapproved, investigationalunknownsubstrateDetailsDB00176Fluvoxamineapproved, investigationalunknownsubstrateinhibitorDetailsDB00321AmitriptylineapprovedunknownsubstrateDetailsDB00540NortriptylineapprovedunknownsubstrateDetailsDB00215CitalopramapprovednosubstrateinhibitorDetailsDB00924CyclobenzaprineapprovedunknownsubstrateDetailsDB00472Fluoxetineapproved, vet_approvednosubstrateinhibitorDetailsDB01104SertralineapprovedunknownsubstrateinhibitorDetailsDB06148Mianserinapproved, investigationalunknownsubstrateDetailsDB01435Antipyrineapproved, investigationalunknownsubstrateDetailsDB01118Amiodaroneapproved, investigationalnosubstrateinhibitorDetailsDB00250Dapsoneapproved, investigationalunknownsubstrateDetailsDB00531Cyclophosphamideapproved, investigationalunknownsubstrateinducerDetailsDB05109Trabectedinapproved, investigationalunknownsubstrateDetailsDB00946Phenprocoumonapproved, investigationalunknownsubstrateDetailsDB00682WarfarinapprovedunknownsubstrateinducerDetailsDB00285VenlafaxineapprovedunknownsubstrateDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB00972AzelastineapprovedunknownsubstrateinhibitorDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00661VerapamilapprovedunknownsubstrateinhibitorDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateinducerDetailsDB00201CaffeineapprovedunknownsubstrateDetailsDB00318Codeineapproved, illicitunknownsubstrateDetailsDB00514DextromethorphanapprovedunknownsubstrateDetailsDB01248Docetaxelapproved, investigationalunknownsubstrateinhibitorDetailsDB00502HaloperidolapprovedunknownsubstrateinhibitorDetailsDB00281Lidocaineapproved, vet_approvedunknownsubstrateDetailsDB00571Propranololapproved, investigationalunknownsubstrateDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00446Chloramphenicolapproved, vet_approved, withdrawnunknowninhibitorDetailsDB00537Ciprofloxacinapproved, investigationalunknowninhibitorDetailsDB01059NorfloxacinapprovedunknowninhibitorDetailsDB06403Ambrisentanapproved, investigationalunknownsubstrateDetailsDB06413Armodafinilapproved, investigationalunknowninducerDetailsDB00865Benzphetamineapproved, illicitunknownsubstrateDetailsDB00612BisoprololapprovedunknownsubstrateDetailsDB00136Calcitriolapproved, nutraceuticalunknownsubstrateinducerDetailsDB00608Chloroquineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00349Clobazamapproved, illicitnosubstrateinducerDetailsDB00628Clorazepic acidapproved, illicitunknownsubstrateDetailsDB01396Digitoxinapproved, investigationalunknownsubstrateDetailsDB04855DronedaroneapprovedunknownsubstrateinhibitorDetailsDB04574Estrone sulfateapprovedunknownsubstrateDetailsDB06414EtravirineapprovedunknownsubstrateinducerDetailsDB01590EverolimusapprovedunknownsubstrateDetailsDB00949FelbamateapprovedunknownsubstrateinducerDetailsDB06702FesoterodineapprovedunknownsubstrateDetailsDB00690Flurazepamapproved, illicit, investigationalunknownsubstrateDetailsDB00499Flutamideapproved, investigationalunknownsubstrateDetailsDB01018Guanfacineapproved, investigationalunknownsubstrateDetailsDB04845Ixabepiloneapproved, investigationalunknownsubstrateDetailsDB00448Lansoprazoleapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00367Levonorgestrelapproved, investigationalunknownsubstrateDetailsDB00358Mefloquineapproved, investigationalunknownsubstrateinhibitorDetailsDB04868Nilotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB06712Nilvadipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00497Oxycodoneapproved, illicit, investigationalunknownsubstrateDetailsDB06589PazopanibapprovedunknownsubstrateinhibitorDetailsDB01621Pipotiazineapproved, investigationalunknownsubstrateDetailsDB01058Praziquantelapproved, investigational, vet_approvedunknownsubstrateDetailsDB01087PrimaquineapprovedunknownsubstrateinhibitorDetailsDB00647Dextropropoxypheneapproved, illicit, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00912Repaglinideapproved, investigationalunknownsubstrateDetailsDB06228RivaroxabanapprovedunknownsubstrateDetailsDB06176Romidepsinapproved, investigationalunknownsubstrateDetailsDB06207SilodosinapprovedunknownsubstrateDetailsDB00706Tamsulosinapproved, investigationalunknownsubstrateDetailsDB00444TeniposideapprovedunknownsubstrateinhibitorDetailsDB00759Tetracyclineapproved, vet_approved, withdrawnunknownsubstrateinhibitorDetailsDB00277TheophyllineapprovedunknownsubstrateDetailsDB01036Tolterodineapproved, investigationalunknownsubstrateDetailsDB06212TolvaptanapprovedunknownsubstrateDetailsDB00193Tramadolapproved, investigationalunknownsubstrateDetailsDB00440Trimethoprimapproved, vet_approvedunknownsubstrateDetailsDB01198ZopicloneapprovedunknownsubstrateDetailsDB00357Aminoglutethimideapproved, investigationalunknowninducerDetailsDB01320Fosphenytoinapproved, investigationalunknownsubstrateinducerDetailsDB00607Nafcillinapproved, investigationalunknowninducerDetailsDB00776OxcarbazepineapprovedunknowninhibitorinducerDetailsDB00312Pentobarbitalapproved, investigational, vet_approvedunknowninducerDetailsDB01174Phenobarbitalapproved, investigationalunknowninducerDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinducerDetailsDB00794Primidoneapproved, vet_approvedunknowninducerDetailsDB01201Rifapentineapproved, investigationalunknownsubstrateinducerDetailsDB01394ColchicineapprovedunknownsubstrateinhibitorDetailsDB01253ErgometrineapprovedunknownsubstrateDetailsDB01221Ketamineapproved, vet_approvedunknownsubstrateinducerDetailsDB00353MethylergometrineapprovedunknownsubstrateinhibitorDetailsDB06335SaxagliptinapprovedunknownsubstrateDetailsDB00708Sufentanilapproved, investigationalunknownsubstrateDetailsDB01128BicalutamideapprovedunknownsubstrateinhibitorDetailsDB01151Desipramineapproved, investigationalunknowninhibitorDetailsDB00916MetronidazoleapprovedunknowninhibitorDetailsDB06268Sitaxentanapproved, investigational, withdrawnunknowninhibitorDetailsDB01424Aminophenazoneapproved, withdrawnunknownsubstrateDetailsDB00363ClozapineapprovednosubstrateinhibitorinducerDetailsDB00420Promazineapproved, vet_approvedunknownsubstrateDetailsDB01136Carvedilolapproved, investigationalunknownsubstrateDetailsDB00549Zafirlukastapproved, investigationalunknownsubstrateinhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00482Celecoxibapproved, investigationalunknownsubstrateDetailsDB01016GlyburideapprovedunknownsubstrateinhibitorDetailsDB01138SulfinpyrazoneapprovedunknownsubstrateinducerDetailsDB06739SeratrodastexperimentalunknownsubstrateinducerDetailsDB06738KetobemidoneinvestigationalunknownsubstrateDetailsDB01242Clomipramineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00655EstroneapprovednosubstrateDetailsDB00458ImipramineapprovedunknownsubstrateDetailsDB00546AdinazolamexperimentalunknownsubstrateDetailsDB00231Temazepamapproved, investigationalunknownsubstrateDetailsDB03701VanoxerineinvestigationalunknownsubstrateDetailsDB00169Cholecalciferolapproved, nutraceuticalunknownsubstrateDetailsDB01192Oxymorphoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB01173OrphenadrineapprovedunknownsubstrateinhibitorDetailsDB06772CabazitaxelapprovedunknownsubstrateDetailsDB02709ResveratrolinvestigationalnoinhibitorDetailsDB06700Desvenlafaxineapproved, investigationalnosubstrateinhibitorDetailsDB06697ArtemetherapprovedunknownsubstrateinducerDetailsDB06708LumefantrineapprovedunknownsubstrateDetailsDB00819Acetazolamideapproved, vet_approvedunknowninhibitorDetailsDB06742Ambroxolapproved, investigationalunknownsubstrateDetailsDB01223AminophyllineapprovedunknownsubstrateDetailsDB00278Argatrobanapproved, investigationalunknownsubstrateDetailsDB01169Arsenic trioxideapproved, investigationalunknowninhibitorDetailsDB00207AzithromycinapprovedunknownsubstrateinhibitorDetailsDB01393Bezafibrateapproved, investigationalunknownsubstrateDetailsDB04794Bifonazoleapproved, investigationalunknowninhibitorDetailsDB01194BrinzolamideapprovednosubstrateDetailsDB00520CaspofunginapprovedunknowninhibitorDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknowninducerDetailsDB00356ChlorzoxazoneapprovedunknownsubstrateinhibitorDetailsDB00845Clofazimineapproved, investigationalunknowninhibitorDetailsDB06470ClomethiazoleinvestigationalunknownsubstrateDetailsDB01559Clotiazepamapproved, illicitunknownsubstrateDetailsDB00987Cytarabineapproved, investigationalunknownsubstrateDetailsDB01406DanazolapprovedunknowninhibitorDetailsDB00694DaunorubicinapprovedunknownsubstrateinhibitorDetailsDB01093Dimethyl sulfoxideapproved, vet_approvedunknowninhibitorDetailsDB00822DisulfiramapprovedunknownsubstrateDetailsDB00254Doxycyclineapproved, investigational, vet_approvedunknowninhibitorDetailsDB01127EconazoleapprovednoinhibitorDetailsDB00751Epinastineapproved, investigationalunknownsubstrateDetailsDB00668Epinephrineapproved, vet_approvedunknowninhibitorDetailsDB01196Estramustineapproved, investigationalunknownsubstrateDetailsDB00898EthanolapprovedunknownsubstrateinhibitorinducerDetailsDB01466Ethylmorphineexperimental, illicitunknownsubstrateDetailsDB00301Flucloxacillinapproved, investigationalunknownsubstrateinducerDetailsDB01544Flunitrazepamapproved, illicitunknownsubstrateDetailsDB00947Fulvestrantapproved, investigationalunknownsubstrateDetailsDB01275HydralazineapprovednoinhibitorDetailsDB00724Imiquimodapproved, investigationalunknownsubstrateDetailsDB01029Irbesartanapproved, investigationalnoinhibitorDetailsDB00602Ivermectinapproved, investigational, vet_approvednosubstrateDetailsDB01103QuinacrineinvestigationalunknownsubstrateDetailsDB01071MequitazineexperimentalunknowninhibitorDetailsDB04817Metamizoleapproved, investigational, withdrawnunknowninducerDetailsDB04833Methaqualoneillicit, withdrawnunknownsubstrateDetailsDB01028Methoxyfluraneapproved, investigational, vet_approved, withdrawnunknownsubstrateDetailsDB06710MethyltestosteroneapprovedunknownsubstrateDetailsDB00379Mexiletineapproved, investigationalunknownsubstrateDetailsDB01204Mitoxantroneapproved, investigationalunknowninhibitorDetailsDB00295Morphineapproved, investigationalnosubstrateDetailsDB01183Naloxoneapproved, vet_approvedunknownsubstrateinhibitorDetailsDB02701Nicotinamideapproved, investigationalunknowninhibitorDetailsDB00184NicotineapprovedunknownsubstrateDetailsDB01595NitrazepamapprovedunknownsubstrateDetailsDB00768OlopatadineapprovednosubstrateDetailsDB00316AcetaminophenapprovedunknownsubstrateinducerDetailsDB01074Perhexilineapproved, investigationalunknownsubstrateDetailsDB00850PerphenazineapprovedunknownsubstrateDetailsDB00454MeperidineapprovedunknownsubstrateinducerDetailsDB03783PhenacetinwithdrawnunknownsubstrateDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB00812Phenylbutazoneapproved, vet_approvedunknowninducerDetailsDB01085Pilocarpineapproved, investigationalunknowninhibitorDetailsDB01588Prazepamapproved, illicitunknownsubstrateDetailsDB01032Probenecidapproved, investigationalunknowninducerDetailsDB01182PropafenoneapprovedunknownsubstrateDetailsDB01589Quazepamapproved, illicitnosubstrateDetailsDB00481Raloxifeneapproved, investigationalunknowninhibitorDetailsDB00863Ranitidineapproved, withdrawnunknowninhibitorDetailsDB01220Rifaximinapproved, investigationalunknownsubstrateinducerDetailsDB00296RopivacaineapprovedunknownsubstrateDetailsDB01698Rutinapproved, experimental, investigationalunknowninducerDetailsDB01001Salbutamolapproved, vet_approvedunknowninhibitorDetailsDB01236Sevofluraneapproved, vet_approvedunknownsubstrateDetailsDB00359Sulfadiazineapproved, investigational, vet_approvedunknownsubstrateDetailsDB01015SulfamethoxazoleapprovedunknownsubstrateDetailsDB01349TasosartanexperimentalunknownsubstrateDetailsDB00763MethimazoleapprovedunknowninhibitorDetailsDB04572Thiotepaapproved, investigationalunknownsubstrateDetailsDB01007TioconazoleapprovedunknowninhibitorDetailsDB00273TopiramateapprovedunknowninducerDetailsDB00347TrimethadioneapprovedunknownsubstrateDetailsDB13179TroleandomycinapprovedunknownsubstrateinhibitorDetailsDB00313Valproic acidapproved, investigationalunknowninhibitorDetailsDB01392Yohimbineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00495ZidovudineapprovedunknownsubstrateDetailsDB04828ZomepiracwithdrawnunknownsubstrateDetailsDB01380Cortisone acetateapproved, investigationalunknownsubstrateinducerDetailsDB01384ParamethasoneexperimentalunknownsubstrateinhibitorinducerDetailsDB01587KetazolamapprovedunknownsubstrateinhibitorDetailsDB08811TofisopamexperimentalunknowninhibitorDetailsDB00617ParamethadioneapprovedunknownsubstrateDetailsDB00755Tretinoinapproved, investigational, nutraceuticalunknownsubstrateDetailsDB00980Ramelteonapproved, investigationalunknownsubstrateDetailsDB04946IloperidoneapprovedunknownsubstrateDetailsDB01418Acenocoumarolapproved, investigationalunknownsubstrateDetailsDB06684VilazodoneapprovedunknownsubstrateDetailsDB00255Diethylstilbestrolapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00575ClonidineapprovedunknownsubstrateDetailsDB00973EzetimibeapprovedunknowninhibitorDetailsDB00400Griseofulvinapproved, investigational, vet_approvedunknowninducerDetailsDB00808IndapamideapprovedunknownsubstrateDetailsDB05521Telaprevirapproved, withdrawnunknownsubstrateinhibitorDetailsDB08820IvacaftorapprovednosubstrateinhibitorDetailsDB06634CasopitantinvestigationalunknownDetailsDB04975BanoxantroneinvestigationalunknownsubstrateDetailsDB05039IndacaterolapprovedunknownsubstrateDetailsDB08816TicagrelorapprovedunknownsubstrateinhibitorDetailsDB06774CapsaicinapprovedunknowninhibitorDetailsDB06174Noscapineapproved, investigationalunknowninhibitorDetailsDB01333CefradineapprovedunknowninducerDetailsDB06777Chenodeoxycholic acidapprovedunknownsubstrateDetailsDB00856Chlorphenesinapproved, experimentalunknowninducerDetailsDB04920Clevidipineapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB01764DalfopristinapprovedunknowninhibitorDetailsDB01609Deferasiroxapproved, investigationalunknowninducerDetailsDB00485Dicloxacillinapproved, investigational, vet_approvedunknowninducerDetailsDB06370IndisulaminvestigationalunknowninhibitorDetailsDB01083Orlistatapproved, investigationalunknowninducerDetailsDB00239OxiconazoleapprovedunknowninducerDetailsDB00082PegvisomantapprovedunknowninducerDetailsDB06762PinacidilapprovedunknownsubstrateDetailsDB01369QuinupristinapprovedunknowninhibitorDetailsDB00337Pimecrolimusapproved, investigationalunknownsubstrateDetailsDB00041AldesleukinapprovedunknowninhibitorDetailsDB06605ApixabanapprovednosubstrateDetailsDB08827Lomitapideapproved, investigationalnosubstrateDetailsDB08828Vismodegibapproved, investigationalnosubstrateDetailsDB00620Triamcinoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB08864RilpivirineapprovednosubstrateinhibitorinducerDetailsDB06209PrasugrelapprovednosubstrateDetailsDB06216AsenapineapprovedunknownsubstrateDetailsDB00435Nitric OxideapprovedunknowninhibitorDetailsDB08867UlipristalapprovednosubstrateDetailsDB08815Lurasidoneapproved, investigationalunknownsubstrateDetailsDB08870Brentuximab vedotinapproved, investigationalnosubstrateinhibitorDetailsDB04871Lorcaserinapproved, withdrawnnosubstrateDetailsDB05294VandetanibapprovedunknownsubstrateDetailsDB08873Boceprevirapproved, withdrawnunknownsubstrateinhibitorDetailsDB08875Cabozantinibapproved, investigationalnosubstrateDetailsDB08877RuxolitinibapprovedunknownsubstrateDetailsDB05812AbirateroneapprovedunknownsubstrateinhibitorDetailsDB08881VemurafenibapprovedunknownsubstrateinducerDetailsDB08882LinagliptinapprovedunknownsubstrateinhibitorDetailsDB08883PerampanelapprovednosubstrateinducerDetailsDB08865Crizotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB06626Axitinibapproved, investigationalnosubstrateDetailsDB08893MirabegronapprovednosubstrateDetailsDB06237AvanafilapprovedunknownsubstrateDetailsDB08896RegorafenibapprovedunknownsubstrateinhibitorDetailsDB08899EnzalutamideapprovednosubstrateinducerDetailsDB08895Tofacitinibapproved, investigationalnosubstrateDetailsDB06616BosutinibapprovednosubstrateinhibitorDetailsDB08901Ponatinibapproved, investigationalunknownsubstrateDetailsDB08903BedaquilineapprovednosubstrateDetailsDB06201RufinamideapprovedunknowninducerDetailsDB08906Fluticasone furoateapprovednosubstrateinhibitorinducerDetailsDB08907CanagliflozinapprovedunknownsubstrateDetailsDB06203AlogliptinapprovedunknownsubstrateDetailsDB04938Ospemifeneapproved, investigationalunknownsubstrateDetailsDB08910PomalidomideapprovedunknownsubstrateDetailsDB08911TrametinibapprovedunknownsubstrateinducerDetailsDB08912Dabrafenibapproved, investigationalnosubstrateinhibitorinducerDetailsDB05773Trastuzumab emtansineapproved, investigationalunknownsubstrateDetailsDB08833Taurochenodeoxycholic acidexperimentalunknownsubstrateDetailsDB01142Doxepinapproved, investigationalnosubstrateDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB08918Levomilnacipranapproved, investigationalunknownsubstrateDetailsDB08932MacitentanapprovednosubstrateDetailsDB08933LuliconazoleapprovednoinhibitorDetailsDB06292DapagliflozinapprovednosubstrateDetailsDB09039Eliglustatapproved, investigationalnosubstrateDetailsDB05676Apremilastapproved, investigationalnosubstrateDetailsDB09049NaloxegolapprovedunknownsubstrateDetailsDB09053IbrutinibapprovedunknownsubstrateDetailsDB00951Isoniazidapproved, investigationalunknownDetailsDB09074OlaparibapprovedunknownsubstrateinhibitorDetailsDB09078Lenvatinibapproved, investigationalnosubstrateinhibitorinducerDetailsDB09073Palbociclibapproved, investigationalnosubstrateinhibitorDetailsDB09054IdelalisibapprovednosubstrateinhibitorinducerDetailsDB09068Vortioxetineapproved, investigationalnosubstrateDetailsDB09082VilanterolapprovednosubstrateDetailsDB09083IvabradineapprovednosubstrateDetailsDB09026Aliskirenapproved, investigationalnosubstrateDetailsDB09101ElvitegravirapprovednosubstrateinhibitorDetailsDB06016Cariprazineapproved, investigationalnosubstrateinhibitorinducerDetailsDB08439ParecoxibapprovedunknownsubstrateDetailsDB09128Brexpiprazoleapproved, investigationalnosubstrateDetailsDB09291Rolapitantapproved, investigationalnosubstrateDetailsDB04908Flibanserinapproved, investigationalnosubstrateDetailsDB09102Daclatasvirapproved, investigationalunknownsubstrateDetailsDB09143Sonidegibapproved, investigationalunknownsubstrateDetailsDB06636Isavuconazoniumapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB06603Panobinostatapproved, investigationalunknownsubstrateDetailsDB05239Cobimetinibapproved, investigationalnosubstrateinhibitorDetailsDB09570Ixazomibapproved, investigationalunknownsubstrateDetailsDB09330OsimertinibapprovednosubstrateinhibitorinducerDetailsDB11362SelexipagapprovednosubstrateDetailsDB09119Eslicarbazepine acetateapprovednoinducerDetailsDB06789Hydroxyprogesterone caproateapproved, investigationalunknownsubstrateDetailsDB08931RiociguatapprovedunknownsubstrateDetailsDB09183DasabuvirapprovednosubstrateDetailsDB09297Paritaprevirapproved, investigationalnosubstrateDetailsDB09317Synthetic Conjugated Estrogens, AapprovednosubstrateDetailsDB09318Synthetic Conjugated Estrogens, BapprovednosubstrateDetailsDB09389NorgestrelapprovedunknownsubstrateDetailsDB11581Venetoclaxapproved, investigationalnosubstrateinhibitorDetailsDB09280LumacaftorapprovednoinducerDetailsDB01323St. John's Wortapproved, investigational, nutraceuticalunknownsubstrateinduceractivatorDetailsDB09381Esterified estrogensapprovedunknownsubstrateDetailsDB00957Norgestimateapproved, investigationalunknownsubstrateinducerDetailsDB04911Oritavancinapproved, investigationalunknowninhibitorinducerDetailsDB06717FosaprepitantapprovedunknownsubstrateinhibitorinducerDetailsDB00648MitotaneapprovedunknowninducerDetailsDB08909Glycerol phenylbutyrateapprovedunknowninducerDetailsDB09048Netupitantapproved, investigationalnosubstrateinhibitorDetailsDB12332Rucaparibapproved, investigationalnosubstrateinhibitorDetailsDB11921Deflazacortapproved, investigationalnosubstrateinducerDetailsDB11737Icotinibexperimental, investigationalunknownsubstrateDetailsDB06654Safinamideapproved, investigationalunknownsubstrateDetailsDB12161Deutetrabenazineapproved, investigationalnosubstrateDetailsDB09555Dexchlorpheniramine maleateapprovedunknownsubstrateDetailsDB11613Velpatasvirapproved, investigationalnosubstrateDetailsDB05541Brivaracetamapproved, investigationalnosubstrateDetailsDB11915Valbenazineapproved, investigationalnosubstrateDetailsDB06670OdanacatibinvestigationalnosubstrateDetailsDB05351Dexlansoprazoleapproved, investigationalunknownsubstrateDetailsDB06290SimeprevirapprovedunknownsubstrateinhibitorDetailsDB11575GrazoprevirapprovednosubstrateinhibitorDetailsDB11943Delafloxacinapproved, investigationalunknowninducerDetailsDB01685TopiroxostatexperimentalunknowninhibitorDetailsDB08922PerospironeexperimentalunknownsubstrateDetailsDB09118StiripentolapprovedunknownsubstrateinhibitorinducerDetailsDB09166EtizolamexperimentalunknownsubstrateDetailsDB11614RupatadineapprovednosubstrateDetailsDB09262ImidafenacininvestigationalnosubstrateDetailsDB00143Glutathioneapproved, investigational, nutraceuticalunknownDetailsDB09238Manidipineapproved, investigationalunknownsubstrateinhibitorDetailsDB09123DienogestapprovedunknownsubstrateDetailsDB11828Neratinibapproved, investigationalunknownsubstrateDetailsDB12026Voxilaprevirapproved, investigationalnosubstrateDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB06412Oxymetholoneapproved, illicitunknowninhibitorDetailsDB00503Ritonavirapproved, investigationalunknownsubstrateinhibitorDetailsDB06595Midostaurinapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB11574ElbasvirapprovedunknownsubstrateDetailsDB12483Copanlisibapproved, investigationalnosubstrateDetailsDB11767Sarilumabapproved, investigationalnoinhibitorinducerDetailsDB12001Abemaciclibapproved, investigationalunknownsubstrateinhibitorDetailsDB12267Brigatinibapproved, investigationalnosubstrateDetailsDB11817Baricitinibapproved, investigationalunknownsubstrateDetailsDB13074Macimorelinapproved, investigationalunknownsubstrateDetailsDB09223BlonanserininvestigationalnosubstrateDetailsDB09236Lacidipineapproved, investigationalunknownsubstrateDetailsDB09061Cannabidiolapproved, investigationalunknownsubstrateinhibitorDetailsDB13943Testosterone cypionateapprovedunknownsubstrateinhibitorinducerDetailsDB13944Testosterone enanthateapprovedunknownsubstrateinhibitorinducerDetailsDB13946Testosterone undecanoateapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13941Piperaquineapproved, experimental, investigationalunknownsubstrateinhibitorDetailsDB01420Testosterone propionateapproved, investigational, vet_approved, withdrawnnosubstrateDetailsDB09195LorpiprazoleapprovednosubstrateDetailsDB11799Bictegravirapproved, investigationalunknownsubstrateDetailsDB11901Apalutamideapproved, investigationalnosubstrateinducerDetailsDB09225Zotepineapproved, investigational, withdrawnnosubstrateDetailsDB09230AzelnidipineinvestigationalunknownsubstrateDetailsDB09231BenidipineexperimentalnosubstrateinhibitorDetailsDB09235EfonidipineexperimentalunknownsubstrateinhibitorDetailsDB11642Pitolisantapproved, investigationalunknownsubstrateinducerDetailsDB11633Isavuconazoleapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB09237Levamlodipineapproved, investigationalunknownsubstrateDetailsDB11712Tezacaftorapproved, investigationalnosubstrateinhibitorinducerDetailsDB11130Opiumapproved, illicitnosubstrateDetailsDB11251Tocopherolapproved, investigationalnosubstrateDetailsDB14003alpha-Tocopherol acetateapprovednosubstrateDetailsDB11586Asunaprevirapproved, investigational, withdrawnnosubstrateinducerDetailsDB13975Black cohoshexperimentalnoinhibitorDetailsDB12278Propiverineapproved, investigationalnosubstrateDetailsDB14011NabiximolsinvestigationalunknownsubstrateDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorDetailsDB11641Vinflunineapproved, investigationalnosubstrateDetailsDB11635TocofersolanapprovednosubstrateDetailsDB11637Delamanidapproved, investigationalnosubstrateDetailsDB13746Bioallethrinapproved, experimentalnosubstrateDetailsDB14019FosnetupitantapprovedunknownsubstrateinhibitorDetailsDB12010Fostamatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB01049Ergoloid mesylateapprovednosubstrateDetailsDB11274Dihydro-alpha-ergocryptineapprovednosubstrateDetailsDB13293Ipecacapproved, withdrawnnosubstrateDetailsDB11198Peppermint oilapproved, investigationalunknowninhibitorDetailsDB13456MidecamycinexperimentalnosubstrateinhibitorDetailsDB12532Oxetacaineapproved, investigationalnoinhibitorDetailsDB11672Curcuminapproved, investigationalunknowninhibitorDetailsDB11779DanoprevirinvestigationalnoinhibitorDetailsDB09289TianeptineinvestigationalnosubstrateDetailsDB01357MestranolapprovednosubstrateDetailsDB04829Lysergic acid diethylamideillicit, investigational, withdrawnnosubstrateDetailsDB00247MethysergideapprovednosubstrateDetailsDB13399TergurideexperimentalnosubstrateDetailsDB14185Aripiprazole lauroxilapproved, investigationalunknownsubstrateDetailsDB11718Encorafenibapproved, investigationalnosubstrateinhibitorinducerDetailsDB14538Hydrocortisone aceponateexperimental, vet_approvedunknownsubstrateinducerDetailsDB14539Hydrocortisone acetateapproved, vet_approvedunknownsubstrateinducerDetailsDB14540Hydrocortisone butyrateapproved, vet_approvedunknownsubstrateinducerDetailsDB14541Hydrocortisone cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB14542Hydrocortisone phosphateapproved, vet_approvedunknownsubstrateDetailsDB14543Hydrocortisone probutateapproved, vet_approvedunknownsubstrateinducerDetailsDB14544Hydrocortisone valerateapproved, vet_approvedunknownsubstrateinducerDetailsDB14568Ivosidenibapproved, investigationalunknownsubstrateinducerDetailsDB126293,5-diiodothyropropionic acidinvestigationalnosubstrateDetailsDB014565-androstenedioneexperimental, illicitnosubstrateDetailsDB00240AlclometasoneapprovednosubstrateDetailsDB04630Aldosteroneexperimental, investigationalnosubstrateDetailsDB00288AmcinonideapprovednosubstrateinducerDetailsDB01536Androstenedioneexperimental, illicitnosubstrateDetailsDB00394Beclomethasone dipropionateapproved, investigationalnosubstrateinducerDetailsDB11750Clobetasolapproved, experimental, investigationalnosubstrateinducerDetailsDB01013Clobetasol propionateapprovednosubstrateinducerDetailsDB13158ClobetasoneapprovednosubstrateDetailsDB04652CorticosteroneexperimentalnosubstrateDetailsDB01285Corticotropinapproved, investigational, vet_approvednosubstrateinducerDetailsDB04839Cyproterone acetateapproved, investigationalnosubstrateinhibitorDetailsDB11636NomegestrolapprovednosubstrateDetailsDB13981Nomegestrol acetateapproved, investigationalnosubstrateDetailsDB00304DesogestrelapprovednosubstrateDetailsDB01260Desonideapproved, investigationalnosubstrateinducerDetailsDB06780Desoxycorticosterone acetateapprovednosubstrateDetailsDB01134Desoxycorticosterone pivalateexperimental, vet_approvednosubstrateDetailsDB11487Dexamethasone isonicotinatevet_approvednosubstrateinhibitorinducerDetailsDB09095Difluocortoloneapproved, investigational, withdrawnnosubstrateinducerDetailsDB06781DifluprednateapprovednosubstrateDetailsDB00378Dydrogesteroneapproved, investigational, withdrawnnosubstrateDetailsDB03515EquileninexperimentalnosubstrateDetailsDB02187EquilinexperimentalnosubstrateDetailsDB13866EtynodiolexperimentalnosubstrateDetailsDB00823Ethynodiol diacetateapprovednosubstrateDetailsDB00687Fludrocortisoneapproved, investigationalunknownsubstrateDetailsDB00663Flumethasoneapproved, vet_approvednosubstrateDetailsDB00591Fluocinolone acetonideapproved, investigational, vet_approvednosubstrateinducerDetailsDB01047Fluocinonideapproved, investigationalnosubstrateinducerDetailsDB08971Fluocortoloneapproved, withdrawnnosubstrateinducerDetailsDB08970FluprednideneexperimentalnosubstrateinducerDetailsDB09378FluprednisoloneapprovednosubstrateDetailsDB00846FlurandrenolideapprovednosubstrateDetailsDB13867Fluticasoneapproved, experimentalnosubstrateinhibitorinducerDetailsDB08905Formestaneapproved, investigational, withdrawnnoinducerDetailsDB06730GestodeneinvestigationalnosubstrateinhibitorDetailsDB11619GestrinoneapprovednosubstrateDetailsDB06786Halcinonideapproved, investigational, withdrawnnosubstrateDetailsDB05212HE3286investigationalnosubstrateDetailsDB14545Hydrocortisone succinateapprovedunknownsubstrateinducerDetailsDB14570HydroxyprogesteroneexperimentalnosubstrateDetailsDB01583LiotrixapprovednosubstrateDetailsDB14596Loteprednol etabonateapprovedunknownsubstrateDetailsDB12474Lynestrenolapproved, investigationalnosubstrateDetailsDB09124Medrogestoneapproved, withdrawnnosubstrateDetailsDB00253MedrysoneapprovednosubstrateinducerDetailsDB00351Megestrol acetateapproved, investigational, vet_approvednosubstrateDetailsDB11529Melengestrolvet_approvednosubstrateDetailsDB09383Meprednisoneapproved, investigationalnosubstrateinducerDetailsDB00764MometasoneexperimentalnosubstrateinducerDetailsDB14512Mometasone furoateapproved, investigational, vet_approvednosubstrateinducerDetailsDB06713Norelgestrominapproved, investigationalnosubstrateDetailsDB09371NorethynodrelapprovednosubstrateDetailsDB01130Prednicarbateapproved, investigationalnosubstrateDetailsDB13208PrednylideneexperimentalnosubstrateinducerDetailsDB02789Pregnenoloneapproved, experimentalnosubstrateDetailsDB13602PromegestoneexperimentalnosubstrateDetailsDB00896RimexoloneapprovednosubstrateinducerDetailsDB01117AtovaquoneapprovednosubstrateDetailsDB11753Rifamycinapproved, investigationalnoinhibitorinducerDetailsDB13528ChlormadinoneexperimentalnosubstrateDetailsDB13857DemegestoneexperimentalnosubstrateDetailsDB13685QuingestanolexperimentalnosubstrateDetailsDB14055(S)-Warfarinexperimental, investigationalnosubstrateDetailsDB13347DiphenadioneexperimentalnosubstrateDetailsDB08794Ethyl biscoumacetatewithdrawnunknownsubstrateDetailsDB01483BarbitalillicitnoinducerDetailsDB01154Thiamylalapproved, vet_approvednosubstrateinducerDetailsDB09229AranidipineexperimentalnosubstrateDetailsDB09227BarnidipineexperimentalnosubstrateinhibitorDetailsDB13488BencyclaneexperimentalnosubstrateDetailsDB01244Bepridilapproved, withdrawnnosubstrateDetailsDB08838AgmatineexperimentalnosubstrateDetailsDB11960CarboxyamidotriazoleinvestigationalnosubstrateDetailsDB13835CaroverineexperimentalnosubstrateDetailsDB09232CilnidipineinvestigationalnosubstrateDetailsDB00568Cinnarizineapproved, investigationalnosubstrateDetailsDB04838CyclandelateapprovednosubstrateDetailsDB09234DarodipineexperimentalnosubstrateDetailsDB14068DexniguldipineexperimentalnosubstrateDetailsDB14063DexverapamilexperimentalnosubstrateDetailsDB06446DotarizineinvestigationalnosubstrateDetailsDB14064EmopamilexperimentalnosubstrateDetailsDB08992EperisoneinvestigationalnosubstrateDetailsDB08980FendilinewithdrawnnosubstrateDetailsDB13961Fish oilapproved, nutraceuticalnosubstrateDetailsDB04841FlunarizineapprovednosubstrateDetailsDB04842Fluspirileneapproved, investigationalnosubstrateDetailsDB12923GallopamilinvestigationalnosubstrateDetailsDB13766Lidoflazineapproved, experimentalnosubstrateDetailsDB14065LomerizineexperimentalnosubstrateDetailsDB00825LevomentholapprovednosubstrateDetailsDB12092NaftopidilinvestigationalnosubstrateDetailsDB09239NiguldipineexperimentalnosubstrateDetailsDB09240NiludipineexperimentalnosubstrateDetailsDB04743Nimesulideapproved, investigational, withdrawnnosubstrateDetailsDB06152NylidrinapprovednosubstrateDetailsDB13500Otiloniumexperimental, investigationalnosubstrateDetailsDB13791PenfluridolexperimentalnosubstrateDetailsDB09090PinaveriumapprovednosubstrateDetailsDB04825Prenylamineapproved, withdrawnnosubstrateDetailsDB13725TerodilineexperimentalnosubstrateDetailsDB12093TetrahydropalmatineinvestigationalnosubstrateDetailsDB14066TetrandrineexperimentalnosubstrateDetailsDB09216Tolfenamic acidapproved, investigationalnosubstrateDetailsDB07615TranilastinvestigationalnosubstrateDetailsDB09089TrimebutineapprovednosubstrateDetailsDB05885SeletracetaminvestigationalnosubstrateDetailsDB12131VinpocetineinvestigationalnosubstrateDetailsDB13950WIN 55212-2experimentalnosubstrateinhibitorDetailsDB040706-Deoxyerythronolide BexperimentalnoinhibitorDetailsDB06318AVE9633investigationalnoinhibitorDetailsDB07348Brefeldin AexperimentalnoinhibitorDetailsDB11752Bryostatin 1investigationalnoinhibitorDetailsDB01152Candicidinapproved, withdrawnnoinhibitorDetailsDB11383Carbomycinvet_approvednoinhibitorDetailsDB06419CethromycininvestigationalnosubstrateinhibitorDetailsDB06342Coltuximab ravtansineinvestigationalnoinhibitorDetailsDB00954DirithromycinexperimentalnoinhibitorDetailsDB11400Doramectinvet_approvednoinhibitorDetailsDB12266EpofolateinvestigationalnoinhibitorDetailsDB01873Epothilone DinvestigationalnoinhibitorDetailsDB11405Eprinomectinvet_approvednoinhibitorDetailsDB13338FlurithromycinexperimentalnoinhibitorDetailsDB05814GPI-1485investigationalnoinhibitorDetailsDB09309KitasamycinexperimentalnoinhibitorDetailsDB05903KOS-1584investigationalnoinhibitorDetailsDB12089Lorvotuzumab mertansineinvestigationalnoinhibitorDetailsDB13287MiocamycinapprovednoinhibitorDetailsDB12489Mirvetuximab soravtansineapproved, investigationalnosubstrateinhibitorDetailsDB06587MitemcinalinvestigationalnoinhibitorDetailsDB11442Oleandomycinvet_approvednoinhibitorDetailsDB03010Patupiloneexperimental, investigationalnoinhibitorDetailsDB06233RidaforolimusinvestigationalnoinhibitorDetailsDB13409RokitamycinexperimentalnoinhibitorDetailsDB12391SagopiloneinvestigationalnoinhibitorDetailsDB11459Selamectinvet_approvednoinhibitorDetailsDB09308SolithromycininvestigationalnoinhibitorDetailsDB11470Tildipirosinvet_approvednoinhibitorDetailsDB01241GemfibrozilapprovedunknownsubstrateDetailsDB06791LanreotideapprovednoinhibitorDetailsDB00104Octreotideapproved, investigationalnoinhibitorDetailsDB06663PasireotideapprovednoinhibitorDetailsDB09099Somatostatinapproved, investigationalnoinhibitorDetailsDB04894Vapreotideexperimental, investigationalnoinhibitorDetailsDB12781BalaglitazoneinvestigationalnosubstrateDetailsDB09201CiglitazoneexperimentalnosubstrateDetailsDB09198LobeglitazoneexperimentalnosubstrateDetailsDB09199NetoglitazoneexperimentalnosubstrateDetailsDB09200Rivoglitazoneexperimental, investigationalnosubstrateDetailsDB00412Rosiglitazoneapproved, investigationalnosubstrateinducerDetailsDB09063CeritinibapprovednosubstrateinhibitorDetailsDB06469LestaurtinibinvestigationalnoinhibitorDetailsDB11805SaracatinibinvestigationalnoinhibitorDetailsDB11703Acalabrutinibapproved, investigationalunknownsubstrateinhibitorDetailsDB01267PaliperidoneapprovedunknownsubstrateDetailsDB01645GenisteininvestigationalunknowninducerDetailsDB05928DovitinibinvestigationalunknowninhibitorDetailsDB08496(R)-warfarinexperimentalunknownsubstrateDetailsDB119196-O-benzylguanineinvestigationalnosubstrateDetailsDB14583Segesterone acetateapproved, experimental, investigationalunknownsubstrateDetailsDB00563MethotrexateapprovednosubstrateDetailsDB04884DapoxetineinvestigationalnosubstrateinhibitorDetailsDB08953Indalpineinvestigational, withdrawnnosubstrateinhibitorDetailsDB00715Paroxetineapproved, investigationalnosubstrateinhibitorDetailsDB04832Zimelidineapproved, withdrawnnoinhibitorDetailsDB04896Milnacipranapproved, investigationalnosubstrateinhibitorDetailsDB02703Fusidic acidapproved, investigationalunknownsubstrateinhibitorDetailsDB11730Ribociclibapproved, investigationalnosubstrateinhibitorDetailsDB09079NintedanibapprovednosubstrateDetailsDB14634Fluprednidene acetateexperimentalnoinducerDetailsDB14637Fluprednisolone acetateexperimentalnosubstrateDetailsDB01656RoflumilastapprovednosubstrateDetailsDB09034Suvorexantapproved, investigationalnosubstrateDetailsDB09071Tasimelteonapproved, investigationalnosubstrateDetailsDB09030VorapaxarapprovednosubstrateDetailsDB01624Zuclopenthixolapproved, investigationalnosubstrateDetailsDB13385DihydroergocryptineexperimentalnosubstrateDetailsDB11273DihydroergocornineapprovednosubstrateDetailsDB13345Dihydroergocristineapproved, experimentalnosubstrateDetailsDB06218LacosamideapprovednosubstrateDetailsDB12329Eravacyclineapproved, investigationalunknownsubstrateDetailsDB06458RemacemideinvestigationalnoinhibitorDetailsDB08874FidaxomicinapprovednoinhibitorDetailsDB11742Ebastineapproved, investigationalnosubstrateDetailsDB09036Siltuximabapproved, investigationalnoinducerDetailsDB06273TocilizumabapprovednoinducerDetailsDB12301Doravirineapproved, investigationalunknownsubstrateDetailsDB11952Duvelisibapproved, investigationalnosubstrateDetailsDB13997Baloxavir marboxilapproved, investigationalnosubstrateinhibitorDetailsDB00186LorazepamapprovednosubstrateDetailsDB125159-aminocamptothecininvestigationalnosubstrateDetailsDB12952Methylprednisoneapproved, investigationalnosubstrateDetailsDB04861Nebivololapproved, investigationalunknownsubstrateDetailsDB11963Dacomitinibapproved, investigationalnosubstrateDetailsDB12141Gilteritinibapproved, investigationalnosubstrateDetailsDB14723Larotrectinibapproved, investigationalunknownsubstrateDetailsDB125371,2-Benzodiazepineapproved, investigationalunknownsubstrateDetailsDB09017Brotizolaminvestigational, withdrawnunknownsubstrateDetailsDB11094Vitamin Dapproved, nutraceutical, vet_approvednosubstrateDetailsDB01352Aprobarbitalexperimental, illicitunknowninducerDetailsDB00590DoxazosinapprovednosubstrateDetailsDB05482SN-38investigationalunknownsubstrateinhibitorDetailsDB06480PrucaloprideapprovednosubstrateDetailsDB11978Glasdegibapproved, investigationalunknownsubstrateDetailsDB12582PiperineinvestigationalunknowninhibitorDetailsDB00191Phentermineapproved, illicitnosubstrateDetailsDB12245Triclabendazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00264Metoprololapproved, investigationalnosubstrateDetailsDB11823Esketamineapproved, investigationalunknownsubstrateinducerDetailsDB00163Vitamin Eapproved, nutraceutical, vet_approvedunknownsubstrateinducerDetailsDB12371Siponimodapproved, investigationalunknownsubstrateDetailsDB12147Erdafitinibapproved, investigationalnosubstrateinhibitorinducerDetailsDB09299Tenofovir alafenamideapprovednosubstrateDetailsDB00982IsotretinoinapprovedunknownsubstrateDetailsDB12015Alpelisibapproved, investigationalunknownsubstrateDetailsDB12240Polatuzumab vedotinapproved, investigationalnosubstrateDetailsDB00905Bimatoprostapproved, investigationalunknownsubstrateDetailsDB11942Selinexorapproved, investigationalunknownsubstrateDetailsDB14669Betamethasone phosphateapproved, vet_approvedunknownsubstrateinducerDetailsDB14652Clocortolone acetateexperimentalunknowninducerDetailsDB13843CloprednolexperimentalunknowninducerDetailsDB14681CortisoneexperimentalunknowninducerDetailsDB13003CortivazolinvestigationalunknowninducerDetailsDB13728HalometasoneexperimentalunknowninducerDetailsDB14659Melengestrol acetateexperimentalunknowninducerDetailsDB14644Methylprednisolone hemisuccinateapprovedunknowninducerDetailsDB14633Prednisolone hemisuccinateexperimentalunknowninducerDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknownsubstrateinducerDetailsDB14646Prednisone acetateapproved, experimental, investigationalunknowninducerDetailsDB02520DitiocarbexperimentalunknowninhibitorDetailsDB06731SeproxetineinvestigationalunknowninhibitorDetailsDB00627Niacinapproved, investigational, nutraceuticalunknowninhibitorDetailsDB06282LevocetirizineapprovedunknownsubstrateDetailsDB09173ButyrfentanylillicitunknownsubstrateDetailsDB12978Pexidartinibapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB01551Dihydrocodeineapproved, illicitunknownsubstrateDetailsDB05154PretomanidapprovedunknownsubstrateDetailsDB01395DrospirenoneapprovedunknownsubstrateDetailsDB01611HydroxychloroquineapprovedunknownsubstrateDetailsDB11986Entrectinibapproved, investigationalunknownsubstrateDetailsDB12500Fedratinibapproved, investigationalunknownsubstrateDetailsDB12825Lefamulinapproved, investigationalunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknownsubstrateDetailsDB01319FosamprenavirapprovedunknownsubstrateinhibitorDetailsDB01050IbuprofenapprovednosubstrateDetailsDB15489MexazolamexperimentalunknownsubstrateDetailsDB00334Olanzapineapproved, investigationalunknowninhibitorDetailsDB09288PropacetamolexperimentalunknownsubstrateinducerDetailsDB01233Metoclopramideapproved, investigationalunknownsubstrateDetailsDB11761Tenapanorapproved, investigationalunknownsubstrateDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB14600Edetate disodium anhydrousapproved, vet_approvedunknowninhibitorDetailsDB01217Anastrozoleapproved, investigationalunknownsubstrateinhibitorDetailsDB14575EslicarbazepineapprovedunknowninducerDetailsDB12808Trifaroteneapproved, investigationalunknownsubstrateDetailsDB15444Elexacaftorapproved, investigationalnosubstrateinhibitorDetailsDB15566Prednisolone acetateapproved, vet_approvedunknownsubstrateinducerDetailsDB00557HydroxyzineapprovednosubstrateDetailsDB14240Echinaceaapproved, experimentalunknowninducerDetailsDB11560Lesinuradapproved, investigationalunknowninducerDetailsDB15035Zanubrutinibapproved, investigationalnosubstrateDetailsDB01381Ginkgo bilobaapproved, investigational, nutraceuticalunknowninhibitorinducerDetailsDB13879Glecaprevirapproved, investigationalunknowninhibitorDetailsDB14975Voxelotorapproved, investigationalunknownsubstrateDetailsDB00717NorethisteroneapprovedunknownsubstrateDetailsDB06119Cenobamateapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB13007Enfortumab vedotinapproved, investigationalunknownsubstrateDetailsDB14962Trastuzumab deruxtecanapproved, investigationalunknownsubstrateDetailsDB11951Lemborexantapproved, investigationalunknownsubstrateDetailsDB12941Darolutamideapproved, investigationalunknownsubstrateDetailsDB06077Lumateperoneapproved, investigationalnosubstrateDetailsDB15091Upadacitinibapproved, investigationalnosubstrateDetailsDB15328Ubrogepantapproved, investigationalunknownsubstrateDetailsDB15233Avapritinibapproved, investigationalunknownsubstrateDetailsDB12887Tazemetostatapproved, investigationalunknownsubstrateDetailsDB12457Rimegepantapproved, investigationalnosubstrateinhibitorDetailsDB13609UmifenovirinvestigationalunknownsubstrateDetailsDB11837Osilodrostatapproved, investigationalunknownsubstrateinhibitorDetailsDB14678Norethindrone enanthateexperimentalunknownsubstrateDetailsDB09241Methylene blueapproved, investigationalunknowninhibitorDetailsDB12612Ozanimodapproved, investigationalunknownsubstrateDetailsDB14598Edetate calcium disodium anhydrousapprovedunknowninhibitorDetailsDB11689Selumetinibapproved, investigationalnosubstrateDetailsDB15102Pemigatinibapproved, investigationalnosubstrateDetailsDB14761Remdesivirapproved, investigationalunknownsubstrateinhibitorDetailsDB11791Capmatinibapproved, investigationalunknownsubstrateDetailsDB15685Selpercatinibapproved, investigationalunknownsubstrateDetailsDB14840RipretinibapprovedunknownsubstrateDetailsDB00714Apomorphineapproved, investigationalunknownDetailsDB12674Lurbinectedinapproved, investigationalunknownsubstrateDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB05015Belinostatapproved, investigationalunknownsubstrateDetailsDB11796Fostemsavirapproved, investigationalunknownsubstrateDetailsDB11932Abametapirapproved, investigationalnoinhibitorDetailsDB15305Risdiplamapproved, investigationalunknownsubstrateDetailsDB14881Oliceridineapproved, investigationalnosubstrateDetailsDB12499Clascoteroneapproved, investigationalnoinhibitorDetailsDB15822Pralsetinibapproved, investigationalnosubstrateinhibitorinducerDetailsDB06448Lonafarnibapproved, investigationalunknownsubstrateinhibitorDetailsDB15982BerotralstatapprovednoinhibitorDetailsDB06137Tirbanibulinapproved, investigationalnosubstrateinhibitorDetailsDB14895Vibegronapproved, investigationalnosubstrateDetailsDB00475Chlordiazepoxideapproved, illicit, investigationalunknownsubstrateDetailsDB00752Tranylcypromineapproved, investigationalunknowninhibitorDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB05667Levoketoconazoleapproved, investigationalnosubstrateinhibitorinducerDetailsDB00476DuloxetineapprovedunknowninhibitorDetailsDB11693Voclosporinapproved, investigationalunknownsubstrateinhibitorDetailsDB15133Tepotinibapproved, investigationalnosubstrateinhibitorDetailsDB00747Scopolamineapproved, investigationalnosubstrateDetailsDB00330EthambutolapprovedunknowninhibitorDetailsDB14989Umbralisibapproved, investigational, withdrawnunknownsubstrateDetailsDB14984Casimersenapproved, investigationalnoinhibitorDetailsDB00545Pyridostigmineapproved, investigationalnoinducerDetailsDB11800Tivozanibapproved, investigationalunknownsubstrateDetailsDB12016Ponesimodapproved, investigationalunknownsubstrateDetailsDB08995Diosminapproved, investigationalunknowninhibitorDetailsDB05316Pimavanserinapproved, investigationalunknownsubstrateDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownsubstrateDetailsDB12235Estetrolapproved, investigationalunknownsubstrateDetailsDB16222Loncastuximab tesirineapproved, investigationalunknownDetailsDB11886Infigratinibapproved, investigationalnosubstrateDetailsDB12471Ibrexafungerpapproved, investigationalunknownsubstrateinhibitorDetailsDB12543Samidorphanapproved, investigationalnosubstrateDetailsDB16165Finerenoneapproved, investigationalunknownsubstrateDetailsDB16703Belumosudilapproved, investigationalnosubstrateDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB15463Belzutifanapproved, investigationalnosubstrateDetailsDB12265Fexinidazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB16390Mobocertinibapproved, investigationalunknownsubstrateDetailsDB16732Tisotumab vedotinapprovednosubstrateDetailsDB16098Atogepantapproved, investigationalnosubstrateDetailsDB16226Maralixibatapproved, investigationalnoinhibitorDetailsDB15011Avacopanapproved, investigationalnosubstrateinhibitorinducerDetailsDB12597Asciminibapproved, investigationalnosubstrateinhibitorDetailsDB06234Maribavirapproved, investigationalnosubstrateDetailsDB16691Nirmatrelvirapproved, investigationalnosubstrateinhibitorDetailsDB15031DaridorexantapprovednosubstrateDetailsDB12713Sotagliflozinapproved, investigationalnosubstrateinhibitorinducerDetailsDB14973Abrocitinibapproved, investigationalnosubstrateDetailsDB05467Palovaroteneapproved, investigationalnosubstrateinducerDetailsDB16236Mitapivatapproved, investigationalnosubstrateinducerDetailsDB12834SecnidazoleapprovedunknownsubstrateinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknownsubstrateinhibitorDetailsDB00486Nabiloneapproved, investigationalunknownsubstrateinhibitorDetailsDB06230Nalmefeneapproved, investigational, withdrawnnosubstrateDetailsDB11697Pacritinibapproved, investigationalnosubstrateinhibitorinducerDetailsDB05087Ganaxoloneapproved, investigationalnosubstrateDetailsDB01041Thalidomideapproved, investigational, withdrawnnosubstrateinducerDetailsDB14921Mavacamtenapproved, investigationalnosubstrateinducerDetailsDB09185Viloxazineapproved, investigational, withdrawnnoinhibitorDetailsDB00951Isoniazidapproved, investigationalunknowninhibitorDetailsDB12020Tecovirimatapproved, investigationalnoinducerDetailsDB06083Tapinarofapproved, investigationalnosubstrateDetailsDB01024Mycophenolic acidapproved, investigationalunknownsubstrateDetailsDB10534GrapefruitapprovedunknowninhibitorDetailsDB04951Pirfenidoneapproved, investigationalunknowninhibitorDetailsDB15673Lenacapavirapproved, investigationalnosubstrateinhibitorDetailsDB12095Telotristat ethylapproved, investigationalnoinhibitorinducerDetailsDB15149Futibatinibapproved, investigationalnosubstrateDetailsDB17083LinzagolixapprovednosubstrateDetailsDB11739Vonoprazanapproved, investigationalunknownsubstrateDetailsDB09065CobicistatapprovedyesinhibitorDetailsDB16267Olutasidenibapproved, investigationalnosubstrateinducerDetailsDB15568Adagrasibapproved, investigationalunknownsubstrateinhibitorDetailsDB12236Bexagliflozinapproved, investigationalunknownsubstrateDetailsDB17472Pirtobrutinibapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB06374Elacestrantapproved, investigationalunknownsubstrateDetailsDB11682Daprodustatapproved, investigationalnosubstrateDetailsDB09065CobicistatapprovednosubstrateDetailsDB12548Sparsentanapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB12513Omaveloxoloneapproved, investigationalunknownsubstrateinducerDetailsDB15688Zavegepantapproved, investigationalunknownsubstrateDetailsDB06045Trofinetideapproved, investigationalunknowninhibitorDetailsDB16217Leniolisibapproved, investigationalnosubstrateDetailsDB12255Vadadustatapproved, investigationalunknowndownregulatorDetailsDB14924Ritlecitinibapproved, investigationalunknownsubstrateinhibitorDetailsDB12874Quizartinibapproved, investigationalnosubstrateDetailsDB15490Zuranoloneapproved, experimentalnosubstrateDetailsDB11763Momelotinibapproved, investigationalunknownsubstrateDetailsDB12184GepironeinvestigationalnosubstrateDetailsDB14766EtrasimodapprovednosubstrateDetailsDB15114Vamoroloneapproved, investigationalnosubstrateinducerDetailsDB12218Capivasertibapproved, investigationalnosubstrateDetailsDB16826RepotrectinibinvestigationalnosubstrateinhibitorinducerDetailsDB11679FruquintinibinvestigationalnosubstrateDetailsDB00176Fluvoxamineapproved, investigationalunknowninhibitorDetailsDB00599Thiopentalapproved, vet_approvedunknownsubstrateDetailsDB08930DolutegravirapprovednosubstrateDetailsDB06595Midostaurinapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB13174RheinexperimentalunknowninhibitorDetailsDB11994Diacereinapproved, investigationalunknowninhibitorDetailsDB11605MyrrhapprovedunknowninducerDetailsDB11691Naldemedineapproved, investigationalnosubstrateDetailsDB13878Pibrentasvirapproved, investigationalunknowninhibitorDetailsDB13879Glecaprevirapproved, investigationalunknownsubstrateinhibitorDetailsDB09205Moxisylyteapproved, investigationalnosubstrateDetailsDB09568Omega-3-carboxylic acidsapproved, investigationalnosubstrateDetailsDB01601LopinavirapprovednoinhibitorDetailsDB01149Nefazodoneapproved, withdrawnnoinhibitorDetailsDB13141Ambroxol acefyllinateexperimental, investigationalnosubstrateDetailsDB11792MirodenafilinvestigationalunknownsubstrateDetailsDB11979Elagolixapproved, investigationalnosubstrateDetailsDB08865Crizotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB11703Acalabrutinibapproved, investigationalunknownsubstrateDetailsDB12267Brigatinibapproved, investigationalunknowninducerDetailsDB12307ForetinibinvestigationalunknownsubstrateDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB00593EthosuximideapprovedunknownsubstrateDetailsDB01201Rifapentineapproved, investigationalunknowninducerDetailsDB00643Mebendazoleapproved, vet_approvedunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknowninhibitorDetailsDB00334Olanzapineapproved, investigationalunknowninhibitorDetailsDB09212LoxoprofenapprovedunknownsubstrateDetailsDB00635Prednisoneapproved, vet_approvedunknowninducerDetailsDB01222BudesonideapprovedunknownsubstrateinducerDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB11951Lemborexantapproved, investigationalunknowninhibitorinducerDetailsDB12887Tazemetostatapproved, investigationalunknownsubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninducerDetailsDB11652Tucatinibapproved, investigationalunknownsubstrateDetailsDB15035Zanubrutinibapproved, investigationalunknownsubstrateDetailsDB15685Selpercatinibapproved, investigationalunknowninhibitorDetailsDB00409Remoxiprideapproved, withdrawnunknowninhibitorDetailsDB15305Risdiplamapproved, investigationalunknowninhibitorDetailsDB06448Lonafarnibapproved, investigationalnosubstrateinhibitorDetailsDB11853Relugolixapproved, investigationalunknownsubstrateinducerDetailsDB01586Ursodeoxycholic acidapproved, investigationalunknowninducerDetailsDB11742Ebastineapproved, investigationalunknownsubstrateDetailsDB15569Sotorasibapproved, investigationalunknownsubstrateDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB00647Dextropropoxypheneapproved, illicit, investigational, withdrawnunknowninhibitorDetailsDB00333MethadoneapprovednoinhibitorDetailsDB01167Itraconazoleapproved, investigationalnoinhibitorDetailsDB16536Birch bark extractapproved, experimentalunknowninhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateinhibitorDetails"
                    }
                },
                {
                    "Label": "Cytochrome P450 2C19",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 2C19",
                        "Synonyms": "(R)-limonene 6-monooxygenase\n(S)-limonene 6-monooxygenase\n(S)-limonene 7-monooxygenase\n1.14.13.-\nCYPIIC17\nCYPIIC19\nCytochrome P450-11A\nCytochrome P450-254C\nMephenytoin 4-hydroxylase",
                        "Gene Name": "CYP2C19",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0020694|Cytochrome P450 2C19\nMDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDVSKSLTNLSKI\nYGPVFTLYFGLERMVVLHGYEVVKEALIDLGEEFSGRGHFPLAERANRGFGIVFSNGKRW\nKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICS\nIIFQKRFDYKDQQFLNLMEKLNENIRIVSTPWIQICNNFPTIIDYFPGTHNKLLKNLAFM\nESDILEKVKEHQESMDINNPRDFIDCFLIKMEKEKQNQQSEFTIENLVITAADLLGAGTE\nTTSTTLRYALLLLLKHPEVTAKVQEEIERVVGRNRSPCMQDRGHMPYTDAVVHEVQRYID\nLIPTSLPHAVTCDVKFRNYLIPKGTTILTSLTSVLHDNKEFPNPEMFDPRHFLDEGGNFK\nKSNYFMPFSAGKRICVGEGLARMELFLFLTFILQNFNLKSLIDPKDLDTTPVVNGFASVP\nPFYQLCFIPV",
                        "Number of residues": "490",
                        "Molecular Weight": "55930.545",
                        "Theoretical pI": "7.42",
                        "GO Classification": "Functions(R)-limonene 6-monooxygenase activity / (S)-limonene 6-monooxygenase activity / (S)-limonene 7-monooxygenase activity / arachidonic acid epoxygenase activity / enzyme binding / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity / oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen / oxygen binding / steroid hydroxylase activityProcessesarachidonic acid metabolic process / drug metabolic process / epoxygenase P450 pathway / exogenous drug catabolic process / heterocycle metabolic process / monoterpenoid metabolic process / omega-hydroxylase P450 pathway / oxidation-reduction process / small molecule metabolic process / steroid metabolic process / xenobiotic metabolic processComponentscytoplasm / endoplasmic reticulum membrane / intracellular membrane-bounded organelle",
                        "General Function": "Steroid hydroxylase activity",
                        "Specific Function": "Responsible for the metabolism of a number of therapeutic agents such as the anticonvulsant drug S-mephenytoin, omeprazole, proguanil, certain barbiturates, diazepam, propranolol, citalopram and imipramine.",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0020695|Cytochrome P450 2C19 (CYP2C19)\nATGGATCCTTTTGTGGTCCTTGTGCTCTGTCTCTCATGTTTGCTTCTCCTTTCAATCTGG\nAGACAGAGCTCTGGGAGAGGAAAACTCCCTCCTGGCCCCACTCCTCTCCCAGTGATTGGA\nAATATCCTACAGATAGATATTAAGGATGTCAGCAAATCCTTAACCAATCTCTCAAAAATC\nTATGGCCCTGTGTTCACTCTGTATTTTGGCCTGGAACGCATGGTGGTGCTGCATGGATAT\nGAAGTGGTGAAGGAAGCCCTGATTGATCTTGGAGAGGAGTTTTCTGGAAGAGGCCATTTC\nCCACTGGCTGAAAGAGCTAACAGAGGATTTGGAATCGTTTTCAGCAATGGAAAGAGATGG\nAAGGAGATCCGGCGTTTCTCCCTCATGACGCTGCGGAATTTTGGGATGGGGAAGAGGAGC\nATTGAGGACCGTGTTCAAGAGGAAGCCCGCTGCCTTGTGGAGGAGTTGAGAAAAACCAAG\nGCTTCACCCTGTGATCCCACTTTCATCCTGGGCTGTGCTCCCTGCAATGTGATCTGCTCC\nATTATTTTCCAGAAACGTTTCGATTATAAAGATCAGCAATTTCTTAACTTGATGGAAAAA\nTTGAATGAAAACATCAGGATTGTAAGCACCCCCTGGATCCAGATATGCAATAATTTTCCC\nACTATCATTGATTATTTCCCGGGAACCCATAACAAATTACTTAAAAACCTTGCTTTTATG\nGAAAGTGATATTTTGGAGAAAGTAAAAGAACACCAAGAATCGATGGACATCAACAACCCT\nCGGGACTTTATTGATTGCTTCCTGATCAAAATGGAGAAGGAAAAGCAAAACCAACAGTCT\nGAATTCACTATTGAAAACTTGGTAATCACTGCAGCTGACTTACTTGGAGCTGGGACAGAG\nACAACAAGCACAACCCTGAGATATGCTCTCCTTCTCCTGCTGAAGCACCCAGAGGTCACA\nGCTAAAGTCCAGGAAGAGATTGAACGTGTCATTGGCAGAAACCGGAGCCCCTGCATGCAG\nGACAGGGGCCACATGCCCTACACAGATGCTGTGGTGCACGAGGTCCAGAGATACATCGAC\nCTCATCCCCACCAGCCTGCCCCATGCAGTGACCTGTGACGTTAAATTCAGAAACTACCTC\nATTCCCAAGGGCACAACCATATTAACTTCCCTCACTTCTGTGCTACATGACAACAAAGAA\nTTTCCCAACCCAGAGATGTTTGACCCTCGTCACTTTCTGGATGAAGGTGGAAATTTTAAG\nAAAAGTAACTACTTCATGCCTTTCTCAGCAGGAAAACGGATTTGTGTGGGAGAGGGCCTG\nGCCCGCATGGAGCTGTTTTTATTCCTGACCTTCATTTTACAGAACTTTAACCTGAAATCT\nCTGATTGACCCAAAGGACCTTGACACAACTCCTGTTGTCAATGGATTTGCTTCTGTCCCG\nCCCTTCTATCAGCTGTGCTTCATTCCTGTCTGA",
                        "Chromosome Location": "10",
                        "Locus": "10q24.1-q24.3",
                        "External Identifiers": "ResourceLinkUniProtKB IDP33261UniProtKB Entry NameCP2CJ_HUMANGenBank Protein ID181344GenBank Gene IDM61854HGNC IDHGNC:2621",
                        "General References": "Romkes M, Faletto MB, Blaisdell JA, Raucy JL, Goldstein JA: Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. Biochemistry. 1991 Apr 2;30(13):3247-55. [Article] Romkes M, Faletto MB, Blaisdell JA, Raucy JL, Goldstein JA: Cloning and expression of complementary DNAs for multiple members of the human cytochrome PH50IIC subfamily. Biochemistry. 1993 Feb 9;32(5):1390. [Article] Deloukas P, Earthrowl ME, Grafham DV, Rubenfield M, French L, Steward CA, Sims SK, Jones MC, Searle S, Scott C, Howe K, Hunt SE, Andrews TD, Gilbert JG, Swarbreck D, Ashurst JL, Taylor A, Battles J, Bird CP, Ainscough R, Almeida JP, Ashwell RI, Ambrose KD, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Bates K, Beasley H, Bray-Allen S, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Cahill P, Camire D, Carter NP, Chapman JC, Clark SY, Clarke G, Clee CM, Clegg S, Corby N, Coulson A, Dhami P, Dutta I, Dunn M, Faulkner L, Frankish A, Frankland JA, Garner P, Garnett J, Gribble S, Griffiths C, Grocock R, Gustafson E, Hammond S, Harley JL, Hart E, Heath PD, Ho TP, Hopkins B, Horne J, Howden PJ, Huckle E, Hynds C, Johnson C, Johnson D, Kana A, Kay M, Kimberley AM, Kershaw JK, Kokkinaki M, Laird GK, Lawlor S, Lee HM, Leongamornlert DA, Laird G, Lloyd C, Lloyd DM, Loveland J, Lovell J, McLaren S, McLay KE, McMurray A, Mashreghi-Mohammadi M, Matthews L, Milne S, Nickerson T, Nguyen M, Overton-Larty E, Palmer SA, Pearce AV, Peck AI, Pelan S, Phillimore B, Porter K, Rice CM, Rogosin A, Ross MT, Sarafidou T, Sehra HK, Shownkeen R, Skuce CD, Smith M, Standring L, Sycamore N, Tester J, Thorpe A, Torcasso W, Tracey A, Tromans A, Tsolas J, Wall M, Walsh J, Wang H, Weinstock K, West AP, Willey DL, Whitehead SL, Wilming L, Wray PW, Young L, Chen Y, Lovering RC, Moschonas NK, Siebert R, Fechtel K, Bentley D, Durbin R, Hubbard T, Doucette-Stamm L, Beck S, Smith DR, Rogers J: The DNA sequence and comparative analysis of human chromosome 10. Nature. 2004 May 27;429(6990):375-81. [Article] Wrighton SA, Stevens JC, Becker GW, VandenBranden M: Isolation and characterization of human liver cytochrome P450 2C19: correlation between 2C19 and S-mephenytoin 4'-hydroxylation. Arch Biochem Biophys. 1993 Oct;306(1):240-5. [Article] Miyazawa M, Shindo M, Shimada T: Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes. Drug Metab Dispos. 2002 May;30(5):602-7. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Reynald RL, Sansen S, Stout CD, Johnson EF: Structural characterization of human cytochrome P450 2C19: active site differences between P450s 2C8, 2C9, and 2C19. J Biol Chem. 2012 Dec 28;287(53):44581-91. doi: 10.1074/jbc.M112.424895. Epub 2012 Nov 1. [Article] de Morais SM, Wilkinson GR, Blaisdell J, Nakamura K, Meyer UA, Goldstein JA: The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J Biol Chem. 1994 Jun 3;269(22):15419-22. [Article] De Morais SM, Wilkinson GR, Blaisdell J, Meyer UA, Nakamura K, Goldstein JA: Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Mol Pharmacol. 1994 Oct;46(4):594-8. [Article] Xiao ZS, Goldstein JA, Xie HG, Blaisdell J, Wang W, Jiang CH, Yan FX, He N, Huang SL, Xu ZH, Zhou HH: Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele. J Pharmacol Exp Ther. 1997 Apr;281(1):604-9. [Article] Ibeanu GC, Goldstein JA, Meyer U, Benhamou S, Bouchardy C, Dayer P, Ghanayem BI, Blaisdell J: Identification of new human CYP2C19 alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian poor metabolizer of mephenytoin. J Pharmacol Exp Ther. 1998 Sep;286(3):1490-5. [Article] Ibeanu GC, Blaisdell J, Ghanayem BI, Beyeler C, Benhamou S, Bouchardy C, Wilkinson GR, Dayer P, Daly AK, Goldstein JA: An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in Caucasians. Pharmacogenetics. 1998 Apr;8(2):129-35. [Article] Ibeanu GC, Blaisdell J, Ferguson RJ, Ghanayem BI, Brosen K, Benhamou S, Bouchardy C, Wilkinson GR, Dayer P, Goldstein JA: A novel transversion in the intron 5 donor splice junction of CYP2C19 and a sequence polymorphism in exon 3 contribute to the poor metabolizer phenotype for the anticonvulsant drug S-mephenytoin. J Pharmacol Exp Ther. 1999 Aug;290(2):635-40. [Article] Blaisdell J, Mohrenweiser H, Jackson J, Ferguson S, Coulter S, Chanas B, Xi T, Ghanayem B, Goldstein JA: Identification and functional characterization of new potentially defective alleles of human CYP2C19. Pharmacogenetics. 2002 Dec;12(9):703-11. [Article] Morita J, Kobayashi K, Wanibuchi A, Kimura M, Irie S, Ishizaki T, Chiba K: A novel single nucleotide polymorphism (SNP) of the CYP2C19 gene in a Japanese subject with lowered capacity of mephobarbital 4'-hydroxylation. Drug Metab Pharmacokinet. 2004 Jun;19(3):236-8. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article] Fukushima-Uesaka H, Saito Y, Maekawa K, Ozawa S, Hasegawa R, Kajio H, Kuzuya N, Yasuda K, Kawamoto M, Kamatani N, Suzuki K, Yanagawa T, Tohkin M, Sawada J: Genetic variations and haplotypes of CYP2C19 in a Japanese population. Drug Metab Pharmacokinet. 2005 Aug;20(4):300-7. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00188Bortezomibapproved, investigationalnosubstrateinhibitorDetailsDB00213PantoprazoleapprovedunknownsubstrateinhibitorDetailsDB00215CitalopramapprovednosubstrateinhibitorDetailsDB00220NelfinavirapprovednosubstrateinducerDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinducerDetailsDB00273TopiramateapprovedunknowninhibitorDetailsDB00328Indomethacinapproved, investigationalunknownsubstrateinhibitorDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00349Clobazamapproved, illicitnosubstrateDetailsDB00395CarisoprodolapprovedunknownsubstrateDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00420Promazineapproved, vet_approvedunknownsubstrateDetailsDB00444TeniposideapprovedunknownsubstrateDetailsDB00448Lansoprazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00546AdinazolamexperimentalunknownsubstrateDetailsDB00582VoriconazoleapprovedunknownsubstrateinhibitorDetailsDB00665Nilutamideapproved, investigationalunknownsubstrateinhibitorDetailsDB00679Thioridazineapproved, withdrawnunknownsubstrateDetailsDB00736Esomeprazoleapproved, investigationalnosubstrateinhibitorDetailsDB00738Pentamidineapproved, investigationalunknownsubstrateDetailsDB00794Primidoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00849MethylphenobarbitalapprovedunknownsubstrateDetailsDB00949FelbamateapprovedunknowninhibitorDetailsDB01018Guanfacineapproved, investigationalunknownsubstrateDetailsDB01104SertralineapprovedunknownsubstrateinhibitorDetailsDB01124Tolbutamideapproved, investigationalunknownsubstrateDetailsDB01129Rabeprazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB01131ProguanilapprovedunknownsubstrateDetailsDB01166Cilostazolapproved, investigationalunknownsubstrateDetailsDB01171Moclobemideapproved, investigationalunknownsubstrateinhibitorDetailsDB01174Phenobarbitalapproved, investigationalunknownsubstrateinducerDetailsDB01274Arformoterolapproved, investigationalunknownsubstrateDetailsDB01320Fosphenytoinapproved, investigationalunknownsubstrateDetailsDB01544Flunitrazepamapproved, illicitunknownsubstrateDetailsDB00176Fluvoxamineapproved, investigationalnoinhibitorDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknowninhibitorDetailsDB00208TiclopidineapprovedunknownsubstrateinhibitorDetailsDB00321AmitriptylineapprovedunknownsubstrateinhibitorDetailsDB00343Diltiazemapproved, investigationalunknownsubstrateDetailsDB00455Loratadineapproved, investigationalnosubstrateinhibitorDetailsDB00458ImipramineapprovedunknownsubstrateinhibitorDetailsDB00503Ritonavirapproved, investigationalnoinducerDetailsDB00532Mephenytoinapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknownsubstrateDetailsDB00622Nicardipineapproved, investigationalunknowninhibitorDetailsDB00625Efavirenzapproved, investigationalunknowninducerDetailsDB00745Modafinilapproved, investigationalunknowninhibitorDetailsDB00752Tranylcypromineapproved, investigationalunknowninhibitorDetailsDB00776OxcarbazepineapprovedunknowninhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB01041Thalidomideapproved, investigational, withdrawnnosubstrateinhibitorDetailsDB01424Aminophenazoneapproved, withdrawnunknownsubstrateDetailsDB00333MethadoneapprovedunknownsubstrateDetailsDB06442AvasimibeinvestigationalunknowninhibitorDetailsDB01065Melatoninapproved, nutraceutical, vet_approvedunknownsubstrateDetailsDB01076AtorvastatinapprovednoinhibitorDetailsDB01095FluvastatinapprovedunknowninhibitorDetailsDB00196Fluconazoleapproved, investigationalunknowninhibitorDetailsDB00619ImatinibapprovednosubstrateDetailsDB00468QuinineapprovedunknownsubstrateinhibitorDetailsDB01142Doxepinapproved, investigationalnosubstrateDetailsDB01435Antipyrineapproved, investigationalunknownsubstrateDetailsDB00250Dapsoneapproved, investigationalunknownsubstrateDetailsDB00675TamoxifenapprovedunknownsubstrateDetailsDB05109Trabectedinapproved, investigationalunknownsubstrateDetailsDB01418Acenocoumarolapproved, investigationalunknownsubstrateDetailsDB00682WarfarinapprovedunknownsubstrateinhibitorDetailsDB00540NortriptylineapprovedunknownsubstrateDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00972AzelastineapprovedunknownsubstrateinhibitorDetailsDB01075Diphenhydramineapproved, investigationalunknownsubstrateDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00446Chloramphenicolapproved, vet_approved, withdrawnunknowninhibitorDetailsDB01242Clomipramineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00758ClopidogrelapprovednosubstrateDetailsDB00531Cyclophosphamideapproved, investigationalunknownsubstrateDetailsDB01355HexobarbitalexperimentalunknownsubstrateDetailsDB00571Propranololapproved, investigationalunknownsubstrateDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00472Fluoxetineapproved, vet_approvedunknownsubstrateinhibitorDetailsDB06403Ambrisentanapproved, investigationalunknownsubstrateDetailsDB01175EscitalopramapprovednosubstrateDetailsDB06414EtravirineapprovedunknownsubstrateinhibitorDetailsDB01181IfosfamideapprovedunknownsubstrateDetailsDB05246MethsuximideapprovedunknownsubstrateinhibitorDetailsDB00726TrimipramineapprovedunknownsubstrateDetailsDB00357Aminoglutethimideapproved, investigationalunknowninducerDetailsDB00564Carbamazepineapproved, investigationalunknowninhibitorinducerDetailsDB01601LopinavirapprovedunknowninhibitorDetailsDB01045RifampicinapprovedunknowninducerDetailsDB06413Armodafinilapproved, investigationalunknowninhibitorDetailsDB00705DelavirdineapprovedunknowninhibitorDetailsDB01241GemfibrozilapprovedunknowninhibitorDetailsDB00951Isoniazidapproved, investigationalunknowninhibitorDetailsDB06268Sitaxentanapproved, investigational, withdrawnunknowninhibitorDetailsDB00216Eletriptanapproved, investigationalunknownsubstrateDetailsDB00363ClozapineapprovednosubstrateinhibitorDetailsDB00425ZolpidemapprovedunknownsubstrateDetailsDB01036Tolterodineapproved, investigationalunknownsubstrateDetailsDB01283Lumiracoxibapproved, investigationalunknownsubstrateDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateinhibitorDetailsDB00672Chlorpropamideapproved, investigationalunknownsubstrateDetailsDB01120GliclazideapprovedunknownsubstrateDetailsDB01016GlyburideapprovedunknownsubstrateDetailsDB06739SeratrodastexperimentalunknownsubstrateDetailsDB06697ArtemetherapprovedunknownsubstrateinducerDetailsDB00945Acetylsalicylic acidapproved, vet_approvedunknowninducerDetailsDB01118Amiodaroneapproved, investigationalunknownsubstrateinhibitorDetailsDB00701Amprenavirapproved, investigationalunknowninhibitorDetailsDB00673Aprepitantapproved, investigationalunknownsubstrateinhibitorDetailsDB00289AtomoxetineapprovedunknownsubstrateDetailsDB01558Bromazepamapproved, illicit, investigationalunknownsubstrateDetailsDB00297Bupivacaineapproved, investigationalunknownsubstrateDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknowninhibitorDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknowninhibitorDetailsDB00604Cisaprideapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB06470ClomethiazoleinvestigationalunknownsubstrateDetailsDB01559Clotiazepamapproved, illicitunknownsubstrateDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknowninducerDetailsDB00514DextromethorphanapprovedunknownsubstrateDetailsDB01093Dimethyl sulfoxideapproved, vet_approvedunknowninhibitorDetailsDB00590DoxazosinapprovedunknownsubstrateDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00898EthanolapprovedunknowninhibitorDetailsDB01628Etoricoxibapproved, investigationalunknowninhibitorDetailsDB00502HaloperidolapprovedunknownsubstrateDetailsDB01050IbuprofenapprovedunknownsubstrateDetailsDB06738KetobemidoneinvestigationalunknownsubstrateDetailsDB00678LosartanapprovedunknowninhibitorDetailsDB01043Memantineapproved, investigationalunknowninhibitorDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB00184NicotineapprovedunknownsubstrateDetailsDB06712Nilvadipineapproved, investigationalunknowninhibitorDetailsDB00717NorethisteroneapprovedunknownsubstrateinducerDetailsDB00334Olanzapineapproved, investigationalunknowninhibitorDetailsDB00312Pentobarbitalapproved, investigational, vet_approvedunknownsubstrateDetailsDB00850PerphenazineapprovedunknownsubstrateDetailsDB00454MeperidineapprovedunknownsubstrateDetailsDB03783PhenacetinwithdrawnunknownsubstrateDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB01058Praziquantelapproved, investigational, vet_approvedunknownsubstrateDetailsDB00635Prednisoneapproved, vet_approvedunknowninducerDetailsDB00818Propofolapproved, investigational, vet_approvedunknownsubstrateDetailsDB01589Quazepamapproved, illicitnosubstrateDetailsDB01224QuetiapineapprovedunknownsubstrateDetailsDB01037Selegilineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00966Telmisartanapproved, investigationalunknowninhibitorDetailsDB00624Testosteroneapproved, investigationalunknownsubstrateDetailsDB00763MethimazoleapprovedunknowninhibitorDetailsDB00373TimololapprovedunknownsubstrateDetailsDB01007TioconazoleapprovedunknowninhibitorDetailsDB00347TrimethadioneapprovedunknownsubstrateDetailsDB00313Valproic acidapproved, investigationalunknownsubstrateinhibitorDetailsDB00661VerapamilapprovedunknownsubstrateDetailsDB00549Zafirlukastapproved, investigationalunknowninhibitorDetailsDB00909Zonisamideapproved, investigationalunknownsubstrateinhibitorDetailsDB00398Sorafenibapproved, investigationalunknowninhibitorDetailsDB00932Tipranavirapproved, investigationalunknownsubstrateinhibitorDetailsDB00980Ramelteonapproved, investigationalunknownsubstrateDetailsDB01128BicalutamideapprovedunknowninhibitorDetailsDB01259Lapatinibapproved, investigationalunknownsubstrateDetailsDB01621Pipotiazineapproved, investigationalunknownsubstrateDetailsDB00918Almotriptanapproved, investigationalunknownsubstrateDetailsDB04920Clevidipineapproved, investigationalunknowninhibitorDetailsDB00109Enfuvirtideapproved, investigationalunknownsubstrateDetailsDB00239OxiconazoleapprovedunknownsubstrateDetailsDB06204TapentadolapprovedunknownsubstrateDetailsDB06209PrasugrelapprovednosubstrateDetailsDB04871Lorcaserinapproved, withdrawnnosubstrateDetailsDB08864RilpivirineapprovedunknownsubstrateinhibitorDetailsDB06605ApixabanapprovedunknownsubstrateDetailsDB06626Axitinibapproved, investigationalnosubstrateDetailsDB08828Vismodegibapproved, investigationalunknowninhibitorDetailsDB08899EnzalutamideapprovednoinducerDetailsDB08895Tofacitinibapproved, investigationalnosubstrateDetailsDB04938Ospemifeneapproved, investigationalunknownsubstrateDetailsDB00317Gefitinibapproved, investigationalunknowninhibitorDetailsDB08918Levomilnacipranapproved, investigationalunknownsubstrateDetailsDB08932MacitentanapprovednosubstrateDetailsDB08933LuliconazoleapprovednoinhibitorDetailsDB09049NaloxegolapprovedunknowninhibitorDetailsDB00951Isoniazidapproved, investigationalunknownDetailsDB09054IdelalisibapprovednoinhibitorDetailsDB09068Vortioxetineapproved, investigationalnosubstrateDetailsDB09280LumacaftorapprovednoinducerDetailsDB09570Ixazomibapproved, investigationalunknownsubstrateDetailsDB06176Romidepsinapproved, investigationalunknownsubstrateDetailsDB09119Eslicarbazepine acetateapprovednoinhibitorDetailsDB06789Hydroxyprogesterone caproateapproved, investigationalunknowninducerDetailsDB05812AbirateroneapprovedunknowninhibitorDetailsDB09118StiripentolapprovedunknownsubstrateinhibitorDetailsDB06595Midostaurinapproved, investigationalunknowninhibitorinducerDetailsDB05541Brivaracetamapproved, investigationalnosubstrateDetailsDB05351Dexlansoprazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB01685TopiroxostatexperimentalunknowninhibitorDetailsDB09120Zucapsaicinapproved, investigationalunknowninhibitorDetailsDB09198LobeglitazoneexperimentalnoinhibitorDetailsDB09167DosulepinapprovedunknowninhibitorDetailsDB09166EtizolamexperimentalunknownsubstrateDetailsDB11614RupatadineapprovednosubstrateDetailsDB12319Benzbromaroneinvestigational, withdrawnunknowninhibitorDetailsDB09238Manidipineapproved, investigationalunknowninhibitorDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB12070Letermovirapproved, investigationalnoinducerDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB09061Cannabidiolapproved, investigationalunknownsubstrateinhibitorDetailsDB13943Testosterone cypionateapprovedunknownsubstrateDetailsDB13944Testosterone enanthateapprovedunknownsubstrateDetailsDB13946Testosterone undecanoateapproved, investigationalunknownsubstrateDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateDetailsDB11638Artenimolapproved, experimental, investigationalunknowninhibitorDetailsDB13941Piperaquineapproved, experimental, investigationalunknownsubstrateinhibitorDetailsDB11901Apalutamideapproved, investigationalnoinducerDetailsDB11633Isavuconazoleapproved, investigationalunknowninhibitorDetailsDB11586Asunaprevirapproved, investigational, withdrawnnosubstrateDetailsDB14011NabiximolsinvestigationalunknownsubstrateDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorDetailsDB11632Opicaponeapproved, investigationalnoinducerDetailsDB13746Bioallethrinapproved, experimentalnosubstrateDetailsDB04948Lofexidineapproved, investigationalnosubstrateDetailsDB00598LabetalolapprovedunknownsubstrateDetailsDB11967Binimetinibapproved, investigationalnosubstrateDetailsDB11718Encorafenibapproved, investigationalnosubstrateDetailsDB12474Lynestrenolapproved, investigationalnosubstrateinhibitorDetailsDB00615Rifabutinapproved, investigationalnoinducerDetailsDB01201Rifapentineapproved, investigationalnoinducerDetailsDB01220Rifaximinapproved, investigationalnoinducerDetailsDB11753Rifamycinapproved, investigationalnoinhibitorDetailsDB01483BarbitalillicitnosubstrateinducerDetailsDB00418Secobarbitalapproved, vet_approvednoinducerDetailsDB00599Thiopentalapproved, vet_approvednosubstrateDetailsDB06654Safinamideapproved, investigationalunknowninhibitorDetailsDB09078Lenvatinibapproved, investigationalunknowninhibitorDetailsDB05928DovitinibinvestigationalunknowninhibitorDetailsDB08496(R)-warfarinexperimentalunknownsubstrateDetailsDB14055(S)-Warfarinexperimental, investigationalunknownsubstrateDetailsDB04911Oritavancinapproved, investigationalunknowninhibitorDetailsDB06218LacosamideapprovedunknownsubstrateDetailsDB13762DexrabeprazoleexperimentalunknownsubstrateDetailsDB12319Benzbromaroneinvestigational, withdrawnunknowninhibitorDetailsDB09213Dexibuprofenapproved, investigationalunknownsubstrateDetailsDB00518Albendazoleapproved, vet_approvednosubstrateDetailsDB14025ClinafloxacininvestigationalunknowninhibitorDetailsDB06731SeproxetineinvestigationalunknowninhibitorDetailsDB14575EslicarbazepineapprovedunknowninhibitorDetailsDB01323St. John's Wortapproved, investigational, nutraceuticalnosubstrateinducerDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateDetailsDB12245Triclabendazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB11823Esketamineapproved, investigationalunknownsubstrateDetailsDB06684VilazodoneapprovedunknownsubstrateDetailsDB12015Alpelisibapproved, investigationalunknowninhibitorDetailsDB00977EthinylestradiolapprovedunknowninhibitorDetailsDB06730GestodeneinvestigationalunknowninhibitorDetailsDB00641SimvastatinapprovedunknownsubstrateDetailsDB00227Lovastatinapproved, investigationalunknownsubstrateDetailsDB00715Paroxetineapproved, investigationalunknownsubstrateDetailsDB00956Hydrocodoneapproved, illicit, investigationalunknownsubstrateDetailsDB04861Nebivololapproved, investigationalunknownsubstrateDetailsDB12500Fedratinibapproved, investigationalunknownsubstrateDetailsDB08502CapravirineinvestigationalunknownsubstrateDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB01039FenofibrateapprovedunknowninhibitorDetailsDB15444Elexacaftorapproved, investigationalnoinhibitorDetailsDB14975Voxelotorapproved, investigationalunknownsubstrateDetailsDB00741Hydrocortisoneapproved, vet_approvedunknowninducerDetailsDB06119Cenobamateapproved, investigationalunknownsubstrateinhibitorDetailsDB01222BudesonideapprovedunknowninducerDetailsDB00959Methylprednisoloneapproved, vet_approvedunknowninducerDetailsDB15328Ubrogepantapproved, investigationalunknowninhibitorDetailsDB00983Formoterolapproved, investigationalunknownsubstrateDetailsDB01006Letrozoleapproved, investigationalunknowninhibitorDetailsDB11837Osilodrostatapproved, investigationalunknowninhibitorDetailsDB00443Betamethasoneapproved, vet_approvedunknowninducerDetailsDB09241Methylene blueapproved, investigationalunknownsubstrateinhibitorDetailsDB11689Selumetinibapproved, investigationalnosubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninducerDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknowninducerDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB14881Oliceridineapproved, investigationalunknownsubstrateDetailsDB12499Clascoteroneapproved, investigationalnoinhibitorDetailsDB15093Somapacitanapproved, investigationalunknowninhibitorDetailsDB06448Lonafarnibapproved, investigationalnosubstrateinhibitorDetailsDB04951Pirfenidoneapproved, investigationalunknownsubstrateinhibitorDetailsDB06137Tirbanibulinapproved, investigationalnoinhibitorDetailsDB00935Oxymetazolineapproved, investigationalnosubstrateDetailsDB08912Dabrafenibapproved, investigationalnosubstrateinhibitorinducerDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB00476DuloxetineapprovedunknowninhibitorDetailsDB00052Somatotropinapproved, investigationalunknowninhibitorDetailsDB00330EthambutolapprovedunknowninhibitorDetailsDB14984Casimersenapproved, investigationalnoinhibitorDetailsDB01086Benzocaineapproved, investigationalunknownsubstrateDetailsDB08896RegorafenibapprovedunknowninhibitorDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownsubstrateDetailsDB05271RotigotineapprovednoinhibitorDetailsDB01183Naloxoneapproved, vet_approvedunknownsubstrateDetailsDB12543Samidorphanapproved, investigationalnosubstrateDetailsDB12151Brincidofovirapproved, investigationalnoinhibitorDetailsDB16703Belumosudilapproved, investigationalnoinhibitorDetailsDB15463Belzutifanapproved, investigationalnosubstrateDetailsDB12265Fexinidazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB16220Lonapegsomatropinapproved, investigationalunknowninhibitorDetailsDB16349VicagrelinvestigationalunknownsubstrateDetailsDB12597Asciminibapproved, investigationalnoinhibitorDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB14973Abrocitinibapproved, investigationalnosubstrateDetailsDB05467Palovaroteneapproved, investigationalnosubstrateDetailsDB16236Mitapivatapproved, investigationalnoinducerDetailsDB12834SecnidazoleapprovedunknowninhibitorDetailsDB00470Dronabinolapproved, illicitnosubstrateinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknownsubstrateDetailsDB11697Pacritinibapproved, investigationalnoinhibitorDetailsDB05087Ganaxoloneapproved, investigationalnosubstrateDetailsDB06016Cariprazineapproved, investigationalnoinhibitorDetailsDB14921Mavacamtenapproved, investigationalnosubstrateinducerDetailsDB12020Tecovirimatapproved, investigationalnoinhibitorDetailsDB06083Tapinarofapproved, investigationalnosubstrateDetailsDB00285VenlafaxineapprovednosubstrateDetailsDB12095Telotristat ethylapproved, investigationalnoinhibitorDetailsDB11739Vonoprazanapproved, investigationalunknownsubstrateinhibitorDetailsDB16267Olutasidenibapproved, investigationalnosubstrateDetailsDB02709ResveratrolinvestigationalnoinhibitorDetailsDB17472Pirtobrutinibapproved, investigationalunknowninhibitorinducerDetailsDB12548Sparsentanapproved, investigationalunknowninducerDetailsDB00381AmlodipineapprovednoinhibitorDetailsDB00862VardenafilapprovedunknowninhibitorDetailsDB11712Tezacaftorapproved, investigationalnoinhibitorDetailsDB15669Fezolinetantapproved, investigationalnosubstrateDetailsDB06700Desvenlafaxineapproved, investigationalnosubstrateDetailsDB11763Momelotinibapproved, investigationalunknownsubstrateDetailsDB14766EtrasimodapprovednosubstrateDetailsDB16826RepotrectinibinvestigationalnoinducerDetailsDB11679FruquintinibinvestigationalnosubstrateDetails"
                    }
                }
            ],
            "carriers": [
                {
                    "Label": "Serum albumin",
                    "Detailed Info": {
                        "Name": "Serum albumin",
                        "Synonyms": "Serum albumin precursor",
                        "Gene Name": "ALB",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0001058|Serum albumin\nMKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPF\nEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEP\nERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLF\nFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAV\nARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLK\nECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYAR\nRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFE\nQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVV\nLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTL\nSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLV\nAASQAALGL",
                        "Number of residues": "609",
                        "Molecular Weight": "69365.94",
                        "Theoretical pI": "6.21",
                        "GO Classification": "Functionsantioxidant activity / chaperone binding / copper ion binding / DNA binding / drug binding / fatty acid binding / pyridoxal phosphate binding / toxic substance bindingProcessesbile acid and bile salt transport / bile acid metabolic process / blood coagulation / cellular response to starvation / hemolysis by symbiont of host erythrocytes / lipoprotein metabolic process / maintenance of mitochondrion location / negative regulation of apoptotic process / negative regulation of programmed cell death / platelet activation / platelet degranulation / receptor-mediated endocytosis / retina homeostasis / small molecule metabolic process / sodium-independent organic anion transport / transmembrane transport / transportComponentsblood microparticle / endoplasmic reticulum / extracellular exosome / extracellular region / extracellular space / Golgi apparatus / myelin sheath / nucleus / platelet alpha granule lumen / protein complex",
                        "General Function": "Toxic substance binding",
                        "Specific Function": "Serum albumin, the main protein of plasma, has a good binding capacity for water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin and drugs. Its main function is the regulation of the colloidal osmotic pressure of blood. Major zinc transporter in plasma, typically binds about 80% of all plasma zinc.",
                        "Pfam Domain Function": "Serum_albumin (PF00273)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Secreted",
                        "Gene sequence": ">lcl|BSEQ0010372|Serum albumin (ALB)\nATGAAGTGGGTAACCTTTATTTCCCTTCTTTTTCTCTTTAGCTCGGCTTATTCCAGGGGT\nGTGTTTCGTCGAGATGCACACAAGAGTGAGGTTGCTCATCGGTTTAAAGATTTGGGAGAA\nGAAAATTTCAAAGCCTTGGTGTTGATTGCCTTTGCTCAGTATCTTCAGCAGTGTCCATTT\nGAAGATCATGTAAAATTAGTGAATGAAGTAACTGAATTTGCAAAAACATGTGTTGCTGAT\nGAGTCAGCTGAAAATTGTGACAAATCACTTCATACCCTTTTTGGAGACAAATTATGCACA\nGTTGCAACTCTTCGTGAAACCTATGGTGAAATGGCTGACTGCTGTGCAAAACAAGAACCT\nGAGAGAAATGAATGCTTCTTGCAACACAAAGATGACAACCCAAACCTCCCCCGATTGGTG\nAGACCAGAGGTTGATGTGATGTGCACTGCTTTTCATGACAATGAAGAGACATTTTTGAAA\nAAATACTTATATGAAATTGCCAGAAGACATCCTTACTTTTATGCCCCGGAACTCCTTTTC\nTTTGCTAAAAGGTATAAAGCTGCTTTTACAGAATGTTGCCAAGCTGCTGATAAAGCTGCC\nTGCCTGTTGCCAAAGCTCGATGAACTTCGGGATGAAGGGAAGGCTTCGTCTGCCAAACAG\nAGACTCAAGTGTGCCAGTCTCCAAAAATTTGGAGAAAGAGCTTTCAAAGCATGGGCAGTA\nGCTCGCCTGAGCCAGAGATTTCCCAAAGCTGAGTTTGCAGAAGTTTCCAAGTTAGTGACA\nGATCTTACCAAAGTCCACACGGAATGCTGCCATGGAGATCTGCTTGAATGTGCTGATGAC\nAGGGCGGACCTTGCCAAGTATATCTGTGAAAATCAAGATTCGATCTCCAGTAAACTGAAG\nGAATGCTGTGAAAAACCTCTGTTGGAAAAATCCCACTGCATTGCCGAAGTGGAAAATGAT\nGAGATGCCTGCTGACTTGCCTTCATTAGCTGCTGATTTTGTTGAAAGTAAGGATGTTTGC\nAAAAACTATGCTGAGGCAAAGGATGTCTTCCTGGGCATGTTTTTGTATGAATATGCAAGA\nAGGCATCCTGATTACTCTGTCGTGCTGCTGCTGAGACTTGCCAAGACATATGAAACCACT\nCTAGAGAAGTGCTGTGCCGCTGCAGATCCTCATGAATGCTATGCCAAAGTGTTCGATGAA\nTTTAAACCTCTTGTGGAAGAGCCTCAGAATTTAATCAAACAAAATTGTGAGCTTTTTGAG\nCAGCTTGGAGAGTACAAATTCCAGAATGCGCTATTAGTTCGTTACACCAAGAAAGTACCC\nCAAGTGTCAACTCCAACTCTTGTAGAGGTCTCAAGAAACCTAGGAAAAGTGGGCAGCAAA\nTGTTGTAAACATCCTGAAGCAAAAAGAATGCCCTGTGCAGAAGACTATCTATCCGTGGTC\nCTGAACCAGTTATGTGTGTTGCATGAGAAAACGCCAGTAAGTGACAGAGTCACCAAATGC\nTGCACAGAATCCTTGGTGAACAGGCGACCATGCTTTTCAGCTCTGGAAGTCGATGAAACA\nTACGTTCCCAAAGAGTTTAATGCTGAAACATTCACCTTCCATGCAGATATATGCACACTT\nTCTGAGAAGGAGAGACAAATCAAGAAACAAACTGCACTTGTTGAGCTCGTGAAACACAAG\nCCCAAGGCAACAAAAGAGCAACTGAAAGCTGTTATGGATGATTTCGCAGCTTTTGTAGAG\nAAGTGCTGCAAGGCTGACGATAAGGAGACCTGCTTTGCCGAGGAGGGTAAAAAACTTGTT\nGCTGCAAGTCAAGCTGCCTTAGGCTTATAA",
                        "Chromosome Location": "4",
                        "Locus": "4q11-q13",
                        "External Identifiers": "ResourceLinkUniProtKB IDP02768UniProtKB Entry NameALBU_HUMANGenBank Protein ID28590GenBank Gene IDV00494GenAtlas IDALBHGNC IDHGNC:399",
                        "General References": "Lawn RM, Adelman J, Bock SC, Franke AE, Houck CM, Najarian RC, Seeburg PH, Wion KL: The sequence of human serum albumin cDNA and its expression in E. coli. Nucleic Acids Res. 1981 Nov 25;9(22):6103-114. [Article] Dugaiczyk A, Law SW, Dennison OE: Nucleotide sequence and the encoded amino acids of human serum albumin mRNA. Proc Natl Acad Sci U S A. 1982 Jan;79(1):71-5. [Article] Minghetti PP, Ruffner DE, Kuang WJ, Dennison OE, Hawkins JW, Beattie WG, Dugaiczyk A: Molecular structure of the human albumin gene is revealed by nucleotide sequence within q11-22 of chromosome 4. J Biol Chem. 1986 May 25;261(15):6747-57. [Article] Yu Y, Zhang C, Zhou G, Wu S, Qu X, Wei H, Xing G, Dong C, Zhai Y, Wan J, Ouyang S, Li L, Zhang S, Zhou K, Zhang Y, Wu C, He F: Gene expression profiling in human fetal liver and identification of tissue- and developmental-stage-specific genes through compiled expression profiles and efficient cloning of full-length cDNAs. Genome Res. 2001 Aug;11(8):1392-403. [Article] Bechtel S, Rosenfelder H, Duda A, Schmidt CP, Ernst U, Wellenreuther R, Mehrle A, Schuster C, Bahr A, Blocker H, Heubner D, Hoerlein A, Michel G, Wedler H, Kohrer K, Ottenwalder B, Poustka A, Wiemann S, Schupp I: The full-ORF clone resource of the German cDNA Consortium. BMC Genomics. 2007 Oct 31;8:399. [Article] Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Clark HF, Gurney AL, Abaya E, Baker K, Baldwin D, Brush J, Chen J, Chow B, Chui C, Crowley C, Currell B, Deuel B, Dowd P, Eaton D, Foster J, Grimaldi C, Gu Q, Hass PE, Heldens S, Huang A, Kim HS, Klimowski L, Jin Y, Johnson S, Lee J, Lewis L, Liao D, Mark M, Robbie E, Sanchez C, Schoenfeld J, Seshagiri S, Simmons L, Singh J, Smith V, Stinson J, Vagts A, Vandlen R, Watanabe C, Wieand D, Woods K, Xie MH, Yansura D, Yi S, Yu G, Yuan J, Zhang M, Zhang Z, Goddard A, Wood WI, Godowski P, Gray A: The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res. 2003 Oct;13(10):2265-70. Epub 2003 Sep 15. [Article] Urano Y, Watanabe K, Sakai M, Tamaoki T: The human albumin gene. Characterization of the 5' and 3' flanking regions and the polymorphic gene transcripts. J Biol Chem. 1986 Mar 5;261(7):3244-51. [Article] Meloun B, Moravek L, Kostka V: Complete amino acid sequence of human serum albumin. FEBS Lett. 1975 Oct 15;58(1):134-7. [Article] Corbett JM, Wheeler CH, Baker CS, Yacoub MH, Dunn MJ: The human myocardial two-dimensional gel protein database: update 1994. Electrophoresis. 1994 Nov;15(11):1459-65. [Article] Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, Thomas GR, Vandekerckhove J: Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol. 2003 May;21(5):566-9. Epub 2003 Mar 31. [Article] Mogard MH, Kobayashi R, Chen CF, Lee TD, Reeve JR Jr, Shively JE, Walsh JH: The amino acid sequence of kinetensin, a novel peptide isolated from pepsin-treated human plasma: homology with human serum albumin, neurotensin and angiotensin. Biochem Biophys Res Commun. 1986 May 14;136(3):983-8. [Article] Carraway RE, Mitra SP, Cochrane DE: Structure of a biologically active neurotensin-related peptide obtained from pepsin-treated albumin(s). J Biol Chem. 1987 May 5;262(13):5968-73. [Article] Walker JE: Lysine residue 199 of human serum albumin is modified by acetylsalicyclic acid. FEBS Lett. 1976 Jul 15;66(2):173-5. [Article] Lapolla A, Fedele D, Reitano R, Arico NC, Seraglia R, Traldi P, Marotta E, Tonani R: Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides. J Am Soc Mass Spectrom. 2004 Apr;15(4):496-509. [Article] Jacobsen C: Lysine residue 240 of human serum albumin is involved in high-affinity binding of bilirubin. Biochem J. 1978 May 1;171(2):453-9. [Article] Garlick RL, Mazer JS: The principal site of nonenzymatic glycosylation of human serum albumin in vivo. J Biol Chem. 1983 May 25;258(10):6142-6. [Article] Shaklai N, Garlick RL, Bunn HF: Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J Biol Chem. 1984 Mar 25;259(6):3812-7. [Article] Iberg N, Fluckiger R: Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites. J Biol Chem. 1986 Oct 15;261(29):13542-5. [Article] Watkins S, Madison J, Galliano M, Minchiotti L, Putnam FW: A nucleotide insertion and frameshift cause analbuminemia in an Italian family. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2275-9. [Article] Lu J, Stewart AJ, Sadler PJ, Pinheiro TJ, Blindauer CA: Albumin as a zinc carrier: properties of its high-affinity zinc-binding site. Biochem Soc Trans. 2008 Dec;36(Pt 6):1317-21. doi: 10.1042/BST0361317. [Article] Han G, Ye M, Zhou H, Jiang X, Feng S, Jiang X, Tian R, Wan D, Zou H, Gu J: Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography. Proteomics. 2008 Apr;8(7):1346-61. doi: 10.1002/pmic.200700884. [Article] Mayya V, Lundgren DH, Hwang SI, Rezaul K, Wu L, Eng JK, Rodionov V, Han DK: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal. 2009 Aug 18;2(84):ra46. doi: 10.1126/scisignal.2000007. [Article] Burkard TR, Planyavsky M, Kaupe I, Breitwieser FP, Burckstummer T, Bennett KL, Superti-Furga G, Colinge J: Initial characterization of the human central proteome. BMC Syst Biol. 2011 Jan 26;5:17. doi: 10.1186/1752-0509-5-17. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Tagliabracci VS, Wiley SE, Guo X, Kinch LN, Durrant E, Wen J, Xiao J, Cui J, Nguyen KB, Engel JL, Coon JJ, Grishin N, Pinna LA, Pagliarini DJ, Dixon JE: A Single Kinase Generates the Majority of the Secreted Phosphoproteome. Cell. 2015 Jun 18;161(7):1619-32. doi: 10.1016/j.cell.2015.05.028. [Article] Vaca Jacome AS, Rabilloud T, Schaeffer-Reiss C, Rompais M, Ayoub D, Lane L, Bairoch A, Van Dorsselaer A, Carapito C: N-terminome analysis of the human mitochondrial proteome. Proteomics. 2015 Jul;15(14):2519-24. doi: 10.1002/pmic.201400617. Epub 2015 Jun 8. [Article] Carter DC, He XM, Munson SH, Twigg PD, Gernert KM, Broom MB, Miller TY: Three-dimensional structure of human serum albumin. Science. 1989 Jun 9;244(4909):1195-8. [Article] Carter DC, He XM: Structure of human serum albumin. Science. 1990 Jul 20;249(4966):302-3. [Article] He XM, Carter DC: Atomic structure and chemistry of human serum albumin. Nature. 1992 Jul 16;358(6383):209-15. [Article] Curry S, Mandelkow H, Brick P, Franks N: Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Biol. 1998 Sep;5(9):827-35. [Article] Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K: Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng. 1999 Jun;12(6):439-46. [Article] Bhattacharya AA, Curry S, Franks NP: Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures. J Biol Chem. 2000 Dec 8;275(49):38731-8. [Article] Petitpas I, Grune T, Bhattacharya AA, Curry S: Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. J Mol Biol. 2001 Dec 14;314(5):955-60. [Article] Brennan SO, Herbert P: Albumin Canterbury (313 Lys----Asn). A point mutation in the second domain of serum albumin. Biochim Biophys Acta. 1987 Apr 8;912(2):191-7. [Article] Takahashi N, Takahashi Y, Blumberg BS, Putnam FW: Amino acid substitutions in genetic variants of human serum albumin and in sequences inferred from molecular cloning. Proc Natl Acad Sci U S A. 1987 Jul;84(13):4413-7. [Article] Takahashi N, Takahashi Y, Isobe T, Putnam FW, Fujita M, Satoh C, Neel JV: Amino acid substitutions in inherited albumin variants from Amerindian and Japanese populations. Proc Natl Acad Sci U S A. 1987 Nov;84(22):8001-5. [Article] Arai K, Ishioka N, Huss K, Madison J, Putnam FW: Identical structural changes in inherited albumin variants from different populations. Proc Natl Acad Sci U S A. 1989 Jan;86(2):434-8. [Article] Arai K, Madison J, Huss K, Ishioka N, Satoh C, Fujita M, Neel JV, Sakurabayashi I, Putnam FW: Point substitutions in Japanese alloalbumins. Proc Natl Acad Sci U S A. 1989 Aug;86(16):6092-6. [Article] Arai K, Madison J, Shimizu A, Putnam FW: Point substitutions in albumin genetic variants from Asia. Proc Natl Acad Sci U S A. 1990 Jan;87(1):497-501. [Article] Brennan SO, Myles T, Peach RJ, Donaldson D, George PM: Albumin Redhill (-1 Arg, 320 Ala----Thr): a glycoprotein variant of human serum albumin whose precursor has an aberrant signal peptidase cleavage site. Proc Natl Acad Sci U S A. 1990 Jan;87(1):26-30. [Article] Galliano M, Minchiotti L, Porta F, Rossi A, Ferri G, Madison J, Watkins S, Putnam FW: Mutations in genetic variants of human serum albumin found in Italy. Proc Natl Acad Sci U S A. 1990 Nov;87(22):8721-5. [Article] Watkins S, Madison J, Davis E, Sakamoto Y, Galliano M, Minchiotti L, Putnam FW: A donor splice mutation and a single-base deletion produce two carboxyl-terminal variants of human serum albumin. Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):5959-63. [Article] Madison J, Arai K, Sakamoto Y, Feld RD, Kyle RA, Watkins S, Davis E, Matsuda Y, Amaki I, Putnam FW: Genetic variants of serum albumin in Americans and Japanese. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9853-7. [Article] Peach RJ, Brennan SO: Structural characterization of a glycoprotein variant of human serum albumin: albumin Casebrook (494 Asp----Asn). Biochim Biophys Acta. 1991 Jul 26;1097(1):49-54. [Article] Minchiotti L, Galliano M, Stoppini M, Ferri G, Crespeau H, Rochu D, Porta F: Two alloalbumins with identical electrophoretic mobility are produced by differently charged amino acid substitutions. Biochim Biophys Acta. 1992 Mar 12;1119(3):232-8. [Article] Carlson J, Sakamoto Y, Laurell CB, Madison J, Watkins S, Putnam FW: Alloalbuminemia in Sweden: structural study and phenotypic distribution of nine albumin variants. Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8225-9. [Article] Minchiotti L, Galliano M, Zapponi MC, Tenni R: The structural characterization and bilirubin-binding properties of albumin Herborn, a [Lys240-->Glu] albumin mutant. Eur J Biochem. 1993 Jun 1;214(2):437-44. [Article] Brennan SO, Fellowes AP: Albumin Hawkes Bay; a low level variant caused by loss of a sulphydryl group at position 177. Biochim Biophys Acta. 1993 Aug 4;1182(1):46-50. [Article] Galliano M, Minchiotti L, Iadarola P, Stoppini M, Giagnoni P, Watkins S, Madison J, Putnam FW: Protein and DNA sequence analysis of a 'private' genetic variant: albumin Ortonovo (Glu-505-->Lys). Biochim Biophys Acta. 1993 Nov 25;1225(1):27-32. [Article] Madison J, Galliano M, Watkins S, Minchiotti L, Porta F, Rossi A, Putnam FW: Genetic variants of human serum albumin in Italy: point mutants and a carboxyl-terminal variant. Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6476-80. [Article] Sunthornthepvarakul T, Angkeow P, Weiss RE, Hayashi Y, Refetoff S: An identical missense mutation in the albumin gene results in familial dysalbuminemic hyperthyroxinemia in 8 unrelated families. Biochem Biophys Res Commun. 1994 Jul 29;202(2):781-7. [Article] Rushbrook JI, Becker E, Schussler GC, Divino CM: Identification of a human serum albumin species associated with familial dysalbuminemic hyperthyroxinemia. J Clin Endocrinol Metab. 1995 Feb;80(2):461-7. [Article] Wada N, Chiba H, Shimizu C, Kijima H, Kubo M, Koike T: A novel missense mutation in codon 218 of the albumin gene in a distinct phenotype of familial dysalbuminemic hyperthyroxinemia in a Japanese kindred. J Clin Endocrinol Metab. 1997 Oct;82(10):3246-50. [Article] Sunthornthepvarakul T, Likitmaskul S, Ngowngarmratana S, Angsusingha K, Kitvitayasak S, Scherberg NH, Refetoff S: Familial dysalbuminemic hypertriiodothyroninemia: a new, dominantly inherited albumin defect. J Clin Endocrinol Metab. 1998 May;83(5):1448-54. [Article] Spahr CS, Davis MT, McGinley MD, Robinson JH, Bures EJ, Beierle J, Mort J, Courchesne PL, Chen K, Wahl RC, Yu W, Luethy R, Patterson SD: Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry. I. Profiling an unfractionated tryptic digest. Proteomics. 2001 Jan;1(1):93-107. [Article] Minchiotti L, Campagnoli M, Rossi A, Cosulich ME, Monti M, Pucci P, Kragh-Hansen U, Granel B, Disdier P, Weiller PJ, Galliano M: A nucleotide insertion and frameshift cause albumin Kenitra, an extended and O-glycosylated mutant of human serum albumin with two additional disulfide bridges. Eur J Biochem. 2001 Jan;268(2):344-52. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00070Hyaluronidase (ovine)approved, investigationalunknowninhibitorDetailsDB00137Luteinapproved, investigational, nutraceuticalunknownDetailsDB00459AcitretinapprovedunknownDetailsDB00576Sulfamethizoleapproved, investigational, vet_approvedunknownDetailsDB00743Gadobenic acidapproved, investigationalunknownbinderDetailsDB00815Sodium lauryl sulfateexperimentalunknownbinderDetailsDB00936Salicylic acidapproved, investigational, vet_approvednoother/unknownDetailsDB00946Phenprocoumonapproved, investigationalnobinderregulatorDetailsDB00995Auranofinapproved, investigationalunknownDetailsDB01120GliclazideapprovedunknownDetailsDB01328Cefonicidapproved, investigationalnoother/unknownDetailsDB01329Cefoperazoneapproved, investigationalnoother/unknownDetailsDB01396Digitoxinapproved, investigationalnoDetailsDB03017Lauric acidapproved, experimentalunknownDetailsDB03193Stearic acidapproved, experimentalunknownDetailsDB03600Capric acidexperimentalnoDetailsDB03796Palmitic AcidapprovedunknownDetailsDB04224Oleic Acidapproved, investigational, vet_approvedunknownDetailsDB04557Arachidonic AcidexperimentalnoDetailsDB04711IodipamideapprovedunknownbinderDetailsDB06412Oxymetholoneapproved, illicitunknownDetailsDB01197Captoprilapprovednoother/unknownDetailsDB01050IbuprofenapprovednobinderDetailsDB00563MethotrexateapprovednobinderDetailsDB00451LevothyroxineapprovednoDetailsDB00279Liothyronineapproved, vet_approvedunknownDetailsDB00605Sulindacapproved, investigationalunknownDetailsDB00749Etodolacapproved, investigational, vet_approvedunknownDetailsDB00861Diflunisalapproved, investigationalunknownDetailsDB01009Ketoprofenapproved, vet_approvedunknownDetailsDB00586Diclofenacapproved, vet_approvedunknownDetailsDB00783Estradiolapproved, investigational, vet_approvednoDetailsDB00655EstroneapprovednoDetailsDB00624Testosteroneapproved, investigationalnobinderDetailsDB01307Insulin detemirapprovednobinderDetailsDB01418Acenocoumarolapproved, investigationalnoDetailsDB00802Alfentanilapproved, illicitunknownDetailsDB00818Propofolapproved, investigational, vet_approvednoDetailsDB00228Enfluraneapproved, investigational, vet_approvedunknownbinderDetailsDB00753Isofluraneapproved, vet_approvedunknownDetailsDB01189DesfluraneapprovedunknownbinderDetailsDB01159Halothaneapproved, vet_approvedunknownDetailsDB01236Sevofluraneapproved, vet_approvedunknownbinderDetailsDB00252Phenytoinapproved, vet_approvedunknownDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknownDetailsDB00540NortriptylineapprovednobinderDetailsDB00321AmitriptylineapprovednobinderDetailsDB00903Etacrynic acidapproved, investigationalunknownDetailsDB00695Furosemideapproved, vet_approvednobinderDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvednoDetailsDB00682WarfarinapprovednobinderregulatorDetailsDB00554Piroxicamapproved, investigationalunknownDetailsDB00573FenoprofenapprovedunknownDetailsDB00328Indomethacinapproved, investigationalunknownDetailsDB03585Oxyphenbutazoneapproved, withdrawnunknownDetailsDB00544FluorouracilapprovednoDetailsDB01232Saquinavirapproved, investigationalunknownDetailsDB01032Probenecidapproved, investigationalnoDetailsDB01044Gatifloxacinapproved, investigational, withdrawnunknownother/unknownDetailsDB01068Clonazepamapproved, illicitnoDetailsDB01147Cloxacillinapproved, investigational, vet_approvednobinderDetailsDB01327Cefazolinapprovedunknownother/unknownDetailsDB00931Metacyclineapproved, investigationalnoDetailsDB01015SulfamethoxazoleapprovednosubstrateDetailsDB00415Ampicillinapproved, vet_approvednoother/unknownDetailsDB00567Cephalexinapproved, investigational, vet_approvednobinderDetailsDB00759Tetracyclineapproved, vet_approved, withdrawnnoDetailsDB01212Ceftriaxoneapprovednoother/unknownDetailsDB01330CefotetanapprovednoDetailsDB00274Cefmetazoleapproved, investigationalnoDetailsDB00495ZidovudineapprovednoDetailsDB01397Magnesium salicylateexperimentalnoDetailsDB00788Naproxenapproved, vet_approvednoDetailsDB00334Olanzapineapproved, investigationalnobinderDetailsDB01056Tocainideapprovednoother/unknownDetailsDB01320Fosphenytoinapproved, investigationalnoother/unknownDetailsDB00712Flurbiprofenapproved, investigationalnoother/unknownDetailsDB07402AzapropazonewithdrawnunknownDetailsDB075173-CARBOXY-4-METHYL-5-PROPYL-2-FURANPROPIONICexperimentalunknownDetailsDB07992Indoxyl sulfateexperimentalunknownDetailsDB08231Myristic acidexperimentalunknownDetailsDB08496(R)-warfarinexperimentalunknownDetailsDB08735R,S-Warfarin alcoholexperimentalunknownDetailsDB08736S,R-Warfarin alcoholexperimentalunknownDetailsDB00430CefpiramideapprovedunknownDetailsDB01583LiotrixapprovedunknownDetailsDB01294Bismuth subsalicylateapproved, vet_approvednobinderDetailsDB00456Cefalotinapproved, investigational, vet_approvedunknownbinderDetailsDB01581Sulfamerazineapproved, vet_approvedunknownDetailsDB01582Sulfamethazineapproved, investigational, vet_approvedunknownDetailsDB01587KetazolamapprovedunknownDetailsDB01614Acepromazineexperimental, vet_approvedunknownDetailsDB01621Pipotiazineapproved, investigationalunknownDetailsDB04574Estrone sulfateapprovedunknownDetailsDB06710MethyltestosteroneapprovedunknownDetailsDB01622ThioproperazineexperimentalunknownDetailsDB01623ThiothixeneapprovedunknownDetailsDB06705Gadofosveset trisodiumapprovedunknownsubstrateDetailsDB00454MeperidineapprovedunknownbinderDetailsDB01016GlyburideapprovedunknownbinderDetailsDB00912Repaglinideapproved, investigationalunknownDetailsDB00731Nateglinideapproved, investigationalunknownDetailsDB08867UlipristalapprovednosubstrateDetailsDB05294VandetanibapprovedunknownbinderDetailsDB05521Telaprevirapproved, withdrawnnosubstrateDetailsDB05812AbirateroneapprovedunknownbinderDetailsDB08881VemurafenibapprovedunknownsubstrateDetailsDB08828Vismodegibapproved, investigationalunknownbinderDetailsDB08893MirabegronapprovednobinderDetailsDB00635Prednisoneapproved, vet_approvedunknownsubstrateDetailsDB08899EnzalutamideapprovednobinderDetailsDB08820IvacaftorapprovednocarrierDetailsDB00776OxcarbazepineapprovedunknownsubstrateDetailsDB06201RufinamideapprovedunknownsubstrateDetailsDB06716Fospropofolapproved, illicit, investigationalunknownsubstrateDetailsDB04855DronedaroneapprovednobinderDetailsDB06209PrasugrelapprovedunknownsubstrateDetailsDB08860PitavastatinapprovedunknownsubstrateDetailsDB01183Naloxoneapproved, vet_approvedunknownbinderDetailsDB01242Clomipramineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateDetailsDB00472Fluoxetineapproved, vet_approvedunknownsubstrateDetailsDB00317Gefitinibapproved, investigationalunknownsubstrateDetailsDB00619ImatinibapprovednobinderDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateDetailsDB00678LosartanapprovedunknownsubstrateDetailsDB00412Rosiglitazoneapproved, investigationalunknownsubstrateDetailsDB01098RosuvastatinapprovedunknownsubstrateDetailsDB00864Tacrolimusapproved, investigationalunknownsubstrateDetailsDB00717NorethisteroneapprovedunknownsubstrateDetailsDB08931RiociguatapprovedunknownsubstrateDetailsDB08895Tofacitinibapproved, investigationalunknownDetailsDB08932MacitentanapprovednobinderDetailsDB06290SimeprevirapprovednobinderDetailsDB00493CefotaximeapprovedunknownDetailsDB09280LumacaftorapprovednocarrierDetailsDB09130Copperapproved, investigationalnobinderDetailsDB11093Calcium citrateapproved, investigationalnosubstrateDetailsDB11348Calcium PhosphateapprovednosubstrateDetailsDB11575GrazoprevirapprovednosubstrateDetailsDB11943Delafloxacinapproved, investigationalnosubstrateDetailsDB01685TopiroxostatexperimentalunknownbinderDetailsDB09093Chlortetracyclineapproved, investigational, vet_approvednoDetailsDB06796Mangafodipirapproved, investigational, withdrawnunknownbinderDetailsDB09262ImidafenacininvestigationalnosubstrateDetailsDB00276Amsacrineapproved, investigationalunknownDetailsDB11359GuaiacolapprovedunknownDetailsDB03255Phenolapproved, experimentalunknownDetailsDB06728AnilineexperimentalunknownDetailsDB06713Norelgestrominapproved, investigationalunknownDetailsDB01370Aluminiumapproved, investigationalunknownDetailsDB13014HypericininvestigationalunknownDetailsDB01057EchothiophateapprovedunknownDetailsDB11397Dichlorvosvet_approvedunknownDetailsDB00677Isoflurophateapproved, investigational, withdrawnunknownDetailsDB00943Zalcitabineapproved, investigationalunknownDetailsDB01072Atazanavirapproved, investigationalnobinderDetailsDB00649Stavudineapproved, investigationalunknownDetailsDB00900DidanosineapprovedunknownDetailsDB00625Efavirenzapproved, investigationalunknownDetailsDB00879Emtricitabineapproved, investigationalunknownbinderDetailsDB00220NelfinavirapprovednobinderDetailsDB00238NevirapineapprovedunknownDetailsDB00503Ritonavirapproved, investigationalunknownsubstrateDetailsDB00709Lamivudineapproved, investigationalunknownDetailsDB04216Quercetinexperimental, investigationalunknownDetailsDB00997Doxorubicinapproved, investigationalunknownDetailsDB04816Dantronapproved, investigational, withdrawnunknownDetailsDB00755Tretinoinapproved, investigational, nutraceuticalunknownbinderDetailsDB00515CisplatinapprovedunknownDetailsDB00162Vitamin Aapproved, nutraceutical, vet_approvedunknownbinderDetailsDB04690CamptothecinexperimentalunknownDetailsDB02709ResveratrolinvestigationalunknownDetailsDB00744Zileutonapproved, investigational, withdrawnunknownDetailsDB04539GlyphosateexperimentalunknownDetailsDB11590ThimerosalapprovedunknownDetailsDB05134TanespimycininvestigationalunknownDetailsDB01124Tolbutamideapproved, investigationalunknownDetailsDB01276Exenatideapproved, investigationalunknownDetailsDB00414Acetohexamideapproved, investigational, withdrawnunknownDetailsDB00458ImipramineapprovedunknownDetailsDB00159Icosapentapproved, nutraceuticalnobinderDetailsDB00951Isoniazidapproved, investigationalunknownDetailsDB01104SertralineapprovedunknownbinderDetailsDB09383Meprednisoneapproved, investigationalunknownDetailsDB00266DicoumarolapprovedunknownDetailsDB04828ZomepiracwithdrawnunknownDetailsDB00500TolmetinapprovedunknownDetailsDB11217ArbutinapprovedunknownDetailsDB09526Hydroquinoneapproved, investigationalunknownDetailsDB00784Mefenamic acidapprovedunknownDetailsDB00313Valproic acidapproved, investigationalunknownDetailsDB01169Arsenic trioxideapproved, investigationalnosubstrateDetailsDB11828Neratinibapproved, investigationalnosubstrateDetailsDB00607Nafcillinapproved, investigationalunknownDetailsDB12483Copanlisibapproved, investigationalunknownsubstrateDetailsDB00512VancomycinapprovednosubstrateDetailsDB12001Abemaciclibapproved, investigationalunknownbinderDetailsDB08864RilpivirineapprovednobinderDetailsDB13928Semaglutideapproved, investigationalnosubstrateDetailsDB09087Potassium alumapprovedunknownbinderDetailsDB09223BlonanserininvestigationalnosubstrateDetailsDB09236Lacidipineapproved, investigationalunknownbinderDetailsDB09124Medrogestoneapproved, withdrawnnobinderDetailsDB11827Ertugliflozinapproved, investigationalnobinderDetailsDB09139Technetium Tc-99m oxidronateapprovednobinderDetailsDB13943Testosterone cypionateapprovednoother/unknownDetailsDB13944Testosterone enanthateapprovednoother/unknownDetailsDB13946Testosterone undecanoateapproved, investigationalnobinderDetailsDB13952Estradiol acetateapproved, investigational, vet_approvednoDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvednoDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvednoDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvednoDetailsDB13956Estradiol valerateapproved, investigational, vet_approvednoDetailsDB11638Artenimolapproved, experimental, investigationalunknownligandDetailsDB01420Testosterone propionateapproved, investigational, vet_approved, withdrawnnosubstrateDetailsDB09195LorpiprazoleapprovednosubstrateDetailsDB09204ArotinololinvestigationalnosubstrateDetailsDB08814Triflusalapproved, investigationalnosubstrateDetailsDB09229AranidipineexperimentalnobinderDetailsDB09333Iopodic acidapproved, investigational, withdrawnnosubstrateDetailsDB09347Acetrizoic acidwithdrawnnobinderDetailsDB09348Propiolactoneapproved, withdrawnnobinderDetailsDB11130Opiumapproved, illicitnobinderDetailsDB06778Cupric sulfateapprovedunknownDetailsDB09053IbrutinibapprovednosubstrateDetailsDB11182Rose bengalapproved, investigationalunknownbinderDetailsDB13967Patent BlueapprovedyesbinderDetailsDB13909Bismuth subgallateapprovedunknowncarrierDetailsDB09418Potassium perchlorateapproved, investigationalunknownbinderDetailsDB11641Vinflunineapproved, investigationalnosubstrateDetailsDB13421Edoxudineapproved, investigational, withdrawnnobinderDetailsDB11134Cupric oxideapprovedunknownbinderDetailsDB11148Butambenapproved, withdrawnnosubstrateDetailsDB11637Delamanidapproved, investigationalunknownsubstrateDetailsDB13751Glycyrrhizic acidapproved, experimentalnobinderDetailsDB12965Silverapproved, investigationalunknownbinderDetailsDB14185Aripiprazole lauroxilapproved, investigationalunknownbinderDetailsDB14481Calcium phosphate dihydrateapprovednoDetailsDB14517Aluminium phosphateapproved, investigationalunknownDetailsDB14518Aluminum acetateapproved, investigationalunknownDetailsDB00432Trifluridineapproved, investigationalunknownbinderDetailsDB14582Patisiranapproved, investigationalunknownligandDetailsDB09213Dexibuprofenapproved, investigationalnoDetailsDB12455Omadacyclineapproved, investigationalunknownDetailsDB12836Grapiprantinvestigational, vet_approvednosubstrateDetailsDB11753Rifamycinapproved, investigationalnosubstrateDetailsDB11963Dacomitinibapproved, investigationalnobinderDetailsDB11855Revefenacinapproved, investigationalnobinderDetailsDB12141Gilteritinibapproved, investigationalnobinderDetailsDB06480PrucaloprideapprovedunknownbinderDetailsDB11978Glasdegibapproved, investigationalnobinderDetailsDB00214TorasemideapprovedunknownsubstrateDetailsDB00227Lovastatinapproved, investigationalnosubstrateDetailsDB09564Insulin degludecapprovednobinderDetailsDB00245BenzatropineapprovednobinderDetailsDB00264Metoprololapproved, investigationalnobinderDetailsDB00286Conjugated estrogensapprovednobinderDetailsDB00289AtomoxetineapprovednobinderDetailsDB00294Etonogestrelapproved, investigationalnobinderDetailsDB00295Morphineapproved, investigationalnobinderDetailsDB00310ChlorthalidoneapprovednoDetailsDB00304DesogestrelapprovednobinderDetailsDB00327Hydromorphoneapproved, illicitnobinderDetailsDB09073Palbociclibapproved, investigationalnobinderDetailsDB00332Ipratropiumapproved, experimentalnobinderDetailsDB01142Doxepinapproved, investigationalnobinderDetailsDB01076AtorvastatinapprovednobinderDetailsDB06655LiraglutideapprovedunknownbinderDetailsDB01235LevodopaapprovedunknownbinderDetailsDB01238Aripiprazoleapproved, investigationalunknownbinderDetailsDB00404Alprazolamapproved, illicit, investigationalunknownbinderDetailsDB00421SpironolactoneapprovedunknownbinderDetailsDB00335AtenololapprovednosubstrateDetailsDB01126Dutasterideapproved, investigationalnobinderDetailsDB09299Tenofovir alafenamideapprovednobinderDetailsDB00343Diltiazemapproved, investigationalnobinderDetailsDB14126Tenofovirexperimental, investigationalnobinderDetailsDB00476DuloxetineapprovedunknownligandDetailsDB00497Oxycodoneapproved, illicit, investigationalunknownbinderDetailsDB00481Raloxifeneapproved, investigationalnobinderDetailsDB00537Ciprofloxacinapproved, investigationalunknownbinderDetailsDB00461NabumetoneapprovedunknownDetailsDB00982IsotretinoinapprovedunknownbinderDetailsDB00584Enalaprilapproved, vet_approvednobinderDetailsDB01067Glipizideapproved, investigationalnobinderDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedunknownbinderDetailsDB00737MeclizineapprovednobinderDetailsDB00768OlopatadineapprovednobinderDetailsDB00571Propranololapproved, investigationalunknownDetailsDB00575ClonidineapprovedunknownbinderDetailsDB00787AcyclovirapprovedunknownbinderDetailsDB00490Buspironeapproved, investigationalunknownbinderDetailsDB01029Irbesartanapproved, investigationalunknownbinderDetailsDB06282LevocetirizineapprovedunknownbinderDetailsDB00598LabetalolapprovedunknownsubstrateDetailsDB01026Ketoconazoleapproved, investigationalunknownligandDetailsDB00675TamoxifenapprovedunknownsubstrateDetailsDB12978Pexidartinibapproved, investigationalunknownbinderDetailsDB01136Carvedilolapproved, investigationalunknownbinderDetailsDB04861Nebivololapproved, investigationalunknownbinderDetailsDB01611HydroxychloroquineapprovedunknownbinderDetailsDB01045RifampicinapprovedunknownligandDetailsDB01394ColchicineapprovedunknownbinderDetailsDB00333MethadoneapprovednoDetailsDB11757Istradefyllineapproved, investigationalunknownbinderDetailsDB00620Triamcinoloneapproved, vet_approvedunknownbinderDetailsDB00924CyclobenzaprineapprovedunknownsubstrateDetailsDB00881Quinaprilapproved, investigationalunknownbinderDetailsDB09079NintedanibapprovedunknownsubstrateDetailsDB00999Hydrochlorothiazideapproved, vet_approvedunknownbinderDetailsDB01241GemfibrozilapprovedunknownbinderDetailsDB01039FenofibrateapprovedunknownbinderDetailsDB01062Oxybutyninapproved, investigationalunknownbinderDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknownbinderDetailsDB01275HydralazineapprovedunknownbinderDetailsDB01195Flecainideapproved, withdrawnunknownbinderDetailsDB00687Fludrocortisoneapproved, investigationalunknownsubstrateDetailsDB00316AcetaminophenapprovedunknownbinderDetailsDB00278Argatrobanapproved, investigationalunknownbinderDetailsDB06216AsenapineapprovedunknownbinderDetailsDB15444Elexacaftorapproved, investigationalunknownsubstrateDetailsDB00860Prednisoloneapproved, vet_approvedunknownbinderDetailsDB15566Prednisolone acetateapproved, vet_approvedunknownbinderDetailsDB11703Acalabrutinibapproved, investigationalunknownbinderDetailsDB14513Magnesiumapproved, experimental, investigationalunknownDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknownbinderDetailsDB00661VerapamilapprovedunknownsubstrateDetailsDB00273TopiramateapprovedunknownbinderDetailsDB06119Cenobamateapproved, investigationalunknownbinderDetailsDB01222BudesonideapprovedunknownbinderDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknownbinderDetailsDB00950Fexofenadineapproved, investigationalunknownsubstrateDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownbinderDetailsDB09237Levamlodipineapproved, investigationalunknownbinderDetailsDB12941Darolutamideapproved, investigationalunknownbinderDetailsDB14879Cefiderocolapproved, investigationalnoligandDetailsDB00852PseudoephedrineapprovedunknownbinderDetailsDB00983Formoterolapproved, investigationalunknownsubstrateDetailsDB00993AzathioprineapprovedunknownbinderDetailsDB00557HydroxyzineapprovedunknownsubstrateregulatorDetailsDB01118Amiodaroneapproved, investigationalunknownbinderDetailsDB01069Promethazineapproved, investigationalunknownbinderDetailsDB01115NifedipineapprovedunknownbinderDetailsDB01132Pioglitazoneapproved, investigationalunknownsubstrateDetailsDB00814Meloxicamapproved, vet_approvedunknownDetailsDB00938SalmeterolapprovedunknownbinderDetailsDB00878Chlorhexidineapproved, vet_approved, withdrawnunknownsubstrateDetailsDB01006Letrozoleapproved, investigationalunknownbinderDetailsDB00246ZiprasidoneapprovedunknownDetailsDB01060Amoxicillinapproved, vet_approvedunknownbinderDetailsDB01137Levofloxacinapproved, investigationalunknownsubstrateDetailsDB09100Thyroid, porcineapprovedunknownbinderDetailsDB01013Clobetasol propionateapprovedunknownbinderDetailsDB00957Norgestimateapproved, investigationalunknownbinderDetailsDB00977EthinylestradiolapprovedunknownbinderDetailsDB00555Lamotrigineapproved, investigationalunknownsubstrateDetailsDB01264DarunavirapprovedunknownsubstrateDetailsDB00608Chloroquineapproved, investigational, vet_approvedunknownbinderDetailsDB12466Favipiravirapproved, investigationalunknowncarrierDetailsDB01601LopinavirapprovedunknownsubstrateDetailsDB14999Human interferon betaapproved, investigationalunknownbinderDetailsDB00126Ascorbic acidapproved, nutraceuticalunknownbinderDetailsDB00443Betamethasoneapproved, vet_approvedunknownDetailsDB05382Iodineapproved, investigationalunknownbinderDetailsDB11642Pitolisantapproved, investigationalnobinderDetailsDB00152Thiamineapproved, investigational, nutraceutical, vet_approvedunknownbinderDetailsDB00165Pyridoxineapproved, investigational, nutraceutical, vet_approvedunknownbinderDetailsDB00595Oxytetracyclineapproved, investigational, vet_approvedunknownbinderDetailsDB00870Suprofenapproved, withdrawnunknownbinderDetailsDB00774Hydroflumethiazideapproved, investigational, withdrawnunknownbinderDetailsDB09241Methylene blueapproved, investigationalunknownbinderDetailsDB15534Colchiceineapproved, experimentalunknownsubstrateDetailsDB01053Benzylpenicillinapproved, vet_approvedunknownbinderDetailsDB01324PolythiazideapprovedunknownbinderDetailsDB07565Chloramphenicol succinateapprovedunknownbinderDetailsDB01914D-glucoseapproved, investigational, vet_approvedunknownbinderDetailsDB14533Zinc chlorideapproved, investigationalunknownbinderDetailsDB11689Selumetinibapproved, investigationalunknowncarrierDetailsDB04911Oritavancinapproved, investigationalunknownbinderDetailsDB14548Zinc sulfate, unspecified formapproved, experimentalunknownbinderDetailsDB00734Risperidoneapproved, investigationalunknownbinderDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknownbinderDetailsDB01364EphedrineapprovedunknownbinderDetailsDB00237Butabarbitalapproved, illicitunknownbinderDetailsDB01133Tiludronic acidapproved, investigational, vet_approvedunknownbinderDetailsDB14840RipretinibapprovedunknownbinderDetailsDB00845Clofazimineapproved, investigationalunknownbinderDetailsDB00842OxazepamapprovedunknownbinderDetailsDB00714Apomorphineapproved, investigationalunknownbinderDetailsDB09274Artesunateapproved, investigationalunknownbinderDetailsDB15690Fluoroestradiol F-18approvedunknownbinderDetailsDB00808IndapamideapprovedunknownbinderDetailsDB08816TicagrelorapprovedunknownbinderDetailsDB14669Betamethasone phosphateapproved, vet_approvedunknownbinderDetailsDB12674Lurbinectedinapproved, investigationalunknownbinderDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknownbinderDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknownbinderDetailsDB00104Octreotideapproved, investigationalunknownbinderDetailsDB11677Triheptanoinapproved, investigationalunknownbinderDetailsDB12404Remimazolamapproved, investigationalunknownbinderDetailsDB11796Fostemsavirapproved, investigationalunknowncarrierDetailsDB15305Risdiplamapproved, investigationalunknownbinderDetailsDB11820Nifurtimoxapproved, investigationalunknownbinderDetailsDB00847Cysteamineapproved, investigationalunknownbinderDetailsDB15093Somapacitanapproved, investigationalunknownbinderDetailsDB00908Quinidineapproved, investigationalunknownbinderDetailsDB15935Lumasiranapproved, investigationalnobinderDetailsDB04951Pirfenidoneapproved, investigationalunknownbinderDetailsDB11853Relugolixapproved, investigationalunknownbinderDetailsDB01380Cortisone acetateapproved, investigationalunknownbinderDetailsDB15248Bulevirtideapproved, investigationalunknownbinderDetailsDB00501Cimetidineapproved, investigationalunknownsubstrateDetailsDB15456Vericiguatapproved, investigationalunknownbinderDetailsDB11751Cabotegravirapproved, investigationalunknownbinderDetailsDB15133Tepotinibapproved, investigationalunknownbinderDetailsDB06151Acetylcysteineapproved, investigationalunknownbinderDetailsDB00346Alfuzosinapproved, investigationalunknownbinderDetailsDB00376TrihexyphenidylapprovedunknownbinderDetailsDB00391Sulpirideapproved, investigationalnobinderDetailsDB01083Orlistatapproved, investigationalunknownbinderDetailsDB08877RuxolitinibapprovedunknownbinderDetailsDB00640Adenosineapproved, investigationalunknownbinderDetailsDB00853Temozolomideapproved, investigationalnobinderDetailsDB06237AvanafilapprovedunknownbinderDetailsDB04854FebuxostatapprovedunknownbinderDetailsDB01086Benzocaineapproved, investigationalunknownbinderDetailsDB11800Tivozanibapproved, investigationalunknownbinderDetailsDB00080Daptomycinapproved, investigationalnobinderDetailsDB00434CyproheptadineapprovedunknownbinderDetailsDB00083Botulinum toxin type Aapproved, investigationalunknownbinderDetailsDB00968MethyldopaapprovednobinderDetailsDB08995Diosminapproved, investigationalunknownbinderDetailsDB08822Azilsartan medoxomilapproved, investigationalnobinderDetailsDB00438CeftazidimeapprovednobinderDetailsDB09069Trimetazidineapproved, investigationalunknownbinderDetailsDB00601Linezolidapproved, investigationalnobinderDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownbinderDetailsDB12235Estetrolapproved, investigationalunknownbinderDetailsDB01064Isoprenalineapproved, investigationalunknownbinderDetailsDB12471Ibrexafungerpapproved, investigationalunknownbinderDetailsDB06695Dabigatran etexilateapprovedunknownbinderDetailsDB16165Finerenoneapproved, investigationalunknownbinderDetailsDB16703Belumosudilapproved, investigationalnobinderDetailsDB00877Sirolimusapproved, investigationalnobinderDetailsDB06234Maribavirapproved, investigationalnobinderDetailsDB14973Abrocitinibapproved, investigationalnobinderDetailsDB15575Padeliporfinapproved, experimentalunknownbinderDetailsDB09070Tiboloneapproved, investigationalunknownbinderDetailsDB04847Roxadustatapproved, investigationalunknownbinderDetailsDB09074OlaparibapprovedunknownbinderDetailsDB15171Tirzepatideapproved, investigationalunknownbinderDetailsDB13959Medium-chain triglyceridesapprovedunknownbinderDetailsDB06813Pralatrexateapproved, investigationalnobinderDetailsDB00342Terfenadineapproved, withdrawnunknownbinderregulatorDetailsDB13514Pranoprofenexperimental, investigationalnoregulatorDetailsDB00427TriprolidineapprovedunknownbinderregulatorDetailsDB00485Dicloxacillinapproved, investigational, vet_approvedunknownbinderregulatorDetailsDB01173OrphenadrineapprovedunknownbinderregulatorDetailsDB01619PhenindamineapprovedunknownbinderregulatorDetailsDB00792Tripelennamineapproved, vet_approvedunknownbinderregulatorDetailsDB08912Dabrafenibapproved, investigationalnobinderDetailsDB16699Vutrisiranapproved, investigationalunknownligandDetailsDB06150Sulfadimethoxineapproved, vet_approved, withdrawnunknownsubstrateDetailsDB00254Doxycyclineapproved, investigational, vet_approvedunknownsubstratebinderDetailsDB08936ChlorcyclizineapprovedunknownregulatorDetailsDB00568Cinnarizineapproved, investigationalunknownregulatorDetailsDB01176CyclizineapprovedunknownregulatorDetailsDB00366Doxylamineapproved, vet_approvedunknownregulatorDetailsDB00850PerphenazineapprovedunknownregulatorDetailsDB01024Mycophenolic acidapproved, investigationalunknownbinderDetailsDB08865Crizotinibapproved, investigationalunknownbinderDetailsDB13310OrmeloxifeneexperimentalunknownbinderDetailsDB00758ClopidogrelapprovednobinderDetailsDB15149Futibatinibapproved, investigationalnobinderDetailsDB08930DolutegravirapprovednobinderDetailsDB17083LinzagolixapprovednobinderDetailsDB11739Vonoprazanapproved, investigationalunknownbinderDetailsDB11793Niraparibapproved, investigationalunknownbinderDetailsDB00642Pemetrexedapproved, investigationalnobinderDetailsDB12243Edaravoneapproved, investigationalnobinderDetailsDB00795SulfasalazineapprovednobinderDetailsDB00303Ertapenemapproved, investigationalnobinderDetailsDB01119DiazoxideapprovedunknownbinderDetailsDB01101Capecitabineapproved, investigationalnobinderDetailsDB00363ClozapineapprovednobinderDetailsDB00349Clobazamapproved, illicitnobinderDetailsDB00770Alprostadilapproved, investigationalunknownbinderDetailsDB00683Midazolamapproved, illicitnobinderDetailsDB11901Apalutamideapproved, investigationalnobinderDetailsDB09128Brexpiprazoleapproved, investigationalnosubstrateDetailsDB08906Fluticasone furoateapprovednobinderDetailsDB12255Vadadustatapproved, investigationalunknownbinderDetailsDB09076UmeclidiniumapprovednobinderDetailsDB01005HydroxyureaapprovednobinderDetailsDB00526Oxaliplatinapproved, investigationalnobinderDetailsDB06772CabazitaxelapprovedunknownbinderDetailsDB12874Quizartinibapproved, investigationalnobinderDetailsDB01042MelphalanapprovedunknownbinderDetailsDB08903BedaquilineapprovednobinderDetailsDB11718Encorafenibapproved, investigationalnobinderDetailsDB11967Binimetinibapproved, investigationalnobinderDetails"
                    }
                },
                {
                    "Label": "Alpha-1-acid glycoprotein 1",
                    "Detailed Info": {
                        "Name": "Alpha-1-acid glycoprotein 1",
                        "Synonyms": "AGP 1\nAGP1\nOMD 1\nOrosomucoid-1",
                        "Gene Name": "ORM1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0001842|Alpha-1-acid glycoprotein 1\nMALSWVLTVLSLLPLLEAQIPLCANLVPVPITNATLDQITGKWFYIASAFRNEEYNKSVQ\nEIQATFFYFTPNKTEDTIFLREYQTRQDQCIYNTTYLNVQRENGTISRYVGGQEHFAHLL\nILRDTKTYMLAFDVNDEKNWGLSVYADKPETTKEQLGEFYEALDCLRIPKSDVVYTDWKK\nDKCEPLEKQHEKERKQEEGES",
                        "Number of residues": "201",
                        "Molecular Weight": "23511.38",
                        "Theoretical pI": "4.66",
                        "GO Classification": "Processesacute-phase response / inflammatory response / negative regulation of interleukin-6 production / negative regulation of tumor necrosis factor production / regulation of immune system process / transportComponentsblood microparticle / extracellular exosome / extracellular region / extracellular space",
                        "General Function": "Not Available",
                        "Specific Function": "Functions as transport protein in the blood stream. Binds various ligands in the interior of its beta-barrel domain. Also binds synthetic drugs and influences their distribution and availability in the body. Appears to function in modulating the activity of the immune system during the acute-phase reaction.",
                        "Pfam Domain Function": "Lipocalin (PF00061)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Secreted",
                        "Gene sequence": ">lcl|BSEQ0010649|Alpha-1-acid glycoprotein 1 (ORM1)\nATGGCGCTGTCCTGGGTTCTTACAGTCCTGAGCCTCCTACCTCTGCTGGAAGCCCAGATC\nCCATTGTGTGCCAACCTAGTACCGGTGCCCATCACCAACGCCACCCTGGACCGGATCACT\nGGCAAGTGGTTTTATATCGCATCGGCCTTTCGAAACGAGGAGTACAATAAGTCGGTTCAG\nGAGATCCAAGCAACCTTCTTTTACTTCACCCCCAACAAGACAGAGGACACGATCTTTCTC\nAGAGAGTACCAGACCCGACAGGACCAGTGCATCTATAACACCACCTACCTGAATGTCCAG\nCGGGAAAATGGGACCATCTCCAGATACGTGGGAGGCCAAGAGCATTTCGCTCACTTGCTG\nATCCTCAGGGACACCAAGACCTACATGCTTGCTTTTGACGTGAACGATGAGAAGAACTGG\nGGGCTGTCTGTCTATGCTGACAAGCCAGAGACGACCAAGGAGCAACTGGGAGAGTTCTAC\nGAAGCTCTCGACTGCTTGCGCATTCCCAAGTCAGATGTCGTGTACACCGATTGGAAAAAG\nGATAAGTGTGAGCCACTGGAGAAGCAGCACGAGAAGGAGAGGAAACAGGAGGAGGGGGAA\nTCCTAG",
                        "Chromosome Location": "9",
                        "Locus": "9q31-q32",
                        "External Identifiers": "ResourceLinkUniProtKB IDP02763UniProtKB Entry NameA1AG1_HUMANGenBank Protein ID757907GenBank Gene IDX02544GenAtlas IDORM1HGNC IDHGNC:8498",
                        "General References": "Dente L, Pizza MG, Metspalu A, Cortese R: Structure and expression of the genes coding for human alpha 1-acid glycoprotein. EMBO J. 1987 Aug;6(8):2289-96. [Article] Board PG, Jones IM, Bentley AK: Molecular cloning and nucleotide sequence of human alpha 1 acid glycoprotein cDNA. Gene. 1986;44(1):127-31. [Article] Dente L, Ciliberto G, Cortese R: Structure of the human alpha 1-acid glycoprotein gene: sequence homology with other human acute phase protein genes. Nucleic Acids Res. 1985 Jun 11;13(11):3941-52. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Humphray SJ, Oliver K, Hunt AR, Plumb RW, Loveland JE, Howe KL, Andrews TD, Searle S, Hunt SE, Scott CE, Jones MC, Ainscough R, Almeida JP, Ambrose KD, Ashwell RI, Babbage AK, Babbage S, Bagguley CL, Bailey J, Banerjee R, Barker DJ, Barlow KF, Bates K, Beasley H, Beasley O, Bird CP, Bray-Allen S, Brown AJ, Brown JY, Burford D, Burrill W, Burton J, Carder C, Carter NP, Chapman JC, Chen Y, Clarke G, Clark SY, Clee CM, Clegg S, Collier RE, Corby N, Crosier M, Cummings AT, Davies J, Dhami P, Dunn M, Dutta I, Dyer LW, Earthrowl ME, Faulkner L, Fleming CJ, Frankish A, Frankland JA, French L, Fricker DG, Garner P, Garnett J, Ghori J, Gilbert JG, Glison C, Grafham DV, Gribble S, Griffiths C, Griffiths-Jones S, Grocock R, Guy J, Hall RE, Hammond S, Harley JL, Harrison ES, Hart EA, Heath PD, Henderson CD, Hopkins BL, Howard PJ, Howden PJ, Huckle E, Johnson C, Johnson D, Joy AA, Kay M, Keenan S, Kershaw JK, Kimberley AM, King A, Knights A, Laird GK, Langford C, Lawlor S, Leongamornlert DA, Leversha M, Lloyd C, Lloyd DM, Lovell J, Martin S, Mashreghi-Mohammadi M, Matthews L, McLaren S, McLay KE, McMurray A, Milne S, Nickerson T, Nisbett J, Nordsiek G, Pearce AV, Peck AI, Porter KM, Pandian R, Pelan S, Phillimore B, Povey S, Ramsey Y, Rand V, Scharfe M, Sehra HK, Shownkeen R, Sims SK, Skuce CD, Smith M, Steward CA, Swarbreck D, Sycamore N, Tester J, Thorpe A, Tracey A, Tromans A, Thomas DW, Wall M, Wallis JM, West AP, Whitehead SL, Willey DL, Williams SA, Wilming L, Wray PW, Young L, Ashurst JL, Coulson A, Blocker H, Durbin R, Sulston JE, Hubbard T, Jackson MJ, Bentley DR, Beck S, Rogers J, Dunham I: DNA sequence and analysis of human chromosome 9. Nature. 2004 May 27;429(6990):369-74. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Schmid K, Kaufmann H, Isemura S, Bauer F, Emura J, Motoyama T, Ishiguro M, Nanno S: Structure of 1 -acid glycoprotein. The complete amino acid sequence, multiple amino acid substitutions, and homology with the immunoglobulins. Biochemistry. 1973 Jul 3;12(14):2711-24. [Article] Ikenaka T, Ishiguro M, Emura J, Kaufmann H, Isemura S, Bauer W, Schmid K: Isolation and partial characterization of the cyanogen bromide fragments of 1 -acid glycoprotein and the elucidation of the amino acid sequence of the carboxyl-terminal cyanogen bromide fragment. Biochemistry. 1972 Sep 26;11(20):3817-29. [Article] Schmid K, Burgi W, Collins JH, Nanno S: The disulfide bonds of alpha1-acid glycoprotein. Biochemistry. 1974 Jun 18;13(13):2694-7. [Article] Treuheit MJ, Costello CE, Halsall HB: Analysis of the five glycosylation sites of human alpha 1-acid glycoprotein. Biochem J. 1992 Apr 1;283 ( Pt 1):105-12. [Article] Zhang H, Li XJ, Martin DB, Aebersold R: Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat Biotechnol. 2003 Jun;21(6):660-6. Epub 2003 May 18. [Article] Hagglund P, Bunkenborg J, Elortza F, Jensen ON, Roepstorff P: A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation. J Proteome Res. 2004 May-Jun;3(3):556-66. [Article] Kristiansen TZ, Bunkenborg J, Gronborg M, Molina H, Thuluvath PJ, Argani P, Goggins MG, Maitra A, Pandey A: A proteomic analysis of human bile. Mol Cell Proteomics. 2004 Jul;3(7):715-28. Epub 2004 Apr 14. [Article] Bunkenborg J, Pilch BJ, Podtelejnikov AV, Wisniewski JR: Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. Proteomics. 2004 Feb;4(2):454-65. [Article] Liu T, Qian WJ, Gritsenko MA, Camp DG 2nd, Monroe ME, Moore RJ, Smith RD: Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J Proteome Res. 2005 Nov-Dec;4(6):2070-80. [Article] Fitos I, Visy J, Zsila F, Mady G, Simonyi M: Selective binding of imatinib to the genetic variants of human alpha1-acid glycoprotein. Biochim Biophys Acta. 2006 Nov;1760(11):1704-12. Epub 2006 Aug 25. [Article] Ramachandran P, Boontheung P, Xie Y, Sondej M, Wong DT, Loo JA: Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry. J Proteome Res. 2006 Jun;5(6):1493-503. [Article] Zsila F, Iwao Y: The drug binding site of human alpha1-acid glycoprotein: insight from induced circular dichroism and electronic absorption spectra. Biochim Biophys Acta. 2007 May;1770(5):797-809. Epub 2007 Jan 28. [Article] Chen R, Jiang X, Sun D, Han G, Wang F, Ye M, Wang L, Zou H: Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009 Feb;8(2):651-61. doi: 10.1021/pr8008012. [Article] Nilsson J, Ruetschi U, Halim A, Hesse C, Carlsohn E, Brinkmalm G, Larson G: Enrichment of glycopeptides for glycan structure and attachment site identification. Nat Methods. 2009 Nov;6(11):809-11. doi: 10.1038/nmeth.1392. Epub 2009 Oct 18. [Article] Halim A, Nilsson J, Ruetschi U, Hesse C, Larson G: Human urinary glycoproteomics; attachment site specific analysis of N- and O-linked glycosylations by CID and ECD. Mol Cell Proteomics. 2012 Apr;11(4):M111.013649. doi: 10.1074/mcp.M111.013649. Epub 2011 Dec 14. [Article] Schonfeld DL, Ravelli RB, Mueller U, Skerra A: The 1.8-A crystal structure of alpha1-acid glycoprotein (Orosomucoid) solved by UV RIP reveals the broad drug-binding activity of this human plasma lipocalin. J Mol Biol. 2008 Dec 12;384(2):393-405. doi: 10.1016/j.jmb.2008.09.020. Epub 2008 Sep 16. [Article] Yuasa I, Umetsu K, Vogt U, Nakamura H, Nanba E, Tamaki N, Irizawa Y: Human orosomucoid polymorphism: molecular basis of the three common ORM1 alleles, ORM1*F1, ORM1*F2, and ORM1*S. Hum Genet. 1997 Mar;99(3):393-8. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00280Disopyramideapprovednoother/unknownDetailsDB00706Tamsulosinapproved, investigationalnoDetailsDB00908Quinidineapproved, investigationalunknownbinderDetailsDB00946Phenprocoumonapproved, investigationalnoDetailsDB01359Penbutololapproved, investigationalunknownother/unknownDetailsDB01429AprindineexperimentalunknownDetailsDB01418Acenocoumarolapproved, investigationalnoDetailsDB00682WarfarinapprovednoDetailsDB00802Alfentanilapproved, illicitunknownDetailsDB00540NortriptylineapprovednobinderDetailsDB00321AmitriptylineapprovednobinderDetailsDB01232Saquinavirapproved, investigationalunknownDetailsDB00334Olanzapineapproved, investigationalnobinderDetailsDB00543AmoxapineapprovednoDetailsDB00457PrazosinapprovednosubstrateDetailsDB00571Propranololapproved, investigationalnoDetailsDB00458ImipramineapprovednoDetailsDB01151Desipramineapproved, investigationalnoDetailsDB04821Nomifensineapproved, withdrawnnoDetailsDB01156BupropionapprovednoantagonistDetailsDB00934Maprotilineapproved, investigationalnoDetailsDB01426Ajmalineapproved, experimentalunknownDetailsDB00454MeperidineapprovedunknownbinderDetailsDB00731Nateglinideapproved, investigationalunknownDetailsDB08867UlipristalapprovednosubstrateDetailsDB05294VandetanibapprovedunknownbinderDetailsDB05521Telaprevirapproved, withdrawnnosubstrateDetailsDB05812AbirateroneapprovedunknownbinderDetailsDB08881VemurafenibapprovedunknownsubstrateDetailsDB08828Vismodegibapproved, investigationalunknownbinderDetailsDB08893MirabegronapprovednobinderDetailsDB08820IvacaftorapprovednocarrierDetailsDB08860PitavastatinapprovedunknownsubstrateDetailsDB08907CanagliflozinapprovedunknownsubstrateDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateDetailsDB00472Fluoxetineapproved, vet_approvedunknownsubstrateDetailsDB00317Gefitinibapproved, investigationalunknownsubstrateDetailsDB00619ImatinibapprovednobinderDetailsDB00864Tacrolimusapproved, investigationalunknownsubstrateDetailsDB08931RiociguatapprovedunknownsubstrateDetailsDB11575GrazoprevirapprovednosubstrateDetailsDB01685TopiroxostatexperimentalunknownbinderDetailsDB00276Amsacrineapproved, investigationalunknownDetailsDB00396Progesteroneapproved, vet_approvedunknownbinderDetailsDB00975DipyridamoleapprovedunknownDetailsDB00281Lidocaineapproved, vet_approvedunknownDetailsDB09236Lacidipineapproved, investigationalunknownbinderDetailsDB09204ArotinololinvestigationalnosubstrateDetailsDB09229AranidipineexperimentalnobinderDetailsDB11148Butambenapproved, withdrawnnosubstrateDetailsDB11637Delamanidapproved, investigationalunknownsubstrateDetailsDB00243Ranolazineapproved, investigationalnobinderDetailsDB01142Doxepinapproved, investigationalnobinderDetailsDB01126Dutasterideapproved, investigationalnobinderDetailsDB00343Diltiazemapproved, investigationalnobinderDetailsDB00481Raloxifeneapproved, investigationalnobinderDetailsDB00490Buspironeapproved, investigationalunknownbinderDetailsDB12978Pexidartinibapproved, investigationalunknownbinderDetailsDB00333MethadoneapprovednoDetailsDB01233Metoclopramideapproved, investigationalunknownbinderDetailsDB01062Oxybutyninapproved, investigationalunknownbinderDetailsDB00661VerapamilapprovedunknownsubstrateDetailsDB01190Clindamycinapproved, vet_approvedunknownsubstrateDetailsDB00246ZiprasidoneapprovedunknownDetailsDB01264DarunavirapprovedunknownsubstrateDetailsDB01601LopinavirapprovedunknownsubstrateDetailsDB00503Ritonavirapproved, investigationalunknownsubstrateDetailsDB11642Pitolisantapproved, investigationalnobinderDetailsDB00734Risperidoneapproved, investigationalunknownbinderDetailsDB12674Lurbinectedinapproved, investigationalunknownbinderDetailsDB11853Relugolixapproved, investigationalunknownbinderDetailsDB15133Tepotinibapproved, investigationalunknownbinderDetailsDB00346Alfuzosinapproved, investigationalunknownbinderDetailsDB00853Temozolomideapproved, investigationalnobinderDetailsDB06237AvanafilapprovedunknownbinderDetailsDB00080Daptomycinapproved, investigationalnobinderDetailsDB12235Estetrolapproved, investigationalunknownbinderDetailsDB01627Lincomycinapproved, vet_approvednobinderDetailsDB16703Belumosudilapproved, investigationalnobinderDetailsDB00877Sirolimusapproved, investigationalnobinderDetailsDB06234Maribavirapproved, investigationalnobinderDetailsDB09074OlaparibapprovedunknownbinderDetailsDB00220NelfinavirapprovednobinderDetailsDB00296RopivacaineapprovednobinderDetailsDB00572Atropineapproved, vet_approvedunknownbinderDetailsDB15149Futibatinibapproved, investigationalnobinderDetailsDB11739Vonoprazanapproved, investigationalunknownbinderDetailsDB05239Cobimetinibapproved, investigationalnobinderDetailsDB00363ClozapineapprovednobinderDetailsDB00349Clobazamapproved, illicitnobinderDetailsDB00683Midazolamapproved, illicitnobinderDetailsDB09128Brexpiprazoleapproved, investigationalnosubstrateDetailsDB08906Fluticasone furoateapprovednobinderDetailsDB09076UmeclidiniumapprovedunknownbinderDetailsDB01042MelphalanapprovedunknownbinderDetailsDB08903BedaquilineapprovednobinderDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknownbinderDetailsDB01041Thalidomideapproved, investigational, withdrawnyesbinderDetailsDB09262ImidafenacininvestigationalnosubstrateDetailsDB11828Neratinibapproved, investigationalnosubstrateDetailsDB00512VancomycinapprovednosubstrateDetailsDB12001Abemaciclibapproved, investigationalunknownbinderDetailsDB09053IbrutinibapprovednosubstrateDetailsDB11641Vinflunineapproved, investigationalnosubstrateDetailsDB14582Patisiranapproved, investigationalunknownligandDetailsDB00289AtomoxetineapprovednobinderDetailsDB00332Ipratropiumapproved, experimentalnobinderDetailsDB00404Alprazolamapproved, illicit, investigationalunknownbinderDetailsDB00421SpironolactoneapprovedunknownbinderDetailsDB00476DuloxetineapprovedunknownligandDetailsDB00497Oxycodoneapproved, illicit, investigationalunknownbinderDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedunknownbinderDetailsDB01029Irbesartanapproved, investigationalunknownbinderDetailsDB01591SolifenacinapprovedunknownbinderDetailsDB00598LabetalolapprovedunknownsubstrateDetailsDB01203NadololapprovedunknownbinderDetailsDB01611HydroxychloroquineapprovedunknownbinderDetailsDB01045RifampicinapprovedunknownligandDetailsDB11757Istradefyllineapproved, investigationalunknownbinderDetailsDB01195Flecainideapproved, withdrawnunknownbinderDetailsDB00278Argatrobanapproved, investigationalunknownbinderDetailsDB06216AsenapineapprovedunknownbinderDetailsDB01072Atazanavirapproved, investigationalnobinderDetailsDB11703Acalabrutinibapproved, investigationalunknownbinderDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknownbinderDetailsDB00950Fexofenadineapproved, investigationalunknownsubstrateDetailsDB01115NifedipineapprovedunknownbinderDetailsDB00938SalmeterolapprovedunknownbinderDetailsDB00608Chloroquineapproved, investigational, vet_approvedunknownbinderDetailsDB12466Favipiravirapproved, investigationalunknowncarrierDetailsDB00907Cocaineapproved, illicitunknownbinderDetailsDB11689Selumetinibapproved, investigationalunknowncarrierDetailsDB14840RipretinibapprovedunknownbinderDetailsDB00808IndapamideapprovedunknownbinderDetailsDB00409Remoxiprideapproved, withdrawnunknownbinderDetailsDB00960Pindololapproved, investigationalunknownbinderDetailsDB01086Benzocaineapproved, investigationalunknownbinderDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownbinderDetailsDB08932MacitentanapprovednobinderDetailsDB00342Terfenadineapproved, withdrawnunknownbinderregulatorDetailsDB00748CarbinoxamineapprovedunknownbinderregulatorDetailsDB08865Crizotinibapproved, investigationalunknownbinderDetailsDB08930DolutegravirapprovednobinderDetailsDB12147Erdafitinibapproved, investigationalnobinderDetailsDB11978Glasdegibapproved, investigationalnobinderDetails"
                    }
                }
            ],
            "transporters": [
                {
                    "Label": "P-glycoprotein 1",
                    "Detailed Info": {
                        "Name": "Multidrug resistance protein 1",
                        "Synonyms": "3.6.3.44\nATP-binding cassette sub-family B member 1\nMDR1\nP-glycoprotein 1\nPGY1",
                        "Gene Name": "ABCB1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0037114|Multidrug resistance protein 1\nMDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLYMVVGTLAAII\nHGAGLPLMMLVFGEMTDIFANAGNLEDLMSNITNRSDINDTGFFMNLEEDMTRYAYYYSG\nIGAGVLVAAYIQVSFWCLAAGRQIHKIRKQFFHAIMRQEIGWFDVHDVGELNTRLTDDVS\nKINEGIGDKIGMFFQSMATFFTGFIVGFTRGWKLTLVILAISPVLGLSAAVWAKILSSFT\nDKELLAYAKAGAVAEEVLAAIRTVIAFGGQKKELERYNKNLEEAKRIGIKKAITANISIG\nAAFLLIYASYALAFWYGTTLVLSGEYSIGQVLTVFFSVLIGAFSVGQASPSIEAFANARG\nAAYEIFKIIDNKPSIDSYSKSGHKPDNIKGNLEFRNVHFSYPSRKEVKILKGLNLKVQSG\nQTVALVGNSGCGKSTTVQLMQRLYDPTEGMVSVDGQDIRTINVRFLREIIGVVSQEPVLF\nATTIAENIRYGRENVTMDEIEKAVKEANAYDFIMKLPHKFDTLVGERGAQLSGGQKQRIA\nIARALVRNPKILLLDEATSALDTESEAVVQVALDKARKGRTTIVIAHRLSTVRNADVIAG\nFDDGVIVEKGNHDELMKEKGIYFKLVTMQTAGNEVELENAADESKSEIDALEMSSNDSRS\nSLIRKRSTRRSVRGSQAQDRKLSTKEALDESIPPVSFWRIMKLNLTEWPYFVVGVFCAII\nNGGLQPAFAIIFSKIIGVFTRIDDPETKRQNSNLFSLLFLALGIISFITFFLQGFTFGKA\nGEILTKRLRYMVFRSMLRQDVSWFDDPKNTTGALTTRLANDAAQVKGAIGSRLAVITQNI\nANLGTGIIISFIYGWQLTLLLLAIVPIIAIAGVVEMKMLSGQALKDKKELEGSGKIATEA\nIENFRTVVSLTQEQKFEHMYAQSLQVPYRNSLRKAHIFGITFSFTQAMMYFSYAGCFRFG\nAYLVAHKLMSFEDVLLVFSAVVFGAMAVGQVSSFAPDYAKAKISAAHIIMIIEKTPLIDS\nYSTEGLMPNTLEGNVTFGEVVFNYPTRPDIPVLQGLSLEVKKGQTLALVGSSGCGKSTVV\nQLLERFYDPLAGKVLLDGKEIKRLNVQWLRAHLGIVSQEPILFDCSIAENIAYGDNSRVV\nSQEEIVRAAKEANIHAFIESLPNKYSTKVGDKGTQLSGGQKQRIAIARALVRQPHILLLD\nEATSALDTESEKVVQEALDKAREGRTCIVIAHRLSTIQNADLIVVFQNGRVKEHGTHQQL\nLAQKGIYFSMVSVQAGTKRQ",
                        "Number of residues": "1280",
                        "Molecular Weight": "141477.255",
                        "Theoretical pI": "9.44",
                        "GO Classification": "FunctionsATP binding / ATPase activity, coupled to transmembrane movement of substances / transporter activity / xenobiotic-transporting ATPase activityProcessesdrug transmembrane transport / G2/M transition of mitotic cell cycle / response to drug / small molecule metabolic process / stem cell proliferation / transmembrane transport / transportComponentscell surface / extracellular exosome / integral component of membrane / membrane / plasma membrane",
                        "General Function": "Xenobiotic-transporting atpase activity",
                        "Specific Function": "Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells.",
                        "Pfam Domain Function": "ABC_tran (PF00005)\nABC_membrane (PF00664)",
                        "Transmembrane Regions": "45-67\n117-137\n187-208\n216-236\n293-316\n331-352\n712-732\n757-777\n833-853\n855-874\n935-957\n974-995",
                        "Cellular Location": "Cell membrane",
                        "Gene sequence": ">lcl|BSEQ0016291|Multidrug resistance protein 1 (ABCB1)\nATGGATCTTGAAGGGGACCGCAATGGAGGAGCAAAGAAGAAGAACTTTTTTAAACTGAAC\nAATAAAAGTGAAAAAGATAAGAAGGAAAAGAAACCAACTGTCAGTGTATTTTCAATGTTT\nCGCTATTCAAATTGGCTTGACAAGTTGTATATGGTGGTGGGAACTTTGGCTGCCATCATC\nCATGGGGCTGGACTTCCTCTCATGATGCTGGTGTTTGGAGAAATGACAGATATCTTTGCA\nAATGCAGGAAATTTAGAAGATCTGATGTCAAACATCACTAATAGAAGTGATATCAATGAT\nACAGGGTTCTTCATGAATCTGGAGGAAGACATGACCAGGTATGCCTATTATTACAGTGGA\nATTGGTGCTGGGGTGCTGGTTGCTGCTTACATTCAGGTTTCATTTTGGTGCCTGGCAGCT\nGGAAGACAAATACACAAAATTAGAAAACAGTTTTTTCATGCTATAATGCGACAGGAGATA\nGGCTGGTTTGATGTGCACGATGTTGGGGAGCTTAACACCCGACTTACAGATGATGTCTCC\nAAGATTAATGAAGGAATTGGTGACAAAATTGGAATGTTCTTTCAGTCAATGGCAACATTT\nTTCACTGGGTTTATAGTAGGATTTACACGTGGTTGGAAGCTAACCCTTGTGATTTTGGCC\nATCAGTCCTGTTCTTGGACTGTCAGCTGCTGTCTGGGCAAAGATACTATCTTCATTTACT\nGATAAAGAACTCTTAGCGTATGCAAAAGCTGGAGCAGTAGCTGAAGAGGTCTTGGCAGCA\nATTAGAACTGTGATTGCATTTGGAGGACAAAAGAAAGAACTTGAAAGGTACAACAAAAAT\nTTAGAAGAAGCTAAAAGAATTGGGATAAAGAAAGCTATTACAGCCAATATTTCTATAGGT\nGCTGCTTTCCTGCTGATCTATGCATCTTATGCTCTGGCCTTCTGGTATGGGACCACCTTG\nGTCCTCTCAGGGGAATATTCTATTGGACAAGTACTCACTGTATTCTTTTCTGTATTAATT\nGGGGCTTTTAGTGTTGGACAGGCATCTCCAAGCATTGAAGCATTTGCAAATGCAAGAGGA\nGCAGCTTATGAAATCTTCAAGATAATTGATAATAAGCCAAGTATTGACAGCTATTCGAAG\nAGTGGGCACAAACCAGATAATATTAAGGGAAATTTGGAATTCAGAAATGTTCACTTCAGT\nTACCCATCTCGAAAAGAAGTTAAGATCTTGAAGGGTCTGAACCTGAAGGTGCAGAGTGGG\nCAGACGGTGGCCCTGGTTGGAAACAGTGGCTGTGGGAAGAGCACAACAGTCCAGCTGATG\nCAGAGGCTCTATGACCCCACAGAGGGGATGGTCAGTGTTGATGGACAGGATATTAGGACC\nATAAATGTAAGGTTTCTACGGGAAATCATTGGTGTGGTGAGTCAGGAACCTGTATTGTTT\nGCCACCACGATAGCTGAAAACATTCGCTATGGCCGTGAAAATGTCACCATGGATGAGATT\nGAGAAAGCTGTCAAGGAAGCCAATGCCTATGACTTTATCATGAAACTGCCTCATAAATTT\nGACACCCTGGTTGGAGAGAGAGGGGCCCAGTTGAGTGGTGGGCAGAAGCAGAGGATCGCC\nATTGCACGTGCCCTGGTTCGCAACCCCAAGATCCTCCTGCTGGATGAGGCCACGTCAGCC\nTTGGACACAGAAAGCGAAGCAGTGGTTCAGGTGGCTCTGGATAAGGCCAGAAAAGGTCGG\nACCACCATTGTGATAGCTCATCGTTTGTCTACAGTTCGTAATGCTGACGTCATCGCTGGT\nTTCGATGATGGAGTCATTGTGGAGAAAGGAAATCATGATGAACTCATGAAAGAGAAAGGC\nATTTACTTCAAACTTGTCACAATGCAGACAGCAGGAAATGAAGTTGAATTAGAAAATGCA\nGCTGATGAATCCAAAAGTGAAATTGATGCCTTGGAAATGTCTTCAAATGATTCAAGATCC\nAGTCTAATAAGAAAAAGATCAACTCGTAGGAGTGTCCGTGGATCACAAGCCCAAGACAGA\nAAGCTTAGTACCAAAGAGGCTCTGGATGAAAGTATACCTCCAGTTTCCTTTTGGAGGATT\nATGAAGCTAAATTTAACTGAATGGCCTTATTTTGTTGTTGGTGTATTTTGTGCCATTATA\nAATGGAGGCCTGCAACCAGCATTTGCAATAATATTTTCAAAGATTATAGGGGTTTTTACA\nAGAATTGATGATCCTGAAACAAAACGACAGAATAGTAACTTGTTTTCACTATTGTTTCTA\nGCCCTTGGAATTATTTCTTTTATTACATTTTTCCTTCAGGGTTTCACATTTGGCAAAGCT\nGGAGAGATCCTCACCAAGCGGCTCCGATACATGGTTTTCCGATCCATGCTCAGACAGGAT\nGTGAGTTGGTTTGATGACCCTAAAAACACCACTGGAGCATTGACTACCAGGCTCGCCAAT\nGATGCTGCTCAAGTTAAAGGGGCTATAGGTTCCAGGCTTGCTGTAATTACCCAGAATATA\nGCAAATCTTGGGACAGGAATAATTATATCCTTCATCTATGGTTGGCAACTAACACTGTTA\nCTCTTAGCAATTGTACCCATCATTGCAATAGCAGGAGTTGTTGAAATGAAAATGTTGTCT\nGGACAAGCACTGAAAGATAAGAAAGAACTAGAAGGTTCTGGGAAGATCGCTACTGAAGCA\nATAGAAAACTTCCGAACCGTTGTTTCTTTGACTCAGGAGCAGAAGTTTGAACATATGTAT\nGCTCAGAGTTTGCAGGTACCATACAGAAACTCTTTGAGGAAAGCACACATCTTTGGAATT\nACATTTTCCTTCACCCAGGCAATGATGTATTTTTCCTATGCTGGATGTTTCCGGTTTGGA\nGCCTACTTGGTGGCACATAAACTCATGAGCTTTGAGGATGTTCTGTTAGTATTTTCAGCT\nGTTGTCTTTGGTGCCATGGCCGTGGGGCAAGTCAGTTCATTTGCTCCTGACTATGCCAAA\nGCCAAAATATCAGCAGCCCACATCATCATGATCATTGAAAAAACCCCTTTGATTGACAGC\nTACAGCACGGAAGGCCTAATGCCGAACACATTGGAAGGAAATGTCACATTTGGTGAAGTT\nGTATTCAACTATCCCACCCGACCGGACATCCCAGTGCTTCAGGGACTGAGCCTGGAGGTG\nAAGAAGGGCCAGACGCTGGCTCTGGTGGGCAGCAGTGGCTGTGGGAAGAGCACAGTGGTC\nCAGCTCCTGGAGCGGTTCTACGACCCCTTGGCAGGGAAAGTGCTGCTTGATGGCAAAGAA\nATAAAGCGACTGAATGTTCAGTGGCTCCGAGCACACCTGGGCATCGTGTCCCAGGAGCCC\nATCCTGTTTGACTGCAGCATTGCTGAGAACATTGCCTATGGAGACAACAGCCGGGTGGTG\nTCACAGGAAGAGATTGTGAGGGCAGCAAAGGAGGCCAACATACATGCCTTCATCGAGTCA\nCTGCCTAATAAATATAGCACTAAAGTAGGAGACAAAGGAACTCAGCTCTCTGGTGGCCAG\nAAACAACGCATTGCCATAGCTCGTGCCCTTGTTAGACAGCCTCATATTTTGCTTTTGGAT\nGAAGCCACGTCAGCTCTGGATACAGAAAGTGAAAAGGTTGTCCAAGAAGCCCTGGACAAA\nGCCAGAGAAGGCCGCACCTGCATTGTGATTGCTCACCGCCTGTCCACCATCCAGAATGCA\nGACTTAATAGTGGTGTTTCAGAATGGCAGAGTCAAGGAGCATGGCACGCATCAGCAGCTG\nCTGGCACAGAAAGGCATCTATTTTTCAATGGTCAGTGTCCAGGCTGGAACAAAGCGCCAG\nTGA",
                        "Chromosome Location": "7",
                        "Locus": "7q21.1",
                        "External Identifiers": "ResourceLinkUniProtKB IDP08183UniProtKB Entry NameMDR1_HUMANGenBank Protein ID307180GenBank Gene IDM14758GenAtlas IDABCB1HGNC IDHGNC:40",
                        "General References": "Chen CJ, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, Roninson IB: Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell. 1986 Nov 7;47(3):381-9. [Article] Chen CJ, Clark D, Ueda K, Pastan I, Gottesman MM, Roninson IB: Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins. J Biol Chem. 1990 Jan 5;265(1):506-14. [Article] Chen G, Duran GE, Steger KA, Lacayo NJ, Jaffrezou JP, Dumontet C, Sikic BI: Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins. J Biol Chem. 1997 Feb 28;272(9):5974-82. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, Wagner-McPherson C, Layman D, Maas J, Jaeger S, Walker R, Wylie K, Sekhon M, Becker MC, O'Laughlin MD, Schaller ME, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Cordes M, Du H, Sun H, Edwards J, Bradshaw-Cordum H, Ali J, Andrews S, Isak A, Vanbrunt A, Nguyen C, Du F, Lamar B, Courtney L, Kalicki J, Ozersky P, Bielicki L, Scott K, Holmes A, Harkins R, Harris A, Strong CM, Hou S, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Leonard S, Rohlfing T, Rock SM, Tin-Wollam AM, Abbott A, Minx P, Maupin R, Strowmatt C, Latreille P, Miller N, Johnson D, Murray J, Woessner JP, Wendl MC, Yang SP, Schultz BR, Wallis JW, Spieth J, Bieri TA, Nelson JO, Berkowicz N, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Bedell JA, Mardis ER, Clifton SW, Chissoe SL, Marra MA, Raymond C, Haugen E, Gillett W, Zhou Y, James R, Phelps K, Iadanoto S, Bubb K, Simms E, Levy R, Clendenning J, Kaul R, Kent WJ, Furey TS, Baertsch RA, Brent MR, Keibler E, Flicek P, Bork P, Suyama M, Bailey JA, Portnoy ME, Torrents D, Chinwalla AT, Gish WR, Eddy SR, McPherson JD, Olson MV, Eichler EE, Green ED, Waterston RH, Wilson RK: The DNA sequence of human chromosome 7. Nature. 2003 Jul 10;424(6945):157-64. [Article] Gekeler V, Weger S, Probst H: mdr1/P-glycoprotein gene segments analyzed from various human leukemic cell lines exhibiting different multidrug resistance profiles. Biochem Biophys Res Commun. 1990 Jun 15;169(2):796-802. [Article] Kioka N, Tsubota J, Kakehi Y, Komano T, Gottesman MM, Pastan I, Ueda K: P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance. Biochem Biophys Res Commun. 1989 Jul 14;162(1):224-31. [Article] Kerb R, Hoffmeyer S, Brinkmann U: ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2. Pharmacogenomics. 2001 Feb;2(1):51-64. [Article] Begley GS, Horvath AR, Taylor JC, Higgins CF: Cytoplasmic domains of the transporter associated with antigen processing and P-glycoprotein interact with subunits of the proteasome. Mol Immunol. 2005 Jan;42(1):137-41. [Article] Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP: A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7. doi: 10.1073/pnas.0805139105. Epub 2008 Jul 31. [Article] Burkard TR, Planyavsky M, Kaupe I, Breitwieser FP, Burckstummer T, Bennett KL, Superti-Furga G, Colinge J: Initial characterization of the human central proteome. BMC Syst Biol. 2011 Jan 26;5:17. doi: 10.1186/1752-0509-5-17. [Article] Katayama K, Yamaguchi M, Noguchi K, Sugimoto Y: Protein phosphatase complex PP5/PPP2R3C dephosphorylates P-glycoprotein/ABCB1 and down-regulates the expression and function. Cancer Lett. 2014 Apr 1;345(1):124-31. doi: 10.1016/j.canlet.2013.12.007. Epub 2013 Dec 11. [Article] Choi KH, Chen CJ, Kriegler M, Roninson IB: An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene. Cell. 1988 May 20;53(4):519-29. [Article] Mickley LA, Lee JS, Weng Z, Zhan Z, Alvarez M, Wilson W, Bates SE, Fojo T: Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors. Blood. 1998 Mar 1;91(5):1749-56. [Article] Decleves X, Chevillard S, Charpentier C, Vielh P, Laplanche JL: A new polymorphism (N21D) in the exon 2 of the human MDR1 gene encoding the P-glycoprotein. Hum Mutat. 2000 May;15(5):486. [Article] Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M, Brinkmann U: Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3473-8. [Article] Cascorbi I, Gerloff T, Johne A, Meisel C, Hoffmeyer S, Schwab M, Schaeffeler E, Eichelbaum M, Brinkmann U, Roots I: Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther. 2001 Mar;69(3):169-74. [Article] Honda T, Dan Y, Koyabu N, Ieiri I, Otsubo K, Higuchi S, Ohtani H, Sawada Y: Polymorphism of MDR1 gene in healthy japanese subjects: a novel SNP with an amino acid substitution (Glu108Lys). Drug Metab Pharmacokinet. 2002;17(5):479-81. [Article] Itoda M, Saito Y, Komamura K, Ueno K, Kamakura S, Ozawa S, Sawada J: Twelve novel single nucleotide polymorphisms in ABCB1/MDR1 among Japanese patients with ventricular tachycardia who were administered amiodarone. Drug Metab Pharmacokinet. 2002;17(6):566-71. [Article] Saito S, Iida A, Sekine A, Miura Y, Ogawa C, Kawauchi S, Higuchi S, Nakamura Y: Three hundred twenty-six genetic variations in genes encoding nine members of ATP-binding cassette, subfamily B (ABCB/MDR/TAP), in the Japanese population. J Hum Genet. 2002;47(1):38-50. [Article] Brant SR, Panhuysen CI, Nicolae D, Reddy DM, Bonen DK, Karaliukas R, Zhang L, Swanson E, Datta LW, Moran T, Ravenhill G, Duerr RH, Achkar JP, Karban AS, Cho JH: MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet. 2003 Dec;73(6):1282-92. Epub 2003 Nov 7. [Article] Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE: The consensus coding sequences of human breast and colorectal cancers. Science. 2006 Oct 13;314(5797):268-74. Epub 2006 Sep 7. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00171ATPinvestigational, nutraceuticalunknownDetailsDB00778Roxithromycinapproved, investigational, withdrawnunknownDetailsDB04881ElacridarinvestigationalunknownDetailsDB04905TesmilifeneinvestigationalyesinducerDetailsDB05449FM-VP4investigationalunknownDetailsDB06240TariquidarinvestigationalunknownDetailsDB06191ZosuquidarinvestigationalyesinhibitorDetailsDB00661VerapamilapprovedunknownsubstrateinhibitorDetailsDB01232Saquinavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00220NelfinavirapprovednosubstrateinhibitorinducerDetailsDB00224IndinavirapprovedunknownsubstrateinhibitorinducerDetailsDB00701Amprenavirapproved, investigationalunknownsubstrateinducerDetailsDB01045RifampicinapprovedunknowninducerDetailsDB00206Reserpineapproved, investigational, withdrawnunknownsubstrateinhibitorinducerDetailsDB01115NifedipineapprovedunknownsubstrateinducerDetailsDB00834Mifepristoneapproved, investigationalunknowninhibitorinducerDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00257Clotrimazoleapproved, vet_approvedunknowninhibitorinducerDetailsDB00564Carbamazepineapproved, investigationalunknowninducerDetailsDB00656Trazodoneapproved, investigationalunknowninducerDetailsDB01149Nefazodoneapproved, withdrawnunknowninhibitorinducerDetailsDB00503Ritonavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00390DigoxinapprovedunknownsubstrateinhibitorinducerDetailsDB00279Liothyronineapproved, vet_approvedunknowninducerDetailsDB00451LevothyroxineapprovedunknowninducerDetailsDB00440Trimethoprimapproved, vet_approvedunknownsubstrateDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateinhibitorinducerDetailsDB02261Platelet Activating FactorexperimentalunknownsubstrateinducerDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00501Cimetidineapproved, investigationalunknownsubstrateinducerDetailsDB04630Aldosteroneexperimental, investigationalunknownsubstrateinducerDetailsDB00864Tacrolimusapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00877Sirolimusapproved, investigationalnosubstrateinhibitorinducerDetailsDB01174Phenobarbitalapproved, investigationalunknownsubstrateinducerDetailsDB00199Erythromycinapproved, investigational, vet_approvednosubstrateinhibitorDetailsDB01118Amiodaroneapproved, investigationalunknowninhibitorinducerDetailsDB01323St. John's Wortapproved, investigational, nutraceuticalunknowninducerDetailsDB00541Vincristineapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00570VinblastineapprovedunknownsubstrateinhibitorinducerDetailsDB02659Cholic AcidapprovedunknowninducerDetailsDB00675TamoxifenapprovedunknownsubstrateinhibitorinducerDetailsDB00428Streptozocinapproved, investigationalunknowninducerDetailsDB01204Mitoxantroneapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00997Doxorubicinapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00694DaunorubicinapprovedunknownsubstrateinhibitorinducerDetailsDB00908Quinidineapproved, investigationalunknownsubstrateinhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB01388Mibefradilinvestigational, withdrawnunknownsubstrateinhibitorDetailsDB04540Cholesterolapproved, investigationalunknowninhibitorDetailsDB00358Mefloquineapproved, investigationalunknownsubstrateinhibitorDetailsDB00622Nicardipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00381AmlodipineapprovedunknownsubstrateinhibitorDetailsDB00972AzelastineapprovedunknowninhibitorDetailsDB00863Ranitidineapproved, withdrawnunknownsubstrateinhibitorDetailsDB00773EtoposideapprovedunknownsubstrateinhibitorDetailsDB00333MethadoneapprovedunknowninhibitorDetailsDB00641SimvastatinapprovedunknowninhibitorDetailsDB00227Lovastatinapproved, investigationalunknowninhibitorDetailsDB01076AtorvastatinapprovednosubstrateinhibitorDetailsDB01229Paclitaxelapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00457PrazosinapprovedunknownsubstrateinhibitormodulatorDetailsDB01054Nitrendipineapproved, investigationalunknowninhibitorDetailsDB00975DipyridamoleapprovedunknownsubstrateinhibitorDetailsDB00343Diltiazemapproved, investigationalunknownsubstrateinhibitorDetailsDB01394ColchicineapprovedunknownsubstrateinducerDetailsDB01211ClarithromycinapprovedunknownsubstrateinhibitorDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00970Dactinomycinapproved, investigationalunknownsubstrateinhibitorDetailsDB13179TroleandomycinapprovedunknowninhibitorDetailsDB00831Trifluoperazineapproved, investigationalunknowninhibitorDetailsDB00342Terfenadineapproved, withdrawnunknowninhibitorDetailsDB00468QuinineapprovedunknownsubstrateinhibitorDetailsDB01167Itraconazoleapproved, investigationalunknowninhibitorDetailsDB00328Indomethacinapproved, investigationalunknownsubstrateinhibitorDetailsDB02587Colforsinexperimental, investigationalunknowninhibitorDetailsDB00623FluphenazineapprovedunknowninhibitorDetailsDB01023Felodipineapproved, investigationalunknowninhibitorDetailsDB01136Carvedilolapproved, investigationalunknowninhibitorDetailsDB00421SpironolactoneapprovedunknowninducerDetailsDB00281Lidocaineapproved, vet_approvedunknowninhibitorDetailsDB00537Ciprofloxacinapproved, investigationalunknownsubstrateDetailsDB00207AzithromycinapprovedunknownsubstrateinhibitorDetailsDB00316AcetaminophenapprovedunknownsubstrateinhibitorDetailsDB00196Fluconazoleapproved, investigationalunknowninhibitorDetailsDB00213PantoprazoleapprovedunknownsubstrateinhibitorDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00448Lansoprazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00678LosartanapprovedunknownsubstrateinhibitorDetailsDB00584Enalaprilapproved, vet_approvedunknowninhibitorDetailsDB00590DoxazosinapprovedunknowninhibitorDetailsDB01340CilazaprilapprovedunknowninhibitorDetailsDB01197CaptoprilapprovedunknowninhibitorDetailsDB00796Candesartan cilexetilapprovedunknowninhibitorDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB00696ErgotamineapprovedunknowninhibitorDetailsDB01253ErgometrineapprovedunknowninhibitorDetailsDB00320Dihydroergotamineapproved, investigationalunknowninhibitorDetailsDB01200Bromocriptineapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00836LoperamideapprovedunknownsubstrateDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedunknowninhibitorDetailsDB00802Alfentanilapproved, illicitunknowninhibitorDetailsDB00401NisoldipineapprovedunknowninhibitorDetailsDB04832Zimelidineapproved, withdrawnunknowninhibitorDetailsDB00382Tacrineapproved, investigational, withdrawnunknownsubstrateDetailsDB00669Sumatriptanapproved, investigationalunknownsubstrateDetailsDB01037Selegilineapproved, investigational, vet_approvedunknowninhibitorDetailsDB00458ImipramineapprovedunknownsubstrateDetailsDB00502HaloperidolapprovedunknownsubstrateinhibitorDetailsDB00176Fluvoxamineapproved, investigationalunknowninhibitorDetailsDB00690Flurazepamapproved, illicit, investigationalunknowninhibitorDetailsDB00472Fluoxetineapproved, vet_approvedunknowninhibitorDetailsDB01142Doxepinapproved, investigationalunknownsubstrateDetailsDB01151Desipramineapproved, investigationalunknowninhibitorDetailsDB01242Clomipramineapproved, investigational, vet_approvedunknowninhibitorDetailsDB01239Chlorprothixeneapproved, experimental, investigational, withdrawnunknowninhibitorDetailsDB00490Buspironeapproved, investigationalunknowninhibitorDetailsDB01100PimozideapprovedunknowninhibitorDetailsDB00295Morphineapproved, investigationalnosubstrateDetailsDB00602Ivermectinapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00741Hydrocortisoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00637Astemizoleapproved, withdrawnunknowninhibitorDetailsDB00508Triflupromazineapproved, vet_approvedunknowninhibitorDetailsDB00344ProtriptylineapprovedunknowninhibitorDetailsDB01069Promethazineapproved, investigationalunknowninhibitorDetailsDB01244Bepridilapproved, withdrawnunknowninhibitorDetailsDB00455Loratadineapproved, investigationalnosubstrateinhibitorDetailsDB00967Desloratadineapproved, investigationalunknowninhibitorDetailsDB00285VenlafaxineapprovedunknownsubstrateinhibitorDetailsDB01104SertralineapprovedunknowninhibitorDetailsDB00234Reboxetineapproved, experimentalunknowninhibitorDetailsDB00715Paroxetineapproved, investigationalunknowninhibitorDetailsDB00215CitalopramapprovedunknownsubstrateinhibitorDetailsDB01196Estramustineapproved, investigationalunknowninhibitorDetailsDB04348Taurocholic acidapproved, experimentalunknownsubstrateinhibitorDetailsDB00875Flupentixolapproved, investigational, withdrawnunknowninhibitorDetailsDB00351Megestrol acetateapproved, investigational, vet_approvedunknowninhibitorDetailsDB02010StaurosporineexperimentalunknowninhibitorDetailsDB01103QuinacrineinvestigationalunknowninhibitorDetailsDB01645GenisteininvestigationalunknowninhibitorDetailsDB04216Quercetinexperimental, investigationalunknowninhibitorDetailsDB01137Levofloxacinapproved, investigationalunknownsubstrateinhibitorDetailsDB03467NaringeninexperimentalunknowndownregulatorDetailsDB01016GlyburideapprovedunknowninhibitorDetailsDB00950Fexofenadineapproved, investigationalunknownsubstrateDetailsDB00726TrimipramineapprovedunknownsubstrateDetailsDB00571Propranololapproved, investigationalunknownsubstrateDetailsDB00635Prednisoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00276Amsacrineapproved, investigationalunknowninhibitorDetailsDB00027Gramicidin DapprovedunknownsubstrateinhibitorDetailsDB01086Benzocaineapproved, investigationalunknowninhibitorDetailsDB01601LopinavirapprovedunknowninhibitorinducerDetailsDB00520CaspofunginapprovedunknowninhibitorDetailsDB00175PravastatinapprovednosubstrateDetailsDB00619ImatinibapprovednosubstrateinhibitorDetailsDB00398Sorafenibapproved, investigationalunknownsubstrateinhibitorDetailsDB01268Sunitinibapproved, investigationalunknowninhibitorDetailsDB01162TerazosinapprovedunknowninhibitorDetailsDB00470Dronabinolapproved, illicitunknowninhibitorDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknowninhibitorDetailsDB00966Telmisartanapproved, investigationalunknowninhibitorDetailsDB01254Dasatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00317Gefitinibapproved, investigationalunknownsubstrateinhibitorDetailsDB04868Nilotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00655EstroneapprovedunknownsubstrateinducerDetailsDB01259Lapatinibapproved, investigationalunknowninhibitorDetailsDB01263Posaconazoleapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00365Grepafloxacinapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB01396Digitoxinapproved, investigationalunknownsubstrateDetailsDB01208Sparfloxacinapproved, investigational, withdrawnunknownsubstrateDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB01224QuetiapineapprovedunknownsubstrateDetailsDB00334Olanzapineapproved, investigationalnosubstrateDetailsDB00363ClozapineapprovedunknownsubstrateDetailsDB01183Naloxoneapproved, vet_approvedunknownsubstrateDetailsDB04690CamptothecinexperimentalunknownsubstrateDetailsDB00860Prednisoloneapproved, vet_approvedunknownsubstrateDetailsDB01193Acebutololapproved, investigationalunknownsubstrateDetailsDB01050IbuprofenapprovedunknownsubstrateDetailsDB00945Acetylsalicylic acidapproved, vet_approvedunknownsubstrateinducermodulatorDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB00443Betamethasoneapproved, vet_approvedunknownsubstrateDetailsDB00539Toremifeneapproved, investigationalunknownsubstrateDetailsDB00255Diethylstilbestrolapproved, investigational, withdrawnunknownsubstrateDetailsDB00882Clomifeneapproved, investigationalunknownsubstrateDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstratedownregulatorregulatorDetailsDB01248Docetaxelapproved, investigationalunknownsubstrateDetailsDB00563MethotrexateapprovedunknownsubstrateDetailsDB00373TimololapprovedunknownsubstrateDetailsDB01203NadololapprovedunknownsubstrateDetailsDB00523Alitretinoinapproved, investigationalunknownsubstrateDetailsDB01339Vecuroniumapproved, investigationalunknownsubstrateDetailsDB04840Debrisoquineapproved, investigationalunknownsubstrateDetailsDB00441GemcitabineapprovednosubstrateDetailsDB01030Topotecanapproved, investigationalunknownsubstrateDetailsDB02901Stanoloneillicit, investigationalunknownsubstrateDetailsDB00751Epinastineapproved, investigationalunknownsubstrateDetailsDB00717NorethisteroneapprovedunknowninhibitorDetailsDB04573Estriolapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB03203SphingosineexperimentalunknownsubstrateDetailsDB00439Cerivastatinapproved, withdrawnunknownsubstrateDetailsDB00286Conjugated estrogensapprovedunknownsubstrateDetailsDB01202LevetiracetamapprovedunknownsubstrateDetailsDB00252Phenytoinapproved, vet_approvedunknownsubstrateDetailsDB00585NizatidineapprovedunknownsubstrateDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00555Lamotrigineapproved, investigationalunknownsubstrateinhibitorDetailsDB01261Sitagliptinapproved, investigationalunknownsubstrateDetailsDB01072Atazanavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB01169Arsenic trioxideapproved, investigationalunknowninhibitorDetailsDB06772CabazitaxelapprovedunknownsubstrateinhibitorDetailsDB01583LiotrixapprovedunknowninducerDetailsDB06287TemsirolimusapprovedunknownsubstrateinhibitorDetailsDB01587KetazolamapprovedunknownsubstrateDetailsDB04877VoacamineexperimentalunknowninhibitorDetailsDB00977EthinylestradiolapprovedunknownsubstrateDetailsDB01182PropafenoneapprovedunknowninhibitorDetailsDB00216Eletriptanapproved, investigationalunknownsubstrateDetailsDB04855DronedaroneapprovednoinhibitorDetailsDB06176Romidepsinapproved, investigationalunknownsubstrateDetailsDB06207SilodosinapprovedunknownsubstrateDetailsDB06414EtravirineapprovedunknowninhibitorDetailsDB06228RivaroxabanapprovedunknownsubstrateDetailsDB06695Dabigatran etexilateapprovedunknownsubstrateDetailsDB00973EzetimibeapprovedunknownsubstrateDetailsDB06702FesoterodineapprovedunknownsubstrateDetailsDB06212TolvaptanapprovednosubstrateinhibitorDetailsDB08860PitavastatinapprovedunknownsubstrateDetailsDB06589PazopanibapprovedunknownsubstrateDetailsDB08864RilpivirineapprovedunknowninhibitorDetailsDB08873Boceprevirapproved, withdrawnunknowninhibitorDetailsDB05521Telaprevirapproved, withdrawnunknownsubstrateinhibitorDetailsDB08874FidaxomicinapprovednosubstrateDetailsDB05039IndacaterolapprovedunknownsubstrateDetailsDB00349Clobazamapproved, illicitnosubstrateDetailsDB08882LinagliptinapprovedunknownsubstrateDetailsDB08827Lomitapideapproved, investigationalnoinhibitorDetailsDB08816TicagrelorapprovedunknownsubstrateinhibitorDetailsDB08865Crizotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB06605ApixabanapprovedunknownsubstrateDetailsDB06626Axitinibapproved, investigationalnosubstrateinhibitorDetailsDB08828Vismodegibapproved, investigationalunknownsubstrateDetailsDB08889Carfilzomibapproved, investigationalunknownsubstrateinhibitorDetailsDB08893MirabegronapprovedunknownsubstrateinhibitorDetailsDB08896RegorafenibapprovedunknownsubstrateinhibitorDetailsDB08899EnzalutamideapprovednoinhibitorDetailsDB08820IvacaftorapprovednoinhibitorDetailsDB06616BosutinibapprovednosubstrateDetailsDB08901Ponatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB08906Fluticasone furoateapprovednosubstrateinducerDetailsDB08907CanagliflozinapprovedunknownsubstrateinhibitorDetailsDB08910PomalidomideapprovedunknownsubstrateDetailsDB00480LenalidomideapprovednosubstrateDetailsDB08912Dabrafenibapproved, investigationalnosubstrateDetailsDB05773Trastuzumab emtansineapproved, investigationalunknownsubstrateDetailsDB00495ZidovudineapprovedunknownsubstrateDetailsDB00758ClopidogrelapprovednosubstrateDetailsDB08916AfatinibapprovedunknownsubstrateinhibitorDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateDetailsDB00709Lamivudineapproved, investigationalunknownsubstrateDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB08918Levomilnacipranapproved, investigationalunknownsubstrateDetailsDB06290SimeprevirapprovedunknownsubstrateinhibitorDetailsDB08934SofosbuvirapprovednosubstrateDetailsDB06292DapagliflozinapprovedunknownsubstrateDetailsDB09076UmeclidiniumapprovednosubstrateDetailsDB09075EdoxabanapprovednosubstrateDetailsDB09063CeritinibapprovednosubstrateDetailsDB09078Lenvatinibapproved, investigationalnosubstrateinhibitorDetailsDB09079NintedanibapprovednosubstrateinhibitorDetailsDB09054IdelalisibapprovednosubstrateinhibitorDetailsDB09065CobicistatapprovedunknowninhibitorDetailsDB09291Rolapitantapproved, investigationalnoinhibitorDetailsDB09102Daclatasvirapproved, investigationalunknownsubstrateinhibitorDetailsDB06636Isavuconazoniumapproved, investigationalnoinhibitorDetailsDB06603Panobinostatapproved, investigationalnosubstrateDetailsDB09330OsimertinibapprovednosubstrateDetailsDB11362SelexipagapprovednosubstrateDetailsDB06403Ambrisentanapproved, investigationalunknownsubstrateDetailsDB09296Ombitasvirapproved, investigationalnosubstrateDetailsDB11574ElbasvirapprovednosubstrateinhibitorDetailsDB11575GrazoprevirapprovednosubstrateDetailsDB09161Technetium Tc-99m sestamibiapproved, investigationalnosubstrateDetailsDB11581Venetoclaxapproved, investigationalnosubstrateinhibitorDetailsDB05015Belinostatapproved, investigationalunknownsubstrateDetailsDB11613Velpatasvirapproved, investigationalnosubstrateinhibitorDetailsDB09027LedipasvirapprovednosubstratetransporterDetailsDB09198LobeglitazoneexperimentalnoDetailsDB09031Miltefosineapproved, investigationalunknownDetailsDB09280LumacaftorapprovednoinhibitorinducerDetailsDB11828Neratinibapproved, investigationalunknowninhibitorDetailsDB12026Voxilaprevirapproved, investigationalnosubstrateinhibitorDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB05889Inotuzumab ozogamicinapproved, investigationalunknownsubstrateDetailsDB13878Pibrentasvirapproved, investigationalunknownsubstrateinhibitorDetailsDB13879Glecaprevirapproved, investigationalunknownsubstrateinhibitorDetailsDB12483Copanlisibapproved, investigationalunknownsubstrateDetailsDB12001Abemaciclibapproved, investigationalunknownsubstrateinhibitorDetailsDB12364Betrixabanapproved, investigationalnosubstrateDetailsDB13919CandesartanexperimentalunknowninhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateinhibitorDetailsDB12332Rucaparibapproved, investigationalnosubstrateinhibitorDetailsDB09270Ubidecarenoneapproved, investigational, nutraceuticalnosubstrateDetailsDB11827Ertugliflozinapproved, investigationalnosubstrateDetailsDB13943Testosterone cypionateapprovedunknowninhibitorDetailsDB13944Testosterone enanthateapprovedunknowninhibitorDetailsDB13946Testosterone undecanoateapproved, investigationalunknowninhibitorDetailsDB09160Technetium Tc-99m tetrofosminapprovednobinderDetailsDB13951Stanolone acetateexperimentalunknownsubstrateDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateDetailsDB01420Testosterone propionateapproved, investigational, vet_approved, withdrawnnosubstrateDetailsDB11901Apalutamideapproved, investigationalunknowninducerDetailsDB11633Isavuconazoleapproved, investigationalunknowninhibitorDetailsDB11251Tocopherolapproved, investigationalnotransporterDetailsDB14003alpha-Tocopherol acetateapprovednosubstrateDetailsDB09099Somatostatinapproved, investigationalunknownsubstrateDetailsDB11635TocofersolanapprovedunknownantagonistDetailsDB11641Vinflunineapproved, investigationalnosubstrateDetailsDB11672Curcuminapproved, investigationalunknowninhibitorDetailsDB11995Avatrombopagapproved, investigationalunknownsubstrateDetailsDB09297Paritaprevirapproved, investigationalunknownsubstrateDetailsDB09183DasabuvirapprovedunknownsubstrateDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedunknownDetailsDB14062Concanamycin AexperimentalyesinhibitorDetailsDB14061HycanthoneexperimentalyesinhibitorDetailsDB14063DexverapamilexperimentalyesinhibitorDetailsDB14064EmopamilexperimentalyesinhibitorDetailsDB14065LomerizineexperimentalyesinhibitorDetailsDB14066TetrandrineexperimentalunknowninhibitorDetailsDB14067Dofequidarexperimental, investigationalunknowninhibitorDetailsDB14068DexniguldipineexperimentalunknowninhibitorDetailsDB14069ONT-093investigationalyesinhibitorDetailsDB14070HM-30181experimentalyesinhibitorDetailsDB14071DesmethylsertralineexperimentalunknowninhibitorDetailsDB14072Reversin 121experimentalyesinhibitorDetailsDB14146LoxicodegolinvestigationalunknownDetailsDB14538Hydrocortisone aceponateexperimental, vet_approvedunknownDetailsDB14539Hydrocortisone acetateapproved, vet_approvedunknownDetailsDB14540Hydrocortisone butyrateapproved, vet_approvedunknownDetailsDB14541Hydrocortisone cypionateapproved, investigational, vet_approvedunknownDetailsDB14542Hydrocortisone phosphateapproved, vet_approvedunknownDetailsDB14543Hydrocortisone probutateapproved, vet_approvedunknownDetailsDB14544Hydrocortisone valerateapproved, vet_approvedunknownDetailsDB14568Ivosidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB11979Elagolixapproved, investigationalunknownsubstrateinhibitorDetailsDB13867Fluticasoneapproved, experimentalnosubstrateDetailsDB00608Chloroquineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00613Amodiaquineapproved, investigationalunknowninhibitorDetailsDB01087PrimaquineapprovedunknowninhibitorDetailsDB01611HydroxychloroquineapprovedunknowninhibitorDetailsDB01267PaliperidoneapprovedunknownsubstrateinhibitorDetailsDB05928DovitinibinvestigationalunknowninhibitorDetailsDB13125Lusutrombopagapproved, investigationalunknownsubstrateDetailsDB14635Curcumin sulfateexperimentalunknownDetailsDB14641Estriol tripropionateexperimentalunknownDetailsDB11952Duvelisibapproved, investigationalnosubstrateDetailsDB09213Dexibuprofenapproved, investigationalunknownDetailsDB11760Talazoparibapproved, investigationalunknownsubstrateDetailsDB12455Omadacyclineapproved, investigationalunknownsubstrateDetailsDB12836Grapiprantinvestigational, vet_approvednosubstrateDetailsDB12035Sarecyclineapproved, investigationalunknowninhibitorDetailsDB11753Rifamycinapproved, investigationalnosubstrateinhibitorDetailsDB11963Dacomitinibapproved, investigationalnosubstrateinhibitorDetailsDB11855Revefenacinapproved, investigationalnosubstrateDetailsDB12141Gilteritinibapproved, investigationalnosubstrateDetailsDB14126Tenofovirexperimental, investigationalnosubstrateDetailsDB00300Tenofovir disoproxilapproved, investigationalunknownsubstrateinhibitorDetailsDB09299Tenofovir alafenamideapprovedunknownsubstrateDetailsDB01264DarunavirapprovedunknownsubstrateinhibitorinducerDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateinhibitorDetailsDB00862VardenafilapprovedunknownsubstrateinhibitorDetailsDB00776OxcarbazepineapprovedunknownsubstrateDetailsDB00248CabergolineapprovednosubstrateDetailsDB06480PrucaloprideapprovednosubstrateDetailsDB00734Risperidoneapproved, investigationalunknownsubstrateDetailsDB01117AtovaquoneapprovednoinhibitorDetailsDB00788Naproxenapproved, vet_approvednoinhibitorDetailsDB00615Rifabutinapproved, investigationalunknowninducerDetailsDB12582PiperineinvestigationalunknowninhibitorDetailsDB11978Glasdegibapproved, investigationalnosubstrateinhibitorDetailsDB09074OlaparibapprovednosubstrateinhibitorDetailsDB00243Ranolazineapproved, investigationalnosubstrateinhibitorDetailsDB00321AmitriptylineapprovedunknownsubstrateDetailsDB00341CetirizineapprovednosubstrateinhibitorDetailsDB09073Palbociclibapproved, investigationalnosubstrateinhibitorDetailsDB01079Tegaserodapproved, investigational, withdrawnunknownsubstrateDetailsDB13867Fluticasoneapproved, experimentalunknownsubstrateDetailsDB12147Erdafitinibapproved, investigationalnosubstrateinhibitorDetailsDB00736Esomeprazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00476DuloxetineapprovedunknowninhibitorDetailsDB00481Raloxifeneapproved, investigationalunknownsubstrateDetailsDB12015Alpelisibapproved, investigationalunknowninhibitorDetailsDB11712Tezacaftorapproved, investigationalnosubstrateinhibitorDetailsDB00768OlopatadineapprovednosubstrateDetailsDB00698Nitrofurantoinapproved, vet_approvedunknownsubstrateDetailsDB00451LevothyroxineapprovednoinducerDetailsDB00394Beclomethasone dipropionateapproved, investigationalunknownsubstrateinducerDetailsDB00612BisoprololapprovedunknownsubstrateinhibitorDetailsDB00916MetronidazoleapprovedunknowninhibitorDetailsDB00482Celecoxibapproved, investigationalunknownsubstrateDetailsDB11986Entrectinibapproved, investigationalunknownsubstrateinhibitorDetailsDB12500Fedratinibapproved, investigationalunknownsubstrateinhibitorDetailsDB12825Lefamulinapproved, investigationalunknownsubstrateDetailsDB01222BudesonideapprovednosubstrateDetailsDB11757Istradefyllineapproved, investigationalunknowninhibitorDetailsDB01233Metoclopramideapproved, investigationalunknownsubstrateDetailsDB01175EscitalopramapprovedunknownsubstrateDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknowninhibitorDetailsDB01217Anastrozoleapproved, investigationalunknownsubstrateDetailsDB01195Flecainideapproved, withdrawnunknownsubstrateDetailsDB01418Acenocoumarolapproved, investigationalunknownsubstrateDetailsDB05676Apremilastapproved, investigationalunknownsubstrateDetailsDB11732Lasmiditanapproved, investigationalunknownsubstrateinhibitorDetailsDB11586Asunaprevirapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB15444Elexacaftorapproved, investigationalnosubstrateinhibitorDetailsDB15566Prednisolone acetateapproved, vet_approvedunknownsubstrateDetailsDB15035Zanubrutinibapproved, investigationalnosubstrateDetailsDB00273TopiramateapprovedunknownsubstrateDetailsDB09237Levamlodipineapproved, investigationalunknownsubstrateDetailsDB14962Trastuzumab deruxtecanapproved, investigationalnosubstrateDetailsDB13007Enfortumab vedotinapproved, investigationalunknownsubstrateDetailsDB11951Lemborexantapproved, investigationalunknownsubstrateDetailsDB12941Darolutamideapproved, investigationalunknownsubstrateDetailsDB15091Upadacitinibapproved, investigationalnosubstrateinhibitorDetailsDB15328Ubrogepantapproved, investigationalunknownsubstrateDetailsDB15233Avapritinibapproved, investigationalunknowninhibitormodulatorDetailsDB00993AzathioprineapprovedunknownsubstrateDetailsDB00557HydroxyzineapprovedunknownsubstrateDetailsDB11077Polyethylene glycol 400approvedunknowninhibitorDetailsDB12887Tazemetostatapproved, investigationalunknownsubstrateDetailsDB01006Letrozoleapproved, investigationalunknownsubstrateDetailsDB00246ZiprasidoneapprovedunknownDetailsDB01190Clindamycinapproved, vet_approvedunknownsubstrateDetailsDB09287Polyethylene glycolapproved, vet_approvednoinhibitorDetailsDB00957Norgestimateapproved, investigationalunknowninhibitorDetailsDB11770TalinololinvestigationalunknownsubstrateDetailsDB04881ElacridarinvestigationalunknowninhibitorDetailsDB00932Tipranavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB11869ValspodarinvestigationalunknowninhibitorDetailsDB00518Albendazoleapproved, vet_approvednosubstrateDetailsDB05239Cobimetinibapproved, investigationalnosubstrateDetailsDB06670OdanacatibinvestigationalunknownsubstrateDetailsDB04877VoacamineexperimentalnoinhibitorDetailsDB08930DolutegravirapprovednosubstrateDetailsDB00586Diclofenacapproved, vet_approvedunknowninducerDetailsDB11817Baricitinibapproved, investigationalunknownsubstrateDetailsDB11363Alectinibapproved, investigationalunknowninhibitorDetailsDB14723Larotrectinibapproved, investigationalunknownsubstrateDetailsDB00588Fluticasone propionateapprovedunknownsubstrateDetailsDB11430Monensinexperimental, vet_approvedunknownsubstrateDetailsDB03825Rhodamine 6GexperimentalunknownsubstrateDetailsDB09239NiguldipineexperimentalunknowninhibitorDetailsDB04851BiricodarinvestigationalunknowninhibitorDetailsDB06240TariquidarinvestigationalunknowninhibitorDetailsDB12799LaniquidarinvestigationalunknowninhibitorDetailsDB12923GallopamilinvestigationalunknowninhibitorDetailsDB06420AnnamycininvestigationalunknownDetailsDB00540NortriptylineapprovedunknownsubstrateDetailsDB00454MeperidineapprovedunknownsubstrateDetailsDB00652Pentazocineapproved, vet_approvedunknownsubstrateDetailsDB00818Propofolapproved, investigational, vet_approvedunknowninducerDetailsDB01590EverolimusapprovedunknownsubstrateinhibitorDetailsDB01212CeftriaxoneapprovedunknowninhibitorDetailsDB00872Conivaptanapproved, investigationalunknowninhibitorDetailsDB11544Salinomycinvet_approvedunknowninhibitorDetailsDB00909Zonisamideapproved, investigationalunknowninhibitorDetailsDB14057ValinomycinexperimentalunknownsubstrateinhibitorDetailsDB04908Flibanserinapproved, investigationalunknowninhibitorDetailsDB09039Eliglustatapproved, investigationalnosubstrateinhibitorDetailsDB01128BicalutamideapprovedunknowninhibitorDetailsDB00648MitotaneapprovedunknowninhibitorDetailsDB06448Lonafarnibapproved, investigationalnosubstrateinhibitorDetailsDB04960TipifarnibinvestigationalunknowninhibitorDetailsDB09048Netupitantapproved, investigationalunknowninhibitorDetailsDB09034Suvorexantapproved, investigationalunknownDetailsDB09030VorapaxarapprovedunknownDetailsDB05294VandetanibapprovedunknowninhibitorDetailsDB14062Concanamycin AexperimentalunknowninhibitorDetailsDB14061HycanthoneexperimentalunknowninhibitorDetailsDB08881VemurafenibapprovedunknownsubstrateinhibitorDetailsDB14063DexverapamilexperimentalunknowninhibitorDetailsDB14064EmopamilexperimentalunknowninhibitorDetailsDB14065LomerizineexperimentalunknowninhibitorDetailsDB14066TetrandrineexperimentalunknowninhibitorDetailsDB14069ONT-093investigationalunknowninhibitorDetailsDB14067Dofequidarexperimental, investigationalunknowninhibitorDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknowninhibitorDetailsDB12457Rimegepantapproved, investigationalunknownsubstrateDetailsDB12466Favipiravirapproved, investigationalunknowninhibitorDetailsDB00253MedrysoneapprovedunknownsubstrateDetailsDB09241Methylene blueapproved, investigationalunknownsubstrateinhibitorDetailsDB12612Ozanimodapproved, investigationalunknownsubstrateDetailsDB08868Fingolimodapproved, investigationalnoinhibitorDetailsDB07565Chloramphenicol succinateapprovedunknownsubstrateDetailsDB11689Selumetinibapproved, investigationalunknownsubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknownsubstrateinducerDetailsDB11652Tucatinibapproved, investigationalunknownsubstrateDetailsDB15102Pemigatinibapproved, investigationalnosubstrateinhibitorDetailsDB00315Zolmitriptanapproved, investigationalnoDetailsDB14761Remdesivirapproved, investigationalunknownsubstrateDetailsDB11791Capmatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB04845Ixabepiloneapproved, investigationalunknownsubstrateinhibitorDetailsDB15685Selpercatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB14840RipretinibapprovedunknownsubstrateinhibitorDetailsDB00845Clofazimineapproved, investigationalunknownsubstrateinhibitorDetailsDB09038EmpagliflozinapprovedunknownsubstrateDetailsDB06419CethromycininvestigationalunknownsubstrateinhibitorDetailsDB00674GalantamineapprovednoinhibitorDetailsDB09026Aliskirenapproved, investigationalnosubstrateDetailsDB09274Artesunateapproved, investigationalunknownsubstrateDetailsDB00188Bortezomibapproved, investigationalnosubstrateDetailsDB14669Betamethasone phosphateapproved, vet_approvedunknownsubstrateinducerDetailsDB12674Lurbinectedinapproved, investigationalunknownsubstrateinhibitorDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00104Octreotideapproved, investigationalunknownsubstrateDetailsDB11796Fostemsavirapproved, investigationalunknownsubstrateDetailsDB15719Belantamab mafodotinapprovedunknownsubstrateDetailsDB15305Risdiplamapproved, investigationalunknownsubstrateDetailsDB15822Pralsetinibapproved, investigationalnosubstrateinhibitorDetailsDB14845Filgotinibapproved, investigationalunknownsubstrateDetailsDB15982BerotralstatapprovednosubstrateinhibitorDetailsDB11853Relugolixapproved, investigationalunknownsubstrateinhibitorDetailsDB14895Vibegronapproved, investigationalnosubstrateDetailsDB01380Cortisone acetateapproved, investigationalunknownsubstrateinducerDetailsDB11632Opicaponeapproved, investigationalnosubstrateDetailsDB15456Vericiguatapproved, investigationalunknownsubstrateDetailsDB11751Cabotegravirapproved, investigationalunknownsubstrateDetailsDB11693Voclosporinapproved, investigationalunknownsubstrateinhibitorDetailsDB15133Tepotinibapproved, investigationalnosubstrateinhibitorDetailsDB00052Somatotropinapproved, investigationalunknownsubstrateDetailsDB00346Alfuzosinapproved, investigationalunknownsubstrateDetailsDB15442Trilaciclibapproved, investigationalunknownsubstrateDetailsDB14989Umbralisibapproved, investigational, withdrawnunknowninhibitorDetailsDB00391Sulpirideapproved, investigationalunknownsubstrateDetailsDB00853Temozolomideapproved, investigationalnosubstrateDetailsDB06237AvanafilapprovedunknownsubstrateDetailsDB11800Tivozanibapproved, investigationalunknownsubstrateDetailsDB00080Daptomycinapproved, investigationalnosubstrateDetailsDB06288Amisulprideapproved, investigationalnosubstrateDetailsDB08995Diosminapproved, investigationalunknowninhibitorDetailsDB04876Vildagliptinapproved, investigationalnosubstrateDetailsDB08822Azilsartan medoxomilapproved, investigationalnoinhibitorDetailsDB00360Sapropterinapproved, investigationalunknowninhibitorDetailsDB05667Levoketoconazoleapproved, investigationalnoinhibitorDetailsDB16222Loncastuximab tesirineapproved, investigationalunknownsubstrateDetailsDB15569Sotorasibapproved, investigationalunknowninhibitorDetailsDB11886Infigratinibapproved, investigationalnosubstrateinhibitorDetailsDB12471Ibrexafungerpapproved, investigationalunknownsubstratetransporterDetailsDB16703Belumosudilapproved, investigationalnosubstrateinhibitorDetailsDB16261Odevixibatapproved, investigationalunknownsubstrateDetailsDB15463Belzutifanapproved, investigationalnosubstrateDetailsDB16220Lonapegsomatropinapproved, investigationalunknownsubstrateDetailsDB16390Mobocertinibapproved, investigationalunknownsubstrateinhibitorDetailsDB16732Tisotumab vedotinapprovednosubstrateDetailsDB16098Atogepantapproved, investigationalnosubstrateDetailsDB08931RiociguatapprovednosubstrateDetailsDB15011Avacopanapproved, investigationalnosubstrateDetailsDB12597Asciminibapproved, investigationalnosubstrateinhibitorDetailsDB06234Maribavirapproved, investigationalnoinhibitorDetailsDB16691Nirmatrelvirapproved, investigationalnosubstrateinhibitorDetailsDB12713Sotagliflozinapproved, investigationalnoinhibitorDetailsDB14973Abrocitinibapproved, investigationalunknowninhibitorDetailsDB16236Mitapivatapproved, investigationalnosubstrateinhibitorDetailsDB09061Cannabidiolapproved, investigationalnoinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknowninhibitorDetailsDB14009Medical Cannabisexperimental, investigationalunknowninhibitorDetailsDB11697Pacritinibapproved, investigationalnoinhibitorDetailsDB06016Cariprazineapproved, investigationalunknowninhibitorDetailsDB16407AzvudineinvestigationalunknownactivatorregulatorDetailsDB12541SAR-405838investigationalnosubstrateDetailsDB00661VerapamilapprovedunknowninhibitorblockerDetailsDB09118StiripentolapprovedunknowninhibitorDetailsDB04951Pirfenidoneapproved, investigationalunknowninhibitorDetailsDB13997Baloxavir marboxilapproved, investigationalunknownsubstrateinhibitorDetailsDB15673Lenacapavirapproved, investigationalnosubstrateDetailsDB16650Deucravacitinibapproved, investigationalunknownsubstrateDetailsDB12095Telotristat ethylapproved, investigationalnosubstrateinhibitorDetailsDB15149Futibatinibapproved, investigationalnosubstrateinhibitorDetailsDB11739Vonoprazanapproved, investigationalunknowninhibitorDetailsDB11793Niraparibapproved, investigationalnosubstrateDetailsDB12489Mirvetuximab soravtansineapproved, investigationalnosubstrateDetailsDB16267Olutasidenibapproved, investigationalnoinhibitorDetailsDB12240Polatuzumab vedotinapproved, investigationalnosubstrateDetailsDB15568Adagrasibapproved, investigationalunknowninhibitorDetailsDB12236Bexagliflozinapproved, investigationalunknownsubstrateDetailsDB17472Pirtobrutinibapproved, investigationalunknownsubstrateinhibitorDetailsDB06374Elacestrantapproved, investigationalunknowninhibitorDetailsDB00683Midazolamapproved, illicitnosubstrateDetailsDB12548Sparsentanapproved, investigationalunknownsubstrateinhibitorDetailsDB15688Zavegepantapproved, investigationalunknownsubstrateDetailsDB16217Leniolisibapproved, investigationalnosubstrateDetailsDB01238Aripiprazoleapproved, investigationalunknowninhibitorDetailsDB09082VilanterolapprovednosubstrateDetailsDB12874Quizartinibapproved, investigationalnosubstrateinhibitorDetailsDB11763Momelotinibapproved, investigationalunknownsubstrateDetailsDB11718Encorafenibapproved, investigationalnosubstrateinhibitorDetailsDB15097Gefapixantapproved, investigationalnosubstrateDetailsDB11967Binimetinibapproved, investigationalnosubstrateDetailsDB16826RepotrectinibinvestigationalnosubstrateinhibitorDetails"
                    }
                }
            ]
        },
        "Disease Information": {
            "Alcohol Dependency": null,
            "Anorexia Nervosa": "Anorexia nervosa (AN), often referred to simply as anorexia,[12] is an eating disorder characterized by low weight, food restriction, body image disturbance, fear of gaining weight, and an overpowering desire to be thin.[1]\n",
            "Bulimia Nervosa": "Bulimia nervosa, also known as simply bulimia, is an eating disorder characterized by binge eating followed by purging or fasting, and excessive concern with body shape and weight.[9][2] This activity aims to expel the body of calories eaten from the binging phase of the process.[9] Binge eating refers to eating a large amount of food in a short amount of time.[2] Purging refers to the attempts to get rid of the food consumed.[2] This may be done by vomiting or taking laxatives.[2]\n",
            "Cataplexy": "Cataplexy is a sudden and transient episode of muscle weakness accompanied by full conscious awareness, typically triggered by emotions such as laughing, crying, or terror.[1] Cataplexy affects approximately 20% of people who have narcolepsy,[2] and is caused by an autoimmune destruction of hypothalamic neurons that produce the neuropeptide hypocretin (also called orexin), which regulates arousal and has a role in stabilization of the transition between wake and sleep states.[3] Cataplexy without narcolepsy is rare and the cause is unknown.\n",
            "Depression": "Depression may refer to:\n",
            "Major Depressive Disorder": "Major depressive disorder (MDD), also known as clinical depression, is a mental disorder[9] characterized by at least two weeks of pervasive low mood, low self-esteem, and loss of interest or pleasure in normally enjoyable activities. Introduced by a group of US clinicians in the mid-1970s,[10] the term was adopted by the American Psychiatric Association for this symptom cluster under mood disorders in the 1980 version of the Diagnostic and Statistical Manual of Mental Disorders (DSM-III), and has become widely used since.\n",
            "Major depressive disorder, recurrent episode": null,
            "Myoclonus": "Myoclonus is a brief, involuntary, irregular (lacking rhythm) twitching  of a muscle, a joint, or a group of muscles, different from clonus, which is rhythmic or regular. Myoclonus (myo- \"muscle\", clonus \"spasm\") describes a medical sign and, generally, is not a diagnosis of a disease. These myoclonic twitches, jerks, or seizures are usually caused by sudden muscle contractions (positive myoclonus) or brief lapses of contraction (negative myoclonus).  The most common circumstance under which they occur is while falling asleep (hypnic jerk).  Myoclonic jerks occur in healthy people and are experienced occasionally by everyone.  However, when they appear with more persistence and become more widespread they can be a sign of various neurological disorders.  Hiccups are a kind of myoclonic jerk specifically affecting the diaphragm.  When a spasm is caused by another person it is known as a provoked spasm.  Shuddering attacks in babies fall in this category.\n",
            "Obesity": "Obesity is a medical condition, sometimes considered a disease,[8][9][10] in which excess body fat has accumulated to such an extent that it can potentially have negative affects on health. People are classified as obese when their body mass index (BMI)\u2014a person's weight divided by the square of the person's height\u2014is over 30\u00a0kg/m2; the range 25\u201330\u00a0kg/m2 is defined as overweight.[1] Some East Asian countries use lower values to calculate obesity.[11] Obesity is a major cause of disability and is correlated with various diseases and conditions, particularly cardiovascular diseases, type 2 diabetes, obstructive sleep apnea, certain types of cancer, and osteoarthritis.[2][12][13]\n",
            "Obsessive Compulsive Disorder": "Obsessive\u2013compulsive disorder (OCD) is a mental and behavioral disorder in which an individual has intrusive thoughts (an obsession) and feels the need to perform certain routines (compulsions) repeatedly to relieve the distress caused by the obsession, to the extent where it impairs general function.[7][1][2]\n",
            "Panic Disorder With Agoraphobia": null,
            "Panic disorder without agoraphobia": null,
            "Premature Ejaculation": "Premature ejaculation (PE) occurs when a man expels semen (and most likely experiences orgasm) soon after beginning sexual activity, and with minimal penile stimulation. It has also been called early ejaculation, rapid ejaculation, rapid climax, premature climax and (historically) ejaculatio praecox. There is no uniform cut-off defining \"premature\", but a consensus of experts at the International Society for Sexual Medicine endorsed a definition of around one minute after penetration.[1] The International Classification of Diseases (ICD-10) applies a cut-off of 15 seconds from the beginning of sexual intercourse.[1]\n",
            "Premenstrual Dysphoric Disorder": "Premenstrual dysphoric disorder (PMDD) is a mood disorder characterized by emotional, cognitive, and physical symptoms. PMDD causes significant distress or impairment in menstruating women during the luteal phase of the menstrual cycle. The symptoms occur in the luteal phase (between ovulation and menses), improve within a few days after the onset of menses, and are minimal or absent in the week after menses.[1] PMDD has a profound impact on a person's quality of life and dramatically increases the risk of suicidal ideation and even suicide attempts.[2] Many women of reproductive age experience discomfort or mild mood changes prior to menstruation. However, 5\u20138% experience severe premenstrual syndrome causing significant distress or functional impairment.[3] Within this population of reproductive age, some will meet the criteria for PMDD. \n"
        }
    },
    "RITALIN": {
        "Active Ingredients": {
            "METHYLPHENIDATE HYDROCHLORIDE": "COC(=O)C(C1CCCCN1)C2=CC=CC=C2.Cl"
        },
        "Drug Information": {
            "Identification": {
                "Summary": "Methylphenidate is a stimulant used in the management of Attention Deficit Hyperactivity Disorder (ADHD).",
                "Brand Names": "Adhansia, Aptensio, Biphentin, Concerta, Cotempla, Daytrana, Foquest, Jornay, Metadate, Methylin, Quillichew, Quillivant, Relexxii, Ritalin",
                "Generic Name": "Methylphenidate",
                "DrugBank Accession Number": "DB00422",
                "Background": "Methylphenidate is a central nervous system stimulant used most commonly in the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) and for narcolepsy. Also known as the marketed products Ritalin, Concerta, or Biphentin, methylphenidate is used with other treatment modalities (psychological, educational, cognitive behaviour therapy, etc) to improve the following group of developmentally inappropriate symptoms associated with ADHD: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. Long-acting formulations of psychostimulants such as methylphenidate, Dextroamphetamine, and Lisdexamfetamine are considered the most effective and widely used treatment for ADHD, and are considered first-line options for children, adolescents, and adults as recommended by CADDRA (Canadian ADHD Resource Alliance). 12 CADDRA recommends the use of methylphenidate due to long term studies, of over twenty years in duration, which show methylphenidate is safe and effective. \nWhile its exact mechanism is unclear, methylphenidate (MPH) has been shown to act as a norepinephrine and dopamine reuptake inhibitor (NDRI), thereby increasing the presence of these neurotransmitters in the extraneuronal space and prolonging their action.6 There is a dose-related effect of psychostimulants on receptor stimulation, where higher doses are shown to increase norepinephrine (NE) and dopamine (DA) efflux throughout the brain which can result in impaired cognition and locomotor-activating effects. In contrast, low doses are found to selectively activate NE and DA neurotransmission within the prefrontal cortex which is an area of the brain thought to play a prominent role in ADHD pathophysiology, thereby improving clinical efficacy and preventing side effects.8 The lower doses used to treat ADHD are not associated with the locomotor-activating effects associated with higher doses and instead reduce movement, impulsivity, and increase cognitive function including sustained attention and working memory.6,7 Methylphenidate's beneficial effects in sustaining attention have also been shown to be mediated by alpha-1 adrenergic receptor activity.9 Clinical findings have shown that children with ADHD have an abnormality in the dopamine transporter gene (DAT1), the D4 receptor gene (DRD-4), and/or the D2 receptor gene that may be at least partly overcome by the dopaminergic effects of methylphenidate, suggesting a possible mode of action.15\nWhen provided as Biphentin\u00ae, methylphenidate is released through a multi-layer release delivery system (MLRTM) where 40% of the dose is provided as an immediate release and 60% is provided through a gradual release. Biphentin was designed to be an alternative to separate doses of immediate-release (IR) methylphenidate by providing a biphasic concentration-time profile when given as a single dose. The MLRTM release system allows for a sustained effect for 10-12 hours, allowing for once-daily dosing that covers the major times that ADHD impairment might occur (such as school, homework periods, during the work day, etc).\nWhen provided as Concerta\u00ae, methylphenidate is released through the patented Osmotic Controlled-Release Oral Delivery (OROS) system where 22% of the dose is provided as an immediate release and 78% is provided through a gradual release.1 OROS is comprised of an osmotically active trilayer core surrounded by a semipermeable membrane with an immediate-release drug overcoat. Within an aqueous environment, such as the stomach, the drug overcoat, which consists of 22% of the dose, dissolves within one hour, providing an initial immediate-release formulation of methylphenidate. Water then permeates through the membrane into the tablet core where the osmotically active polymer excipients expand, allowing methylphenidate to release slowly through the orifice over a period of 6-7 hours. Concerta also provides a sustained 10-12 hour effect, allowing for once-daily dosing.\nMethylphenidate contains a blackbox warning stating that CNS stimulants, including methylphenidate-containing products and amphetamines, have a high potential for abuse and dependence. This abuse potential is likely related to the effects associated with higher doses of methylphenidate, which induce surface expression of the dopamine transporter (DAT).10 In particular, increased dopamine in key brain areas is associated with the reinforcing and addictive properties of psychostimulants such as methylphenidate, and even amplifies the potency and reinforcing effects of other drugs of abuse such as amphetamines, making ADHD sufferers more susceptible to their addictive effects.11 Concerns about abuse potential have spurred research into medications with fewer effects on DAT and the use of non-stimulant ADHD medications including Atomoxetine and Guanfacine.",
                "Type": "Small Molecule",
                "Groups": "Approved, Investigational",
                "Structure": "3DDownload MOLSDF3D-SDFPDBSMILESInChI\n\n\n Similar StructuresStructure for Methylphenidate (DB00422)\u00d7 Close",
                "Weight": "Average: 233.3062 Monoisotopic: 233.141578857",
                "Chemical Formula": "C14H19NO2",
                "Synonyms": "Methyl phenidylacetatemethyl phenyl(piperidin-2-yl)acetatemethyl \u03b1-phenyl-\u03b1-(2-piperidyl)acetatemethyl \u03b1-phenyl-\u03b1-2-piperidinylacetateMethylphenidanMethylphenidateMethylphenidatumMetilfenidatoMPH\u03b1-phenyl-2-piperidineacetic acid methyl ester"
            },
            "Pharmacology": {
                "Indication": "Methylphenidate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years of age and older and for the treatment of narcolepsy.\nReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See how",
                "Associated Conditions": "Attention Deficit Hyperactivity Disorder (ADHD)\nNarcolepsy",
                "Contraindications & Blackbox Warnings": "Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events with our Clinical APILearn more",
                "Pharmacodynamics": "Methylphenidate is a racemic mixture comprised of the d- and l-isomers. The d-isomer is more pharmacologically active than the l-isomer. Radioligand binding studies demonstrate that binding of methylphenidate in the brain is localized to dopamine-rich areas, in particular in the prefrontal cortex which has been demonstrated to play a prominent role in ADHD pathophysiology.8 In a number of animal models, methylphenidate enhances locomotor activity and induces stereotypic behaviours.",
                "Mechanism of action": "While its exact mechanism is unclear, methylphenidate (MPH) has been shown to act as a norepinephrine and dopamine reuptake inhibitor (NDRI), thereby increasing the presence of these neurotransmitters in the extraneuronal space and prolonging their action.6 There is a dose-related effect of psychostimulants on receptor stimulation, where higher doses are shown to increase norepinephrine (NE) and dopamine (DA) efflux throughout the brain which can result in impaired cognition and locomotor-activating effects. In contrast, low doses are found to selectively activate NE and DE neurotransmission within the prefrontal cortex which is an area of the brain thought to play a prominent role in ADHD pathophysiology, thereby improving clinical efficacy and preventing side effects.8 The lower doses used to treat ADHD are not associated with the locomotor-activating effects associated with higher doses and instead reduce movement, impulsivity, and increase cognitive function including sustained attention and working memory.6,7 Methylphenidate's beneficial effects in sustaining attention have also been shown to be mediated by alpha-1 adrenergic receptor activity.9\nClinical findings have shown that children with ADHD have an abnormality in the dopamine transporter gene (DAT1), the D4 receptor gene (DRD-4), and/or the D2 receptor gene that may be at least partly overcome by the dopaminergic effects of methylphenidate, suggesting a possible mode of action.15\nTargetActionsOrganismASodium-dependent dopamine transporterinhibitorHumansU5-hydroxytryptamine receptor 1ANot AvailableHumansUSodium-dependent noradrenaline transporterinhibitorHumans",
                "Absorption": "Concerta\u00ae: Methylphenidate is readily absorbed. Following oral administration of Concerta, plasma methylhphenidate concentrations reach an initial maximum at about 1 hour followed by gradual ascending concentrations over the next 5-9 hours. Mean times to reach peak plasma concentrations across all doses of Concerta occurred between 6-10 hours. Once daily dosing minimizes the fluctuations between peak and trough concentrations associated with multiple doses of immediate-release methylphenidate treatments.15 Depending on the doses provided, Cmax was found to range from 6.0-15.0ng/mL, Tmax ranged from 8.1-9.4h, and AUC ranged from 50.4-121.5 ng\u00b7h/mL in children.15\nWhen provided as Concerta\u00ae, methylphenidate is released through the patented Osmotic Controlled-Release Oral Delivery (OROS) system where 22% of the dose is provided as an immediate release and 78% is provided through a gradual release.1 OROS is comprised of an osmotically active trilayer core surrounded by a semipermeable membrane with an immediate-release drug overcoat. Within an aqueous environment, such as the stomach, the drug overcoat, which consists of 22% of the dose, dissolves within one hour, providing an initial immediate-release formulation of methylphenidate. Water then permeates through the membrane into the tablet core where the osmotically active polymer excipients expand, allowing methylphenidate to release slowly through the orifice over a period of 6-7 hours. Concerta also provides a sustained 10-12 hour effect, allowing for once-daily dosing.\nBiphentin\u00ae: Methylphenidate is rapidly and extensively absorbed following oral administration, with peak blood levels obtained in 1-3 hours.16\nWhen provided as Biphentin\u00ae, methylphenidate is released through a multi-layer release delivery system (MLRTM) where 40% of the dose is provided as an immediate release and 60% is provided through a gradual release. Biphentin was designed to be an alternative to separate doses of immediate-release (IR) methylphenidate by providing a biphasic concentration-time profile when given as a single dose. The MLRTM release system allows for a sustained effect for 10-12 hours, allowing for once-daily dosing that covers the major times that ADHD impairment might occur (such as school, homework periods, during the workday, etc).\nMethylphenidate (immediate release): Methylphenidate hydrochloride is rapidly and extensively absorbed from the tablets following oral administration; however, owing to extensive first-pass metabolism, bioavailability is low (approx. 30%) and large individual differences exist (11-52%). In one study, the administration of methylphenidate hydrochloride with food accelerated absorption but had no effect on the amount absorbed. Peak plasma concentrations of 10.8 and 7.8 ng/mL were observed, on average, 2 hours after administration of 0.30 mg/kg in children and adults, respectively. Peak plasma concentrations showed marked variability between subjects. Both the area under the concentration-time curve (AUC), and the peak plasma concentrations (Cmax) showed dose-proportionality.17",
                "Volume of distribution": "Concerta: Plasma methylphenidate concentrations in adults decline bi-exponentially\nfollowing oral administration.15\nBiphentin: The apparent distribution volume of methylphenidate in children is approximately 20 L/kg, with\nsubstantial variability (11 to 33 L/kg).16\nMethylphenidate (immediate release): The apparent distribution volume of methylphenidate in children was approximately 20 L/kg, with substantial variability (11-33 L/kg). The volume of distribution after an intravenous dose (Vss) is 2.23 L/kg for the racemate in healthy adult volunteers.17",
                "Protein binding": "Concerta: In humans, 15 \u00b1 5% of methylphenidate in the blood is bound to plasma proteins. 15\nBiphentin: In blood, methylphenidate and its metabolites are distributed between plasma (57%) and\nerythrocytes (43%). Methylphenidate and its metabolites exhibit low plasma protein binding\n(approximately 15%).16\nMethylphenidate (immediate release): In blood, methylphenidate and its metabolites are distributed between plasma (57%) and erythrocytes (43%). Methylphenidate and its metabolites exhibit low plasma protein binding (approx. 15%).17",
                "Metabolism": "Methylphenidate is hepatically metabolized. More specifically, it is rapidly and extensively metabolized by carboxylesterase CES1A1. Via this enzyme, methylphenidate undergoes de-esterification to ritalinic acid (a-phenyl-2-piperidine acetic acid, PPAA), which has little to no pharmacologic activity.\nHover over products below to view reaction partnersMethylphenidate\n\n\n\u03b1-phenyl-2-piperidine acetic acid (ritalinic acid)",
                "Route of elimination": "After oral administration of an immediate release formulation of methylphenidate, 78%-97% of the dose is excreted in the urine and 1%-3% in the feces in the form of metabolites within 48-96 hours. Only small quantities (<1%) of unchanged methylphenidate appear in the urine. Most of the dose is excreted in the urine as ritalinic acid (60%-86%), the remainder being accounted for by minor metabolites.",
                "Half-life": "Concerta: The half-life of methylphenidate in adults following oral administration of Concerta\u00ae was approximately 3.5 h.15\nBiphentin: Methylphenidate is eliminated from plasma with a mean half-life of 2.4 hours in children and 2.1 hours in adults.16\nMethylphenidate (immediate release): Methylphenidate is eliminated from the plasma with a mean half-life of 2.4 hours in children and 2.1 hours in adults.17",
                "Clearance": "The apparent mean systemic clearance after an oral dose is 10.2 and 10.5 L/h/kg in children and adults, respectively for a 0.3 mg/kg dose, and 0.565 L/h/kg after an intravenous dose of the racemate in healthy adult volunteers.17",
                "Adverse Effects": "Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support & research outcomes with our structured adverse effects data.See a data sample",
                "Toxicity": "Symptoms of overdose include vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes. LD50=190mg/kg (orally in mice)",
                "Pathways": "Not Available",
                "Pharmacogenomic Effects/ADRs": "Not Available"
            },
            "Interactions": {
                "Drug Interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. ApprovedVet approvedNutraceuticalIllicitWithdrawnInvestigationalExperimentalAll DrugsDrugInteractionIntegrate drug-drug interactions in your software\n\n\nAcebutololMethylphenidate may decrease the antihypertensive activities of Acebutolol.AceclofenacThe risk or severity of hypertension can be increased when Methylphenidate is combined with Aceclofenac.AcemetacinThe risk or severity of hypertension can be increased when Methylphenidate is combined with Acemetacin.AcenocoumarolThe metabolism of Acenocoumarol can be decreased when combined with Methylphenidate.AcetazolamideThe therapeutic efficacy of Acetazolamide can be decreased when used in combination with Methylphenidate.AcetophenazineThe risk or severity of adverse effects can be increased when Acetophenazine is combined with Methylphenidate.Acetylsalicylic acidThe risk or severity of hypertension can be increased when Methylphenidate is combined with Acetylsalicylic acid.AlclofenacThe risk or severity of hypertension can be increased when Methylphenidate is combined with Alclofenac.AlfentanilThe risk or severity of hypertension can be increased when Methylphenidate is combined with Alfentanil.AlimemazineThe risk or severity of adverse effects can be increased when Alimemazine is combined with Methylphenidate.Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more",
                "Food Interactions": "Avoid alcohol. Co-administration with alcohol may cause a \"dose-dumping\" effect with some extended-release formulations of methylphenidate. It may also potentiate the CNS effects of methylphenidate.\nTake with or without food. Patients may take methylphenidate with food to alleviate GI upset."
            },
            "Products": {
                "": "Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access now  Access drug product information from over 10 global regions.Access now",
                "Product Ingredients": "IngredientUNIICASInChI KeyMethylphenidate hydrochloride4B3SC438HI23655-65-4JUMYIBMBTDDLNG-UHFFFAOYSA-N",
                "Product Images": "PreviousNext",
                "International/Other Brands": "Equasym XL / Medikinet XL / Quillivant / Riphenidate / Rubifen SR",
                "Brand Name Prescription Products": "NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImageAdhansia XRCapsule, extended release70 mg/1OralAdlon Therapeutics L.P.2019-07-012023-11-30USAdhansia XRCapsule, extended release35 mg/1OralAdlon Therapeutics L.P.2019-07-012023-09-30USAdhansia XRCapsule, extended release55 mg/1OralAdlon Therapeutics L.P.2019-07-012023-11-30USAdhansia XRCapsule, extended release25 mg/1OralAdlon Therapeutics L.P.2019-07-012023-11-30USAdhansia XRCapsule, extended release85 mg/1OralAdlon Therapeutics L.P.2019-07-012023-11-30USAdhansia XRCapsule, extended release45 mg/1OralAdlon Therapeutics L.P.2019-07-012023-09-30USAptensio XRCapsule, extended release30 mg/1OralRhodes Pharmaceuticals L.P.2015-04-17Not applicableUSAptensio XRCapsule, extended release10 mg/1OralRhodes Pharmaceuticals L.P.2015-04-17Not applicableUSAptensio XRCapsule, extended release50 mg/1OralRhodes Pharmaceuticals L.P.2015-04-17Not applicableUSAptensio XRCapsule, extended release20 mg/1OralRhodes Pharmaceuticals L.P.2015-04-17Not applicableUS",
                "Generic Prescription Products": "NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImageMetadate ERTablet, extended release20 mg/1OralUpstate Pharma, LLC2014-11-01Not applicableUSMetadate ERTablet, extended release20 mg/1OralUnither Pharmaceuticals1988-06-01Not applicableUSMetadate ERTablet, extended release20 mg/1OralLannett Company, Inc.2014-11-01Not applicableUSMethylinTablet10 mg/1OralGolden State Medical Supply2010-05-202015-06-30USMethylinTablet5 mg/1OralGolden State Medical Supply2010-05-202015-06-30USMethylinTablet20 mg/1OralGolden State Medical Supply2010-05-202015-06-30USMethylin ERTablet, extended release10 mg/1OralGolden State Medical Supply2010-05-202015-06-30USMethylin ERTablet, extended release20 mg/1Oralbryant ranch prepack2011-03-182013-03-31USMethylin ERTablet, extended release20 mg/1OralGolden State Medical Supply2010-05-202015-06-30USMethylphenidateSolution5 mg/5mLOralKVK-Tech, Inc.2016-11-21Not applicableUS"
            },
            "Categories": {
                "ATC Codes": "N06BA04 \u2014 MethylphenidateN06BA \u2014 Centrally acting sympathomimeticsN06B \u2014 PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICSN06 \u2014 PSYCHOANALEPTICSN \u2014 NERVOUS SYSTEM",
                "Drug Categories": "Acids, Carbocyclic\nAgents that produce hypertension\nAgents that reduce seizure threshold\nCentral Nervous System Agents\nCentral Nervous System Stimulants\nCentral Nervous System Stimulation\nCentrally Acting Sympathomimetics\nDopamine Agents\nDopamine Uptake Inhibitors\nHeterocyclic Compounds, Fused-Ring\nMembrane Transport Modulators\nMethylphenidate and isomer\nNervous System\nNeurotransmitter Agents\nNeurotransmitter Uptake Inhibitors\nPhenylacetates\nPiperidines\nPsychoanaleptics\nPsychostimulants, Agents Used for ADHD and Nootropics\nRespiratory and CNS Stimulants",
                "Chemical TaxonomyProvided by Classyfire": "DescriptionThis compound belongs to the class of organic compounds known as aralkylamines. These are alkylamines in which the alkyl group is substituted at one carbon atom by an aromatic hydrocarbyl group.KingdomOrganic compoundsSuper ClassOrganic nitrogen compoundsClassOrganonitrogen compoundsSub ClassAminesDirect ParentAralkylaminesAlternative ParentsPiperidines / Benzene and substituted derivatives / Methyl esters / Amino acids and derivatives / Monocarboxylic acids and derivatives / Dialkylamines / Azacyclic compounds / Organopnictogen compounds / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds\n\n\n show 1 moreSubstituentsAmino acid or derivatives / Aralkylamine / Aromatic heteromonocyclic compound / Azacycle / Benzenoid / Carbonyl group / Carboxylic acid derivative / Carboxylic acid ester / Hydrocarbon derivative / Methyl ester / Monocarboxylic acid or derivatives / Monocyclic benzene moiety / Organic oxide / Organic oxygen compound / Organoheterocyclic compound / Organooxygen compound / Organopnictogen compound / Piperidine / Secondary aliphatic amine / Secondary amine\n\n\n show 10 moreMolecular FrameworkAromatic heteromonocyclic compoundsExternal Descriptorspiperidines, methyl ester, beta-amino acid ester (CHEBI:84276)",
                "Description": "This compound belongs to the class of organic compounds known as aralkylamines. These are alkylamines in which the alkyl group is substituted at one carbon atom by an aromatic hydrocarbyl group.",
                "Kingdom": "Organic compounds",
                "Super Class": "Organic nitrogen compounds",
                "Class": "Organonitrogen compounds",
                "Sub Class": "Amines",
                "Direct Parent": "Aralkylamines",
                "Alternative Parents": "Piperidines / Benzene and substituted derivatives / Methyl esters / Amino acids and derivatives / Monocarboxylic acids and derivatives / Dialkylamines / Azacyclic compounds / Organopnictogen compounds / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds\n\n\n show 1 more",
                "Substituents": "Amino acid or derivatives / Aralkylamine / Aromatic heteromonocyclic compound / Azacycle / Benzenoid / Carbonyl group / Carboxylic acid derivative / Carboxylic acid ester / Hydrocarbon derivative / Methyl ester / Monocarboxylic acid or derivatives / Monocyclic benzene moiety / Organic oxide / Organic oxygen compound / Organoheterocyclic compound / Organooxygen compound / Organopnictogen compound / Piperidine / Secondary aliphatic amine / Secondary amine\n\n\n show 10 more",
                "Molecular Framework": "Aromatic heteromonocyclic compounds",
                "External Descriptors": "piperidines, methyl ester, beta-amino acid ester (CHEBI:84276)",
                "Affected organisms": "Humans and other mammals"
            },
            "Chemical Identifiers": {
                "UNII": "207ZZ9QZ49",
                "CAS number": "113-45-1",
                "InChI Key": "DUGOZIWVEXMGBE-UHFFFAOYSA-N",
                "InChI": "InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3",
                "IUPAC Name": "methyl 2-phenyl-2-(piperidin-2-yl)acetate",
                "SMILES": "COC(=O)C(C1CCCCN1)C1=CC=CC=C1"
            },
            "References": {
                "Synthesis Reference": "US2512572",
                "General References": "Keating GM, McClellan K, Jarvis B: Methylphenidate (OROS formulation). CNS Drugs. 2001;15(6):495-500; discussion 501-3. [Article] Markowitz JS, DeVane CL, Pestreich LK, Patrick KS, Muniz R: A comprehensive in vitro screening of d-, l-, and dl-threo-methylphenidate: an exploratory study. J Child Adolesc Psychopharmacol. 2006 Dec;16(6):687-98. [Article] Fone KC, Nutt DJ: Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder. Curr Opin Pharmacol. 2005 Feb;5(1):87-93. [Article] Sharma RP, Javaid JI, Pandey GN, Easton M, Davis JM: Pharmacological effects of methylphenidate on plasma homovanillic acid and growth hormone. Psychiatry Res. 1990 Apr;32(1):9-17. [Article] Hodgkins P, Shaw M, Coghill D, Hechtman L: Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options. Eur Child Adolesc Psychiatry. 2012 Sep;21(9):477-92. doi: 10.1007/s00787-012-0286-5. Epub 2012 Jul 5. [Article] Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AF, Kelley AE, Schmeichel B, Hamilton C, Spencer RC: Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry. 2006 Nov 15;60(10):1111-20. doi: 10.1016/j.biopsych.2006.04.022. Epub 2006 Jun 23. [Article] Solanto MV: Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res. 1998 Jul;94(1):127-52. [Article] Brennan AR, Arnsten AF: Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function. Ann N Y Acad Sci. 2008;1129:236-45. doi: 10.1196/annals.1417.007. [Article] Berridge CW, Shumsky JS, Andrzejewski ME, McGaughy JA, Spencer RC, Devilbiss DM, Waterhouse BD: Differential sensitivity to psychostimulants across prefrontal cognitive tasks: differential involvement of noradrenergic alpha(1) - and alpha(2)-receptors. Biol Psychiatry. 2012 Mar 1;71(5):467-73. doi: 10.1016/j.biopsych.2011.07.022. Epub 2011 Sep 3. [Article] Calipari ES, Ferris MJ, Salahpour A, Caron MG, Jones SR: Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression. Nat Commun. 2013;4:2720. doi: 10.1038/ncomms3720. [Article] Marshall CA, Brodnik ZD, Mortensen OV, Reith MEA, Shumsky JS, Waterhouse BD, Espana RA, Kortagere S: Selective activation of Dopamine D3 receptors and norepinephrine transporter blockade enhances sustained attention. Neuropharmacology. 2019 Apr;148:178-188. doi: 10.1016/j.neuropharm.2019.01.003. Epub 2019 Jan 8. [Article] CADDRA - Canadian ADHD Practice Guidelines [Link] Concerta FDA label [Link] FDA Approved Drug Products: Daytrana\u00ae transdermal system [Link] Health Canada Label - Concerta [File] Health Canada Label - Biphentin [File] Health Canada - Ritalin [File]",
                "External Links": "Human Metabolome DatabaseHMDB0014566KEGG DrugD04999KEGG CompoundC07196PubChem Compound4158PubChem Substance46505929ChemSpider4015BindingDB50062912RxNav6901ChEBI84276ChEMBLCHEMBL796Therapeutic Targets DatabaseDAP000024PharmGKBPA10054RxListRxList Drug PageDrugs.comDrugs.com Drug PagePDRhealthPDRhealth Drug PageWikipediaMethylphenidate",
                "Human Metabolome Database": "HMDB0014566",
                "KEGG Drug": "D04999",
                "KEGG Compound": "C07196",
                "PubChem Compound": "4158",
                "PubChem Substance": "46505929",
                "ChemSpider": "4015",
                "BindingDB": "50062912",
                "RxNav": "6901",
                "ChEBI": "84276",
                "ChEMBL": "CHEMBL796",
                "Therapeutic Targets Database": "DAP000024",
                "PharmGKB": "PA10054",
                "RxList": "RxList Drug Page",
                "Drugs.com": "Drugs.com Drug Page",
                "PDRhealth": "PDRhealth Drug Page",
                "Wikipedia": "Methylphenidate"
            },
            "Clinical Trials": {
                "Clinical Trials": "PhaseStatusPurposeConditionsCount4Active Not RecruitingBasic ScienceCognitive Functioning / Exercise Test / Hypothermia14Active Not RecruitingTreatmentAttention Deficit Hyperactivity Disorder (ADHD)14CompletedNot AvailableAttention Deficit Hyperactivity Disorder (ADHD)34CompletedNot AvailableHealthy Subjects (HS)24CompletedNot AvailableNeurofibromatosis, type 1 (von Recklinghausen's disease)14CompletedBasic ScienceAnxiety Disorders14CompletedBasic ScienceAttention Deficit Hyperactivity Disorder (ADHD)44CompletedBasic ScienceAttention Deficit Hyperactivity Disorder (ADHD) / Healthy Subjects (HS)14CompletedBasic ScienceAttention Deficit Hyperactivity Disorder (ADHD) / Substance Use Disorders (SUD)14CompletedBasic ScienceCarboxylesterase 1 (CES1) Genotype / CES1 Activity2"
            },
            "Pharmacoeconomics": {
                "Manufacturers": "Shire development inc\nUcb inc\nNovartis pharmaceuticals corp\nMallinckrodt inc\nTris pharma inc\nOrtho mcneil janssen pharmaceutical inc\nAble laboratories inc\nActavis elizabeth llc\nWatson laboratories inc\nOrtho-McNeil-Janssen Pharmaceuticals, Inc.",
                "Packagers": "Alliant Pharmaceuticals Inc.\nAlza Corp.\nApothecon\nBryant Ranch Prepack\nCardinal Health\nCaremark LLC\nChattem Chemicals Inc.\nD.M. Graham Laboratories Inc.\nDispensing Solutions\nElan Pharmaceuticals Inc.\nEurand Pharmaceuticals Inc.\nJanssen-Ortho Inc.\nMajor Pharmaceuticals\nMallinckrodt Inc.\nMckesson Corp.\nMcNeil Laboratories\nNovartis AG\nNoven Pharmaceuticals Inc.\nNucare Pharmaceuticals Inc.\nOrtho Mcneil Janssen Pharmaceutical Inc.\nPatriot Pharmaceuticals\nPD-Rx Pharmaceuticals Inc.\nPhysicians Total Care Inc.\nPurdue Pharma LP\nQualitest\nQuality Care\nSandoz\nSciele Pharma Inc.\nShire Inc.\nStat Rx Usa\nSuperior Pharmeceuticals\nUCB Pharma\nUpstate Pharma LLC\nWatson Pharmaceuticals",
                "Dosage Forms": "FormRouteStrengthCapsule, extended releaseOral25 mg/1Capsule, extended releaseOral35 mg/1Capsule, extended releaseOral45 mg/1Capsule, extended releaseOral55 mg/1Capsule, extended releaseOral70 mg/1Capsule, extended releaseOral85 mg/1Capsule, extended releaseOral15 mg/1Capsule, extended releaseOral10 mgCapsule, extended releaseOral15 mgCapsule, extended releaseOral30 mgCapsule, extended releaseOral40 mgCapsule, extended releaseOral50 mgCapsule, extended releaseOral60 mgCapsule, extended releaseOral80 mgTabletOral27.000 mgTablet, extended releaseOral18 mg/1Tablet, extended releaseOral18 mgTablet, extended releaseOral27 mgTablet, extended releaseOral27 mg/1Tablet, extended releaseOral36 mgTablet, extended releaseOral36 mg/1Tablet, extended releaseOral54 mgTablet, extended releaseOral54 mg/1TabletOral18 mgTablet, extended releaseOralTabletOral36 mgTabletOral54 mgTablet, film coatedOral18 mgTablet, film coatedOral27 mgTablet, film coatedOral36 mgTablet, film coatedOral54 mgTablet, orally disintegratingOral17.3 mg/1Tablet, orally disintegratingOral25.9 mg/1Tablet, orally disintegratingOral8.6 mg/1PatchTransdermal10 mg/9hPatchTransdermal15 mg/9hPatchTransdermal20 mg/9hPatchTransdermal30 mg/9hCapsuleOral10 MGCapsuleOral30 MGCapsuleOral40 MGCapsuleOral50 MGCapsuleOral60 MGCapsuleOral100 mg/1CapsuleOral20 mg/1CapsuleOral40 mg/1CapsuleOral60 mg/1CapsuleOral80 mg/1CapsuleOral5 MGTabletOralCapsule, extended releaseOral5 MGCapsuleOral34.6000 mgCapsule, delayed release pelletsOral10 mgCapsule, delayed release pelletsOral20 mgCapsule, delayed release pelletsOral30 mgCapsule, delayed release pelletsOral40 mgCapsule, delayed release pelletsOral5 mgCapsule, delayed releaseOralTablet, extended releaseOral10 mg/1Capsule, extended releaseOral10 mg/1Capsule, extended releaseOral20 mg/1Capsule, extended releaseOral30 mg/1Capsule, extended releaseOral50 mg/1TabletOral2.5 mg/1Tablet, chewableOral10 mg/1Tablet, chewableOral2.5 mg/1Tablet, chewableOral5 mg/1PatchTransdermal1.1 mg/1hPatchTransdermal1.6 mg/1hPatchTransdermal2.2 mg/1hPatchTransdermal3.3 mg/1hTabletOral20 mg/1TabletOral5 mg/1Capsule, extended releaseOral40 mg/1Capsule, extended releaseOral60 mg/1SolutionOral1 mg/1mLSolutionOral10 mg/10mLSolutionOral10 mg/5mLSolutionOral2 mg/1mLSolutionOral5 mg/5mLTabletOral10 mg/1TabletOral18 mg/1TabletOral27 mg/1TabletOral36 mg/1TabletOral54 mg/1Tablet, extended releaseOral20 mg/1Tablet, extended releaseOral45 mg/1Tablet, extended releaseOral63 mg/1Tablet, extended releaseOral72 mg/1Tablet, film coated, extended releaseOral18 mg/1Tablet, film coated, extended releaseOral27 mg/1Tablet, film coated, extended releaseOral36 mg/1Tablet, film coated, extended releaseOral54 mg/1Tablet, film coated, extended releaseOral20 mg/1PatchTransdermal27.5 mg/1mgPatchTransdermal41.3 mg/1mgPatchTransdermal55 mg/1mgPatchTransdermal82.5 mg/1mgTabletOral10.00 mgTabletOral20.00 mgTabletOral5.00 mgTabletOral20 mgTabletOral5 mgTablet, chewable, extended releaseOral20 mg/1Tablet, chewable, extended releaseOral30 mg/1Tablet, chewable, extended releaseOral40 mg/1PowderOral5 mg / mLSuspension, extended releaseOral300 mg/60mLSuspension, extended releaseOral600 mg/120mLSuspension, extended releaseOral750 mg/150mLSuspension, extended releaseOral900 mg/180mLCapsule, extended releaseOral15.000 mgCapsuleOralCapsule, delayed releaseOral10 mgCapsule, delayed releaseOral20 mgCapsule, delayed releaseOral30 mgCapsule, delayed releaseOral40 mgCapsuleOral20 mgTablet, film coatedOral20 mgTablet, extended releaseOral20 mgCapsule, extended releaseOral20 mgTabletOral10 mgTabletOral10.000 mgTabletOral18.000 mg",
                "Prices": "Unit descriptionCostUnitDaytrana 30 15 mg/9hr Patches Box175.64USD boxDaytrana 30 30 mg/9hr Patches Box174.73USD boxDaytrana 30 10 mg/9hr Patches Box172.78USD boxDaytrana 30 20 mg/9hr Patches Box168.72USD boxMethylphenidate hcl powder44.62USD gConcerta er 54 mg tablet25.45USD tabletConcerta er 36 mg tablet23.38USD tabletConcerta er 27 mg tablet22.65USD tabletConcerta er 18 mg tablet22.11USD tabletMetadate cd 50 mg capsule7.08USD capsuleMetadate cd 60 mg capsule7.02USD capsuleConcerta 54 mg Controlled Release Tabs6.18USD tabMetadate cd 40 mg capsule5.77USD capsuleConcerta 36 mg Controlled Release Tabs5.72USD tabFocalin xr 30 mg capsule5.42USD capsuleFocalin XR 20 mg 24 Hour Capsule5.31USD capsuleDaytrana 10 mg/9 hr patch5.16USD patchDaytrana 15 mg/9 hr patch5.16USD patchDaytrana 20 mg/9 hour patch5.16USD patchDaytrana 30 mg/9 hour patch5.16USD patchFocalin xr 15 mg capsule5.16USD capsuleFocalin xr 20 mg capsule5.16USD capsuleFocalin XR 30 mg 24 Hour Capsule5.15USD capsuleFocalin xr 10 mg capsule5.02USD capsuleConcerta 18 mg Controlled Release Tabs5.0USD tabConcerta 27 mg Controlled Release Tabs5.0USD tabFocalin XR 10 mg 24 Hour Capsule4.96USD capsuleFocalin xr 5 mg capsule4.95USD capsuleConcerta 54 mg tablet sa4.91USD tabletFocalin XR 15 mg 24 Hour Capsule4.89USD capsuleFocalin XR 5 mg 24 Hour Capsule4.83USD capsuleRitalin la 40 mg capsule4.55USD capsuleConcerta 36 mg tablet sa4.51USD tabletRitalin la 30 mg capsule4.43USD capsuleRitalin LA 10 mg 24 Hour Capsule4.42USD capsuleRitalin LA 20 mg 24 Hour Capsule4.42USD capsuleRitalin LA 30 mg 24 Hour Capsule4.42USD capsuleRitalin LA 40 mg 24 Hour Capsule4.42USD capsuleConcerta 27 mg tablet sa4.37USD tabletRitalin la 10 mg capsule4.33USD capsuleRitalin la 20 mg capsule4.33USD capsuleConcerta 18 mg tablet sa4.27USD tabletMetadate cd 20 mg capsule4.24USD capsuleMetadate cd 30 mg capsule4.24USD capsuleMetadate cd 10 mg capsule4.2USD capsuleMethylphenidate er 10 mg tablet3.24USD tabletRitalin SR 20 mg Controlled Release Tabs3.0USD tabRitalin sr 20 mg tablet2.67USD tabletRitalin 20 mg tablet1.87USD tabletFocalin 10 mg tablet1.7USD tabletRitalin 5 mg tablet1.42USD tabletMetadate er 20 mg tablet1.32USD tabletMethylin ER 20 mg Controlled Release Tabs1.3USD tabRitalin 10 mg tablet1.29USD tabletMetadate er 10 mg tablet sa1.28USD tabletFocalin 5 mg tablet1.26USD tabletMethylphenidate HCl CR 20 mg Controlled Release Tabs1.2USD tabMethylin er 20 mg tablet1.12USD tabletMethylphenidate HCl 20 mg tablet1.05USD tabletMethylin ER 10 mg1.0USD tabMethylphenidate HCl 10 mg tablet0.95USD tabletMethylphenidate HCl 5 mg tablet0.94USD tabletMethylin er 10 mg tablet0.84USD tabletFocalin 2.5 mg tablet0.76USD tabletMethylin 20 mg tablet0.69USD tabletMethylphenidate 20 mg tablet0.69USD tabletRitalin 20 mg Tablet0.67USD tabletRitalin Sr 20 mg Extended-Release Tablet0.67USD tabletMethylin 10 mg tablet0.48USD tabletMethylphenidate 10 mg tablet0.48USD tabletRitalin 10 mg Tablet0.38USD tabletApo-Methylphenidate 20 mg Tablet0.37USD tabletApo-Methylphenidate Sr 20 mg Extended-Release Tablet0.37USD tabletPms-Methylphenidate 20 mg Tablet0.37USD tabletSandoz Methylphenidate 20 mg Extended-Release Tablet0.37USD tabletMethylin 5 mg tablet0.33USD tabletMethylphenidate 5 mg tablet0.33USD tabletApo-Methylphenidate 10 mg Tablet0.17USD tabletPms-Methylphenidate 10 mg Tablet0.17USD tabletPms-Methylphenidate 5 mg Tablet0.1USD tablet  DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.",
                "Patents": "Patent NumberPediatric ExtensionApprovedExpires (estimated)RegionUS5958446No1999-09-282012-12-12USCA2355644No2009-01-202019-12-17CanadaCA2264852No2005-11-012017-09-16CanadaUS8999386No2015-04-072033-04-14USUS6919373Yes2005-07-192018-01-31USUS6930129Yes2005-08-162018-01-31USUS9000038Yes2015-04-072018-01-31USUS9144549No2015-09-292017-07-31USUS9029416No2015-05-122017-07-31USUS8163798Yes2012-04-242018-01-31USUS8629179Yes2014-01-142018-01-31USUS6344215No2002-02-052020-10-27USUS6228398No2001-05-082019-11-01USUS6635284No2003-10-212015-12-04USUS7431944No2008-10-072015-12-04USUS5837284No1998-11-172015-12-04USUS7691880No2010-04-062024-10-07USUS6210705No2001-04-032018-09-30USUS6348211No2002-02-192018-09-30USUS8632802No2014-01-212025-10-07USUS9034370No2015-05-192025-10-07USUS8062667No2011-11-222029-03-29USUS8465765No2013-06-182031-02-15USUS8778390No2014-07-152031-02-15USUS8563033No2013-10-222031-02-15USUS8956649No2015-02-172031-02-15USUS9040083No2015-05-262031-02-15USUS8287903No2012-10-162031-02-15USUS9295642No2016-03-292033-08-14USUS8202537No2012-06-192027-03-15USUS7438930Yes2008-10-212020-06-16USUS9066869Yes2015-06-302020-06-16USUS7247318Yes2007-07-242020-06-16USUS7083808Yes2006-08-012020-06-16USUS6419960Yes2002-07-162020-06-16USUS8580310Yes2013-11-122020-06-16USUS8840924No2014-09-232026-06-05USUS9668981No2017-06-062025-10-07USUS9545399No2017-01-172033-08-14USUS9089496No2015-07-282032-06-28USUS9072680No2015-07-072032-06-28USUS9844544No2017-12-192033-08-14USUS9801823Yes2017-10-312020-06-16USUS10039719Yes2018-08-072020-06-16USUS9498447No2016-11-222032-03-23USUS9283214No2016-03-152032-03-23USUS9023389No2015-05-052032-03-23USUS8927010No2015-01-062032-03-23USUS9028868No2015-05-122032-03-23USUS9034902No2015-05-192032-03-23USUS9603809No2017-03-282032-03-23USUS8916588No2014-12-232032-03-23USUS10182995No2019-01-222032-03-23USUS10111839No2018-10-302035-10-30USUS9974752No2018-05-222035-10-30USUS10292939No2019-05-212035-10-30USUS10292938No2019-05-212035-10-30USUS10292937No2019-05-212032-03-23USUS10449159No2019-10-222035-10-30USUS10463624No2019-11-052019-12-16USUS10512613No2019-12-242035-10-30USUS10500162No2019-12-102035-10-30USUS10507186No2019-12-172035-10-30USUS10512612No2019-12-242035-10-30USUS10568841No2020-02-252035-10-30USUS10617651No2020-04-142032-03-23USUS10688060No2020-06-232035-10-30USUS10722473No2020-07-282038-11-19USUS10857143No2020-12-082033-08-14USUS10881618No2021-01-052032-03-23USUS10905652No2021-02-022032-03-23USUS11103495No2021-08-312033-08-14USUS11103494No2021-08-312033-08-14USUS11166947No2021-11-092038-01-25USUS11241391No2012-03-232032-03-23USUS11241392No2012-03-232032-03-23USUS11633389No2013-08-142033-08-14US"
            },
            "Properties": {
                "State": "Solid",
                "Experimental Properties": "PropertyValueSourcewater solubility1255mg/LNot Available",
                "Predicted Properties": "PropertyValueSourceWater Solubility0.182 mg/mLALOGPSlogP1.47ALOGPSlogP2.25ChemaxonlogS-3.1ALOGPSpKa (Strongest Basic)9.09ChemaxonPhysiological Charge1ChemaxonHydrogen Acceptor Count2ChemaxonHydrogen Donor Count1ChemaxonPolar Surface Area38.33 \u00c52ChemaxonRotatable Bond Count4ChemaxonRefractivity66.73 m3\u00b7mol-1ChemaxonPolarizability25.91 \u00c53ChemaxonNumber of Rings2ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleYesChemaxonMDDR-like RuleNoChemaxon",
                "Predicted ADMET Features": "PropertyValueProbabilityHuman Intestinal Absorption+0.9941Blood Brain Barrier+0.9663Caco-2 permeable+0.6564P-glycoprotein substrateSubstrate0.5466P-glycoprotein inhibitor INon-inhibitor0.7964P-glycoprotein inhibitor IINon-inhibitor0.9601Renal organic cation transporterInhibitor0.532CYP450 2C9 substrateNon-substrate0.7897CYP450 2D6 substrateNon-substrate0.9116CYP450 3A4 substrateNon-substrate0.5985CYP450 1A2 substrateNon-inhibitor0.592CYP450 2C9 inhibitorNon-inhibitor0.897CYP450 2D6 inhibitorNon-inhibitor0.5245CYP450 2C19 inhibitorNon-inhibitor0.9265CYP450 3A4 inhibitorNon-inhibitor0.8539CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9328Ames testNon AMES toxic0.9133CarcinogenicityNon-carcinogens0.9648BiodegradationNot ready biodegradable0.5759Rat acute toxicity2.7718 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.8466hERG inhibition (predictor II)Non-inhibitor0.7491  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)"
            },
            "Spectra": {
                "Mass Spec (NIST)": "Download (7.79 KB)",
                "Spectra": "SpectrumSpectrum TypeSplash KeyPredicted GC-MS Spectrum - GC-MSPredicted GC-MSNot AvailableGC-MS Spectrum - CI-BGC-MSsplash10-001i-0090000000-b461cd02e59ebf84d3f9GC-MS Spectrum - EI-BGC-MSsplash10-001i-9100000000-c75de12fbdae54dce658Mass Spectrum (Electron Ionization)MSsplash10-001i-9100000000-1a9c5badbee827946da1Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available"
            },
            "Interested in using DrugBank in a commercial product or application?": {},
            "Stay up-to-date with the latest from DrugBank!": {},
            "Thank you for subscribing!": {}
        },
        "Additional Information": {
            "targets": [
                {
                    "Label": "Sodium-dependent dopamine transporter",
                    "Detailed Info": {
                        "Name": "Sodium-dependent dopamine transporter",
                        "Synonyms": "DA transporter\nDAT1\nSolute carrier family 6 member 3",
                        "Gene Name": "SLC6A3",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0010450|Sodium-dependent dopamine transporter\nMSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNPRQSPVEAQDR\nETWGKKIDFLLSVIGFAVDLANVWRFPYLCYKNGGGAFLVPYLLFMVIAGMPLFYMELAL\nGQFNREGAAGVWKICPILKGVGFTVILISLYVGFFYNVIIAWALHYLFSSFTTELPWIHC\nNNSWNSPNCSDAHPGDSSGDSSGLNDTFGTTPAAEYFERGVLHLHQSHGIDDLGPPRWQL\nTACLVLVIVLLYFSLWKGVKTSGKVVWITATMPYVVLTALLLRGVTLPGAIDGIRAYLSV\nDFYRLCEASVWIDAATQVCFSLGVGFGVLIAFSSYNKFTNNCYRDAIVTTSINSLTSFSS\nGFVVFSFLGYMAQKHSVPIGDVAKDGPGLIFIIYPEAIATLPLSSAWAVVFFIMLLTLGI\nDSAMGGMESVITGLIDEFQLLHRHRELFTLFIVLATFLLSLFCVTNGGIYVFTLLDHFAA\nGTSILFGVLIEAIGVAWFYGVGQFSDDIQQMTGQRPSLYWRLCWKLVSPCFLLFVVVVSI\nVTFRPPHYGAYIFPDWANALGWVIATSSMAMVPIYAAYKFCSLPGSFREKLAYAIAPEKD\nRELVDRGEVRQFTLRHWLKV",
                        "Number of residues": "620",
                        "Molecular Weight": "68494.255",
                        "Theoretical pI": "6.92",
                        "GO Classification": "Functionsdopamine / dopamine binding / dopamine transmembrane transporter activity / monoamine transmembrane transporter activityProcessesadenohypophysis development / ammonium transmembrane transport / dopamine biosynthetic process / dopamine catabolic process / dopamine transport / dopamine uptake involved in synaptic transmission / lactation / locomotory behavior / monoamine transport / neurotransmitter biosynthetic process / positive regulation of multicellular organism growth / prepulse inhibition / regulation of dopamine metabolic process / response to cocaine / sensory perception of smell / synaptic transmission / transmembrane transportComponentsaxon / cell surface / cytoplasm / flotillin complex / integral component of membrane / integral component of plasma membrane / neuronal cell body / plasma membrane",
                        "General Function": "Monoamine transmembrane transporter activity",
                        "Specific Function": "Amine transporter. Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals.",
                        "Pfam Domain Function": "SNF (PF00209)",
                        "Transmembrane Regions": "69-89\n96-116\n140-160\n238-256\n265-282\n318-335\n347-368\n401-420\n447-465\n481-501\n522-541\n560-578",
                        "Cellular Location": "Cell membrane",
                        "Gene sequence": ">lcl|BSEQ0010451|Sodium-dependent dopamine transporter (SLC6A3)\nATGAGTAAGAGCAAATGCTCCGTGGGACTCATGTCTTCCGTGGTGGCCCCGGCTAAGGAG\nCCCAATGCCGTGGGCCCGAAGGAGGTGGAGCTCATCCTTGTCAAGGAGCAGAACGGAGTG\nCAGCTCACCAGCTCCACCCTCACCAACCCGCGGCAGAGCCCCGTGGAGGCCCAGGATCGG\nGAGACCTGGGGCAAGAAGATCGACTTTCTCCTGTCCGTCATTGGCTTTGCTGTGGACCTG\nGCCAACGTCTGGCGGTTCCCCTACCTGTGCTACAAAAATGGTGGCGGTGCCTTCCTGGTC\nCCCTACCTGCTCTTCATGGTCATTGCTGGGATGCCACTTTTCTACATGGAGCTGGCCCTC\nGGCCAGTTCAACAGGGAAGGGGCCGCTGGTGTCTGGAAGATCTGCCCCATACTGAAAGGT\nGTGGGCTTCACGGTCATCCTCATCTCACTGTATGTCGGCTTCTTCTACAACGTCATCATC\nGCCTGGGCGCTGCACTATCTCTTCTCCTCCTTCACCACGGAGCTCCCCTGGATCCACTGC\nAACAACTCCTGGAACAGCCCCAACTGCTCGGATGCCCATCCTGGTGACTCCAGTGGAGAC\nAGCTCGGGCCTCAACGACACTTTTGGGACCACACCTGCTGCCGAGTACTTTGAACGTGGC\nGTGCTGCACCTCCACCAGAGCCATGGCATCGACGACCTGGGGCCTCCGCGGTGGCAGCTC\nACAGCCTGCCTGGTGCTGGTCATCGTGCTGCTCTACTTCAGCCTCTGGAAGGGCGTGAAG\nACCTCAGGGAAGGTGGTATGGATCACAGCCACCATGCCATACGTGGTCCTCACTGCCCTG\nCTCCTGCGTGGGGTCACCCTCCCTGGAGCCATAGACGGCATCAGAGCATACCTGAGCGTT\nGACTTCTACCGGCTCTGCGAGGCGTCTGTTTGGATTGACGCGGCCACCCAGGTGTGCTTC\nTCCCTGGGCGTGGGGTTCGGGGTGCTGATCGCCTTCTCCAGCTACAACAAGTTCACCAAC\nAACTGCTACAGGGACGCGATTGTCACCACCTCCATCAACTCCCTGACGAGCTTCTCCTCC\nGGCTTCGTCGTCTTCTCCTTCCTGGGGTACATGGCACAGAAGCACAGTGTGCCCATCGGG\nGACGTGGCCAAGGACGGGCCAGGGCTGATCTTCATCATCTACCCGGAAGCCATCGCCACG\nCTCCCTCTGTCCTCAGCCTGGGCCGTGGTCTTCTTCATCATGCTGCTCACCCTGGGTATC\nGACAGCGCCATGGGTGGTATGGAGTCAGTGATCACCGGGCTCATCGATGAGTTCCAGCTG\nCTGCACAGACACCGTGAGCTCTTCACGCTCTTCATCGTCCTGGCGACCTTCCTCCTGTCC\nCTGTTCTGCGTCACCAACGGTGGCATCTACGTCTTCACGCTCCTGGACCATTTTGCAGCC\nGGCACGTCCATCCTCTTTGGAGTGCTCATCGAAGCCATCGGAGTGGCCTGGTTCTATGGT\nGTTGGGCAGTTCAGCGACGACATCCAGCAGATGACCGGGCAGCGGCCCAGCCTGTACTGG\nCGGCTGTGCTGGAAGCTGGTCAGCCCCTGCTTTCTCCTGTTCGTGGTCGTGGTCAGCATT\nGTGACCTTCAGACCCCCCCACTACGGAGCCTACATCTTCCCCGACTGGGCCAACGCGCTG\nGGCTGGGTCATCGCCACATCCTCCATGGCCATGGTGCCCATCTATGCGGCCTACAAGTTC\nTGCAGCCTGCCTGGGTCCTTTCGAGAGAAACTGGCCTACGCCATTGCACCCGAGAAGGAC\nCGTGAGCTGGTGGACAGAGGGGAGGTGCGCCAGTTCACGCTCCGCCACTGGCTCAAGGTG\nTAG",
                        "Chromosome Location": "5",
                        "Locus": "5p15.3",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ01959UniProtKB Entry NameSC6A3_HUMANGenBank Protein ID553260GenBank Gene IDM96670GenAtlas IDSLC6A3HGNC IDHGNC:11049",
                        "General References": "Vandenbergh DJ, Persico AM, Uhl GR: A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs. Brain Res Mol Brain Res. 1992 Sep;15(1-2):161-6. [Article] Giros B, el Mestikawy S, Godinot N, Zheng K, Han H, Yang-Feng T, Caron MG: Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol Pharmacol. 1992 Sep;42(3):383-90. [Article] Pristupa ZB, Wilson JM, Hoffman BJ, Kish SJ, Niznik HB: Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding. Mol Pharmacol. 1994 Jan;45(1):125-35. [Article] Kawarai T, Kawakami H, Yamamura Y, Nakamura S: Structure and organization of the gene encoding human dopamine transporter. Gene. 1997 Aug 11;195(1):11-8. [Article] Vandenbergh DJ, Thompson MD, Cook EH, Bendahhou E, Nguyen T, Krasowski MD, Zarrabian D, Comings D, Sellers EM, Tyndale RF, George SR, O'Dowd BF, Uhl GR: Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations. Mol Psychiatry. 2000 May;5(3):283-92. [Article] Greenwood TA, Alexander M, Keck PE, McElroy S, Sadovnick AD, Remick RA, Kelsoe JR: Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. Am J Med Genet. 2001 Mar 8;105(2):145-51. [Article] Miller-Butterworth CM, Kaplan JR, Shaffer J, Devlin B, Manuck SB, Ferrell RE: Sequence variation in the primate dopamine transporter gene and its relationship to social dominance. Mol Biol Evol. 2008 Jan;25(1):18-28. Epub 2007 Oct 13. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Donovan DM, Vandenbergh DJ, Perry MP, Bird GS, Ingersoll R, Nanthakumar E, Uhl GR: Human and mouse dopamine transporter genes: conservation of 5'-flanking sequence elements and gene structures. Brain Res Mol Brain Res. 1995 Jun;30(2):327-35. [Article] Bannon MJ, Poosch MS, Xia Y, Goebel DJ, Cassin B, Kapatos G: Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7095-9. [Article] Torres GE, Yao WD, Mohn AR, Quan H, Kim KM, Levey AI, Staudinger J, Caron MG: Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron. 2001 Apr;30(1):121-34. [Article] Carneiro AM, Ingram SL, Beaulieu JM, Sweeney A, Amara SG, Thomas SM, Caron MG, Torres GE: The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter. J Neurosci. 2002 Aug 15;22(16):7045-54. [Article] Torres GE, Sweeney AL, Beaulieu JM, Shashidharan P, Caron MG: Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant. Proc Natl Acad Sci U S A. 2004 Nov 2;101(44):15650-5. Epub 2004 Oct 25. [Article] Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington J, Lipshutz R, Daley GQ, Lander ES: Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet. 1999 Jul;22(3):231-8. [Article] Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE: The consensus coding sequences of human breast and colorectal cancers. Science. 2006 Oct 13;314(5797):268-74. Epub 2006 Sep 7. [Article] Kurian MA, Zhen J, Cheng SY, Li Y, Mordekar SR, Jardine P, Morgan NV, Meyer E, Tee L, Pasha S, Wassmer E, Heales SJ, Gissen P, Reith ME, Maher ER: Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia. J Clin Invest. 2009 Jun;119(6):1595-603. doi: 10.1172/JCI39060. Epub 2009 May 26. [Article] Bevilacqua L, Doly S, Kaprio J, Yuan Q, Tikkanen R, Paunio T, Zhou Z, Wedenoja J, Maroteaux L, Diaz S, Belmer A, Hodgkinson CA, Dell'osso L, Suvisaari J, Coccaro E, Rose RJ, Peltonen L, Virkkunen M, Goldman D: A population-specific HTR2B stop codon predisposes to severe impulsivity. Nature. 2010 Dec 23;468(7327):1061-6. doi: 10.1038/nature09629. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00422Methylphenidateapproved, investigationalyesinhibitorDetailsDB00745Modafinilapproved, investigationalyesinhibitorDetailsDB01156BupropionapprovedyesinhibitorDetailsDB00191Phentermineapproved, illicityesinhibitorDetailsDB00476DuloxetineapprovedunknowninhibitorDetailsDB00579Mazindolapproved, investigationalyesinhibitorDetailsDB00721Procaineapproved, investigational, vet_approvedyesinhibitorDetailsDB00830Phenmetrazineapproved, illicityesinhibitorDetailsDB00907Cocaineapproved, illicityesinhibitorDetailsDB00937Diethylpropionapproved, illicityesinhibitorDetailsDB01161Chloroprocaineapproved, investigationalunknowninhibitorDetailsDB00182Amphetamineapproved, illicit, investigationalyesnegative modulatorDetailsDB00245BenzatropineapprovedyesinhibitorDetailsDB01463Fencamfaminexperimental, illicit, withdrawnyesinhibitorDetailsDB04947AltropaneinvestigationalunknownDetailsDB01576Dextroamphetamineapproved, illicityesnegative modulatorDetailsDB12305DasotralineinvestigationalunknownDetailsDB06156TesofensineinvestigationalunknownDetailsDB06333TrodusquemineinvestigationalunknownDetailsDB01149Nefazodoneapproved, withdrawnunknowninhibitorDetailsDB04821Nomifensineapproved, withdrawnunknownDetailsDB01104SertralineapprovedunknowninhibitorbinderDetailsDB01146Diphenylpyralineapproved, investigationalunknowninhibitorDetailsDB01175EscitalopramapprovednoinhibitorDetailsDB00726TrimipramineapprovedunknowninhibitorDetailsDB01114ChlorpheniramineapprovedunknowninhibitorDetailsDB01105Sibutramineapproved, illicit, investigational, withdrawnyesinhibitorDetailsDB00285VenlafaxineapprovedunknowninhibitorDetailsDB00988DopamineapprovedyesinducerDetailsDB00865Benzphetamineapproved, illicitunknowninhibitorDetailsDB06701Dexmethylphenidateapproved, investigationalyesinhibitorDetailsDB01454Midomafetamineexperimental, illicit, investigationalunknownnegative modulatorDetailsDB00852PseudoephedrineapprovedyesinhibitorDetailsDB014724-Methoxyamphetamineexperimental, illicityesinhibitorDetailsDB01577Metamfetamineapproved, illicit, withdrawnyesnegative modulatorDetailsDB01363Ephedra sinica rootnutraceuticalyesnegative modulatorDetailsDB01442MMDAexperimental, illicityesnegative modulatorDetailsDB01454Midomafetamineexperimental, illicit, investigationalunknownDetailsDB08824Ioflupane I-123approvednoDetailsDB00408LoxapineapprovedunknownbinderDetailsDB00458ImipramineapprovedunknowninhibitorDetailsDB00454MeperidineapprovedunknowninhibitorDetailsDB00543AmoxapineapprovedunknownbinderDetailsDB06148Mianserinapproved, investigationalunknownbinderDetailsDB06413Armodafinilapproved, investigationalyesantagonistinhibitorDetailsDB03701VanoxerineinvestigationalyesantagonistDetailsDB09194EtoperidonewithdrawnnoinhibitorDetailsDB14754SolriamfetolapprovedunknownDetailsDB01576Dextroamphetamineapproved, illicitunknownDetailsDB06700Desvenlafaxineapproved, investigationalunknowninhibitorDetailsDB01238Aripiprazoleapproved, investigationalunknownmodulatorDetailsDB00852PseudoephedrineapprovedunknowninhibitorDetailsDB00907Cocaineapproved, illicitnoinhibitorDetailsDB00721Procaineapproved, investigational, vet_approvedunknowninhibitorDetailsDB16629SerdexmethylphenidateapprovedyesinhibitorDetails"
                    }
                },
                {
                    "Label": "5-hydroxytryptamine receptor 1A",
                    "Detailed Info": {
                        "Name": "5-hydroxytryptamine receptor 1A",
                        "Synonyms": "5-HT-1A\nADRB2RL1\nADRBRL1\nG-21\nSerotonin receptor 1A",
                        "Gene Name": "HTR1A",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0018934|5-hydroxytryptamine receptor 1A\nMDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAA\nIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCC\nTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPED\nRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADT\nRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGN\nSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLP\nFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFC\nRQ",
                        "Number of residues": "422",
                        "Molecular Weight": "46106.335",
                        "Theoretical pI": "9.05",
                        "GO Classification": "Functionsserotonin receptor activityProcessesadenylate cyclase-inhibiting serotonin receptor signaling pathway / behavioral fear response / cell proliferation / exploration behavior / G-protein coupled receptor signaling pathway / positive regulation of cell proliferation / regulation of behavior / regulation of dopamine metabolic process / regulation of hormone secretion / regulation of serotonin secretion / serotonin metabolic process / serotonin receptor signaling pathway / vasoconstrictionComponentsintegral component of plasma membrane / plasma membrane",
                        "General Function": "Serotonin receptor activity",
                        "Specific Function": "G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for various drugs and psychoactive substances. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Beta-arrestin family members inhibit signaling via G proteins and mediate activation of alternative signaling pathways. Signaling inhibits adenylate cyclase activity and activates a phosphatidylinositol-calcium second messenger system that regulates the release of Ca(2+) ions from intracellular stores. Plays a role in the regulation of 5-hydroxytryptamine release and in the regulation of dopamine and 5-hydroxytryptamine metabolism. Plays a role in the regulation of dopamine and 5-hydroxytryptamine levels in the brain, and thereby affects neural activity, mood and behavior. Plays a role in the response to anxiogenic stimuli.",
                        "Pfam Domain Function": "7tm_1 (PF00001)",
                        "Transmembrane Regions": "37-62\n74-98\n111-132\n153-178\n192-217\n346-367\n379-403",
                        "Cellular Location": "Cell membrane",
                        "Gene sequence": ">lcl|BSEQ0018935|5-hydroxytryptamine receptor 1A (HTR1A)\nATGGATGTGCTCAGCCCTGGTCAGGGCAACAACACCACATCACCACCGGCTCCCTTTGAG\nACCGGCGGCAACACTACTGGTATCTCCGACGTGACCGTCAGCTACCAAGTGATCACCTCT\nCTGCTGCTGGGCACGCTCATCTTCTGCGCGGTGCTGGGCAATGCGTGCGTGGTGGCTGCC\nATCGCCTTGGAGCGCTCCCTGCAGAACGTGGCCAATTATCTTATTGGCTCTTTGGCGGTC\nACCGACCTCATGGTGTCGGTGTTGGTGCTGCCCATGGCCGCGCTGTATCAGGTGCTCAAC\nAAGTGGACACTGGGCCAGGTAACCTGCGACCTGTTCATCGCCCTCGACGTGCTGTGCTGC\nACCTCATCCATCTTGCACCTGTGCGCCATCGCGCTGGACAGGTACTGGGCCATCACGGAC\nCCCATCGACTACGTGAACAAGAGGACGCCCCGGCGCGCCGCTGCGCTCATCTCGCTCACT\nTGGCTTATTGGCTTCCTCATCTCTATCCCGCCCATGCTGGGCTGGCGCACCCCGGAAGAC\nCGCTCGGACCCCGACGCATGCACCATTAGCAAGGATCATGGCTACACTATCTATTCCACC\nTTTGGAGCTTTCTACATCCCGCTGCTGCTCATGCTGGTTCTCTATGGGCGCATATTCCGA\nGCTGCGCGCTTCCGCATCCGCAAGACGGTCAAAAAGGTGGAGAAGACCGGAGCGGACACC\nCGCCATGGAGCATCTCCCGCCCCGCAGCCCAAGAAGAGTGTGAATGGAGAGTCGGGGAGC\nAGGAACTGGAGGCTGGGCGTGGAGAGCAAGGCTGGGGGTGCTCTGTGCGCCAATGGCGCG\nGTGAGGCAAGGTGACGATGGCGCCGCCCTGGAGGTGATCGAGGTGCACCGAGTGGGCAAC\nTCCAAAGAGCACTTGCCTCTGCCCAGCGAGGCTGGTCCTACCCCTTGTGCCCCCGCCTCT\nTTCGAGAGGAAAAATGAGCGCAACGCCGAGGCGAAGCGCAAGATGGCCCTGGCCCGAGAG\nAGGAAGACAGTGAAGACGCTGGGCATCATCATGGGCACCTTCATCCTCTGCTGGCTGCCC\nTTCTTCATCGTGGCTCTTGTTCTGCCCTTCTGCGAGAGCAGCTGCCACATGCCCACCCTG\nTTGGGCGCCATAATCAATTGGCTGGGCTACTCCAACTCTCTGCTTAACCCCGTCATTTAC\nGCATACTTCAACAAGGACTTTCAAAACGCGTTTAAGAAGATCATTAAGTGTAAGTTCTGC\nCGCCAGTGA",
                        "Chromosome Location": "5",
                        "Locus": "5q11.2-q13",
                        "External Identifiers": "ResourceLinkUniProtKB IDP08908UniProtKB Entry Name5HT1A_HUMANGenBank Protein ID189928GenBank Gene IDM28269GenAtlas IDHTR1AHGNC IDHGNC:5286",
                        "General References": "Kobilka BK, Frielle T, Collins S, Yang-Feng T, Kobilka TS, Francke U, Lefkowitz RJ, Caron MG: An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature. 1987 Sep 3-9;329(6134):75-9. [Article] Kitano T, Liu YH, Ueda S, Saitou N: Human-specific amino acid changes found in 103 protein-coding genes. Mol Biol Evol. 2004 May;21(5):936-44. Epub 2004 Mar 10. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Parks CL, Chang LS, Shenk T: A polymerase chain reaction mediated by a single primer: cloning of genomic sequences adjacent to a serotonin receptor protein coding region. Nucleic Acids Res. 1991 Dec;19(25):7155-60. [Article] Aune TM, McGrath KM, Sarr T, Bombara MP, Kelley KA: Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine. J Immunol. 1993 Aug 1;151(3):1175-83. [Article] Fargin A, Raymond JR, Lohse MJ, Kobilka BK, Caron MG, Lefkowitz RJ: The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor. Nature. 1988 Sep 22;335(6188):358-60. [Article] Harrington MA, Shaw K, Zhong P, Ciaranello RD: Agonist-induced desensitization and loss of high-affinity binding sites of stably expressed human 5-HT1A receptors. J Pharmacol Exp Ther. 1994 Mar;268(3):1098-106. [Article] Vasilescu J, Zweitzig DR, Denis NJ, Smith JC, Ethier M, Haines DS, Figeys D: The proteomic reactor facilitates the analysis of affinity-purified proteins by mass spectrometry: application for identifying ubiquitinated proteins in human cells. J Proteome Res. 2007 Jan;6(1):298-305. [Article] Nichols DE, Nichols CD: Serotonin receptors. Chem Rev. 2008 May;108(5):1614-41. doi: 10.1021/cr078224o. Epub 2008 May 14. [Article] Polter AM, Li X: 5-HT1A receptor-regulated signal transduction pathways in brain. Cell Signal. 2010 Oct;22(10):1406-12. doi: 10.1016/j.cellsig.2010.03.019. Epub 2010 Apr 2. [Article] Pytliak M, Vargova V, Mechirova V, Felsoci M: Serotonin receptors - from molecular biology to clinical applications. Physiol Res. 2011;60(1):15-25. Epub 2010 Oct 15. [Article] Jiang YC, Wu HM, Cheng KH, Sunny Sun H: Menstrual cycle-dependent febrile episode mediated by sequence-specific repression of poly(ADP-ribose) polymerase-1 on the transcription of the human serotonin receptor 1A gene. Hum Mutat. 2012 Jan;33(1):209-17. doi: 10.1002/humu.21622. Epub 2011 Nov 7. [Article] Singh P, Paila YD, Chattopadhyay A: Role of glycosphingolipids in the function of human serotonin(1)A receptors. J Neurochem. 2012 Dec;123(5):716-24. doi: 10.1111/jnc.12008. Epub 2012 Oct 11. [Article] Akama KT, Thompson LI, Milner TA, McEwen BS: Post-synaptic density-95 (PSD-95) binding capacity of G-protein-coupled receptor 30 (GPR30), an estrogen receptor that can be identified in hippocampal dendritic spines. J Biol Chem. 2013 Mar 1;288(9):6438-50. doi: 10.1074/jbc.M112.412478. Epub 2013 Jan 8. [Article] Nakhai B, Nielsen DA, Linnoila M, Goldman D: Two naturally occurring amino acid substitutions in the human 5-HT1A receptor: glycine 22 to serine 22 and isoleucine 28 to valine 28. Biochem Biophys Res Commun. 1995 May 16;210(2):530-6. [Article] Kawanishi Y, Harada S, Tachikawa H, Okubo T, Shiraishi H: Novel mutations in the promoter and coding region of the human 5-HT1A receptor gene and association analysis in schizophrenia. Am J Med Genet. 1998 Sep 7;81(5):434-9. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00490Buspironeapproved, investigationalyespartial agonistDetailsDB00216Eletriptanapproved, investigationalunknownagonistDetailsDB00246ZiprasidoneapprovedyesagonistDetailsDB01238Aripiprazoleapproved, investigationalunknownpartial agonistDetailsDB00247MethysergideapprovedyesagonistDetailsDB00363ClozapineapprovedunknownantagonistDetailsDB00589Lisurideapproved, investigationalunknownagonistDetailsDB00656Trazodoneapproved, investigationalyesantagonistpartial agonistDetailsDB00866Alprenololexperimental, withdrawnyesantagonistDetailsDB00960Pindololapproved, investigationalunknownantagonistinhibitorligandDetailsDB01224Quetiapineapprovedunknownantagonistpartial agonistDetailsDB04884DapoxetineinvestigationalunknownDetailsDB04888BifeprunoxinvestigationalunknownDetailsDB04908Flibanserinapproved, investigationalyesagonistDetailsDB04970LesopitroninvestigationalunknownDetailsDB12061PardoprunoxinvestigationalunknownDetailsDB05339MN-305investigationalunknownDetailsDB05509LI-301investigationalunknownDetailsDB00571Propranololapproved, investigationalunknownother/unknownDetailsDB06216AsenapineapprovedunknownantagonistDetailsDB06393XaliprodeninvestigationalunknownDetailsDB06506RepinotaninvestigationalunknownDetailsDB06446DotarizineinvestigationalunknownDetailsDB06454SarizotaninvestigationalunknownDetailsDB06538RobalzotaninvestigationalunknownDetailsDB06684VilazodoneapprovedunknownagonistDetailsDB01186Pergolideapproved, investigational, vet_approved, withdrawnunknownagonistDetailsDB01200Bromocriptineapproved, investigational, withdrawnunknownagonistDetailsDB00248CabergolineapprovedunknownagonistDetailsDB00413Pramipexoleapproved, investigationalunknownagonistDetailsDB05271RotigotineapprovedunknownagonistDetailsDB00714Apomorphineapproved, investigationalunknownagonistDetailsDB01267PaliperidoneapprovedunknownantagonistDetailsDB01618MolindoneapprovedunknownantagonistDetailsDB00321AmitriptylineapprovedunknowninhibitorinducerDetailsDB01142Doxepinapproved, investigationalunknownantagonistDetailsDB01149Nefazodoneapproved, withdrawnyesantagonistDetailsDB00540NortriptylineapprovedunknownantagonistDetailsDB00726TrimipramineapprovedunknownantagonistDetailsDB01392Yohimbineapproved, investigational, vet_approvedunknownpartial agonistDetailsDB00952Naratriptanapproved, investigationalyesagonistDetailsDB00315Zolmitriptanapproved, investigationalnoagonistDetailsDB00669Sumatriptanapproved, investigationalyesagonistDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedyesantagonistDetailsDB08807BopindololexperimentalunknownDetailsDB00904Ondansetronapproved, withdrawnunknownother/unknownDetailsDB01616Alverineapproved, investigationalyesantagonistDetailsDB01614Acepromazineexperimental, vet_approvedyesantagonistDetailsDB01621Pipotiazineapproved, investigationalyesantagonistDetailsDB08810CinitaprideinvestigationalyesagonistDetailsDB04946IloperidoneapprovedunknownantagonistDetailsDB08815Lurasidoneapproved, investigationalunknownantagonistDetailsDB01359Penbutololapproved, investigationalyesantagonistDetailsDB04829Lysergic acid diethylamideillicit, investigational, withdrawnunknownDetailsDB00408LoxapineapprovedunknownbinderDetailsDB00458ImipramineapprovedunknownactivatorDetailsDB00543AmoxapineapprovedunknownantagonistDetailsDB00988DopamineapprovedunknownbinderDetailsDB00696ErgotamineapprovedunknownagonistDetailsDB01151Desipramineapproved, investigationalunknownbinderDetailsDB06148Mianserinapproved, investigationalunknownblockerDetailsDB09068Vortioxetineapproved, investigationalyesagonistDetailsDB09128Brexpiprazoleapproved, investigationalunknownpartial agonistDetailsDB08922Perospironeexperimentalyespartial agonistDetailsDB09167DosulepinapprovedyesantagonistDetailsDB09061Cannabidiolapproved, investigationalunknownagonistDetailsDB09244PirlindoleexperimentalunknownantagonistDetailsDB06153Pizotifenapprovedunknownpartial agonistDetailsDB140105-methoxy-N,N-dimethyltryptamineexperimental, illicitunknownagonistDetailsDB14011NabiximolsinvestigationalunknownDetailsDB14009Medical Cannabisexperimental, investigationalunknownDetailsDB11755TetrahydrocannabivarininvestigationalyesagonistDetailsDB04948Lofexidineapproved, investigationalnoagonistDetailsDB05562NaluzotaninvestigationalunknownagonistDetailsDB09289TianeptineinvestigationalunknowninhibitorDetailsDB14185Aripiprazole lauroxilapproved, investigationalyespartial agonistDetailsDB00422Methylphenidateapproved, investigationalunknownDetailsDB00502HaloperidolapprovedunknownDetailsDB01175EscitalopramapprovedunknowninhibitorDetailsDB15665SEP-363856investigationalunknownagonistDetailsDB00734Risperidoneapproved, investigationalunknownantagonistDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnnoagonistDetailsDB00935Oxymetazolineapproved, investigationalunknownagonistDetailsDB16629SerdexmethylphenidateapprovedunknownagonistDetailsDB00320Dihydroergotamineapproved, investigationalunknownagonistDetailsDB06016Cariprazineapproved, investigationalunknownpartial agonistDetailsDB12540LecozotaninvestigationalunknownantagonistDetailsDB00953RizatriptanapprovedunknownagonistDetailsDB12184Gepironeinvestigationalyespartial agonistDetailsDB13025TiaprideinvestigationalyesantagonistDetailsDB09304SetiptilineexperimentalunknownantagonistDetailsDB13345Dihydroergocristineapproved, experimentalyesantagonistDetailsDB01049Ergoloid mesylateapprovedyesantagonistagonistDetailsDB11273DihydroergocornineapprovedyesantagonistagonistDetailsDB12141Gilteritinibapproved, investigationalnoinhibitorDetailsDB00715Paroxetineapproved, investigationalunknownDetailsDB01239Chlorprothixeneapproved, experimental, investigational, withdrawnyesinhibitorDetailsDB01221Ketamineapproved, vet_approvedunknownantagonistDetailsDB00334Olanzapineapproved, investigationalunknowninhibitorDetailsDB12540LecozotaninvestigationalunknownregulatorDetails"
                    }
                },
                {
                    "Label": "Sodium-dependent noradrenaline transporter",
                    "Detailed Info": {
                        "Name": "Sodium-dependent noradrenaline transporter",
                        "Synonyms": "NAT1\nNET\nNET1\nNorepinephrine transporter\nSLC6A5\nSolute carrier family 6 member 2",
                        "Gene Name": "SLC6A2",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0000970|Sodium-dependent noradrenaline transporter\nMLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWG\nKKIDFLLSVVGFAVDLANVWRFPYLCYKNGGGAFLIPYTLFLIIAGMPLFYMELALGQYN\nREGAATVWKICPFFKGVGYAVILIALYVGFYYNVIIAWSLYYLFSSFTLNLPWTDCGHTW\nNSPNCTDPKLLNGSVLGNHTKYSKYKFTPAAEFYERGVLHLHESSGIHDIGLPQWQLLLC\nLMVVVIVLYFSLWKGVKTSGKVVWITATLPYFVLFVLLVHGVTLPGASNGINAYLHIDFY\nRLKEATVWIDAATQIFFSLGAGFGVLIAFASYNKFDNNCYRDALLTSSINCITSFVSGFA\nIFSILGYMAHEHKVNIEDVATEGAGLVFILYPEAISTLSGSTFWAVVFFVMLLALGLDSS\nMGGMEAVITGLADDFQVLKRHRKLFTFGVTFSTFLLALFCITKGGIYVLTLLDTFAAGTS\nILFAVLMEAIGVSWFYGVDRFSNDIQQMMGFRPGLYWRLCWKFVSPAFLLFVVVVSIINF\nKPLTYDDYIFPPWANWVGWGIALSSMVLVPIYVIYKFLSTQGSLWERLAYGITPENEHHL\nVAQRDIRQFQLQHWLAI",
                        "Number of residues": "617",
                        "Molecular Weight": "69331.42",
                        "Theoretical pI": "7.53",
                        "GO Classification": "Functionsmonoamine transmembrane transporter activity / norepinephrineProcessesmonoamine transport / norepinephrine transport / response to pain / synaptic transmission / transmembrane transport / transportComponentsintegral component of plasma membrane / membrane / neuron projection / plasma membrane",
                        "General Function": "Norepinephrine:sodium symporter activity",
                        "Specific Function": "Amine transporter. Terminates the action of noradrenaline by its high affinity sodium-dependent reuptake into presynaptic terminals.",
                        "Pfam Domain Function": "SNF (PF00209)",
                        "Transmembrane Regions": "65-85\n93-112\n136-156\n235-253\n262-279\n315-332\n344-365\n398-417\n444-462\n478-498\n519-538\n557-575",
                        "Cellular Location": "Membrane",
                        "Gene sequence": ">lcl|BSEQ0010343|Sodium-dependent noradrenaline transporter (SLC6A2)\nATGCTTCTGGCGCGGATGAACCCGCAGGTGCAGCCCGAGAACAACGGGGCGGACACGGGT\nCCAGAGCAGCCCCTTCGGGCGCGCAAAACTGCGGAGCTGCTGGTGGTGAAGGAGCGCAAC\nGGCGTCCAGTGCCTGCTGGCGCCCCGCGACGGCGACGCGCAGCCCCGGGAGACCTGGGGC\nAAGAAGATCGACTTCCTGCTGTCCGTAGTCGGCTTCGCAGTGGACCTGGCCAACGTGTGG\nCGCTTCCCCTACCTCTGCTACAAGAACGGCGGCGGTGCCTTCTTGATCCCGTACACACTG\nTTCCTTATCATCGCGGGGATGCCCCTGTTCTACATGGAGCTGGCTCTGGGACAGTACAAC\nCGGGAGGGGGCTGCCACCGTTTGGAAAATCTGCCCATTCTTCAAAGGCGTTGGCTATGCT\nGTCATCCTGATCGCCCTGTACGTTGGCTTCTACTACAACGTCATCATCGCCTGGTCACTC\nTACTACCTCTTCTCCTCCTTCACCCTCAACCTGCCCTGGACCGACTGTGGCCACACCTGG\nAACAGCCCCAACTGTACCGACCCCAAGCTCCTCAATGGCTCCGTGCTTGGCAACCACACC\nAAGTACTCCAAGTACAAGTTCACGCCGGCAGCCGAGTTTTATGAGCGTGGTGTCCTGCAC\nCTTCACGAGAGCAGCGGGATTCATGACATCGGCCTGCCCCAGTGGCAGCTCTTGCTCTGT\nCTGATGGTCGTCGTCATCGTCTTGTATTTTAGCCTCTGGAAAGGGGTGAAGACATCAGGA\nAAGGTGGTGTGGATCACAGCCACGCTGCCTTACTTCGTGCTGTTCGTGCTCCTGGTCCAT\nGGCGTCACGCTGCCCGGAGCCTCCAATGGCATCAATGCCTACCTGCACATCGACTTCTAC\nCGCTTGAAAGAGGCCACGGTATGGATTGATGCCGCAACTCAGATATTTTTTTCCTTGGGG\nGCTGGATTTGGAGTATTGATTGCATTTGCCAGTTACAACAAATTTGACAACAACTGTTAC\nAGGGATGCCCTGCTGACCAGCAGCATCAACTGTATCACCAGCTTCGTCTCTGGGTTCGCC\nATCTTCTCCATCCTTGGTTACATGGCCCATGAACACAAGGTCAACATTGAGGATGTGGCC\nACAGAAGGAGCTGGCCTAGTGTTCATCCTGTATCCAGAGGCCATTTCTACCCTGTCTGGA\nTCTACATTCTGGGCTGTTGTGTTTTTCGTCATGCTCCTGGCGCTGGGCCTTGACAGCTCA\nATGGGAGGCATGGAGGCTGTCATCACGGGCCTGGCAGATGACTTCCAGGTCCTGAAGCGA\nCACCGGAAACTCTTCACATTTGGCGTCACCTTCAGCACTTTCCTTCTCGCCCTGTTCTGC\nATAACCAAGGGTGGAATTTACGTCTTGACCCTCCTGGACACCTTTGCTGCGGGCACCTCC\nATCCTTTTTGCTGTCCTCATGGAAGCCATCGGAGTTTCCTGGTTTTATGGAGTGGACAGG\nTTCAGCAACGACATCCAGCAGATGATGGGGTTCAGGCCGGGTCTATACTGGAGACTGTGC\nTGGAAGTTCGTCAGTCCTGCCTTCCTCCTGTTCGTGGTTGTGGTCAGCATCATCAACTTC\nAAGCCACTCACCTACGACGACTACATCTTCCCGCCCTGGGCCAACTGGGTGGGGTGGGGC\nATCGCCCTGTCCTCCATGGTCCTGGTGCCCATCTACGTCATCTATAAGTTCCTCAGCACG\nCAGGGCTCTCTTTGGGAGAGACTGGCCTATGGCATCACGCCAGAGAACGAGCACCACCTG\nGTGGCTCAGAGGGACATCAGACAGTTCCAGTTGCAACACTGGCTGGCCATCTGA",
                        "Chromosome Location": "16",
                        "Locus": "16q12.2",
                        "External Identifiers": "ResourceLinkUniProtKB IDP23975UniProtKB Entry NameSC6A2_HUMANGenBank Protein ID189258GenBank Gene IDM65105GenAtlas IDSLC6A2HGNC IDHGNC:11048",
                        "General References": "Pacholczyk T, Blakely RD, Amara SG: Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature. 1991 Mar 28;350(6316):350-4. [Article] Porzgen P, Bonisch H, Bruss M: Molecular cloning and organization of the coding region of the human norepinephrine transporter gene. Biochem Biophys Res Commun. 1995 Oct 24;215(3):1145-50. [Article] Porzgen P, Bonisch H, Hammermann R, Bruss M: The human noradrenaline transporter gene contains multiple polyadenylation sites and two alternatively spliced C-terminal exons. Biochim Biophys Acta. 1998 Jul 9;1398(3):365-70. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Martin J, Han C, Gordon LA, Terry A, Prabhakar S, She X, Xie G, Hellsten U, Chan YM, Altherr M, Couronne O, Aerts A, Bajorek E, Black S, Blumer H, Branscomb E, Brown NC, Bruno WJ, Buckingham JM, Callen DF, Campbell CS, Campbell ML, Campbell EW, Caoile C, Challacombe JF, Chasteen LA, Chertkov O, Chi HC, Christensen M, Clark LM, Cohn JD, Denys M, Detter JC, Dickson M, Dimitrijevic-Bussod M, Escobar J, Fawcett JJ, Flowers D, Fotopulos D, Glavina T, Gomez M, Gonzales E, Goodstein D, Goodwin LA, Grady DL, Grigoriev I, Groza M, Hammon N, Hawkins T, Haydu L, Hildebrand CE, Huang W, Israni S, Jett J, Jewett PB, Kadner K, Kimball H, Kobayashi A, Krawczyk MC, Leyba T, Longmire JL, Lopez F, Lou Y, Lowry S, Ludeman T, Manohar CF, Mark GA, McMurray KL, Meincke LJ, Morgan J, Moyzis RK, Mundt MO, Munk AC, Nandkeshwar RD, Pitluck S, Pollard M, Predki P, Parson-Quintana B, Ramirez L, Rash S, Retterer J, Ricke DO, Robinson DL, Rodriguez A, Salamov A, Saunders EH, Scott D, Shough T, Stallings RL, Stalvey M, Sutherland RD, Tapia R, Tesmer JG, Thayer N, Thompson LS, Tice H, Torney DC, Tran-Gyamfi M, Tsai M, Ulanovsky LE, Ustaszewska A, Vo N, White PS, Williams AL, Wills PL, Wu JR, Wu K, Yang J, Dejong P, Bruce D, Doggett NA, Deaven L, Schmutz J, Grimwood J, Richardson P, Rokhsar DS, Eichler EE, Gilna P, Lucas SM, Myers RM, Rubin EM, Pennacchio LA: The sequence and analysis of duplication-rich human chromosome 16. Nature. 2004 Dec 23;432(7020):988-94. [Article] Torres GE, Yao WD, Mohn AR, Quan H, Kim KM, Levey AI, Staudinger J, Caron MG: Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron. 2001 Apr;30(1):121-34. [Article] Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, Blakely RD, Robertson D: Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med. 2000 Feb 24;342(8):541-9. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00191Phentermineapproved, illicityesinhibitorDetailsDB00234Reboxetineapproved, experimentalyesinhibitorDetailsDB00289AtomoxetineapprovedyesinhibitorDetailsDB00344ProtriptylineapprovedyesinhibitorDetailsDB00458ImipramineapprovedyesinhibitorDetailsDB00579Mazindolapproved, investigationalyesinhibitorDetailsDB00830Phenmetrazineapproved, illicityesinhibitorDetailsDB00937Diethylpropionapproved, illicityesinhibitorDetailsDB00193Tramadolapproved, investigationalyesinhibitorDetailsDB00226Guanadrelapprovedyespartial agonistDetailsDB00285VenlafaxineapprovedyesinhibitorDetailsDB00321AmitriptylineapprovedyesinhibitorDetailsDB00422Methylphenidateapproved, investigationalunknowninhibitorDetailsDB00476DuloxetineapprovedyesinhibitorDetailsDB00540NortriptylineapprovedyesinhibitorDetailsDB00543AmoxapineapprovedunknowninhibitorDetailsDB00726TrimipramineapprovedyesinhibitorDetailsDB00907Cocaineapproved, illicityesinhibitorDetailsDB00934Maprotilineapproved, investigationalyesinhibitorDetailsDB01105Sibutramineapproved, illicit, investigational, withdrawnyesinhibitorDetailsDB01142Doxepinapproved, investigationalyesinhibitorDetailsDB01149Nefazodoneapproved, withdrawnyesinhibitorDetailsDB01151Desipramineapproved, investigationalyesinhibitorDetailsDB01156BupropionapprovedyesinhibitorDetailsDB01170GuanethidineapprovedyesinducerDetailsDB01242Clomipramineapproved, investigational, vet_approvedunknowninhibitorDetailsDB00715Paroxetineapproved, investigationalunknowninhibitorDetailsDB04836Amineptineillicit, withdrawnunknownDetailsDB04840Debrisoquineapproved, investigationalyesinducerDetailsDB04889BicifadineinvestigationalunknownDetailsDB04896Milnacipranapproved, investigationalyesinhibitorDetailsDB05012XEN-2174investigationalunknownDetailsDB05688CRx-119investigationalunknownDetailsDB12305DasotralineinvestigationalunknownDetailsDB06156TesofensineinvestigationalunknownDetailsDB05964AmitifadineinvestigationalunknownDetailsDB05642DDP-225investigationalunknownDetailsDB06204TapentadolapprovedunknowninhibitorDetailsDB06333TrodusquemineinvestigationalunknownDetailsDB04821Nomifensineapproved, withdrawnunknownDetailsDB01175EscitalopramapprovedunknowninhibitorDetailsDB01114ChlorpheniramineapprovedunknowninhibitorDetailsDB01381Ginkgo bilobaapproved, investigational, nutraceuticalunknowninhibitorDetailsDB01173OrphenadrineapprovedyesinhibitorDetailsDB06700Desvenlafaxineapproved, investigationalyesinhibitorDetailsDB06148Mianserinapproved, investigationalunknowninhibitorDetailsDB06701Dexmethylphenidateapproved, investigationalyesinhibitorDetailsDB00852PseudoephedrineapprovedyesinhibitorDetailsDB01576Dextroamphetamineapproved, illicityesnegative modulatorDetailsDB01579Phendimetrazineapproved, illicityesnegative modulatorDetailsDB01363Ephedra sinica rootnutraceuticalyesnegative modulatorDetailsDB01442MMDAexperimental, illicityesnegative modulatorDetailsDB01577Metamfetamineapproved, illicit, withdrawnyesnegative modulatorDetailsDB01454Midomafetamineexperimental, illicit, investigationalyesnegative modulatorDetailsDB01364Ephedrineapprovedunknowninverse agonistDetailsDB00368NorepinephrineapprovedunknownsubstrateDetailsDB06262Droxidopaapproved, investigationalunknownsubstrateDetailsDB01454Midomafetamineexperimental, illicit, investigationalunknownDetailsDB06704Iobenguaneapproved, investigationalnosubstrateDetailsDB08918Levomilnacipranapproved, investigationalyesinhibitorDetailsDB00408LoxapineapprovedunknownbinderDetailsDB00182Amphetamineapproved, illicit, investigationalunknownagonistsubstrateDetailsDB00514DextromethorphanapprovedunknowninhibitorDetailsDB00988DopamineapprovedunknowninhibitorDetailsDB00454MeperidineapprovedunknowninhibitorDetailsDB01221Ketamineapproved, vet_approvedunknowninhibitorDetailsDB09068Vortioxetineapproved, investigationalunknownblockerDetailsDB09546Iobenguane sulfate I-123approved, investigationalnosubstrateDetailsDB09167DosulepinapprovedyesinhibitorDetailsDB09185Viloxazineapproved, investigational, withdrawnyesinhibitorDetailsDB09194EtoperidonewithdrawnnoinhibitorDetailsDB13931NetarsudilapprovedyesinhibitorDetailsDB09225Zotepineapproved, investigational, withdrawnyesantagonistDetailsDB09363Rauwolfia serpentina rootinvestigationalunknowninhibitorDetailsDB00245BenzatropineapprovednoinhibitorDetailsDB14754SolriamfetolapprovedunknownDetailsDB00924CyclobenzaprineapprovedunknowninhibitorDetailsDB01104SertralineapprovedunknowninhibitordownregulatorDetailsDB00852PseudoephedrineapprovedunknowninhibitorDetailsDB00540NortriptylineapprovedunknownsubstrateinhibitorDetailsDB00721Procaineapproved, investigational, vet_approvedunknowninhibitorDetailsDB16629SerdexmethylphenidateapprovedyesinhibitorDetails"
                    }
                }
            ],
            "enzymes": [
                {
                    "Label": "Carboxylesterase",
                    "Detailed Info": {
                        "Name": "Carboxylesterase",
                        "Synonyms": "Carboxylesterase 1A1\nCES1A1",
                        "Gene Name": "CES1A1a",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0019626|Carboxylesterase\nMWLRAFILATLSASAAW",
                        "Number of residues": "17",
                        "Molecular Weight": "1908.25",
                        "Theoretical pI": "Not Available",
                        "GO Classification": "Functionscarboxylic ester hydrolase activity",
                        "General Function": "Carboxylic ester hydrolase activity",
                        "Specific Function": "Not Available",
                        "Pfam Domain Function": "Not Available",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Not Available",
                        "Chromosome Location": "Not Available",
                        "Locus": "Not Available",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ6LAP9UniProtKB Entry NameQ6LAP9_HUMAN",
                        "General References": "Langmann T, Becker A, Aslanidis C, Notka F, Ullrich H, Schwer H, Schmitz G: Structural organization and characterization of the promoter region of a human carboxylesterase gene. Biochim Biophys Acta. 1997 Jan 3;1350(1):65-74. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00422Methylphenidateapproved, investigationalunknownsubstrateDetailsDB11793Niraparibapproved, investigationalnosubstrateDetailsDB08934SofosbuvirapprovednosubstrateDetailsDB16629SerdexmethylphenidateapprovednosubstrateDetailsDB15071Omidenepag isopropylapproved, investigationalunknownsubstrateDetails"
                    }
                }
            ]
        },
        "Disease Information": {
            "Attention Deficit Hyperactivity Disorder": "Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterised by executive dysfunction occasioning symptoms of inattention, hyperactivity, impulsivity and emotional dysregulation that are excessive and pervasive, impairing in multiple contexts, and otherwise age-inappropriate.[3][4][5][6]\n",
            "Narcolepsy": "Narcolepsy is a chronic neurological disorder that involves a decreased ability to regulate sleep\u2013wake cycles.[1] Symptoms often include periods of excessive daytime sleepiness and brief involuntary sleep episodes. [1] Narcolepsy paired with cataplexy is evidenced to be an autoimmune disorder.[3] These experiences of cataplexy can be brought on by strong emotions. Less commonly, there may be vivid hallucinations or an inability to move (sleep paralysis) while falling asleep or waking up. People with narcolepsy tend to sleep about the same number of hours per day as people without, but the quality of sleep tends to be lessened.[1]\n"
        }
    },
    "TYLENOL": {
        "Active Ingredients": {
            "ACETAMINOPHEN": "CC(=O)NC1=CC=C(C=C1)O"
        },
        "Drug Information": {
            "Identification": {
                "Summary": "Acetaminophen is an analgesic drug used alone or in combination with opioids for pain management, and as an antipyretic agent.",
                "Brand Names": "Acephen, Acetadryl, Allzital, Apadaz, Arthriten Inflammatory Pain, Bupap, Butapap, Cetafen, Children's Silapap, Coricidin Hbp Cold & Flu, Darvocet-N, Dayquil Sinex, Diphen, Dolofin, Dologen, Dologesic Reformulated Jun 2016, Duralgina, Dvorah, Endocet, Esgic, Exaprin, Excedrin, Excedrin PM Triple Action, Excedrin Tension Headache, Feverall, Fioricet, Fioricet With Codeine, Goody's Back & Body Pain Relief, Goody's Body Pain, Goody's Extra Strength, Goody's Headache Relief Shot, Goody's PM, Hycet, Legatrin PM, Little Fevers, Lorcet, Lortab, Mapap, Mersyndol, Midol Complete, Midol Cramps & Bodyaches, Nalocet, Norco, Orbivan, Pamprin Max Formula, Pamprin Multi-symptom, Panadol, Pediacare Children's Fever Reducer Pain Reliever, Percocet, Percogesic Reformulated Jan 2011, Pharbetol, Premsyn Pms, Prolate, Rivacocet, Robaxacet, Robaxacet-8, Roxicet, Sudafed PE Sinus Headache, Tactinal, Tencon, Trezix, Triatec, Triatec-30, Triatec-8, Tylenol, Tylenol PM, Tylenol With Codeine, Ultracet, Vanatol, Vanatol S, Vanquish, Xodol, Xolox, Zamicet, Zflex, Zydone",
                "Generic Name": "Acetaminophen",
                "DrugBank Accession Number": "DB00316",
                "Background": "Acetaminophen (paracetamol), also commonly known as Tylenol, is the most commonly taken analgesic worldwide and is recommended as first-line therapy in pain conditions by the World Health Organization (WHO).10 It is also used for its antipyretic effects, helping to reduce fever.23 This drug was initially approved by the U.S. FDA in 1951 and is available in a variety of forms including syrup form, regular tablets, effervescent tablets, injection, suppository, and other forms.15,16,23,Label\nAcetaminophen is often found combined with other drugs in more than 600 over the counter (OTC) allergy medications, cold medications, sleep medications, pain relievers, and other products.19 Confusion about dosing of this drug may be caused by the availability of different formulas, strengths, and dosage instructions for children of different ages.19 Due to the possibility of fatal overdose and liver failure associated with the incorrect use of acetaminophen, it is important to follow current and available national and manufacturer dosing guidelines while this drug is taken or prescribed.20,21,Label",
                "Type": "Small Molecule",
                "Groups": "Approved",
                "Structure": "3DDownload MOLSDF3D-SDFPDBSMILESInChI\n\n\n Similar StructuresStructure for Acetaminophen (DB00316)\u00d7 Close",
                "Weight": "Average: 151.1626 Monoisotopic: 151.063328537",
                "Chemical Formula": "C8H9NO2",
                "Synonyms": "4-(Acetylamino)phenol4-acetamidophenol4'-hydroxyacetanilideAcenolAcetaminof\u00e9nAcetaminophenAc\u00e9taminoph\u00e8neAPAPN-acetyl-p-aminophenolp-acetamidophenolp-acetaminophenolp-Acetylaminophenolp-hydroxy-acetanilidp-hydroxyacetanilidep-hydroxyphenolacetamideParacetamolParac\u00e9tamolParacetamolum",
                "External IDs": "NSC-109028\nNSC-3991"
            },
            "Pharmacology": {
                "Indication": "In general, acetaminophen is used for the treatment of mild to moderate pain and reduction of fever.23 It is available over the counter in various forms, the most common being oral forms.\nAcetaminophen injection is indicated for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever.Label\nBecause of its low risk of causing allergic reactions, this drug can be administered in patients who are intolerant to salicylates and those with allergic tendencies, including bronchial asthmatics.23 Specific dosing guidelines should be followed when administering acetaminophen to children.18\nReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See how",
                "Associated Conditions": "Acute Gouty Arthritis\nAcute Musculoskeletal Pain\nAllergic Reaction\nAllergy to Tree Pollen\nAnkylosing Spondylitis (AS)\nChills\nCold\nCommon Cold\nCough\nCough caused by Common Cold\nCoughing caused by Flu caused by Influenza\nDyskinesia of the Biliary Tract\nDyskinesia of the Urinary Tract\nFebrile Convulsions\nFebrile Illness Acute\nFever\nFibromyalgia\nFlu caused by Influenza\nHeadache\nJoint dislocations\nMenstrual Distress (Dysmenorrhea)\nMild pain\nMuscle Inflammation\nMuscle Injuries\nMuscle Spasms\nMusculoskeletal Pain\nMyalgia\nNasal Congestion\nNeuropathic Pain\nOsteoarthritis (OA)\nPain\nPostoperative pain\nPremenstrual cramps\nRheumatoid Arthritis\nRhinopharyngitis\nRhinorrhoea\nSevere Pain\nSinusitis\nSpasms\nSpastic Pain of the Gastrointestinal Tract\nSprains\nSymptoms Cold\nTension Headache\nToothache\nUpper Respiratory Tract Infection\nWhiplash Syndrome\nAcute Torticollis\nArticular inflammation\nCold or flu syndrome\nMild to moderate pain\nMinor aches and pains\nMinor pain\nModerate Pain\nModerate to severe pain",
                "Associated Therapies": "Airway secretion clearance therapy\nAnti-spasmodics\nBronchodilation",
                "Contraindications & Blackbox Warnings": "Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events with our Clinical APILearn more",
                "Pharmacodynamics": "Animal and clinical studies have determined that acetaminophen has both antipyretic and analgesic effects. This drug has been shown to lack anti-inflammatory effects. As opposed to the salicylate drug class, acetaminophen does not disrupt tubular secretion of uric acid and does not affect acid-base balance if taken at the recommended doses.23 Acetaminophen does not disrupt hemostasis and does not have inhibitory activities against platelet aggregation.Label,23 Allergic reactions are rare occurrences following acetaminophen use.23",
                "Mechanism of action": "According to its FDA labeling, acetaminophen's exact mechanism of action has not been fully establishedLabel - despite this, it is often categorized alongside NSAIDs (nonsteroidal anti-inflammatory drugs) due to its ability to inhibit the cyclooxygenase (COX) pathways.14 It is thought to exert central actions which ultimately lead to the alleviation of pain symptoms.14\nOne theory is that acetaminophen increases the pain threshold by inhibiting two isoforms of cyclooxygenase, COX-1 and COX-2, which are involved in prostaglandin (PG) synthesis. Prostaglandins are responsible for eliciting pain sensations.13 Acetaminophen does not inhibit cyclooxygenase in peripheral tissues and, therefore, has no peripheral anti-inflammatory effects. Though acetylsalicylic acid (aspirin) is an irreversible inhibitor of COX and directly blocks the active site of this enzyme, studies have shown that acetaminophen (paracetamol) blocks COX indirectly.24 Studies also suggest that acetaminophen selectively blocks a variant type of the COX enzyme that is unique from the known variants COX-1 and COX-2.6 This enzyme has been referred to as COX-3. The antipyretic actions of acetaminophen are likely attributed to direct action on heat-regulating centers in the brain, resulting in peripheral vasodilation, sweating, and loss of body heat.24 The exact mechanism of action of this drug is not fully understood at this time, but future research may contribute to deeper knowledge.24 \nTargetActionsOrganismAProstaglandin G/H synthase 2inhibitorHumansAProstaglandin G/H synthase 1inhibitorHumansUProstaglandin E synthase 3inhibitorHumansUTransient receptor potential cation channel subfamily V member 1activatorHumans",
                "Absorption": "Acetaminophen has 88% oral bioavailability and reaches its highest plasma concentration 90 minutes after ingestion.9\nPeak blood levels of free acetaminophen are not reached until 3 hours after rectal administration of the suppository form of acetaminophen and the peak blood concentration is approximately 50% of the observed concentration after the ingestion of an equivalent oral dose (10-20 mcg/mL).23\nThe percentage of a systemically absorbed rectal dose of acetaminophen is inconsistent, demonstrated by major differences in the bioavailability of acetaminophen after a dose administered rectally. Higher rectal doses or an increased frequency of administration may be used to attain blood concentrations of acetaminophen similar to those attained after oral acetaminophen administration.Label",
                "Volume of distribution": "Volume of distribution is about 0.9L/kg. 10 to 20% of the drug is bound to red blood cells.11 Acetaminophen appears to be widely distributed throughout most body tissues except in fat.Label",
                "Protein binding": "The binding of acetaminophen to plasma proteins is low (ranging from 10% to 25%), when given at therapeutic doses.Label",
                "Metabolism": "Acetaminophen is the major metabolite of phenacetin and acetanilid.23 Acetaminophen is mainly metabolized in the liver by first-order kinetics and its metabolism of comprised of 3 pathways: conjugation with glucuronide, conjugation with sulfate, and oxidation through the cytochrome P450 enzyme pathway, mainly CYP2E1, to produce a reactive metabolite (N-acetyl-p-benzoquinone imine or NAPQI). At normal therapeutic doses, NAPQI undergoes fast conjugation with glutathione and is subsequently metabolized to produce both cysteine and mercapturic acid conjugates.Label\nHigh doses of acetaminophen (overdoses) can lead to hepatic necrosis due to the depletion of glutathione and of binding of high levels of reactive metabolite (NAPQI) to important parts of liver cells. The abovementioned damage to the liver can be prevented by the early administration of sulfhydryl compounds, for example, methionine and N-acetylcysteine.12\nHover over products below to view reaction partnersAcetaminophen\n\n\nNAPQI\n\n\nAcetaminophen cysteine\n\n\nAcetaminophen glucuronide\n\n\nAcetaminophen sulfate",
                "Route of elimination": "Acetaminophen metabolites are mainly excreted in the urine. Less than 5% is excreted in the urine as free (unconjugated) acetaminophen and at least 90% of the administered dose is excreted within 24 hours.23",
                "Half-life": "The half-life for adults is 2.5 h after an intravenous dose of 15 mg/kg.Label After an overdose, the half-life can range from 4 to 8 hours depending on the severity of injury to the liver, as it heavily metabolizes acetaminophen.9",
                "Clearance": "Adults: 0.27 L/h/kg following a 15 mg/kg intravenous (IV) dose.Label\nChildren: 0.34 L/h/kg following a 15 mg/kg intravenous (IV dose).Label",
                "Adverse Effects": "Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support & research outcomes with our structured adverse effects data.See a data sample",
                "Toxicity": "LD50 = 338 mg/kg (oral, mouse); LD50 = 1944 mg/kg (oral, rat)24\nOverdose and liver toxicity \nAcetaminophen overdose may be manifested by renal tubular necrosis, hypoglycemic coma, and thrombocytopenia. Sometimes, liver necrosis can occur as well as liver failure. Death and the requirement of a liver transplant may also occur.Label Metabolism by the CYP2E1 pathway releases a toxic acetaminophen metabolite known as N-acetyl-p-benzoquinoneimine(NAPQI). The toxic effects caused by this drug are attributed to NAPQI, not acetaminophen alone.24\nCarcinogenesis\nLong-term studies in mice and rats have been completed by the National Toxicology Program to study the carcinogenic risk of acetaminophen. In 2-year feeding studies, F344/N rats and B6C3F1 mice consumed a diet containing acetaminophen up to 6,000 ppm. Female rats showed evidence of carcinogenic activity demonstrated by a higher incidence of mononuclear cell leukemia at doses 0.8 times the maximum human daily dose (MHDD). No evidence of carcinogenesis in male rats (0.7 times) or mice (1.2 to 1.4 times the MHDD) was noted.Label The clinical relevance of this finding in humans is unknown.\nMutagenesis\nAcetaminophen was not found to be mutagenic in the bacterial reverse mutation assay (Ames test). Despite this finding, acetaminophen tested positive in the in vitro mouse lymphoma assay as well as the in vitro chromosomal aberration assay using human lymphocytes. In published studies, acetaminophen has been reported to be clastogenic (disrupting chromosomes) when given a high dose of 1,500 mg/kg/day to the rat model (3.6 times the MHDD). No clastogenicity was observed at a dose of 750 mg/kg/day (1.8 times the MHDD), indicating that this drug has a threshold before it may cause mutagenesis.Label The clinical relevance of this finding in humans is unknown.\nImpairment of Fertility\nIn studies conducted by the National Toxicology Program, fertility assessments have been performed in Swiss mice in a continuous breeding study. No effects on fertility were seen.Label \nUse in pregnancy and nursing\nThe FDA label for acetaminophen considers it a pregnancy category C drug, meaning this drug has demonstrated adverse effects in animal studies. No human clinical studies in pregnancy have been done to this date for intravenous acetaminophen.Label Use acetaminophen only when necessary during pregnancy.Label Epidemiological data on oral acetaminophen use in pregnant women demonstrate no increase in the risk of major congenital malformations.Label While prospective clinical studies examining the results of nursing with acetaminophen use have not been conducted, acetaminophen is found secreted in human milk at low concentrations after oral administration. Data from more than 15 nursing mothers taking acetaminophen was obtained, and the calculated daily dose of acetaminophen that reaches the infant is about 1 to 2% of the maternal dose. Caution should be observed when acetaminophen is taken by a nursing woman.Label",
                "Pathways": "PathwayCategoryAcetaminophen Metabolism PathwayDrug metabolismAcetaminophen Action PathwayDrug action",
                "Pharmacogenomic Effects/ADRs": "Not Available"
            },
            "Interactions": {
                "Drug Interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. ApprovedVet approvedNutraceuticalIllicitWithdrawnInvestigationalExperimentalAll DrugsDrugInteractionIntegrate drug-drug interactions in your software\n\n\nAbacavirAcetaminophen may decrease the excretion rate of Abacavir which could result in a higher serum level.AbametapirThe serum concentration of Acetaminophen can be increased when it is combined with Abametapir.AbataceptThe metabolism of Acetaminophen can be increased when combined with Abatacept.AbemaciclibThe metabolism of Abemaciclib can be increased when combined with Acetaminophen.AbirateroneThe serum concentration of Acetaminophen can be increased when it is combined with Abiraterone.AcalabrutinibThe metabolism of Acalabrutinib can be increased when combined with Acetaminophen.AcebutololThe metabolism of Acetaminophen can be decreased when combined with Acebutolol.AceclofenacThe risk or severity of adverse effects can be increased when Acetaminophen is combined with Aceclofenac.AcemetacinThe risk or severity of adverse effects can be increased when Acetaminophen is combined with Acemetacin.AcenocoumarolThe serum concentration of Acenocoumarol can be increased when it is combined with Acetaminophen.Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more",
                "Food Interactions": "Avoid alcohol. Alcohol may increase the risk of hepatotoxicity.\nTake with or without food. The absorption is unaffected by food."
            },
            "Products": {
                "": "Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access now  Access drug product information from over 10 global regions.Access now",
                "Product Images": "PreviousNext",
                "International/Other Brands": "Acamol (Teva) / Aceta Elixir / Aceta Tablets / Acetalgin / Actamin / Actimol / Algotropyl / Alvedon / Aminofen / Anacin-3 / Anhiba / Apacet / Banesin / Calpol / Conacetol / Dafalgan / Dapa X-S / Disprol / Dolprone / Dymadon / Dypap / Enelfa / Febridol / Febrilix / Finimal / Gelocatil / Genapap / Genebs / Injectapap / Liquiprin / Napafen / Oraphen-PD / Paldesic / Panofen / Paraspen / Parmol / Redutemp / Rounox / Salzone / Snaplets-FR / St. Joseph Fever Reducer / Suppap / Tapanol / Valorin",
                "Brand Name Prescription Products": "NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage7T Gummy ESTablet, chewable500 mg/1Oral7T Pharma LLC2019-09-01Not applicableUSAcetaminophenInjection10 mg/1mLIntravenousB. Braun Medical Inc.2021-02-18Not applicableUSAcetaminophenTablet325 mg/1OralRemedy Repack2011-03-092012-08-16USAcetaminophenInjection1000 mg/100mLIntravenousHikma Pharmaceuticals USA Inc.2022-06-03Not applicableUSAcetaminophenInjection10 mg/1mLIntravenousFresenius Kabi USA, LLC2020-12-06Not applicableUSAcetaminophenInjection10 mg/1mLIntravenousB. Braun Medical Inc.2021-02-18Not applicableUSAcetaminophen InjectionSolution10 mg / mLIntravenousAvir Pharma Inc2019-09-13Not applicableCanadaAcetaminophen InjectionSolution500 mg / 50 mLIntravenousB. Braun Melsungen AgNot applicableNot applicableCanadaAcetaminophen InjectionSolution100 mg / 10 mLIntravenousB. Braun Melsungen AgNot applicableNot applicableCanadaAcetaminophen InjectionSolution10 mg / mLIntravenousBaxter Laboratories2023-01-13Not applicableCanada",
                "Generic Prescription Products": "NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImageAcephenSuppository325 mg/1RectalRemedy Repack2015-01-162016-01-16USAcetaminophenInjection, solution10 mg/1mLIntravenousWockhardt USA LLC.2023-04-18Not applicableUSAcetaminophenInjection, solution10 mg/1mLIntravenousSandoz Inc2020-12-06Not applicableUSAcetaminophenInjection, solution10 mg/1mLIntravenousCivica, Inc.2022-11-10Not applicableUSAcetaminophenInjection, solution1000 mg/100mLIntravenousMylan Institutional LLC2020-12-07Not applicableUSAcetaminophenInjection, solution10 mg/1mLIntravenousSolupharm Pharmazeutische Erzeugnisse GmbH2020-12-07Not applicableUSAcetaminophenInjection, solution10 mg/1mLIntravenousNorthstar RxLLC2023-11-01Not applicableUSAcetaminophenInjection, solution10 mg/1mLIntravenousEugia US LLC2020-10-21Not applicableUSAcetaminophenInjection, solution10 mg/1mLIntravenousSandoz Inc2020-12-06Not applicableUSAcetaminophenInjection, solution10 mg/1mLIntravenousHikma Pharmaceuticals USA Inc.2023-03-01Not applicableUS",
                "Over the Counter Products": "NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage222 AF Extra Strength Caplet (500mg)Tablet500 mgOralMerck Frosst Canada & Cie, Merck Frosst Canada & Co.1992-12-311997-08-14Canada222 AF Regular Strength Caplet (325mg)Tablet325 mgOralMerck Frosst Canada & Cie, Merck Frosst Canada & Co.1992-12-311997-08-14Canada222af Extra Strength 500mgTablet500 mgOralMerck Frosst Canada & Cie, Merck Frosst Canada & Co.1978-12-311997-08-14Canada222af Regular Strength 325mgTablet325 mgOralMerck Frosst Canada & Cie, Merck Frosst Canada & Co.1977-12-311997-08-14Canada24 / 7 Life Extra Strength Pain RelieverTablet500 mg/1OralLil' Drug Store Products, Inc.2021-01-05Not applicableUS365 Everyday Value AcetaminophenTablet500 mg/1OralWhole Foods Market, Inc.2018-08-23Not applicableUS365 Everyday Value AcetaminophenTablet500 mg/1OralWhole Foods Market, Inc.2020-08-23Not applicableUS7 Select AcetaminophenTablet500 mg/1Oral7-Eleven2014-05-142021-03-31US7 Select Childrens Pain ReliefSuspension160 mg/5mLOral7-Eleven2014-08-132021-02-28US8 Hour Arthritis PainTablet, extended release650 mg/1OralAmerisource Bergen2020-01-13Not applicableUS",
                "Mixture Products": "NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage(extra Strength) Acetaminophen, Caffeine & 8mg Codeine Phosphate CapletsAcetaminophen (500 mg) + Caffeine (15 mg) + Codeine phosphate (8 mg)TabletOralStanley Pharmaceuticals, A Division Of Vita Health Products Inc.1998-07-222002-07-31Canada10 Person ANSIAcetaminophen (325 mg/1) + Acetylsalicylic acid (325 mg/1) + Bacitracin zinc (400 [iU]/1g) + Benzalkonium chloride (0.13 g/100g) + Benzalkonium chloride (0.40 mL/100mL) + Benzocaine (6 mL/100mL) + Ethanol (60 mL/100mL) + Ibuprofen (200 mg/1) + Lidocaine (0.5 1/100g) + Neomycin sulfate (5 mg/1g) + Polymyxin B sulfate (5000 [iU]/1g) + Water (98.6 mL/100mL)KitOphthalmic; Oral; TopicalGenuine First Aid2010-04-24Not applicableUS24 / 7 Life Extra Strength Pain Reliever PMAcetaminophen (500 mg/1) + Diphenhydramine hydrochloride (25 mg/1)Tablet, film coatedOralLil' Drug Store Products, Inc.2020-12-17Not applicableUS24/7 Life Cold and Flu DayTime SevereAcetaminophen (325 mg/1) + Dextromethorphan hydrobromide monohydrate (10 mg/1) + Guaifenesin (200 mg/1) + Phenylephrine hydrochloride (5 mg/1)Tablet, film coatedOralLil' Drug Store Products, Inc.2021-10-27Not applicableUS25 Person ANSIAcetaminophen (325 mg/1) + Acetylsalicylic acid (325 mg/1) + Bacitracin zinc (400 [iU]/1g) + Benzalkonium chloride (0.13 g/100g) + Benzalkonium chloride (0.40 mL/100mL) + Benzocaine (6 mL/100mL) + Ethanol (60 mL/100mL) + Ethanol (62 g/100g) + Ibuprofen (200 mg/1) + Isopropyl alcohol (70 mL/100mL) + Lidocaine (0.5 g/100g) + Neomycin sulfate (5 mg/1g) + Polymyxin B sulfate (5000 [iU]/1g) + Water (98.6 mL/100mL)KitOphthalmic; Oral; TopicalGenuine First Aid2010-04-25Not applicableUS4017 First Aid KitAcetaminophen (325 mg/1) + Benzalkonium chloride (0.13 g/100g) + Benzalkonium chloride (1.3 mg/1mL) + Ethanol (0.5 mL/1mL) + Lidocaine hydrochloride (20 mg/1mL) + Lidocaine hydrochloride (0.5 g/100g) + Neomycin sulfate (3.5 mg/1g) + Water (98.6 mL/100mL)Cream; Kit; Liquid; Ointment; Swab; TabletOphthalmic; Oral; TopicalHoneywell Safety Products USA, Inc2018-10-18Not applicableUS4022 First Aid KitAcetaminophen (325 mg/1) + Benzalkonium chloride (0.13 g/100g) + Benzalkonium chloride (1.3 mg/1mL) + Ethanol (0.5 mL/1mL) + Lidocaine hydrochloride (20 mg/1mL) + Lidocaine hydrochloride (0.5 g/100g) + Neomycin sulfate (3.5 mg/1g) + Water (98.6 mL/100mL)Cream; Kit; Liquid; Ointment; Swab; TabletOphthalmic; Oral; TopicalHoneywell Safety Products USA, Inc2018-10-18Not applicableUS4056 First Aid KitAcetaminophen (325 mg/1) + Benzalkonium chloride (0.13 g/100g) + Benzalkonium chloride (1.3 mg/1mL) + Ethanol (0.5 mL/1mL) + Lidocaine hydrochloride (20 mg/1mL) + Lidocaine hydrochloride (0.5 g/100g) + Neomycin sulfate (3.5 mg/1g) + Water (98.6 mL/100mL)KitOphthalmic; Oral; TopicalHoneywell Safety Products USA, Inc2018-10-182019-10-18US4068 First Aid KitAcetaminophen (325 mg/1) + Benzalkonium chloride (0.13 g/100g) + Benzalkonium chloride (1.3 mg/1mL) + Ethanol (0.5 mL/1mL) + Lidocaine hydrochloride (20 mg/1mL) + Lidocaine hydrochloride (0.5 g/100g) + Neomycin sulfate (3.5 mg/1g) + Water (98.6 mL/100mL)KitOphthalmic; Oral; TopicalHoneywell Safety Products USA, Inc2018-10-18Not applicableUS4069 First Aid KitAcetaminophen (325 mg/1) + Benzalkonium chloride (0.13 g/100g) + Benzalkonium chloride (1.3 mg/1mL) + Ethanol (0.5 mL/1mL) + Lidocaine hydrochloride (20 mg/1mL) + Lidocaine hydrochloride (0.5 g/100g) + Neomycin sulfate (3.5 mg/1g) + Water (98.6 mL/100mL)KitTopicalHoneywell Safety Products USA, Inc2018-10-182019-03-10US",
                "Unapproved/Other Products": "NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage4017 First Aid KitAcetaminophen (325 mg/1) + Benzalkonium chloride (0.13 g/100g) + Benzalkonium chloride (1.3 mg/1mL) + Ethanol (0.5 mL/1mL) + Lidocaine hydrochloride (20 mg/1mL) + Lidocaine hydrochloride (0.5 g/100g) + Neomycin sulfate (3.5 mg/1g) + Water (98.6 mL/100mL)Cream; Kit; Liquid; Ointment; Swab; TabletOphthalmic; Oral; TopicalHoneywell Safety Products USA, Inc2018-10-18Not applicableUS4022 First Aid KitAcetaminophen (325 mg/1) + Benzalkonium chloride (0.13 g/100g) + Benzalkonium chloride (1.3 mg/1mL) + Ethanol (0.5 mL/1mL) + Lidocaine hydrochloride (20 mg/1mL) + Lidocaine hydrochloride (0.5 g/100g) + Neomycin sulfate (3.5 mg/1g) + Water (98.6 mL/100mL)Cream; Kit; Liquid; Ointment; Swab; TabletOphthalmic; Oral; TopicalHoneywell Safety Products USA, Inc2018-10-18Not applicableUS4056 First Aid KitAcetaminophen (325 mg/1) + Benzalkonium chloride (0.13 g/100g) + Benzalkonium chloride (1.3 mg/1mL) + Ethanol (0.5 mL/1mL) + Lidocaine hydrochloride (20 mg/1mL) + Lidocaine hydrochloride (0.5 g/100g) + Neomycin sulfate (3.5 mg/1g) + Water (98.6 mL/100mL)KitOphthalmic; Oral; TopicalHoneywell Safety Products USA, Inc2018-10-182019-10-18US4068 First Aid KitAcetaminophen (325 mg/1) + Benzalkonium chloride (0.13 g/100g) + Benzalkonium chloride (1.3 mg/1mL) + Ethanol (0.5 mL/1mL) + Lidocaine hydrochloride (20 mg/1mL) + Lidocaine hydrochloride (0.5 g/100g) + Neomycin sulfate (3.5 mg/1g) + Water (98.6 mL/100mL)KitOphthalmic; Oral; TopicalHoneywell Safety Products USA, Inc2018-10-18Not applicableUS4069 First Aid KitAcetaminophen (325 mg/1) + Benzalkonium chloride (0.13 g/100g) + Benzalkonium chloride (1.3 mg/1mL) + Ethanol (0.5 mL/1mL) + Lidocaine hydrochloride (20 mg/1mL) + Lidocaine hydrochloride (0.5 g/100g) + Neomycin sulfate (3.5 mg/1g) + Water (98.6 mL/100mL)KitTopicalHoneywell Safety Products USA, Inc2018-10-182019-03-10US4076 First Aid KitAcetaminophen (325 mg/1) + Ammonia (0.045 g/0.3mL) + Benzalkonium chloride (0.13 g/100g) + Benzalkonium chloride (1.3 mg/1mL) + Ethanol (0.5 mL/1mL) + Lidocaine hydrochloride (20 mg/1mL) + Lidocaine hydrochloride (0.5 g/100g) + Neomycin sulfate (3.5 mg/1g) + Water (98.6 mL/100mL)KitTopicalHoneywell Safety Products USA, Inc2018-10-18Not applicableUS4081 First Aid KitAcetaminophen (325 mg/1) + Benzalkonium chloride (0.13 g/100g) + Benzalkonium chloride (1.3 mg/1mL) + Ethanol (0.5 mL/1mL) + Lidocaine hydrochloride (0.5 g/100g) + Lidocaine hydrochloride (20 mg/1mL) + Neomycin sulfate (3.5 mg/1g) + Water (98.6 mL/100mL)KitOphthalmic; Oral; TopicalHoneywell Safety Products USA, Inc2018-10-182019-10-18US4082 First Aid KitAcetaminophen (325 mg/1) + Benzalkonium chloride (0.13 g/100g) + Benzalkonium chloride (1.3 mg/1mL) + Ethanol (0.5 mL/1mL) + Lidocaine hydrochloride (20 mg/1mL) + Lidocaine hydrochloride (0.5 g/100g) + Neomycin sulfate (3.5 mg/1g) + Water (98.6 mL/100mL)KitOphthalmic; Oral; TopicalHoneywell Safety Products USA, Inc2018-10-182019-10-18US4083 First Aid KitAcetaminophen (325 mg/1) + Benzalkonium chloride (0.13 g/100g) + Benzalkonium chloride (1.3 mg/1mL) + Ethanol (0.5 mL/1mL) + Lidocaine hydrochloride (20 mg/1mL) + Lidocaine hydrochloride (0.5 g/100g) + Neomycin sulfate (3.5 mg/1g) + Water (98.6 mL/100mL)KitOphthalmic; Oral; TopicalHoneywell Safety Products USA, Inc2018-10-182019-10-18US4084 First Aid KitAcetaminophen (325 mg/1) + Benzalkonium chloride (0.13 g/100g) + Benzalkonium chloride (1.3 mg/1mL) + Ethanol (0.5 mL/1mL) + Lidocaine hydrochloride (20 mg/1mL) + Lidocaine hydrochloride (0.5 g/100g) + Neomycin sulfate (3.5 mg/1g) + Water (98.6 mL/100mL)KitOphthalmic; Oral; TopicalHoneywell Safety Products USA, Inc2018-10-182019-10-18US"
            },
            "Categories": {
                "ATC Codes": "N02BE71 \u2014 Paracetamol, combinations with psycholepticsN02BE \u2014 AnilidesN02B \u2014 OTHER ANALGESICS AND ANTIPYRETICSN02 \u2014 ANALGESICSN \u2014 NERVOUS SYSTEMN02BE01 \u2014 ParacetamolN02BE \u2014 AnilidesN02B \u2014 OTHER ANALGESICS AND ANTIPYRETICSN02 \u2014 ANALGESICSN \u2014 NERVOUS SYSTEMN02AJ13 \u2014 Tramadol and paracetamolN02AJ \u2014 Opioids in combination with non-opioid analgesicsN02A \u2014 OPIOIDSN02 \u2014 ANALGESICSN \u2014 NERVOUS SYSTEMN02AJ17 \u2014 Oxycodone and paracetamolN02AJ \u2014 Opioids in combination with non-opioid analgesicsN02A \u2014 OPIOIDSN02 \u2014 ANALGESICSN \u2014 NERVOUS SYSTEMN02BE51 \u2014 Paracetamol, combinations excl. psycholepticsN02BE \u2014 AnilidesN02B \u2014 OTHER ANALGESICS AND ANTIPYRETICSN02 \u2014 ANALGESICSN \u2014 NERVOUS SYSTEMN02AJ06 \u2014 Codeine and paracetamolN02AJ \u2014 Opioids in combination with non-opioid analgesicsN02A \u2014 OPIOIDSN02 \u2014 ANALGESICSN \u2014 NERVOUS SYSTEMN02AJ01 \u2014 Dihydrocodeine and paracetamolN02AJ \u2014 Opioids in combination with non-opioid analgesicsN02A \u2014 OPIOIDSN02 \u2014 ANALGESICSN \u2014 NERVOUS SYSTEM",
                "Drug Categories": "Acetaminophen and Prodrugs\nAmides\nAmines\nAnalgesics\nAnalgesics, Non-Narcotic\nAnilides\nAniline Compounds\nAntipyretics\nCentral Nervous System Agents\nCytochrome P-450 CYP1A2 Substrates\nCytochrome P-450 CYP2A6 Substrates\nCytochrome P-450 CYP2D6 Substrates\nCytochrome P-450 CYP2E1 Substrates\nCytochrome P-450 CYP3A Inducers\nCytochrome P-450 CYP3A Inhibitors\nCytochrome P-450 CYP3A Substrates\nCytochrome P-450 CYP3A4 Inducers\nCytochrome P-450 CYP3A4 Inducers (strength unknown)\nCytochrome P-450 CYP3A4 Inhibitors\nCytochrome P-450 CYP3A4 Inhibitors (weak)\nCytochrome P-450 CYP3A4 Substrates\nCytochrome P-450 Enzyme Inducers\nCytochrome P-450 Enzyme Inhibitors\nCytochrome P-450 Substrates\nDrugs that are Mainly Renally Excreted\nMethemoglobinemia Associated Agents\nMiscellaneous Analgesics and Antipyretics\nNervous System\nP-glycoprotein inhibitors\nP-glycoprotein substrates\nSensory System Agents\nUGT1A1 Substrates\nUGT1A6 substrate\nUGT1A9 Substrates",
                "Chemical TaxonomyProvided by Classyfire": "DescriptionThis compound belongs to the class of organic compounds known as 1-hydroxy-2-unsubstituted benzenoids. These are phenols that a unsubstituted at the 2-position.KingdomOrganic compoundsSuper ClassBenzenoidsClassPhenolsSub Class1-hydroxy-2-unsubstituted benzenoidsDirect Parent1-hydroxy-2-unsubstituted benzenoidsAlternative ParentsBenzene and substituted derivatives / Propargyl-type 1,3-dipolar organic compounds / Carboximidic acids / Organopnictogen compounds / Organooxygen compounds / Organonitrogen compounds / Hydrocarbon derivativesSubstituents1-hydroxy-2-unsubstituted benzenoid / Aromatic homomonocyclic compound / Carboximidic acid / Carboximidic acid derivative / Hydrocarbon derivative / Monocyclic benzene moiety / Organic 1,3-dipolar compound / Organic nitrogen compound / Organic oxygen compound / Organonitrogen compoundMolecular FrameworkAromatic homomonocyclic compoundsExternal Descriptorsphenols, acetamides (CHEBI:46195)  / a small molecule (CPD-7669)",
                "Description": "This compound belongs to the class of organic compounds known as 1-hydroxy-2-unsubstituted benzenoids. These are phenols that a unsubstituted at the 2-position.",
                "Kingdom": "Organic compounds",
                "Super Class": "Benzenoids",
                "Class": "Phenols",
                "Sub Class": "1-hydroxy-2-unsubstituted benzenoids",
                "Direct Parent": "1-hydroxy-2-unsubstituted benzenoids",
                "Alternative Parents": "Benzene and substituted derivatives / Propargyl-type 1,3-dipolar organic compounds / Carboximidic acids / Organopnictogen compounds / Organooxygen compounds / Organonitrogen compounds / Hydrocarbon derivatives",
                "Substituents": "1-hydroxy-2-unsubstituted benzenoid / Aromatic homomonocyclic compound / Carboximidic acid / Carboximidic acid derivative / Hydrocarbon derivative / Monocyclic benzene moiety / Organic 1,3-dipolar compound / Organic nitrogen compound / Organic oxygen compound / Organonitrogen compound",
                "Molecular Framework": "Aromatic homomonocyclic compounds",
                "External Descriptors": "phenols, acetamides (CHEBI:46195)  / a small molecule (CPD-7669)",
                "Affected organisms": "Humans and other mammals"
            },
            "Chemical Identifiers": {
                "UNII": "362O9ITL9D",
                "CAS number": "103-90-2",
                "InChI Key": "RZVAJINKPMORJF-UHFFFAOYSA-N",
                "InChI": "InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)",
                "IUPAC Name": "N-(4-hydroxyphenyl)acetamide",
                "SMILES": "CC(=O)NC1=CC=C(O)C=C1"
            },
            "References": {
                "Synthesis Reference": "Jeffrey L. Finnan, Rudolph E. Lisa, Douglass N. Schmidt, \"Process for preparing spray dried acetaminophen powder and the powder prepared thereby.\" U.S. Patent US4710519, issued October, 1975.\nUS4710519",
                "General References": "Kis B, Snipes JA, Busija DW: Acetaminophen and the cyclooxygenase-3 puzzle: sorting out facts, fictions, and uncertainties. J Pharmacol Exp Ther. 2005 Oct;315(1):1-7. Epub 2005 May 6. [Article] Aronoff DM, Oates JA, Boutaud O: New insights into the mechanism of action of acetaminophen: Its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases. Clin Pharmacol Ther. 2006 Jan;79(1):9-19. [Article] Bertolini A, Ferrari A, Ottani A, Guerzoni S, Tacchi R, Leone S: Paracetamol: new vistas of an old drug. CNS Drug Rev. 2006 Fall-Winter;12(3-4):250-75. [Article] Graham GG, Scott KF: Mechanism of action of paracetamol. Am J Ther. 2005 Jan-Feb;12(1):46-55. [Article] Ohki S, Ogino N, Yamamoto S, Hayaishi O: Prostaglandin hydroperoxidase, an integral part of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J Biol Chem. 1979 Feb 10;254(3):829-36. [Article] Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, Simmons DL: COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13926-31. Epub 2002 Sep 19. [Article] Adjei AA, Gaedigk A, Simon SD, Weinshilboum RM, Leeder JS: Interindividual variability in acetaminophen sulfation by human fetal liver: implications for pharmacogenetic investigations of drug-induced birth defects. Birth Defects Res A Clin Mol Teratol. 2008 Mar;82(3):155-65. doi: 10.1002/bdra.20535. [Article] Hazai E, Vereczkey L, Monostory K: Reduction of toxic metabolite formation of acetaminophen. Biochem Biophys Res Commun. 2002 Mar 8;291(4):1089-94. [Article] Mazaleuskaya LL, Sangkuhl K, Thorn CF, FitzGerald GA, Altman RB, Klein TE: PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses. Pharmacogenet Genomics. 2015 Aug;25(8):416-26. doi: 10.1097/FPC.0000000000000150. [Article] Ennis ZN, Dideriksen D, Vaegter HB, Handberg G, Pottegard A: Acetaminophen for Chronic Pain: A Systematic Review on Efficacy. Basic Clin Pharmacol Toxicol. 2016 Mar;118(3):184-9. doi: 10.1111/bcpt.12527. Epub 2015 Dec 28. [Article] Bannwarth B, Pehourcq F: [Pharmacologic basis for using paracetamol: pharmacokinetic and pharmacodynamic issues]. Drugs. 2003;63 Spec No 2:5-13. [Article] Forrest JA, Clements JA, Prescott LF: Clinical pharmacokinetics of paracetamol. Clin Pharmacokinet. 1982 Mar-Apr;7(2):93-107. [Article] Ricciotti E, FitzGerald GA: Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011 May;31(5):986-1000. doi: 10.1161/ATVBAHA.110.207449. [Article] Valerie Gerriets; Thomas M. Nappe (2019). Acetaminophen. StatPearls publishing. Acetaminophen tablet, DailyMed [Link] Acetaminophen effervescent tablets, Cleveland Clinic [Link] FDA safety communication: FDA has reviewed possible risks of pain medicine use during pregnancy [Link] U.S. National Medical Library: MedlinePlus- Acetaminophen dosing for children [Link] FDA consumer health information: Acetaminophen [Link] FDA : Acetaminophen Information [Link] Using Acetaminophen and Nonsteroidal Anti-inflammatory Drugs Safely [Link] FDA Approved Drug Products: Acetaminophen solution for intravenous injection [Link] Acetaminophen monograph, suppository [File] Acetaminophen data sheet, ebi.ac.uk [File] Tylenol arthritis pain label, OTC [File]",
                "External Links": "Human Metabolome DatabaseHMDB0001859KEGG DrugD00217KEGG CompoundC06804PubChem Compound1983PubChem Substance46506142ChemSpider1906BindingDB26197RxNav161ChEBI46195ChEMBLCHEMBL112ZINCZINC000013550868Therapeutic Targets DatabaseDAP001436PharmGKBPA448015PDBe LigandTYLRxListRxList Drug PageDrugs.comDrugs.com Drug PageWikipediaParacetamol",
                "Human Metabolome Database": "HMDB0001859",
                "KEGG Drug": "D00217",
                "KEGG Compound": "C06804",
                "PubChem Compound": "1983",
                "PubChem Substance": "46506142",
                "ChemSpider": "1906",
                "BindingDB": "26197",
                "RxNav": "161",
                "ChEBI": "46195",
                "ChEMBL": "CHEMBL112",
                "ZINC": "ZINC000013550868",
                "Therapeutic Targets Database": "DAP001436",
                "PharmGKB": "PA448015",
                "PDBe Ligand": "TYL",
                "RxList": "RxList Drug Page",
                "Drugs.com": "Drugs.com Drug Page",
                "Wikipedia": "Paracetamol",
                "PDB Entries": "1tyl / 1tym / 2dpz / 2ocu / 3py4 / 4a9j / 4a9k / 4cut / 4yji / 5pbe",
                "FDA label": "Download (392 KB)",
                "MSDS": "Download (71.9 KB)"
            },
            "Clinical Trials": {
                "Clinical Trials": "PhaseStatusPurposeConditionsCount4Active Not RecruitingSupportive CareShivering14Active Not RecruitingTreatmentAnalgesia14Active Not RecruitingTreatmentInfants, Premature / Opioids Use / Postoperative pain14Active Not RecruitingTreatmentLumbar Disc Disease / Lumbar Spine Disc Herniation / Radiculopathy Lumbar14Active Not RecruitingTreatmentLumbar Erector Spinae Plane Block / Pericapsular Nerve Group Block (PENG Block)14Active Not RecruitingTreatmentOocyte Retrieval / Postoperative pain14Active Not RecruitingTreatmentPostoperative pain14CompletedNot AvailableAlcohol Related Disorders24CompletedNot AvailableCesarean Section; Dehiscence14CompletedNot AvailableChronic Pain1"
            },
            "Pharmacoeconomics": {
                "Manufacturers": "Ortho mcneil pharmaceutical inc\nG and w laboratories inc\nAble laboratories inc\nActavis mid atlantic llc\nPerrigo new york inc\nRoxane laboratories inc\nPolymedica industries inc\nMcneil consumer healthcare\nOhm laboratories inc\nL perrigo co\nRanbaxy inc",
                "Packagers": "Actavis Group\nAdvent Pharmaceuticals Inc.\nAmneal Pharmaceuticals\nAristos Pharmaceuticals\nA-S Medication Solutions LLC\nBergen Brunswig\nChain Drug\nConcord Labs\nCVS Pharmacy\nDRX Pharmaceuticals\nEqualine Vitamins\nG & W Labs\nInternational Ethical Labs Inc.\nIvax Pharmaceuticals\nKroger Co.\nLetco Medical Inc.\nLongs Drug Store\nMajor Pharmaceuticals\nMallinckrodt Inc.\nManeesh Pharmaceuticals Ltd.\nMcNeil Laboratories\nMedique Products\nMedtech Labs\nNexgen Pharma Inc.\nNovartis AG\nNucare Pharmaceuticals Inc.\nPCA LLC\nPerrigo Co.\nPharmpak Inc.\nPhysicians Total Care Inc.\nPrepackage Specialists\nPrescript Pharmaceuticals\nQualitest\nQuality Care\nRite Aid Corp.\nS&P Healthcare\nSchwarz Pharma Inc.\nTeva Pharmaceutical Industries Ltd.\nValeant Ltd.\nWalgreen Co.\nWatson Pharmaceuticals\nXanodyne Pharmaceuticals Inc.",
                "Dosage Forms": "FormRouteStrengthCream; kit; liquid; ointment; swab; tabletOphthalmic; Oral; TopicalKitOphthalmic; Oral; Respiratory (inhalation); TopicalKit; liquid; ointment; spray; swab; tabletOphthalmic; Oral; TopicalKit; liquid; lozenge; ointment; spray; swab; tabletOphthalmic; Oral; TopicalKitOral; Respiratory (inhalation); TopicalKit; liquid; ointment; tabletOphthalmic; Oral; TopicalInhalant; kit; liquid; ointment; spray; swab; tabletOphthalmic; Oral; Respiratory (inhalation); TopicalKit; liquid; ointment; swab; tabletOphthalmic; Oral; TopicalKit; liquid; ointment; swab; tabletOral; TopicalKit; liquid; ointment; spray; tabletOphthalmic; Oral; TopicalGel; kit; liquid; ointment; swab; tabletOral; TopicalCream; kit; liquid; ointment; swab; tabletOral; TopicalCream; kit; liquid; swab; tabletOral; TopicalKitOphthalmic; Oral; TopicalTablet, chewableOral500 mg/1Capsule, coatedOral500 mg/1USuppositoryRectal325 mg/1SuppositoryRectal160 mgSuppositoryRectal650 mgTablet, effervescentOral500 mg/1Tablet, chewableOral100 mgSolutionOral3000 mgSolutionOral200 mgSolutionOral0.1 gSolutionOral10 gSolutionOral10 mgSyrupOral3.02 gSyrupOral3.33 gTabletOral500 mgTabletOral555.56 mgSolutionBuccal; Oral10 gBar, chewableOral160 mg/1InjectionIntravenous10 mg/1mLInjectionIntravenous1000 mg/100mLInjection, solutionIntravenous1000 mg/100mLSolutionOral1000 mg/30mLSuppositoryRectal120 mg/1SuppositoryRectal650 mg / supSuspensionOral160 mg/100mLSyrupOral500 mg/15mLTabletNot applicable650 mg/1TabletOral0.325 g/1gTabletOral0.5 g/1gTabletOral325 mg/1TabletOral500 mg/5001Tablet, chewableOral325 mg/1Tablet, coatedOral325 mg/1Tablet, extended releaseOral650 mg/1Tablet, film coatedOral500 mg/1SolutionOralTabletNot applicableTabletOral160 mg / tabTabletOral500.0 mgSolutionOral500 mg/15mLTabletOral500.4 mg/556mgSolutionOral3.333 g/100mLSuspension / dropsOral80 mg/0.8mLSolutionIntravenous100 mg / 10 mLSolutionIntravenous1000 mg / 100 mLSolutionIntravenous500 mg / 50 mLSolutionOral325 mg/10.15mLSolutionOral650 mg/20.3mLElixirOral32 mg / mLSolutionOral80 mg / 5 mLSolutionOral80 mg / mLSolutionOral160 mg / 5 mLSuppositoryRectal650 mg/1Capsule, gelatin coated499.5 mg/1TabletOral324.9 mg/361mgSyrupOral160 mg / 5 mLSolutionIntravenous100 mgSyrupOral2 gTablet, film coatedOral518 mgTablet, chewableBuccal100 mgSolutionOral100.0000 mgElixirOral3.33 gSuspensionOral3 gKitOral; TopicalKitTopicalCapsuleTabletOral4.000 mgPowderOral500 mgCapsuleOral200 mgPowder, for solutionOral500 mgCapsule, coatedOral500 mgCapsule, liquid filledNot applicableGranule, effervescentOralTablet, orally disintegratingOral325 mg/1Capsule, gelatin coatedOralSyrupOral3 gSolutionIntravenous1.000 gTabletOral500.00 mgSyrupOral3.04 gTabletOral35 mgTablet, sugar coatedOralSolutionOral500 mg/5mLCapsuleOral500 mg/1SolutionOral100 MG/MLTablet, extended releaseOral650.0 mgCapsule, gelatin coatedOral325 mg/1TabletOral325.00 mgSuspensionOral250 mgTabletOralSuppositoryRectalSuppositoryRectal75 MGGranuleOral1000 MGGranuleOral250 MGSyrupOral200 mg/5mLTabletOral555.000 mgSolutionOral500.000 mgTabletOral5.000 mgTablet, coatedOral500 MGLiquidTopicalSuspensionOral150 mlCapsuleOral250.0000 mgSuspensionOral5 gTablet, coatedOral250 mgTabletOral25 mgElixirOral160 mg / 5 mLElixirOral80 mg / mLLiquidOral160 mg / 5 mLSuspensionOral160 mg / 5 mLSyrupOral80 mg / 5 mLTabletOral80 mg / tabTablet, chewableOral80 mgPowderOral250 mgSyrupOral1 mg/5mlPowderOral160 mg / sachetElixirOral160 mg/5mLSuspensionOral32 mg/1mLSuspensionOral320 mg/10mLSuspensionOral325 mg/10.15mLSuspensionOral650 mg/20.3mLTablet, orally disintegratingOral80 mg/1SolutionOral160 mg/5mLTabletOral80 mg/1SolutionOral160 mg/10.15mLLiquidOral160 mg/5mLLiquidOral80 mg/2.5mLKit; suspension; tablet, chewableOralPowderOral160 mg/1SuspensionOralTabletOral2 mgPowderSolutionOral2.500 gKit; tablet, coatedOralCapsule, gelatin coatedOral10.50 mgPowderNot applicablePowder90 mg/100mgPowderNot applicable90 mg/100mgPowderNot applicable89.605 mg/89.605mgPowderNot applicable90 mg/90mgKit; tabletOralTabletOral4.00 mgCapsule, gelatin coated; kit; tabletOralTabletOral833.333 mgSolutionIntravenous1000 mgSolutionIntravenous500 mgKit; liquid; solutionOralKit; tablet; tablet, coatedOralCapsule; kitOralCapsule, gelatin coated; capsule, liquid filled; kitOralSuspensionOral80 mg/0.8mLTabletOral300 mgTablet, chewableOralSolutionOral2.0000 gCream; kit; liquid; ointment; tablet; tablet, chewable; tablet, film coatedOral; TopicalSyrupOral3200 mgTabletOral250 mgTabletOral500 mgCapsule, liquid filledOral500 mgCapsule, liquid filledOral500 mgSyrupOral3000 mgTablet, orally disintegratingOralSolutionOral100.00 mgTabletOral500.000 mgSyrupOral2.400 gSuppositoryRectal120 mg / supSuppositoryRectal325 mg / supTablet; tablet, film coatedOralBar, chewableOral80 mg/1EnemaRectalSuppositoryRectal300 MGTablet, effervescentOral1000 MGTablet, effervescentOral500 MGTablet, coatedTabletGranuleOral650.00 mgKit; tablet, film coatedOralTablet, delayed releaseOral650 mg/1Tablet, delayed releaseOral500 mg/1LiquidOral500 mg/5mLTabletOral500 mg/1CapsuleOral500 mg / capTablet, orally disintegratingOral500 mgCapsule, gelatin coatedOral500 mg/1SuspensionOral500 mg/15mLCapsule, liquid filledOral500 mg/1Tablet, chewableOral500.0 mgSolutionOral500 mg / 15 mLTabletOral500.000 mgSuppositoryRectal80 mg/1Tablet, effervescentOralCapsuleOralPowder, for suspensionOralCapsuleOral15 mgSolutionOral55.000 mgSuppositoryRectal125 mgSuppositoryRectal250 mgGranuleOralLiquidOral675 mg/15mLTablet, film coatedOralCapsule, coatedOral500 mg/1PowderOralLiquidOral1000 mg/60mLCapsule, coatedOralSolutionOral3 gPowderParenteral600 mgPowder, for solutionOralTabletOral750.000 mgTablet, film coatedTopicalTablet, for solutionOralLiquidOral650 mg/50mLTabletOral15 mgTabletOral325.000 mgKit; powderOralElixirOralTabletOralSuspensionOral80 mg / mLSuspensionOral200 mg/2mLSuspensionOral160 mg/1.6mLSolution / dropsOral80 mg/0.8mLSolutionIntravenous10.00 mgCream; kit; tablet, film coatedOral; TopicalTablet, chewableOral160 mg/1Tablet, orally disintegratingOral160 mg/1Tablet, chewableOral160 mgTabletOral160 mg/1TabletOral650.000 mgTablet, effervescentOral120 mgCapsule, delayed release pelletsOralCapsuleOral25 mgPowder, for solutionOral1000 mgLiquidOral.8 mL/1mLCream; kit; liquidOral; TopicalSuppositoryRectalSyrupOralGranule, effervescentOral1000 MGTablet, film coated, extended releaseOral650 mg/1TabletOral125 mgSolutionOral3.2 gTablet, chewableOral80 mg/1TabletOral80.000 mgPowderNot applicable1 kg/1kgCapsuleOralKit; solution; suspensionOralKit; tablet, coated; tablet, film coatedOralCapsule, liquid filled; kit; solutionNasal; OralKit; liquidOralCapsule, liquid filledOralPowder, for solutionOral125 mgPowder, for solutionOral250 mgPowder, for solutionOral50 mgTablet, extended releaseOral665 mgCapsuleOral325 mg/1570mgTabletOral350 MG/200MGSolution / drops; suspension / dropsGranule, for solutionOralSolutionIntravenous500.000 mgTabletOral325 mgTabletOral500 1/1Tablet, multilayerOralCapsule, coatedOral500 mgTablet, film coatedOral200 mgPowder150 MGSolutionOral3200 mgInjection, solutionIntravenous10 mg/1mLSolutionIntravenous10 mg / mLGranule, for solutionOralSyrupOral6.5 gSuspensionOral160 mg/5mLTablet, coatedOralTablet, effervescentOralTabletOral9 mgTablet, for solutionOral500 mgTablet, chewableOral120 mgSyrupOral60 mg/0.6mlTablet, film coatedOral665 mgTablet, effervescentOral65 mgTablet, chewableOralTablet, film coatedOral2 mgTablet, film coatedOral25 mgCapsuleOral500.04 mgSuspensionOral100 mlTabletOral325 mg / tabTabletOral500 mg / tabTablet, film coatedOral1 gTabletOral250 mgTablet, solubleOralTablet, film coatedOral160 mgEnemaRectal125 MgInjectionIntravenous10 mg/mlSolution / drops; suspension / dropsSyrupOralSyrupOral120 mgSolution, concentrateIntravenous1 gSolutionParenteral10 mg/mlSolutionParenteralSolutionIntravenous1.00 g/100mlSuspensionOralElixirOral120 mg/5mlSolutionIntravenousSolutionOral40 mg/mlSolutionOral200 mg/5mLSolutionIntravenous10 MG/MLGranule, effervescentOralSolution / dropsOral100 MG/MLSuppositoryRectal1000 MGInjection, solutionIntravenousTabletOral1000 MGInjection, solutionIntravenous10 MG/MLTabletDentalSolutionOralTablet, film coatedOral1000 MGGranuleOralTabletOral8 mgTablet, extended releaseOralTablet, film coated, extended releaseOral665 mgInjectionParenteralSuppositoryRectal200 mgSolution150 mg/1mlInjection, solutionIntravenous1 g/100mlLiquidOral80 mg/0.8mLSyrupOral250 gLiquid; solution / dropsOral80 mg / mLSolution / dropsOral80 mg / mLSuspensionSolutionOral10.00 gSolutionOral0.1000 gSyrupOral150 mlSyrupOral2.4 G/100MLSuppositoryRectal160 mg / supSuspensionOral50 mg/mlTabletOral650 mg/1SolutionOral0.1000 gTabletOral15.000 mgTabletOral300.000 mgSolutionOral3 gCapsuleOral325 mgTablet, film coatedOralSolution / dropsOralSyrupOral80 mg/0.8mLTablet, film coatedOral325 mg/1InjectionParenteral10 mg/mlTabletOral500.00 mgCapsule, liquid filled; kitOralLiquidOral80 mg / 5 mLSolutionOral100 mgSuppositoryRectal150 MGSuppositoryRectal600 MGSyrupOral2.4 gInjectionIntravenousSolutionIntravenous1000.000 mgSyrupOral3.2 gTabletOral750 mg/1Kit; tablet; tablet, film coatedOralLiquidOral80 mg / mLTabletOral500 mg/583mgTabletOral12.5 mgSuppositoryTablet, film coatedOral150 mgSyrupOral3.200 gSolutionOral100.000 mgTabletOral600 MGSolutionIntravenous1 gGranuleOral500 mgTabletOral162.00 mgCapsuleOral10.000 mgGranule, effervescentOral125 MGGranule, effervescentOral500 MGGranule, for solutionOral1000 MGSuppositoryRectal5 mgTablet, for suspensionTablet, orally disintegratingOralSuppositoryRectal350 mgSolution / dropsOral15 mlTabletOral0.5 grSolution / dropsOral30 mlLiquidOral100 mg/1mLSuppositoryRectal80.000 mgSolution / drops; suspension / drops80 mgSyrupOral250 mgTabletOral400.000 mgElixirOralSuppositoryRectal100 mgDrug delivery systemOralGranuleOral6.28 gKit; solutionOralKit; powder, for solutionOralKitOralSolutionIntramuscular; Intravenous300 mgSolutionIntravenous10 mgSyrupOral160 mg/5mLTablet, extended releaseOralSuppositoryRectal300 mg/1Kit; syrupOralSuspensionOral100.000 mgTablet, extended releaseOral650 mgTablet, film coatedOral650 mg/1SuspensionOral3.2 gTablet, extended releaseOral650 mg / tabLiquidOral500 mg/15mLPowderOral500 mg/0.95gTablet, coatedOral500 mg/1Capsule, liquid filledOral325 mg/1Tablet, delayed releaseOral1000 mg/1Tablet, delayed releaseOralSuppositoryRectal120 mgPowder125 mgPowder250 mgPowder500 mgSuppositoryRectal240 mgSolutionOral1000.000 mgSolutionOral10.000 gTablet, film coatedOral325 mgTabletOral30 mgSuspensionOral1000 mg/1Kit; suspensionOralPowder, for solutionOralSolutionOral650 mg / 15 mLGranuleOral500.000 mgKit; tablet, chewableOral; TopicalTablet, solubleOral250 mgTablet, solubleOral500 mgSolutionOral120 mg / 5 mLCapsuleOral450 mgInjection, solution, concentrateIntravenous10 mg/mlCapsuleOral10.00 mgTablet, sugar coatedOral30 mgSyrupOral3 gGranuleOral500 mgCapsuleOral250.000 mgLiquidOralSolutionParenteral500 mgTablet, film coatedSolution / dropsOral500 mg/5mlTablet, film coatedOral500 mgSyrupOral150 mg/5mLSuspensionOral250 mg/5mLSyrupOral500 mg/5mlTabletOral325 mgSolution120 mg/5mlSyrupOral120 mg/5mlSyrupOral250 mg/5mLSolutionOral120 mg/5mlTablet, coatedOral325 mgSuspensionOral500 mg/5mlTabletOral300 mgSuppositoryRectal80 mgSuppositoryRectal325 mgCapsuleOral500 mgTabletOral120 mgSolution10 mg/1mlSolution500 mg/5mlSolutionElixirTabletOral650 mgTablet, coatedOral500 mgSuspensionOral120 mg/5mLSyrupOral240 mg/5mLSuppositoryRectal500 mgSyrupTabletOral160 mgTabletOral80 mg",
                "Prices": "Unit descriptionCostUnitTylenol 100 325 mg tablet Bottle16.98USD bottlePhrenilin Forte 50-650 mg capsule5.24USD capsulePhrenilin forte capsule4.46USD capsuleNorco 7.5-325 tablet2.77USD tabletNorco 10-325 tablet2.76USD tabletPropoxyphen-apap 100-325 mg tablet2.66USD tabletDarvocet-N 100 100-650 mg tablet2.33USD tabletNorco 10-325 mg tablet2.14USD tabletUltracet 37.5-325 mg tablet1.95USD tabletPropoxyphen-apap 100-500 mg tablet1.85USD tabletUltracet tablet1.79USD tabletDarvocet-n 100 tablet1.72USD tabletTylenol with Codeine #4 300-60 mg tablet1.65USD tabletPhrenilin 50-325 mg tablet1.63USD tabletNorco 7.5-325 mg tablet1.61USD tabletDarvocet a500 tablet1.5USD tabletNorco 5-325 mg tablet1.43USD tabletDarvocet A500 100-500 mg tablet1.38USD tabletPhrenilin tablet1.32USD tabletNorco 5-325 tablet1.19USD tabletDarvocet-n 50 tablet1.14USD tabletHydrocodone-apap 10-750 tablet1.12USD tabletTylenol with Codeine #3 300-30 mg tablet1.1USD tabletTencon tablet1.01USD tabletHydrocodone-apap 7.5-650 tablet0.93USD tabletPropoxyphene-apap 50-325 mg tablet0.93USD tabletCo-gesic 5-500 tablet0.92USD eachSedapap 50-650 mg tablet0.92USD tabletClemastine fum 2.68 mg tablet0.86USD tabletFeverall 120 mg suppository0.8USD suppositoryFeverall 325 mg suppository0.8USD suppositoryFeverall 80 mg suppository0.8USD suppositoryTavist nd 10 mg tablet0.74USD tabletDarvocet-N 50 50-325 mg tablet0.73USD tabletHydrocodone-apap 10-325 tablet0.7USD tabletHydrocodone-apap 7.5-325 tablet0.62USD tabletHydrocodone-apap 10-660 tablet0.61USD tabletAcephen 650 mg suppository0.55USD suppositoryPropoxyphen-apap 100-650 mg tablet0.55USD tabletAcephen 120 mg suppository0.54USD suppositoryAcephen 325 mg suppository0.54USD suppositoryHydrocodone-apap 5-325 tablet0.54USD tabletHydrocodone-apap 10-500 tablet0.53USD tabletTavist-1 1.34 mg tablet0.5USD tabletAcetaminophen 325 mg suppository0.44USD suppositoryFeverall 650 mg suppository0.43USD suppositoryDrixoral cold & allergy tablet sa0.4USD tabletAcetaminophen 650 mg suppository0.39USD suppositoryAcetaminophen 120 mg suppository0.38USD suppositoryApap-butalbital 325-50 tablet0.38USD tabletHydrocodone-apap 10-650 tablet0.37USD eachHydrocodone-apap 2.5-500 tablet0.33USD tabletTylenol flu max-strn gelcap0.24USD capsuleMomentum caplet0.23USD capletTylenol cold gelcap0.23USD capsuleTylenol cold head congestion0.23USD eachTylenol cold multi-symp gelcap0.23USD capsuleTylenol allergy m-s caplet0.22USD capletTylenol cold multi-symptom caplet0.22USD capletTylenol cold head cong caplet0.21USD capletTylenol cold multi-symp caplet0.21USD capletTylenol cold severe congestion0.21USD eachTylenol sinus caplet0.21USD capletExcedrin quicktabs0.2USD tabletTylenol allergy m-s night caplet0.2USD capletTylenol chest congestion caplet0.2USD capletTylenol cold head congest caplet0.2USD capletTylenol sinus congestion&pain0.2USD eachExcedrin menstrual cmplt gelcap0.19USD capsuleJr. tylenol 160 mg meltaways0.19USD eachTylenol allergy complete caplet0.19USD capletTylenol allergy complete gelcap0.19USD capsuleTylenol allergy sinus gelcap0.19USD capsuleTylenol allergy sinus geltab0.19USD tabletTylenol flu nighttime gelcap0.19USD capsuleTylenol sinus congest-pain caplet0.19USD capletTylenol sinus gelcap0.19USD capsuleTylenol sinus geltab0.19USD tabletTylenol sinus nighttime caplet0.19USD capletTylenol arthritis geltab0.18USD tabletChild tylenol cold/cough tablet0.17USD tabletChildrens apap 80 mg tablet chew0.17USD tabletTavist max-str sinus caplet0.17USD capletTylenol allergy sinus caplet0.17USD capletTylenol cold caplet0.17USD capletTylenol severe allergy caplet0.17USD capletTylenol allergy multi-symptom0.16USD eachTylenol cold relief nightime0.16USD eachTylenol pm ex-strength gelcap0.16USD capsuleWomen's tylenol 500-25 capsule0.16USD capsuleExcedrin migraine geltabs0.15USD tabletTylenol cold relief caplet0.15USD capletExcedrin extra strength caplet0.14USD capletExcedrin migraine caplet0.14USD capletExcedrin sinus headache tablet0.14USD tabletExcedrin tension headache tablet0.14USD tabletHydrocodone-apap 7.5-750 tablet0.13USD tabletTylenol arthritis caplet sa0.13USD capletTylenol ex-str 500 mg tablet0.13USD tabletAcetaminophen 650 mg caplet0.12USD capletApap jr str 160 mg tablet chew0.12USD tabletHydrocodone-apap 7.5-500 tablet0.12USD tabletTylenol day & night value pack0.12USD eachAcetaminophen 500 mg geltab0.11USD tabletAcetaminophen 500 mg tablet0.11USD tabletChild's tylenol 80 mg meltaway0.11USD eachEql pain relief 500 mg caplet0.1USD capletEql pain relief 500 mg geltab0.1USD tabletExcedrin back & body caplet0.1USD capletExcedrin sinus headache caplet0.1USD capletExcedrin tension headache caplet0.1USD capletSoba pain rel 500 mg gelcap0.1USD capsuleTylenol 8 hour 650 mg caplet0.1USD capletTylenol p.m. ex-str geltab0.1USD tabletTylenol pm ex-strength caplet0.1USD capletAcetaminophen 160 mg tablet chw0.09USD tabletPain reliever 500 mg caplet0.09USD capletTylenol ex-str 500 mg geltab0.09USD tabletAcetaminophen pm caplet0.08USD capletExcedrin pm 500-38 mg tablet0.08USD tabletPain reliever 160 mg tablet0.08USD tabletTylenol es for arthritis pain0.08USD eachTylenol ex-str 500 mg caplet0.08USD capletTylenol pm ex-strength geltab0.08USD tabletAcetaminophen 80 mg tablet chew0.07USD tabletAcetaminophen powder dense0.07USD gApap 325 mg tablet0.07USD tabletApap child's 80 mg tablet chew0.07USD tabletSoba pain rel xs 500 mg tablet0.07USD tabletTylenol 325 mg tablet0.07USD tabletAcetaminophen 500 mg gelcap0.06USD tabletCVS Pharmacy non-aspirin 500 mg caplet0.06USD capletCVS Pharmacy non-aspirin 500 mg tablet0.06USD tabletCVS Pharmacy pain relief 500 mg gelcap0.06USD capsuleCVS Pharmacy pain rlf cool ice caplet0.06USD capletEql pain relief 325 mg tablet0.06USD tabletPain relief 500 mg caplet0.06USD capletPain reliever 325 mg tablet0.06USD tabletSoba pain reliever 500 mg tablet0.06USD tabletChild tylenol cough-runny nose0.05USD mlChild tylenol cough-sore thrt0.05USD mlChilds tylenol cold-cough susp0.05USD mlMapap 325 mg tablet0.05USD tabletNon-aspirin 500 mg geltab0.05USD tabletPain relief without asa tablet0.05USD tabletTylenol ex-str 500 mg gelcap0.05USD capsuleChilds tylenol cold-aller susp0.04USD mlChilds tylenol plus cold susp0.04USD mlChilds tylenol plus flu susp0.04USD mlCVS Pharmacy acetaminophen 325 mg tablet0.04USD tabletNon-aspirin 500 mg tablet0.04USD tabletPain reliever 500 mg geltab0.04USD tabletQ-pap ex-str 500 mg tablet0.04USD tabletRa acetaminophen pm caplet0.04USD capletAcetaminophen 325 mg tablet0.03USD tabletAcetaminophen 500 mg caplet0.03USD capletGenapap 325 mg tablet0.03USD tabletGenapap 500 mg tablet0.03USD tabletPain relief 500 mg tablet0.03USD eachPain reliever 500 mg gelcap0.03USD capsulePain reliever 500 mg tablet0.03USD tabletPain relief 325 mg tablet0.02USD tabletPain reliever w-o asa 325 mg0.02USD eachTylenol cold & flu severe liq0.02USD mlTylenol cold m-s severe day liquid0.02USD mlTylenol cough & sore throat lq0.02USD mlTylenol nighttime liquid0.02USD mlTylenol pm liquid0.02USD mlTylenol sore throat liquid0.02USD mlMaxapap 325 mg tablet0.01USD tabletMaxapap 500 mg caplet0.01USD eachMaxapap 500 mg tablet0.01USD tablet  DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.",
                "Patents": "Patent NumberPediatric ExtensionApprovedExpires (estimated)RegionUSRE39221No2006-08-012011-08-09USUS5972916No1999-10-262017-07-14USUS6488962No2002-12-032020-06-20USUS6028222Yes2000-02-222018-02-05USUS6992218Yes2006-01-312021-12-06USUS8372432No2013-02-122029-03-11USUS8668929No2014-03-112029-03-11USUS8377453No2013-02-192029-11-19USUS7976870No2011-07-122027-06-01USUS8741885No2014-06-032032-05-16USUS8992975No2015-03-312032-05-16USUS8597681No2013-12-032030-12-21USUS8980319No2015-03-172030-12-21USUS8394408No2013-03-122029-03-11USUS9050335No2015-06-092032-05-16USUS8658631No2014-02-252032-05-16USUS9399012Yes2016-07-262032-03-11USUS9610265Yes2017-04-042029-05-13USUS9468636No2016-10-182032-05-16USUS9132125No2015-09-152030-07-01USUS8828978No2014-09-092030-07-01USUS9549923No2017-01-242030-07-01USUS8748413No2014-06-102030-07-01USUS8461137No2013-06-112031-02-22USUS9987238Yes2018-06-052029-05-13USUS10383834No2019-08-202028-11-13USUS8741959No2014-06-032030-04-19USUS10532036No2020-01-142025-09-22USUS11197830No2021-12-142039-02-27USUS11534407No2019-02-272039-02-27US"
            },
            "Properties": {
                "State": "Solid",
                "Experimental Properties": "PropertyValueSourcemelting point (\u00b0C)168-172https://www.medisca.com/NDC_SPECS/MUS/0409/MSDS/0409.pdfboiling point (\u00b0C)>500http://www.inchem.org/documents/icsc/icsc/eics1330.htmwater solubilityvery slightly soluble in cold water but greater solubility in hot waterhttp://www.inchem.org/documents/pims/pharm/pim396.htmlogP0.46https://www.medisca.com/NDC_SPECS/MUS/0409/MSDS/0409.pdf",
                "Predicted Properties": "PropertyValueSourceWater Solubility4.15 mg/mLALOGPSlogP0.51ALOGPSlogP0.91ChemaxonlogS-1.6ALOGPSpKa (Strongest Acidic)9.46ChemaxonpKa (Strongest Basic)-4.4ChemaxonPhysiological Charge0ChemaxonHydrogen Acceptor Count2ChemaxonHydrogen Donor Count2ChemaxonPolar Surface Area49.33 \u00c52ChemaxonRotatable Bond Count1ChemaxonRefractivity42.9 m3\u00b7mol-1ChemaxonPolarizability15.52 \u00c53ChemaxonNumber of Rings1ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterNoChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxon",
                "Predicted ADMET Features": "PropertyValueProbabilityHuman Intestinal Absorption+0.9921Blood Brain Barrier+0.9544Caco-2 permeable+0.8285P-glycoprotein substrateNon-substrate0.8202P-glycoprotein inhibitor INon-inhibitor0.982P-glycoprotein inhibitor IINon-inhibitor0.9781Renal organic cation transporterNon-inhibitor0.9292CYP450 2C9 substrateNon-substrate0.7259CYP450 2D6 substrateSubstrate0.8918CYP450 3A4 substrateNon-substrate0.5554CYP450 1A2 substrateNon-inhibitor0.9045CYP450 2C9 inhibitorNon-inhibitor0.907CYP450 2D6 inhibitorNon-inhibitor0.9755CYP450 2C19 inhibitorNon-inhibitor0.9161CYP450 3A4 inhibitorNon-inhibitor0.8496CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.8842Ames testNon AMES toxic0.8767CarcinogenicityNon-carcinogens0.7654BiodegradationReady biodegradable0.6342Rat acute toxicity1.8596 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9717hERG inhibition (predictor II)Non-inhibitor0.9597  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)"
            },
            "Spectra": {
                "Mass Spec (NIST)": "Download (7.63 KB)",
                "Spectra": "SpectrumSpectrum TypeSplash KeyGC-MS Spectrum - GC-MS (2 TMS)GC-MSsplash10-0a4i-4971200000-17e6e1373f10ba4ec138Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot AvailableGC-MS Spectrum - EI-BGC-MSsplash10-0a4i-1900000000-df97f74a81da3a46a697GC-MS Spectrum - EI-BGC-MSsplash10-0a4i-4900000000-ef277124e1b50b5f010eGC-MS Spectrum - CI-BGC-MSsplash10-0udi-0900000000-7aa6a54b74b345d91e37GC-MS Spectrum - GC-MSGC-MSsplash10-0a4i-4971200000-17e6e1373f10ba4ec138Mass Spectrum (Electron Ionization)MSsplash10-0a4i-4900000000-ffdd0f8a1e6e450fc162MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated)LC-MS/MSsplash10-0w29-3900000000-97741eddc3be9c7eaea8MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated)LC-MS/MSsplash10-0ik9-1900000000-1ddd59340d1db920fa66MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated)LC-MS/MSsplash10-00kf-9000000000-148fa91ce08e13165712MS/MS Spectrum - EI-B (HITACHI M-80) , PositiveLC-MS/MSsplash10-0a4i-1900000000-5997c3f6cdebc5326b65MS/MS Spectrum - EI-B (Unknown) , PositiveLC-MS/MSsplash10-0a4i-4900000000-ef277124e1b50b5f010eMS/MS Spectrum - CI-B (Unknown) , PositiveLC-MS/MSsplash10-0udi-0900000000-7aa6a54b74b345d91e37Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableLC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-0zfr-0900000000-125e44ce332576a1e155LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-0udi-0900000000-7e46df4b4b653c90c258LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-0udi-0900000000-bb6e34d2d574a249d721LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-0udi-0900000000-2f45dd7efce38361f806LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-0pb9-0900000000-e48b48d64b6b985ab455LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-0a4i-0900000000-b72b0e33fd35512fe6deLC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-0a4i-0900000000-97bcaa95f26159307d03LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-0udi-0900000000-c50b4b79792e2c2e68f9LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-0udi-0900000000-7e46df4b4b653c90c258LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-0udi-0900000000-2b07cd2813d3f23e88f1LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-0pb9-0900000000-5b92f09589afe838f23aLC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-0a4i-0900000000-f0ca5ff6526b9f005034LC-MS/MS Spectrum - LC-ESI-ITFT , negativeLC-MS/MSsplash10-0udi-0900000000-7e45ef71674dcdde9068LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0w29-1900000000-38d21a339e82f461beacLC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0udi-0900000000-d953f92b362e4b262210LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0udi-0900000000-3170dca3f927500ea230LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0udi-0900000000-f835e92fb0bae0c7b8bcLC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0w29-0900000000-4e01c7ff07665fcdb218LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-03di-0900000000-a3c279c288bb690496b3LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-03di-2900000000-4435e0230105d5d28a94LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-03di-6900000000-76671cc7ad1df1b5983dLC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0udi-0900000000-9895c5f2b10912092523LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0udi-0900000000-d73797c93a4ef79ea79eLC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0w29-0900000000-22d62a7732ed3d99e87dLC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-03di-0900000000-c652f4f179daa6465678LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-03di-2900000000-0e7e745540d8ec7b99f4LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-03di-6900000000-2a4263b38fa30bc64dd0LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0w29-0900000000-cf0ac615ec636ce7a253LC-MS/MS Spectrum - LC-ESI-IT , positiveLC-MS/MSsplash10-03di-0900000000-428d8023ee5761fed84cLC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-03di-0900000000-ed26fb95b6aea6986085LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-03di-1900000000-5b942e17f1e66a3832b8LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-03di-0900000000-d6a7498b8d87d4e00028LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-03di-0900000000-9ff40d4cd8c0f46836c2LC-MS/MS Spectrum - LC-ESI-QFT , positiveLC-MS/MSsplash10-0w29-0900000000-fcf8e62537bd6db11b3aLC-MS/MS Spectrum - LC-ESI-QFT , positiveLC-MS/MSsplash10-0w29-0900000000-c27e8f1522f41492aae31H NMR Spectrum1D NMRNot Applicable1H NMR Spectrum1D NMRNot Applicable13C NMR Spectrum1D NMRNot Applicable[1H,13C] 2D NMR Spectrum2D NMRNot Applicable"
            },
            "Interested in using DrugBank in a commercial product or application?": {},
            "Stay up-to-date with the latest from DrugBank!": {},
            "Thank you for subscribing!": {}
        },
        "Additional Information": {
            "targets": [
                {
                    "Label": "Prostaglandin G/H synthase 2",
                    "Detailed Info": {
                        "Name": "Prostaglandin G/H synthase 2",
                        "Synonyms": "1.14.99.1\nCOX-2\nCOX2\nCyclooxygenase-2\nPGH synthase 2\nPGHS-2\nPHS II\nProstaglandin H2 synthase 2\nProstaglandin-endoperoxide synthase 2",
                        "Gene Name": "PTGS2",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0021832|Prostaglandin G/H synthase 2\nMLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFL\nTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADY\nGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGS\nNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKY\nQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCD\nVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQ\nNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRV\nAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEAL\nYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEV\nGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKER\nSTEL",
                        "Number of residues": "604",
                        "Molecular Weight": "68995.625",
                        "Theoretical pI": "7.41",
                        "GO Classification": "Functionsarachidonate 15-lipoxygenase activity / enzyme binding / heme binding / lipid binding / metal ion binding / peroxidase activity / prostaglandin-endoperoxide synthase activityProcessesangiogenesis / arachidonic acid metabolic process / bone mineralization / brown fat cell differentiation / cellular response to ATP / cellular response to fluid shear stress / cellular response to hypoxia / cellular response to mechanical stimulus / cellular response to UV / cyclooxygenase pathway / decidualization / embryo implantation / hair cycle / inflammatory response / learning / lipoxygenase pathway / maintenance of blood-brain barrier / memory / movement of cell or subcellular component / NAD metabolic process / negative regulation of calcium ion transport / negative regulation of cell cycle / negative regulation of cell proliferation / negative regulation of smooth muscle contraction / negative regulation of synaptic transmission, dopaminergic / nicotinamide metabolic process / ovulation / positive regulation of apoptotic process / positive regulation of brown fat cell differentiation / positive regulation of cell migration involved in sprouting angiogenesis / positive regulation of fever generation / positive regulation of fibroblast growth factor production / positive regulation of NF-kappaB import into nucleus / positive regulation of nitric oxide biosynthetic process / positive regulation of platelet-derived growth factor production / positive regulation of prostaglandin biosynthetic process / positive regulation of smooth muscle cell proliferation / positive regulation of smooth muscle contraction / positive regulation of synaptic plasticity / positive regulation of synaptic transmission, glutamatergic / positive regulation of transforming growth factor beta production / positive regulation of vascular endothelial growth factor production / positive regulation of vasoconstriction / prostaglandin biosynthetic process / prostaglandin metabolic process / regulation of blood pressure / regulation of inflammatory response / response to drug / response to estradiol / response to fatty acid / response to fructose / response to glucocorticoid / response to lipopolysaccharide / response to lithium ion / response to manganese ion / response to oxidative stress / response to tumor necrosis factor / response to vitamin D / sensory perception of pain / small molecule metabolic process / vitamin metabolic process / water-soluble vitamin metabolic processComponentscaveola / cytoplasm / endoplasmic reticulum / endoplasmic reticulum lumen / endoplasmic reticulum membrane / neuron projection / nucleus / protein complex",
                        "General Function": "Prostaglandin-endoperoxide synthase activity",
                        "Specific Function": "Converts arachidonate to prostaglandin H2 (PGH2), a committed step in prostanoid synthesis. Constitutively expressed in some tissues in physiological conditions, such as the endothelium, kidney and brain, and in pathological conditions, such as in cancer. PTGS2 is responsible for production of inflammatory prostaglandins. Up-regulation of PTGS2 is also associated with increased cell adhesion, phenotypic changes, resistance to apoptosis and tumor angiogenesis. In cancer cells, PTGS2 is a key step in the production of prostaglandin E2 (PGE2), which plays important roles in modulating motility, proliferation and resistance to apoptosis.",
                        "Pfam Domain Function": "An_peroxidase (PF03098)\nEGF (PF00008)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Microsome membrane",
                        "Gene sequence": ">lcl|BSEQ0021833|Prostaglandin G/H synthase 2 (PTGS2)\nATGCTCGCCCGCGCCCTGCTGCTGTGCGCGGTCCTGGCGCTCAGCCATACAGCAAATCCT\nTGCTGTTCCCACCCATGTCAAAACCGAGGTGTATGTATGAGTGTGGGATTTGACCAGTAT\nAAGTGCGATTGTACCCGGACAGGATTCTATGGAGAAAACTGCTCAACACCGGAATTTTTG\nACAAGAATAAAATTATTTCTGAAACCCACTCCAAACACAGTGCACTACATACTTACCCAC\nTTCAAGGGATTTTGGAACGTTGTGAATAACATTCCCTTCCTTCGAAATGCAATTATGAGT\nTATGTGTTGACATCCAGATCACATTTGATTGACAGTCCACCAACTTACAATGCTGACTAT\nGGCTACAAAAGCTGGGAAGCCTTCTCTAACCTCTCCTATTATACTAGAGCCCTTCCTCCT\nGTGCCTGATGATTGCCCGACTCCCTTGGGTGTCAAAGGTAAAAAGCAGCTTCCTGATTCA\nAATGAGATTGTGGAAAAATTGCTTCTAAGAAGAAAGTTCATCCCTGATCCCCAGGGCTCA\nAACATGATGTTTGCATTCTTTGCCCAGCACTTCACGCATCAGTTTTTCAAGACAGATCAT\nAAGCGAGGGCCAGCTTTCACCAACGGGCTGGGCCATGGGGTGGACTTAAATCATATTTAC\nGGTGAAACTCTGGCTAGACAGCGTAAACTGCGCCTTTTCAAGGATGGAAAAATGAAATAT\nCAGATAATTGATGGAGAGATGTATCCTCCCACAGTCAAAGATACTCAGGCAGAGATGATC\nTACCCTCCTCAAGTCCCTGAGCATCTACGGTTTGCTGTGGGGCAGGAGGTCTTTGGTCTG\nGTGCCTGGTCTGATGATGTATGCCACAATCTGGCTGCGGGAACACAACAGAGTATGCGAT\nGTGCTTAAACAGGAGCATCCTGAATGGGGTGATGAGCAGTTGTTCCAGACAAGCAGGCTA\nATACTGATAGGAGAGACTATTAAGATTGTGATTGAAGATTATGTGCAACACTTGAGTGGC\nTATCACTTCAAACTGAAATTTGACCCAGAACTACTTTTCAACAAACAATTCCAGTACCAA\nAATCGTATTGCTGCTGAATTTAACACCCTCTATCACTGGCATCCCCTTCTGCCTGACACC\nTTTCAAATTCATGACCAGAAATACAACTATCAACAGTTTATCTACAACAACTCTATATTG\nCTGGAACATGGAATTACCCAGTTTGTTGAATCATTCACCAGGCAAATTGCTGGCAGGGTT\nGCTGGTGGTAGGAATGTTCCACCCGCAGTACAGAAAGTATCACAGGCTTCCATTGACCAG\nAGCAGGCAGATGAAATACCAGTCTTTTAATGAGTACCGCAAACGCTTTATGCTGAAGCCC\nTATGAATCATTTGAAGAACTTACAGGAGAAAAGGAAATGTCTGCAGAGTTGGAAGCACTC\nTATGGTGACATCGATGCTGTGGAGCTGTATCCTGCCCTTCTGGTAGAAAAGCCTCGGCCA\nGATGCCATCTTTGGTGAAACCATGGTAGAAGTTGGAGCACCATTCTCCTTGAAAGGACTT\nATGGGTAATGTTATATGTTCTCCTGCCTACTGGAAGCCAAGCACTTTTGGTGGAGAAGTG\nGGTTTTCAAATCATCAACACTGCCTCAATTCAGTCTCTCATCTGCAATAACGTGAAGGGC\nTGTCCCTTTACTTCATTCAGTGTTCCAGATCCAGAGCTCATTAAAACAGTCACCATCAAT\nGCAAGTTCTTCCCGCTCCGGACTAGATGATATCAATCCCACAGTACTACTAAAAGAACGT\nTCGACTGAACTGTAG",
                        "Chromosome Location": "1",
                        "Locus": "1q25.2-q25.3",
                        "External Identifiers": "ResourceLinkUniProtKB IDP35354UniProtKB Entry NamePGH2_HUMANGenBank Protein ID291988GenBank Gene IDL15326GenAtlas IDPTGS2HGNC IDHGNC:9605",
                        "General References": "Jones DA, Carlton DP, McIntyre TM, Zimmerman GA, Prescott SM: Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem. 1993 Apr 25;268(12):9049-54. [Article] Hla T, Neilson K: Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7384-8. [Article] Kosaka T, Miyata A, Ihara H, Hara S, Sugimoto T, Takeda O, Takahashi E, Tanabe T: Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. Eur J Biochem. 1994 May 1;221(3):889-97. [Article] Appleby SB, Ristimaki A, Neilson K, Narko K, Hla T: Structure of the human cyclo-oxygenase-2 gene. Biochem J. 1994 Sep 15;302 ( Pt 3):723-7. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Gregory SG, Barlow KF, McLay KE, Kaul R, Swarbreck D, Dunham A, Scott CE, Howe KL, Woodfine K, Spencer CC, Jones MC, Gillson C, Searle S, Zhou Y, Kokocinski F, McDonald L, Evans R, Phillips K, Atkinson A, Cooper R, Jones C, Hall RE, Andrews TD, Lloyd C, Ainscough R, Almeida JP, Ambrose KD, Anderson F, Andrew RW, Ashwell RI, Aubin K, Babbage AK, Bagguley CL, Bailey J, Beasley H, Bethel G, Bird CP, Bray-Allen S, Brown JY, Brown AJ, Buckley D, Burton J, Bye J, Carder C, Chapman JC, Clark SY, Clarke G, Clee C, Cobley V, Collier RE, Corby N, Coville GJ, Davies J, Deadman R, Dunn M, Earthrowl M, Ellington AG, Errington H, Frankish A, Frankland J, French L, Garner P, Garnett J, Gay L, Ghori MR, Gibson R, Gilby LM, Gillett W, Glithero RJ, Grafham DV, Griffiths C, Griffiths-Jones S, Grocock R, Hammond S, Harrison ES, Hart E, Haugen E, Heath PD, Holmes S, Holt K, Howden PJ, Hunt AR, Hunt SE, Hunter G, Isherwood J, James R, Johnson C, Johnson D, Joy A, Kay M, Kershaw JK, Kibukawa M, Kimberley AM, King A, Knights AJ, Lad H, Laird G, Lawlor S, Leongamornlert DA, Lloyd DM, Loveland J, Lovell J, Lush MJ, Lyne R, Martin S, Mashreghi-Mohammadi M, Matthews L, Matthews NS, McLaren S, Milne S, Mistry S, Moore MJ, Nickerson T, O'Dell CN, Oliver K, Palmeiri A, Palmer SA, Parker A, Patel D, Pearce AV, Peck AI, Pelan S, Phelps K, Phillimore BJ, Plumb R, Rajan J, Raymond C, Rouse G, Saenphimmachak C, Sehra HK, Sheridan E, Shownkeen R, Sims S, Skuce CD, Smith M, Steward C, Subramanian S, Sycamore N, Tracey A, Tromans A, Van Helmond Z, Wall M, Wallis JM, White S, Whitehead SL, Wilkinson JE, Willey DL, Williams H, Wilming L, Wray PW, Wu Z, Coulson A, Vaudin M, Sulston JE, Durbin R, Hubbard T, Wooster R, Dunham I, Carter NP, McVean G, Ross MT, Harrow J, Olson MV, Beck S, Rogers J, Bentley DR, Banerjee R, Bryant SP, Burford DC, Burrill WD, Clegg SM, Dhami P, Dovey O, Faulkner LM, Gribble SM, Langford CF, Pandian RD, Porter KM, Prigmore E: The DNA sequence and biological annotation of human chromosome 1. Nature. 2006 May 18;441(7091):315-21. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Barnett J, Chow J, Ives D, Chiou M, Mackenzie R, Osen E, Nguyen B, Tsing S, Bach C, Freire J, et al.: Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system. Biochim Biophys Acta. 1994 Nov 16;1209(1):130-9. [Article] Kim SF, Huri DA, Snyder SH: Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science. 2005 Dec 23;310(5756):1966-70. [Article] Sevigny MB, Li CF, Alas M, Hughes-Fulford M: Glycosylation regulates turnover of cyclooxygenase-2. FEBS Lett. 2006 Dec 11;580(28-29):6533-6. Epub 2006 Nov 9. [Article] Goodman JE, Bowman ED, Chanock SJ, Alberg AJ, Harris CC: Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis. 2004 Dec;25(12):2467-72. Epub 2004 Aug 12. [Article] Smith WL, DeWitt DL, Garavito RM: Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem. 2000;69:145-82. [Article] Sostres C, Gargallo CJ, Lanas A: Aspirin, cyclooxygenase inhibition and colorectal cancer. World J Gastrointest Pharmacol Ther. 2014 Feb 6;5(1):40-9. doi: 10.4292/wjgpt.v5.i1.40. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00154Dihomo-gamma-linolenic acidinvestigational, nutraceuticalyesDetailsDB00159Icosapentapproved, nutraceuticalyesinhibitorDetailsDB00480Lenalidomideapprovedunknownnegative modulatorDetailsDB00482Celecoxibapproved, investigationalyesinhibitorDetailsDB00533Rofecoxibapproved, investigational, withdrawnyesinhibitorDetailsDB00580Valdecoxibapproved, investigational, withdrawnyesinhibitorDetailsDB00605Sulindacapproved, investigationalyesinhibitorDetailsDB00712Flurbiprofenapproved, investigationalyesinhibitorDetailsDB00784Mefenamic acidapprovedyesinhibitorDetailsDB00812Phenylbutazoneapproved, vet_approvedyesinhibitorDetailsDB00821Carprofenapproved, vet_approved, withdrawnyesinhibitorDetailsDB00991OxaprozinapprovedyesinhibitorDetailsDB00244MesalazineapprovedyesinhibitorDetailsDB00316AcetaminophenapprovedyesinhibitorDetailsDB00328Indomethacinapproved, investigationalyesinhibitorDetailsDB00461NabumetoneapprovedyesinhibitorDetailsDB00465KetorolacapprovedyesinhibitorDetailsDB00469TenoxicamapprovedyesinhibitorDetailsDB00500TolmetinapprovedyesinhibitorDetailsDB00573FenoprofenapprovedyesinhibitorDetailsDB00586Diclofenacapproved, vet_approvedyesinhibitorDetailsDB00749Etodolacapproved, investigational, vet_approvedyesinhibitorDetailsDB00788Naproxenapproved, vet_approvedyesinhibitorDetailsDB00814Meloxicamapproved, vet_approvedyesinhibitorDetailsDB00861Diflunisalapproved, investigationalyesinhibitorDetailsDB00870Suprofenapproved, withdrawnyesinhibitorDetailsDB00939Meclofenamic acidapproved, vet_approvedyesinhibitorDetailsDB00945Acetylsalicylic acidapproved, vet_approvedyesinhibitorDetailsDB00963Bromfenacapproved, withdrawnyesinhibitorDetailsDB01009Ketoprofenapproved, vet_approvedyesinhibitorDetailsDB01014Balsalazideapproved, investigationalyesinhibitorDetailsDB01050IbuprofenapprovedyesinhibitorDetailsDB01283Lumiracoxibapproved, investigationalyesinhibitorDetailsDB01399SalsalateapprovedyesinhibitorDetailsDB00936Salicylic acidapproved, investigational, vet_approvedyesinhibitorDetailsDB01404Ginsenginvestigational, nutraceuticalunknowninhibitorDetailsDB01628Etoricoxibapproved, investigationalyesinhibitorDetailsDB01600Tiaprofenic acidapprovedyesinhibitorDetailsDB04743Nimesulideapproved, investigational, withdrawnyesinhibitorDetailsDB02709ResveratrolinvestigationalunknowninhibitorDetailsDB04725LicofeloneinvestigationalunknownDetailsDB05095CimicoxibinvestigationalunknownDetailsDB02266Flufenamic acidapprovedunknownDetailsDB00554Piroxicamapproved, investigationalyesinhibitorDetailsDB01397Magnesium salicylateexperimentalyesinhibitorDetailsDB00250Dapsoneapproved, investigationalunknownsubstrateDetailsDB01041Thalidomideapproved, investigational, withdrawnnosubstrateDetailsDB06725Lornoxicamapproved, investigationalyesinhibitorDetailsDB03866Prostaglandin G2experimentalunknownDetailsDB034771-Phenylsulfonamide-3-Trifluoromethyl-5-ParabromophenylpyrazoleexperimentalunknownDetailsDB06802Nepafenacapproved, investigationalunknowninhibitorDetailsDB00795SulfasalazineapprovedyesinhibitorDetailsDB04552Niflumic acidexperimentalyesinhibitorDetailsDB01435Antipyrineapproved, investigationalunknowninhibitorDetailsDB01419AntrafenineapprovedunknowninhibitorDetailsDB01401Choline magnesium trisalicylateapprovedunknowninhibitorDetailsDB00233Aminosalicylic acidapprovedunknowninhibitorDetailsDB00963Bromfenacapproved, withdrawnunknowninhibitorDetailsDB00887BumetanideapprovedunknowninducerDetailsDB06774CapsaicinapprovedunknowninhibitorDetailsDB00856Chlorphenesinapproved, experimentalunknowninhibitorDetailsDB05095CimicoxibinvestigationalunknowninhibitorDetailsDB00720Clodronic acidapproved, investigational, vet_approvedunknowninhibitorDetailsDB06195SeliciclibinvestigationalunknowninhibitorDetailsDB00035DesmopressinapprovedunknowninducerDetailsDB05804Prasterone sulfateinvestigationalunknowninducerDetailsDB01395DrospirenoneapprovedunknowninhibitorinducerDetailsDB06804Nonoxynol-9approved, withdrawnunknowninducerDetailsDB00515CisplatinapprovedunknowninhibitorDetailsDB00884Risedronic acidapproved, investigationalunknowninducerDetailsDB00360Sapropterinapproved, investigationalunknowninducerDetailsDB06436SemaxanibinvestigationalunknowninducerDetailsDB05875Sar9, Met (O2)11-Substance PinvestigationalunknowninducerDetailsDB00041AldesleukinapprovedunknowninducerDetailsDB00620Triamcinoloneapproved, vet_approvedunknowninhibitorDetailsDB08819TafluprostapprovedunknowninducerDetailsDB08910PomalidomideapprovedyesinhibitorDetailsDB00773EtoposideapprovedunknownsubstrateDetailsDB08439ParecoxibapprovedyesinhibitorDetailsDB09217Firocoxibexperimental, vet_approvedunknownDetailsDB13167Alclofenacapproved, withdrawnyesantagonistDetailsDB09213Dexibuprofenapproved, investigationalyesinhibitorDetailsDB11133Omega-3 fatty acidsapproved, nutraceuticalunknownsubstrateDetailsDB13168Omega-6 fatty acidsnutraceuticalunknownsubstrateDetailsDB06736Aceclofenacapproved, investigationalyesinhibitorDetailsDB13783Acemetacinapproved, investigationalyesantagonistDetailsDB09215DroxicamwithdrawnyesinhibitorDetailsDB09212LoxoprofenapprovedyesantagonistDetailsDB09216Tolfenamic acidapproved, investigationalyesantagonistDetailsDB09214Dexketoprofenapproved, investigationalunknownantagonistDetailsDB09214Dexketoprofenapproved, investigationalunknowninhibitorDetailsDB09295TalniflumateexperimentalunknownantagonistDetailsDB09295TalniflumateexperimentalunknowninhibitorDetailsDB09285MorniflumateexperimentalunknownDetailsDB09285MorniflumateexperimentalunknowninhibitorDetailsDB09288PropacetamolexperimentalyesantagonistDetailsDB11079Trolamine salicylateapprovedyesinhibitorDetailsDB11071Phenyl salicylateapprovedunknownantagonistDetailsDB13346Bufexamacapproved, withdrawnyesinhibitorDetailsDB11327DipyrithioneapprovedunknownDetailsDB13961Fish oilapproved, nutraceuticalyesinhibitorDetailsDB11323Glycol salicylateapprovedyesantagonistDetailsDB11201Menthyl salicylateapprovedyesantagonistDetailsDB13501Bendazacapproved, withdrawnunknownDetailsDB09061Cannabidiolapproved, investigationalunknowninhibitorDetailsDB14011NabiximolsinvestigationalunknowninhibitorDetailsDB14009Medical Cannabisexperimental, investigationalunknowninhibitorDetailsDB11752Bryostatin 1investigationalunknowninducerDetailsDB00482Celecoxibapproved, investigationalunknowninhibitorDetailsDB14060NS-398experimentalunknowninhibitorDetailsDB13514Pranoprofenexperimental, investigationalyesinhibitorDetailsDB00328Indomethacinapproved, investigationalyesinhibitorDetailsDB01250OlsalazineapprovedyesinhibitorDetails"
                    }
                },
                {
                    "Label": "Prostaglandin G/H synthase 1",
                    "Detailed Info": {
                        "Name": "Prostaglandin G/H synthase 1",
                        "Synonyms": "1.14.99.1\nCOX-1\nCOX1\nCyclooxygenase-1\nPGH synthase 1\nPGHS-1\nPHS 1\nProstaglandin H2 synthase 1\nProstaglandin-endoperoxide synthase 1",
                        "Gene Name": "PTGS1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0036935|Prostaglandin G/H synthase 1\nMSRSLLLWFLLFLLLLPPLPVLLADPGAPTPVNPCCYYPCQHQGICVRFGLDRYQCDCTR\nTGYSGPNCTIPGLWTWLRNSLRPSPSFTHFLLTHGRWFWEFVNATFIREMLMRLVLTVRS\nNLIPSPPTYNSAHDYISWESFSNVSYYTRILPSVPKDCPTPMGTKGKKQLPDAQLLARRF\nLLRRKFIPDPQGTNLMFAFFAQHFTHQFFKTSGKMGPGFTKALGHGVDLGHIYGDNLERQ\nYQLRLFKDGKLKYQVLDGEMYPPSVEEAPVLMHYPRGIPPQSQMAVGQEVFGLLPGLMLY\nATLWLREHNRVCDLLKAEHPTWGDEQLFQTTRLILIGETIKIVIEEYVQQLSGYFLQLKF\nDPELLFGVQFQYRNRIAMEFNHLYHWHPLMPDSFKVGSQEYSYEQFLFNTSMLVDYGVEA\nLVDAFSRQIAGRIGGGRNMDHHILHVAVDVIRESREMRLQPFNEYRKRFGMKPYTSFQEL\nVGEKEMAAELEELYGDIDALEFYPGLLLEKCHPNSIFGESMIEIGAPFSLKGLLGNPICS\nPEYWKPSTFGGEVGFNIVKTATLKKLVCLNTKTCPYVSFRVPDASQDDGPAVERPSTEL",
                        "Number of residues": "599",
                        "Molecular Weight": "68685.82",
                        "Theoretical pI": "7.39",
                        "GO Classification": "Functionsdioxygenase activity / heme binding / lipid binding / metal ion binding / peroxidase activity / prostaglandin-endoperoxide synthase activityProcessesaging / arachidonic acid metabolic process / cyclooxygenase pathway / inflammatory response / learning / lipid metabolic process / maintenance of blood-brain barrier / memory / negative regulation of epinephrine secretion / negative regulation of norepinephrine secretion / positive regulation of smooth muscle contraction / positive regulation of vasoconstriction / prostaglandin biosynthetic process / regulation of blood pressure / regulation of cell proliferation / response to corticosterone / response to fatty acid / response to organonitrogen compound / response to oxidative stress / sensory perception of pain / small molecule metabolic process / xenobiotic metabolic processComponentscytoplasm / endoplasmic reticulum membrane / extracellular exosome / Golgi apparatus / intracellular membrane-bounded organelle / nuclear envelope / nucleus / photoreceptor outer segment",
                        "General Function": "Prostaglandin-endoperoxide synthase activity",
                        "Specific Function": "Converts arachidonate to prostaglandin H2 (PGH2), a committed step in prostanoid synthesis. Involved in the constitutive production of prostanoids in particular in the stomach and platelets. In gastric epithelial cells, it is a key step in the generation of prostaglandins, such as prostaglandin E2 (PGE2), which plays an important role in cytoprotection. In platelets, it is involved in the generation of thromboxane A2 (TXA2), which promotes platelet activation and aggregation, vasoconstriction and proliferation of vascular smooth muscle cells.",
                        "Pfam Domain Function": "An_peroxidase (PF03098)\nEGF (PF00008)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Microsome membrane",
                        "Gene sequence": ">lcl|BSEQ0021254|Prostaglandin G/H synthase 1 (PTGS1)\nATGAGCCGGAGTCTCTTGCTCTGGTTCTTGCTGTTCCTGCTCCTGCTCCCGCCGCTCCCC\nGTCCTGCTCGCGGACCCAGGGGCGCCCACGCCAGTGAATCCCTGTTGTTACTATCCATGC\nCAGCACCAGGGCATCTGTGTCCGCTTCGGCCTTGACCGCTACCAGTGTGACTGCACCCGC\nACGGGCTATTCCGGCCCCAACTGCACCATCCCTGGCCTGTGGACCTGGCTCCGGAATTCA\nCTGCGGCCCAGCCCCTCTTTCACCCACTTCCTGCTCACTCACGGGCGCTGGTTCTGGGAG\nTTTGTCAATGCCACCTTCATCCGAGAGATGCTCATGCGCCTGGTACTCACAGTGCGCTCC\nAACCTTATCCCCAGTCCCCCCACCTACAACTCAGCACATGACTACATCAGCTGGGAGTCT\nTTCTCCAACGTGAGCTATTACACTCGTATTCTGCCCTCTGTGCCTAAAGATTGCCCCACA\nCCCATGGGAACCAAAGGGAAGAAGCAGTTGCCAGATGCCCAGCTCCTGGCCCGCCGCTTC\nCTGCTCAGGAGGAAGTTCATACCTGACCCCCAAGGCACCAACCTCATGTTTGCCTTCTTT\nGCACAACACTTCACCCACCAGTTCTTCAAAACTTCTGGCAAGATGGGTCCTGGCTTCACC\nAAGGCCTTGGGCCATGGGGTAGACCTCGGCCACATTTATGGAGACAATCTGGAGCGTCAG\nTATCAACTGCGGCTCTTTAAGGATGGGAAACTCAAGTACCAGGTGCTGGATGGAGAAATG\nTACCCGCCCTCGGTAGAAGAGGCGCCTGTGTTGATGCACTACCCCCGAGGCATCCCGCCC\nCAGAGCCAGATGGCTGTGGGCCAGGAGGTGTTTGGGCTGCTTCCTGGGCTCATGCTGTAT\nGCCACGCTCTGGCTACGTGAGCACAACCGTGTGTGTGACCTGCTGAAGGCTGAGCACCCC\nACCTGGGGCGATGAGCAGCTTTTCCAGACGACCCGCCTCATCCTCATAGGGGAGACCATC\nAAGATTGTCATCGAGGAGTACGTGCAGCAGCTGAGTGGCTATTTCCTGCAGCTGAAATTT\nGACCCAGAGCTGCTGTTCGGTGTCCAGTTCCAATACCGCAACCGCATTGCCATGGAGTTC\nAACCATCTCTACCACTGGCACCCCCTCATGCCTGACTCCTTCAAGGTGGGCTCCCAGGAG\nTACAGCTACGAGCAGTTCTTGTTCAACACCTCCATGTTGGTGGACTATGGGGTTGAGGCC\nCTGGTGGATGCCTTCTCTCGCCAGATTGCTGGCCGGATCGGTGGGGGCAGGAACATGGAC\nCACCACATCCTGCATGTGGCTGTGGATGTCATCAGGGAGTCTCGGGAGATGCGGCTGCAG\nCCCTTCAATGAGTACCGCAAGAGGTTTGGCATGAAACCCTACACCTCCTTCCAGGAGCTC\nGTAGGAGAGAAGGAGATGGCAGCAGAGTTGGAGGAATTGTATGGAGACATTGATGCGTTG\nGAGTTCTACCCTGGACTGCTTCTTGAAAAGTGCCATCCAAACTCTATCTTTGGGGAGAGT\nATGATAGAGATTGGGGCTCCCTTTTCCCTCAAGGGTCTCCTAGGGAATCCCATCTGTTCT\nCCGGAGTACTGGAAGCCGAGCACATTTGGCGGCGAGGTGGGCTTTAACATTGTCAAGACG\nGCCACACTGAAGAAGCTGGTCTGCCTCAACACCAAGACCTGTCCCTACGTTTCCTTCCGT\nGTGCCGGATGCCAGTCAGGATGATGGGCCTGCTGTGGAGCGACCATCCACAGAGCTCTGA",
                        "Chromosome Location": "9",
                        "Locus": "9q32-q33.3",
                        "External Identifiers": "ResourceLinkUniProtKB IDP23219UniProtKB Entry NamePGH1_HUMANGenBank Protein ID387018GenBank Gene IDM31822GenAtlas IDPTGS1HGNC IDHGNC:9604",
                        "General References": "Yokoyama C, Tanabe T: Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme. Biochem Biophys Res Commun. 1989 Dec 15;165(2):888-94. [Article] Funk CD, Funk LB, Kennedy ME, Pong AS, Fitzgerald GA: Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J. 1991 Jun;5(9):2304-12. [Article] Takahashi Y, Ueda N, Yoshimoto T, Yamamoto S, Yokoyama C, Miyata A, Tanabe T, Fuse I, Hattori A, Shibata A: Immunoaffinity purification and cDNA cloning of human platelet prostaglandin endoperoxide synthase (cyclooxygenase). Biochem Biophys Res Commun. 1992 Jan 31;182(2):433-8. [Article] Diaz A, Reginato AM, Jimenez SA: Alternative splicing of human prostaglandin G/H synthase mRNA and evidence of differential regulation of the resulting transcripts by transforming growth factor beta 1, interleukin 1 beta, and tumor necrosis factor alpha. J Biol Chem. 1992 May 25;267(15):10816-22. [Article] Qin N, Zhang SP, Reitz TL, Mei JM, Flores CM: Cloning, expression, and functional characterization of human cyclooxygenase-1 splicing variants: evidence for intron 1 retention. J Pharmacol Exp Ther. 2005 Dec;315(3):1298-305. Epub 2005 Sep 1. [Article] Scott BT, Hasstedt SJ, Bovill EG, Callas PW, Valliere JE, Wang L, Wu KK, Long GL: Characterization of the human prostaglandin H synthase 1 gene (PTGS1): exclusion by genetic linkage analysis as a second modifier gene in familial thrombosis. Blood Coagul Fibrinolysis. 2002 Sep;13(6):519-31. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Humphray SJ, Oliver K, Hunt AR, Plumb RW, Loveland JE, Howe KL, Andrews TD, Searle S, Hunt SE, Scott CE, Jones MC, Ainscough R, Almeida JP, Ambrose KD, Ashwell RI, Babbage AK, Babbage S, Bagguley CL, Bailey J, Banerjee R, Barker DJ, Barlow KF, Bates K, Beasley H, Beasley O, Bird CP, Bray-Allen S, Brown AJ, Brown JY, Burford D, Burrill W, Burton J, Carder C, Carter NP, Chapman JC, Chen Y, Clarke G, Clark SY, Clee CM, Clegg S, Collier RE, Corby N, Crosier M, Cummings AT, Davies J, Dhami P, Dunn M, Dutta I, Dyer LW, Earthrowl ME, Faulkner L, Fleming CJ, Frankish A, Frankland JA, French L, Fricker DG, Garner P, Garnett J, Ghori J, Gilbert JG, Glison C, Grafham DV, Gribble S, Griffiths C, Griffiths-Jones S, Grocock R, Guy J, Hall RE, Hammond S, Harley JL, Harrison ES, Hart EA, Heath PD, Henderson CD, Hopkins BL, Howard PJ, Howden PJ, Huckle E, Johnson C, Johnson D, Joy AA, Kay M, Keenan S, Kershaw JK, Kimberley AM, King A, Knights A, Laird GK, Langford C, Lawlor S, Leongamornlert DA, Leversha M, Lloyd C, Lloyd DM, Lovell J, Martin S, Mashreghi-Mohammadi M, Matthews L, McLaren S, McLay KE, McMurray A, Milne S, Nickerson T, Nisbett J, Nordsiek G, Pearce AV, Peck AI, Porter KM, Pandian R, Pelan S, Phillimore B, Povey S, Ramsey Y, Rand V, Scharfe M, Sehra HK, Shownkeen R, Sims SK, Skuce CD, Smith M, Steward CA, Swarbreck D, Sycamore N, Tester J, Thorpe A, Tracey A, Tromans A, Thomas DW, Wall M, Wallis JM, West AP, Whitehead SL, Willey DL, Williams SA, Wilming L, Wray PW, Young L, Ashurst JL, Coulson A, Blocker H, Durbin R, Sulston JE, Hubbard T, Jackson MJ, Bentley DR, Beck S, Rogers J, Dunham I: DNA sequence and analysis of human chromosome 9. Nature. 2004 May 27;429(6990):369-74. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Smith WL, DeWitt DL, Garavito RM: Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem. 2000;69:145-82. [Article] Sostres C, Gargallo CJ, Lanas A: Aspirin, cyclooxygenase inhibition and colorectal cancer. World J Gastrointest Pharmacol Ther. 2014 Feb 6;5(1):40-9. doi: 10.4292/wjgpt.v5.i1.40. [Article] Vaca Jacome AS, Rabilloud T, Schaeffer-Reiss C, Rompais M, Ayoub D, Lane L, Bairoch A, Van Dorsselaer A, Carapito C: N-terminome analysis of the human mitochondrial proteome. Proteomics. 2015 Jul;15(14):2519-24. doi: 10.1002/pmic.201400617. Epub 2015 Jun 8. [Article] Goodman JE, Bowman ED, Chanock SJ, Alberg AJ, Harris CC: Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis. 2004 Dec;25(12):2467-72. Epub 2004 Aug 12. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00244MesalazineapprovedyesinhibitorDetailsDB00316AcetaminophenapprovedyesinhibitorDetailsDB00328Indomethacinapproved, investigationalunknowninhibitorDetailsDB00461NabumetoneapprovedunknowninhibitorDetailsDB00465KetorolacapprovedunknowninhibitorDetailsDB00469TenoxicamapprovedunknowninhibitorDetailsDB00500TolmetinapprovedunknowninhibitorDetailsDB00554Piroxicamapproved, investigationalunknowninhibitorDetailsDB00573FenoprofenapprovedunknowninhibitorDetailsDB00586Diclofenacapproved, vet_approvedyesinhibitorDetailsDB00749Etodolacapproved, investigational, vet_approvedunknowninhibitorDetailsDB00788Naproxenapproved, vet_approvedyesinhibitorDetailsDB00861Diflunisalapproved, investigationalunknowninhibitorDetailsDB00870Suprofenapproved, withdrawnyesinhibitorDetailsDB00939Meclofenamic acidapproved, vet_approvedyesinhibitorDetailsDB00945Acetylsalicylic acidapproved, vet_approvedyesinhibitorDetailsDB00963Bromfenacapproved, withdrawnunknowninhibitorDetailsDB01009Ketoprofenapproved, vet_approvedunknowninhibitorDetailsDB01014Balsalazideapproved, investigationalyesinhibitorDetailsDB01050IbuprofenapprovedyesinhibitorDetailsDB00154Dihomo-gamma-linolenic acidinvestigational, nutraceuticalyesinhibitorDetailsDB00159Icosapentapproved, nutraceuticalyesinhibitorDetailsDB00712Flurbiprofenapproved, investigationalunknowninhibitorDetailsDB00784Mefenamic acidapprovedunknowninhibitorDetailsDB01399SalsalateapprovedyesinhibitorDetailsDB00350Minoxidilapproved, investigationalunknowninducerDetailsDB00605Sulindacapproved, investigationalunknowninhibitorDetailsDB00936Salicylic acidapproved, investigational, vet_approvedyesinhibitorDetailsDB01283Lumiracoxibapproved, investigationalyesinhibitorDetailsDB01837O-acetyl-L-serineexperimentalunknownDetailsDB02110Protoporphyrin Ix Containing CoexperimentalunknownDetailsDB021982-Bromoacetyl GroupexperimentalunknownDetailsDB03753Flurbiprofen Methyl EsterexperimentalunknownDetailsDB02379Beta-D-GlucoseexperimentalunknownDetailsDB04557Arachidonic AcidexperimentalunknownDetailsDB04817Metamizoleapproved, investigational, withdrawnunknownDetailsDB03783PhenacetinwithdrawnunknownDetailsDB01892HyperforinnutraceuticalunknowninhibitorDetailsDB02709ResveratrolinvestigationalunknowninhibitorDetailsDB12445NitroaspirininvestigationalunknowninhibitorDetailsDB00814Meloxicamapproved, vet_approvedunknowninhibitorDetailsDB02266Flufenamic acidapprovedunknownDetailsDB00991OxaprozinapprovedyesinhibitorDetailsDB01600Tiaprofenic acidapprovedyesinhibitorDetailsDB01397Magnesium salicylateexperimentalyesinhibitorDetailsDB00250Dapsoneapproved, investigationalunknownsubstrateDetailsDB01041Thalidomideapproved, investigational, withdrawnnosubstrateDetailsDB00711Diethylcarbamazineapproved, investigational, vet_approvedunknowninhibitorDetailsDB06725Lornoxicamapproved, investigationalyesinhibitorDetailsDB00821Carprofenapproved, vet_approved, withdrawnunknowninhibitorDetailsDB00796Candesartan cilexetilapprovedunknownsubstrateDetailsDB01029Irbesartanapproved, investigationalunknownsubstrateDetailsDB01181IfosfamideapprovedunknownsubstrateDetailsDB05109Trabectedinapproved, investigationalunknownsubstrateDetailsDB00313Valproic acidapproved, investigationalunknownsubstrateDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00582VoriconazoleapprovedunknownsubstrateDetailsDB01075Diphenhydramineapproved, investigationalunknownsubstrateDetailsDB00216Eletriptanapproved, investigationalunknownsubstrateDetailsDB01355HexobarbitalexperimentalunknownsubstrateDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB00470Dronabinolapproved, illicitnoinhibitorDetailsDB01198ZopicloneapprovedunknownsubstrateDetailsDB00471MontelukastapprovedunknownsubstrateDetailsDB00549Zafirlukastapproved, investigationalunknownsubstrateDetailsDB00744Zileutonapproved, investigational, withdrawnunknownsubstrateDetailsDB00533Rofecoxibapproved, investigational, withdrawnunknownsubstrateDetailsDB00412Rosiglitazoneapproved, investigationalunknownsubstrateDetailsDB01221Ketamineapproved, vet_approvedunknownsubstrateDetailsDB00672Chlorpropamideapproved, investigationalunknownsubstrateDetailsDB00731Nateglinideapproved, investigationalunknownsubstrateDetailsDB06737ZaltoprofenexperimentalunknownsubstrateDetailsDB06739SeratrodastexperimentalunknownsubstrateDetailsDB06738KetobemidoneinvestigationalunknownsubstrateDetailsDB00812Phenylbutazoneapproved, vet_approvedyesinhibitorDetailsDB02773(3-Chloro-4-Propoxy-Phenyl)-Acetic AcidexperimentalunknownDetailsDB02047(+)-2-(4-biphenyl)propionic acidexperimentalunknownDetailsDB079812-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1R)-1-(hydroxymethyl)propyl]acetamideexperimentalunknownDetailsDB079831-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACIDexperimentalunknownDetailsDB079842-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamideexperimentalunknownDetailsDB03752P-(2'-Iodo-5'-Thenoyl)Hydrotropic AcidexperimentalunknownDetailsDB03667Acetic Acid Salicyloyl-Amino-EsterexperimentalunknownDetailsDB06802Nepafenacapproved, investigationalunknowninhibitorDetailsDB00795SulfasalazineapprovedyesinhibitorDetailsDB01435Antipyrineapproved, investigationalunknowninhibitorDetailsDB01419AntrafenineapprovedunknowninhibitorDetailsDB01401Choline magnesium trisalicylateapprovedunknowninhibitorDetailsDB08814Triflusalapproved, investigationalyesantagonistDetailsDB04552Niflumic acidexperimentalunknownDetailsDB00035DesmopressinapprovedunknowninducerDetailsDB00773EtoposideapprovedunknownsubstrateDetailsDB09213Dexibuprofenapproved, investigationalunknowninhibitorDetailsDB06736Aceclofenacapproved, investigationalyesinhibitorDetailsDB13919CandesartanexperimentalunknownsubstrateDetailsDB13783Acemetacinapproved, investigationalyesantagonistDetailsDB09215DroxicamwithdrawnyesinhibitorDetailsDB09212LoxoprofenapprovedyesantagonistDetailsDB09216Tolfenamic acidapproved, investigationalyesantagonistDetailsDB09214Dexketoprofenapproved, investigationalunknownantagonistDetailsDB09214Dexketoprofenapproved, investigationalunknowninhibitorDetailsDB09295TalniflumateexperimentalunknownantagonistDetailsDB09295TalniflumateexperimentalunknowninhibitorDetailsDB09288PropacetamolexperimentalyesantagonistDetailsDB11079Trolamine salicylateapprovedyesinhibitorDetailsDB11071Phenyl salicylateapprovedunknownantagonistDetailsDB13346Bufexamacapproved, withdrawnyesinhibitorDetailsDB11323Glycol salicylateapprovedyesantagonistDetailsDB11201Menthyl salicylateapprovedyesantagonistDetailsDB13501Bendazacapproved, withdrawnunknownDetailsDB09061Cannabidiolapproved, investigationalunknowninhibitorDetailsDB14011NabiximolsinvestigationalunknowninhibitorDetailsDB14009Medical Cannabisexperimental, investigationalunknowninhibitorDetailsDB13514Pranoprofenexperimental, investigationalyesinhibitorDetailsDB00328Indomethacinapproved, investigationalyesinhibitorDetailsDB01250OlsalazineapprovedyesinhibitorDetails"
                    }
                },
                {
                    "Label": "Prostaglandin E synthase 3",
                    "Detailed Info": {
                        "Name": "Prostaglandin E synthase 3",
                        "Synonyms": "5.3.99.3\ncPGES\nCytosolic prostaglandin E2 synthase\nHsp90 co-chaperone\nP23\nProgesterone receptor complex p23\nTEBP\nTelomerase-binding protein p23",
                        "Gene Name": "PTGES3",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0004870|Prostaglandin E synthase 3\nMQPASAKWYDRRDYVFIEFCVEDSKDVNVNFEKSKLTFSCLGGSDNFKHLNEIDLFHCID\nPNDSKHKRTDRSILCCLRKGESGQSWPRLTKERAKLNWLSVDFNNWKDWEDDSDEDMSNF\nDRFSEMMNNMGGDEDVDLPEVDGADDDSQDSDDEKMPDLE",
                        "Number of residues": "160",
                        "Molecular Weight": "18697.195",
                        "Theoretical pI": "4.11",
                        "GO Classification": "Functionsprostaglandin-E synthase activity / telomerase activity / unfolded protein bindingProcessesarachidonic acid metabolic process / cellular response to heat / chaperone cofactor-dependent protein refolding / cyclooxygenase pathway / prostaglandin biosynthetic process / regulation of cellular response to heat / RNA-dependent DNA replication / signal transduction / small molecule metabolic process / telomere maintenanceComponentschromosome, telomeric region / cytoplasm / cytosol / extracellular exosome / nucleoplasm / nucleus / telomerase holoenzyme complex",
                        "General Function": "Unfolded protein binding",
                        "Specific Function": "Cytosolic prostaglandin synthase that catalyzes the oxidoreduction of prostaglandin endoperoxide H2 (PGH2) to prostaglandin E2 (PGE2) (PubMed:10922363). Molecular chaperone that localizes to genomic response elements in a hormone-dependent manner and disrupts receptor-mediated transcriptional activation, by promoting disassembly of transcriptional regulatory complexes (PubMed:11274138, PubMed:12077419). Facilitates HIF alpha proteins hydroxylation via interaction with EGLN1/PHD2, leading to recruit EGLN1/PHD2 to the HSP90 pathway (PubMed:24711448).",
                        "Pfam Domain Function": "CS (PF04969)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Cytoplasm",
                        "Gene sequence": ">lcl|BSEQ0021328|Prostaglandin E synthase 3 (PTGES3)\nATGCAGCCTGCTTCTGCAAAGTGGTACGATCGAAGGGACTATGTCTTCATTGAATTTTGT\nGTTGAAGACAGTAAGGATGTTAATGTAAATTTTGAAAAATCCAAACTTACATTCAGTTGT\nCTCGGAGGAAGTGATAATTTTAAGCATTTAAATGAAATTGATCTTTTTCACTGTATTGAT\nCCAAATGATTCCAAGCATAAAAGAACGGACAGATCAATTTTATGTTGTTTACGAAAAGGA\nGAATCTGGCCAGTCATGGCCAAGGTTAACAAAAGAAAGGGCAAAGCTTAATTGGCTTAGT\nGTCGACTTCAATAATTGGAAAGACTGGGAAGATGATTCAGATGAAGACATGTCTAATTTT\nGATCGTTTCTCTGAGGATTCACAAGACAGTGATGATGAAAAAATGCCAGATCTGGAGTAA",
                        "Chromosome Location": "12",
                        "Locus": "12q13.3|12",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ15185UniProtKB Entry NameTEBP_HUMANGenBank Gene IDL24804GenAtlas IDPTGES3HGNC IDHGNC:16049",
                        "General References": "Johnson JL, Beito TG, Krco CJ, Toft DO: Characterization of a novel 23-kilodalton protein of unactive progesterone receptor complexes. Mol Cell Biol. 1994 Mar;14(3):1956-63. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Scherer SE, Muzny DM, Buhay CJ, Chen R, Cree A, Ding Y, Dugan-Rocha S, Gill R, Gunaratne P, Harris RA, Hawes AC, Hernandez J, Hodgson AV, Hume J, Jackson A, Khan ZM, Kovar-Smith C, Lewis LR, Lozado RJ, Metzker ML, Milosavljevic A, Miner GR, Montgomery KT, Morgan MB, Nazareth LV, Scott G, Sodergren E, Song XZ, Steffen D, Lovering RC, Wheeler DA, Worley KC, Yuan Y, Zhang Z, Adams CQ, Ansari-Lari MA, Ayele M, Brown MJ, Chen G, Chen Z, Clerc-Blankenburg KP, Davis C, Delgado O, Dinh HH, Draper H, Gonzalez-Garay ML, Havlak P, Jackson LR, Jacob LS, Kelly SH, Li L, Li Z, Liu J, Liu W, Lu J, Maheshwari M, Nguyen BV, Okwuonu GO, Pasternak S, Perez LM, Plopper FJ, Santibanez J, Shen H, Tabor PE, Verduzco D, Waldron L, Wang Q, Williams GA, Zhang J, Zhou J, Allen CC, Amin AG, Anyalebechi V, Bailey M, Barbaria JA, Bimage KE, Bryant NP, Burch PE, Burkett CE, Burrell KL, Calderon E, Cardenas V, Carter K, Casias K, Cavazos I, Cavazos SR, Ceasar H, Chacko J, Chan SN, Chavez D, Christopoulos C, Chu J, Cockrell R, Cox CD, Dang M, Dathorne SR, David R, Davis CM, Davy-Carroll L, Deshazo DR, Donlin JE, D'Souza L, Eaves KA, Egan A, Emery-Cohen AJ, Escotto M, Flagg N, Forbes LD, Gabisi AM, Garza M, Hamilton C, Henderson N, Hernandez O, Hines S, Hogues ME, Huang M, Idlebird DG, Johnson R, Jolivet A, Jones S, Kagan R, King LM, Leal B, Lebow H, Lee S, LeVan JM, Lewis LC, London P, Lorensuhewa LM, Loulseged H, Lovett DA, Lucier A, Lucier RL, Ma J, Madu RC, Mapua P, Martindale AD, Martinez E, Massey E, Mawhiney S, Meador MG, Mendez S, Mercado C, Mercado IC, Merritt CE, Miner ZL, Minja E, Mitchell T, Mohabbat F, Mohabbat K, Montgomery B, Moore N, Morris S, Munidasa M, Ngo RN, Nguyen NB, Nickerson E, Nwaokelemeh OO, Nwokenkwo S, Obregon M, Oguh M, Oragunye N, Oviedo RJ, Parish BJ, Parker DN, Parrish J, Parks KL, Paul HA, Payton BA, Perez A, Perrin W, Pickens A, Primus EL, Pu LL, Puazo M, Quiles MM, Quiroz JB, Rabata D, Reeves K, Ruiz SJ, Shao H, Sisson I, Sonaike T, Sorelle RP, Sutton AE, Svatek AF, Svetz LA, Tamerisa KS, Taylor TR, Teague B, Thomas N, Thorn RD, Trejos ZY, Trevino BK, Ukegbu ON, Urban JB, Vasquez LI, Vera VA, Villasana DM, Wang L, Ward-Moore S, Warren JT, Wei X, White F, Williamson AL, Wleczyk R, Wooden HS, Wooden SH, Yen J, Yoon L, Yoon V, Zorrilla SE, Nelson D, Kucherlapati R, Weinstock G, Gibbs RA: The finished DNA sequence of human chromosome 12. Nature. 2006 Mar 16;440(7082):346-51. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Forsythe HL, Jarvis JL, Turner JW, Elmore LW, Holt SE: Stable association of hsp90 and p23, but Not hsp70, with active human telomerase. J Biol Chem. 2001 May 11;276(19):15571-4. Epub 2001 Mar 23. [Article] Freeman BC, Yamamoto KR: Disassembly of transcriptional regulatory complexes by molecular chaperones. Science. 2002 Jun 21;296(5576):2232-5. [Article] Tanioka T, Nakatani Y, Semmyo N, Murakami M, Kudo I: Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem. 2000 Oct 20;275(42):32775-82. [Article] Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M: Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006 Nov 3;127(3):635-48. [Article] Beranova-Giorgianni S, Zhao Y, Desiderio DM, Giorgianni F: Phosphoproteomic analysis of the human pituitary. Pituitary. 2006;9(2):109-20. [Article] Giorgianni F, Zhao Y, Desiderio DM, Beranova-Giorgianni S: Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line. Electrophoresis. 2007 Jun;28(12):2027-34. [Article] Carrascal M, Ovelleiro D, Casas V, Gay M, Abian J: Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment. J Proteome Res. 2008 Dec;7(12):5167-76. [Article] Zahedi RP, Lewandrowski U, Wiesner J, Wortelkamp S, Moebius J, Schutz C, Walter U, Gambaryan S, Sickmann A: Phosphoproteome of resting human platelets. J Proteome Res. 2008 Feb;7(2):526-34. Epub 2007 Dec 19. [Article] Daub H, Olsen JV, Bairlein M, Gnad F, Oppermann FS, Korner R, Greff Z, Keri G, Stemmann O, Mann M: Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol Cell. 2008 Aug 8;31(3):438-48. doi: 10.1016/j.molcel.2008.07.007. [Article] Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP: A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7. doi: 10.1073/pnas.0805139105. Epub 2008 Jul 31. [Article] Han G, Ye M, Zhou H, Jiang X, Feng S, Jiang X, Tian R, Wan D, Zou H, Gu J: Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography. Proteomics. 2008 Apr;8(7):1346-61. doi: 10.1002/pmic.200700884. [Article] Gauci S, Helbig AO, Slijper M, Krijgsveld J, Heck AJ, Mohammed S: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal Chem. 2009 Jun 1;81(11):4493-501. doi: 10.1021/ac9004309. [Article] Oppermann FS, Gnad F, Olsen JV, Hornberger R, Greff Z, Keri G, Mann M, Daub H: Large-scale proteomics analysis of the human kinome. Mol Cell Proteomics. 2009 Jul;8(7):1751-64. doi: 10.1074/mcp.M800588-MCP200. Epub 2009 Apr 15. [Article] Mayya V, Lundgren DH, Hwang SI, Rezaul K, Wu L, Eng JK, Rodionov V, Han DK: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal. 2009 Aug 18;2(84):ra46. doi: 10.1126/scisignal.2000007. [Article] Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M: Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009 Aug 14;325(5942):834-40. doi: 10.1126/science.1175371. Epub 2009 Jul 16. [Article] Olsen JV, Vermeulen M, Santamaria A, Kumar C, Miller ML, Jensen LJ, Gnad F, Cox J, Jensen TS, Nigg EA, Brunak S, Mann M: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3. doi: 10.1126/scisignal.2000475. [Article] Burkard TR, Planyavsky M, Kaupe I, Breitwieser FP, Burckstummer T, Bennett KL, Superti-Furga G, Colinge J: Initial characterization of the human central proteome. BMC Syst Biol. 2011 Jan 26;5:17. doi: 10.1186/1752-0509-5-17. [Article] Rigbolt KT, Prokhorova TA, Akimov V, Henningsen J, Johansen PT, Kratchmarova I, Kassem M, Mann M, Olsen JV, Blagoev B: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci Signal. 2011 Mar 15;4(164):rs3. doi: 10.1126/scisignal.2001570. [Article] Van Damme P, Lasa M, Polevoda B, Gazquez C, Elosegui-Artola A, Kim DS, De Juan-Pardo E, Demeyer K, Hole K, Larrea E, Timmerman E, Prieto J, Arnesen T, Sherman F, Gevaert K, Aldabe R: N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12449-54. doi: 10.1073/pnas.1210303109. Epub 2012 Jul 18. [Article] Song D, Li LS, Arsenault PR, Tan Q, Bigham AW, Heaton-Johnson KJ, Master SR, Lee FS: Defective Tibetan PHD2 binding to p23 links high altitude adaption to altered oxygen sensing. J Biol Chem. 2014 May 23;289(21):14656-65. doi: 10.1074/jbc.M113.541227. Epub 2014 Apr 7. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Vaca Jacome AS, Rabilloud T, Schaeffer-Reiss C, Rompais M, Ayoub D, Lane L, Bairoch A, Van Dorsselaer A, Carapito C: N-terminome analysis of the human mitochondrial proteome. Proteomics. 2015 Jul;15(14):2519-24. doi: 10.1002/pmic.201400617. Epub 2015 Jun 8. [Article] Weaver AJ, Sullivan WP, Felts SJ, Owen BA, Toft DO: Crystal structure and activity of human p23, a heat shock protein 90 co-chaperone. J Biol Chem. 2000 Jul 28;275(30):23045-52. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB05036Grn163linvestigationalunknownDetailsDB00316AcetaminophenapprovedunknowninhibitorDetailsDB09130Copperapproved, investigationalunknownDetails"
                    }
                },
                {
                    "Label": "Transient receptor potential cation channel subfamily V member 1",
                    "Detailed Info": {
                        "Name": "Transient receptor potential cation channel subfamily V member 1",
                        "Synonyms": "Capsaicin receptor\nOsm-9-like TRP channel 1\nOTRPC1\nTrpV1\nVanilloid receptor 1\nVR1",
                        "Gene Name": "TRPV1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0037113|Transient receptor potential cation channel subfamily V member 1\nMKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFP\nVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFE\nAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEI\nARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKT\nKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTA\nDNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQE\nPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLN\nRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEIL\nSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVAS\nMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIE\nDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVF\nIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKA\nFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRS\nSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK",
                        "Number of residues": "839",
                        "Molecular Weight": "94955.33",
                        "Theoretical pI": "7.26",
                        "GO Classification": "FunctionsATP binding / calcium channel activity / calcium-release channel activity / excitatory extracellular ligand-gated ion channel activity / phosphoprotein binding / transmembrane signaling receptor activityProcessescalcium ion transmembrane transport / cell surface receptor signaling pathway / cellular response to alkaloid / cellular response to ATP / chemosensory behavior / ion transmembrane transport / thermoception / transmembrane transport / transportComponentscell junction / dendritic spine membrane / integral component of membrane / integral component of plasma membrane / intrinsic component of plasma membrane / plasma membrane / postsynaptic membrane",
                        "General Function": "Transmembrane signaling receptor activity",
                        "Specific Function": "Ligand-activated non-selective calcium permeant cation channel involved in detection of noxious chemical and thermal stimuli. Seems to mediate proton influx and may be involved in intracellular acidosis in nociceptive neurons. Involved in mediation of inflammatory pain and hyperalgesia. Sensitized by a phosphatidylinositol second messenger system activated by receptor tyrosine kinases, which involves PKC isozymes and PCL. Can be activated by endogenous compounds, including 12-hydroperoxytetraenoic acid and bradykinin. Acts as ionotropic endocannabinoid receptor with central neuromodulatory effects. Triggers a form of long-term depression (TRPV1-LTD) mediated by the endocannabinoid anandamine in the hippocampus and nucleus accumbens by affecting AMPA receptors endocytosis (By similarity). Activation by vanilloids, like capsaicin, and temperatures higher than 42 degrees Celsius, exhibits a time- and Ca(2+)-dependent outward rectification, followed by a long-lasting refractory state. Mild extracellular acidic pH (6.5) potentiates channel activation by noxious heat and vanilloids, whereas acidic conditions (pH <6) directly activate the channel.",
                        "Pfam Domain Function": "Ion_trans (PF00520)\nAnk_2 (PF12796)",
                        "Transmembrane Regions": "434-454\n472-497\n511-531\n536-556\n572-599\n659-687",
                        "Cellular Location": "Cell junction",
                        "Gene sequence": ">lcl|BSEQ0020500|Transient receptor potential cation channel subfamily V member 1 (TRPV1)\nATGAAGAAATGGAGCAGCACAGACTTGGGGGCAGCTGCGGACCCACTCCAAAAGGACACC\nTGCCCAGACCCCCTGGATGGAGACCCTAACTCCAGGCCACCTCCAGCCAAGCCCCAGCTC\nTCCACGGCCAAGAGCCGCACCCGGCTCTTTGGGAAGGGTGACTCGGAGGAGGCTTTCCCG\nGTGGATTGCCCTCACGAGGAAGGTGAGCTGGACTCCTGCCCGACCATCACAGTCAGCCCT\nGTTATCACCATCCAGAGGCCAGGAGACGGCCCCACCGGTGCCAGGCTGCTGTCCCAGGAC\nTCTGTCGCCGCCAGCACCGAGAAGACCCTCAGGCTCTATGATCGCAGGAGTATCTTTGAA\nGCCGTTGCTCAGAATAACTGCCAGGATCTGGAGAGCCTGCTGCTCTTCCTGCAGAAGAGC\nAAGAAGCACCTCACAGACAACGAGTTCAAAGACCCTGAGACAGGGAAGACCTGTCTGCTG\nAAAGCCATGCTCAACCTGCACGACGGACAGAACACCACCATCCCCCTGCTCCTGGAGATC\nGCGCGGCAAACGGACAGCCTGAAGGAGCTTGTCAACGCCAGCTACACGGACAGCTACTAC\nAAGGGCCAGACAGCACTGCACATCGCCATCGAGAGACGCAACATGGCCCTGGTGACCCTC\nCTGGTGGAGAACGGAGCAGACGTCCAGGCTGCGGCCCATGGGGACTTCTTTAAGAAAACC\nAAAGGGCGGCCTGGATTCTACTTCGGTGAACTGCCCCTGTCCCTGGCCGCGTGCACCAAC\nCAGCTGGGCATCGTGAAGTTCCTGCTGCAGAACTCCTGGCAGACGGCCGACATCAGCGCC\nAGGGACTCGGTGGGCAACACGGTGCTGCACGCCCTGGTGGAGGTGGCCGACAACACGGCC\nGACAACACGAAGTTTGTGACGAGCATGTACAATGAGATTCTGATGCTGGGGGCCAAACTG\nCACCCGACGCTGAAGCTGGAGGAGCTCACCAACAAGAAGGGAATGACGCCGCTGGCTCTG\nGCAGCTGGGACCGGGAAGATCGGGGTCTTGGCCTATATTCTCCAGCGGGAGATCCAGGAG\nCCCGAGTGCAGGCACCTGTCCAGGAAGTTCACCGAGTGGGCCTACGGGCCCGTGCACTCC\nTCGCTGTACGACCTGTCCTGCATCGACACCTGCGAGAAGAACTCGGTGCTGGAGGTGATC\nGCCTACAGCAGCAGCGAGACCCCTAATCGCCACGACATGCTCTTGGTGGAGCCGCTGAAC\nCGACTCCTGCAGGACAAGTGGGACAGATTCGTCAAGCGCATCTTCTACTTCAACTTCCTG\nGTCTACTGCCTGTACATGATCATCTTCACCATGGCTGCCTACTACAGGCCCGTGGATGGC\nTTGCCTCCCTTTAAGATGGAAAAAACTGGAGACTATTTCCGAGTTACTGGAGAGATCCTG\nTCTGTGTTAGGAGGAGTCTACTTCTTTTTCCGAGGGATTCAGTATTTCCTGCAGAGGCGG\nCCGTCGATGAAGACCCTGTTTGTGGACAGCTACAGTGAGATGCTTTTCTTTCTGCAGTCA\nCTGTTCATGCTGGCCACCGTGGTGCTGTACTTCAGCCACCTCAAGGAGTATGTGGCTTCC\nATGGTATTCTCCCTGGCCTTGGGCTGGACCAACATGCTCTACTACACCCGCGGTTTCCAG\nCAGATGGGCATCTATGCCGTCATGATAGAGAAGATGATCCTGAGAGACCTGTGCCGTTTC\nATGTTTGTCTACATCGTCTTCTTGTTCGGGTTTTCCACAGCGGTGGTGACGCTGATTGAA\nGACGGGAAGAATGACTCCCTGCCGTCTGAGTCCACGTCGCACAGGTGGCGGGGGCCTGCC\nTGCAGGCCCCCCGATAGCTCCTACAACAGCCTGTACTCCACCTGCCTGGAGCTGTTCAAG\nTTCACCATCGGCATGGGCGACCTGGAGTTCACTGAGAACTATGACTTCAAGGCTGTCTTC\nATCATCCTGCTGCTGGCCTATGTAATTCTCACCTACATCCTCCTGCTCAACATGCTCATC\nGCCCTCATGGGTGAGACTGTCAACAAGATCGCACAGGAGAGCAAGAACATCTGGAAGCTG\nCAGAGAGCCATCACCATCCTGGACACGGAGAAGAGCTTCCTTAAGTGCATGAGGAAGGCC\nTTCCGCTCAGGCAAGCTGCTGCAGGTGGGGTACACACCTGATGGCAAGGACGACTACCGG\nTGGTGCTTCAGGGTGGACGAGGTGAACTGGACCACCTGGAACACCAACGTGGGCATCATC\nAACGAAGACCCGGGCAACTGTGAGGGCGTCAAGCGCACCCTGAGCTTCTCCCTGCGGTCA\nAGCAGAGTTTCAGGCAGACACTGGAAGAACTTTGCCCTGGTCCCCCTTTTAAGAGAGGCA\nAGTGCTCGAGATAGGCAGTCTGCTCAGCCCGAGGAAGTTTATCTGCGACAGTTTTCAGGG\nTCTCTGAAGCCAGAGGACGCTGAGGTCTTCAAGAGTCCTGCCGCTTCCGGGGAGAAGTGA",
                        "Chromosome Location": "17",
                        "Locus": "17p13.3",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ8NER1UniProtKB Entry NameTRPV1_HUMANGenBank Protein ID8977866GenBank Gene IDAJ277028GenAtlas IDTRPV1HGNC IDHGNC:12716",
                        "General References": "Hayes P, Meadows HJ, Gunthorpe MJ, Harries MH, Duckworth DM, Cairns W, Harrison DC, Clarke CE, Ellington K, Prinjha RK, Barton AJ, Medhurst AD, Smith GD, Topp S, Murdock P, Sanger GJ, Terrett J, Jenkins O, Benham CD, Randall AD, Gloger IS, Davis JB: Cloning and functional expression of a human orthologue of rat vanilloid receptor-1. Pain. 2000 Nov;88(2):205-15. [Article] Cortright DN, Crandall M, Sanchez JF, Zou T, Krause JE, White G: The tissue distribution and functional characterization of human VR1. Biochem Biophys Res Commun. 2001 Mar;281(5):1183-9. [Article] McIntyre P, McLatchie LM, Chambers A, Phillips E, Clarke M, Savidge J, Toms C, Peacock M, Shah K, Winter J, Weerasakera N, Webb M, Rang HP, Bevan S, James IF: Pharmacological differences between the human and rat vanilloid receptor 1 (VR1). Br J Pharmacol. 2001 Mar;132(5):1084-94. [Article] Wiemann S, Weil B, Wellenreuther R, Gassenhuber J, Glassl S, Ansorge W, Bocher M, Blocker H, Bauersachs S, Blum H, Lauber J, Dusterhoft A, Beyer A, Kohrer K, Strack N, Mewes HW, Ottenwalder B, Obermaier B, Tampe J, Heubner D, Wambutt R, Korn B, Klein M, Poustka A: Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs. Genome Res. 2001 Mar;11(3):422-35. [Article] Zody MC, Garber M, Adams DJ, Sharpe T, Harrow J, Lupski JR, Nicholson C, Searle SM, Wilming L, Young SK, Abouelleil A, Allen NR, Bi W, Bloom T, Borowsky ML, Bugalter BE, Butler J, Chang JL, Chen CK, Cook A, Corum B, Cuomo CA, de Jong PJ, DeCaprio D, Dewar K, FitzGerald M, Gilbert J, Gibson R, Gnerre S, Goldstein S, Grafham DV, Grocock R, Hafez N, Hagopian DS, Hart E, Norman CH, Humphray S, Jaffe DB, Jones M, Kamal M, Khodiyar VK, LaButti K, Laird G, Lehoczky J, Liu X, Lokyitsang T, Loveland J, Lui A, Macdonald P, Major JE, Matthews L, Mauceli E, McCarroll SA, Mihalev AH, Mudge J, Nguyen C, Nicol R, O'Leary SB, Osoegawa K, Schwartz DC, Shaw-Smith C, Stankiewicz P, Steward C, Swarbreck D, Venkataraman V, Whittaker CA, Yang X, Zimmer AR, Bradley A, Hubbard T, Birren BW, Rogers J, Lander ES, Nusbaum C: DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. Nature. 2006 Apr 20;440(7087):1045-9. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Smith GD, Gunthorpe MJ, Kelsell RE, Hayes PD, Reilly P, Facer P, Wright JE, Jerman JC, Walhin JP, Ooi L, Egerton J, Charles KJ, Smart D, Randall AD, Anand P, Davis JB: TRPV3 is a temperature-sensitive vanilloid receptor-like protein. Nature. 2002 Jul 11;418(6894):186-90. Epub 2002 Jun 23. [Article] Stander S, Moormann C, Schumacher M, Buddenkotte J, Artuc M, Shpacovitch V, Brzoska T, Lippert U, Henz BM, Luger TA, Metze D, Steinhoff M: Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures. Exp Dermatol. 2004 Mar;13(3):129-39. [Article] Gavva NR, Klionsky L, Qu Y, Shi L, Tamir R, Edenson S, Zhang TJ, Viswanadhan VN, Toth A, Pearce LV, Vanderah TW, Porreca F, Blumberg PM, Lile J, Sun Y, Wild K, Louis JC, Treanor JJ: Molecular determinants of vanilloid sensitivity in TRPV1. J Biol Chem. 2004 May 7;279(19):20283-95. Epub 2004 Mar 2. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00132alpha-Linolenic acidapproved, investigational, nutraceuticalyesinhibitorDetailsDB00159Icosapentapproved, nutraceuticalunknowninducerDetailsDB00168Aspartameinvestigational, nutraceuticalunknowninducerDetailsDB06515ResiniferatoxininvestigationalunknownDetailsDB06774CapsaicinapprovedyesagonistregulatorDetailsDB00316AcetaminophenapprovedunknownactivatorDetailsDB09120Zucapsaicinapproved, investigationalyesagonistactivatorDetailsDB02955Ricinoleic acidexperimentalunknownDetailsDB11324NonivamideinvestigationalyesagonistDetailsDB09061Cannabidiolapproved, investigationalunknownactivatorDetailsDB09288PropacetamolexperimentalyesantagonistDetailsDB11131Capsicum oleoresinapprovedyesagonistactivatorDetailsDB14011NabiximolsinvestigationalunknownDetailsDB14009Medical Cannabisexperimental, investigationalunknownDetailsDB11345(S)-camphorexperimentalyesagonistactivatorDetailsDB01744Camphorapproved, withdrawnyesagonistactivatorDetailsDB14050CannabidivarininvestigationalyesagonistDetailsDB00193Tramadolapproved, investigationalnoagonistDetails"
                    }
                }
            ],
            "enzymes": [
                {
                    "Label": "Cytochrome P450 2E1",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 2E1",
                        "Synonyms": "1.14.13.-\n4-nitrophenol 2-hydroxylase\nCYP2E\nCYPIIE1\nCytochrome P450-J",
                        "Gene Name": "CYP2E1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0012460|Cytochrome P450 2E1\nMSALGVTVALLVWAAFLLLVSMWRQVHSSWNLPPGPFPLPIIGNLFQLELKNIPKSFTRL\nAQRFGPVFTLYVGSQRMVVMHGYKAVKEALLDYKDEFSGRGDLPAFHAHRDRGIIFNNGP\nTWKDIRRFSLTTLRNYGMGKQGNESRIQREAHFLLEALRKTQGQPFDPTFLIGCAPCNVI\nADILFRKHFDYNDEKFLRLMYLFNENFHLLSTPWLQLYNNFPSFLHYLPGSHRKVIKNVA\nEVKEYVSERVKEHHQSLDPNCPRDLTDCLLVEMEKEKHSAERLYTMDGITVTVADLFFAG\nTETTSTTLRYGLLILMKYPEIEEKLHEEIDRVIGPSRIPAIKDRQEMPYMDAVVHEIQRF\nITLVPSNLPHEATRDTIFRGYLIPKGTVVVPTLDSVLYDNQEFPDPEKFKPEHFLNENGK\nFKYSDYFKPFSTGKRVCAGEGLARMELFLLLCAILQHFNLKPLVDPKDIDLSPIHIGFGC\nIPPRYKLCVIPRS",
                        "Number of residues": "493",
                        "Molecular Weight": "56848.42",
                        "Theoretical pI": "8.22",
                        "GO Classification": "Functionsarachidonic acid epoxygenase activity / enzyme binding / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity / oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen / oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen / oxygen binding / steroid hydroxylase activityProcessesdrug metabolic process / epoxygenase P450 pathway / exogenous drug catabolic process / heterocycle metabolic process / monoterpenoid metabolic process / oxidation-reduction process / response to ethanol / response to organonitrogen compound / response to ozone / small molecule metabolic process / steroid metabolic process / triglyceride metabolic process / xenobiotic metabolic processComponentscytoplasm / endoplasmic reticulum membrane / Golgi membrane / intracellular membrane-bounded organelle / intrinsic component of endoplasmic reticulum membrane / mitochondrion",
                        "General Function": "Steroid hydroxylase activity",
                        "Specific Function": "Metabolizes several precarcinogens, drugs, and solvents to reactive metabolites. Inactivates a number of drugs and xenobiotics and also bioactivates many xenobiotic substrates to their hepatotoxic or carcinogenic forms.",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0012461|Cytochrome P450 2E1 (CYP2E1)\nATGTCTGCCCTCGGAGTCACCGTGGCCCTGCTGGTGTGGGCGGCCTTCCTCCTGCTGGTG\nTCCATGTGGAGGCAGGTGCACAGCAGCTGGAATCTGCCCCCAGGCCCTTTCCCGCTTCCC\nATCATCGGGAACCTCTTCCAGTTGGAATTGAAGAATATTCCCAAGTCCTTCACCCGGTTG\nGCCCAGCGCTTCGGGCCGGTGTTCACGCTGTACGTGGGCTCGCAGCGCATGGTGGTGATG\nCACGGCTACAAGGCGGTGAAGGAAGCGCTGCTGGACTACAAGGACGAGTTCTCGGGCAGA\nGGCGACCTCCCCGCGTTCCATGCGCACAGGGACAGGGGAATCATTTTTAATAATGGACCT\nACCTGGAAGGACATCCGGCGGTTTTCCCTGACCACCCTCCGGAACTATGGGATGGGGAAA\nCAGGGCAATGAGAGCCGGATCCAGAGGGAGGCCCACTTCCTGCTGGAAGCACTCAGGAAG\nACCCAAGGCCAGCCTTTCGACCCCACCTTCCTCATCGGCTGCGCGCCCTGCAACGTCATA\nGCCGACATCCTCTTCCGCAAGCATTTTGACTACAATGATGAGAAGTTTCTAAGGCTGATG\nTATTTGTTTAATGAGAACTTCCACCTACTCAGCACTCCCTGGCTCCAGCTTTACAATAAT\nTTTCCCAGCTTTCTACACTACTTGCCTGGAAGCCACAGAAAAGTCATAAAAAATGTGGCT\nGAAGTAAAAGAGTATGTGTCTGAAAGGGTGAAGGAGCACCATCAATCTCTGGACCCCAAC\nTGTCCCCGGGACCTCACCGACTGCCTGCTCGTGGAAATGGAGAAGGAAAAGCACAGTGCA\nGAGCGCTTGTACACAATGGACGGTATCACCGTGACTGTGGCCGACCTGTTCTTTGCGGGG\nACAGAGACCACCAGCACAACTCTGAGATATGGGCTCCTGATTCTCATGAAATACCCTGAG\nATCGAAGAGAAGCTCCATGAAGAAATTGACAGGGTGATTGGGCCAAGCCGAATCCCTGCC\nATCAAGGATAGGCAAGAGATGCCCTACATGGATGCTGTGGTGCATGAGATTCAGCGGTTC\nATCACCCTCGTGCCCTCCAACCTGCCCCATGAAGCAACCCGAGACACCATTTTCAGAGGA\nTACCTCATCCCCAAGGGCACAGTCGTAGTGCCAACTCTGGACTCTGTTTTGTATGACAAC\nCAAGAATTTCCTGATCCAGAAAAGTTTAAGCCAGAACACTTCCTGAATGAAAATGGAAAG\nTTCAAGTACAGTGACTATTTCAAGCCATTTTCCACAGGAAAACGAGTGTGTGCTGGAGAA\nGGCCTGGCTCGCATGGAGTTGTTTCTTTTGTTGTGTGCCATTTTGCAGCATTTTAATTTG\nAAGCCTCTCGTTGACCCAAAGGATATCGACCTCAGCCCTATACATATTGGGTTTGGCTGT\nATCCCACCACGTTACAAACTCTGTGTCATTCCCCGCTCATGA",
                        "Chromosome Location": "10",
                        "Locus": "10q24.3-qter",
                        "External Identifiers": "ResourceLinkUniProtKB IDP05181UniProtKB Entry NameCP2E1_HUMANGenBank Protein ID181360GenBank Gene IDJ02625HGNC IDHGNC:2631",
                        "General References": "Song BJ, Gelboin HV, Park SS, Yang CS, Gonzalez FJ: Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P-450s. Transcriptional and post-transcriptional regulation of the rat enzyme. J Biol Chem. 1986 Dec 15;261(35):16689-97. [Article] Umeno M, McBride OW, Yang CS, Gelboin HV, Gonzalez FJ: Human ethanol-inducible P450IIE1: complete gene sequence, promoter characterization, chromosome mapping, and cDNA-directed expression. Biochemistry. 1988 Dec 13;27(25):9006-13. [Article] Deloukas P, Earthrowl ME, Grafham DV, Rubenfield M, French L, Steward CA, Sims SK, Jones MC, Searle S, Scott C, Howe K, Hunt SE, Andrews TD, Gilbert JG, Swarbreck D, Ashurst JL, Taylor A, Battles J, Bird CP, Ainscough R, Almeida JP, Ashwell RI, Ambrose KD, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Bates K, Beasley H, Bray-Allen S, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Cahill P, Camire D, Carter NP, Chapman JC, Clark SY, Clarke G, Clee CM, Clegg S, Corby N, Coulson A, Dhami P, Dutta I, Dunn M, Faulkner L, Frankish A, Frankland JA, Garner P, Garnett J, Gribble S, Griffiths C, Grocock R, Gustafson E, Hammond S, Harley JL, Hart E, Heath PD, Ho TP, Hopkins B, Horne J, Howden PJ, Huckle E, Hynds C, Johnson C, Johnson D, Kana A, Kay M, Kimberley AM, Kershaw JK, Kokkinaki M, Laird GK, Lawlor S, Lee HM, Leongamornlert DA, Laird G, Lloyd C, Lloyd DM, Loveland J, Lovell J, McLaren S, McLay KE, McMurray A, Mashreghi-Mohammadi M, Matthews L, Milne S, Nickerson T, Nguyen M, Overton-Larty E, Palmer SA, Pearce AV, Peck AI, Pelan S, Phillimore B, Porter K, Rice CM, Rogosin A, Ross MT, Sarafidou T, Sehra HK, Shownkeen R, Skuce CD, Smith M, Standring L, Sycamore N, Tester J, Thorpe A, Torcasso W, Tracey A, Tromans A, Tsolas J, Wall M, Walsh J, Wang H, Weinstock K, West AP, Willey DL, Whitehead SL, Wilming L, Wray PW, Young L, Chen Y, Lovering RC, Moschonas NK, Siebert R, Fechtel K, Bentley D, Durbin R, Hubbard T, Doucette-Stamm L, Beck S, Smith DR, Rogers J: The DNA sequence and comparative analysis of human chromosome 10. Nature. 2004 May 27;429(6990):375-81. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Lasker JM, Raucy J, Kubota S, Bloswick BP, Black M, Lieber CS: Purification and characterization of human liver cytochrome P-450-ALC. Biochem Biophys Res Commun. 1987 Oct 14;148(1):232-8. [Article] Robinson RC, Shorr RG, Varrichio A, Park SS, Gelboin HV, Miller H, Friedman FK: Human liver cytochrome P-450 related to a rat acetone-inducible, nitrosamine-metabolizing cytochrome P-450: identification and isolation. Pharmacology. 1989;39(3):137-44. [Article] Gillam EM, Guo Z, Guengerich FP: Expression of modified human cytochrome P450 2E1 in Escherichia coli, purification, and spectral and catalytic properties. Arch Biochem Biophys. 1994 Jul;312(1):59-66. [Article] Zerilli A, Ratanasavanh D, Lucas D, Goasduff T, Dreano Y, Menard C, Picart D, Berthou F: Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1. Chem Res Toxicol. 1997 Oct;10(10):1205-12. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Porubsky PR, Meneely KM, Scott EE: Structures of human cytochrome P-450 2E1. Insights into the binding of inhibitors and both small molecular weight and fatty acid substrates. J Biol Chem. 2008 Nov 28;283(48):33698-707. doi: 10.1074/jbc.M805999200. Epub 2008 Sep 24. [Article] Hu Y, Oscarson M, Johansson I, Yue QY, Dahl ML, Tabone M, Arinco S, Albano E, Ingelman-Sundberg M: Genetic polymorphism of human CYP2E1: characterization of two variant alleles. Mol Pharmacol. 1997 Mar;51(3):370-6. [Article] Fairbrother KS, Grove J, de Waziers I, Steimel DT, Day CP, Crespi CL, Daly AK: Detection and characterization of novel polymorphisms in the CYP2E1 gene. Pharmacogenetics. 1998 Dec;8(6):543-52. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00184NicotineapprovedunknownsubstrateinhibitorinducerDetailsDB00228Enfluraneapproved, investigational, vet_approvedunknownsubstrateDetailsDB00356ChlorzoxazoneapprovedunknownsubstrateinhibitorDetailsDB00753Isofluraneapproved, vet_approvedunknownsubstrateDetailsDB00851Dacarbazineapproved, investigationalunknownsubstrateDetailsDB00898EthanolapprovedunknownsubstrateinducerDetailsDB01028Methoxyfluraneapproved, investigational, vet_approved, withdrawnunknownsubstrateDetailsDB01159Halothaneapproved, vet_approvedunknownsubstrateDetailsDB01204Mitoxantroneapproved, investigationalunknownsubstrateinducerDetailsDB01213Fomepizoleapproved, vet_approvedunknownsubstrateinhibitorinducerDetailsDB01236Sevofluraneapproved, vet_approvednosubstrateDetailsDB00593EthosuximideapprovedunknownsubstrateDetailsDB00118Ademetionineapproved, investigational, nutraceuticalunknowninhibitorDetailsDB00277TheophyllineapprovedunknownsubstrateDetailsDB00636Clofibrateapproved, investigationalunknowninducerDetailsDB00780PhenelzineapprovedunknowninducerDetailsDB00908Quinidineapproved, investigationalnosubstrateDetailsDB00951Isoniazidapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB01115NifedipineapprovedunknowninhibitorDetailsDB01173OrphenadrineapprovedunknowninhibitorDetailsDB00250Dapsoneapproved, investigationalunknownsubstrateDetailsDB04977PlitidepsininvestigationalunknownsubstrateDetailsDB05708GTS-21investigationalunknownsubstrateDetailsDB00316AcetaminophenapprovedunknownsubstrateDetailsDB00468QuinineapprovedunknownsubstrateDetailsDB05109Trabectedinapproved, investigationalunknownsubstrateDetailsDB06728AnilineexperimentalunknownsubstrateDetailsDB00822DisulfiramapprovedunknowninhibitorDetailsDB01136Carvedilolapproved, investigationalunknownsubstrateDetailsDB00201CaffeineapprovednosubstrateDetailsDB00818Propofolapproved, investigational, vet_approvedunknowninhibitorDetailsDB00969Alosetronapproved, withdrawnunknowninhibitorDetailsDB01223AminophyllineapprovedunknownsubstrateDetailsDB00972AzelastineapprovedunknowninhibitorDetailsDB04794Bifonazoleapproved, investigationalunknowninhibitorDetailsDB01558Bromazepamapproved, illicit, investigationalunknowninhibitorDetailsDB01156BupropionapprovedunknownsubstrateDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknowninhibitorDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00257Clotrimazoleapproved, vet_approvedunknowninhibitorDetailsDB01394ColchicineapprovedunknowninducerDetailsDB01151Desipramineapproved, investigationalunknowninhibitorDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknowninducerDetailsDB01191Dexfenfluramineapproved, illicit, investigational, withdrawnunknowninhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknowninhibitorDetailsDB01127EconazoleapprovednoinhibitorDetailsDB00655EstroneapprovedunknownsubstrateDetailsDB00773EtoposideapprovedunknownsubstrateDetailsDB01628Etoricoxibapproved, investigationalunknowninhibitorDetailsDB00949FelbamateapprovedunknownsubstrateDetailsDB00623FluphenazineapprovedunknowninhibitorDetailsDB00690Flurazepamapproved, illicit, investigationalunknowninhibitorDetailsDB09462Glycerinapproved, investigationalunknowninducerDetailsDB00458ImipramineapprovedunknowninhibitorDetailsDB00883Isosorbide dinitrateapproved, investigationalunknowninhibitorDetailsDB01167Itraconazoleapproved, investigationalnoinhibitorDetailsDB01403Methotrimeprazineapproved, investigationalunknowninhibitorDetailsDB01011Metyraponeapproved, investigationalunknowninhibitorDetailsDB00379Mexiletineapproved, investigationalunknownsubstrateDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB00622Nicardipineapproved, investigationalunknownsubstrateDetailsDB02701Nicotinamideapproved, investigationalunknownsubstrateinhibitorDetailsDB06712Nilvadipineapproved, investigationalunknownsubstrateDetailsDB00540NortriptylineapprovedunknowninhibitorDetailsDB00904Ondansetronapproved, withdrawnunknownsubstrateDetailsDB03783PhenacetinwithdrawnunknownsubstrateDetailsDB01435Antipyrineapproved, investigationalunknownsubstrateDetailsDB01174Phenobarbitalapproved, investigationalunknownsubstrateinducerDetailsDB01045RifampicinapprovedunknowninducerDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateinhibitorDetailsDB00675TamoxifenapprovedunknownsubstrateDetailsDB01079Tegaserodapproved, investigational, withdrawnunknowninhibitorDetailsDB01412TheobromineinvestigationalunknownsubstrateDetailsDB00763MethimazoleapprovedunknowninhibitorDetailsDB00679Thioridazineapproved, withdrawnunknowninhibitorDetailsDB00208TiclopidineapprovedunknowninhibitorDetailsDB01007TioconazoleapprovedunknowninhibitorDetailsDB00347TrimethadioneapprovedunknownsubstrateDetailsDB00617ParamethadioneapprovedunknownsubstrateDetailsDB04946IloperidoneapprovedunknownsubstrateDetailsDB00255Diethylstilbestrolapproved, investigational, withdrawnunknowninhibitorDetailsDB00918Almotriptanapproved, investigationalunknownsubstrateDetailsDB06770Benzyl alcoholapprovedunknownsubstrateDetailsDB06774CapsaicinapprovedunknownsubstrateDetailsDB04920Clevidipineapproved, investigationalunknownsubstrateDetailsDB00633Dexmedetomidineapproved, vet_approvedunknownsubstrateDetailsDB06370IndisulaminvestigationalunknowninhibitorDetailsDB00109Enfuvirtideapproved, investigationalunknownsubstrateDetailsDB00041AldesleukinapprovedunknowninhibitorDetailsDB04858TirapazamineinvestigationalunknownsubstrateDetailsDB00428Streptozocinapproved, investigationalunknowninducerDetailsDB06637DalfampridineapprovedunknownsubstrateDetailsDB08868Fingolimodapproved, investigationalunknownsubstrateDetailsDB06201RufinamideapprovedunknowninhibitorDetailsDB01068Clonazepamapproved, illicitunknowninhibitorDetailsDB01544Flunitrazepamapproved, illicitunknowninhibitorDetailsDB01595NitrazepamapprovedunknowninhibitorDetailsDB08846Ellagic acidinvestigationalunknowninhibitorDetailsDB06595Midostaurinapproved, investigationalunknowninhibitorDetailsDB13174RheinexperimentalunknowninhibitorDetailsDB11994Diacereinapproved, investigationalunknowninhibitorDetailsDB11943Delafloxacinapproved, investigationalunknowninducerDetailsDB09120Zucapsaicinapproved, investigationalunknowninhibitorDetailsDB13941Piperaquineapproved, experimental, investigationalunknowninducerDetailsDB09328Vayarinapproved, investigationalunknowninhibitorDetailsDB00486Nabiloneapproved, investigationalnosubstrateinhibitorDetailsDB04379N-Methyl-N-(Methylbenzyl)FormamideexperimentalunknownsubstrateDetailsDB01154Thiamylalapproved, vet_approvednosubstrateDetailsDB09256Tegafurapproved, investigationalunknownsubstrateDetailsDB09288PropacetamolexperimentalnosubstrateDetailsDB14046Dichlorobenzeneapproved, experimentalunknownsubstrateDetailsDB139631,2-dichlorobenzeneexperimentalunknownsubstrateDetailsDB01844N,N-dimethylformamideexperimentalunknownsubstrateDetailsDB02520DitiocarbexperimentalunknowninhibitorDetailsDB00627Niacinapproved, investigational, nutraceuticalunknowninhibitorDetailsDB04856DexloxiglumideinvestigationalunknownsubstrateDetailsDB00661VerapamilapprovedunknownsubstrateDetailsDB06119Cenobamateapproved, investigationalunknownsubstrateDetailsDB01104SertralineapprovedunknownsubstrateDetailsDB00252Phenytoinapproved, vet_approvednosubstrateDetailsDB00794Primidoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00869DorzolamideapprovednosubstrateDetailsDB13609UmifenovirinvestigationalunknownsubstrateDetailsDB11837Osilodrostatapproved, investigationalunknowninhibitorDetailsDB12466Favipiravirapproved, investigationalunknowninhibitorDetailsDB11689Selumetinibapproved, investigationalnosubstrateDetailsDB14840RipretinibapprovedunknownDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknowninducerDetailsDB12499Clascoteroneapproved, investigationalnoinhibitorDetailsDB06448Lonafarnibapproved, investigationalnosubstrateDetailsDB04951Pirfenidoneapproved, investigationalunknownsubstrateDetailsDB01189DesfluraneapprovednosubstrateDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB08864RilpivirineapprovedunknowninhibitorDetailsDB00330EthambutolapprovedunknowninhibitorDetailsDB01086Benzocaineapproved, investigationalunknownsubstrateDetailsDB08995Diosminapproved, investigationalunknowninhibitorDetailsDB00412Rosiglitazoneapproved, investigationalunknownsubstrateDetailsDB00602Ivermectinapproved, investigational, vet_approvednosubstrateDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB09061Cannabidiolapproved, investigationalnosubstrateinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknowninhibitorDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorDetailsDB06016Cariprazineapproved, investigationalnoinhibitorDetailsDB00755Tretinoinapproved, investigational, nutraceuticalunknownsubstrateDetails"
                    }
                },
                {
                    "Label": "Cytochrome P450 1A2",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 1A2",
                        "Synonyms": "1.14.14.1\nCholesterol 25-hydroxylase\nCYPIA2\nCytochrome P(3)450\nCytochrome P450 4\nCytochrome P450-P3",
                        "Gene Name": "CYP1A2",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0004778|Cytochrome P450 1A2\nMALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPLLGHVLTLGKN\nPHLALSRMSQRYGDVLQIRIGSTPVLVLSRLDTIRQALVRQGDDFKGRPDLYTSTLITDG\nQSLTFSTDSGPVWAARRRLAQNALNTFSIASDPASSSSCYLEEHVSKEAKALISRLQELM\nAGPGHFDPYNQVVVSVANVIGAMCFGQHFPESSDEMLSLVKNTHEFVETASSGNPLDFFP\nILRYLPNPALQRFKAFNQRFLWFLQKTVQEHYQDFDKNSVRDITGALFKHSKKGPRASGN\nLIPQEKIVNLVNDIFGAGFDTVTTAISWSLMYLVTKPEIQRKIQKELDTVIGRERRPRLS\nDRPQLPYLEAFILETFRHSSFLPFTIPHSTTRDTTLNGFYIPKKCCVFVNQWQVNHDPEL\nWEDPSEFRPERFLTADGTAINKPLSEKMMLFGMGKRRCIGEVLAKWEIFLFLAILLQQLE\nFSVPPGVKVDLTPIYGLTMKHARCEHVQARRFSIN",
                        "Number of residues": "515",
                        "Molecular Weight": "58293.76",
                        "Theoretical pI": "9.43",
                        "GO Classification": "Functionsaromatase activity / caffeine oxidase activity / demethylase activity / electron carrier activity / enzyme binding / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity / oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenProcessesalkaloid metabolic process / arachidonic acid metabolic process / cellular respiration / cellular response to cadmium ion / dibenzo-p-dioxin metabolic process / drug catabolic process / drug metabolic process / epoxygenase P450 pathway / exogenous drug catabolic process / heterocycle metabolic process / hydrogen peroxide biosynthetic process / lung development / methylation / monocarboxylic acid metabolic process / monoterpenoid metabolic process / omega-hydroxylase P450 pathway / oxidation-reduction process / oxidative deethylation / oxidative demethylation / porphyrin-containing compound metabolic process / post-embryonic development / regulation of gene expression / response to estradiol / response to immobilization stress / response to lipopolysaccharide / small molecule metabolic process / steroid catabolic process / toxin biosynthetic process / xenobiotic metabolic processComponentsendoplasmic reticulum membrane / intracellular membrane-bounded organelle",
                        "General Function": "Oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen",
                        "Specific Function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Most active in catalyzing 2-hydroxylation. Caffeine is metabolized primarily by cytochrome CYP1A2 in the liver through an initial N3-demethylation. Also acts in the metabolism of aflatoxin B1 and acetaminophen. Participates in the bioactivation of carcinogenic aromatic and heterocyclic amines. Catalizes the N-hydroxylation of heterocyclic amines and the O-deethylation of phenacetin.",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0011742|Cytochrome P450 1A2 (CYP1A2)\nATGGCATTGTCCCAGTCTGTTCCCTTCTCGGCCACAGAGCTTCTCCTGGCCTCTGCCATC\nTTCTGCCTGGTATTCTGGGTGCTCAAGGGTTTGAGGCCTCGGGTCCCCAAAGGCCTGAAA\nAGTCCACCAGAGCCATGGGGCTGGCCCTTGCTCGGGCATGTGCTGACCCTGGGGAAGAAC\nCCGCACCTGGCACTGTCAAGGATGAGCCAGCGCTACGGGGACGTCCTGCAGATCCGCATT\nGGCTCCACGCCCGTGCTGGTGCTGAGCCGCCTGGACACCATCCGGCAGGCCCTGGTGCGG\nCAGGGCGACGATTTCAAGGGCCGGCCTGACCTCTACACCTCCACCCTCATCACTGATGGC\nCAGAGCTTGACCTTCAGCACAGACTCTGGACCGGTGTGGGCTGCCCGCCGGCGCCTGGCC\nCAGAATGCCCTCAACACCTTCTCCATCGCCTCTGACCCAGCTTCCTCATCCTCCTGCTAC\nCTGGAGGAGCATGTGAGCAAGGAGGCTAAGGCCCTGATCAGCAGGTTGCAGGAGCTGATG\nGCAGGGCCTGGGCACTTCGACCCTTACAATCAGGTGGTGGTGTCAGTGGCCAACGTCATT\nGGTGCCATGTGCTTCGGACAGCACTTCCCTGAGAGTAGCGATGAGATGCTCAGCCTCGTG\nAAGAACACTCATGAGTTCGTGGAGACTGCCTCCTCCGGGAACCCCCTGGACTTCTTCCCC\nATCCTTCGCTACCTGCCTAACCCTGCCCTGCAGAGGTTCAAGGCCTTCAACCAGAGGTTC\nCTGTGGTTCCTGCAGAAAACAGTCCAGGAGCACTATCAGGACTTTGACAAGAACAGTGTC\nCGGGACATCACGGGTGCCCTGTTCAAGCACAGCAAGAAGGGGCCTAGAGCCAGCGGCAAC\nCTCATCCCACAGGAGAAGATTGTCAACCTTGTCAATGACATCTTTGGAGCAGGATTTGAC\nACAGTCACCACAGCCATCTCCTGGAGCCTCATGTACCTTGTGACCAAGCCTGAGATACAG\nAGGAAGATCCAGAAGGAGCTGGACACTGTGATTGGCAGGGAGCGGCGGCCCCGGCTCTCT\nGACAGACCCCAGCTGCCCTACTTGGAGGCCTTCATCCTGGAGACCTTCCGACACTCCTCC\nTTCTTGCCCTTCACCATCCCCCACAGCACAACAAGGGACACAACGCTGAATGGCTTCTAC\nATCCCCAAGAAATGCTGTGTCTTCGTAAACCAGTGGCAGGTCAACCATGACCCAGAGCTG\nTGGGAGGACCCCTCTGAGTTCCGGCCTGAGCGGTTCCTCACCGCCGATGGCACTGCCATT\nAACAAGCCCTTGAGTGAGAAGATGATGCTGTTTGGCATGGGCAAGCGCCGGTGTATCGGG\nGAAGTCCTGGCCAAGTGGGAGATCTTCCTCTTCCTGGCCATCCTGCTACAGCAACTGGAG\nTTCAGCGTGCCGCCGGGCGTGAAAGTCGACCTGACCCCCATCTACGGGCTGACCATGAAG\nCACGCCCGCTGTGAACATGTCCAGGCGCGGCTGCGCTTCTCCATCAATTGA",
                        "Chromosome Location": "15",
                        "Locus": "15q24",
                        "External Identifiers": "ResourceLinkUniProtKB IDP05177UniProtKB Entry NameCP1A2_HUMANGenBank Gene IDZ00036GenAtlas IDCYP1A2HGNC IDHGNC:2596",
                        "General References": "Jaiswal AK, Nebert DW, Gonzalez FJ: Human P3(450): cDNA and complete amino acid sequence. Nucleic Acids Res. 1986 Aug 26;14(16):6773-4. [Article] Quattrochi LC, Pendurthi UR, Okino ST, Potenza C, Tukey RH: Human cytochrome P-450 4 mRNA and gene: part of a multigene family that contains Alu sequences in its mRNA. Proc Natl Acad Sci U S A. 1986 Sep;83(18):6731-5. [Article] Ikeya K, Jaiswal AK, Owens RA, Jones JE, Nebert DW, Kimura S: Human CYP1A2: sequence, gene structure, comparison with the mouse and rat orthologous gene, and differences in liver 1A2 mRNA expression. Mol Endocrinol. 1989 Sep;3(9):1399-408. [Article] Jaiswal AK, Nebert DW, McBride OW, Gonzalez FJ: Human P(3)450: cDNA and complete protein sequence, repetitive Alu sequences in the 3' nontranslated region, and localization of gene to chromosome 15. J Exp Pathol. 1987 Winter;3(1):1-17. [Article] Corchero J, Pimprale S, Kimura S, Gonzalez FJ: Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation. Pharmacogenetics. 2001 Feb;11(1):1-6. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Wrighton SA, Campanile C, Thomas PE, Maines SL, Watkins PB, Parker G, Mendez-Picon G, Haniu M, Shively JE, Levin W, et al.: Identification of a human liver cytochrome P-450 homologous to the major isosafrole-inducible cytochrome P-450 in the rat. Mol Pharmacol. 1986 Apr;29(4):405-10. [Article] Quattrochi LC, Okino ST, Pendurthi UR, Tukey RH: Cloning and isolation of human cytochrome P-450 cDNAs homologous to dioxin-inducible rabbit mRNAs encoding P-450 4 and P-450 6. DNA. 1985 Oct;4(5):395-400. [Article] Zhou H, Josephy PD, Kim D, Guengerich FP: Functional characterization of four allelic variants of human cytochrome P450 1A2. Arch Biochem Biophys. 2004 Feb 1;422(1):23-30. [Article] Honda A, Miyazaki T, Ikegami T, Iwamoto J, Maeda T, Hirayama T, Saito Y, Teramoto T, Matsuzaki Y: Cholesterol 25-hydroxylation activity of CYP3A. J Lipid Res. 2011 Aug;52(8):1509-16. doi: 10.1194/jlr.M014084. Epub 2011 May 16. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Sansen S, Yano JK, Reynald RL, Schoch GA, Griffin KJ, Stout CD, Johnson EF: Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2. J Biol Chem. 2007 May 11;282(19):14348-55. Epub 2007 Feb 20. [Article] Huang JD, Guo WC, Lai MD, Guo YL, Lambert GH: Detection of a novel cytochrome P-450 1A2 polymorphism (F21L) in Chinese. Drug Metab Dispos. 1999 Jan;27(1):98-101. [Article] Chevalier D, Cauffiez C, Allorge D, Lo-Guidice JM, Lhermitte M, Lafitte JJ, Broly F: Five novel natural allelic variants-951A>C, 1042G>A (D348N), 1156A>T (I386F), 1217G>A (C406Y) and 1291C>T (C431Y)-of the human CYP1A2 gene in a French Caucasian population. Hum Mutat. 2001 Apr;17(4):355-6. [Article] Murayama N, Soyama A, Saito Y, Nakajima Y, Komamura K, Ueno K, Kamakura S, Kitakaze M, Kimura H, Goto Y, Saitoh O, Katoh M, Ohnuma T, Kawai M, Sugai K, Ohtsuki T, Suzuki C, Minami N, Ozawa S, Sawada J: Six novel nonsynonymous CYP1A2 gene polymorphisms: catalytic activities of the naturally occurring variant enzymes. J Pharmacol Exp Ther. 2004 Jan;308(1):300-6. Epub 2003 Oct 16. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article] Soyama A, Saito Y, Hanioka N, Maekawa K, Komamura K, Kamakura S, Kitakaze M, Tomoike H, Ueno K, Goto Y, Kimura H, Katoh M, Sugai K, Saitoh O, Kawai M, Ohnuma T, Ohtsuki T, Suzuki C, Minami N, Kamatani N, Ozawa S, Sawada J: Single nucleotide polymorphisms and haplotypes of CYP1A2 in a Japanese population. Drug Metab Pharmacokinet. 2005 Feb;20(1):24-33. [Article] Jiang Z, Dalton TP, Jin L, Wang B, Tsuneoka Y, Shertzer HG, Deka R, Nebert DW: Toward the evaluation of function in genetic variability: characterizing human SNP frequencies and establishing BAC-transgenic mice carrying the human CYP1A1_CYP1A2 locus. Hum Mutat. 2005 Feb;25(2):196-206. [Article] Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H: Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA. 2006 Mar 8;295(10):1135-41. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00176Fluvoxamineapproved, investigationalunknownsubstrateinhibitorDetailsDB00188Bortezomibapproved, investigationalnosubstrateinhibitorDetailsDB00201CaffeineapprovedunknownsubstrateinhibitorDetailsDB00261AnagrelideapprovedunknownsubstrateinhibitorDetailsDB00268Ropiniroleapproved, investigationalunknownsubstrateDetailsDB00277TheophyllineapprovedunknownsubstrateDetailsDB00281Lidocaineapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00286Conjugated estrogensapprovedunknownsubstrateinhibitorDetailsDB00296RopivacaineapprovednosubstrateDetailsDB00315Zolmitriptanapproved, investigationalnosubstrateDetailsDB00316AcetaminophenapprovedunknownsubstrateDetailsDB00321AmitriptylineapprovedunknownsubstrateDetailsDB00334Olanzapineapproved, investigationalnosubstrateDetailsDB00363ClozapineapprovednosubstrateDetailsDB00365Grepafloxacinapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00370MirtazapineapprovedunknownsubstrateDetailsDB00379Mexiletineapproved, investigationalunknownsubstrateinhibitorDetailsDB00382Tacrineapproved, investigational, withdrawnunknownsubstrateDetailsDB00458ImipramineapprovedunknownsubstrateinhibitorDetailsDB00476DuloxetineapprovedunknownsubstrateinhibitorDetailsDB00499Flutamideapproved, investigationalunknownsubstrateDetailsDB00502HaloperidolapprovedunknownsubstrateDetailsDB00537Ciprofloxacinapproved, investigationalunknowninhibitorDetailsDB00540NortriptylineapprovedunknownsubstrateDetailsDB00544FluorouracilapprovedunknownsubstrateDetailsDB00571Propranololapproved, investigationalunknownsubstrateDetailsDB00655EstroneapprovedunknownsubstrateDetailsDB00661VerapamilapprovedunknownsubstrateDetailsDB00682WarfarinapprovedunknownsubstrateDetailsDB00697Tizanidineapproved, investigationalunknownsubstrateDetailsDB00740Riluzoleapproved, investigationalunknownsubstrateDetailsDB00744Zileutonapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00851Dacarbazineapproved, investigationalunknownsubstrateDetailsDB00863Ranitidineapproved, withdrawnunknownsubstrateinhibitorDetailsDB00904Ondansetronapproved, withdrawnunknownsubstrateinhibitorDetailsDB00924CyclobenzaprineapprovedunknownsubstrateDetailsDB00978Lomefloxacinapproved, investigationalunknownsubstrateinhibitorDetailsDB00980Ramelteonapproved, investigationalunknownsubstrateDetailsDB00998Frovatriptanapproved, investigationalunknownsubstrateDetailsDB01002Levobupivacaineapproved, investigationalunknownsubstrateDetailsDB01012CinacalcetapprovedunknownsubstrateDetailsDB01094HesperetinexperimentalunknownsubstrateDetailsDB01097Leflunomideapproved, investigationalunknownsubstrateDetailsDB01100PimozideapprovedunknownsubstrateDetailsDB01165OfloxacinapprovedunknowninhibitorDetailsDB01182PropafenoneapprovedunknownsubstrateinhibitorDetailsDB01242Clomipramineapproved, investigational, vet_approvednosubstrateDetailsDB00969Alosetronapproved, withdrawnunknownsubstrateinhibitorDetailsDB01367RasagilineapprovedunknownsubstrateDetailsDB00356ChlorzoxazoneapprovedunknownsubstrateDetailsDB00467Enoxacinapproved, investigationalunknowninhibitorDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00487PefloxacinapprovedunknowninhibitorDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00532Mephenytoinapproved, investigational, withdrawnunknownsubstrateDetailsDB00533Rofecoxibapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknownsubstrateDetailsDB00730Thiabendazoleapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00908Quinidineapproved, investigationalunknowninhibitorDetailsDB00972AzelastineapprovedunknownsubstrateDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB01045RifampicinapprovedunknowninducerDetailsDB01059NorfloxacinapprovedunknowninhibitorDetailsDB01418Acenocoumarolapproved, investigationalunknownsubstrateDetailsDB01424Aminophenazoneapproved, withdrawnunknownsubstrateDetailsDB00377Palonosetronapproved, investigationalunknownsubstrateDetailsDB05708GTS-21investigationalunknownsubstrateDetailsDB06442AvasimibeinvestigationalunknowninhibitorDetailsDB01065Melatoninapproved, nutraceutical, vet_approvedunknownsubstrateDetailsDB01115NifedipineapprovedunknownsubstrateinhibitorDetailsDB00619ImatinibapprovednosubstrateDetailsDB00468QuinineapprovedunknownsubstrateDetailsDB01142Doxepinapproved, investigationalnosubstrateDetailsDB00564Carbamazepineapproved, investigationalunknowninhibitorinducerDetailsDB00425ZolpidemapprovedunknownsubstrateDetailsDB00951Isoniazidapproved, investigationalunknowninhibitorDetailsDB00472Fluoxetineapproved, vet_approvedunknownsubstrateinhibitorDetailsDB01435Antipyrineapproved, investigationalunknownsubstrateDetailsDB01118Amiodaroneapproved, investigationalunknowninhibitorDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00568Cinnarizineapproved, investigationalunknownsubstrateDetailsDB04841FlunarizineapprovedunknownsubstrateDetailsDB00788Naproxenapproved, vet_approvedunknownsubstrateDetailsDB03783PhenacetinwithdrawnunknownsubstrateDetailsDB00553MethoxsalenapprovedunknowninhibitorDetailsDB01388Mibefradilinvestigational, withdrawnunknowninhibitorDetailsDB00745Modafinilapproved, investigationalunknowninducerDetailsDB00607Nafcillinapproved, investigationalunknowninducerDetailsDB06732beta-NaphthoflavoneexperimentalunknowninducerDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknowninducerDetailsDB01223AminophyllineapprovedunknownsubstrateDetailsDB06216AsenapineapprovedunknownsubstrateDetailsDB00195Betaxololapproved, investigationalunknownsubstrateDetailsDB04574Estrone sulfateapprovedunknownsubstrateDetailsDB00629Guanabenzapproved, investigationalunknownsubstrateDetailsDB01623ThiothixeneapprovedunknownsubstrateDetailsDB00831Trifluoperazineapproved, investigationalunknownsubstrateDetailsDB01174Phenobarbitalapproved, investigationalnoinducerDetailsDB01241GemfibrozilapprovedunknowninhibitorDetailsDB00752Tranylcypromineapproved, investigationalunknowninhibitorDetailsDB01087PrimaquineapprovedunknownsubstrateinducerDetailsDB00758ClopidogrelapprovednosubstrateDetailsDB00420Promazineapproved, vet_approvedunknownsubstrateinhibitorDetailsDB01136Carvedilolapproved, investigationalunknownsubstrateDetailsDB01628Etoricoxibapproved, investigationalunknownsubstrateDetailsDB01645GenisteininvestigationalunknownsubstrateinhibitorDetailsDB07453alpha-NaphthoflavoneexperimentalunknownDetailsDB02709ResveratrolinvestigationalnosubstrateinhibitorinducerDetailsDB00518Albendazoleapproved, vet_approvedunknowninducerDetailsDB01558Bromazepamapproved, illicit, investigationalunknownsubstrateDetailsDB00215CitalopramapprovednoinhibitorDetailsDB01151Desipramineapproved, investigationalunknownproduct ofDetailsDB01191Dexfenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB00625Efavirenzapproved, investigationalunknownsubstrateinhibitorDetailsDB00898EthanolapprovedunknownsubstrateDetailsDB00773EtoposideapprovedunknownsubstrateDetailsDB00400Griseofulvinapproved, investigational, vet_approvedunknowninducerDetailsDB01283Lumiracoxibapproved, investigationalunknownsubstrateDetailsDB00772Malathionapproved, investigationalunknownsubstrateDetailsDB00934Maprotilineapproved, investigationalunknownsubstrateDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorinducerDetailsDB00333MethadoneapprovedunknownsubstrateDetailsDB01028Methoxyfluraneapproved, investigational, vet_approved, withdrawnunknownsubstrateDetailsDB06148Mianserinapproved, investigationalunknownsubstrateDetailsDB00184NicotineapprovedunknownsubstrateinducerDetailsDB00806Pentoxifyllineapproved, investigationalunknownsubstrateDetailsDB00850PerphenazineapprovedunknownsubstrateDetailsDB00388PhenylephrineapprovedunknowninducerDetailsDB01058Praziquantelapproved, investigational, vet_approvedunknownsubstrateDetailsDB00818Propofolapproved, investigational, vet_approvedunknowninhibitorDetailsDB01129Rabeprazoleapproved, investigationalunknowninhibitorinducerDetailsDB00503Ritonavirapproved, investigationalunknowninducerDetailsDB00412Rosiglitazoneapproved, investigationalunknowninhibitorDetailsDB01037Selegilineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB01079Tegaserodapproved, investigational, withdrawnunknowninhibitorDetailsDB01405TemafloxacinwithdrawnunknownsubstrateinhibitorDetailsDB01412TheobromineinvestigationalunknownsubstrateDetailsDB00763MethimazoleapprovedunknowninhibitorDetailsDB00208TiclopidineapprovedunknowninhibitorDetailsDB06264TolperisoneinvestigationalunknownsubstrateDetailsDB00384TriamtereneapprovedunknownsubstrateDetailsDB00313Valproic acidapproved, investigationalunknowninhibitorDetailsDB00549Zafirlukastapproved, investigationalunknowninhibitorDetailsDB01303OxtriphyllineapprovedunknownsubstrateDetailsDB00398Sorafenibapproved, investigationalunknownsubstrateDetailsDB00418Secobarbitalapproved, vet_approvedunknowninducerDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateDetailsDB01166Cilostazolapproved, investigationalunknownsubstrateDetailsDB01254Dasatinibapproved, investigationalunknownsubstrateDetailsDB06210EltrombopagapprovedunknownsubstrateDetailsDB06413Armodafinilapproved, investigationalunknowninducerDetailsDB00575ClonidineapprovedunknownsubstrateDetailsDB06594Agomelatineapproved, investigationalunknownsubstrateDetailsDB06510MuraglitazarinvestigationalunknownsubstrateDetailsDB06770Benzyl alcoholapprovedunknownsubstrateDetailsDB06774CapsaicinapprovedunknownsubstrateinducerDetailsDB00633Dexmedetomidineapproved, vet_approvedunknowninhibitorDetailsDB06235VadimezaninvestigationalunknownsubstrateDetailsDB00461NabumetoneapprovedunknownsubstrateDetailsDB06803Niclosamideapproved, investigational, vet_approvedunknowninhibitorDetailsDB00435Nitric OxideapprovedunknowninhibitorDetailsDB06820SulconazoleapprovedunknowninhibitorDetailsDB00428Streptozocinapproved, investigationalunknowninducerDetailsDB06589PazopanibapprovedunknownsubstrateDetailsDB08867UlipristalapprovednosubstrateDetailsDB04871Lorcaserinapproved, withdrawnnosubstrateDetailsDB08881VemurafenibapprovedunknowninhibitorDetailsDB06605ApixabanapprovedunknownsubstrateDetailsDB06626Axitinibapproved, investigationalnosubstrateDetailsDB08910PomalidomideapprovedunknownsubstrateDetailsDB06290SimeprevirapprovednoinhibitorDetailsDB06292DapagliflozinapprovednosubstrateDetailsDB00951Isoniazidapproved, investigationalunknownDetailsDB05812AbirateroneapprovedunknowninhibitorDetailsDB09570Ixazomibapproved, investigationalunknownsubstrateDetailsDB09330OsimertinibapprovednoinducerDetailsDB06769Bendamustineapproved, investigationalnosubstrateDetailsDB00105Interferon alfa-2bapprovedunknowninhibitorDetailsDB05990Obeticholic acidapprovedunknowninhibitordownregulatorDetailsDB01173OrphenadrineapprovedunknowninhibitorDetailsDB00715Paroxetineapproved, investigationalunknownsubstrateinhibitorDetailsDB00008Peginterferon alfa-2aapproved, investigationalunknowninhibitorDetailsDB00022Peginterferon alfa-2bapprovedunknowninhibitorDetailsDB12332Rucaparibapproved, investigationalnosubstrateinhibitorinducerDetailsDB11737Icotinibexperimental, investigationalunknownsubstrateDetailsDB12161Deutetrabenazineapproved, investigationalnosubstrateDetailsDB06595Midostaurinapproved, investigationalunknowninhibitorinducerDetailsDB05015Belinostatapproved, investigationalunknowninducerDetailsDB13174RheinexperimentalunknowninhibitorDetailsDB11994Diacereinapproved, investigationalunknowninhibitorDetailsDB09120Zucapsaicinapproved, investigationalunknowninhibitorDetailsDB09118StiripentolapprovedunknownsubstrateinhibitorinducerDetailsDB09198LobeglitazoneexperimentalnoinhibitorDetailsDB09167DosulepinapprovedunknowninhibitorDetailsDB12026Voxilaprevirapproved, investigationalnosubstrateDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB09225Zotepineapproved, investigational, withdrawnnosubstrateDetailsDB11642Pitolisantapproved, investigationalunknowninducerDetailsDB13975Black cohoshexperimentalnoinhibitorDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorinducerDetailsDB11198Peppermint oilapproved, investigationalunknowninhibitorDetailsDB04948Lofexidineapproved, investigationalnosubstrateDetailsDB11672Curcuminapproved, investigationalunknowninhibitorDetailsDB00238NevirapineapprovedunknowninhibitorDetailsDB11967Binimetinibapproved, investigationalnosubstrateDetailsDB06654Safinamideapproved, investigationalunknowninhibitorDetailsDB08883PerampanelapprovedunknownsubstrateDetailsDB09078Lenvatinibapproved, investigationalunknowninhibitorDetailsDB05928DovitinibinvestigationalunknowninducerDetailsDB08496(R)-warfarinexperimentalunknownsubstrateDetailsDB141328-chlorotheophyllineexperimentalnosubstrateDetailsDB01320Fosphenytoinapproved, investigationalunknowninducerDetailsDB00993AzathioprineapprovednosubstrateDetailsDB14029FurafyllineexperimentalnoinhibitorDetailsDB04076HypoxanthineexperimentalnosubstrateDetailsDB12406LisofyllineinvestigationalnosubstrateDetailsDB02134XanthineexperimentalnosubstrateDetailsDB06771BesifloxacinapprovednoinhibitorDetailsDB00827Cinoxacinapproved, investigational, withdrawnnoinhibitorDetailsDB11511Difloxacinvet_approvednoinhibitorDetailsDB06160GarenoxacininvestigationalnoinhibitorDetailsDB01044Gatifloxacinapproved, investigational, withdrawnnoinhibitorDetailsDB01155Gemifloxacinapproved, investigationalnoinhibitorDetailsDB00218Moxifloxacinapproved, investigationalnoinhibitorDetailsDB06600NemonoxacininvestigationalnoinhibitorDetailsDB11443Orbifloxacinvet_approvednoinhibitorDetailsDB11774PazufloxacininvestigationalnoinhibitorDetailsDB13823Pipemidic acidexperimentalnoinhibitorDetailsDB11892PrulifloxacininvestigationalnoinhibitorDetailsDB00817Rosoxacinapproved, investigationalnoinhibitorDetailsDB13772RufloxacinexperimentalnoinhibitorDetailsDB11491Sarafloxacinvet_approved, withdrawnnoinhibitorDetailsDB13261Sitafloxacinexperimental, investigationalnoinhibitorDetailsDB01208Sparfloxacinapproved, investigational, withdrawnunknowninhibitorDetailsDB05488Technetium Tc-99m ciprofloxacininvestigationalnoinhibitorDetailsDB00685Trovafloxacinapproved, investigational, withdrawnnoinhibitorDetailsDB016678-azaguanineexperimentalnosubstrateDetailsDB043569-DeazaguanineexperimentalnosubstrateDetailsDB024899-MethylguanineexperimentalnosubstrateDetailsDB13573AcefyllineexperimentalnosubstrateDetailsDB13203BamifyllineexperimentalnosubstrateDetailsDB14018BromotheophyllineapprovednosubstrateDetailsDB13812BufyllineexperimentalnosubstrateDetailsDB09273DoxofyllineexperimentalnosubstrateDetailsDB13592EtamiphyllineexperimentalnosubstrateDetailsDB01482FenethyllineexperimentalnosubstrateDetailsDB13634PentifyllineexperimentalnosubstrateDetailsDB06479PropentofyllineinvestigationalunknownsubstrateDetailsDB13449ProxyphyllineexperimentalnosubstrateDetailsDB09256Tegafurapproved, investigationalunknownsubstrateDetailsDB09288PropacetamolexperimentalnosubstrateDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB00280DisopyramideapprovedunknownsubstrateDetailsDB00454MeperidineapprovedunknowninducerDetailsDB09290RamosetroninvestigationalunknownsubstrateDetailsDB09071Tasimelteonapproved, investigationalunknownsubstrateDetailsDB04951Pirfenidoneapproved, investigationalunknownsubstrateinhibitorDetailsDB12945Dihydralazineapproved, experimentalunknownsubstrateinhibitorDetailsDB11450Pimobendanvet_approvedunknownsubstrateDetailsDB08880TeriflunomideapprovedunknowninducerDetailsDB01609Deferasiroxapproved, investigationalunknowninhibitorDetailsDB08972FlumequinewithdrawnunknowninhibitorDetailsDB14025ClinafloxacininvestigationalunknowninhibitorDetailsDB11753Rifamycinapproved, investigationalnoinhibitorDetailsDB01056TocainideapprovednosubstrateinhibitorDetailsDB09185Viloxazineapproved, investigational, withdrawnnoinhibitorDetailsDB12245Triclabendazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00455Loratadineapproved, investigationalunknownsubstrateDetailsDB05676Apremilastapproved, investigationalunknownsubstrateDetailsDB11404Enrofloxacinvet_approvedunknowninhibitorDetailsDB00779Nalidixic acidapproved, investigationalunknowninhibitorDetailsDB05396Albinterferon Alfa-2BinvestigationalunknowninhibitorDetailsDB12814Cepeginterferon alfa-2BinvestigationalunknowninhibitorDetailsDB15119Ropeginterferon alfa-2bapproved, investigationalnoinhibitorDetailsDB09122Peginterferon beta-1aapprovedunknowndownregulatorDetailsDB00033Interferon gamma-1bapproved, investigationalunknowninhibitorDetailsDB00068Interferon beta-1bapprovedunknowninhibitorDetailsDB00060Interferon beta-1aapproved, investigationalunknowninhibitorDetailsDB00069Interferon alfacon-1approved, investigationalunknowninhibitorDetailsDB00018Interferon alfa-n3approved, investigationalunknowninhibitorDetailsDB00011Interferon alfa-n1approved, investigationalunknowninhibitorDetailsDB15131Interferon alfa-2cinvestigationalunknowninhibitorDetailsDB00034Interferon alfa-2aapproved, investigationalunknowninhibitorDetailsDB05258Interferon alfainvestigationalunknowninhibitorDetailsDB14999Human interferon betaapproved, investigationalunknowndownregulatorDetailsDB01306Insulin aspartapprovedunknowninducerDetailsDB09456Insulin beefapprovedunknowninducerDetailsDB09564Insulin degludecapprovednoinducerDetailsDB01307Insulin detemirapprovednoinducerDetailsDB00047Insulin glargineapprovedunknowninducerDetailsDB01309Insulin glulisineapprovedunknowninducerDetailsDB00030Insulin humanapproved, investigationalunknowninducerDetailsDB00046Insulin lisproapprovedunknowninducerDetailsDB11567Insulin peglisproinvestigationalunknowninducerDetailsDB00071Insulin porkapprovedunknowninducerDetailsDB05115NN344investigationalunknowninducerDetailsDB11568Insulin tregopilinvestigationalunknowninducerDetailsDB00675TamoxifenapprovedunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknownsubstrateDetailsDB01233Metoclopramideapproved, investigationalunknownsubstrateDetailsDB04889BicifadineinvestigationalunknownsubstrateDetailsDB09061Cannabidiolapproved, investigationalunknowninhibitorDetailsDB14011NabiximolsinvestigationalunknowninhibitorDetailsDB01217Anastrozoleapproved, investigationalunknowninhibitorDetailsDB01195Flecainideapproved, withdrawnunknownsubstrateDetailsDB12001Abemaciclibapproved, investigationalunknowninhibitorDetailsDB01072Atazanavirapproved, investigationalunknowninhibitorDetailsDB15444Elexacaftorapproved, investigationalnoinhibitorDetailsDB00717NorethisteroneapprovedunknownsubstrateDetailsDB06077Lumateperoneapproved, investigationalnosubstrateDetailsDB00252Phenytoinapproved, vet_approvednoinducerDetailsDB00794Primidoneapproved, vet_approvedunknowninducerDetailsDB00927FamotidineapprovednoinhibitorDetailsDB00977EthinylestradiolapprovedunknownsubstrateDetailsDB00440Trimethoprimapproved, vet_approvedunknownsubstrateDetailsDB13609UmifenovirinvestigationalunknownsubstrateDetailsDB01601LopinavirapprovedunknownsubstrateinhibitorDetailsDB11837Osilodrostatapproved, investigationalunknowninhibitorDetailsDB09241Methylene blueapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB11689Selumetinibapproved, investigationalnosubstrateDetailsDB11791Capmatinibapproved, investigationalunknowninhibitorDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB00409Remoxiprideapproved, withdrawnunknowninhibitorDetailsDB11932Abametapirapproved, investigationalnosubstrateinhibitorDetailsDB12499Clascoteroneapproved, investigationalnoinhibitorDetailsDB15093Somapacitanapproved, investigationalunknowninducerDetailsDB15822Pralsetinibapproved, investigationalnosubstrateDetailsDB06448Lonafarnibapproved, investigationalnosubstrateDetailsDB06137Tirbanibulinapproved, investigationalnoinhibitorDetailsDB08912Dabrafenibapproved, investigationalnoinhibitorDetailsDB11632Opicaponeapproved, investigationalnoinhibitorDetailsDB00784Mefenamic acidapprovedunknownsubstrateinhibitorDetailsDB00052Somatotropinapproved, investigationalunknowninducerDetailsDB00330EthambutolapprovedunknowninhibitorDetailsDB15442Trilaciclibapproved, investigationalunknowninducerDetailsDB14989Umbralisibapproved, investigational, withdrawnunknownsubstrateDetailsDB04854FebuxostatapprovednosubstrateDetailsDB01086Benzocaineapproved, investigationalunknownsubstrateDetailsDB11564Insulin argineexperimentalunknowninducerDetailsDB01381Ginkgo bilobaapproved, investigational, nutraceuticalnoinhibitorDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownsubstrateDetailsDB12151Brincidofovirapproved, investigationalnoinhibitorDetailsDB16703Belumosudilapproved, investigationalnoinhibitorDetailsDB12265Fexinidazoleapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB16220Lonapegsomatropinapproved, investigationalunknowninducerDetailsDB15011Avacopanapproved, investigationalnoinducerDetailsDB06234Maribavirapproved, investigationalnosubstrateDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB05667Levoketoconazoleapproved, investigationalnoinducerDetailsDB16236Mitapivatapproved, investigationalnosubstrateDetailsDB09061Cannabidiolapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00470Dronabinolapproved, illicitnoinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknowninhibitorDetailsDB11697Pacritinibapproved, investigationalnoinhibitorinducerDetailsDB06016Cariprazineapproved, investigationalnoinhibitorDetailsDB06083Tapinarofapproved, investigationalnosubstrateDetailsDB01656RoflumilastapprovednosubstrateDetailsDB16650Deucravacitinibapproved, investigationalunknownsubstrateDetailsDB11793Niraparibapproved, investigationalnoinducerDetailsDB16267Olutasidenibapproved, investigationalnosubstrateinducerDetailsDB15568Adagrasibapproved, investigationalunknownsubstrateDetailsDB17472Pirtobrutinibapproved, investigationalunknowninhibitorDetailsDB00349Clobazamapproved, illicitnosubstrateDetailsDB16217Leniolisibapproved, investigationalnosubstrateinhibitorDetailsDB11712Tezacaftorapproved, investigationalnoinhibitorDetailsDB15669Fezolinetantapproved, investigationalnosubstrateDetailsDB14924Ritlecitinibapproved, investigationalunknownsubstrateinhibitorDetailsDB11763Momelotinibapproved, investigationalunknownsubstrateDetailsDB11718Encorafenibapproved, investigationalnoinhibitorDetails"
                    }
                },
                {
                    "Label": "Cytochrome P450 3A4",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 3A4",
                        "Synonyms": "1,8-cineole 2-exo-monooxygenase\n1.14.13.-\nAlbendazole monooxygenase\nAlbendazole sulfoxidase\nCholesterol 25-hydroxylase\nCYP3A3\nCYPIIIA3\nCYPIIIA4\nCytochrome P450 3A3\nCytochrome P450 HLp\nCytochrome P450 NF-25\nCytochrome P450-PCN1\nNifedipine oxidase\nQuinine 3-monooxygenase\nTaurochenodeoxycholate 6-alpha-hydroxylase",
                        "Gene Name": "CYP3A4",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0021936|Cytochrome P450 3A4\nMALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMF\nDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISI\nAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYS\nMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICV\nFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSI\nIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVV\nNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFS\nKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLG\nGLLQPEKPVVLKVESRDGTVSGA",
                        "Number of residues": "503",
                        "Molecular Weight": "57342.67",
                        "Theoretical pI": "8.25",
                        "GO Classification": "Functionsalbendazole monooxygenase activity / aromatase activity / caffeine oxidase activity / enzyme binding / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity / oxygen binding / quinine 3-monooxygenase activity / steroid binding / steroid hydroxylase activity / taurochenodeoxycholate 6alpha-hydroxylase activity / testosterone 6-beta-hydroxylase activity / vitamin D 24-hydroxylase activity / vitamin D3 25-hydroxylase activityProcessesalkaloid catabolic process / androgen metabolic process / calcitriol biosynthetic process from calciol / drug catabolic process / drug metabolic process / exogenous drug catabolic process / heterocycle metabolic process / lipid metabolic process / monoterpenoid metabolic process / oxidation-reduction process / oxidative demethylation / small molecule metabolic process / steroid catabolic process / steroid metabolic process / vitamin D metabolic process / xenobiotic metabolic processComponentscytoplasm / endoplasmic reticulum membrane / integral component of membrane / intracellular membrane-bounded organelle",
                        "General Function": "Vitamin d3 25-hydroxylase activity",
                        "Specific Function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation reactions (e.g. caffeine 8-oxidation, omeprazole sulphoxidation, midazolam 1'-hydroxylation and midazolam 4-hydroxylation) of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,8-cineole 2-exo-monooxygenase. The enzyme also hydroxylates etoposide (PubMed:11159812). Catalyzes 4-beta-hydroxylation of cholesterol. May catalyze 25-hydroxylation of cholesterol in vitro (PubMed:21576599).",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "2-22",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0021937|Cytochrome P450 3A4 (CYP3A4)\nATGGCTCTCATCCCAGACTTGGCCATGGAAACCTGGCTTCTCCTGGCTGTCAGCCTGGTG\nCTCCTCTATCTATATGGAACCCATTCACATGGACTTTTTAAGAAGCTTGGAATTCCAGGG\nCCCACACCTCTGCCTTTTTTGGGAAATATTTTGTCCTACCATAAGGGCTTTTGTATGTTT\nGACATGGAATGTCATAAAAAGTATGGAAAAGTGTGGGGCTTTTATGATGGTCAACAGCCT\nGTGCTGGCTATCACAGATCCTGACATGATCAAAACAGTGCTAGTGAAAGAATGTTATTCT\nGTCTTCACAAACCGGAGGCCTTTTGGTCCAGTGGGATTTATGAAAAGTGCCATCTCTATA\nGCTGAGGATGAAGAATGGAAGAGATTACGATCATTGCTGTCTCCAACCTTCACCAGTGGA\nAAACTCAAGGAGATGGTCCCTATCATTGCCCAGTATGGAGATGTGTTGGTGAGAAATCTG\nAGGCGGGAAGCAGAGACAGGCAAGCCTGTCACCTTGAAAGACGTCTTTGGGGCCTACAGC\nATGGATGTGATCACTAGCACATCATTTGGAGTGAACATCGACTCTCTCAACAATCCACAA\nGACCCCTTTGTGGAAAACACCAAGAAGCTTTTAAGATTTGATTTTTTGGATCCATTCTTT\nCTCTCAATAATCTTTCCATTCCTCATCCCAATTCTTGAAGTATTAAATATCTGTGTGTTT\nCCAAGAGAAGTTACAAATTTTTTAAGAAAATCTGTAAAAAGGATGAAAGAAAGTCGCCTC\nGAAGATACACAAAAGCACCGAGTGGATTTCCTTCAGCTGATGATTGACTCTCAGAATTCA\nAAAGAAACTGAGTCCCACAAAGCTCTGTCCGATCTGGAGCTCGTGGCCCAATCAATTATC\nTTTATTTTTGCTGGCTATGAAACCACGAGCAGTGTTCTCTCCTTCATTATGTATGAACTG\nGCCACTCACCCTGATGTCCAGCAGAAACTGCAGGAGGAAATTGATGCAGTTTTACCCAAT\nAAGGCACCACCCACCTATGATACTGTGCTACAGATGGAGTATCTTGACATGGTGGTGAAT\nGAAACGCTCAGATTATTCCCAATTGCTATGAGACTTGAGAGGGTCTGCAAAAAAGATGTT\nGAGATCAATGGGATGTTCATTCCCAAAGGGGTGGTGGTGATGATTCCAAGCTATGCTCTT\nCACCGTGACCCAAAGTACTGGACAGAGCCTGAGAAGTTCCTCCCTGAAAGATTCAGCAAG\nAAGAACAAGGACAACATAGATCCTTACATATACACACCCTTTGGAAGTGGACCCAGAAAC\nTGCATTGGCATGAGGTTTGCTCTCATGAACATGAAACTTGCTCTAATCAGAGTCCTTCAG\nAACTTCTCCTTCAAACCTTGTAAAGAAACACAGATCCCCCTGAAATTAAGCTTAGGAGGA\nCTTCTTCAACCAGAAAAACCCGTTGTTCTAAAGGTTGAGTCAAGGGATGGCACCGTAAGT\nGGAGCCTGA",
                        "Chromosome Location": "7",
                        "Locus": "7q21.1",
                        "External Identifiers": "ResourceLinkUniProtKB IDP08684UniProtKB Entry NameCP3A4_HUMANGenBank Gene IDM18907GenAtlas IDCYP3A4HGNC IDHGNC:2637",
                        "General References": "Molowa DT, Schuetz EG, Wrighton SA, Watkins PB, Kremers P, Mendez-Picon G, Parker GA, Guzelian PS: Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver. Proc Natl Acad Sci U S A. 1986 Jul;83(14):5311-5. [Article] Gonzalez FJ, Schmid BJ, Umeno M, Mcbride OW, Hardwick JP, Meyer UA, Gelboin HV, Idle JR: Human P450PCN1: sequence, chromosome localization, and direct evidence through cDNA expression that P450PCN1 is nifedipine oxidase. DNA. 1988 Mar;7(2):79-86. [Article] Beaune PH, Umbenhauer DR, Bork RW, Lloyd RS, Guengerich FP: Isolation and sequence determination of a cDNA clone related to human cytochrome P-450 nifedipine oxidase. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8064-8. [Article] Spurr NK, Gough AC, Stevenson K, Wolf CR: The human cytochrome P450 CYP3 locus: assignment to chromosome 7q22-qter. Hum Genet. 1989 Jan;81(2):171-4. [Article] Bork RW, Muto T, Beaune PH, Srivastava PK, Lloyd RS, Guengerich FP: Characterization of mRNA species related to human liver cytochrome P-450 nifedipine oxidase and the regulation of catalytic activity. J Biol Chem. 1989 Jan 15;264(2):910-9. [Article] Chen Q, Wu J, Yu Y: [Establishment of transgenic cell line CHL-3A4 and its metabolic activation]. Zhonghua Yu Fang Yi Xue Za Zhi. 1998 Sep;32(5):281-4. [Article] Gellner K, Eiselt R, Hustert E, Arnold H, Koch I, Haberl M, Deglmann CJ, Burk O, Buntefuss D, Escher S, Bishop C, Koebe HG, Brinkmann U, Klenk HP, Kleine K, Meyer UA, Wojnowski L: Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics. 2001 Mar;11(2):111-21. [Article] Hsieh KP, Lin YY, Cheng CL, Lai ML, Lin MS, Siest JP, Huang JD: Novel mutations of CYP3A4 in Chinese. Drug Metab Dispos. 2001 Mar;29(3):268-73. [Article] Komori M, Hashizume T, Ohi H, Miura T, Kitada M, Nagashima K, Kamataki T: Cytochrome P-450 in human liver microsomes: high-performance liquid chromatographic isolation of three forms and their characterization. J Biochem. 1988 Dec;104(6):912-6. [Article] Watkins PB, Wrighton SA, Maurel P, Schuetz EG, Mendez-Picon G, Parker GA, Guzelian PS: Identification of an inducible form of cytochrome P-450 in human liver. Proc Natl Acad Sci U S A. 1985 Sep;82(18):6310-4. [Article] Aoyama T, Yamano S, Waxman DJ, Lapenson DP, Meyer UA, Fischer V, Tyndale R, Inaba T, Kalow W, Gelboin HV, et al.: Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. J Biol Chem. 1989 Jun 25;264(18):10388-95. [Article] Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP: Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther. 1994 Jul;270(1):414-23. [Article] Kolars JC, Lown KS, Schmiedlin-Ren P, Ghosh M, Fang C, Wrighton SA, Merion RM, Watkins PB: CYP3A gene expression in human gut epithelium. Pharmacogenetics. 1994 Oct;4(5):247-59. [Article] Zhang H, Coville PF, Walker RJ, Miners JO, Birkett DJ, Wanwimolruk S: Evidence for involvement of human CYP3A in the 3-hydroxylation of quinine. Br J Clin Pharmacol. 1997 Mar;43(3):245-52. [Article] Zhao XJ, Kawashiro T, Ishizaki T: Mutual inhibition between quinine and etoposide by human liver microsomes. Evidence for cytochrome P4503A4 involvement in their major metabolic pathways. Drug Metab Dispos. 1998 Feb;26(2):188-91. [Article] Miyazawa M, Shindo M, Shimada T: Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes. Drug Metab Dispos. 2001 Feb;29(2):200-5. [Article] Finta C, Zaphiropoulos PG: Intergenic mRNA molecules resulting from trans-splicing. J Biol Chem. 2002 Feb 22;277(8):5882-90. Epub 2001 Nov 28. [Article] Dauchy S, Dutheil F, Weaver RJ, Chassoux F, Daumas-Duport C, Couraud PO, Scherrmann JM, De Waziers I, Decleves X: ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J Neurochem. 2008 Dec;107(6):1518-28. doi: 10.1111/j.1471-4159.2008.05720.x. [Article] Agarwal V, Kommaddi RP, Valli K, Ryder D, Hyde TM, Kleinman JE, Strobel HW, Ravindranath V: Drug metabolism in human brain: high levels of cytochrome P4503A43 in brain and metabolism of anti-anxiety drug alprazolam to its active metabolite. PLoS One. 2008 Jun 11;3(6):e2337. doi: 10.1371/journal.pone.0002337. [Article] Pabarcus MK, Hoe N, Sadeghi S, Patterson C, Wiertz E, Correia MA: CYP3A4 ubiquitination by gp78 (the tumor autocrine motility factor receptor, AMFR) and CHIP E3 ligases. Arch Biochem Biophys. 2009 Mar 1;483(1):66-74. doi: 10.1016/j.abb.2008.12.001. Epub 2008 Dec 10. [Article] Dutheil F, Dauchy S, Diry M, Sazdovitch V, Cloarec O, Mellottee L, Bieche I, Ingelman-Sundberg M, Flinois JP, de Waziers I, Beaune P, Decleves X, Duyckaerts C, Loriot MA: Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function. Drug Metab Dispos. 2009 Jul;37(7):1528-38. doi: 10.1124/dmd.109.027011. Epub 2009 Apr 9. [Article] Honda A, Miyazaki T, Ikegami T, Iwamoto J, Maeda T, Hirayama T, Saito Y, Teramoto T, Matsuzaki Y: Cholesterol 25-hydroxylation activity of CYP3A. J Lipid Res. 2011 Aug;52(8):1509-16. doi: 10.1194/jlr.M014084. Epub 2011 May 16. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Yano JK, Wester MR, Schoch GA, Griffin KJ, Stout CD, Johnson EF: The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-A resolution. J Biol Chem. 2004 Sep 10;279(37):38091-4. Epub 2004 Jul 16. [Article] Williams PA, Cosme J, Vinkovic DM, Ward A, Angove HC, Day PJ, Vonrhein C, Tickle IJ, Jhoti H: Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone. Science. 2004 Jul 30;305(5684):683-6. Epub 2004 Jul 15. [Article] Sata F, Sapone A, Elizondo G, Stocker P, Miller VP, Zheng W, Raunio H, Crespi CL, Gonzalez FJ: CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activity. Clin Pharmacol Ther. 2000 Jan;67(1):48-56. [Article] Dai D, Tang J, Rose R, Hodgson E, Bienstock RJ, Mohrenweiser HW, Goldstein JA: Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos. J Pharmacol Exp Ther. 2001 Dec;299(3):825-31. [Article] Eiselt R, Domanski TL, Zibat A, Mueller R, Presecan-Siedel E, Hustert E, Zanger UM, Brockmoller J, Klenk HP, Meyer UA, Khan KK, He YA, Halpert JR, Wojnowski L: Identification and functional characterization of eight CYP3A4 protein variants. Pharmacogenetics. 2001 Jul;11(5):447-58. [Article] Lamba JK, Lin YS, Thummel K, Daly A, Watkins PB, Strom S, Zhang J, Schuetz EG: Common allelic variants of cytochrome P4503A4 and their prevalence in different populations. Pharmacogenetics. 2002 Mar;12(2):121-32. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB05478Pradefovir mesylateinvestigationalunknownDetailsDB00180Flunisolideapproved, investigationalunknownsubstrateinducerDetailsDB00185CevimelineapprovedunknownsubstrateDetailsDB00188Bortezomibapproved, investigationalnosubstrateDetailsDB00196Fluconazoleapproved, investigationalunknowninhibitorDetailsDB00204Dofetilideapproved, investigationalunknownsubstrateDetailsDB00213PantoprazoleapprovedunknownsubstrateDetailsDB00216Eletriptanapproved, investigationalunknownsubstrateDetailsDB00220NelfinavirapprovednosubstrateinhibitorDetailsDB00224IndinavirapprovedunknownsubstrateinhibitorDetailsDB00227Lovastatinapproved, investigationalunknownsubstrateinhibitorDetailsDB00234Reboxetineapproved, experimentalunknownsubstrateinhibitorDetailsDB00238NevirapineapprovedunknownsubstrateinducerDetailsDB00243Ranolazineapproved, investigationalnosubstrateinhibitorDetailsDB00246ZiprasidoneapprovedunknownsubstrateDetailsDB00270Isradipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00280DisopyramideapprovedunknownsubstrateDetailsDB00286Conjugated estrogensapprovednosubstrateDetailsDB00294Etonogestrelapproved, investigationalnosubstrateDetailsDB00297Bupivacaineapproved, investigationalunknownsubstrateDetailsDB00307Bexaroteneapproved, investigationalunknownsubstrateinducerDetailsDB00309Vindesineapproved, investigationalunknownsubstrateDetailsDB00317Gefitinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00320Dihydroergotamineapproved, investigationalunknownsubstrateinhibitorDetailsDB00324Fluorometholoneapproved, investigationalunknownsubstrateinducerDetailsDB00342Terfenadineapproved, withdrawnunknownsubstrateinhibitorDetailsDB00343Diltiazemapproved, investigationalunknownsubstrateinhibitorDetailsDB00346Alfuzosinapproved, investigationalunknownsubstrateDetailsDB00361Vinorelbineapproved, investigationalnosubstrateDetailsDB00365Grepafloxacinapproved, investigational, withdrawnunknownsubstrateDetailsDB00370MirtazapineapprovedunknownsubstrateinhibitorDetailsDB00381AmlodipineapprovednosubstrateDetailsDB00393Nimodipineapproved, investigationalunknownsubstrateDetailsDB00398Sorafenibapproved, investigationalunknownsubstrateinhibitorDetailsDB00401NisoldipineapprovedunknownsubstrateDetailsDB00402Eszopicloneapproved, investigationalunknownsubstrateDetailsDB00404Alprazolamapproved, illicit, investigationalunknownsubstrateDetailsDB00425ZolpidemapprovedunknownsubstrateDetailsDB00443Betamethasoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00455Loratadineapproved, investigationalnosubstrateinhibitorDetailsDB00468QuinineapprovedunknownsubstrateinhibitorinducerDetailsDB00470Dronabinolapproved, illicitnosubstrateinhibitorDetailsDB00471MontelukastapprovedunknownsubstrateDetailsDB00490Buspironeapproved, investigationalunknownsubstrateDetailsDB00496Darifenacinapproved, investigationalunknownsubstrateDetailsDB00518Albendazoleapproved, vet_approvedunknownsubstrateDetailsDB00528Lercanidipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00533Rofecoxibapproved, investigational, withdrawnunknownsubstrateinducerDetailsDB00539Toremifeneapproved, investigationalunknownsubstrateinhibitorDetailsDB00541Vincristineapproved, investigationalunknownsubstrateDetailsDB00559Bosentanapproved, investigationalunknownsubstrateinducerDetailsDB00570VinblastineapprovedunknownsubstrateinhibitorinducerDetailsDB00582VoriconazoleapprovedunknownsubstrateinhibitorDetailsDB00588Fluticasone propionateapprovedunknownsubstrateinhibitorDetailsDB00593EthosuximideapprovedunknownsubstrateDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknownsubstrateinducerDetailsDB00604Cisaprideapproved, investigational, withdrawnunknownsubstrateDetailsDB00615Rifabutinapproved, investigationalunknownsubstrateinducerDetailsDB00619ImatinibapprovednosubstrateinhibitorDetailsDB00622Nicardipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00624Testosteroneapproved, investigationalunknownsubstrateinducerDetailsDB00625Efavirenzapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00635Prednisoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00636Clofibrateapproved, investigationalunknownsubstrateinducerDetailsDB00637Astemizoleapproved, withdrawnunknownsubstrateinhibitorDetailsDB00641SimvastatinapprovedunknownsubstrateDetailsDB00673Aprepitantapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00674GalantamineapprovednosubstrateDetailsDB00675TamoxifenapprovedunknownsubstrateinhibitorinducerDetailsDB00678LosartanapprovedunknownsubstrateinhibitorDetailsDB00683Midazolamapproved, illicitunknownsubstrateinhibitorDetailsDB00696ErgotamineapprovedunknownsubstrateinhibitorDetailsDB00700EplerenoneapprovedunknownsubstrateDetailsDB00701Amprenavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00705DelavirdineapprovedunknownsubstrateinhibitorDetailsDB00731Nateglinideapproved, investigationalunknownsubstrateDetailsDB00736Esomeprazoleapproved, investigationalunknownsubstrateDetailsDB00741Hydrocortisoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00744Zileutonapproved, investigational, withdrawnunknownsubstrateDetailsDB00745Modafinilapproved, investigationalunknownsubstrateinducerDetailsDB00757Dolasetronapproved, investigationalunknownsubstrateDetailsDB00758ClopidogrelapprovednosubstrateDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateinhibitorDetailsDB00769HydrocortamateapprovedunknowninducerDetailsDB00773EtoposideapprovedunknownsubstrateinhibitorinducerDetailsDB00778Roxithromycinapproved, investigational, withdrawnnosubstrateinhibitorDetailsDB00802Alfentanilapproved, illicitunknownsubstrateDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB00820Tadalafilapproved, investigationalnosubstrateDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00834Mifepristoneapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00836LoperamideapprovedunknownsubstrateinhibitorDetailsDB00843DonepezilapprovedunknownsubstrateDetailsDB00860Prednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB00862VardenafilapprovedunknownsubstrateinhibitorDetailsDB00864Tacrolimusapproved, investigationalunknownsubstrateDetailsDB00872Conivaptanapproved, investigationalunknownsubstrateinhibitorDetailsDB00877Sirolimusapproved, investigationalnosubstrateDetailsDB00889Granisetronapproved, investigationalunknownsubstrateDetailsDB00897Triazolamapproved, investigationalunknownsubstrateDetailsDB00904Ondansetronapproved, withdrawnunknownsubstrateDetailsDB00906Tiagabineapproved, investigationalunknownsubstrateDetailsDB00907Cocaineapproved, illicitunknownsubstrateDetailsDB00909Zonisamideapproved, investigationalunknownsubstrateDetailsDB00910Paricalcitolapproved, investigationalunknownsubstrateDetailsDB00911Tinidazoleapproved, investigationalunknownsubstrateDetailsDB00918Almotriptanapproved, investigationalunknownsubstrateDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00932Tipranavirapproved, investigationalunknownsubstrateinhibitorDetailsDB00938SalmeterolapprovedunknownsubstrateDetailsDB00956Hydrocodoneapproved, illicit, investigationalunknownsubstrateDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB00962Zaleplonapproved, illicit, investigationalunknownsubstrateDetailsDB00976TelithromycinapprovedunknownsubstrateinhibitorDetailsDB00977EthinylestradiolapprovedunknownsubstrateDetailsDB00990Exemestaneapproved, investigationalunknownsubstrateDetailsDB00997Doxorubicinapproved, investigationalnosubstrateinhibitorDetailsDB01002Levobupivacaineapproved, investigationalunknownsubstrateDetailsDB01006Letrozoleapproved, investigationalunknownsubstrateDetailsDB01008Busulfanapproved, investigationalunknownsubstrateDetailsDB01012CinacalcetapprovedunknownsubstrateDetailsDB01023Felodipineapproved, investigationalunknownsubstrateDetailsDB01026Ketoconazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB01045RifampicinapprovedunknowninducerDetailsDB01054Nitrendipineapproved, investigationalunknownsubstrateDetailsDB01062Oxybutyninapproved, investigationalunknownsubstrateinhibitorDetailsDB01068Clonazepamapproved, illicitunknownsubstrateDetailsDB01072Atazanavirapproved, investigationalnosubstrateinhibitorDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB01100PimozideapprovedunknownsubstrateDetailsDB01105Sibutramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB01114ChlorpheniramineapprovedunknownsubstrateDetailsDB01115NifedipineapprovedunknownsubstrateinhibitorinducerDetailsDB01129Rabeprazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB01132Pioglitazoneapproved, investigationalunknownsubstrateinducerDetailsDB01149Nefazodoneapproved, withdrawnunknownsubstrateinhibitorDetailsDB01166Cilostazolapproved, investigationalunknownsubstrateDetailsDB01167Itraconazoleapproved, investigationalnosubstrateinhibitorDetailsDB01175EscitalopramapprovednosubstrateDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB01190Clindamycinapproved, vet_approvedunknownsubstrateinhibitorDetailsDB01200Bromocriptineapproved, investigational, withdrawnnosubstrateinhibitorDetailsDB01206Lomustineapproved, investigationalunknowninhibitorDetailsDB01211ClarithromycinapprovedunknownsubstrateinhibitorDetailsDB01215Estazolamapproved, illicitunknownsubstrateDetailsDB01216FinasterideapprovedunknownsubstrateDetailsDB01218HalofantrineapprovedunknownsubstrateDetailsDB01222BudesonideapprovednosubstrateinducerDetailsDB01224QuetiapineapprovedunknownsubstrateDetailsDB01227Levacetylmethadolapproved, investigational, withdrawnunknownsubstrateDetailsDB01229Paclitaxelapproved, vet_approvedunknownsubstrateinducerDetailsDB01232Saquinavirapproved, investigationalunknownsubstrateinhibitorDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB01238Aripiprazoleapproved, investigationalnosubstrateDetailsDB01254Dasatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB01256RetapamulinapprovedunknownsubstrateDetailsDB01261Sitagliptinapproved, investigationalunknownsubstrateDetailsDB01259Lapatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB01264DarunavirapprovedunknownsubstrateinhibitorDetailsDB01268Sunitinibapproved, investigationalnosubstrateinhibitorDetailsDB01263Posaconazoleapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB01388Mibefradilinvestigational, withdrawnunknownsubstrateinhibitorDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknowninducerDetailsDB01601LopinavirapprovedunknownsubstrateinhibitorDetailsDB01411PranlukastinvestigationalnosubstrateDetailsDB01410Ciclesonideapproved, investigationalnosubstrateDetailsDB00969Alosetronapproved, withdrawnunknownsubstrateDetailsDB04835Maravirocapproved, investigationalunknownsubstrateDetailsDB01409TiotropiumapprovedunknownsubstrateDetailsDB01591SolifenacinapprovednosubstrateDetailsDB01011Metyraponeapproved, investigationalunknowninhibitorinducerDetailsDB00377Palonosetronapproved, investigationalunknownsubstrateDetailsDB04856DexloxiglumideinvestigationalunknownsubstrateDetailsDB04886Calanolide AinvestigationalunknownsubstrateDetailsDB00580Valdecoxibapproved, investigational, withdrawnunknownsubstrateDetailsDB06144Sertindoleapproved, investigational, withdrawnunknownsubstrateDetailsDB04977PlitidepsininvestigationalunknownsubstrateDetailsDB04905TesmilifeneinvestigationalunknownsubstrateinhibitorinducerDetailsDB00333MethadoneapprovedunknownsubstrateinhibitorinducerDetailsDB04934RifalazilinvestigationalunknownsubstrateDetailsDB04957AzimilideinvestigationalunknownsubstrateDetailsDB00199Erythromycinapproved, investigational, vet_approvednosubstrateinhibitorDetailsDB01628Etoricoxibapproved, investigationalunknownsubstrateinhibitorDetailsDB00564Carbamazepineapproved, investigationalunknownsubstrateinducerDetailsDB06155Rimonabantapproved, investigationalunknownsubstrateDetailsDB06267Udenafilapproved, investigationalunknownsubstrateDetailsDB06287TemsirolimusapprovedunknownsubstrateDetailsDB06442AvasimibeinvestigationalunknowninducerDetailsDB08502CapravirineinvestigationalunknownsubstrateDetailsDB06652VicrivirocinvestigationalunknownsubstrateDetailsDB06685LaquinimodinvestigationalunknownsubstrateDetailsDB01095FluvastatinapprovedunknownsubstrateinhibitorDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateDetailsDB00248CabergolineapprovedunknownsubstrateDetailsDB00589Lisurideapproved, investigationalunknownsubstrateDetailsDB01186Pergolideapproved, investigational, vet_approved, withdrawnunknowninhibitorDetailsDB05271RotigotineapprovedunknownsubstrateDetailsDB00439Cerivastatinapproved, withdrawnunknownsubstrateinhibitorinducerDetailsDB00257Clotrimazoleapproved, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00734Risperidoneapproved, investigationalunknownsubstrateDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB01037Selegilineapproved, investigational, vet_approvedunknownsubstrateDetailsDB01159Halothaneapproved, vet_approvedunknownsubstrateDetailsDB01181IfosfamideapprovedunknownsubstrateinhibitorinducerDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB00814Meloxicamapproved, vet_approvedunknownsubstrateDetailsDB00908Quinidineapproved, investigationalunknownsubstrateinhibitorDetailsDB00656Trazodoneapproved, investigationalunknownsubstrateDetailsDB00176Fluvoxamineapproved, investigationalunknownsubstrateinhibitorDetailsDB00321AmitriptylineapprovedunknownsubstrateDetailsDB00540NortriptylineapprovedunknownsubstrateDetailsDB00215CitalopramapprovednosubstrateinhibitorDetailsDB00924CyclobenzaprineapprovedunknownsubstrateDetailsDB00472Fluoxetineapproved, vet_approvednosubstrateinhibitorDetailsDB01104SertralineapprovedunknownsubstrateinhibitorDetailsDB06148Mianserinapproved, investigationalunknownsubstrateDetailsDB01435Antipyrineapproved, investigationalunknownsubstrateDetailsDB01118Amiodaroneapproved, investigationalnosubstrateinhibitorDetailsDB00250Dapsoneapproved, investigationalunknownsubstrateDetailsDB00531Cyclophosphamideapproved, investigationalunknownsubstrateinducerDetailsDB05109Trabectedinapproved, investigationalunknownsubstrateDetailsDB00946Phenprocoumonapproved, investigationalunknownsubstrateDetailsDB00682WarfarinapprovedunknownsubstrateinducerDetailsDB00285VenlafaxineapprovedunknownsubstrateDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB00972AzelastineapprovedunknownsubstrateinhibitorDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00661VerapamilapprovedunknownsubstrateinhibitorDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateinducerDetailsDB00201CaffeineapprovedunknownsubstrateDetailsDB00318Codeineapproved, illicitunknownsubstrateDetailsDB00514DextromethorphanapprovedunknownsubstrateDetailsDB01248Docetaxelapproved, investigationalunknownsubstrateinhibitorDetailsDB00502HaloperidolapprovedunknownsubstrateinhibitorDetailsDB00281Lidocaineapproved, vet_approvedunknownsubstrateDetailsDB00571Propranololapproved, investigationalunknownsubstrateDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00446Chloramphenicolapproved, vet_approved, withdrawnunknowninhibitorDetailsDB00537Ciprofloxacinapproved, investigationalunknowninhibitorDetailsDB01059NorfloxacinapprovedunknowninhibitorDetailsDB06403Ambrisentanapproved, investigationalunknownsubstrateDetailsDB06413Armodafinilapproved, investigationalunknowninducerDetailsDB00865Benzphetamineapproved, illicitunknownsubstrateDetailsDB00612BisoprololapprovedunknownsubstrateDetailsDB00136Calcitriolapproved, nutraceuticalunknownsubstrateinducerDetailsDB00608Chloroquineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00349Clobazamapproved, illicitnosubstrateinducerDetailsDB00628Clorazepic acidapproved, illicitunknownsubstrateDetailsDB01396Digitoxinapproved, investigationalunknownsubstrateDetailsDB04855DronedaroneapprovedunknownsubstrateinhibitorDetailsDB04574Estrone sulfateapprovedunknownsubstrateDetailsDB06414EtravirineapprovedunknownsubstrateinducerDetailsDB01590EverolimusapprovedunknownsubstrateDetailsDB00949FelbamateapprovedunknownsubstrateinducerDetailsDB06702FesoterodineapprovedunknownsubstrateDetailsDB00690Flurazepamapproved, illicit, investigationalunknownsubstrateDetailsDB00499Flutamideapproved, investigationalunknownsubstrateDetailsDB01018Guanfacineapproved, investigationalunknownsubstrateDetailsDB04845Ixabepiloneapproved, investigationalunknownsubstrateDetailsDB00448Lansoprazoleapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00367Levonorgestrelapproved, investigationalunknownsubstrateDetailsDB00358Mefloquineapproved, investigationalunknownsubstrateinhibitorDetailsDB04868Nilotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB06712Nilvadipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00497Oxycodoneapproved, illicit, investigationalunknownsubstrateDetailsDB06589PazopanibapprovedunknownsubstrateinhibitorDetailsDB01621Pipotiazineapproved, investigationalunknownsubstrateDetailsDB01058Praziquantelapproved, investigational, vet_approvedunknownsubstrateDetailsDB01087PrimaquineapprovedunknownsubstrateinhibitorDetailsDB00647Dextropropoxypheneapproved, illicit, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00912Repaglinideapproved, investigationalunknownsubstrateDetailsDB06228RivaroxabanapprovedunknownsubstrateDetailsDB06176Romidepsinapproved, investigationalunknownsubstrateDetailsDB06207SilodosinapprovedunknownsubstrateDetailsDB00706Tamsulosinapproved, investigationalunknownsubstrateDetailsDB00444TeniposideapprovedunknownsubstrateinhibitorDetailsDB00759Tetracyclineapproved, vet_approved, withdrawnunknownsubstrateinhibitorDetailsDB00277TheophyllineapprovedunknownsubstrateDetailsDB01036Tolterodineapproved, investigationalunknownsubstrateDetailsDB06212TolvaptanapprovedunknownsubstrateDetailsDB00193Tramadolapproved, investigationalunknownsubstrateDetailsDB00440Trimethoprimapproved, vet_approvedunknownsubstrateDetailsDB01198ZopicloneapprovedunknownsubstrateDetailsDB00357Aminoglutethimideapproved, investigationalunknowninducerDetailsDB01320Fosphenytoinapproved, investigationalunknownsubstrateinducerDetailsDB00607Nafcillinapproved, investigationalunknowninducerDetailsDB00776OxcarbazepineapprovedunknowninhibitorinducerDetailsDB00312Pentobarbitalapproved, investigational, vet_approvedunknowninducerDetailsDB01174Phenobarbitalapproved, investigationalunknowninducerDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinducerDetailsDB00794Primidoneapproved, vet_approvedunknowninducerDetailsDB01201Rifapentineapproved, investigationalunknownsubstrateinducerDetailsDB01394ColchicineapprovedunknownsubstrateinhibitorDetailsDB01253ErgometrineapprovedunknownsubstrateDetailsDB01221Ketamineapproved, vet_approvedunknownsubstrateinducerDetailsDB00353MethylergometrineapprovedunknownsubstrateinhibitorDetailsDB06335SaxagliptinapprovedunknownsubstrateDetailsDB00708Sufentanilapproved, investigationalunknownsubstrateDetailsDB01128BicalutamideapprovedunknownsubstrateinhibitorDetailsDB01151Desipramineapproved, investigationalunknowninhibitorDetailsDB00916MetronidazoleapprovedunknowninhibitorDetailsDB06268Sitaxentanapproved, investigational, withdrawnunknowninhibitorDetailsDB01424Aminophenazoneapproved, withdrawnunknownsubstrateDetailsDB00363ClozapineapprovednosubstrateinhibitorinducerDetailsDB00420Promazineapproved, vet_approvedunknownsubstrateDetailsDB01136Carvedilolapproved, investigationalunknownsubstrateDetailsDB00549Zafirlukastapproved, investigationalunknownsubstrateinhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00482Celecoxibapproved, investigationalunknownsubstrateDetailsDB01016GlyburideapprovedunknownsubstrateinhibitorDetailsDB01138SulfinpyrazoneapprovedunknownsubstrateinducerDetailsDB06739SeratrodastexperimentalunknownsubstrateinducerDetailsDB06738KetobemidoneinvestigationalunknownsubstrateDetailsDB01242Clomipramineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00655EstroneapprovednosubstrateDetailsDB00458ImipramineapprovedunknownsubstrateDetailsDB00546AdinazolamexperimentalunknownsubstrateDetailsDB00231Temazepamapproved, investigationalunknownsubstrateDetailsDB03701VanoxerineinvestigationalunknownsubstrateDetailsDB00169Cholecalciferolapproved, nutraceuticalunknownsubstrateDetailsDB01192Oxymorphoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB01173OrphenadrineapprovedunknownsubstrateinhibitorDetailsDB06772CabazitaxelapprovedunknownsubstrateDetailsDB02709ResveratrolinvestigationalnoinhibitorDetailsDB06700Desvenlafaxineapproved, investigationalnosubstrateinhibitorDetailsDB06697ArtemetherapprovedunknownsubstrateinducerDetailsDB06708LumefantrineapprovedunknownsubstrateDetailsDB00819Acetazolamideapproved, vet_approvedunknowninhibitorDetailsDB06742Ambroxolapproved, investigationalunknownsubstrateDetailsDB01223AminophyllineapprovedunknownsubstrateDetailsDB00278Argatrobanapproved, investigationalunknownsubstrateDetailsDB01169Arsenic trioxideapproved, investigationalunknowninhibitorDetailsDB00207AzithromycinapprovedunknownsubstrateinhibitorDetailsDB01393Bezafibrateapproved, investigationalunknownsubstrateDetailsDB04794Bifonazoleapproved, investigationalunknowninhibitorDetailsDB01194BrinzolamideapprovednosubstrateDetailsDB00520CaspofunginapprovedunknowninhibitorDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknowninducerDetailsDB00356ChlorzoxazoneapprovedunknownsubstrateinhibitorDetailsDB00845Clofazimineapproved, investigationalunknowninhibitorDetailsDB06470ClomethiazoleinvestigationalunknownsubstrateDetailsDB01559Clotiazepamapproved, illicitunknownsubstrateDetailsDB00987Cytarabineapproved, investigationalunknownsubstrateDetailsDB01406DanazolapprovedunknowninhibitorDetailsDB00694DaunorubicinapprovedunknownsubstrateinhibitorDetailsDB01093Dimethyl sulfoxideapproved, vet_approvedunknowninhibitorDetailsDB00822DisulfiramapprovedunknownsubstrateDetailsDB00254Doxycyclineapproved, investigational, vet_approvedunknowninhibitorDetailsDB01127EconazoleapprovednoinhibitorDetailsDB00751Epinastineapproved, investigationalunknownsubstrateDetailsDB00668Epinephrineapproved, vet_approvedunknowninhibitorDetailsDB01196Estramustineapproved, investigationalunknownsubstrateDetailsDB00898EthanolapprovedunknownsubstrateinhibitorinducerDetailsDB01466Ethylmorphineexperimental, illicitunknownsubstrateDetailsDB00301Flucloxacillinapproved, investigationalunknownsubstrateinducerDetailsDB01544Flunitrazepamapproved, illicitunknownsubstrateDetailsDB00947Fulvestrantapproved, investigationalunknownsubstrateDetailsDB01275HydralazineapprovednoinhibitorDetailsDB00724Imiquimodapproved, investigationalunknownsubstrateDetailsDB01029Irbesartanapproved, investigationalnoinhibitorDetailsDB00602Ivermectinapproved, investigational, vet_approvednosubstrateDetailsDB01103QuinacrineinvestigationalunknownsubstrateDetailsDB01071MequitazineexperimentalunknowninhibitorDetailsDB04817Metamizoleapproved, investigational, withdrawnunknowninducerDetailsDB04833Methaqualoneillicit, withdrawnunknownsubstrateDetailsDB01028Methoxyfluraneapproved, investigational, vet_approved, withdrawnunknownsubstrateDetailsDB06710MethyltestosteroneapprovedunknownsubstrateDetailsDB00379Mexiletineapproved, investigationalunknownsubstrateDetailsDB01204Mitoxantroneapproved, investigationalunknowninhibitorDetailsDB00295Morphineapproved, investigationalnosubstrateDetailsDB01183Naloxoneapproved, vet_approvedunknownsubstrateinhibitorDetailsDB02701Nicotinamideapproved, investigationalunknowninhibitorDetailsDB00184NicotineapprovedunknownsubstrateDetailsDB01595NitrazepamapprovedunknownsubstrateDetailsDB00768OlopatadineapprovednosubstrateDetailsDB00316AcetaminophenapprovedunknownsubstrateinducerDetailsDB01074Perhexilineapproved, investigationalunknownsubstrateDetailsDB00850PerphenazineapprovedunknownsubstrateDetailsDB00454MeperidineapprovedunknownsubstrateinducerDetailsDB03783PhenacetinwithdrawnunknownsubstrateDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB00812Phenylbutazoneapproved, vet_approvedunknowninducerDetailsDB01085Pilocarpineapproved, investigationalunknowninhibitorDetailsDB01588Prazepamapproved, illicitunknownsubstrateDetailsDB01032Probenecidapproved, investigationalunknowninducerDetailsDB01182PropafenoneapprovedunknownsubstrateDetailsDB01589Quazepamapproved, illicitnosubstrateDetailsDB00481Raloxifeneapproved, investigationalunknowninhibitorDetailsDB00863Ranitidineapproved, withdrawnunknowninhibitorDetailsDB01220Rifaximinapproved, investigationalunknownsubstrateinducerDetailsDB00296RopivacaineapprovedunknownsubstrateDetailsDB01698Rutinapproved, experimental, investigationalunknowninducerDetailsDB01001Salbutamolapproved, vet_approvedunknowninhibitorDetailsDB01236Sevofluraneapproved, vet_approvedunknownsubstrateDetailsDB00359Sulfadiazineapproved, investigational, vet_approvedunknownsubstrateDetailsDB01015SulfamethoxazoleapprovedunknownsubstrateDetailsDB01349TasosartanexperimentalunknownsubstrateDetailsDB00763MethimazoleapprovedunknowninhibitorDetailsDB04572Thiotepaapproved, investigationalunknownsubstrateDetailsDB01007TioconazoleapprovedunknowninhibitorDetailsDB00273TopiramateapprovedunknowninducerDetailsDB00347TrimethadioneapprovedunknownsubstrateDetailsDB13179TroleandomycinapprovedunknownsubstrateinhibitorDetailsDB00313Valproic acidapproved, investigationalunknowninhibitorDetailsDB01392Yohimbineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00495ZidovudineapprovedunknownsubstrateDetailsDB04828ZomepiracwithdrawnunknownsubstrateDetailsDB01380Cortisone acetateapproved, investigationalunknownsubstrateinducerDetailsDB01384ParamethasoneexperimentalunknownsubstrateinhibitorinducerDetailsDB01587KetazolamapprovedunknownsubstrateinhibitorDetailsDB08811TofisopamexperimentalunknowninhibitorDetailsDB00617ParamethadioneapprovedunknownsubstrateDetailsDB00755Tretinoinapproved, investigational, nutraceuticalunknownsubstrateDetailsDB00980Ramelteonapproved, investigationalunknownsubstrateDetailsDB04946IloperidoneapprovedunknownsubstrateDetailsDB01418Acenocoumarolapproved, investigationalunknownsubstrateDetailsDB06684VilazodoneapprovedunknownsubstrateDetailsDB00255Diethylstilbestrolapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00575ClonidineapprovedunknownsubstrateDetailsDB00973EzetimibeapprovedunknowninhibitorDetailsDB00400Griseofulvinapproved, investigational, vet_approvedunknowninducerDetailsDB00808IndapamideapprovedunknownsubstrateDetailsDB05521Telaprevirapproved, withdrawnunknownsubstrateinhibitorDetailsDB08820IvacaftorapprovednosubstrateinhibitorDetailsDB06634CasopitantinvestigationalunknownDetailsDB04975BanoxantroneinvestigationalunknownsubstrateDetailsDB05039IndacaterolapprovedunknownsubstrateDetailsDB08816TicagrelorapprovedunknownsubstrateinhibitorDetailsDB06774CapsaicinapprovedunknowninhibitorDetailsDB06174Noscapineapproved, investigationalunknowninhibitorDetailsDB01333CefradineapprovedunknowninducerDetailsDB06777Chenodeoxycholic acidapprovedunknownsubstrateDetailsDB00856Chlorphenesinapproved, experimentalunknowninducerDetailsDB04920Clevidipineapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB01764DalfopristinapprovedunknowninhibitorDetailsDB01609Deferasiroxapproved, investigationalunknowninducerDetailsDB00485Dicloxacillinapproved, investigational, vet_approvedunknowninducerDetailsDB06370IndisulaminvestigationalunknowninhibitorDetailsDB01083Orlistatapproved, investigationalunknowninducerDetailsDB00239OxiconazoleapprovedunknowninducerDetailsDB00082PegvisomantapprovedunknowninducerDetailsDB06762PinacidilapprovedunknownsubstrateDetailsDB01369QuinupristinapprovedunknowninhibitorDetailsDB00337Pimecrolimusapproved, investigationalunknownsubstrateDetailsDB00041AldesleukinapprovedunknowninhibitorDetailsDB06605ApixabanapprovednosubstrateDetailsDB08827Lomitapideapproved, investigationalnosubstrateDetailsDB08828Vismodegibapproved, investigationalnosubstrateDetailsDB00620Triamcinoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB08864RilpivirineapprovednosubstrateinhibitorinducerDetailsDB06209PrasugrelapprovednosubstrateDetailsDB06216AsenapineapprovedunknownsubstrateDetailsDB00435Nitric OxideapprovedunknowninhibitorDetailsDB08867UlipristalapprovednosubstrateDetailsDB08815Lurasidoneapproved, investigationalunknownsubstrateDetailsDB08870Brentuximab vedotinapproved, investigationalnosubstrateinhibitorDetailsDB04871Lorcaserinapproved, withdrawnnosubstrateDetailsDB05294VandetanibapprovedunknownsubstrateDetailsDB08873Boceprevirapproved, withdrawnunknownsubstrateinhibitorDetailsDB08875Cabozantinibapproved, investigationalnosubstrateDetailsDB08877RuxolitinibapprovedunknownsubstrateDetailsDB05812AbirateroneapprovedunknownsubstrateinhibitorDetailsDB08881VemurafenibapprovedunknownsubstrateinducerDetailsDB08882LinagliptinapprovedunknownsubstrateinhibitorDetailsDB08883PerampanelapprovednosubstrateinducerDetailsDB08865Crizotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB06626Axitinibapproved, investigationalnosubstrateDetailsDB08893MirabegronapprovednosubstrateDetailsDB06237AvanafilapprovedunknownsubstrateDetailsDB08896RegorafenibapprovedunknownsubstrateinhibitorDetailsDB08899EnzalutamideapprovednosubstrateinducerDetailsDB08895Tofacitinibapproved, investigationalnosubstrateDetailsDB06616BosutinibapprovednosubstrateinhibitorDetailsDB08901Ponatinibapproved, investigationalunknownsubstrateDetailsDB08903BedaquilineapprovednosubstrateDetailsDB06201RufinamideapprovedunknowninducerDetailsDB08906Fluticasone furoateapprovednosubstrateinhibitorinducerDetailsDB08907CanagliflozinapprovedunknownsubstrateDetailsDB06203AlogliptinapprovedunknownsubstrateDetailsDB04938Ospemifeneapproved, investigationalunknownsubstrateDetailsDB08910PomalidomideapprovedunknownsubstrateDetailsDB08911TrametinibapprovedunknownsubstrateinducerDetailsDB08912Dabrafenibapproved, investigationalnosubstrateinhibitorinducerDetailsDB05773Trastuzumab emtansineapproved, investigationalunknownsubstrateDetailsDB08833Taurochenodeoxycholic acidexperimentalunknownsubstrateDetailsDB01142Doxepinapproved, investigationalnosubstrateDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB08918Levomilnacipranapproved, investigationalunknownsubstrateDetailsDB08932MacitentanapprovednosubstrateDetailsDB08933LuliconazoleapprovednoinhibitorDetailsDB06292DapagliflozinapprovednosubstrateDetailsDB09039Eliglustatapproved, investigationalnosubstrateDetailsDB05676Apremilastapproved, investigationalnosubstrateDetailsDB09049NaloxegolapprovedunknownsubstrateDetailsDB09053IbrutinibapprovedunknownsubstrateDetailsDB00951Isoniazidapproved, investigationalunknownDetailsDB09074OlaparibapprovedunknownsubstrateinhibitorDetailsDB09078Lenvatinibapproved, investigationalnosubstrateinhibitorinducerDetailsDB09073Palbociclibapproved, investigationalnosubstrateinhibitorDetailsDB09054IdelalisibapprovednosubstrateinhibitorinducerDetailsDB09068Vortioxetineapproved, investigationalnosubstrateDetailsDB09082VilanterolapprovednosubstrateDetailsDB09083IvabradineapprovednosubstrateDetailsDB09026Aliskirenapproved, investigationalnosubstrateDetailsDB09101ElvitegravirapprovednosubstrateinhibitorDetailsDB06016Cariprazineapproved, investigationalnosubstrateinhibitorinducerDetailsDB08439ParecoxibapprovedunknownsubstrateDetailsDB09128Brexpiprazoleapproved, investigationalnosubstrateDetailsDB09291Rolapitantapproved, investigationalnosubstrateDetailsDB04908Flibanserinapproved, investigationalnosubstrateDetailsDB09102Daclatasvirapproved, investigationalunknownsubstrateDetailsDB09143Sonidegibapproved, investigationalunknownsubstrateDetailsDB06636Isavuconazoniumapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB06603Panobinostatapproved, investigationalunknownsubstrateDetailsDB05239Cobimetinibapproved, investigationalnosubstrateinhibitorDetailsDB09570Ixazomibapproved, investigationalunknownsubstrateDetailsDB09330OsimertinibapprovednosubstrateinhibitorinducerDetailsDB11362SelexipagapprovednosubstrateDetailsDB09119Eslicarbazepine acetateapprovednoinducerDetailsDB06789Hydroxyprogesterone caproateapproved, investigationalunknownsubstrateDetailsDB08931RiociguatapprovedunknownsubstrateDetailsDB09183DasabuvirapprovednosubstrateDetailsDB09297Paritaprevirapproved, investigationalnosubstrateDetailsDB09317Synthetic Conjugated Estrogens, AapprovednosubstrateDetailsDB09318Synthetic Conjugated Estrogens, BapprovednosubstrateDetailsDB09389NorgestrelapprovedunknownsubstrateDetailsDB11581Venetoclaxapproved, investigationalnosubstrateinhibitorDetailsDB09280LumacaftorapprovednoinducerDetailsDB01323St. John's Wortapproved, investigational, nutraceuticalunknownsubstrateinduceractivatorDetailsDB09381Esterified estrogensapprovedunknownsubstrateDetailsDB00957Norgestimateapproved, investigationalunknownsubstrateinducerDetailsDB04911Oritavancinapproved, investigationalunknowninhibitorinducerDetailsDB06717FosaprepitantapprovedunknownsubstrateinhibitorinducerDetailsDB00648MitotaneapprovedunknowninducerDetailsDB08909Glycerol phenylbutyrateapprovedunknowninducerDetailsDB09048Netupitantapproved, investigationalnosubstrateinhibitorDetailsDB12332Rucaparibapproved, investigationalnosubstrateinhibitorDetailsDB11921Deflazacortapproved, investigationalnosubstrateinducerDetailsDB11737Icotinibexperimental, investigationalunknownsubstrateDetailsDB06654Safinamideapproved, investigationalunknownsubstrateDetailsDB12161Deutetrabenazineapproved, investigationalnosubstrateDetailsDB09555Dexchlorpheniramine maleateapprovedunknownsubstrateDetailsDB11613Velpatasvirapproved, investigationalnosubstrateDetailsDB05541Brivaracetamapproved, investigationalnosubstrateDetailsDB11915Valbenazineapproved, investigationalnosubstrateDetailsDB06670OdanacatibinvestigationalnosubstrateDetailsDB05351Dexlansoprazoleapproved, investigationalunknownsubstrateDetailsDB06290SimeprevirapprovedunknownsubstrateinhibitorDetailsDB11575GrazoprevirapprovednosubstrateinhibitorDetailsDB11943Delafloxacinapproved, investigationalunknowninducerDetailsDB01685TopiroxostatexperimentalunknowninhibitorDetailsDB08922PerospironeexperimentalunknownsubstrateDetailsDB09118StiripentolapprovedunknownsubstrateinhibitorinducerDetailsDB09166EtizolamexperimentalunknownsubstrateDetailsDB11614RupatadineapprovednosubstrateDetailsDB09262ImidafenacininvestigationalnosubstrateDetailsDB00143Glutathioneapproved, investigational, nutraceuticalunknownDetailsDB09238Manidipineapproved, investigationalunknownsubstrateinhibitorDetailsDB09123DienogestapprovedunknownsubstrateDetailsDB11828Neratinibapproved, investigationalunknownsubstrateDetailsDB12026Voxilaprevirapproved, investigationalnosubstrateDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB06412Oxymetholoneapproved, illicitunknowninhibitorDetailsDB00503Ritonavirapproved, investigationalunknownsubstrateinhibitorDetailsDB06595Midostaurinapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB11574ElbasvirapprovedunknownsubstrateDetailsDB12483Copanlisibapproved, investigationalnosubstrateDetailsDB11767Sarilumabapproved, investigationalnoinhibitorinducerDetailsDB12001Abemaciclibapproved, investigationalunknownsubstrateinhibitorDetailsDB12267Brigatinibapproved, investigationalnosubstrateDetailsDB11817Baricitinibapproved, investigationalunknownsubstrateDetailsDB13074Macimorelinapproved, investigationalunknownsubstrateDetailsDB09223BlonanserininvestigationalnosubstrateDetailsDB09236Lacidipineapproved, investigationalunknownsubstrateDetailsDB09061Cannabidiolapproved, investigationalunknownsubstrateinhibitorDetailsDB13943Testosterone cypionateapprovedunknownsubstrateinhibitorinducerDetailsDB13944Testosterone enanthateapprovedunknownsubstrateinhibitorinducerDetailsDB13946Testosterone undecanoateapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13941Piperaquineapproved, experimental, investigationalunknownsubstrateinhibitorDetailsDB01420Testosterone propionateapproved, investigational, vet_approved, withdrawnnosubstrateDetailsDB09195LorpiprazoleapprovednosubstrateDetailsDB11799Bictegravirapproved, investigationalunknownsubstrateDetailsDB11901Apalutamideapproved, investigationalnosubstrateinducerDetailsDB09225Zotepineapproved, investigational, withdrawnnosubstrateDetailsDB09230AzelnidipineinvestigationalunknownsubstrateDetailsDB09231BenidipineexperimentalnosubstrateinhibitorDetailsDB09235EfonidipineexperimentalunknownsubstrateinhibitorDetailsDB11642Pitolisantapproved, investigationalunknownsubstrateinducerDetailsDB11633Isavuconazoleapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB09237Levamlodipineapproved, investigationalunknownsubstrateDetailsDB11712Tezacaftorapproved, investigationalnosubstrateinhibitorinducerDetailsDB11130Opiumapproved, illicitnosubstrateDetailsDB11251Tocopherolapproved, investigationalnosubstrateDetailsDB14003alpha-Tocopherol acetateapprovednosubstrateDetailsDB11586Asunaprevirapproved, investigational, withdrawnnosubstrateinducerDetailsDB13975Black cohoshexperimentalnoinhibitorDetailsDB12278Propiverineapproved, investigationalnosubstrateDetailsDB14011NabiximolsinvestigationalunknownsubstrateDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorDetailsDB11641Vinflunineapproved, investigationalnosubstrateDetailsDB11635TocofersolanapprovednosubstrateDetailsDB11637Delamanidapproved, investigationalnosubstrateDetailsDB13746Bioallethrinapproved, experimentalnosubstrateDetailsDB14019FosnetupitantapprovedunknownsubstrateinhibitorDetailsDB12010Fostamatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB01049Ergoloid mesylateapprovednosubstrateDetailsDB11274Dihydro-alpha-ergocryptineapprovednosubstrateDetailsDB13293Ipecacapproved, withdrawnnosubstrateDetailsDB11198Peppermint oilapproved, investigationalunknowninhibitorDetailsDB13456MidecamycinexperimentalnosubstrateinhibitorDetailsDB12532Oxetacaineapproved, investigationalnoinhibitorDetailsDB11672Curcuminapproved, investigationalunknowninhibitorDetailsDB11779DanoprevirinvestigationalnoinhibitorDetailsDB09289TianeptineinvestigationalnosubstrateDetailsDB01357MestranolapprovednosubstrateDetailsDB04829Lysergic acid diethylamideillicit, investigational, withdrawnnosubstrateDetailsDB00247MethysergideapprovednosubstrateDetailsDB13399TergurideexperimentalnosubstrateDetailsDB14185Aripiprazole lauroxilapproved, investigationalunknownsubstrateDetailsDB11718Encorafenibapproved, investigationalnosubstrateinhibitorinducerDetailsDB14538Hydrocortisone aceponateexperimental, vet_approvedunknownsubstrateinducerDetailsDB14539Hydrocortisone acetateapproved, vet_approvedunknownsubstrateinducerDetailsDB14540Hydrocortisone butyrateapproved, vet_approvedunknownsubstrateinducerDetailsDB14541Hydrocortisone cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB14542Hydrocortisone phosphateapproved, vet_approvedunknownsubstrateDetailsDB14543Hydrocortisone probutateapproved, vet_approvedunknownsubstrateinducerDetailsDB14544Hydrocortisone valerateapproved, vet_approvedunknownsubstrateinducerDetailsDB14568Ivosidenibapproved, investigationalunknownsubstrateinducerDetailsDB126293,5-diiodothyropropionic acidinvestigationalnosubstrateDetailsDB014565-androstenedioneexperimental, illicitnosubstrateDetailsDB00240AlclometasoneapprovednosubstrateDetailsDB04630Aldosteroneexperimental, investigationalnosubstrateDetailsDB00288AmcinonideapprovednosubstrateinducerDetailsDB01536Androstenedioneexperimental, illicitnosubstrateDetailsDB00394Beclomethasone dipropionateapproved, investigationalnosubstrateinducerDetailsDB11750Clobetasolapproved, experimental, investigationalnosubstrateinducerDetailsDB01013Clobetasol propionateapprovednosubstrateinducerDetailsDB13158ClobetasoneapprovednosubstrateDetailsDB04652CorticosteroneexperimentalnosubstrateDetailsDB01285Corticotropinapproved, investigational, vet_approvednosubstrateinducerDetailsDB04839Cyproterone acetateapproved, investigationalnosubstrateinhibitorDetailsDB11636NomegestrolapprovednosubstrateDetailsDB13981Nomegestrol acetateapproved, investigationalnosubstrateDetailsDB00304DesogestrelapprovednosubstrateDetailsDB01260Desonideapproved, investigationalnosubstrateinducerDetailsDB06780Desoxycorticosterone acetateapprovednosubstrateDetailsDB01134Desoxycorticosterone pivalateexperimental, vet_approvednosubstrateDetailsDB11487Dexamethasone isonicotinatevet_approvednosubstrateinhibitorinducerDetailsDB09095Difluocortoloneapproved, investigational, withdrawnnosubstrateinducerDetailsDB06781DifluprednateapprovednosubstrateDetailsDB00378Dydrogesteroneapproved, investigational, withdrawnnosubstrateDetailsDB03515EquileninexperimentalnosubstrateDetailsDB02187EquilinexperimentalnosubstrateDetailsDB13866EtynodiolexperimentalnosubstrateDetailsDB00823Ethynodiol diacetateapprovednosubstrateDetailsDB00687Fludrocortisoneapproved, investigationalunknownsubstrateDetailsDB00663Flumethasoneapproved, vet_approvednosubstrateDetailsDB00591Fluocinolone acetonideapproved, investigational, vet_approvednosubstrateinducerDetailsDB01047Fluocinonideapproved, investigationalnosubstrateinducerDetailsDB08971Fluocortoloneapproved, withdrawnnosubstrateinducerDetailsDB08970FluprednideneexperimentalnosubstrateinducerDetailsDB09378FluprednisoloneapprovednosubstrateDetailsDB00846FlurandrenolideapprovednosubstrateDetailsDB13867Fluticasoneapproved, experimentalnosubstrateinhibitorinducerDetailsDB08905Formestaneapproved, investigational, withdrawnnoinducerDetailsDB06730GestodeneinvestigationalnosubstrateinhibitorDetailsDB11619GestrinoneapprovednosubstrateDetailsDB06786Halcinonideapproved, investigational, withdrawnnosubstrateDetailsDB05212HE3286investigationalnosubstrateDetailsDB14545Hydrocortisone succinateapprovedunknownsubstrateinducerDetailsDB14570HydroxyprogesteroneexperimentalnosubstrateDetailsDB01583LiotrixapprovednosubstrateDetailsDB14596Loteprednol etabonateapprovedunknownsubstrateDetailsDB12474Lynestrenolapproved, investigationalnosubstrateDetailsDB09124Medrogestoneapproved, withdrawnnosubstrateDetailsDB00253MedrysoneapprovednosubstrateinducerDetailsDB00351Megestrol acetateapproved, investigational, vet_approvednosubstrateDetailsDB11529Melengestrolvet_approvednosubstrateDetailsDB09383Meprednisoneapproved, investigationalnosubstrateinducerDetailsDB00764MometasoneexperimentalnosubstrateinducerDetailsDB14512Mometasone furoateapproved, investigational, vet_approvednosubstrateinducerDetailsDB06713Norelgestrominapproved, investigationalnosubstrateDetailsDB09371NorethynodrelapprovednosubstrateDetailsDB01130Prednicarbateapproved, investigationalnosubstrateDetailsDB13208PrednylideneexperimentalnosubstrateinducerDetailsDB02789Pregnenoloneapproved, experimentalnosubstrateDetailsDB13602PromegestoneexperimentalnosubstrateDetailsDB00896RimexoloneapprovednosubstrateinducerDetailsDB01117AtovaquoneapprovednosubstrateDetailsDB11753Rifamycinapproved, investigationalnoinhibitorinducerDetailsDB13528ChlormadinoneexperimentalnosubstrateDetailsDB13857DemegestoneexperimentalnosubstrateDetailsDB13685QuingestanolexperimentalnosubstrateDetailsDB14055(S)-Warfarinexperimental, investigationalnosubstrateDetailsDB13347DiphenadioneexperimentalnosubstrateDetailsDB08794Ethyl biscoumacetatewithdrawnunknownsubstrateDetailsDB01483BarbitalillicitnoinducerDetailsDB01154Thiamylalapproved, vet_approvednosubstrateinducerDetailsDB09229AranidipineexperimentalnosubstrateDetailsDB09227BarnidipineexperimentalnosubstrateinhibitorDetailsDB13488BencyclaneexperimentalnosubstrateDetailsDB01244Bepridilapproved, withdrawnnosubstrateDetailsDB08838AgmatineexperimentalnosubstrateDetailsDB11960CarboxyamidotriazoleinvestigationalnosubstrateDetailsDB13835CaroverineexperimentalnosubstrateDetailsDB09232CilnidipineinvestigationalnosubstrateDetailsDB00568Cinnarizineapproved, investigationalnosubstrateDetailsDB04838CyclandelateapprovednosubstrateDetailsDB09234DarodipineexperimentalnosubstrateDetailsDB14068DexniguldipineexperimentalnosubstrateDetailsDB14063DexverapamilexperimentalnosubstrateDetailsDB06446DotarizineinvestigationalnosubstrateDetailsDB14064EmopamilexperimentalnosubstrateDetailsDB08992EperisoneinvestigationalnosubstrateDetailsDB08980FendilinewithdrawnnosubstrateDetailsDB13961Fish oilapproved, nutraceuticalnosubstrateDetailsDB04841FlunarizineapprovednosubstrateDetailsDB04842Fluspirileneapproved, investigationalnosubstrateDetailsDB12923GallopamilinvestigationalnosubstrateDetailsDB13766Lidoflazineapproved, experimentalnosubstrateDetailsDB14065LomerizineexperimentalnosubstrateDetailsDB00825LevomentholapprovednosubstrateDetailsDB12092NaftopidilinvestigationalnosubstrateDetailsDB09239NiguldipineexperimentalnosubstrateDetailsDB09240NiludipineexperimentalnosubstrateDetailsDB04743Nimesulideapproved, investigational, withdrawnnosubstrateDetailsDB06152NylidrinapprovednosubstrateDetailsDB13500Otiloniumexperimental, investigationalnosubstrateDetailsDB13791PenfluridolexperimentalnosubstrateDetailsDB09090PinaveriumapprovednosubstrateDetailsDB04825Prenylamineapproved, withdrawnnosubstrateDetailsDB13725TerodilineexperimentalnosubstrateDetailsDB12093TetrahydropalmatineinvestigationalnosubstrateDetailsDB14066TetrandrineexperimentalnosubstrateDetailsDB09216Tolfenamic acidapproved, investigationalnosubstrateDetailsDB07615TranilastinvestigationalnosubstrateDetailsDB09089TrimebutineapprovednosubstrateDetailsDB05885SeletracetaminvestigationalnosubstrateDetailsDB12131VinpocetineinvestigationalnosubstrateDetailsDB13950WIN 55212-2experimentalnosubstrateinhibitorDetailsDB040706-Deoxyerythronolide BexperimentalnoinhibitorDetailsDB06318AVE9633investigationalnoinhibitorDetailsDB07348Brefeldin AexperimentalnoinhibitorDetailsDB11752Bryostatin 1investigationalnoinhibitorDetailsDB01152Candicidinapproved, withdrawnnoinhibitorDetailsDB11383Carbomycinvet_approvednoinhibitorDetailsDB06419CethromycininvestigationalnosubstrateinhibitorDetailsDB06342Coltuximab ravtansineinvestigationalnoinhibitorDetailsDB00954DirithromycinexperimentalnoinhibitorDetailsDB11400Doramectinvet_approvednoinhibitorDetailsDB12266EpofolateinvestigationalnoinhibitorDetailsDB01873Epothilone DinvestigationalnoinhibitorDetailsDB11405Eprinomectinvet_approvednoinhibitorDetailsDB13338FlurithromycinexperimentalnoinhibitorDetailsDB05814GPI-1485investigationalnoinhibitorDetailsDB09309KitasamycinexperimentalnoinhibitorDetailsDB05903KOS-1584investigationalnoinhibitorDetailsDB12089Lorvotuzumab mertansineinvestigationalnoinhibitorDetailsDB13287MiocamycinapprovednoinhibitorDetailsDB12489Mirvetuximab soravtansineapproved, investigationalnosubstrateinhibitorDetailsDB06587MitemcinalinvestigationalnoinhibitorDetailsDB11442Oleandomycinvet_approvednoinhibitorDetailsDB03010Patupiloneexperimental, investigationalnoinhibitorDetailsDB06233RidaforolimusinvestigationalnoinhibitorDetailsDB13409RokitamycinexperimentalnoinhibitorDetailsDB12391SagopiloneinvestigationalnoinhibitorDetailsDB11459Selamectinvet_approvednoinhibitorDetailsDB09308SolithromycininvestigationalnoinhibitorDetailsDB11470Tildipirosinvet_approvednoinhibitorDetailsDB01241GemfibrozilapprovedunknownsubstrateDetailsDB06791LanreotideapprovednoinhibitorDetailsDB00104Octreotideapproved, investigationalnoinhibitorDetailsDB06663PasireotideapprovednoinhibitorDetailsDB09099Somatostatinapproved, investigationalnoinhibitorDetailsDB04894Vapreotideexperimental, investigationalnoinhibitorDetailsDB12781BalaglitazoneinvestigationalnosubstrateDetailsDB09201CiglitazoneexperimentalnosubstrateDetailsDB09198LobeglitazoneexperimentalnosubstrateDetailsDB09199NetoglitazoneexperimentalnosubstrateDetailsDB09200Rivoglitazoneexperimental, investigationalnosubstrateDetailsDB00412Rosiglitazoneapproved, investigationalnosubstrateinducerDetailsDB09063CeritinibapprovednosubstrateinhibitorDetailsDB06469LestaurtinibinvestigationalnoinhibitorDetailsDB11805SaracatinibinvestigationalnoinhibitorDetailsDB11703Acalabrutinibapproved, investigationalunknownsubstrateinhibitorDetailsDB01267PaliperidoneapprovedunknownsubstrateDetailsDB01645GenisteininvestigationalunknowninducerDetailsDB05928DovitinibinvestigationalunknowninhibitorDetailsDB08496(R)-warfarinexperimentalunknownsubstrateDetailsDB119196-O-benzylguanineinvestigationalnosubstrateDetailsDB14583Segesterone acetateapproved, experimental, investigationalunknownsubstrateDetailsDB00563MethotrexateapprovednosubstrateDetailsDB04884DapoxetineinvestigationalnosubstrateinhibitorDetailsDB08953Indalpineinvestigational, withdrawnnosubstrateinhibitorDetailsDB00715Paroxetineapproved, investigationalnosubstrateinhibitorDetailsDB04832Zimelidineapproved, withdrawnnoinhibitorDetailsDB04896Milnacipranapproved, investigationalnosubstrateinhibitorDetailsDB02703Fusidic acidapproved, investigationalunknownsubstrateinhibitorDetailsDB11730Ribociclibapproved, investigationalnosubstrateinhibitorDetailsDB09079NintedanibapprovednosubstrateDetailsDB14634Fluprednidene acetateexperimentalnoinducerDetailsDB14637Fluprednisolone acetateexperimentalnosubstrateDetailsDB01656RoflumilastapprovednosubstrateDetailsDB09034Suvorexantapproved, investigationalnosubstrateDetailsDB09071Tasimelteonapproved, investigationalnosubstrateDetailsDB09030VorapaxarapprovednosubstrateDetailsDB01624Zuclopenthixolapproved, investigationalnosubstrateDetailsDB13385DihydroergocryptineexperimentalnosubstrateDetailsDB11273DihydroergocornineapprovednosubstrateDetailsDB13345Dihydroergocristineapproved, experimentalnosubstrateDetailsDB06218LacosamideapprovednosubstrateDetailsDB12329Eravacyclineapproved, investigationalunknownsubstrateDetailsDB06458RemacemideinvestigationalnoinhibitorDetailsDB08874FidaxomicinapprovednoinhibitorDetailsDB11742Ebastineapproved, investigationalnosubstrateDetailsDB09036Siltuximabapproved, investigationalnoinducerDetailsDB06273TocilizumabapprovednoinducerDetailsDB12301Doravirineapproved, investigationalunknownsubstrateDetailsDB11952Duvelisibapproved, investigationalnosubstrateDetailsDB13997Baloxavir marboxilapproved, investigationalnosubstrateinhibitorDetailsDB00186LorazepamapprovednosubstrateDetailsDB125159-aminocamptothecininvestigationalnosubstrateDetailsDB12952Methylprednisoneapproved, investigationalnosubstrateDetailsDB04861Nebivololapproved, investigationalunknownsubstrateDetailsDB11963Dacomitinibapproved, investigationalnosubstrateDetailsDB12141Gilteritinibapproved, investigationalnosubstrateDetailsDB14723Larotrectinibapproved, investigationalunknownsubstrateDetailsDB125371,2-Benzodiazepineapproved, investigationalunknownsubstrateDetailsDB09017Brotizolaminvestigational, withdrawnunknownsubstrateDetailsDB11094Vitamin Dapproved, nutraceutical, vet_approvednosubstrateDetailsDB01352Aprobarbitalexperimental, illicitunknowninducerDetailsDB00590DoxazosinapprovednosubstrateDetailsDB05482SN-38investigationalunknownsubstrateinhibitorDetailsDB06480PrucaloprideapprovednosubstrateDetailsDB11978Glasdegibapproved, investigationalunknownsubstrateDetailsDB12582PiperineinvestigationalunknowninhibitorDetailsDB00191Phentermineapproved, illicitnosubstrateDetailsDB12245Triclabendazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00264Metoprololapproved, investigationalnosubstrateDetailsDB11823Esketamineapproved, investigationalunknownsubstrateinducerDetailsDB00163Vitamin Eapproved, nutraceutical, vet_approvedunknownsubstrateinducerDetailsDB12371Siponimodapproved, investigationalunknownsubstrateDetailsDB12147Erdafitinibapproved, investigationalnosubstrateinhibitorinducerDetailsDB09299Tenofovir alafenamideapprovednosubstrateDetailsDB00982IsotretinoinapprovedunknownsubstrateDetailsDB12015Alpelisibapproved, investigationalunknownsubstrateDetailsDB12240Polatuzumab vedotinapproved, investigationalnosubstrateDetailsDB00905Bimatoprostapproved, investigationalunknownsubstrateDetailsDB11942Selinexorapproved, investigationalunknownsubstrateDetailsDB14669Betamethasone phosphateapproved, vet_approvedunknownsubstrateinducerDetailsDB14652Clocortolone acetateexperimentalunknowninducerDetailsDB13843CloprednolexperimentalunknowninducerDetailsDB14681CortisoneexperimentalunknowninducerDetailsDB13003CortivazolinvestigationalunknowninducerDetailsDB13728HalometasoneexperimentalunknowninducerDetailsDB14659Melengestrol acetateexperimentalunknowninducerDetailsDB14644Methylprednisolone hemisuccinateapprovedunknowninducerDetailsDB14633Prednisolone hemisuccinateexperimentalunknowninducerDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknownsubstrateinducerDetailsDB14646Prednisone acetateapproved, experimental, investigationalunknowninducerDetailsDB02520DitiocarbexperimentalunknowninhibitorDetailsDB06731SeproxetineinvestigationalunknowninhibitorDetailsDB00627Niacinapproved, investigational, nutraceuticalunknowninhibitorDetailsDB06282LevocetirizineapprovedunknownsubstrateDetailsDB09173ButyrfentanylillicitunknownsubstrateDetailsDB12978Pexidartinibapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB01551Dihydrocodeineapproved, illicitunknownsubstrateDetailsDB05154PretomanidapprovedunknownsubstrateDetailsDB01395DrospirenoneapprovedunknownsubstrateDetailsDB01611HydroxychloroquineapprovedunknownsubstrateDetailsDB11986Entrectinibapproved, investigationalunknownsubstrateDetailsDB12500Fedratinibapproved, investigationalunknownsubstrateDetailsDB12825Lefamulinapproved, investigationalunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknownsubstrateDetailsDB01319FosamprenavirapprovedunknownsubstrateinhibitorDetailsDB01050IbuprofenapprovednosubstrateDetailsDB15489MexazolamexperimentalunknownsubstrateDetailsDB00334Olanzapineapproved, investigationalunknowninhibitorDetailsDB09288PropacetamolexperimentalunknownsubstrateinducerDetailsDB01233Metoclopramideapproved, investigationalunknownsubstrateDetailsDB11761Tenapanorapproved, investigationalunknownsubstrateDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB14600Edetate disodium anhydrousapproved, vet_approvedunknowninhibitorDetailsDB01217Anastrozoleapproved, investigationalunknownsubstrateinhibitorDetailsDB14575EslicarbazepineapprovedunknowninducerDetailsDB12808Trifaroteneapproved, investigationalunknownsubstrateDetailsDB15444Elexacaftorapproved, investigationalnosubstrateinhibitorDetailsDB15566Prednisolone acetateapproved, vet_approvedunknownsubstrateinducerDetailsDB00557HydroxyzineapprovednosubstrateDetailsDB14240Echinaceaapproved, experimentalunknowninducerDetailsDB11560Lesinuradapproved, investigationalunknowninducerDetailsDB15035Zanubrutinibapproved, investigationalnosubstrateDetailsDB01381Ginkgo bilobaapproved, investigational, nutraceuticalunknowninhibitorinducerDetailsDB13879Glecaprevirapproved, investigationalunknowninhibitorDetailsDB14975Voxelotorapproved, investigationalunknownsubstrateDetailsDB00717NorethisteroneapprovedunknownsubstrateDetailsDB06119Cenobamateapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB13007Enfortumab vedotinapproved, investigationalunknownsubstrateDetailsDB14962Trastuzumab deruxtecanapproved, investigationalunknownsubstrateDetailsDB11951Lemborexantapproved, investigationalunknownsubstrateDetailsDB12941Darolutamideapproved, investigationalunknownsubstrateDetailsDB06077Lumateperoneapproved, investigationalnosubstrateDetailsDB15091Upadacitinibapproved, investigationalnosubstrateDetailsDB15328Ubrogepantapproved, investigationalunknownsubstrateDetailsDB15233Avapritinibapproved, investigationalunknownsubstrateDetailsDB12887Tazemetostatapproved, investigationalunknownsubstrateDetailsDB12457Rimegepantapproved, investigationalnosubstrateinhibitorDetailsDB13609UmifenovirinvestigationalunknownsubstrateDetailsDB11837Osilodrostatapproved, investigationalunknownsubstrateinhibitorDetailsDB14678Norethindrone enanthateexperimentalunknownsubstrateDetailsDB09241Methylene blueapproved, investigationalunknowninhibitorDetailsDB12612Ozanimodapproved, investigationalunknownsubstrateDetailsDB14598Edetate calcium disodium anhydrousapprovedunknowninhibitorDetailsDB11689Selumetinibapproved, investigationalnosubstrateDetailsDB15102Pemigatinibapproved, investigationalnosubstrateDetailsDB14761Remdesivirapproved, investigationalunknownsubstrateinhibitorDetailsDB11791Capmatinibapproved, investigationalunknownsubstrateDetailsDB15685Selpercatinibapproved, investigationalunknownsubstrateDetailsDB14840RipretinibapprovedunknownsubstrateDetailsDB00714Apomorphineapproved, investigationalunknownDetailsDB12674Lurbinectedinapproved, investigationalunknownsubstrateDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB05015Belinostatapproved, investigationalunknownsubstrateDetailsDB11796Fostemsavirapproved, investigationalunknownsubstrateDetailsDB11932Abametapirapproved, investigationalnoinhibitorDetailsDB15305Risdiplamapproved, investigationalunknownsubstrateDetailsDB14881Oliceridineapproved, investigationalnosubstrateDetailsDB12499Clascoteroneapproved, investigationalnoinhibitorDetailsDB15822Pralsetinibapproved, investigationalnosubstrateinhibitorinducerDetailsDB06448Lonafarnibapproved, investigationalunknownsubstrateinhibitorDetailsDB15982BerotralstatapprovednoinhibitorDetailsDB06137Tirbanibulinapproved, investigationalnosubstrateinhibitorDetailsDB14895Vibegronapproved, investigationalnosubstrateDetailsDB00475Chlordiazepoxideapproved, illicit, investigationalunknownsubstrateDetailsDB00752Tranylcypromineapproved, investigationalunknowninhibitorDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB05667Levoketoconazoleapproved, investigationalnosubstrateinhibitorinducerDetailsDB00476DuloxetineapprovedunknowninhibitorDetailsDB11693Voclosporinapproved, investigationalunknownsubstrateinhibitorDetailsDB15133Tepotinibapproved, investigationalnosubstrateinhibitorDetailsDB00747Scopolamineapproved, investigationalnosubstrateDetailsDB00330EthambutolapprovedunknowninhibitorDetailsDB14989Umbralisibapproved, investigational, withdrawnunknownsubstrateDetailsDB14984Casimersenapproved, investigationalnoinhibitorDetailsDB00545Pyridostigmineapproved, investigationalnoinducerDetailsDB11800Tivozanibapproved, investigationalunknownsubstrateDetailsDB12016Ponesimodapproved, investigationalunknownsubstrateDetailsDB08995Diosminapproved, investigationalunknowninhibitorDetailsDB05316Pimavanserinapproved, investigationalunknownsubstrateDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownsubstrateDetailsDB12235Estetrolapproved, investigationalunknownsubstrateDetailsDB16222Loncastuximab tesirineapproved, investigationalunknownDetailsDB11886Infigratinibapproved, investigationalnosubstrateDetailsDB12471Ibrexafungerpapproved, investigationalunknownsubstrateinhibitorDetailsDB12543Samidorphanapproved, investigationalnosubstrateDetailsDB16165Finerenoneapproved, investigationalunknownsubstrateDetailsDB16703Belumosudilapproved, investigationalnosubstrateDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB15463Belzutifanapproved, investigationalnosubstrateDetailsDB12265Fexinidazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB16390Mobocertinibapproved, investigationalunknownsubstrateDetailsDB16732Tisotumab vedotinapprovednosubstrateDetailsDB16098Atogepantapproved, investigationalnosubstrateDetailsDB16226Maralixibatapproved, investigationalnoinhibitorDetailsDB15011Avacopanapproved, investigationalnosubstrateinhibitorinducerDetailsDB12597Asciminibapproved, investigationalnosubstrateinhibitorDetailsDB06234Maribavirapproved, investigationalnosubstrateDetailsDB16691Nirmatrelvirapproved, investigationalnosubstrateinhibitorDetailsDB15031DaridorexantapprovednosubstrateDetailsDB12713Sotagliflozinapproved, investigationalnosubstrateinhibitorinducerDetailsDB14973Abrocitinibapproved, investigationalnosubstrateDetailsDB05467Palovaroteneapproved, investigationalnosubstrateinducerDetailsDB16236Mitapivatapproved, investigationalnosubstrateinducerDetailsDB12834SecnidazoleapprovedunknownsubstrateinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknownsubstrateinhibitorDetailsDB00486Nabiloneapproved, investigationalunknownsubstrateinhibitorDetailsDB06230Nalmefeneapproved, investigational, withdrawnnosubstrateDetailsDB11697Pacritinibapproved, investigationalnosubstrateinhibitorinducerDetailsDB05087Ganaxoloneapproved, investigationalnosubstrateDetailsDB01041Thalidomideapproved, investigational, withdrawnnosubstrateinducerDetailsDB14921Mavacamtenapproved, investigationalnosubstrateinducerDetailsDB09185Viloxazineapproved, investigational, withdrawnnoinhibitorDetailsDB00951Isoniazidapproved, investigationalunknowninhibitorDetailsDB12020Tecovirimatapproved, investigationalnoinducerDetailsDB06083Tapinarofapproved, investigationalnosubstrateDetailsDB01024Mycophenolic acidapproved, investigationalunknownsubstrateDetailsDB10534GrapefruitapprovedunknowninhibitorDetailsDB04951Pirfenidoneapproved, investigationalunknowninhibitorDetailsDB15673Lenacapavirapproved, investigationalnosubstrateinhibitorDetailsDB12095Telotristat ethylapproved, investigationalnoinhibitorinducerDetailsDB15149Futibatinibapproved, investigationalnosubstrateDetailsDB17083LinzagolixapprovednosubstrateDetailsDB11739Vonoprazanapproved, investigationalunknownsubstrateDetailsDB09065CobicistatapprovedyesinhibitorDetailsDB16267Olutasidenibapproved, investigationalnosubstrateinducerDetailsDB15568Adagrasibapproved, investigationalunknownsubstrateinhibitorDetailsDB12236Bexagliflozinapproved, investigationalunknownsubstrateDetailsDB17472Pirtobrutinibapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB06374Elacestrantapproved, investigationalunknownsubstrateDetailsDB11682Daprodustatapproved, investigationalnosubstrateDetailsDB09065CobicistatapprovednosubstrateDetailsDB12548Sparsentanapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB12513Omaveloxoloneapproved, investigationalunknownsubstrateinducerDetailsDB15688Zavegepantapproved, investigationalunknownsubstrateDetailsDB06045Trofinetideapproved, investigationalunknowninhibitorDetailsDB16217Leniolisibapproved, investigationalnosubstrateDetailsDB12255Vadadustatapproved, investigationalunknowndownregulatorDetailsDB14924Ritlecitinibapproved, investigationalunknownsubstrateinhibitorDetailsDB12874Quizartinibapproved, investigationalnosubstrateDetailsDB15490Zuranoloneapproved, experimentalnosubstrateDetailsDB11763Momelotinibapproved, investigationalunknownsubstrateDetailsDB12184GepironeinvestigationalnosubstrateDetailsDB14766EtrasimodapprovednosubstrateDetailsDB15114Vamoroloneapproved, investigationalnosubstrateinducerDetailsDB12218Capivasertibapproved, investigationalnosubstrateDetailsDB16826RepotrectinibinvestigationalnosubstrateinhibitorinducerDetailsDB11679FruquintinibinvestigationalnosubstrateDetailsDB00176Fluvoxamineapproved, investigationalunknowninhibitorDetailsDB00599Thiopentalapproved, vet_approvedunknownsubstrateDetailsDB08930DolutegravirapprovednosubstrateDetailsDB06595Midostaurinapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB13174RheinexperimentalunknowninhibitorDetailsDB11994Diacereinapproved, investigationalunknowninhibitorDetailsDB11605MyrrhapprovedunknowninducerDetailsDB11691Naldemedineapproved, investigationalnosubstrateDetailsDB13878Pibrentasvirapproved, investigationalunknowninhibitorDetailsDB13879Glecaprevirapproved, investigationalunknownsubstrateinhibitorDetailsDB09205Moxisylyteapproved, investigationalnosubstrateDetailsDB09568Omega-3-carboxylic acidsapproved, investigationalnosubstrateDetailsDB01601LopinavirapprovednoinhibitorDetailsDB01149Nefazodoneapproved, withdrawnnoinhibitorDetailsDB13141Ambroxol acefyllinateexperimental, investigationalnosubstrateDetailsDB11792MirodenafilinvestigationalunknownsubstrateDetailsDB11979Elagolixapproved, investigationalnosubstrateDetailsDB08865Crizotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB11703Acalabrutinibapproved, investigationalunknownsubstrateDetailsDB12267Brigatinibapproved, investigationalunknowninducerDetailsDB12307ForetinibinvestigationalunknownsubstrateDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB00593EthosuximideapprovedunknownsubstrateDetailsDB01201Rifapentineapproved, investigationalunknowninducerDetailsDB00643Mebendazoleapproved, vet_approvedunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknowninhibitorDetailsDB00334Olanzapineapproved, investigationalunknowninhibitorDetailsDB09212LoxoprofenapprovedunknownsubstrateDetailsDB00635Prednisoneapproved, vet_approvedunknowninducerDetailsDB01222BudesonideapprovedunknownsubstrateinducerDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB11951Lemborexantapproved, investigationalunknowninhibitorinducerDetailsDB12887Tazemetostatapproved, investigationalunknownsubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninducerDetailsDB11652Tucatinibapproved, investigationalunknownsubstrateDetailsDB15035Zanubrutinibapproved, investigationalunknownsubstrateDetailsDB15685Selpercatinibapproved, investigationalunknowninhibitorDetailsDB00409Remoxiprideapproved, withdrawnunknowninhibitorDetailsDB15305Risdiplamapproved, investigationalunknowninhibitorDetailsDB06448Lonafarnibapproved, investigationalnosubstrateinhibitorDetailsDB11853Relugolixapproved, investigationalunknownsubstrateinducerDetailsDB01586Ursodeoxycholic acidapproved, investigationalunknowninducerDetailsDB11742Ebastineapproved, investigationalunknownsubstrateDetailsDB15569Sotorasibapproved, investigationalunknownsubstrateDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB00647Dextropropoxypheneapproved, illicit, investigational, withdrawnunknowninhibitorDetailsDB00333MethadoneapprovednoinhibitorDetailsDB01167Itraconazoleapproved, investigationalnoinhibitorDetailsDB16536Birch bark extractapproved, experimentalunknowninhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateinhibitorDetails"
                    }
                },
                {
                    "Label": "Cytochrome P450 2D6",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 2D6",
                        "Synonyms": "1.14.14.1\nCholesterol 25-hydroxylase\nCYP2DL1\nCYPIID6\nCytochrome P450-DB1\nDebrisoquine 4-hydroxylase",
                        "Gene Name": "CYP2D6",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0004641|Cytochrome P450 2D6\nMGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVDFQNTPYCFDQ\nLRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVF\nLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDK\nAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKV\nLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVA\nDLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVI\nHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHF\nLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGV\nFAFLVSPSPYELCAVPR",
                        "Number of residues": "497",
                        "Molecular Weight": "55768.94",
                        "Theoretical pI": "7.26",
                        "GO Classification": "Functionsarachidonic acid epoxygenase activity / aromatase activity / drug binding / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity / oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen / oxygen binding / steroid hydroxylase activityProcessesalkaloid catabolic process / alkaloid metabolic process / arachidonic acid metabolic process / coumarin metabolic process / drug catabolic process / drug metabolic process / exogenous drug catabolic process / heterocycle metabolic process / isoquinoline alkaloid metabolic process / monoterpenoid metabolic process / negative regulation of binding / negative regulation of cellular organofluorine metabolic process / oxidation-reduction process / oxidative demethylation / small molecule metabolic process / steroid metabolic process / xenobiotic metabolic processComponentscytoplasm / endoplasmic reticulum / endoplasmic reticulum membrane / mitochondrion",
                        "General Function": "Steroid hydroxylase activity",
                        "Specific Function": "Responsible for the metabolism of many drugs and environmental chemicals that it oxidizes. It is involved in the metabolism of drugs such as antiarrhythmics, adrenoceptor antagonists, and tricyclic antidepressants.",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0019275|Cytochrome P450 2D6 (CYP2D6)\nATGGGGCTAGAAGCACTGGTGCCCCTGGCCGTGATAGTGGCCATCTTCCTGCTCCTGGTG\nGACCTGATGCACCGGCGCCAACGCTGGGCTGCACGCTACCCACCAGGCCCCCTGCCACTG\nCCCGGGCTGGGCAACCTGCTGCATGTGGACTTCCAGAACACACCATACTGCTTCGACCAG\nTTGCGGCGCCGCTTCGGGGACGTGTTCAGCCTGCAGCTGGCCTGGACGCCGGTGGTCGTG\nCTCAATGGGCTGGCGGCCGTGCGCGAGGCGCTGGTGACCCACGGCGAGGACACCGCCGAC\nCGCCCGCCTGTGCCCATCACCCAGATCCTGGGTTTCGGGCCGCGTTCCCAAGGGGTGTTC\nCTGGCGCGCTATGGGCCCGCGTGGCGCGAGCAGAGGCGCTTCTCCGTGTCCACCTTGCGC\nAACTTGGGCCTGGGCAAGAAGTCGCTGGAGCAGTGGGTGACCGAGGAGGCCGCCTGCCTT\nTGTGCCGCCTTCGCCAACCACTCCGGACGCCCCTTTCGCCCCAACGGTCTCTTGGACAAA\nGCCGTGAGCAACGTGATCGCCTCCCTCACCTGCGGGCGCCGCTTCGAGTACGACGACCCT\nCGCTTCCTCAGGCTGCTGGACCTAGCTCAGGAGGGACTGAAGGAGGAGTCGGGCTTTCTG\nCGCGAGGTGCTGAATGCTGTCCCCGTCCTCCTGCATATCCCAGCGCTGGCTGGCAAGGTC\nCTACGCTTCCAAAAGGCTTTCCTGACCCAGCTGGATGAGCTGCTAACTGAGCACAGGATG\nACCTGGGACCCAGCCCAGCCCCCCCGAGACCTGACTGAGGCCTTCCTGGCAGAGATGGAG\nAAGGCCAAGGGGAACCCTGAGAGCAGCTTCAATGATGAGAACCTGCGCATAGTGGTGGCT\nGACCTGTTCTCTGCCGGGATGGTGACCACCTCGACCACGCTGGCCTGGGGCCTCCTGCTC\nATGATCCTACATCCGGATGTGCAGCGCCGTGTCCAACAGGAGATCGACGACGTGATAGGG\nCAGGTGCGGCGACCAGAGATGGGTGACCAGGCTCACATGCCCTACACCACTGCCGTGATT\nCATGAGGTGCAGCGCTTTGGGGACATCGTCCCCCTGGGTGTGACCCATATGACATCCCGT\nGACATCGAAGTACAGGGCTTCCGCATCCCTAAGGGAACGACACTCATCACCAACCTGTCA\nTCGGTGCTGAAGGATGAGGCCGTCTGGGAGAAGCCCTTCCGCTTCCACCCCGAACACTTC\nCTGGATGCCCAGGGCCACTTTGTGAAGCCGGAGGCCTTCCTGCCTTTCTCAGCAGGCCGC\nCGTGCATGCCTCGGGGAGCCCCTGGCCCGCATGGAGCTCTTCCTCTTCTTCACCTCCCTG\nCTGCAGCACTTCAGCTTCTCGGTGCCCACTGGACAGCCCCGGCCCAGCCACCATGGTGTC\nTTTGCTTTCCTGGTGAGCCCATCCCCCTATGAGCTTTGTGCTGTGCCCCGCTAG",
                        "Chromosome Location": "22",
                        "Locus": "22q13.1",
                        "External Identifiers": "ResourceLinkUniProtKB IDP10635UniProtKB Entry NameCP2D6_HUMANGenBank Protein ID181350GenBank Gene IDM20403GenAtlas IDCYP2D6HGNC IDHGNC:2625",
                        "General References": "Gonzalez FJ, Vilbois F, Hardwick JP, McBride OW, Nebert DW, Gelboin HV, Meyer UA: Human debrisoquine 4-hydroxylase (P450IID1): cDNA and deduced amino acid sequence and assignment of the CYP2D locus to chromosome 22. Genomics. 1988 Feb;2(2):174-9. [Article] Gonzalez FJ, Skoda RC, Kimura S, Umeno M, Zanger UM, Nebert DW, Gelboin HV, Hardwick JP, Meyer UA: Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature. 1988 Feb 4;331(6155):442-6. [Article] Kimura S, Umeno M, Skoda RC, Meyer UA, Gonzalez FJ: The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene. Am J Hum Genet. 1989 Dec;45(6):889-904. [Article] Gaedigk A, Bhathena A, Ndjountche L, Pearce RE, Abdel-Rahman SM, Alander SW, Bradford LD, Rogan PK, Leeder JS: Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans. Pharmacogenomics J. 2005;5(3):173-82. [Article] Dunham I, Shimizu N, Roe BA, Chissoe S, Hunt AR, Collins JE, Bruskiewich R, Beare DM, Clamp M, Smink LJ, Ainscough R, Almeida JP, Babbage A, Bagguley C, Bailey J, Barlow K, Bates KN, Beasley O, Bird CP, Blakey S, Bridgeman AM, Buck D, Burgess J, Burrill WD, O'Brien KP, et al.: The DNA sequence of human chromosome 22. Nature. 1999 Dec 2;402(6761):489-95. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Honda A, Miyazaki T, Ikegami T, Iwamoto J, Maeda T, Hirayama T, Saito Y, Teramoto T, Matsuzaki Y: Cholesterol 25-hydroxylation activity of CYP3A. J Lipid Res. 2011 Aug;52(8):1509-16. doi: 10.1194/jlr.M014084. Epub 2011 May 16. [Article] Rowland P, Blaney FE, Smyth MG, Jones JJ, Leydon VR, Oxbrow AK, Lewis CJ, Tennant MG, Modi S, Eggleston DS, Chenery RJ, Bridges AM: Crystal structure of human cytochrome P450 2D6. J Biol Chem. 2006 Mar 17;281(11):7614-22. Epub 2005 Dec 13. [Article] Tyndale R, Aoyama T, Broly F, Matsunaga T, Inaba T, Kalow W, Gelboin HV, Meyer UA, Gonzalez FJ: Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: possible association with the poor metabolizer phenotype. Pharmacogenetics. 1991 Oct;1(1):26-32. [Article] Yokota H, Tamura S, Furuya H, Kimura S, Watanabe M, Kanazawa I, Kondo I, Gonzalez FJ: Evidence for a new variant CYP2D6 allele CYP2D6J in a Japanese population associated with lower in vivo rates of sparteine metabolism. Pharmacogenetics. 1993 Oct;3(5):256-63. [Article] Evert B, Griese EU, Eichelbaum M: A missense mutation in exon 6 of the CYP2D6 gene leading to a histidine 324 to proline exchange is associated with the poor metabolizer phenotype of sparteine. Naunyn Schmiedebergs Arch Pharmacol. 1994 Oct;350(4):434-9. [Article] Daly AK, Leathart JB, London SJ, Idle JR: An inactive cytochrome P450 CYP2D6 allele containing a deletion and a base substitution. Hum Genet. 1995 Mar;95(3):337-41. [Article] Masimirembwa C, Persson I, Bertilsson L, Hasler J, Ingelman-Sundberg M: A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: association with diminished debrisoquine hydroxylase activity. Br J Clin Pharmacol. 1996 Dec;42(6):713-9. [Article] Marez D, Legrand M, Sabbagh N, Lo-Guidice JM, Boone P, Broly F: An additional allelic variant of the CYP2D6 gene causing impaired metabolism of sparteine. Hum Genet. 1996 May;97(5):668-70. [Article] Marez D, Legrand M, Sabbagh N, Lo Guidice JM, Spire C, Lafitte JJ, Meyer UA, Broly F: Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution. Pharmacogenetics. 1997 Jun;7(3):193-202. [Article] Wang SL, Lai MD, Huang JD: G169R mutation diminishes the metabolic activity of CYP2D6 in Chinese. Drug Metab Dispos. 1999 Mar;27(3):385-8. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article] Dai DP, Geng PW, Wang SH, Cai J, Hu LM, Nie JJ, Hu JH, Hu GX, Cai JP: In vitro functional assessment of 22 newly identified CYP2D6 allelic variants in the Chinese population. Basic Clin Pharmacol Toxicol. 2015 Jul;117(1):39-43. doi: 10.1111/bcpt.12363. Epub 2015 Jan 14. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00176Fluvoxamineapproved, investigationalunknownsubstrateinhibitorDetailsDB00182Amphetamineapproved, illicit, investigationalunknownsubstrateDetailsDB00185CevimelineapprovedunknownsubstrateDetailsDB00193Tramadolapproved, investigationalunknownsubstrateDetailsDB00243Ranolazineapproved, investigationalnosubstrateinhibitorDetailsDB00264Metoprololapproved, investigationalunknownsubstrateinhibitorDetailsDB00281Lidocaineapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00285VenlafaxineapprovedunknownsubstrateinhibitorDetailsDB00289AtomoxetineapprovedunknownsubstrateDetailsDB00318Codeineapproved, illicitunknownsubstrateDetailsDB00370MirtazapineapprovedunknownsubstrateDetailsDB00373TimololapprovedunknownsubstrateDetailsDB00379Mexiletineapproved, investigationalunknownsubstrateDetailsDB00433Prochlorperazineapproved, vet_approvedunknownsubstrateDetailsDB00454MeperidineapprovedunknownsubstrateDetailsDB00476DuloxetineapprovedunknownsubstrateinhibitorDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00496Darifenacinapproved, investigationalunknownsubstrateinhibitorDetailsDB00497Oxycodoneapproved, illicit, investigationalunknownsubstrateDetailsDB00502HaloperidolapprovedunknownsubstrateinhibitorDetailsDB00503Ritonavirapproved, investigationalunknownsubstrateinhibitorDetailsDB00514DextromethorphanapprovedunknownsubstrateDetailsDB00521CarteololapprovedunknownsubstrateDetailsDB00557HydroxyzineapprovednoinhibitorDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00575ClonidineapprovedunknownsubstrateDetailsDB00623FluphenazineapprovedunknowninhibitorDetailsDB00647Dextropropoxypheneapproved, illicit, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00656Trazodoneapproved, investigationalunknownsubstrateinhibitorDetailsDB00674GalantamineapprovednosubstrateDetailsDB00675TamoxifenapprovedunknownsubstrateinhibitorDetailsDB00679Thioridazineapproved, withdrawnunknownsubstrateinhibitorDetailsDB00699Nicergolineapproved, investigationalunknownsubstrateDetailsDB00715Paroxetineapproved, investigationalunknownsubstrateinhibitorDetailsDB00734Risperidoneapproved, investigationalunknownsubstrateinhibitorDetailsDB00757Dolasetronapproved, investigationalunknownsubstrateDetailsDB00805MinaprineapprovedunknownsubstrateDetailsDB00843DonepezilapprovedunknownsubstrateDetailsDB00850PerphenazineapprovedunknownsubstrateinhibitorDetailsDB00863Ranitidineapproved, withdrawnunknowninhibitorDetailsDB00866Alprenololexperimental, withdrawnunknownsubstrateDetailsDB00904Ondansetronapproved, withdrawnunknownsubstrateDetailsDB00914Phenforminapproved, investigational, withdrawnunknownsubstrateDetailsDB00918Almotriptanapproved, investigationalunknownsubstrateDetailsDB00934Maprotilineapproved, investigationalunknownsubstrateDetailsDB00956Hydrocodoneapproved, illicit, investigationalunknownsubstrateDetailsDB00960Pindololapproved, investigationalunknownsubstrateinhibitorDetailsDB01012CinacalcetapprovedunknowninhibitorDetailsDB01035ProcainamideapprovedunknownsubstrateDetailsDB01036Tolterodineapproved, investigationalunknownsubstrateDetailsDB01069Promethazineapproved, investigationalunknownsubstrateinhibitorDetailsDB01074Perhexilineapproved, investigationalunknownsubstrateinhibitorDetailsDB01114ChlorpheniramineapprovedunknownsubstrateinhibitorDetailsDB01136Carvedilolapproved, investigationalunknownsubstrateDetailsDB01142Doxepinapproved, investigationalnosubstrateinhibitorDetailsDB01151Desipramineapproved, investigationalunknownsubstrateinhibitorDetailsDB01193Acebutololapproved, investigationalunknownsubstrateinhibitorDetailsDB01195Flecainideapproved, withdrawnunknownsubstrateinhibitorDetailsDB01228Encainideapproved, investigational, withdrawnunknownsubstrateDetailsDB01233Metoclopramideapproved, investigationalunknownsubstrateinhibitorDetailsDB01242Clomipramineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB01171Moclobemideapproved, investigationalunknownsubstrateinhibitorDetailsDB01274Arformoterolapproved, investigationalunknownsubstrateDetailsDB01410Ciclesonideapproved, investigationalunknownsubstrateDetailsDB01466Ethylmorphineexperimental, illicitunknownsubstrateDetailsDB01409TiotropiumapprovednosubstrateDetailsDB01075Diphenhydramineapproved, investigationalunknownsubstrateinhibitorDetailsDB04840Debrisoquineapproved, investigationalunknownsubstrateDetailsDB00215CitalopramapprovednosubstrateinhibitorDetailsDB00234Reboxetineapproved, experimentalunknowninhibitorDetailsDB00257Clotrimazoleapproved, vet_approvedunknowninhibitorDetailsDB00317Gefitinibapproved, investigationalnosubstrateinhibitorDetailsDB00321AmitriptylineapprovedunknownsubstrateDetailsDB00342Terfenadineapproved, withdrawnunknownsubstrateinhibitorDetailsDB00343Diltiazemapproved, investigationalunknownsubstrateDetailsDB00356ChlorzoxazoneapprovedunknownsubstrateDetailsDB00363ClozapineapprovednosubstrateinhibitorDetailsDB00455Loratadineapproved, investigationalunknownsubstrateinhibitorDetailsDB00458ImipramineapprovedunknownsubstrateinhibitorDetailsDB00468QuinineapprovedunknownsubstrateinhibitorDetailsDB00482Celecoxibapproved, investigationalunknownsubstrateinhibitorDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00532Mephenytoinapproved, investigational, withdrawnunknownsubstrateDetailsDB00540NortriptylineapprovedunknownsubstrateinhibitorDetailsDB00613Amodiaquineapproved, investigationalunknowninhibitorDetailsDB00622Nicardipineapproved, investigationalunknowninhibitorDetailsDB00705DelavirdineapprovedunknownsubstrateinhibitorDetailsDB00726TrimipramineapprovedunknownsubstrateDetailsDB00752Tranylcypromineapproved, investigationalunknowninhibitorDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknowninhibitorDetailsDB00908Quinidineapproved, investigationalunknowninhibitorDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00933Mesoridazineapproved, investigationalunknownsubstrateDetailsDB00972AzelastineapprovedunknownsubstrateinhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB01071MequitazineexperimentalunknownsubstrateDetailsDB01104SertralineapprovedunknownsubstrateinhibitorDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB01115NifedipineapprovedunknowninhibitorDetailsDB01118Amiodaroneapproved, investigationalnoinhibitorDetailsDB01131ProguanilapprovednoinhibitorDetailsDB01149Nefazodoneapproved, withdrawnunknownsubstrateinhibitorDetailsDB01156BupropionapprovedunknowninhibitorDetailsDB01175EscitalopramapprovednosubstrateinhibitorDetailsDB01182PropafenoneapprovedunknownsubstrateinhibitorDetailsDB01191Dexfenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateinhibitorDetailsDB01192Oxymorphoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB01218HalofantrineapprovedunknowninhibitorDetailsDB01238Aripiprazoleapproved, investigationalnosubstrateDetailsDB01403Methotrimeprazineapproved, investigationalunknownsubstrateinhibitorDetailsDB01551Dihydrocodeineapproved, illicitunknownsubstrateDetailsDB00377Palonosetronapproved, investigationalunknownsubstrateDetailsDB04861Nebivololapproved, investigationalunknownsubstrateDetailsDB04889BicifadineinvestigationalunknownsubstrateDetailsDB015621-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidineexperimental, illicitunknowninhibitorDetailsDB06144Sertindoleapproved, investigational, withdrawnunknownsubstrateDetailsDB06148Mianserinapproved, investigationalunknownsubstrateDetailsDB04905TesmilifeneinvestigationalunknownsubstrateDetailsDB01624Zuclopenthixolapproved, investigationalunknownsubstrateDetailsDB00571Propranololapproved, investigationalunknownsubstrateinhibitorDetailsDB05271RotigotineapprovedunknownsubstrateinhibitorDetailsDB00472Fluoxetineapproved, vet_approvednosubstrateinhibitorDetailsDB01095FluvastatinapprovedunknownsubstrateDetailsDB01076AtorvastatinapprovednoinhibitorDetailsDB00439Cerivastatinapproved, withdrawnunknowninhibitorDetailsDB00619ImatinibapprovednosubstrateinhibitorDetailsDB00334Olanzapineapproved, investigationalnosubstrateinhibitorDetailsDB00792Tripelennamineapproved, vet_approvedunknowninhibitorDetailsDB00188Bortezomibapproved, investigationalunknownsubstrateDetailsDB05109Trabectedinapproved, investigationalunknownsubstrateDetailsDB00568Cinnarizineapproved, investigationalunknownsubstrateDetailsDB04841FlunarizineapprovedunknownsubstrateDetailsDB06726BufuralolexperimentalunknownsubstrateDetailsDB014724-Methoxyamphetamineexperimental, illicitunknownsubstrateDetailsDB03783PhenacetinwithdrawnunknownsubstrateDetailsDB06727Sparteineexperimental, withdrawnunknownsubstrateinhibitorDetailsDB00283Clemastineapproved, investigationalunknowninhibitorDetailsDB00907Cocaineapproved, illicitunknowninhibitorDetailsDB00997Doxorubicinapproved, investigationalnosubstrateinhibitorDetailsDB00333MethadoneapprovednosubstrateinhibitorDetailsDB01388Mibefradilinvestigational, withdrawnunknowninhibitorDetailsDB00211MidodrineapprovedunknownsubstrateDetailsDB00208TiclopidineapprovedunknownsubstrateinhibitorDetailsDB00543AmoxapineapprovedunknownsubstrateinhibitorDetailsDB00608Chloroquineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB04946IloperidoneapprovedunknownsubstrateDetailsDB01577Metamfetamineapproved, illicit, withdrawnunknownsubstrateDetailsDB01621Pipotiazineapproved, investigationalunknownsubstrateinhibitorDetailsDB00706Tamsulosinapproved, investigationalunknownsubstrateDetailsDB04844Tetrabenazineapproved, investigationalunknownsubstrateDetailsDB01601LopinavirapprovedunknownsubstrateDetailsDB00932Tipranavirapproved, investigationalunknownsubstrateinhibitorDetailsDB04855DronedaroneapprovedunknownsubstrateinhibitorDetailsDB00951Isoniazidapproved, investigationalunknowninhibitorDetailsDB06708LumefantrineapprovedunknowninhibitorDetailsDB04868Nilotinibapproved, investigationalunknowninhibitorDetailsDB01424Aminophenazoneapproved, withdrawnunknownsubstrateDetailsDB00238NevirapineapprovedunknownsubstrateinhibitorDetailsDB00216Eletriptanapproved, investigationalunknownsubstrateDetailsDB00425ZolpidemapprovedunknownsubstrateDetailsDB01628Etoricoxibapproved, investigationalunknowninhibitorDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateDetailsDB00316AcetaminophenapprovedunknownsubstrateDetailsDB00924CyclobenzaprineapprovedunknownsubstrateDetailsDB00381AmlodipineapprovedunknowninhibitorDetailsDB00701Amprenavirapproved, investigationalunknownsubstrateDetailsDB01429AprindineexperimentalunknownsubstrateDetailsDB00637Astemizoleapproved, withdrawnunknownsubstrateDetailsDB01244Bepridilapproved, withdrawnunknownsubstrateinhibitorDetailsDB00195Betaxololapproved, investigationalunknownsubstrateDetailsDB00810Biperidenapproved, investigationalunknowninhibitorDetailsDB00297Bupivacaineapproved, investigationalunknownsubstrateDetailsDB00490Buspironeapproved, investigationalunknownsubstrateDetailsDB00201CaffeineapprovedunknownsubstrateDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknowninhibitorDetailsDB00604Cisaprideapproved, investigational, withdrawnunknowninhibitorDetailsDB01093Dimethyl sulfoxideapproved, vet_approvedunknowninhibitorDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB00590DoxazosinapprovedunknownsubstrateDetailsDB00625Efavirenzapproved, investigationalunknowninhibitorDetailsDB00751Epinastineapproved, investigationalunknownsubstrateinhibitorDetailsDB01023Felodipineapproved, investigationalunknowninhibitorDetailsDB01611HydroxychloroquineapprovedunknownsubstrateinhibitorDetailsDB01177IdarubicinapprovedunknownsubstrateDetailsDB00224IndinavirapprovedunknowninhibitorDetailsDB00598LabetalolapprovedunknownsubstrateinhibitorDetailsDB00448Lansoprazoleapproved, investigationalunknowninhibitorDetailsDB00528Lercanidipineapproved, investigationalunknowninhibitorDetailsDB01206Lomustineapproved, investigationalunknowninhibitorDetailsDB06691Mepyramineapproved, vet_approvedunknowninhibitorDetailsDB01028Methoxyfluraneapproved, investigational, vet_approved, withdrawnunknownsubstrateDetailsDB00834Mifepristoneapproved, investigationalunknowninhibitorDetailsDB00731Nateglinideapproved, investigationalunknownsubstrateDetailsDB00220NelfinavirapprovednoinhibitorDetailsDB02701Nicotinamideapproved, investigationalunknowninhibitorDetailsDB00184NicotineapprovedunknownsubstrateDetailsDB00627Niacinapproved, investigational, nutraceuticalunknowninhibitorDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB01096OxamniquineapprovedunknownsubstrateinhibitorDetailsDB01580OxprenololapprovedunknownsubstrateinhibitorDetailsDB01062Oxybutyninapproved, investigationalunknowninhibitorDetailsDB00738Pentamidineapproved, investigationalunknownsubstrateDetailsDB01435Antipyrineapproved, investigationalunknownsubstrateDetailsDB01100PimozideapprovednoinhibitorDetailsDB00592Piperazineapproved, vet_approvedunknownsubstrateDetailsDB01087PrimaquineapprovedunknowninhibitorDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateDetailsDB01224QuetiapineapprovedunknownsubstrateDetailsDB00409Remoxiprideapproved, withdrawnunknownsubstrateDetailsDB00412Rosiglitazoneapproved, investigationalunknowninhibitorDetailsDB01232Saquinavirapproved, investigationalunknowninhibitorDetailsDB01037Selegilineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00641SimvastatinapprovedunknownsubstrateDetailsDB06729SulfaphenazoleapprovedunknowninhibitorDetailsDB01079Tegaserodapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00277TheophyllineapprovedunknownsubstrateDetailsDB00763MethimazoleapprovedunknowninhibitorDetailsDB01623ThiothixeneapprovedunknowninhibitorDetailsDB00209TrospiumapprovedunknowninhibitorDetailsDB00661VerapamilapprovedunknowninhibitorDetailsDB00570VinblastineapprovedunknowninhibitorDetailsDB00361Vinorelbineapproved, investigationalnoinhibitorDetailsDB01392Yohimbineapproved, investigational, vet_approvedunknownsubstrateDetailsDB06287TemsirolimusapprovedunknowninhibitorDetailsDB00398Sorafenibapproved, investigationalunknowninhibitorDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateDetailsDB01128BicalutamideapprovedunknowninhibitorDetailsDB01129Rabeprazoleapproved, investigationalunknowninhibitorDetailsDB01166Cilostazolapproved, investigationalunknownsubstrateDetailsDB06216AsenapineapprovedunknownsubstrateinhibitorDetailsDB06589PazopanibapprovedunknowninhibitorDetailsDB06702FesoterodineapprovedunknownsubstrateDetailsDB06684VilazodoneapprovedunknownsubstrateDetailsDB00836LoperamideapprovedunknownsubstrateDetailsDB06506RepinotaninvestigationalunknownsubstrateDetailsDB06770Benzyl alcoholapprovedunknownsubstrateDetailsDB04920Clevidipineapproved, investigationalunknownsubstrateDetailsDB00633Dexmedetomidineapproved, vet_approvedunknowninhibitorDetailsDB06370IndisulaminvestigationalunknowninhibitorDetailsDB06735EnclomipheneinvestigationalunknownsubstrateDetailsDB06204TapentadolapprovedunknownsubstrateDetailsDB04871Lorcaserinapproved, withdrawnnosubstrateinhibitorDetailsDB05812AbirateroneapprovedunknowninhibitorDetailsDB08881VemurafenibapprovedunknowninhibitorDetailsDB08893MirabegronapprovednosubstrateinhibitorDetailsDB08901Ponatinibapproved, investigationalunknownsubstrateDetailsDB06203AlogliptinapprovedunknownsubstrateDetailsDB08918Levomilnacipranapproved, investigationalunknownsubstrateDetailsDB06292DapagliflozinapprovednosubstrateDetailsDB09039Eliglustatapproved, investigationalnosubstrateinhibitorDetailsDB09048Netupitantapproved, investigationalnosubstrateDetailsDB09049NaloxegolapprovedunknowninhibitorDetailsDB09076UmeclidiniumapprovednosubstrateDetailsDB09065CobicistatapprovednosubstrateinhibitorDetailsDB09068Vortioxetineapproved, investigationalnosubstrateDetailsDB06016Cariprazineapproved, investigationalnosubstrateinhibitorDetailsDB00349Clobazamapproved, illicitnoinhibitorDetailsDB09128Brexpiprazoleapproved, investigationalnosubstrateDetailsDB09291Rolapitantapproved, investigationalnoinhibitorDetailsDB06678EsmirtazapineinvestigationalunknownsubstrateDetailsDB06603Panobinostatapproved, investigationalnoinhibitorDetailsDB09570Ixazomibapproved, investigationalunknownsubstrateDetailsDB06412Oxymetholoneapproved, illicitunknowninhibitorDetailsDB09183DasabuvirapprovednosubstrateDetailsDB06512DeramciclaneinvestigationalunknowninhibitorDetailsDB00022Peginterferon alfa-2bapprovedunknowninhibitorDetailsDB00494Entacaponeapproved, investigationalunknowninhibitorDetailsDB04938Ospemifeneapproved, investigationalunknowninhibitorDetailsDB06820SulconazoleapprovedunknowninhibitorDetailsDB08909Glycerol phenylbutyrateapprovedunknowninhibitorDetailsDB00420Promazineapproved, vet_approvedunknownsubstrateDetailsDB09118StiripentolapprovedunknowninhibitorDetailsDB12332Rucaparibapproved, investigationalnosubstrateinhibitorDetailsDB09555Dexchlorpheniramine maleateapprovednosubstrateinhibitorDetailsDB12161Deutetrabenazineapproved, investigationalnosubstrateDetailsDB06217Vernakalantapproved, investigationalunknownsubstrateinhibitorDetailsDB06595Midostaurinapproved, investigationalunknowninhibitorDetailsDB11915Valbenazineapproved, investigationalnosubstrateDetailsDB13174RheinexperimentalunknowninhibitorDetailsDB11994Diacereinapproved, investigationalunknowninhibitorDetailsDB08922PerospironeexperimentalunknownsubstrateDetailsDB09167DosulepinapprovedunknownsubstrateinhibitorDetailsDB11614RupatadineapprovednosubstrateDetailsDB09238Manidipineapproved, investigationalunknowninhibitorDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateDetailsDB09061Cannabidiolapproved, investigationalunknownsubstrateinhibitorDetailsDB11638Artenimolapproved, experimental, investigationalunknowninhibitorDetailsDB09195LorpiprazoleapprovednosubstrateDetailsDB09224MelperoneinvestigationalunknowninhibitorDetailsDB11642Pitolisantapproved, investigationalunknownsubstrateinhibitorDetailsDB11633Isavuconazoleapproved, investigationalunknowninhibitorDetailsDB11130Opiumapproved, illicitnosubstrateDetailsDB09053IbrutinibapprovednosubstrateDetailsDB11586Asunaprevirapproved, investigational, withdrawnnosubstrateinhibitorDetailsDB140105-methoxy-N,N-dimethyltryptamineexperimental, illicitunknownsubstrateDetailsDB13975Black cohoshexperimentalnoinhibitorDetailsDB14011NabiximolsinvestigationalunknownsubstrateDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorDetailsDB13293Ipecacapproved, withdrawnnosubstrateDetailsDB04948Lofexidineapproved, investigationalnosubstrateDetailsDB11672Curcuminapproved, investigationalunknowninhibitorDetailsDB04829Lysergic acid diethylamideillicit, investigational, withdrawnnosubstrateDetailsDB14185Aripiprazole lauroxilapproved, investigationalunknownsubstrateDetailsDB11718Encorafenibapproved, investigationalnosubstrateinhibitorDetailsDB06608Tafenoquineapproved, investigationalnosubstrateDetailsDB11979Elagolixapproved, investigationalnosubstrateDetailsDB11785AnisodamineinvestigationalnosubstrateDetailsDB09204ArotinololinvestigationalnosubstrateDetailsDB00335AtenololapprovednosubstrateDetailsDB09013BefunololexperimentalnosubstrateDetailsDB01295BevantololexperimentalnosubstrateDetailsDB08807BopindololexperimentalnosubstrateDetailsDB12752BucindololinvestigationalnosubstrateDetailsDB08808BupranololexperimentalnosubstrateDetailsDB04846Celiprololapproved, investigationalnosubstrateDetailsDB13508CloranololexperimentalnosubstrateDetailsDB13757EpanololexperimentalnosubstrateDetailsDB13443EsatenololexperimentalnosubstrateDetailsDB00187Esmololapproved, withdrawnnosubstrateDetailsDB08952IndenololwithdrawnnosubstrateDetailsDB12212LandiololinvestigationalnosubstrateDetailsDB09351Levobetaxololapproved, investigationalnosubstrateDetailsDB01210LevobunololapprovednosubstrateDetailsDB13530MepindololexperimentalnosubstrateDetailsDB01214MetipranololapprovednosubstrateDetailsDB01359Penbutololapproved, investigationalnosubstrateDetailsDB01297PractololapprovednosubstrateDetailsDB00489SotalolapprovednosubstrateDetailsDB11770TalinololinvestigationalnosubstrateDetailsDB13775TertatololexperimentalnosubstrateDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB06654Safinamideapproved, investigationalunknowninhibitorDetailsDB04818IproniazidwithdrawnunknowninhibitorDetailsDB01267PaliperidoneapprovedunknownsubstrateDetailsDB09078Lenvatinibapproved, investigationalunknowninhibitorDetailsDB08864RilpivirineapprovedunknowninhibitorDetailsDB04911Oritavancinapproved, investigationalunknowninhibitorinducerDetailsDB04884DapoxetineinvestigationalnosubstrateDetailsDB12693RitanserininvestigationalnoinhibitorDetailsDB02703Fusidic acidapproved, investigationalunknownsubstrateinhibitorDetailsDB09288PropacetamolexperimentalnosubstrateDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB11963Dacomitinibapproved, investigationalunknownsubstrateinhibitorDetailsDB14025ClinafloxacininvestigationalunknowninhibitorDetailsDB01323St. John's Wortapproved, investigational, nutraceuticalnoinhibitorDetailsDB01454Midomafetamineexperimental, illicit, investigationalnosubstrateDetailsDB11855Revefenacinapproved, investigationalnosubstrateDetailsDB12245Triclabendazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB01576Dextroamphetamineapproved, illicitnosubstrateDetailsDB06700Desvenlafaxineapproved, investigationalnoinhibitorDetailsDB00737MeclizineapprovednosubstrateDetailsDB01591SolifenacinapprovedunknownsubstrateDetailsDB13679Dexchlorpheniramineexperimental, investigationalunknownsubstrateinhibitorDetailsDB12523Mizolastineapproved, investigationalunknowninhibitorDetailsDB01173OrphenadrineapprovedunknowninhibitorDetailsDB09173ButyrfentanylillicitunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknownsubstrateDetailsDB04957AzimilideinvestigationalunknownsubstrateDetailsDB09061Cannabidiolapproved, investigationalunknowninhibitorDetailsDB14011NabiximolsinvestigationalunknownsubstrateinhibitorDetailsDB01590EverolimusapprovedunknowninhibitorDetailsDB12001Abemaciclibapproved, investigationalunknowninhibitorDetailsDB11732Lasmiditanapproved, investigationalnoinhibitorDetailsDB15444Elexacaftorapproved, investigationalnoinhibitorDetailsDB15091Upadacitinibapproved, investigationalunknownsubstrateDetailsDB00252Phenytoinapproved, vet_approvednosubstrateDetailsDB15328Ubrogepantapproved, investigationalunknowninhibitorDetailsDB00983Formoterolapproved, investigationalunknownsubstrateDetailsDB01264DarunavirapprovedunknowninhibitorDetailsDB13609UmifenovirinvestigationalunknownsubstrateDetailsDB11837Osilodrostatapproved, investigationalunknownsubstrateinhibitorDetailsDB12500Fedratinibapproved, investigationalunknowninhibitorDetailsDB09241Methylene blueapproved, investigationalunknownsubstrateinhibitorDetailsDB14761Remdesivirapproved, investigationalunknownsubstrateDetailsDB14840RipretinibapprovedunknownsubstrateDetailsDB00845Clofazimineapproved, investigationalunknowninhibitorDetailsDB14881Oliceridineapproved, investigationalunknownsubstrateDetailsDB12499Clascoteroneapproved, investigationalnoinhibitorDetailsDB15822Pralsetinibapproved, investigationalnosubstrateDetailsDB15982BerotralstatapprovednoinhibitorDetailsDB04951Pirfenidoneapproved, investigationalunknownsubstrateinhibitorDetailsDB06137Tirbanibulinapproved, investigationalnoinhibitorDetailsDB00549Zafirlukastapproved, investigationalunknowninhibitorDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB00745Modafinilapproved, investigationalunknowninducerDetailsDB00330EthambutolapprovedunknowninhibitorDetailsDB01086Benzocaineapproved, investigationalunknownsubstrateDetailsDB05316Pimavanserinapproved, investigationalunknownsubstrateDetailsDB11753Rifamycinapproved, investigationalunknowninhibitorDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownsubstrateDetailsDB15119Ropeginterferon alfa-2bapproved, investigationalnoinhibitorDetailsDB12151Brincidofovirapproved, investigationalnoinhibitorDetailsDB16703Belumosudilapproved, investigationalnosubstrateinhibitorDetailsDB12265Fexinidazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00602Ivermectinapproved, investigational, vet_approvednosubstrateDetailsDB12713Sotagliflozinapproved, investigationalnoinhibitorDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB00470Dronabinolapproved, illicitnoinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknowninhibitorDetailsDB05087Ganaxoloneapproved, investigationalnosubstrateDetailsDB09185Viloxazineapproved, investigational, withdrawnnosubstrateinhibitorDetailsDB14921Mavacamtenapproved, investigationalnoDetailsDB06083Tapinarofapproved, investigationalnosubstrateDetailsDB16650Deucravacitinibapproved, investigationalunknownsubstrateDetailsDB12095Telotristat ethylapproved, investigationalnoinhibitorDetailsDB15149Futibatinibapproved, investigationalnosubstrateDetailsDB11739Vonoprazanapproved, investigationalunknownsubstrateDetailsDB05239Cobimetinibapproved, investigationalnoinhibitorDetailsDB02709ResveratrolinvestigationalnoinhibitorDetailsDB15568Adagrasibapproved, investigationalunknownsubstrateinhibitorDetailsDB12236Bexagliflozinapproved, investigationalunknownsubstrateDetailsDB17472Pirtobrutinibapproved, investigationalunknowninhibitorDetailsDB15688Zavegepantapproved, investigationalunknownsubstrateDetailsDB00862VardenafilapprovedunknowninhibitorDetailsDB16217Leniolisibapproved, investigationalnosubstrateDetailsDB00953RizatriptanapprovednoinhibitorDetailsDB11712Tezacaftorapproved, investigationalnoinhibitorDetails"
                    }
                },
                {
                    "Label": "Cytochrome P450 2A6",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 2A6",
                        "Synonyms": "1,4-cineole 2-exo-monooxygenase\n1.14.13.-\nCoumarin 7-hydroxylase\nCYP2A3\nCYPIIA6\nCytochrome P450 IIA3\nCytochrome P450(I)",
                        "Gene Name": "CYP2A6",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0037226|Cytochrome P450 2A6\nMLASGMLLVALLVCLTVMVLMSVWQQRKSKGKLPPGPTPLPFIGNYLQLNTEQMYNSLMK\nISERYGPVFTIHLGPRRVVVLCGHDAVREALVDQAEEFSGRGEQATFDWVFKGYGVVFSN\nGERAKQLRRFSIATLRDFGVGKRGIEERIQEEAGFLIDALRGTGGANIDPTFFLSRTVSN\nVISSIVFGDRFDYKDKEFLSLLRMMLGIFQFTSTSTGQLYEMFSSVMKHLPGPQQQAFQL\nLQGLEDFIAKKVEHNQRTLDPNSPRDFIDSFLIRMQEEEKNPNTEFYLKNLVMTTLNLFI\nGGTETVSTTLRYGFLLLMKHPEVEAKVHEEIDRVIGKNRQPKFEDRAKMPYMEAVIHEIQ\nRFGDVIPMSLARRVKKDTKFRDFFLPKGTEVFPMLGSVLRDPSFFSNPQDFNPQHFLNEK\nGQFKKSDAFVPFSIGKRNCFGEGLARMELFLFFTTVMQNFRLKSSQSPKDIDVSPKHVGF\nATIPRNYTMSFLPR",
                        "Number of residues": "494",
                        "Molecular Weight": "56501.005",
                        "Theoretical pI": "9.69",
                        "GO Classification": "Functionsarachidonic acid epoxygenase activity / coumarin 7-hydroxylase activity / enzyme binding / heme binding / iron ion binding / oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen / oxygen binding / steroid hydroxylase activityProcessescoumarin catabolic process / coumarin metabolic process / drug metabolic process / epoxygenase P450 pathway / exogenous drug catabolic process / oxidation-reduction process / small molecule metabolic process / steroid metabolic process / xenobiotic metabolic processComponentscytoplasm / cytoplasmic microtubule / endoplasmic reticulum membrane / intracellular membrane-bounded organelle",
                        "General Function": "Steroid hydroxylase activity",
                        "Specific Function": "Exhibits a high coumarin 7-hydroxylase activity. Can act in the hydroxylation of the anti-cancer drugs cyclophosphamide and ifosphamide. Competent in the metabolic activation of aflatoxin B1. Constitutes the major nicotine C-oxidase. Acts as a 1,4-cineole 2-exo-monooxygenase. Possesses low phenacetin O-deethylation activity.",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0021356|Cytochrome P450 2A6 (CYP2A6)\nATGCTGGCCTCAGGGATGCTTCTGGTGGCCTTGCTGGTCTGCCTGACTGTAATGGTCTTG\nATGTCTGTTTGGCAGCAGAGGAAGAGCAAGGGGAAGCTGCCTCCGGGACCCACCCCATTG\nCCCTTCATTGGAAACTACCTGCAGCTGAACACAGAGCAGATGTACAACTCCCTCATGAAG\nATCAGTGAGCGCTATGGCCCCGTGTTCACCATTCACTTGGGGCCCCGGCGGGTCGTGGTG\nCTGTGTGGACATGATGCCGTCAGGGAGGCTCTGGTGGACCAGGCTGAGGAGTTCAGCGGG\nCGAGGCGAGCAAGCCACCTTCGACTGGGTCTTCAAAGGCTATGGCGTGGTATTCAGCAAC\nGGGGAGCGCGCCAAGCAGCTCCGGCGCTTCTCCATCGCCACCCTGCGGGACTTCGGGGTG\nGGCAAGCGAGGCATCGAGGAGCGCATCCAGGAGGAGGCGGGCTTCCTCATCGACGCCCTC\nCGGGGCACTGGCGGCGCCAATATCGATCCCACCTTCTTCCTGAGCCGCACAGTCTCCAAT\nGTCATCAGCTCCATTGTCTTTGGGGACCGCTTTGACTATAAGGACAAAGAGTTCCTGTCA\nCTGTTGCGCATGATGCTAGGAATCTTCCAGTTCACGTCAACCTCCACGGGGCAGCTCTAT\nGAGATGTTCTCTTCGGTGATGAAACACCTGCCAGGACCACAGCAACAGGCCTTTCAGTTG\nCTGCAAGGGCTGGAGGACTTCATAGCCAAGAAGGTGGAGCACAACCAGCGCACGCTGGAT\nCCCAATTCCCCACGGGACTTCATTGACTCCTTTCTCATCCGCATGCAGGAGGAGGAGAAG\nAACCCCAACACGGAGTTCTACTTGAAAAACCTGGTGATGACCACGTTGAACCTCTTCATT\nGGGGGCACCGAGACCGTCAGCACCACCCTGCGCTATGGCTTCTTGCTGCTCATGAAGCAC\nCCAGAGGTGGAGGCCAAGGTCCATGAGGAGATTGACAGAGTGATCGGCAAGAACCGGCAG\nCCCAAGTTTGAGGACCGGGCCAAGATGCCCTACATGGAGGCAGTGATCCACGAGATCCAA\nAGATTTGGAGACGTGATCCCCATGAGTTTGGCCCGCAGAGTCAAAAAGGACACCAAGTTT\nCGGGATTTCTTCCTCCCTAAGGGCACCGAAGTGTACCCTATGCTGGGCTCTGTGCTGAGA\nGACCCCAGTTTCTTCTCCAACCCCCAGGACTTCAATCCCCAGCACTTCCTGAATGAGAAG\nGGGCAGTTTAAGAAGAGTGATGCTTTTGTGCCCTTTTCCATCGGAAAGCGGAACTGTTTC\nGGAGAAGGCCTGGCCAGAATGGAGCTCTTTCTCTTCTTCACCACCGTCATGCAGAACTTC\nCGCCTCAAGTCCTCCCAGTCACCTAAGGACATTGACGTGTCCCCCAAACACGTGGGCTTT\nGCCACGATCCCACGAAACTACACCATGAGCTTCCTGCCCCGCTGA",
                        "Chromosome Location": "19",
                        "Locus": "19q13.2",
                        "External Identifiers": "ResourceLinkUniProtKB IDP11509UniProtKB Entry NameCP2A6_HUMANGenBank Gene IDX13897GenAtlas IDCYP2A6HGNC IDHGNC:2610",
                        "General References": "Miles JS, Bickmore W, Brook JD, McLaren AW, Meehan R, Wolf CR: Close linkage of the human cytochrome P450IIA and P450IIB gene subfamilies: implications for the assignment of substrate specificity. Nucleic Acids Res. 1989 Apr 25;17(8):2907-17. [Article] Yamano S, Nagata K, Yamazoe Y, Kato R, Gelboin HV, Gonzalez FJ: cDNA and deduced amino acid sequences of human P450 IIA3 (CYP2A3). Nucleic Acids Res. 1989 Jun 26;17(12):4888. [Article] Yamano S, Tatsuno J, Gonzalez FJ: The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry. 1990 Feb 6;29(5):1322-9. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Grimwood J, Gordon LA, Olsen A, Terry A, Schmutz J, Lamerdin J, Hellsten U, Goodstein D, Couronne O, Tran-Gyamfi M, Aerts A, Altherr M, Ashworth L, Bajorek E, Black S, Branscomb E, Caenepeel S, Carrano A, Caoile C, Chan YM, Christensen M, Cleland CA, Copeland A, Dalin E, Dehal P, Denys M, Detter JC, Escobar J, Flowers D, Fotopulos D, Garcia C, Georgescu AM, Glavina T, Gomez M, Gonzales E, Groza M, Hammon N, Hawkins T, Haydu L, Ho I, Huang W, Israni S, Jett J, Kadner K, Kimball H, Kobayashi A, Larionov V, Leem SH, Lopez F, Lou Y, Lowry S, Malfatti S, Martinez D, McCready P, Medina C, Morgan J, Nelson K, Nolan M, Ovcharenko I, Pitluck S, Pollard M, Popkie AP, Predki P, Quan G, Ramirez L, Rash S, Retterer J, Rodriguez A, Rogers S, Salamov A, Salazar A, She X, Smith D, Slezak T, Solovyev V, Thayer N, Tice H, Tsai M, Ustaszewska A, Vo N, Wagner M, Wheeler J, Wu K, Xie G, Yang J, Dubchak I, Furey TS, DeJong P, Dickson M, Gordon D, Eichler EE, Pennacchio LA, Richardson P, Stubbs L, Rokhsar DS, Myers RM, Rubin EM, Lucas SM: The DNA sequence and biology of human chromosome 19. Nature. 2004 Apr 1;428(6982):529-35. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Maurice M, Emiliani S, Dalet-Beluche I, Derancourt J, Lange R: Isolation and characterization of a cytochrome P450 of the IIA subfamily from human liver microsomes. Eur J Biochem. 1991 Sep 1;200(2):511-7. [Article] Yun CH, Shimada T, Guengerich FP: Purification and characterization of human liver microsomal cytochrome P-450 2A6. Mol Pharmacol. 1991 Nov;40(5):679-85. [Article] Kitagawa K, Kunugita N, Kitagawa M, Kawamoto T: CYP2A6*6, a novel polymorphism in cytochrome p450 2A6, has a single amino acid substitution (R128Q) that inactivates enzymatic activity. J Biol Chem. 2001 May 25;276(21):17830-5. Epub 2001 Feb 16. [Article] Phillips IR, Shephard EA, Ashworth A, Rabin BR: Isolation and sequence of a human cytochrome P-450 cDNA clone. Proc Natl Acad Sci U S A. 1985 Feb;82(4):983-7. [Article] Miyazawa M, Shindo M, Shimada T: Roles of cytochrome P450 3A enzymes in the 2-hydroxylation of 1,4-cineole, a monoterpene cyclic ether, by rat and human liver microsomes. Xenobiotica. 2001 Oct;31(10):713-23. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Yano JK, Hsu MH, Griffin KJ, Stout CD, Johnson EF: Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen. Nat Struct Mol Biol. 2005 Sep;12(9):822-3. Epub 2005 Aug 7. [Article] Yano JK, Denton TT, Cerny MA, Zhang X, Johnson EF, Cashman JR: Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization. J Med Chem. 2006 Nov 30;49(24):6987-7001. [Article] DeVore NM, Smith BD, Urban MJ, Scott EE: Key residues controlling phenacetin metabolism by human cytochrome P450 2A enzymes. Drug Metab Dispos. 2008 Dec;36(12):2582-90. doi: 10.1124/dmd.108.023770. Epub 2008 Sep 8. [Article] Hadidi H, Zahlsen K, Idle JR, Cholerton S: A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin. Food Chem Toxicol. 1997 Sep;35(9):903-7. [Article] Oscarson M, McLellan RA, Gullsten H, Agundez JA, Benitez J, Rautio A, Raunio H, Pelkonen O, Ingelman-Sundberg M: Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism. FEBS Lett. 1999 Oct 29;460(2):321-7. [Article] Ariyoshi N, Sawamura Y, Kamataki T: A novel single nucleotide polymorphism altering stability and activity of CYP2a6. Biochem Biophys Res Commun. 2001 Mar 2;281(3):810-4. [Article] Kiyotani K, Fujieda M, Yamazaki H, Shimada T, Guengerich FP, Parkinson A, Nakagawa K, Ishizaki T, Kamataki T: Twenty one novel single nucleotide polymorphisms (SNPs) of the CYP2A6 gene in Japanese and Caucasians. Drug Metab Pharmacokinet. 2002;17(5):482-7. [Article] Saito S, Iida A, Sekine A, Kawauchi S, Higuchi S, Ogawa C, Nakamura Y: Catalog of 680 variations among eight cytochrome p450 ( CYP) genes, nine esterase genes, and two other genes in the Japanese population. J Hum Genet. 2003;48(5):249-70. Epub 2003 Apr 29. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article] Mwenifumbo JC, Al Koudsi N, Ho MK, Zhou Q, Hoffmann EB, Sellers EM, Tyndale RF: Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent. Hum Mutat. 2008 May;29(5):679-88. doi: 10.1002/humu.20698. [Article] Ho MK, Mwenifumbo JC, Zhao B, Gillam EM, Tyndale RF: A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent. Pharmacogenet Genomics. 2008 Jan;18(1):67-75. doi: 10.1097/FPC.0b013e3282f3606e. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB04665CoumarinexperimentalunknownDetailsDB00184NicotineapprovedunknownsubstrateinhibitorDetailsDB01006Letrozoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00356ChlorzoxazoneapprovedunknownsubstrateDetailsDB00553MethoxsalenapprovedunknowninhibitorDetailsDB00752Tranylcypromineapproved, investigationalunknowninhibitorDetailsDB01011Metyraponeapproved, investigationalunknowninhibitorDetailsDB01085Pilocarpineapproved, investigationalunknowninhibitorDetailsDB01159Halothaneapproved, vet_approvedunknownsubstrateDetailsDB04977PlitidepsininvestigationalunknownsubstrateDetailsDB01115NifedipineapprovedunknownsubstrateDetailsDB01037Selegilineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB01181IfosfamideapprovedunknownsubstrateDetailsDB00313Valproic acidapproved, investigationalunknownsubstrateDetailsDB00238NevirapineapprovedunknownsubstrateDetailsDB00568Cinnarizineapproved, investigationalunknownsubstrateDetailsDB04841FlunarizineapprovedunknownsubstrateDetailsDB00471MontelukastapprovedunknownsubstrateDetailsDB07609N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINEexperimentalunknownDetailsDB07617N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINEexperimentalunknownDetailsDB07621(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINEexperimentalunknownDetailsDB076234,4'-DIPYRIDYL DISULFIDEexperimentalunknownDetailsDB00182Amphetamineapproved, illicit, investigationalunknowninhibitorDetailsDB00972AzelastineapprovedunknownsubstrateinhibitorDetailsDB00604Cisaprideapproved, investigational, withdrawnunknownsubstrateDetailsDB06470ClomethiazoleinvestigationalunknownsubstrateDetailsDB00257Clotrimazoleapproved, vet_approvedunknowninhibitorDetailsDB00363ClozapineapprovednosubstrateDetailsDB00531Cyclophosphamideapproved, investigationalunknownsubstrateDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknowninducerDetailsDB00216Eletriptanapproved, investigationalunknowninducerDetailsDB01544Flunitrazepamapproved, illicitunknownsubstrateDetailsDB00544FluorouracilapprovedunknownsubstrateDetailsDB01213Fomepizoleapproved, vet_approvedunknowninhibitorDetailsDB00951Isoniazidapproved, investigationalunknowninhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB00281Lidocaineapproved, vet_approvedunknownsubstrateDetailsDB01043Memantineapproved, investigationalunknowninhibitorDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB01028Methoxyfluraneapproved, investigational, vet_approved, withdrawnunknownsubstrateDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB06712Nilvadipineapproved, investigationalunknowninhibitorDetailsDB00316AcetaminophenapprovedunknownsubstrateDetailsDB03783PhenacetinwithdrawnunknownsubstrateDetailsDB01435Antipyrineapproved, investigationalunknownsubstrateDetailsDB01174Phenobarbitalapproved, investigationalunknowninducerDetailsDB00396Progesteroneapproved, vet_approvedunknowninducerDetailsDB01045RifampicinapprovedunknowninducerDetailsDB06739SeratrodastexperimentalunknowninhibitorDetailsDB01236Sevofluraneapproved, vet_approvedunknownsubstrateDetailsDB00675TamoxifenapprovedunknownsubstrateDetailsDB00763MethimazoleapprovedunknowninhibitorDetailsDB00495ZidovudineapprovedunknownsubstrateDetailsDB00690Flurazepamapproved, illicit, investigationalunknownsubstrateDetailsDB00755Tretinoinapproved, investigational, nutraceuticalunknownsubstrateDetailsDB01274Arformoterolapproved, investigationalunknownsubstrateDetailsDB04871Lorcaserinapproved, withdrawnnosubstrateDetailsDB01118Amiodaroneapproved, investigationalunknowninhibitorDetailsDB00312Pentobarbitalapproved, investigational, vet_approvedunknowninducerDetailsDB06292DapagliflozinapprovednosubstrateDetailsDB09068Vortioxetineapproved, investigationalnosubstrateDetailsDB09256Tegafurapproved, investigationalnosubstrateDetailsDB09327Tegafur-uracilapproved, investigationalnosubstrateDetailsDB11586Asunaprevirapproved, investigational, withdrawnnosubstrateDetailsDB09274Artesunateapproved, investigationalunknownsubstrateDetailsDB12245Triclabendazoleapproved, investigationalunknowninhibitorDetailsDB00916MetronidazoleapprovedunknownsubstrateDetailsDB05676Apremilastapproved, investigationalunknownsubstrateDetailsDB01039FenofibrateapprovedunknowninhibitorDetailsDB00717NorethisteroneapprovedunknownsubstrateDetailsDB00635Prednisoneapproved, vet_approvedunknowninducerDetailsDB00741Hydrocortisoneapproved, vet_approvedunknowninducerDetailsDB06119Cenobamateapproved, investigationalunknownsubstrateDetailsDB01222BudesonideapprovedunknowninducerDetailsDB00959Methylprednisoloneapproved, vet_approvedunknowninducerDetailsDB00252Phenytoinapproved, vet_approvednosubstrateDetailsDB00983Formoterolapproved, investigationalunknownsubstrateDetailsDB00443Betamethasoneapproved, vet_approvedunknowninducerDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninducerDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknowninducerDetailsDB06448Lonafarnibapproved, investigationalnosubstrateDetailsDB00330EthambutolapprovedunknowninhibitorDetailsDB15119Ropeginterferon alfa-2bapproved, investigationalnoinhibitorDetailsDB09061Cannabidiolapproved, investigationalunknowninhibitorDetailsDB00470Dronabinolapproved, illicitnoinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknowninhibitorDetailsDB14009Medical Cannabisexperimental, investigationalunknowninhibitorDetailsDB12816Terpinen-4-olinvestigationalnosubstrateDetailsDB06374Elacestrantapproved, investigationalunknownsubstrateDetailsDB01194BrinzolamideapprovednosubstrateDetails"
                    }
                },
                {
                    "Label": "UDP-glucuronosyltransferase 1-6",
                    "Detailed Info": {
                        "Name": "UDP-glucuronosyltransferase 1-6",
                        "Synonyms": "2.4.1.17\nGNT1\nPhenol-metabolizing UDP-glucuronosyltransferase\nUDP-glucuronosyltransferase 1-F\nUDP-glucuronosyltransferase 1A6\nUDPGT 1-6\nUGT-1F\nUGT1\nUGT1F",
                        "Gene Name": "UGT1A6",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0008545|UDP-glucuronosyltransferase 1-6\nMACLLRSFQRISAGVFFLALWGMVVGDKLLVVPQDGSHWLSMKDIVEVLSDRGHEIVVVV\nPEVNLLLKESKYYTRKIYPVPYDQEELKNRYQSFGNNHFAERSFLTAPQTEYRNNMIVIG\nLYFINCQSLLQDRDTLNFFKESKFDALFTDPALPCGVILAEYLGLPSVYLFRGFPCSLEH\nTFSRSPDPVSYIPRCYTKFSDHMTFSQRVANFLVNLLEPYLFYCLFSKYEELASAVLKRD\nVDIITLYQKVSVWLLRYDFVLEYPRPVMPNMVFIGGINCKKRKDLSQEFEAYINASGEHG\nIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDLL\nGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTSE\nDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHDL\nTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH",
                        "Number of residues": "532",
                        "Molecular Weight": "60750.215",
                        "Theoretical pI": "Not Available",
                        "GO Classification": "Functionsenzyme binding / glucuronosyltransferase activity / protein heterodimerization activity / protein homodimerization activityProcessescellular glucuronidation / cellular response to hormone stimulus / flavonoid biosynthetic process / flavonoid glucuronidation / negative regulation of cellular glucuronidation / negative regulation of fatty acid metabolic process / negative regulation of glucuronosyltransferase activity / small molecule metabolic process / xenobiotic glucuronidation / xenobiotic metabolic processComponentsendoplasmic reticulum / endoplasmic reticulum membrane / extracellular exosome / integral component of membrane",
                        "General Function": "Protein homodimerization activity",
                        "Specific Function": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isoform has specificity for phenols. Isoform 3 lacks transferase activity but acts as a negative regulator of isoform 1 (By similarity).",
                        "Pfam Domain Function": "UDPGT (PF00201)",
                        "Transmembrane Regions": "490-506",
                        "Cellular Location": "Microsome",
                        "Gene sequence": ">lcl|BSEQ0020785|UDP-glucuronosyltransferase 1-6 (UGT1A6)\nATGGCCTGCCTCCTTCGCTCATTTCAGAGAATTTCTGCAGGGGTTTTCTTCTTAGCACTT\nTGGGGCATGGTTGTAGGTGACAAGCTGCTGGTGGTCCCTCAGGACGGAAGCCACTGGCTT\nAGTATGAAGGATATAGTTGAGGTTCTCAGTGACCGGGGTCATGAGATTGTAGTGGTGGTG\nCCTGAAGTTAATTTGCTTTTGAAAGAATCCAAATACTACACAAGAAAAATCTATCCAGTG\nCCGTATGACCAAGAAGAGCTGAAGAACCGTTACCAATCATTTGGAAACAATCACTTTGCT\nGAGCGATCATTCCTAACTGCTCCTCAGACAGAGTACAGGAATAACATGATTGTTATTGGC\nCTGTACTTCATCAACTGCCAGAGCCTCCTGCAGGACAGGGACACCCTGAACTTCTTTAAG\nGAGAGCAAGTTTGATGCTCTTTTCACAGACCCAGCCTTACCCTGTGGGGTGATCCTGGCT\nGAGTATTTGGGCCTACCATCTGTGTACCTCTTCAGGGGTTTTCCGTGTTCCCTGGAGCAT\nACATTCAGCAGAAGCCCAGACCCTGTGTCCTACATTCCCAGGTGCTACACAAAGTTTTCA\nGACCACATGACTTTTTCCCAACGAGTGGCCAACTTCCTTGTTAATTTGTTGGAGCCCTAT\nCTATTTTATTGTCTGTTTTCAAAGTATGAAGAACTCGCATCAGCTGTCCTCAAGAGAGAT\nGTGGATATAATCACCTTATATCAGAAGGTCTCTGTTTGGCTGTTAAGATATGACTTTGTG\nCTTGAATATCCTAGGCCGGTCATGCCCAACATGGTCTTCATTGGAGGTATCAACTGTAAG\nAAGAGGAAAGACTTGTCTCAGGAATTTGAAGCCTACATTAATGCTTCTGGAGAACATGGA\nATTGTGGTTTTCTCTTTGGGATCAATGGTCTCAGAAATTCCAGAGAAGAAAGCTATGGCA\nATTGCTGATGCTTTGGGCAAAATCCCTCAGACAGTCCTGTGGCGGTACACTGGAACCCGA\nCCATCGAATCTTGCGAACAACACGATACTTGTTAAGTGGCTACCCCAAAACGATCTGCTT\nGGTCACCCGATGACCCGTGCCTTTATCACCCATGCTGGTTCCCATGGTGTTTATGAAAGC\nATATGCAATGGCGTTCCCATGGTGATGATGCCCTTGTTTGGTGATCAGATGGACAATGCA\nAAGCGCATGGAGACTAAGGGAGCTGGAGTGACCCTGAATGTTCTGGAAATGACTTCTGAA\nGATTTAGAAAATGCTCTAAAAGCAGTCATCAATGACAAAAGTTACAAGGAGAACATCATG\nCGCCTCTCCAGCCTTCACAAGGACCGCCCGGTGGAGCCGCTGGACCTGGCCGTGTTCTGG\nGTGGAGTTTGTGATGAGGCACAAGGGCGCGCCACACCTGCGCCCCGCAGCCCACGACCTC\nACCTGGTACCAGTACCATTCCTTGGACGTGATTGGTTTCCTCTTGGCCGTCGTGCTGACA\nGTGGCCTTCATCACCTTTAAATGTTGTGCTTATGGCTACCGGAAATGCTTGGGGAAAAAA\nGGGCGAGTTAAGAAAGCCCACAAATCCAAGACCCATTGA",
                        "Chromosome Location": "2",
                        "Locus": "Not Available",
                        "External Identifiers": "ResourceLinkUniProtKB IDP19224UniProtKB Entry NameUD16_HUMANHGNC IDHGNC:12538",
                        "General References": "Ritter JK, Chen F, Sheen YY, Tran HM, Kimura S, Yeatman MT, Owens IS: A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem. 1992 Feb 15;267(5):3257-61. [Article] Harding D, Fournel-Gigleux S, Jackson MR, Burchell B: Cloning and substrate specificity of a human phenol UDP-glucuronosyltransferase expressed in COS-7 cells. Proc Natl Acad Sci U S A. 1988 Nov;85(22):8381-5. [Article] Gong QH, Cho JW, Huang T, Potter C, Gholami N, Basu NK, Kubota S, Carvalho S, Pennington MW, Owens IS, Popescu NC: Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics. 2001 Jun;11(4):357-68. [Article] Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Munzel PA, Lehmkoster T, Bruck M, Ritter JK, Bock KW: Aryl hydrocarbon receptor-inducible or constitutive expression of human UDP glucuronosyltransferase UGT1A6. Arch Biochem Biophys. 1998 Feb 1;350(1):72-8. [Article] Girard H, Levesque E, Bellemare J, Journault K, Caillier B, Guillemette C: Genetic diversity at the UGT1 locus is amplified by a novel 3' alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity. Pharmacogenet Genomics. 2007 Dec;17(12):1077-89. [Article] Bellemare J, Rouleau M, Girard H, Harvey M, Guillemette C: Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro. Drug Metab Dispos. 2010 Oct;38(10):1785-9. doi: 10.1124/dmd.110.034835. Epub 2010 Jul 7. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Ciotti M, Marrone A, Potter C, Owens IS: Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications. Pharmacogenetics. 1997 Dec;7(6):485-95. [Article] Nagar S, Zalatoris JJ, Blanchard RL: Human UGT1A6 pharmacogenetics: identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cells. Pharmacogenetics. 2004 Aug;14(8):487-99. [Article] Menard V, Girard H, Harvey M, Perusse L, Guillemette C: Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. Hum Mutat. 2009 Apr;30(4):677-87. doi: 10.1002/humu.20946. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB00818Propofolapproved, investigational, vet_approvedunknownsubstrateDetailsDB01024Mycophenolic acidapproved, investigationalunknownsubstrateDetailsDB08826DeferiproneapprovedunknownsubstrateDetailsDB00316AcetaminophenapprovedunknownsubstrateDetailsDB00313Valproic acidapproved, investigationalunknownsubstrateDetailsDB01320Fosphenytoinapproved, investigationalnoinhibitorDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinhibitorDetailsDB09288PropacetamolexperimentalnosubstrateDetailsDB00945Acetylsalicylic acidapproved, vet_approvedunknownsubstrateDetailsDB00788Naproxenapproved, vet_approvedunknownsubstrateDetailsDB00564Carbamazepineapproved, investigationalunknowninducerDetailsDB15598Ferric maltolapprovedunknownsubstrateDetailsDB12243Edaravoneapproved, investigationalnosubstrateDetailsDB00349Clobazamapproved, illicitnoinhibitorDetailsDB00555Lamotrigineapproved, investigationalunknownsubstrateDetailsDB00503Ritonavirapproved, investigationalnoinducerDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB00794Primidoneapproved, vet_approvedunknowninducerDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB00714Apomorphineapproved, investigationalunknownsubstrateDetailsDB11796Fostemsavirapproved, investigationalunknownsubstrateDetailsDB00871TerbutalineapprovedunknownsubstrateDetailsDB00960Pindololapproved, investigationalunknownsubstrateDetailsDB12471Ibrexafungerpapproved, investigationalunknownsubstrateDetails"
                    }
                },
                {
                    "Label": "UDP-glucuronosyltransferase 1-1",
                    "Detailed Info": {
                        "Name": "UDP-glucuronosyltransferase 1-1",
                        "Synonyms": "2.4.1.17\nBilirubin-specific UDPGT isozyme 1\nGNT1\nhUG-BR1\nUDP-glucuronosyltransferase 1-A\nUDP-glucuronosyltransferase 1A1\nUDPGT 1-1\nUGT-1A\nUGT1\nUGT1A",
                        "Gene Name": "UGT1A1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0006823|UDP-glucuronosyltransferase 1-1\nMAVESQGGRPLVLGLLLCVLGPVVSHAGKILLIPVDGSHWLSMLGAIQQLQQRGHEIVVL\nAPDASLYIRDGAFYTLKTYPVPFQREDVKESFVSLGHNVFENDSFLQRVIKTYKKIKKDS\nAMLLSGCSHLLHNKELMASLAESSFDVMLTDPFLPCSPIVAQYLSLPTVFFLHALPCSLE\nFEATQCPNPFSYVPRPLSSHSDHMTFLQRVKNMLIAFSQNFLCDVVYSPYATLASEFLQR\nEVTVQDLLSSASVWLFRSDFVKDYPRPIMPNMVFVGGINCLHQNPLSQEFEAYINASGEH\nGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDL\nLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTS\nEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHD\nLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH",
                        "Number of residues": "533",
                        "Molecular Weight": "59590.91",
                        "Theoretical pI": "8.09",
                        "GO Classification": "Functionsenzyme binding / enzyme inhibitor activity / glucuronosyltransferase activity / protein heterodimerization activity / protein homodimerization activity / retinoic acid binding / steroid bindingProcessesacute-phase response / bilirubin conjugation / biphenyl catabolic process / cellular glucuronidation / cellular response to ethanol / cellular response to glucocorticoid stimulus / cellular response to hormone stimulus / digestion / drug metabolic process / estrogen metabolic process / flavone metabolic process / flavonoid biosynthetic process / flavonoid glucuronidation / heme catabolic process / heterocycle metabolic process / liver development / negative regulation of catalytic activity / negative regulation of cellular glucuronidation / negative regulation of fatty acid metabolic process / negative regulation of glucuronosyltransferase activity / negative regulation of steroid metabolic process / organ regeneration / porphyrin-containing compound metabolic process / response to drug / response to lipopolysaccharide / response to nutrient / response to starvation / retinoic acid metabolic process / small molecule metabolic process / steroid metabolic process / xenobiotic glucuronidation / xenobiotic metabolic processComponentscytochrome complex / endoplasmic reticulum / endoplasmic reticulum chaperone complex / endoplasmic reticulum membrane / integral component of plasma membrane",
                        "General Function": "Steroid binding",
                        "Specific Function": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isoform glucuronidates bilirubin IX-alpha to form both the IX-alpha-C8 and IX-alpha-C12 monoconjugates and diconjugate. Is also able to catalyze the glucuronidation of 17beta-estradiol, 17alpha-ethinylestradiol, 1-hydroxypyrene, 4-methylumbelliferone, 1-naphthol, paranitrophenol, scopoletin, and umbelliferone. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1.",
                        "Pfam Domain Function": "UDPGT (PF00201)",
                        "Transmembrane Regions": "491-507",
                        "Cellular Location": "Microsome",
                        "Gene sequence": ">lcl|BSEQ0021360|UDP-glucuronosyltransferase 1-1 (UGT1A1)\nATGGCTGTGGAGTCCCAGGGCGGACGCCCACTTGTCCTGGGCCTGCTGCTGTGTGTGCTG\nGGCCCAGTGGTGTCCCATGCTGGGAAGATACTGTTGATCCCAGTGGATGGCAGCCACTGG\nCTGAGCATGCTTGGGGCCATCCAGCAGCTGCAGCAGAGGGGACATGAAATAGTTGTCCTA\nGCACCTGACGCCTCGTTGTACATCAGAGACGGAGCATTTTACACCTTGAAGACGTACCCT\nGTGCCATTCCAAAGGGAGGATGTGAAAGAGTCTTTTGTTAGTCTCGGGCATAATGTTTTT\nGAGAATGATTCTTTCCTGCAGCGTGTGATCAAAACATACAAGAAAATAAAAAAGGACTCT\nGCTATGCTTTTGTCTGGCTGTTCCCACTTACTGCACAACAAGGAGCTCATGGCCTCCCTG\nGCAGAAAGCAGCTTTGATGTCATGCTGACGGACCCTTTCCTTCCTTGCAGCCCCATCGTG\nGCCCAGTACCTGTCTCTGCCCACTGTATTCTTCTTGCATGCACTGCCATGCAGCCTGGAA\nTTTGAGGCTACCCAGTGCCCCAACCCATTCTCCTACGTGCCCAGGCCTCTCTCCTCTCAT\nTCAGATCACATGACCTTCCTGCAGCGGGTGAAGAACATGCTCATTGCCTTTTCACAGAAC\nTTTCTGTGCGACGTGGTTTATTCCCCGTATGCAACCCTTGCCTCAGAATTCCTTCAGAGA\nGAGGTGACTGTCCAGGACCTATTGAGCTCTGCATCTGTCTGGCTGTTTAGAAGTGACTTT\nGTGAAGGATTACCCTAGGCCCATCATGCCCAATATGGTTTTTGTTGGTGGAATCAACTGC\nCTTCACCAAAATCCACTATCCCAGGAATTTGAAGCCTACATTAATGCTTCTGGAGAACAT\nGGAATTGTGGTTTTCTCTTTGGGATCAATGGTCTCAGAAATTCCAGAGAAGAAAGCTATG\nGCAATTGCTGATGCTTTGGGCAAAATCCCTCAGACAGTCCTGTGGCGGTACACTGGAACC\nCGACCATCGAATCTTGCGAACAACACGATACTTGTTAAGTGGCTACCCCAAAACGATCTG\nCTTGGTCACCCGATGACCCGTGCCTTTATCACCCATGCTGGTTCCCATGGTGTTTATGAA\nAGCATATGCAATGGCGTTCCCATGGTGATGATGCCCTTGTTTGGTGATCAGATGGACAAT\nGCAAAGCGCATGGAGACTAAGGGAGCTGGAGTGACCCTGAATGTTCTGGAAATGACTTCT\nGAAGATTTAGAAAATGCTCTAAAAGCAGTCATCAATGACAAAAGTTACAAGGAGAACATC\nATGCGCCTCTCCAGCCTTCACAAGGACCGCCCGGTGGAGCCGCTGGACCTGGCCGTGTTC\nTGGGTGGAGTTTGTGATGAGGCACAAGGGCGCGCCACACCTGCGCCCCGCAGCCCACGAC\nCTCACCTGGTACCAGTACCATTCCTTGGACGTGATTGGTTTCCTCTTGGCCGTCGTGCTG\nACAGTGGCCTTCATCACCTTTAAATGTTGTGCTTATGGCTACCGGAAATGCTTGGGGAAA\nAAAGGGCGAGTTAAGAAAGCCCACAAATCCAAGACCCATTGA",
                        "Chromosome Location": "2",
                        "Locus": "2q37",
                        "External Identifiers": "ResourceLinkUniProtKB IDP22309UniProtKB Entry NameUD11_HUMANGenBank Protein ID184473GenBank Gene IDM57899HGNC IDHGNC:12530",
                        "General References": "Ritter JK, Crawford JM, Owens IS: Cloning of two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells. J Biol Chem. 1991 Jan 15;266(2):1043-7. [Article] Ritter JK, Chen F, Sheen YY, Tran HM, Kimura S, Yeatman MT, Owens IS: A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem. 1992 Feb 15;267(5):3257-61. [Article] Gong QH, Cho JW, Huang T, Potter C, Gholami N, Basu NK, Kubota S, Carvalho S, Pennington MW, Owens IS, Popescu NC: Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics. 2001 Jun;11(4):357-68. [Article] Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article] Meunier L, Usherwood YK, Chung KT, Hendershot LM: A subset of chaperones and folding enzymes form multiprotein complexes in endoplasmic reticulum to bind nascent proteins. Mol Biol Cell. 2002 Dec;13(12):4456-69. [Article] Levesque E, Girard H, Journault K, Lepine J, Guillemette C: Regulation of the UGT1A1 bilirubin-conjugating pathway: role of a new splicing event at the UGT1A locus. Hepatology. 2007 Jan;45(1):128-38. [Article] Udomuksorn W, Elliot DJ, Lewis BC, Mackenzie PI, Yoovathaworn K, Miners JO: Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates. Pharmacogenet Genomics. 2007 Dec;17(12):1017-29. [Article] Girard H, Levesque E, Bellemare J, Journault K, Caillier B, Guillemette C: Genetic diversity at the UGT1 locus is amplified by a novel 3' alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity. Pharmacogenet Genomics. 2007 Dec;17(12):1077-89. [Article] Tang L, Singh R, Liu Z, Hu M: Structure and concentration changes affect characterization of UGT isoform-specific metabolism of isoflavones. Mol Pharm. 2009 Sep-Oct;6(5):1466-82. doi: 10.1021/mp8002557. [Article] Sneitz N, Bakker CT, de Knegt RJ, Halley DJ, Finel M, Bosma PJ: Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants. Hum Mutat. 2010 Jan;31(1):52-9. doi: 10.1002/humu.21133. [Article] Johnson AD, Kavousi M, Smith AV, Chen MH, Dehghan A, Aspelund T, Lin JP, van Duijn CM, Harris TB, Cupples LA, Uitterlinden AG, Launer L, Hofman A, Rivadeneira F, Stricker B, Yang Q, O'Donnell CJ, Gudnason V, Witteman JC: Genome-wide association meta-analysis for total serum bilirubin levels. Hum Mol Genet. 2009 Jul 15;18(14):2700-10. doi: 10.1093/hmg/ddp202. Epub 2009 May 4. [Article] Chen R, Jiang X, Sun D, Han G, Wang F, Ye M, Wang L, Zou H: Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009 Feb;8(2):651-61. doi: 10.1021/pr8008012. [Article] Bellemare J, Rouleau M, Girard H, Harvey M, Guillemette C: Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro. Drug Metab Dispos. 2010 Oct;38(10):1785-9. doi: 10.1124/dmd.110.034835. Epub 2010 Jul 7. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Bosma PJ, Chowdhury JR, Huang TJ, Lahiri P, Elferink RP, Van Es HH, Lederstein M, Whitington PF, Jansen PL, Chowdhury NR: Mechanisms of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I. FASEB J. 1992 Jul;6(10):2859-63. [Article] Aono S, Yamada Y, Keino H, Hanada N, Nakagawa T, Sasaoka Y, Yazawa T, Sato H, Koiwai O: Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II. Biochem Biophys Res Commun. 1993 Dec 30;197(3):1239-44. [Article] Moghrabi N, Clarke DJ, Boxer M, Burchell B: Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2. Genomics. 1993 Oct;18(1):171-3. [Article] Ritter JK, Yeatman MT, Kaiser C, Gridelli B, Owens IS: A phenylalanine codon deletion at the UGT1 gene complex locus of a Crigler-Najjar type I patient generates a pH-sensitive bilirubin UDP-glucuronosyltransferase. J Biol Chem. 1993 Nov 5;268(31):23573-9. [Article] Labrune P, Myara A, Hadchouel M, Ronchi F, Bernard O, Trivin F, Chowdhury NR, Chowdhury JR, Munnich A, Odievre M: Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases. Hum Genet. 1994 Dec;94(6):693-7. [Article] Erps LT, Ritter JK, Hersh JH, Blossom D, Martin NC, Owens IS: Identification of two single base substitutions in the UGT1 gene locus which abolish bilirubin uridine diphosphate glucuronosyltransferase activity in vitro. J Clin Invest. 1994 Feb;93(2):564-70. [Article] Seppen J, Bosma PJ, Goldhoorn BG, Bakker CT, Chowdhury JR, Chowdhury NR, Jansen PL, Oude Elferink RP: Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase. J Clin Invest. 1994 Dec;94(6):2385-91. [Article] Aono S, Adachi Y, Uyama E, Yamada Y, Keino H, Nanno T, Koiwai O, Sato H: Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome. Lancet. 1995 Apr 15;345(8955):958-9. [Article] Seppen J, Steenken E, Lindhout D, Bosma PJ, Elferink RP: A mutation which disrupts the hydrophobic core of the signal peptide of bilirubin UDP-glucuronosyltransferase, an endoplasmic reticulum membrane protein, causes Crigler-Najjar type II. FEBS Lett. 1996 Jul 29;390(3):294-8. [Article] Ciotti M, Chen F, Rubaltelli FF, Owens IS: Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease. Biochim Biophys Acta. 1998 Jul 1;1407(1):40-50. [Article] Yamamoto K, Soeda Y, Kamisako T, Hosaka H, Fukano M, Sato H, Fujiyama Y, Adachi Y, Satoh Y, Bamba T: Analysis of bilirubin uridine 5'-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II. J Hum Genet. 1998;43(2):111-4. [Article] Maruo Y, Sato H, Yamano T, Doida Y, Shimada M: Gilbert syndrome caused by a homozygous missense mutation (Tyr486Asp) of bilirubin UDP-glucuronosyltransferase gene. J Pediatr. 1998 Jun;132(6):1045-7. [Article] Kadakol A, Ghosh SS, Sappal BS, Sharma G, Chowdhury JR, Chowdhury NR: Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype. Hum Mutat. 2000 Oct;16(4):297-306. [Article] Maruo Y, Nishizawa K, Sato H, Sawa H, Shimada M: Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene. Pediatrics. 2000 Nov;106(5):E59. [Article] Kadakol A, Sappal BS, Ghosh SS, Lowenheim M, Chowdhury A, Chowdhury S, Santra A, Arias IM, Chowdhury JR, Chowdhury NR: Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus. J Med Genet. 2001 Apr;38(4):244-9. [Article] Labrune P, Myara A, Chalas J, Le Bihan B, Capel L, Francoual J: Association of a homozygous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome. Hum Mutat. 2002 Nov;20(5):399-401. [Article] Sutomo R, Laosombat V, Sadewa AH, Yokoyama N, Nakamura H, Matsuo M, Nishio H: Novel missense mutation of the UGT1A1 gene in Thai siblings with Gilbert's syndrome. Pediatr Int. 2002 Aug;44(4):427-32. [Article] Ohnishi A, Emi Y: Rapid proteasomal degradation of translocation-deficient UDP-glucuronosyltransferase 1A1 proteins in patients with Crigler-Najjar type II. Biochem Biophys Res Commun. 2003 Oct 24;310(3):735-41. [Article] Servedio V, d'Apolito M, Maiorano N, Minuti B, Torricelli F, Ronchi F, Zancan L, Perrotta S, Vajro P, Boschetto L, Iolascon A: Spectrum of UGT1A1 mutations in Crigler-Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation. Hum Mutat. 2005 Mar;25(3):325. [Article] D'Apolito M, Marrone A, Servedio V, Vajro P, De Falco L, Iolascon A: Seven novel mutations of the UGT1A1 gene in patients with unconjugated hyperbilirubinemia. Haematologica. 2007 Jan;92(1):133-4. [Article] Khan S, Irfan M, Sher G, Zubaida B, Alvi MA, Yasinzai M, Naeem M: UGT1A1 gene mutations in Pakistani children suffering from inherited nonhemolytic unconjugated hyperbilirubinemias. Ann Hum Genet. 2013 Nov;77(6):482-7. doi: 10.1111/ahg.12039. Epub 2013 Aug 29. [Article] Minucci A, Canu G, Gentile L, Cimino V, Giardina B, Zuppi C, Capoluongo E: Identification of a novel mutation in UDP-glucuronosyltransferase (UGT1A1) gene in a child with neonatal unconjugated hyperbilirubinemia. Clin Biochem. 2013 Jan;46(1-2):170-2. doi: 10.1016/j.clinbiochem.2012.10.007. Epub 2012 Oct 22. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB01024Mycophenolic acidapproved, investigationalunknownsubstrateDetailsDB01048Abacavirapproved, investigationalunknownsubstrateDetailsDB00173Adenineapproved, nutraceuticalunknowninhibitorDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknownsubstrateDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00818Propofolapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00973EzetimibeapprovedunknownsubstrateDetailsDB01045RifampicinapprovedunknowninducerDetailsDB00678LosartanapprovedunknownsubstrateDetailsDB00712Flurbiprofenapproved, investigationalunknownsubstrateinhibitorDetailsDB00328Indomethacinapproved, investigationalunknownsubstrateinhibitorDetailsDB00870Suprofenapproved, withdrawnunknownsubstrateDetailsDB06741GavestinelinvestigationalunknownsubstrateDetailsDB04868Nilotinibapproved, investigationalunknowninhibitorDetailsDB06210EltrombopagapprovedunknownsubstrateinhibitorDetailsDB00295Morphineapproved, investigationalnosubstrateDetailsDB05039IndacaterolapprovedunknownsubstrateDetailsDB06510MuraglitazarinvestigationalunknownsubstrateDetailsDB00704Naltrexoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB06817RaltegravirapprovedunknownsubstrateDetailsDB04953Ezogabineapproved, investigationalunknownsubstrateDetailsDB01420Testosterone propionateapproved, investigational, vet_approved, withdrawnunknowninducerDetailsDB06589PazopanibapprovedunknowninhibitorDetailsDB06626Axitinibapproved, investigationalnosubstrateDetailsDB08896RegorafenibapprovedunknowninhibitorDetailsDB00316AcetaminophenapprovedunknownsubstrateDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB00227Lovastatinapproved, investigationalnosubstrateDetailsDB00641SimvastatinapprovedunknownsubstrateDetailsDB01544Flunitrazepamapproved, illicitunknowninhibitorDetailsDB00530Erlotinibapproved, investigationalunknowninhibitorDetailsDB00773EtoposideapprovedunknownsubstrateDetailsDB01095FluvastatinapprovedunknownsubstrateDetailsDB00398Sorafenibapproved, investigationalunknowninhibitorDetailsDB08930DolutegravirapprovednosubstrateDetailsDB09101ElvitegravirapprovednosubstrateDetailsDB09183DasabuvirapprovedunknowninhibitorDetailsDB05015Belinostatapproved, investigationalunknownsubstrateDetailsDB11943Delafloxacinapproved, investigationalnosubstrateDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB13878Pibrentasvirapproved, investigationalunknowninhibitorDetailsDB13879Glecaprevirapproved, investigationalunknowninhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB11827Ertugliflozinapproved, investigationalnoinhibitorDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateDetailsDB11799Bictegravirapproved, investigationalunknownsubstrateDetailsDB12010Fostamatinibapproved, investigationalunknowninhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB00224IndinavirapprovedunknowninhibitorDetailsDB00564Carbamazepineapproved, investigationalnoinducerDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinducerDetailsDB01174Phenobarbitalapproved, investigationalnoinducerDetailsDB00932Tipranavirapproved, investigationalnoinducerDetailsDB00220NelfinavirapprovednoinducerDetailsDB00625Efavirenzapproved, investigationalnoinducerDetailsDB00906Tiagabineapproved, investigationalnosubstrateDetailsDB00313Valproic acidapproved, investigationalnosubstrateinhibitorDetailsDB00909Zonisamideapproved, investigationalnosubstrateDetailsDB01136Carvedilolapproved, investigationalnosubstrateDetailsDB03496Alvocidibexperimental, investigationalnosubstrateDetailsDB00695Furosemideapproved, vet_approvednosubstrateDetailsDB01241GemfibrozilapprovednosubstrateinhibitorDetailsDB01067Glipizideapproved, investigationalnosubstrateDetailsDB00451LevothyroxineapprovednosubstrateDetailsDB00916MetronidazoleapprovednosubstrateDetailsDB01183Naloxoneapproved, vet_approvednosubstrateDetailsDB00481Raloxifeneapproved, investigationalnosubstrateDetailsDB00193Tramadolapproved, investigationalnosubstrateDetailsDB00495ZidovudineapprovednosubstrateinducerDetailsDB09298Silibininexperimental, investigationalnoinhibitorDetailsDB09276Sodium aurothiomalateapproved, investigationalnoinhibitorDetailsDB00977EthinylestradiolapprovednosubstrateinducerDetailsDB00439Cerivastatinapproved, withdrawnnosubstrateDetailsDB00947Fulvestrantapproved, investigationalnosubstrateDetailsDB01009Ketoprofenapproved, vet_approvednosubstrateDetailsDB11967Binimetinibapproved, investigationalnosubstrateDetailsDB01072Atazanavirapproved, investigationalnoinhibitorDetailsDB12020Tecovirimatapproved, investigationalunknownsubstrateDetailsDB02703Fusidic acidapproved, investigationalunknownsubstrateDetailsDB09288PropacetamolexperimentalnosubstrateDetailsDB01609Deferasiroxapproved, investigationalunknownsubstrateinhibitorDetailsDB14575EslicarbazepineapprovedunknownsubstrateDetailsDB09213Dexibuprofenapproved, investigationalunknownsubstrateDetailsDB09119Eslicarbazepine acetateapprovedunknownsubstrateDetailsDB11963Dacomitinibapproved, investigationalnoinhibitorDetailsDB01032Probenecidapproved, investigationalnoinhibitorDetailsDB00350Minoxidilapproved, investigationalnosubstrateDetailsDB00279Liothyronineapproved, vet_approvednosubstrateDetailsDB00304DesogestrelapprovednoinducerDetailsDB00598LabetalolapprovedunknownsubstrateDetailsDB12978Pexidartinibapproved, investigationalunknowninhibitorDetailsDB09297Paritaprevirapproved, investigationalunknowninhibitorDetailsDB09079NintedanibapprovedunknownsubstrateDetailsDB00455Loratadineapproved, investigationalunknownDetailsDB06077Lumateperoneapproved, investigationalnosubstrateDetailsDB15328Ubrogepantapproved, investigationalunknowninhibitorDetailsDB00957Norgestimateapproved, investigationalunknownsubstrateDetailsDB11689Selumetinibapproved, investigationalnosubstrateDetailsDB12893Sacituzumab govitecanapproved, investigationalnosubstrateDetailsDB15456Vericiguatapproved, investigationalunknownsubstrateDetailsDB09296Ombitasvirapproved, investigationalunknowninhibitorDetailsDB11751Cabotegravirapproved, investigationalunknownsubstrateDetailsDB04854FebuxostatapprovednosubstrateDetailsDB12016Ponesimodapproved, investigationalunknownsubstrateDetailsDB08804Nandrolone decanoateapproved, illicitunknownsubstrateDetailsDB16703Belumosudilapproved, investigationalnoinhibitorDetailsDB12597Asciminibapproved, investigationalnoinhibitorDetailsDB12713Sotagliflozinapproved, investigationalnosubstrateDetailsDB16236Mitapivatapproved, investigationalnoinducerDetailsDB09074OlaparibapprovedunknowninhibitorDetailsDB08912Dabrafenibapproved, investigationalnoinhibitorDetailsDB15673Lenacapavirapproved, investigationalnosubstrateDetailsDB00470Dronabinolapproved, illicitnosubstrateDetailsDB12243Edaravoneapproved, investigationalnosubstrateDetailsDB12236Bexagliflozinapproved, investigationalunknownsubstrateDetailsDB00349Clobazamapproved, illicitnoupregulatorDetailsDB12255Vadadustatapproved, investigationalunknownsubstrateinducerDetailsDB12874Quizartinibapproved, investigationalnoinhibitorDetailsDB06700Desvenlafaxineapproved, investigationalnosubstrateDetailsDB11763Momelotinibapproved, investigationalunknowninhibitorinducerDetailsDB11718Encorafenibapproved, investigationalnoinhibitorDetailsDB16826RepotrectinibinvestigationalnoinhibitorDetailsDB00555Lamotrigineapproved, investigationalunknownsubstrateDetailsDB00503Ritonavirapproved, investigationalnoinducerDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB00794Primidoneapproved, vet_approvedunknowninducerDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB00714Apomorphineapproved, investigationalunknownsubstrateDetailsDB11796Fostemsavirapproved, investigationalunknownsubstrateDetailsDB00871TerbutalineapprovedunknownsubstrateDetailsDB00960Pindololapproved, investigationalunknownsubstrateDetailsDB12471Ibrexafungerpapproved, investigationalunknownsubstrateDetails"
                    }
                },
                {
                    "Label": "UDP-glucuronosyltransferase 1-9",
                    "Detailed Info": {
                        "Name": "UDP-glucuronosyltransferase 1-9",
                        "Synonyms": "2.4.1.17\nGNT1\nlugP4\nUDP-glucuronosyltransferase 1-I\nUDP-glucuronosyltransferase 1A9\nUDPGT 1-9\nUGT-1I\nUGT1\nUGT1I",
                        "Gene Name": "UGT1A9",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0006817|UDP-glucuronosyltransferase 1-9\nMACTGWTSPLPLCVCLLLTCGFAEAGKLLVVPMDGSHWFTMRSVVEKLILRGHEVVVVMP\nEVSWQLGRSLNCTVKTYSTSYTLEDLDREFKAFAHAQWKAQVRSIYSLLMGSYNDIFDLF\nFSNCRSLFKDKKLVEYLKESSFDAVFLDPFDNCGLIVAKYFSLPSVVFARGILCHYLEEG\nAQCPAPLSYVPRILLGFSDAMTFKERVRNHIMHLEEHLLCHRFFKNALEIASEILQTPVT\nEYDLYSHTSIWLLRTDFVLDYPKPVMPNMIFIGGINCHQGKPLPMEFEAYINASGEHGIV\nVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQNDLLGH\nPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMTSEDL\nENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAHDLTW\nYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH",
                        "Number of residues": "530",
                        "Molecular Weight": "59940.495",
                        "Theoretical pI": "7.96",
                        "GO Classification": "Functionsenzyme binding / enzyme inhibitor activity / glucuronosyltransferase activity / protein heterodimerization activity / protein homodimerization activity / retinoic acid bindingProcessescellular glucuronidation / cellular lipid metabolic process / cellular response to hormone stimulus / flavone metabolic process / flavonoid biosynthetic process / flavonoid glucuronidation / metabolic process / negative regulation of cellular glucuronidation / negative regulation of fatty acid metabolic process / negative regulation of glucuronosyltransferase activity / retinoic acid metabolic process / small molecule metabolic process / xenobiotic glucuronidation / xenobiotic metabolic processComponentsendoplasmic reticulum / endoplasmic reticulum membrane / extracellular exosome / integral component of membrane",
                        "General Function": "Retinoic acid binding",
                        "Specific Function": "UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isoform has specificity for phenols. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1.",
                        "Pfam Domain Function": "UDPGT (PF00201)",
                        "Transmembrane Regions": "488-504",
                        "Cellular Location": "Microsome",
                        "Gene sequence": ">lcl|BSEQ0012464|UDP-glucuronosyltransferase 1-9 (UGT1A9)\nATGGCTTGCACAGGGTGGACCAGCCCCCTTCCTCTATGTGTGTGTCTGCTGCTGACCTGT\nGGCTTTGCCGAGGCAGGGAAGCTACTGGTAGTGCCCATGGATGGGAGCCACTGGTTCACC\nATGAGGTCGGTGGTGGAGAAACTCATTCTCAGGGGGCATGAGGTGGTTGTAGTCATGCCA\nGAGGTGAGTTGGCAACTGGGAAGATCACTGAATTGCACAGTGAAGACTTATTCAACTTCA\nTATACCCTGGAGGATCTGGACCGGGAGTTCAAGGCTTTTGCCCATGCTCAATGGAAAGCA\nCAAGTACGAAGTATATATTCTCTATTAATGGGTTCATACAATGACATTTTTGACTTATTT\nTTTTCAAATTGCAGGAGTTTGTTTAAAGACAAAAAATTAGTAGAATACTTAAAGGAGAGT\nTCTTTTGATGCAGTGTTTCTCGATCCTTTTGATAACTGTGGCTTAATTGTTGCCAAATAT\nTTCTCCCTCCCCTCCGTGGTCTTCGCCAGGGGAATACTTTGCCACTATCTTGAAGAAGGT\nGCACAGTGCCCTGCTCCTCTTTCCTATGTCCCCAGAATTCTCTTAGGGTTCTCAGATGCC\nATGACTTTCAAGGAGAGAGTACGGAACCACATCATGCACTTGGAGGAACATTTATTATGC\nCACCGTTTTTTCAAAAATGCCCTAGAAATAGCCTCTGAAATTCTCCAAACACCTGTTACG\nGAGTATGATCTCTACAGCCACACATCAATTTGGTTGTTGCGAACGGACTTTGTTTTGGAC\nTATCCCAAACCCGTGATGCCCAACATGATCTTCATTGGTGGTATCAACTGCCATCAGGGA\nAAGCCGTTGCCTATGGAATTTGAAGCCTACATTAATGCTTCTGGAGAACATGGAATTGTG\nGTTTTCTCTTTGGGATCAATGGTCTCAGAAATTCCAGAGAAGAAAGCTATGGCAATTGCT\nGATGCTTTGGGCAAAATCCCTCAGACAGTCCTGTGGCGGTACACTGGAACCCGACCATCG\nAATCTTGCGAACAACACGATACTTGTTAAGTGGCTACCCCAAAACGATCTGCTTGGTCAC\nCCGATGACCCGTGCCTTTATCACCCATGCTGGTTCCCATGGTGTTTATGAAAGCATATGC\nAATGGCGTTCCCATGGTGATGATGCCCTTGTTTGGTGATCAGATGGACAATGCAAAGCGC\nATGGAGACTAAGGGAGCTGGAGTGACCCTGAATGTTCTGGAAATGACTTCTGAAGATTTA\nGAAAATGCTCTAAAAGCAGTCATCAATGACAAAAGTTACAAGGAGAACATCATGCGCCTC\nTCCAGCCTTCACAAGGACCGCCCGGTGGAGCCGCTGGACCTGGCCGTGTTCTGGGTGGAG\nTTTGTGATGAGGCACAAGGGCGCGCCACACCTGCGCCCCGCAGCCCACGACCTCACCTGG\nTACCAGTACCATTCCTTGGACGTGATTGGTTTCCTCTTGGCCGTCGTGCTGACAGTGGCC\nTTCATCACCTTTAAATGTTGTGCTTATGGCTACCGGAAATGCTTGGGGAAAAAAGGGCGA\nGTTAAGAAAGCCCACAAATCCAAGACCCATTGA",
                        "Chromosome Location": "2",
                        "Locus": "2q37",
                        "External Identifiers": "ResourceLinkUniProtKB IDO60656UniProtKB Entry NameUD19_HUMANGenBank Protein ID7690346GenBank Gene IDS55985HGNC IDHGNC:12541",
                        "General References": "Wooster R, Sutherland L, Ebner T, Clarke D, Da Cruz e Silva O, Burchell B: Cloning and stable expression of a new member of the human liver phenol/bilirubin: UDP-glucuronosyltransferase cDNA family. Biochem J. 1991 Sep 1;278 ( Pt 2):465-9. [Article] Gong QH, Cho JW, Huang T, Potter C, Gholami N, Basu NK, Kubota S, Carvalho S, Pennington MW, Owens IS, Popescu NC: Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics. 2001 Jun;11(4):357-68. [Article] Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Girard H, Levesque E, Bellemare J, Journault K, Caillier B, Guillemette C: Genetic diversity at the UGT1 locus is amplified by a novel 3' alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity. Pharmacogenet Genomics. 2007 Dec;17(12):1077-89. [Article] Tang L, Singh R, Liu Z, Hu M: Structure and concentration changes affect characterization of UGT isoform-specific metabolism of isoflavones. Mol Pharm. 2009 Sep-Oct;6(5):1466-82. doi: 10.1021/mp8002557. [Article] Bellemare J, Rouleau M, Girard H, Harvey M, Guillemette C: Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro. Drug Metab Dispos. 2010 Oct;38(10):1785-9. doi: 10.1124/dmd.110.034835. Epub 2010 Jul 7. [Article] Nakajima M, Koga T, Sakai H, Yamanaka H, Fujiwara R, Yokoi T: N-Glycosylation plays a role in protein folding of human UGT1A9. Biochem Pharmacol. 2010 Apr 15;79(8):1165-72. doi: 10.1016/j.bcp.2009.11.020. Epub 2009 Nov 29. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE: The consensus coding sequences of human breast and colorectal cancers. Science. 2006 Oct 13;314(5797):268-74. Epub 2006 Sep 7. [Article] Menard V, Girard H, Harvey M, Perusse L, Guillemette C: Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. Hum Mutat. 2009 Apr;30(4):677-87. doi: 10.1002/humu.20946. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00398Sorafenibapproved, investigationalunknownsubstrateinhibitorDetailsDB00328Indomethacinapproved, investigationalunknownsubstrateDetailsDB00494Entacaponeapproved, investigationalunknownsubstrateDetailsDB00749Etodolacapproved, investigational, vet_approvedunknownsubstrateDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateDetailsDB00818Propofolapproved, investigational, vet_approvedunknownsubstrateDetailsDB01024Mycophenolic acidapproved, investigationalunknownsubstrateDetailsDB00313Valproic acidapproved, investigationalunknownsubstrateDetailsDB00502HaloperidolapprovedunknownsubstrateDetailsDB00744Zileutonapproved, investigational, withdrawnunknownsubstrateDetailsDB00712Flurbiprofenapproved, investigationalunknownsubstrateDetailsDB01050IbuprofenapprovedunknownsubstrateDetailsDB01283Lumiracoxibapproved, investigationalunknownsubstrateDetailsDB00580Valdecoxibapproved, investigational, withdrawnunknownsubstrateDetailsDB00731Nateglinideapproved, investigationalunknownsubstrateDetailsDB06739SeratrodastexperimentalunknownsubstrateDetailsDB06741GavestinelinvestigationalunknownsubstrateDetailsDB06738KetobemidoneinvestigationalunknownsubstrateDetailsDB06403Ambrisentanapproved, investigationalunknownsubstrateDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknownsubstrateDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB04824Phenolphthaleinapproved, withdrawnunknownDetailsDB04552Niflumic acidexperimentalunknownDetailsDB06235VadimezaninvestigationalunknownsubstrateDetailsDB04953Ezogabineapproved, investigationalunknownsubstrateDetailsDB06204TapentadolapprovedunknownsubstrateDetailsDB06695Dabigatran etexilateapprovedunknownsubstrateDetailsDB08896RegorafenibapprovedunknownsubstrateinhibitorDetailsDB08907CanagliflozinapprovedunknownsubstrateDetailsDB00316AcetaminophenapprovedunknownsubstrateDetailsDB00842OxazepamapprovedunknownsubstrateDetailsDB06292DapagliflozinapprovednosubstrateDetailsDB01685TopiroxostatexperimentalunknownsubstrateDetailsDB05016Atalurenapproved, investigationalnosubstrateDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateDetailsDB08930DolutegravirapprovednosubstrateDetailsDB11827Ertugliflozinapproved, investigationalnosubstrateDetailsDB11638Artenimolapproved, experimental, investigationalnosubstrateDetailsDB11633Isavuconazoleapproved, investigationalunknowninhibitorDetailsDB09285MorniflumateexperimentalunknowninhibitorDetailsDB12010Fostamatinibapproved, investigationalunknownsubstrateDetailsDB01039FenofibrateapprovednosubstrateDetailsDB01320Fosphenytoinapproved, investigationalnoinhibitorDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinhibitorDetailsDB09288PropacetamolexperimentalnosubstrateDetailsDB01609Deferasiroxapproved, investigationalunknowninhibitorDetailsDB09213Dexibuprofenapproved, investigationalunknownsubstrateDetailsDB06210EltrombopagapprovednoinhibitorDetailsDB00784Mefenamic acidapprovednoinhibitorDetailsDB00861Diflunisalapproved, investigationalnoinhibitorDetailsDB04552Niflumic acidexperimentalnoinhibitorDetailsDB01045RifampicinapprovedunknowninhibitorDetailsDB11978Glasdegibapproved, investigationalnosubstrateDetailsDB00788Naproxenapproved, vet_approvedunknownsubstrateDetailsDB00586Diclofenacapproved, vet_approvedunknownsubstrateDetailsDB00598LabetalolapprovedunknownsubstrateDetailsDB01241GemfibrozilapprovedunknownsubstrateDetailsDB12941Darolutamideapproved, investigationalunknownDetailsDB00983Formoterolapproved, investigationalunknownsubstrateDetailsDB00977EthinylestradiolapprovedunknownsubstrateDetailsDB13609UmifenovirinvestigationalunknownsubstrateinhibitorDetailsDB09241Methylene blueapproved, investigationalunknowninhibitorDetailsDB09038EmpagliflozinapprovedunknownsubstrateDetailsDB09274Artesunateapproved, investigationalunknownsubstrateDetailsDB00935Oxymetazolineapproved, investigationalnosubstrateDetailsDB15456Vericiguatapproved, investigationalunknownsubstrateDetailsDB11751Cabotegravirapproved, investigationalunknownsubstrateDetailsDB04854FebuxostatapprovednosubstrateDetailsDB16703Belumosudilapproved, investigationalnosubstrateinhibitorDetailsDB12713Sotagliflozinapproved, investigationalnosubstrateDetailsDB04847Roxadustatapproved, investigationalunknownsubstrateDetailsDB09061Cannabidiolapproved, investigationalnosubstrateinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknownsubstrateinhibitorDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorDetailsDB09185Viloxazineapproved, investigational, withdrawnnosubstrateDetailsDB16650Deucravacitinibapproved, investigationalunknownsubstrateDetailsDB00470Dronabinolapproved, illicitnosubstrateDetailsDB12243Edaravoneapproved, investigationalnosubstrateDetailsDB12236Bexagliflozinapproved, investigationalunknownsubstrateDetailsDB17472Pirtobrutinibapproved, investigationalunknownsubstrateDetailsDB06045Trofinetideapproved, investigationalunknowninhibitorDetailsDB12255Vadadustatapproved, investigationalunknownsubstrateDetailsDB11763Momelotinibapproved, investigationalunknowninhibitorDetailsDB00555Lamotrigineapproved, investigationalunknownsubstrateDetailsDB00503Ritonavirapproved, investigationalnoinducerDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB00794Primidoneapproved, vet_approvedunknowninducerDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB00714Apomorphineapproved, investigationalunknownsubstrateDetailsDB11796Fostemsavirapproved, investigationalunknownsubstrateDetailsDB00871TerbutalineapprovedunknownsubstrateDetailsDB00960Pindololapproved, investigationalunknownsubstrateDetailsDB12471Ibrexafungerpapproved, investigationalunknownsubstrateDetails"
                    }
                },
                {
                    "Label": "UDP-glucuronosyltransferase 2B15",
                    "Detailed Info": {
                        "Name": "UDP-glucuronosyltransferase 2B15",
                        "Synonyms": "2.4.1.17\nHLUG4\nUDP-glucuronosyltransferase 2B8\nUDPGT 2B15\nUDPGT 2B8\nUDPGTh-3\nUGT2B8",
                        "Gene Name": "UGT2B15",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0017513|UDP-glucuronosyltransferase 2B15\nMSLKWTSVFLLIQLSCYFSSGSCGKVLVWPTEYSHWINMKTILEELVQRGHEVTVLTSSA\nSTLVNASKSSAIKLEVYPTSLTKNYLEDSLLKILDRWIYGVSKNTFWSYFSQLQELCWEY\nYDYSNKLCKDAVLNKKLMMKLQESKFDVILADALNPCGELLAELFNIPFLYSLRFSVGYT\nFEKNGGGFLFPPSYVPVVMSELSDQMIFMERIKNMIHMLYFDFWFQIYDLKKWDQFYSEV\nLGRPTTLFETMGKAEMWLIRTYWDFEFPRPFLPNVDFVGGLHCKPAKPLPKEMEEFVQSS\nGENGIVVFSLGSMISNMSEESANMIASALAQIPQKVLWRFDGKKPNTLGSNTRLYKWLPQ\nNDLLGHPKTKAFITHGGTNGIYEAIYHGIPMVGIPLFADQHDNIAHMKAKGAALSVDIRT\nMSSRDLLNALKSVINDPVYKENVMKLSRIHHDQPMKPLDRAVFWIEFVMRHKGAKHLRVA\nAHNLTWIQYHSLDVIAFLLACVATVIFIITKFCLFCFRKLAKKGKKKKRD",
                        "Number of residues": "530",
                        "Molecular Weight": "61035.815",
                        "Theoretical pI": "Not Available",
                        "GO Classification": "Functionsglucuronosyltransferase activityProcessescellular glucuronidation / cellular response to hormone stimulus / flavonoid biosynthetic process / flavonoid glucuronidation / steroid metabolic process / xenobiotic metabolic processComponentsendoplasmic reticulum membrane / integral component of membrane / intracellular membrane-bounded organelle",
                        "General Function": "Glucuronosyltransferase activity",
                        "Specific Function": "UDPGTs are of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isozyme displays activity toward several classes of xenobiotic substrates, including simple phenolic compounds, 7-hydroxylated coumarins, flavonoids, anthraquinones, and certain drugs and their hydroxylated metabolites. It also catalyzes the glucuronidation of endogenous estrogens and androgens.",
                        "Pfam Domain Function": "UDPGT (PF00201)",
                        "Transmembrane Regions": "495-515",
                        "Cellular Location": "Microsome membrane",
                        "Gene sequence": ">lcl|BSEQ0017514|UDP-glucuronosyltransferase 2B15 (UGT2B15)\nATGTCTCTGAAATGGACGTCAGTCTTTCTGCTGATACAGCTCAGTTGTTACTTTAGCTCT\nGGAAGCTGTGGAAAGGTGCTAGTGTGGCCCACAGAATACAGCCATTGGATAAATATGAAG\nACAATCCTGGAAGAGCTTGTTCAGAGGGGTCATGAGGTGACTGTGTTGACATCTTCGGCT\nTCTACTCTTGTCAATGCCAGTAAATCATCTGCTATTAAATTAGAAGTTTATCCTACATCT\nTTAACTAAAAATTATTTGGAAGATTCTCTTCTGAAAATTCTCGATAGATGGATATATGGT\nGTTTCAAAAAATACATTTTGGTCATATTTTTCACAATTACAAGAATTGTGTTGGGAATAT\nTATGACTACAGTAACAAGCTCTGTAAAGATGCAGTTTTGAATAAGAAACTTATGATGAAA\nCTACAAGAGTCAAAGTTTGATGTCATTCTGGCAGATGCCCTTAATCCCTGTGGTGAGCTA\nCTGGCTGAACTATTTAACATACCCTTTCTGTACAGTCTTCGATTCTCTGTTGGCTACACA\nTTTGAGAAGAATGGTGGAGGATTTCTGTTCCCTCCTTCCTATGTACCTGTTGTTATGTCA\nGAATTAAGTGATCAAATGATTTTCATGGAGAGGATAAAAAATATGATACATATGCTTTAT\nTTTGACTTTTGGTTTCAAATTTATGATCTGAAGAAGTGGGACCAGTTTTATAGTGAAGTT\nCTAGGAAGACCCACTACATTATTTGAGACAATGGGGAAAGCTGAAATGTGGCTCATTCGA\nACCTATTGGGATTTTGAATTTCCTCGCCCATTCTTACCAAATGTTGATTTTGTTGGAGGA\nCTTCACTGTAAACCAGCCAAACCCCTGCCTAAGGAAATGGAAGAGTTTGTGCAGAGCTCT\nGGAGAAAATGGTATTGTGGTGTTTTCTCTGGGGTCGATGATCAGTAACATGTCAGAAGAA\nAGTGCCAACATGATTGCATCAGCCCTTGCCCAGATCCCACAAAAGGTTCTATGGAGATTT\nGATGGCAAGAAGCCAAATACTTTAGGTTCCAATACTCGACTGTACAAGTGGTTACCCCAG\nAATGACCTTCTTGGTCATCCCAAAACCAAAGCTTTTATAACTCATGGTGGAACCAATGGC\nATCTATGAGGCGATCTACCATGGGATCCCTATGGTGGGCATTCCCTTGTTTGCGGATCAA\nCATGATAACATTGCTCACATGAAAGCCAAGGGAGCAGCCCTCAGTGTGGACATCAGGACC\nATGTCAAGTAGAGATTTGCTCAATGCATTGAAGTCAGTCATTAATGACCCTGTCTATAAA\nGAGAATGTCATGAAATTATCAAGAATTCATCATGACCAACCAATGAAGCCCCTGGATCGA\nGCAGTCTTCTGGATTGAGTTTGTCATGCGCCACAAAGGAGCCAAGCACCTTCGAGTCGCA\nGCTCACAACCTCACCTGGATCCAGTACCACTCTTTGGATGTGATAGCATTCCTGCTGGCC\nTGCGTGGCAACTGTGATATTTATCATCACAAAATTTTGCCTGTTTTGTTTCCGAAAGCTT\nGCCAAAAAAGGAAAGAAGAAGAAAAGAGATTAG",
                        "Chromosome Location": "4",
                        "Locus": "Not Available",
                        "External Identifiers": "ResourceLinkUniProtKB IDP54855UniProtKB Entry NameUDB15_HUMANHGNC IDHGNC:12546",
                        "General References": "Chen F, Ritter JK, Wang MG, McBride OW, Lubet RA, Owens IS: Characterization of a cloned human dihydrotestosterone/androstanediol UDP-glucuronosyltransferase and its comparison to other steroid isoforms. Biochemistry. 1993 Oct 12;32(40):10648-57. [Article] Green MD, Oturu EM, Tephly TR: Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates. Drug Metab Dispos. 1994 Sep-Oct;22(5):799-805. [Article] Levesque E, Beaulieu M, Green MD, Tephly TR, Belanger A, Hum DW: Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics. 1997 Aug;7(4):317-25. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article] Coffman BL, Tephly TR, Irshaid YM, Green MD, Smith C, Jackson MR, Wooster R, Burchell B: Characterization and primary sequence of a human hepatic microsomal estriol UDPglucuronosyltransferase. Arch Biochem Biophys. 1990 Aug 15;281(1):170-5. [Article] Chen R, Jiang X, Sun D, Han G, Wang F, Ye M, Wang L, Zou H: Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009 Feb;8(2):651-61. doi: 10.1021/pr8008012. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Toide K, Umeda S, Yamazaki H, Takahashi Y, Terauchi Y, Fujii T, Kamataki T: A major genotype in UDP-glucuronosyltransferase 2B15. Drug Metab Pharmacokinet. 2002;17(2):164-6. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknownsubstrateDetailsDB00295Morphineapproved, investigationalnosubstrateDetailsDB00973EzetimibeapprovedunknownsubstrateDetailsDB06695Dabigatran etexilateapprovedunknownsubstrateDetailsDB00316AcetaminophenapprovedunknownsubstrateDetailsDB00842OxazepamapprovedunknownsubstrateDetailsDB00186LorazepamapprovedunknownsubstrateDetailsDB00313Valproic acidapproved, investigationalunknownsubstrateDetailsDB11943Delafloxacinapproved, investigationalnosubstrateDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateDetailsDB09288PropacetamolexperimentalnosubstrateDetailsDB00455Loratadineapproved, investigationalunknownDetailsDB06077Lumateperoneapproved, investigationalnosubstrateDetailsDB00983Formoterolapproved, investigationalunknownsubstrateDetailsDB00783Estradiolapproved, investigational, vet_approvedunknowninducerDetailsDB00514DextromethorphanapprovedunknownsubstrateDetailsDB09185Viloxazineapproved, investigational, withdrawnnosubstrateDetailsDB06045Trofinetideapproved, investigationalunknowninhibitorDetailsDB06700Desvenlafaxineapproved, investigationalnosubstrateDetailsDB00555Lamotrigineapproved, investigationalunknownsubstrateDetailsDB00503Ritonavirapproved, investigationalnoinducerDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB00794Primidoneapproved, vet_approvedunknowninducerDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB00714Apomorphineapproved, investigationalunknownsubstrateDetailsDB11796Fostemsavirapproved, investigationalunknownsubstrateDetailsDB00871TerbutalineapprovedunknownsubstrateDetailsDB00960Pindololapproved, investigationalunknownsubstrateDetailsDB12471Ibrexafungerpapproved, investigationalunknownsubstrateDetails"
                    }
                },
                {
                    "Label": "Sulfotransferase 1A1",
                    "Detailed Info": {
                        "Name": "Sulfotransferase 1A1",
                        "Synonyms": "2.8.2.1\nAryl sulfotransferase 1\nHAST1/HAST2\nP-PST 1\nPhenol sulfotransferase 1\nPhenol-sulfating phenol sulfotransferase 1\nST1A1\nST1A3\nSTP\nSTP1\nThermostable phenol sulfotransferase\nTs-PST",
                        "Gene Name": "SULT1A1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0037102|Sulfotransferase 1A1\nMELIQDTSRPPLEYVKGVPLIKYFAEALGPLQSFQARPDDLLISTYPKSGTTWVSQILDM\nIYQGGDLEKCHRAPIFMRVPFLEFKAPGIPSGMETLKDTPAPRLLKTHLPLALLPQTLLD\nQKVKVVYVARNAKDVAVSYYHFYHMAKVHPEPGTWDSFLEKFMVGEVSYGSWYQHVQEWW\nELSRTHPVLYLFYEDMKENPKREIQKILEFVGRSLPEETVDFVVQHTSFKEMKKNPMTNY\nTTVPQEFMDHSISPFMRKGMAGDWKTTFTVAQNERFDADYAEKMAGCSLSFRSEL",
                        "Number of residues": "295",
                        "Molecular Weight": "34165.13",
                        "Theoretical pI": "6.61",
                        "GO Classification": "Functionsaryl sulfotransferase activity / flavonol 3-sulfotransferase activity / steroid sulfotransferase activity / sulfotransferase activityProcesses3'-phosphoadenosine 5'-phosphosulfate metabolic process / amine metabolic process / catecholamine metabolic process / estrogen metabolic process / flavonoid metabolic process / small molecule metabolic process / sulfation / xenobiotic metabolic processComponentscytosol",
                        "General Function": "Sulfotransferase activity",
                        "Specific Function": "Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation of catecholamines, phenolic drugs and neurotransmitters. Has also estrogen sulfotransferase activity. responsible for the sulfonation and activation of minoxidil. Is Mediates the metabolic activation of carcinogenic N-hydroxyarylamines to DNA binding products and could so participate as modulating factor of cancer risk.",
                        "Pfam Domain Function": "Sulfotransfer_1 (PF00685)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Cytoplasm",
                        "Gene sequence": ">lcl|BSEQ0016255|Sulfotransferase 1A1 (SULT1A1)\nATGGAGCTGATCCAGGACACCTCCCGCCCGCCACTGGAGTACGTGAAGGGGGTCCCGCTC\nATCAAGTACTTTGCAGAGGCACTGGGGCCCCTGCAGAGCTTCCAGGCCCGGCCTGATGAC\nCTGCTCATCAGCACCTACCCCAAGTCCGGCACTACCTGGGTAAGCCAGATTCTGGACATG\nATCTACCAGGGTGGTGACCTGGAGAAGTGTCACCGAGCTCCCATCTTCATGCGGGTGCCC\nTTCCTTGAGTTCAAAGCCCCAGGGATTCCCTCAGGGATGGAGACTCTGAAAGACACACCG\nGCCCCACGACTCCTGAAGACACACCTGCCCCTGGCTCTGCTCCCCCAGACTCTGTTGGAT\nCAGAAGGTCAAGGTGGTCTATGTTGCCCGCAACGCAAAGGATGTGGCAGTTTCCTACTAC\nCACTTCTACCACATGGCCAAGGTGCACCCTGAGCCTGGGACCTGGGACAGCTTCCTGGAG\nAAGTTCATGGTCGGAGAAGTGTCCTACGGATCCTGGTACCAGCACGTGCAGGAGTGGTGG\nGAGCTGAGCCGCACCCACCCTGTTCTCTACCTCTTCTATGAAGACATGAAGGAGAACCCG\nAAAAGGGAGATTCAAAAGATCCTGGAGTTTGTGGGGCGCTCCCTGCCAGAGGAGACCGTG\nGACTTCGTGGTTCAGCACACGTCGTTCAAGGAGATGAAGAAGAACCCTATGACCAACTAC\nACCACCGTCCCCCAGGAGTTCATGGACCACAGCATCTCCCCCTTCATGAGGAAAGGCATG\nGCTGGGGACTGGAAGACCACCTTCACCGTGGCGCAGAATGAGCGCTTCGATGCGGACTAT\nGCGGAGAAGATGGCAGGCTGCAGCCTCAGCTTCCGCTCTGAGCTGTGA",
                        "Chromosome Location": "16",
                        "Locus": "16p12.1",
                        "External Identifiers": "ResourceLinkUniProtKB IDP50225UniProtKB Entry NameST1A1_HUMANGenBank Protein ID179042GenBank Gene IDL10819GenAtlas IDSULT1A1HGNC IDHGNC:11453",
                        "General References": "Zhu X, Veronese ME, Bernard CC, Sansom LN, McManus ME: Identification of two human brain aryl sulfotransferase cDNAs. Biochem Biophys Res Commun. 1993 Aug 31;195(1):120-7. [Article] Zhu X, Veronese ME, Sansom LN, McManus ME: Molecular characterisation of a human aryl sulfotransferase cDNA. Biochem Biophys Res Commun. 1993 Apr 30;192(2):671-6. [Article] Wilborn TW, Comer KA, Dooley TP, Reardon IM, Heinrikson RL, Falany CN: Sequence analysis and expression of the cDNA for the phenol-sulfating form of human liver phenol sulfotransferase. Mol Pharmacol. 1993 Jan;43(1):70-7. [Article] Yamazoe Y, Nagata K, Ozawa S, Kato R: Structural similarity and diversity of sulfotransferases. Chem Biol Interact. 1994 Jun;92(1-3):107-17. [Article] Hwang SR, Kohn AB, Hook VY: Molecular cloning of an isoform of phenol sulfotransferase from human brain hippocampus. Biochem Biophys Res Commun. 1995 Feb 15;207(2):701-7. [Article] Jones AL, Hagen M, Coughtrie MW, Roberts RC, Glatt H: Human platelet phenolsulfotransferases: cDNA cloning, stable expression in V79 cells and identification of a novel allelic variant of the phenol-sulfating form. Biochem Biophys Res Commun. 1995 Mar 17;208(2):855-62. [Article] Ozawa S, Nagata K, Shimada M, Ueda M, Tsuzuki T, Yamazoe Y, Kato R: Primary structures and properties of two related forms of aryl sulfotransferases in human liver. Pharmacogenetics. 1995;5 Spec No:S135-40. [Article] Dooley TP, Huang Z: Genomic organization and DNA sequences of two human phenol sulfotransferase genes (STP1 and STP2) on the short arm of chromosome 16. Biochem Biophys Res Commun. 1996 Nov 1;228(1):134-40. [Article] Bernier F, Soucy P, Luu-The V: Human phenol sulfotransferase gene contains two alternative promoters: Structure and expression of the gene. DNA Cell Biol. 1996 May;15(5):367-75. [Article] Dajani R, Hood AM, Coughtrie MW: A single amino acid, glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3. Mol Pharmacol. 1998 Dec;54(6):942-8. [Article] Martin J, Han C, Gordon LA, Terry A, Prabhakar S, She X, Xie G, Hellsten U, Chan YM, Altherr M, Couronne O, Aerts A, Bajorek E, Black S, Blumer H, Branscomb E, Brown NC, Bruno WJ, Buckingham JM, Callen DF, Campbell CS, Campbell ML, Campbell EW, Caoile C, Challacombe JF, Chasteen LA, Chertkov O, Chi HC, Christensen M, Clark LM, Cohn JD, Denys M, Detter JC, Dickson M, Dimitrijevic-Bussod M, Escobar J, Fawcett JJ, Flowers D, Fotopulos D, Glavina T, Gomez M, Gonzales E, Goodstein D, Goodwin LA, Grady DL, Grigoriev I, Groza M, Hammon N, Hawkins T, Haydu L, Hildebrand CE, Huang W, Israni S, Jett J, Jewett PB, Kadner K, Kimball H, Kobayashi A, Krawczyk MC, Leyba T, Longmire JL, Lopez F, Lou Y, Lowry S, Ludeman T, Manohar CF, Mark GA, McMurray KL, Meincke LJ, Morgan J, Moyzis RK, Mundt MO, Munk AC, Nandkeshwar RD, Pitluck S, Pollard M, Predki P, Parson-Quintana B, Ramirez L, Rash S, Retterer J, Ricke DO, Robinson DL, Rodriguez A, Salamov A, Saunders EH, Scott D, Shough T, Stallings RL, Stalvey M, Sutherland RD, Tapia R, Tesmer JG, Thayer N, Thompson LS, Tice H, Torney DC, Tran-Gyamfi M, Tsai M, Ulanovsky LE, Ustaszewska A, Vo N, White PS, Williams AL, Wills PL, Wu JR, Wu K, Yang J, Dejong P, Bruce D, Doggett NA, Deaven L, Schmutz J, Grimwood J, Richardson P, Rokhsar DS, Eichler EE, Gilna P, Lucas SM, Myers RM, Rubin EM, Pennacchio LA: The sequence and analysis of duplication-rich human chromosome 16. Nature. 2004 Dec 23;432(7020):988-94. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Dooley TP, Obermoeller RD, Leiter EH, Chapman HD, Falany CN, Deng Z, Siciliano MJ: Mapping of the phenol sulfotransferase gene (STP) to human chromosome 16p12.1-p11.2 and to mouse chromosome 7. Genomics. 1993 Nov;18(2):440-3. [Article] Veronese ME, Burgess W, Zhu X, McManus ME: Functional characterization of two human sulphotransferase cDNAs that encode monoamine- and phenol-sulphating forms of phenol sulphotransferase: substrate kinetics, thermal-stability and inhibitor-sensitivity studies. Biochem J. 1994 Sep 1;302 ( Pt 2):497-502. [Article] Falany CN, Zhuang W, Falany JL: Characterization of expressed human phenol-sulfating phenol sulfotransferase: effect of mutating cys70 on activity and thermostability. Chem Biol Interact. 1994 Jun;92(1-3):57-66. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Vaca Jacome AS, Rabilloud T, Schaeffer-Reiss C, Rompais M, Ayoub D, Lane L, Bairoch A, Van Dorsselaer A, Carapito C: N-terminome analysis of the human mitochondrial proteome. Proteomics. 2015 Jul;15(14):2519-24. doi: 10.1002/pmic.201400617. Epub 2015 Jun 8. [Article] Gamage NU, Duggleby RG, Barnett AC, Tresillian M, Latham CF, Liyou NE, McManus ME, Martin JL: Structure of a human carcinogen-converting enzyme, SULT1A1. Structural and kinetic implications of substrate inhibition. J Biol Chem. 2003 Feb 28;278(9):7655-62. Epub 2002 Dec 5. [Article] Gamage NU, Tsvetanov S, Duggleby RG, McManus ME, Martin JL: The structure of human SULT1A1 crystallized with estradiol. An insight into active site plasticity and substrate inhibition with multi-ring substrates. J Biol Chem. 2005 Dec 16;280(50):41482-6. Epub 2005 Oct 12. [Article] Lu J, Li H, Zhang J, Li M, Liu MY, An X, Liu MC, Chang W: Crystal structures of SULT1A2 and SULT1A1 *3: insights into the substrate inhibition and the role of Tyr149 in SULT1A2. Biochem Biophys Res Commun. 2010 May 28;396(2):429-34. doi: 10.1016/j.bbrc.2010.04.109. Epub 2010 Apr 22. [Article] Alcolombri U, Elias M, Tawfik DS: Directed evolution of sulfotransferases and paraoxonases by ancestral libraries. J Mol Biol. 2011 Aug 26;411(4):837-53. doi: 10.1016/j.jmb.2011.06.037. Epub 2011 Jun 24. [Article] Berger I, Guttman C, Amar D, Zarivach R, Aharoni A: The molecular basis for the broad substrate specificity of human sulfotransferase 1A1. PLoS One. 2011;6(11):e26794. doi: 10.1371/journal.pone.0026794. Epub 2011 Nov 1. [Article] Raftogianis RB, Wood TC, Otterness DM, Van Loon JA, Weinshilboum RM: Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochem Biophys Res Commun. 1997 Oct 9;239(1):298-304. [Article] Engelke CE, Meinl W, Boeing H, Glatt H: Association between functional genetic polymorphisms of human sulfotransferases 1A1 and 1A2. Pharmacogenetics. 2000 Mar;10(2):163-9. [Article] Burkard TR, Planyavsky M, Kaupe I, Breitwieser FP, Burckstummer T, Bennett KL, Superti-Furga G, Colinge J: Initial characterization of the human central proteome. BMC Syst Biol. 2011 Jan 26;5:17. doi: 10.1186/1752-0509-5-17. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB01812Adenosine 3',5'-diphosphateexperimentalunknownDetailsDB04417P-NitrophenolexperimentalunknownDetailsDB00316AcetaminophenapprovedunknownsubstrateDetailsDB00675TamoxifenapprovedunknownsubstrateDetailsDB11077Polyethylene glycol 400approvedunknownsubstrateDetailsDB09070Tiboloneapproved, investigationalunknownsubstrateDetailsDB09288PropacetamolexperimentalnosubstrateDetailsDB09100Thyroid, porcineapprovedunknownsubstrateDetailsDB00714Apomorphineapproved, investigationalunknownsubstrateDetailsDB00867Ritodrineapproved, investigationalnosubstrateDetailsDB00871TerbutalineapprovedunknownsubstrateDetailsDB00960Pindololapproved, investigationalunknownsubstrateDetailsDB00968MethyldopaapprovednosubstrateDetailsDB12471Ibrexafungerpapproved, investigationalunknownsubstrateDetailsDB00867Ritodrineapproved, investigationalnosubstrateDetailsDB12243Edaravoneapproved, investigationalnosubstrateDetails"
                    }
                },
                {
                    "Label": "Sulfotransferase 1A3/1A4",
                    "Detailed Info": {
                        "Name": "Sulfotransferase 1A3",
                        "Synonyms": "2.8.2.1\nAryl sulfotransferase 1A3/1A4\nCatecholamine-sulfating phenol sulfotransferase\nHAST3\nM-PST\nMonoamine-sulfating phenol sulfotransferase\nPlacental estrogen sulfotransferase\nST1A3\nSTM\nSulfotransferase 1A3/1A4\nSulfotransferase, monoamine-preferring\nThermolabile phenol sulfotransferase\nTL-PST",
                        "Gene Name": "SULT1A3",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0051284|Sulfotransferase 1A3\nMELIQDTSRPPLEYVKGVPLIKYFAEALGPLQSFQARPDDLLINTYPKSGTTWVSQILDM\nIYQGGDLEKCNRAPIYVRVPFLEVNDPGEPSGLETLKDTPPPRLIKSHLPLALLPQTLLD\nQKVKVVYVARNPKDVAVSYYHFHRMEKAHPEPGTWDSFLEKFMAGEVSYGSWYQHVQEWW\nELSRTHPVLYLFYEDMKENPKREIQKILEFVGRSLPEETMDFMVQHTSFKEMKKNPMTNY\nTTVPQELMDHSISPFMRKGMAGDWKTTFTVAQNERFDADYAEKMAGCSLSFRSEL",
                        "Number of residues": "295",
                        "Molecular Weight": "34195.96",
                        "Theoretical pI": "Not Available",
                        "GO Classification": "Functionsamine sulfotransferase activity / aryl sulfotransferase activity / sulfate binding / sulfotransferase activityProcesses3'-phosphoadenosine 5'-phosphosulfate metabolic process / calcineurin-mediated signaling / cellular response to dopamine / dopamine catabolic process / dopamine receptor signaling pathway / ERK1 and ERK2 cascade / ethanol catabolic process / flavonoid metabolic process / IRE1-mediated unfolded protein response / negative regulation of neuron death / NMDA selective glutamate receptor signaling pathway / steroid metabolic process / sulfation / xenobiotic metabolic processComponentscytosol",
                        "General Function": "Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation of phenolic monoamines (neurotransmitters such as dopamine, norepinephrine and serotonin) and phenolic and catechol drugs.",
                        "Specific Function": "Amine sulfotransferase activity",
                        "Pfam Domain Function": "Sulfotransfer_1 (PF00685)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Cytoplasm",
                        "Gene sequence": ">lcl|BSEQ0051285|Sulfotransferase 1A3 (SULT1A3)\nATGGAGCTGATCCAGGACACCTCCCGCCCGCCACTGGAGTACGTGAAGGGGGTCCCGCTC\nATCAAGTACTTTGCAGAGGCACTGGGGCCCCTGCAGAGCTTCCAGGCCCGACCTGATGAC\nCTGCTCATCAACACCTACCCCAAGTCTGGCACCACCTGGGTGAGCCAGATACTGGACATG\nATCTACCAGGGCGGCGACCTAGAGAAGTGTAACCGGGCTCCCATCTACGTACGGGTGCCC\nTTCCTTGAGGTCAATGATCCAGGGGAACCCTCAGGGCTGGAGACTCTGAAAGACACACCG\nCCCCCACGGCTCATCAAGTCACACCTGCCCCTGGCTCTGCTCCCTCAGACTCTGTTGGAT\nCAGAAGGTCAAGGTGGTCTATGTTGCCCGAAACCCAAAGGACGTGGCGGTCTCCTACTAC\nCATTTCCACCGTATGGAAAAGGCGCACCCTGAGCCTGGGACCTGGGACAGCTTCCTGGAA\nAAGTTCATGGCTGGAGAAGTGTCCTACGGGTCCTGGTACCAGCACGTGCAGGAGTGGTGG\nGAGCTGAGCCGCACCCACCCTGTTCTCTACCTCTTCTATGAAGACATGAAGGAGAACCCC\nAAAAGGGAGATTCAAAAGATCCTGGAGTTTGTGGGGCGCTCCCTGCCAGAGGAGACCATG\nGACTTCATGGTTCAGCACACGTCGTTCAAGGAGATGAAGAAGAACCCTATGACCAACTAC\nACCACCGTCCCCCAGGAGCTCATGGACCACAGCATCTCCCCCTTCATGAGGAAAGGCATG\nGCTGGGGACTGGAAGACCACCTTCACCGTGGCGCAGAATGAGCGCTTCGATGCGGACTAT\nGCGGAGAAGATGGCAGGCTGCAGCCTCAGCTTCCGCTCTGAGCTGTGA",
                        "Chromosome Location": "Not Available",
                        "Locus": "Not Available",
                        "External Identifiers": "ResourceLinkUniProtKB IDP0DMM9UniProtKB Entry NameST1A3_HUMANHGNC IDHGNC:11455",
                        "General References": "Zhu X, Veronese ME, Bernard CC, Sansom LN, McManus ME: Identification of two human brain aryl sulfotransferase cDNAs. Biochem Biophys Res Commun. 1993 Aug 31;195(1):120-7. [Article] Bernier F, Lopez Solache I, Labrie F, Luu-The V: Cloning and expression of cDNA encoding human placental estrogen sulfotransferase. Mol Cell Endocrinol. 1994 Feb;99(1):R11-5. [Article] Dooley TP, Probst P, Munroe PB, Mole SE, Liu Z, Doggett NA: Genomic organization and DNA sequence of the human catecholamine-sulfating phenol sulfotransferase gene (STM). Biochem Biophys Res Commun. 1994 Dec 15;205(2):1325-32. [Article] Wood TC, Aksoy IA, Aksoy S, Weinshilboum RM: Human liver thermolabile phenol sulfotransferase: cDNA cloning, expression and characterization. Biochem Biophys Res Commun. 1994 Feb 15;198(3):1119-27. [Article] Aksoy IA, Weinshilboum RM: Human thermolabile phenol sulfotransferase gene (STM): molecular cloning and structural characterization. Biochem Biophys Res Commun. 1995 Mar 17;208(2):786-95. [Article] Jones AL, Hagen M, Coughtrie MW, Roberts RC, Glatt H: Human platelet phenolsulfotransferases: cDNA cloning, stable expression in V79 cells and identification of a novel allelic variant of the phenol-sulfating form. Biochem Biophys Res Commun. 1995 Mar 17;208(2):855-62. [Article] Bernier F, Leblanc G, Labrie F, Luu-The V: Structure of human estrogen and aryl sulfotransferase gene. Two mRNA species issued from a single gene. J Biol Chem. 1994 Nov 11;269(45):28200-5. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Martin J, Han C, Gordon LA, Terry A, Prabhakar S, She X, Xie G, Hellsten U, Chan YM, Altherr M, Couronne O, Aerts A, Bajorek E, Black S, Blumer H, Branscomb E, Brown NC, Bruno WJ, Buckingham JM, Callen DF, Campbell CS, Campbell ML, Campbell EW, Caoile C, Challacombe JF, Chasteen LA, Chertkov O, Chi HC, Christensen M, Clark LM, Cohn JD, Denys M, Detter JC, Dickson M, Dimitrijevic-Bussod M, Escobar J, Fawcett JJ, Flowers D, Fotopulos D, Glavina T, Gomez M, Gonzales E, Goodstein D, Goodwin LA, Grady DL, Grigoriev I, Groza M, Hammon N, Hawkins T, Haydu L, Hildebrand CE, Huang W, Israni S, Jett J, Jewett PB, Kadner K, Kimball H, Kobayashi A, Krawczyk MC, Leyba T, Longmire JL, Lopez F, Lou Y, Lowry S, Ludeman T, Manohar CF, Mark GA, McMurray KL, Meincke LJ, Morgan J, Moyzis RK, Mundt MO, Munk AC, Nandkeshwar RD, Pitluck S, Pollard M, Predki P, Parson-Quintana B, Ramirez L, Rash S, Retterer J, Ricke DO, Robinson DL, Rodriguez A, Salamov A, Saunders EH, Scott D, Shough T, Stallings RL, Stalvey M, Sutherland RD, Tapia R, Tesmer JG, Thayer N, Thompson LS, Tice H, Torney DC, Tran-Gyamfi M, Tsai M, Ulanovsky LE, Ustaszewska A, Vo N, White PS, Williams AL, Wills PL, Wu JR, Wu K, Yang J, Dejong P, Bruce D, Doggett NA, Deaven L, Schmutz J, Grimwood J, Richardson P, Rokhsar DS, Eichler EE, Gilna P, Lucas SM, Myers RM, Rubin EM, Pennacchio LA: The sequence and analysis of duplication-rich human chromosome 16. Nature. 2004 Dec 23;432(7020):988-94. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Aksoy IA, Callen DF, Apostolou S, Her C, Weinshilboum RM: Thermolabile phenol sulfotransferase gene (STM): localization to human chromosome 16p11.2. Genomics. 1994 Sep 1;23(1):275-7. [Article] Veronese ME, Burgess W, Zhu X, McManus ME: Functional characterization of two human sulphotransferase cDNAs that encode monoamine- and phenol-sulphating forms of phenol sulphotransferase: substrate kinetics, thermal-stability and inhibitor-sensitivity studies. Biochem J. 1994 Sep 1;302 ( Pt 2):497-502. [Article] Burkard TR, Planyavsky M, Kaupe I, Breitwieser FP, Burckstummer T, Bennett KL, Superti-Furga G, Colinge J: Initial characterization of the human central proteome. BMC Syst Biol. 2011 Jan 26;5:17. doi: 10.1186/1752-0509-5-17. [Article] Bidwell LM, McManus ME, Gaedigk A, Kakuta Y, Negishi M, Pedersen L, Martin JL: Crystal structure of human catecholamine sulfotransferase. J Mol Biol. 1999 Oct 29;293(3):521-30. [Article] Lu JH, Li HT, Liu MC, Zhang JP, Li M, An XM, Chang WR: Crystal structure of human sulfotransferase SULT1A3 in complex with dopamine and 3'-phosphoadenosine 5'-phosphate. Biochem Biophys Res Commun. 2005 Sep 23;335(2):417-23. [Article] Thomae BA, Rifki OF, Theobald MA, Eckloff BW, Wieben ED, Weinshilboum RM: Human catecholamine sulfotransferase (SULT1A3) pharmacogenetics: functional genetic polymorphism. J Neurochem. 2003 Nov;87(4):809-19. [Article] Hildebrandt MA, Salavaggione OE, Martin YN, Flynn HC, Jalal S, Wieben ED, Weinshilboum RM: Human SULT1A3 pharmacogenetics: gene duplication and functional genomic studies. Biochem Biophys Res Commun. 2004 Sep 3;321(4):870-8. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00316AcetaminophenapprovedunknownsubstrateDetailsDB09288PropacetamolexperimentalnosubstrateDetailsDB14635Curcumin sulfateexperimentalunknownsubstrateDetailsDB00388PhenylephrineapprovedunknownsubstrateDetailsDB09100Thyroid, porcineapprovedunknownsubstrateDetailsDB00977EthinylestradiolapprovedunknownsubstrateDetailsDB00714Apomorphineapproved, investigationalunknownsubstrateDetailsDB00867Ritodrineapproved, investigationalnosubstrateDetailsDB00871TerbutalineapprovedunknownsubstrateDetailsDB00960Pindololapproved, investigationalunknownsubstrateDetailsDB00968MethyldopaapprovednosubstrateDetailsDB12471Ibrexafungerpapproved, investigationalunknownsubstrateDetailsDB00867Ritodrineapproved, investigationalnosubstrateDetailsDB12243Edaravoneapproved, investigationalnosubstrateDetails"
                    }
                },
                {
                    "Label": "Arylamine N-acetyltransferase 2",
                    "Detailed Info": {
                        "Name": "Arylamine N-acetyltransferase 2",
                        "Synonyms": "2.3.1.5\nAAC2\nArylamide acetylase 2\nN-acetyltransferase type 2\nNAT-2\nPNAT\nPolymorphic arylamine N-acetyltransferase",
                        "Gene Name": "NAT2",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0006940|Arylamine N-acetyltransferase 2\nMDIEAYFERIGYKNSRNKLDLETLTDILEHQIRAVPFENLNMHCGQAMELGLEAIFDHIV\nRRNRGGWCLQVNQLLYWALTTIGFQTTMLGGYFYIPPVNKYSTGMVHLLLQVTIDGRNYI\nVDAGSGSSSQMWQPLELISGKDQPQVPCIFCLTEERGIWYLDQIRREQYITNKEFLNSHL\nLPKKKHQKIYLFTLEPRTIEDFESMNTYLQTSPTSSFITTSFCSLQTPEGVYCLVGFILT\nYRKFNYKDNTDLVEFKTLTEEEVEEVLKNIFKISLGRNLVPKPGDGSLTI",
                        "Number of residues": "290",
                        "Molecular Weight": "33542.235",
                        "Theoretical pI": "5.67",
                        "GO Classification": "Functionsarylamine N-acetyltransferase activityProcessessmall molecule metabolic process / xenobiotic metabolic processComponentscytosol",
                        "General Function": "Arylamine n-acetyltransferase activity",
                        "Specific Function": "Participates in the detoxification of a plethora of hydrazine and arylamine drugs. Catalyzes the N- or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens.",
                        "Pfam Domain Function": "Acetyltransf_2 (PF00797)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Cytoplasm",
                        "Gene sequence": ">lcl|BSEQ0012509|Arylamine N-acetyltransferase 2 (NAT2)\nATGGACATTGAAGCATATTTTGAAAGAATTGGCTATAAGAACTCTAGGAACAAATTGGAC\nTTGGAAACATTAACTGACATTCTTGAGCACCAGATCCGGGCTGTTCCCTTTGAGAACCTT\nAACATGCATTGTGGGCAAGCCATGGAGTTGGGCTTAGAGGCTATTTTTGATCACATTGTA\nAGAAGAAACCGGGGTGGGTGGTGTCTCCAGGTCAATCAACTTCTGTACTGGGCTCTGACC\nACAATCGGTTTTCAGACCACAATGTTAGGAGGGTATTTTTACATCCCTCCAGTTAACAAA\nTACAGCACTGGCATGGTTCACCTTCTCCTGCAGGTGACCATTGACGGCAGGAATTACATT\nGTCGATGCTGGGTCTGGAAGCTCCTCCCAGATGTGGCAGCCTCTAGAATTAATTTCTGGG\nAAGGATCAGCCTCAGGTGCCTTGCATTTTCTGCTTGACAGAAGAGAGAGGAATCTGGTAC\nCTGGACCAAATCAGGAGAGAGCAGTATATTACAAACAAAGAATTTCTTAATTCTCATCTC\nCTGCCAAAGAAGAAACACCAAAAAATATACTTATTTACGCTTGAACCTCGAACAATTGAA\nGATTTTGAGTCTATGAATACATACCTGCAGACGTCTCCAACATCTTCATTTATAACCACA\nTCATTTTGTTCCTTGCAGACCCCAGAAGGGGTTTACTGTTTGGTGGGCTTCATCCTCACC\nTATAGAAAATTCAATTATAAAGACAATACAGATCTGGTCGAGTTTAAAACTCTCACTGAG\nGAAGAGGTTGAAGAAGTGCTGAGAAATATATTTAAGATTTCCTTGGGGAGAAATCTCGTG\nCCCAAACCTGGTGATGGATCCCTTACTATTTAG",
                        "Chromosome Location": "8",
                        "Locus": "8p22",
                        "External Identifiers": "ResourceLinkUniProtKB IDP11245UniProtKB Entry NameARY2_HUMANGenBank Protein ID219412GenBank Gene IDD90040HGNC IDHGNC:7646",
                        "General References": "Grant DM, Blum M, Demierre A, Meyer UA: Nucleotide sequence of an intronless gene for a human arylamine N-acetyltransferase related to polymorphic drug acetylation. Nucleic Acids Res. 1989 May 25;17(10):3978. [Article] Blum M, Grant DM, McBride W, Heim M, Meyer UA: Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol. 1990 Apr;9(3):193-203. [Article] Ohsako S, Deguchi T: Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver. J Biol Chem. 1990 Mar 15;265(8):4630-4. [Article] Deguchi T: Sequences and expression of alleles of polymorphic arylamine N-acetyltransferase of human liver. J Biol Chem. 1992 Sep 5;267(25):18140-7. [Article] Ferguson RJ, Doll MA, Rustan TD, Gray K, Hein DW: Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles. Drug Metab Dispos. 1994 May-Jun;22(3):371-6. [Article] Patin E, Barreiro LB, Sabeti PC, Austerlitz F, Luca F, Sajantila A, Behar DM, Semino O, Sakuntabhai A, Guiso N, Gicquel B, McElreavey K, Harding RM, Heyer E, Quintana-Murci L: Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes. Am J Hum Genet. 2006 Mar;78(3):423-36. Epub 2006 Jan 13. [Article] Nusbaum C, Mikkelsen TS, Zody MC, Asakawa S, Taudien S, Garber M, Kodira CD, Schueler MG, Shimizu A, Whittaker CA, Chang JL, Cuomo CA, Dewar K, FitzGerald MG, Yang X, Allen NR, Anderson S, Asakawa T, Blechschmidt K, Bloom T, Borowsky ML, Butler J, Cook A, Corum B, DeArellano K, DeCaprio D, Dooley KT, Dorris L 3rd, Engels R, Glockner G, Hafez N, Hagopian DS, Hall JL, Ishikawa SK, Jaffe DB, Kamat A, Kudoh J, Lehmann R, Lokitsang T, Macdonald P, Major JE, Matthews CD, Mauceli E, Menzel U, Mihalev AH, Minoshima S, Murayama Y, Naylor JW, Nicol R, Nguyen C, O'Leary SB, O'Neill K, Parker SC, Polley A, Raymond CK, Reichwald K, Rodriguez J, Sasaki T, Schilhabel M, Siddiqui R, Smith CL, Sneddon TP, Talamas JA, Tenzin P, Topham K, Venkataraman V, Wen G, Yamazaki S, Young SK, Zeng Q, Zimmer AR, Rosenthal A, Birren BW, Platzer M, Shimizu N, Lander ES: DNA sequence and analysis of human chromosome 8. Nature. 2006 Jan 19;439(7074):331-5. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Ebisawa T, Deguchi T: Structure and restriction fragment length polymorphism of genes for human liver arylamine N-acetyltransferases. Biochem Biophys Res Commun. 1991 Jun 28;177(3):1252-7. [Article] Grant DM, Lottspeich F, Meyer UA: Evidence for two closely related isozymes of arylamine N-acetyltransferase in human liver. FEBS Lett. 1989 Feb 13;244(1):203-7. [Article] Wu H, Dombrovsky L, Tempel W, Martin F, Loppnau P, Goodfellow GH, Grant DM, Plotnikov AN: Structural basis of substrate-binding specificity of human arylamine N-acetyltransferases. J Biol Chem. 2007 Oct 12;282(41):30189-97. Epub 2007 Jul 26. [Article] Vatsis KP, Martell KJ, Weber WW: Diverse point mutations in the human gene for polymorphic N-acetyltransferase. Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6333-7. [Article] Abe M, Deguchi T, Suzuki T: The structure and characteristics of a fourth allele of polymorphic N-acetyltransferase gene found in the Japanese population. Biochem Biophys Res Commun. 1993 Mar 31;191(3):811-6. [Article] Lin HJ, Han CY, Lin BK, Hardy S: Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene. Pharmacogenetics. 1994 Jun;4(3):125-34. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00250Dapsoneapproved, investigationalunknownsubstrateDetailsDB01015SulfamethoxazoleapprovedunknownsubstrateDetailsDB00951Isoniazidapproved, investigationalunknownsubstrateDetailsDB04953Ezogabineapproved, investigationalunknownsubstrateDetailsDB00316AcetaminophenapprovedunknowninhibitorDetailsDB01068Clonazepamapproved, illicitunknownsubstrateDetailsDB11640Amifampridineapproved, investigationalnosubstrateDetailsDB09288PropacetamolexperimentalnoinhibitorDetailsDB00945Acetylsalicylic acidapproved, vet_approvedunknownsubstrateDetailsDB12612Ozanimodapproved, investigationalunknownsubstrateDetails"
                    }
                },
                {
                    "Label": "Fatty-acid amide hydrolase 1",
                    "Detailed Info": {
                        "Name": "Fatty-acid amide hydrolase 1",
                        "Synonyms": "3.5.1.99\nAnandamide amidohydrolase 1\nFAAH1\nOleamide hydrolase 1",
                        "Gene Name": "FAAH",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0011585|Fatty-acid amide hydrolase 1\nMVQYELWAALPGASGVALACCFVAAAVALRWSGRRTARGAVVRARQRQRAGLENMDRAAQ\nRFRLQNPDLDSEALLALPLPQLVQKLHSRELAPEAVLFTYVGKAWEVNKGTNCVTSYLAD\nCETQLSQAPRQGLLYGVPVSLKECFTYKGQDSTLGLSLNEGVPAECDSVVVHVLKLQGAV\nPFVHTNVPQSMFSYDCSNPLFGQTVNPWKSSKSPGGSSGGEGALIGSGGSPLGLGTDIGG\nSIRFPSSFCGICGLKPTGNRLSKSGLKGCVYGQEAVRLSVGPMARDVESLALCLRALLCE\nDMFRLDPTVPPLPFREEVYTSSQPLRVGYYETDNYTMPSPAMRRAVLETKQSLEAAGHTL\nVPFLPSNIPHALETLSTGGLFSDGGHTFLQNFKGDFVDPCLGDLVSILKLPQWLKGLLAF\nLVKPLLPRLSAFLSNMKSRSAGKLWELQHEIEVYRKTVIAQWRALDLDVVLTPMLAPALD\nLNAPGRATGAVSYTMLYNCLDFPAGVVPVTTVTAEDEAQMEHYRGYFGDIWDKMLQKGMK\nKSVGLPVAVQCVALPWQEELCLRFMREVERLMTPEKQSS",
                        "Number of residues": "579",
                        "Molecular Weight": "63065.28",
                        "Theoretical pI": "7.72",
                        "GO Classification": "Functionsacylglycerol lipase activity / carbon-nitrogen ligase activity, with glutamine as amido-N-donor / fatty acid amide hydrolase activityProcessesarachidonic acid metabolic process / fatty acid catabolic process / small molecule metabolic processComponentscytoskeleton / endoplasmic reticulum membrane / integral component of membrane / organelle membrane",
                        "General Function": "Fatty acid amide hydrolase activity",
                        "Specific Function": "Degrades bioactive fatty acid amides like oleamide, the endogenous cannabinoid, anandamide and myristic amide to their corresponding acids, thereby serving to terminate the signaling functions of these molecules. Hydrolyzes polyunsaturated substrate anandamide preferentially as compared to monounsaturated substrates.",
                        "Pfam Domain Function": "Amidase (PF01425)",
                        "Transmembrane Regions": "9-29",
                        "Cellular Location": "Endomembrane system",
                        "Gene sequence": ">lcl|BSEQ0011586|Fatty-acid amide hydrolase 1 (FAAH)\nATGGTGCAGTACGAGCTGTGGGCCGCGCTGCCTGGCGCCTCCGGGGTCGCCCTGGCCTGC\nTGCTTCGTGGCGGCGGCCGTGGCCCTGCGCTGGTCCGGGCGCCGGACGGCGCGGGGCGCG\nGTGGTCCGGGCGCGACAGAGGCAGCGAGCGGGCCTGGAGAACATGGACAGGGCGGCGCAG\nCGCTTCCGGCTCCAGAACCCAGACCTGGACTCAGAGGCGCTGCTAGCCCTGCCCCTGCCT\nCAGCTGGTGCAGAAGTTACACAGTAGAGAGCTGGCCCCTGAGGCCGTGCTCTTCACCTAT\nGTGGGAAAGGCCTGGGAAGTGAACAAAGGGACCAACTGTGTGACCTCCTATCTGGCTGAC\nTGTGAGACTCAGCTGTCTCAGGCCCCAAGGCAGGGCCTGCTCTATGGCGTCCCTGTGAGC\nCTCAAGGAGTGCTTCACCTACAAGGGCCAGGACTCCACGCTGGGCTTGAGCCTGAATGAA\nGGGGTGCCGGCGGAGTGCGACAGCGTAGTGGTGCATGTGCTGAAGCTGCAGGGTGCCGTG\nCCCTTCGTGCACACCAATGTTCCACAGTCCATGTTCAGCTATGACTGCAGTAACCCCCTC\nTTTGGCCAGACCGTGAACCCATGGAAGTCCTCCAAAAGCCCAGGGGGCTCCTCAGGGGGT\nGAAGGGGCCCTCATCGGGTCTGGAGGCTCCCCCCTGGGCTTAGGCACTGATATCGGAGGC\nAGCATCCGCTTCCCCTCCTCCTTCTGCGGCATCTGCGGCCTCAAGCCCACAGGGAACCGC\nCTCAGCAAGAGTGGCCTGAAGGGCTGTGTCTATGGACAGGAGGCAGTGCGTCTCTCCGTG\nGGCCCCATGGCCCGGGACGTGGAGAGCCTGGCACTGTGCCTGCGAGCCCTGCTGTGCGAG\nGACATGTTCCGCTTGGACCCCACTGTGCCTCCCTTGCCCTTCAGAGAAGAGGTCTACACC\nAGCTCTCAGCCCCTGCGTGTGGGGTACTATGAGACTGACAACTATACCATGCCCTCCCCG\nGCCATGAGGCGGGCCGTGCTGGAGACCAAACAGAGCCTTGAGGCTGCGGGGCACACGCTG\nGTTCCCTTCTTGCCAAGCAACATACCCCATGCTCTGGAGACCCTGTCAACAGGTGGGCTC\nTTCAGTGATGGTGGCCACACCTTCCTACAGAACTTCAAAGGTGATTTCGTGGACCCCTGC\nCTGGGGGACCTGGTCTCAATTCTGAAGCTTCCCCAATGGCTTAAAGGACTGCTGGCCTTC\nCTGGTGAAGCCTCTGCTGCCAAGGCTGTCAGCTTTCCTCAGCAACATGAAGTCTCGTTCG\nGCTGGAAAACTCTGGGAACTGCAGCACGAGATCGAGGTGTACCGCAAAACCGTGATTGCC\nCAGTGGAGGGCGCTGGACCTGGATGTGGTGCTGACCCCCATGCTGGCCCCTGCTCTGGAC\nTTGAATGCCCCAGGCAGGGCCACAGGGGCCGTCAGCTACACTATGCTGTACAACTGCCTG\nGACTTCCCTGCAGGGGTGGTGCCTGTCACCACGGTGACTGCTGAGGACGAGGCCCAGATG\nGAACATTACAGGGGCTACTTTGGGGATATCTGGGACAAGATGCTGCAGAAGGGCATGAAG\nAAGAGTGTGGGGCTGCCGGTGGCCGTGCAGTGTGTGGCTCTGCCCTGGCAAGAAGAGTTG\nTGTCTGCGGTTCATGCGGGAGGTGGAGCGACTGATGACCCCTGAAAAGCAGTCATCCTGA",
                        "Chromosome Location": "1",
                        "Locus": "1p35-p34",
                        "External Identifiers": "ResourceLinkUniProtKB IDO00519UniProtKB Entry NameFAAH1_HUMANGenBank Protein ID2149156GenBank Gene IDU82535GenAtlas IDFAAHHGNC IDHGNC:3553",
                        "General References": "Giang DK, Cravatt BF: Molecular characterization of human and mouse fatty acid amide hydrolases. Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2238-42. [Article] Wan M, Cravatt BF, Ring HZ, Zhang X, Francke U: Conserved chromosomal location and genomic structure of human and mouse fatty-acid amide hydrolase genes and evaluation of clasper as a candidate neurological mutation. Genomics. 1998 Dec 15;54(3):408-14. [Article] Gregory SG, Barlow KF, McLay KE, Kaul R, Swarbreck D, Dunham A, Scott CE, Howe KL, Woodfine K, Spencer CC, Jones MC, Gillson C, Searle S, Zhou Y, Kokocinski F, McDonald L, Evans R, Phillips K, Atkinson A, Cooper R, Jones C, Hall RE, Andrews TD, Lloyd C, Ainscough R, Almeida JP, Ambrose KD, Anderson F, Andrew RW, Ashwell RI, Aubin K, Babbage AK, Bagguley CL, Bailey J, Beasley H, Bethel G, Bird CP, Bray-Allen S, Brown JY, Brown AJ, Buckley D, Burton J, Bye J, Carder C, Chapman JC, Clark SY, Clarke G, Clee C, Cobley V, Collier RE, Corby N, Coville GJ, Davies J, Deadman R, Dunn M, Earthrowl M, Ellington AG, Errington H, Frankish A, Frankland J, French L, Garner P, Garnett J, Gay L, Ghori MR, Gibson R, Gilby LM, Gillett W, Glithero RJ, Grafham DV, Griffiths C, Griffiths-Jones S, Grocock R, Hammond S, Harrison ES, Hart E, Haugen E, Heath PD, Holmes S, Holt K, Howden PJ, Hunt AR, Hunt SE, Hunter G, Isherwood J, James R, Johnson C, Johnson D, Joy A, Kay M, Kershaw JK, Kibukawa M, Kimberley AM, King A, Knights AJ, Lad H, Laird G, Lawlor S, Leongamornlert DA, Lloyd DM, Loveland J, Lovell J, Lush MJ, Lyne R, Martin S, Mashreghi-Mohammadi M, Matthews L, Matthews NS, McLaren S, Milne S, Mistry S, Moore MJ, Nickerson T, O'Dell CN, Oliver K, Palmeiri A, Palmer SA, Parker A, Patel D, Pearce AV, Peck AI, Pelan S, Phelps K, Phillimore BJ, Plumb R, Rajan J, Raymond C, Rouse G, Saenphimmachak C, Sehra HK, Sheridan E, Shownkeen R, Sims S, Skuce CD, Smith M, Steward C, Subramanian S, Sycamore N, Tracey A, Tromans A, Van Helmond Z, Wall M, Wallis JM, White S, Whitehead SL, Wilkinson JE, Willey DL, Williams H, Wilming L, Wray PW, Wu Z, Coulson A, Vaudin M, Sulston JE, Durbin R, Hubbard T, Wooster R, Dunham I, Carter NP, McVean G, Ross MT, Harrow J, Olson MV, Beck S, Rogers J, Bentley DR, Banerjee R, Bryant SP, Burford DC, Burrill WD, Clegg SM, Dhami P, Dovey O, Faulkner LM, Gribble SM, Langford CF, Pandian RD, Porter KM, Prigmore E: The DNA sequence and biological annotation of human chromosome 1. Nature. 2006 May 18;441(7091):315-21. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, Thomas GR, Vandekerckhove J: Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol. 2003 May;21(5):566-9. Epub 2003 Mar 31. [Article] Wei BQ, Mikkelsen TS, McKinney MK, Lander ES, Cravatt BF: A second fatty acid amide hydrolase with variable distribution among placental mammals. J Biol Chem. 2006 Dec 1;281(48):36569-78. Epub 2006 Oct 2. [Article] Sipe JC, Chiang K, Gerber AL, Beutler E, Cravatt BF: A missense mutation in human fatty acid amide hydrolase associated with problem drug use. Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8394-9. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Chiang KP, Gerber AL, Sipe JC, Cravatt BF: Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use. Hum Mol Genet. 2004 Sep 15;13(18):2113-9. Epub 2004 Jul 14. [Article] Flanagan JM, Gerber AL, Cadet JL, Beutler E, Sipe JC: The fatty acid amide hydrolase 385 A/A (P129T) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addiction. Hum Genet. 2006 Nov;120(4):581-8. Epub 2006 Sep 14. [Article] Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE: The consensus coding sequences of human breast and colorectal cancers. Science. 2006 Oct 13;314(5797):268-74. Epub 2006 Sep 7. [Article] Sim MS, Hatim A, Reynolds GP, Mohamed Z: Association of a functional FAAH polymorphism with methamphetamine-induced symptoms and dependence in a Malaysian population. Pharmacogenomics. 2013 Apr;14(5):505-14. doi: 10.2217/pgs.13.25. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB02465Methoxy arachidonyl fluorophosphonateexperimentalunknownDetailsDB00599Thiopentalapproved, vet_approvedunknowninhibitorDetailsDB00818Propofolapproved, investigational, vet_approvedunknownsubstrateDetailsDB068941-DodecanolexperimentalunknownDetailsDB083854-(quinolin-3-ylmethyl)piperidine-1-carboxylic acidexperimentalunknownDetailsDB084004-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acidexperimentalunknownDetailsDB09061Cannabidiolapproved, investigationalunknowninhibitorDetailsDB12010Fostamatinibapproved, investigationalunknowninhibitorDetailsDB14009Medical Cannabisexperimental, investigationalunknowninhibitorDetailsDB14011NabiximolsinvestigationalunknowninhibitorinducerDetailsDB00316AcetaminophenapprovedunknownsubstrateDetails"
                    }
                },
                {
                    "Label": "Glutathione S-transferase P",
                    "Detailed Info": {
                        "Name": "Glutathione S-transferase P",
                        "Synonyms": "2.5.1.18\nFAEES3\nGST class-pi\nGST3\nGSTP1-1",
                        "Gene Name": "GSTP1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0010574|Glutathione S-transferase P\nMPPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGD\nLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYISLIYTNYEAGKDDYV\nKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAY\nVGRLSARPKLKAFLASPEYVNLPINGNGKQ",
                        "Number of residues": "210",
                        "Molecular Weight": "23355.625",
                        "Theoretical pI": "5.3",
                        "GO Classification": "Functionsdinitrosyl-iron complex binding / glutathione transferase activity / JUN kinase binding / kinase regulator activity / nitric oxide binding / S-nitrosoglutathione bindingProcessescellular response to lipopolysaccharide / central nervous system development / common myeloid progenitor cell proliferation / glutathione derivative biosynthetic process / glutathione metabolic process / negative regulation of acute inflammatory response / negative regulation of apoptotic process / negative regulation of biosynthetic process / negative regulation of ERK1 and ERK2 cascade / negative regulation of extrinsic apoptotic signaling pathway / negative regulation of fibroblast proliferation / negative regulation of I-kappaB kinase/NF-kappaB signaling / negative regulation of interleukin-1 beta production / negative regulation of JUN kinase activity / negative regulation of leukocyte proliferation / negative regulation of MAP kinase activity / negative regulation of MAPK cascade / negative regulation of monocyte chemotactic protein-1 production / negative regulation of nitric-oxide synthase biosynthetic process / negative regulation of protein kinase activity / negative regulation of stress-activated MAPK cascade / negative regulation of tumor necrosis factor production / negative regulation of tumor necrosis factor-mediated signaling pathway / nitric oxide storage / positive regulation of superoxide anion generation / regulation of ERK1 and ERK2 cascade / regulation of stress-activated MAPK cascade / response to reactive oxygen species / small molecule metabolic process / xenobiotic metabolic processComponentscytoplasm / cytosol / extracellular exosome / extracellular space / intracellular / mitochondrion / nucleus / TRAF2-GSTP1 complex / vesicle",
                        "General Function": "S-nitrosoglutathione binding",
                        "Specific Function": "Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Regulates negatively CDK5 activity via p25/p35 translocation to prevent neurodegeneration.",
                        "Pfam Domain Function": "GST_C (PF00043)\nGST_N (PF02798)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Cytoplasm",
                        "Gene sequence": ">lcl|BSEQ0010575|Glutathione S-transferase P (GSTP1)\nATGCCGCCCTACACCGTGGTCTATTTCCCAGTTCGAGGCCGCTGCGCGGCCCTGCGCATG\nCTGCTGGCAGATCAGGGCCAGAGCTGGAAGGAGGAGGTGGTGACCGTGGAGACGTGGCAG\nGAGGGCTCACTCAAAGCCTCCTGCCTATACGGGCAGCTCCCCAAGTTCCAGGACGGAGAC\nCTCACCCTGTACCAGTCCAATACCATCCTGCGTCACCTGGGCCGCACCCTTGGGCTCTAT\nGGGAAGGACCAGCAGGAGGCAGCCCTGGTGGACATGGTGAATGACGGCGTGGAGGACCTC\nCGCTGCAAATACATCTCCCTCATCTACACCAACTATGAGGCGGGCAAGGATGACTATGTG\nAAGGCACTGCCCGGGCAACTGAAGCCTTTTGAGACCCTGCTGTCCCAGAACCAGGGAGGC\nAAGACCTTCATTGTGGGAGACCAGATCTCCTTCGCTGACTACAACCTGCTGGACTTGCTG\nCTGATCCATGAGGTCCTAGCCCCTGGCTGCCTGGATGCGTTCCCCCTGCTCTCAGCATAT\nGTGGGGCGCCTCAGTGCCCGGCCCAAGCTCAAGGCCTTCCTGGCCTCCCCTGAGTACGTG\nAACCTCCCCATCAATGGCAACGGGAAACAGTGA",
                        "Chromosome Location": "11",
                        "Locus": "11q13",
                        "External Identifiers": "ResourceLinkUniProtKB IDP09211UniProtKB Entry NameGSTP1_HUMANGenBank Protein ID31946GenBank Gene IDM24485GenAtlas IDGSTP1HGNC IDHGNC:4638",
                        "General References": "Kano T, Sakai M, Muramatsu M: Structure and expression of a human class pi glutathione S-transferase messenger RNA. Cancer Res. 1987 Nov 1;47(21):5626-30. [Article] Cowell IG, Dixon KH, Pemble SE, Ketterer B, Taylor JB: The structure of the human glutathione S-transferase pi gene. Biochem J. 1988 Oct 1;255(1):79-83. [Article] Morrow CS, Cowan KH, Goldsmith ME: Structure of the human genomic glutathione S-transferase-pi gene. Gene. 1989 Jan 30;75(1):3-11. [Article] Moscow JA, Fairchild CR, Madden MJ, Ransom DT, Wieand HS, O'Brien EE, Poplack DG, Cossman J, Myers CE, Cowan KH: Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res. 1989 Mar 15;49(6):1422-8. [Article] Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J: Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem. 1997 Apr 11;272(15):10004-12. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Alin P, Mannervik B, Jornvall H: Structural evidence for three different types of glutathione transferase in human tissues. FEBS Lett. 1985 Mar 25;182(2):319-22. [Article] Mannervik B, Alin P, Guthenberg C, Jensson H, Tahir MK, Warholm M, Jornvall H: Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. Proc Natl Acad Sci U S A. 1985 Nov;82(21):7202-6. [Article] Singh SV, Ahmad H, Kurosky A, Awasthi YC: Purification and characterization of unique glutathione S-transferases from human muscle. Arch Biochem Biophys. 1988 Jul;264(1):13-22. [Article] Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, Thomas GR, Vandekerckhove J: Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol. 2003 May;21(5):566-9. Epub 2003 Mar 31. [Article] Ji H, Reid GE, Moritz RL, Eddes JS, Burgess AW, Simpson RJ: A two-dimensional gel database of human colon carcinoma proteins. Electrophoresis. 1997 Mar-Apr;18(3-4):605-13. [Article] Ahmad H, Wilson DE, Fritz RR, Singh SV, Medh RD, Nagle GT, Awasthi YC, Kurosky A: Primary and secondary structural analyses of glutathione S-transferase pi from human placenta. Arch Biochem Biophys. 1990 May 1;278(2):398-408. [Article] Kong KH, Takasu K, Inoue H, Takahashi K: Tyrosine-7 in human class Pi glutathione S-transferase is important for lowering the pKa of the thiol group of glutathione in the enzyme-glutathione complex. Biochem Biophys Res Commun. 1992 Apr 15;184(1):194-7. [Article] Kong KH, Nishida M, Inoue H, Takahashi K: Tyrosine-7 is an essential residue for the catalytic activity of human class PI glutathione S-transferase: chemical modification and site-directed mutagenesis studies. Biochem Biophys Res Commun. 1992 Feb 14;182(3):1122-9. [Article] Kong KH, Inoue H, Takahashi K: Site-directed mutagenesis study on the roles of evolutionally conserved aspartic acid residues in human glutathione S-transferase P1-1. Protein Eng. 1993 Jan;6(1):93-9. [Article] Goto S, Kawakatsu M, Izumi S, Urata Y, Kageyama K, Ihara Y, Koji T, Kondo T: Glutathione S-transferase pi localizes in mitochondria and protects against oxidative stress. Free Radic Biol Med. 2009 May 15;46(10):1392-403. doi: 10.1016/j.freeradbiomed.2009.02.025. Epub 2009 Mar 6. [Article] Okamura T, Singh S, Buolamwini J, Haystead T, Friedman H, Bigner D, Ali-Osman F: Tyrosine phosphorylation of the human glutathione S-transferase P1 by epidermal growth factor receptor. J Biol Chem. 2009 Jun 19;284(25):16979-89. doi: 10.1074/jbc.M808153200. Epub 2009 Mar 2. [Article] Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M: Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009 Aug 14;325(5942):834-40. doi: 10.1126/science.1175371. Epub 2009 Jul 16. [Article] Burkard TR, Planyavsky M, Kaupe I, Breitwieser FP, Burckstummer T, Bennett KL, Superti-Furga G, Colinge J: Initial characterization of the human central proteome. BMC Syst Biol. 2011 Jan 26;5:17. doi: 10.1186/1752-0509-5-17. [Article] Sun KH, Chang KH, Clawson S, Ghosh S, Mirzaei H, Regnier F, Shah K: Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity. J Neurochem. 2011 Sep;118(5):902-14. doi: 10.1111/j.1471-4159.2011.07343.x. Epub 2011 Jul 8. [Article] Bienvenut WV, Sumpton D, Martinez A, Lilla S, Espagne C, Meinnel T, Giglione C: Comparative large scale characterization of plant versus mammal proteins reveals similar and idiosyncratic N-alpha-acetylation features. Mol Cell Proteomics. 2012 Jun;11(6):M111.015131. doi: 10.1074/mcp.M111.015131. Epub 2012 Jan 5. [Article] Van Damme P, Lasa M, Polevoda B, Gazquez C, Elosegui-Artola A, Kim DS, De Juan-Pardo E, Demeyer K, Hole K, Larrea E, Timmerman E, Prieto J, Arnesen T, Sherman F, Gevaert K, Aldabe R: N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12449-54. doi: 10.1073/pnas.1210303109. Epub 2012 Jul 18. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Vaca Jacome AS, Rabilloud T, Schaeffer-Reiss C, Rompais M, Ayoub D, Lane L, Bairoch A, Van Dorsselaer A, Carapito C: N-terminome analysis of the human mitochondrial proteome. Proteomics. 2015 Jul;15(14):2519-24. doi: 10.1002/pmic.201400617. Epub 2015 Jun 8. [Article] Reinemer P, Dirr HW, Ladenstein R, Huber R, Lo Bello M, Federici G, Parker MW: Three-dimensional structure of class pi glutathione S-transferase from human placenta in complex with S-hexylglutathione at 2.8 A resolution. J Mol Biol. 1992 Sep 5;227(1):214-26. [Article] Oakley AJ, Rossjohn J, Lo Bello M, Caccuri AM, Federici G, Parker MW: The three-dimensional structure of the human Pi class glutathione transferase P1-1 in complex with the inhibitor ethacrynic acid and its glutathione conjugate. Biochemistry. 1997 Jan 21;36(3):576-85. [Article] Ji X, Tordova M, O'Donnell R, Parsons JF, Hayden JB, Gilliland GL, Zimniak P: Structure and function of the xenobiotic substrate-binding site and location of a potential non-substrate-binding site in a class pi glutathione S-transferase. Biochemistry. 1997 Aug 12;36(32):9690-702. [Article] Oakley AJ, Lo Bello M, Battistoni A, Ricci G, Rossjohn J, Villar HO, Parker MW: The structures of human glutathione transferase P1-1 in complex with glutathione and various inhibitors at high resolution. J Mol Biol. 1997 Nov 21;274(1):84-100. [Article] Prade L, Huber R, Manoharan TH, Fahl WE, Reuter W: Structures of class pi glutathione S-transferase from human placenta in complex with substrate, transition-state analogue and inhibitor. Structure. 1997 Oct 15;5(10):1287-95. [Article] Ji X, Blaszczyk J, Xiao B, O'Donnell R, Hu X, Herzog C, Singh SV, Zimniak P: Structure and function of residue 104 and water molecules in the xenobiotic substrate-binding site in human glutathione S-transferase P1-1. Biochemistry. 1999 Aug 10;38(32):10231-8. [Article] Nicotra M, Paci M, Sette M, Oakley AJ, Parker MW, Lo Bello M, Caccuri AM, Federici G, Ricci G: Solution structure of glutathione bound to human glutathione transferase P1-1: comparison of NMR measurements with the crystal structure. Biochemistry. 1998 Mar 3;37(9):3020-7. [Article] Ang WH, Parker LJ, De Luca A, Juillerat-Jeanneret L, Morton CJ, Lo Bello M, Parker MW, Dyson PJ: Rational design of an organometallic glutathione transferase inhibitor. Angew Chem Int Ed Engl. 2009;48(21):3854-7. doi: 10.1002/anie.200900185. [Article] Federici L, Lo Sterzo C, Pezzola S, Di Matteo A, Scaloni F, Federici G, Caccuri AM: Structural basis for the binding of the anticancer compound 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol to human glutathione s-transferases. Cancer Res. 2009 Oct 15;69(20):8025-34. doi: 10.1158/0008-5472.CAN-09-1314. Epub 2009 Oct 6. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB01242Clomipramineapproved, investigational, vet_approvedunknowninhibitorDetailsDB00143Glutathioneapproved, investigational, nutraceuticalunknownDetailsDB01834(9R,10R)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthreneexperimentalunknownDetailsDB01915S-HydroxycysteineexperimentalunknownDetailsDB02633Cibacron BlueexperimentalunknownDetailsDB038142-(N-morpholino)ethanesulfonic acidexperimentalunknownDetailsDB04132S-HexylglutathioneexperimentalunknownDetailsDB03003Glutathione sulfonic acidexperimentalunknownDetailsDB03686S-(4-nitrobenzyl)glutathioneexperimentalunknownDetailsDB04972CanfosfamideinvestigationalunknownDetailsDB05460EzatiostatinvestigationalunknownDetailsDB07849S-NONYL-CYSTEINEexperimentalunknownDetailsDB08370S-(4-BROMOBENZYL)CYSTEINEexperimentalunknownDetailsDB00163Vitamin Eapproved, nutraceutical, vet_approvedunknowninhibitorDetailsDB00291ChlorambucilapprovedunknownsubstrateDetailsDB01008Busulfanapproved, investigationalunknownsubstrateDetailsDB00773EtoposideapprovedunknownsubstrateDetailsDB00515CisplatinapprovedunknownsubstrateDetailsDB00958CarboplatinapprovedunknownsubstrateDetailsDB00526Oxaliplatinapproved, investigationalnosubstrateDetailsDB03619Deoxycholic acidapprovedunknownDetailsDB06246ExisulindinvestigationalunknowninhibitorDetailsDB13014HypericininvestigationalunknowninhibitorDetailsDB00363ClozapineapprovedunknownDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknownDetailsDB11831DinitrochlorobenzeneinvestigationalunknownDetailsDB11672Curcuminapproved, investigationalunknownDetailsDB00903Etacrynic acidapproved, investigationalunknowninhibitorDetailsDB14001alpha-Tocopherol succinateapproved, nutraceutical, vet_approvedunknowninhibitorDetailsDB14002D-alpha-Tocopherol acetateapproved, nutraceutical, vet_approvedunknowninhibitorDetailsDB11672Curcuminapproved, investigationalunknowninhibitorDetailsDB14635Curcumin sulfateexperimentalunknownDetailsDB00316AcetaminophenapprovedunknownsubstrateDetailsDB14924Ritlecitinibapproved, investigationalunknownsubstrateDetailsDB03310Glutathione disulfideapproved, experimental, investigationalunknownactivatorDetailsDB03619Deoxycholic acidapprovedunknowninhibitorDetailsDB00321AmitriptylineapprovedunknowninhibitorDetailsDB00291ChlorambucilapprovedunknownsubstrateDetails"
                    }
                },
                {
                    "Label": "Glutathione S-transferase Mu 1",
                    "Detailed Info": {
                        "Name": "Glutathione S-transferase Mu 1",
                        "Synonyms": "2.5.1.18\nGST class-mu 1\nGST HB subunit 4\nGST1\nGSTM1-1\nGSTM1a-1a\nGSTM1b-1b\nGTH4",
                        "Gene Name": "GSTM1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0037080|Glutathione S-transferase Mu 1\nMPMILGYWDIRGLAHAIRLLLEYTDSSYEEKKYTMGDAPDYDRSQWLNEKFKLGLDFPNL\nPYLIDGAHKITQSNAILCYIARKHNLCGETEEEKIRVDILENQTMDNHMQLGMICYNPEF\nEKLKPKYLEELPEKLKLYSEFLGKRPWFAGNKITFVDFLVYDVLDLHRIFEPKCLDAFPN\nLKDFISRFEGLEKISAYMKSSRFLPRPVFSKMAVWGNK",
                        "Number of residues": "218",
                        "Molecular Weight": "25711.555",
                        "Theoretical pI": "6.67",
                        "GO Classification": "Functionsenzyme binding / glutathione binding / glutathione transferase activity / protein homodimerization activityProcessescellular detoxification of nitrogen compound / glutathione derivative biosynthetic process / glutathione metabolic process / nitrobenzene metabolic process / small molecule metabolic process / xenobiotic catabolic process / xenobiotic metabolic processComponentscytoplasm / cytosol",
                        "General Function": "Protein homodimerization activity",
                        "Specific Function": "Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles.",
                        "Pfam Domain Function": "GST_C (PF00043)\nGST_N (PF02798)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Cytoplasm",
                        "Gene sequence": ">lcl|BSEQ0020484|Glutathione S-transferase Mu 1 (GSTM1)\nATGCCCATGATACTGGGGTACTGGGACATCCGCGGGCTGGCCCACGCCATCCGCCTGCTC\nCTGGAATACACAGACTCAAGCTATGAGGAAAAGAAGTACACGATGGGGGACGCTCCTGAT\nTATGACAGAAGCCAGTGGCTGAATGAAAAATTCAAGCTGGGCCTGGACTTTCCCAATCTG\nCCCTACTTGATTGATGGGGCTCACAAGATCACCCAGAGCAACGCCATCTTGTGCTACATT\nGCCCGCAAGCACAACCTGTGTGGGGAGACAGAAGAGGAGAAGATTCGTGTGGACATTTTG\nGAGAACCAGACCATGGACAACCATATGCAGCTGGGCATGATCTGCTACAATCCAGAATTT\nGAGAAACTGAAGCCAAAGTACTTGGAGGAACTCCCTGAAAAGCTAAAGCTCTACTCAGAG\nTTTCTGGGGAAGCGGCCATGGTTTGCAGGAAACAAGATCACTTTTGTAGATTTTCTCGTC\nTATGATGTCCTTGACCTCCACCGTATATTTGAGCCCAAGTGCTTGGACGCCTTCCCAAAT\nCTGAAGGACTTCATCTCCCGCTTTGAGGGCTTGGAGAAGATCTCTGCCTACATGAAGTCC\nAGCCGCTTCCTCCCAAGACCTGTGTTCTCAAAGATGGCTGTCTGGGGCAACAAGTAG",
                        "Chromosome Location": "1",
                        "Locus": "1p13.3",
                        "External Identifiers": "ResourceLinkUniProtKB IDP09488UniProtKB Entry NameGSTM1_HUMANGenBank Protein ID31924GenBank Gene IDX08020GenAtlas IDGSTM1HGNC IDHGNC:4632",
                        "General References": "DeJong JL, Chang CM, Whang-Peng J, Knutsen T, Tu CP: The human liver glutathione S-transferase gene superfamily: expression and chromosome mapping of an Hb subunit cDNA. Nucleic Acids Res. 1988 Sep 12;16(17):8541-54. [Article] Seidegard J, Vorachek WR, Pero RW, Pearson WR: Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci U S A. 1988 Oct;85(19):7293-7. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Zhong S, Spurr NK, Hayes JD, Wolf CR: Deduced amino acid sequence, gene structure and chromosomal location of a novel human class Mu glutathione S-transferase, GSTM4. Biochem J. 1993 Apr 1;291 ( Pt 1):41-50. [Article] Mera N, Ohmori S, Itahashi K, Kiuchi M, Igarashi T, Rikihisa T, Kitada M: Immunochemical evidence for the occurrence of Mu class glutathione S-transferase in human fetal livers. J Biochem. 1994 Aug;116(2):315-20. [Article] Tsuchida S, Maki T, Sato K: Purification and characterization of glutathione transferases with an activity toward nitroglycerin from human aorta and heart. Multiplicity of the human class Mu forms. J Biol Chem. 1990 May 5;265(13):7150-7. [Article] Alin P, Mannervik B, Jornvall H: Structural evidence for three different types of glutathione transferase in human tissues. FEBS Lett. 1985 Mar 25;182(2):319-22. [Article] Mannervik B, Alin P, Guthenberg C, Jensson H, Tahir MK, Warholm M, Jornvall H: Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. Proc Natl Acad Sci U S A. 1985 Nov;82(21):7202-6. [Article] Singhal SS, Ahmad H, Sharma R, Gupta S, Haque AK, Awasthi YC: Purification and characterization of human muscle glutathione S-transferases: evidence that glutathione S-transferase zeta corresponds to a locus distinct from GST1, GST2, and GST3. Arch Biochem Biophys. 1991 Feb 15;285(1):64-73. [Article] Singhal SS, Saxena M, Awasthi S, Ahmad H, Sharma R, Awasthi YC: Gender related differences in the expression and characteristics of glutathione S-transferases of human colon. Biochim Biophys Acta. 1992 Nov 15;1171(1):19-26. [Article] Hubbard MJ, McHugh NJ: Human ERp29: isolation, primary structural characterisation and two-dimensional gel mapping. Electrophoresis. 2000 Nov;21(17):3785-96. [Article] Comstock KE, Sanderson BJ, Claflin G, Henner WD: GST1 gene deletion determined by polymerase chain reaction. Nucleic Acids Res. 1990 Jun 25;18(12):3670. [Article] Pearson WR, Vorachek WR, Xu SJ, Berger R, Hart I, Vannais D, Patterson D: Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13. Am J Hum Genet. 1993 Jul;53(1):220-33. [Article] Patskovsky YV, Patskovska LN, Listowsky I: Functions of His107 in the catalytic mechanism of human glutathione S-transferase hGSTM1a-1a. Biochemistry. 1999 Jan 26;38(4):1193-202. [Article] Patskovsky Y, Patskovska L, Almo SC, Listowsky I: Transition state model and mechanism of nucleophilic aromatic substitution reactions catalyzed by human glutathione S-transferase M1a-1a. Biochemistry. 2006 Mar 28;45(12):3852-62. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00143Glutathioneapproved, investigational, nutraceuticalunknownDetailsDB01834(9R,10R)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthreneexperimentalunknownDetailsDB02165Zinc trihydroxideexperimentalunknownDetailsDB02458S-(2,4-dinitrophenyl)glutathioneexperimentalunknownDetailsDB033145-fluorotryptophanexperimentalunknownDetailsDB04187(9S,10S)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthreneexperimentalunknownDetailsDB01008Busulfanapproved, investigationalunknownsubstrateDetailsDB00515CisplatinapprovedunknownsubstrateDetailsDB00958CarboplatinapprovedunknownsubstrateDetailsDB00526Oxaliplatinapproved, investigationalnosubstrateDetailsDB00993AzathioprineapprovedunknownsubstrateDetailsDB11672Curcuminapproved, investigationalunknowninhibitorDetailsDB00316AcetaminophenapprovedunknownsubstrateDetailsDB01020Isosorbide mononitrateapprovednosubstrateDetailsDB00608Chloroquineapproved, investigational, vet_approvedunknowninhibitorDetailsDB14924Ritlecitinibapproved, investigationalunknownDetailsDB03310Glutathione disulfideapproved, experimental, investigationalunknownactivatorDetailsDB03619Deoxycholic acidapprovedunknowninhibitorDetailsDB00321AmitriptylineapprovedunknowninhibitorDetailsDB00291ChlorambucilapprovedunknownsubstrateDetails"
                    }
                }
            ],
            "carriers": [
                {
                    "Label": "Serum albumin",
                    "Detailed Info": {
                        "Name": "Serum albumin",
                        "Synonyms": "Serum albumin precursor",
                        "Gene Name": "ALB",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0001058|Serum albumin\nMKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPF\nEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEP\nERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLF\nFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAV\nARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLK\nECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYAR\nRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFE\nQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVV\nLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTL\nSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLV\nAASQAALGL",
                        "Number of residues": "609",
                        "Molecular Weight": "69365.94",
                        "Theoretical pI": "6.21",
                        "GO Classification": "Functionsantioxidant activity / chaperone binding / copper ion binding / DNA binding / drug binding / fatty acid binding / pyridoxal phosphate binding / toxic substance bindingProcessesbile acid and bile salt transport / bile acid metabolic process / blood coagulation / cellular response to starvation / hemolysis by symbiont of host erythrocytes / lipoprotein metabolic process / maintenance of mitochondrion location / negative regulation of apoptotic process / negative regulation of programmed cell death / platelet activation / platelet degranulation / receptor-mediated endocytosis / retina homeostasis / small molecule metabolic process / sodium-independent organic anion transport / transmembrane transport / transportComponentsblood microparticle / endoplasmic reticulum / extracellular exosome / extracellular region / extracellular space / Golgi apparatus / myelin sheath / nucleus / platelet alpha granule lumen / protein complex",
                        "General Function": "Toxic substance binding",
                        "Specific Function": "Serum albumin, the main protein of plasma, has a good binding capacity for water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin and drugs. Its main function is the regulation of the colloidal osmotic pressure of blood. Major zinc transporter in plasma, typically binds about 80% of all plasma zinc.",
                        "Pfam Domain Function": "Serum_albumin (PF00273)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Secreted",
                        "Gene sequence": ">lcl|BSEQ0010372|Serum albumin (ALB)\nATGAAGTGGGTAACCTTTATTTCCCTTCTTTTTCTCTTTAGCTCGGCTTATTCCAGGGGT\nGTGTTTCGTCGAGATGCACACAAGAGTGAGGTTGCTCATCGGTTTAAAGATTTGGGAGAA\nGAAAATTTCAAAGCCTTGGTGTTGATTGCCTTTGCTCAGTATCTTCAGCAGTGTCCATTT\nGAAGATCATGTAAAATTAGTGAATGAAGTAACTGAATTTGCAAAAACATGTGTTGCTGAT\nGAGTCAGCTGAAAATTGTGACAAATCACTTCATACCCTTTTTGGAGACAAATTATGCACA\nGTTGCAACTCTTCGTGAAACCTATGGTGAAATGGCTGACTGCTGTGCAAAACAAGAACCT\nGAGAGAAATGAATGCTTCTTGCAACACAAAGATGACAACCCAAACCTCCCCCGATTGGTG\nAGACCAGAGGTTGATGTGATGTGCACTGCTTTTCATGACAATGAAGAGACATTTTTGAAA\nAAATACTTATATGAAATTGCCAGAAGACATCCTTACTTTTATGCCCCGGAACTCCTTTTC\nTTTGCTAAAAGGTATAAAGCTGCTTTTACAGAATGTTGCCAAGCTGCTGATAAAGCTGCC\nTGCCTGTTGCCAAAGCTCGATGAACTTCGGGATGAAGGGAAGGCTTCGTCTGCCAAACAG\nAGACTCAAGTGTGCCAGTCTCCAAAAATTTGGAGAAAGAGCTTTCAAAGCATGGGCAGTA\nGCTCGCCTGAGCCAGAGATTTCCCAAAGCTGAGTTTGCAGAAGTTTCCAAGTTAGTGACA\nGATCTTACCAAAGTCCACACGGAATGCTGCCATGGAGATCTGCTTGAATGTGCTGATGAC\nAGGGCGGACCTTGCCAAGTATATCTGTGAAAATCAAGATTCGATCTCCAGTAAACTGAAG\nGAATGCTGTGAAAAACCTCTGTTGGAAAAATCCCACTGCATTGCCGAAGTGGAAAATGAT\nGAGATGCCTGCTGACTTGCCTTCATTAGCTGCTGATTTTGTTGAAAGTAAGGATGTTTGC\nAAAAACTATGCTGAGGCAAAGGATGTCTTCCTGGGCATGTTTTTGTATGAATATGCAAGA\nAGGCATCCTGATTACTCTGTCGTGCTGCTGCTGAGACTTGCCAAGACATATGAAACCACT\nCTAGAGAAGTGCTGTGCCGCTGCAGATCCTCATGAATGCTATGCCAAAGTGTTCGATGAA\nTTTAAACCTCTTGTGGAAGAGCCTCAGAATTTAATCAAACAAAATTGTGAGCTTTTTGAG\nCAGCTTGGAGAGTACAAATTCCAGAATGCGCTATTAGTTCGTTACACCAAGAAAGTACCC\nCAAGTGTCAACTCCAACTCTTGTAGAGGTCTCAAGAAACCTAGGAAAAGTGGGCAGCAAA\nTGTTGTAAACATCCTGAAGCAAAAAGAATGCCCTGTGCAGAAGACTATCTATCCGTGGTC\nCTGAACCAGTTATGTGTGTTGCATGAGAAAACGCCAGTAAGTGACAGAGTCACCAAATGC\nTGCACAGAATCCTTGGTGAACAGGCGACCATGCTTTTCAGCTCTGGAAGTCGATGAAACA\nTACGTTCCCAAAGAGTTTAATGCTGAAACATTCACCTTCCATGCAGATATATGCACACTT\nTCTGAGAAGGAGAGACAAATCAAGAAACAAACTGCACTTGTTGAGCTCGTGAAACACAAG\nCCCAAGGCAACAAAAGAGCAACTGAAAGCTGTTATGGATGATTTCGCAGCTTTTGTAGAG\nAAGTGCTGCAAGGCTGACGATAAGGAGACCTGCTTTGCCGAGGAGGGTAAAAAACTTGTT\nGCTGCAAGTCAAGCTGCCTTAGGCTTATAA",
                        "Chromosome Location": "4",
                        "Locus": "4q11-q13",
                        "External Identifiers": "ResourceLinkUniProtKB IDP02768UniProtKB Entry NameALBU_HUMANGenBank Protein ID28590GenBank Gene IDV00494GenAtlas IDALBHGNC IDHGNC:399",
                        "General References": "Lawn RM, Adelman J, Bock SC, Franke AE, Houck CM, Najarian RC, Seeburg PH, Wion KL: The sequence of human serum albumin cDNA and its expression in E. coli. Nucleic Acids Res. 1981 Nov 25;9(22):6103-114. [Article] Dugaiczyk A, Law SW, Dennison OE: Nucleotide sequence and the encoded amino acids of human serum albumin mRNA. Proc Natl Acad Sci U S A. 1982 Jan;79(1):71-5. [Article] Minghetti PP, Ruffner DE, Kuang WJ, Dennison OE, Hawkins JW, Beattie WG, Dugaiczyk A: Molecular structure of the human albumin gene is revealed by nucleotide sequence within q11-22 of chromosome 4. J Biol Chem. 1986 May 25;261(15):6747-57. [Article] Yu Y, Zhang C, Zhou G, Wu S, Qu X, Wei H, Xing G, Dong C, Zhai Y, Wan J, Ouyang S, Li L, Zhang S, Zhou K, Zhang Y, Wu C, He F: Gene expression profiling in human fetal liver and identification of tissue- and developmental-stage-specific genes through compiled expression profiles and efficient cloning of full-length cDNAs. Genome Res. 2001 Aug;11(8):1392-403. [Article] Bechtel S, Rosenfelder H, Duda A, Schmidt CP, Ernst U, Wellenreuther R, Mehrle A, Schuster C, Bahr A, Blocker H, Heubner D, Hoerlein A, Michel G, Wedler H, Kohrer K, Ottenwalder B, Poustka A, Wiemann S, Schupp I: The full-ORF clone resource of the German cDNA Consortium. BMC Genomics. 2007 Oct 31;8:399. [Article] Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Clark HF, Gurney AL, Abaya E, Baker K, Baldwin D, Brush J, Chen J, Chow B, Chui C, Crowley C, Currell B, Deuel B, Dowd P, Eaton D, Foster J, Grimaldi C, Gu Q, Hass PE, Heldens S, Huang A, Kim HS, Klimowski L, Jin Y, Johnson S, Lee J, Lewis L, Liao D, Mark M, Robbie E, Sanchez C, Schoenfeld J, Seshagiri S, Simmons L, Singh J, Smith V, Stinson J, Vagts A, Vandlen R, Watanabe C, Wieand D, Woods K, Xie MH, Yansura D, Yi S, Yu G, Yuan J, Zhang M, Zhang Z, Goddard A, Wood WI, Godowski P, Gray A: The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res. 2003 Oct;13(10):2265-70. Epub 2003 Sep 15. [Article] Urano Y, Watanabe K, Sakai M, Tamaoki T: The human albumin gene. Characterization of the 5' and 3' flanking regions and the polymorphic gene transcripts. J Biol Chem. 1986 Mar 5;261(7):3244-51. [Article] Meloun B, Moravek L, Kostka V: Complete amino acid sequence of human serum albumin. FEBS Lett. 1975 Oct 15;58(1):134-7. [Article] Corbett JM, Wheeler CH, Baker CS, Yacoub MH, Dunn MJ: The human myocardial two-dimensional gel protein database: update 1994. Electrophoresis. 1994 Nov;15(11):1459-65. [Article] Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, Thomas GR, Vandekerckhove J: Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol. 2003 May;21(5):566-9. Epub 2003 Mar 31. [Article] Mogard MH, Kobayashi R, Chen CF, Lee TD, Reeve JR Jr, Shively JE, Walsh JH: The amino acid sequence of kinetensin, a novel peptide isolated from pepsin-treated human plasma: homology with human serum albumin, neurotensin and angiotensin. Biochem Biophys Res Commun. 1986 May 14;136(3):983-8. [Article] Carraway RE, Mitra SP, Cochrane DE: Structure of a biologically active neurotensin-related peptide obtained from pepsin-treated albumin(s). J Biol Chem. 1987 May 5;262(13):5968-73. [Article] Walker JE: Lysine residue 199 of human serum albumin is modified by acetylsalicyclic acid. FEBS Lett. 1976 Jul 15;66(2):173-5. [Article] Lapolla A, Fedele D, Reitano R, Arico NC, Seraglia R, Traldi P, Marotta E, Tonani R: Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides. J Am Soc Mass Spectrom. 2004 Apr;15(4):496-509. [Article] Jacobsen C: Lysine residue 240 of human serum albumin is involved in high-affinity binding of bilirubin. Biochem J. 1978 May 1;171(2):453-9. [Article] Garlick RL, Mazer JS: The principal site of nonenzymatic glycosylation of human serum albumin in vivo. J Biol Chem. 1983 May 25;258(10):6142-6. [Article] Shaklai N, Garlick RL, Bunn HF: Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J Biol Chem. 1984 Mar 25;259(6):3812-7. [Article] Iberg N, Fluckiger R: Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites. J Biol Chem. 1986 Oct 15;261(29):13542-5. [Article] Watkins S, Madison J, Galliano M, Minchiotti L, Putnam FW: A nucleotide insertion and frameshift cause analbuminemia in an Italian family. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2275-9. [Article] Lu J, Stewart AJ, Sadler PJ, Pinheiro TJ, Blindauer CA: Albumin as a zinc carrier: properties of its high-affinity zinc-binding site. Biochem Soc Trans. 2008 Dec;36(Pt 6):1317-21. doi: 10.1042/BST0361317. [Article] Han G, Ye M, Zhou H, Jiang X, Feng S, Jiang X, Tian R, Wan D, Zou H, Gu J: Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography. Proteomics. 2008 Apr;8(7):1346-61. doi: 10.1002/pmic.200700884. [Article] Mayya V, Lundgren DH, Hwang SI, Rezaul K, Wu L, Eng JK, Rodionov V, Han DK: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal. 2009 Aug 18;2(84):ra46. doi: 10.1126/scisignal.2000007. [Article] Burkard TR, Planyavsky M, Kaupe I, Breitwieser FP, Burckstummer T, Bennett KL, Superti-Furga G, Colinge J: Initial characterization of the human central proteome. BMC Syst Biol. 2011 Jan 26;5:17. doi: 10.1186/1752-0509-5-17. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Tagliabracci VS, Wiley SE, Guo X, Kinch LN, Durrant E, Wen J, Xiao J, Cui J, Nguyen KB, Engel JL, Coon JJ, Grishin N, Pinna LA, Pagliarini DJ, Dixon JE: A Single Kinase Generates the Majority of the Secreted Phosphoproteome. Cell. 2015 Jun 18;161(7):1619-32. doi: 10.1016/j.cell.2015.05.028. [Article] Vaca Jacome AS, Rabilloud T, Schaeffer-Reiss C, Rompais M, Ayoub D, Lane L, Bairoch A, Van Dorsselaer A, Carapito C: N-terminome analysis of the human mitochondrial proteome. Proteomics. 2015 Jul;15(14):2519-24. doi: 10.1002/pmic.201400617. Epub 2015 Jun 8. [Article] Carter DC, He XM, Munson SH, Twigg PD, Gernert KM, Broom MB, Miller TY: Three-dimensional structure of human serum albumin. Science. 1989 Jun 9;244(4909):1195-8. [Article] Carter DC, He XM: Structure of human serum albumin. Science. 1990 Jul 20;249(4966):302-3. [Article] He XM, Carter DC: Atomic structure and chemistry of human serum albumin. Nature. 1992 Jul 16;358(6383):209-15. [Article] Curry S, Mandelkow H, Brick P, Franks N: Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Biol. 1998 Sep;5(9):827-35. [Article] Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K: Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng. 1999 Jun;12(6):439-46. [Article] Bhattacharya AA, Curry S, Franks NP: Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures. J Biol Chem. 2000 Dec 8;275(49):38731-8. [Article] Petitpas I, Grune T, Bhattacharya AA, Curry S: Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. J Mol Biol. 2001 Dec 14;314(5):955-60. [Article] Brennan SO, Herbert P: Albumin Canterbury (313 Lys----Asn). A point mutation in the second domain of serum albumin. Biochim Biophys Acta. 1987 Apr 8;912(2):191-7. [Article] Takahashi N, Takahashi Y, Blumberg BS, Putnam FW: Amino acid substitutions in genetic variants of human serum albumin and in sequences inferred from molecular cloning. Proc Natl Acad Sci U S A. 1987 Jul;84(13):4413-7. [Article] Takahashi N, Takahashi Y, Isobe T, Putnam FW, Fujita M, Satoh C, Neel JV: Amino acid substitutions in inherited albumin variants from Amerindian and Japanese populations. Proc Natl Acad Sci U S A. 1987 Nov;84(22):8001-5. [Article] Arai K, Ishioka N, Huss K, Madison J, Putnam FW: Identical structural changes in inherited albumin variants from different populations. Proc Natl Acad Sci U S A. 1989 Jan;86(2):434-8. [Article] Arai K, Madison J, Huss K, Ishioka N, Satoh C, Fujita M, Neel JV, Sakurabayashi I, Putnam FW: Point substitutions in Japanese alloalbumins. Proc Natl Acad Sci U S A. 1989 Aug;86(16):6092-6. [Article] Arai K, Madison J, Shimizu A, Putnam FW: Point substitutions in albumin genetic variants from Asia. Proc Natl Acad Sci U S A. 1990 Jan;87(1):497-501. [Article] Brennan SO, Myles T, Peach RJ, Donaldson D, George PM: Albumin Redhill (-1 Arg, 320 Ala----Thr): a glycoprotein variant of human serum albumin whose precursor has an aberrant signal peptidase cleavage site. Proc Natl Acad Sci U S A. 1990 Jan;87(1):26-30. [Article] Galliano M, Minchiotti L, Porta F, Rossi A, Ferri G, Madison J, Watkins S, Putnam FW: Mutations in genetic variants of human serum albumin found in Italy. Proc Natl Acad Sci U S A. 1990 Nov;87(22):8721-5. [Article] Watkins S, Madison J, Davis E, Sakamoto Y, Galliano M, Minchiotti L, Putnam FW: A donor splice mutation and a single-base deletion produce two carboxyl-terminal variants of human serum albumin. Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):5959-63. [Article] Madison J, Arai K, Sakamoto Y, Feld RD, Kyle RA, Watkins S, Davis E, Matsuda Y, Amaki I, Putnam FW: Genetic variants of serum albumin in Americans and Japanese. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9853-7. [Article] Peach RJ, Brennan SO: Structural characterization of a glycoprotein variant of human serum albumin: albumin Casebrook (494 Asp----Asn). Biochim Biophys Acta. 1991 Jul 26;1097(1):49-54. [Article] Minchiotti L, Galliano M, Stoppini M, Ferri G, Crespeau H, Rochu D, Porta F: Two alloalbumins with identical electrophoretic mobility are produced by differently charged amino acid substitutions. Biochim Biophys Acta. 1992 Mar 12;1119(3):232-8. [Article] Carlson J, Sakamoto Y, Laurell CB, Madison J, Watkins S, Putnam FW: Alloalbuminemia in Sweden: structural study and phenotypic distribution of nine albumin variants. Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8225-9. [Article] Minchiotti L, Galliano M, Zapponi MC, Tenni R: The structural characterization and bilirubin-binding properties of albumin Herborn, a [Lys240-->Glu] albumin mutant. Eur J Biochem. 1993 Jun 1;214(2):437-44. [Article] Brennan SO, Fellowes AP: Albumin Hawkes Bay; a low level variant caused by loss of a sulphydryl group at position 177. Biochim Biophys Acta. 1993 Aug 4;1182(1):46-50. [Article] Galliano M, Minchiotti L, Iadarola P, Stoppini M, Giagnoni P, Watkins S, Madison J, Putnam FW: Protein and DNA sequence analysis of a 'private' genetic variant: albumin Ortonovo (Glu-505-->Lys). Biochim Biophys Acta. 1993 Nov 25;1225(1):27-32. [Article] Madison J, Galliano M, Watkins S, Minchiotti L, Porta F, Rossi A, Putnam FW: Genetic variants of human serum albumin in Italy: point mutants and a carboxyl-terminal variant. Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6476-80. [Article] Sunthornthepvarakul T, Angkeow P, Weiss RE, Hayashi Y, Refetoff S: An identical missense mutation in the albumin gene results in familial dysalbuminemic hyperthyroxinemia in 8 unrelated families. Biochem Biophys Res Commun. 1994 Jul 29;202(2):781-7. [Article] Rushbrook JI, Becker E, Schussler GC, Divino CM: Identification of a human serum albumin species associated with familial dysalbuminemic hyperthyroxinemia. J Clin Endocrinol Metab. 1995 Feb;80(2):461-7. [Article] Wada N, Chiba H, Shimizu C, Kijima H, Kubo M, Koike T: A novel missense mutation in codon 218 of the albumin gene in a distinct phenotype of familial dysalbuminemic hyperthyroxinemia in a Japanese kindred. J Clin Endocrinol Metab. 1997 Oct;82(10):3246-50. [Article] Sunthornthepvarakul T, Likitmaskul S, Ngowngarmratana S, Angsusingha K, Kitvitayasak S, Scherberg NH, Refetoff S: Familial dysalbuminemic hypertriiodothyroninemia: a new, dominantly inherited albumin defect. J Clin Endocrinol Metab. 1998 May;83(5):1448-54. [Article] Spahr CS, Davis MT, McGinley MD, Robinson JH, Bures EJ, Beierle J, Mort J, Courchesne PL, Chen K, Wahl RC, Yu W, Luethy R, Patterson SD: Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry. I. Profiling an unfractionated tryptic digest. Proteomics. 2001 Jan;1(1):93-107. [Article] Minchiotti L, Campagnoli M, Rossi A, Cosulich ME, Monti M, Pucci P, Kragh-Hansen U, Granel B, Disdier P, Weiller PJ, Galliano M: A nucleotide insertion and frameshift cause albumin Kenitra, an extended and O-glycosylated mutant of human serum albumin with two additional disulfide bridges. Eur J Biochem. 2001 Jan;268(2):344-52. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00070Hyaluronidase (ovine)approved, investigationalunknowninhibitorDetailsDB00137Luteinapproved, investigational, nutraceuticalunknownDetailsDB00459AcitretinapprovedunknownDetailsDB00576Sulfamethizoleapproved, investigational, vet_approvedunknownDetailsDB00743Gadobenic acidapproved, investigationalunknownbinderDetailsDB00815Sodium lauryl sulfateexperimentalunknownbinderDetailsDB00936Salicylic acidapproved, investigational, vet_approvednoother/unknownDetailsDB00946Phenprocoumonapproved, investigationalnobinderregulatorDetailsDB00995Auranofinapproved, investigationalunknownDetailsDB01120GliclazideapprovedunknownDetailsDB01328Cefonicidapproved, investigationalnoother/unknownDetailsDB01329Cefoperazoneapproved, investigationalnoother/unknownDetailsDB01396Digitoxinapproved, investigationalnoDetailsDB03017Lauric acidapproved, experimentalunknownDetailsDB03193Stearic acidapproved, experimentalunknownDetailsDB03600Capric acidexperimentalnoDetailsDB03796Palmitic AcidapprovedunknownDetailsDB04224Oleic Acidapproved, investigational, vet_approvedunknownDetailsDB04557Arachidonic AcidexperimentalnoDetailsDB04711IodipamideapprovedunknownbinderDetailsDB06412Oxymetholoneapproved, illicitunknownDetailsDB01197Captoprilapprovednoother/unknownDetailsDB01050IbuprofenapprovednobinderDetailsDB00563MethotrexateapprovednobinderDetailsDB00451LevothyroxineapprovednoDetailsDB00279Liothyronineapproved, vet_approvedunknownDetailsDB00605Sulindacapproved, investigationalunknownDetailsDB00749Etodolacapproved, investigational, vet_approvedunknownDetailsDB00861Diflunisalapproved, investigationalunknownDetailsDB01009Ketoprofenapproved, vet_approvedunknownDetailsDB00586Diclofenacapproved, vet_approvedunknownDetailsDB00783Estradiolapproved, investigational, vet_approvednoDetailsDB00655EstroneapprovednoDetailsDB00624Testosteroneapproved, investigationalnobinderDetailsDB01307Insulin detemirapprovednobinderDetailsDB01418Acenocoumarolapproved, investigationalnoDetailsDB00802Alfentanilapproved, illicitunknownDetailsDB00818Propofolapproved, investigational, vet_approvednoDetailsDB00228Enfluraneapproved, investigational, vet_approvedunknownbinderDetailsDB00753Isofluraneapproved, vet_approvedunknownDetailsDB01189DesfluraneapprovedunknownbinderDetailsDB01159Halothaneapproved, vet_approvedunknownDetailsDB01236Sevofluraneapproved, vet_approvedunknownbinderDetailsDB00252Phenytoinapproved, vet_approvedunknownDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknownDetailsDB00540NortriptylineapprovednobinderDetailsDB00321AmitriptylineapprovednobinderDetailsDB00903Etacrynic acidapproved, investigationalunknownDetailsDB00695Furosemideapproved, vet_approvednobinderDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvednoDetailsDB00682WarfarinapprovednobinderregulatorDetailsDB00554Piroxicamapproved, investigationalunknownDetailsDB00573FenoprofenapprovedunknownDetailsDB00328Indomethacinapproved, investigationalunknownDetailsDB03585Oxyphenbutazoneapproved, withdrawnunknownDetailsDB00544FluorouracilapprovednoDetailsDB01232Saquinavirapproved, investigationalunknownDetailsDB01032Probenecidapproved, investigationalnoDetailsDB01044Gatifloxacinapproved, investigational, withdrawnunknownother/unknownDetailsDB01068Clonazepamapproved, illicitnoDetailsDB01147Cloxacillinapproved, investigational, vet_approvednobinderDetailsDB01327Cefazolinapprovedunknownother/unknownDetailsDB00931Metacyclineapproved, investigationalnoDetailsDB01015SulfamethoxazoleapprovednosubstrateDetailsDB00415Ampicillinapproved, vet_approvednoother/unknownDetailsDB00567Cephalexinapproved, investigational, vet_approvednobinderDetailsDB00759Tetracyclineapproved, vet_approved, withdrawnnoDetailsDB01212Ceftriaxoneapprovednoother/unknownDetailsDB01330CefotetanapprovednoDetailsDB00274Cefmetazoleapproved, investigationalnoDetailsDB00495ZidovudineapprovednoDetailsDB01397Magnesium salicylateexperimentalnoDetailsDB00788Naproxenapproved, vet_approvednoDetailsDB00334Olanzapineapproved, investigationalnobinderDetailsDB01056Tocainideapprovednoother/unknownDetailsDB01320Fosphenytoinapproved, investigationalnoother/unknownDetailsDB00712Flurbiprofenapproved, investigationalnoother/unknownDetailsDB07402AzapropazonewithdrawnunknownDetailsDB075173-CARBOXY-4-METHYL-5-PROPYL-2-FURANPROPIONICexperimentalunknownDetailsDB07992Indoxyl sulfateexperimentalunknownDetailsDB08231Myristic acidexperimentalunknownDetailsDB08496(R)-warfarinexperimentalunknownDetailsDB08735R,S-Warfarin alcoholexperimentalunknownDetailsDB08736S,R-Warfarin alcoholexperimentalunknownDetailsDB00430CefpiramideapprovedunknownDetailsDB01583LiotrixapprovedunknownDetailsDB01294Bismuth subsalicylateapproved, vet_approvednobinderDetailsDB00456Cefalotinapproved, investigational, vet_approvedunknownbinderDetailsDB01581Sulfamerazineapproved, vet_approvedunknownDetailsDB01582Sulfamethazineapproved, investigational, vet_approvedunknownDetailsDB01587KetazolamapprovedunknownDetailsDB01614Acepromazineexperimental, vet_approvedunknownDetailsDB01621Pipotiazineapproved, investigationalunknownDetailsDB04574Estrone sulfateapprovedunknownDetailsDB06710MethyltestosteroneapprovedunknownDetailsDB01622ThioproperazineexperimentalunknownDetailsDB01623ThiothixeneapprovedunknownDetailsDB06705Gadofosveset trisodiumapprovedunknownsubstrateDetailsDB00454MeperidineapprovedunknownbinderDetailsDB01016GlyburideapprovedunknownbinderDetailsDB00912Repaglinideapproved, investigationalunknownDetailsDB00731Nateglinideapproved, investigationalunknownDetailsDB08867UlipristalapprovednosubstrateDetailsDB05294VandetanibapprovedunknownbinderDetailsDB05521Telaprevirapproved, withdrawnnosubstrateDetailsDB05812AbirateroneapprovedunknownbinderDetailsDB08881VemurafenibapprovedunknownsubstrateDetailsDB08828Vismodegibapproved, investigationalunknownbinderDetailsDB08893MirabegronapprovednobinderDetailsDB00635Prednisoneapproved, vet_approvedunknownsubstrateDetailsDB08899EnzalutamideapprovednobinderDetailsDB08820IvacaftorapprovednocarrierDetailsDB00776OxcarbazepineapprovedunknownsubstrateDetailsDB06201RufinamideapprovedunknownsubstrateDetailsDB06716Fospropofolapproved, illicit, investigationalunknownsubstrateDetailsDB04855DronedaroneapprovednobinderDetailsDB06209PrasugrelapprovedunknownsubstrateDetailsDB08860PitavastatinapprovedunknownsubstrateDetailsDB01183Naloxoneapproved, vet_approvedunknownbinderDetailsDB01242Clomipramineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateDetailsDB00472Fluoxetineapproved, vet_approvedunknownsubstrateDetailsDB00317Gefitinibapproved, investigationalunknownsubstrateDetailsDB00619ImatinibapprovednobinderDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateDetailsDB00678LosartanapprovedunknownsubstrateDetailsDB00412Rosiglitazoneapproved, investigationalunknownsubstrateDetailsDB01098RosuvastatinapprovedunknownsubstrateDetailsDB00864Tacrolimusapproved, investigationalunknownsubstrateDetailsDB00717NorethisteroneapprovedunknownsubstrateDetailsDB08931RiociguatapprovedunknownsubstrateDetailsDB08895Tofacitinibapproved, investigationalunknownDetailsDB08932MacitentanapprovednobinderDetailsDB06290SimeprevirapprovednobinderDetailsDB00493CefotaximeapprovedunknownDetailsDB09280LumacaftorapprovednocarrierDetailsDB09130Copperapproved, investigationalnobinderDetailsDB11093Calcium citrateapproved, investigationalnosubstrateDetailsDB11348Calcium PhosphateapprovednosubstrateDetailsDB11575GrazoprevirapprovednosubstrateDetailsDB11943Delafloxacinapproved, investigationalnosubstrateDetailsDB01685TopiroxostatexperimentalunknownbinderDetailsDB09093Chlortetracyclineapproved, investigational, vet_approvednoDetailsDB06796Mangafodipirapproved, investigational, withdrawnunknownbinderDetailsDB09262ImidafenacininvestigationalnosubstrateDetailsDB00276Amsacrineapproved, investigationalunknownDetailsDB11359GuaiacolapprovedunknownDetailsDB03255Phenolapproved, experimentalunknownDetailsDB06728AnilineexperimentalunknownDetailsDB06713Norelgestrominapproved, investigationalunknownDetailsDB01370Aluminiumapproved, investigationalunknownDetailsDB13014HypericininvestigationalunknownDetailsDB01057EchothiophateapprovedunknownDetailsDB11397Dichlorvosvet_approvedunknownDetailsDB00677Isoflurophateapproved, investigational, withdrawnunknownDetailsDB00943Zalcitabineapproved, investigationalunknownDetailsDB01072Atazanavirapproved, investigationalnobinderDetailsDB00649Stavudineapproved, investigationalunknownDetailsDB00900DidanosineapprovedunknownDetailsDB00625Efavirenzapproved, investigationalunknownDetailsDB00879Emtricitabineapproved, investigationalunknownbinderDetailsDB00220NelfinavirapprovednobinderDetailsDB00238NevirapineapprovedunknownDetailsDB00503Ritonavirapproved, investigationalunknownsubstrateDetailsDB00709Lamivudineapproved, investigationalunknownDetailsDB04216Quercetinexperimental, investigationalunknownDetailsDB00997Doxorubicinapproved, investigationalunknownDetailsDB04816Dantronapproved, investigational, withdrawnunknownDetailsDB00755Tretinoinapproved, investigational, nutraceuticalunknownbinderDetailsDB00515CisplatinapprovedunknownDetailsDB00162Vitamin Aapproved, nutraceutical, vet_approvedunknownbinderDetailsDB04690CamptothecinexperimentalunknownDetailsDB02709ResveratrolinvestigationalunknownDetailsDB00744Zileutonapproved, investigational, withdrawnunknownDetailsDB04539GlyphosateexperimentalunknownDetailsDB11590ThimerosalapprovedunknownDetailsDB05134TanespimycininvestigationalunknownDetailsDB01124Tolbutamideapproved, investigationalunknownDetailsDB01276Exenatideapproved, investigationalunknownDetailsDB00414Acetohexamideapproved, investigational, withdrawnunknownDetailsDB00458ImipramineapprovedunknownDetailsDB00159Icosapentapproved, nutraceuticalnobinderDetailsDB00951Isoniazidapproved, investigationalunknownDetailsDB01104SertralineapprovedunknownbinderDetailsDB09383Meprednisoneapproved, investigationalunknownDetailsDB00266DicoumarolapprovedunknownDetailsDB04828ZomepiracwithdrawnunknownDetailsDB00500TolmetinapprovedunknownDetailsDB11217ArbutinapprovedunknownDetailsDB09526Hydroquinoneapproved, investigationalunknownDetailsDB00784Mefenamic acidapprovedunknownDetailsDB00313Valproic acidapproved, investigationalunknownDetailsDB01169Arsenic trioxideapproved, investigationalnosubstrateDetailsDB11828Neratinibapproved, investigationalnosubstrateDetailsDB00607Nafcillinapproved, investigationalunknownDetailsDB12483Copanlisibapproved, investigationalunknownsubstrateDetailsDB00512VancomycinapprovednosubstrateDetailsDB12001Abemaciclibapproved, investigationalunknownbinderDetailsDB08864RilpivirineapprovednobinderDetailsDB13928Semaglutideapproved, investigationalnosubstrateDetailsDB09087Potassium alumapprovedunknownbinderDetailsDB09223BlonanserininvestigationalnosubstrateDetailsDB09236Lacidipineapproved, investigationalunknownbinderDetailsDB09124Medrogestoneapproved, withdrawnnobinderDetailsDB11827Ertugliflozinapproved, investigationalnobinderDetailsDB09139Technetium Tc-99m oxidronateapprovednobinderDetailsDB13943Testosterone cypionateapprovednoother/unknownDetailsDB13944Testosterone enanthateapprovednoother/unknownDetailsDB13946Testosterone undecanoateapproved, investigationalnobinderDetailsDB13952Estradiol acetateapproved, investigational, vet_approvednoDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvednoDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvednoDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvednoDetailsDB13956Estradiol valerateapproved, investigational, vet_approvednoDetailsDB11638Artenimolapproved, experimental, investigationalunknownligandDetailsDB01420Testosterone propionateapproved, investigational, vet_approved, withdrawnnosubstrateDetailsDB09195LorpiprazoleapprovednosubstrateDetailsDB09204ArotinololinvestigationalnosubstrateDetailsDB08814Triflusalapproved, investigationalnosubstrateDetailsDB09229AranidipineexperimentalnobinderDetailsDB09333Iopodic acidapproved, investigational, withdrawnnosubstrateDetailsDB09347Acetrizoic acidwithdrawnnobinderDetailsDB09348Propiolactoneapproved, withdrawnnobinderDetailsDB11130Opiumapproved, illicitnobinderDetailsDB06778Cupric sulfateapprovedunknownDetailsDB09053IbrutinibapprovednosubstrateDetailsDB11182Rose bengalapproved, investigationalunknownbinderDetailsDB13967Patent BlueapprovedyesbinderDetailsDB13909Bismuth subgallateapprovedunknowncarrierDetailsDB09418Potassium perchlorateapproved, investigationalunknownbinderDetailsDB11641Vinflunineapproved, investigationalnosubstrateDetailsDB13421Edoxudineapproved, investigational, withdrawnnobinderDetailsDB11134Cupric oxideapprovedunknownbinderDetailsDB11148Butambenapproved, withdrawnnosubstrateDetailsDB11637Delamanidapproved, investigationalunknownsubstrateDetailsDB13751Glycyrrhizic acidapproved, experimentalnobinderDetailsDB12965Silverapproved, investigationalunknownbinderDetailsDB14185Aripiprazole lauroxilapproved, investigationalunknownbinderDetailsDB14481Calcium phosphate dihydrateapprovednoDetailsDB14517Aluminium phosphateapproved, investigationalunknownDetailsDB14518Aluminum acetateapproved, investigationalunknownDetailsDB00432Trifluridineapproved, investigationalunknownbinderDetailsDB14582Patisiranapproved, investigationalunknownligandDetailsDB09213Dexibuprofenapproved, investigationalnoDetailsDB12455Omadacyclineapproved, investigationalunknownDetailsDB12836Grapiprantinvestigational, vet_approvednosubstrateDetailsDB11753Rifamycinapproved, investigationalnosubstrateDetailsDB11963Dacomitinibapproved, investigationalnobinderDetailsDB11855Revefenacinapproved, investigationalnobinderDetailsDB12141Gilteritinibapproved, investigationalnobinderDetailsDB06480PrucaloprideapprovedunknownbinderDetailsDB11978Glasdegibapproved, investigationalnobinderDetailsDB00214TorasemideapprovedunknownsubstrateDetailsDB00227Lovastatinapproved, investigationalnosubstrateDetailsDB09564Insulin degludecapprovednobinderDetailsDB00245BenzatropineapprovednobinderDetailsDB00264Metoprololapproved, investigationalnobinderDetailsDB00286Conjugated estrogensapprovednobinderDetailsDB00289AtomoxetineapprovednobinderDetailsDB00294Etonogestrelapproved, investigationalnobinderDetailsDB00295Morphineapproved, investigationalnobinderDetailsDB00310ChlorthalidoneapprovednoDetailsDB00304DesogestrelapprovednobinderDetailsDB00327Hydromorphoneapproved, illicitnobinderDetailsDB09073Palbociclibapproved, investigationalnobinderDetailsDB00332Ipratropiumapproved, experimentalnobinderDetailsDB01142Doxepinapproved, investigationalnobinderDetailsDB01076AtorvastatinapprovednobinderDetailsDB06655LiraglutideapprovedunknownbinderDetailsDB01235LevodopaapprovedunknownbinderDetailsDB01238Aripiprazoleapproved, investigationalunknownbinderDetailsDB00404Alprazolamapproved, illicit, investigationalunknownbinderDetailsDB00421SpironolactoneapprovedunknownbinderDetailsDB00335AtenololapprovednosubstrateDetailsDB01126Dutasterideapproved, investigationalnobinderDetailsDB09299Tenofovir alafenamideapprovednobinderDetailsDB00343Diltiazemapproved, investigationalnobinderDetailsDB14126Tenofovirexperimental, investigationalnobinderDetailsDB00476DuloxetineapprovedunknownligandDetailsDB00497Oxycodoneapproved, illicit, investigationalunknownbinderDetailsDB00481Raloxifeneapproved, investigationalnobinderDetailsDB00537Ciprofloxacinapproved, investigationalunknownbinderDetailsDB00461NabumetoneapprovedunknownDetailsDB00982IsotretinoinapprovedunknownbinderDetailsDB00584Enalaprilapproved, vet_approvednobinderDetailsDB01067Glipizideapproved, investigationalnobinderDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedunknownbinderDetailsDB00737MeclizineapprovednobinderDetailsDB00768OlopatadineapprovednobinderDetailsDB00571Propranololapproved, investigationalunknownDetailsDB00575ClonidineapprovedunknownbinderDetailsDB00787AcyclovirapprovedunknownbinderDetailsDB00490Buspironeapproved, investigationalunknownbinderDetailsDB01029Irbesartanapproved, investigationalunknownbinderDetailsDB06282LevocetirizineapprovedunknownbinderDetailsDB00598LabetalolapprovedunknownsubstrateDetailsDB01026Ketoconazoleapproved, investigationalunknownligandDetailsDB00675TamoxifenapprovedunknownsubstrateDetailsDB12978Pexidartinibapproved, investigationalunknownbinderDetailsDB01136Carvedilolapproved, investigationalunknownbinderDetailsDB04861Nebivololapproved, investigationalunknownbinderDetailsDB01611HydroxychloroquineapprovedunknownbinderDetailsDB01045RifampicinapprovedunknownligandDetailsDB01394ColchicineapprovedunknownbinderDetailsDB00333MethadoneapprovednoDetailsDB11757Istradefyllineapproved, investigationalunknownbinderDetailsDB00620Triamcinoloneapproved, vet_approvedunknownbinderDetailsDB00924CyclobenzaprineapprovedunknownsubstrateDetailsDB00881Quinaprilapproved, investigationalunknownbinderDetailsDB09079NintedanibapprovedunknownsubstrateDetailsDB00999Hydrochlorothiazideapproved, vet_approvedunknownbinderDetailsDB01241GemfibrozilapprovedunknownbinderDetailsDB01039FenofibrateapprovedunknownbinderDetailsDB01062Oxybutyninapproved, investigationalunknownbinderDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknownbinderDetailsDB01275HydralazineapprovedunknownbinderDetailsDB01195Flecainideapproved, withdrawnunknownbinderDetailsDB00687Fludrocortisoneapproved, investigationalunknownsubstrateDetailsDB00316AcetaminophenapprovedunknownbinderDetailsDB00278Argatrobanapproved, investigationalunknownbinderDetailsDB06216AsenapineapprovedunknownbinderDetailsDB15444Elexacaftorapproved, investigationalunknownsubstrateDetailsDB00860Prednisoloneapproved, vet_approvedunknownbinderDetailsDB15566Prednisolone acetateapproved, vet_approvedunknownbinderDetailsDB11703Acalabrutinibapproved, investigationalunknownbinderDetailsDB14513Magnesiumapproved, experimental, investigationalunknownDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknownbinderDetailsDB00661VerapamilapprovedunknownsubstrateDetailsDB00273TopiramateapprovedunknownbinderDetailsDB06119Cenobamateapproved, investigationalunknownbinderDetailsDB01222BudesonideapprovedunknownbinderDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknownbinderDetailsDB00950Fexofenadineapproved, investigationalunknownsubstrateDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownbinderDetailsDB09237Levamlodipineapproved, investigationalunknownbinderDetailsDB12941Darolutamideapproved, investigationalunknownbinderDetailsDB14879Cefiderocolapproved, investigationalnoligandDetailsDB00852PseudoephedrineapprovedunknownbinderDetailsDB00983Formoterolapproved, investigationalunknownsubstrateDetailsDB00993AzathioprineapprovedunknownbinderDetailsDB00557HydroxyzineapprovedunknownsubstrateregulatorDetailsDB01118Amiodaroneapproved, investigationalunknownbinderDetailsDB01069Promethazineapproved, investigationalunknownbinderDetailsDB01115NifedipineapprovedunknownbinderDetailsDB01132Pioglitazoneapproved, investigationalunknownsubstrateDetailsDB00814Meloxicamapproved, vet_approvedunknownDetailsDB00938SalmeterolapprovedunknownbinderDetailsDB00878Chlorhexidineapproved, vet_approved, withdrawnunknownsubstrateDetailsDB01006Letrozoleapproved, investigationalunknownbinderDetailsDB00246ZiprasidoneapprovedunknownDetailsDB01060Amoxicillinapproved, vet_approvedunknownbinderDetailsDB01137Levofloxacinapproved, investigationalunknownsubstrateDetailsDB09100Thyroid, porcineapprovedunknownbinderDetailsDB01013Clobetasol propionateapprovedunknownbinderDetailsDB00957Norgestimateapproved, investigationalunknownbinderDetailsDB00977EthinylestradiolapprovedunknownbinderDetailsDB00555Lamotrigineapproved, investigationalunknownsubstrateDetailsDB01264DarunavirapprovedunknownsubstrateDetailsDB00608Chloroquineapproved, investigational, vet_approvedunknownbinderDetailsDB12466Favipiravirapproved, investigationalunknowncarrierDetailsDB01601LopinavirapprovedunknownsubstrateDetailsDB14999Human interferon betaapproved, investigationalunknownbinderDetailsDB00126Ascorbic acidapproved, nutraceuticalunknownbinderDetailsDB00443Betamethasoneapproved, vet_approvedunknownDetailsDB05382Iodineapproved, investigationalunknownbinderDetailsDB11642Pitolisantapproved, investigationalnobinderDetailsDB00152Thiamineapproved, investigational, nutraceutical, vet_approvedunknownbinderDetailsDB00165Pyridoxineapproved, investigational, nutraceutical, vet_approvedunknownbinderDetailsDB00595Oxytetracyclineapproved, investigational, vet_approvedunknownbinderDetailsDB00870Suprofenapproved, withdrawnunknownbinderDetailsDB00774Hydroflumethiazideapproved, investigational, withdrawnunknownbinderDetailsDB09241Methylene blueapproved, investigationalunknownbinderDetailsDB15534Colchiceineapproved, experimentalunknownsubstrateDetailsDB01053Benzylpenicillinapproved, vet_approvedunknownbinderDetailsDB01324PolythiazideapprovedunknownbinderDetailsDB07565Chloramphenicol succinateapprovedunknownbinderDetailsDB01914D-glucoseapproved, investigational, vet_approvedunknownbinderDetailsDB14533Zinc chlorideapproved, investigationalunknownbinderDetailsDB11689Selumetinibapproved, investigationalunknowncarrierDetailsDB04911Oritavancinapproved, investigationalunknownbinderDetailsDB14548Zinc sulfate, unspecified formapproved, experimentalunknownbinderDetailsDB00734Risperidoneapproved, investigationalunknownbinderDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknownbinderDetailsDB01364EphedrineapprovedunknownbinderDetailsDB00237Butabarbitalapproved, illicitunknownbinderDetailsDB01133Tiludronic acidapproved, investigational, vet_approvedunknownbinderDetailsDB14840RipretinibapprovedunknownbinderDetailsDB00845Clofazimineapproved, investigationalunknownbinderDetailsDB00842OxazepamapprovedunknownbinderDetailsDB00714Apomorphineapproved, investigationalunknownbinderDetailsDB09274Artesunateapproved, investigationalunknownbinderDetailsDB15690Fluoroestradiol F-18approvedunknownbinderDetailsDB00808IndapamideapprovedunknownbinderDetailsDB08816TicagrelorapprovedunknownbinderDetailsDB14669Betamethasone phosphateapproved, vet_approvedunknownbinderDetailsDB12674Lurbinectedinapproved, investigationalunknownbinderDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknownbinderDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknownbinderDetailsDB00104Octreotideapproved, investigationalunknownbinderDetailsDB11677Triheptanoinapproved, investigationalunknownbinderDetailsDB12404Remimazolamapproved, investigationalunknownbinderDetailsDB11796Fostemsavirapproved, investigationalunknowncarrierDetailsDB15305Risdiplamapproved, investigationalunknownbinderDetailsDB11820Nifurtimoxapproved, investigationalunknownbinderDetailsDB00847Cysteamineapproved, investigationalunknownbinderDetailsDB15093Somapacitanapproved, investigationalunknownbinderDetailsDB00908Quinidineapproved, investigationalunknownbinderDetailsDB15935Lumasiranapproved, investigationalnobinderDetailsDB04951Pirfenidoneapproved, investigationalunknownbinderDetailsDB11853Relugolixapproved, investigationalunknownbinderDetailsDB01380Cortisone acetateapproved, investigationalunknownbinderDetailsDB15248Bulevirtideapproved, investigationalunknownbinderDetailsDB00501Cimetidineapproved, investigationalunknownsubstrateDetailsDB15456Vericiguatapproved, investigationalunknownbinderDetailsDB11751Cabotegravirapproved, investigationalunknownbinderDetailsDB15133Tepotinibapproved, investigationalunknownbinderDetailsDB06151Acetylcysteineapproved, investigationalunknownbinderDetailsDB00346Alfuzosinapproved, investigationalunknownbinderDetailsDB00376TrihexyphenidylapprovedunknownbinderDetailsDB00391Sulpirideapproved, investigationalnobinderDetailsDB01083Orlistatapproved, investigationalunknownbinderDetailsDB08877RuxolitinibapprovedunknownbinderDetailsDB00640Adenosineapproved, investigationalunknownbinderDetailsDB00853Temozolomideapproved, investigationalnobinderDetailsDB06237AvanafilapprovedunknownbinderDetailsDB04854FebuxostatapprovedunknownbinderDetailsDB01086Benzocaineapproved, investigationalunknownbinderDetailsDB11800Tivozanibapproved, investigationalunknownbinderDetailsDB00080Daptomycinapproved, investigationalnobinderDetailsDB00434CyproheptadineapprovedunknownbinderDetailsDB00083Botulinum toxin type Aapproved, investigationalunknownbinderDetailsDB00968MethyldopaapprovednobinderDetailsDB08995Diosminapproved, investigationalunknownbinderDetailsDB08822Azilsartan medoxomilapproved, investigationalnobinderDetailsDB00438CeftazidimeapprovednobinderDetailsDB09069Trimetazidineapproved, investigationalunknownbinderDetailsDB00601Linezolidapproved, investigationalnobinderDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownbinderDetailsDB12235Estetrolapproved, investigationalunknownbinderDetailsDB01064Isoprenalineapproved, investigationalunknownbinderDetailsDB12471Ibrexafungerpapproved, investigationalunknownbinderDetailsDB06695Dabigatran etexilateapprovedunknownbinderDetailsDB16165Finerenoneapproved, investigationalunknownbinderDetailsDB16703Belumosudilapproved, investigationalnobinderDetailsDB00877Sirolimusapproved, investigationalnobinderDetailsDB06234Maribavirapproved, investigationalnobinderDetailsDB14973Abrocitinibapproved, investigationalnobinderDetailsDB15575Padeliporfinapproved, experimentalunknownbinderDetailsDB09070Tiboloneapproved, investigationalunknownbinderDetailsDB04847Roxadustatapproved, investigationalunknownbinderDetailsDB09074OlaparibapprovedunknownbinderDetailsDB15171Tirzepatideapproved, investigationalunknownbinderDetailsDB13959Medium-chain triglyceridesapprovedunknownbinderDetailsDB06813Pralatrexateapproved, investigationalnobinderDetailsDB00342Terfenadineapproved, withdrawnunknownbinderregulatorDetailsDB13514Pranoprofenexperimental, investigationalnoregulatorDetailsDB00427TriprolidineapprovedunknownbinderregulatorDetailsDB00485Dicloxacillinapproved, investigational, vet_approvedunknownbinderregulatorDetailsDB01173OrphenadrineapprovedunknownbinderregulatorDetailsDB01619PhenindamineapprovedunknownbinderregulatorDetailsDB00792Tripelennamineapproved, vet_approvedunknownbinderregulatorDetailsDB08912Dabrafenibapproved, investigationalnobinderDetailsDB16699Vutrisiranapproved, investigationalunknownligandDetailsDB06150Sulfadimethoxineapproved, vet_approved, withdrawnunknownsubstrateDetailsDB00254Doxycyclineapproved, investigational, vet_approvedunknownsubstratebinderDetailsDB08936ChlorcyclizineapprovedunknownregulatorDetailsDB00568Cinnarizineapproved, investigationalunknownregulatorDetailsDB01176CyclizineapprovedunknownregulatorDetailsDB00366Doxylamineapproved, vet_approvedunknownregulatorDetailsDB00850PerphenazineapprovedunknownregulatorDetailsDB01024Mycophenolic acidapproved, investigationalunknownbinderDetailsDB08865Crizotinibapproved, investigationalunknownbinderDetailsDB13310OrmeloxifeneexperimentalunknownbinderDetailsDB00758ClopidogrelapprovednobinderDetailsDB15149Futibatinibapproved, investigationalnobinderDetailsDB08930DolutegravirapprovednobinderDetailsDB17083LinzagolixapprovednobinderDetailsDB11739Vonoprazanapproved, investigationalunknownbinderDetailsDB11793Niraparibapproved, investigationalunknownbinderDetailsDB00642Pemetrexedapproved, investigationalnobinderDetailsDB12243Edaravoneapproved, investigationalnobinderDetailsDB00795SulfasalazineapprovednobinderDetailsDB00303Ertapenemapproved, investigationalnobinderDetailsDB01119DiazoxideapprovedunknownbinderDetailsDB01101Capecitabineapproved, investigationalnobinderDetailsDB00363ClozapineapprovednobinderDetailsDB00349Clobazamapproved, illicitnobinderDetailsDB00770Alprostadilapproved, investigationalunknownbinderDetailsDB00683Midazolamapproved, illicitnobinderDetailsDB11901Apalutamideapproved, investigationalnobinderDetailsDB09128Brexpiprazoleapproved, investigationalnosubstrateDetailsDB08906Fluticasone furoateapprovednobinderDetailsDB12255Vadadustatapproved, investigationalunknownbinderDetailsDB09076UmeclidiniumapprovednobinderDetailsDB01005HydroxyureaapprovednobinderDetailsDB00526Oxaliplatinapproved, investigationalnobinderDetailsDB06772CabazitaxelapprovedunknownbinderDetailsDB12874Quizartinibapproved, investigationalnobinderDetailsDB01042MelphalanapprovedunknownbinderDetailsDB08903BedaquilineapprovednobinderDetailsDB11718Encorafenibapproved, investigationalnobinderDetailsDB11967Binimetinibapproved, investigationalnobinderDetails"
                    }
                }
            ],
            "transporters": [
                {
                    "Label": "P-glycoprotein 1",
                    "Detailed Info": {
                        "Name": "Multidrug resistance protein 1",
                        "Synonyms": "3.6.3.44\nATP-binding cassette sub-family B member 1\nMDR1\nP-glycoprotein 1\nPGY1",
                        "Gene Name": "ABCB1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0037114|Multidrug resistance protein 1\nMDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLYMVVGTLAAII\nHGAGLPLMMLVFGEMTDIFANAGNLEDLMSNITNRSDINDTGFFMNLEEDMTRYAYYYSG\nIGAGVLVAAYIQVSFWCLAAGRQIHKIRKQFFHAIMRQEIGWFDVHDVGELNTRLTDDVS\nKINEGIGDKIGMFFQSMATFFTGFIVGFTRGWKLTLVILAISPVLGLSAAVWAKILSSFT\nDKELLAYAKAGAVAEEVLAAIRTVIAFGGQKKELERYNKNLEEAKRIGIKKAITANISIG\nAAFLLIYASYALAFWYGTTLVLSGEYSIGQVLTVFFSVLIGAFSVGQASPSIEAFANARG\nAAYEIFKIIDNKPSIDSYSKSGHKPDNIKGNLEFRNVHFSYPSRKEVKILKGLNLKVQSG\nQTVALVGNSGCGKSTTVQLMQRLYDPTEGMVSVDGQDIRTINVRFLREIIGVVSQEPVLF\nATTIAENIRYGRENVTMDEIEKAVKEANAYDFIMKLPHKFDTLVGERGAQLSGGQKQRIA\nIARALVRNPKILLLDEATSALDTESEAVVQVALDKARKGRTTIVIAHRLSTVRNADVIAG\nFDDGVIVEKGNHDELMKEKGIYFKLVTMQTAGNEVELENAADESKSEIDALEMSSNDSRS\nSLIRKRSTRRSVRGSQAQDRKLSTKEALDESIPPVSFWRIMKLNLTEWPYFVVGVFCAII\nNGGLQPAFAIIFSKIIGVFTRIDDPETKRQNSNLFSLLFLALGIISFITFFLQGFTFGKA\nGEILTKRLRYMVFRSMLRQDVSWFDDPKNTTGALTTRLANDAAQVKGAIGSRLAVITQNI\nANLGTGIIISFIYGWQLTLLLLAIVPIIAIAGVVEMKMLSGQALKDKKELEGSGKIATEA\nIENFRTVVSLTQEQKFEHMYAQSLQVPYRNSLRKAHIFGITFSFTQAMMYFSYAGCFRFG\nAYLVAHKLMSFEDVLLVFSAVVFGAMAVGQVSSFAPDYAKAKISAAHIIMIIEKTPLIDS\nYSTEGLMPNTLEGNVTFGEVVFNYPTRPDIPVLQGLSLEVKKGQTLALVGSSGCGKSTVV\nQLLERFYDPLAGKVLLDGKEIKRLNVQWLRAHLGIVSQEPILFDCSIAENIAYGDNSRVV\nSQEEIVRAAKEANIHAFIESLPNKYSTKVGDKGTQLSGGQKQRIAIARALVRQPHILLLD\nEATSALDTESEKVVQEALDKAREGRTCIVIAHRLSTIQNADLIVVFQNGRVKEHGTHQQL\nLAQKGIYFSMVSVQAGTKRQ",
                        "Number of residues": "1280",
                        "Molecular Weight": "141477.255",
                        "Theoretical pI": "9.44",
                        "GO Classification": "FunctionsATP binding / ATPase activity, coupled to transmembrane movement of substances / transporter activity / xenobiotic-transporting ATPase activityProcessesdrug transmembrane transport / G2/M transition of mitotic cell cycle / response to drug / small molecule metabolic process / stem cell proliferation / transmembrane transport / transportComponentscell surface / extracellular exosome / integral component of membrane / membrane / plasma membrane",
                        "General Function": "Xenobiotic-transporting atpase activity",
                        "Specific Function": "Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells.",
                        "Pfam Domain Function": "ABC_tran (PF00005)\nABC_membrane (PF00664)",
                        "Transmembrane Regions": "45-67\n117-137\n187-208\n216-236\n293-316\n331-352\n712-732\n757-777\n833-853\n855-874\n935-957\n974-995",
                        "Cellular Location": "Cell membrane",
                        "Gene sequence": ">lcl|BSEQ0016291|Multidrug resistance protein 1 (ABCB1)\nATGGATCTTGAAGGGGACCGCAATGGAGGAGCAAAGAAGAAGAACTTTTTTAAACTGAAC\nAATAAAAGTGAAAAAGATAAGAAGGAAAAGAAACCAACTGTCAGTGTATTTTCAATGTTT\nCGCTATTCAAATTGGCTTGACAAGTTGTATATGGTGGTGGGAACTTTGGCTGCCATCATC\nCATGGGGCTGGACTTCCTCTCATGATGCTGGTGTTTGGAGAAATGACAGATATCTTTGCA\nAATGCAGGAAATTTAGAAGATCTGATGTCAAACATCACTAATAGAAGTGATATCAATGAT\nACAGGGTTCTTCATGAATCTGGAGGAAGACATGACCAGGTATGCCTATTATTACAGTGGA\nATTGGTGCTGGGGTGCTGGTTGCTGCTTACATTCAGGTTTCATTTTGGTGCCTGGCAGCT\nGGAAGACAAATACACAAAATTAGAAAACAGTTTTTTCATGCTATAATGCGACAGGAGATA\nGGCTGGTTTGATGTGCACGATGTTGGGGAGCTTAACACCCGACTTACAGATGATGTCTCC\nAAGATTAATGAAGGAATTGGTGACAAAATTGGAATGTTCTTTCAGTCAATGGCAACATTT\nTTCACTGGGTTTATAGTAGGATTTACACGTGGTTGGAAGCTAACCCTTGTGATTTTGGCC\nATCAGTCCTGTTCTTGGACTGTCAGCTGCTGTCTGGGCAAAGATACTATCTTCATTTACT\nGATAAAGAACTCTTAGCGTATGCAAAAGCTGGAGCAGTAGCTGAAGAGGTCTTGGCAGCA\nATTAGAACTGTGATTGCATTTGGAGGACAAAAGAAAGAACTTGAAAGGTACAACAAAAAT\nTTAGAAGAAGCTAAAAGAATTGGGATAAAGAAAGCTATTACAGCCAATATTTCTATAGGT\nGCTGCTTTCCTGCTGATCTATGCATCTTATGCTCTGGCCTTCTGGTATGGGACCACCTTG\nGTCCTCTCAGGGGAATATTCTATTGGACAAGTACTCACTGTATTCTTTTCTGTATTAATT\nGGGGCTTTTAGTGTTGGACAGGCATCTCCAAGCATTGAAGCATTTGCAAATGCAAGAGGA\nGCAGCTTATGAAATCTTCAAGATAATTGATAATAAGCCAAGTATTGACAGCTATTCGAAG\nAGTGGGCACAAACCAGATAATATTAAGGGAAATTTGGAATTCAGAAATGTTCACTTCAGT\nTACCCATCTCGAAAAGAAGTTAAGATCTTGAAGGGTCTGAACCTGAAGGTGCAGAGTGGG\nCAGACGGTGGCCCTGGTTGGAAACAGTGGCTGTGGGAAGAGCACAACAGTCCAGCTGATG\nCAGAGGCTCTATGACCCCACAGAGGGGATGGTCAGTGTTGATGGACAGGATATTAGGACC\nATAAATGTAAGGTTTCTACGGGAAATCATTGGTGTGGTGAGTCAGGAACCTGTATTGTTT\nGCCACCACGATAGCTGAAAACATTCGCTATGGCCGTGAAAATGTCACCATGGATGAGATT\nGAGAAAGCTGTCAAGGAAGCCAATGCCTATGACTTTATCATGAAACTGCCTCATAAATTT\nGACACCCTGGTTGGAGAGAGAGGGGCCCAGTTGAGTGGTGGGCAGAAGCAGAGGATCGCC\nATTGCACGTGCCCTGGTTCGCAACCCCAAGATCCTCCTGCTGGATGAGGCCACGTCAGCC\nTTGGACACAGAAAGCGAAGCAGTGGTTCAGGTGGCTCTGGATAAGGCCAGAAAAGGTCGG\nACCACCATTGTGATAGCTCATCGTTTGTCTACAGTTCGTAATGCTGACGTCATCGCTGGT\nTTCGATGATGGAGTCATTGTGGAGAAAGGAAATCATGATGAACTCATGAAAGAGAAAGGC\nATTTACTTCAAACTTGTCACAATGCAGACAGCAGGAAATGAAGTTGAATTAGAAAATGCA\nGCTGATGAATCCAAAAGTGAAATTGATGCCTTGGAAATGTCTTCAAATGATTCAAGATCC\nAGTCTAATAAGAAAAAGATCAACTCGTAGGAGTGTCCGTGGATCACAAGCCCAAGACAGA\nAAGCTTAGTACCAAAGAGGCTCTGGATGAAAGTATACCTCCAGTTTCCTTTTGGAGGATT\nATGAAGCTAAATTTAACTGAATGGCCTTATTTTGTTGTTGGTGTATTTTGTGCCATTATA\nAATGGAGGCCTGCAACCAGCATTTGCAATAATATTTTCAAAGATTATAGGGGTTTTTACA\nAGAATTGATGATCCTGAAACAAAACGACAGAATAGTAACTTGTTTTCACTATTGTTTCTA\nGCCCTTGGAATTATTTCTTTTATTACATTTTTCCTTCAGGGTTTCACATTTGGCAAAGCT\nGGAGAGATCCTCACCAAGCGGCTCCGATACATGGTTTTCCGATCCATGCTCAGACAGGAT\nGTGAGTTGGTTTGATGACCCTAAAAACACCACTGGAGCATTGACTACCAGGCTCGCCAAT\nGATGCTGCTCAAGTTAAAGGGGCTATAGGTTCCAGGCTTGCTGTAATTACCCAGAATATA\nGCAAATCTTGGGACAGGAATAATTATATCCTTCATCTATGGTTGGCAACTAACACTGTTA\nCTCTTAGCAATTGTACCCATCATTGCAATAGCAGGAGTTGTTGAAATGAAAATGTTGTCT\nGGACAAGCACTGAAAGATAAGAAAGAACTAGAAGGTTCTGGGAAGATCGCTACTGAAGCA\nATAGAAAACTTCCGAACCGTTGTTTCTTTGACTCAGGAGCAGAAGTTTGAACATATGTAT\nGCTCAGAGTTTGCAGGTACCATACAGAAACTCTTTGAGGAAAGCACACATCTTTGGAATT\nACATTTTCCTTCACCCAGGCAATGATGTATTTTTCCTATGCTGGATGTTTCCGGTTTGGA\nGCCTACTTGGTGGCACATAAACTCATGAGCTTTGAGGATGTTCTGTTAGTATTTTCAGCT\nGTTGTCTTTGGTGCCATGGCCGTGGGGCAAGTCAGTTCATTTGCTCCTGACTATGCCAAA\nGCCAAAATATCAGCAGCCCACATCATCATGATCATTGAAAAAACCCCTTTGATTGACAGC\nTACAGCACGGAAGGCCTAATGCCGAACACATTGGAAGGAAATGTCACATTTGGTGAAGTT\nGTATTCAACTATCCCACCCGACCGGACATCCCAGTGCTTCAGGGACTGAGCCTGGAGGTG\nAAGAAGGGCCAGACGCTGGCTCTGGTGGGCAGCAGTGGCTGTGGGAAGAGCACAGTGGTC\nCAGCTCCTGGAGCGGTTCTACGACCCCTTGGCAGGGAAAGTGCTGCTTGATGGCAAAGAA\nATAAAGCGACTGAATGTTCAGTGGCTCCGAGCACACCTGGGCATCGTGTCCCAGGAGCCC\nATCCTGTTTGACTGCAGCATTGCTGAGAACATTGCCTATGGAGACAACAGCCGGGTGGTG\nTCACAGGAAGAGATTGTGAGGGCAGCAAAGGAGGCCAACATACATGCCTTCATCGAGTCA\nCTGCCTAATAAATATAGCACTAAAGTAGGAGACAAAGGAACTCAGCTCTCTGGTGGCCAG\nAAACAACGCATTGCCATAGCTCGTGCCCTTGTTAGACAGCCTCATATTTTGCTTTTGGAT\nGAAGCCACGTCAGCTCTGGATACAGAAAGTGAAAAGGTTGTCCAAGAAGCCCTGGACAAA\nGCCAGAGAAGGCCGCACCTGCATTGTGATTGCTCACCGCCTGTCCACCATCCAGAATGCA\nGACTTAATAGTGGTGTTTCAGAATGGCAGAGTCAAGGAGCATGGCACGCATCAGCAGCTG\nCTGGCACAGAAAGGCATCTATTTTTCAATGGTCAGTGTCCAGGCTGGAACAAAGCGCCAG\nTGA",
                        "Chromosome Location": "7",
                        "Locus": "7q21.1",
                        "External Identifiers": "ResourceLinkUniProtKB IDP08183UniProtKB Entry NameMDR1_HUMANGenBank Protein ID307180GenBank Gene IDM14758GenAtlas IDABCB1HGNC IDHGNC:40",
                        "General References": "Chen CJ, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, Roninson IB: Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell. 1986 Nov 7;47(3):381-9. [Article] Chen CJ, Clark D, Ueda K, Pastan I, Gottesman MM, Roninson IB: Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins. J Biol Chem. 1990 Jan 5;265(1):506-14. [Article] Chen G, Duran GE, Steger KA, Lacayo NJ, Jaffrezou JP, Dumontet C, Sikic BI: Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins. J Biol Chem. 1997 Feb 28;272(9):5974-82. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, Wagner-McPherson C, Layman D, Maas J, Jaeger S, Walker R, Wylie K, Sekhon M, Becker MC, O'Laughlin MD, Schaller ME, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Cordes M, Du H, Sun H, Edwards J, Bradshaw-Cordum H, Ali J, Andrews S, Isak A, Vanbrunt A, Nguyen C, Du F, Lamar B, Courtney L, Kalicki J, Ozersky P, Bielicki L, Scott K, Holmes A, Harkins R, Harris A, Strong CM, Hou S, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Leonard S, Rohlfing T, Rock SM, Tin-Wollam AM, Abbott A, Minx P, Maupin R, Strowmatt C, Latreille P, Miller N, Johnson D, Murray J, Woessner JP, Wendl MC, Yang SP, Schultz BR, Wallis JW, Spieth J, Bieri TA, Nelson JO, Berkowicz N, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Bedell JA, Mardis ER, Clifton SW, Chissoe SL, Marra MA, Raymond C, Haugen E, Gillett W, Zhou Y, James R, Phelps K, Iadanoto S, Bubb K, Simms E, Levy R, Clendenning J, Kaul R, Kent WJ, Furey TS, Baertsch RA, Brent MR, Keibler E, Flicek P, Bork P, Suyama M, Bailey JA, Portnoy ME, Torrents D, Chinwalla AT, Gish WR, Eddy SR, McPherson JD, Olson MV, Eichler EE, Green ED, Waterston RH, Wilson RK: The DNA sequence of human chromosome 7. Nature. 2003 Jul 10;424(6945):157-64. [Article] Gekeler V, Weger S, Probst H: mdr1/P-glycoprotein gene segments analyzed from various human leukemic cell lines exhibiting different multidrug resistance profiles. Biochem Biophys Res Commun. 1990 Jun 15;169(2):796-802. [Article] Kioka N, Tsubota J, Kakehi Y, Komano T, Gottesman MM, Pastan I, Ueda K: P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance. Biochem Biophys Res Commun. 1989 Jul 14;162(1):224-31. [Article] Kerb R, Hoffmeyer S, Brinkmann U: ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2. Pharmacogenomics. 2001 Feb;2(1):51-64. [Article] Begley GS, Horvath AR, Taylor JC, Higgins CF: Cytoplasmic domains of the transporter associated with antigen processing and P-glycoprotein interact with subunits of the proteasome. Mol Immunol. 2005 Jan;42(1):137-41. [Article] Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP: A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7. doi: 10.1073/pnas.0805139105. Epub 2008 Jul 31. [Article] Burkard TR, Planyavsky M, Kaupe I, Breitwieser FP, Burckstummer T, Bennett KL, Superti-Furga G, Colinge J: Initial characterization of the human central proteome. BMC Syst Biol. 2011 Jan 26;5:17. doi: 10.1186/1752-0509-5-17. [Article] Katayama K, Yamaguchi M, Noguchi K, Sugimoto Y: Protein phosphatase complex PP5/PPP2R3C dephosphorylates P-glycoprotein/ABCB1 and down-regulates the expression and function. Cancer Lett. 2014 Apr 1;345(1):124-31. doi: 10.1016/j.canlet.2013.12.007. Epub 2013 Dec 11. [Article] Choi KH, Chen CJ, Kriegler M, Roninson IB: An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene. Cell. 1988 May 20;53(4):519-29. [Article] Mickley LA, Lee JS, Weng Z, Zhan Z, Alvarez M, Wilson W, Bates SE, Fojo T: Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors. Blood. 1998 Mar 1;91(5):1749-56. [Article] Decleves X, Chevillard S, Charpentier C, Vielh P, Laplanche JL: A new polymorphism (N21D) in the exon 2 of the human MDR1 gene encoding the P-glycoprotein. Hum Mutat. 2000 May;15(5):486. [Article] Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M, Brinkmann U: Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3473-8. [Article] Cascorbi I, Gerloff T, Johne A, Meisel C, Hoffmeyer S, Schwab M, Schaeffeler E, Eichelbaum M, Brinkmann U, Roots I: Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther. 2001 Mar;69(3):169-74. [Article] Honda T, Dan Y, Koyabu N, Ieiri I, Otsubo K, Higuchi S, Ohtani H, Sawada Y: Polymorphism of MDR1 gene in healthy japanese subjects: a novel SNP with an amino acid substitution (Glu108Lys). Drug Metab Pharmacokinet. 2002;17(5):479-81. [Article] Itoda M, Saito Y, Komamura K, Ueno K, Kamakura S, Ozawa S, Sawada J: Twelve novel single nucleotide polymorphisms in ABCB1/MDR1 among Japanese patients with ventricular tachycardia who were administered amiodarone. Drug Metab Pharmacokinet. 2002;17(6):566-71. [Article] Saito S, Iida A, Sekine A, Miura Y, Ogawa C, Kawauchi S, Higuchi S, Nakamura Y: Three hundred twenty-six genetic variations in genes encoding nine members of ATP-binding cassette, subfamily B (ABCB/MDR/TAP), in the Japanese population. J Hum Genet. 2002;47(1):38-50. [Article] Brant SR, Panhuysen CI, Nicolae D, Reddy DM, Bonen DK, Karaliukas R, Zhang L, Swanson E, Datta LW, Moran T, Ravenhill G, Duerr RH, Achkar JP, Karban AS, Cho JH: MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet. 2003 Dec;73(6):1282-92. Epub 2003 Nov 7. [Article] Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE: The consensus coding sequences of human breast and colorectal cancers. Science. 2006 Oct 13;314(5797):268-74. Epub 2006 Sep 7. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00171ATPinvestigational, nutraceuticalunknownDetailsDB00778Roxithromycinapproved, investigational, withdrawnunknownDetailsDB04881ElacridarinvestigationalunknownDetailsDB04905TesmilifeneinvestigationalyesinducerDetailsDB05449FM-VP4investigationalunknownDetailsDB06240TariquidarinvestigationalunknownDetailsDB06191ZosuquidarinvestigationalyesinhibitorDetailsDB00661VerapamilapprovedunknownsubstrateinhibitorDetailsDB01232Saquinavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00220NelfinavirapprovednosubstrateinhibitorinducerDetailsDB00224IndinavirapprovedunknownsubstrateinhibitorinducerDetailsDB00701Amprenavirapproved, investigationalunknownsubstrateinducerDetailsDB01045RifampicinapprovedunknowninducerDetailsDB00206Reserpineapproved, investigational, withdrawnunknownsubstrateinhibitorinducerDetailsDB01115NifedipineapprovedunknownsubstrateinducerDetailsDB00834Mifepristoneapproved, investigationalunknowninhibitorinducerDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00257Clotrimazoleapproved, vet_approvedunknowninhibitorinducerDetailsDB00564Carbamazepineapproved, investigationalunknowninducerDetailsDB00656Trazodoneapproved, investigationalunknowninducerDetailsDB01149Nefazodoneapproved, withdrawnunknowninhibitorinducerDetailsDB00503Ritonavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00390DigoxinapprovedunknownsubstrateinhibitorinducerDetailsDB00279Liothyronineapproved, vet_approvedunknowninducerDetailsDB00451LevothyroxineapprovedunknowninducerDetailsDB00440Trimethoprimapproved, vet_approvedunknownsubstrateDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateinhibitorinducerDetailsDB02261Platelet Activating FactorexperimentalunknownsubstrateinducerDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00501Cimetidineapproved, investigationalunknownsubstrateinducerDetailsDB04630Aldosteroneexperimental, investigationalunknownsubstrateinducerDetailsDB00864Tacrolimusapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00877Sirolimusapproved, investigationalnosubstrateinhibitorinducerDetailsDB01174Phenobarbitalapproved, investigationalunknownsubstrateinducerDetailsDB00199Erythromycinapproved, investigational, vet_approvednosubstrateinhibitorDetailsDB01118Amiodaroneapproved, investigationalunknowninhibitorinducerDetailsDB01323St. John's Wortapproved, investigational, nutraceuticalunknowninducerDetailsDB00541Vincristineapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00570VinblastineapprovedunknownsubstrateinhibitorinducerDetailsDB02659Cholic AcidapprovedunknowninducerDetailsDB00675TamoxifenapprovedunknownsubstrateinhibitorinducerDetailsDB00428Streptozocinapproved, investigationalunknowninducerDetailsDB01204Mitoxantroneapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00997Doxorubicinapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00694DaunorubicinapprovedunknownsubstrateinhibitorinducerDetailsDB00908Quinidineapproved, investigationalunknownsubstrateinhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB01388Mibefradilinvestigational, withdrawnunknownsubstrateinhibitorDetailsDB04540Cholesterolapproved, investigationalunknowninhibitorDetailsDB00358Mefloquineapproved, investigationalunknownsubstrateinhibitorDetailsDB00622Nicardipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00381AmlodipineapprovedunknownsubstrateinhibitorDetailsDB00972AzelastineapprovedunknowninhibitorDetailsDB00863Ranitidineapproved, withdrawnunknownsubstrateinhibitorDetailsDB00773EtoposideapprovedunknownsubstrateinhibitorDetailsDB00333MethadoneapprovedunknowninhibitorDetailsDB00641SimvastatinapprovedunknowninhibitorDetailsDB00227Lovastatinapproved, investigationalunknowninhibitorDetailsDB01076AtorvastatinapprovednosubstrateinhibitorDetailsDB01229Paclitaxelapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00457PrazosinapprovedunknownsubstrateinhibitormodulatorDetailsDB01054Nitrendipineapproved, investigationalunknowninhibitorDetailsDB00975DipyridamoleapprovedunknownsubstrateinhibitorDetailsDB00343Diltiazemapproved, investigationalunknownsubstrateinhibitorDetailsDB01394ColchicineapprovedunknownsubstrateinducerDetailsDB01211ClarithromycinapprovedunknownsubstrateinhibitorDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00970Dactinomycinapproved, investigationalunknownsubstrateinhibitorDetailsDB13179TroleandomycinapprovedunknowninhibitorDetailsDB00831Trifluoperazineapproved, investigationalunknowninhibitorDetailsDB00342Terfenadineapproved, withdrawnunknowninhibitorDetailsDB00468QuinineapprovedunknownsubstrateinhibitorDetailsDB01167Itraconazoleapproved, investigationalunknowninhibitorDetailsDB00328Indomethacinapproved, investigationalunknownsubstrateinhibitorDetailsDB02587Colforsinexperimental, investigationalunknowninhibitorDetailsDB00623FluphenazineapprovedunknowninhibitorDetailsDB01023Felodipineapproved, investigationalunknowninhibitorDetailsDB01136Carvedilolapproved, investigationalunknowninhibitorDetailsDB00421SpironolactoneapprovedunknowninducerDetailsDB00281Lidocaineapproved, vet_approvedunknowninhibitorDetailsDB00537Ciprofloxacinapproved, investigationalunknownsubstrateDetailsDB00207AzithromycinapprovedunknownsubstrateinhibitorDetailsDB00316AcetaminophenapprovedunknownsubstrateinhibitorDetailsDB00196Fluconazoleapproved, investigationalunknowninhibitorDetailsDB00213PantoprazoleapprovedunknownsubstrateinhibitorDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00448Lansoprazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00678LosartanapprovedunknownsubstrateinhibitorDetailsDB00584Enalaprilapproved, vet_approvedunknowninhibitorDetailsDB00590DoxazosinapprovedunknowninhibitorDetailsDB01340CilazaprilapprovedunknowninhibitorDetailsDB01197CaptoprilapprovedunknowninhibitorDetailsDB00796Candesartan cilexetilapprovedunknowninhibitorDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB00696ErgotamineapprovedunknowninhibitorDetailsDB01253ErgometrineapprovedunknowninhibitorDetailsDB00320Dihydroergotamineapproved, investigationalunknowninhibitorDetailsDB01200Bromocriptineapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00836LoperamideapprovedunknownsubstrateDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedunknowninhibitorDetailsDB00802Alfentanilapproved, illicitunknowninhibitorDetailsDB00401NisoldipineapprovedunknowninhibitorDetailsDB04832Zimelidineapproved, withdrawnunknowninhibitorDetailsDB00382Tacrineapproved, investigational, withdrawnunknownsubstrateDetailsDB00669Sumatriptanapproved, investigationalunknownsubstrateDetailsDB01037Selegilineapproved, investigational, vet_approvedunknowninhibitorDetailsDB00458ImipramineapprovedunknownsubstrateDetailsDB00502HaloperidolapprovedunknownsubstrateinhibitorDetailsDB00176Fluvoxamineapproved, investigationalunknowninhibitorDetailsDB00690Flurazepamapproved, illicit, investigationalunknowninhibitorDetailsDB00472Fluoxetineapproved, vet_approvedunknowninhibitorDetailsDB01142Doxepinapproved, investigationalunknownsubstrateDetailsDB01151Desipramineapproved, investigationalunknowninhibitorDetailsDB01242Clomipramineapproved, investigational, vet_approvedunknowninhibitorDetailsDB01239Chlorprothixeneapproved, experimental, investigational, withdrawnunknowninhibitorDetailsDB00490Buspironeapproved, investigationalunknowninhibitorDetailsDB01100PimozideapprovedunknowninhibitorDetailsDB00295Morphineapproved, investigationalnosubstrateDetailsDB00602Ivermectinapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00741Hydrocortisoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00637Astemizoleapproved, withdrawnunknowninhibitorDetailsDB00508Triflupromazineapproved, vet_approvedunknowninhibitorDetailsDB00344ProtriptylineapprovedunknowninhibitorDetailsDB01069Promethazineapproved, investigationalunknowninhibitorDetailsDB01244Bepridilapproved, withdrawnunknowninhibitorDetailsDB00455Loratadineapproved, investigationalnosubstrateinhibitorDetailsDB00967Desloratadineapproved, investigationalunknowninhibitorDetailsDB00285VenlafaxineapprovedunknownsubstrateinhibitorDetailsDB01104SertralineapprovedunknowninhibitorDetailsDB00234Reboxetineapproved, experimentalunknowninhibitorDetailsDB00715Paroxetineapproved, investigationalunknowninhibitorDetailsDB00215CitalopramapprovedunknownsubstrateinhibitorDetailsDB01196Estramustineapproved, investigationalunknowninhibitorDetailsDB04348Taurocholic acidapproved, experimentalunknownsubstrateinhibitorDetailsDB00875Flupentixolapproved, investigational, withdrawnunknowninhibitorDetailsDB00351Megestrol acetateapproved, investigational, vet_approvedunknowninhibitorDetailsDB02010StaurosporineexperimentalunknowninhibitorDetailsDB01103QuinacrineinvestigationalunknowninhibitorDetailsDB01645GenisteininvestigationalunknowninhibitorDetailsDB04216Quercetinexperimental, investigationalunknowninhibitorDetailsDB01137Levofloxacinapproved, investigationalunknownsubstrateinhibitorDetailsDB03467NaringeninexperimentalunknowndownregulatorDetailsDB01016GlyburideapprovedunknowninhibitorDetailsDB00950Fexofenadineapproved, investigationalunknownsubstrateDetailsDB00726TrimipramineapprovedunknownsubstrateDetailsDB00571Propranololapproved, investigationalunknownsubstrateDetailsDB00635Prednisoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00276Amsacrineapproved, investigationalunknowninhibitorDetailsDB00027Gramicidin DapprovedunknownsubstrateinhibitorDetailsDB01086Benzocaineapproved, investigationalunknowninhibitorDetailsDB01601LopinavirapprovedunknowninhibitorinducerDetailsDB00520CaspofunginapprovedunknowninhibitorDetailsDB00175PravastatinapprovednosubstrateDetailsDB00619ImatinibapprovednosubstrateinhibitorDetailsDB00398Sorafenibapproved, investigationalunknownsubstrateinhibitorDetailsDB01268Sunitinibapproved, investigationalunknowninhibitorDetailsDB01162TerazosinapprovedunknowninhibitorDetailsDB00470Dronabinolapproved, illicitunknowninhibitorDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknowninhibitorDetailsDB00966Telmisartanapproved, investigationalunknowninhibitorDetailsDB01254Dasatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00317Gefitinibapproved, investigationalunknownsubstrateinhibitorDetailsDB04868Nilotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00655EstroneapprovedunknownsubstrateinducerDetailsDB01259Lapatinibapproved, investigationalunknowninhibitorDetailsDB01263Posaconazoleapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00365Grepafloxacinapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB01396Digitoxinapproved, investigationalunknownsubstrateDetailsDB01208Sparfloxacinapproved, investigational, withdrawnunknownsubstrateDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB01224QuetiapineapprovedunknownsubstrateDetailsDB00334Olanzapineapproved, investigationalnosubstrateDetailsDB00363ClozapineapprovedunknownsubstrateDetailsDB01183Naloxoneapproved, vet_approvedunknownsubstrateDetailsDB04690CamptothecinexperimentalunknownsubstrateDetailsDB00860Prednisoloneapproved, vet_approvedunknownsubstrateDetailsDB01193Acebutololapproved, investigationalunknownsubstrateDetailsDB01050IbuprofenapprovedunknownsubstrateDetailsDB00945Acetylsalicylic acidapproved, vet_approvedunknownsubstrateinducermodulatorDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB00443Betamethasoneapproved, vet_approvedunknownsubstrateDetailsDB00539Toremifeneapproved, investigationalunknownsubstrateDetailsDB00255Diethylstilbestrolapproved, investigational, withdrawnunknownsubstrateDetailsDB00882Clomifeneapproved, investigationalunknownsubstrateDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstratedownregulatorregulatorDetailsDB01248Docetaxelapproved, investigationalunknownsubstrateDetailsDB00563MethotrexateapprovedunknownsubstrateDetailsDB00373TimololapprovedunknownsubstrateDetailsDB01203NadololapprovedunknownsubstrateDetailsDB00523Alitretinoinapproved, investigationalunknownsubstrateDetailsDB01339Vecuroniumapproved, investigationalunknownsubstrateDetailsDB04840Debrisoquineapproved, investigationalunknownsubstrateDetailsDB00441GemcitabineapprovednosubstrateDetailsDB01030Topotecanapproved, investigationalunknownsubstrateDetailsDB02901Stanoloneillicit, investigationalunknownsubstrateDetailsDB00751Epinastineapproved, investigationalunknownsubstrateDetailsDB00717NorethisteroneapprovedunknowninhibitorDetailsDB04573Estriolapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB03203SphingosineexperimentalunknownsubstrateDetailsDB00439Cerivastatinapproved, withdrawnunknownsubstrateDetailsDB00286Conjugated estrogensapprovedunknownsubstrateDetailsDB01202LevetiracetamapprovedunknownsubstrateDetailsDB00252Phenytoinapproved, vet_approvedunknownsubstrateDetailsDB00585NizatidineapprovedunknownsubstrateDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00555Lamotrigineapproved, investigationalunknownsubstrateinhibitorDetailsDB01261Sitagliptinapproved, investigationalunknownsubstrateDetailsDB01072Atazanavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB01169Arsenic trioxideapproved, investigationalunknowninhibitorDetailsDB06772CabazitaxelapprovedunknownsubstrateinhibitorDetailsDB01583LiotrixapprovedunknowninducerDetailsDB06287TemsirolimusapprovedunknownsubstrateinhibitorDetailsDB01587KetazolamapprovedunknownsubstrateDetailsDB04877VoacamineexperimentalunknowninhibitorDetailsDB00977EthinylestradiolapprovedunknownsubstrateDetailsDB01182PropafenoneapprovedunknowninhibitorDetailsDB00216Eletriptanapproved, investigationalunknownsubstrateDetailsDB04855DronedaroneapprovednoinhibitorDetailsDB06176Romidepsinapproved, investigationalunknownsubstrateDetailsDB06207SilodosinapprovedunknownsubstrateDetailsDB06414EtravirineapprovedunknowninhibitorDetailsDB06228RivaroxabanapprovedunknownsubstrateDetailsDB06695Dabigatran etexilateapprovedunknownsubstrateDetailsDB00973EzetimibeapprovedunknownsubstrateDetailsDB06702FesoterodineapprovedunknownsubstrateDetailsDB06212TolvaptanapprovednosubstrateinhibitorDetailsDB08860PitavastatinapprovedunknownsubstrateDetailsDB06589PazopanibapprovedunknownsubstrateDetailsDB08864RilpivirineapprovedunknowninhibitorDetailsDB08873Boceprevirapproved, withdrawnunknowninhibitorDetailsDB05521Telaprevirapproved, withdrawnunknownsubstrateinhibitorDetailsDB08874FidaxomicinapprovednosubstrateDetailsDB05039IndacaterolapprovedunknownsubstrateDetailsDB00349Clobazamapproved, illicitnosubstrateDetailsDB08882LinagliptinapprovedunknownsubstrateDetailsDB08827Lomitapideapproved, investigationalnoinhibitorDetailsDB08816TicagrelorapprovedunknownsubstrateinhibitorDetailsDB08865Crizotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB06605ApixabanapprovedunknownsubstrateDetailsDB06626Axitinibapproved, investigationalnosubstrateinhibitorDetailsDB08828Vismodegibapproved, investigationalunknownsubstrateDetailsDB08889Carfilzomibapproved, investigationalunknownsubstrateinhibitorDetailsDB08893MirabegronapprovedunknownsubstrateinhibitorDetailsDB08896RegorafenibapprovedunknownsubstrateinhibitorDetailsDB08899EnzalutamideapprovednoinhibitorDetailsDB08820IvacaftorapprovednoinhibitorDetailsDB06616BosutinibapprovednosubstrateDetailsDB08901Ponatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB08906Fluticasone furoateapprovednosubstrateinducerDetailsDB08907CanagliflozinapprovedunknownsubstrateinhibitorDetailsDB08910PomalidomideapprovedunknownsubstrateDetailsDB00480LenalidomideapprovednosubstrateDetailsDB08912Dabrafenibapproved, investigationalnosubstrateDetailsDB05773Trastuzumab emtansineapproved, investigationalunknownsubstrateDetailsDB00495ZidovudineapprovedunknownsubstrateDetailsDB00758ClopidogrelapprovednosubstrateDetailsDB08916AfatinibapprovedunknownsubstrateinhibitorDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateDetailsDB00709Lamivudineapproved, investigationalunknownsubstrateDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB08918Levomilnacipranapproved, investigationalunknownsubstrateDetailsDB06290SimeprevirapprovedunknownsubstrateinhibitorDetailsDB08934SofosbuvirapprovednosubstrateDetailsDB06292DapagliflozinapprovedunknownsubstrateDetailsDB09076UmeclidiniumapprovednosubstrateDetailsDB09075EdoxabanapprovednosubstrateDetailsDB09063CeritinibapprovednosubstrateDetailsDB09078Lenvatinibapproved, investigationalnosubstrateinhibitorDetailsDB09079NintedanibapprovednosubstrateinhibitorDetailsDB09054IdelalisibapprovednosubstrateinhibitorDetailsDB09065CobicistatapprovedunknowninhibitorDetailsDB09291Rolapitantapproved, investigationalnoinhibitorDetailsDB09102Daclatasvirapproved, investigationalunknownsubstrateinhibitorDetailsDB06636Isavuconazoniumapproved, investigationalnoinhibitorDetailsDB06603Panobinostatapproved, investigationalnosubstrateDetailsDB09330OsimertinibapprovednosubstrateDetailsDB11362SelexipagapprovednosubstrateDetailsDB06403Ambrisentanapproved, investigationalunknownsubstrateDetailsDB09296Ombitasvirapproved, investigationalnosubstrateDetailsDB11574ElbasvirapprovednosubstrateinhibitorDetailsDB11575GrazoprevirapprovednosubstrateDetailsDB09161Technetium Tc-99m sestamibiapproved, investigationalnosubstrateDetailsDB11581Venetoclaxapproved, investigationalnosubstrateinhibitorDetailsDB05015Belinostatapproved, investigationalunknownsubstrateDetailsDB11613Velpatasvirapproved, investigationalnosubstrateinhibitorDetailsDB09027LedipasvirapprovednosubstratetransporterDetailsDB09198LobeglitazoneexperimentalnoDetailsDB09031Miltefosineapproved, investigationalunknownDetailsDB09280LumacaftorapprovednoinhibitorinducerDetailsDB11828Neratinibapproved, investigationalunknowninhibitorDetailsDB12026Voxilaprevirapproved, investigationalnosubstrateinhibitorDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB05889Inotuzumab ozogamicinapproved, investigationalunknownsubstrateDetailsDB13878Pibrentasvirapproved, investigationalunknownsubstrateinhibitorDetailsDB13879Glecaprevirapproved, investigationalunknownsubstrateinhibitorDetailsDB12483Copanlisibapproved, investigationalunknownsubstrateDetailsDB12001Abemaciclibapproved, investigationalunknownsubstrateinhibitorDetailsDB12364Betrixabanapproved, investigationalnosubstrateDetailsDB13919CandesartanexperimentalunknowninhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateinhibitorDetailsDB12332Rucaparibapproved, investigationalnosubstrateinhibitorDetailsDB09270Ubidecarenoneapproved, investigational, nutraceuticalnosubstrateDetailsDB11827Ertugliflozinapproved, investigationalnosubstrateDetailsDB13943Testosterone cypionateapprovedunknowninhibitorDetailsDB13944Testosterone enanthateapprovedunknowninhibitorDetailsDB13946Testosterone undecanoateapproved, investigationalunknowninhibitorDetailsDB09160Technetium Tc-99m tetrofosminapprovednobinderDetailsDB13951Stanolone acetateexperimentalunknownsubstrateDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateDetailsDB01420Testosterone propionateapproved, investigational, vet_approved, withdrawnnosubstrateDetailsDB11901Apalutamideapproved, investigationalunknowninducerDetailsDB11633Isavuconazoleapproved, investigationalunknowninhibitorDetailsDB11251Tocopherolapproved, investigationalnotransporterDetailsDB14003alpha-Tocopherol acetateapprovednosubstrateDetailsDB09099Somatostatinapproved, investigationalunknownsubstrateDetailsDB11635TocofersolanapprovedunknownantagonistDetailsDB11641Vinflunineapproved, investigationalnosubstrateDetailsDB11672Curcuminapproved, investigationalunknowninhibitorDetailsDB11995Avatrombopagapproved, investigationalunknownsubstrateDetailsDB09297Paritaprevirapproved, investigationalunknownsubstrateDetailsDB09183DasabuvirapprovedunknownsubstrateDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedunknownDetailsDB14062Concanamycin AexperimentalyesinhibitorDetailsDB14061HycanthoneexperimentalyesinhibitorDetailsDB14063DexverapamilexperimentalyesinhibitorDetailsDB14064EmopamilexperimentalyesinhibitorDetailsDB14065LomerizineexperimentalyesinhibitorDetailsDB14066TetrandrineexperimentalunknowninhibitorDetailsDB14067Dofequidarexperimental, investigationalunknowninhibitorDetailsDB14068DexniguldipineexperimentalunknowninhibitorDetailsDB14069ONT-093investigationalyesinhibitorDetailsDB14070HM-30181experimentalyesinhibitorDetailsDB14071DesmethylsertralineexperimentalunknowninhibitorDetailsDB14072Reversin 121experimentalyesinhibitorDetailsDB14146LoxicodegolinvestigationalunknownDetailsDB14538Hydrocortisone aceponateexperimental, vet_approvedunknownDetailsDB14539Hydrocortisone acetateapproved, vet_approvedunknownDetailsDB14540Hydrocortisone butyrateapproved, vet_approvedunknownDetailsDB14541Hydrocortisone cypionateapproved, investigational, vet_approvedunknownDetailsDB14542Hydrocortisone phosphateapproved, vet_approvedunknownDetailsDB14543Hydrocortisone probutateapproved, vet_approvedunknownDetailsDB14544Hydrocortisone valerateapproved, vet_approvedunknownDetailsDB14568Ivosidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB11979Elagolixapproved, investigationalunknownsubstrateinhibitorDetailsDB13867Fluticasoneapproved, experimentalnosubstrateDetailsDB00608Chloroquineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00613Amodiaquineapproved, investigationalunknowninhibitorDetailsDB01087PrimaquineapprovedunknowninhibitorDetailsDB01611HydroxychloroquineapprovedunknowninhibitorDetailsDB01267PaliperidoneapprovedunknownsubstrateinhibitorDetailsDB05928DovitinibinvestigationalunknowninhibitorDetailsDB13125Lusutrombopagapproved, investigationalunknownsubstrateDetailsDB14635Curcumin sulfateexperimentalunknownDetailsDB14641Estriol tripropionateexperimentalunknownDetailsDB11952Duvelisibapproved, investigationalnosubstrateDetailsDB09213Dexibuprofenapproved, investigationalunknownDetailsDB11760Talazoparibapproved, investigationalunknownsubstrateDetailsDB12455Omadacyclineapproved, investigationalunknownsubstrateDetailsDB12836Grapiprantinvestigational, vet_approvednosubstrateDetailsDB12035Sarecyclineapproved, investigationalunknowninhibitorDetailsDB11753Rifamycinapproved, investigationalnosubstrateinhibitorDetailsDB11963Dacomitinibapproved, investigationalnosubstrateinhibitorDetailsDB11855Revefenacinapproved, investigationalnosubstrateDetailsDB12141Gilteritinibapproved, investigationalnosubstrateDetailsDB14126Tenofovirexperimental, investigationalnosubstrateDetailsDB00300Tenofovir disoproxilapproved, investigationalunknownsubstrateinhibitorDetailsDB09299Tenofovir alafenamideapprovedunknownsubstrateDetailsDB01264DarunavirapprovedunknownsubstrateinhibitorinducerDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateinhibitorDetailsDB00862VardenafilapprovedunknownsubstrateinhibitorDetailsDB00776OxcarbazepineapprovedunknownsubstrateDetailsDB00248CabergolineapprovednosubstrateDetailsDB06480PrucaloprideapprovednosubstrateDetailsDB00734Risperidoneapproved, investigationalunknownsubstrateDetailsDB01117AtovaquoneapprovednoinhibitorDetailsDB00788Naproxenapproved, vet_approvednoinhibitorDetailsDB00615Rifabutinapproved, investigationalunknowninducerDetailsDB12582PiperineinvestigationalunknowninhibitorDetailsDB11978Glasdegibapproved, investigationalnosubstrateinhibitorDetailsDB09074OlaparibapprovednosubstrateinhibitorDetailsDB00243Ranolazineapproved, investigationalnosubstrateinhibitorDetailsDB00321AmitriptylineapprovedunknownsubstrateDetailsDB00341CetirizineapprovednosubstrateinhibitorDetailsDB09073Palbociclibapproved, investigationalnosubstrateinhibitorDetailsDB01079Tegaserodapproved, investigational, withdrawnunknownsubstrateDetailsDB13867Fluticasoneapproved, experimentalunknownsubstrateDetailsDB12147Erdafitinibapproved, investigationalnosubstrateinhibitorDetailsDB00736Esomeprazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00476DuloxetineapprovedunknowninhibitorDetailsDB00481Raloxifeneapproved, investigationalunknownsubstrateDetailsDB12015Alpelisibapproved, investigationalunknowninhibitorDetailsDB11712Tezacaftorapproved, investigationalnosubstrateinhibitorDetailsDB00768OlopatadineapprovednosubstrateDetailsDB00698Nitrofurantoinapproved, vet_approvedunknownsubstrateDetailsDB00451LevothyroxineapprovednoinducerDetailsDB00394Beclomethasone dipropionateapproved, investigationalunknownsubstrateinducerDetailsDB00612BisoprololapprovedunknownsubstrateinhibitorDetailsDB00916MetronidazoleapprovedunknowninhibitorDetailsDB00482Celecoxibapproved, investigationalunknownsubstrateDetailsDB11986Entrectinibapproved, investigationalunknownsubstrateinhibitorDetailsDB12500Fedratinibapproved, investigationalunknownsubstrateinhibitorDetailsDB12825Lefamulinapproved, investigationalunknownsubstrateDetailsDB01222BudesonideapprovednosubstrateDetailsDB11757Istradefyllineapproved, investigationalunknowninhibitorDetailsDB01233Metoclopramideapproved, investigationalunknownsubstrateDetailsDB01175EscitalopramapprovedunknownsubstrateDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknowninhibitorDetailsDB01217Anastrozoleapproved, investigationalunknownsubstrateDetailsDB01195Flecainideapproved, withdrawnunknownsubstrateDetailsDB01418Acenocoumarolapproved, investigationalunknownsubstrateDetailsDB05676Apremilastapproved, investigationalunknownsubstrateDetailsDB11732Lasmiditanapproved, investigationalunknownsubstrateinhibitorDetailsDB11586Asunaprevirapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB15444Elexacaftorapproved, investigationalnosubstrateinhibitorDetailsDB15566Prednisolone acetateapproved, vet_approvedunknownsubstrateDetailsDB15035Zanubrutinibapproved, investigationalnosubstrateDetailsDB00273TopiramateapprovedunknownsubstrateDetailsDB09237Levamlodipineapproved, investigationalunknownsubstrateDetailsDB14962Trastuzumab deruxtecanapproved, investigationalnosubstrateDetailsDB13007Enfortumab vedotinapproved, investigationalunknownsubstrateDetailsDB11951Lemborexantapproved, investigationalunknownsubstrateDetailsDB12941Darolutamideapproved, investigationalunknownsubstrateDetailsDB15091Upadacitinibapproved, investigationalnosubstrateinhibitorDetailsDB15328Ubrogepantapproved, investigationalunknownsubstrateDetailsDB15233Avapritinibapproved, investigationalunknowninhibitormodulatorDetailsDB00993AzathioprineapprovedunknownsubstrateDetailsDB00557HydroxyzineapprovedunknownsubstrateDetailsDB11077Polyethylene glycol 400approvedunknowninhibitorDetailsDB12887Tazemetostatapproved, investigationalunknownsubstrateDetailsDB01006Letrozoleapproved, investigationalunknownsubstrateDetailsDB00246ZiprasidoneapprovedunknownDetailsDB01190Clindamycinapproved, vet_approvedunknownsubstrateDetailsDB09287Polyethylene glycolapproved, vet_approvednoinhibitorDetailsDB00957Norgestimateapproved, investigationalunknowninhibitorDetailsDB11770TalinololinvestigationalunknownsubstrateDetailsDB04881ElacridarinvestigationalunknowninhibitorDetailsDB00932Tipranavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB11869ValspodarinvestigationalunknowninhibitorDetailsDB00518Albendazoleapproved, vet_approvednosubstrateDetailsDB05239Cobimetinibapproved, investigationalnosubstrateDetailsDB06670OdanacatibinvestigationalunknownsubstrateDetailsDB04877VoacamineexperimentalnoinhibitorDetailsDB08930DolutegravirapprovednosubstrateDetailsDB00586Diclofenacapproved, vet_approvedunknowninducerDetailsDB11817Baricitinibapproved, investigationalunknownsubstrateDetailsDB11363Alectinibapproved, investigationalunknowninhibitorDetailsDB14723Larotrectinibapproved, investigationalunknownsubstrateDetailsDB00588Fluticasone propionateapprovedunknownsubstrateDetailsDB11430Monensinexperimental, vet_approvedunknownsubstrateDetailsDB03825Rhodamine 6GexperimentalunknownsubstrateDetailsDB09239NiguldipineexperimentalunknowninhibitorDetailsDB04851BiricodarinvestigationalunknowninhibitorDetailsDB06240TariquidarinvestigationalunknowninhibitorDetailsDB12799LaniquidarinvestigationalunknowninhibitorDetailsDB12923GallopamilinvestigationalunknowninhibitorDetailsDB06420AnnamycininvestigationalunknownDetailsDB00540NortriptylineapprovedunknownsubstrateDetailsDB00454MeperidineapprovedunknownsubstrateDetailsDB00652Pentazocineapproved, vet_approvedunknownsubstrateDetailsDB00818Propofolapproved, investigational, vet_approvedunknowninducerDetailsDB01590EverolimusapprovedunknownsubstrateinhibitorDetailsDB01212CeftriaxoneapprovedunknowninhibitorDetailsDB00872Conivaptanapproved, investigationalunknowninhibitorDetailsDB11544Salinomycinvet_approvedunknowninhibitorDetailsDB00909Zonisamideapproved, investigationalunknowninhibitorDetailsDB14057ValinomycinexperimentalunknownsubstrateinhibitorDetailsDB04908Flibanserinapproved, investigationalunknowninhibitorDetailsDB09039Eliglustatapproved, investigationalnosubstrateinhibitorDetailsDB01128BicalutamideapprovedunknowninhibitorDetailsDB00648MitotaneapprovedunknowninhibitorDetailsDB06448Lonafarnibapproved, investigationalnosubstrateinhibitorDetailsDB04960TipifarnibinvestigationalunknowninhibitorDetailsDB09048Netupitantapproved, investigationalunknowninhibitorDetailsDB09034Suvorexantapproved, investigationalunknownDetailsDB09030VorapaxarapprovedunknownDetailsDB05294VandetanibapprovedunknowninhibitorDetailsDB14062Concanamycin AexperimentalunknowninhibitorDetailsDB14061HycanthoneexperimentalunknowninhibitorDetailsDB08881VemurafenibapprovedunknownsubstrateinhibitorDetailsDB14063DexverapamilexperimentalunknowninhibitorDetailsDB14064EmopamilexperimentalunknowninhibitorDetailsDB14065LomerizineexperimentalunknowninhibitorDetailsDB14066TetrandrineexperimentalunknowninhibitorDetailsDB14069ONT-093investigationalunknowninhibitorDetailsDB14067Dofequidarexperimental, investigationalunknowninhibitorDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknowninhibitorDetailsDB12457Rimegepantapproved, investigationalunknownsubstrateDetailsDB12466Favipiravirapproved, investigationalunknowninhibitorDetailsDB00253MedrysoneapprovedunknownsubstrateDetailsDB09241Methylene blueapproved, investigationalunknownsubstrateinhibitorDetailsDB12612Ozanimodapproved, investigationalunknownsubstrateDetailsDB08868Fingolimodapproved, investigationalnoinhibitorDetailsDB07565Chloramphenicol succinateapprovedunknownsubstrateDetailsDB11689Selumetinibapproved, investigationalunknownsubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknownsubstrateinducerDetailsDB11652Tucatinibapproved, investigationalunknownsubstrateDetailsDB15102Pemigatinibapproved, investigationalnosubstrateinhibitorDetailsDB00315Zolmitriptanapproved, investigationalnoDetailsDB14761Remdesivirapproved, investigationalunknownsubstrateDetailsDB11791Capmatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB04845Ixabepiloneapproved, investigationalunknownsubstrateinhibitorDetailsDB15685Selpercatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB14840RipretinibapprovedunknownsubstrateinhibitorDetailsDB00845Clofazimineapproved, investigationalunknownsubstrateinhibitorDetailsDB09038EmpagliflozinapprovedunknownsubstrateDetailsDB06419CethromycininvestigationalunknownsubstrateinhibitorDetailsDB00674GalantamineapprovednoinhibitorDetailsDB09026Aliskirenapproved, investigationalnosubstrateDetailsDB09274Artesunateapproved, investigationalunknownsubstrateDetailsDB00188Bortezomibapproved, investigationalnosubstrateDetailsDB14669Betamethasone phosphateapproved, vet_approvedunknownsubstrateinducerDetailsDB12674Lurbinectedinapproved, investigationalunknownsubstrateinhibitorDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00104Octreotideapproved, investigationalunknownsubstrateDetailsDB11796Fostemsavirapproved, investigationalunknownsubstrateDetailsDB15719Belantamab mafodotinapprovedunknownsubstrateDetailsDB15305Risdiplamapproved, investigationalunknownsubstrateDetailsDB15822Pralsetinibapproved, investigationalnosubstrateinhibitorDetailsDB14845Filgotinibapproved, investigationalunknownsubstrateDetailsDB15982BerotralstatapprovednosubstrateinhibitorDetailsDB11853Relugolixapproved, investigationalunknownsubstrateinhibitorDetailsDB14895Vibegronapproved, investigationalnosubstrateDetailsDB01380Cortisone acetateapproved, investigationalunknownsubstrateinducerDetailsDB11632Opicaponeapproved, investigationalnosubstrateDetailsDB15456Vericiguatapproved, investigationalunknownsubstrateDetailsDB11751Cabotegravirapproved, investigationalunknownsubstrateDetailsDB11693Voclosporinapproved, investigationalunknownsubstrateinhibitorDetailsDB15133Tepotinibapproved, investigationalnosubstrateinhibitorDetailsDB00052Somatotropinapproved, investigationalunknownsubstrateDetailsDB00346Alfuzosinapproved, investigationalunknownsubstrateDetailsDB15442Trilaciclibapproved, investigationalunknownsubstrateDetailsDB14989Umbralisibapproved, investigational, withdrawnunknowninhibitorDetailsDB00391Sulpirideapproved, investigationalunknownsubstrateDetailsDB00853Temozolomideapproved, investigationalnosubstrateDetailsDB06237AvanafilapprovedunknownsubstrateDetailsDB11800Tivozanibapproved, investigationalunknownsubstrateDetailsDB00080Daptomycinapproved, investigationalnosubstrateDetailsDB06288Amisulprideapproved, investigationalnosubstrateDetailsDB08995Diosminapproved, investigationalunknowninhibitorDetailsDB04876Vildagliptinapproved, investigationalnosubstrateDetailsDB08822Azilsartan medoxomilapproved, investigationalnoinhibitorDetailsDB00360Sapropterinapproved, investigationalunknowninhibitorDetailsDB05667Levoketoconazoleapproved, investigationalnoinhibitorDetailsDB16222Loncastuximab tesirineapproved, investigationalunknownsubstrateDetailsDB15569Sotorasibapproved, investigationalunknowninhibitorDetailsDB11886Infigratinibapproved, investigationalnosubstrateinhibitorDetailsDB12471Ibrexafungerpapproved, investigationalunknownsubstratetransporterDetailsDB16703Belumosudilapproved, investigationalnosubstrateinhibitorDetailsDB16261Odevixibatapproved, investigationalunknownsubstrateDetailsDB15463Belzutifanapproved, investigationalnosubstrateDetailsDB16220Lonapegsomatropinapproved, investigationalunknownsubstrateDetailsDB16390Mobocertinibapproved, investigationalunknownsubstrateinhibitorDetailsDB16732Tisotumab vedotinapprovednosubstrateDetailsDB16098Atogepantapproved, investigationalnosubstrateDetailsDB08931RiociguatapprovednosubstrateDetailsDB15011Avacopanapproved, investigationalnosubstrateDetailsDB12597Asciminibapproved, investigationalnosubstrateinhibitorDetailsDB06234Maribavirapproved, investigationalnoinhibitorDetailsDB16691Nirmatrelvirapproved, investigationalnosubstrateinhibitorDetailsDB12713Sotagliflozinapproved, investigationalnoinhibitorDetailsDB14973Abrocitinibapproved, investigationalunknowninhibitorDetailsDB16236Mitapivatapproved, investigationalnosubstrateinhibitorDetailsDB09061Cannabidiolapproved, investigationalnoinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknowninhibitorDetailsDB14009Medical Cannabisexperimental, investigationalunknowninhibitorDetailsDB11697Pacritinibapproved, investigationalnoinhibitorDetailsDB06016Cariprazineapproved, investigationalunknowninhibitorDetailsDB16407AzvudineinvestigationalunknownactivatorregulatorDetailsDB12541SAR-405838investigationalnosubstrateDetailsDB00661VerapamilapprovedunknowninhibitorblockerDetailsDB09118StiripentolapprovedunknowninhibitorDetailsDB04951Pirfenidoneapproved, investigationalunknowninhibitorDetailsDB13997Baloxavir marboxilapproved, investigationalunknownsubstrateinhibitorDetailsDB15673Lenacapavirapproved, investigationalnosubstrateDetailsDB16650Deucravacitinibapproved, investigationalunknownsubstrateDetailsDB12095Telotristat ethylapproved, investigationalnosubstrateinhibitorDetailsDB15149Futibatinibapproved, investigationalnosubstrateinhibitorDetailsDB11739Vonoprazanapproved, investigationalunknowninhibitorDetailsDB11793Niraparibapproved, investigationalnosubstrateDetailsDB12489Mirvetuximab soravtansineapproved, investigationalnosubstrateDetailsDB16267Olutasidenibapproved, investigationalnoinhibitorDetailsDB12240Polatuzumab vedotinapproved, investigationalnosubstrateDetailsDB15568Adagrasibapproved, investigationalunknowninhibitorDetailsDB12236Bexagliflozinapproved, investigationalunknownsubstrateDetailsDB17472Pirtobrutinibapproved, investigationalunknownsubstrateinhibitorDetailsDB06374Elacestrantapproved, investigationalunknowninhibitorDetailsDB00683Midazolamapproved, illicitnosubstrateDetailsDB12548Sparsentanapproved, investigationalunknownsubstrateinhibitorDetailsDB15688Zavegepantapproved, investigationalunknownsubstrateDetailsDB16217Leniolisibapproved, investigationalnosubstrateDetailsDB01238Aripiprazoleapproved, investigationalunknowninhibitorDetailsDB09082VilanterolapprovednosubstrateDetailsDB12874Quizartinibapproved, investigationalnosubstrateinhibitorDetailsDB11763Momelotinibapproved, investigationalunknownsubstrateDetailsDB11718Encorafenibapproved, investigationalnosubstrateinhibitorDetailsDB15097Gefapixantapproved, investigationalnosubstrateDetailsDB11967Binimetinibapproved, investigationalnosubstrateDetailsDB16826RepotrectinibinvestigationalnosubstrateinhibitorDetails"
                    }
                }
            ]
        },
        "Disease Information": {
            "Acute Gouty Arthritis": null,
            "Acute Musculoskeletal Pain": null,
            "Allergic Reaction": "Allergies, also known as allergic diseases, are various conditions caused by hypersensitivity of the immune system to typically harmless substances in the environment.[11] These diseases include hay fever, food allergies, atopic dermatitis, allergic asthma, and anaphylaxis.[1] Symptoms may include red eyes, an itchy rash, sneezing, coughing, a runny nose, shortness of breath, or swelling.[12] Note that food intolerances and food poisoning are separate conditions.[3][4]\n",
            "Allergy to Tree Pollen": null,
            "Ankylosing Spondylitis": "Ankylosing spondylitis (AS) is a type of arthritis characterized by long-term inflammation of the joints of the spine, typically where the spine joins the pelvis.[2] Occasionally, areas affected may include other joints such as the shoulders or hips. Eye and bowel problems may occur as well as back pain.[2] Joint mobility in the affected areas generally worsens over time.[2][5]\n",
            "Chills": "Chills is a feeling of coldness occurring during a high fever, but sometimes is also a common symptom which occurs alone in specific people. It occurs during fever due to the release of cytokines and prostaglandins as part of the inflammatory response, which increases the set point for body temperature in the hypothalamus. The increased set point causes the body temperature to rise (pyrexia), but also makes the patient feel cold or chills until the new set point is reached. Shivering also occurs along with chills because the patient's body produces heat during muscle contraction in a physiological attempt to increase body temperature to the new set point.[1] When it does not accompany a high fever, it is normally a light chill. \n",
            "Cold": "Cold is the presence of low temperature, especially in the atmosphere. In common usage, cold is often a subjective perception. A lower bound to temperature is absolute zero, defined as 0.00\u00a0K on the Kelvin scale, an absolute thermodynamic temperature scale. This corresponds to \u2212273.15\u00a0\u00b0C on the Celsius scale, \u2212459.67\u00a0\u00b0F on the Fahrenheit scale, and 0.00\u00a0\u00b0R on the Rankine scale.\n",
            "Common Cold": "The common cold or the cold is a viral infectious disease of the upper respiratory tract that primarily affects the respiratory mucosa of the nose, throat, sinuses, and larynx.[6][8] Signs and symptoms may appear fewer than two days after exposure to the virus.[6] These may include coughing, sore throat, runny nose, sneezing, headache, and fever.[3][4] People usually recover in seven to ten days,[3] but some symptoms may last up to three weeks.[7] Occasionally, those with other health problems may develop pneumonia.[3]\n",
            "Cough": "A cough is a sudden expulsion of air through the large breathing passages which can help clear them of fluids, irritants, foreign particles and microbes. As a protective reflex, coughing can be repetitive with the cough reflex following three phases: an inhalation, a forced exhalation against a closed glottis, and a violent release of air from the lungs following opening of the glottis, usually accompanied by a distinctive sound.[1]\n",
            "Cough caused by Common Cold": null,
            "Coughing caused by Flu caused by Influenza": null,
            "Dyskinesia of the Biliary Tract": null,
            "Dyskinesia of the Urinary Tract": null,
            "Febrile Convulsions": null,
            "Febrile Illness Acute": null,
            "Fever": "Fever or pyrexia in humans is defined as having a body temperature above the normal range due to an increase in the body's temperature set point in the hypothalamus.[5][6][12][7] There is no single agreed-upon upper limit for normal temperature: sources use values ranging between 37.2 and 38.3\u00a0\u00b0C (99.0 and 100.9\u00a0\u00b0F) in humans.[1][7][8] The increase in set point triggers increased muscle contractions and causes a feeling of cold or chills.[2] This results in greater heat production and efforts to conserve heat.[3] When the set point temperature returns to normal, a person feels hot, becomes flushed, and may begin to sweat.[3] Rarely a fever may trigger a febrile seizure, with this being more common in young children.[4] Fevers do not typically go higher than 41 to 42\u00a0\u00b0C (106 to 108\u00a0\u00b0F).[6]\n",
            "Fibromyalgia": "Fibromyalgia is a medical condition defined by the presence of chronic widespread pain, fatigue, waking unrefreshed, cognitive symptoms, lower abdominal pain or cramps, and depression.[9] Other symptoms include insomnia[10] and a general hypersensitivity.[11][12]\n",
            "Flu caused by Influenza": null,
            "Headache": "Headache, also known as cephalalgia, is the symptom of pain in the face, head, or neck. It can occur as a migraine, tension-type headache, or cluster headache.[1][2] There is an increased risk of depression in those with severe headaches.[3]\n",
            "Joint dislocations": "A joint dislocation, also called luxation, occurs when there is an abnormal separation in the joint, where two or more bones meet.[1] A partial dislocation is referred to as a subluxation. Dislocations are often caused by sudden trauma on the joint like an impact or fall. A joint dislocation can cause damage to the surrounding ligaments, tendons, muscles, and nerves.[2] Dislocations can occur in any major joint (shoulder, knees, etc.) or minor joint (toes, fingers, etc.). The most common joint dislocation is a shoulder dislocation.[1]\n",
            "Menstrual Distress": null,
            "Mild pain": null,
            "Muscle Inflammation": null,
            "Muscle Injuries": null,
            "Muscle Spasms": null,
            "Musculoskeletal Pain": null,
            "Myalgia": "Myalgia (also called muscle pain and muscle ache in layman's terms) is the medical term for muscle pain.  Myalgia is a symptom of many diseases. The most common cause of acute myalgia is the overuse of a muscle or group of muscles; another likely cause is viral infection, especially when there has been no trauma.\n",
            "Nasal Congestion": "Nasal congestion is the partial or complete blockage of nasal passages, leading to impaired nasal breathing, usually due to membranes lining the nose becoming swollen from inflammation of blood vessels.[1]\n",
            "Neuropathic Pain": null,
            "Osteoarthritis": "Osteoarthritis (OA) is a type of degenerative joint disease that results from breakdown of joint cartilage and underlying bone which affects 1 in 7 adults in the United States.[5][6] It is believed to be the fourth leading cause of disability in the world.[7] The most common symptoms are joint pain and stiffness.[1] Usually the symptoms progress slowly over years.[1] Other symptoms may include joint swelling, decreased range of motion, and, when the back is affected, weakness or numbness of the arms and legs.[1] The most commonly involved joints are the two near the ends of the fingers and the joint at the base of the thumbs, the knee and hip joints, and the joints of the neck and lower back.[1] The symptoms can interfere with work and normal daily activities.[1] Unlike some other types of arthritis, only the joints, not internal organs, are affected.[1]\n",
            "Pain": "Pain is a distressing feeling often caused by intense or damaging stimuli. The International Association for the Study of Pain defines pain as \"an unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage.\"[1]\n",
            "Postoperative pain": "Pain is a distressing feeling often caused by intense or damaging stimuli. The International Association for the Study of Pain defines pain as \"an unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage.\"[1]\n",
            "Premenstrual cramps": null,
            "Rheumatoid Arthritis": "Rheumatoid arthritis (RA) is a long-term autoimmune disorder that primarily affects joints.[1] It typically results in warm, swollen, and painful joints.[1] Pain and stiffness often worsen following rest.[1] Most commonly, the wrist and hands are involved, with the same joints typically involved on both sides of the body.[1] The disease may also affect other parts of the body, including skin, eyes, lungs, heart, nerves and blood.[1] This may result in a low red blood cell count, inflammation around the lungs, and inflammation around the heart.[1] Fever and low energy may also be present.[1] Often, symptoms come on gradually over weeks to months.[2]\n",
            "Rhinopharyngitis": "The common cold or the cold is a viral infectious disease of the upper respiratory tract that primarily affects the respiratory mucosa of the nose, throat, sinuses, and larynx.[6][8] Signs and symptoms may appear fewer than two days after exposure to the virus.[6] These may include coughing, sore throat, runny nose, sneezing, headache, and fever.[3][4] People usually recover in seven to ten days,[3] but some symptoms may last up to three weeks.[7] Occasionally, those with other health problems may develop pneumonia.[3]\n",
            "Rhinorrhoea": "Rhinorrhea, rhinorrhoea, or informally runny nose is the free discharge of a thin mucus fluid from the nose;[1] it is a common condition. It is a common symptom of allergies (hay fever) or certain viral infections, such as the common cold or COVID-19. It can be a side effect of crying, exposure to cold temperatures, cocaine abuse,[2] or drug withdrawal, such as from methadone or other opioids.[3] Treatment for rhinorrhea may be aimed at reducing symptoms or treating underlying causes. Rhinorrhea usually resolves without intervention, but may require treatment by a doctor if symptoms last more than 10 days or if symptoms are the result of foreign bodies in the nose.[4]\n",
            "Severe Pain": null,
            "Sinusitis": "Sinusitis, also known as rhinosinusitis, is inflammation of the mucous membranes that line the sinuses resulting in symptoms that may include thick nasal mucus, a plugged nose, and facial pain.[1][8] Other signs and symptoms may include fever, headaches, a poor sense of smell, sore throat, a feeling that phlegm is oozing out from the back of the nose to the throat along with a necessity to clear the throat frequently[3] and frequent attacks of cough.[3][2]\n",
            "Spasms": "Spasm is a sudden, involuntary contraction of a muscle, a group of muscles or a hollow organ.\n",
            "Spastic Pain of the Gastrointestinal Tract": null,
            "Sprains": "A sprain is a soft tissue injury of the ligaments within a joint, often caused by a sudden movement abruptly forcing the joint to exceed its functional range of motion. Ligaments are tough, inelastic fibers made of collagen that connect two or more bones to form a joint and are important for joint stability and proprioception, which is the body's sense of limb position and movement.[1] Sprains may be mild (first degree), moderate (second degree), or severe (third degree), with the latter two classes involving some degree of tearing of the ligament.  Sprains can occur at any joint but most commonly occur in the ankle, knee, or wrist.[2] An equivalent injury to a muscle or tendon is known as a strain.\n",
            "Symptoms Cold": null,
            "Tension Headache": "Tension headache, also known as stress headache, or tension-type headache (TTH), is the most common type of primary headache. The pain can radiate from the lower back of the head, the neck, eyes or other muscle groups in the body typically affecting both sides of the head. Tension-type headaches account for nearly 90% of all headaches.\n",
            "Toothache": "Toothache, also known as dental pain or tooth pain,[3] is pain in the teeth or their supporting structures, caused by dental diseases or pain referred to the teeth by non-dental diseases. When severe it may impact sleep, eating, and other daily activities.\n",
            "Upper Respiratory Tract Infection": null,
            "Whiplash Syndrome": null,
            "Acute Torticollis": null,
            "Articular inflammation": null,
            "Cold or flu syndrome": null,
            "Mild to moderate pain": null,
            "Minor aches and pains": null,
            "Minor pain": null,
            "Moderate Pain": null,
            "Moderate to severe pain": null
        }
    },
    "VIAGRA": {
        "Active Ingredients": {
            "SILDENAFIL CITRATE": "CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O"
        },
        "Drug Information": {
            "Identification": {
                "Summary": "Sildenafil is a phosphodiesterase inhibitor used for the treatment of erectile dysfunction.",
                "Brand Names": "Liqrev, Revatio, Viagra, Vizarsin",
                "Generic Name": "Sildenafil",
                "DrugBank Accession Number": "DB00203",
                "Background": "In eliciting its mechanism of action, sildenafil ultimately prevents or minimizes the breakdown of cyclic guanosine monophosphate (cGMP) by inhibiting cGMP specific phosphodiesterase type 5 (PDE5) 11,12,13,14,15,16,8,9. The result of doing so allows cGMP present in both the penis and pulmonary vasculature to elicit smooth muscle relaxation and vasodilation that subsequently facilitates relief in pulmonary arterial hypertension and the increased flow of blood into the spongy erectile tissue of the penis that consequently allows it to grow in size and become erect and rigid 11,12,13,14,15,16,8,9.\nInterestingly enough, it is precisely via this mechanism why sildenafil was at first researched as a potential treatment for angina - or chest pain associated with inadequate blood flow to the heart - before being serendipitously indicated for treating erectile dysfunction in the late 1980s 7. Nevertheless, it is because of this mechanism that sildenafil is also indicated for treating pulmonary arterial hypertension but is also additionally notorious for interacting with various anti-anginal or anti-hypertensive agents to develop potentially rapid, excessive, and/or fatal hypotensive crises 4,5,6.\nRegardless, sildenafil, among a variety of other similar or related PDE5 inhibitors, has become a common and effective treatment for erectile dysfunction and since its formal approval for medical use in the public in 1998 7, continues to see millions of prescriptions written for it internationally. Although the medication has historically been most popularly recognized as Pfizer's brand name Viagra, sildenafil is currently available generically and even as a non-prescription over the counter medication in some countries 10.",
                "Type": "Small Molecule",
                "Groups": "Approved, Investigational",
                "Structure": "3DDownload MOLSDF3D-SDFPDBSMILESInChI\n\n\n Similar StructuresStructure for Sildenafil (DB00203)\u00d7 Close",
                "Weight": "Average: 474.576 Monoisotopic: 474.204924168",
                "Chemical Formula": "C22H30N6O4S",
                "Synonyms": "1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazineSildenafilSildenafilo",
                "External IDs": "HIP-0908\nHIP0908"
            },
            "Pharmacology": {
                "Indication": "Sildenafil is a phosphodiesterase-5 (PDE5) inhibitor that is predominantly employed for two primary indications:\n(1) the treatment of erectile dysfunction 5,8,12,13,16; and\n(2) treatment of pulmonary hypertension, where:\na) the US FDA specifically indicates sildenafil for the treatment of pulmonary arterial hypertension (PAH) (WHO Group I) in adults to improve exercise ability and delay clinical worsening 11. The delay in clinical worsening was demonstrated when sildenafil was added to background epoprostenol therapy 11. Studies establishing effectiveness were short-term (12 to 16 weeks), and included predominately patients with New York Heart Association (NYHA) Functional Class II-III symptoms and idiopathic etiology (71%) or associated with connective tissue disease (CTD) (25%) 11;\nb) the Canadian product monograph specifically indicates sildenafil for the treatment of primary pulmonary arterial hypertension (PPH) or pulmonary hypertension secondary to connective tissue disease (CTD) in adult patients with WHO functional class II or III who have not responded to conventional therapy 14. In addition, improvement in exercise ability and delay in clinical worsening was demonstrated in adult patients who were already stabilized on background epoprostenol therapy 14; and\nc) the EMA product information specifically indicates sildenafil for the treatment of adult patients with pulmonary arterial hypertension classified as WHO functional class II and III, to improve exercise capacity 15. Efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease 15. The EMA label also indicates sildenafil for the treatment of pediatric patients aged 1 year to 17 years old with pulmonary arterial hypertension 15. Efficacy in terms of improvement of exercise capacity or pulmonary hemodynamics has been shown in primary pulmonary hypertension and pulmonary hypertension associated with congenital heart disease 15.\nReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See how",
                "Associated Conditions": "Erectile Dysfunction\nNYHA Functional Class II-III Pulmonary arterial hypertension\nPremature Ejaculation\nPulmonary Arterial Hypertension (PAH)",
                "Contraindications & Blackbox Warnings": "Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events with our Clinical APILearn more",
                "Pharmacodynamics": "In vitro studies have shown that sildenafil is selective for phosphodiesterase-5 (PDE5) 11,12,13,14,15,16,8,9. Its effect is more potent on PDE5 than on other known phosphodiesterases 11,12,13,14,15,16,8,9. In particular, there is a 10-times selectivity over PDE6 which is involved in the phototransduction pathway in the retina 11,12,13,14,15,16,8,9. There is an 80-times selectivity over PDE1, and over 700-times over PDE 2, 3, 4, 7, 8, 9, 10 and 11 11,12,13,14,15,16,8,9. And finally, sildenafil has greater than 4,000-times selectivity for PDE5 over PDE3, the cAMP-specific phosphodiesterase isoform involved in the control of cardiac contractility 11,12,13,14,15,16,8,9.\nIn eight double-blind, placebo-controlled crossover studies of patients with either organic or psychogenic erectile dysfunction, sexual stimulation resulted in improved erections, as assessed by an objective measurement of hardness and duration of erections (via the use of RigiScan\u00ae), after sildenafil administration compared with placebo 11,12,13,14,15,16,8,9. Most studies assessed the efficacy of sildenafil approximately 60 minutes post-dose 11,12,13,14,15,16,8,9. The erectile response, as assessed by RigiScan\u00ae, generally increased with increasing sildenafil dose and plasma concentration 11,12,13,14,15,16,8,9. The time course of effect was examined in one study, showing an effect for up to 4 hours but the response was diminished compared to 2 hours 11,12,13,14,15,16,8,9.\nSildenafil causes mild and transient decreases in systemic blood pressure which, in the majority of cases, do not translate into clinical effects 11,12,13,14,15,16,8,9. After chronic dosing of 80 mg, three times a day to patients with systemic hypertension the mean change from baseline in systolic and diastolic blood pressure was a decrease of 9.4 mmHg and 9.1 mmHg respectively 11,12,13,14,15,16,8,9. After chronic dosing of 80 mg, three times a day to patients with pulmonary arterial hypertension lesser effects in blood pressure reduction were observed (a reduction in both systolic and diastolic pressure of 2 mmHg)11,12,13,14,15,16,8,9 . At the recommended dose of 20 mg three times a day no reductions in systolic or diastolic pressure were seen 11,12,13,14,15,16,8,9.\nSingle oral doses of sildenafil up to 100 mg in healthy volunteers produced no clinically relevant effects on ECG 11,12,13,14,15,16,8,9. After chronic dosing of 80 mg three times a day to patients with pulmonary arterial hypertension no clinically relevant effects on the ECG were reported either 11,12,13,14,15,16,8,9.\nIn a study of the hemodynamic effects of a single oral 100 mg dose of sildenafil in 14 patients with severe coronary artery disease (CAD) (> 70 % stenosis of at least one coronary artery), the mean resting systolic and diastolic blood pressures decreased by 7 % and 6 % respectively compared to baseline 11,12,13,14,15,16,8,9. Mean pulmonary systolic blood pressure decreased by 9% 11,12,13,14,15,16,8,9. Sildenafil showed no effect on cardiac output and did not impair blood flow through the stenosed coronary arteries 11,12,13,14,15,16,8,9.\nMild and transient differences in color discrimination (blue/green) were detected in some subjects using the Farnsworth-Munsell 100 hue test at 1 hour following a 100 mg dose, with no effects evident after 2 hours post-dose 11,12,13,14,15,16,8,9. The postulated mechanism for this change in color discrimination is related to inhibition of PDE6, which is involved in the phototransduction cascade of the retina 11,12,13,14,15,16,8,9. Sildenafil has no effect on visual acuity or contrast sensitivity. In a small size placebo-controlled study of patients with documented early age-related macular degeneration (n = 9), sildenafil (single dose, 100 mg) demonstrated no significant changes in visual tests conducted (which included visual acuity, Amsler grid, color discrimination simulated traffic light, and the Humphrey perimeter and photostress test) 11,12,13,14,15,16,8,9.",
                "Mechanism of action": "Sildenafil is an oral therapy for erectile dysfunction 5,12,13,16,8. In the natural setting, i.e. with sexual stimulation, it restores impaired erectile function by increasing blood flow to the penis 5,12,13,16,8.\nThe physiological mechanism responsible for the erection of the penis involves the release of nitric oxide (NO) in the corpus cavernosum during sexual stimulation 5,12,13,16,8. Nitric oxide then activates the enzyme guanylate cyclase, which results in increased levels of cyclic guanosine monophosphate (cGMP), producing smooth muscle relaxation in the corpus cavernosum and allowing inflow of blood 5,12,13,16,8.\nSildenafil is a potent and selective inhibitor of cGMP specific phosphodiesterase type 5 (PDE5) in the corpus cavernosum, where PDE5 is responsible for degradation of cGMP 5,12,13,16,8. Sildenafil has a peripheral site of action on erections 5,12,13,16,8. Sildenafil has no direct relaxant effect on isolated human corpus cavernosum but potently enhances the relaxant effect of NO on this tissue 5,12,13,16,8. When the NO/cGMP pathway is activated, as occurs with sexual stimulation, inhibition of PDE5 by sildenafil results in increased corpus cavernosum levels of cGMP 5,12,13,16,8. Therefore sexual stimulation is required in order for sildenafil to produce its intended beneficial pharmacological effects 5,12,13,16,8.\nMoreover, apart from the presence of PDE5 in the corpus cavernosum of the penis, PDE5 is also present in the pulmonary vasculature 4,11,14,15,9. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation 4,11,14,15,9. In patients with pulmonary arterial hypertension, this can lead to vasodilation of the pulmonary vascular bed and, to a lesser degree, vasodilatation in the systemic circulation 4,11,14,15,9.\nTargetActionsOrganismAcGMP-specific 3',5'-cyclic phosphodiesteraseinhibitorHumansNRetinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gammainhibitorHumansNRetinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gammainhibitorHumansUOrnithine decarboxylasedownregulatorHumansUProgrammed cell death 1 ligand 1downregulatorHumans",
                "Absorption": "Sildenafil is known to be quickly absorbed, with maximum plasma concentrations being observed within 30-120 minutes (with a median of 60 minutes) of oral administration in a fasting patient 11,12,13,14,15,16,8,9. Moreover, the mean absolute bioavailability observed for sildenafil is about 41% (from a range of 25-63%) 11,12,13,14,15,16,8,9. In particular, after oral three times a day dosing of sildenafil, the AUC and Cmax increase in proportion with dose over the recommended dosage range of 25-100 mg 11,12,13,14,15,16,8,9.\nWhen used in pulmonary arterial hypertension patients, however, the oral bioavailability of sildenafil after a dosing regimen of 80 mg three times a day, was on average 43% greater than compared to the lower doses 11,12,13,14,15,16,8,9.\nFinally, if sildenafil is administered orally with food, the rate of absorption is observed to be decreased with a mean delay in Tmax of about 60 minutes and a mean decrease in Cmax of approximately 29% 11,12,13,14,15,16,8,9. Regardless, the extent of absorption is not observed to be significantly affected as the recorded AUC decreased by only about 11 % 11,12,13,14,15,16,8,9.",
                "Volume of distribution": "The mean steady-state volume of distribution documented for sildenafil is approximately 105 L - a value which suggests the medication undergoes distribution into the tissues 11,12,13,14,15,16,8,9.",
                "Protein binding": "It is generally observed that sildenafil and its main circulating N-desmethyl metabolite are both estimated to be about 96% bound to plasma proteins 11,12,13,14,15,16,8,9. Nevertheless, it has been determined that protein binding for sildenafil is independent of total drug concentrations 11,12,13,14,15,16,8,9.",
                "Metabolism": "The metabolism of sildenafil is facilitated primarily by the CYP3A4 hepatic microsomal isoenzymes and to a minor extent, via the CYP2C9 hepatic isoenzymes 6,11,12,13,14,15,16,8,9. The predominant circulating metabolite results from the N-demethylation of sildenafil 6,11,12,13,14,15,16,8,9. This particular resultant metabolite possesses a phosphodiesterase selectivity that is similar to the parent sildenafil molecule and a corresponding in vitro potency for PDE5 that is approximately 50% that of the parent drug 6,11,12,13,14,15,16,8,9. Moreover, plasma concentrations of the metabolite are about 40% of those recorded for sildenafil, a percentage that accounts for about 20% of sildenafil\u2019s pharmacologic effects 6,11,12,13,14,15,16,8,9. This primary N-desmethyl metabolite of sildenafil also undergoes further metabolism, with a terminal half-life of about 4 hours 6,11,12,13,14,15,16,8,9.\nIn patients with pulmonary arterial hypertension, plasma concentrations of the primary N-desmethyl metabolite are about 72% those of the original parent sildenafil molecule after a regimen of 20 mg three times a day - which is consequently responsible for about a 36% contribution to sildenafil\u2019s overall pharmacological effects 6,11,12,13,14,15,16,8,9.\nHover over products below to view reaction partnersSildenafil\n\n\nN-Desmethyl sildenafil (UK-103,320)\n\n\nN-Desmethyl sildenafil",
                "Route of elimination": "After either oral or intravenous administration, sildenafil is excreted as metabolites predominantly in the feces (approximately 80% of the administered oral dose) and to a lesser extent in the urine (approximately 13% of the administered oral dose) 11,12,13,14,15,16,8,9.",
                "Half-life": "The terminal phase half-life observed for sildenafil is approximately 3 to 5 hours 11,12,13,14,15,16,8,9.",
                "Clearance": "The total body clearance documented for sildenafil is 41 L/h 11,12,13,14,15,16,8,9.",
                "Adverse Effects": "Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!See the data  Improve decision support & research outcomes with our structured adverse effects data.See a data sample",
                "Toxicity": "In single-dose volunteer studies of doses up to 800 mg, adverse reactions were similar to those seen at lower doses, but the incidence rates and severities were increased 11,12,13,14,15,16,8,9. Doses of 200 mg did not result in increased efficacy but the incidence of adverse reaction (headache, flushing, dizziness, dyspepsia, nasal congestion, altered vision) was increased 11,12,13,14,15,16,8,9.\nDue to the lack of data on the effect of sildenafil indicated for the treatment of pulmonary arterial hypertension (PAH) in pregnant women, sildenafil is not recommended for women of childbearing potential unless also using appropriate contraceptive measures 11,14,15,9.\nThe safety and efficacy of sildenafil indicated for treating PAH in a woman during labor and delivery have not been studied 11,14,15,9. Caution should ultimately be exercised when sildenafil is administered to nursing women as it is not known if sildenafil or its metabolites are excreted in human breast milk 11,14,15,9.\nThe safety and efficacy of sildenafil for the treatment of PAH in children below 1 year of age has not been established as no data is available 15.\nClinical experience with the elderly population in the use of sildenafil for the treatment of PAH has been varied. Some reports suggest that there are no identified differences in responses between elderly and younger patients 11 while others have documented that clinical efficacy as measured by 6-minute walk distance could be less in elderly patients 9. In general, dose selection for an elderly patient should be cautious, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy 11.\nConversely, when sildenafil was used to treat erectile dysfunction in healthy elderly volunteers (65 years or over), a reduced clearance of sildenafil was observed 12,8. This reduction resulted in about 90% higher plasma concentrations of sildenafil and the active N-desmethyl metabolite compared to those seen in healthy younger volunteers (18-45 years) 12,8. Due to age-differences in plasma protein binding, the corresponding increase in free sildenafil plasma concentration was approximately 40% 12,8.\nSildenafil was not carcinogenic when administered to rats for 24 months at a dose resulting in total systemic drug exposure (AUCs) for unbound sildenafil and its major metabolite of 29- and 42- times, for male and female rats, respectively, the exposures observed in human males given the Maximum Recommended Human Dose (MRHD) of 100 mg 11,12,13,14,15,16,8,9. Sildenafil was not carcinogenic when administered to mice for 18-21 months at dosages up to the Maximum Tolerated Dose (MTD) of 10 mg/kg/day, approximately 0.6 times the MRHD on a mg/m2 basis 11,12,13,14,15,16,8,9.\nSildenafil was negative in in vitro bacterial and Chinese hamster ovary cell assays to detect mutagenicity, and in vitro human lymphocytes and in vivo mouse micronucleus assays to detect clastogenicity 11,12,13,14,15,16,8,9.\nThere was no impairment of fertility in rats given sildenafil up to 60 mg/kg/day for 36 days to females and 102 days to males, a dose producing an AUC value of more than 25 times the human male AUC 11,12,13,14,15,16,8,9.",
                "Pathways": "Not Available",
                "Pharmacogenomic Effects/ADRs": "Interacting Gene/EnzymeAllele nameGenotype(s)Defining Change(s)Type(s)DescriptionDetailsAngiotensin-converting enzyme---Not AvailableAlu insertions / Alu insertions\u00a0 \u2026 show all Effect Directly StudiedPatients with this genotype have increased frequency of positive erectile response when using sildenafil to treat erectile dysfunctionDetailsGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3---(T;T)T allele, homozygoteEffect Directly StudiedPatients with this genotype have increased frequency of positive erectile response when using sildenafil to treat erectile dysfunctionDetails"
            },
            "Interactions": {
                "Drug Interactions": "This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. ApprovedVet approvedNutraceuticalIllicitWithdrawnInvestigationalExperimentalAll DrugsDrugInteractionIntegrate drug-drug interactions in your software\n\n\nAbaloparatideThe risk or severity of hypotension can be increased when Sildenafil is combined with Abaloparatide.AbametapirThe serum concentration of Sildenafil can be increased when it is combined with Abametapir.AbataceptThe metabolism of Sildenafil can be increased when combined with Abatacept.AbciximabThe risk or severity of hemorrhage can be increased when Abciximab is combined with Sildenafil.AbemaciclibThe serum concentration of Abemaciclib can be increased when it is combined with Sildenafil.AbirateroneThe metabolism of Sildenafil can be decreased when combined with Abiraterone.AbrocitinibThe serum concentration of Sildenafil can be increased when it is combined with Abrocitinib.AcalabrutinibThe metabolism of Sildenafil can be decreased when combined with Acalabrutinib.AcebutololThe metabolism of Sildenafil can be decreased when combined with Acebutolol.AcenocoumarolThe risk or severity of hemorrhage can be increased when Acenocoumarol is combined with Sildenafil.Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more",
                "Food Interactions": "Take with or without food. If taken with a high-fat meal the medicine may take a little longer to start working."
            },
            "Products": {
                "": "Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access now  Access drug product information from over 10 global regions.Access now",
                "Product Ingredients": "IngredientUNIICASInChI KeySildenafil citrateBW9B0ZE037171599-83-0DEIYFTQMQPDXOT-UHFFFAOYSA-N",
                "Product Images": "PreviousNext",
                "Brand Name Prescription Products": "NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImageAct SildenafilTablet50 mgOralActavis Pharma Company2012-11-082018-06-26CanadaAct SildenafilTablet25 mgOralActavis Pharma Company2012-11-082018-06-26CanadaAct SildenafilTablet100 mgOralActavis Pharma Company2012-11-082018-06-26CanadaGranpidamTablet, film coated20 mgOralAccord Healthcare S.L.U.2021-01-12Not applicableEUGranpidamTablet, film coated20 mgOralAccord Healthcare S.L.U.2021-01-12Not applicableEUGranpidamTablet, film coated20 mgOralAccord Healthcare S.L.U.2021-01-12Not applicableEUGranpidamTablet, film coated20 mgOralAccord Healthcare S.L.U.2021-01-12Not applicableEUGranpidamTablet, film coated20 mgOralAccord Healthcare S.L.U.2021-01-12Not applicableEULiqrevSuspension10 mg/1mLOralCmp Pharma, Inc.2023-04-30Not applicableUSM-sildenafilTablet50 mgOralMantra Pharma IncNot applicableNot applicableCanada",
                "Generic Prescription Products": "NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImageAccel-sildenafilTablet25 mgOralAccel Pharma Inc2019-08-15Not applicableCanadaAccel-sildenafilTablet100 mgOralAccel Pharma Inc2019-08-15Not applicableCanadaAccel-sildenafilTablet50 mgOralAccel Pharma Inc2019-08-15Not applicableCanadaAg-sildenafilTablet25 mgOralAngita Pharma Inc.2018-12-212022-11-15CanadaAg-sildenafilTablet100 mgOralAngita Pharma Inc.2018-12-212022-11-15CanadaAg-sildenafilTablet50 mgOralAngita Pharma Inc.2018-12-212022-11-15CanadaAg-sildenafil TabletsTablet100 mgOralAngita Pharma Inc.2021-07-30Not applicableCanadaAg-sildenafil TabletsTablet50 mgOralAngita Pharma Inc.Not applicableNot applicableCanadaAg-sildenafil TabletsTablet25 mgOralAngita Pharma Inc.Not applicableNot applicableCanadaApo-sildenafilTablet25 mgOralApotex Corporation2012-11-14Not applicableCanada",
                "Mixture Products": "NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImageDAPOKSEL 30 MG/50 MG FILM TABLET ,3 FILM TABLETSildenafil citrate (50 mg) + Dapoxetine hydrochloride (30 mg)Tablet, film coatedOralNOBEL \u0130LA\u00c7 SAN. VE T\u0130C. A.\u015e.2020-08-142017-11-14TurkeyDAPOKSEL 30 MG/50 MG FILM TABLET ,6 FILM TABLETSildenafil citrate (50 mg) + Dapoxetine hydrochloride (30 mg)Tablet, film coatedOralNOBEL \u0130LA\u00c7 SAN. VE T\u0130C. A.\u015e.2020-08-142017-11-14TurkeyDAPOXIL 30/50 MG FILM KAPLI TABLET, 3 FILM KAPLI TABLETSildenafil citrate (50 mg) + Dapoxetine hydrochloride (30 mg)Tablet, coatedOralV\u0130TAL\u0130S \u0130LA\u00c7 SAN. T\u0130C. A.\u015e.2020-08-142021-02-15TurkeyDAPOXIL 30/50 MG FILM KAPLI TABLET, 6 FILM KAPLI TABLETSildenafil citrate (50 mg) + Dapoxetine hydrochloride (30 mg)Tablet, coatedOralV\u0130TAL\u0130S \u0130LA\u00c7 SAN. T\u0130C. A.\u015e.2020-08-142021-02-15TurkeyDAPOXIL 30/50 MG FILM KAPLI TABLET,18 FILM KAPLI TABLETSildenafil citrate (50 mg) + Dapoxetine hydrochloride (30 mg)Tablet, coatedOralV\u0130TAL\u0130S \u0130LA\u00c7 SAN. T\u0130C. A.\u015e.2020-08-142021-02-15Turkey"
            },
            "Categories": {
                "ATC Codes": "G01AE10 \u2014 Combinations of sulfonamidesG01AE \u2014 SulfonamidesG01A \u2014 ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDSG01 \u2014 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICSG \u2014 GENITO URINARY SYSTEM AND SEX HORMONESG04BE03 \u2014 SildenafilG04BE \u2014 Drugs used in erectile dysfunctionG04B \u2014 UROLOGICALSG04 \u2014 UROLOGICALSG \u2014 GENITO URINARY SYSTEM AND SEX HORMONES",
                "Drug Categories": "Agents Causing Muscle Toxicity\nAmides\nCardiovascular Agents\nCytochrome P-450 CYP2C19 Inhibitors\nCytochrome P-450 CYP2C19 Inhibitors (weak)\nCytochrome P-450 CYP2C19 Substrates\nCytochrome P-450 CYP2C9 Inhibitors\nCytochrome P-450 CYP2C9 Inhibitors (weak)\nCytochrome P-450 CYP2C9 Substrates\nCytochrome P-450 CYP2D6 Substrates\nCytochrome P-450 CYP2E1 Inhibitors\nCytochrome P-450 CYP2E1 Inhibitors (strength unknown)\nCytochrome P-450 CYP2E1 Substrates\nCytochrome P-450 CYP3A Substrates\nCytochrome P-450 CYP3A4 Substrates\nCytochrome P-450 CYP3A5 Substrates\nCytochrome P-450 CYP3A7 Substrates\nCytochrome P-450 Enzyme Inhibitors\nCytochrome P-450 Substrates\nDrugs Used in Erectile Dysfunction\nEnzyme Inhibitors\nGenitourinary Agents\nHeterocyclic Compounds, Fused-Ring\nOATP1B1/SLCO1B1 Inhibitors\nP-glycoprotein inhibitors\nP-glycoprotein substrates\nPhosphodiesterase 5 Inhibitors\nPhosphodiesterase Inhibitors\nPiperazines\nPurines\nSulfonamides\nSulfones\nSulfur Compounds\nUrological Agents\nUrologicals\nVasodilating Agents",
                "Chemical TaxonomyProvided by Classyfire": "DescriptionThis compound belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring.KingdomOrganic compoundsSuper ClassBenzenoidsClassBenzene and substituted derivativesSub ClassBenzenesulfonamidesDirect ParentBenzenesulfonamidesAlternative ParentsPyrazolopyrimidines / Benzenesulfonyl compounds / Phenoxy compounds / Phenol ethers / Pyrimidones / Alkyl aryl ethers / N-methylpiperazines / Organosulfonamides / Sulfonyls / Pyrazoles / Heteroaromatic compounds / Trialkylamines / Lactams / Azacyclic compounds / Hydrocarbon derivatives / Organic oxides / Organopnictogen compounds\n\n\n show 7 moreSubstituents1,4-diazinane / Alkyl aryl ether / Amine / Aromatic heteropolycyclic compound / Azacycle / Azole / Benzenesulfonamide / Benzenesulfonyl group / Ether / Heteroaromatic compound / Hydrocarbon derivative / Lactam / N-alkylpiperazine / N-methylpiperazine / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organic sulfonic acid or derivatives / Organoheterocyclic compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Organosulfonic acid amide / Organosulfonic acid or derivatives / Organosulfur compound / Phenol ether / Phenoxy compound / Piperazine / Pyrazole / Pyrazolopyrimidine / Pyrimidine / Pyrimidone / Sulfonyl / Tertiary aliphatic amine / Tertiary amine\n\n\n show 25 moreMolecular FrameworkAromatic heteropolycyclic compoundsExternal Descriptorssulfonamide, piperazines, pyrazolopyrimidine (CHEBI:9139)",
                "Description": "This compound belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring.",
                "Kingdom": "Organic compounds",
                "Super Class": "Benzenoids",
                "Class": "Benzene and substituted derivatives",
                "Sub Class": "Benzenesulfonamides",
                "Direct Parent": "Benzenesulfonamides",
                "Alternative Parents": "Pyrazolopyrimidines / Benzenesulfonyl compounds / Phenoxy compounds / Phenol ethers / Pyrimidones / Alkyl aryl ethers / N-methylpiperazines / Organosulfonamides / Sulfonyls / Pyrazoles / Heteroaromatic compounds / Trialkylamines / Lactams / Azacyclic compounds / Hydrocarbon derivatives / Organic oxides / Organopnictogen compounds\n\n\n show 7 more",
                "Substituents": "1,4-diazinane / Alkyl aryl ether / Amine / Aromatic heteropolycyclic compound / Azacycle / Azole / Benzenesulfonamide / Benzenesulfonyl group / Ether / Heteroaromatic compound / Hydrocarbon derivative / Lactam / N-alkylpiperazine / N-methylpiperazine / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organic sulfonic acid or derivatives / Organoheterocyclic compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Organosulfonic acid amide / Organosulfonic acid or derivatives / Organosulfur compound / Phenol ether / Phenoxy compound / Piperazine / Pyrazole / Pyrazolopyrimidine / Pyrimidine / Pyrimidone / Sulfonyl / Tertiary aliphatic amine / Tertiary amine\n\n\n show 25 more",
                "Molecular Framework": "Aromatic heteropolycyclic compounds",
                "External Descriptors": "sulfonamide, piperazines, pyrazolopyrimidine (CHEBI:9139)",
                "Affected organisms": "Humans and other mammals"
            },
            "Chemical Identifiers": {
                "UNII": "3M7OB98Y7H",
                "CAS number": "139755-83-2",
                "InChI Key": "BNRNXUUZRGQAQC-UHFFFAOYSA-N",
                "InChI": "InChI=1S/C22H30N6O4S/c1-5-7-17-19-20(27(4)25-17)22(29)24-21(23-19)16-14-15(8-9-18(16)32-6-2)33(30,31)28-12-10-26(3)11-13-28/h8-9,14H,5-7,10-13H2,1-4H3,(H,23,24,29)",
                "IUPAC Name": "5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1H,4H,7H-pyrazolo[4,3-d]pyrimidin-7-one",
                "SMILES": "CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1"
            },
            "References": {
                "Synthesis Reference": "Peter James Dunn, Albert Shaw Wood, \"Process for preparing sildenafil.\" U.S. Patent US5955611, issued December, 1994.\nUS5955611",
                "General References": "Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM, Osterloh IH, Gingell C: Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res. 1996 Jun;8(2):47-52. [Article] Cheitlin MD, Hutter AM Jr, Brindis RG, Ganz P, Kaul S, Russell RO Jr, Zusman RM: ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association. J Am Coll Cardiol. 1999 Jan;33(1):273-82. [Article] Fries R, Shariat K, von Wilmowsky H, Bohm M: Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy. Circulation. 2005 Nov 8;112(19):2980-5. [Article] Unegbu C, Noje C, Coulson JD, Segal JB, Romer L: Pulmonary Hypertension Therapy and a Systematic Review of Efficacy and Safety of PDE-5 Inhibitors. Pediatrics. 2017 Mar;139(3). pii: peds.2016-1450. doi: 10.1542/peds.2016-1450. [Article] Gong B, Ma M, Xie W, Yang X, Huang Y, Sun T, Luo Y, Huang J: Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis. Int Urol Nephrol. 2017 Oct;49(10):1731-1740. doi: 10.1007/s11255-017-1644-5. Epub 2017 Jul 24. [Article] Nichols DJ, Muirhead GJ, Harness JA: Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality. Br J Clin Pharmacol. 2002;53 Suppl 1:5S-12S. [Article] Goldstein I, Burnett AL, Rosen RC, Park PW, Stecher VJ: The Serendipitous Story of Sildenafil: An Unexpected Oral Therapy for Erectile Dysfunction. Sex Med Rev. 2019 Jan;7(1):115-128. doi: 10.1016/j.sxmr.2018.06.005. Epub 2018 Oct 6. [Article] Electronic Medicines Compendium: Sildenafil 25mg, 50mg, 100mg film-coated tablets Monograph [Link] Electronic Medicines Compendium: Revatio (sildenafil citrate) 20 mg film-coated tablets Monograph [Link] Forbes: With Viagra Now Available Over-The-Counter In The U.K., Will The U.S. Follow Suit? [Link] Revatio (sildenafil) FDA Label [File] Viagra (sildenafil citrate) FDA Label [File] Viagra (sildenafil citrate) Tablets 25 mg, 50 mg, and 100 mg Canadian Product Monograph [File] Revatio (sildenafil citrate) Canadian Product Monograph [File] Revatio (sildenafil citrate) EMA Label [File] Viagra (sildenafil citrate) EMA Label [File]",
                "External Links": "Human Metabolome DatabaseHMDB0005039KEGG DrugD08514KEGG CompoundC07259PubChem Compound5212PubChem Substance46508371ChemSpider5023BindingDB50238854RxNav136411ChEBI9139ChEMBLCHEMBL192ZINCZINC000019796168Therapeutic Targets DatabaseDAP000614PharmGKBPA451346PDBe LigandVIARxListRxList Drug PageDrugs.comDrugs.com Drug PagePDRhealthPDRhealth Drug PageWikipediaSildenafil",
                "Human Metabolome Database": "HMDB0005039",
                "KEGG Drug": "D08514",
                "KEGG Compound": "C07259",
                "PubChem Compound": "5212",
                "PubChem Substance": "46508371",
                "ChemSpider": "5023",
                "BindingDB": "50238854",
                "RxNav": "136411",
                "ChEBI": "9139",
                "ChEMBL": "CHEMBL192",
                "ZINC": "ZINC000019796168",
                "Therapeutic Targets Database": "DAP000614",
                "PharmGKB": "PA451346",
                "PDBe Ligand": "VIA",
                "RxList": "RxList Drug Page",
                "Drugs.com": "Drugs.com Drug Page",
                "PDRhealth": "PDRhealth Drug Page",
                "Wikipedia": "Sildenafil",
                "PDB Entries": "1tbf / 1udt / 1xos / 2h42 / 3jwq",
                "FDA label": "Download (80.5 KB)",
                "MSDS": "Download (37.1 KB)"
            },
            "Clinical Trials": {
                "Clinical Trials": "PhaseStatusPurposeConditionsCount4CompletedNot AvailableSexual impotency14CompletedBasic ScienceEmphysema14CompletedBasic ScienceSyndrome, Metabolic14CompletedDiagnosticLeft Ventricular Dysfunction / Pulmonary Arterial Hypertension (PAH)14CompletedEducational/Counseling/TrainingBlindness14CompletedOtherHealthy, Male14CompletedOtherSexual impotency14CompletedPreventionFoetal distress syndrome14CompletedPreventionHigh Altitude Pulmonary Edema / Other and unspecified effects of high altitude14CompletedTreatmentAngina Pectoris1"
            },
            "Pharmacoeconomics": {
                "Manufacturers": "Pfizer inc\nPfizer ireland pharmaceuticals",
                "Packagers": "A-S Medication Solutions LLC\nBryant Ranch Prepack\nCardinal Health\nDirect Dispensing Inc.\nDiversified Healthcare Services Inc.\nGallipot\nMSN Laboratories Ltd.\nMurfreesboro Pharmaceutical Nursing Supply\nNucare Pharmaceuticals Inc.\nPD-Rx Pharmaceuticals Inc.\nPfizer Inc.\nPhysicians Total Care Inc.\nPreferred Pharmaceuticals Inc.\nPrepackage Specialists\nPrepak Systems Inc.\nRebel Distributors Corp.\nRedpharm Drug\nSouthwood Pharmaceuticals\nStat Rx Usa\nUS Pharmaceutical Group",
                "Dosage Forms": "FormRouteStrengthTablet, film coatedOral140.5 MGTabletOral25 mgTabletOral50.000 mgTabletOral140.48 mgSuspensionOral25 MG/MLInjection, suspensionTablet, film coatedOral140480 MgTablet, film coatedOral70240 MgTablet, film coatedOralTablet, film coatedOralTablet, coatedOralTablet, chewableOralTablet, delayed releaseOral35.112 mgCapsuleOral50.00 mgTablet, film coatedOral70.225 mgFilm, solubleOral70241 MgTabletOral100 mgTabletOral50 mgCapsule, liquid filledOral25 mgCapsule, liquid filledOral50 mgTablet, solubleOral50 mgTabletOral70.240 mgSolutionIntravenous10 mgTabletOral100.0 mgTabletOral25.0 mgTabletOral50.0 mgSolutionOral0.01838 gTabletOral140.450 mgTabletOral70.225 mgSuspensionOral10 mg/1mLSolutionOral1.838 gTabletOral140.480 mgTablet, film coatedOral70.24 mgTabletOral50.00 mgGelOral28.100 mgTabletOral140.400 mgTabletOral100.000 mgFilm, solubleOral100 mgFilm, solubleOral25 MGFilm, solubleOral50 MGFilm, solubleOral75 MGTabletOral28.090 mgInjection, solutionIntravenous0.8 MG/MLInjection, solutionIntravenous0.8 mg/1mLPowder, for suspensionOral10 MG/MLSolutionIntravenous0.8 mg / mLSyrupTabletOral20 mgTablet, film coatedOral20 MGTablet, coatedOral20 mgTablet, film coatedOral20.0 mg/unitTabletOralSuspensionOral25.000 mgFilm, solubleOral70.23 MGTablet, film coatedOral100.0 mgTablet, film coatedOral50.0 mgCapsuleOral25 mgCapsuleOral50 mgTablet, film coatedOral25 mgFor suspensionOral10 mg/1mLInjection, solutionIntravenous10 mg/12.5mLTabletOral100 mg/1TabletOral20 mg/1TabletOral25 mg/1TabletOral50 mg/1Tablet, film coatedOral20 mg/1Tablet, chewableBuccal50 mgTablet, chewableOral50 mgTablet, coatedOral70.24 mgTablet, coatedOral50 mgTablet, chewableOral100 MGPowder, for suspensionOral10 mg/1mLTablet, chewableOral25 MGTablet, film coatedOral100 mgTablet, film coatedOral50 mgTablet, film coatedOral100 mg/1Tablet, film coatedOral25 mg/1Tablet, film coatedOral50 mg/1Tablet, orally disintegratingOral50 mgTablet, coatedOral100 mgTablet, coatedOral25 mgTablet, orally disintegratingOralFilm, solubleOralTablet, orally disintegratingOral100 mgTablet, orally disintegratingOral25 mgTabletOral70.241 mgTablet, film coatedOral140.48 MGFilmBuccal70.230 mg",
                "Prices": "Unit descriptionCostUnitSildenafil citrate powder24.38USD gViagra 50 mg tablet19.45USD tabletViagra 100 mg tablet19.45USD tabletViagra 25 mg tablet19.45USD tabletRevatio 20 mg tablet17.5USD tabletRevatio 10 mg/12.5 ml vial9.33USD ml  DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.",
                "Patents": "Patent NumberPediatric ExtensionApprovedExpires (estimated)RegionUS5250534No1993-10-052012-03-27USCA2324324No2005-12-202020-10-26CanadaCA2044748No1998-02-032011-06-17CanadaUS6469012Yes2002-10-222020-04-22USUS11337979No2018-12-242038-12-24USUS11464778No2018-12-242038-12-24USUS11759468No2018-12-242038-12-24US"
            },
            "Properties": {
                "State": "Solid",
                "Experimental Properties": "PropertyValueSourcemelting point (\u00b0C)189-190 \u00b0CNot Availablewater solubility3.5 mg/mLNot AvailablelogP1.9Not Available",
                "Predicted Properties": "PropertyValueSourceWater Solubility0.46 mg/mLALOGPSlogP1.8ALOGPSlogP1.87ChemaxonlogS-3ALOGPSpKa (Strongest Acidic)11.14ChemaxonpKa (Strongest Basic)5.99ChemaxonPhysiological Charge0ChemaxonHydrogen Acceptor Count8ChemaxonHydrogen Donor Count1ChemaxonPolar Surface Area109.13 \u00c52ChemaxonRotatable Bond Count6ChemaxonRefractivity139.44 m3\u00b7mol-1ChemaxonPolarizability51.18 \u00c53ChemaxonNumber of Rings4ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterNoChemaxonVeber's RuleNoChemaxonMDDR-like RuleYesChemaxon",
                "Predicted ADMET Features": "PropertyValueProbabilityHuman Intestinal Absorption+1.0Blood Brain Barrier+0.6461Caco-2 permeable+0.7078P-glycoprotein substrateSubstrate0.7753P-glycoprotein inhibitor IInhibitor0.672P-glycoprotein inhibitor IIInhibitor0.8877Renal organic cation transporterNon-inhibitor0.648CYP450 2C9 substrateNon-substrate0.6553CYP450 2D6 substrateSubstrate0.8918CYP450 3A4 substrateSubstrate0.7254CYP450 1A2 substrateNon-inhibitor0.823CYP450 2C9 inhibitorInhibitor0.6864CYP450 2D6 inhibitorNon-inhibitor0.8394CYP450 2C19 inhibitorNon-inhibitor0.8222CYP450 3A4 inhibitorInhibitor0.849CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.5839Ames testNon AMES toxic0.5683CarcinogenicityNon-carcinogens0.6658BiodegradationNot ready biodegradable0.7641Rat acute toxicity2.6730 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.8664hERG inhibition (predictor II)Inhibitor0.7602  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)"
            },
            "Spectra": {
                "Mass Spec (NIST)": "Not Available",
                "Spectra": "SpectrumSpectrum TypeSplash KeyPredicted GC-MS Spectrum - GC-MSPredicted GC-MSNot AvailablePredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-004i-0002900000-b281f59f40caaba85ac9Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-004i-4436900000-0c5804e76b9d495c76d6Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0459-6292000000-5a32bfcdda2067978be9Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-00di-0001900000-51b4957d0b3d25c41773Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-01vk-0302900000-86c63c2fd17f7c5b7d6fPredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-03dj-8916100000-e941afc576d544ed32a7LC-MS/MS Spectrum - LC-ESI-qTof , PositiveLC-MS/MSNot AvailableLC-MS/MS Spectrum - LC-ESI-qTof , PositiveLC-MS/MSNot AvailableMS/MS Spectrum - , positiveLC-MS/MSsplash10-0059-2494500000-e3f8387aee5a0463363cMS/MS Spectrum - , positiveLC-MS/MSsplash10-05s0-3892000000-aa19715309275e16a6c0"
            },
            "Interested in using DrugBank in a commercial product or application?": {},
            "Stay up-to-date with the latest from DrugBank!": {},
            "Thank you for subscribing!": {}
        },
        "Additional Information": {
            "targets": [
                {
                    "Label": "cGMP-specific 3',5'-cyclic phosphodiesterase",
                    "Detailed Info": {
                        "Name": "cGMP-specific 3',5'-cyclic phosphodiesterase",
                        "Synonyms": "3.1.4.35\nCGB-PDE\ncGMP-binding cGMP-specific phosphodiesterase\nPDE5",
                        "Gene Name": "PDE5A",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0036966|cGMP-specific 3',5'-cyclic phosphodiesterase\nMERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAE\nRVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEG\nTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLI\nSADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPL\nNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDE\nKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIIS\nFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTME\nPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGK\nVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETREL\nQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWIL\nSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGV\nNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAI\nLATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAE\nLVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCF\nPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN",
                        "Number of residues": "875",
                        "Molecular Weight": "99984.14",
                        "Theoretical pI": "6.0",
                        "GO Classification": "Functions3',5'-cyclic-GMP phosphodiesterase activity / 3',5'-cyclic-nucleotide phosphodiesterase activity / cGMP binding / metal ion bindingProcessesblood coagulation / cGMP catabolic process / negative regulation of cardiac muscle contraction / negative regulation of T cell proliferation / positive regulation of cardiac muscle hypertrophy / positive regulation of MAP kinase activity / positive regulation of oocyte development / regulation of cGMP metabolic process / relaxation of cardiac muscle / signal transductionComponentscytosol",
                        "General Function": "Metal ion binding",
                        "Specific Function": "Plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides. This phosphodiesterase catalyzes the specific hydrolysis of cGMP to 5'-GMP (PubMed:9714779, PubMed:15489334). Specifically regulates nitric-oxide-generated cGMP (PubMed:15489334).",
                        "Pfam Domain Function": "GAF (PF01590)\nPDEase_I (PF00233)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Cytoplasmic",
                        "Gene sequence": ">lcl|BSEQ0009989|cGMP-specific 3',5'-cyclic phosphodiesterase (PDE5A)\nATGGAGCGGGCCGGCCCCAGCTTCGGGCAGCAGCGACAGCAGCAGCAGCCCCAGCAGCAG\nAAGCAGCAGCAGAGGGATCAGGACTCGGTCGAAGCATGGCTGGACGATCACTGGGACTTT\nACCTTCTCATACTTTGTTAGAAAAGCCACCAGAGAAATGGTCAATGCATGGTTTGCTGAG\nAGAGTTCACACCATCCCTGTGTGCAAGGAAGGTATCAGAGGCCACACCGAATCTTGCTCT\nTGTCCCTTGCAGCAGAGTCCTCGTGCAGATAACAGTGCCCCTGGAACACCAACCAGGAAA\nATCTCTGCCTCTGAATTTGACCGGCCTCTTAGACCCATTGTTGTCAAGGATTCTGAGGGA\nACTGTGAGCTTCCTCTCTGACTCAGAAAAGAAGGAACAGATGCCTCTAACCCCTCCAAGG\nTTTGATCATGATGAAGGGGACCAGTGCTCAAGACTCTTGGAATTAGTGAAGGATATTTCT\nAGTCATTTGGATGTCACAGCCTTATGTCACAAAATTTTCTTGCATATCCATGGACTGATA\nTCTGCTGACCGCTATTCCCTGTTCCTTGTCTGTGAAGACAGCTCCAATGACAAGTTTCTT\nATCAGCCGCCTCTTTGATGTTGCTGAAGGTTCAACACTGGAAGAAGTTTCAAATAACTGT\nATCCGCTTAGAATGGAACAAAGGCATTGTGGGACATGTGGCAGCGCTTGGTGAGCCCTTG\nAACATCAAAGATGCATATGAGGATCCTCGGTTCAATGCAGAAGTTGACCAAATTACAGGC\nTACAAGACACAAAGCATTCTTTGTATGCCAATTAAGAATCATAGGGAAGAGGTTGTTGGT\nGTAGCCCAGGCCATCAACAAGAAATCAGGAAACGGTGGGACATTTACTGAAAAAGATGAA\nAAGGACTTTGCTGCTTATTTGGCATTTTGTGGTATTGTTCTTCATAATGCTCAGCTCTAT\nGAGACTTCACTGCTGGAGAACAAGAGAAATCAGGTGCTGCTTGACCTTGCTAGTTTAATT\nTTTGAAGAACAACAATCATTAGAAGTAATTTTGAAGAAAATAGCTGCCACTATTATCTCT\nTTCATGCAAGTGCAGAAATGCACCATTTTCATAGTGGATGAAGATTGCTCCGATTCTTTT\nTCTAGTGTGTTTCACATGGAGTGTGAGGAATTAGAAAAATCATCTGATACATTAACAAGG\nGAACATGATGCAAACAAAATCAATTACATGTATGCTCAGTATGTCAAAAATACTATGGAA\nCCACTTAATATCCCAGATGTCAGTAAGGATAAAAGATTTCCCTGGACAACTGAAAATACA\nGGAAATGTAAACCAGCAGTGCATTAGAAGTTTGCTTTGTACACCTATAAAAAATGGAAAG\nAAGAATAAAGTTATAGGGGTTTGCCAACTTGTTAATAAGATGGAGGAGAATACTGGCAAG\nGTTAAGCCTTTCAACCGAAATGACGAACAGTTTCTGGAAGCTTTTGTCATCTTTTGTGGC\nTTGGGGATCCAGAACACGCAGATGTATGAAGCAGTGGAGAGAGCCATGGCCAAGCAAATG\nGTCACATTGGAGGTTCTGTCGTATCATGCTTCAGCAGCAGAGGAAGAAACAAGAGAGCTA\nCAGTCGTTAGCGGCTGCTGTGGTGCCATCTGCCCAGACCCTTAAAATTACTGACTTTAGC\nTTCAGTGACTTTGAGCTGTCTGATCTGGAAACAGCACTGTGTACAATTCGGATGTTTACT\nGACCTCAACCTTGTGCAGAACTTCCAGATGAAACATGAGGTTCTTTGCAGATGGATTTTA\nAGTGTTAAGAAGAATTATCGGAAGAATGTTGCCTATCATAATTGGAGACATGCCTTTAAT\nACAGCTCAGTGCATGTTTGCTGCTCTAAAAGCAGGCAAAATTCAGAACAAGCTGACTGAC\nCTGGAGATACTTGCATTGCTGATTGCTGCACTAAGCCACGATTTGGATCACCGTGGTGTG\nAATAACTCTTACATACAGCGAAGTGAACATCCACTTGCCCAGCTTTACTGCCATTCAATC\nATGGAACACCATCATTTTGACCAGTGCCTGATGATTCTTAATAGTCCAGGCAATCAGATT\nCTCAGTGGCCTCTCCATTGAAGAATATAAGACCACGTTGAAAATAATCAAGCAAGCTATT\nTTAGCTACAGACCTAGCACTGTACATTAAGAGGCGAGGAGAATTTTTTGAACTTATAAGA\nAAAAATCAATTCAATTTGGAAGATCCTCATCAAAAGGAGTTGTTTTTGGCAATGCTGATG\nACAGCTTGTGATCTTTCTGCAATTACAAAACCCTGGCCTATTCAACAACGGATAGCAGAA\nCTTGTAGCAACTGAATTTTTTGATCAAGGAGACAGAGAGAGAAAAGAACTCAACATAGAA\nCCCACTGATCTAATGAACAGGGAGAAGAAAAACAAAATCCCAAGTATGCAAGTTGGGTTC\nATAGATGCCATCTGCTTGCAACTGTATGAGGCCCTGACCCACGTGTCAGAGGACTGTTTC\nCCTTTGCTAGATGGCTGCAGAAAGAACAGGCAGAAATGGCAGGCCCTTGCAGAACAGCAG\nGAGAAGATGCTGATTAATGGGGAAAGCGGCCAGGCCAAGCGGAACTGA",
                        "Chromosome Location": "4",
                        "Locus": "4q25-q27",
                        "External Identifiers": "ResourceLinkUniProtKB IDO76074UniProtKB Entry NamePDE5A_HUMANGenBank Protein ID3420185GenBank Gene IDAF043731GenAtlas IDPDE5AHGNC IDHGNC:8784",
                        "General References": "Loughney K, Hill TR, Florio VA, Uher L, Rosman GJ, Wolda SL, Jones BA, Howard ML, McAllister-Lucas LM, Sonnenburg WK, Francis SH, Corbin JD, Beavo JA, Ferguson K: Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3',5'-cyclic nucleotide phosphodiesterase. Gene. 1998 Aug 17;216(1):139-47. [Article] Yanaka N, Kotera J, Ohtsuka A, Akatsuka H, Imai Y, Michibata H, Fujishige K, Kawai E, Takebayashi S, Okumura K, Omori K: Expression, structure and chromosomal localization of the human cGMP-binding cGMP-specific phosphodiesterase PDE5A gene. Eur J Biochem. 1998 Jul 15;255(2):391-9. [Article] Stacey P, Rulten S, Dapling A, Phillips SC: Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5). Biochem Biophys Res Commun. 1998 Jun 18;247(2):249-54. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Zhou L, Thompson WJ, Potter DE: Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1999 Jul;40(8):1745-52. [Article] Rybalkin SD, Rybalkina IG, Feil R, Hofmann F, Beavo JA: Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells. J Biol Chem. 2002 Feb 1;277(5):3310-7. Epub 2001 Nov 26. [Article] Sung BJ, Hwang KY, Jeon YH, Lee JI, Heo YS, Kim JH, Moon J, Yoon JM, Hyun YL, Kim E, Eum SJ, Park SY, Lee JO, Lee TG, Ro S, Cho JM: Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules. Nature. 2003 Sep 4;425(6953):98-102. [Article] Lee DI, Zhu G, Sasaki T, Cho GS, Hamdani N, Holewinski R, Jo SH, Danner T, Zhang M, Rainer PP, Bedja D, Kirk JA, Ranek MJ, Dostmann WR, Kwon C, Margulies KB, Van Eyk JE, Paulus WJ, Takimoto E, Kass DA: Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease. Nature. 2015 Mar 26;519(7544):472-6. doi: 10.1038/nature14332. Epub 2015 Mar 18. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00203Sildenafilapproved, investigationalyesinhibitorDetailsDB00862VardenafilapprovedyesinhibitorDetailsDB00975DipyridamoleapprovedyesinhibitorDetailsDB01972Guanosine-5'-MonophosphateexperimentalunknownDetailsDB03597gamma-Glutamyl[S-(2-iodobenzyl)cysteinyl]glycineexperimentalunknownDetailsDB00277TheophyllineapprovedyesinhibitorDetailsDB00820Tadalafilapproved, investigationalyesinhibitorDetailsDB05415OSI-461investigationalunknownDetailsDB06237AvanafilapprovedyesinhibitorDetailsDB06246ExisulindinvestigationalunknownDetailsDB06267Udenafilapproved, investigationalyesinhibitorDetailsDB079543-isobutyl-1-methyl-7H-xanthineexperimentalunknownDetailsDB087295-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamideexperimentalunknownDetailsDB09282Molsidomineapproved, investigationalunknownsubstrateDetailsDB12010Fostamatinibapproved, investigationalunknowninhibitorDetailsDB00201CaffeineapprovedunknowninhibitorDetailsDB09283TrapidilexperimentalyesinhibitorDetailsDB00201CaffeineapprovedyesinhibitorDetailsDB01113Papaverineapproved, investigationalunknowninhibitorDetails"
                    }
                },
                {
                    "Label": "Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",
                    "Detailed Info": {
                        "Name": "Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",
                        "Synonyms": "3.1.4.35\nGMP-PDE gamma\nPDEG",
                        "Gene Name": "PDE6G",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0006851|Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma\nMNLEPPKAEFRSATRVAGGPVTPRKGPPKFKQRQTRQFKSKPPKKGVQGFGDDIPGMEGL\nGTDITVICPWEAFNHLELHELAQYGII",
                        "Number of residues": "87",
                        "Molecular Weight": "9643.09",
                        "Theoretical pI": "10.16",
                        "GO Classification": "Functions3',5'-cyclic-GMP phosphodiesterase activity / cGMP binding / enzyme inhibitor activityProcessesactivation of MAPK activity / negative regulation of catalytic activity / phototransduction, visible light / positive regulation of epidermal growth factor receptor signaling pathway / positive regulation of G-protein coupled receptor protein signaling pathway / regulation of rhodopsin mediated signaling pathway / rhodopsin mediated signaling pathway / visual perceptionComponentsphotoreceptor disc membrane / plasma membrane",
                        "General Function": "Enzyme inhibitor activity",
                        "Specific Function": "Participates in processes of transmission and amplification of the visual signal. cGMP-PDEs are the effector molecules in G-protein-mediated phototransduction in vertebrate rods and cones.",
                        "Pfam Domain Function": "PDE6_gamma (PF04868)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Cytoplasmic",
                        "Gene sequence": ">lcl|BSEQ0017138|Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma (PDE6G)\nATGAACCTGGAACCGCCCAAGGCTGAGTTCCGGTCAGCCACCAGGGTGGCCGGGGGACCT\nGTCACCCCCAGGAAAGGGCCCCCTAAATTTAAGCAGCGACAGACCAGGCAGTTCAAGAGC\nAAGCCCCCAAAGAAAGGCGTTCAAGGGTTTGGGGACGACATCCCTGGAATGGAAGGCCTG\nGGAACAGACATCACAGTCATCTGCCCTTGGGAGGCCTTCAACCACCTGGAGCTGCACGAG\nCTGGCCCAATATGGCATCATCTAG",
                        "Chromosome Location": "17",
                        "Locus": "17q25",
                        "External Identifiers": "ResourceLinkUniProtKB IDP18545UniProtKB Entry NameCNRG_HUMANGenBank Protein ID189703GenBank Gene IDM36476HGNC IDHGNC:8789",
                        "General References": "Tuteja N, Danciger M, Klisak I, Tuteja R, Inana G, Mohandas T, Sparkes RS, Farber DB: Isolation and characterization of cDNA encoding the gamma-subunit of cGMP phosphodiesterase in human retina. Gene. 1990 Apr 16;88(2):227-32. [Article] Piriev NI, Purishko VA, Khramtsov NV, Lipkin VM: [The organization of the gamma-subunit gene of human photoreceptor cyclic GMP phosphodiesterase]. Dokl Akad Nauk SSSR. 1990;315(1):229-31. [Article] Hahn LB, Berson EL, Dryja TP: Evaluation of the gene encoding the gamma subunit of rod phosphodiesterase in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1994 Mar;35(3):1077-82. [Article] Bechtel S, Rosenfelder H, Duda A, Schmidt CP, Ernst U, Wellenreuther R, Mehrle A, Schuster C, Bahr A, Blocker H, Heubner D, Hoerlein A, Michel G, Wedler H, Kohrer K, Ottenwalder B, Poustka A, Wiemann S, Schupp I: The full-ORF clone resource of the German cDNA Consortium. BMC Genomics. 2007 Oct 31;8:399. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Dvir L, Srour G, Abu-Ras R, Miller B, Shalev SA, Ben-Yosef T: Autosomal-recessive early-onset retinitis pigmentosa caused by a mutation in PDE6G, the gene encoding the gamma subunit of rod cGMP phosphodiesterase. Am J Hum Genet. 2010 Aug 13;87(2):258-64. doi: 10.1016/j.ajhg.2010.06.016. Epub 2010 Jul 22. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00203Sildenafilapproved, investigationalnoinhibitorDetailsDB00862Vardenafilapprovedunknowninhibitorallosteric modulatorDetailsDB079543-isobutyl-1-methyl-7H-xanthineexperimentalunknownDetailsDB00820Tadalafilapproved, investigationalnoinhibitorDetails"
                    }
                },
                {
                    "Label": "Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",
                    "Detailed Info": {
                        "Name": "Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",
                        "Synonyms": "3.1.4.35\nGMP-PDE gamma",
                        "Gene Name": "PDE6H",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0012474|Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma\nMSDNTTLPAPASNQGPTTPRKGPPKFKQRQTRQFKSKPPKKGVKGFGDDIPGMEGLGTDI\nTVICPWEAFSHLELHELAQFGII",
                        "Number of residues": "83",
                        "Molecular Weight": "9074.36",
                        "Theoretical pI": "9.98",
                        "GO Classification": "Functions3',5'-cyclic-GMP phosphodiesterase activity / cGMP binding / enzyme inhibitor activityProcessesactivation of MAPK activity / negative regulation of catalytic activity / positive regulation of epidermal growth factor receptor signaling pathway / positive regulation of G-protein coupled receptor protein signaling pathway / response to stimulus / visual perception",
                        "General Function": "Enzyme inhibitor activity",
                        "Specific Function": "Participates in processes of transmission and amplification of the visual signal. cGMP-PDEs are the effector molecules in G-protein-mediated phototransduction in vertebrate rods and cones.",
                        "Pfam Domain Function": "PDE6_gamma (PF04868)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Cytoplasmic",
                        "Gene sequence": ">lcl|BSEQ0012475|Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma (PDE6H)\nATGAGTGACAACACTACTCTGCCTGCTCCAGCTTCAAACCAGGGTCCTACCACCCCACGC\nAAAGGCCCTCCCAAGTTCAAGCAGAGGCAGACTCGCCAATTCAAGAGTAAACCTCCAAAG\nAAAGGTGTGAAAGGATTTGGAGATGACATTCCAGGAATGGAGGGGCTAGGAACAGATATC\nACAGTGATTTGTCCATGGGAGGCATTCAGCCACCTGGAATTGCATGAGCTCGCTCAGTTT\nGGGATTATCTGA",
                        "Chromosome Location": "12",
                        "Locus": "12p13",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ13956UniProtKB Entry NameCNCG_HUMANGenBank Protein ID1311544GenBank Gene IDD45399HGNC IDHGNC:8790",
                        "General References": "Shimizu-Matsumoto A, Itoh K, Inazawa J, Nishida K, Matsumoto Y, Kinoshita S, Matsubara K, Okubo K: Isolation and chromosomal localization of the human cone cGMP phosphodiesterase gamma cDNA (PDE6H). Genomics. 1996 Feb 15;32(1):121-4. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Piri N, Gao YQ, Danciger M, Mendoza E, Fishman GA, Farber DB: A substitution of G to C in the cone cGMP-phosphodiesterase gamma subunit gene found in a distinctive form of cone dystrophy. Ophthalmology. 2005 Jan;112(1):159-66. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00203Sildenafilapproved, investigationalnoinhibitorDetailsDB00862Vardenafilapprovedunknowninhibitorallosteric modulatorDetails"
                    }
                },
                {
                    "Label": "Ornithine decarboxylase",
                    "Detailed Info": {
                        "Name": "Ornithine decarboxylase",
                        "Synonyms": "4.1.1.17\nODC",
                        "Gene Name": "ODC1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0016082|Ornithine decarboxylase\nMNNFGNEEFDCHFLDEGFTAKDILDQKINEVSSSDDKDAFYVADLGDILKKHLRWLKALP\nRVTPFYAVKCNDSKAIVKTLAATGTGFDCASKTEIQLVQSLGVPPERIIYANPCKQVSQI\nKYAANNGVQMMTFDSEVELMKVARAHPKAKLVLRIATDDSKAVCRLSVKFGATLRTSRLL\nLERAKELNIDVVGVSFHVGSGCTDPETFVQAISDARCVFDMGAEVGFSMYLLDIGGGFPG\nSEDVKLKFEEITGVINPALDKYFPSDSGVRIIAEPGRYYVASAFTLAVNIIAKKIVLKEQ\nTGSDDEDESSEQTFMYYVNDGVYGSFNCILYDHAHVKPLLQKRPKPDEKYYSSSIWGPTC\nDGLDRIVERCDLPEMHVGDWMLFENMGAYTVAAASTFNGFQRPTIYYVMSGPAWQLMQQF\nQNPDFPPEVEEQDASTLPVSCAWESGMKRHRAACASASINV",
                        "Number of residues": "461",
                        "Molecular Weight": "51147.73",
                        "Theoretical pI": "4.88",
                        "GO Classification": "Functionsornithine decarboxylase activity / protein homodimerization activityProcessescellular nitrogen compound metabolic process / kidney development / polyamine metabolic process / positive regulation of cell proliferation / putrescine biosynthetic process from ornithine / regulation of cellular amino acid metabolic process / regulation of protein catabolic process / response to virus / small molecule metabolic processComponentscytoplasm / cytosol / perinuclear region of cytoplasm",
                        "General Function": "Protein homodimerization activity",
                        "Specific Function": "Key enzyme of polyamine biosynthesis that converts ornithine into putrescine, which is the precursor for the polyamines, spermidine and spermine.",
                        "Pfam Domain Function": "Orn_Arg_deC_N (PF02784)\nOrn_DAP_Arg_deC (PF00278)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Not Available",
                        "Gene sequence": ">lcl|BSEQ0000804|1386 bp\nATGAACAACTTTGGTAATGAAGAGTTTGACTGCCACTTCCTCGATGAAGGTTTTACTGCC\nAAGGACATTCTGGACCAGAAAATTAATGAAGTTTCTTCTTCTGATGATAAGGATGCCTTC\nTATGTGGCAGACCTGGGAGACATTCTAAAGAAACATCTGAGGTGGTTAAAAGCTCTCCCT\nCGTGTCACCCCCTTTTATGCAGTCAAATGTAATGATAGCAAAGCCATCGTGAAGACCCTT\nGCTGCTACCGGGACAGGATTTGACTGTGCTAGCAAGACTGAAATACAGTTGGTGCAGAGT\nCTGGGGGTGCCTCCAGAGAGGATTATCTATGCAAATCCTTGTAAACAAGTATCTCAAATT\nAAGTATGCTGCTAATAATGGAGTCCAGATGATGACTTTTGATAGTGAAGTTGAGTTGATG\nAAAGTTGCCAGAGCACATCCCAAAGCAAAGTTGGTTTTGCGGATTGCCACTGATGATTCC\nAAAGCAGTCTGTCGTCTCAGTGTGAAATTCGGTGCCACGCTCAGAACCAGCAGGCTCCTT\nTTGGAACGGGCGAAAGAGCTAAATATCGATGTTGTTGGTGTCAGCTTCCATGTAGGAAGC\nGGCTGTACCGATCCTGAGACCTTCGTGCAGGCAATCTCTGATGCCCGCTGTGTTTTTGAC\nATGGGGGCTGAGGTTGGTTTCAGCATGTATCTGCTTGATATTGGCGGTGGCTTTCCTGGA\nTCTGAGGATGTGAAACTTAAATTTGAAGAGATCACCGGCGTAATCAACCCAGCGTTGGAC\nAAATACTTTCCGTCAGACTCTGGAGTGAGAATCATAGCTGAGCCCGGCAGATACTATGTT\nGCATCAGCTTTCACGCTTGCAGTTAATATCATTGCCAAGAAAATTGTATTAAAGGAACAG\nACGGGCTCTGATGACGAAGATGAGTCGAGTGAGCAGACCTTTATGTATTATGTGAATGAT\nGGCGTCTATGGATCATTTAATTGCATACTCTATGACCACGCACATGTAAAGCCCCTTCTG\nCAAAAGAGACCTAAACCAGATGAGAAGTATTATTCATCCAGCATATGGGGACCAACATGT\nGATGGCCTCGATCGGATTGTTGAGCGCTGTGACCTGCCTGAAATGCATGTGGGTGATTGG\nATGCTCTTTGAAAACATGGGCGCTTACACTGTTGCTGCTGCCTCTACGTTCAATGGCTTC\nCAGAGGCCGACGATCTACTATGTGATGTCAGGGCCTGCGTGGCAACTCATGCAGCAATTC\nCAGAACCCCGACTTCCCACCCGAAGTAGAGGAACAGGATGCCAGCACCCTGCCTGTGTCT\nTGTGCCTGGGAGAGTGGGATGAAACGCCACAGAGCAGCCTGTGCTTCGGCTAGTATTAAT\nGTGTAG",
                        "Chromosome Location": "Not Available",
                        "Locus": "2p25",
                        "External Identifiers": "ResourceLinkUniProtKB IDP11926UniProtKB Entry NameDCOR_HUMANGenBank Protein ID29893806GenBank Gene IDM16650GenAtlas IDODC1HGNC IDHGNC:8109",
                        "General References": "Hickok NJ, Seppanen PJ, Gunsalus GL, Janne OA: Complete amino acid sequence of human ornithine decarboxylase deduced from complementary DNA. DNA. 1987 Jun;6(3):179-87. [Article] Fitzgerald MC, Flanagan MA: Characterization and sequence analysis of the human ornithine decarboxylase gene. DNA. 1989 Nov;8(9):623-34. [Article] van Steeg H, van Oostrom CT, Martens JW, van Kreyl C, Schepens J, Wieringa B: Nucleotide sequence of the human ornithine decarboxylase gene. Nucleic Acids Res. 1989 Nov 11;17(21):8855-6. [Article] Hickok NJ, Wahlfors J, Crozat A, Halmekyto M, Alhonen L, Janne J, Janne OA: Human ornithine decarboxylase-encoding loci: nucleotide sequence of the expressed gene and characterization of a pseudogene. Gene. 1990 Sep 14;93(2):257-63. [Article] Moshier JA, Gilbert JD, Skunca M, Dosescu J, Almodovar KM, Luk GD: Isolation and expression of a human ornithine decarboxylase gene. J Biol Chem. 1990 Mar 25;265(9):4884-92. [Article] Moshier JA, Osborne DL, Skunca M, Dosescu J, Gilbert JD, Fitzgerald MC, Polidori G, Wagner RL, Friezner Degen SJ, Luk GD, et al.: Multiple promoter elements govern expression of the human ornithine decarboxylase gene in colon carcinoma cells. Nucleic Acids Res. 1992 May 25;20(10):2581-90. [Article] Wright PS, Cooper JR, Cross-Doersen DE, Miller JA, Chmielewski PA, Wagner RL, Streng KA, Flanagan MA: Regulation of ornithine decarboxylase mRNA levels in human breast cancer cells: pattern of expression and involvement of core enhancer promoter element. Cell Growth Differ. 1995 Sep;6(9):1097-102. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Hsieh JT, Denning MF, Heidel SM, Verma AK: Expression of human chromosome 2 ornithine decarboxylase gene in ornithine decarboxylase-deficient Chinese hamster ovary cells. Cancer Res. 1990 Apr 15;50(8):2239-44. [Article] Kaczmarek L, Calabretta B, Ferrari S, de Riel JK: Cell-cycle-dependent expression of human ornithine decarboxylase. J Cell Physiol. 1987 Sep;132(3):545-51. [Article] Bauer PM, Fukuto JM, Buga GM, Pegg AE, Ignarro LJ: Nitric oxide inhibits ornithine decarboxylase by S-nitrosylation. Biochem Biophys Res Commun. 1999 Aug 27;262(2):355-8. [Article] Bauer PM, Buga GM, Fukuto JM, Pegg AE, Ignarro LJ: Nitric oxide inhibits ornithine decarboxylase via S-nitrosylation of cysteine 360 in the active site of the enzyme. J Biol Chem. 2001 Sep 14;276(37):34458-64. Epub 2001 Jul 18. [Article] Leong WF, Chow VT: Transcriptomic and proteomic analyses of rhabdomyosarcoma cells reveal differential cellular gene expression in response to enterovirus 71 infection. Cell Microbiol. 2006 Apr;8(4):565-80. [Article] Kanerva K, Makitie LT, Pelander A, Heiskala M, Andersson LC: Human ornithine decarboxylase paralogue (ODCp) is an antizyme inhibitor but not an arginine decarboxylase. Biochem J. 2008 Jan 1;409(1):187-92. [Article] Almrud JJ, Oliveira MA, Kern AD, Grishin NV, Phillips MA, Hackert ML: Crystal structure of human ornithine decarboxylase at 2.1 A resolution: structural insights to antizyme binding. J Mol Biol. 2000 Jan 7;295(1):7-16. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00114Pyridoxal phosphateapproved, investigational, nutraceuticalunknowncofactorDetailsDB01917PutrescineexperimentalunknownDetailsDB02209Pyridoxine phosphateexperimentalunknownDetailsDB02824N-Pyridoxyl-Glycine-5-MonophosphateexperimentalunknownDetailsDB03856L-Eflornithineexperimental, investigationalunknownDetailsDB04083N(6)-(pyridoxal phosphate)-L-lysineexperimentalunknownDetailsDB04263GeneticinexperimentalunknownDetailsDB00127Spermineexperimental, nutraceuticalunknownproduct ofDetailsDB06243Eflornithineapproved, withdrawnyesantagonistblockerDetailsDB00313Valproic acidapproved, investigationalunknowndownregulatorDetailsDB00203Sildenafilapproved, investigationalunknowndownregulatorDetails"
                    }
                },
                {
                    "Label": "Programmed cell death 1 ligand 1",
                    "Detailed Info": {
                        "Name": "Programmed cell death 1 ligand 1",
                        "Synonyms": "B7 homolog 1\nB7-H1\nB7H1\nPD-L1\nPDCD1L1\nPDCD1LG1\nPDL1",
                        "Gene Name": "CD274",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0006712|Programmed cell death 1 ligand 1\nMRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEME\nDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGG\nADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTT\nTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTH\nLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET",
                        "Number of residues": "290",
                        "Molecular Weight": "33275.095",
                        "Theoretical pI": "7.25",
                        "GO Classification": "Processescell surface receptor signaling pathway / immune response / negative regulation of activated T cell proliferation / negative regulation of interferon-gamma production / negative regulation of interleukin-10 production / negative regulation of tumor necrosis factor superfamily cytokine production / positive regulation of cell migration / positive regulation of interleukin-10 secretion / positive regulation of T cell proliferation / response to cytokine / signal transduction / T cell costimulation / toxin transportComponentsendomembrane system / external side of plasma membrane / extracellular exosome / integral component of membrane / plasma membrane",
                        "General Function": "Not Available",
                        "Specific Function": "Involved in the costimulatory signal, essential for T-cell proliferation and production of IL10 and IFNG, in an IL2-dependent and a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation and cytokine production.",
                        "Pfam Domain Function": "V-set (PF07686)\nC2-set_2 (PF08205)",
                        "Transmembrane Regions": "239-259",
                        "Cellular Location": "Cell membrane",
                        "Gene sequence": ">lcl|BSEQ0019421|Programmed cell death 1 ligand 1 (CD274)\nATGAGGATATTTGCTGTCTTTATATTCATGACCTACTGGCATTTGCTGAACGCCCCATAC\nAACAAAATCAACCAAAGAATTTTGGTTGTGGATCCAGTCACCTCTGAACATGAACTGACA\nTGTCAGGCTGAGGGCTACCCCAAGGCCGAAGTCATCTGGACAAGCAGTGACCATCAAGTC\nCTGAGTGGTAAGACCACCACCACCAATTCCAAGAGAGAGGAGAAGCTTTTCAATGTGACC\nAGCACACTGAGAATCAACACAACAACTAATGAGATTTTCTACTGCACTTTTAGGAGATTA\nGATCCTGAGGAAAACCATACAGCTGAATTGGTCATCCCAGAACTACCTCTGGCACATCCT\nCCAAATGAAAGGACTCACTTGGTAATTCTGGGAGCCATCTTATTATGCCTTGGTGTAGCA\nCTGACATTCATCTTCCGTTTAAGAAAAGGGAGAATGATGGATGTGAAAAAATGTGGCATC\nCAAGATACAAACTCAAAGAAGCAAAGTGATACACATTTGGAGGAGACGTAA",
                        "Chromosome Location": "9",
                        "Locus": "Not Available",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ9NZQ7UniProtKB Entry NamePD1L1_HUMANGenBank Gene IDBC113736GenAtlas IDCD274HGNC IDHGNC:17635",
                        "General References": "Dong H, Zhu G, Tamada K, Chen L: B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med. 1999 Dec;5(12):1365-9. [Article] Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, Fitz LJ, Malenkovich N, Okazaki T, Byrne MC, Horton HF, Fouser L, Carter L, Ling V, Bowman MR, Carreno BM, Collins M, Wood CR, Honjo T: Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med. 2000 Oct 2;192(7):1027-34. [Article] He XH, Xu LH, Liu Y: Identification of a novel splice variant of human PD-L1 mRNA encoding an isoform-lacking Igv-like domain. Acta Pharmacol Sin. 2005 Apr;26(4):462-8. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Humphray SJ, Oliver K, Hunt AR, Plumb RW, Loveland JE, Howe KL, Andrews TD, Searle S, Hunt SE, Scott CE, Jones MC, Ainscough R, Almeida JP, Ambrose KD, Ashwell RI, Babbage AK, Babbage S, Bagguley CL, Bailey J, Banerjee R, Barker DJ, Barlow KF, Bates K, Beasley H, Beasley O, Bird CP, Bray-Allen S, Brown AJ, Brown JY, Burford D, Burrill W, Burton J, Carder C, Carter NP, Chapman JC, Chen Y, Clarke G, Clark SY, Clee CM, Clegg S, Collier RE, Corby N, Crosier M, Cummings AT, Davies J, Dhami P, Dunn M, Dutta I, Dyer LW, Earthrowl ME, Faulkner L, Fleming CJ, Frankish A, Frankland JA, French L, Fricker DG, Garner P, Garnett J, Ghori J, Gilbert JG, Glison C, Grafham DV, Gribble S, Griffiths C, Griffiths-Jones S, Grocock R, Guy J, Hall RE, Hammond S, Harley JL, Harrison ES, Hart EA, Heath PD, Henderson CD, Hopkins BL, Howard PJ, Howden PJ, Huckle E, Johnson C, Johnson D, Joy AA, Kay M, Keenan S, Kershaw JK, Kimberley AM, King A, Knights A, Laird GK, Langford C, Lawlor S, Leongamornlert DA, Leversha M, Lloyd C, Lloyd DM, Lovell J, Martin S, Mashreghi-Mohammadi M, Matthews L, McLaren S, McLay KE, McMurray A, Milne S, Nickerson T, Nisbett J, Nordsiek G, Pearce AV, Peck AI, Porter KM, Pandian R, Pelan S, Phillimore B, Povey S, Ramsey Y, Rand V, Scharfe M, Sehra HK, Shownkeen R, Sims SK, Skuce CD, Smith M, Steward CA, Swarbreck D, Sycamore N, Tester J, Thorpe A, Tracey A, Tromans A, Thomas DW, Wall M, Wallis JM, West AP, Whitehead SL, Willey DL, Williams SA, Wilming L, Wray PW, Young L, Ashurst JL, Coulson A, Blocker H, Durbin R, Sulston JE, Hubbard T, Jackson MJ, Bentley DR, Beck S, Rogers J, Dunham I: DNA sequence and analysis of human chromosome 9. Nature. 2004 May 27;429(6990):369-74. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Chen R, Jiang X, Sun D, Han G, Wang F, Ye M, Wang L, Zou H: Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009 Feb;8(2):651-61. doi: 10.1021/pr8008012. [Article] Lin DY, Tanaka Y, Iwasaki M, Gittis AG, Su HP, Mikami B, Okazaki T, Honjo T, Minato N, Garboczi DN: The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors. Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3011-6. doi: 10.1073/pnas.0712278105. Epub 2008 Feb 14. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB11595Atezolizumabapproved, investigationalyesinhibitorantibodyDetailsDB11945Avelumabapproved, investigationalyesinhibitorantibodyDetailsDB11714Durvalumabapproved, investigationalyesinhibitorantibodyDetailsDB15769EnvafolimabinvestigationalunknowninhibitorantibodyDetailsDB15770CosibelimabinvestigationalunknowninhibitorantibodyDetailsDB15771AUNP-12investigationalunknowninhibitorantibodyDetailsDB15772CA-170investigationalunknowninhibitorDetailsDB15773anti-OX40 antibody BMS 986178investigationalunknowninhibitorDetailsDB00313Valproic acidapproved, investigationalunknowndownregulatorDetailsDB00203Sildenafilapproved, investigationalunknowndownregulatorDetailsDB14776CamrelizumabinvestigationalunknowninhibitorantibodyDetailsDB09035NivolumabapprovedunknowninhibitorantibodyDetailsDB09037PembrolizumabapprovedunknowninhibitorantibodyDetails"
                    }
                }
            ],
            "enzymes": [
                {
                    "Label": "Cytochrome P450 3A4",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 3A4",
                        "Synonyms": "1,8-cineole 2-exo-monooxygenase\n1.14.13.-\nAlbendazole monooxygenase\nAlbendazole sulfoxidase\nCholesterol 25-hydroxylase\nCYP3A3\nCYPIIIA3\nCYPIIIA4\nCytochrome P450 3A3\nCytochrome P450 HLp\nCytochrome P450 NF-25\nCytochrome P450-PCN1\nNifedipine oxidase\nQuinine 3-monooxygenase\nTaurochenodeoxycholate 6-alpha-hydroxylase",
                        "Gene Name": "CYP3A4",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0021936|Cytochrome P450 3A4\nMALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMF\nDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISI\nAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYS\nMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICV\nFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSI\nIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVV\nNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFS\nKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLG\nGLLQPEKPVVLKVESRDGTVSGA",
                        "Number of residues": "503",
                        "Molecular Weight": "57342.67",
                        "Theoretical pI": "8.25",
                        "GO Classification": "Functionsalbendazole monooxygenase activity / aromatase activity / caffeine oxidase activity / enzyme binding / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity / oxygen binding / quinine 3-monooxygenase activity / steroid binding / steroid hydroxylase activity / taurochenodeoxycholate 6alpha-hydroxylase activity / testosterone 6-beta-hydroxylase activity / vitamin D 24-hydroxylase activity / vitamin D3 25-hydroxylase activityProcessesalkaloid catabolic process / androgen metabolic process / calcitriol biosynthetic process from calciol / drug catabolic process / drug metabolic process / exogenous drug catabolic process / heterocycle metabolic process / lipid metabolic process / monoterpenoid metabolic process / oxidation-reduction process / oxidative demethylation / small molecule metabolic process / steroid catabolic process / steroid metabolic process / vitamin D metabolic process / xenobiotic metabolic processComponentscytoplasm / endoplasmic reticulum membrane / integral component of membrane / intracellular membrane-bounded organelle",
                        "General Function": "Vitamin d3 25-hydroxylase activity",
                        "Specific Function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation reactions (e.g. caffeine 8-oxidation, omeprazole sulphoxidation, midazolam 1'-hydroxylation and midazolam 4-hydroxylation) of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,8-cineole 2-exo-monooxygenase. The enzyme also hydroxylates etoposide (PubMed:11159812). Catalyzes 4-beta-hydroxylation of cholesterol. May catalyze 25-hydroxylation of cholesterol in vitro (PubMed:21576599).",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "2-22",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0021937|Cytochrome P450 3A4 (CYP3A4)\nATGGCTCTCATCCCAGACTTGGCCATGGAAACCTGGCTTCTCCTGGCTGTCAGCCTGGTG\nCTCCTCTATCTATATGGAACCCATTCACATGGACTTTTTAAGAAGCTTGGAATTCCAGGG\nCCCACACCTCTGCCTTTTTTGGGAAATATTTTGTCCTACCATAAGGGCTTTTGTATGTTT\nGACATGGAATGTCATAAAAAGTATGGAAAAGTGTGGGGCTTTTATGATGGTCAACAGCCT\nGTGCTGGCTATCACAGATCCTGACATGATCAAAACAGTGCTAGTGAAAGAATGTTATTCT\nGTCTTCACAAACCGGAGGCCTTTTGGTCCAGTGGGATTTATGAAAAGTGCCATCTCTATA\nGCTGAGGATGAAGAATGGAAGAGATTACGATCATTGCTGTCTCCAACCTTCACCAGTGGA\nAAACTCAAGGAGATGGTCCCTATCATTGCCCAGTATGGAGATGTGTTGGTGAGAAATCTG\nAGGCGGGAAGCAGAGACAGGCAAGCCTGTCACCTTGAAAGACGTCTTTGGGGCCTACAGC\nATGGATGTGATCACTAGCACATCATTTGGAGTGAACATCGACTCTCTCAACAATCCACAA\nGACCCCTTTGTGGAAAACACCAAGAAGCTTTTAAGATTTGATTTTTTGGATCCATTCTTT\nCTCTCAATAATCTTTCCATTCCTCATCCCAATTCTTGAAGTATTAAATATCTGTGTGTTT\nCCAAGAGAAGTTACAAATTTTTTAAGAAAATCTGTAAAAAGGATGAAAGAAAGTCGCCTC\nGAAGATACACAAAAGCACCGAGTGGATTTCCTTCAGCTGATGATTGACTCTCAGAATTCA\nAAAGAAACTGAGTCCCACAAAGCTCTGTCCGATCTGGAGCTCGTGGCCCAATCAATTATC\nTTTATTTTTGCTGGCTATGAAACCACGAGCAGTGTTCTCTCCTTCATTATGTATGAACTG\nGCCACTCACCCTGATGTCCAGCAGAAACTGCAGGAGGAAATTGATGCAGTTTTACCCAAT\nAAGGCACCACCCACCTATGATACTGTGCTACAGATGGAGTATCTTGACATGGTGGTGAAT\nGAAACGCTCAGATTATTCCCAATTGCTATGAGACTTGAGAGGGTCTGCAAAAAAGATGTT\nGAGATCAATGGGATGTTCATTCCCAAAGGGGTGGTGGTGATGATTCCAAGCTATGCTCTT\nCACCGTGACCCAAAGTACTGGACAGAGCCTGAGAAGTTCCTCCCTGAAAGATTCAGCAAG\nAAGAACAAGGACAACATAGATCCTTACATATACACACCCTTTGGAAGTGGACCCAGAAAC\nTGCATTGGCATGAGGTTTGCTCTCATGAACATGAAACTTGCTCTAATCAGAGTCCTTCAG\nAACTTCTCCTTCAAACCTTGTAAAGAAACACAGATCCCCCTGAAATTAAGCTTAGGAGGA\nCTTCTTCAACCAGAAAAACCCGTTGTTCTAAAGGTTGAGTCAAGGGATGGCACCGTAAGT\nGGAGCCTGA",
                        "Chromosome Location": "7",
                        "Locus": "7q21.1",
                        "External Identifiers": "ResourceLinkUniProtKB IDP08684UniProtKB Entry NameCP3A4_HUMANGenBank Gene IDM18907GenAtlas IDCYP3A4HGNC IDHGNC:2637",
                        "General References": "Molowa DT, Schuetz EG, Wrighton SA, Watkins PB, Kremers P, Mendez-Picon G, Parker GA, Guzelian PS: Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver. Proc Natl Acad Sci U S A. 1986 Jul;83(14):5311-5. [Article] Gonzalez FJ, Schmid BJ, Umeno M, Mcbride OW, Hardwick JP, Meyer UA, Gelboin HV, Idle JR: Human P450PCN1: sequence, chromosome localization, and direct evidence through cDNA expression that P450PCN1 is nifedipine oxidase. DNA. 1988 Mar;7(2):79-86. [Article] Beaune PH, Umbenhauer DR, Bork RW, Lloyd RS, Guengerich FP: Isolation and sequence determination of a cDNA clone related to human cytochrome P-450 nifedipine oxidase. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8064-8. [Article] Spurr NK, Gough AC, Stevenson K, Wolf CR: The human cytochrome P450 CYP3 locus: assignment to chromosome 7q22-qter. Hum Genet. 1989 Jan;81(2):171-4. [Article] Bork RW, Muto T, Beaune PH, Srivastava PK, Lloyd RS, Guengerich FP: Characterization of mRNA species related to human liver cytochrome P-450 nifedipine oxidase and the regulation of catalytic activity. J Biol Chem. 1989 Jan 15;264(2):910-9. [Article] Chen Q, Wu J, Yu Y: [Establishment of transgenic cell line CHL-3A4 and its metabolic activation]. Zhonghua Yu Fang Yi Xue Za Zhi. 1998 Sep;32(5):281-4. [Article] Gellner K, Eiselt R, Hustert E, Arnold H, Koch I, Haberl M, Deglmann CJ, Burk O, Buntefuss D, Escher S, Bishop C, Koebe HG, Brinkmann U, Klenk HP, Kleine K, Meyer UA, Wojnowski L: Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics. 2001 Mar;11(2):111-21. [Article] Hsieh KP, Lin YY, Cheng CL, Lai ML, Lin MS, Siest JP, Huang JD: Novel mutations of CYP3A4 in Chinese. Drug Metab Dispos. 2001 Mar;29(3):268-73. [Article] Komori M, Hashizume T, Ohi H, Miura T, Kitada M, Nagashima K, Kamataki T: Cytochrome P-450 in human liver microsomes: high-performance liquid chromatographic isolation of three forms and their characterization. J Biochem. 1988 Dec;104(6):912-6. [Article] Watkins PB, Wrighton SA, Maurel P, Schuetz EG, Mendez-Picon G, Parker GA, Guzelian PS: Identification of an inducible form of cytochrome P-450 in human liver. Proc Natl Acad Sci U S A. 1985 Sep;82(18):6310-4. [Article] Aoyama T, Yamano S, Waxman DJ, Lapenson DP, Meyer UA, Fischer V, Tyndale R, Inaba T, Kalow W, Gelboin HV, et al.: Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. J Biol Chem. 1989 Jun 25;264(18):10388-95. [Article] Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP: Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther. 1994 Jul;270(1):414-23. [Article] Kolars JC, Lown KS, Schmiedlin-Ren P, Ghosh M, Fang C, Wrighton SA, Merion RM, Watkins PB: CYP3A gene expression in human gut epithelium. Pharmacogenetics. 1994 Oct;4(5):247-59. [Article] Zhang H, Coville PF, Walker RJ, Miners JO, Birkett DJ, Wanwimolruk S: Evidence for involvement of human CYP3A in the 3-hydroxylation of quinine. Br J Clin Pharmacol. 1997 Mar;43(3):245-52. [Article] Zhao XJ, Kawashiro T, Ishizaki T: Mutual inhibition between quinine and etoposide by human liver microsomes. Evidence for cytochrome P4503A4 involvement in their major metabolic pathways. Drug Metab Dispos. 1998 Feb;26(2):188-91. [Article] Miyazawa M, Shindo M, Shimada T: Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes. Drug Metab Dispos. 2001 Feb;29(2):200-5. [Article] Finta C, Zaphiropoulos PG: Intergenic mRNA molecules resulting from trans-splicing. J Biol Chem. 2002 Feb 22;277(8):5882-90. Epub 2001 Nov 28. [Article] Dauchy S, Dutheil F, Weaver RJ, Chassoux F, Daumas-Duport C, Couraud PO, Scherrmann JM, De Waziers I, Decleves X: ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J Neurochem. 2008 Dec;107(6):1518-28. doi: 10.1111/j.1471-4159.2008.05720.x. [Article] Agarwal V, Kommaddi RP, Valli K, Ryder D, Hyde TM, Kleinman JE, Strobel HW, Ravindranath V: Drug metabolism in human brain: high levels of cytochrome P4503A43 in brain and metabolism of anti-anxiety drug alprazolam to its active metabolite. PLoS One. 2008 Jun 11;3(6):e2337. doi: 10.1371/journal.pone.0002337. [Article] Pabarcus MK, Hoe N, Sadeghi S, Patterson C, Wiertz E, Correia MA: CYP3A4 ubiquitination by gp78 (the tumor autocrine motility factor receptor, AMFR) and CHIP E3 ligases. Arch Biochem Biophys. 2009 Mar 1;483(1):66-74. doi: 10.1016/j.abb.2008.12.001. Epub 2008 Dec 10. [Article] Dutheil F, Dauchy S, Diry M, Sazdovitch V, Cloarec O, Mellottee L, Bieche I, Ingelman-Sundberg M, Flinois JP, de Waziers I, Beaune P, Decleves X, Duyckaerts C, Loriot MA: Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function. Drug Metab Dispos. 2009 Jul;37(7):1528-38. doi: 10.1124/dmd.109.027011. Epub 2009 Apr 9. [Article] Honda A, Miyazaki T, Ikegami T, Iwamoto J, Maeda T, Hirayama T, Saito Y, Teramoto T, Matsuzaki Y: Cholesterol 25-hydroxylation activity of CYP3A. J Lipid Res. 2011 Aug;52(8):1509-16. doi: 10.1194/jlr.M014084. Epub 2011 May 16. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Yano JK, Wester MR, Schoch GA, Griffin KJ, Stout CD, Johnson EF: The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-A resolution. J Biol Chem. 2004 Sep 10;279(37):38091-4. Epub 2004 Jul 16. [Article] Williams PA, Cosme J, Vinkovic DM, Ward A, Angove HC, Day PJ, Vonrhein C, Tickle IJ, Jhoti H: Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone. Science. 2004 Jul 30;305(5684):683-6. Epub 2004 Jul 15. [Article] Sata F, Sapone A, Elizondo G, Stocker P, Miller VP, Zheng W, Raunio H, Crespi CL, Gonzalez FJ: CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activity. Clin Pharmacol Ther. 2000 Jan;67(1):48-56. [Article] Dai D, Tang J, Rose R, Hodgson E, Bienstock RJ, Mohrenweiser HW, Goldstein JA: Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos. J Pharmacol Exp Ther. 2001 Dec;299(3):825-31. [Article] Eiselt R, Domanski TL, Zibat A, Mueller R, Presecan-Siedel E, Hustert E, Zanger UM, Brockmoller J, Klenk HP, Meyer UA, Khan KK, He YA, Halpert JR, Wojnowski L: Identification and functional characterization of eight CYP3A4 protein variants. Pharmacogenetics. 2001 Jul;11(5):447-58. [Article] Lamba JK, Lin YS, Thummel K, Daly A, Watkins PB, Strom S, Zhang J, Schuetz EG: Common allelic variants of cytochrome P4503A4 and their prevalence in different populations. Pharmacogenetics. 2002 Mar;12(2):121-32. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB05478Pradefovir mesylateinvestigationalunknownDetailsDB00180Flunisolideapproved, investigationalunknownsubstrateinducerDetailsDB00185CevimelineapprovedunknownsubstrateDetailsDB00188Bortezomibapproved, investigationalnosubstrateDetailsDB00196Fluconazoleapproved, investigationalunknowninhibitorDetailsDB00204Dofetilideapproved, investigationalunknownsubstrateDetailsDB00213PantoprazoleapprovedunknownsubstrateDetailsDB00216Eletriptanapproved, investigationalunknownsubstrateDetailsDB00220NelfinavirapprovednosubstrateinhibitorDetailsDB00224IndinavirapprovedunknownsubstrateinhibitorDetailsDB00227Lovastatinapproved, investigationalunknownsubstrateinhibitorDetailsDB00234Reboxetineapproved, experimentalunknownsubstrateinhibitorDetailsDB00238NevirapineapprovedunknownsubstrateinducerDetailsDB00243Ranolazineapproved, investigationalnosubstrateinhibitorDetailsDB00246ZiprasidoneapprovedunknownsubstrateDetailsDB00270Isradipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00280DisopyramideapprovedunknownsubstrateDetailsDB00286Conjugated estrogensapprovednosubstrateDetailsDB00294Etonogestrelapproved, investigationalnosubstrateDetailsDB00297Bupivacaineapproved, investigationalunknownsubstrateDetailsDB00307Bexaroteneapproved, investigationalunknownsubstrateinducerDetailsDB00309Vindesineapproved, investigationalunknownsubstrateDetailsDB00317Gefitinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00320Dihydroergotamineapproved, investigationalunknownsubstrateinhibitorDetailsDB00324Fluorometholoneapproved, investigationalunknownsubstrateinducerDetailsDB00342Terfenadineapproved, withdrawnunknownsubstrateinhibitorDetailsDB00343Diltiazemapproved, investigationalunknownsubstrateinhibitorDetailsDB00346Alfuzosinapproved, investigationalunknownsubstrateDetailsDB00361Vinorelbineapproved, investigationalnosubstrateDetailsDB00365Grepafloxacinapproved, investigational, withdrawnunknownsubstrateDetailsDB00370MirtazapineapprovedunknownsubstrateinhibitorDetailsDB00381AmlodipineapprovednosubstrateDetailsDB00393Nimodipineapproved, investigationalunknownsubstrateDetailsDB00398Sorafenibapproved, investigationalunknownsubstrateinhibitorDetailsDB00401NisoldipineapprovedunknownsubstrateDetailsDB00402Eszopicloneapproved, investigationalunknownsubstrateDetailsDB00404Alprazolamapproved, illicit, investigationalunknownsubstrateDetailsDB00425ZolpidemapprovedunknownsubstrateDetailsDB00443Betamethasoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00455Loratadineapproved, investigationalnosubstrateinhibitorDetailsDB00468QuinineapprovedunknownsubstrateinhibitorinducerDetailsDB00470Dronabinolapproved, illicitnosubstrateinhibitorDetailsDB00471MontelukastapprovedunknownsubstrateDetailsDB00490Buspironeapproved, investigationalunknownsubstrateDetailsDB00496Darifenacinapproved, investigationalunknownsubstrateDetailsDB00518Albendazoleapproved, vet_approvedunknownsubstrateDetailsDB00528Lercanidipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00533Rofecoxibapproved, investigational, withdrawnunknownsubstrateinducerDetailsDB00539Toremifeneapproved, investigationalunknownsubstrateinhibitorDetailsDB00541Vincristineapproved, investigationalunknownsubstrateDetailsDB00559Bosentanapproved, investigationalunknownsubstrateinducerDetailsDB00570VinblastineapprovedunknownsubstrateinhibitorinducerDetailsDB00582VoriconazoleapprovedunknownsubstrateinhibitorDetailsDB00588Fluticasone propionateapprovedunknownsubstrateinhibitorDetailsDB00593EthosuximideapprovedunknownsubstrateDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknownsubstrateinducerDetailsDB00604Cisaprideapproved, investigational, withdrawnunknownsubstrateDetailsDB00615Rifabutinapproved, investigationalunknownsubstrateinducerDetailsDB00619ImatinibapprovednosubstrateinhibitorDetailsDB00622Nicardipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00624Testosteroneapproved, investigationalunknownsubstrateinducerDetailsDB00625Efavirenzapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00635Prednisoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00636Clofibrateapproved, investigationalunknownsubstrateinducerDetailsDB00637Astemizoleapproved, withdrawnunknownsubstrateinhibitorDetailsDB00641SimvastatinapprovedunknownsubstrateDetailsDB00673Aprepitantapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00674GalantamineapprovednosubstrateDetailsDB00675TamoxifenapprovedunknownsubstrateinhibitorinducerDetailsDB00678LosartanapprovedunknownsubstrateinhibitorDetailsDB00683Midazolamapproved, illicitunknownsubstrateinhibitorDetailsDB00696ErgotamineapprovedunknownsubstrateinhibitorDetailsDB00700EplerenoneapprovedunknownsubstrateDetailsDB00701Amprenavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00705DelavirdineapprovedunknownsubstrateinhibitorDetailsDB00731Nateglinideapproved, investigationalunknownsubstrateDetailsDB00736Esomeprazoleapproved, investigationalunknownsubstrateDetailsDB00741Hydrocortisoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00744Zileutonapproved, investigational, withdrawnunknownsubstrateDetailsDB00745Modafinilapproved, investigationalunknownsubstrateinducerDetailsDB00757Dolasetronapproved, investigationalunknownsubstrateDetailsDB00758ClopidogrelapprovednosubstrateDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateinhibitorDetailsDB00769HydrocortamateapprovedunknowninducerDetailsDB00773EtoposideapprovedunknownsubstrateinhibitorinducerDetailsDB00778Roxithromycinapproved, investigational, withdrawnnosubstrateinhibitorDetailsDB00802Alfentanilapproved, illicitunknownsubstrateDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB00820Tadalafilapproved, investigationalnosubstrateDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00834Mifepristoneapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00836LoperamideapprovedunknownsubstrateinhibitorDetailsDB00843DonepezilapprovedunknownsubstrateDetailsDB00860Prednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB00862VardenafilapprovedunknownsubstrateinhibitorDetailsDB00864Tacrolimusapproved, investigationalunknownsubstrateDetailsDB00872Conivaptanapproved, investigationalunknownsubstrateinhibitorDetailsDB00877Sirolimusapproved, investigationalnosubstrateDetailsDB00889Granisetronapproved, investigationalunknownsubstrateDetailsDB00897Triazolamapproved, investigationalunknownsubstrateDetailsDB00904Ondansetronapproved, withdrawnunknownsubstrateDetailsDB00906Tiagabineapproved, investigationalunknownsubstrateDetailsDB00907Cocaineapproved, illicitunknownsubstrateDetailsDB00909Zonisamideapproved, investigationalunknownsubstrateDetailsDB00910Paricalcitolapproved, investigationalunknownsubstrateDetailsDB00911Tinidazoleapproved, investigationalunknownsubstrateDetailsDB00918Almotriptanapproved, investigationalunknownsubstrateDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00932Tipranavirapproved, investigationalunknownsubstrateinhibitorDetailsDB00938SalmeterolapprovedunknownsubstrateDetailsDB00956Hydrocodoneapproved, illicit, investigationalunknownsubstrateDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB00962Zaleplonapproved, illicit, investigationalunknownsubstrateDetailsDB00976TelithromycinapprovedunknownsubstrateinhibitorDetailsDB00977EthinylestradiolapprovedunknownsubstrateDetailsDB00990Exemestaneapproved, investigationalunknownsubstrateDetailsDB00997Doxorubicinapproved, investigationalnosubstrateinhibitorDetailsDB01002Levobupivacaineapproved, investigationalunknownsubstrateDetailsDB01006Letrozoleapproved, investigationalunknownsubstrateDetailsDB01008Busulfanapproved, investigationalunknownsubstrateDetailsDB01012CinacalcetapprovedunknownsubstrateDetailsDB01023Felodipineapproved, investigationalunknownsubstrateDetailsDB01026Ketoconazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB01045RifampicinapprovedunknowninducerDetailsDB01054Nitrendipineapproved, investigationalunknownsubstrateDetailsDB01062Oxybutyninapproved, investigationalunknownsubstrateinhibitorDetailsDB01068Clonazepamapproved, illicitunknownsubstrateDetailsDB01072Atazanavirapproved, investigationalnosubstrateinhibitorDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB01100PimozideapprovedunknownsubstrateDetailsDB01105Sibutramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB01114ChlorpheniramineapprovedunknownsubstrateDetailsDB01115NifedipineapprovedunknownsubstrateinhibitorinducerDetailsDB01129Rabeprazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB01132Pioglitazoneapproved, investigationalunknownsubstrateinducerDetailsDB01149Nefazodoneapproved, withdrawnunknownsubstrateinhibitorDetailsDB01166Cilostazolapproved, investigationalunknownsubstrateDetailsDB01167Itraconazoleapproved, investigationalnosubstrateinhibitorDetailsDB01175EscitalopramapprovednosubstrateDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB01190Clindamycinapproved, vet_approvedunknownsubstrateinhibitorDetailsDB01200Bromocriptineapproved, investigational, withdrawnnosubstrateinhibitorDetailsDB01206Lomustineapproved, investigationalunknowninhibitorDetailsDB01211ClarithromycinapprovedunknownsubstrateinhibitorDetailsDB01215Estazolamapproved, illicitunknownsubstrateDetailsDB01216FinasterideapprovedunknownsubstrateDetailsDB01218HalofantrineapprovedunknownsubstrateDetailsDB01222BudesonideapprovednosubstrateinducerDetailsDB01224QuetiapineapprovedunknownsubstrateDetailsDB01227Levacetylmethadolapproved, investigational, withdrawnunknownsubstrateDetailsDB01229Paclitaxelapproved, vet_approvedunknownsubstrateinducerDetailsDB01232Saquinavirapproved, investigationalunknownsubstrateinhibitorDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB01238Aripiprazoleapproved, investigationalnosubstrateDetailsDB01254Dasatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB01256RetapamulinapprovedunknownsubstrateDetailsDB01261Sitagliptinapproved, investigationalunknownsubstrateDetailsDB01259Lapatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB01264DarunavirapprovedunknownsubstrateinhibitorDetailsDB01268Sunitinibapproved, investigationalnosubstrateinhibitorDetailsDB01263Posaconazoleapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB01388Mibefradilinvestigational, withdrawnunknownsubstrateinhibitorDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknowninducerDetailsDB01601LopinavirapprovedunknownsubstrateinhibitorDetailsDB01411PranlukastinvestigationalnosubstrateDetailsDB01410Ciclesonideapproved, investigationalnosubstrateDetailsDB00969Alosetronapproved, withdrawnunknownsubstrateDetailsDB04835Maravirocapproved, investigationalunknownsubstrateDetailsDB01409TiotropiumapprovedunknownsubstrateDetailsDB01591SolifenacinapprovednosubstrateDetailsDB01011Metyraponeapproved, investigationalunknowninhibitorinducerDetailsDB00377Palonosetronapproved, investigationalunknownsubstrateDetailsDB04856DexloxiglumideinvestigationalunknownsubstrateDetailsDB04886Calanolide AinvestigationalunknownsubstrateDetailsDB00580Valdecoxibapproved, investigational, withdrawnunknownsubstrateDetailsDB06144Sertindoleapproved, investigational, withdrawnunknownsubstrateDetailsDB04977PlitidepsininvestigationalunknownsubstrateDetailsDB04905TesmilifeneinvestigationalunknownsubstrateinhibitorinducerDetailsDB00333MethadoneapprovedunknownsubstrateinhibitorinducerDetailsDB04934RifalazilinvestigationalunknownsubstrateDetailsDB04957AzimilideinvestigationalunknownsubstrateDetailsDB00199Erythromycinapproved, investigational, vet_approvednosubstrateinhibitorDetailsDB01628Etoricoxibapproved, investigationalunknownsubstrateinhibitorDetailsDB00564Carbamazepineapproved, investigationalunknownsubstrateinducerDetailsDB06155Rimonabantapproved, investigationalunknownsubstrateDetailsDB06267Udenafilapproved, investigationalunknownsubstrateDetailsDB06287TemsirolimusapprovedunknownsubstrateDetailsDB06442AvasimibeinvestigationalunknowninducerDetailsDB08502CapravirineinvestigationalunknownsubstrateDetailsDB06652VicrivirocinvestigationalunknownsubstrateDetailsDB06685LaquinimodinvestigationalunknownsubstrateDetailsDB01095FluvastatinapprovedunknownsubstrateinhibitorDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateDetailsDB00248CabergolineapprovedunknownsubstrateDetailsDB00589Lisurideapproved, investigationalunknownsubstrateDetailsDB01186Pergolideapproved, investigational, vet_approved, withdrawnunknowninhibitorDetailsDB05271RotigotineapprovedunknownsubstrateDetailsDB00439Cerivastatinapproved, withdrawnunknownsubstrateinhibitorinducerDetailsDB00257Clotrimazoleapproved, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00734Risperidoneapproved, investigationalunknownsubstrateDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB01037Selegilineapproved, investigational, vet_approvedunknownsubstrateDetailsDB01159Halothaneapproved, vet_approvedunknownsubstrateDetailsDB01181IfosfamideapprovedunknownsubstrateinhibitorinducerDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB00814Meloxicamapproved, vet_approvedunknownsubstrateDetailsDB00908Quinidineapproved, investigationalunknownsubstrateinhibitorDetailsDB00656Trazodoneapproved, investigationalunknownsubstrateDetailsDB00176Fluvoxamineapproved, investigationalunknownsubstrateinhibitorDetailsDB00321AmitriptylineapprovedunknownsubstrateDetailsDB00540NortriptylineapprovedunknownsubstrateDetailsDB00215CitalopramapprovednosubstrateinhibitorDetailsDB00924CyclobenzaprineapprovedunknownsubstrateDetailsDB00472Fluoxetineapproved, vet_approvednosubstrateinhibitorDetailsDB01104SertralineapprovedunknownsubstrateinhibitorDetailsDB06148Mianserinapproved, investigationalunknownsubstrateDetailsDB01435Antipyrineapproved, investigationalunknownsubstrateDetailsDB01118Amiodaroneapproved, investigationalnosubstrateinhibitorDetailsDB00250Dapsoneapproved, investigationalunknownsubstrateDetailsDB00531Cyclophosphamideapproved, investigationalunknownsubstrateinducerDetailsDB05109Trabectedinapproved, investigationalunknownsubstrateDetailsDB00946Phenprocoumonapproved, investigationalunknownsubstrateDetailsDB00682WarfarinapprovedunknownsubstrateinducerDetailsDB00285VenlafaxineapprovedunknownsubstrateDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB00972AzelastineapprovedunknownsubstrateinhibitorDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00661VerapamilapprovedunknownsubstrateinhibitorDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateinducerDetailsDB00201CaffeineapprovedunknownsubstrateDetailsDB00318Codeineapproved, illicitunknownsubstrateDetailsDB00514DextromethorphanapprovedunknownsubstrateDetailsDB01248Docetaxelapproved, investigationalunknownsubstrateinhibitorDetailsDB00502HaloperidolapprovedunknownsubstrateinhibitorDetailsDB00281Lidocaineapproved, vet_approvedunknownsubstrateDetailsDB00571Propranololapproved, investigationalunknownsubstrateDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00446Chloramphenicolapproved, vet_approved, withdrawnunknowninhibitorDetailsDB00537Ciprofloxacinapproved, investigationalunknowninhibitorDetailsDB01059NorfloxacinapprovedunknowninhibitorDetailsDB06403Ambrisentanapproved, investigationalunknownsubstrateDetailsDB06413Armodafinilapproved, investigationalunknowninducerDetailsDB00865Benzphetamineapproved, illicitunknownsubstrateDetailsDB00612BisoprololapprovedunknownsubstrateDetailsDB00136Calcitriolapproved, nutraceuticalunknownsubstrateinducerDetailsDB00608Chloroquineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00349Clobazamapproved, illicitnosubstrateinducerDetailsDB00628Clorazepic acidapproved, illicitunknownsubstrateDetailsDB01396Digitoxinapproved, investigationalunknownsubstrateDetailsDB04855DronedaroneapprovedunknownsubstrateinhibitorDetailsDB04574Estrone sulfateapprovedunknownsubstrateDetailsDB06414EtravirineapprovedunknownsubstrateinducerDetailsDB01590EverolimusapprovedunknownsubstrateDetailsDB00949FelbamateapprovedunknownsubstrateinducerDetailsDB06702FesoterodineapprovedunknownsubstrateDetailsDB00690Flurazepamapproved, illicit, investigationalunknownsubstrateDetailsDB00499Flutamideapproved, investigationalunknownsubstrateDetailsDB01018Guanfacineapproved, investigationalunknownsubstrateDetailsDB04845Ixabepiloneapproved, investigationalunknownsubstrateDetailsDB00448Lansoprazoleapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00367Levonorgestrelapproved, investigationalunknownsubstrateDetailsDB00358Mefloquineapproved, investigationalunknownsubstrateinhibitorDetailsDB04868Nilotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB06712Nilvadipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00497Oxycodoneapproved, illicit, investigationalunknownsubstrateDetailsDB06589PazopanibapprovedunknownsubstrateinhibitorDetailsDB01621Pipotiazineapproved, investigationalunknownsubstrateDetailsDB01058Praziquantelapproved, investigational, vet_approvedunknownsubstrateDetailsDB01087PrimaquineapprovedunknownsubstrateinhibitorDetailsDB00647Dextropropoxypheneapproved, illicit, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00912Repaglinideapproved, investigationalunknownsubstrateDetailsDB06228RivaroxabanapprovedunknownsubstrateDetailsDB06176Romidepsinapproved, investigationalunknownsubstrateDetailsDB06207SilodosinapprovedunknownsubstrateDetailsDB00706Tamsulosinapproved, investigationalunknownsubstrateDetailsDB00444TeniposideapprovedunknownsubstrateinhibitorDetailsDB00759Tetracyclineapproved, vet_approved, withdrawnunknownsubstrateinhibitorDetailsDB00277TheophyllineapprovedunknownsubstrateDetailsDB01036Tolterodineapproved, investigationalunknownsubstrateDetailsDB06212TolvaptanapprovedunknownsubstrateDetailsDB00193Tramadolapproved, investigationalunknownsubstrateDetailsDB00440Trimethoprimapproved, vet_approvedunknownsubstrateDetailsDB01198ZopicloneapprovedunknownsubstrateDetailsDB00357Aminoglutethimideapproved, investigationalunknowninducerDetailsDB01320Fosphenytoinapproved, investigationalunknownsubstrateinducerDetailsDB00607Nafcillinapproved, investigationalunknowninducerDetailsDB00776OxcarbazepineapprovedunknowninhibitorinducerDetailsDB00312Pentobarbitalapproved, investigational, vet_approvedunknowninducerDetailsDB01174Phenobarbitalapproved, investigationalunknowninducerDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinducerDetailsDB00794Primidoneapproved, vet_approvedunknowninducerDetailsDB01201Rifapentineapproved, investigationalunknownsubstrateinducerDetailsDB01394ColchicineapprovedunknownsubstrateinhibitorDetailsDB01253ErgometrineapprovedunknownsubstrateDetailsDB01221Ketamineapproved, vet_approvedunknownsubstrateinducerDetailsDB00353MethylergometrineapprovedunknownsubstrateinhibitorDetailsDB06335SaxagliptinapprovedunknownsubstrateDetailsDB00708Sufentanilapproved, investigationalunknownsubstrateDetailsDB01128BicalutamideapprovedunknownsubstrateinhibitorDetailsDB01151Desipramineapproved, investigationalunknowninhibitorDetailsDB00916MetronidazoleapprovedunknowninhibitorDetailsDB06268Sitaxentanapproved, investigational, withdrawnunknowninhibitorDetailsDB01424Aminophenazoneapproved, withdrawnunknownsubstrateDetailsDB00363ClozapineapprovednosubstrateinhibitorinducerDetailsDB00420Promazineapproved, vet_approvedunknownsubstrateDetailsDB01136Carvedilolapproved, investigationalunknownsubstrateDetailsDB00549Zafirlukastapproved, investigationalunknownsubstrateinhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00482Celecoxibapproved, investigationalunknownsubstrateDetailsDB01016GlyburideapprovedunknownsubstrateinhibitorDetailsDB01138SulfinpyrazoneapprovedunknownsubstrateinducerDetailsDB06739SeratrodastexperimentalunknownsubstrateinducerDetailsDB06738KetobemidoneinvestigationalunknownsubstrateDetailsDB01242Clomipramineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00655EstroneapprovednosubstrateDetailsDB00458ImipramineapprovedunknownsubstrateDetailsDB00546AdinazolamexperimentalunknownsubstrateDetailsDB00231Temazepamapproved, investigationalunknownsubstrateDetailsDB03701VanoxerineinvestigationalunknownsubstrateDetailsDB00169Cholecalciferolapproved, nutraceuticalunknownsubstrateDetailsDB01192Oxymorphoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB01173OrphenadrineapprovedunknownsubstrateinhibitorDetailsDB06772CabazitaxelapprovedunknownsubstrateDetailsDB02709ResveratrolinvestigationalnoinhibitorDetailsDB06700Desvenlafaxineapproved, investigationalnosubstrateinhibitorDetailsDB06697ArtemetherapprovedunknownsubstrateinducerDetailsDB06708LumefantrineapprovedunknownsubstrateDetailsDB00819Acetazolamideapproved, vet_approvedunknowninhibitorDetailsDB06742Ambroxolapproved, investigationalunknownsubstrateDetailsDB01223AminophyllineapprovedunknownsubstrateDetailsDB00278Argatrobanapproved, investigationalunknownsubstrateDetailsDB01169Arsenic trioxideapproved, investigationalunknowninhibitorDetailsDB00207AzithromycinapprovedunknownsubstrateinhibitorDetailsDB01393Bezafibrateapproved, investigationalunknownsubstrateDetailsDB04794Bifonazoleapproved, investigationalunknowninhibitorDetailsDB01194BrinzolamideapprovednosubstrateDetailsDB00520CaspofunginapprovedunknowninhibitorDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknowninducerDetailsDB00356ChlorzoxazoneapprovedunknownsubstrateinhibitorDetailsDB00845Clofazimineapproved, investigationalunknowninhibitorDetailsDB06470ClomethiazoleinvestigationalunknownsubstrateDetailsDB01559Clotiazepamapproved, illicitunknownsubstrateDetailsDB00987Cytarabineapproved, investigationalunknownsubstrateDetailsDB01406DanazolapprovedunknowninhibitorDetailsDB00694DaunorubicinapprovedunknownsubstrateinhibitorDetailsDB01093Dimethyl sulfoxideapproved, vet_approvedunknowninhibitorDetailsDB00822DisulfiramapprovedunknownsubstrateDetailsDB00254Doxycyclineapproved, investigational, vet_approvedunknowninhibitorDetailsDB01127EconazoleapprovednoinhibitorDetailsDB00751Epinastineapproved, investigationalunknownsubstrateDetailsDB00668Epinephrineapproved, vet_approvedunknowninhibitorDetailsDB01196Estramustineapproved, investigationalunknownsubstrateDetailsDB00898EthanolapprovedunknownsubstrateinhibitorinducerDetailsDB01466Ethylmorphineexperimental, illicitunknownsubstrateDetailsDB00301Flucloxacillinapproved, investigationalunknownsubstrateinducerDetailsDB01544Flunitrazepamapproved, illicitunknownsubstrateDetailsDB00947Fulvestrantapproved, investigationalunknownsubstrateDetailsDB01275HydralazineapprovednoinhibitorDetailsDB00724Imiquimodapproved, investigationalunknownsubstrateDetailsDB01029Irbesartanapproved, investigationalnoinhibitorDetailsDB00602Ivermectinapproved, investigational, vet_approvednosubstrateDetailsDB01103QuinacrineinvestigationalunknownsubstrateDetailsDB01071MequitazineexperimentalunknowninhibitorDetailsDB04817Metamizoleapproved, investigational, withdrawnunknowninducerDetailsDB04833Methaqualoneillicit, withdrawnunknownsubstrateDetailsDB01028Methoxyfluraneapproved, investigational, vet_approved, withdrawnunknownsubstrateDetailsDB06710MethyltestosteroneapprovedunknownsubstrateDetailsDB00379Mexiletineapproved, investigationalunknownsubstrateDetailsDB01204Mitoxantroneapproved, investigationalunknowninhibitorDetailsDB00295Morphineapproved, investigationalnosubstrateDetailsDB01183Naloxoneapproved, vet_approvedunknownsubstrateinhibitorDetailsDB02701Nicotinamideapproved, investigationalunknowninhibitorDetailsDB00184NicotineapprovedunknownsubstrateDetailsDB01595NitrazepamapprovedunknownsubstrateDetailsDB00768OlopatadineapprovednosubstrateDetailsDB00316AcetaminophenapprovedunknownsubstrateinducerDetailsDB01074Perhexilineapproved, investigationalunknownsubstrateDetailsDB00850PerphenazineapprovedunknownsubstrateDetailsDB00454MeperidineapprovedunknownsubstrateinducerDetailsDB03783PhenacetinwithdrawnunknownsubstrateDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB00812Phenylbutazoneapproved, vet_approvedunknowninducerDetailsDB01085Pilocarpineapproved, investigationalunknowninhibitorDetailsDB01588Prazepamapproved, illicitunknownsubstrateDetailsDB01032Probenecidapproved, investigationalunknowninducerDetailsDB01182PropafenoneapprovedunknownsubstrateDetailsDB01589Quazepamapproved, illicitnosubstrateDetailsDB00481Raloxifeneapproved, investigationalunknowninhibitorDetailsDB00863Ranitidineapproved, withdrawnunknowninhibitorDetailsDB01220Rifaximinapproved, investigationalunknownsubstrateinducerDetailsDB00296RopivacaineapprovedunknownsubstrateDetailsDB01698Rutinapproved, experimental, investigationalunknowninducerDetailsDB01001Salbutamolapproved, vet_approvedunknowninhibitorDetailsDB01236Sevofluraneapproved, vet_approvedunknownsubstrateDetailsDB00359Sulfadiazineapproved, investigational, vet_approvedunknownsubstrateDetailsDB01015SulfamethoxazoleapprovedunknownsubstrateDetailsDB01349TasosartanexperimentalunknownsubstrateDetailsDB00763MethimazoleapprovedunknowninhibitorDetailsDB04572Thiotepaapproved, investigationalunknownsubstrateDetailsDB01007TioconazoleapprovedunknowninhibitorDetailsDB00273TopiramateapprovedunknowninducerDetailsDB00347TrimethadioneapprovedunknownsubstrateDetailsDB13179TroleandomycinapprovedunknownsubstrateinhibitorDetailsDB00313Valproic acidapproved, investigationalunknowninhibitorDetailsDB01392Yohimbineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00495ZidovudineapprovedunknownsubstrateDetailsDB04828ZomepiracwithdrawnunknownsubstrateDetailsDB01380Cortisone acetateapproved, investigationalunknownsubstrateinducerDetailsDB01384ParamethasoneexperimentalunknownsubstrateinhibitorinducerDetailsDB01587KetazolamapprovedunknownsubstrateinhibitorDetailsDB08811TofisopamexperimentalunknowninhibitorDetailsDB00617ParamethadioneapprovedunknownsubstrateDetailsDB00755Tretinoinapproved, investigational, nutraceuticalunknownsubstrateDetailsDB00980Ramelteonapproved, investigationalunknownsubstrateDetailsDB04946IloperidoneapprovedunknownsubstrateDetailsDB01418Acenocoumarolapproved, investigationalunknownsubstrateDetailsDB06684VilazodoneapprovedunknownsubstrateDetailsDB00255Diethylstilbestrolapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00575ClonidineapprovedunknownsubstrateDetailsDB00973EzetimibeapprovedunknowninhibitorDetailsDB00400Griseofulvinapproved, investigational, vet_approvedunknowninducerDetailsDB00808IndapamideapprovedunknownsubstrateDetailsDB05521Telaprevirapproved, withdrawnunknownsubstrateinhibitorDetailsDB08820IvacaftorapprovednosubstrateinhibitorDetailsDB06634CasopitantinvestigationalunknownDetailsDB04975BanoxantroneinvestigationalunknownsubstrateDetailsDB05039IndacaterolapprovedunknownsubstrateDetailsDB08816TicagrelorapprovedunknownsubstrateinhibitorDetailsDB06774CapsaicinapprovedunknowninhibitorDetailsDB06174Noscapineapproved, investigationalunknowninhibitorDetailsDB01333CefradineapprovedunknowninducerDetailsDB06777Chenodeoxycholic acidapprovedunknownsubstrateDetailsDB00856Chlorphenesinapproved, experimentalunknowninducerDetailsDB04920Clevidipineapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB01764DalfopristinapprovedunknowninhibitorDetailsDB01609Deferasiroxapproved, investigationalunknowninducerDetailsDB00485Dicloxacillinapproved, investigational, vet_approvedunknowninducerDetailsDB06370IndisulaminvestigationalunknowninhibitorDetailsDB01083Orlistatapproved, investigationalunknowninducerDetailsDB00239OxiconazoleapprovedunknowninducerDetailsDB00082PegvisomantapprovedunknowninducerDetailsDB06762PinacidilapprovedunknownsubstrateDetailsDB01369QuinupristinapprovedunknowninhibitorDetailsDB00337Pimecrolimusapproved, investigationalunknownsubstrateDetailsDB00041AldesleukinapprovedunknowninhibitorDetailsDB06605ApixabanapprovednosubstrateDetailsDB08827Lomitapideapproved, investigationalnosubstrateDetailsDB08828Vismodegibapproved, investigationalnosubstrateDetailsDB00620Triamcinoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB08864RilpivirineapprovednosubstrateinhibitorinducerDetailsDB06209PrasugrelapprovednosubstrateDetailsDB06216AsenapineapprovedunknownsubstrateDetailsDB00435Nitric OxideapprovedunknowninhibitorDetailsDB08867UlipristalapprovednosubstrateDetailsDB08815Lurasidoneapproved, investigationalunknownsubstrateDetailsDB08870Brentuximab vedotinapproved, investigationalnosubstrateinhibitorDetailsDB04871Lorcaserinapproved, withdrawnnosubstrateDetailsDB05294VandetanibapprovedunknownsubstrateDetailsDB08873Boceprevirapproved, withdrawnunknownsubstrateinhibitorDetailsDB08875Cabozantinibapproved, investigationalnosubstrateDetailsDB08877RuxolitinibapprovedunknownsubstrateDetailsDB05812AbirateroneapprovedunknownsubstrateinhibitorDetailsDB08881VemurafenibapprovedunknownsubstrateinducerDetailsDB08882LinagliptinapprovedunknownsubstrateinhibitorDetailsDB08883PerampanelapprovednosubstrateinducerDetailsDB08865Crizotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB06626Axitinibapproved, investigationalnosubstrateDetailsDB08893MirabegronapprovednosubstrateDetailsDB06237AvanafilapprovedunknownsubstrateDetailsDB08896RegorafenibapprovedunknownsubstrateinhibitorDetailsDB08899EnzalutamideapprovednosubstrateinducerDetailsDB08895Tofacitinibapproved, investigationalnosubstrateDetailsDB06616BosutinibapprovednosubstrateinhibitorDetailsDB08901Ponatinibapproved, investigationalunknownsubstrateDetailsDB08903BedaquilineapprovednosubstrateDetailsDB06201RufinamideapprovedunknowninducerDetailsDB08906Fluticasone furoateapprovednosubstrateinhibitorinducerDetailsDB08907CanagliflozinapprovedunknownsubstrateDetailsDB06203AlogliptinapprovedunknownsubstrateDetailsDB04938Ospemifeneapproved, investigationalunknownsubstrateDetailsDB08910PomalidomideapprovedunknownsubstrateDetailsDB08911TrametinibapprovedunknownsubstrateinducerDetailsDB08912Dabrafenibapproved, investigationalnosubstrateinhibitorinducerDetailsDB05773Trastuzumab emtansineapproved, investigationalunknownsubstrateDetailsDB08833Taurochenodeoxycholic acidexperimentalunknownsubstrateDetailsDB01142Doxepinapproved, investigationalnosubstrateDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB08918Levomilnacipranapproved, investigationalunknownsubstrateDetailsDB08932MacitentanapprovednosubstrateDetailsDB08933LuliconazoleapprovednoinhibitorDetailsDB06292DapagliflozinapprovednosubstrateDetailsDB09039Eliglustatapproved, investigationalnosubstrateDetailsDB05676Apremilastapproved, investigationalnosubstrateDetailsDB09049NaloxegolapprovedunknownsubstrateDetailsDB09053IbrutinibapprovedunknownsubstrateDetailsDB00951Isoniazidapproved, investigationalunknownDetailsDB09074OlaparibapprovedunknownsubstrateinhibitorDetailsDB09078Lenvatinibapproved, investigationalnosubstrateinhibitorinducerDetailsDB09073Palbociclibapproved, investigationalnosubstrateinhibitorDetailsDB09054IdelalisibapprovednosubstrateinhibitorinducerDetailsDB09068Vortioxetineapproved, investigationalnosubstrateDetailsDB09082VilanterolapprovednosubstrateDetailsDB09083IvabradineapprovednosubstrateDetailsDB09026Aliskirenapproved, investigationalnosubstrateDetailsDB09101ElvitegravirapprovednosubstrateinhibitorDetailsDB06016Cariprazineapproved, investigationalnosubstrateinhibitorinducerDetailsDB08439ParecoxibapprovedunknownsubstrateDetailsDB09128Brexpiprazoleapproved, investigationalnosubstrateDetailsDB09291Rolapitantapproved, investigationalnosubstrateDetailsDB04908Flibanserinapproved, investigationalnosubstrateDetailsDB09102Daclatasvirapproved, investigationalunknownsubstrateDetailsDB09143Sonidegibapproved, investigationalunknownsubstrateDetailsDB06636Isavuconazoniumapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB06603Panobinostatapproved, investigationalunknownsubstrateDetailsDB05239Cobimetinibapproved, investigationalnosubstrateinhibitorDetailsDB09570Ixazomibapproved, investigationalunknownsubstrateDetailsDB09330OsimertinibapprovednosubstrateinhibitorinducerDetailsDB11362SelexipagapprovednosubstrateDetailsDB09119Eslicarbazepine acetateapprovednoinducerDetailsDB06789Hydroxyprogesterone caproateapproved, investigationalunknownsubstrateDetailsDB08931RiociguatapprovedunknownsubstrateDetailsDB09183DasabuvirapprovednosubstrateDetailsDB09297Paritaprevirapproved, investigationalnosubstrateDetailsDB09317Synthetic Conjugated Estrogens, AapprovednosubstrateDetailsDB09318Synthetic Conjugated Estrogens, BapprovednosubstrateDetailsDB09389NorgestrelapprovedunknownsubstrateDetailsDB11581Venetoclaxapproved, investigationalnosubstrateinhibitorDetailsDB09280LumacaftorapprovednoinducerDetailsDB01323St. John's Wortapproved, investigational, nutraceuticalunknownsubstrateinduceractivatorDetailsDB09381Esterified estrogensapprovedunknownsubstrateDetailsDB00957Norgestimateapproved, investigationalunknownsubstrateinducerDetailsDB04911Oritavancinapproved, investigationalunknowninhibitorinducerDetailsDB06717FosaprepitantapprovedunknownsubstrateinhibitorinducerDetailsDB00648MitotaneapprovedunknowninducerDetailsDB08909Glycerol phenylbutyrateapprovedunknowninducerDetailsDB09048Netupitantapproved, investigationalnosubstrateinhibitorDetailsDB12332Rucaparibapproved, investigationalnosubstrateinhibitorDetailsDB11921Deflazacortapproved, investigationalnosubstrateinducerDetailsDB11737Icotinibexperimental, investigationalunknownsubstrateDetailsDB06654Safinamideapproved, investigationalunknownsubstrateDetailsDB12161Deutetrabenazineapproved, investigationalnosubstrateDetailsDB09555Dexchlorpheniramine maleateapprovedunknownsubstrateDetailsDB11613Velpatasvirapproved, investigationalnosubstrateDetailsDB05541Brivaracetamapproved, investigationalnosubstrateDetailsDB11915Valbenazineapproved, investigationalnosubstrateDetailsDB06670OdanacatibinvestigationalnosubstrateDetailsDB05351Dexlansoprazoleapproved, investigationalunknownsubstrateDetailsDB06290SimeprevirapprovedunknownsubstrateinhibitorDetailsDB11575GrazoprevirapprovednosubstrateinhibitorDetailsDB11943Delafloxacinapproved, investigationalunknowninducerDetailsDB01685TopiroxostatexperimentalunknowninhibitorDetailsDB08922PerospironeexperimentalunknownsubstrateDetailsDB09118StiripentolapprovedunknownsubstrateinhibitorinducerDetailsDB09166EtizolamexperimentalunknownsubstrateDetailsDB11614RupatadineapprovednosubstrateDetailsDB09262ImidafenacininvestigationalnosubstrateDetailsDB00143Glutathioneapproved, investigational, nutraceuticalunknownDetailsDB09238Manidipineapproved, investigationalunknownsubstrateinhibitorDetailsDB09123DienogestapprovedunknownsubstrateDetailsDB11828Neratinibapproved, investigationalunknownsubstrateDetailsDB12026Voxilaprevirapproved, investigationalnosubstrateDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB06412Oxymetholoneapproved, illicitunknowninhibitorDetailsDB00503Ritonavirapproved, investigationalunknownsubstrateinhibitorDetailsDB06595Midostaurinapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB11574ElbasvirapprovedunknownsubstrateDetailsDB12483Copanlisibapproved, investigationalnosubstrateDetailsDB11767Sarilumabapproved, investigationalnoinhibitorinducerDetailsDB12001Abemaciclibapproved, investigationalunknownsubstrateinhibitorDetailsDB12267Brigatinibapproved, investigationalnosubstrateDetailsDB11817Baricitinibapproved, investigationalunknownsubstrateDetailsDB13074Macimorelinapproved, investigationalunknownsubstrateDetailsDB09223BlonanserininvestigationalnosubstrateDetailsDB09236Lacidipineapproved, investigationalunknownsubstrateDetailsDB09061Cannabidiolapproved, investigationalunknownsubstrateinhibitorDetailsDB13943Testosterone cypionateapprovedunknownsubstrateinhibitorinducerDetailsDB13944Testosterone enanthateapprovedunknownsubstrateinhibitorinducerDetailsDB13946Testosterone undecanoateapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB13941Piperaquineapproved, experimental, investigationalunknownsubstrateinhibitorDetailsDB01420Testosterone propionateapproved, investigational, vet_approved, withdrawnnosubstrateDetailsDB09195LorpiprazoleapprovednosubstrateDetailsDB11799Bictegravirapproved, investigationalunknownsubstrateDetailsDB11901Apalutamideapproved, investigationalnosubstrateinducerDetailsDB09225Zotepineapproved, investigational, withdrawnnosubstrateDetailsDB09230AzelnidipineinvestigationalunknownsubstrateDetailsDB09231BenidipineexperimentalnosubstrateinhibitorDetailsDB09235EfonidipineexperimentalunknownsubstrateinhibitorDetailsDB11642Pitolisantapproved, investigationalunknownsubstrateinducerDetailsDB11633Isavuconazoleapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB09237Levamlodipineapproved, investigationalunknownsubstrateDetailsDB11712Tezacaftorapproved, investigationalnosubstrateinhibitorinducerDetailsDB11130Opiumapproved, illicitnosubstrateDetailsDB11251Tocopherolapproved, investigationalnosubstrateDetailsDB14003alpha-Tocopherol acetateapprovednosubstrateDetailsDB11586Asunaprevirapproved, investigational, withdrawnnosubstrateinducerDetailsDB13975Black cohoshexperimentalnoinhibitorDetailsDB12278Propiverineapproved, investigationalnosubstrateDetailsDB14011NabiximolsinvestigationalunknownsubstrateDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorDetailsDB11641Vinflunineapproved, investigationalnosubstrateDetailsDB11635TocofersolanapprovednosubstrateDetailsDB11637Delamanidapproved, investigationalnosubstrateDetailsDB13746Bioallethrinapproved, experimentalnosubstrateDetailsDB14019FosnetupitantapprovedunknownsubstrateinhibitorDetailsDB12010Fostamatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB01049Ergoloid mesylateapprovednosubstrateDetailsDB11274Dihydro-alpha-ergocryptineapprovednosubstrateDetailsDB13293Ipecacapproved, withdrawnnosubstrateDetailsDB11198Peppermint oilapproved, investigationalunknowninhibitorDetailsDB13456MidecamycinexperimentalnosubstrateinhibitorDetailsDB12532Oxetacaineapproved, investigationalnoinhibitorDetailsDB11672Curcuminapproved, investigationalunknowninhibitorDetailsDB11779DanoprevirinvestigationalnoinhibitorDetailsDB09289TianeptineinvestigationalnosubstrateDetailsDB01357MestranolapprovednosubstrateDetailsDB04829Lysergic acid diethylamideillicit, investigational, withdrawnnosubstrateDetailsDB00247MethysergideapprovednosubstrateDetailsDB13399TergurideexperimentalnosubstrateDetailsDB14185Aripiprazole lauroxilapproved, investigationalunknownsubstrateDetailsDB11718Encorafenibapproved, investigationalnosubstrateinhibitorinducerDetailsDB14538Hydrocortisone aceponateexperimental, vet_approvedunknownsubstrateinducerDetailsDB14539Hydrocortisone acetateapproved, vet_approvedunknownsubstrateinducerDetailsDB14540Hydrocortisone butyrateapproved, vet_approvedunknownsubstrateinducerDetailsDB14541Hydrocortisone cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB14542Hydrocortisone phosphateapproved, vet_approvedunknownsubstrateDetailsDB14543Hydrocortisone probutateapproved, vet_approvedunknownsubstrateinducerDetailsDB14544Hydrocortisone valerateapproved, vet_approvedunknownsubstrateinducerDetailsDB14568Ivosidenibapproved, investigationalunknownsubstrateinducerDetailsDB126293,5-diiodothyropropionic acidinvestigationalnosubstrateDetailsDB014565-androstenedioneexperimental, illicitnosubstrateDetailsDB00240AlclometasoneapprovednosubstrateDetailsDB04630Aldosteroneexperimental, investigationalnosubstrateDetailsDB00288AmcinonideapprovednosubstrateinducerDetailsDB01536Androstenedioneexperimental, illicitnosubstrateDetailsDB00394Beclomethasone dipropionateapproved, investigationalnosubstrateinducerDetailsDB11750Clobetasolapproved, experimental, investigationalnosubstrateinducerDetailsDB01013Clobetasol propionateapprovednosubstrateinducerDetailsDB13158ClobetasoneapprovednosubstrateDetailsDB04652CorticosteroneexperimentalnosubstrateDetailsDB01285Corticotropinapproved, investigational, vet_approvednosubstrateinducerDetailsDB04839Cyproterone acetateapproved, investigationalnosubstrateinhibitorDetailsDB11636NomegestrolapprovednosubstrateDetailsDB13981Nomegestrol acetateapproved, investigationalnosubstrateDetailsDB00304DesogestrelapprovednosubstrateDetailsDB01260Desonideapproved, investigationalnosubstrateinducerDetailsDB06780Desoxycorticosterone acetateapprovednosubstrateDetailsDB01134Desoxycorticosterone pivalateexperimental, vet_approvednosubstrateDetailsDB11487Dexamethasone isonicotinatevet_approvednosubstrateinhibitorinducerDetailsDB09095Difluocortoloneapproved, investigational, withdrawnnosubstrateinducerDetailsDB06781DifluprednateapprovednosubstrateDetailsDB00378Dydrogesteroneapproved, investigational, withdrawnnosubstrateDetailsDB03515EquileninexperimentalnosubstrateDetailsDB02187EquilinexperimentalnosubstrateDetailsDB13866EtynodiolexperimentalnosubstrateDetailsDB00823Ethynodiol diacetateapprovednosubstrateDetailsDB00687Fludrocortisoneapproved, investigationalunknownsubstrateDetailsDB00663Flumethasoneapproved, vet_approvednosubstrateDetailsDB00591Fluocinolone acetonideapproved, investigational, vet_approvednosubstrateinducerDetailsDB01047Fluocinonideapproved, investigationalnosubstrateinducerDetailsDB08971Fluocortoloneapproved, withdrawnnosubstrateinducerDetailsDB08970FluprednideneexperimentalnosubstrateinducerDetailsDB09378FluprednisoloneapprovednosubstrateDetailsDB00846FlurandrenolideapprovednosubstrateDetailsDB13867Fluticasoneapproved, experimentalnosubstrateinhibitorinducerDetailsDB08905Formestaneapproved, investigational, withdrawnnoinducerDetailsDB06730GestodeneinvestigationalnosubstrateinhibitorDetailsDB11619GestrinoneapprovednosubstrateDetailsDB06786Halcinonideapproved, investigational, withdrawnnosubstrateDetailsDB05212HE3286investigationalnosubstrateDetailsDB14545Hydrocortisone succinateapprovedunknownsubstrateinducerDetailsDB14570HydroxyprogesteroneexperimentalnosubstrateDetailsDB01583LiotrixapprovednosubstrateDetailsDB14596Loteprednol etabonateapprovedunknownsubstrateDetailsDB12474Lynestrenolapproved, investigationalnosubstrateDetailsDB09124Medrogestoneapproved, withdrawnnosubstrateDetailsDB00253MedrysoneapprovednosubstrateinducerDetailsDB00351Megestrol acetateapproved, investigational, vet_approvednosubstrateDetailsDB11529Melengestrolvet_approvednosubstrateDetailsDB09383Meprednisoneapproved, investigationalnosubstrateinducerDetailsDB00764MometasoneexperimentalnosubstrateinducerDetailsDB14512Mometasone furoateapproved, investigational, vet_approvednosubstrateinducerDetailsDB06713Norelgestrominapproved, investigationalnosubstrateDetailsDB09371NorethynodrelapprovednosubstrateDetailsDB01130Prednicarbateapproved, investigationalnosubstrateDetailsDB13208PrednylideneexperimentalnosubstrateinducerDetailsDB02789Pregnenoloneapproved, experimentalnosubstrateDetailsDB13602PromegestoneexperimentalnosubstrateDetailsDB00896RimexoloneapprovednosubstrateinducerDetailsDB01117AtovaquoneapprovednosubstrateDetailsDB11753Rifamycinapproved, investigationalnoinhibitorinducerDetailsDB13528ChlormadinoneexperimentalnosubstrateDetailsDB13857DemegestoneexperimentalnosubstrateDetailsDB13685QuingestanolexperimentalnosubstrateDetailsDB14055(S)-Warfarinexperimental, investigationalnosubstrateDetailsDB13347DiphenadioneexperimentalnosubstrateDetailsDB08794Ethyl biscoumacetatewithdrawnunknownsubstrateDetailsDB01483BarbitalillicitnoinducerDetailsDB01154Thiamylalapproved, vet_approvednosubstrateinducerDetailsDB09229AranidipineexperimentalnosubstrateDetailsDB09227BarnidipineexperimentalnosubstrateinhibitorDetailsDB13488BencyclaneexperimentalnosubstrateDetailsDB01244Bepridilapproved, withdrawnnosubstrateDetailsDB08838AgmatineexperimentalnosubstrateDetailsDB11960CarboxyamidotriazoleinvestigationalnosubstrateDetailsDB13835CaroverineexperimentalnosubstrateDetailsDB09232CilnidipineinvestigationalnosubstrateDetailsDB00568Cinnarizineapproved, investigationalnosubstrateDetailsDB04838CyclandelateapprovednosubstrateDetailsDB09234DarodipineexperimentalnosubstrateDetailsDB14068DexniguldipineexperimentalnosubstrateDetailsDB14063DexverapamilexperimentalnosubstrateDetailsDB06446DotarizineinvestigationalnosubstrateDetailsDB14064EmopamilexperimentalnosubstrateDetailsDB08992EperisoneinvestigationalnosubstrateDetailsDB08980FendilinewithdrawnnosubstrateDetailsDB13961Fish oilapproved, nutraceuticalnosubstrateDetailsDB04841FlunarizineapprovednosubstrateDetailsDB04842Fluspirileneapproved, investigationalnosubstrateDetailsDB12923GallopamilinvestigationalnosubstrateDetailsDB13766Lidoflazineapproved, experimentalnosubstrateDetailsDB14065LomerizineexperimentalnosubstrateDetailsDB00825LevomentholapprovednosubstrateDetailsDB12092NaftopidilinvestigationalnosubstrateDetailsDB09239NiguldipineexperimentalnosubstrateDetailsDB09240NiludipineexperimentalnosubstrateDetailsDB04743Nimesulideapproved, investigational, withdrawnnosubstrateDetailsDB06152NylidrinapprovednosubstrateDetailsDB13500Otiloniumexperimental, investigationalnosubstrateDetailsDB13791PenfluridolexperimentalnosubstrateDetailsDB09090PinaveriumapprovednosubstrateDetailsDB04825Prenylamineapproved, withdrawnnosubstrateDetailsDB13725TerodilineexperimentalnosubstrateDetailsDB12093TetrahydropalmatineinvestigationalnosubstrateDetailsDB14066TetrandrineexperimentalnosubstrateDetailsDB09216Tolfenamic acidapproved, investigationalnosubstrateDetailsDB07615TranilastinvestigationalnosubstrateDetailsDB09089TrimebutineapprovednosubstrateDetailsDB05885SeletracetaminvestigationalnosubstrateDetailsDB12131VinpocetineinvestigationalnosubstrateDetailsDB13950WIN 55212-2experimentalnosubstrateinhibitorDetailsDB040706-Deoxyerythronolide BexperimentalnoinhibitorDetailsDB06318AVE9633investigationalnoinhibitorDetailsDB07348Brefeldin AexperimentalnoinhibitorDetailsDB11752Bryostatin 1investigationalnoinhibitorDetailsDB01152Candicidinapproved, withdrawnnoinhibitorDetailsDB11383Carbomycinvet_approvednoinhibitorDetailsDB06419CethromycininvestigationalnosubstrateinhibitorDetailsDB06342Coltuximab ravtansineinvestigationalnoinhibitorDetailsDB00954DirithromycinexperimentalnoinhibitorDetailsDB11400Doramectinvet_approvednoinhibitorDetailsDB12266EpofolateinvestigationalnoinhibitorDetailsDB01873Epothilone DinvestigationalnoinhibitorDetailsDB11405Eprinomectinvet_approvednoinhibitorDetailsDB13338FlurithromycinexperimentalnoinhibitorDetailsDB05814GPI-1485investigationalnoinhibitorDetailsDB09309KitasamycinexperimentalnoinhibitorDetailsDB05903KOS-1584investigationalnoinhibitorDetailsDB12089Lorvotuzumab mertansineinvestigationalnoinhibitorDetailsDB13287MiocamycinapprovednoinhibitorDetailsDB12489Mirvetuximab soravtansineapproved, investigationalnosubstrateinhibitorDetailsDB06587MitemcinalinvestigationalnoinhibitorDetailsDB11442Oleandomycinvet_approvednoinhibitorDetailsDB03010Patupiloneexperimental, investigationalnoinhibitorDetailsDB06233RidaforolimusinvestigationalnoinhibitorDetailsDB13409RokitamycinexperimentalnoinhibitorDetailsDB12391SagopiloneinvestigationalnoinhibitorDetailsDB11459Selamectinvet_approvednoinhibitorDetailsDB09308SolithromycininvestigationalnoinhibitorDetailsDB11470Tildipirosinvet_approvednoinhibitorDetailsDB01241GemfibrozilapprovedunknownsubstrateDetailsDB06791LanreotideapprovednoinhibitorDetailsDB00104Octreotideapproved, investigationalnoinhibitorDetailsDB06663PasireotideapprovednoinhibitorDetailsDB09099Somatostatinapproved, investigationalnoinhibitorDetailsDB04894Vapreotideexperimental, investigationalnoinhibitorDetailsDB12781BalaglitazoneinvestigationalnosubstrateDetailsDB09201CiglitazoneexperimentalnosubstrateDetailsDB09198LobeglitazoneexperimentalnosubstrateDetailsDB09199NetoglitazoneexperimentalnosubstrateDetailsDB09200Rivoglitazoneexperimental, investigationalnosubstrateDetailsDB00412Rosiglitazoneapproved, investigationalnosubstrateinducerDetailsDB09063CeritinibapprovednosubstrateinhibitorDetailsDB06469LestaurtinibinvestigationalnoinhibitorDetailsDB11805SaracatinibinvestigationalnoinhibitorDetailsDB11703Acalabrutinibapproved, investigationalunknownsubstrateinhibitorDetailsDB01267PaliperidoneapprovedunknownsubstrateDetailsDB01645GenisteininvestigationalunknowninducerDetailsDB05928DovitinibinvestigationalunknowninhibitorDetailsDB08496(R)-warfarinexperimentalunknownsubstrateDetailsDB119196-O-benzylguanineinvestigationalnosubstrateDetailsDB14583Segesterone acetateapproved, experimental, investigationalunknownsubstrateDetailsDB00563MethotrexateapprovednosubstrateDetailsDB04884DapoxetineinvestigationalnosubstrateinhibitorDetailsDB08953Indalpineinvestigational, withdrawnnosubstrateinhibitorDetailsDB00715Paroxetineapproved, investigationalnosubstrateinhibitorDetailsDB04832Zimelidineapproved, withdrawnnoinhibitorDetailsDB04896Milnacipranapproved, investigationalnosubstrateinhibitorDetailsDB02703Fusidic acidapproved, investigationalunknownsubstrateinhibitorDetailsDB11730Ribociclibapproved, investigationalnosubstrateinhibitorDetailsDB09079NintedanibapprovednosubstrateDetailsDB14634Fluprednidene acetateexperimentalnoinducerDetailsDB14637Fluprednisolone acetateexperimentalnosubstrateDetailsDB01656RoflumilastapprovednosubstrateDetailsDB09034Suvorexantapproved, investigationalnosubstrateDetailsDB09071Tasimelteonapproved, investigationalnosubstrateDetailsDB09030VorapaxarapprovednosubstrateDetailsDB01624Zuclopenthixolapproved, investigationalnosubstrateDetailsDB13385DihydroergocryptineexperimentalnosubstrateDetailsDB11273DihydroergocornineapprovednosubstrateDetailsDB13345Dihydroergocristineapproved, experimentalnosubstrateDetailsDB06218LacosamideapprovednosubstrateDetailsDB12329Eravacyclineapproved, investigationalunknownsubstrateDetailsDB06458RemacemideinvestigationalnoinhibitorDetailsDB08874FidaxomicinapprovednoinhibitorDetailsDB11742Ebastineapproved, investigationalnosubstrateDetailsDB09036Siltuximabapproved, investigationalnoinducerDetailsDB06273TocilizumabapprovednoinducerDetailsDB12301Doravirineapproved, investigationalunknownsubstrateDetailsDB11952Duvelisibapproved, investigationalnosubstrateDetailsDB13997Baloxavir marboxilapproved, investigationalnosubstrateinhibitorDetailsDB00186LorazepamapprovednosubstrateDetailsDB125159-aminocamptothecininvestigationalnosubstrateDetailsDB12952Methylprednisoneapproved, investigationalnosubstrateDetailsDB04861Nebivololapproved, investigationalunknownsubstrateDetailsDB11963Dacomitinibapproved, investigationalnosubstrateDetailsDB12141Gilteritinibapproved, investigationalnosubstrateDetailsDB14723Larotrectinibapproved, investigationalunknownsubstrateDetailsDB125371,2-Benzodiazepineapproved, investigationalunknownsubstrateDetailsDB09017Brotizolaminvestigational, withdrawnunknownsubstrateDetailsDB11094Vitamin Dapproved, nutraceutical, vet_approvednosubstrateDetailsDB01352Aprobarbitalexperimental, illicitunknowninducerDetailsDB00590DoxazosinapprovednosubstrateDetailsDB05482SN-38investigationalunknownsubstrateinhibitorDetailsDB06480PrucaloprideapprovednosubstrateDetailsDB11978Glasdegibapproved, investigationalunknownsubstrateDetailsDB12582PiperineinvestigationalunknowninhibitorDetailsDB00191Phentermineapproved, illicitnosubstrateDetailsDB12245Triclabendazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00264Metoprololapproved, investigationalnosubstrateDetailsDB11823Esketamineapproved, investigationalunknownsubstrateinducerDetailsDB00163Vitamin Eapproved, nutraceutical, vet_approvedunknownsubstrateinducerDetailsDB12371Siponimodapproved, investigationalunknownsubstrateDetailsDB12147Erdafitinibapproved, investigationalnosubstrateinhibitorinducerDetailsDB09299Tenofovir alafenamideapprovednosubstrateDetailsDB00982IsotretinoinapprovedunknownsubstrateDetailsDB12015Alpelisibapproved, investigationalunknownsubstrateDetailsDB12240Polatuzumab vedotinapproved, investigationalnosubstrateDetailsDB00905Bimatoprostapproved, investigationalunknownsubstrateDetailsDB11942Selinexorapproved, investigationalunknownsubstrateDetailsDB14669Betamethasone phosphateapproved, vet_approvedunknownsubstrateinducerDetailsDB14652Clocortolone acetateexperimentalunknowninducerDetailsDB13843CloprednolexperimentalunknowninducerDetailsDB14681CortisoneexperimentalunknowninducerDetailsDB13003CortivazolinvestigationalunknowninducerDetailsDB13728HalometasoneexperimentalunknowninducerDetailsDB14659Melengestrol acetateexperimentalunknowninducerDetailsDB14644Methylprednisolone hemisuccinateapprovedunknowninducerDetailsDB14633Prednisolone hemisuccinateexperimentalunknowninducerDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknownsubstrateinducerDetailsDB14646Prednisone acetateapproved, experimental, investigationalunknowninducerDetailsDB02520DitiocarbexperimentalunknowninhibitorDetailsDB06731SeproxetineinvestigationalunknowninhibitorDetailsDB00627Niacinapproved, investigational, nutraceuticalunknowninhibitorDetailsDB06282LevocetirizineapprovedunknownsubstrateDetailsDB09173ButyrfentanylillicitunknownsubstrateDetailsDB12978Pexidartinibapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB01551Dihydrocodeineapproved, illicitunknownsubstrateDetailsDB05154PretomanidapprovedunknownsubstrateDetailsDB01395DrospirenoneapprovedunknownsubstrateDetailsDB01611HydroxychloroquineapprovedunknownsubstrateDetailsDB11986Entrectinibapproved, investigationalunknownsubstrateDetailsDB12500Fedratinibapproved, investigationalunknownsubstrateDetailsDB12825Lefamulinapproved, investigationalunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknownsubstrateDetailsDB01319FosamprenavirapprovedunknownsubstrateinhibitorDetailsDB01050IbuprofenapprovednosubstrateDetailsDB15489MexazolamexperimentalunknownsubstrateDetailsDB00334Olanzapineapproved, investigationalunknowninhibitorDetailsDB09288PropacetamolexperimentalunknownsubstrateinducerDetailsDB01233Metoclopramideapproved, investigationalunknownsubstrateDetailsDB11761Tenapanorapproved, investigationalunknownsubstrateDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB14600Edetate disodium anhydrousapproved, vet_approvedunknowninhibitorDetailsDB01217Anastrozoleapproved, investigationalunknownsubstrateinhibitorDetailsDB14575EslicarbazepineapprovedunknowninducerDetailsDB12808Trifaroteneapproved, investigationalunknownsubstrateDetailsDB15444Elexacaftorapproved, investigationalnosubstrateinhibitorDetailsDB15566Prednisolone acetateapproved, vet_approvedunknownsubstrateinducerDetailsDB00557HydroxyzineapprovednosubstrateDetailsDB14240Echinaceaapproved, experimentalunknowninducerDetailsDB11560Lesinuradapproved, investigationalunknowninducerDetailsDB15035Zanubrutinibapproved, investigationalnosubstrateDetailsDB01381Ginkgo bilobaapproved, investigational, nutraceuticalunknowninhibitorinducerDetailsDB13879Glecaprevirapproved, investigationalunknowninhibitorDetailsDB14975Voxelotorapproved, investigationalunknownsubstrateDetailsDB00717NorethisteroneapprovedunknownsubstrateDetailsDB06119Cenobamateapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB13007Enfortumab vedotinapproved, investigationalunknownsubstrateDetailsDB14962Trastuzumab deruxtecanapproved, investigationalunknownsubstrateDetailsDB11951Lemborexantapproved, investigationalunknownsubstrateDetailsDB12941Darolutamideapproved, investigationalunknownsubstrateDetailsDB06077Lumateperoneapproved, investigationalnosubstrateDetailsDB15091Upadacitinibapproved, investigationalnosubstrateDetailsDB15328Ubrogepantapproved, investigationalunknownsubstrateDetailsDB15233Avapritinibapproved, investigationalunknownsubstrateDetailsDB12887Tazemetostatapproved, investigationalunknownsubstrateDetailsDB12457Rimegepantapproved, investigationalnosubstrateinhibitorDetailsDB13609UmifenovirinvestigationalunknownsubstrateDetailsDB11837Osilodrostatapproved, investigationalunknownsubstrateinhibitorDetailsDB14678Norethindrone enanthateexperimentalunknownsubstrateDetailsDB09241Methylene blueapproved, investigationalunknowninhibitorDetailsDB12612Ozanimodapproved, investigationalunknownsubstrateDetailsDB14598Edetate calcium disodium anhydrousapprovedunknowninhibitorDetailsDB11689Selumetinibapproved, investigationalnosubstrateDetailsDB15102Pemigatinibapproved, investigationalnosubstrateDetailsDB14761Remdesivirapproved, investigationalunknownsubstrateinhibitorDetailsDB11791Capmatinibapproved, investigationalunknownsubstrateDetailsDB15685Selpercatinibapproved, investigationalunknownsubstrateDetailsDB14840RipretinibapprovedunknownsubstrateDetailsDB00714Apomorphineapproved, investigationalunknownDetailsDB12674Lurbinectedinapproved, investigationalunknownsubstrateDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB05015Belinostatapproved, investigationalunknownsubstrateDetailsDB11796Fostemsavirapproved, investigationalunknownsubstrateDetailsDB11932Abametapirapproved, investigationalnoinhibitorDetailsDB15305Risdiplamapproved, investigationalunknownsubstrateDetailsDB14881Oliceridineapproved, investigationalnosubstrateDetailsDB12499Clascoteroneapproved, investigationalnoinhibitorDetailsDB15822Pralsetinibapproved, investigationalnosubstrateinhibitorinducerDetailsDB06448Lonafarnibapproved, investigationalunknownsubstrateinhibitorDetailsDB15982BerotralstatapprovednoinhibitorDetailsDB06137Tirbanibulinapproved, investigationalnosubstrateinhibitorDetailsDB14895Vibegronapproved, investigationalnosubstrateDetailsDB00475Chlordiazepoxideapproved, illicit, investigationalunknownsubstrateDetailsDB00752Tranylcypromineapproved, investigationalunknowninhibitorDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB05667Levoketoconazoleapproved, investigationalnosubstrateinhibitorinducerDetailsDB00476DuloxetineapprovedunknowninhibitorDetailsDB11693Voclosporinapproved, investigationalunknownsubstrateinhibitorDetailsDB15133Tepotinibapproved, investigationalnosubstrateinhibitorDetailsDB00747Scopolamineapproved, investigationalnosubstrateDetailsDB00330EthambutolapprovedunknowninhibitorDetailsDB14989Umbralisibapproved, investigational, withdrawnunknownsubstrateDetailsDB14984Casimersenapproved, investigationalnoinhibitorDetailsDB00545Pyridostigmineapproved, investigationalnoinducerDetailsDB11800Tivozanibapproved, investigationalunknownsubstrateDetailsDB12016Ponesimodapproved, investigationalunknownsubstrateDetailsDB08995Diosminapproved, investigationalunknowninhibitorDetailsDB05316Pimavanserinapproved, investigationalunknownsubstrateDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownsubstrateDetailsDB12235Estetrolapproved, investigationalunknownsubstrateDetailsDB16222Loncastuximab tesirineapproved, investigationalunknownDetailsDB11886Infigratinibapproved, investigationalnosubstrateDetailsDB12471Ibrexafungerpapproved, investigationalunknownsubstrateinhibitorDetailsDB12543Samidorphanapproved, investigationalnosubstrateDetailsDB16165Finerenoneapproved, investigationalunknownsubstrateDetailsDB16703Belumosudilapproved, investigationalnosubstrateDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB15463Belzutifanapproved, investigationalnosubstrateDetailsDB12265Fexinidazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB16390Mobocertinibapproved, investigationalunknownsubstrateDetailsDB16732Tisotumab vedotinapprovednosubstrateDetailsDB16098Atogepantapproved, investigationalnosubstrateDetailsDB16226Maralixibatapproved, investigationalnoinhibitorDetailsDB15011Avacopanapproved, investigationalnosubstrateinhibitorinducerDetailsDB12597Asciminibapproved, investigationalnosubstrateinhibitorDetailsDB06234Maribavirapproved, investigationalnosubstrateDetailsDB16691Nirmatrelvirapproved, investigationalnosubstrateinhibitorDetailsDB15031DaridorexantapprovednosubstrateDetailsDB12713Sotagliflozinapproved, investigationalnosubstrateinhibitorinducerDetailsDB14973Abrocitinibapproved, investigationalnosubstrateDetailsDB05467Palovaroteneapproved, investigationalnosubstrateinducerDetailsDB16236Mitapivatapproved, investigationalnosubstrateinducerDetailsDB12834SecnidazoleapprovedunknownsubstrateinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknownsubstrateinhibitorDetailsDB00486Nabiloneapproved, investigationalunknownsubstrateinhibitorDetailsDB06230Nalmefeneapproved, investigational, withdrawnnosubstrateDetailsDB11697Pacritinibapproved, investigationalnosubstrateinhibitorinducerDetailsDB05087Ganaxoloneapproved, investigationalnosubstrateDetailsDB01041Thalidomideapproved, investigational, withdrawnnosubstrateinducerDetailsDB14921Mavacamtenapproved, investigationalnosubstrateinducerDetailsDB09185Viloxazineapproved, investigational, withdrawnnoinhibitorDetailsDB00951Isoniazidapproved, investigationalunknowninhibitorDetailsDB12020Tecovirimatapproved, investigationalnoinducerDetailsDB06083Tapinarofapproved, investigationalnosubstrateDetailsDB01024Mycophenolic acidapproved, investigationalunknownsubstrateDetailsDB10534GrapefruitapprovedunknowninhibitorDetailsDB04951Pirfenidoneapproved, investigationalunknowninhibitorDetailsDB15673Lenacapavirapproved, investigationalnosubstrateinhibitorDetailsDB12095Telotristat ethylapproved, investigationalnoinhibitorinducerDetailsDB15149Futibatinibapproved, investigationalnosubstrateDetailsDB17083LinzagolixapprovednosubstrateDetailsDB11739Vonoprazanapproved, investigationalunknownsubstrateDetailsDB09065CobicistatapprovedyesinhibitorDetailsDB16267Olutasidenibapproved, investigationalnosubstrateinducerDetailsDB15568Adagrasibapproved, investigationalunknownsubstrateinhibitorDetailsDB12236Bexagliflozinapproved, investigationalunknownsubstrateDetailsDB17472Pirtobrutinibapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB06374Elacestrantapproved, investigationalunknownsubstrateDetailsDB11682Daprodustatapproved, investigationalnosubstrateDetailsDB09065CobicistatapprovednosubstrateDetailsDB12548Sparsentanapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB12513Omaveloxoloneapproved, investigationalunknownsubstrateinducerDetailsDB15688Zavegepantapproved, investigationalunknownsubstrateDetailsDB06045Trofinetideapproved, investigationalunknowninhibitorDetailsDB16217Leniolisibapproved, investigationalnosubstrateDetailsDB12255Vadadustatapproved, investigationalunknowndownregulatorDetailsDB14924Ritlecitinibapproved, investigationalunknownsubstrateinhibitorDetailsDB12874Quizartinibapproved, investigationalnosubstrateDetailsDB15490Zuranoloneapproved, experimentalnosubstrateDetailsDB11763Momelotinibapproved, investigationalunknownsubstrateDetailsDB12184GepironeinvestigationalnosubstrateDetailsDB14766EtrasimodapprovednosubstrateDetailsDB15114Vamoroloneapproved, investigationalnosubstrateinducerDetailsDB12218Capivasertibapproved, investigationalnosubstrateDetailsDB16826RepotrectinibinvestigationalnosubstrateinhibitorinducerDetailsDB11679FruquintinibinvestigationalnosubstrateDetailsDB00176Fluvoxamineapproved, investigationalunknowninhibitorDetailsDB00599Thiopentalapproved, vet_approvedunknownsubstrateDetailsDB08930DolutegravirapprovednosubstrateDetailsDB06595Midostaurinapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB13174RheinexperimentalunknowninhibitorDetailsDB11994Diacereinapproved, investigationalunknowninhibitorDetailsDB11605MyrrhapprovedunknowninducerDetailsDB11691Naldemedineapproved, investigationalnosubstrateDetailsDB13878Pibrentasvirapproved, investigationalunknowninhibitorDetailsDB13879Glecaprevirapproved, investigationalunknownsubstrateinhibitorDetailsDB09205Moxisylyteapproved, investigationalnosubstrateDetailsDB09568Omega-3-carboxylic acidsapproved, investigationalnosubstrateDetailsDB01601LopinavirapprovednoinhibitorDetailsDB01149Nefazodoneapproved, withdrawnnoinhibitorDetailsDB13141Ambroxol acefyllinateexperimental, investigationalnosubstrateDetailsDB11792MirodenafilinvestigationalunknownsubstrateDetailsDB11979Elagolixapproved, investigationalnosubstrateDetailsDB08865Crizotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB11703Acalabrutinibapproved, investigationalunknownsubstrateDetailsDB12267Brigatinibapproved, investigationalunknowninducerDetailsDB12307ForetinibinvestigationalunknownsubstrateDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB00593EthosuximideapprovedunknownsubstrateDetailsDB01201Rifapentineapproved, investigationalunknowninducerDetailsDB00643Mebendazoleapproved, vet_approvedunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknowninhibitorDetailsDB00334Olanzapineapproved, investigationalunknowninhibitorDetailsDB09212LoxoprofenapprovedunknownsubstrateDetailsDB00635Prednisoneapproved, vet_approvedunknowninducerDetailsDB01222BudesonideapprovedunknownsubstrateinducerDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB11951Lemborexantapproved, investigationalunknowninhibitorinducerDetailsDB12887Tazemetostatapproved, investigationalunknownsubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninducerDetailsDB11652Tucatinibapproved, investigationalunknownsubstrateDetailsDB15035Zanubrutinibapproved, investigationalunknownsubstrateDetailsDB15685Selpercatinibapproved, investigationalunknowninhibitorDetailsDB00409Remoxiprideapproved, withdrawnunknowninhibitorDetailsDB15305Risdiplamapproved, investigationalunknowninhibitorDetailsDB06448Lonafarnibapproved, investigationalnosubstrateinhibitorDetailsDB11853Relugolixapproved, investigationalunknownsubstrateinducerDetailsDB01586Ursodeoxycholic acidapproved, investigationalunknowninducerDetailsDB11742Ebastineapproved, investigationalunknownsubstrateDetailsDB15569Sotorasibapproved, investigationalunknownsubstrateDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB00647Dextropropoxypheneapproved, illicit, investigational, withdrawnunknowninhibitorDetailsDB00333MethadoneapprovednoinhibitorDetailsDB01167Itraconazoleapproved, investigationalnoinhibitorDetailsDB16536Birch bark extractapproved, experimentalunknowninhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateinhibitorDetails"
                    }
                },
                {
                    "Label": "Cytochrome P450 3A5",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 3A5",
                        "Synonyms": "1.14.14.1\nCYPIIIA5\nCytochrome P450 HLp2\nCytochrome P450-PCN3",
                        "Gene Name": "CYP3A5",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0004639|Cytochrome P450 3A5\nMDLIPNLAVETWLLLAVSLVLLYLYGTRTHGLFKRLGIPGPTPLPLLGNVLSYRQGLWKF\nDTECYKKYGKMWGTYEGQLPVLAITDPDVIRTVLVKECYSVFTNRRSLGPVGFMKSAISL\nAEDEEWKRIRSLLSPTFTSGKLKEMFPIIAQYGDVLVRNLRREAEKGKPVTLKDIFGAYS\nMDVITGTSFGVNIDSLNNPQDPFVESTKKFLKFGFLDPLFLSIILFPFLTPVFEALNVSL\nFPKDTINFLSKSVNRMKKSRLNDKQKHRLDFLQLMIDSQNSKETESHKALSDLELAAQSI\nIFIFAGYETTSSVLSFTLYELATHPDVQQKLQKEIDAVLPNKAPPTYDAVVQMEYLDMVV\nNETLRLFPVAIRLERTCKKDVEINGVFIPKGSMVVIPTYALHHDPKYWTEPEEFRPERFS\nKKKDSIDPYIYTPFGTGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLDTQG\nLLQPEKPIVLKVDSRDGTLSGE",
                        "Number of residues": "502",
                        "Molecular Weight": "57108.065",
                        "Theoretical pI": "9.09",
                        "GO Classification": "Functionsaromatase activity / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity / oxygen bindingProcessesalkaloid catabolic process / drug catabolic process / oxidative demethylation / small molecule metabolic process / steroid metabolic process / xenobiotic metabolic processComponentsendoplasmic reticulum membrane / intracellular membrane-bounded organelle",
                        "General Function": "Oxygen binding",
                        "Specific Function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0016766|Cytochrome P450 3A5 (CYP3A5)\nATGGACCTCATCCCAAATTTGGCGGTGGAAACCTGGCTTCTCCTGGCTGTCAGCCTGGTG\nCTCCTCTATCTATATGGGACCCGTACACATGGACTTTTTAAGAGACTGGGAATTCCAGGG\nCCCACACCTCTGCCTTTGTTGGGAAATGTTTTGTCCTATCGTCAGGGTCTCTGGAAATTT\nGACACAGAGTGCTATAAAAAGTATGGAAAAATGTGGGGAACGTATGAAGGTCAACTCCCT\nGTGCTGGCCATCACAGATCCCGACGTGATCAGAACAGTGCTAGTGAAAGAATGTTATTCT\nGTCTTCACAAATCGAAGGTCTTTAGGCCCAGTGGGATTTATGAAAAGTGCCATCTCTTTA\nGCTGAGGATGAAGAATGGAAGAGAATACGGTCATTGCTGTCTCCAACCTTCACCAGCGGA\nAAACTCAAGGAGATGTTCCCCATCATTGCCCAGTATGGAGATGTATTGGTGAGAAACTTG\nAGGCGGGAAGCAGAGAAAGGCAAGCCTGTCACCTTGAAAGACATCTTTGGGGCCTACAGC\nATGGATGTGATTACTGGCACATCATTTGGAGTGAACATCGACTCTCTCAACAATCCACAA\nGACCCCTTTGTGGAGAGCACTAAGAAGTTCCTAAAATTTGGTTTCTTAGATCCATTATTT\nCTCTCAATAATACTCTTTCCATTCCTTACCCCAGTTTTTGAAGCATTAAATGTCTCTCTG\nTTTCCAAAAGATACCATAAATTTTTTAAGTAAATCTGTAAACAGAATGAAGAAAAGTCGC\nCTCAACGACAAACAAAAGCACCGACTAGATTTCCTTCAGCTGATGATTGACTCCCAGAAT\nTCGAAAGAAACTGAGTCCCACAAAGCTCTGTCTGATCTGGAGCTCGCAGCCCAGTCAATA\nATCTTCATTTTTGCTGGCTATGAAACCACCAGCAGTGTTCTTTCCTTCACTTTATATGAA\nCTGGCCACTCACCCTGATGTCCAGCAGAAACTGCAAAAGGAGATTGATGCAGTTTTGCCC\nAATAAGGCACCACCTACCTATGATGCCGTGGTACAGATGGAGTACCTTGACATGGTGGTG\nAATGAAACACTCAGATTATTCCCAGTTGCTATTAGACTTGAGAGGACTTGCAAGAAAGAT\nGTTGAAATCAATGGGGTATTCATTCCCAAAGGGTCAATGGTGGTGATTCCAACTTATGCT\nCTTCACCATGACCCAAAGTACTGGACAGAGCCTGAGGAGTTCCGCCCTGAAAGGTTCAGT\nAAGAAGAAGGACAGCATAGATCCTTACATATACACACCCTTTGGAACTGGACCCAGAAAC\nTGCATTGGCATGAGGTTTGCTCTCATGAACATGAAACTTGCTCTAATCAGAGTCCTTCAG\nAACTTCTCCTTCAAACCTTGTAAAGAAACACAGATCCCCTTGAAATTAGACACGCAAGGA\nCTTCTTCAACCAGAAAAACCCATTGTTCTAAAGGTGGATTCAAGAGATGGAACCCTAAGT\nGGAGAATGA",
                        "Chromosome Location": "7",
                        "Locus": "7q21.1",
                        "External Identifiers": "ResourceLinkUniProtKB IDP20815UniProtKB Entry NameCP3A5_HUMANGenBank Protein ID181346GenBank Gene IDJ04813GenAtlas IDCYP3A5HGNC IDHGNC:2638",
                        "General References": "Aoyama T, Yamano S, Waxman DJ, Lapenson DP, Meyer UA, Fischer V, Tyndale R, Inaba T, Kalow W, Gelboin HV, et al.: Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. J Biol Chem. 1989 Jun 25;264(18):10388-95. [Article] Schuetz JD, Molowa DT, Guzelian PS: Characterization of a cDNA encoding a new member of the glucocorticoid-responsive cytochromes P450 in human liver. Arch Biochem Biophys. 1989 Nov 1;274(2):355-65. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Scherer SW, Cheung J, MacDonald JR, Osborne LR, Nakabayashi K, Herbrick JA, Carson AR, Parker-Katiraee L, Skaug J, Khaja R, Zhang J, Hudek AK, Li M, Haddad M, Duggan GE, Fernandez BA, Kanematsu E, Gentles S, Christopoulos CC, Choufani S, Kwasnicka D, Zheng XH, Lai Z, Nusskern D, Zhang Q, Gu Z, Lu F, Zeesman S, Nowaczyk MJ, Teshima I, Chitayat D, Shuman C, Weksberg R, Zackai EH, Grebe TA, Cox SR, Kirkpatrick SJ, Rahman N, Friedman JM, Heng HH, Pelicci PG, Lo-Coco F, Belloni E, Shaffer LG, Pober B, Morton CC, Gusella JF, Bruns GA, Korf BR, Quade BJ, Ligon AH, Ferguson H, Higgins AW, Leach NT, Herrick SR, Lemyre E, Farra CG, Kim HG, Summers AM, Gripp KW, Roberts W, Szatmari P, Winsor EJ, Grzeschik KH, Teebi A, Minassian BA, Kere J, Armengol L, Pujana MA, Estivill X, Wilson MD, Koop BF, Tosi S, Moore GE, Boright AP, Zlotorynski E, Kerem B, Kroisel PM, Petek E, Oscier DG, Mould SJ, Dohner H, Dohner K, Rommens JM, Vincent JB, Venter JC, Li PW, Mural RJ, Adams MD, Tsui LC: Human chromosome 7: DNA sequence and biology. Science. 2003 May 2;300(5620):767-72. Epub 2003 Apr 10. [Article] Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, Wagner-McPherson C, Layman D, Maas J, Jaeger S, Walker R, Wylie K, Sekhon M, Becker MC, O'Laughlin MD, Schaller ME, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Cordes M, Du H, Sun H, Edwards J, Bradshaw-Cordum H, Ali J, Andrews S, Isak A, Vanbrunt A, Nguyen C, Du F, Lamar B, Courtney L, Kalicki J, Ozersky P, Bielicki L, Scott K, Holmes A, Harkins R, Harris A, Strong CM, Hou S, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Leonard S, Rohlfing T, Rock SM, Tin-Wollam AM, Abbott A, Minx P, Maupin R, Strowmatt C, Latreille P, Miller N, Johnson D, Murray J, Woessner JP, Wendl MC, Yang SP, Schultz BR, Wallis JW, Spieth J, Bieri TA, Nelson JO, Berkowicz N, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Bedell JA, Mardis ER, Clifton SW, Chissoe SL, Marra MA, Raymond C, Haugen E, Gillett W, Zhou Y, James R, Phelps K, Iadanoto S, Bubb K, Simms E, Levy R, Clendenning J, Kaul R, Kent WJ, Furey TS, Baertsch RA, Brent MR, Keibler E, Flicek P, Bork P, Suyama M, Bailey JA, Portnoy ME, Torrents D, Chinwalla AT, Gish WR, Eddy SR, McPherson JD, Olson MV, Eichler EE, Green ED, Waterston RH, Wilson RK: The DNA sequence of human chromosome 7. Nature. 2003 Jul 10;424(6945):157-64. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Gellner K, Eiselt R, Hustert E, Arnold H, Koch I, Haberl M, Deglmann CJ, Burk O, Buntefuss D, Escher S, Bishop C, Koebe HG, Brinkmann U, Klenk HP, Kleine K, Meyer UA, Wojnowski L: Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics. 2001 Mar;11(2):111-21. [Article] Schuetz JD, Schuetz EG, Thottassery JV, Guzelian PS, Strom S, Sun D: Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells. Mol Pharmacol. 1996 Jan;49(1):63-72. [Article] Jounaidi Y, Guzelian PS, Maurel P, Vilarem MJ: Sequence of the 5'-flanking region of CYP3A5: comparative analysis with CYP3A4 and CYP3A7. Biochem Biophys Res Commun. 1994 Dec 30;205(3):1741-7. [Article] Finta C, Zaphiropoulos PG: Intergenic mRNA molecules resulting from trans-splicing. J Biol Chem. 2002 Feb 22;277(8):5882-90. Epub 2001 Nov 28. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Jounaidi Y, Hyrailles V, Gervot L, Maurel P: Detection of CYP3A5 allelic variant: a candidate for the polymorphic expression of the protein? Biochem Biophys Res Commun. 1996 Apr 16;221(2):466-70. [Article] Chou FC, Tzeng SJ, Huang JD: Genetic polymorphism of cytochrome P450 3A5 in Chinese. Drug Metab Dispos. 2001 Sep;29(9):1205-9. [Article] Lee SJ, Usmani KA, Chanas B, Ghanayem B, Xi T, Hodgson E, Mohrenweiser HW, Goldstein JA: Genetic findings and functional studies of human CYP3A5 single nucleotide polymorphisms in different ethnic groups. Pharmacogenetics. 2003 Aug;13(8):461-72. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00224IndinavirapprovedunknownsubstrateinhibitorDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinducerDetailsDB00468QuinineapprovedunknownsubstrateDetailsDB00541Vincristineapproved, investigationalnosubstrateDetailsDB00661VerapamilapprovedunknownsubstrateinhibitorDetailsDB00683Midazolamapproved, illicitunknownsubstrateDetailsDB00694DaunorubicinapprovedunknowninducerDetailsDB00758ClopidogrelapprovednosubstrateDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateDetailsDB00834Mifepristoneapproved, investigationalunknownsubstrateDetailsDB00864Tacrolimusapproved, investigationalunknownsubstrateDetailsDB01026Ketoconazoleapproved, investigationalnoinhibitorDetailsDB01232Saquinavirapproved, investigationalunknownsubstrateinhibitorDetailsDB13179TroleandomycinapprovedunknowninhibitorDetailsDB04856DexloxiglumideinvestigationalunknownsubstrateDetailsDB04957AzimilideinvestigationalunknownsubstrateDetailsDB06267Udenafilapproved, investigationalunknownsubstrateDetailsDB06287TemsirolimusapprovedunknownsubstrateinhibitorDetailsDB00802Alfentanilapproved, illicitunknownsubstrateDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateDetailsDB01181IfosfamideapprovedunknownsubstrateDetailsDB00321AmitriptylineapprovedunknownsubstrateDetailsDB00540NortriptylineapprovedunknownsubstrateDetailsDB00619ImatinibapprovednosubstrateinhibitorDetailsDB00675TamoxifenapprovedunknownsubstrateDetailsDB01041Thalidomideapproved, investigational, withdrawnnosubstrateinducerDetailsDB00220NelfinavirapprovednosubstrateinhibitorDetailsDB00238NevirapineapprovedunknownsubstrateDetailsDB06652VicrivirocinvestigationalunknownsubstrateDetailsDB00972AzelastineapprovedunknownsubstrateDetailsDB01211ClarithromycinapprovedunknownsubstrateinhibitorDetailsDB00404Alprazolamapproved, illicit, investigationalunknownsubstrateDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB00897Triazolamapproved, investigationalunknownsubstrateDetailsDB00604Cisaprideapproved, investigational, withdrawnunknownsubstrateDetailsDB00637Astemizoleapproved, withdrawnunknownsubstrateDetailsDB01114ChlorpheniramineapprovedunknownsubstrateDetailsDB00342Terfenadineapproved, withdrawnunknownsubstrateDetailsDB00381AmlodipineapprovedunknownsubstrateinhibitorDetailsDB00343Diltiazemapproved, investigationalunknownsubstrateinhibitorDetailsDB01023Felodipineapproved, investigationalunknownsubstrateDetailsDB00528Lercanidipineapproved, investigationalunknownsubstrateDetailsDB00401NisoldipineapprovedunknownsubstrateDetailsDB01054Nitrendipineapproved, investigationalunknownsubstrateDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB00439Cerivastatinapproved, withdrawnunknownsubstrateDetailsDB00641SimvastatinapprovedunknownsubstrateDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00741Hydrocortisoneapproved, vet_approvedunknownsubstrateDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateDetailsDB00624Testosteroneapproved, investigationalunknownsubstrateDetailsDB01238Aripiprazoleapproved, investigationalnosubstrateDetailsDB00490Buspironeapproved, investigationalunknownsubstrateDetailsDB01166Cilostazolapproved, investigationalunknownsubstrateDetailsDB00250Dapsoneapproved, investigationalunknownsubstrateDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB01248Docetaxelapproved, investigationalunknownsubstrateDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB00700EplerenoneapprovedunknownsubstrateDetailsDB01216FinasterideapprovedunknownsubstrateDetailsDB00502HaloperidolapprovedunknownsubstrateDetailsDB00281Lidocaineapproved, vet_approvedunknownsubstrateDetailsDB00731Nateglinideapproved, investigationalunknownsubstrateDetailsDB00904Ondansetronapproved, withdrawnunknownsubstrateDetailsDB01100PimozideapprovedunknownsubstrateDetailsDB00571Propranololapproved, investigationalunknownsubstrateDetailsDB01224QuetiapineapprovedunknownsubstrateDetailsDB00938SalmeterolapprovedunknownsubstrateDetailsDB00877Sirolimusapproved, investigationalnosubstrateDetailsDB00398Sorafenibapproved, investigationalunknownsubstrateDetailsDB01268Sunitinibapproved, investigationalunknownsubstrateDetailsDB01229Paclitaxelapproved, vet_approvedunknownsubstrateDetailsDB00656Trazodoneapproved, investigationalunknownsubstrateDetailsDB00962Zaleplonapproved, illicit, investigationalunknownsubstrateDetailsDB01167Itraconazoleapproved, investigationalnoinhibitorDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00446Chloramphenicolapproved, vet_approved, withdrawnunknowninhibitorDetailsDB00537Ciprofloxacinapproved, investigationalunknowninhibitorDetailsDB00705DelavirdineapprovedunknowninhibitorDetailsDB06730GestodeneinvestigationalunknowninhibitorDetailsDB01388Mibefradilinvestigational, withdrawnunknowninhibitorDetailsDB06731SeproxetineinvestigationalunknowninhibitorDetailsDB00582VoriconazoleapprovedunknownsubstrateinhibitorDetailsDB00313Valproic acidapproved, investigationalunknownsubstrateDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB06772CabazitaxelapprovedunknownsubstrateDetailsDB06697ArtemetherapprovedunknownsubstrateDetailsDB00701Amprenavirapproved, investigationalunknownsubstrateDetailsDB00278Argatrobanapproved, investigationalunknownsubstrateDetailsDB00394Beclomethasone dipropionateapproved, investigationalunknowninducerDetailsDB00564Carbamazepineapproved, investigationalunknownsubstrateinducerDetailsDB00608Chloroquineapproved, investigational, vet_approvednosubstrateDetailsDB00822DisulfiramapprovedunknownsubstrateDetailsDB00655EstroneapprovedunknownsubstrateDetailsDB00773EtoposideapprovedunknownsubstrateDetailsDB00499Flutamideapproved, investigationalunknownsubstrateDetailsDB01218HalofantrineapprovedunknownsubstrateDetailsDB01103QuinacrineinvestigationalnosubstrateDetailsDB00745Modafinilapproved, investigationalnosubstrateinducerDetailsDB00622Nicardipineapproved, investigationalunknowninhibitorDetailsDB00776OxcarbazepineapprovednoinhibitorinducerDetailsDB01062Oxybutyninapproved, investigationalunknownsubstrateDetailsDB00497Oxycodoneapproved, illicit, investigationalunknownsubstrateDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB01174Phenobarbitalapproved, investigationalnoinducerDetailsDB01058Praziquantelapproved, investigational, vet_approvedunknownsubstrateDetailsDB00206Reserpineapproved, investigational, withdrawnunknowninducerDetailsDB00444TeniposideapprovednosubstrateDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknowninhibitorDetailsDB00862VardenafilapprovedunknownsubstrateDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateDetailsDB00588Fluticasone propionateapprovedunknownsubstrateinhibitorDetailsDB00738Pentamidineapproved, investigationalunknownsubstrateDetailsDB00755Tretinoinapproved, investigational, nutraceuticalnosubstrateDetailsDB01254Dasatinibapproved, investigationalunknownsubstrateDetailsDB01259Lapatinibapproved, investigationalunknownsubstrateDetailsDB04946IloperidoneapprovedunknownsubstrateDetailsDB06176Romidepsinapproved, investigationalunknownsubstrateDetailsDB06335SaxagliptinapprovedunknownsubstrateDetailsDB06413Armodafinilapproved, investigationalunknowninducerDetailsDB00575ClonidineapprovedunknownsubstrateDetailsDB06419CethromycininvestigationalunknownsubstrateDetailsDB08873Boceprevirapproved, withdrawnunknownsubstrateinhibitorDetailsDB06228RivaroxabanapprovedunknownsubstrateDetailsDB08883PerampanelapprovednosubstrateDetailsDB08865Crizotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB06605ApixabanapprovedunknownsubstrateDetailsDB06626Axitinibapproved, investigationalnosubstrateDetailsDB08899EnzalutamideapprovednosubstrateinducerDetailsDB08901Ponatinibapproved, investigationalunknownsubstrateDetailsDB05773Trastuzumab emtansineapproved, investigationalunknownsubstrateDetailsDB00531Cyclophosphamideapproved, investigationalunknownsubstrateDetailsDB01095FluvastatinapprovedunknownsubstrateDetailsDB00472Fluoxetineapproved, vet_approvedunknownsubstrateDetailsDB00317Gefitinibapproved, investigationalunknownsubstrateDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB09053IbrutinibapprovedunknownsubstrateDetailsDB09068Vortioxetineapproved, investigationalnosubstrateDetailsDB09102Daclatasvirapproved, investigationalunknownsubstrateDetailsDB06403Ambrisentanapproved, investigationalnosubstrateDetailsDB06789Hydroxyprogesterone caproateapproved, investigationalunknownsubstrateDetailsDB09297Paritaprevirapproved, investigationalnosubstrateDetailsDB12161Deutetrabenazineapproved, investigationalnosubstrateDetailsDB11915Valbenazineapproved, investigationalnosubstrateDetailsDB08820IvacaftorapprovednosubstrateinhibitorDetailsDB09054IdelalisibapprovednosubstrateinhibitorDetailsDB09065CobicistatapprovednosubstrateDetailsDB06412Oxymetholoneapproved, illicitunknowninhibitorDetailsDB00503Ritonavirapproved, investigationalunknownsubstrateinhibitorDetailsDB06595Midostaurinapproved, investigationalunknowninducerDetailsDB11574ElbasvirapprovedunknownsubstrateDetailsDB12483Copanlisibapproved, investigationalnosubstrateDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB09061Cannabidiolapproved, investigationalunknownsubstrateinhibitorDetailsDB13943Testosterone cypionateapprovedunknownsubstrateDetailsDB13944Testosterone enanthateapprovedunknownsubstrateDetailsDB13946Testosterone undecanoateapproved, investigationalunknownsubstrateDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateDetailsDB09231BenidipineexperimentalnosubstrateDetailsDB11633Isavuconazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB11712Tezacaftorapproved, investigationalnosubstrateinducerDetailsDB11586Asunaprevirapproved, investigational, withdrawnnosubstrateinducerDetailsDB14011NabiximolsinvestigationalunknownsubstrateDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorDetailsDB00625Efavirenzapproved, investigationalunknowninducerDetailsDB00199Erythromycinapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB14185Aripiprazole lauroxilapproved, investigationalunknownsubstrateDetailsDB14538Hydrocortisone aceponateexperimental, vet_approvedunknownsubstrateDetailsDB14539Hydrocortisone acetateapproved, vet_approvedunknownsubstrateDetailsDB14540Hydrocortisone butyrateapproved, vet_approvedunknownsubstrateDetailsDB14541Hydrocortisone cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB14542Hydrocortisone phosphateapproved, vet_approvedunknownsubstrateDetailsDB14543Hydrocortisone probutateapproved, vet_approvedunknownsubstrateDetailsDB14544Hydrocortisone valerateapproved, vet_approvedunknownsubstrateDetailsDB01222BudesonideapprovednoinducerDetailsDB06654Safinamideapproved, investigationalunknowninhibitorDetailsDB11703Acalabrutinibapproved, investigationalunknowninhibitorDetailsDB01267PaliperidoneapprovedunknownsubstrateDetailsDB11737Icotinibexperimental, investigationalunknownsubstrateinducerDetailsDB00909Zonisamideapproved, investigationalnosubstrateDetailsDB09256Tegafurapproved, investigationalunknownsubstrateDetailsDB12301Doravirineapproved, investigationalunknownsubstrateDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateDetailsDB09074OlaparibapprovedunknownsubstrateinhibitorDetailsDB00455Loratadineapproved, investigationalunknownsubstrateDetailsDB13867Fluticasoneapproved, experimentalunknownsubstrateinhibitorinducerDetailsDB08906Fluticasone furoateapprovednosubstrateinhibitorinducerDetailsDB01126Dutasterideapproved, investigationalnosubstrateDetailsDB00905Bimatoprostapproved, investigationalunknownsubstrateDetailsDB00916MetronidazoleapprovedunknownsubstrateDetailsDB00288AmcinonideapprovedunknowninducerDetailsDB00443Betamethasoneapproved, vet_approvedunknowninducerDetailsDB14669Betamethasone phosphateapproved, vet_approvedunknowninducerDetailsDB11750Clobetasolapproved, experimental, investigationalunknowninducerDetailsDB01013Clobetasol propionateapprovedunknowninducerDetailsDB14652Clocortolone acetateexperimentalunknowninducerDetailsDB13843CloprednolexperimentalunknowninducerDetailsDB14681CortisoneexperimentalunknowninducerDetailsDB01380Cortisone acetateapproved, investigationalunknowninducerDetailsDB13003CortivazolinvestigationalunknowninducerDetailsDB11921Deflazacortapproved, investigationalunknowninducerDetailsDB11487Dexamethasone isonicotinatevet_approvedunknowninducerDetailsDB09095Difluocortoloneapproved, investigational, withdrawnunknowninducerDetailsDB01047Fluocinonideapproved, investigationalunknowninducerDetailsDB08971Fluocortoloneapproved, withdrawnunknowninducerDetailsDB00324Fluorometholoneapproved, investigationalunknowninducerDetailsDB08970FluprednideneexperimentalunknowninducerDetailsDB14634Fluprednidene acetateexperimentalunknowninducerDetailsDB13728HalometasoneexperimentalunknowninducerDetailsDB00253MedrysoneapprovedunknowninducerDetailsDB14659Melengestrol acetateexperimentalunknowninducerDetailsDB09383Meprednisoneapproved, investigationalunknowninducerDetailsDB14644Methylprednisolone hemisuccinateapprovedunknowninducerDetailsDB00764MometasoneexperimentalunknowninducerDetailsDB14512Mometasone furoateapproved, investigational, vet_approvednoinducerDetailsDB01384ParamethasoneexperimentalunknowninducerDetailsDB14633Prednisolone hemisuccinateexperimentalunknowninducerDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninducerDetailsDB00635Prednisoneapproved, vet_approvedunknowninducerDetailsDB14646Prednisone acetateapproved, experimental, investigationalunknowninducerDetailsDB13208PrednylideneexperimentalunknowninducerDetailsDB00896RimexoloneapprovedunknowninducerDetailsDB00620Triamcinoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB01045RifampicinapprovedunknowninducerDetailsDB00196Fluconazoleapproved, investigationalunknowninhibitorDetailsDB02520DitiocarbexperimentalunknowninhibitorDetailsDB00367Levonorgestrelapproved, investigationalunknownsubstrateDetailsDB01016GlyburideapprovedunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknownsubstrateDetailsDB09061Cannabidiolapproved, investigationalunknowninhibitorDetailsDB11761Tenapanorapproved, investigationalunknownsubstrateDetailsDB14011NabiximolsinvestigationalunknowninhibitorDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB04855DronedaroneapprovedunknownsubstrateinhibitorDetailsDB01217Anastrozoleapproved, investigationalunknownsubstrateDetailsDB15444Elexacaftorapproved, investigationalnosubstrateDetailsDB00557HydroxyzineapprovednosubstrateDetailsDB06119Cenobamateapproved, investigationalunknownsubstrateinhibitorDetailsDB11951Lemborexantapproved, investigationalunknownsubstrateDetailsDB01115NifedipineapprovedunknownsubstrateDetailsDB01190Clindamycinapproved, vet_approvedunknownsubstrateDetailsDB00977EthinylestradiolapprovedunknownsubstrateDetailsDB13609UmifenovirinvestigationalunknownsubstrateDetailsDB11837Osilodrostatapproved, investigationalunknowninhibitorDetailsDB09241Methylene blueapproved, investigationalunknowninhibitorDetailsDB11689Selumetinibapproved, investigationalnosubstrateDetailsDB00845Clofazimineapproved, investigationalunknowninhibitorDetailsDB00714Apomorphineapproved, investigationalunknownsubstrateDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB15822Pralsetinibapproved, investigationalnoinhibitorinducerDetailsDB06448Lonafarnibapproved, investigationalnosubstrateinhibitorDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB05667Levoketoconazoleapproved, investigationalnoinhibitorinducerDetailsDB14984Casimersenapproved, investigationalnoinhibitorDetailsDB12016Ponesimodapproved, investigationalunknownsubstrateDetailsDB05316Pimavanserinapproved, investigationalunknownsubstrateDetailsDB08816TicagrelorapprovedunknownsubstrateactivatorDetailsDB16222Loncastuximab tesirineapproved, investigationalunknownsubstrateDetailsDB12543Samidorphanapproved, investigationalnosubstrateDetailsDB12265Fexinidazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB16390Mobocertinibapproved, investigationalunknownsubstrateDetailsDB12834SecnidazoleapprovedunknownsubstrateDetailsDB00470Dronabinolapproved, illicitnoinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknowninhibitorDetailsDB06230Nalmefeneapproved, investigational, withdrawnnosubstrateDetailsDB05087Ganaxoloneapproved, investigationalnosubstrateDetailsDB06016Cariprazineapproved, investigationalnoinducerDetailsDB09185Viloxazineapproved, investigational, withdrawnnoinhibitorDetailsDB14921Mavacamtenapproved, investigationalnosubstrateDetailsDB01024Mycophenolic acidapproved, investigationalunknownsubstrateDetailsDB11739Vonoprazanapproved, investigationalunknownsubstrateDetailsDB05239Cobimetinibapproved, investigationalnoDetailsDB12240Polatuzumab vedotinapproved, investigationalnosubstrateDetailsDB17472Pirtobrutinibapproved, investigationalunknowninducerDetailsDB00349Clobazamapproved, illicitnosubstrateDetailsDB09065CobicistatapprovedyesinhibitorDetailsDB16217Leniolisibapproved, investigationalnosubstrateDetailsDB12874Quizartinibapproved, investigationalnosubstrateDetailsDB05812AbirateroneapprovedunknowninhibitorDetailsDB11718Encorafenibapproved, investigationalnoinhibitorDetailsDB01072Atazanavirapproved, investigationalunknowninhibitorDetailsDB15114Vamoroloneapproved, investigationalnosubstrateDetailsDB16826RepotrectinibinvestigationalunknownDetailsDB11679FruquintinibinvestigationalnosubstrateDetailsDB00176Fluvoxamineapproved, investigationalunknowninhibitorDetailsDB00599Thiopentalapproved, vet_approvedunknownsubstrateDetailsDB08930DolutegravirapprovednosubstrateDetailsDB06595Midostaurinapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB13174RheinexperimentalunknowninhibitorDetailsDB11994Diacereinapproved, investigationalunknowninhibitorDetailsDB11605MyrrhapprovedunknowninducerDetailsDB11691Naldemedineapproved, investigationalnosubstrateDetailsDB13878Pibrentasvirapproved, investigationalunknowninhibitorDetailsDB13879Glecaprevirapproved, investigationalunknownsubstrateinhibitorDetailsDB09205Moxisylyteapproved, investigationalnosubstrateDetailsDB09568Omega-3-carboxylic acidsapproved, investigationalnosubstrateDetailsDB01601LopinavirapprovednoinhibitorDetailsDB01149Nefazodoneapproved, withdrawnnoinhibitorDetailsDB13141Ambroxol acefyllinateexperimental, investigationalnosubstrateDetailsDB11792MirodenafilinvestigationalunknownsubstrateDetailsDB11979Elagolixapproved, investigationalnosubstrateDetailsDB08865Crizotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB11703Acalabrutinibapproved, investigationalunknownsubstrateDetailsDB12267Brigatinibapproved, investigationalunknowninducerDetailsDB12307ForetinibinvestigationalunknownsubstrateDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB00593EthosuximideapprovedunknownsubstrateDetailsDB01201Rifapentineapproved, investigationalunknowninducerDetailsDB00643Mebendazoleapproved, vet_approvedunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknowninhibitorDetailsDB00334Olanzapineapproved, investigationalunknowninhibitorDetailsDB09212LoxoprofenapprovedunknownsubstrateDetailsDB00635Prednisoneapproved, vet_approvedunknowninducerDetailsDB01222BudesonideapprovedunknownsubstrateinducerDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB11951Lemborexantapproved, investigationalunknowninhibitorinducerDetailsDB12887Tazemetostatapproved, investigationalunknownsubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninducerDetailsDB11652Tucatinibapproved, investigationalunknownsubstrateDetailsDB15035Zanubrutinibapproved, investigationalunknownsubstrateDetailsDB15685Selpercatinibapproved, investigationalunknowninhibitorDetailsDB00409Remoxiprideapproved, withdrawnunknowninhibitorDetailsDB15305Risdiplamapproved, investigationalunknowninhibitorDetailsDB06448Lonafarnibapproved, investigationalnosubstrateinhibitorDetailsDB11853Relugolixapproved, investigationalunknownsubstrateinducerDetailsDB01586Ursodeoxycholic acidapproved, investigationalunknowninducerDetailsDB11742Ebastineapproved, investigationalunknownsubstrateDetailsDB15569Sotorasibapproved, investigationalunknownsubstrateDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB00647Dextropropoxypheneapproved, illicit, investigational, withdrawnunknowninhibitorDetailsDB00333MethadoneapprovednoinhibitorDetailsDB01167Itraconazoleapproved, investigationalnoinhibitorDetailsDB16536Birch bark extractapproved, experimentalunknowninhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateinhibitorDetails"
                    }
                },
                {
                    "Label": "Cytochrome P450 3A7",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 3A7",
                        "Synonyms": "1.14.14.1\nCYPIIIA7\nCytochrome P450-HFLA",
                        "Gene Name": "CYP3A7",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0006949|Cytochrome P450 3A7\nMDLIPNLAVETWLLLAVSLILLYLYGTRTHGLFKKLGIPGPTPLPFLGNALSFRKGYWTF\nDMECYKKYRKVWGIYDCQQPMLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKNAISI\nAEDEEWKRIRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKHVFGAYS\nMDVITSTSFGVSIDSLNNPQDPFVENTKKLLRFNPLDPFVLSIKVFPFLTPILEALNITV\nFPRKVISFLTKSVKQIKEGRLKETQKHRVDFLQLMIDSQNSKDSETHKALSDLELMAQSI\nIFIFAGYETTSSVLSFIIYELATHPDVQQKVQKEIDTVLPNKAPPTYDTVLQLEYLDMVV\nNETLRLFPVAMRLERVCKKDVEINGMFIPKGVVVMIPSYVLHHDPKYWREPEKFLPERFS\nKKNKDNIDPYIYTPFGSGPRNCIGMRFALVNMKLALVRVLQNFSFKPCKETQIPLKLRFG\nGLLLTEKPIVLKAESRDETVSGA",
                        "Number of residues": "503",
                        "Molecular Weight": "57525.03",
                        "Theoretical pI": "9.59",
                        "GO Classification": "Functionsaromatase activity / heme binding / iron ion binding / monooxygenase activity / oxygen bindingProcessessmall molecule metabolic process / xenobiotic metabolic processComponentsendoplasmic reticulum membrane",
                        "General Function": "Oxygen binding",
                        "Specific Function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0019448|Cytochrome P450 3A7 (CYP3A7)\nATGGATCTCATCCCAAACTTGGCCGTGGAAACCTGGCTTCTCCTGGCTGTCAGCCTGATA\nCTCCTCTATCTATATGGAACCCGTACACATGGACTTTTTAAGAAGCTTGGAATTCCAGGG\nCCCACACCTCTGCCTTTTTTGGGAAATGCTTTGTCCTTCCGTAAGGGCTATTGGACGTTT\nGACATGGAATGTTATAAAAAGTATAGAAAAGTCTGGGGTATTTATGACTGTCAACAGCCT\nATGCTGGCTATCACAGATCCCGACATGATCAAAACAGTGCTAGTGAAAGAATGTTATTCT\nGTCTTCACAAACCGGAGGCCTTTCGGGCCAGTGGGATTTATGAAAAATGCCATCTCTATA\nGCTGAGGATGAAGAATGGAAGAGAATACGATCATTGCTGTCTCCAACATTCACCAGCGGA\nAAACTCAAGGAGATGGTCCCTATCATTGCCCAGTATGGAGATGTGTTGGTGAGAAATCTG\nAGGCGGGAAGCAGAGACAGGCAAGCCTGTCACCTTGAAACACGTCTTTGGGGCCTACAGC\nATGGATGTGATCACTAGCACATCATTTGGAGTGAGCATCGACTCTCTCAACAATCCACAA\nGACCCCTTTGTGGAAAACACCAAGAAGCTTTTAAGATTTAATCCATTAGATCCATTCGTT\nCTCTCAATAAAAGTCTTTCCATTCCTTACCCCAATTCTTGAAGCATTAAATATCACTGTG\nTTTCCAAGAAAAGTTATAAGTTTTCTAACAAAATCTGTAAAACAGATAAAAGAAGGTCGC\nCTCAAAGAGACACAAAAGCACCGAGTGGATTTCCTTCAGCTGATGATTGACTCTCAGAAT\nTCAAAAGACTCTGAGACCCACAAAGCTCTGTCTGATCTGGAGCTCATGGCCCAATCAATT\nATCTTTATTTTTGCTGGCTATGAAACCACGAGCAGTGTTCTCTCCTTCATTATATATGAA\nCTGGCCACTCACCCTGATGTCCAGCAGAAAGTGCAGAAGGAAATTGATACAGTTTTACCC\nAATAAGGCACCACCCACCTATGATACTGTGCTACAGTTGGAGTATCTTGACATGGTGGTG\nAATGAAACACTCAGATTATTCCCAGTTGCTATGAGACTTGAGAGGGTCTGCAAAAAAGAT\nGTTGAAATCAATGGGATGTTTATTCCCAAAGGGGTGGTGGTGATGATTCCAAGCTATGTT\nCTTCATCATGACCCAAAGTACTGGACAGAGCCTGAGAAGTTCCTCCCTGAAAGGTTCAGT\nAAAAAGAACAAGGACAACATAGATCCTTACATATACACACCCTTTGGAAGTGGACCCAGA\nAACTGCATTGGCATGAGGTTTGCTCTCGTGAACATGAAACTTGCTCTAGTCAGAGTCCTT\nCAGAACTTCTCCTTCAAACCTTGTAAAGAAACACAGATCCCCCTGAAATTACGCTTTGGA\nGGACTTCTTCTAACAGAAAAACCCATTGTTCTAAAGGCTGAGTCAAGGGATGAGACCTTT\nGTAGATATGGAGCCCATTCACATGGACTTTTTAAGAAGCTTGGCATTCCAGGGCCCACAC\nCTCTGCTTTTTTTGGGAACTACTTTGTCCTACCATCAGATCCCGCTGA",
                        "Chromosome Location": "7",
                        "Locus": "7q21-q22.1",
                        "External Identifiers": "ResourceLinkUniProtKB IDP24462UniProtKB Entry NameCP3A7_HUMANGenBank Protein ID220149GenBank Gene IDD00408HGNC IDHGNC:2640",
                        "General References": "Komori M, Nishio K, Ohi H, Kitada M, Kamataki T: Molecular cloning and sequence analysis of cDNA containing the entire coding region for human fetal liver cytochrome P-450. J Biochem. 1989 Feb;105(2):161-3. [Article] Finta C, Zaphiropoulos PG: The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons. Gene. 2000 Dec 30;260(1-2):13-23. [Article] Gellner K, Eiselt R, Hustert E, Arnold H, Koch I, Haberl M, Deglmann CJ, Burk O, Buntefuss D, Escher S, Bishop C, Koebe HG, Brinkmann U, Klenk HP, Kleine K, Meyer UA, Wojnowski L: Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics. 2001 Mar;11(2):111-21. [Article] Scherer SW, Cheung J, MacDonald JR, Osborne LR, Nakabayashi K, Herbrick JA, Carson AR, Parker-Katiraee L, Skaug J, Khaja R, Zhang J, Hudek AK, Li M, Haddad M, Duggan GE, Fernandez BA, Kanematsu E, Gentles S, Christopoulos CC, Choufani S, Kwasnicka D, Zheng XH, Lai Z, Nusskern D, Zhang Q, Gu Z, Lu F, Zeesman S, Nowaczyk MJ, Teshima I, Chitayat D, Shuman C, Weksberg R, Zackai EH, Grebe TA, Cox SR, Kirkpatrick SJ, Rahman N, Friedman JM, Heng HH, Pelicci PG, Lo-Coco F, Belloni E, Shaffer LG, Pober B, Morton CC, Gusella JF, Bruns GA, Korf BR, Quade BJ, Ligon AH, Ferguson H, Higgins AW, Leach NT, Herrick SR, Lemyre E, Farra CG, Kim HG, Summers AM, Gripp KW, Roberts W, Szatmari P, Winsor EJ, Grzeschik KH, Teebi A, Minassian BA, Kere J, Armengol L, Pujana MA, Estivill X, Wilson MD, Koop BF, Tosi S, Moore GE, Boright AP, Zlotorynski E, Kerem B, Kroisel PM, Petek E, Oscier DG, Mould SJ, Dohner H, Dohner K, Rommens JM, Vincent JB, Venter JC, Li PW, Mural RJ, Adams MD, Tsui LC: Human chromosome 7: DNA sequence and biology. Science. 2003 May 2;300(5620):767-72. Epub 2003 Apr 10. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Wrighton SA, Vandenbranden M: Isolation and characterization of human fetal liver cytochrome P450HLp2: a third member of the P450III gene family. Arch Biochem Biophys. 1989 Jan;268(1):144-51. [Article] Komori M, Nishio K, Fujitani T, Ohi H, Kitada M, Mima S, Itahashi K, Kamataki T: Isolation of a new human fetal liver cytochrome P450 cDNA clone: evidence for expression of a limited number of forms of cytochrome P450 in human fetal livers. Arch Biochem Biophys. 1989 Jul;272(1):219-25. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00199Erythromycinapproved, investigational, vet_approvednosubstrateinhibitorDetailsDB00908Quinidineapproved, investigationalunknownsubstrateDetailsDB00404Alprazolamapproved, illicit, investigationalunknownsubstrateDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB00897Triazolamapproved, investigationalunknownsubstrateDetailsDB00224IndinavirapprovedunknowninhibitorDetailsDB00220NelfinavirapprovednoinhibitorDetailsDB01232Saquinavirapproved, investigationalunknownsubstrateinhibitorDetailsDB00604Cisaprideapproved, investigational, withdrawnunknownsubstrateDetailsDB00637Astemizoleapproved, withdrawnunknownsubstrateDetailsDB01114ChlorpheniramineapprovedunknownsubstrateDetailsDB00342Terfenadineapproved, withdrawnunknownsubstrateDetailsDB00343Diltiazemapproved, investigationalunknownsubstrateinhibitorDetailsDB01023Felodipineapproved, investigationalunknownsubstrateDetailsDB00528Lercanidipineapproved, investigationalunknownsubstrateDetailsDB00401NisoldipineapprovedunknownsubstrateDetailsDB01054Nitrendipineapproved, investigationalunknownsubstrateDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB00439Cerivastatinapproved, withdrawnunknownsubstrateDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00741Hydrocortisoneapproved, vet_approvedunknownsubstrateDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00624Testosteroneapproved, investigationalunknownsubstrateDetailsDB00802Alfentanilapproved, illicitunknownsubstrateDetailsDB01238Aripiprazoleapproved, investigationalnosubstrateDetailsDB00490Buspironeapproved, investigationalunknownsubstrateDetailsDB01166Cilostazolapproved, investigationalunknownsubstrateDetailsDB00250Dapsoneapproved, investigationalunknownsubstrateDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB00514DextromethorphanapprovedunknownsubstrateDetailsDB01248Docetaxelapproved, investigationalunknownsubstrateDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB01216FinasterideapprovedunknownsubstrateDetailsDB00619ImatinibapprovednosubstrateinhibitorDetailsDB00502HaloperidolapprovedunknownsubstrateDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateDetailsDB01227Levacetylmethadolapproved, investigational, withdrawnunknownsubstrateDetailsDB00281Lidocaineapproved, vet_approvedunknownsubstrateDetailsDB00333MethadoneapprovedunknownsubstrateDetailsDB00731Nateglinideapproved, investigationalunknownsubstrateDetailsDB00904Ondansetronapproved, withdrawnunknownsubstrateDetailsDB01100PimozideapprovedunknownsubstrateDetailsDB00571Propranololapproved, investigationalunknownsubstrateDetailsDB00468QuinineapprovedunknownsubstrateDetailsDB00938SalmeterolapprovedunknownsubstrateDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateDetailsDB00877Sirolimusapproved, investigationalnosubstrateDetailsDB00398Sorafenibapproved, investigationalunknownsubstrateDetailsDB01268Sunitinibapproved, investigationalunknownsubstrateDetailsDB00675TamoxifenapprovedunknownsubstrateDetailsDB01229Paclitaxelapproved, vet_approvedunknownsubstrateDetailsDB06287TemsirolimusapprovedunknownsubstrateDetailsDB00656Trazodoneapproved, investigationalunknownsubstrateDetailsDB00541Vincristineapproved, investigationalunknownsubstrateDetailsDB00962Zaleplonapproved, illicit, investigationalunknownsubstrateDetailsDB01167Itraconazoleapproved, investigationalnoinhibitorDetailsDB00446Chloramphenicolapproved, vet_approved, withdrawnunknowninhibitorDetailsDB00537Ciprofloxacinapproved, investigationalunknowninhibitorDetailsDB00705DelavirdineapprovedunknowninhibitorDetailsDB06730GestodeneinvestigationalunknowninhibitorDetailsDB01388Mibefradilinvestigational, withdrawnunknowninhibitorDetailsDB06731SeproxetineinvestigationalunknowninhibitorDetailsDB00582VoriconazoleapprovedunknownsubstrateinhibitorDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB00257Clotrimazoleapproved, vet_approvedunknowninducerDetailsDB00458ImipramineapprovedunknownsubstrateDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinducerDetailsDB01058Praziquantelapproved, investigational, vet_approvedunknownsubstrateDetailsDB01045RifampicinapprovedunknowninducerDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknowninhibitorDetailsDB00588Fluticasone propionateapprovedunknownsubstrateDetailsDB00755Tretinoinapproved, investigational, nutraceuticalunknownsubstrateDetailsDB04946IloperidoneapprovedunknownsubstrateDetailsDB01708Prasteroneapproved, investigational, nutraceuticalunknownsubstrateinhibitorDetailsDB05804Prasterone sulfateinvestigationalunknownsubstrateDetailsDB01174Phenobarbitalapproved, investigationalnoinducerDetailsDB09102Daclatasvirapproved, investigationalunknownsubstrateDetailsDB09054IdelalisibapprovednosubstrateinhibitorDetailsDB09065CobicistatapprovednosubstrateDetailsDB06412Oxymetholoneapproved, illicitnoinhibitorDetailsDB00503Ritonavirapproved, investigationalnosubstrateinhibitorDetailsDB06595Midostaurinapproved, investigationalunknowninducerDetailsDB11574ElbasvirapprovedunknownsubstrateDetailsDB12483Copanlisibapproved, investigationalnosubstrateDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB13943Testosterone cypionateapprovedunknownsubstrateDetailsDB13944Testosterone enanthateapprovedunknownsubstrateDetailsDB13946Testosterone undecanoateapproved, investigationalunknownsubstrateDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateDetailsDB14009Medical Cannabisexperimental, investigationalunknowninhibitorDetailsDB00625Efavirenzapproved, investigationalunknowninducerDetailsDB13179TroleandomycinapprovedunknowninhibitorDetailsDB14185Aripiprazole lauroxilapproved, investigationalunknownsubstrateDetailsDB14538Hydrocortisone aceponateexperimental, vet_approvedunknownsubstrateDetailsDB14539Hydrocortisone acetateapproved, vet_approvedunknownsubstrateDetailsDB14540Hydrocortisone butyrateapproved, vet_approvedunknownsubstrateDetailsDB14541Hydrocortisone cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB14542Hydrocortisone phosphateapproved, vet_approvedunknownsubstrateDetailsDB14543Hydrocortisone probutateapproved, vet_approvedunknownsubstrateDetailsDB14544Hydrocortisone valerateapproved, vet_approvedunknownsubstrateDetailsDB13867Fluticasoneapproved, experimentalunknownsubstrateDetailsDB08906Fluticasone furoateapprovednosubstrateDetailsDB00916MetronidazoleapprovedunknownsubstrateDetailsDB00683Midazolamapproved, illicitunknownsubstrateDetailsDB00238NevirapineapprovedunknownsubstrateDetailsDB01016GlyburideapprovedunknownsubstrateDetailsDB00620Triamcinoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB09061Cannabidiolapproved, investigationalunknowninhibitorDetailsDB14011NabiximolsinvestigationalunknowninhibitorDetailsDB01224QuetiapineapprovedunknownDetailsDB00443Betamethasoneapproved, vet_approvedunknownDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB15305Risdiplamapproved, investigationalunknownsubstrateDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB01059NorfloxacinapprovednoinhibitorDetailsDB16390Mobocertinibapproved, investigationalunknownsubstrateDetailsDB09061Cannabidiolapproved, investigationalnoinhibitorDetailsDB00470Dronabinolapproved, illicitnoinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknowninhibitorDetailsDB00349Clobazamapproved, illicitnosubstrateDetailsDB09065CobicistatapprovedyesinhibitorDetailsDB12874Quizartinibapproved, investigationalnosubstrateDetailsDB11718Encorafenibapproved, investigationalnoinhibitorDetailsDB01072Atazanavirapproved, investigationalnoinhibitorDetailsDB11679FruquintinibinvestigationalnosubstrateDetailsDB00176Fluvoxamineapproved, investigationalunknowninhibitorDetailsDB00599Thiopentalapproved, vet_approvedunknownsubstrateDetailsDB08930DolutegravirapprovednosubstrateDetailsDB06595Midostaurinapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB13174RheinexperimentalunknowninhibitorDetailsDB11994Diacereinapproved, investigationalunknowninhibitorDetailsDB11605MyrrhapprovedunknowninducerDetailsDB11691Naldemedineapproved, investigationalnosubstrateDetailsDB13878Pibrentasvirapproved, investigationalunknowninhibitorDetailsDB13879Glecaprevirapproved, investigationalunknownsubstrateinhibitorDetailsDB09205Moxisylyteapproved, investigationalnosubstrateDetailsDB09568Omega-3-carboxylic acidsapproved, investigationalnosubstrateDetailsDB01601LopinavirapprovednoinhibitorDetailsDB01149Nefazodoneapproved, withdrawnnoinhibitorDetailsDB13141Ambroxol acefyllinateexperimental, investigationalnosubstrateDetailsDB11792MirodenafilinvestigationalunknownsubstrateDetailsDB11979Elagolixapproved, investigationalnosubstrateDetailsDB08865Crizotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB11703Acalabrutinibapproved, investigationalunknownsubstrateDetailsDB12267Brigatinibapproved, investigationalunknowninducerDetailsDB12307ForetinibinvestigationalunknownsubstrateDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB00593EthosuximideapprovedunknownsubstrateDetailsDB01201Rifapentineapproved, investigationalunknowninducerDetailsDB00643Mebendazoleapproved, vet_approvedunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknowninhibitorDetailsDB00334Olanzapineapproved, investigationalunknowninhibitorDetailsDB09212LoxoprofenapprovedunknownsubstrateDetailsDB00635Prednisoneapproved, vet_approvedunknowninducerDetailsDB01222BudesonideapprovedunknownsubstrateinducerDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB11951Lemborexantapproved, investigationalunknowninhibitorinducerDetailsDB12887Tazemetostatapproved, investigationalunknownsubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninducerDetailsDB11652Tucatinibapproved, investigationalunknownsubstrateDetailsDB15035Zanubrutinibapproved, investigationalunknownsubstrateDetailsDB15685Selpercatinibapproved, investigationalunknowninhibitorDetailsDB00409Remoxiprideapproved, withdrawnunknowninhibitorDetailsDB15305Risdiplamapproved, investigationalunknowninhibitorDetailsDB06448Lonafarnibapproved, investigationalnosubstrateinhibitorDetailsDB11853Relugolixapproved, investigationalunknownsubstrateinducerDetailsDB01586Ursodeoxycholic acidapproved, investigationalunknowninducerDetailsDB11742Ebastineapproved, investigationalunknownsubstrateDetailsDB15569Sotorasibapproved, investigationalunknownsubstrateDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB00647Dextropropoxypheneapproved, illicit, investigational, withdrawnunknowninhibitorDetailsDB00333MethadoneapprovednoinhibitorDetailsDB01167Itraconazoleapproved, investigationalnoinhibitorDetailsDB16536Birch bark extractapproved, experimentalunknowninhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateinhibitorDetails"
                    }
                },
                {
                    "Label": "Cytochrome P450 2C9",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 2C9",
                        "Synonyms": "(R)-limonene 6-monooxygenase\n(S)-limonene 6-monooxygenase\n(S)-limonene 7-monooxygenase\n1.14.13.-\nCholesterol 25-hydroxylase\nCYP2C10\nCYPIIC9\nCytochrome P-450MP\nCytochrome P450 MP-4\nCytochrome P450 MP-8\nCytochrome P450 PB-1\nS-mephenytoin 4-hydroxylase",
                        "Gene Name": "CYP2C9",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0005471|Cytochrome P450 2C9\nMDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDISKSLTNLSKV\nYGPVFTLYFGLKPIVVLHGYEAVKEALIDLGEEFSGRGIFPLAERANRGFGIVFSNGKKW\nKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICS\nIIFHKRFDYKDQQFLNLMEKLNENIKILSSPWIQICNNFSPIIDYFPGTHNKLLKNVAFM\nKSYILEKVKEHQESMDMNNPQDFIDCFLMKMEKEKHNQPSEFTIESLENTAVDLFGAGTE\nTTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRSHMPYTDAVVHEVQRYID\nLLPTSLPHAVTCDIKFRNYLIPKGTTILISLTSVLHDNKEFPNPEMFDPHHFLDEGGNFK\nKSKYFMPFSAGKRICVGEALAGMELFLFLTSILQNFNLKSLVDPKNLDTTPVVNGFASVP\nPFYQLCFIPV",
                        "Number of residues": "490",
                        "Molecular Weight": "55627.365",
                        "Theoretical pI": "7.99",
                        "GO Classification": "Functions(R)-limonene 6-monooxygenase activity / (S)-limonene 6-monooxygenase activity / (S)-limonene 7-monooxygenase activity / arachidonic acid epoxygenase activity / aromatase activity / caffeine oxidase activity / drug binding / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity / oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen / oxygen binding / steroid hydroxylase activityProcessesarachidonic acid metabolic process / cellular amide metabolic process / drug catabolic process / drug metabolic process / epoxygenase P450 pathway / exogenous drug catabolic process / monocarboxylic acid metabolic process / monoterpenoid metabolic process / omega-hydroxylase P450 pathway / oxidation-reduction process / oxidative demethylation / small molecule metabolic process / steroid metabolic process / urea metabolic process / xenobiotic metabolic processComponentscytoplasm / endoplasmic reticulum membrane / intracellular membrane-bounded organelle",
                        "General Function": "Steroid hydroxylase activity",
                        "Specific Function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. This enzyme contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S-warfarin, diclofenac, phenytoin, tolbutamide and losartan.",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0016893|Cytochrome P450 2C9 (CYP2C9)\nATGGATTCTCTTGTGGTCCTTGTGCTCTGTCTCTCATGTTTGCTTCTCCTTTCACTCTGG\nAGACAGAGCTCTGGGAGAGGAAAACTCCCTCCTGGCCCCACTCCTCTCCCAGTGATTGGA\nAATATCCTACAGATAGGTATTAAGGACATCAGCAAATCCTTAACCAATCTCTCAAAGGTC\nTATGGCCCTGTGTTCACTCTGTATTTTGGCCTGAAACCCATAGTGGTGCTGCATGGATAT\nGAAGCAGTGAAGGAAGCCCTGATTGATCTTGGAGAGGAGTTTTCTGGAAGAGGCATTTTC\nCCACTGGCTGAAAGAGCTAACAGAGGATTTGGAATTGTTTTCAGCAATGGAAAGAAATGG\nAAGGAGATCCGGCGTTTCTCCCTCATGACGCTGCGGAATTTTGGGATGGGGAAGAGGAGC\nATTGAGGACCGTGTTCAAGAGGAAGCCCGCTGCCTTGTGGAGGAGTTGAGAAAAACCAAG\nGCCTCACCCTGTGATCCCACTTTCATCCTGGGCTGTGCTCCCTGCAATGTGATCTGCTCC\nATTATTTTCCATAAACGTTTTGATTATAAAGATCAGCAATTTCTTAACTTAATGGAAAAG\nTTGAATGAAAACATCAAGATTTTGAGCAGCCCCTGGATCCAGATCTGCAATAATTTTTCT\nCCTATCATTGATTACTTCCCGGGAACTCACAACAAATTACTTAAAAACGTTGCTTTTATG\nAAAAGTTATATTTTGGAAAAAGTAAAAGAACACCAAGAATCAATGGACATGAACAACCCT\nCAGGACTTTATTGATTGCTTCCTGATGAAAATGGAGAAGGAAAAGCACAACCAACCATCT\nGAATTTACTATTGAAAGCTTGGAAAACACTGCAGTTGACTTGTTTGGAGCTGGGACAGAG\nACGACAAGCACAACCCTGAGATATGCTCTCCTTCTCCTGCTGAAGCACCCAGAGGTCACA\nGCTAAAGTCCAGGAAGAGATTGAACGTGTGATTGGCAGAAACCGGAGCCCCTGCATGCAA\nGACAGGAGCCACATGCCCTACACAGATGCTGTGGTGCACGAGGTCCAGAGATACATTGAC\nCTTCTCCCCACCAGCCTGCCCCATGCAGTGACCTGTGACATTAAATTCAGAAACTATCTC\nATTCCCAAGGGCACAACCATATTAATTTCCCTGACTTCTGTGCTACATGACAACAAAGAA\nTTTCCCAACCCAGAGATGTTTGACCCTCATCACTTTCTGGATGAAGGTGGCAATTTTAAG\nAAAAGTAAATACTTCATGCCTTTCTCAGCAGGAAAACGGATTTGTGTGGGAGAAGCCCTG\nGCCGGCATGGAGCTGTTTTTATTCCTGACCTCCATTTTACAGAACTTTAACCTGAAATCT\nCTGGTTGACCCAAAGAACCTTGACACCACTCCAGTTGTCAATGGATTTGCCTCTGTGCCG\nCCCTTCTACCAGCTGTGCTTCATTCCTGTCTGA",
                        "Chromosome Location": "10",
                        "Locus": "10q24",
                        "External Identifiers": "ResourceLinkUniProtKB IDP11712UniProtKB Entry NameCP2C9_HUMANGenBank Gene IDAY341248GenAtlas IDCYP2C9HGNC IDHGNC:2623",
                        "General References": "Meehan RR, Gosden JR, Rout D, Hastie ND, Friedberg T, Adesnik M, Buckland R, van Heyningen V, Fletcher J, Spurr NK, et al.: Human cytochrome P-450 PB-1: a multigene family involved in mephenytoin and steroid oxidations that maps to chromosome 10. Am J Hum Genet. 1988 Jan;42(1):26-37. [Article] Kimura S, Pastewka J, Gelboin HV, Gonzalez FJ: cDNA and amino acid sequences of two members of the human P450IIC gene subfamily. Nucleic Acids Res. 1987 Dec 10;15(23):10053-4. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Deloukas P, Earthrowl ME, Grafham DV, Rubenfield M, French L, Steward CA, Sims SK, Jones MC, Searle S, Scott C, Howe K, Hunt SE, Andrews TD, Gilbert JG, Swarbreck D, Ashurst JL, Taylor A, Battles J, Bird CP, Ainscough R, Almeida JP, Ashwell RI, Ambrose KD, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Bates K, Beasley H, Bray-Allen S, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Cahill P, Camire D, Carter NP, Chapman JC, Clark SY, Clarke G, Clee CM, Clegg S, Corby N, Coulson A, Dhami P, Dutta I, Dunn M, Faulkner L, Frankish A, Frankland JA, Garner P, Garnett J, Gribble S, Griffiths C, Grocock R, Gustafson E, Hammond S, Harley JL, Hart E, Heath PD, Ho TP, Hopkins B, Horne J, Howden PJ, Huckle E, Hynds C, Johnson C, Johnson D, Kana A, Kay M, Kimberley AM, Kershaw JK, Kokkinaki M, Laird GK, Lawlor S, Lee HM, Leongamornlert DA, Laird G, Lloyd C, Lloyd DM, Loveland J, Lovell J, McLaren S, McLay KE, McMurray A, Mashreghi-Mohammadi M, Matthews L, Milne S, Nickerson T, Nguyen M, Overton-Larty E, Palmer SA, Pearce AV, Peck AI, Pelan S, Phillimore B, Porter K, Rice CM, Rogosin A, Ross MT, Sarafidou T, Sehra HK, Shownkeen R, Skuce CD, Smith M, Standring L, Sycamore N, Tester J, Thorpe A, Torcasso W, Tracey A, Tromans A, Tsolas J, Wall M, Walsh J, Wang H, Weinstock K, West AP, Willey DL, Whitehead SL, Wilming L, Wray PW, Young L, Chen Y, Lovering RC, Moschonas NK, Siebert R, Fechtel K, Bentley D, Durbin R, Hubbard T, Doucette-Stamm L, Beck S, Smith DR, Rogers J: The DNA sequence and comparative analysis of human chromosome 10. Nature. 2004 May 27;429(6990):375-81. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Yasumori T, Kawano S, Nagata K, Shimada M, Yamazoe Y, Kato R: Nucleotide sequence of a human liver cytochrome P-450 related to the rat male specific form. J Biochem. 1987 Nov;102(5):1075-82. [Article] Umbenhauer DR, Martin MV, Lloyd RS, Guengerich FP: Cloning and sequence determination of a complementary DNA related to human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylase. Biochemistry. 1987 Feb 24;26(4):1094-9. [Article] Ged C, Umbenhauer DR, Bellew TM, Bork RW, Srivastava PK, Shinriki N, Lloyd RS, Guengerich FP: Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 (S)-mephenytoin 4'-hydroxylase. Biochemistry. 1988 Sep 6;27(18):6929-40. [Article] Ohgiya S, Komori M, Ohi H, Shiramatsu K, Shinriki N, Kamataki T: Six-base deletion occurring in messages of human cytochrome P-450 in the CYP2C subfamily results in reduction of tolbutamide hydroxylase activity. Biochem Int. 1992 Sep;27(6):1073-81. [Article] Shimada T, Misono KS, Guengerich FP: Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction. J Biol Chem. 1986 Jan 15;261(2):909-21. [Article] Komori M, Hashizume T, Ohi H, Miura T, Kitada M, Nagashima K, Kamataki T: Cytochrome P-450 in human liver microsomes: high-performance liquid chromatographic isolation of three forms and their characterization. J Biochem. 1988 Dec;104(6):912-6. [Article] Srivastava PK, Yun CH, Beaune PH, Ged C, Guengerich FP: Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes. Mol Pharmacol. 1991 Jul;40(1):69-79. [Article] Haining RL, Hunter AP, Veronese ME, Trager WF, Rettie AE: Allelic variants of human cytochrome P450 2C9: baculovirus-mediated expression, purification, structural characterization, substrate stereoselectivity, and prochiral selectivity of the wild-type and I359L mutant forms. Arch Biochem Biophys. 1996 Sep 15;333(2):447-58. [Article] Sandhu P, Baba T, Guengerich FP: Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity. Arch Biochem Biophys. 1993 Nov 1;306(2):443-50. [Article] Miyazawa M, Shindo M, Shimada T: Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes. Drug Metab Dispos. 2002 May;30(5):602-7. [Article] Honda A, Miyazaki T, Ikegami T, Iwamoto J, Maeda T, Hirayama T, Saito Y, Teramoto T, Matsuzaki Y: Cholesterol 25-hydroxylation activity of CYP3A. J Lipid Res. 2011 Aug;52(8):1509-16. doi: 10.1194/jlr.M014084. Epub 2011 May 16. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Williams PA, Cosme J, Ward A, Angove HC, Matak Vinkovic D, Jhoti H: Crystal structure of human cytochrome P450 2C9 with bound warfarin. Nature. 2003 Jul 24;424(6947):464-8. Epub 2003 Jul 13. [Article] Stubbins MJ, Harries LW, Smith G, Tarbit MH, Wolf CR: Genetic analysis of the human cytochrome P450 CYP2C9 locus. Pharmacogenetics. 1996 Oct;6(5):429-39. [Article] Bhasker CR, Miners JO, Coulter S, Birkett DJ: Allelic and functional variability of cytochrome P4502C9. Pharmacogenetics. 1997 Feb;7(1):51-8. [Article] Imai J, Ieiri I, Mamiya K, Miyahara S, Furuumi H, Nanba E, Yamane M, Fukumaki Y, Ninomiya H, Tashiro N, Otsubo K, Higuchi S: Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locus. Pharmacogenetics. 2000 Feb;10(1):85-9. [Article] Dickmann LJ, Rettie AE, Kneller MB, Kim RB, Wood AJ, Stein CM, Wilkinson GR, Schwarz UI: Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans. Mol Pharmacol. 2001 Aug;60(2):382-7. [Article] Higashi MK, Veenstra DL, Kondo LM, Wittkowsky AK, Srinouanprachanh SL, Farin FM, Rettie AE: Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy. JAMA. 2002 Apr 3;287(13):1690-8. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB03317Ferroheme CexperimentalunknownDetailsDB00196Fluconazoleapproved, investigationalunknowninhibitorDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateinhibitorDetailsDB00222GlimepirideapprovedunknownsubstrateDetailsDB00250Dapsoneapproved, investigationalunknownsubstrateinducerDetailsDB00327Hydromorphoneapproved, illicitnosubstrateDetailsDB00469TenoxicamapprovedunknownsubstrateDetailsDB00470Dronabinolapproved, illicitnosubstrateinhibitorinducerDetailsDB00471MontelukastapprovedunknownsubstrateDetailsDB00472Fluoxetineapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00482Celecoxibapproved, investigationalunknownsubstrateDetailsDB00549Zafirlukastapproved, investigationalunknownsubstrateinhibitorDetailsDB00559Bosentanapproved, investigationalunknownsubstrateinducerDetailsDB00580Valdecoxibapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00582VoriconazoleapprovedunknownsubstrateinhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknownsubstrateDetailsDB00617ParamethadioneapprovedunknownsubstrateDetailsDB00675TamoxifenapprovedunknownsubstrateinhibitorDetailsDB00678LosartanapprovedunknownsubstrateDetailsDB00682WarfarinapprovedunknownsubstrateinducerDetailsDB00712Flurbiprofenapproved, investigationalunknownsubstrateDetailsDB00731Nateglinideapproved, investigationalunknownsubstrateDetailsDB00744Zileutonapproved, investigational, withdrawnunknownsubstrateDetailsDB00749Etodolacapproved, investigational, vet_approvedunknownsubstrateDetailsDB00784Mefenamic acidapprovedunknownsubstrateinhibitorDetailsDB00814Meloxicamapproved, vet_approvedunknownsubstrateDetailsDB00870Suprofenapproved, withdrawnunknownsubstrateinhibitorDetailsDB00916MetronidazoleapprovedunknowninhibitorDetailsDB00946Phenprocoumonapproved, investigationalunknownsubstrateDetailsDB01015SulfamethoxazoleapprovedunknownsubstrateinhibitorDetailsDB01029Irbesartanapproved, investigationalunknownsubstrateDetailsDB01050IbuprofenapprovedunknownsubstrateDetailsDB01067Glipizideapproved, investigationalunknownsubstrateDetailsDB01095FluvastatinapprovedunknownsubstrateinhibitorDetailsDB01104SertralineapprovedunknownsubstrateinhibitorDetailsDB01136Carvedilolapproved, investigationalunknownsubstrateDetailsDB01283Lumiracoxibapproved, investigationalunknownsubstrateDetailsDB00969Alosetronapproved, withdrawnnosubstrateDetailsDB00176Fluvoxamineapproved, investigationalnoinhibitorDetailsDB00214TorasemideapprovedunknownsubstrateinhibitorDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinhibitorinducerDetailsDB00412Rosiglitazoneapproved, investigationalunknownsubstrateinhibitorDetailsDB00448Lansoprazoleapproved, investigationalunknowninhibitorinducerDetailsDB00503Ritonavirapproved, investigationalunknowninducerDetailsDB00532Mephenytoinapproved, investigational, withdrawnunknownsubstrateDetailsDB00673Aprepitantapproved, investigationalunknowninhibitorinducerDetailsDB00705DelavirdineapprovedunknowninhibitorDetailsDB01016GlyburideapprovedunknownsubstrateinhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB01118Amiodaroneapproved, investigationalunknowninhibitorDetailsDB01124Tolbutamideapproved, investigationalunknownsubstrateDetailsDB01241GemfibrozilapprovedunknowninhibitorDetailsDB01381Ginkgo bilobaapproved, investigational, nutraceuticalunknowninhibitorDetailsDB01418Acenocoumarolapproved, investigationalunknownsubstrateDetailsDB04856DexloxiglumideinvestigationalunknownsubstrateinhibitorDetailsDB06442AvasimibeinvestigationalunknowninhibitorDetailsDB01098RosuvastatinapprovednosubstrateDetailsDB01065Melatoninapproved, nutraceutical, vet_approvedunknownsubstrateDetailsDB00796Candesartan cilexetilapprovedunknownsubstrateDetailsDB00641SimvastatinapprovedunknowninhibitorDetailsDB01076AtorvastatinapprovednoinhibitorDetailsDB00439Cerivastatinapproved, withdrawnunknowninhibitorDetailsDB01072Atazanavirapproved, investigationalnosubstrateinhibitorDetailsDB01181IfosfamideapprovedunknownsubstrateDetailsDB00619ImatinibapprovednosubstrateinhibitorDetailsDB00468QuinineapprovedunknownsubstrateDetailsDB01142Doxepinapproved, investigationalnosubstrateDetailsDB00321AmitriptylineapprovedunknownsubstrateDetailsDB04557Arachidonic AcidexperimentalunknownsubstrateDetailsDB01045RifampicinapprovedunknowninducerDetailsDB01174Phenobarbitalapproved, investigationalunknownsubstrateinducerDetailsDB00404Alprazolamapproved, illicit, investigationalunknownsubstrateDetailsDB00363ClozapineapprovednosubstrateDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB01357MestranolapprovedunknownsubstrateDetailsDB00788Naproxenapproved, vet_approvedunknownsubstrateDetailsDB00531Cyclophosphamideapproved, investigationalunknownsubstrateDetailsDB01355HexobarbitalexperimentalunknownsubstrateDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00554Piroxicamapproved, investigationalunknownsubstrateDetailsDB00208TiclopidineapprovedunknowninhibitorDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknownsubstrateDetailsDB00715Paroxetineapproved, investigationalunknowninhibitorDetailsDB01435Antipyrineapproved, investigationalunknownsubstrateDetailsDB00177Valsartanapproved, investigationalunknownsubstrateDetailsDB00188Bortezomibapproved, investigationalnosubstrateinhibitorDetailsDB01041Thalidomideapproved, investigational, withdrawnnosubstrateDetailsDB05109Trabectedinapproved, investigationalunknownsubstrateDetailsDB00313Valproic acidapproved, investigationalunknownsubstrateinhibitorDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00238NevirapineapprovedunknowninducerDetailsDB06652VicrivirocinvestigationalunknownsubstrateDetailsDB00972AzelastineapprovedunknownsubstrateinhibitorDetailsDB00568Cinnarizineapproved, investigationalunknownsubstrateDetailsDB04841FlunarizineapprovedunknownsubstrateDetailsDB01075Diphenhydramineapproved, investigationalunknownsubstrateDetailsDB06725Lornoxicamapproved, investigationalunknownsubstrateDetailsDB01039FenofibrateapprovedunknowninhibitorDetailsDB00951Isoniazidapproved, investigationalunknowninhibitorDetailsDB00812Phenylbutazoneapproved, vet_approvedunknownsubstrateinhibitorDetailsDB06729SulfaphenazoleapprovedunknowninhibitorDetailsDB00444TeniposideapprovedunknowninhibitorDetailsDB06414EtravirineapprovedunknownsubstrateinhibitorDetailsDB01320Fosphenytoinapproved, investigationalunknownsubstrateinducerDetailsDB01221Ketamineapproved, vet_approvedunknownsubstrateDetailsDB00359Sulfadiazineapproved, investigational, vet_approvedunknowninhibitorDetailsDB01138SulfinpyrazoneapprovedunknowninhibitorDetailsDB00263Sulfisoxazoleapproved, vet_approvedunknowninhibitorDetailsDB01198ZopicloneapprovedunknownsubstrateDetailsDB00564Carbamazepineapproved, investigationalunknowninducerDetailsDB00794Primidoneapproved, vet_approvedunknownsubstrateinducerDetailsDB01201Rifapentineapproved, investigationalunknowninducerDetailsDB00418Secobarbitalapproved, vet_approvedunknowninducerDetailsDB00625Efavirenzapproved, investigationalunknowninhibitorDetailsDB01097Leflunomideapproved, investigationalunknownsubstrateinhibitorDetailsDB04868Nilotinibapproved, investigationalunknowninhibitorDetailsDB00398Sorafenibapproved, investigationalunknowninhibitorDetailsDB01101Capecitabineapproved, investigationalnodownregulatorDetailsDB00544FluorouracilapprovedunknowninhibitorDetailsDB06268Sitaxentanapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00752Tranylcypromineapproved, investigationalunknowninhibitorDetailsDB01424Aminophenazoneapproved, withdrawnunknownsubstrateDetailsDB00216Eletriptanapproved, investigationalunknownsubstrateDetailsDB00758ClopidogrelapprovednosubstrateinhibitorDetailsDB00843DonepezilapprovedunknownsubstrateDetailsDB00661VerapamilapprovedunknownsubstrateinhibitorDetailsDB00425ZolpidemapprovedunknownsubstrateDetailsDB01036Tolterodineapproved, investigationalunknownsubstrateDetailsDB00328Indomethacinapproved, investigationalunknownsubstrateDetailsDB00936Salicylic acidapproved, investigational, vet_approvedunknownsubstrateDetailsDB01628Etoricoxibapproved, investigationalunknownsubstrateinhibitorDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB00818Propofolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00672Chlorpropamideapproved, investigationalunknownsubstrateDetailsDB01120GliclazideapprovedunknownsubstrateDetailsDB00201CaffeineapprovedunknownsubstrateDetailsDB00514DextromethorphanapprovedunknownsubstrateDetailsDB01009Ketoprofenapproved, vet_approvedunknownsubstrateinhibitorDetailsDB04725LicofeloneinvestigationalunknownsubstrateDetailsDB06737ZaltoprofenexperimentalunknownsubstrateDetailsDB06739SeratrodastexperimentalunknownsubstrateDetailsDB06738KetobemidoneinvestigationalunknownsubstrateDetailsDB06736Aceclofenacapproved, investigationalunknownsubstrateDetailsDB08798SulfamoxoleexperimentalunknowninhibitorDetailsDB06697ArtemetherapprovedunknownsubstrateDetailsDB00945Acetylsalicylic acidapproved, vet_approvedunknownsubstrateDetailsDB00613Amodiaquineapproved, investigationalunknowninhibitorDetailsDB00701Amprenavirapproved, investigationalunknownsubstrateDetailsDB01117AtovaquoneapprovedunknowninhibitorDetailsDB01156BupropionapprovedunknownsubstrateDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00604Cisaprideapproved, investigational, withdrawnunknowninhibitorDetailsDB00257Clotrimazoleapproved, vet_approvedunknowninhibitorDetailsDB01176CyclizineapprovedunknowninhibitorDetailsDB00266DicoumarolapprovedunknownsubstrateDetailsDB00757Dolasetronapproved, investigationalunknownsubstrateDetailsDB00869DorzolamideapprovednosubstrateDetailsDB00668Epinephrineapproved, vet_approvedunknowninhibitorDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00655EstroneapprovedunknownsubstrateDetailsDB00898EthanolapprovedunknowninhibitorDetailsDB01023Felodipineapproved, investigationalunknowninhibitorDetailsDB01195Flecainideapproved, withdrawnunknowninhibitorDetailsDB01544Flunitrazepamapproved, illicitunknownsubstrateDetailsDB00502HaloperidolapprovedunknownsubstrateDetailsDB01159Halothaneapproved, vet_approvedunknownsubstrateDetailsDB01177IdarubicinapprovedunknownsubstrateDetailsDB00281Lidocaineapproved, vet_approvedunknownsubstrateDetailsDB01601LopinavirapprovedunknowninhibitorinducerDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknowninhibitorDetailsDB00333MethadoneapprovedunknownsubstrateDetailsDB01028Methoxyfluraneapproved, investigational, vet_approved, withdrawnunknownsubstrateDetailsDB01171Moclobemideapproved, investigationalunknownsubstrateDetailsDB00745Modafinilapproved, investigationalunknowninhibitorinducerDetailsDB00184NicotineapprovedunknownsubstrateDetailsDB00904Ondansetronapproved, withdrawnunknownsubstrateDetailsDB00850PerphenazineapprovedunknownsubstrateDetailsDB03783PhenacetinwithdrawnunknownsubstrateDetailsDB01411PranlukastinvestigationalnoinhibitorDetailsDB01131ProguanilapprovedunknownsubstrateDetailsDB01069Promethazineapproved, investigationalunknowninhibitorDetailsDB01589Quazepamapproved, illicitnosubstrateDetailsDB00908Quinidineapproved, investigationalunknownsubstrateinhibitorDetailsDB00533Rofecoxibapproved, investigational, withdrawnunknownsubstrateDetailsDB01037Selegilineapproved, investigational, vet_approvedunknownsubstrateDetailsDB06150Sulfadimethoxineapproved, vet_approved, withdrawnunknowninhibitorDetailsDB00576Sulfamethizoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB00891SulfapyridineapprovedunknowninhibitorDetailsDB00231Temazepamapproved, investigationalunknownsubstrateDetailsDB00624Testosteroneapproved, investigationalunknownsubstrateDetailsDB00763MethimazoleapprovedunknowninhibitorDetailsDB00323Tolcaponeapproved, withdrawnnoinhibitorDetailsDB00347TrimethadioneapprovedunknownsubstrateDetailsDB00726TrimipramineapprovedunknownsubstrateDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB04898Ximelagatranapproved, investigational, withdrawnunknownsubstrateDetailsDB00495ZidovudineapprovedunknownsubstrateDetailsDB00755Tretinoinapproved, investigational, nutraceuticalunknownsubstrateDetailsDB01128BicalutamideapprovedunknowninhibitorDetailsDB01129Rabeprazoleapproved, investigationalunknowninhibitorDetailsDB01274Arformoterolapproved, investigationalunknownsubstrateDetailsDB04574Estrone sulfateapprovedunknownsubstrateinhibitorDetailsDB06413Armodafinilapproved, investigationalnoinhibitorDetailsDB00255Diethylstilbestrolapproved, investigational, withdrawnunknowninhibitorDetailsDB00420Promazineapproved, vet_approvedunknownsubstrateDetailsDB06594Agomelatineapproved, investigationalunknowninhibitorDetailsDB04831Tienilic acidwithdrawnunknowninhibitorDetailsDB06174Noscapineapproved, investigationalunknowninhibitorDetailsDB04920Clevidipineapproved, investigationalunknowninhibitorDetailsDB06370IndisulaminvestigationalunknownsubstrateDetailsDB06803Niclosamideapproved, investigational, vet_approvedunknownsubstrateDetailsDB00515CisplatinapprovedunknowninhibitorDetailsDB06820SulconazoleapprovedunknowninhibitorDetailsDB01154Thiamylalapproved, vet_approvedunknownsubstrateDetailsDB08828Vismodegibapproved, investigationalnosubstrateinhibitorDetailsDB00374Treprostinilapproved, investigationalunknownsubstrateDetailsDB06204TapentadolapprovedunknownsubstrateDetailsDB06209PrasugrelapprovednosubstrateDetailsDB08860PitavastatinapprovedunknownsubstrateDetailsDB08875Cabozantinibapproved, investigationalnosubstrateDetailsDB06605ApixabanapprovedunknownsubstrateDetailsDB08896RegorafenibapprovedunknowninhibitorDetailsDB08899EnzalutamideapprovednoinducerDetailsDB04938Ospemifeneapproved, investigationalunknownsubstrateDetailsDB00317Gefitinibapproved, investigationalunknowninhibitorDetailsDB06292DapagliflozinapprovednosubstrateDetailsDB09048Netupitantapproved, investigationalnosubstrateDetailsDB09080OlodaterolapprovednosubstrateDetailsDB09068Vortioxetineapproved, investigationalnosubstrateDetailsDB08439ParecoxibapprovedunknownsubstrateDetailsDB09280LumacaftorapprovednoinhibitorinducerDetailsDB09570Ixazomibapproved, investigationalunknownsubstrateDetailsDB11560Lesinuradapproved, investigationalnosubstrateDetailsDB05812AbirateroneapprovedunknowninhibitorDetailsDB08816TicagrelorapprovedunknowninhibitorinducerDetailsDB09063CeritinibapprovedunknowninhibitorDetailsDB00322FloxuridineapprovedunknowninhibitorDetailsDB05219Crisaboroleapproved, investigationalnoinhibitorDetailsDB06595Midostaurinapproved, investigationalunknowninhibitorinducerDetailsDB05015Belinostatapproved, investigationalunknowninhibitorDetailsDB05541Brivaracetamapproved, investigationalnosubstrateDetailsDB11611LifitegrastapprovednoinhibitorDetailsDB13174RheinexperimentalunknowninhibitorDetailsDB11994Diacereinapproved, investigationalunknowninhibitorDetailsDB03756Doconexentapproved, investigationalunknownsubstrateinhibitorDetailsDB11943Delafloxacinapproved, investigationalunknowninducerDetailsDB01685TopiroxostatexperimentalunknowninhibitorDetailsDB09120Zucapsaicinapproved, investigationalunknowninhibitorDetailsDB09118StiripentolapprovedunknowninhibitorDetailsDB09198LobeglitazoneexperimentalnoinhibitorDetailsDB09167DosulepinapprovedunknowninhibitorDetailsDB11614RupatadineapprovednosubstrateDetailsDB12319Benzbromaroneinvestigational, withdrawnunknowninhibitorDetailsDB09238Manidipineapproved, investigationalunknowninhibitorDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB13919CandesartanexperimentalunknownsubstrateinhibitorDetailsDB12070Letermovirapproved, investigationalnoinducerDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB09061Cannabidiolapproved, investigationalnosubstrateinhibitorDetailsDB13943Testosterone cypionateapprovedunknownsubstrateDetailsDB13944Testosterone enanthateapprovedunknownsubstrateDetailsDB13946Testosterone undecanoateapproved, investigationalunknownsubstrateDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13941Piperaquineapproved, experimental, investigationalunknownsubstrateDetailsDB11901Apalutamideapproved, investigationalnoinducerDetailsDB11633Isavuconazoleapproved, investigationalunknowninhibitorinducerDetailsDB11586Asunaprevirapproved, investigational, withdrawnnosubstrateDetailsDB13975Black cohoshexperimentalnoinhibitorDetailsDB14011NabiximolsinvestigationalnosubstrateDetailsDB14009Medical Cannabisexperimental, investigationalnosubstrateinhibitorinducerDetailsDB13746Bioallethrinapproved, experimentalnosubstrateDetailsDB00486Nabiloneapproved, investigationalnosubstrateinhibitorDetailsDB14033Acetyl sulfisoxazoleapproved, vet_approvedunknowninhibitorDetailsDB11995Avatrombopagapproved, investigationalunknowninducerDetailsDB11672Curcuminapproved, investigationalnoinhibitorDetailsDB00949FelbamateapprovedunknowninhibitorDetailsDB13136Fluindioneapproved, investigationalunknownsubstrateDetailsDB14568Ivosidenibapproved, investigationalunknowninducerDetailsDB12474Lynestrenolapproved, investigationalnosubstrateDetailsDB00615Rifabutinapproved, investigationalnoinducerDetailsDB11753Rifamycinapproved, investigationalnoinhibitorinducerDetailsDB04818IproniazidwithdrawnunknowninhibitorDetailsDB01645GenisteininvestigationalunknowninhibitorDetailsDB09078Lenvatinibapproved, investigationalunknowninhibitorDetailsDB08881VemurafenibapprovedunknowninhibitorDetailsDB00839Tolazamideapproved, investigationalunknownsubstrateDetailsDB00414Acetohexamideapproved, investigational, withdrawnunknownsubstrateDetailsDB01251Gliquidoneapproved, investigationalunknownsubstrateDetailsDB01289GlisoxepideinvestigationalunknownsubstrateDetailsDB08962Glibornurideinvestigational, withdrawnunknownsubstrateDetailsDB13406CarbutamideexperimentalunknownsubstrateDetailsDB13675MetahexamideexperimentalunknownsubstrateDetailsDB08496(R)-warfarinexperimentalunknownsubstrateDetailsDB14055(S)-Warfarinexperimental, investigationalunknownsubstrateDetailsDB00022Peginterferon alfa-2bapprovedunknowninducerDetailsDB04911Oritavancinapproved, investigationalunknowninhibitorDetailsDB06717FosaprepitantapprovedunknowninducerDetailsDB09288PropacetamolexperimentalnosubstrateDetailsDB14635Curcumin sulfateexperimentalnoinhibitorDetailsDB01080VigabatrinapprovedunknowninducerDetailsDB06218LacosamideapprovednosubstrateDetailsDB09213Dexibuprofenapproved, investigationalnosubstrateDetailsDB08912Dabrafenibapproved, investigationalnosubstrateinhibitorinducerDetailsDB00834Mifepristoneapproved, investigationalnoinhibitorDetailsDB00980Ramelteonapproved, investigationalnosubstrateDetailsDB00440Trimethoprimapproved, vet_approvedunknownsubstrateDetailsDB04665CoumarinexperimentalnosubstrateDetailsDB14025ClinafloxacininvestigationalunknowninhibitorDetailsDB06731SeproxetineinvestigationalunknowninhibitorDetailsDB00621Oxandroloneapproved, investigationalunknowninhibitorDetailsDB11963Dacomitinibapproved, investigationalnosubstrateDetailsDB00220NelfinavirapprovednoinducerDetailsDB07615TranilastinvestigationalnosubstrateDetailsDB12245Triclabendazoleapproved, investigationalunknownsubstrateDetailsDB11823Esketamineapproved, investigationalunknownsubstrateDetailsDB00465KetorolacapprovedunknownsubstrateDetailsDB00304DesogestrelapprovednosubstrateDetailsDB00455Loratadineapproved, investigationalunknownsubstrateDetailsDB12371Siponimodapproved, investigationalunknownsubstrateDetailsDB00334Olanzapineapproved, investigationalnoinhibitorDetailsDB12147Erdafitinibapproved, investigationalnosubstrateDetailsDB00476DuloxetineapprovedunknownsubstrateDetailsDB00461NabumetoneapprovednosubstrateDetailsDB12015Alpelisibapproved, investigationalunknowninducerDetailsDB00590DoxazosinapprovedunknownsubstrateDetailsDB01032Probenecidapproved, investigationalunknowninhibitorDetailsDB12978Pexidartinibapproved, investigationalunknowninhibitorDetailsDB11757Istradefyllineapproved, investigationalunknownsubstrateDetailsDB00622Nicardipineapproved, investigationalnoinhibitorDetailsDB01137Levofloxacinapproved, investigationalnoinhibitorDetailsDB08502CapravirineinvestigationalunknownsubstrateDetailsDB01217Anastrozoleapproved, investigationalunknowninhibitorDetailsDB12808Trifaroteneapproved, investigationalunknownsubstrateDetailsDB12001Abemaciclibapproved, investigationalunknowninhibitorDetailsDB15444Elexacaftorapproved, investigationalnoinhibitorDetailsDB14975Voxelotorapproved, investigationalunknownsubstrateDetailsDB00635Prednisoneapproved, vet_approvedunknowninducerDetailsDB00741Hydrocortisoneapproved, vet_approvedunknowninducerDetailsDB01222BudesonideapprovedunknowninducerDetailsDB00959Methylprednisoloneapproved, vet_approvedunknowninducerDetailsDB15328Ubrogepantapproved, investigationalunknowninhibitorDetailsDB15233Avapritinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00983Formoterolapproved, investigationalunknownsubstrateDetailsDB01115NifedipineapprovedunknowninhibitorinducerDetailsDB00957Norgestimateapproved, investigationalunknownsubstrateDetailsDB00977EthinylestradiolapprovedunknownsubstrateDetailsDB12457Rimegepantapproved, investigationalnosubstrateDetailsDB13609UmifenovirinvestigationalunknownsubstrateDetailsDB00443Betamethasoneapproved, vet_approvedunknowninducerDetailsDB09241Methylene blueapproved, investigationalunknowninhibitorDetailsDB11689Selumetinibapproved, investigationalnosubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninducerDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB14881Oliceridineapproved, investigationalunknownsubstrateDetailsDB12499Clascoteroneapproved, investigationalnoinhibitorDetailsDB15822Pralsetinibapproved, investigationalnoinhibitorinducerDetailsDB06448Lonafarnibapproved, investigationalnosubstrateDetailsDB04951Pirfenidoneapproved, investigationalunknownsubstrateinhibitorDetailsDB06137Tirbanibulinapproved, investigationalnoinhibitorDetailsDB11632Opicaponeapproved, investigationalnoinhibitorDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB08864RilpivirineapprovedunknowninhibitorDetailsDB00330EthambutolapprovedunknowninhibitorDetailsDB14989Umbralisibapproved, investigational, withdrawnunknownsubstrateDetailsDB08877RuxolitinibapprovednosubstrateDetailsDB14984Casimersenapproved, investigationalnoinhibitorDetailsDB06237AvanafilapprovedunknownsubstrateDetailsDB04854FebuxostatapprovednosubstrateDetailsDB08995Diosminapproved, investigationalunknowninhibitorDetailsDB08822Azilsartan medoxomilapproved, investigationalnosubstrateDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownDetailsDB15569Sotorasibapproved, investigationalunknowninducerDetailsDB12151Brincidofovirapproved, investigationalnoinhibitorDetailsDB15011Avacopanapproved, investigationalnoinhibitorDetailsDB12597Asciminibapproved, investigationalnoinhibitorDetailsDB08932MacitentanapprovednosubstrateDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB14973Abrocitinibapproved, investigationalnosubstrateDetailsDB16236Mitapivatapproved, investigationalnosubstrateinducerDetailsDB14737Cannabinolexperimental, investigationalunknownsubstrateinhibitorDetailsDB06016Cariprazineapproved, investigationalnoinhibitorDetailsDB14921Mavacamtenapproved, investigationalnosubstrateinducerDetailsDB06083Tapinarofapproved, investigationalnosubstrateDetailsDB15133Tepotinibapproved, investigationalnoinhibitorDetailsDB00285VenlafaxineapprovednosubstrateDetailsDB12095Telotristat ethylapproved, investigationalnoinhibitorDetailsDB15149Futibatinibapproved, investigationalnosubstrateDetailsDB17083LinzagolixapprovednosubstrateDetailsDB11739Vonoprazanapproved, investigationalunknownsubstrateDetailsDB16267Olutasidenibapproved, investigationalnosubstrateinducerDetailsDB02709ResveratrolinvestigationalunknowninhibitorDetailsDB15568Adagrasibapproved, investigationalunknownsubstrateinhibitorDetailsDB17449Anacaulaseapproved, investigationalunknowninhibitorDetailsDB17472Pirtobrutinibapproved, investigationalunknowninhibitorDetailsDB06374Elacestrantapproved, investigationalunknownsubstrateDetailsDB00349Clobazamapproved, illicitnoinhibitorDetailsDB12548Sparsentanapproved, investigationalunknowninducerDetailsDB00381AmlodipineapprovednoinhibitorDetailsDB00862VardenafilapprovedunknownsubstrateinhibitorDetailsDB08820IvacaftorapprovednoinhibitorDetailsDB11712Tezacaftorapproved, investigationalnoDetailsDB01194BrinzolamideapprovedunknownsubstrateDetailsDB15669Fezolinetantapproved, investigationalnosubstrateDetailsDB12255Vadadustatapproved, investigationalunknowninhibitorDetailsDB14924Ritlecitinibapproved, investigationalunknownsubstrateDetailsDB11763Momelotinibapproved, investigationalunknownsubstrateDetailsDB14766EtrasimodapprovednosubstrateDetailsDB11718Encorafenibapproved, investigationalnoinhibitorinducerDetailsDB16826RepotrectinibinvestigationalnoinducerDetailsDB11679FruquintinibinvestigationalnosubstrateDetails"
                    }
                },
                {
                    "Label": "Cytochrome P450 2C19",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 2C19",
                        "Synonyms": "(R)-limonene 6-monooxygenase\n(S)-limonene 6-monooxygenase\n(S)-limonene 7-monooxygenase\n1.14.13.-\nCYPIIC17\nCYPIIC19\nCytochrome P450-11A\nCytochrome P450-254C\nMephenytoin 4-hydroxylase",
                        "Gene Name": "CYP2C19",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0020694|Cytochrome P450 2C19\nMDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDVSKSLTNLSKI\nYGPVFTLYFGLERMVVLHGYEVVKEALIDLGEEFSGRGHFPLAERANRGFGIVFSNGKRW\nKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICS\nIIFQKRFDYKDQQFLNLMEKLNENIRIVSTPWIQICNNFPTIIDYFPGTHNKLLKNLAFM\nESDILEKVKEHQESMDINNPRDFIDCFLIKMEKEKQNQQSEFTIENLVITAADLLGAGTE\nTTSTTLRYALLLLLKHPEVTAKVQEEIERVVGRNRSPCMQDRGHMPYTDAVVHEVQRYID\nLIPTSLPHAVTCDVKFRNYLIPKGTTILTSLTSVLHDNKEFPNPEMFDPRHFLDEGGNFK\nKSNYFMPFSAGKRICVGEGLARMELFLFLTFILQNFNLKSLIDPKDLDTTPVVNGFASVP\nPFYQLCFIPV",
                        "Number of residues": "490",
                        "Molecular Weight": "55930.545",
                        "Theoretical pI": "7.42",
                        "GO Classification": "Functions(R)-limonene 6-monooxygenase activity / (S)-limonene 6-monooxygenase activity / (S)-limonene 7-monooxygenase activity / arachidonic acid epoxygenase activity / enzyme binding / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity / oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen / oxygen binding / steroid hydroxylase activityProcessesarachidonic acid metabolic process / drug metabolic process / epoxygenase P450 pathway / exogenous drug catabolic process / heterocycle metabolic process / monoterpenoid metabolic process / omega-hydroxylase P450 pathway / oxidation-reduction process / small molecule metabolic process / steroid metabolic process / xenobiotic metabolic processComponentscytoplasm / endoplasmic reticulum membrane / intracellular membrane-bounded organelle",
                        "General Function": "Steroid hydroxylase activity",
                        "Specific Function": "Responsible for the metabolism of a number of therapeutic agents such as the anticonvulsant drug S-mephenytoin, omeprazole, proguanil, certain barbiturates, diazepam, propranolol, citalopram and imipramine.",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0020695|Cytochrome P450 2C19 (CYP2C19)\nATGGATCCTTTTGTGGTCCTTGTGCTCTGTCTCTCATGTTTGCTTCTCCTTTCAATCTGG\nAGACAGAGCTCTGGGAGAGGAAAACTCCCTCCTGGCCCCACTCCTCTCCCAGTGATTGGA\nAATATCCTACAGATAGATATTAAGGATGTCAGCAAATCCTTAACCAATCTCTCAAAAATC\nTATGGCCCTGTGTTCACTCTGTATTTTGGCCTGGAACGCATGGTGGTGCTGCATGGATAT\nGAAGTGGTGAAGGAAGCCCTGATTGATCTTGGAGAGGAGTTTTCTGGAAGAGGCCATTTC\nCCACTGGCTGAAAGAGCTAACAGAGGATTTGGAATCGTTTTCAGCAATGGAAAGAGATGG\nAAGGAGATCCGGCGTTTCTCCCTCATGACGCTGCGGAATTTTGGGATGGGGAAGAGGAGC\nATTGAGGACCGTGTTCAAGAGGAAGCCCGCTGCCTTGTGGAGGAGTTGAGAAAAACCAAG\nGCTTCACCCTGTGATCCCACTTTCATCCTGGGCTGTGCTCCCTGCAATGTGATCTGCTCC\nATTATTTTCCAGAAACGTTTCGATTATAAAGATCAGCAATTTCTTAACTTGATGGAAAAA\nTTGAATGAAAACATCAGGATTGTAAGCACCCCCTGGATCCAGATATGCAATAATTTTCCC\nACTATCATTGATTATTTCCCGGGAACCCATAACAAATTACTTAAAAACCTTGCTTTTATG\nGAAAGTGATATTTTGGAGAAAGTAAAAGAACACCAAGAATCGATGGACATCAACAACCCT\nCGGGACTTTATTGATTGCTTCCTGATCAAAATGGAGAAGGAAAAGCAAAACCAACAGTCT\nGAATTCACTATTGAAAACTTGGTAATCACTGCAGCTGACTTACTTGGAGCTGGGACAGAG\nACAACAAGCACAACCCTGAGATATGCTCTCCTTCTCCTGCTGAAGCACCCAGAGGTCACA\nGCTAAAGTCCAGGAAGAGATTGAACGTGTCATTGGCAGAAACCGGAGCCCCTGCATGCAG\nGACAGGGGCCACATGCCCTACACAGATGCTGTGGTGCACGAGGTCCAGAGATACATCGAC\nCTCATCCCCACCAGCCTGCCCCATGCAGTGACCTGTGACGTTAAATTCAGAAACTACCTC\nATTCCCAAGGGCACAACCATATTAACTTCCCTCACTTCTGTGCTACATGACAACAAAGAA\nTTTCCCAACCCAGAGATGTTTGACCCTCGTCACTTTCTGGATGAAGGTGGAAATTTTAAG\nAAAAGTAACTACTTCATGCCTTTCTCAGCAGGAAAACGGATTTGTGTGGGAGAGGGCCTG\nGCCCGCATGGAGCTGTTTTTATTCCTGACCTTCATTTTACAGAACTTTAACCTGAAATCT\nCTGATTGACCCAAAGGACCTTGACACAACTCCTGTTGTCAATGGATTTGCTTCTGTCCCG\nCCCTTCTATCAGCTGTGCTTCATTCCTGTCTGA",
                        "Chromosome Location": "10",
                        "Locus": "10q24.1-q24.3",
                        "External Identifiers": "ResourceLinkUniProtKB IDP33261UniProtKB Entry NameCP2CJ_HUMANGenBank Protein ID181344GenBank Gene IDM61854HGNC IDHGNC:2621",
                        "General References": "Romkes M, Faletto MB, Blaisdell JA, Raucy JL, Goldstein JA: Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. Biochemistry. 1991 Apr 2;30(13):3247-55. [Article] Romkes M, Faletto MB, Blaisdell JA, Raucy JL, Goldstein JA: Cloning and expression of complementary DNAs for multiple members of the human cytochrome PH50IIC subfamily. Biochemistry. 1993 Feb 9;32(5):1390. [Article] Deloukas P, Earthrowl ME, Grafham DV, Rubenfield M, French L, Steward CA, Sims SK, Jones MC, Searle S, Scott C, Howe K, Hunt SE, Andrews TD, Gilbert JG, Swarbreck D, Ashurst JL, Taylor A, Battles J, Bird CP, Ainscough R, Almeida JP, Ashwell RI, Ambrose KD, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Bates K, Beasley H, Bray-Allen S, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Cahill P, Camire D, Carter NP, Chapman JC, Clark SY, Clarke G, Clee CM, Clegg S, Corby N, Coulson A, Dhami P, Dutta I, Dunn M, Faulkner L, Frankish A, Frankland JA, Garner P, Garnett J, Gribble S, Griffiths C, Grocock R, Gustafson E, Hammond S, Harley JL, Hart E, Heath PD, Ho TP, Hopkins B, Horne J, Howden PJ, Huckle E, Hynds C, Johnson C, Johnson D, Kana A, Kay M, Kimberley AM, Kershaw JK, Kokkinaki M, Laird GK, Lawlor S, Lee HM, Leongamornlert DA, Laird G, Lloyd C, Lloyd DM, Loveland J, Lovell J, McLaren S, McLay KE, McMurray A, Mashreghi-Mohammadi M, Matthews L, Milne S, Nickerson T, Nguyen M, Overton-Larty E, Palmer SA, Pearce AV, Peck AI, Pelan S, Phillimore B, Porter K, Rice CM, Rogosin A, Ross MT, Sarafidou T, Sehra HK, Shownkeen R, Skuce CD, Smith M, Standring L, Sycamore N, Tester J, Thorpe A, Torcasso W, Tracey A, Tromans A, Tsolas J, Wall M, Walsh J, Wang H, Weinstock K, West AP, Willey DL, Whitehead SL, Wilming L, Wray PW, Young L, Chen Y, Lovering RC, Moschonas NK, Siebert R, Fechtel K, Bentley D, Durbin R, Hubbard T, Doucette-Stamm L, Beck S, Smith DR, Rogers J: The DNA sequence and comparative analysis of human chromosome 10. Nature. 2004 May 27;429(6990):375-81. [Article] Wrighton SA, Stevens JC, Becker GW, VandenBranden M: Isolation and characterization of human liver cytochrome P450 2C19: correlation between 2C19 and S-mephenytoin 4'-hydroxylation. Arch Biochem Biophys. 1993 Oct;306(1):240-5. [Article] Miyazawa M, Shindo M, Shimada T: Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes. Drug Metab Dispos. 2002 May;30(5):602-7. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Reynald RL, Sansen S, Stout CD, Johnson EF: Structural characterization of human cytochrome P450 2C19: active site differences between P450s 2C8, 2C9, and 2C19. J Biol Chem. 2012 Dec 28;287(53):44581-91. doi: 10.1074/jbc.M112.424895. Epub 2012 Nov 1. [Article] de Morais SM, Wilkinson GR, Blaisdell J, Nakamura K, Meyer UA, Goldstein JA: The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J Biol Chem. 1994 Jun 3;269(22):15419-22. [Article] De Morais SM, Wilkinson GR, Blaisdell J, Meyer UA, Nakamura K, Goldstein JA: Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Mol Pharmacol. 1994 Oct;46(4):594-8. [Article] Xiao ZS, Goldstein JA, Xie HG, Blaisdell J, Wang W, Jiang CH, Yan FX, He N, Huang SL, Xu ZH, Zhou HH: Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele. J Pharmacol Exp Ther. 1997 Apr;281(1):604-9. [Article] Ibeanu GC, Goldstein JA, Meyer U, Benhamou S, Bouchardy C, Dayer P, Ghanayem BI, Blaisdell J: Identification of new human CYP2C19 alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian poor metabolizer of mephenytoin. J Pharmacol Exp Ther. 1998 Sep;286(3):1490-5. [Article] Ibeanu GC, Blaisdell J, Ghanayem BI, Beyeler C, Benhamou S, Bouchardy C, Wilkinson GR, Dayer P, Daly AK, Goldstein JA: An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in Caucasians. Pharmacogenetics. 1998 Apr;8(2):129-35. [Article] Ibeanu GC, Blaisdell J, Ferguson RJ, Ghanayem BI, Brosen K, Benhamou S, Bouchardy C, Wilkinson GR, Dayer P, Goldstein JA: A novel transversion in the intron 5 donor splice junction of CYP2C19 and a sequence polymorphism in exon 3 contribute to the poor metabolizer phenotype for the anticonvulsant drug S-mephenytoin. J Pharmacol Exp Ther. 1999 Aug;290(2):635-40. [Article] Blaisdell J, Mohrenweiser H, Jackson J, Ferguson S, Coulter S, Chanas B, Xi T, Ghanayem B, Goldstein JA: Identification and functional characterization of new potentially defective alleles of human CYP2C19. Pharmacogenetics. 2002 Dec;12(9):703-11. [Article] Morita J, Kobayashi K, Wanibuchi A, Kimura M, Irie S, Ishizaki T, Chiba K: A novel single nucleotide polymorphism (SNP) of the CYP2C19 gene in a Japanese subject with lowered capacity of mephobarbital 4'-hydroxylation. Drug Metab Pharmacokinet. 2004 Jun;19(3):236-8. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article] Fukushima-Uesaka H, Saito Y, Maekawa K, Ozawa S, Hasegawa R, Kajio H, Kuzuya N, Yasuda K, Kawamoto M, Kamatani N, Suzuki K, Yanagawa T, Tohkin M, Sawada J: Genetic variations and haplotypes of CYP2C19 in a Japanese population. Drug Metab Pharmacokinet. 2005 Aug;20(4):300-7. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00188Bortezomibapproved, investigationalnosubstrateinhibitorDetailsDB00213PantoprazoleapprovedunknownsubstrateinhibitorDetailsDB00215CitalopramapprovednosubstrateinhibitorDetailsDB00220NelfinavirapprovednosubstrateinducerDetailsDB00252Phenytoinapproved, vet_approvednosubstrateinducerDetailsDB00273TopiramateapprovedunknowninhibitorDetailsDB00328Indomethacinapproved, investigationalunknownsubstrateinhibitorDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00349Clobazamapproved, illicitnosubstrateDetailsDB00395CarisoprodolapprovedunknownsubstrateDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00420Promazineapproved, vet_approvedunknownsubstrateDetailsDB00444TeniposideapprovedunknownsubstrateDetailsDB00448Lansoprazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00546AdinazolamexperimentalunknownsubstrateDetailsDB00582VoriconazoleapprovedunknownsubstrateinhibitorDetailsDB00665Nilutamideapproved, investigationalunknownsubstrateinhibitorDetailsDB00679Thioridazineapproved, withdrawnunknownsubstrateDetailsDB00736Esomeprazoleapproved, investigationalnosubstrateinhibitorDetailsDB00738Pentamidineapproved, investigationalunknownsubstrateDetailsDB00794Primidoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00849MethylphenobarbitalapprovedunknownsubstrateDetailsDB00949FelbamateapprovedunknowninhibitorDetailsDB01018Guanfacineapproved, investigationalunknownsubstrateDetailsDB01104SertralineapprovedunknownsubstrateinhibitorDetailsDB01124Tolbutamideapproved, investigationalunknownsubstrateDetailsDB01129Rabeprazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB01131ProguanilapprovedunknownsubstrateDetailsDB01166Cilostazolapproved, investigationalunknownsubstrateDetailsDB01171Moclobemideapproved, investigationalunknownsubstrateinhibitorDetailsDB01174Phenobarbitalapproved, investigationalunknownsubstrateinducerDetailsDB01274Arformoterolapproved, investigationalunknownsubstrateDetailsDB01320Fosphenytoinapproved, investigationalunknownsubstrateDetailsDB01544Flunitrazepamapproved, illicitunknownsubstrateDetailsDB00176Fluvoxamineapproved, investigationalnoinhibitorDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknowninhibitorDetailsDB00208TiclopidineapprovedunknownsubstrateinhibitorDetailsDB00321AmitriptylineapprovedunknownsubstrateinhibitorDetailsDB00343Diltiazemapproved, investigationalunknownsubstrateDetailsDB00455Loratadineapproved, investigationalnosubstrateinhibitorDetailsDB00458ImipramineapprovedunknownsubstrateinhibitorDetailsDB00503Ritonavirapproved, investigationalnoinducerDetailsDB00532Mephenytoinapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknownsubstrateDetailsDB00622Nicardipineapproved, investigationalunknowninhibitorDetailsDB00625Efavirenzapproved, investigationalunknowninducerDetailsDB00745Modafinilapproved, investigationalunknowninhibitorDetailsDB00752Tranylcypromineapproved, investigationalunknowninhibitorDetailsDB00776OxcarbazepineapprovedunknowninhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB01041Thalidomideapproved, investigational, withdrawnnosubstrateinhibitorDetailsDB01424Aminophenazoneapproved, withdrawnunknownsubstrateDetailsDB00333MethadoneapprovedunknownsubstrateDetailsDB06442AvasimibeinvestigationalunknowninhibitorDetailsDB01065Melatoninapproved, nutraceutical, vet_approvedunknownsubstrateDetailsDB01076AtorvastatinapprovednoinhibitorDetailsDB01095FluvastatinapprovedunknowninhibitorDetailsDB00196Fluconazoleapproved, investigationalunknowninhibitorDetailsDB00619ImatinibapprovednosubstrateDetailsDB00468QuinineapprovedunknownsubstrateinhibitorDetailsDB01142Doxepinapproved, investigationalnosubstrateDetailsDB01435Antipyrineapproved, investigationalunknownsubstrateDetailsDB00250Dapsoneapproved, investigationalunknownsubstrateDetailsDB00675TamoxifenapprovedunknownsubstrateDetailsDB05109Trabectedinapproved, investigationalunknownsubstrateDetailsDB01418Acenocoumarolapproved, investigationalunknownsubstrateDetailsDB00682WarfarinapprovedunknownsubstrateinhibitorDetailsDB00540NortriptylineapprovedunknownsubstrateDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00972AzelastineapprovedunknownsubstrateinhibitorDetailsDB01075Diphenhydramineapproved, investigationalunknownsubstrateDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00446Chloramphenicolapproved, vet_approved, withdrawnunknowninhibitorDetailsDB01242Clomipramineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00758ClopidogrelapprovednosubstrateDetailsDB00531Cyclophosphamideapproved, investigationalunknownsubstrateDetailsDB01355HexobarbitalexperimentalunknownsubstrateDetailsDB00571Propranololapproved, investigationalunknownsubstrateDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00472Fluoxetineapproved, vet_approvedunknownsubstrateinhibitorDetailsDB06403Ambrisentanapproved, investigationalunknownsubstrateDetailsDB01175EscitalopramapprovednosubstrateDetailsDB06414EtravirineapprovedunknownsubstrateinhibitorDetailsDB01181IfosfamideapprovedunknownsubstrateDetailsDB05246MethsuximideapprovedunknownsubstrateinhibitorDetailsDB00726TrimipramineapprovedunknownsubstrateDetailsDB00357Aminoglutethimideapproved, investigationalunknowninducerDetailsDB00564Carbamazepineapproved, investigationalunknowninhibitorinducerDetailsDB01601LopinavirapprovedunknowninhibitorDetailsDB01045RifampicinapprovedunknowninducerDetailsDB06413Armodafinilapproved, investigationalunknowninhibitorDetailsDB00705DelavirdineapprovedunknowninhibitorDetailsDB01241GemfibrozilapprovedunknowninhibitorDetailsDB00951Isoniazidapproved, investigationalunknowninhibitorDetailsDB06268Sitaxentanapproved, investigational, withdrawnunknowninhibitorDetailsDB00216Eletriptanapproved, investigationalunknownsubstrateDetailsDB00363ClozapineapprovednosubstrateinhibitorDetailsDB00425ZolpidemapprovedunknownsubstrateDetailsDB01036Tolterodineapproved, investigationalunknownsubstrateDetailsDB01283Lumiracoxibapproved, investigationalunknownsubstrateDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateinhibitorDetailsDB00672Chlorpropamideapproved, investigationalunknownsubstrateDetailsDB01120GliclazideapprovedunknownsubstrateDetailsDB01016GlyburideapprovedunknownsubstrateDetailsDB06739SeratrodastexperimentalunknownsubstrateDetailsDB06697ArtemetherapprovedunknownsubstrateinducerDetailsDB00945Acetylsalicylic acidapproved, vet_approvedunknowninducerDetailsDB01118Amiodaroneapproved, investigationalunknownsubstrateinhibitorDetailsDB00701Amprenavirapproved, investigationalunknowninhibitorDetailsDB00673Aprepitantapproved, investigationalunknownsubstrateinhibitorDetailsDB00289AtomoxetineapprovedunknownsubstrateDetailsDB01558Bromazepamapproved, illicit, investigationalunknownsubstrateDetailsDB00297Bupivacaineapproved, investigationalunknownsubstrateDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknowninhibitorDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknowninhibitorDetailsDB00604Cisaprideapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB06470ClomethiazoleinvestigationalunknownsubstrateDetailsDB01559Clotiazepamapproved, illicitunknownsubstrateDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknowninducerDetailsDB00514DextromethorphanapprovedunknownsubstrateDetailsDB01093Dimethyl sulfoxideapproved, vet_approvedunknowninhibitorDetailsDB00590DoxazosinapprovedunknownsubstrateDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstrateDetailsDB00898EthanolapprovedunknowninhibitorDetailsDB01628Etoricoxibapproved, investigationalunknowninhibitorDetailsDB00502HaloperidolapprovedunknownsubstrateDetailsDB01050IbuprofenapprovedunknownsubstrateDetailsDB06738KetobemidoneinvestigationalunknownsubstrateDetailsDB00678LosartanapprovedunknowninhibitorDetailsDB01043Memantineapproved, investigationalunknowninhibitorDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB00184NicotineapprovedunknownsubstrateDetailsDB06712Nilvadipineapproved, investigationalunknowninhibitorDetailsDB00717NorethisteroneapprovedunknownsubstrateinducerDetailsDB00334Olanzapineapproved, investigationalunknowninhibitorDetailsDB00312Pentobarbitalapproved, investigational, vet_approvedunknownsubstrateDetailsDB00850PerphenazineapprovedunknownsubstrateDetailsDB00454MeperidineapprovedunknownsubstrateDetailsDB03783PhenacetinwithdrawnunknownsubstrateDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB01058Praziquantelapproved, investigational, vet_approvedunknownsubstrateDetailsDB00635Prednisoneapproved, vet_approvedunknowninducerDetailsDB00818Propofolapproved, investigational, vet_approvedunknownsubstrateDetailsDB01589Quazepamapproved, illicitnosubstrateDetailsDB01224QuetiapineapprovedunknownsubstrateDetailsDB01037Selegilineapproved, investigational, vet_approvedunknownsubstrateDetailsDB00966Telmisartanapproved, investigationalunknowninhibitorDetailsDB00624Testosteroneapproved, investigationalunknownsubstrateDetailsDB00763MethimazoleapprovedunknowninhibitorDetailsDB00373TimololapprovedunknownsubstrateDetailsDB01007TioconazoleapprovedunknowninhibitorDetailsDB00347TrimethadioneapprovedunknownsubstrateDetailsDB00313Valproic acidapproved, investigationalunknownsubstrateinhibitorDetailsDB00661VerapamilapprovedunknownsubstrateDetailsDB00549Zafirlukastapproved, investigationalunknowninhibitorDetailsDB00909Zonisamideapproved, investigationalunknownsubstrateinhibitorDetailsDB00398Sorafenibapproved, investigationalunknowninhibitorDetailsDB00932Tipranavirapproved, investigationalunknownsubstrateinhibitorDetailsDB00980Ramelteonapproved, investigationalunknownsubstrateDetailsDB01128BicalutamideapprovedunknowninhibitorDetailsDB01259Lapatinibapproved, investigationalunknownsubstrateDetailsDB01621Pipotiazineapproved, investigationalunknownsubstrateDetailsDB00918Almotriptanapproved, investigationalunknownsubstrateDetailsDB04920Clevidipineapproved, investigationalunknowninhibitorDetailsDB00109Enfuvirtideapproved, investigationalunknownsubstrateDetailsDB00239OxiconazoleapprovedunknownsubstrateDetailsDB06204TapentadolapprovedunknownsubstrateDetailsDB06209PrasugrelapprovednosubstrateDetailsDB04871Lorcaserinapproved, withdrawnnosubstrateDetailsDB08864RilpivirineapprovedunknownsubstrateinhibitorDetailsDB06605ApixabanapprovedunknownsubstrateDetailsDB06626Axitinibapproved, investigationalnosubstrateDetailsDB08828Vismodegibapproved, investigationalunknowninhibitorDetailsDB08899EnzalutamideapprovednoinducerDetailsDB08895Tofacitinibapproved, investigationalnosubstrateDetailsDB04938Ospemifeneapproved, investigationalunknownsubstrateDetailsDB00317Gefitinibapproved, investigationalunknowninhibitorDetailsDB08918Levomilnacipranapproved, investigationalunknownsubstrateDetailsDB08932MacitentanapprovednosubstrateDetailsDB08933LuliconazoleapprovednoinhibitorDetailsDB09049NaloxegolapprovedunknowninhibitorDetailsDB00951Isoniazidapproved, investigationalunknownDetailsDB09054IdelalisibapprovednoinhibitorDetailsDB09068Vortioxetineapproved, investigationalnosubstrateDetailsDB09280LumacaftorapprovednoinducerDetailsDB09570Ixazomibapproved, investigationalunknownsubstrateDetailsDB06176Romidepsinapproved, investigationalunknownsubstrateDetailsDB09119Eslicarbazepine acetateapprovednoinhibitorDetailsDB06789Hydroxyprogesterone caproateapproved, investigationalunknowninducerDetailsDB05812AbirateroneapprovedunknowninhibitorDetailsDB09118StiripentolapprovedunknownsubstrateinhibitorDetailsDB06595Midostaurinapproved, investigationalunknowninhibitorinducerDetailsDB05541Brivaracetamapproved, investigationalnosubstrateDetailsDB05351Dexlansoprazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB01685TopiroxostatexperimentalunknowninhibitorDetailsDB09120Zucapsaicinapproved, investigationalunknowninhibitorDetailsDB09198LobeglitazoneexperimentalnoinhibitorDetailsDB09167DosulepinapprovedunknowninhibitorDetailsDB09166EtizolamexperimentalunknownsubstrateDetailsDB11614RupatadineapprovednosubstrateDetailsDB12319Benzbromaroneinvestigational, withdrawnunknowninhibitorDetailsDB09238Manidipineapproved, investigationalunknowninhibitorDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB12070Letermovirapproved, investigationalnoinducerDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB09061Cannabidiolapproved, investigationalunknownsubstrateinhibitorDetailsDB13943Testosterone cypionateapprovedunknownsubstrateDetailsDB13944Testosterone enanthateapprovedunknownsubstrateDetailsDB13946Testosterone undecanoateapproved, investigationalunknownsubstrateDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateDetailsDB11638Artenimolapproved, experimental, investigationalunknowninhibitorDetailsDB13941Piperaquineapproved, experimental, investigationalunknownsubstrateinhibitorDetailsDB11901Apalutamideapproved, investigationalnoinducerDetailsDB11633Isavuconazoleapproved, investigationalunknowninhibitorDetailsDB11586Asunaprevirapproved, investigational, withdrawnnosubstrateDetailsDB14011NabiximolsinvestigationalunknownsubstrateDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorDetailsDB11632Opicaponeapproved, investigationalnoinducerDetailsDB13746Bioallethrinapproved, experimentalnosubstrateDetailsDB04948Lofexidineapproved, investigationalnosubstrateDetailsDB00598LabetalolapprovedunknownsubstrateDetailsDB11967Binimetinibapproved, investigationalnosubstrateDetailsDB11718Encorafenibapproved, investigationalnosubstrateDetailsDB12474Lynestrenolapproved, investigationalnosubstrateinhibitorDetailsDB00615Rifabutinapproved, investigationalnoinducerDetailsDB01201Rifapentineapproved, investigationalnoinducerDetailsDB01220Rifaximinapproved, investigationalnoinducerDetailsDB11753Rifamycinapproved, investigationalnoinhibitorDetailsDB01483BarbitalillicitnosubstrateinducerDetailsDB00418Secobarbitalapproved, vet_approvednoinducerDetailsDB00599Thiopentalapproved, vet_approvednosubstrateDetailsDB06654Safinamideapproved, investigationalunknowninhibitorDetailsDB09078Lenvatinibapproved, investigationalunknowninhibitorDetailsDB05928DovitinibinvestigationalunknowninhibitorDetailsDB08496(R)-warfarinexperimentalunknownsubstrateDetailsDB14055(S)-Warfarinexperimental, investigationalunknownsubstrateDetailsDB04911Oritavancinapproved, investigationalunknowninhibitorDetailsDB06218LacosamideapprovedunknownsubstrateDetailsDB13762DexrabeprazoleexperimentalunknownsubstrateDetailsDB12319Benzbromaroneinvestigational, withdrawnunknowninhibitorDetailsDB09213Dexibuprofenapproved, investigationalunknownsubstrateDetailsDB00518Albendazoleapproved, vet_approvednosubstrateDetailsDB14025ClinafloxacininvestigationalunknowninhibitorDetailsDB06731SeproxetineinvestigationalunknowninhibitorDetailsDB14575EslicarbazepineapprovedunknowninhibitorDetailsDB01323St. John's Wortapproved, investigational, nutraceuticalnosubstrateinducerDetailsDB12130Lorlatinibapproved, investigationalunknownsubstrateDetailsDB12245Triclabendazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB11823Esketamineapproved, investigationalunknownsubstrateDetailsDB06684VilazodoneapprovedunknownsubstrateDetailsDB12015Alpelisibapproved, investigationalunknowninhibitorDetailsDB00977EthinylestradiolapprovedunknowninhibitorDetailsDB06730GestodeneinvestigationalunknowninhibitorDetailsDB00641SimvastatinapprovedunknownsubstrateDetailsDB00227Lovastatinapproved, investigationalunknownsubstrateDetailsDB00715Paroxetineapproved, investigationalunknownsubstrateDetailsDB00956Hydrocodoneapproved, illicit, investigationalunknownsubstrateDetailsDB04861Nebivololapproved, investigationalunknownsubstrateDetailsDB12500Fedratinibapproved, investigationalunknownsubstrateDetailsDB08502CapravirineinvestigationalunknownsubstrateDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB01039FenofibrateapprovedunknowninhibitorDetailsDB15444Elexacaftorapproved, investigationalnoinhibitorDetailsDB14975Voxelotorapproved, investigationalunknownsubstrateDetailsDB00741Hydrocortisoneapproved, vet_approvedunknowninducerDetailsDB06119Cenobamateapproved, investigationalunknownsubstrateinhibitorDetailsDB01222BudesonideapprovedunknowninducerDetailsDB00959Methylprednisoloneapproved, vet_approvedunknowninducerDetailsDB15328Ubrogepantapproved, investigationalunknowninhibitorDetailsDB00983Formoterolapproved, investigationalunknownsubstrateDetailsDB01006Letrozoleapproved, investigationalunknowninhibitorDetailsDB11837Osilodrostatapproved, investigationalunknowninhibitorDetailsDB00443Betamethasoneapproved, vet_approvedunknowninducerDetailsDB09241Methylene blueapproved, investigationalunknownsubstrateinhibitorDetailsDB11689Selumetinibapproved, investigationalnosubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknowninducerDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknowninducerDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateDetailsDB14881Oliceridineapproved, investigationalunknownsubstrateDetailsDB12499Clascoteroneapproved, investigationalnoinhibitorDetailsDB15093Somapacitanapproved, investigationalunknowninhibitorDetailsDB06448Lonafarnibapproved, investigationalnosubstrateinhibitorDetailsDB04951Pirfenidoneapproved, investigationalunknownsubstrateinhibitorDetailsDB06137Tirbanibulinapproved, investigationalnoinhibitorDetailsDB00935Oxymetazolineapproved, investigationalnosubstrateDetailsDB08912Dabrafenibapproved, investigationalnosubstrateinhibitorinducerDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB00476DuloxetineapprovedunknowninhibitorDetailsDB00052Somatotropinapproved, investigationalunknowninhibitorDetailsDB00330EthambutolapprovedunknowninhibitorDetailsDB14984Casimersenapproved, investigationalnoinhibitorDetailsDB01086Benzocaineapproved, investigationalunknownsubstrateDetailsDB08896RegorafenibapprovedunknowninhibitorDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownsubstrateDetailsDB05271RotigotineapprovednoinhibitorDetailsDB01183Naloxoneapproved, vet_approvedunknownsubstrateDetailsDB12543Samidorphanapproved, investigationalnosubstrateDetailsDB12151Brincidofovirapproved, investigationalnoinhibitorDetailsDB16703Belumosudilapproved, investigationalnoinhibitorDetailsDB15463Belzutifanapproved, investigationalnosubstrateDetailsDB12265Fexinidazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB16220Lonapegsomatropinapproved, investigationalunknowninhibitorDetailsDB16349VicagrelinvestigationalunknownsubstrateDetailsDB12597Asciminibapproved, investigationalnoinhibitorDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB14973Abrocitinibapproved, investigationalnosubstrateDetailsDB05467Palovaroteneapproved, investigationalnosubstrateDetailsDB16236Mitapivatapproved, investigationalnoinducerDetailsDB12834SecnidazoleapprovedunknowninhibitorDetailsDB00470Dronabinolapproved, illicitnosubstrateinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknownsubstrateDetailsDB11697Pacritinibapproved, investigationalnoinhibitorDetailsDB05087Ganaxoloneapproved, investigationalnosubstrateDetailsDB06016Cariprazineapproved, investigationalnoinhibitorDetailsDB14921Mavacamtenapproved, investigationalnosubstrateinducerDetailsDB12020Tecovirimatapproved, investigationalnoinhibitorDetailsDB06083Tapinarofapproved, investigationalnosubstrateDetailsDB00285VenlafaxineapprovednosubstrateDetailsDB12095Telotristat ethylapproved, investigationalnoinhibitorDetailsDB11739Vonoprazanapproved, investigationalunknownsubstrateinhibitorDetailsDB16267Olutasidenibapproved, investigationalnosubstrateDetailsDB02709ResveratrolinvestigationalnoinhibitorDetailsDB17472Pirtobrutinibapproved, investigationalunknowninhibitorinducerDetailsDB12548Sparsentanapproved, investigationalunknowninducerDetailsDB00381AmlodipineapprovednoinhibitorDetailsDB00862VardenafilapprovedunknowninhibitorDetailsDB11712Tezacaftorapproved, investigationalnoinhibitorDetailsDB15669Fezolinetantapproved, investigationalnosubstrateDetailsDB06700Desvenlafaxineapproved, investigationalnosubstrateDetailsDB11763Momelotinibapproved, investigationalunknownsubstrateDetailsDB14766EtrasimodapprovednosubstrateDetailsDB16826RepotrectinibinvestigationalnoinducerDetailsDB11679FruquintinibinvestigationalnosubstrateDetails"
                    }
                },
                {
                    "Label": "Cytochrome P450 2D6",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 2D6",
                        "Synonyms": "1.14.14.1\nCholesterol 25-hydroxylase\nCYP2DL1\nCYPIID6\nCytochrome P450-DB1\nDebrisoquine 4-hydroxylase",
                        "Gene Name": "CYP2D6",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0004641|Cytochrome P450 2D6\nMGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVDFQNTPYCFDQ\nLRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVF\nLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDK\nAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKV\nLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVA\nDLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVI\nHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHF\nLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGV\nFAFLVSPSPYELCAVPR",
                        "Number of residues": "497",
                        "Molecular Weight": "55768.94",
                        "Theoretical pI": "7.26",
                        "GO Classification": "Functionsarachidonic acid epoxygenase activity / aromatase activity / drug binding / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity / oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen / oxygen binding / steroid hydroxylase activityProcessesalkaloid catabolic process / alkaloid metabolic process / arachidonic acid metabolic process / coumarin metabolic process / drug catabolic process / drug metabolic process / exogenous drug catabolic process / heterocycle metabolic process / isoquinoline alkaloid metabolic process / monoterpenoid metabolic process / negative regulation of binding / negative regulation of cellular organofluorine metabolic process / oxidation-reduction process / oxidative demethylation / small molecule metabolic process / steroid metabolic process / xenobiotic metabolic processComponentscytoplasm / endoplasmic reticulum / endoplasmic reticulum membrane / mitochondrion",
                        "General Function": "Steroid hydroxylase activity",
                        "Specific Function": "Responsible for the metabolism of many drugs and environmental chemicals that it oxidizes. It is involved in the metabolism of drugs such as antiarrhythmics, adrenoceptor antagonists, and tricyclic antidepressants.",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0019275|Cytochrome P450 2D6 (CYP2D6)\nATGGGGCTAGAAGCACTGGTGCCCCTGGCCGTGATAGTGGCCATCTTCCTGCTCCTGGTG\nGACCTGATGCACCGGCGCCAACGCTGGGCTGCACGCTACCCACCAGGCCCCCTGCCACTG\nCCCGGGCTGGGCAACCTGCTGCATGTGGACTTCCAGAACACACCATACTGCTTCGACCAG\nTTGCGGCGCCGCTTCGGGGACGTGTTCAGCCTGCAGCTGGCCTGGACGCCGGTGGTCGTG\nCTCAATGGGCTGGCGGCCGTGCGCGAGGCGCTGGTGACCCACGGCGAGGACACCGCCGAC\nCGCCCGCCTGTGCCCATCACCCAGATCCTGGGTTTCGGGCCGCGTTCCCAAGGGGTGTTC\nCTGGCGCGCTATGGGCCCGCGTGGCGCGAGCAGAGGCGCTTCTCCGTGTCCACCTTGCGC\nAACTTGGGCCTGGGCAAGAAGTCGCTGGAGCAGTGGGTGACCGAGGAGGCCGCCTGCCTT\nTGTGCCGCCTTCGCCAACCACTCCGGACGCCCCTTTCGCCCCAACGGTCTCTTGGACAAA\nGCCGTGAGCAACGTGATCGCCTCCCTCACCTGCGGGCGCCGCTTCGAGTACGACGACCCT\nCGCTTCCTCAGGCTGCTGGACCTAGCTCAGGAGGGACTGAAGGAGGAGTCGGGCTTTCTG\nCGCGAGGTGCTGAATGCTGTCCCCGTCCTCCTGCATATCCCAGCGCTGGCTGGCAAGGTC\nCTACGCTTCCAAAAGGCTTTCCTGACCCAGCTGGATGAGCTGCTAACTGAGCACAGGATG\nACCTGGGACCCAGCCCAGCCCCCCCGAGACCTGACTGAGGCCTTCCTGGCAGAGATGGAG\nAAGGCCAAGGGGAACCCTGAGAGCAGCTTCAATGATGAGAACCTGCGCATAGTGGTGGCT\nGACCTGTTCTCTGCCGGGATGGTGACCACCTCGACCACGCTGGCCTGGGGCCTCCTGCTC\nATGATCCTACATCCGGATGTGCAGCGCCGTGTCCAACAGGAGATCGACGACGTGATAGGG\nCAGGTGCGGCGACCAGAGATGGGTGACCAGGCTCACATGCCCTACACCACTGCCGTGATT\nCATGAGGTGCAGCGCTTTGGGGACATCGTCCCCCTGGGTGTGACCCATATGACATCCCGT\nGACATCGAAGTACAGGGCTTCCGCATCCCTAAGGGAACGACACTCATCACCAACCTGTCA\nTCGGTGCTGAAGGATGAGGCCGTCTGGGAGAAGCCCTTCCGCTTCCACCCCGAACACTTC\nCTGGATGCCCAGGGCCACTTTGTGAAGCCGGAGGCCTTCCTGCCTTTCTCAGCAGGCCGC\nCGTGCATGCCTCGGGGAGCCCCTGGCCCGCATGGAGCTCTTCCTCTTCTTCACCTCCCTG\nCTGCAGCACTTCAGCTTCTCGGTGCCCACTGGACAGCCCCGGCCCAGCCACCATGGTGTC\nTTTGCTTTCCTGGTGAGCCCATCCCCCTATGAGCTTTGTGCTGTGCCCCGCTAG",
                        "Chromosome Location": "22",
                        "Locus": "22q13.1",
                        "External Identifiers": "ResourceLinkUniProtKB IDP10635UniProtKB Entry NameCP2D6_HUMANGenBank Protein ID181350GenBank Gene IDM20403GenAtlas IDCYP2D6HGNC IDHGNC:2625",
                        "General References": "Gonzalez FJ, Vilbois F, Hardwick JP, McBride OW, Nebert DW, Gelboin HV, Meyer UA: Human debrisoquine 4-hydroxylase (P450IID1): cDNA and deduced amino acid sequence and assignment of the CYP2D locus to chromosome 22. Genomics. 1988 Feb;2(2):174-9. [Article] Gonzalez FJ, Skoda RC, Kimura S, Umeno M, Zanger UM, Nebert DW, Gelboin HV, Hardwick JP, Meyer UA: Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature. 1988 Feb 4;331(6155):442-6. [Article] Kimura S, Umeno M, Skoda RC, Meyer UA, Gonzalez FJ: The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene. Am J Hum Genet. 1989 Dec;45(6):889-904. [Article] Gaedigk A, Bhathena A, Ndjountche L, Pearce RE, Abdel-Rahman SM, Alander SW, Bradford LD, Rogan PK, Leeder JS: Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans. Pharmacogenomics J. 2005;5(3):173-82. [Article] Dunham I, Shimizu N, Roe BA, Chissoe S, Hunt AR, Collins JE, Bruskiewich R, Beare DM, Clamp M, Smink LJ, Ainscough R, Almeida JP, Babbage A, Bagguley C, Bailey J, Barlow K, Bates KN, Beasley O, Bird CP, Blakey S, Bridgeman AM, Buck D, Burgess J, Burrill WD, O'Brien KP, et al.: The DNA sequence of human chromosome 22. Nature. 1999 Dec 2;402(6761):489-95. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Honda A, Miyazaki T, Ikegami T, Iwamoto J, Maeda T, Hirayama T, Saito Y, Teramoto T, Matsuzaki Y: Cholesterol 25-hydroxylation activity of CYP3A. J Lipid Res. 2011 Aug;52(8):1509-16. doi: 10.1194/jlr.M014084. Epub 2011 May 16. [Article] Rowland P, Blaney FE, Smyth MG, Jones JJ, Leydon VR, Oxbrow AK, Lewis CJ, Tennant MG, Modi S, Eggleston DS, Chenery RJ, Bridges AM: Crystal structure of human cytochrome P450 2D6. J Biol Chem. 2006 Mar 17;281(11):7614-22. Epub 2005 Dec 13. [Article] Tyndale R, Aoyama T, Broly F, Matsunaga T, Inaba T, Kalow W, Gelboin HV, Meyer UA, Gonzalez FJ: Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: possible association with the poor metabolizer phenotype. Pharmacogenetics. 1991 Oct;1(1):26-32. [Article] Yokota H, Tamura S, Furuya H, Kimura S, Watanabe M, Kanazawa I, Kondo I, Gonzalez FJ: Evidence for a new variant CYP2D6 allele CYP2D6J in a Japanese population associated with lower in vivo rates of sparteine metabolism. Pharmacogenetics. 1993 Oct;3(5):256-63. [Article] Evert B, Griese EU, Eichelbaum M: A missense mutation in exon 6 of the CYP2D6 gene leading to a histidine 324 to proline exchange is associated with the poor metabolizer phenotype of sparteine. Naunyn Schmiedebergs Arch Pharmacol. 1994 Oct;350(4):434-9. [Article] Daly AK, Leathart JB, London SJ, Idle JR: An inactive cytochrome P450 CYP2D6 allele containing a deletion and a base substitution. Hum Genet. 1995 Mar;95(3):337-41. [Article] Masimirembwa C, Persson I, Bertilsson L, Hasler J, Ingelman-Sundberg M: A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: association with diminished debrisoquine hydroxylase activity. Br J Clin Pharmacol. 1996 Dec;42(6):713-9. [Article] Marez D, Legrand M, Sabbagh N, Lo-Guidice JM, Boone P, Broly F: An additional allelic variant of the CYP2D6 gene causing impaired metabolism of sparteine. Hum Genet. 1996 May;97(5):668-70. [Article] Marez D, Legrand M, Sabbagh N, Lo Guidice JM, Spire C, Lafitte JJ, Meyer UA, Broly F: Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution. Pharmacogenetics. 1997 Jun;7(3):193-202. [Article] Wang SL, Lai MD, Huang JD: G169R mutation diminishes the metabolic activity of CYP2D6 in Chinese. Drug Metab Dispos. 1999 Mar;27(3):385-8. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article] Dai DP, Geng PW, Wang SH, Cai J, Hu LM, Nie JJ, Hu JH, Hu GX, Cai JP: In vitro functional assessment of 22 newly identified CYP2D6 allelic variants in the Chinese population. Basic Clin Pharmacol Toxicol. 2015 Jul;117(1):39-43. doi: 10.1111/bcpt.12363. Epub 2015 Jan 14. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00176Fluvoxamineapproved, investigationalunknownsubstrateinhibitorDetailsDB00182Amphetamineapproved, illicit, investigationalunknownsubstrateDetailsDB00185CevimelineapprovedunknownsubstrateDetailsDB00193Tramadolapproved, investigationalunknownsubstrateDetailsDB00243Ranolazineapproved, investigationalnosubstrateinhibitorDetailsDB00264Metoprololapproved, investigationalunknownsubstrateinhibitorDetailsDB00281Lidocaineapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00285VenlafaxineapprovedunknownsubstrateinhibitorDetailsDB00289AtomoxetineapprovedunknownsubstrateDetailsDB00318Codeineapproved, illicitunknownsubstrateDetailsDB00370MirtazapineapprovedunknownsubstrateDetailsDB00373TimololapprovedunknownsubstrateDetailsDB00379Mexiletineapproved, investigationalunknownsubstrateDetailsDB00433Prochlorperazineapproved, vet_approvedunknownsubstrateDetailsDB00454MeperidineapprovedunknownsubstrateDetailsDB00476DuloxetineapprovedunknownsubstrateinhibitorDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00496Darifenacinapproved, investigationalunknownsubstrateinhibitorDetailsDB00497Oxycodoneapproved, illicit, investigationalunknownsubstrateDetailsDB00502HaloperidolapprovedunknownsubstrateinhibitorDetailsDB00503Ritonavirapproved, investigationalunknownsubstrateinhibitorDetailsDB00514DextromethorphanapprovedunknownsubstrateDetailsDB00521CarteololapprovedunknownsubstrateDetailsDB00557HydroxyzineapprovednoinhibitorDetailsDB00574Fenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00575ClonidineapprovedunknownsubstrateDetailsDB00623FluphenazineapprovedunknowninhibitorDetailsDB00647Dextropropoxypheneapproved, illicit, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00656Trazodoneapproved, investigationalunknownsubstrateinhibitorDetailsDB00674GalantamineapprovednosubstrateDetailsDB00675TamoxifenapprovedunknownsubstrateinhibitorDetailsDB00679Thioridazineapproved, withdrawnunknownsubstrateinhibitorDetailsDB00699Nicergolineapproved, investigationalunknownsubstrateDetailsDB00715Paroxetineapproved, investigationalunknownsubstrateinhibitorDetailsDB00734Risperidoneapproved, investigationalunknownsubstrateinhibitorDetailsDB00757Dolasetronapproved, investigationalunknownsubstrateDetailsDB00805MinaprineapprovedunknownsubstrateDetailsDB00843DonepezilapprovedunknownsubstrateDetailsDB00850PerphenazineapprovedunknownsubstrateinhibitorDetailsDB00863Ranitidineapproved, withdrawnunknowninhibitorDetailsDB00866Alprenololexperimental, withdrawnunknownsubstrateDetailsDB00904Ondansetronapproved, withdrawnunknownsubstrateDetailsDB00914Phenforminapproved, investigational, withdrawnunknownsubstrateDetailsDB00918Almotriptanapproved, investigationalunknownsubstrateDetailsDB00934Maprotilineapproved, investigationalunknownsubstrateDetailsDB00956Hydrocodoneapproved, illicit, investigationalunknownsubstrateDetailsDB00960Pindololapproved, investigationalunknownsubstrateinhibitorDetailsDB01012CinacalcetapprovedunknowninhibitorDetailsDB01035ProcainamideapprovedunknownsubstrateDetailsDB01036Tolterodineapproved, investigationalunknownsubstrateDetailsDB01069Promethazineapproved, investigationalunknownsubstrateinhibitorDetailsDB01074Perhexilineapproved, investigationalunknownsubstrateinhibitorDetailsDB01114ChlorpheniramineapprovedunknownsubstrateinhibitorDetailsDB01136Carvedilolapproved, investigationalunknownsubstrateDetailsDB01142Doxepinapproved, investigationalnosubstrateinhibitorDetailsDB01151Desipramineapproved, investigationalunknownsubstrateinhibitorDetailsDB01193Acebutololapproved, investigationalunknownsubstrateinhibitorDetailsDB01195Flecainideapproved, withdrawnunknownsubstrateinhibitorDetailsDB01228Encainideapproved, investigational, withdrawnunknownsubstrateDetailsDB01233Metoclopramideapproved, investigationalunknownsubstrateinhibitorDetailsDB01242Clomipramineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB01171Moclobemideapproved, investigationalunknownsubstrateinhibitorDetailsDB01274Arformoterolapproved, investigationalunknownsubstrateDetailsDB01410Ciclesonideapproved, investigationalunknownsubstrateDetailsDB01466Ethylmorphineexperimental, illicitunknownsubstrateDetailsDB01409TiotropiumapprovednosubstrateDetailsDB01075Diphenhydramineapproved, investigationalunknownsubstrateinhibitorDetailsDB04840Debrisoquineapproved, investigationalunknownsubstrateDetailsDB00215CitalopramapprovednosubstrateinhibitorDetailsDB00234Reboxetineapproved, experimentalunknowninhibitorDetailsDB00257Clotrimazoleapproved, vet_approvedunknowninhibitorDetailsDB00317Gefitinibapproved, investigationalnosubstrateinhibitorDetailsDB00321AmitriptylineapprovedunknownsubstrateDetailsDB00342Terfenadineapproved, withdrawnunknownsubstrateinhibitorDetailsDB00343Diltiazemapproved, investigationalunknownsubstrateDetailsDB00356ChlorzoxazoneapprovedunknownsubstrateDetailsDB00363ClozapineapprovednosubstrateinhibitorDetailsDB00455Loratadineapproved, investigationalunknownsubstrateinhibitorDetailsDB00458ImipramineapprovedunknownsubstrateinhibitorDetailsDB00468QuinineapprovedunknownsubstrateinhibitorDetailsDB00482Celecoxibapproved, investigationalunknownsubstrateinhibitorDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00532Mephenytoinapproved, investigational, withdrawnunknownsubstrateDetailsDB00540NortriptylineapprovedunknownsubstrateinhibitorDetailsDB00613Amodiaquineapproved, investigationalunknowninhibitorDetailsDB00622Nicardipineapproved, investigationalunknowninhibitorDetailsDB00705DelavirdineapprovedunknownsubstrateinhibitorDetailsDB00726TrimipramineapprovedunknownsubstrateDetailsDB00752Tranylcypromineapproved, investigationalunknowninhibitorDetailsDB00857Terbinafineapproved, investigational, vet_approvedunknowninhibitorDetailsDB00908Quinidineapproved, investigationalunknowninhibitorDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00933Mesoridazineapproved, investigationalunknownsubstrateDetailsDB00972AzelastineapprovedunknownsubstrateinhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB01071MequitazineexperimentalunknownsubstrateDetailsDB01104SertralineapprovedunknownsubstrateinhibitorDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB01115NifedipineapprovedunknowninhibitorDetailsDB01118Amiodaroneapproved, investigationalnoinhibitorDetailsDB01131ProguanilapprovednoinhibitorDetailsDB01149Nefazodoneapproved, withdrawnunknownsubstrateinhibitorDetailsDB01156BupropionapprovedunknowninhibitorDetailsDB01175EscitalopramapprovednosubstrateinhibitorDetailsDB01182PropafenoneapprovedunknownsubstrateinhibitorDetailsDB01191Dexfenfluramineapproved, illicit, investigational, withdrawnunknownsubstrateinhibitorDetailsDB01192Oxymorphoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB01218HalofantrineapprovedunknowninhibitorDetailsDB01238Aripiprazoleapproved, investigationalnosubstrateDetailsDB01403Methotrimeprazineapproved, investigationalunknownsubstrateinhibitorDetailsDB01551Dihydrocodeineapproved, illicitunknownsubstrateDetailsDB00377Palonosetronapproved, investigationalunknownsubstrateDetailsDB04861Nebivololapproved, investigationalunknownsubstrateDetailsDB04889BicifadineinvestigationalunknownsubstrateDetailsDB015621-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidineexperimental, illicitunknowninhibitorDetailsDB06144Sertindoleapproved, investigational, withdrawnunknownsubstrateDetailsDB06148Mianserinapproved, investigationalunknownsubstrateDetailsDB04905TesmilifeneinvestigationalunknownsubstrateDetailsDB01624Zuclopenthixolapproved, investigationalunknownsubstrateDetailsDB00571Propranololapproved, investigationalunknownsubstrateinhibitorDetailsDB05271RotigotineapprovedunknownsubstrateinhibitorDetailsDB00472Fluoxetineapproved, vet_approvednosubstrateinhibitorDetailsDB01095FluvastatinapprovedunknownsubstrateDetailsDB01076AtorvastatinapprovednoinhibitorDetailsDB00439Cerivastatinapproved, withdrawnunknowninhibitorDetailsDB00619ImatinibapprovednosubstrateinhibitorDetailsDB00334Olanzapineapproved, investigationalnosubstrateinhibitorDetailsDB00792Tripelennamineapproved, vet_approvedunknowninhibitorDetailsDB00188Bortezomibapproved, investigationalunknownsubstrateDetailsDB05109Trabectedinapproved, investigationalunknownsubstrateDetailsDB00568Cinnarizineapproved, investigationalunknownsubstrateDetailsDB04841FlunarizineapprovedunknownsubstrateDetailsDB06726BufuralolexperimentalunknownsubstrateDetailsDB014724-Methoxyamphetamineexperimental, illicitunknownsubstrateDetailsDB03783PhenacetinwithdrawnunknownsubstrateDetailsDB06727Sparteineexperimental, withdrawnunknownsubstrateinhibitorDetailsDB00283Clemastineapproved, investigationalunknowninhibitorDetailsDB00907Cocaineapproved, illicitunknowninhibitorDetailsDB00997Doxorubicinapproved, investigationalnosubstrateinhibitorDetailsDB00333MethadoneapprovednosubstrateinhibitorDetailsDB01388Mibefradilinvestigational, withdrawnunknowninhibitorDetailsDB00211MidodrineapprovedunknownsubstrateDetailsDB00208TiclopidineapprovedunknownsubstrateinhibitorDetailsDB00543AmoxapineapprovedunknownsubstrateinhibitorDetailsDB00608Chloroquineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB04946IloperidoneapprovedunknownsubstrateDetailsDB01577Metamfetamineapproved, illicit, withdrawnunknownsubstrateDetailsDB01621Pipotiazineapproved, investigationalunknownsubstrateinhibitorDetailsDB00706Tamsulosinapproved, investigationalunknownsubstrateDetailsDB04844Tetrabenazineapproved, investigationalunknownsubstrateDetailsDB01601LopinavirapprovedunknownsubstrateDetailsDB00932Tipranavirapproved, investigationalunknownsubstrateinhibitorDetailsDB04855DronedaroneapprovedunknownsubstrateinhibitorDetailsDB00951Isoniazidapproved, investigationalunknowninhibitorDetailsDB06708LumefantrineapprovedunknowninhibitorDetailsDB04868Nilotinibapproved, investigationalunknowninhibitorDetailsDB01424Aminophenazoneapproved, withdrawnunknownsubstrateDetailsDB00238NevirapineapprovedunknownsubstrateinhibitorDetailsDB00216Eletriptanapproved, investigationalunknownsubstrateDetailsDB00425ZolpidemapprovedunknownsubstrateDetailsDB01628Etoricoxibapproved, investigationalunknowninhibitorDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateDetailsDB00316AcetaminophenapprovedunknownsubstrateDetailsDB00924CyclobenzaprineapprovedunknownsubstrateDetailsDB00381AmlodipineapprovedunknowninhibitorDetailsDB00701Amprenavirapproved, investigationalunknownsubstrateDetailsDB01429AprindineexperimentalunknownsubstrateDetailsDB00637Astemizoleapproved, withdrawnunknownsubstrateDetailsDB01244Bepridilapproved, withdrawnunknownsubstrateinhibitorDetailsDB00195Betaxololapproved, investigationalunknownsubstrateDetailsDB00810Biperidenapproved, investigationalunknowninhibitorDetailsDB00297Bupivacaineapproved, investigationalunknownsubstrateDetailsDB00490Buspironeapproved, investigationalunknownsubstrateDetailsDB00201CaffeineapprovedunknownsubstrateDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknowninhibitorDetailsDB00604Cisaprideapproved, investigational, withdrawnunknowninhibitorDetailsDB01093Dimethyl sulfoxideapproved, vet_approvedunknowninhibitorDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB00590DoxazosinapprovedunknownsubstrateDetailsDB00625Efavirenzapproved, investigationalunknowninhibitorDetailsDB00751Epinastineapproved, investigationalunknownsubstrateinhibitorDetailsDB01023Felodipineapproved, investigationalunknowninhibitorDetailsDB01611HydroxychloroquineapprovedunknownsubstrateinhibitorDetailsDB01177IdarubicinapprovedunknownsubstrateDetailsDB00224IndinavirapprovedunknowninhibitorDetailsDB00598LabetalolapprovedunknownsubstrateinhibitorDetailsDB00448Lansoprazoleapproved, investigationalunknowninhibitorDetailsDB00528Lercanidipineapproved, investigationalunknowninhibitorDetailsDB01206Lomustineapproved, investigationalunknowninhibitorDetailsDB06691Mepyramineapproved, vet_approvedunknowninhibitorDetailsDB01028Methoxyfluraneapproved, investigational, vet_approved, withdrawnunknownsubstrateDetailsDB00834Mifepristoneapproved, investigationalunknowninhibitorDetailsDB00731Nateglinideapproved, investigationalunknownsubstrateDetailsDB00220NelfinavirapprovednoinhibitorDetailsDB02701Nicotinamideapproved, investigationalunknowninhibitorDetailsDB00184NicotineapprovedunknownsubstrateDetailsDB00627Niacinapproved, investigational, nutraceuticalunknowninhibitorDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB01096OxamniquineapprovedunknownsubstrateinhibitorDetailsDB01580OxprenololapprovedunknownsubstrateinhibitorDetailsDB01062Oxybutyninapproved, investigationalunknowninhibitorDetailsDB00738Pentamidineapproved, investigationalunknownsubstrateDetailsDB01435Antipyrineapproved, investigationalunknownsubstrateDetailsDB01100PimozideapprovednoinhibitorDetailsDB00592Piperazineapproved, vet_approvedunknownsubstrateDetailsDB01087PrimaquineapprovedunknowninhibitorDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateDetailsDB01224QuetiapineapprovedunknownsubstrateDetailsDB00409Remoxiprideapproved, withdrawnunknownsubstrateDetailsDB00412Rosiglitazoneapproved, investigationalunknowninhibitorDetailsDB01232Saquinavirapproved, investigationalunknowninhibitorDetailsDB01037Selegilineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00641SimvastatinapprovedunknownsubstrateDetailsDB06729SulfaphenazoleapprovedunknowninhibitorDetailsDB01079Tegaserodapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00277TheophyllineapprovedunknownsubstrateDetailsDB00763MethimazoleapprovedunknowninhibitorDetailsDB01623ThiothixeneapprovedunknowninhibitorDetailsDB00209TrospiumapprovedunknowninhibitorDetailsDB00661VerapamilapprovedunknowninhibitorDetailsDB00570VinblastineapprovedunknowninhibitorDetailsDB00361Vinorelbineapproved, investigationalnoinhibitorDetailsDB01392Yohimbineapproved, investigational, vet_approvedunknownsubstrateDetailsDB06287TemsirolimusapprovedunknowninhibitorDetailsDB00398Sorafenibapproved, investigationalunknowninhibitorDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateDetailsDB01128BicalutamideapprovedunknowninhibitorDetailsDB01129Rabeprazoleapproved, investigationalunknowninhibitorDetailsDB01166Cilostazolapproved, investigationalunknownsubstrateDetailsDB06216AsenapineapprovedunknownsubstrateinhibitorDetailsDB06589PazopanibapprovedunknowninhibitorDetailsDB06702FesoterodineapprovedunknownsubstrateDetailsDB06684VilazodoneapprovedunknownsubstrateDetailsDB00836LoperamideapprovedunknownsubstrateDetailsDB06506RepinotaninvestigationalunknownsubstrateDetailsDB06770Benzyl alcoholapprovedunknownsubstrateDetailsDB04920Clevidipineapproved, investigationalunknownsubstrateDetailsDB00633Dexmedetomidineapproved, vet_approvedunknowninhibitorDetailsDB06370IndisulaminvestigationalunknowninhibitorDetailsDB06735EnclomipheneinvestigationalunknownsubstrateDetailsDB06204TapentadolapprovedunknownsubstrateDetailsDB04871Lorcaserinapproved, withdrawnnosubstrateinhibitorDetailsDB05812AbirateroneapprovedunknowninhibitorDetailsDB08881VemurafenibapprovedunknowninhibitorDetailsDB08893MirabegronapprovednosubstrateinhibitorDetailsDB08901Ponatinibapproved, investigationalunknownsubstrateDetailsDB06203AlogliptinapprovedunknownsubstrateDetailsDB08918Levomilnacipranapproved, investigationalunknownsubstrateDetailsDB06292DapagliflozinapprovednosubstrateDetailsDB09039Eliglustatapproved, investigationalnosubstrateinhibitorDetailsDB09048Netupitantapproved, investigationalnosubstrateDetailsDB09049NaloxegolapprovedunknowninhibitorDetailsDB09076UmeclidiniumapprovednosubstrateDetailsDB09065CobicistatapprovednosubstrateinhibitorDetailsDB09068Vortioxetineapproved, investigationalnosubstrateDetailsDB06016Cariprazineapproved, investigationalnosubstrateinhibitorDetailsDB00349Clobazamapproved, illicitnoinhibitorDetailsDB09128Brexpiprazoleapproved, investigationalnosubstrateDetailsDB09291Rolapitantapproved, investigationalnoinhibitorDetailsDB06678EsmirtazapineinvestigationalunknownsubstrateDetailsDB06603Panobinostatapproved, investigationalnoinhibitorDetailsDB09570Ixazomibapproved, investigationalunknownsubstrateDetailsDB06412Oxymetholoneapproved, illicitunknowninhibitorDetailsDB09183DasabuvirapprovednosubstrateDetailsDB06512DeramciclaneinvestigationalunknowninhibitorDetailsDB00022Peginterferon alfa-2bapprovedunknowninhibitorDetailsDB00494Entacaponeapproved, investigationalunknowninhibitorDetailsDB04938Ospemifeneapproved, investigationalunknowninhibitorDetailsDB06820SulconazoleapprovedunknowninhibitorDetailsDB08909Glycerol phenylbutyrateapprovedunknowninhibitorDetailsDB00420Promazineapproved, vet_approvedunknownsubstrateDetailsDB09118StiripentolapprovedunknowninhibitorDetailsDB12332Rucaparibapproved, investigationalnosubstrateinhibitorDetailsDB09555Dexchlorpheniramine maleateapprovednosubstrateinhibitorDetailsDB12161Deutetrabenazineapproved, investigationalnosubstrateDetailsDB06217Vernakalantapproved, investigationalunknownsubstrateinhibitorDetailsDB06595Midostaurinapproved, investigationalunknowninhibitorDetailsDB11915Valbenazineapproved, investigationalnosubstrateDetailsDB13174RheinexperimentalunknowninhibitorDetailsDB11994Diacereinapproved, investigationalunknowninhibitorDetailsDB08922PerospironeexperimentalunknownsubstrateDetailsDB09167DosulepinapprovedunknownsubstrateinhibitorDetailsDB11614RupatadineapprovednosubstrateDetailsDB09238Manidipineapproved, investigationalunknowninhibitorDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateDetailsDB09061Cannabidiolapproved, investigationalunknownsubstrateinhibitorDetailsDB11638Artenimolapproved, experimental, investigationalunknowninhibitorDetailsDB09195LorpiprazoleapprovednosubstrateDetailsDB09224MelperoneinvestigationalunknowninhibitorDetailsDB11642Pitolisantapproved, investigationalunknownsubstrateinhibitorDetailsDB11633Isavuconazoleapproved, investigationalunknowninhibitorDetailsDB11130Opiumapproved, illicitnosubstrateDetailsDB09053IbrutinibapprovednosubstrateDetailsDB11586Asunaprevirapproved, investigational, withdrawnnosubstrateinhibitorDetailsDB140105-methoxy-N,N-dimethyltryptamineexperimental, illicitunknownsubstrateDetailsDB13975Black cohoshexperimentalnoinhibitorDetailsDB14011NabiximolsinvestigationalunknownsubstrateDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorDetailsDB13293Ipecacapproved, withdrawnnosubstrateDetailsDB04948Lofexidineapproved, investigationalnosubstrateDetailsDB11672Curcuminapproved, investigationalunknowninhibitorDetailsDB04829Lysergic acid diethylamideillicit, investigational, withdrawnnosubstrateDetailsDB14185Aripiprazole lauroxilapproved, investigationalunknownsubstrateDetailsDB11718Encorafenibapproved, investigationalnosubstrateinhibitorDetailsDB06608Tafenoquineapproved, investigationalnosubstrateDetailsDB11979Elagolixapproved, investigationalnosubstrateDetailsDB11785AnisodamineinvestigationalnosubstrateDetailsDB09204ArotinololinvestigationalnosubstrateDetailsDB00335AtenololapprovednosubstrateDetailsDB09013BefunololexperimentalnosubstrateDetailsDB01295BevantololexperimentalnosubstrateDetailsDB08807BopindololexperimentalnosubstrateDetailsDB12752BucindololinvestigationalnosubstrateDetailsDB08808BupranololexperimentalnosubstrateDetailsDB04846Celiprololapproved, investigationalnosubstrateDetailsDB13508CloranololexperimentalnosubstrateDetailsDB13757EpanololexperimentalnosubstrateDetailsDB13443EsatenololexperimentalnosubstrateDetailsDB00187Esmololapproved, withdrawnnosubstrateDetailsDB08952IndenololwithdrawnnosubstrateDetailsDB12212LandiololinvestigationalnosubstrateDetailsDB09351Levobetaxololapproved, investigationalnosubstrateDetailsDB01210LevobunololapprovednosubstrateDetailsDB13530MepindololexperimentalnosubstrateDetailsDB01214MetipranololapprovednosubstrateDetailsDB01359Penbutololapproved, investigationalnosubstrateDetailsDB01297PractololapprovednosubstrateDetailsDB00489SotalolapprovednosubstrateDetailsDB11770TalinololinvestigationalnosubstrateDetailsDB13775TertatololexperimentalnosubstrateDetailsDB00780PhenelzineapprovedunknowninhibitorDetailsDB06654Safinamideapproved, investigationalunknowninhibitorDetailsDB04818IproniazidwithdrawnunknowninhibitorDetailsDB01267PaliperidoneapprovedunknownsubstrateDetailsDB09078Lenvatinibapproved, investigationalunknowninhibitorDetailsDB08864RilpivirineapprovedunknowninhibitorDetailsDB04911Oritavancinapproved, investigationalunknowninhibitorinducerDetailsDB04884DapoxetineinvestigationalnosubstrateDetailsDB12693RitanserininvestigationalnoinhibitorDetailsDB02703Fusidic acidapproved, investigationalunknownsubstrateinhibitorDetailsDB09288PropacetamolexperimentalnosubstrateDetailsDB14635Curcumin sulfateexperimentalunknowninhibitorDetailsDB11963Dacomitinibapproved, investigationalunknownsubstrateinhibitorDetailsDB14025ClinafloxacininvestigationalunknowninhibitorDetailsDB01323St. John's Wortapproved, investigational, nutraceuticalnoinhibitorDetailsDB01454Midomafetamineexperimental, illicit, investigationalnosubstrateDetailsDB11855Revefenacinapproved, investigationalnosubstrateDetailsDB12245Triclabendazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB01576Dextroamphetamineapproved, illicitnosubstrateDetailsDB06700Desvenlafaxineapproved, investigationalnoinhibitorDetailsDB00737MeclizineapprovednosubstrateDetailsDB01591SolifenacinapprovedunknownsubstrateDetailsDB13679Dexchlorpheniramineexperimental, investigationalunknownsubstrateinhibitorDetailsDB12523Mizolastineapproved, investigationalunknowninhibitorDetailsDB01173OrphenadrineapprovedunknowninhibitorDetailsDB09173ButyrfentanylillicitunknownsubstrateDetailsDB11757Istradefyllineapproved, investigationalunknownsubstrateDetailsDB04957AzimilideinvestigationalunknownsubstrateDetailsDB09061Cannabidiolapproved, investigationalunknowninhibitorDetailsDB14011NabiximolsinvestigationalunknownsubstrateinhibitorDetailsDB01590EverolimusapprovedunknowninhibitorDetailsDB12001Abemaciclibapproved, investigationalunknowninhibitorDetailsDB11732Lasmiditanapproved, investigationalnoinhibitorDetailsDB15444Elexacaftorapproved, investigationalnoinhibitorDetailsDB15091Upadacitinibapproved, investigationalunknownsubstrateDetailsDB00252Phenytoinapproved, vet_approvednosubstrateDetailsDB15328Ubrogepantapproved, investigationalunknowninhibitorDetailsDB00983Formoterolapproved, investigationalunknownsubstrateDetailsDB01264DarunavirapprovedunknowninhibitorDetailsDB13609UmifenovirinvestigationalunknownsubstrateDetailsDB11837Osilodrostatapproved, investigationalunknownsubstrateinhibitorDetailsDB12500Fedratinibapproved, investigationalunknowninhibitorDetailsDB09241Methylene blueapproved, investigationalunknownsubstrateinhibitorDetailsDB14761Remdesivirapproved, investigationalunknownsubstrateDetailsDB14840RipretinibapprovedunknownsubstrateDetailsDB00845Clofazimineapproved, investigationalunknowninhibitorDetailsDB14881Oliceridineapproved, investigationalunknownsubstrateDetailsDB12499Clascoteroneapproved, investigationalnoinhibitorDetailsDB15822Pralsetinibapproved, investigationalnosubstrateDetailsDB15982BerotralstatapprovednoinhibitorDetailsDB04951Pirfenidoneapproved, investigationalunknownsubstrateinhibitorDetailsDB06137Tirbanibulinapproved, investigationalnoinhibitorDetailsDB00549Zafirlukastapproved, investigationalunknowninhibitorDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB00745Modafinilapproved, investigationalunknowninducerDetailsDB00330EthambutolapprovedunknowninhibitorDetailsDB01086Benzocaineapproved, investigationalunknownsubstrateDetailsDB05316Pimavanserinapproved, investigationalunknownsubstrateDetailsDB11753Rifamycinapproved, investigationalunknowninhibitorDetailsDB00986Glycopyrroniumapproved, investigational, vet_approvedunknownsubstrateDetailsDB15119Ropeginterferon alfa-2bapproved, investigationalnoinhibitorDetailsDB12151Brincidofovirapproved, investigationalnoinhibitorDetailsDB16703Belumosudilapproved, investigationalnosubstrateinhibitorDetailsDB12265Fexinidazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00602Ivermectinapproved, investigational, vet_approvednosubstrateDetailsDB12713Sotagliflozinapproved, investigationalnoinhibitorDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB00470Dronabinolapproved, illicitnoinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknowninhibitorDetailsDB05087Ganaxoloneapproved, investigationalnosubstrateDetailsDB09185Viloxazineapproved, investigational, withdrawnnosubstrateinhibitorDetailsDB14921Mavacamtenapproved, investigationalnoDetailsDB06083Tapinarofapproved, investigationalnosubstrateDetailsDB16650Deucravacitinibapproved, investigationalunknownsubstrateDetailsDB12095Telotristat ethylapproved, investigationalnoinhibitorDetailsDB15149Futibatinibapproved, investigationalnosubstrateDetailsDB11739Vonoprazanapproved, investigationalunknownsubstrateDetailsDB05239Cobimetinibapproved, investigationalnoinhibitorDetailsDB02709ResveratrolinvestigationalnoinhibitorDetailsDB15568Adagrasibapproved, investigationalunknownsubstrateinhibitorDetailsDB12236Bexagliflozinapproved, investigationalunknownsubstrateDetailsDB17472Pirtobrutinibapproved, investigationalunknowninhibitorDetailsDB15688Zavegepantapproved, investigationalunknownsubstrateDetailsDB00862VardenafilapprovedunknowninhibitorDetailsDB16217Leniolisibapproved, investigationalnosubstrateDetailsDB00953RizatriptanapprovednoinhibitorDetailsDB11712Tezacaftorapproved, investigationalnoinhibitorDetails"
                    }
                },
                {
                    "Label": "Cytochrome P450 2E1",
                    "Detailed Info": {
                        "Name": "Cytochrome P450 2E1",
                        "Synonyms": "1.14.13.-\n4-nitrophenol 2-hydroxylase\nCYP2E\nCYPIIE1\nCytochrome P450-J",
                        "Gene Name": "CYP2E1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0012460|Cytochrome P450 2E1\nMSALGVTVALLVWAAFLLLVSMWRQVHSSWNLPPGPFPLPIIGNLFQLELKNIPKSFTRL\nAQRFGPVFTLYVGSQRMVVMHGYKAVKEALLDYKDEFSGRGDLPAFHAHRDRGIIFNNGP\nTWKDIRRFSLTTLRNYGMGKQGNESRIQREAHFLLEALRKTQGQPFDPTFLIGCAPCNVI\nADILFRKHFDYNDEKFLRLMYLFNENFHLLSTPWLQLYNNFPSFLHYLPGSHRKVIKNVA\nEVKEYVSERVKEHHQSLDPNCPRDLTDCLLVEMEKEKHSAERLYTMDGITVTVADLFFAG\nTETTSTTLRYGLLILMKYPEIEEKLHEEIDRVIGPSRIPAIKDRQEMPYMDAVVHEIQRF\nITLVPSNLPHEATRDTIFRGYLIPKGTVVVPTLDSVLYDNQEFPDPEKFKPEHFLNENGK\nFKYSDYFKPFSTGKRVCAGEGLARMELFLLLCAILQHFNLKPLVDPKDIDLSPIHIGFGC\nIPPRYKLCVIPRS",
                        "Number of residues": "493",
                        "Molecular Weight": "56848.42",
                        "Theoretical pI": "8.22",
                        "GO Classification": "Functionsarachidonic acid epoxygenase activity / enzyme binding / heme binding / iron ion binding / monooxygenase activity / oxidoreductase activity / oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen / oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen / oxygen binding / steroid hydroxylase activityProcessesdrug metabolic process / epoxygenase P450 pathway / exogenous drug catabolic process / heterocycle metabolic process / monoterpenoid metabolic process / oxidation-reduction process / response to ethanol / response to organonitrogen compound / response to ozone / small molecule metabolic process / steroid metabolic process / triglyceride metabolic process / xenobiotic metabolic processComponentscytoplasm / endoplasmic reticulum membrane / Golgi membrane / intracellular membrane-bounded organelle / intrinsic component of endoplasmic reticulum membrane / mitochondrion",
                        "General Function": "Steroid hydroxylase activity",
                        "Specific Function": "Metabolizes several precarcinogens, drugs, and solvents to reactive metabolites. Inactivates a number of drugs and xenobiotics and also bioactivates many xenobiotic substrates to their hepatotoxic or carcinogenic forms.",
                        "Pfam Domain Function": "p450 (PF00067)",
                        "Transmembrane Regions": "Not Available",
                        "Cellular Location": "Endoplasmic reticulum membrane",
                        "Gene sequence": ">lcl|BSEQ0012461|Cytochrome P450 2E1 (CYP2E1)\nATGTCTGCCCTCGGAGTCACCGTGGCCCTGCTGGTGTGGGCGGCCTTCCTCCTGCTGGTG\nTCCATGTGGAGGCAGGTGCACAGCAGCTGGAATCTGCCCCCAGGCCCTTTCCCGCTTCCC\nATCATCGGGAACCTCTTCCAGTTGGAATTGAAGAATATTCCCAAGTCCTTCACCCGGTTG\nGCCCAGCGCTTCGGGCCGGTGTTCACGCTGTACGTGGGCTCGCAGCGCATGGTGGTGATG\nCACGGCTACAAGGCGGTGAAGGAAGCGCTGCTGGACTACAAGGACGAGTTCTCGGGCAGA\nGGCGACCTCCCCGCGTTCCATGCGCACAGGGACAGGGGAATCATTTTTAATAATGGACCT\nACCTGGAAGGACATCCGGCGGTTTTCCCTGACCACCCTCCGGAACTATGGGATGGGGAAA\nCAGGGCAATGAGAGCCGGATCCAGAGGGAGGCCCACTTCCTGCTGGAAGCACTCAGGAAG\nACCCAAGGCCAGCCTTTCGACCCCACCTTCCTCATCGGCTGCGCGCCCTGCAACGTCATA\nGCCGACATCCTCTTCCGCAAGCATTTTGACTACAATGATGAGAAGTTTCTAAGGCTGATG\nTATTTGTTTAATGAGAACTTCCACCTACTCAGCACTCCCTGGCTCCAGCTTTACAATAAT\nTTTCCCAGCTTTCTACACTACTTGCCTGGAAGCCACAGAAAAGTCATAAAAAATGTGGCT\nGAAGTAAAAGAGTATGTGTCTGAAAGGGTGAAGGAGCACCATCAATCTCTGGACCCCAAC\nTGTCCCCGGGACCTCACCGACTGCCTGCTCGTGGAAATGGAGAAGGAAAAGCACAGTGCA\nGAGCGCTTGTACACAATGGACGGTATCACCGTGACTGTGGCCGACCTGTTCTTTGCGGGG\nACAGAGACCACCAGCACAACTCTGAGATATGGGCTCCTGATTCTCATGAAATACCCTGAG\nATCGAAGAGAAGCTCCATGAAGAAATTGACAGGGTGATTGGGCCAAGCCGAATCCCTGCC\nATCAAGGATAGGCAAGAGATGCCCTACATGGATGCTGTGGTGCATGAGATTCAGCGGTTC\nATCACCCTCGTGCCCTCCAACCTGCCCCATGAAGCAACCCGAGACACCATTTTCAGAGGA\nTACCTCATCCCCAAGGGCACAGTCGTAGTGCCAACTCTGGACTCTGTTTTGTATGACAAC\nCAAGAATTTCCTGATCCAGAAAAGTTTAAGCCAGAACACTTCCTGAATGAAAATGGAAAG\nTTCAAGTACAGTGACTATTTCAAGCCATTTTCCACAGGAAAACGAGTGTGTGCTGGAGAA\nGGCCTGGCTCGCATGGAGTTGTTTCTTTTGTTGTGTGCCATTTTGCAGCATTTTAATTTG\nAAGCCTCTCGTTGACCCAAAGGATATCGACCTCAGCCCTATACATATTGGGTTTGGCTGT\nATCCCACCACGTTACAAACTCTGTGTCATTCCCCGCTCATGA",
                        "Chromosome Location": "10",
                        "Locus": "10q24.3-qter",
                        "External Identifiers": "ResourceLinkUniProtKB IDP05181UniProtKB Entry NameCP2E1_HUMANGenBank Protein ID181360GenBank Gene IDJ02625HGNC IDHGNC:2631",
                        "General References": "Song BJ, Gelboin HV, Park SS, Yang CS, Gonzalez FJ: Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P-450s. Transcriptional and post-transcriptional regulation of the rat enzyme. J Biol Chem. 1986 Dec 15;261(35):16689-97. [Article] Umeno M, McBride OW, Yang CS, Gelboin HV, Gonzalez FJ: Human ethanol-inducible P450IIE1: complete gene sequence, promoter characterization, chromosome mapping, and cDNA-directed expression. Biochemistry. 1988 Dec 13;27(25):9006-13. [Article] Deloukas P, Earthrowl ME, Grafham DV, Rubenfield M, French L, Steward CA, Sims SK, Jones MC, Searle S, Scott C, Howe K, Hunt SE, Andrews TD, Gilbert JG, Swarbreck D, Ashurst JL, Taylor A, Battles J, Bird CP, Ainscough R, Almeida JP, Ashwell RI, Ambrose KD, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Bates K, Beasley H, Bray-Allen S, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Cahill P, Camire D, Carter NP, Chapman JC, Clark SY, Clarke G, Clee CM, Clegg S, Corby N, Coulson A, Dhami P, Dutta I, Dunn M, Faulkner L, Frankish A, Frankland JA, Garner P, Garnett J, Gribble S, Griffiths C, Grocock R, Gustafson E, Hammond S, Harley JL, Hart E, Heath PD, Ho TP, Hopkins B, Horne J, Howden PJ, Huckle E, Hynds C, Johnson C, Johnson D, Kana A, Kay M, Kimberley AM, Kershaw JK, Kokkinaki M, Laird GK, Lawlor S, Lee HM, Leongamornlert DA, Laird G, Lloyd C, Lloyd DM, Loveland J, Lovell J, McLaren S, McLay KE, McMurray A, Mashreghi-Mohammadi M, Matthews L, Milne S, Nickerson T, Nguyen M, Overton-Larty E, Palmer SA, Pearce AV, Peck AI, Pelan S, Phillimore B, Porter K, Rice CM, Rogosin A, Ross MT, Sarafidou T, Sehra HK, Shownkeen R, Skuce CD, Smith M, Standring L, Sycamore N, Tester J, Thorpe A, Torcasso W, Tracey A, Tromans A, Tsolas J, Wall M, Walsh J, Wang H, Weinstock K, West AP, Willey DL, Whitehead SL, Wilming L, Wray PW, Young L, Chen Y, Lovering RC, Moschonas NK, Siebert R, Fechtel K, Bentley D, Durbin R, Hubbard T, Doucette-Stamm L, Beck S, Smith DR, Rogers J: The DNA sequence and comparative analysis of human chromosome 10. Nature. 2004 May 27;429(6990):375-81. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Lasker JM, Raucy J, Kubota S, Bloswick BP, Black M, Lieber CS: Purification and characterization of human liver cytochrome P-450-ALC. Biochem Biophys Res Commun. 1987 Oct 14;148(1):232-8. [Article] Robinson RC, Shorr RG, Varrichio A, Park SS, Gelboin HV, Miller H, Friedman FK: Human liver cytochrome P-450 related to a rat acetone-inducible, nitrosamine-metabolizing cytochrome P-450: identification and isolation. Pharmacology. 1989;39(3):137-44. [Article] Gillam EM, Guo Z, Guengerich FP: Expression of modified human cytochrome P450 2E1 in Escherichia coli, purification, and spectral and catalytic properties. Arch Biochem Biophys. 1994 Jul;312(1):59-66. [Article] Zerilli A, Ratanasavanh D, Lucas D, Goasduff T, Dreano Y, Menard C, Picart D, Berthou F: Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1. Chem Res Toxicol. 1997 Oct;10(10):1205-12. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Porubsky PR, Meneely KM, Scott EE: Structures of human cytochrome P-450 2E1. Insights into the binding of inhibitors and both small molecular weight and fatty acid substrates. J Biol Chem. 2008 Nov 28;283(48):33698-707. doi: 10.1074/jbc.M805999200. Epub 2008 Sep 24. [Article] Hu Y, Oscarson M, Johansson I, Yue QY, Dahl ML, Tabone M, Arinco S, Albano E, Ingelman-Sundberg M: Genetic polymorphism of human CYP2E1: characterization of two variant alleles. Mol Pharmacol. 1997 Mar;51(3):370-6. [Article] Fairbrother KS, Grove J, de Waziers I, Steimel DT, Day CP, Crespi CL, Daly AK: Detection and characterization of novel polymorphisms in the CYP2E1 gene. Pharmacogenetics. 1998 Dec;8(6):543-52. [Article] Solus JF, Arietta BJ, Harris JR, Sexton DP, Steward JQ, McMunn C, Ihrie P, Mehall JM, Edwards TL, Dawson EP: Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics. 2004 Oct;5(7):895-931. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00184NicotineapprovedunknownsubstrateinhibitorinducerDetailsDB00228Enfluraneapproved, investigational, vet_approvedunknownsubstrateDetailsDB00356ChlorzoxazoneapprovedunknownsubstrateinhibitorDetailsDB00753Isofluraneapproved, vet_approvedunknownsubstrateDetailsDB00851Dacarbazineapproved, investigationalunknownsubstrateDetailsDB00898EthanolapprovedunknownsubstrateinducerDetailsDB01028Methoxyfluraneapproved, investigational, vet_approved, withdrawnunknownsubstrateDetailsDB01159Halothaneapproved, vet_approvedunknownsubstrateDetailsDB01204Mitoxantroneapproved, investigationalunknownsubstrateinducerDetailsDB01213Fomepizoleapproved, vet_approvedunknownsubstrateinhibitorinducerDetailsDB01236Sevofluraneapproved, vet_approvednosubstrateDetailsDB00593EthosuximideapprovedunknownsubstrateDetailsDB00118Ademetionineapproved, investigational, nutraceuticalunknowninhibitorDetailsDB00277TheophyllineapprovedunknownsubstrateDetailsDB00636Clofibrateapproved, investigationalunknowninducerDetailsDB00780PhenelzineapprovedunknowninducerDetailsDB00908Quinidineapproved, investigationalnosubstrateDetailsDB00951Isoniazidapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB01115NifedipineapprovedunknowninhibitorDetailsDB01173OrphenadrineapprovedunknowninhibitorDetailsDB00250Dapsoneapproved, investigationalunknownsubstrateDetailsDB04977PlitidepsininvestigationalunknownsubstrateDetailsDB05708GTS-21investigationalunknownsubstrateDetailsDB00316AcetaminophenapprovedunknownsubstrateDetailsDB00468QuinineapprovedunknownsubstrateDetailsDB05109Trabectedinapproved, investigationalunknownsubstrateDetailsDB06728AnilineexperimentalunknownsubstrateDetailsDB00822DisulfiramapprovedunknowninhibitorDetailsDB01136Carvedilolapproved, investigationalunknownsubstrateDetailsDB00201CaffeineapprovednosubstrateDetailsDB00818Propofolapproved, investigational, vet_approvedunknowninhibitorDetailsDB00969Alosetronapproved, withdrawnunknowninhibitorDetailsDB01223AminophyllineapprovedunknownsubstrateDetailsDB00972AzelastineapprovedunknowninhibitorDetailsDB04794Bifonazoleapproved, investigationalunknowninhibitorDetailsDB01558Bromazepamapproved, illicit, investigationalunknowninhibitorDetailsDB01156BupropionapprovedunknownsubstrateDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknowninhibitorDetailsDB00501Cimetidineapproved, investigationalunknowninhibitorDetailsDB00257Clotrimazoleapproved, vet_approvedunknowninhibitorDetailsDB01394ColchicineapprovedunknowninducerDetailsDB01151Desipramineapproved, investigationalunknowninhibitorDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknowninducerDetailsDB01191Dexfenfluramineapproved, illicit, investigational, withdrawnunknowninhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknowninhibitorDetailsDB01127EconazoleapprovednoinhibitorDetailsDB00655EstroneapprovedunknownsubstrateDetailsDB00773EtoposideapprovedunknownsubstrateDetailsDB01628Etoricoxibapproved, investigationalunknowninhibitorDetailsDB00949FelbamateapprovedunknownsubstrateDetailsDB00623FluphenazineapprovedunknowninhibitorDetailsDB00690Flurazepamapproved, illicit, investigationalunknowninhibitorDetailsDB09462Glycerinapproved, investigationalunknowninducerDetailsDB00458ImipramineapprovedunknowninhibitorDetailsDB00883Isosorbide dinitrateapproved, investigationalunknowninhibitorDetailsDB01167Itraconazoleapproved, investigationalnoinhibitorDetailsDB01403Methotrimeprazineapproved, investigationalunknowninhibitorDetailsDB01011Metyraponeapproved, investigationalunknowninhibitorDetailsDB00379Mexiletineapproved, investigationalunknownsubstrateDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB00622Nicardipineapproved, investigationalunknownsubstrateDetailsDB02701Nicotinamideapproved, investigationalunknownsubstrateinhibitorDetailsDB06712Nilvadipineapproved, investigationalunknownsubstrateDetailsDB00540NortriptylineapprovedunknowninhibitorDetailsDB00904Ondansetronapproved, withdrawnunknownsubstrateDetailsDB03783PhenacetinwithdrawnunknownsubstrateDetailsDB01435Antipyrineapproved, investigationalunknownsubstrateDetailsDB01174Phenobarbitalapproved, investigationalunknownsubstrateinducerDetailsDB01045RifampicinapprovedunknowninducerDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateinhibitorDetailsDB00675TamoxifenapprovedunknownsubstrateDetailsDB01079Tegaserodapproved, investigational, withdrawnunknowninhibitorDetailsDB01412TheobromineinvestigationalunknownsubstrateDetailsDB00763MethimazoleapprovedunknowninhibitorDetailsDB00679Thioridazineapproved, withdrawnunknowninhibitorDetailsDB00208TiclopidineapprovedunknowninhibitorDetailsDB01007TioconazoleapprovedunknowninhibitorDetailsDB00347TrimethadioneapprovedunknownsubstrateDetailsDB00617ParamethadioneapprovedunknownsubstrateDetailsDB04946IloperidoneapprovedunknownsubstrateDetailsDB00255Diethylstilbestrolapproved, investigational, withdrawnunknowninhibitorDetailsDB00918Almotriptanapproved, investigationalunknownsubstrateDetailsDB06770Benzyl alcoholapprovedunknownsubstrateDetailsDB06774CapsaicinapprovedunknownsubstrateDetailsDB04920Clevidipineapproved, investigationalunknownsubstrateDetailsDB00633Dexmedetomidineapproved, vet_approvedunknownsubstrateDetailsDB06370IndisulaminvestigationalunknowninhibitorDetailsDB00109Enfuvirtideapproved, investigationalunknownsubstrateDetailsDB00041AldesleukinapprovedunknowninhibitorDetailsDB04858TirapazamineinvestigationalunknownsubstrateDetailsDB00428Streptozocinapproved, investigationalunknowninducerDetailsDB06637DalfampridineapprovedunknownsubstrateDetailsDB08868Fingolimodapproved, investigationalunknownsubstrateDetailsDB06201RufinamideapprovedunknowninhibitorDetailsDB01068Clonazepamapproved, illicitunknowninhibitorDetailsDB01544Flunitrazepamapproved, illicitunknowninhibitorDetailsDB01595NitrazepamapprovedunknowninhibitorDetailsDB08846Ellagic acidinvestigationalunknowninhibitorDetailsDB06595Midostaurinapproved, investigationalunknowninhibitorDetailsDB13174RheinexperimentalunknowninhibitorDetailsDB11994Diacereinapproved, investigationalunknowninhibitorDetailsDB11943Delafloxacinapproved, investigationalunknowninducerDetailsDB09120Zucapsaicinapproved, investigationalunknowninhibitorDetailsDB13941Piperaquineapproved, experimental, investigationalunknowninducerDetailsDB09328Vayarinapproved, investigationalunknowninhibitorDetailsDB00486Nabiloneapproved, investigationalnosubstrateinhibitorDetailsDB04379N-Methyl-N-(Methylbenzyl)FormamideexperimentalunknownsubstrateDetailsDB01154Thiamylalapproved, vet_approvednosubstrateDetailsDB09256Tegafurapproved, investigationalunknownsubstrateDetailsDB09288PropacetamolexperimentalnosubstrateDetailsDB14046Dichlorobenzeneapproved, experimentalunknownsubstrateDetailsDB139631,2-dichlorobenzeneexperimentalunknownsubstrateDetailsDB01844N,N-dimethylformamideexperimentalunknownsubstrateDetailsDB02520DitiocarbexperimentalunknowninhibitorDetailsDB00627Niacinapproved, investigational, nutraceuticalunknowninhibitorDetailsDB04856DexloxiglumideinvestigationalunknownsubstrateDetailsDB00661VerapamilapprovedunknownsubstrateDetailsDB06119Cenobamateapproved, investigationalunknownsubstrateDetailsDB01104SertralineapprovedunknownsubstrateDetailsDB00252Phenytoinapproved, vet_approvednosubstrateDetailsDB00794Primidoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00869DorzolamideapprovednosubstrateDetailsDB13609UmifenovirinvestigationalunknownsubstrateDetailsDB11837Osilodrostatapproved, investigationalunknowninhibitorDetailsDB12466Favipiravirapproved, investigationalunknowninhibitorDetailsDB11689Selumetinibapproved, investigationalnosubstrateDetailsDB14840RipretinibapprovedunknownDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknowninducerDetailsDB12499Clascoteroneapproved, investigationalnoinhibitorDetailsDB06448Lonafarnibapproved, investigationalnosubstrateDetailsDB04951Pirfenidoneapproved, investigationalunknownsubstrateDetailsDB01189DesfluraneapprovednosubstrateDetailsDB00170Menadioneapproved, nutraceuticalunknowninhibitorDetailsDB08864RilpivirineapprovedunknowninhibitorDetailsDB00330EthambutolapprovedunknowninhibitorDetailsDB01086Benzocaineapproved, investigationalunknownsubstrateDetailsDB08995Diosminapproved, investigationalunknowninhibitorDetailsDB00412Rosiglitazoneapproved, investigationalunknownsubstrateDetailsDB00602Ivermectinapproved, investigational, vet_approvednosubstrateDetailsDB04216Quercetinexperimental, investigationalnoinhibitorDetailsDB09061Cannabidiolapproved, investigationalnosubstrateinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknowninhibitorDetailsDB14009Medical Cannabisexperimental, investigationalunknownsubstrateinhibitorDetailsDB06016Cariprazineapproved, investigationalnoinhibitorDetailsDB00755Tretinoinapproved, investigational, nutraceuticalunknownsubstrateDetails"
                    }
                }
            ],
            "transporters": [
                {
                    "Label": "Multidrug resistance-associated protein 4",
                    "Detailed Info": {
                        "Name": "Multidrug resistance-associated protein 4",
                        "Synonyms": "ATP-binding cassette sub-family C member 4\nMOAT-B\nMRP/cMOAT-related ABC transporter\nMRP4\nMulti-specific organic anion transporter B",
                        "Gene Name": "ABCC4",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0037136|Multidrug resistance-associated protein 4\nMLPVYQEVKPNPLQDANLCSRVFFWWLNPLFKIGHKRRLEEDDMYSVLPEDRSQHLGEEL\nQGFWDKEVLRAENDAQKPSLTRAIIKCYWKSYLVLGIFTLIEESAKVIQPIFLGKIINYF\nENYDPMDSVALNTAYAYATVLTFCTLILAILHHLYFYHVQCAGMRLRVAMCHMIYRKALR\nLSNMAMGKTTTGQIVNLLSNDVNKFDQVTVFLHFLWAGPLQAIAVTALLWMEIGISCLAG\nMAVLIILLPLQSCFGKLFSSLRSKTATFTDARIRTMNEVITGIRIIKMYAWEKSFSNLIT\nNLRKKEISKILRSSCLRGMNLASFFSASKIIVFVTFTTYVLLGSVITASRVFVAVTLYGA\nVRLTVTLFFPSAIERVSEAIVSIRRIQTFLLLDEISQRNRQLPSDGKKMVHVQDFTAFWD\nKASETPTLQGLSFTVRPGELLAVVGPVGAGKSSLLSAVLGELAPSHGLVSVHGRIAYVSQ\nQPWVFSGTLRSNILFGKKYEKERYEKVIKACALKKDLQLLEDGDLTVIGDRGTTLSGGQK\nARVNLARAVYQDADIYLLDDPLSAVDAEVSRHLFELCICQILHEKITILVTHQLQYLKAA\nSQILILKDGKMVQKGTYTEFLKSGIDFGSLLKKDNEESEQPPVPGTPTLRNRTFSESSVW\nSQQSSRPSLKDGALESQDTENVPVTLSEENRSEGKVGFQAYKNYFRAGAHWIVFIFLILL\nNTAAQVAYVLQDWWLSYWANKQSMLNVTVNGGGNVTEKLDLNWYLGIYSGLTVATVLFGI\nARSLLVFYVLVNSSQTLHNKMFESILKAPVLFFDRNPIGRILNRFSKDIGHLDDLLPLTF\nLDFIQTLLQVVGVVSVAVAVIPWIAIPLVPLGIIFIFLRRYFLETSRDVKRLESTTRSPV\nFSHLSSSLQGLWTIRAYKAEERCQELFDAHQDLHSEAWFLFLTTSRWFAVRLDAICAMFV\nIIVAFGSLILAKTLDAGQVGLALSYALTLMGMFQWCVRQSAEVENMMISVERVIEYTDLE\nKEAPWEYQKRPPPAWPHEGVIIFDNVNFMYSPGGPLVLKHLTALIKSQEKVGIVGRTGAG\nKSSLISALFRLSEPEGKIWIDKILTTEIGLHDLRKKMSIIPQEPVLFTGTMRKNLDPFNE\nHTDEELWNALQEVQLKETIEDLPGKMDTELAESGSNFSVGQRQLVCLARAILRKNQILII\nDEATANVDPRTDELIQKKIREKFAHCTVLTIAHRLNTIIDSDKIMVLDSGRLKEYDEPYV\nLLQNKESLFYKMVQQLGKAEAAALTETAKQVYFKRNYPHIGHTDHMVTNTSNGQPSTLTI\nFETAL",
                        "Number of residues": "1325",
                        "Molecular Weight": "149525.33",
                        "Theoretical pI": "8.39",
                        "GO Classification": "Functions15-hydroxyprostaglandin dehydrogenase (NAD+) activity / ATP binding / ATPase activity, coupled to transmembrane movement of substancesProcessesblood coagulation / oxidation-reduction process / platelet activation / platelet degranulation / transmembrane transportComponentsbasolateral plasma membrane / integral component of membrane / membrane / plasma membrane / platelet dense granule membrane",
                        "General Function": "Atpase activity, coupled to transmembrane movement of substances",
                        "Specific Function": "May be an organic anion pump relevant to cellular detoxification.",
                        "Pfam Domain Function": "ABC_tran (PF00005)\nABC_membrane (PF00664)",
                        "Transmembrane Regions": "93-113\n136-156\n207-227\n228-248\n328-348\n351-371\n440-460\n710-730\n771-791\n836-856\n858-878\n954-974\n977-997\n1038-1058",
                        "Cellular Location": "Membrane",
                        "Gene sequence": ">lcl|BSEQ0010828|Multidrug resistance-associated protein 4 (ABCC4)\nATGCTGCCCGTGTACCAGGAGGTGAAGCCCAACCCGCTGCAGGACGCGAACCTCTGCTCA\nCGCGTGTTCTTCTGGTGGCTCAATCCCTTGTTTAAAATTGGCCATAAACGGAGATTAGAG\nGAAGATGATATGTATTCAGTGCTGCCAGAAGACCGCTCACAGCACCTTGGAGAGGAGTTG\nCAAGGGTTCTGGGATAAAGAAGTTTTAAGAGCTGAGAATGACGCACAGAAGCCTTCTTTA\nACAAGAGCAATCATAAAGTGTTACTGGAAATCTTATTTAGTTTTGGGAATTTTTACGTTA\nATTGAGGAAAGTGCCAAAGTAATCCAGCCCATATTTTTGGGAAAAATTATTAATTATTTT\nGAAAATTATGATCCCATGGATTCTGTGGCTTTGAACACAGCGTACGCCTATGCCACGGTG\nCTGACTTTTTGCACGCTCATTTTGGCTATACTGCATCACTTATATTTTTATCACGTTCAG\nTGTGCTGGGATGAGGTTACGAGTAGCCATGTGCCATATGATTTATCGGAAGGCACTTCGT\nCTTAGTAACATGGCCATGGGGAAGACAACCACAGGCCAGATAGTCAATCTGCTGTCCAAT\nGATGTGAACAAGTTTGATCAGGTGACAGTGTTCTTACACTTCCTGTGGGCAGGACCACTG\nCAGGCGATTGCAGTGACTGCCCTACTCTGGATGGAGATAGGAATATCGTGCCTTGCTGGG\nATGGCAGTTCTAATCATTCTCCTGCCCTTGCAAAGCTGTTTTGGGAAGTTGTTCTCATCA\nCTGAGGAGTAAAACTGCAACTTTCACGGATGCCAGGATCAGGACCATGAATGAAGTTATA\nACTGGTATAAGGATAATAAAAATGTACGCCTGGGAAAAGTCATTTTCAAATCTTATTACC\nAATTTGAGAAAGAAGGAGATTTCCAAGATTCTGAGAAGTTCCTGCCTCAGAGGGATGAAT\nTTGGCTTCATTTTTCAGTGCAAGCAAAATCATCGTGTTTGTGACCTTCACCACCTACGTG\nCTCCTCGGCAGTGTGATCACAGCCAGCCGCGTGTTCGTGGCAGTGACGCTGTATGGGGCT\nGTGCGGCTGACGGTTACCCTCTTCTTCCCCTCAGCCATTGAGAGGGTGTCAGAGGCAATC\nGTCAGCATCCGAAGAATCCAGACCTTTTTGCTACTTGATGAGATATCACAGCGCAACCGT\nCAGCTGCCGTCAGATGGTAAAAAGATGGTGCATGTGCAGGATTTTACTGCTTTTTGGGAT\nAAGGCATCAGAGACCCCAACTCTACAAGGCCTTTCCTTTACTGTCAGACCTGGCGAATTG\nTTAGCTGTGGTCGGCCCCGTGGGAGCAGGGAAGTCATCACTGTTAAGTGCCGTGCTCGGG\nGAATTGGCCCCAAGTCACGGGCTGGTCAGCGTGCATGGAAGAATTGCCTATGTGTCTCAG\nCAGCCCTGGGTGTTCTCGGGAACTCTGAGGAGTAATATTTTATTTGGGAAGAAATACGAA\nAAGGAACGATATGAAAAAGTCATAAAGGCTTGTGCTCTGAAAAAGGATTTACAGCTGTTG\nGAGGATGGTGATCTGACTGTGATAGGAGATCGGGGAACCACGCTGAGTGGAGGGCAGAAA\nGCACGGGTAAACCTTGCAAGAGCAGTGTATCAAGATGCTGACATCTATCTCCTGGACGAT\nCCTCTCAGTGCAGTAGATGCGGAAGTTAGCAGACACTTGTTCGAACTGTGTATTTGTCAA\nATTTTGCATGAGAAGATCACAATTTTAGTGACTCATCAGTTGCAGTACCTCAAAGCTGCA\nAGTCAGATTCTGATATTGAAAGATGGTAAAATGGTGCAGAAGGGGACTTACACTGAGTTC\nCTAAAATCTGGTATAGATTTTGGCTCCCTTTTAAAGAAGGATAATGAGGAAAGTGAACAA\nCCTCCAGTTCCAGGAACTCCCACACTAAGGAATCGTACCTTCTCAGAGTCTTCGGTTTGG\nTCTCAACAATCTTCTAGACCCTCCTTGAAAGATGGTGCTCTGGAGAGCCAAGATACAGAG\nAATGTCCCAGTTACACTATCAGAGGAGAACCGTTCTGAAGGAAAAGTTGGTTTTCAGGCC\nTATAAGAATTACTTCAGAGCTGGTGCTCACTGGATTGTCTTCATTTTCCTTATTCTCCTA\nAACACTGCAGCTCAGGTTGCCTATGTGCTTCAAGATTGGTGGCTTTCATACTGGGCAAAC\nAAACAAAGTATGCTAAATGTCACTGTAAATGGAGGAGGAAATGTAACCGAGAAGCTAGAT\nCTTAACTGGTACTTAGGAATTTATTCAGGTTTAACTGTAGCTACCGTTCTTTTTGGCATA\nGCAAGATCTCTATTGGTATTCTACGTCCTTGTTAACTCTTCACAAACTTTGCACAACAAA\nATGTTTGAGTCAATTCTGAAAGCTCCGGTATTATTCTTTGATAGAAATCCAATAGGAAGA\nATTTTAAATCGTTTCTCCAAAGACATTGGACACTTGGATGATTTGCTGCCGCTGACGTTT\nTTAGATTTCATCCAGAGATGGGATCTCGCTGTGTTGTCCTGGCTGGTCTCAAACTCCTAG",
                        "Chromosome Location": "13",
                        "Locus": "13q32",
                        "External Identifiers": "ResourceLinkUniProtKB IDO15439UniProtKB Entry NameMRP4_HUMANGenBank Protein ID3335173GenBank Gene IDAF071202GenAtlas IDABCC4HGNC IDHGNC:55",
                        "General References": "Lee K, Belinsky MG, Bell DW, Testa JR, Kruh GD: Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter. Cancer Res. 1998 Jul 1;58(13):2741-7. [Article] Adachi M, Sampath J, Lan LB, Sun D, Hargrove P, Flatley R, Tatum A, Edwards MZ, Wezeman M, Matherly L, Drake R, Schuetz J: Expression of MRP4 confers resistance to ganciclovir and compromises bystander cell killing. J Biol Chem. 2002 Oct 11;277(41):38998-9004. Epub 2002 Jun 24. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Dunham A, Matthews LH, Burton J, Ashurst JL, Howe KL, Ashcroft KJ, Beare DM, Burford DC, Hunt SE, Griffiths-Jones S, Jones MC, Keenan SJ, Oliver K, Scott CE, Ainscough R, Almeida JP, Ambrose KD, Andrews DT, Ashwell RI, Babbage AK, Bagguley CL, Bailey J, Bannerjee R, Barlow KF, Bates K, Beasley H, Bird CP, Bray-Allen S, Brown AJ, Brown JY, Burrill W, Carder C, Carter NP, Chapman JC, Clamp ME, Clark SY, Clarke G, Clee CM, Clegg SC, Cobley V, Collins JE, Corby N, Coville GJ, Deloukas P, Dhami P, Dunham I, Dunn M, Earthrowl ME, Ellington AG, Faulkner L, Frankish AG, Frankland J, French L, Garner P, Garnett J, Gilbert JG, Gilson CJ, Ghori J, Grafham DV, Gribble SM, Griffiths C, Hall RE, Hammond S, Harley JL, Hart EA, Heath PD, Howden PJ, Huckle EJ, Hunt PJ, Hunt AR, Johnson C, Johnson D, Kay M, Kimberley AM, King A, Laird GK, Langford CJ, Lawlor S, Leongamornlert DA, Lloyd DM, Lloyd C, Loveland JE, Lovell J, Martin S, Mashreghi-Mohammadi M, McLaren SJ, McMurray A, Milne S, Moore MJ, Nickerson T, Palmer SA, Pearce AV, Peck AI, Pelan S, Phillimore B, Porter KM, Rice CM, Searle S, Sehra HK, Shownkeen R, Skuce CD, Smith M, Steward CA, Sycamore N, Tester J, Thomas DW, Tracey A, Tromans A, Tubby B, Wall M, Wallis JM, West AP, Whitehead SL, Willey DL, Wilming L, Wray PW, Wright MW, Young L, Coulson A, Durbin R, Hubbard T, Sulston JE, Beck S, Bentley DR, Rogers J, Ross MT: The DNA sequence and analysis of human chromosome 13. Nature. 2004 Apr 1;428(6982):522-8. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Kool M, de Haas M, Scheffer GL, Scheper RJ, van Eijk MJ, Juijn JA, Baas F, Borst P: Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 1997 Aug 15;57(16):3537-47. [Article] Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M: Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006 Nov 3;127(3):635-48. [Article] Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP: A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7. doi: 10.1073/pnas.0805139105. Epub 2008 Jul 31. [Article] Mayya V, Lundgren DH, Hwang SI, Rezaul K, Wu L, Eng JK, Rodionov V, Han DK: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal. 2009 Aug 18;2(84):ra46. doi: 10.1126/scisignal.2000007. [Article] Olsen JV, Vermeulen M, Santamaria A, Kumar C, Miller ML, Jensen LJ, Gnad F, Cox J, Jensen TS, Nigg EA, Brunak S, Mann M: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3. doi: 10.1126/scisignal.2000475. [Article] Burkard TR, Planyavsky M, Kaupe I, Breitwieser FP, Burckstummer T, Bennett KL, Superti-Furga G, Colinge J: Initial characterization of the human central proteome. BMC Syst Biol. 2011 Jan 26;5:17. doi: 10.1186/1752-0509-5-17. [Article] Hayashi H, Naoi S, Nakagawa T, Nishikawa T, Fukuda H, Imajoh-Ohmi S, Kondo A, Kubo K, Yabuki T, Hattori A, Hirouchi M, Sugiyama Y: Sorting nexin 27 interacts with multidrug resistance-associated protein 4 (MRP4) and mediates internalization of MRP4. J Biol Chem. 2012 Apr 27;287(18):15054-65. doi: 10.1074/jbc.M111.337931. Epub 2012 Mar 12. [Article] Janke D, Mehralivand S, Strand D, Godtel-Armbrust U, Habermeier A, Gradhand U, Fischer C, Toliat MR, Fritz P, Zanger UM, Schwab M, Fromm MF, Nurnberg P, Wojnowski L, Closs EI, Lang T: 6-mercaptopurine and 9-(2-phosphonyl-methoxyethyl) adenine (PMEA) transport altered by two missense mutations in the drug transporter gene ABCC4. Hum Mutat. 2008 May;29(5):659-69. doi: 10.1002/humu.20694. [Article] Yuasa I, Umetsu K, Matsusue A, Nishimukai H, Harihara S, Fukumori Y, Saitou N, Jin F, Chattopadhyay PK, Henke L, Henke J: A Japanese-specific allele in the GALNT11 gene. Leg Med (Tokyo). 2010 Jul;12(4):208-11. doi: 10.1016/j.legalmed.2010.04.001. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00563MethotrexateapprovedunknownsubstrateinhibitorDetailsDB02527Cyclic adenosine monophosphateexperimentalunknownsubstrateinhibitorDetailsDB01032Probenecidapproved, investigationalunknowninhibitorDetailsDB00975DipyridamoleapprovedunknowninhibitorDetailsDB00661VerapamilapprovedunknowninhibitorDetailsDB01138SulfinpyrazoneapprovedunknowninhibitorDetailsDB00203Sildenafilapproved, investigationalunknowninhibitorDetailsDB00158Folic acidapproved, nutraceutical, vet_approvedunknowninhibitorDetailsDB04348Taurocholic acidapproved, experimentalunknowninhibitorDetailsDB00286Conjugated estrogensapprovedunknowninhibitorDetailsDB01586Ursodeoxycholic acidapproved, investigationalunknowninhibitorDetailsDB02659Cholic AcidapprovedunknowninhibitorDetailsDB00533Rofecoxibapproved, investigational, withdrawnunknowninhibitorDetailsDB01009Ketoprofenapproved, vet_approvedunknowninhibitorDetailsDB00328Indomethacinapproved, investigationalunknowninhibitorDetailsDB01050IbuprofenapprovedunknowninhibitorDetailsDB00712Flurbiprofenapproved, investigationalunknowninhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknowninhibitorDetailsDB00482Celecoxibapproved, investigationalunknowninhibitorDetailsDB00352TioguanineapprovedunknowninhibitorDetailsDB00398Sorafenibapproved, investigationalunknowninhibitorDetailsDB01268Sunitinibapproved, investigationalunknowninhibitorDetailsDB01033MercaptopurineapprovedunknownsubstrateDetailsDB00143Glutathioneapproved, investigational, nutraceuticalunknownsubstrateDetailsDB00917DinoprostoneapprovedunknownsubstrateDetailsDB00770Alprostadilapproved, investigationalunknownsubstrateDetailsDB00718Adefovir dipivoxilapproved, investigationalunknownsubstrateDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB01098RosuvastatinapprovedunknownsubstrateDetailsDB00198OseltamivirapprovedunknownsubstrateDetailsDB00814Meloxicamapproved, vet_approvedunknownbinderDetailsDB01327CefazolinapprovedunknownsubstrateDetailsDB00731Nateglinideapproved, investigationalunknownsubstrateDetailsDB08884Gadoxetic acidapprovedunknownsubstrateDetailsDB00495ZidovudineapprovedunknownsubstrateDetailsDB00544FluorouracilapprovedunknownsubstrateDetailsDB00709Lamivudineapproved, investigationalunknownsubstrateDetailsDB00300Tenofovir disoproxilapproved, investigationalunknownsubstrateDetailsDB00171ATPinvestigational, nutraceuticalunknownDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB13146Fluciclovine (18F)approvednosubstrateDetailsDB09213Dexibuprofenapproved, investigationalunknownDetailsDB09299Tenofovir alafenamideapprovednosubstrateDetailsDB14126Tenofovirexperimental, investigationalnosubstrateDetailsDB00481Raloxifeneapproved, investigationalunknownsubstrateDetailsDB00999Hydrochlorothiazideapproved, vet_approvedunknownsubstrateDetailsDB01069Promethazineapproved, investigationalunknowninhibitorDetailsDB01708Prasteroneapproved, investigational, nutraceuticalunknownsubstrateDetailsDB14761Remdesivirapproved, investigationalunknowninhibitorDetailsDB00619ImatinibapprovednosubstrateDetails"
                    }
                },
                {
                    "Label": "Multidrug resistance-associated protein 5",
                    "Detailed Info": {
                        "Name": "Multidrug resistance-associated protein 5",
                        "Synonyms": "ATP-binding cassette sub-family C member 5\nMOAT-C\nMRP5\nMulti-specific organic anion transporter C\npABC11\nSMRP",
                        "Gene Name": "ABCC5",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0006995|Multidrug resistance-associated protein 5\nMKDIDIGKEYIIPSPGYRSVRERTSTSGTHRDREDSKFRRTRPLECQDALETAARAEGLS\nLDASMHSQLRILDEEHPKGKYHHGLSALKPIRTTSKHQHPVDNAGLFSCMTFSWLSSLAR\nVAHKKGELSMEDVWSLSKHESSDVNCRRLERLWQEELNEVGPDAASLRRVVWIFCRTRLI\nLSIVCLMITQLAGFSGPAFMVKHLLEYTQATESNLQYSLLLVLGLLLTEIVRSWSLALTW\nALNYRTGVRLRGAILTMAFKKILKLKNIKEKSLGELINICSNDGQRMFEAAAVGSLLAGG\nPVVAILGMIYNVIILGPTGFLGSAVFILFYPAMMFASRLTAYFRRKCVAATDERVQKMNE\nVLTYIKFIKMYAWVKAFSQSVQKIREEERRILEKAGYFQSITVGVAPIVVVIASVVTFSV\nHMTLGFDLTAAQAFTVVTVFNSMTFALKVTPFSVKSLSEASVAVDRFKSLFLMEEVHMIK\nNKPASPHIKIEMKNATLAWDSSHSSIQNSPKLTPKMKKDKRASRGKKEKVRQLQRTEHQA\nVLAEQKGHLLLDSDERPSPEEEEGKHIHLGHLRLQRTLHSIDLEIQEGKLVGICGSVGSG\nKTSLISAILGQMTLLEGSIAISGTFAYVAQQAWILNATLRDNILFGKEYDEERYNSVLNS\nCCLRPDLAILPSSDLTEIGERGANLSGGQRQRISLARALYSDRSIYILDDPLSALDAHVG\nNHIFNSAIRKHLKSKTVLFVTHQLQYLVDCDEVIFMKEGCITERGTHEELMNLNGDYATI\nFNNLLLGETPPVEINSKKETSGSQKKSQDKGPKTGSVKKEKAVKPEEGQLVQLEEKGQGS\nVPWSVYGVYIQAAGGPLAFLVIMALFMLNVGSTAFSTWWLSYWIKQGSGNTTVTRGNETS\nVSDSMKDNPHMQYYASIYALSMAVMLILKAIRGVVFVKGTLRASSRLHDELFRRILRSPM\nKFFDTTPTGRILNRFSKDMDEVDVRLPFQAEMFIQNVILVFFCVGMIAGVFPWFLVAVGP\nLVILFSVLHIVSRVLIRELKRLDNITQSPFLSHITSSIQGLATIHAYNKGQEFLHRYQEL\nLDDNQAPFFLFTCAMRWLAVRLDLISIALITTTGLMIVLMHGQIPPAYAGLAISYAVQLT\nGLFQFTVRLASETEARFTSVERINHYIKTLSLEAPARIKNKAPSPDWPQEGEVTFENAEM\nRYRENLPLVLKKVSFTIKPKEKIGIVGRTGSGKSSLGMALFRLVELSGGCIKIDGVRISD\nIGLADLRSKLSIIPQEPVLFSGTVRSNLDPFNQYTEDQIWDALERTHMKECIAQLPLKLE\nSEVMENGDNFSVGERQLLCIARALLRHCKILILDEATAAMDTETDLLIQETIREAFADCT\nMLTIAHRLHTVLGSDRIMVLAQGQVVEFDTPSVLLSNDSSRFYAMFAAAENKVAVKG",
                        "Number of residues": "1437",
                        "Molecular Weight": "160658.8",
                        "Theoretical pI": "8.89",
                        "GO Classification": "FunctionsATP binding / ATPase activity, coupled to transmembrane movement of substances / organic anion transmembrane transporter activityProcessescarbohydrate metabolic process / glycosaminoglycan metabolic process / hyaluronan biosynthetic process / hyaluronan metabolic process / small molecule metabolic process / transmembrane transport / transportComponentsintegral component of plasma membrane / membrane / plasma membrane",
                        "General Function": "Organic anion transmembrane transporter activity",
                        "Specific Function": "Acts as a multispecific organic anion pump which can transport nucleotide analogs.",
                        "Pfam Domain Function": "ABC_tran (PF00005)\nABC_membrane (PF00664)",
                        "Transmembrane Regions": "179-199\n219-239\n296-316\n317-337\n400-420\n434-454\n608-628\n848-868\n917-937\n997-1017\n1018-1038\n1104-1124\n1127-1147",
                        "Cellular Location": "Membrane",
                        "Gene sequence": ">lcl|BSEQ0012531|Multidrug resistance-associated protein 5 (ABCC5)\nATGAAGGATATCGACATAGGAAAAGAGTATATCATCCCCAGTCCTGGGTATAGAAGTGTG\nAGGGAGAGAACCAGCACTTCTGGGACGCACAGAGACCGTGAAGATTCCAAGTTCAGGAGA\nACTCGACCGTTGGAATGCCAAGATGCCTTGGAAACAGCAGCCCGAGCCGAGGGCCTCTCT\nCTTGATGCCTCCATGCATTCTCAGCTCAGAATCCTGGATGAGGAGCATCCCAAGGGAAAG\nTACCATCATGGCTTGAGTGCTCTGAAGCCCATCCGGACTACTTCCAAACACCAGCACCCA\nGTGGACAATGCTGGGCTTTTTTCCTGTATGACTTTTTCGTGGCTTTCTTCTCTGGCCCGT\nGTGGCCCACAAGAAGGGGGAGCTCTCAATGGAAGACGTGTGGTCTCTGTCCAAGCACGAG\nTCTTCTGACGTGAACTGCAGAAGACTAGAGAGACTGTGGCAAGAAGAGCTGAATGAAGTT\nGGGCCAGACGCTGCTTCCCTGCGAAGGGTTGTGTGGATCTTCTGCCGCACCAGGCTCATC\nCTGTCCATCGTGTGCCTGATGATCACGCAGCTGGCTGGCTTCAGTGGACCAAATTTTCAG\nGATGGCTGTATTCTGCGGTCAGAATGA",
                        "Chromosome Location": "3",
                        "Locus": "3q27",
                        "External Identifiers": "ResourceLinkUniProtKB IDO15440UniProtKB Entry NameMRP5_HUMANGenBank Protein ID4140698GenBank Gene IDAF104942HGNC IDHGNC:56",
                        "General References": "Belinsky MG, Bain LJ, Balsara BB, Testa JR, Kruh GD: Characterization of MOAT-C and MOAT-D, new members of the MRP/cMOAT subfamily of transporter proteins. J Natl Cancer Inst. 1998 Nov 18;90(22):1735-41. [Article] McAleer MA, Breen MA, White NL, Matthews N: pABC11 (also known as MOAT-C and MRP5), a member of the ABC family of proteins, has anion transporter activity but does not confer multidrug resistance when overexpressed in human embryonic kidney 293 cells. J Biol Chem. 1999 Aug 13;274(33):23541-8. [Article] Suzuki T, Sasaki H, Kuh HJ, Agui M, Tatsumi Y, Tanabe S, Terada M, Saijo N, Nishio K: Detailed structural analysis on both human MRP5 and mouse mrp5 transcripts. Gene. 2000 Jan 25;242(1-2):167-73. [Article] Wijnholds J, Mol CA, van Deemter L, de Haas M, Scheffer GL, Baas F, Beijnen JH, Scheper RJ, Hatse S, De Clercq E, Balzarini J, Borst P: Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7476-81. [Article] Stojic J, Stohr H, Weber BH: Three novel ABCC5 splice variants in human retina and their role as regulators of ABCC5 gene expression. BMC Mol Biol. 2007 May 23;8:42. [Article] Muzny DM, Scherer SE, Kaul R, Wang J, Yu J, Sudbrak R, Buhay CJ, Chen R, Cree A, Ding Y, Dugan-Rocha S, Gill R, Gunaratne P, Harris RA, Hawes AC, Hernandez J, Hodgson AV, Hume J, Jackson A, Khan ZM, Kovar-Smith C, Lewis LR, Lozado RJ, Metzker ML, Milosavljevic A, Miner GR, Morgan MB, Nazareth LV, Scott G, Sodergren E, Song XZ, Steffen D, Wei S, Wheeler DA, Wright MW, Worley KC, Yuan Y, Zhang Z, Adams CQ, Ansari-Lari MA, Ayele M, Brown MJ, Chen G, Chen Z, Clendenning J, Clerc-Blankenburg KP, Chen R, Chen Z, Davis C, Delgado O, Dinh HH, Dong W, Draper H, Ernst S, Fu G, Gonzalez-Garay ML, Garcia DK, Gillett W, Gu J, Hao B, Haugen E, Havlak P, He X, Hennig S, Hu S, Huang W, Jackson LR, Jacob LS, Kelly SH, Kube M, Levy R, Li Z, Liu B, Liu J, Liu W, Lu J, Maheshwari M, Nguyen BV, Okwuonu GO, Palmeiri A, Pasternak S, Perez LM, Phelps KA, Plopper FJ, Qiang B, Raymond C, Rodriguez R, Saenphimmachak C, Santibanez J, Shen H, Shen Y, Subramanian S, Tabor PE, Verduzco D, Waldron L, Wang J, Wang J, Wang Q, Williams GA, Wong GK, Yao Z, Zhang J, Zhang X, Zhao G, Zhou J, Zhou Y, Nelson D, Lehrach H, Reinhardt R, Naylor SL, Yang H, Olson M, Weinstock G, Gibbs RA: The DNA sequence, annotation and analysis of human chromosome 3. Nature. 2006 Apr 27;440(7088):1194-8. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] Suzuki T, Nishio K, Sasaki H, Kurokawa H, Saito-Ohara F, Ikeuchi T, Tanabe S, Terada M, Saijo N: cDNA cloning of a short type of multidrug resistance protein homologue, SMRP, from a human lung cancer cell line. Biochem Biophys Res Commun. 1997 Sep 29;238(3):790-4. [Article] Kool M, de Haas M, Scheffer GL, Scheper RJ, van Eijk MJ, Juijn JA, Baas F, Borst P: Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 1997 Aug 15;57(16):3537-47. [Article] Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP: A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7. doi: 10.1073/pnas.0805139105. Epub 2008 Jul 31. [Article] Olsen JV, Vermeulen M, Santamaria A, Kumar C, Miller ML, Jensen LJ, Gnad F, Cox J, Jensen TS, Nigg EA, Brunak S, Mann M: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3. doi: 10.1126/scisignal.2000475. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB01045RifampicinapprovedunknowninducerDetailsDB00515CisplatinapprovedunknowninducerDetailsDB01138SulfinpyrazoneapprovedunknowninhibitorDetailsDB00203Sildenafilapproved, investigationalunknowninhibitorDetailsDB01032Probenecidapproved, investigationalunknowninhibitorDetailsDB02527Cyclic adenosine monophosphateexperimentalunknowninhibitorDetailsDB00975DipyridamoleapprovedunknowninhibitorDetailsDB00917DinoprostoneapprovedunknowninhibitorDetailsDB00770Alprostadilapproved, investigationalunknowninhibitorDetailsDB00718Adefovir dipivoxilapproved, investigationalunknownsubstrateDetailsDB01033MercaptopurineapprovedunknownsubstrateDetailsDB00143Glutathioneapproved, investigational, nutraceuticalunknownsubstrateDetailsDB01076AtorvastatinapprovednosubstrateDetailsDB00495ZidovudineapprovedunknownsubstrateDetailsDB00544FluorouracilapprovedunknownsubstrateDetailsDB11672Curcuminapproved, investigationalunknowninhibitorDetailsDB14635Curcumin sulfateexperimentalunknownDetailsDB08818Hyaluronic acidapproved, vet_approvedunknownsubstrateDetailsDB00642Pemetrexedapproved, investigationalnoDetails"
                    }
                },
                {
                    "Label": "Multidrug resistance-associated protein 7",
                    "Detailed Info": {
                        "Name": "Multidrug resistance-associated protein 7",
                        "Synonyms": "ATP-binding cassette sub-family C member 10\nMRP7\nSIMRP7",
                        "Gene Name": "ABCC10",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0007017|Multidrug resistance-associated protein 7\nMERLLAQLCGSSAAWPLPLWEGDTTGHCFTQLVLSALPHALLAVLSACYLGTPRSPDYIL\nPCSPGWRLRLAASFLLSVFPLLDLLPVALPPGAGPGPIGLEVLAGCVAAVAWISHSLALW\nVLAHSPHGHSRGPLALALVALLPAPALVLTVLWHCQRGTLLPPLLPGPMARLCLLILQLA\nALLAYALGWAAPGGPREPWAQEPLLPEDQEPEVAEDGESWLSRFSYAWLAPLLARGACGE\nLRQPQDICRLPHRLQPTYLARVFQAHWQEGARLWRALYGAFGRCYLALGLLKLVGTMLGF\nSGPLLLSLLVGFLEEGQEPLSHGLLYALGLAGGAVLGAVLQNQYGYEVYKVTLQARGAVL\nNILYCKALQLGPSRPPTGEALNLLGTDSERLLNFAGSFHEAWGLPLQLAITLYLLYQQVG\nVAFVGGLILALLLVPVNKVIATRIMASNQEMLQHKDARVKLVTELLSGIRVIKFCGWEQA\nLGARVEACRARELGRLRVIKYLDAACVYLWAALPVVISIVIFITYVLMGHQLTATKVFTA\nLALVRMLILPLNNFPWVINGLLEAKVSLDRIQLFLDLPNHNPQAYYSPDPPAEPSTVLEL\nHGALFSWDPVGTSLETFISHLEVKKGMLVGIVGKVGCGKSSLLAAIAGELHRLRGHVAVR\nGLSKGFGLATQEPWIQFATIRDNILFGKTFDAQLYKEVLEACALNDDLSILPAGDQTEVG\nEKGVTLSGGQRARIALARAVYQEKELYLLDDPLAAVDADVANHLLHRCILGMLSYTTRLL\nCTHRTEYLERADAVLLMEAGRLIRAGPPSEILPLVQAVPKAWAENGQESDSATAQSVQNP\nEKTKEGLEEEQSTSGRLLQEESKKEGAVALHVYQAYWKAVGQGLALAILFSLLLMQATRN\nAADWWLSHWISQLKAENSSQEAQPSTSPASMGLFSPQLLLFSPGNLYIPVFPLPKAAPNG\nSSDIRFYLTVYATIAGVNSLCTLLRAVLFAAGTLQAAATLHRRLLHRVLMAPVTFFNATP\nTGRILNRFSSDVACADDSLPFILNILLANAAGLLGLLAVLGSGLPWLLLLLPPLSIMYYH\nVQRHYRASSRELRRLGSLTLSPLYSHLADTLAGLSVLRATGATYRFEEENLRLLELNQRC\nQFATSATMQWLDIRLQLMGAAVVSAIAGIALVQHQQGLANPGLVGLSLSYALSLTGLLSG\nLVSSFTQTEAMLVSVERLEEYTCDLPQEPQGQPLQLGTGWLTQGGVEFQDVVLAYRPGLP\nNALDGVTFCVQPGEKLGIVGRTGSGKSSLLLVLFRLLEPSSGRVLLDGVDTSQLELAQLR\nSQLAIIPQEPFLFSGTVRENLDPQGLHKDRALWQALKQCHLSEVITSMGGLDGELGEGGR\nSLSLGQRQLLCLARALLTDAKILCIDEATASVDQKTDQLLQQTICKRFANKTVLTIAHRL\nNTILNSDRVLVLQAGRVVELDSPATLRNQPHSLFQQLLQSSQQGVPASLGGP",
                        "Number of residues": "1492",
                        "Molecular Weight": "161627.375",
                        "Theoretical pI": "7.07",
                        "GO Classification": "FunctionsATP binding / ATPase activity, coupled to transmembrane movement of substancesProcessestransmembrane transportComponentsintegral component of membrane / lysosomal membrane / plasma membrane",
                        "General Function": "Atpase activity, coupled to transmembrane movement of substances",
                        "Specific Function": "ATP-dependent transporter probably involved in cellular detoxification through lipophilic anion extrusion.",
                        "Pfam Domain Function": "ABC_tran (PF00005)\nABC_membrane (PF00664)",
                        "Transmembrane Regions": "32-52\n70-90\n102-122\n133-153\n172-192\n293-313\n320-340\n391-411\n414-434\n507-527\n538-558\n875-895\n933-953\n974-994\n1051-1071\n1153-1173\n1182-1202",
                        "Cellular Location": "Cell membrane",
                        "Gene sequence": ">lcl|BSEQ0019454|Multidrug resistance-associated protein 7 (ABCC10)\nATGGAACGACTTCTGGCCCAGCTGTGCGGCAGCAGCGCAGCGTGGCCGCTCCCGCTGTGG\nGAGGGGGACACCACAGGCCACTGCTTCACCCAGCTGGTGCTCAGCGCCCTGCCCCACGCG\nCTCCTCGCCGTGCTCAGTGCCTGTTACTTGGGCACCCCGAGGAGTCCAGATTACATCCTA\nCCCTGCAGTCCTGGATGGCGCCTCCGACTTGCAGCTTCCTTCCTGCTTTCCGTCTTCCCG\nCTGCTAGACCTTCTTCCAGTTGCTTTGCCACCAGGGGCAGGCCCAGGACCCATAGGGCTA\nGAGGTGTTGGCAGGGTGCGTGGCAGCTGTGGCCTGGATCAGCCACAGCCTGGCCCTGTGG\nGTGTTGGCACATTCCCCTCATGGCCACTCCCGGGGTCCCTTGGCCTTGGCCCTGGTAGCC\nTTGCTGCCAGCTCCAGCCCTAGTGCTGACCGTGTTGTGGCATTGCCAGCGAGGCACACTT\nCTGCCCCCACTTCTCCCAGGGCCCATGGCCCGCCTATGCTTGCTCATCCTGCAGCTGGCT\nGCACTCTTGGCCTATGCACTGGGATGGGCAGCTCCTGGGGGACCACGAGAACCCTGGGCT\nCAGGAGCCCCTCCTGCCCGAGGATCAAGAACCTGAGGTGGCTGAAGATGGGGAGAGTTGG\nCTGTCACGCTTTTCCTATGCCTGGCTGGCACCCTTGCTGGCCCGTGGGGCCTGTGGAGAG\nCTCCGGCAGCCTCAGGACATTTGCCGCCTCCCCCACAGACTGCAGCCAACCTACCTGGCT\nCGTGTCTTCCAGGCACACTGGCAGGAGGGGGCACGGCTGTGGAGGGCCTTGTATGGGGCC\nTTTGGACGGTGCTATCTGGCACTTGGACTGCTGAAGCTGGTGGGGACCATGTTGGGATTC\nTCAGGGCCCCTGTTGCTCTCCCTACTGGTGGGCTTCCTGGAAGAGGGGCAGGAGCCACTA\nAGCCACGGCCTGCTCTATGCTCTGGGGCTAGCCGGTGGGGCTGTGCTGGGTGCTGTGCTG\nCAGAATCAGTATGGGTATGAGGTATATAAGGTAACACTTCAGGCACGGGGGGCTGTGCTG\nAACATCCTGTACTGCAAGGCTTTACAGCTGGGGCCCAGCCGCCCTCCTACTGGGGAGGCC\nCTGAACCTACTAGGCACTGACTCTGAACGGCTGCTTAACTTTGCTGGGAGCTTCCATGAA\nGCCTGGGGCCTGCCCCTGCAACTGGCCATCACCCTCTACCTGCTGTACCAGCAGGTAGGC\nGTGGCCTTCGTGGGTGGTCTCATCTTGGCACTGCTGCTGGTACCCGTCAACAAAGTGATT\nGCCACCCGCATCATGGCCAGCAACCAGGAAATGCTACAGCACAAGGATGCGCGGGTTAAG\nCTTGTGACAGAGCTGCTGAGTGGCATTCGGGTCATCAAGTTCTGCGGGTGGGAGCAGGCA\nCTGGGAGCCCGAGTAGAGGCCTGCCGGGCTCGAGAGCTGGGGCGACTCCGGGTCATCAAA\nTACCTGGATGCGGCCTGTGTATACCTGTGGGCTGCCCTACCGGTTGTCATCTCCATCGTT\nATCTTCATCACCTATGTCCTCATGGGGCACCAGCTCACTGCCACCAAGGTGTTCACGGCC\nCTGGCACTGGTGCGAATGCTCATTCTTCCTCTCAACAACTTCCCTTGGGTGATCAATGGT\nCTCCTGGAGGCCAAAGTGTCCTTGGACCGGATCCAGCTTTTCCTCGACCTTCCAAACCAC\nAACCCCCAGGCCTACTACAGCCCAGATCCCCCTGCAGAGCCATCTACAGTATTGGAGCTG\nCATGGAGCCTTGTTCTCCTGGGACCCAGTTGGAACCAGCCTGGAGACCTTCATCAGTCAT\nCTCGAAGTGAAAAAGGGTATGCTGGTGGGCATCGTGGGGAAGGTCGGCTGTGGGAAGAGC\nTCCCTGCTGGCTGCCATCGCTGGAGAGCTCCACAGGCTGCGTGGGCATGTGGCAGTGCGG\nGGGCTGTCCAAGGGCTTTGGCCTGGCCACCCAGGAACCCTGGATCCAGTTTGCCACCATC\nCGAGACAACATCCTCTTTGGGAAGACATTTGATGCACAGCTGTACAAGGAGGTGCTAGAA\nGCCTGCGCCCTCAATGATGACCTCAGTATCCTGCCTGCTGGAGACCAGACAGAGGTGGGG\nGAGAAGGGTGTCACCCTTAGCGGAGGACAGCGTGCCCGGATTGCCCTTGCTCGTGCTGTC\nTACCAGGAAAAGGAGCTCTATCTCCTCGATGACCCTCTGGCCGCTGTGGATGCAGATGTG\nGCCAACCACCTGCTGCACAGGTGCATCCTGGGCATGCTGAGCTACACCACACGGCTGCTC\nTGCACCCACCGCACTGAGTACCTGGAGAGGGCTGACGCGGTGCTGCTGATGGAGGCCGGG\nCGCCTCATCCGGGCTGGACCTCCCTCTGAGATTCTGCCACTGGTACAAGCTGTCCCCAAA\nGCCTGGGCTGAGAATGGACAAGAGTCTGACTCAGCCACAGCCCAGTCAGTACAGAACCCA\nGAGAAAACAAAGGAGGGGCTGGAGGAGGAGCAGAGCACATCTGGTCGCCTGCTGCAGGAA\nGAAAGCAAGAAGGAGGGCGCCGTGGCCTTGCACGTGTACCAAGCTTACTGGAAGGCCGTG\nGGCCAGGGCTTGGCCTTAGCCATCCTCTTCTCTCTGCTTCTCATGCAAGCCACGCGGAAC\nGCTGCTGACTGGTGGCTCTCCCACTGGATCTCTCAGCTGAAGGCTGAGAATAGCTCCCAG\nGAGGCGCAACCCTCCACCAGCCCAGCTTCTATGGGGCTCTTCTCTCCGCAGCTGCTCCTC\nTTTTCCCCTGGAAACCTCTACATCCCAGTGTTCCCACTGCCCAAAGCTGCCCCCAATGGC\nTCCTCAGACATCCGTTTCTACCTCACCGTGTATGCGACCATTGCTGGTGTAAATTCCCTC\nTGCACCCTTCTCCGGGCAGTGCTCTTTGCAGCAGGCACCCTTCAAGCAGCTGCCACTCTG\nCATCGCCGCCTGCTGCATCGAGTCCTTATGGCACCAGTGACTTTCTTCAATGCCACACCC\nACGGGCCGGATCCTAAACCGCTTCTCCTCTGATGTGGCCTGTGCGGATGACAGCCTGCCC\nTTCATCCTCAACATCCTCCTGGCCAACGCGGCAGGCCTGCTGGGGCTCCTGGCCGTGCTG\nGGCTCTGGCCTGCCCTGGCTGCTGCTCCTGCTGCCGCCTTTGAGCATCATGTACTATCAC\nGTGCAGCGCCACTACAGGGCCTCCTCACGGGAGCTGCGGCGCCTGGGCAGCCTCACCCTG\nTCTCCACTGTATAGCCATCTGGCCGATACCTTGGCTGGCCTCTCTGTGCTCCGGGCCACA\nGGGGCCACCTACAGGTTTGAGGAGGAGAACCTGCGACTCCTTGAGCTAAACCAGAGGTGC\nCAGTTTGCCACCAGTGCCACAATGCAGTGGCTGGACATTCGGCTACAGCTCATGGGGGCG\nGCAGTGGTCAGCGCTATCGCAGGCATCGCTCTGGTGCAGCACCAGCAGGGCCTCGCTAAC\nCCAGGGCTGGTGGGCTTGTCGCTGTCTTATGCCCTGTCCCTGACGGGCCTGCTCTCGGGC\nCTGGTGAGCAGCTTCACACAGACAGAGGCCATGCTGGTGAGCGTCGAGCGGCTGGAAGAG\nTACACCTGTGACCTGCCCCAGGAACCCCAGGGCCAGCCACTGCAGCTGGGCACCGGCTGG\nCTGACCCAGGGGGGCGTGGAGTTCCAGGACGTGGTGTTGGCGTACCGGCCAGGGCTGCCG\nAATGCCCTGGATGGAGTGACCTTCTGCGTGCAGCCTGGAGAGAAGTTGGGCATCGTGGGC\nCGCACAGGCTCCGGCAAGTCTTCCCTGTTGTTGGTGCTCTTCCGGCTGCTAGAGCCCAGT\nTCAGGGCGAGTGCTGCTGGACGGCGTGGACACCAGCCAGCTGGAGCTGGCCCAGCTCAGA\nTCCCAGTTGGCTATCATCCCCCAGGAGCCCTTTTTGTTCAGTGGGACTGTTCGGGAAAAC\nCTGGACCCCCAGGGCCTACATAAGGACAGGGCCTTGTGGCAGGCCCTGAAGCAGTGCCAC\nCTGAGTGAGGTGATTACATCCATGGGTGGTCTGGATGGTGAGCTGGGTGAGGGGGGCCGG\nAGCTTATCTCTTGGGCAGAGGCAGCTGTTGTGTTTGGCCAGGGCTCTCCTCACAGATGCC\nAAGATCCTGTGTATCGATGAGGCCACAGCAAGTGTGGACCAGAAGACAGACCAGCTGCTC\nCAGCAGACCATCTGCAAACGCTTTGCCAACAAGACAGTGCTGACCATTGCCCATAGGCTC\nAACACGATCCTGAACTCAGACCGGGTGCTGGTGCTACAAGCGGGGAGAGTGGTAGAGCTG\nGACTCCCCGGCCACCCTGCGCAACCAGCCCCACTCCCTGTTCCAGCAGCTGCTGCAGAGC\nAGCCAGCAGGGAGTCCCTGCCTCACTCGGAGGTCCCTGA",
                        "Chromosome Location": "6",
                        "Locus": "6p21.1",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ5T3U5UniProtKB Entry NameMRP7_HUMANGenBank Protein ID21103955GenBank Gene IDAY032599HGNC IDHGNC:52",
                        "General References": "Kao HH, Chang MS, Cheng JF, Huang JD: Genomic structure, gene expression, and promoter analysis of human multidrug resistance-associated protein 7. J Biomed Sci. 2003 Jan-Feb;10(1):98-110. [Article] Hattori A, Okumura K, Nagase T, Kikuno R, Hirosawa M, Ohara O: Characterization of long cDNA clones from human adult spleen. DNA Res. 2000 Dec 31;7(6):357-66. [Article] Mungall AJ, Palmer SA, Sims SK, Edwards CA, Ashurst JL, Wilming L, Jones MC, Horton R, Hunt SE, Scott CE, Gilbert JG, Clamp ME, Bethel G, Milne S, Ainscough R, Almeida JP, Ambrose KD, Andrews TD, Ashwell RI, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Barker DJ, Barlow KF, Bates K, Beare DM, Beasley H, Beasley O, Bird CP, Blakey S, Bray-Allen S, Brook J, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Carder C, Carter NP, Chapman JC, Clark SY, Clark G, Clee CM, Clegg S, Cobley V, Collier RE, Collins JE, Colman LK, Corby NR, Coville GJ, Culley KM, Dhami P, Davies J, Dunn M, Earthrowl ME, Ellington AE, Evans KA, Faulkner L, Francis MD, Frankish A, Frankland J, French L, Garner P, Garnett J, Ghori MJ, Gilby LM, Gillson CJ, Glithero RJ, Grafham DV, Grant M, Gribble S, Griffiths C, Griffiths M, Hall R, Halls KS, Hammond S, Harley JL, Hart EA, Heath PD, Heathcott R, Holmes SJ, Howden PJ, Howe KL, Howell GR, Huckle E, Humphray SJ, Humphries MD, Hunt AR, Johnson CM, Joy AA, Kay M, Keenan SJ, Kimberley AM, King A, Laird GK, Langford C, Lawlor S, Leongamornlert DA, Leversha M, Lloyd CR, Lloyd DM, Loveland JE, Lovell J, Martin S, Mashreghi-Mohammadi M, Maslen GL, Matthews L, McCann OT, McLaren SJ, McLay K, McMurray A, Moore MJ, Mullikin JC, Niblett D, Nickerson T, Novik KL, Oliver K, Overton-Larty EK, Parker A, Patel R, Pearce AV, Peck AI, Phillimore B, Phillips S, Plumb RW, Porter KM, Ramsey Y, Ranby SA, Rice CM, Ross MT, Searle SM, Sehra HK, Sheridan E, Skuce CD, Smith S, Smith M, Spraggon L, Squares SL, Steward CA, Sycamore N, Tamlyn-Hall G, Tester J, Theaker AJ, Thomas DW, Thorpe A, Tracey A, Tromans A, Tubby B, Wall M, Wallis JM, West AP, White SS, Whitehead SL, Whittaker H, Wild A, Willey DJ, Wilmer TE, Wood JM, Wray PW, Wyatt JC, Young L, Younger RM, Bentley DR, Coulson A, Durbin R, Hubbard T, Sulston JE, Dunham I, Rogers J, Beck S: The DNA sequence and analysis of human chromosome 6. Nature. 2003 Oct 23;425(6960):805-11. [Article] Bechtel S, Rosenfelder H, Duda A, Schmidt CP, Ernst U, Wellenreuther R, Mehrle A, Schuster C, Bahr A, Blocker H, Heubner D, Hoerlein A, Michel G, Wedler H, Kohrer K, Ottenwalder B, Poustka A, Wiemann S, Schupp I: The full-ORF clone resource of the German cDNA Consortium. BMC Genomics. 2007 Oct 31;8:399. [Article] Chen ZS, Hopper-Borge E, Belinsky MG, Shchaveleva I, Kotova E, Kruh GD: Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10). Mol Pharmacol. 2003 Feb;63(2):351-8. [Article] Hopper-Borge E, Chen ZS, Shchaveleva I, Belinsky MG, Kruh GD: Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel. Cancer Res. 2004 Jul 15;64(14):4927-30. [Article] Cantin GT, Yi W, Lu B, Park SK, Xu T, Lee JD, Yates JR 3rd: Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis. J Proteome Res. 2008 Mar;7(3):1346-51. doi: 10.1021/pr0705441. Epub 2008 Jan 26. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00541Vincristineapproved, investigationalunknownsubstrateinhibitorDetailsDB00661VerapamilapprovedunknowninhibitorDetailsDB01229Paclitaxelapproved, vet_approvedunknownsubstrateinhibitorDetailsDB04348Taurocholic acidapproved, experimentalunknowninhibitorDetailsDB00203Sildenafilapproved, investigationalunknowninhibitorDetailsDB00563MethotrexateapprovedunknowninhibitorDetailsDB00773EtoposideapprovedunknownsubstrateinhibitorDetailsDB00997Doxorubicinapproved, investigationalunknowninhibitorDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00783Estradiolapproved, investigational, vet_approvedunknowninhibitorDetailsDB00987Cytarabineapproved, investigationalunknownsubstrateDetailsDB00694DaunorubicinapprovedunknownsubstrateDetailsDB01248Docetaxelapproved, investigationalunknownsubstrateDetailsDB00441GemcitabineapprovednosubstrateDetailsDB00300Tenofovir disoproxilapproved, investigationalunknownsubstrateDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknowninhibitorDetails"
                    }
                },
                {
                    "Label": "Solute carrier organic anion transporter family member 1B1",
                    "Detailed Info": {
                        "Name": "Solute carrier organic anion transporter family member 1B1",
                        "Synonyms": "Liver-specific organic anion transporter 1\nLST-1\nLST1\nOATP-2\nOATP-C\nOATP1B1\nOATP2\nOATPC\nSLC21A6\nSodium-independent organic anion-transporting polypeptide 2\nSolute carrier family 21 member 6",
                        "Gene Name": "SLCO1B1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0010701|Solute carrier organic anion transporter family member 1B1\nMDQNQHLNKTAEAQPSENKKTRYCNGLKMFLAALSLSFIAKTLGAIIMKSSIIHIERRFE\nISSSLVGFIDGSFEIGNLLVIVFVSYFGSKLHRPKLIGIGCFIMGIGGVLTALPHFFMGY\nYRYSKETNINSSENSTSTLSTCLINQILSLNRASPEIVGKGCLKESGSYMWIYVFMGNML\nRGIGETPIVPLGLSYIDDFAKEGHSSLYLGILNAIAMIGPIIGFTLGSLFSKMYVDIGYV\nDLSTIRITPTDSRWVGAWWLNFLVSGLFSIISSIPFFFLPQTPNKPQKERKASLSLHVLE\nTNDEKDQTANLTNQGKNITKNVTGFFQSFKSILTNPLYVMFVLLTLLQVSSYIGAFTYVF\nKYVEQQYGQPSSKANILLGVITIPIFASGMFLGGYIIKKFKLNTVGIAKFSCFTAVMSLS\nFYLLYFFILCENKSVAGLTMTYDGNNPVTSHRDVPLSYCNSDCNCDESQWEPVCGNNGIT\nYISPCLAGCKSSSGNKKPIVFYNCSCLEVTGLQNRNYSAHLGECPRDDACTRKFYFFVAI\nQVLNLFFSALGGTSHVMLIVKIVQPELKSLALGFHSMVIRALGGILAPIYFGALIDTTCI\nKWSTNNCGTRGSCRTYNSTSFSRVYLGLSSMLRVSSLVLYIILIYAMKKKYQEKDINASE\nNGSVMDEANLESLNKNKHFVPSAGADSETHC",
                        "Number of residues": "691",
                        "Molecular Weight": "76447.99",
                        "Theoretical pI": "8.68",
                        "GO Classification": "Functionsbile acid transmembrane transporter activity / sodium-independent organic anion transmembrane transporter activityProcessesanion transmembrane transport / bile acid and bile salt transport / bile acid metabolic process / organic anion transport / small molecule metabolic process / sodium-independent organic anion transport / transmembrane transportComponentsbasolateral plasma membrane / integral component of plasma membrane / membrane / plasma membrane",
                        "General Function": "Sodium-independent organic anion transmembrane transporter activity",
                        "Specific Function": "Mediates the Na(+)-independent uptake of organic anions such as pravastatin, taurocholate, methotrexate, dehydroepiandrosterone sulfate, 17-beta-glucuronosyl estradiol, estrone sulfate, prostaglandin E2, thromboxane B2, leukotriene C3, leukotriene E4, thyroxine and triiodothyronine. Involved in the clearance of bile acids and organic anions from the liver.",
                        "Pfam Domain Function": "Kazal_2 (PF07648)\nOATP (PF03137)",
                        "Transmembrane Regions": "29-48\n68-88\n95-119\n169-197\n217-237\n256-280\n332-353\n374-397\n402-425\n538-560\n570-595\n630-647",
                        "Cellular Location": "Basolateral cell membrane",
                        "Gene sequence": ">lcl|BSEQ0010702|Solute carrier organic anion transporter family member 1B1 (SLCO1B1)\nATGGACCAAAATCAACATTTGAATAAAACAGCAGAGGCACAACCTTCAGAGAATAAGAAA\nACAAGATACTGCAATGGATTGAAGATGTTCTTGGCAGCTCTGTCACTCAGCTTTATTGCT\nAAGACACTAGGTGCAATTATTATGAAAAGTTCCATCATTCATATAGAACGGAGATTTGAG\nATATCCTCTTCTCTTGTTGGTTTTATTGACGGAAGCTTTGAAATTGGAAATTTGCTTGTG\nATTGTATTTGTGAGTTACTTTGGATCCAAACTACATAGACCAAAGTTAATTGGAATCGGT\nTGTTTCATTATGGGAATTGGAGGTGTTTTGACTGCTTTGCCACATTTCTTCATGGGATAT\nTACAGGTATTCTAAAGAAACTAATATCAATTCATCAGAAAATTCAACATCGACCTTATCC\nACTTGTTTAATTAATCAAATTTTATCACTCAATAGAGCATCACCTGAGATAGTGGGAAAA\nGGTTGTTTAAAGGAATCTGGGTCATACATGTGGATATATGTGTTCATGGGTAATATGCTT\nCGTGGAATAGGGGAGACTCCCATAGTACCATTGGGGCTTTCTTACATTGATGATTTCGCT\nAAAGAAGGACATTCTTCTTTGTATTTAGGTATATTGAATGCAATAGCAATGATTGGTCCA\nATCATTGGCTTTACCCTGGGATCTCTGTTTTCTAAAATGTACGTGGATATTGGATATGTA\nGATCTAAGCACTATCAGGATAACTCCTACTGATTCTCGATGGGTTGGAGCTTGGTGGCTT\nAATTTCCTTGTGTCTGGACTATTCTCCATTATTTCTTCCATACCATTCTTTTTCTTGCCC\nCAAACTCCAAATAAACCACAAAAAGAAAGAAAAGCTTCACTGTCTTTGCATGTGCTGGAA\nACAAATGATGAAAAGGATCAAACAGCTAATTTGACCAATCAAGGAAAAAATATTACCAAA\nAATGTGACTGGTTTTTTCCAGTCTTTTAAAAGCATCCTTACTAATCCCCTGTATGTTATG\nTTTGTGCTTTTGACGTTGTTACAAGTAAGCAGCTATATTGGTGCTTTTACTTATGTCTTC\nAAATACGTAGAGCAACAGTATGGTCAGCCTTCATCTAAGGCTAACATCTTATTGGGAGTC\nATAACCATACCTATTTTTGCAAGTGGAATGTTTTTAGGAGGATATATCATTAAAAAATTC\nAAACTGAACACCGTTGGAATTGCCAAATTCTCATGTTTTACTGCTGTGATGTCATTGTCC\nTTTTACCTATTATATTTTTTCATACTCTGTGAAAACAAATCAGTTGCCGGACTAACCATG\nACCTATGATGGAAATAATCCAGTGACATCTCATAGAGATGTACCACTTTCTTATTGCAAC\nTCAGACTGCAATTGTGATGAAAGTCAATGGGAACCAGTCTGTGGAAACAATGGAATAACT\nTACATCTCACCCTGTCTAGCAGGTTGCAAATCTTCAAGTGGCAATAAAAAGCCTATAGTG\nTTTTACAACTGCAGTTGTTTGGAAGTAACTGGTCTCCAGAACAGAAATTACTCAGCCCAT\nTTGGGTGAATGCCCAAGAGATGATGCTTGTACAAGGAAATTTTACTTTTTTGTTGCAATA\nCAAGTCTTGAATTTATTTTTCTCTGCACTTGGAGGCACCTCACATGTCATGCTGATTGTT\nAAAATTGTTCAACCTGAATTGAAATCACTTGCACTGGGTTTCCACTCAATGGTTATACGA\nGCACTAGGAGGAATTCTAGCTCCAATATATTTTGGGGCTCTGATTGATACAACGTGTATA\nAAGTGGTCCACCAACAACTGTGGCACACGTGGGTCATGTAGGACATATAATTCCACATCA\nTTTTCAAGGGTCTACTTGGGCTTGTCTTCAATGTTAAGAGTCTCATCACTTGTTTTATAT\nATTATATTAATTTATGCCATGAAGAAAAAATATCAAGAGAAAGATATCAATGCATCAGAA\nAATGGAAGTGTCATGGATGAAGCAAACTTAGAATCCTTAAATAAAAATAAACATTTTGTC\nCCTTCTGCTGGGGCAGATAGTGAAACACATTGTTAA",
                        "Chromosome Location": "12",
                        "Locus": "12p",
                        "External Identifiers": "ResourceLinkUniProtKB IDQ9Y6L6UniProtKB Entry NameSO1B1_HUMANGenBank Protein ID5051630GenBank Gene IDAF060500GenAtlas IDSLCO1B1HGNC IDHGNC:10959",
                        "General References": "Abe T, Kakyo M, Tokui T, Nakagomi R, Nishio T, Nakai D, Nomura H, Unno M, Suzuki M, Naitoh T, Matsuno S, Yawo H: Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J Biol Chem. 1999 Jun 11;274(24):17159-63. [Article] Hsiang B, Zhu Y, Wang Z, Wu Y, Sasseville V, Yang WP, Kirchgessner TG: A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters. J Biol Chem. 1999 Dec 24;274(52):37161-8. [Article] Konig J, Cui Y, Nies AT, Keppler D: A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am J Physiol Gastrointest Liver Physiol. 2000 Jan;278(1):G156-64. [Article] Konig J, Cui Y, Nies AT, Keppler D: Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J Biol Chem. 2000 Jul 28;275(30):23161-8. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article] van de Steeg E, Stranecky V, Hartmannova H, Noskova L, Hrebicek M, Wagenaar E, van Esch A, de Waart DR, Oude Elferink RP, Kenworthy KE, Sticova E, al-Edreesi M, Knisely AS, Kmoch S, Jirsa M, Schinkel AH: Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver. J Clin Invest. 2012 Feb;122(2):519-28. doi: 10.1172/JCI59526. Epub 2012 Jan 9. [Article] Yao J, Hong W, Huang J, Zhan K, Huang H, Hong M: N-Glycosylation dictates proper processing of organic anion transporting polypeptide 1B1. PLoS One. 2012;7(12):e52563. doi: 10.1371/journal.pone.0052563. Epub 2012 Dec 20. [Article] Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62. doi: 10.1016/j.jprot.2013.11.014. Epub 2013 Nov 22. [Article] Tirona RG, Leake BF, Merino G, Kim RB: Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans. J Biol Chem. 2001 Sep 21;276(38):35669-75. Epub 2001 Jul 26. [Article] Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23. [Article] Nozawa T, Nakajima M, Tamai I, Noda K, Nezu J, Sai Y, Tsuji A, Yokoi T: Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis. J Pharmacol Exp Ther. 2002 Aug;302(2):804-13. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB04348Taurocholic acidapproved, experimentalunknownsubstrateinhibitorinducerDetailsDB02659Cholic AcidapprovedunknownsubstrateinhibitorinducerDetailsDB00199Erythromycinapproved, investigational, vet_approvednosubstrateinhibitorDetailsDB01045RifampicinapprovedunknowninhibitorDetailsDB00286Conjugated estrogensapprovedunknownsubstrateinhibitorDetailsDB00655EstroneapprovedunknowninhibitorDetailsDB00783Estradiolapproved, investigational, vet_approvedunknowninhibitorDetailsDB01232Saquinavirapproved, investigationalunknowninhibitorDetailsDB00503Ritonavirapproved, investigationalunknowninhibitorDetailsDB00220NelfinavirapprovednoinhibitorDetailsDB00224IndinavirapprovedunknowninhibitorDetailsDB01892HyperforinnutraceuticalunknowninhibitorDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00908Quinidineapproved, investigationalunknowninhibitorDetailsDB00583Levocarnitineapproved, investigationalunknowninhibitorDetailsDB00877Sirolimusapproved, investigationalnoinhibitorDetailsDB00641SimvastatinapprovedunknownsubstrateinhibitorDetailsDB00227Lovastatinapproved, investigationalunknownsubstrateinhibitorDetailsDB01076AtorvastatinapprovednosubstrateinhibitorDetailsDB00197Troglitazoneapproved, investigational, withdrawnunknowninhibitorDetailsDB00412Rosiglitazoneapproved, investigationalunknowninhibitorDetailsDB01132Pioglitazoneapproved, investigationalunknowninhibitorDetailsDB00762Irinotecanapproved, investigationalunknowninhibitorDetailsDB00520CaspofunginapprovedunknowninhibitorDetailsDB00175PravastatinapprovednosubstrateDetailsDB01393Bezafibrateapproved, investigationalunknowninhibitorDetailsDB06151Acetylcysteineapproved, investigationalunknowninhibitorDetailsDB00661VerapamilapprovedunknowninhibitorDetailsDB00917DinoprostoneapprovedunknownsubstrateDetailsDB01053Benzylpenicillinapproved, vet_approvedunknownsubstrateDetailsDB00563MethotrexateapprovedunknownsubstrateDetailsDB00279Liothyronineapproved, vet_approvedunknownsubstrateDetailsDB00439Cerivastatinapproved, withdrawnunknownsubstrateinhibitorDetailsDB00275Olmesartanapproved, investigationalunknownsubstrateDetailsDB00669Sumatriptanapproved, investigationalunknownsubstrateDetailsDB01092OuabainapprovedunknownsubstrateinhibitorDetailsDB00390DigoxinapprovedunknownsubstrateinhibitorDetailsDB00859PenicillamineapprovedunknownsubstrateDetailsDB00177Valsartanapproved, investigationalunknownsubstrateinhibitorDetailsDB06721GimatecaninvestigationalunknownsubstrateDetailsDB01583LiotrixapprovedunknownsubstrateDetailsDB06210EltrombopagapprovedunknowninhibitorDetailsDB00973EzetimibeapprovedunknownsubstrateDetailsDB02691Glycocholic acidexperimental, investigationalunknownDetailsDB05804Prasterone sulfateinvestigationalunknownDetailsDB00451LevothyroxineapprovedunknowninhibitorDetailsDB00509Dextrothyroxineapproved, investigationalunknownDetailsDB00950Fexofenadineapproved, investigationalunknownsubstrateDetailsDB08855Leukotriene C4experimental, investigationalunknownDetailsDB08856DADLEexperimentalunknownDetailsDB08857Bamet-UD2experimentalunknownDetailsDB08858cis-Diamminechlorocholylglycinateplatinum(II)experimentalunknownDetailsDB01095FluvastatinapprovedunknownsubstrateinhibitorDetailsDB08860PitavastatinapprovedunknownsubstrateinhibitorDetailsDB06589PazopanibapprovedunknowninhibitorDetailsDB06772CabazitaxelapprovedunknowninhibitorDetailsDB08864RilpivirineapprovedunknowninhibitorDetailsDB08884Gadoxetic acidapprovedunknownsubstrateDetailsDB06626Axitinibapproved, investigationalnosubstrateinhibitorDetailsDB08912Dabrafenibapproved, investigationalnosubstrateinhibitorDetailsDB00912Repaglinideapproved, investigationalunknownsubstrateDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB01098RosuvastatinapprovedunknownsubstrateinhibitorDetailsDB06290SimeprevirapprovedunknownsubstrateinhibitorDetailsDB04850PosizolidinvestigationalunknowninhibitorDetailsDB01211ClarithromycinapprovedunknownDetailsDB09054IdelalisibapprovednoinhibitorDetailsDB09272Eluxadolineapproved, investigationalunknownsubstrateinhibitorDetailsDB09292SacubitrilapprovedunknowninhibitorDetailsDB09102Daclatasvirapproved, investigationalunknowninhibitorDetailsDB05239Cobimetinibapproved, investigationalnoweak inhibitorDetailsDB11362SelexipagapprovednosubstrateDetailsDB06403Ambrisentanapproved, investigationalunknownsubstrateDetailsDB11575GrazoprevirapprovednosubstrateDetailsDB09137Technetium Tc-99m mebrofeninapprovednosubstrateDetailsDB13139Levosalbutamolapproved, investigationalnosubstrateDetailsDB13153Levomenolapproved, experimentalunknownsubstrateDetailsDB11613Velpatasvirapproved, investigationalnoinhibitortransporterDetailsDB05521Telaprevirapproved, withdrawnunknowninhibitorDetailsDB09198LobeglitazoneexperimentalnoinhibitorDetailsDB12026Voxilaprevirapproved, investigationalnosubstrateinhibitorDetailsDB13874Enasidenibapproved, investigationalunknowninhibitorDetailsDB13878Pibrentasvirapproved, investigationalunknowninhibitorDetailsDB13879Glecaprevirapproved, investigationalunknownsubstrateinhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateinhibitorDetailsDB12332Rucaparibapproved, investigationalnoinhibitorDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknowninhibitorDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknowninhibitorDetailsDB11901Apalutamideapproved, investigationalunknowninducerDetailsDB09297Paritaprevirapproved, investigationalunknownsubstrateinhibitorDetailsDB00975DipyridamoleapprovedunknowninhibitorDetailsDB01072Atazanavirapproved, investigationalunknowninhibitorDetailsDB00541Vincristineapproved, investigationalunknowninhibitorDetailsDB12319Benzbromaroneinvestigational, withdrawnunknowninhibitorDetailsDB08862Cholecystokininapproved, investigationalunknownsubstrateinhibitorDetailsDB00255Diethylstilbestrolapproved, investigational, withdrawnunknowninhibitorDetailsDB01645GenisteininvestigationalunknowninhibitorDetailsDB00602Ivermectinapproved, investigational, vet_approvedunknowninhibitorDetailsDB01115NifedipineapprovedunknowninhibitorDetailsDB01051Novobiocinapproved, investigational, vet_approved, withdrawnunknowninhibitorDetailsDB00646Nystatinapproved, vet_approvedunknowninhibitorDetailsDB11869ValspodarinvestigationalunknowninhibitorDetailsDB00206Reserpineapproved, investigational, withdrawnunknowninhibitorDetailsDB09298Silibininexperimental, investigationalunknowninhibitorDetailsDB00795SulfasalazineapprovednoinhibitorDetailsDB00932Tipranavirapproved, investigationalunknowninhibitorDetailsDB01601LopinavirapprovedunknowninhibitorDetailsDB01264DarunavirapprovedunknowninhibitorDetailsDB00328Indomethacinapproved, investigationalunknowninhibitorDetailsDB00701Amprenavirapproved, investigationalunknowninhibitorDetailsDB00586Diclofenacapproved, vet_approvedunknowninhibitorDetailsDB04216Quercetinexperimental, investigationalunknowninhibitorDetailsDB00622Nicardipineapproved, investigationalunknowninhibitorDetailsDB00396Progesteroneapproved, vet_approvedunknowninhibitorDetailsDB00570VinblastineapprovedunknowninhibitorDetailsDB00468QuinineapprovedunknowninhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB13919CandesartanexperimentalunknowninhibitorDetailsDB09065CobicistatapprovedunknowninhibitorDetailsDB00976TelithromycinapprovedunknowninhibitorDetailsDB01590EverolimusapprovedunknowninhibitorDetailsDB00203Sildenafilapproved, investigationalunknowninhibitorDetailsDB00864Tacrolimusapproved, investigationalunknowninhibitorDetailsDB00398Sorafenibapproved, investigationalunknowninhibitorDetailsDB04868Nilotinibapproved, investigationalunknowninhibitorDetailsDB11586Asunaprevirapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB11979Elagolixapproved, investigationalunknownsubstrateDetailsDB13867Fluticasoneapproved, experimentalnoinhibitorDetailsDB08906Fluticasone furoateapprovednoinhibitorDetailsDB00588Fluticasone propionateapprovednoinhibitorDetailsDB09078Lenvatinibapproved, investigationalunknowninhibitorDetailsDB05928DovitinibinvestigationalunknowninhibitorDetailsDB08880TeriflunomideapprovedunknowninhibitorDetailsDB02703Fusidic acidapproved, investigationalunknownDetailsDB11753Rifamycinapproved, investigationalnoinhibitorDetailsDB11581Venetoclaxapproved, investigationalunknowninhibitorDetailsDB11855Revefenacinapproved, investigationalnosubstrateDetailsDB09279FimasartaninvestigationalunknownsubstrateDetailsDB00834Mifepristoneapproved, investigationalnoinhibitorDetailsDB00257Clotrimazoleapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00214TorasemideapprovednosubstrateDetailsDB13867Fluticasoneapproved, experimentalunknowninhibitorDetailsDB09299Tenofovir alafenamideapprovednosubstrateDetailsDB00481Raloxifeneapproved, investigationalunknownsubstrateDetailsDB00394Beclomethasone dipropionateapproved, investigationalunknowninhibitorDetailsDB12978Pexidartinibapproved, investigationalunknowninhibitorDetailsDB12500Fedratinibapproved, investigationalunknowninhibitorDetailsDB11757Istradefyllineapproved, investigationalunknowninhibitorDetailsDB01241GemfibrozilapprovedunknowninhibitorDetailsDB04855DronedaroneapprovednoinhibitorDetailsDB15444Elexacaftorapproved, investigationalnoinhibitorDetailsDB14962Trastuzumab deruxtecanapproved, investigationalunknownDetailsDB15091Upadacitinibapproved, investigationalnoinhibitorDetailsDB15328Ubrogepantapproved, investigationalunknownsubstrateinhibitorDetailsDB01211ClarithromycinapprovedunknowninhibitorDetailsDB12941Darolutamideapproved, investigationalunknowninhibitorDetailsDB00588Fluticasone propionateapprovedunknowninhibitorDetailsDB12457Rimegepantapproved, investigationalunknowninhibitorDetailsDB11837Osilodrostatapproved, investigationalunknowninhibitorDetailsDB11936Bempedoic acidapproved, investigationalunknowninhibitorDetailsDB01708Prasteroneapproved, investigational, nutraceuticalunknownsubstrateDetailsDB14761Remdesivirapproved, investigationalunknownsubstrateinhibitorDetailsDB09038EmpagliflozinapprovedunknownsubstrateDetailsDB09274Artesunateapproved, investigationalunknowninhibitorDetailsDB12674Lurbinectedinapproved, investigationalunknowninhibitorDetailsDB11796Fostemsavirapproved, investigationalunknowninhibitorDetailsDB15719Belantamab mafodotinapprovedunknownsubstrateDetailsDB15822Pralsetinibapproved, investigationalnoinhibitorDetailsDB06448Lonafarnibapproved, investigationalnoinhibitorDetailsDB06137Tirbanibulinapproved, investigationalnoinhibitorDetailsDB11632Opicaponeapproved, investigationalnoinhibitorDetailsDB08995Diosminapproved, investigationalunknowninhibitorDetailsDB11886Infigratinibapproved, investigationalnoinhibitorDetailsDB12151Brincidofovirapproved, investigationalnosubstrateinhibitorDetailsDB16703Belumosudilapproved, investigationalnoinhibitorDetailsDB15463Belzutifanapproved, investigationalnosubstrateDetailsDB12265Fexinidazoleapproved, investigationalunknowninhibitorDetailsDB16098Atogepantapproved, investigationalnosubstrateinhibitorDetailsDB06176Romidepsinapproved, investigationalnoinhibitorDetailsDB12597Asciminibapproved, investigationalunknowninhibitorDetailsDB15413Pafolacianineapproved, investigationalnosubstrateDetailsDB12713Sotagliflozinapproved, investigationalnoinhibitorDetailsDB15575Padeliporfinapproved, experimentalunknowninhibitorDetailsDB04847Roxadustatapproved, investigationalunknowninhibitorDetailsDB17083LinzagolixapprovednosubstrateinhibitorDetailsDB16267Olutasidenibapproved, investigationalnoinhibitorDetailsDB00244MesalazineapprovednosubstrateDetailsDB11682Daprodustatapproved, investigationalnoinhibitorDetailsDB06045Trofinetideapproved, investigationalunknowninhibitorDetailsDB16217Leniolisibapproved, investigationalnoinhibitorDetailsDB11712Tezacaftorapproved, investigationalnosubstrateinhibitorDetailsDB01005HydroxyureaapprovednosubstrateDetailsDB05812AbirateroneapprovedunknowninhibitorDetailsDB05467Palovaroteneapproved, investigationalnoinhibitorDetailsDB11763Momelotinibapproved, investigationalunknownsubstrateDetailsDB11718Encorafenibapproved, investigationalnoinhibitorDetailsDB12218Capivasertibapproved, investigationalnoinhibitorDetailsDB16826RepotrectinibinvestigationalnoinhibitorDetails"
                    }
                },
                {
                    "Label": "P-glycoprotein 1",
                    "Detailed Info": {
                        "Name": "Multidrug resistance protein 1",
                        "Synonyms": "3.6.3.44\nATP-binding cassette sub-family B member 1\nMDR1\nP-glycoprotein 1\nPGY1",
                        "Gene Name": "ABCB1",
                        "Organism": "Humans",
                        "Amino acid sequence": ">lcl|BSEQ0037114|Multidrug resistance protein 1\nMDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLYMVVGTLAAII\nHGAGLPLMMLVFGEMTDIFANAGNLEDLMSNITNRSDINDTGFFMNLEEDMTRYAYYYSG\nIGAGVLVAAYIQVSFWCLAAGRQIHKIRKQFFHAIMRQEIGWFDVHDVGELNTRLTDDVS\nKINEGIGDKIGMFFQSMATFFTGFIVGFTRGWKLTLVILAISPVLGLSAAVWAKILSSFT\nDKELLAYAKAGAVAEEVLAAIRTVIAFGGQKKELERYNKNLEEAKRIGIKKAITANISIG\nAAFLLIYASYALAFWYGTTLVLSGEYSIGQVLTVFFSVLIGAFSVGQASPSIEAFANARG\nAAYEIFKIIDNKPSIDSYSKSGHKPDNIKGNLEFRNVHFSYPSRKEVKILKGLNLKVQSG\nQTVALVGNSGCGKSTTVQLMQRLYDPTEGMVSVDGQDIRTINVRFLREIIGVVSQEPVLF\nATTIAENIRYGRENVTMDEIEKAVKEANAYDFIMKLPHKFDTLVGERGAQLSGGQKQRIA\nIARALVRNPKILLLDEATSALDTESEAVVQVALDKARKGRTTIVIAHRLSTVRNADVIAG\nFDDGVIVEKGNHDELMKEKGIYFKLVTMQTAGNEVELENAADESKSEIDALEMSSNDSRS\nSLIRKRSTRRSVRGSQAQDRKLSTKEALDESIPPVSFWRIMKLNLTEWPYFVVGVFCAII\nNGGLQPAFAIIFSKIIGVFTRIDDPETKRQNSNLFSLLFLALGIISFITFFLQGFTFGKA\nGEILTKRLRYMVFRSMLRQDVSWFDDPKNTTGALTTRLANDAAQVKGAIGSRLAVITQNI\nANLGTGIIISFIYGWQLTLLLLAIVPIIAIAGVVEMKMLSGQALKDKKELEGSGKIATEA\nIENFRTVVSLTQEQKFEHMYAQSLQVPYRNSLRKAHIFGITFSFTQAMMYFSYAGCFRFG\nAYLVAHKLMSFEDVLLVFSAVVFGAMAVGQVSSFAPDYAKAKISAAHIIMIIEKTPLIDS\nYSTEGLMPNTLEGNVTFGEVVFNYPTRPDIPVLQGLSLEVKKGQTLALVGSSGCGKSTVV\nQLLERFYDPLAGKVLLDGKEIKRLNVQWLRAHLGIVSQEPILFDCSIAENIAYGDNSRVV\nSQEEIVRAAKEANIHAFIESLPNKYSTKVGDKGTQLSGGQKQRIAIARALVRQPHILLLD\nEATSALDTESEKVVQEALDKAREGRTCIVIAHRLSTIQNADLIVVFQNGRVKEHGTHQQL\nLAQKGIYFSMVSVQAGTKRQ",
                        "Number of residues": "1280",
                        "Molecular Weight": "141477.255",
                        "Theoretical pI": "9.44",
                        "GO Classification": "FunctionsATP binding / ATPase activity, coupled to transmembrane movement of substances / transporter activity / xenobiotic-transporting ATPase activityProcessesdrug transmembrane transport / G2/M transition of mitotic cell cycle / response to drug / small molecule metabolic process / stem cell proliferation / transmembrane transport / transportComponentscell surface / extracellular exosome / integral component of membrane / membrane / plasma membrane",
                        "General Function": "Xenobiotic-transporting atpase activity",
                        "Specific Function": "Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells.",
                        "Pfam Domain Function": "ABC_tran (PF00005)\nABC_membrane (PF00664)",
                        "Transmembrane Regions": "45-67\n117-137\n187-208\n216-236\n293-316\n331-352\n712-732\n757-777\n833-853\n855-874\n935-957\n974-995",
                        "Cellular Location": "Cell membrane",
                        "Gene sequence": ">lcl|BSEQ0016291|Multidrug resistance protein 1 (ABCB1)\nATGGATCTTGAAGGGGACCGCAATGGAGGAGCAAAGAAGAAGAACTTTTTTAAACTGAAC\nAATAAAAGTGAAAAAGATAAGAAGGAAAAGAAACCAACTGTCAGTGTATTTTCAATGTTT\nCGCTATTCAAATTGGCTTGACAAGTTGTATATGGTGGTGGGAACTTTGGCTGCCATCATC\nCATGGGGCTGGACTTCCTCTCATGATGCTGGTGTTTGGAGAAATGACAGATATCTTTGCA\nAATGCAGGAAATTTAGAAGATCTGATGTCAAACATCACTAATAGAAGTGATATCAATGAT\nACAGGGTTCTTCATGAATCTGGAGGAAGACATGACCAGGTATGCCTATTATTACAGTGGA\nATTGGTGCTGGGGTGCTGGTTGCTGCTTACATTCAGGTTTCATTTTGGTGCCTGGCAGCT\nGGAAGACAAATACACAAAATTAGAAAACAGTTTTTTCATGCTATAATGCGACAGGAGATA\nGGCTGGTTTGATGTGCACGATGTTGGGGAGCTTAACACCCGACTTACAGATGATGTCTCC\nAAGATTAATGAAGGAATTGGTGACAAAATTGGAATGTTCTTTCAGTCAATGGCAACATTT\nTTCACTGGGTTTATAGTAGGATTTACACGTGGTTGGAAGCTAACCCTTGTGATTTTGGCC\nATCAGTCCTGTTCTTGGACTGTCAGCTGCTGTCTGGGCAAAGATACTATCTTCATTTACT\nGATAAAGAACTCTTAGCGTATGCAAAAGCTGGAGCAGTAGCTGAAGAGGTCTTGGCAGCA\nATTAGAACTGTGATTGCATTTGGAGGACAAAAGAAAGAACTTGAAAGGTACAACAAAAAT\nTTAGAAGAAGCTAAAAGAATTGGGATAAAGAAAGCTATTACAGCCAATATTTCTATAGGT\nGCTGCTTTCCTGCTGATCTATGCATCTTATGCTCTGGCCTTCTGGTATGGGACCACCTTG\nGTCCTCTCAGGGGAATATTCTATTGGACAAGTACTCACTGTATTCTTTTCTGTATTAATT\nGGGGCTTTTAGTGTTGGACAGGCATCTCCAAGCATTGAAGCATTTGCAAATGCAAGAGGA\nGCAGCTTATGAAATCTTCAAGATAATTGATAATAAGCCAAGTATTGACAGCTATTCGAAG\nAGTGGGCACAAACCAGATAATATTAAGGGAAATTTGGAATTCAGAAATGTTCACTTCAGT\nTACCCATCTCGAAAAGAAGTTAAGATCTTGAAGGGTCTGAACCTGAAGGTGCAGAGTGGG\nCAGACGGTGGCCCTGGTTGGAAACAGTGGCTGTGGGAAGAGCACAACAGTCCAGCTGATG\nCAGAGGCTCTATGACCCCACAGAGGGGATGGTCAGTGTTGATGGACAGGATATTAGGACC\nATAAATGTAAGGTTTCTACGGGAAATCATTGGTGTGGTGAGTCAGGAACCTGTATTGTTT\nGCCACCACGATAGCTGAAAACATTCGCTATGGCCGTGAAAATGTCACCATGGATGAGATT\nGAGAAAGCTGTCAAGGAAGCCAATGCCTATGACTTTATCATGAAACTGCCTCATAAATTT\nGACACCCTGGTTGGAGAGAGAGGGGCCCAGTTGAGTGGTGGGCAGAAGCAGAGGATCGCC\nATTGCACGTGCCCTGGTTCGCAACCCCAAGATCCTCCTGCTGGATGAGGCCACGTCAGCC\nTTGGACACAGAAAGCGAAGCAGTGGTTCAGGTGGCTCTGGATAAGGCCAGAAAAGGTCGG\nACCACCATTGTGATAGCTCATCGTTTGTCTACAGTTCGTAATGCTGACGTCATCGCTGGT\nTTCGATGATGGAGTCATTGTGGAGAAAGGAAATCATGATGAACTCATGAAAGAGAAAGGC\nATTTACTTCAAACTTGTCACAATGCAGACAGCAGGAAATGAAGTTGAATTAGAAAATGCA\nGCTGATGAATCCAAAAGTGAAATTGATGCCTTGGAAATGTCTTCAAATGATTCAAGATCC\nAGTCTAATAAGAAAAAGATCAACTCGTAGGAGTGTCCGTGGATCACAAGCCCAAGACAGA\nAAGCTTAGTACCAAAGAGGCTCTGGATGAAAGTATACCTCCAGTTTCCTTTTGGAGGATT\nATGAAGCTAAATTTAACTGAATGGCCTTATTTTGTTGTTGGTGTATTTTGTGCCATTATA\nAATGGAGGCCTGCAACCAGCATTTGCAATAATATTTTCAAAGATTATAGGGGTTTTTACA\nAGAATTGATGATCCTGAAACAAAACGACAGAATAGTAACTTGTTTTCACTATTGTTTCTA\nGCCCTTGGAATTATTTCTTTTATTACATTTTTCCTTCAGGGTTTCACATTTGGCAAAGCT\nGGAGAGATCCTCACCAAGCGGCTCCGATACATGGTTTTCCGATCCATGCTCAGACAGGAT\nGTGAGTTGGTTTGATGACCCTAAAAACACCACTGGAGCATTGACTACCAGGCTCGCCAAT\nGATGCTGCTCAAGTTAAAGGGGCTATAGGTTCCAGGCTTGCTGTAATTACCCAGAATATA\nGCAAATCTTGGGACAGGAATAATTATATCCTTCATCTATGGTTGGCAACTAACACTGTTA\nCTCTTAGCAATTGTACCCATCATTGCAATAGCAGGAGTTGTTGAAATGAAAATGTTGTCT\nGGACAAGCACTGAAAGATAAGAAAGAACTAGAAGGTTCTGGGAAGATCGCTACTGAAGCA\nATAGAAAACTTCCGAACCGTTGTTTCTTTGACTCAGGAGCAGAAGTTTGAACATATGTAT\nGCTCAGAGTTTGCAGGTACCATACAGAAACTCTTTGAGGAAAGCACACATCTTTGGAATT\nACATTTTCCTTCACCCAGGCAATGATGTATTTTTCCTATGCTGGATGTTTCCGGTTTGGA\nGCCTACTTGGTGGCACATAAACTCATGAGCTTTGAGGATGTTCTGTTAGTATTTTCAGCT\nGTTGTCTTTGGTGCCATGGCCGTGGGGCAAGTCAGTTCATTTGCTCCTGACTATGCCAAA\nGCCAAAATATCAGCAGCCCACATCATCATGATCATTGAAAAAACCCCTTTGATTGACAGC\nTACAGCACGGAAGGCCTAATGCCGAACACATTGGAAGGAAATGTCACATTTGGTGAAGTT\nGTATTCAACTATCCCACCCGACCGGACATCCCAGTGCTTCAGGGACTGAGCCTGGAGGTG\nAAGAAGGGCCAGACGCTGGCTCTGGTGGGCAGCAGTGGCTGTGGGAAGAGCACAGTGGTC\nCAGCTCCTGGAGCGGTTCTACGACCCCTTGGCAGGGAAAGTGCTGCTTGATGGCAAAGAA\nATAAAGCGACTGAATGTTCAGTGGCTCCGAGCACACCTGGGCATCGTGTCCCAGGAGCCC\nATCCTGTTTGACTGCAGCATTGCTGAGAACATTGCCTATGGAGACAACAGCCGGGTGGTG\nTCACAGGAAGAGATTGTGAGGGCAGCAAAGGAGGCCAACATACATGCCTTCATCGAGTCA\nCTGCCTAATAAATATAGCACTAAAGTAGGAGACAAAGGAACTCAGCTCTCTGGTGGCCAG\nAAACAACGCATTGCCATAGCTCGTGCCCTTGTTAGACAGCCTCATATTTTGCTTTTGGAT\nGAAGCCACGTCAGCTCTGGATACAGAAAGTGAAAAGGTTGTCCAAGAAGCCCTGGACAAA\nGCCAGAGAAGGCCGCACCTGCATTGTGATTGCTCACCGCCTGTCCACCATCCAGAATGCA\nGACTTAATAGTGGTGTTTCAGAATGGCAGAGTCAAGGAGCATGGCACGCATCAGCAGCTG\nCTGGCACAGAAAGGCATCTATTTTTCAATGGTCAGTGTCCAGGCTGGAACAAAGCGCCAG\nTGA",
                        "Chromosome Location": "7",
                        "Locus": "7q21.1",
                        "External Identifiers": "ResourceLinkUniProtKB IDP08183UniProtKB Entry NameMDR1_HUMANGenBank Protein ID307180GenBank Gene IDM14758GenAtlas IDABCB1HGNC IDHGNC:40",
                        "General References": "Chen CJ, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, Roninson IB: Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell. 1986 Nov 7;47(3):381-9. [Article] Chen CJ, Clark D, Ueda K, Pastan I, Gottesman MM, Roninson IB: Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins. J Biol Chem. 1990 Jan 5;265(1):506-14. [Article] Chen G, Duran GE, Steger KA, Lacayo NJ, Jaffrezou JP, Dumontet C, Sikic BI: Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins. J Biol Chem. 1997 Feb 28;272(9):5974-82. [Article] Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21. [Article] Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, Wagner-McPherson C, Layman D, Maas J, Jaeger S, Walker R, Wylie K, Sekhon M, Becker MC, O'Laughlin MD, Schaller ME, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Cordes M, Du H, Sun H, Edwards J, Bradshaw-Cordum H, Ali J, Andrews S, Isak A, Vanbrunt A, Nguyen C, Du F, Lamar B, Courtney L, Kalicki J, Ozersky P, Bielicki L, Scott K, Holmes A, Harkins R, Harris A, Strong CM, Hou S, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Leonard S, Rohlfing T, Rock SM, Tin-Wollam AM, Abbott A, Minx P, Maupin R, Strowmatt C, Latreille P, Miller N, Johnson D, Murray J, Woessner JP, Wendl MC, Yang SP, Schultz BR, Wallis JW, Spieth J, Bieri TA, Nelson JO, Berkowicz N, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Bedell JA, Mardis ER, Clifton SW, Chissoe SL, Marra MA, Raymond C, Haugen E, Gillett W, Zhou Y, James R, Phelps K, Iadanoto S, Bubb K, Simms E, Levy R, Clendenning J, Kaul R, Kent WJ, Furey TS, Baertsch RA, Brent MR, Keibler E, Flicek P, Bork P, Suyama M, Bailey JA, Portnoy ME, Torrents D, Chinwalla AT, Gish WR, Eddy SR, McPherson JD, Olson MV, Eichler EE, Green ED, Waterston RH, Wilson RK: The DNA sequence of human chromosome 7. Nature. 2003 Jul 10;424(6945):157-64. [Article] Gekeler V, Weger S, Probst H: mdr1/P-glycoprotein gene segments analyzed from various human leukemic cell lines exhibiting different multidrug resistance profiles. Biochem Biophys Res Commun. 1990 Jun 15;169(2):796-802. [Article] Kioka N, Tsubota J, Kakehi Y, Komano T, Gottesman MM, Pastan I, Ueda K: P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance. Biochem Biophys Res Commun. 1989 Jul 14;162(1):224-31. [Article] Kerb R, Hoffmeyer S, Brinkmann U: ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2. Pharmacogenomics. 2001 Feb;2(1):51-64. [Article] Begley GS, Horvath AR, Taylor JC, Higgins CF: Cytoplasmic domains of the transporter associated with antigen processing and P-glycoprotein interact with subunits of the proteasome. Mol Immunol. 2005 Jan;42(1):137-41. [Article] Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP: A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7. doi: 10.1073/pnas.0805139105. Epub 2008 Jul 31. [Article] Burkard TR, Planyavsky M, Kaupe I, Breitwieser FP, Burckstummer T, Bennett KL, Superti-Furga G, Colinge J: Initial characterization of the human central proteome. BMC Syst Biol. 2011 Jan 26;5:17. doi: 10.1186/1752-0509-5-17. [Article] Katayama K, Yamaguchi M, Noguchi K, Sugimoto Y: Protein phosphatase complex PP5/PPP2R3C dephosphorylates P-glycoprotein/ABCB1 and down-regulates the expression and function. Cancer Lett. 2014 Apr 1;345(1):124-31. doi: 10.1016/j.canlet.2013.12.007. Epub 2013 Dec 11. [Article] Choi KH, Chen CJ, Kriegler M, Roninson IB: An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene. Cell. 1988 May 20;53(4):519-29. [Article] Mickley LA, Lee JS, Weng Z, Zhan Z, Alvarez M, Wilson W, Bates SE, Fojo T: Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors. Blood. 1998 Mar 1;91(5):1749-56. [Article] Decleves X, Chevillard S, Charpentier C, Vielh P, Laplanche JL: A new polymorphism (N21D) in the exon 2 of the human MDR1 gene encoding the P-glycoprotein. Hum Mutat. 2000 May;15(5):486. [Article] Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M, Brinkmann U: Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3473-8. [Article] Cascorbi I, Gerloff T, Johne A, Meisel C, Hoffmeyer S, Schwab M, Schaeffeler E, Eichelbaum M, Brinkmann U, Roots I: Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther. 2001 Mar;69(3):169-74. [Article] Honda T, Dan Y, Koyabu N, Ieiri I, Otsubo K, Higuchi S, Ohtani H, Sawada Y: Polymorphism of MDR1 gene in healthy japanese subjects: a novel SNP with an amino acid substitution (Glu108Lys). Drug Metab Pharmacokinet. 2002;17(5):479-81. [Article] Itoda M, Saito Y, Komamura K, Ueno K, Kamakura S, Ozawa S, Sawada J: Twelve novel single nucleotide polymorphisms in ABCB1/MDR1 among Japanese patients with ventricular tachycardia who were administered amiodarone. Drug Metab Pharmacokinet. 2002;17(6):566-71. [Article] Saito S, Iida A, Sekine A, Miura Y, Ogawa C, Kawauchi S, Higuchi S, Nakamura Y: Three hundred twenty-six genetic variations in genes encoding nine members of ATP-binding cassette, subfamily B (ABCB/MDR/TAP), in the Japanese population. J Hum Genet. 2002;47(1):38-50. [Article] Brant SR, Panhuysen CI, Nicolae D, Reddy DM, Bonen DK, Karaliukas R, Zhang L, Swanson E, Datta LW, Moran T, Ravenhill G, Duerr RH, Achkar JP, Karban AS, Cho JH: MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet. 2003 Dec;73(6):1282-92. Epub 2003 Nov 7. [Article] Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE: The consensus coding sequences of human breast and colorectal cancers. Science. 2006 Oct 13;314(5797):268-74. Epub 2006 Sep 7. [Article]",
                        "Drug Relations": "DrugBank IDNameDrug groupPharmacological action?ActionsDetailsDB00171ATPinvestigational, nutraceuticalunknownDetailsDB00778Roxithromycinapproved, investigational, withdrawnunknownDetailsDB04881ElacridarinvestigationalunknownDetailsDB04905TesmilifeneinvestigationalyesinducerDetailsDB05449FM-VP4investigationalunknownDetailsDB06240TariquidarinvestigationalunknownDetailsDB06191ZosuquidarinvestigationalyesinhibitorDetailsDB00661VerapamilapprovedunknownsubstrateinhibitorDetailsDB01232Saquinavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00220NelfinavirapprovednosubstrateinhibitorinducerDetailsDB00224IndinavirapprovedunknownsubstrateinhibitorinducerDetailsDB00701Amprenavirapproved, investigationalunknownsubstrateinducerDetailsDB01045RifampicinapprovedunknowninducerDetailsDB00206Reserpineapproved, investigational, withdrawnunknownsubstrateinhibitorinducerDetailsDB01115NifedipineapprovedunknownsubstrateinducerDetailsDB00834Mifepristoneapproved, investigationalunknowninhibitorinducerDetailsDB01234Dexamethasoneapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00257Clotrimazoleapproved, vet_approvedunknowninhibitorinducerDetailsDB00564Carbamazepineapproved, investigationalunknowninducerDetailsDB00656Trazodoneapproved, investigationalunknowninducerDetailsDB01149Nefazodoneapproved, withdrawnunknowninhibitorinducerDetailsDB00503Ritonavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00390DigoxinapprovedunknownsubstrateinhibitorinducerDetailsDB00279Liothyronineapproved, vet_approvedunknowninducerDetailsDB00451LevothyroxineapprovedunknowninducerDetailsDB00440Trimethoprimapproved, vet_approvedunknownsubstrateDetailsDB00396Progesteroneapproved, vet_approvedunknownsubstrateinhibitorinducerDetailsDB02261Platelet Activating FactorexperimentalunknownsubstrateinducerDetailsDB00091Cyclosporineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00501Cimetidineapproved, investigationalunknownsubstrateinducerDetailsDB04630Aldosteroneexperimental, investigationalunknownsubstrateinducerDetailsDB00864Tacrolimusapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00877Sirolimusapproved, investigationalnosubstrateinhibitorinducerDetailsDB01174Phenobarbitalapproved, investigationalunknownsubstrateinducerDetailsDB00199Erythromycinapproved, investigational, vet_approvednosubstrateinhibitorDetailsDB01118Amiodaroneapproved, investigationalunknowninhibitorinducerDetailsDB01323St. John's Wortapproved, investigational, nutraceuticalunknowninducerDetailsDB00541Vincristineapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00570VinblastineapprovedunknownsubstrateinhibitorinducerDetailsDB02659Cholic AcidapprovedunknowninducerDetailsDB00675TamoxifenapprovedunknownsubstrateinhibitorinducerDetailsDB00428Streptozocinapproved, investigationalunknowninducerDetailsDB01204Mitoxantroneapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00997Doxorubicinapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB00694DaunorubicinapprovedunknownsubstrateinhibitorinducerDetailsDB00908Quinidineapproved, investigationalunknownsubstrateinhibitorDetailsDB01026Ketoconazoleapproved, investigationalunknowninhibitorDetailsDB01388Mibefradilinvestigational, withdrawnunknownsubstrateinhibitorDetailsDB04540Cholesterolapproved, investigationalunknowninhibitorDetailsDB00358Mefloquineapproved, investigationalunknownsubstrateinhibitorDetailsDB00622Nicardipineapproved, investigationalunknownsubstrateinhibitorDetailsDB00381AmlodipineapprovedunknownsubstrateinhibitorDetailsDB00972AzelastineapprovedunknowninhibitorDetailsDB00863Ranitidineapproved, withdrawnunknownsubstrateinhibitorDetailsDB00773EtoposideapprovedunknownsubstrateinhibitorDetailsDB00333MethadoneapprovedunknowninhibitorDetailsDB00641SimvastatinapprovedunknowninhibitorDetailsDB00227Lovastatinapproved, investigationalunknowninhibitorDetailsDB01076AtorvastatinapprovednosubstrateinhibitorDetailsDB01229Paclitaxelapproved, vet_approvedunknownsubstrateinhibitorDetailsDB00457PrazosinapprovedunknownsubstrateinhibitormodulatorDetailsDB01054Nitrendipineapproved, investigationalunknowninhibitorDetailsDB00975DipyridamoleapprovedunknownsubstrateinhibitorDetailsDB00343Diltiazemapproved, investigationalunknownsubstrateinhibitorDetailsDB01394ColchicineapprovedunknownsubstrateinducerDetailsDB01211ClarithromycinapprovedunknownsubstrateinhibitorDetailsDB00477Chlorpromazineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00970Dactinomycinapproved, investigationalunknownsubstrateinhibitorDetailsDB13179TroleandomycinapprovedunknowninhibitorDetailsDB00831Trifluoperazineapproved, investigationalunknowninhibitorDetailsDB00342Terfenadineapproved, withdrawnunknowninhibitorDetailsDB00468QuinineapprovedunknownsubstrateinhibitorDetailsDB01167Itraconazoleapproved, investigationalunknowninhibitorDetailsDB00328Indomethacinapproved, investigationalunknownsubstrateinhibitorDetailsDB02587Colforsinexperimental, investigationalunknowninhibitorDetailsDB00623FluphenazineapprovedunknowninhibitorDetailsDB01023Felodipineapproved, investigationalunknowninhibitorDetailsDB01136Carvedilolapproved, investigationalunknowninhibitorDetailsDB00421SpironolactoneapprovedunknowninducerDetailsDB00281Lidocaineapproved, vet_approvedunknowninhibitorDetailsDB00537Ciprofloxacinapproved, investigationalunknownsubstrateDetailsDB00207AzithromycinapprovedunknownsubstrateinhibitorDetailsDB00316AcetaminophenapprovedunknownsubstrateinhibitorDetailsDB00196Fluconazoleapproved, investigationalunknowninhibitorDetailsDB00213PantoprazoleapprovedunknownsubstrateinhibitorDetailsDB00338Omeprazoleapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00448Lansoprazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00678LosartanapprovedunknownsubstrateinhibitorDetailsDB00584Enalaprilapproved, vet_approvedunknowninhibitorDetailsDB00590DoxazosinapprovedunknowninhibitorDetailsDB01340CilazaprilapprovedunknowninhibitorDetailsDB01197CaptoprilapprovedunknowninhibitorDetailsDB00796Candesartan cilexetilapprovedunknowninhibitorDetailsDB01110Miconazoleapproved, investigational, vet_approvedunknowninhibitorDetailsDB00696ErgotamineapprovedunknowninhibitorDetailsDB01253ErgometrineapprovedunknowninhibitorDetailsDB00320Dihydroergotamineapproved, investigationalunknowninhibitorDetailsDB01200Bromocriptineapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00836LoperamideapprovedunknownsubstrateDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedunknowninhibitorDetailsDB00802Alfentanilapproved, illicitunknowninhibitorDetailsDB00401NisoldipineapprovedunknowninhibitorDetailsDB04832Zimelidineapproved, withdrawnunknowninhibitorDetailsDB00382Tacrineapproved, investigational, withdrawnunknownsubstrateDetailsDB00669Sumatriptanapproved, investigationalunknownsubstrateDetailsDB01037Selegilineapproved, investigational, vet_approvedunknowninhibitorDetailsDB00458ImipramineapprovedunknownsubstrateDetailsDB00502HaloperidolapprovedunknownsubstrateinhibitorDetailsDB00176Fluvoxamineapproved, investigationalunknowninhibitorDetailsDB00690Flurazepamapproved, illicit, investigationalunknowninhibitorDetailsDB00472Fluoxetineapproved, vet_approvedunknowninhibitorDetailsDB01142Doxepinapproved, investigationalunknownsubstrateDetailsDB01151Desipramineapproved, investigationalunknowninhibitorDetailsDB01242Clomipramineapproved, investigational, vet_approvedunknowninhibitorDetailsDB01239Chlorprothixeneapproved, experimental, investigational, withdrawnunknowninhibitorDetailsDB00490Buspironeapproved, investigationalunknowninhibitorDetailsDB01100PimozideapprovedunknowninhibitorDetailsDB00295Morphineapproved, investigationalnosubstrateDetailsDB00602Ivermectinapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00741Hydrocortisoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00637Astemizoleapproved, withdrawnunknowninhibitorDetailsDB00508Triflupromazineapproved, vet_approvedunknowninhibitorDetailsDB00344ProtriptylineapprovedunknowninhibitorDetailsDB01069Promethazineapproved, investigationalunknowninhibitorDetailsDB01244Bepridilapproved, withdrawnunknowninhibitorDetailsDB00455Loratadineapproved, investigationalnosubstrateinhibitorDetailsDB00967Desloratadineapproved, investigationalunknowninhibitorDetailsDB00285VenlafaxineapprovedunknownsubstrateinhibitorDetailsDB01104SertralineapprovedunknowninhibitorDetailsDB00234Reboxetineapproved, experimentalunknowninhibitorDetailsDB00715Paroxetineapproved, investigationalunknowninhibitorDetailsDB00215CitalopramapprovedunknownsubstrateinhibitorDetailsDB01196Estramustineapproved, investigationalunknowninhibitorDetailsDB04348Taurocholic acidapproved, experimentalunknownsubstrateinhibitorDetailsDB00875Flupentixolapproved, investigational, withdrawnunknowninhibitorDetailsDB00351Megestrol acetateapproved, investigational, vet_approvedunknowninhibitorDetailsDB02010StaurosporineexperimentalunknowninhibitorDetailsDB01103QuinacrineinvestigationalunknowninhibitorDetailsDB01645GenisteininvestigationalunknowninhibitorDetailsDB04216Quercetinexperimental, investigationalunknowninhibitorDetailsDB01137Levofloxacinapproved, investigationalunknownsubstrateinhibitorDetailsDB03467NaringeninexperimentalunknowndownregulatorDetailsDB01016GlyburideapprovedunknowninhibitorDetailsDB00950Fexofenadineapproved, investigationalunknownsubstrateDetailsDB00726TrimipramineapprovedunknownsubstrateDetailsDB00571Propranololapproved, investigationalunknownsubstrateDetailsDB00635Prednisoneapproved, vet_approvedunknownsubstrateinducerDetailsDB00276Amsacrineapproved, investigationalunknowninhibitorDetailsDB00027Gramicidin DapprovedunknownsubstrateinhibitorDetailsDB01086Benzocaineapproved, investigationalunknowninhibitorDetailsDB01601LopinavirapprovedunknowninhibitorinducerDetailsDB00520CaspofunginapprovedunknowninhibitorDetailsDB00175PravastatinapprovednosubstrateDetailsDB00619ImatinibapprovednosubstrateinhibitorDetailsDB00398Sorafenibapproved, investigationalunknownsubstrateinhibitorDetailsDB01268Sunitinibapproved, investigationalunknowninhibitorDetailsDB01162TerazosinapprovedunknowninhibitorDetailsDB00470Dronabinolapproved, illicitunknowninhibitorDetailsDB00921Buprenorphineapproved, illicit, investigational, vet_approvedunknowninhibitorDetailsDB00966Telmisartanapproved, investigationalunknowninhibitorDetailsDB01254Dasatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00317Gefitinibapproved, investigationalunknownsubstrateinhibitorDetailsDB04868Nilotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00655EstroneapprovedunknownsubstrateinducerDetailsDB01259Lapatinibapproved, investigationalunknowninhibitorDetailsDB01263Posaconazoleapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00365Grepafloxacinapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB00829Diazepamapproved, illicit, investigational, vet_approvedunknownsubstrateDetailsDB01396Digitoxinapproved, investigationalunknownsubstrateDetailsDB01208Sparfloxacinapproved, investigational, withdrawnunknownsubstrateDetailsDB00959Methylprednisoloneapproved, vet_approvedunknownsubstrateinducerDetailsDB01224QuetiapineapprovedunknownsubstrateDetailsDB00334Olanzapineapproved, investigationalnosubstrateDetailsDB00363ClozapineapprovedunknownsubstrateDetailsDB01183Naloxoneapproved, vet_approvedunknownsubstrateDetailsDB04690CamptothecinexperimentalunknownsubstrateDetailsDB00860Prednisoloneapproved, vet_approvedunknownsubstrateDetailsDB01193Acebutololapproved, investigationalunknownsubstrateDetailsDB01050IbuprofenapprovedunknownsubstrateDetailsDB00945Acetylsalicylic acidapproved, vet_approvedunknownsubstrateinducermodulatorDetailsDB01184Domperidoneapproved, investigational, vet_approvedunknownsubstrateDetailsDB00443Betamethasoneapproved, vet_approvedunknownsubstrateDetailsDB00539Toremifeneapproved, investigationalunknownsubstrateDetailsDB00255Diethylstilbestrolapproved, investigational, withdrawnunknownsubstrateDetailsDB00882Clomifeneapproved, investigationalunknownsubstrateDetailsDB00783Estradiolapproved, investigational, vet_approvedunknownsubstratedownregulatorregulatorDetailsDB01248Docetaxelapproved, investigationalunknownsubstrateDetailsDB00563MethotrexateapprovedunknownsubstrateDetailsDB00373TimololapprovedunknownsubstrateDetailsDB01203NadololapprovedunknownsubstrateDetailsDB00523Alitretinoinapproved, investigationalunknownsubstrateDetailsDB01339Vecuroniumapproved, investigationalunknownsubstrateDetailsDB04840Debrisoquineapproved, investigationalunknownsubstrateDetailsDB00441GemcitabineapprovednosubstrateDetailsDB01030Topotecanapproved, investigationalunknownsubstrateDetailsDB02901Stanoloneillicit, investigationalunknownsubstrateDetailsDB00751Epinastineapproved, investigationalunknownsubstrateDetailsDB00717NorethisteroneapprovedunknowninhibitorDetailsDB04573Estriolapproved, investigational, vet_approvedunknownsubstrateinducerDetailsDB03203SphingosineexperimentalunknownsubstrateDetailsDB00439Cerivastatinapproved, withdrawnunknownsubstrateDetailsDB00286Conjugated estrogensapprovedunknownsubstrateDetailsDB01202LevetiracetamapprovedunknownsubstrateDetailsDB00252Phenytoinapproved, vet_approvedunknownsubstrateDetailsDB00585NizatidineapprovedunknownsubstrateDetailsDB00530Erlotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB00555Lamotrigineapproved, investigationalunknownsubstrateinhibitorDetailsDB01261Sitagliptinapproved, investigationalunknownsubstrateDetailsDB01072Atazanavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB01169Arsenic trioxideapproved, investigationalunknowninhibitorDetailsDB06772CabazitaxelapprovedunknownsubstrateinhibitorDetailsDB01583LiotrixapprovedunknowninducerDetailsDB06287TemsirolimusapprovedunknownsubstrateinhibitorDetailsDB01587KetazolamapprovedunknownsubstrateDetailsDB04877VoacamineexperimentalunknowninhibitorDetailsDB00977EthinylestradiolapprovedunknownsubstrateDetailsDB01182PropafenoneapprovedunknowninhibitorDetailsDB00216Eletriptanapproved, investigationalunknownsubstrateDetailsDB04855DronedaroneapprovednoinhibitorDetailsDB06176Romidepsinapproved, investigationalunknownsubstrateDetailsDB06207SilodosinapprovedunknownsubstrateDetailsDB06414EtravirineapprovedunknowninhibitorDetailsDB06228RivaroxabanapprovedunknownsubstrateDetailsDB06695Dabigatran etexilateapprovedunknownsubstrateDetailsDB00973EzetimibeapprovedunknownsubstrateDetailsDB06702FesoterodineapprovedunknownsubstrateDetailsDB06212TolvaptanapprovednosubstrateinhibitorDetailsDB08860PitavastatinapprovedunknownsubstrateDetailsDB06589PazopanibapprovedunknownsubstrateDetailsDB08864RilpivirineapprovedunknowninhibitorDetailsDB08873Boceprevirapproved, withdrawnunknowninhibitorDetailsDB05521Telaprevirapproved, withdrawnunknownsubstrateinhibitorDetailsDB08874FidaxomicinapprovednosubstrateDetailsDB05039IndacaterolapprovedunknownsubstrateDetailsDB00349Clobazamapproved, illicitnosubstrateDetailsDB08882LinagliptinapprovedunknownsubstrateDetailsDB08827Lomitapideapproved, investigationalnoinhibitorDetailsDB08816TicagrelorapprovedunknownsubstrateinhibitorDetailsDB08865Crizotinibapproved, investigationalunknownsubstrateinhibitorDetailsDB06605ApixabanapprovedunknownsubstrateDetailsDB06626Axitinibapproved, investigationalnosubstrateinhibitorDetailsDB08828Vismodegibapproved, investigationalunknownsubstrateDetailsDB08889Carfilzomibapproved, investigationalunknownsubstrateinhibitorDetailsDB08893MirabegronapprovedunknownsubstrateinhibitorDetailsDB08896RegorafenibapprovedunknownsubstrateinhibitorDetailsDB08899EnzalutamideapprovednoinhibitorDetailsDB08820IvacaftorapprovednoinhibitorDetailsDB06616BosutinibapprovednosubstrateDetailsDB08901Ponatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB08906Fluticasone furoateapprovednosubstrateinducerDetailsDB08907CanagliflozinapprovedunknownsubstrateinhibitorDetailsDB08910PomalidomideapprovedunknownsubstrateDetailsDB00480LenalidomideapprovednosubstrateDetailsDB08912Dabrafenibapproved, investigationalnosubstrateDetailsDB05773Trastuzumab emtansineapproved, investigationalunknownsubstrateDetailsDB00495ZidovudineapprovedunknownsubstrateDetailsDB00758ClopidogrelapprovednosubstrateDetailsDB08916AfatinibapprovedunknownsubstrateinhibitorDetailsDB00762Irinotecanapproved, investigationalunknownsubstrateDetailsDB00709Lamivudineapproved, investigationalunknownsubstrateDetailsDB00688Mycophenolate mofetilapproved, investigationalunknownsubstrateDetailsDB08918Levomilnacipranapproved, investigationalunknownsubstrateDetailsDB06290SimeprevirapprovedunknownsubstrateinhibitorDetailsDB08934SofosbuvirapprovednosubstrateDetailsDB06292DapagliflozinapprovedunknownsubstrateDetailsDB09076UmeclidiniumapprovednosubstrateDetailsDB09075EdoxabanapprovednosubstrateDetailsDB09063CeritinibapprovednosubstrateDetailsDB09078Lenvatinibapproved, investigationalnosubstrateinhibitorDetailsDB09079NintedanibapprovednosubstrateinhibitorDetailsDB09054IdelalisibapprovednosubstrateinhibitorDetailsDB09065CobicistatapprovedunknowninhibitorDetailsDB09291Rolapitantapproved, investigationalnoinhibitorDetailsDB09102Daclatasvirapproved, investigationalunknownsubstrateinhibitorDetailsDB06636Isavuconazoniumapproved, investigationalnoinhibitorDetailsDB06603Panobinostatapproved, investigationalnosubstrateDetailsDB09330OsimertinibapprovednosubstrateDetailsDB11362SelexipagapprovednosubstrateDetailsDB06403Ambrisentanapproved, investigationalunknownsubstrateDetailsDB09296Ombitasvirapproved, investigationalnosubstrateDetailsDB11574ElbasvirapprovednosubstrateinhibitorDetailsDB11575GrazoprevirapprovednosubstrateDetailsDB09161Technetium Tc-99m sestamibiapproved, investigationalnosubstrateDetailsDB11581Venetoclaxapproved, investigationalnosubstrateinhibitorDetailsDB05015Belinostatapproved, investigationalunknownsubstrateDetailsDB11613Velpatasvirapproved, investigationalnosubstrateinhibitorDetailsDB09027LedipasvirapprovednosubstratetransporterDetailsDB09198LobeglitazoneexperimentalnoDetailsDB09031Miltefosineapproved, investigationalunknownDetailsDB09280LumacaftorapprovednoinhibitorinducerDetailsDB11828Neratinibapproved, investigationalunknowninhibitorDetailsDB12026Voxilaprevirapproved, investigationalnosubstrateinhibitorDetailsDB13874Enasidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB05889Inotuzumab ozogamicinapproved, investigationalunknownsubstrateDetailsDB13878Pibrentasvirapproved, investigationalunknownsubstrateinhibitorDetailsDB13879Glecaprevirapproved, investigationalunknownsubstrateinhibitorDetailsDB12483Copanlisibapproved, investigationalunknownsubstrateDetailsDB12001Abemaciclibapproved, investigationalunknownsubstrateinhibitorDetailsDB12364Betrixabanapproved, investigationalnosubstrateDetailsDB13919CandesartanexperimentalunknowninhibitorDetailsDB12070Letermovirapproved, investigationalnosubstrateinhibitorDetailsDB12332Rucaparibapproved, investigationalnosubstrateinhibitorDetailsDB09270Ubidecarenoneapproved, investigational, nutraceuticalnosubstrateDetailsDB11827Ertugliflozinapproved, investigationalnosubstrateDetailsDB13943Testosterone cypionateapprovedunknowninhibitorDetailsDB13944Testosterone enanthateapprovedunknowninhibitorDetailsDB13946Testosterone undecanoateapproved, investigationalunknowninhibitorDetailsDB09160Technetium Tc-99m tetrofosminapprovednobinderDetailsDB13951Stanolone acetateexperimentalunknownsubstrateDetailsDB13952Estradiol acetateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13953Estradiol benzoateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13954Estradiol cypionateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13955Estradiol dienanthateapproved, investigational, vet_approvedunknownsubstrateDetailsDB13956Estradiol valerateapproved, investigational, vet_approvedunknownsubstrateDetailsDB01420Testosterone propionateapproved, investigational, vet_approved, withdrawnnosubstrateDetailsDB11901Apalutamideapproved, investigationalunknowninducerDetailsDB11633Isavuconazoleapproved, investigationalunknowninhibitorDetailsDB11251Tocopherolapproved, investigationalnotransporterDetailsDB14003alpha-Tocopherol acetateapprovednosubstrateDetailsDB09099Somatostatinapproved, investigationalunknownsubstrateDetailsDB11635TocofersolanapprovedunknownantagonistDetailsDB11641Vinflunineapproved, investigationalnosubstrateDetailsDB11672Curcuminapproved, investigationalunknowninhibitorDetailsDB11995Avatrombopagapproved, investigationalunknownsubstrateDetailsDB09297Paritaprevirapproved, investigationalunknownsubstrateDetailsDB09183DasabuvirapprovedunknownsubstrateDetailsDB00813Fentanylapproved, illicit, investigational, vet_approvedunknownDetailsDB14062Concanamycin AexperimentalyesinhibitorDetailsDB14061HycanthoneexperimentalyesinhibitorDetailsDB14063DexverapamilexperimentalyesinhibitorDetailsDB14064EmopamilexperimentalyesinhibitorDetailsDB14065LomerizineexperimentalyesinhibitorDetailsDB14066TetrandrineexperimentalunknowninhibitorDetailsDB14067Dofequidarexperimental, investigationalunknowninhibitorDetailsDB14068DexniguldipineexperimentalunknowninhibitorDetailsDB14069ONT-093investigationalyesinhibitorDetailsDB14070HM-30181experimentalyesinhibitorDetailsDB14071DesmethylsertralineexperimentalunknowninhibitorDetailsDB14072Reversin 121experimentalyesinhibitorDetailsDB14146LoxicodegolinvestigationalunknownDetailsDB14538Hydrocortisone aceponateexperimental, vet_approvedunknownDetailsDB14539Hydrocortisone acetateapproved, vet_approvedunknownDetailsDB14540Hydrocortisone butyrateapproved, vet_approvedunknownDetailsDB14541Hydrocortisone cypionateapproved, investigational, vet_approvedunknownDetailsDB14542Hydrocortisone phosphateapproved, vet_approvedunknownDetailsDB14543Hydrocortisone probutateapproved, vet_approvedunknownDetailsDB14544Hydrocortisone valerateapproved, vet_approvedunknownDetailsDB14568Ivosidenibapproved, investigationalunknownsubstrateinhibitorDetailsDB11979Elagolixapproved, investigationalunknownsubstrateinhibitorDetailsDB13867Fluticasoneapproved, experimentalnosubstrateDetailsDB00608Chloroquineapproved, investigational, vet_approvedunknownsubstrateinhibitorDetailsDB00613Amodiaquineapproved, investigationalunknowninhibitorDetailsDB01087PrimaquineapprovedunknowninhibitorDetailsDB01611HydroxychloroquineapprovedunknowninhibitorDetailsDB01267PaliperidoneapprovedunknownsubstrateinhibitorDetailsDB05928DovitinibinvestigationalunknowninhibitorDetailsDB13125Lusutrombopagapproved, investigationalunknownsubstrateDetailsDB14635Curcumin sulfateexperimentalunknownDetailsDB14641Estriol tripropionateexperimentalunknownDetailsDB11952Duvelisibapproved, investigationalnosubstrateDetailsDB09213Dexibuprofenapproved, investigationalunknownDetailsDB11760Talazoparibapproved, investigationalunknownsubstrateDetailsDB12455Omadacyclineapproved, investigationalunknownsubstrateDetailsDB12836Grapiprantinvestigational, vet_approvednosubstrateDetailsDB12035Sarecyclineapproved, investigationalunknowninhibitorDetailsDB11753Rifamycinapproved, investigationalnosubstrateinhibitorDetailsDB11963Dacomitinibapproved, investigationalnosubstrateinhibitorDetailsDB11855Revefenacinapproved, investigationalnosubstrateDetailsDB12141Gilteritinibapproved, investigationalnosubstrateDetailsDB14126Tenofovirexperimental, investigationalnosubstrateDetailsDB00300Tenofovir disoproxilapproved, investigationalunknownsubstrateinhibitorDetailsDB09299Tenofovir alafenamideapprovedunknownsubstrateDetailsDB01264DarunavirapprovedunknownsubstrateinhibitorinducerDetailsDB00203Sildenafilapproved, investigationalunknownsubstrateinhibitorDetailsDB00862VardenafilapprovedunknownsubstrateinhibitorDetailsDB00776OxcarbazepineapprovedunknownsubstrateDetailsDB00248CabergolineapprovednosubstrateDetailsDB06480PrucaloprideapprovednosubstrateDetailsDB00734Risperidoneapproved, investigationalunknownsubstrateDetailsDB01117AtovaquoneapprovednoinhibitorDetailsDB00788Naproxenapproved, vet_approvednoinhibitorDetailsDB00615Rifabutinapproved, investigationalunknowninducerDetailsDB12582PiperineinvestigationalunknowninhibitorDetailsDB11978Glasdegibapproved, investigationalnosubstrateinhibitorDetailsDB09074OlaparibapprovednosubstrateinhibitorDetailsDB00243Ranolazineapproved, investigationalnosubstrateinhibitorDetailsDB00321AmitriptylineapprovedunknownsubstrateDetailsDB00341CetirizineapprovednosubstrateinhibitorDetailsDB09073Palbociclibapproved, investigationalnosubstrateinhibitorDetailsDB01079Tegaserodapproved, investigational, withdrawnunknownsubstrateDetailsDB13867Fluticasoneapproved, experimentalunknownsubstrateDetailsDB12147Erdafitinibapproved, investigationalnosubstrateinhibitorDetailsDB00736Esomeprazoleapproved, investigationalunknownsubstrateinhibitorDetailsDB00476DuloxetineapprovedunknowninhibitorDetailsDB00481Raloxifeneapproved, investigationalunknownsubstrateDetailsDB12015Alpelisibapproved, investigationalunknowninhibitorDetailsDB11712Tezacaftorapproved, investigationalnosubstrateinhibitorDetailsDB00768OlopatadineapprovednosubstrateDetailsDB00698Nitrofurantoinapproved, vet_approvedunknownsubstrateDetailsDB00451LevothyroxineapprovednoinducerDetailsDB00394Beclomethasone dipropionateapproved, investigationalunknownsubstrateinducerDetailsDB00612BisoprololapprovedunknownsubstrateinhibitorDetailsDB00916MetronidazoleapprovedunknowninhibitorDetailsDB00482Celecoxibapproved, investigationalunknownsubstrateDetailsDB11986Entrectinibapproved, investigationalunknownsubstrateinhibitorDetailsDB12500Fedratinibapproved, investigationalunknownsubstrateinhibitorDetailsDB12825Lefamulinapproved, investigationalunknownsubstrateDetailsDB01222BudesonideapprovednosubstrateDetailsDB11757Istradefyllineapproved, investigationalunknowninhibitorDetailsDB01233Metoclopramideapproved, investigationalunknownsubstrateDetailsDB01175EscitalopramapprovedunknownsubstrateDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknowninhibitorDetailsDB01217Anastrozoleapproved, investigationalunknownsubstrateDetailsDB01195Flecainideapproved, withdrawnunknownsubstrateDetailsDB01418Acenocoumarolapproved, investigationalunknownsubstrateDetailsDB05676Apremilastapproved, investigationalunknownsubstrateDetailsDB11732Lasmiditanapproved, investigationalunknownsubstrateinhibitorDetailsDB11586Asunaprevirapproved, investigational, withdrawnunknownsubstrateinhibitorDetailsDB15444Elexacaftorapproved, investigationalnosubstrateinhibitorDetailsDB15566Prednisolone acetateapproved, vet_approvedunknownsubstrateDetailsDB15035Zanubrutinibapproved, investigationalnosubstrateDetailsDB00273TopiramateapprovedunknownsubstrateDetailsDB09237Levamlodipineapproved, investigationalunknownsubstrateDetailsDB14962Trastuzumab deruxtecanapproved, investigationalnosubstrateDetailsDB13007Enfortumab vedotinapproved, investigationalunknownsubstrateDetailsDB11951Lemborexantapproved, investigationalunknownsubstrateDetailsDB12941Darolutamideapproved, investigationalunknownsubstrateDetailsDB15091Upadacitinibapproved, investigationalnosubstrateinhibitorDetailsDB15328Ubrogepantapproved, investigationalunknownsubstrateDetailsDB15233Avapritinibapproved, investigationalunknowninhibitormodulatorDetailsDB00993AzathioprineapprovedunknownsubstrateDetailsDB00557HydroxyzineapprovedunknownsubstrateDetailsDB11077Polyethylene glycol 400approvedunknowninhibitorDetailsDB12887Tazemetostatapproved, investigationalunknownsubstrateDetailsDB01006Letrozoleapproved, investigationalunknownsubstrateDetailsDB00246ZiprasidoneapprovedunknownDetailsDB01190Clindamycinapproved, vet_approvedunknownsubstrateDetailsDB09287Polyethylene glycolapproved, vet_approvednoinhibitorDetailsDB00957Norgestimateapproved, investigationalunknowninhibitorDetailsDB11770TalinololinvestigationalunknownsubstrateDetailsDB04881ElacridarinvestigationalunknowninhibitorDetailsDB00932Tipranavirapproved, investigationalunknownsubstrateinhibitorinducerDetailsDB11869ValspodarinvestigationalunknowninhibitorDetailsDB00518Albendazoleapproved, vet_approvednosubstrateDetailsDB05239Cobimetinibapproved, investigationalnosubstrateDetailsDB06670OdanacatibinvestigationalunknownsubstrateDetailsDB04877VoacamineexperimentalnoinhibitorDetailsDB08930DolutegravirapprovednosubstrateDetailsDB00586Diclofenacapproved, vet_approvedunknowninducerDetailsDB11817Baricitinibapproved, investigationalunknownsubstrateDetailsDB11363Alectinibapproved, investigationalunknowninhibitorDetailsDB14723Larotrectinibapproved, investigationalunknownsubstrateDetailsDB00588Fluticasone propionateapprovedunknownsubstrateDetailsDB11430Monensinexperimental, vet_approvedunknownsubstrateDetailsDB03825Rhodamine 6GexperimentalunknownsubstrateDetailsDB09239NiguldipineexperimentalunknowninhibitorDetailsDB04851BiricodarinvestigationalunknowninhibitorDetailsDB06240TariquidarinvestigationalunknowninhibitorDetailsDB12799LaniquidarinvestigationalunknowninhibitorDetailsDB12923GallopamilinvestigationalunknowninhibitorDetailsDB06420AnnamycininvestigationalunknownDetailsDB00540NortriptylineapprovedunknownsubstrateDetailsDB00454MeperidineapprovedunknownsubstrateDetailsDB00652Pentazocineapproved, vet_approvedunknownsubstrateDetailsDB00818Propofolapproved, investigational, vet_approvedunknowninducerDetailsDB01590EverolimusapprovedunknownsubstrateinhibitorDetailsDB01212CeftriaxoneapprovedunknowninhibitorDetailsDB00872Conivaptanapproved, investigationalunknowninhibitorDetailsDB11544Salinomycinvet_approvedunknowninhibitorDetailsDB00909Zonisamideapproved, investigationalunknowninhibitorDetailsDB14057ValinomycinexperimentalunknownsubstrateinhibitorDetailsDB04908Flibanserinapproved, investigationalunknowninhibitorDetailsDB09039Eliglustatapproved, investigationalnosubstrateinhibitorDetailsDB01128BicalutamideapprovedunknowninhibitorDetailsDB00648MitotaneapprovedunknowninhibitorDetailsDB06448Lonafarnibapproved, investigationalnosubstrateinhibitorDetailsDB04960TipifarnibinvestigationalunknowninhibitorDetailsDB09048Netupitantapproved, investigationalunknowninhibitorDetailsDB09034Suvorexantapproved, investigationalunknownDetailsDB09030VorapaxarapprovedunknownDetailsDB05294VandetanibapprovedunknowninhibitorDetailsDB14062Concanamycin AexperimentalunknowninhibitorDetailsDB14061HycanthoneexperimentalunknowninhibitorDetailsDB08881VemurafenibapprovedunknownsubstrateinhibitorDetailsDB14063DexverapamilexperimentalunknowninhibitorDetailsDB14064EmopamilexperimentalunknowninhibitorDetailsDB14065LomerizineexperimentalunknowninhibitorDetailsDB14066TetrandrineexperimentalunknowninhibitorDetailsDB14069ONT-093investigationalunknowninhibitorDetailsDB14067Dofequidarexperimental, investigationalunknowninhibitorDetailsDB00603Medroxyprogesterone acetateapproved, investigationalunknowninhibitorDetailsDB12457Rimegepantapproved, investigationalunknownsubstrateDetailsDB12466Favipiravirapproved, investigationalunknowninhibitorDetailsDB00253MedrysoneapprovedunknownsubstrateDetailsDB09241Methylene blueapproved, investigationalunknownsubstrateinhibitorDetailsDB12612Ozanimodapproved, investigationalunknownsubstrateDetailsDB08868Fingolimodapproved, investigationalnoinhibitorDetailsDB07565Chloramphenicol succinateapprovedunknownsubstrateDetailsDB11689Selumetinibapproved, investigationalunknownsubstrateDetailsDB14631Prednisolone phosphateapproved, vet_approvedunknownsubstrateinducerDetailsDB11652Tucatinibapproved, investigationalunknownsubstrateDetailsDB15102Pemigatinibapproved, investigationalnosubstrateinhibitorDetailsDB00315Zolmitriptanapproved, investigationalnoDetailsDB14761Remdesivirapproved, investigationalunknownsubstrateDetailsDB11791Capmatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB04845Ixabepiloneapproved, investigationalunknownsubstrateinhibitorDetailsDB15685Selpercatinibapproved, investigationalunknownsubstrateinhibitorDetailsDB14840RipretinibapprovedunknownsubstrateinhibitorDetailsDB00845Clofazimineapproved, investigationalunknownsubstrateinhibitorDetailsDB09038EmpagliflozinapprovedunknownsubstrateDetailsDB06419CethromycininvestigationalunknownsubstrateinhibitorDetailsDB00674GalantamineapprovednoinhibitorDetailsDB09026Aliskirenapproved, investigationalnosubstrateDetailsDB09274Artesunateapproved, investigationalunknownsubstrateDetailsDB00188Bortezomibapproved, investigationalnosubstrateDetailsDB14669Betamethasone phosphateapproved, vet_approvedunknownsubstrateinducerDetailsDB12674Lurbinectedinapproved, investigationalunknownsubstrateinhibitorDetailsDB14649Dexamethasone acetateapproved, investigational, vet_approvedunknownsubstrateinhibitorinducerDetailsDB00104Octreotideapproved, investigationalunknownsubstrateDetailsDB11796Fostemsavirapproved, investigationalunknownsubstrateDetailsDB15719Belantamab mafodotinapprovedunknownsubstrateDetailsDB15305Risdiplamapproved, investigationalunknownsubstrateDetailsDB15822Pralsetinibapproved, investigationalnosubstrateinhibitorDetailsDB14845Filgotinibapproved, investigationalunknownsubstrateDetailsDB15982BerotralstatapprovednosubstrateinhibitorDetailsDB11853Relugolixapproved, investigationalunknownsubstrateinhibitorDetailsDB14895Vibegronapproved, investigationalnosubstrateDetailsDB01380Cortisone acetateapproved, investigationalunknownsubstrateinducerDetailsDB11632Opicaponeapproved, investigationalnosubstrateDetailsDB15456Vericiguatapproved, investigationalunknownsubstrateDetailsDB11751Cabotegravirapproved, investigationalunknownsubstrateDetailsDB11693Voclosporinapproved, investigationalunknownsubstrateinhibitorDetailsDB15133Tepotinibapproved, investigationalnosubstrateinhibitorDetailsDB00052Somatotropinapproved, investigationalunknownsubstrateDetailsDB00346Alfuzosinapproved, investigationalunknownsubstrateDetailsDB15442Trilaciclibapproved, investigationalunknownsubstrateDetailsDB14989Umbralisibapproved, investigational, withdrawnunknowninhibitorDetailsDB00391Sulpirideapproved, investigationalunknownsubstrateDetailsDB00853Temozolomideapproved, investigationalnosubstrateDetailsDB06237AvanafilapprovedunknownsubstrateDetailsDB11800Tivozanibapproved, investigationalunknownsubstrateDetailsDB00080Daptomycinapproved, investigationalnosubstrateDetailsDB06288Amisulprideapproved, investigationalnosubstrateDetailsDB08995Diosminapproved, investigationalunknowninhibitorDetailsDB04876Vildagliptinapproved, investigationalnosubstrateDetailsDB08822Azilsartan medoxomilapproved, investigationalnoinhibitorDetailsDB00360Sapropterinapproved, investigationalunknowninhibitorDetailsDB05667Levoketoconazoleapproved, investigationalnoinhibitorDetailsDB16222Loncastuximab tesirineapproved, investigationalunknownsubstrateDetailsDB15569Sotorasibapproved, investigationalunknowninhibitorDetailsDB11886Infigratinibapproved, investigationalnosubstrateinhibitorDetailsDB12471Ibrexafungerpapproved, investigationalunknownsubstratetransporterDetailsDB16703Belumosudilapproved, investigationalnosubstrateinhibitorDetailsDB16261Odevixibatapproved, investigationalunknownsubstrateDetailsDB15463Belzutifanapproved, investigationalnosubstrateDetailsDB16220Lonapegsomatropinapproved, investigationalunknownsubstrateDetailsDB16390Mobocertinibapproved, investigationalunknownsubstrateinhibitorDetailsDB16732Tisotumab vedotinapprovednosubstrateDetailsDB16098Atogepantapproved, investigationalnosubstrateDetailsDB08931RiociguatapprovednosubstrateDetailsDB15011Avacopanapproved, investigationalnosubstrateDetailsDB12597Asciminibapproved, investigationalnosubstrateinhibitorDetailsDB06234Maribavirapproved, investigationalnoinhibitorDetailsDB16691Nirmatrelvirapproved, investigationalnosubstrateinhibitorDetailsDB12713Sotagliflozinapproved, investigationalnoinhibitorDetailsDB14973Abrocitinibapproved, investigationalunknowninhibitorDetailsDB16236Mitapivatapproved, investigationalnosubstrateinhibitorDetailsDB09061Cannabidiolapproved, investigationalnoinhibitorDetailsDB14737Cannabinolexperimental, investigationalunknowninhibitorDetailsDB14009Medical Cannabisexperimental, investigationalunknowninhibitorDetailsDB11697Pacritinibapproved, investigationalnoinhibitorDetailsDB06016Cariprazineapproved, investigationalunknowninhibitorDetailsDB16407AzvudineinvestigationalunknownactivatorregulatorDetailsDB12541SAR-405838investigationalnosubstrateDetailsDB00661VerapamilapprovedunknowninhibitorblockerDetailsDB09118StiripentolapprovedunknowninhibitorDetailsDB04951Pirfenidoneapproved, investigationalunknowninhibitorDetailsDB13997Baloxavir marboxilapproved, investigationalunknownsubstrateinhibitorDetailsDB15673Lenacapavirapproved, investigationalnosubstrateDetailsDB16650Deucravacitinibapproved, investigationalunknownsubstrateDetailsDB12095Telotristat ethylapproved, investigationalnosubstrateinhibitorDetailsDB15149Futibatinibapproved, investigationalnosubstrateinhibitorDetailsDB11739Vonoprazanapproved, investigationalunknowninhibitorDetailsDB11793Niraparibapproved, investigationalnosubstrateDetailsDB12489Mirvetuximab soravtansineapproved, investigationalnosubstrateDetailsDB16267Olutasidenibapproved, investigationalnoinhibitorDetailsDB12240Polatuzumab vedotinapproved, investigationalnosubstrateDetailsDB15568Adagrasibapproved, investigationalunknowninhibitorDetailsDB12236Bexagliflozinapproved, investigationalunknownsubstrateDetailsDB17472Pirtobrutinibapproved, investigationalunknownsubstrateinhibitorDetailsDB06374Elacestrantapproved, investigationalunknowninhibitorDetailsDB00683Midazolamapproved, illicitnosubstrateDetailsDB12548Sparsentanapproved, investigationalunknownsubstrateinhibitorDetailsDB15688Zavegepantapproved, investigationalunknownsubstrateDetailsDB16217Leniolisibapproved, investigationalnosubstrateDetailsDB01238Aripiprazoleapproved, investigationalunknowninhibitorDetailsDB09082VilanterolapprovednosubstrateDetailsDB12874Quizartinibapproved, investigationalnosubstrateinhibitorDetailsDB11763Momelotinibapproved, investigationalunknownsubstrateDetailsDB11718Encorafenibapproved, investigationalnosubstrateinhibitorDetailsDB15097Gefapixantapproved, investigationalnosubstrateDetailsDB11967Binimetinibapproved, investigationalnosubstrateDetailsDB16826RepotrectinibinvestigationalnosubstrateinhibitorDetails"
                    }
                }
            ]
        },
        "Disease Information": {
            "Erectile Dysfunction": "Erectile dysfunction (ED), also referred to as impotence, is a form of sexual dysfunction in males characterized by the persistent or recurring inability to achieve or maintain a penile erection with sufficient rigidity and duration for satisfactory sexual activity. It is the most common sexual problem in males and can cause psychological distress due to its impact on self-image and sexual relationships.\nMajority of ED cases are attributed to physical risk factors and predictive factors. These factors can be categorized as vascular, neurological, local penile, hormonal, and drug-induced. Notable predictors of ED include aging, cardiovascular disease, diabetes mellitus, high blood pressure, obesity, abnormal lipid levels in the blood, hypogonadism, smoking, depression, and medication use. Approximately 10% of cases are linked to psychosocial factors, encompassing conditions like depression, stress, and problems within relationships.[14]\n",
            "NYHA Functional Class II-III Pulmonary arterial hypertension": null,
            "Premature Ejaculation": "Premature ejaculation (PE) occurs when a man expels semen (and most likely experiences orgasm) soon after beginning sexual activity, and with minimal penile stimulation. It has also been called early ejaculation, rapid ejaculation, rapid climax, premature climax and (historically) ejaculatio praecox. There is no uniform cut-off defining \"premature\", but a consensus of experts at the International Society for Sexual Medicine endorsed a definition of around one minute after penetration.[1] The International Classification of Diseases (ICD-10) applies a cut-off of 15 seconds from the beginning of sexual intercourse.[1]\n",
            "Pulmonary Arterial Hypertension": "Pulmonary hypertension (PH or PHTN) is a condition of increased blood pressure in the arteries of the lungs.[7] Symptoms include shortness of breath, fainting, tiredness, chest pain, swelling of the legs, and a fast heartbeat.[7][2] The condition may make it difficult to exercise.[7] Onset is typically gradual.[8]\nAccording to the definition at the 6th World Symposium of Pulmonary Hypertension in 2018, a patient is deemed to have pulmonary hypertension if the pulmonary mean arterial pressure is greater than 20mmHg at rest, revised down from a purely arbitrary 25mmHg, and pulmonary vascular resistance (PVR) greater than 3 Wood units.\n"
        }
    }
}